Citrus Sinensis ID: 004020
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 779 | 2.2.26 [Sep-21-2011] | |||||||
| P43298 | 942 | Probable receptor protein | no | no | 0.948 | 0.784 | 0.610 | 0.0 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.863 | 0.557 | 0.292 | 1e-71 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.863 | 0.557 | 0.292 | 2e-71 | |
| Q9FN37 | 1036 | Phytosulfokine receptor 2 | no | no | 0.858 | 0.645 | 0.303 | 1e-66 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.854 | 0.558 | 0.311 | 1e-64 | |
| O22476 | 1196 | Protein BRASSINOSTEROID I | no | no | 0.872 | 0.568 | 0.293 | 8e-62 | |
| Q9LJF3 | 1164 | Receptor-like protein kin | no | no | 0.827 | 0.554 | 0.303 | 4e-60 | |
| Q9ZWC8 | 1166 | Serine/threonine-protein | no | no | 0.815 | 0.544 | 0.308 | 1e-59 | |
| C0LGP4 | 1010 | Probable LRR receptor-lik | no | no | 0.812 | 0.626 | 0.282 | 3e-57 | |
| C0LGJ1 | 1106 | Probable LRR receptor-lik | no | no | 0.799 | 0.563 | 0.284 | 4e-57 |
| >sp|P43298|TMK1_ARATH Probable receptor protein kinase TMK1 OS=Arabidopsis thaliana GN=TMK1 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 887 bits (2291), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 460/753 (61%), Positives = 564/753 (74%), Gaps = 14/753 (1%)
Query: 24 SQSSSDAAAMQALKTSLGNPASLGWTDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPK 83
+ S D +AM +LK SL P+S GW+DPDPCKW HI C+ + RVTRIQIG ++GTL
Sbjct: 23 ADSDGDLSAMLSLKKSLNPPSSFGWSDPDPCKWTHIVCTGTKRVTRIQIGHSGLQGTLSP 82
Query: 84 ELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143
+L +LS L LE+ N ++G +PSLSGL+SLQ ++ +NNF S+PSD F+GLTSLQ++ +
Sbjct: 83 DLRNLSELERLELQWNNISGPVPSLSGLASLQVLMLSNNNFDSIPSDVFQGLTSLQSVEI 142
Query: 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPI 203
D N F SW IPESL++A+ LQ FSAN AN++G++P FLG D PGL LHLAFN L+G +
Sbjct: 143 DNNPFKSWEIPESLRNASALQNFSANSANVSGSLPGFLGPDEFPGLSILHLAFNNLEGEL 202
Query: 204 PLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQ 263
P+S S +Q+LWLNGQK L G + V+QNMT L ++WLH N F+GPLPD SGL L+
Sbjct: 203 PMSLAGSQVQSLWLNGQK----LTGDITVLQNMTGLKEVWLHSNKFSGPLPDFSGLKELE 258
Query: 264 DFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDA 323
S+RDN TG VP+SL++L SL VVNLTNN QG P F S V D+ K SNSFCL
Sbjct: 259 SLSLRDNSFTGPVPASLLSLESLKVVNLTNNHLQGPVPVFKSSVSVDLDKDSNSFCLSSP 318
Query: 324 GVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLS 383
G CD RV LL I S YP LAESWKGN+PC ++W G++C + GNITV++L+ + L+
Sbjct: 319 G-ECDPRVKSLLLIASSFDYPPRLAESWKGNDPC-TNWIGIAC-SNGNITVISLEKMELT 375
Query: 384 GTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQNVIV 443
GTIS F + SL++++L N LTG IP+ELTTLP+L+ LDVS+N LFGKVP FR NV+V
Sbjct: 376 GTISPEFGAIKSLQRIILGINNLTGMIPQELTTLPNLKTLDVSSNKLFGKVPGFRSNVVV 435
Query: 444 KTDGNPDIGKDSSSFTPKSPPGSSPTPPGGDSGGNGSSGGANKNSNTGKIVGSVVGVVCG 503
T+GNPDIGKD SS + S G G+ G ++ G IVGSV+G +
Sbjct: 436 NTNGNPDIGKDKSSLSSPGSSSPSGGS-GSGINGDKDRRGMKSSTFIGIIVGSVLGGLLS 494
Query: 504 AFIVGL-GFCLYTRKRKRSGRVQSPNAVVIHPSNGG-DGNAVKITVTESSVTGGG-SESQ 560
F++GL FC Y +++KR +S NAVV+HP + G D +VKITV SSV+ GG S++
Sbjct: 495 IFLIGLLVFCWYKKRQKRFSGSESSNAVVVHPRHSGSDNESVKITVAGSSVSVGGISDTY 554
Query: 561 SL--TSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIA 618
+L TS ++ +VEAG+M+ISIQVLR+VTNNFS +N+LG GGFG VYKGELHDGTKIA
Sbjct: 555 TLPGTSEVGDNIQMVEAGNMLISIQVLRSVTNNFSSDNILGSGGFGVVYKGELHDGTKIA 614
Query: 619 VKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRH 678
VKRME+ V++ KGFAEFKSEIAVLTKVRHRHLV LLGYCLDGNE+LLVYEYMPQGTLSRH
Sbjct: 615 VKRMENGVIAGKGFAEFKSEIAVLTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQGTLSRH 674
Query: 679 LFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 738
LF EEGLKPL W +RLT+ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA
Sbjct: 675 LFEWSEEGLKPLLWKQRLTLALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 734
Query: 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAA 771
DFGLVRLAP+ GK SIETR+AGTFGYLAPEYA
Sbjct: 735 DFGLVRLAPE-GKGSIETRIAGTFGYLAPEYAV 766
|
Probable receptor. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 271 bits (694), Expect = 1e-71, Method: Compositional matrix adjust.
Identities = 233/796 (29%), Positives = 369/796 (46%), Gaps = 123/796 (15%)
Query: 63 PSNRVTRIQIGGQNIEGTLPKELNSLSSLTV-LEVMKNKLTGQIP-SLSGLSSLQEVLFD 120
PS + + + G + +G P +L L V L++ N +G +P SL SSL+ V
Sbjct: 301 PSESLQYLYLRGNDFQGVYPNQLADLCKTVVELDLSYNNFSGMVPESLGECSSLELVDIS 360
Query: 121 DNNFT-SVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD 179
+NNF+ +P D L++++T+ L +N F +P+S + L+ + N+TG IP
Sbjct: 361 NNNFSGKLPVDTLLKLSNIKTMVLSFNKFVGG-LPDSFSNLPKLETLDMSSNNLTGIIPS 419
Query: 180 FLGGDT-----------------IPG-------LMHLHLAFNFLQGPIPLSFG---KSSI 212
+ D IP L+ L L+FN+L G IP S G K
Sbjct: 420 GICKDPMNNLKVLYLQNNLFKGPIPDSLSNCSQLVSLDLSFNYLTGSIPSSLGSLSKLKD 479
Query: 213 QTLWLNGQKGDSKLNGSV-AVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDN 270
LWLN +L+G + + + +L L L N TGP+P LS + L S+ +N
Sbjct: 480 LILWLN------QLSGEIPQELMYLQALENLILDFNDLTGPIPASLSNCTKLNWISLSNN 533
Query: 271 QLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK-----------------FNSPVRFDMAK 313
QL+G +P+SL L +LA++ L NN G P N + + K
Sbjct: 534 QLSGEIPASLGRLSNLAILKLGNNSISGNIPAELGNCQSLIWLDLNTNFLNGSIPPPLFK 593
Query: 314 GSNSFCL------------DDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSD- 360
S + + +D C G N+L + G + +PCN
Sbjct: 594 QSGNIAVALLTGKRYVYIKNDGSKECHGAGNLL----EFGGIRQEQLDRISTRHPCNFTR 649
Query: 361 -WKGVS---CDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTT 416
++G++ + G++ ++L L G+I + L L L N+L+G IP++L
Sbjct: 650 VYRGITQPTFNHNGSMIFLDLSYNKLEGSIPKELGAMYYLSILNLGHNDLSGMIPQQLGG 709
Query: 417 LPSLEMLDVSNNHLFGKVPNFRQNVIVKTDGNPDIGKDS-SSFTPKSPPGSS-------- 467
L ++ +LD+S N G +PN ++ + G D+ ++ S P+S P +
Sbjct: 710 LKNVAILDLSYNRFNGTIPNSLTSLTLL--GEIDLSNNNLSGMIPESAPFDTFPDYRFAN 767
Query: 468 ------PTPPGGDSGGNGSSGGANKNSNTGKIVGSVVGVVCGAFIVGLGFCLY------- 514
P P S G AN++ + + S+ G V + L FC++
Sbjct: 768 NSLCGYPLPLPCSS---GPKSDANQHQKSHRRQASLAGSVAMGLLFSL-FCIFGLIIVAI 823
Query: 515 -TRKRKRSGRVQSPNAVVIHPSNGGDGNAVKITVTESSVTGGGSESQSLTSSGPSDLHVV 573
T+KR+R + H + +A K T +++ +L
Sbjct: 824 ETKKRRRKKEAALEAYMDGHSHSATANSAWKFTSAREALS--------------INLAAF 869
Query: 574 EAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFA 633
E ++ L TN F ++++G GGFG VYK +L DG+ +A+K++ VS +G
Sbjct: 870 EKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKL--IHVSGQGDR 927
Query: 634 EFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWT 693
EF +E+ + K++HR+LV LLGYC G ERLLVYEYM G+L L +RK+ G+K L W
Sbjct: 928 EFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKTGIK-LNWP 986
Query: 694 RRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753
R IA+ ARG+ +LH IHRD+K SN+LL +++ A+V+DFG+ RL H
Sbjct: 987 ARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHL 1046
Query: 754 IETRLAGTFGYLAPEY 769
+ LAGT GY+ PEY
Sbjct: 1047 SVSTLAGTPGYVPPEY 1062
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 271 bits (692), Expect = 2e-71, Method: Compositional matrix adjust.
Identities = 233/796 (29%), Positives = 368/796 (46%), Gaps = 123/796 (15%)
Query: 63 PSNRVTRIQIGGQNIEGTLPKELNSLSSLTV-LEVMKNKLTGQIP-SLSGLSSLQEVLFD 120
PS + + + G + +G P +L L V L++ N +G +P SL SSL+ V
Sbjct: 301 PSESLQYLYLRGNDFQGVYPNQLADLCKTVVELDLSYNNFSGMVPESLGECSSLELVDIS 360
Query: 121 DNNFT-SVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD 179
NNF+ +P D L++++T+ L +N F +P+S + L+ + N+TG IP
Sbjct: 361 YNNFSGKLPVDTLSKLSNIKTMVLSFNKFVGG-LPDSFSNLLKLETLDMSSNNLTGVIPS 419
Query: 180 FLGGDT-----------------IPG-------LMHLHLAFNFLQGPIPLSFG---KSSI 212
+ D IP L+ L L+FN+L G IP S G K
Sbjct: 420 GICKDPMNNLKVLYLQNNLFKGPIPDSLSNCSQLVSLDLSFNYLTGSIPSSLGSLSKLKD 479
Query: 213 QTLWLNGQKGDSKLNGSV-AVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDN 270
LWLN +L+G + + + +L L L N TGP+P LS + L S+ +N
Sbjct: 480 LILWLN------QLSGEIPQELMYLQALENLILDFNDLTGPIPASLSNCTKLNWISLSNN 533
Query: 271 QLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK-----------------FNSPVRFDMAK 313
QL+G +P+SL L +LA++ L NN G P N + + K
Sbjct: 534 QLSGEIPASLGRLSNLAILKLGNNSISGNIPAELGNCQSLIWLDLNTNFLNGSIPPPLFK 593
Query: 314 GSNSFCL------------DDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSD- 360
S + + +D C G N+L + G + +PCN
Sbjct: 594 QSGNIAVALLTGKRYVYIKNDGSKECHGAGNLL----EFGGIRQEQLDRISTRHPCNFTR 649
Query: 361 -WKGVS---CDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTT 416
++G++ + G++ ++L L G+I + L L L N+L+G IP++L
Sbjct: 650 VYRGITQPTFNHNGSMIFLDLSYNKLEGSIPKELGAMYYLSILNLGHNDLSGMIPQQLGG 709
Query: 417 LPSLEMLDVSNNHLFGKVPNFRQNVIVKTDGNPDIGKDS-SSFTPKSPPGSS-------- 467
L ++ +LD+S N G +PN ++ + G D+ ++ S P+S P +
Sbjct: 710 LKNVAILDLSYNRFNGTIPNSLTSLTLL--GEIDLSNNNLSGMIPESAPFDTFPDYRFAN 767
Query: 468 ------PTPPGGDSGGNGSSGGANKNSNTGKIVGSVVGVVCGAFIVGLGFCLY------- 514
P P S G AN++ + + S+ G V + L FC++
Sbjct: 768 NSLCGYPLPIPCSS---GPKSDANQHQKSHRRQASLAGSVAMGLLFSL-FCIFGLIIVAI 823
Query: 515 -TRKRKRSGRVQSPNAVVIHPSNGGDGNAVKITVTESSVTGGGSESQSLTSSGPSDLHVV 573
T+KR+R + H + +A K T +++ +L
Sbjct: 824 ETKKRRRKKEAALEAYMDGHSHSATANSAWKFTSAREALS--------------INLAAF 869
Query: 574 EAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFA 633
E ++ L TN F ++++G GGFG VYK +L DG+ +A+K++ VS +G
Sbjct: 870 EKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKL--IHVSGQGDR 927
Query: 634 EFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWT 693
EF +E+ + K++HR+LV LLGYC G ERLLVYEYM G+L L +RK+ G+K L W
Sbjct: 928 EFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKIGIK-LNWP 986
Query: 694 RRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753
R IA+ ARG+ +LH IHRD+K SN+LL +++ A+V+DFG+ RL H
Sbjct: 987 ARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHL 1046
Query: 754 IETRLAGTFGYLAPEY 769
+ LAGT GY+ PEY
Sbjct: 1047 SVSTLAGTPGYVPPEY 1062
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FN37|PSKR2_ARATH Phytosulfokine receptor 2 OS=Arabidopsis thaliana GN=PSKR2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 254 bits (650), Expect = 1e-66, Method: Compositional matrix adjust.
Identities = 232/764 (30%), Positives = 359/764 (46%), Gaps = 95/764 (12%)
Query: 61 CSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQI-PSLSGLSSLQEVLF 119
CS S + ++ I + G LP L S+ L L + N L+G++ +LS LS L+ +L
Sbjct: 206 CSKS--IQQLHIDSNRLTGQLPDYLYSIRELEQLSLSGNYLSGELSKNLSNLSGLKSLLI 263
Query: 120 DDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD 179
+N F+ V D F LT L+ + + N F S P SL + L+ +++G+I
Sbjct: 264 SENRFSDVIPDVFGNLTQLEHLDVSSNKF-SGRFPPSLSQCSKLRVLDLRNNSLSGSINL 322
Query: 180 FLGGDTIPGLMHLHLAFNFLQGPIPLSFG---KSSIQTLWLNGQKGD------------- 223
G T L L LA N GP+P S G K I +L N +G
Sbjct: 323 NFTGFT--DLCVLDLASNHFSGPLPDSLGHCPKMKILSLAKNEFRGKIPDTFKNLQSLLF 380
Query: 224 --------SKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTG 274
+ ++ V+Q+ +L+ L L N +P+ ++G +L ++ + L G
Sbjct: 381 LSLSNNSFVDFSETMNVLQHCRNLSTLILSKNFIGEEIPNNVTGFDNLAILALGNCGLRG 440
Query: 275 IVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVL 334
+PS L+N L V++L+ N F G P + + K + F +D + G + V
Sbjct: 441 QIPSWLLNCKKLEVLDLSWNHFYGTIPHW-------IGKMESLFYIDFSNNTLTGAIPVA 493
Query: 335 LSIVKSV----GYPAVLAES------WKGNNPCNSDWKGVSCDAGGNIT-VVNLKNLGLS 383
++ +K++ G + + +S K N N G+ + + L N L+
Sbjct: 494 ITELKNLIRLNGTASQMTDSSGIPLYVKRNKSSN----GLPYNQVSRFPPSIYLNNNRLN 549
Query: 384 GTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQNVIV 443
GTI RL L L LS N TGTIP ++ L +LE+LD+S NHL+G +P Q++
Sbjct: 550 GTILPEIGRLKELHMLDLSRNNFTGTIPDSISGLDNLEVLDLSYNHLYGSIPLSFQSLTF 609
Query: 444 ---------KTDGNPDIGKDSSSFTPKSPPGSSPTPPGGDSGGN-------GSSGGANKN 487
+ G G SF S G+ DS + G + +N
Sbjct: 610 LSRFSVAYNRLTGAIPSGGQFYSFPHSSFEGNLGLCRAIDSPCDVLMSNMLNPKGSSRRN 669
Query: 488 SNTGKIVGSVVGVVCGAFIVGLGFCLYTRKRKRSGRVQSPNAVVIHPSNGGDGNAVKITV 547
+N GK S + V+ + +G+ L +V++ + D + V
Sbjct: 670 NNGGKFGRSSIVVLTISLAIGITLLL---------------SVILLRISRKDVDDRINDV 714
Query: 548 TESSVTGGGSESQSLTSSGPSDLHVVEA-GSMVISIQVLRNVTNNFSEENVLGRGGFGTV 606
E +++G S++L GPS + + + G +S++ L TNNFS+ N++G GGFG V
Sbjct: 715 DEETISG---VSKAL---GPSKIVLFHSCGCKDLSVEELLKSTNNFSQANIIGCGGFGLV 768
Query: 607 YKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666
YK DG+K AVKR+ + EF++E+ L++ H++LV L GYC GN+RLL+
Sbjct: 769 YKANFPDGSKAAVKRLSGDCGQME--REFQAEVEALSRAEHKNLVSLQGYCKHGNDRLLI 826
Query: 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSN 726
Y +M G+L L R + G L W RL IA ARG+ YLH + + IHRD+K SN
Sbjct: 827 YSFMENGSLDYWLHERVD-GNMTLIWDVRLKIAQGAARGLAYLHKVCEPNVIHRDVKSSN 885
Query: 727 ILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYA 770
ILL + A +ADFGL RL H + T L GT GY+ PEY+
Sbjct: 886 ILLDEKFEAHLADFGLARLLRPYDTH-VTTDLVGTLGYIPPEYS 928
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 248 bits (633), Expect = 1e-64, Method: Compositional matrix adjust.
Identities = 240/771 (31%), Positives = 355/771 (46%), Gaps = 105/771 (13%)
Query: 64 SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNN 123
S + I + G + GT+ + + SSL L + N++ G IP L + D NN
Sbjct: 376 SGSLEAIDLSGNLLSGTIEEVFDGCSSLGELLLTNNQINGSIPEDLWKLPLMALDLDSNN 435
Query: 124 FT-SVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLG 182
FT +P +K T+L + YN + + +P + +A L+R + +TG IP +G
Sbjct: 436 FTGEIPKSLWKS-TNLMEFTASYNRLEGY-LPAEIGNAASLKRLVLSDNQLTGEIPREIG 493
Query: 183 GDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVA-VIQNMTSLT 240
T L L+L N QG IP+ G +S+ TL L G + L G + I + L
Sbjct: 494 KLT--SLSVLNLNANMFQGKIPVELGDCTSLTTLDL----GSNNLQGQIPDKITALAQLQ 547
Query: 241 QLWLHGNSFTG-------------PLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLA 287
L L N+ +G +PDLS L F + N+L+G +P L L
Sbjct: 548 CLVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLV 607
Query: 288 VVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVL 347
++L+NN G+ P +++ +N LD +G A G SI K +G L
Sbjct: 608 EISLSNNHLSGEIPA-------SLSRLTNLTILDLSGNALTG------SIPKEMGNSLKL 654
Query: 348 AESWKGNNPCNSDWKGVSCDAGG--------NIT-----------VVNLKNL-------- 380
+G N N+ G ++ G N+T + NLK L
Sbjct: 655 ----QGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFN 710
Query: 381 GLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQN 440
LSG +SS S + L L + N+ TG IP EL L LE LDVS N L G++P
Sbjct: 711 NLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIP----- 765
Query: 441 VIVKTDGNPDIGKDSSSFTPKSPPGSSPT------PPGGDSGGNGSSGGANKNSNTGKIV 494
K G P++ + + + G P+ P GN G S+ KI
Sbjct: 766 --TKICGLPNL--EFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVVGSDC-KIE 820
Query: 495 GS-------VVGVVCGAFIVGLGFCLYTRKRKRSGRVQSPNAVVIHPSNGGDGNAVKITV 547
G+ + G++ G I+ F R+ + RV+ + P + +K V
Sbjct: 821 GTKLRSAWGIAGLMLGFTIIVFVFVFSLRRWAMTKRVKQRD----DPERMEESR-LKGFV 875
Query: 548 TESSVTGGGSESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVY 607
++ GS S+ S ++ + E + + + + T++FS++N++G GGFGTVY
Sbjct: 876 DQNLYFLSGSRSREPLSI---NIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVY 932
Query: 608 KGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667
K L +AVK++ A +G EF +E+ L KV+H +LV LLGYC E+LLVY
Sbjct: 933 KACLPGEKTVAVKKLSEA--KTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVY 990
Query: 668 EYMPQGTLSRHLFNRKEEG-LKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSN 726
EYM G+L L R + G L+ L+W++RL IA+ ARG+ +LH IHRD+K SN
Sbjct: 991 EYMVNGSLDHWL--RNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASN 1048
Query: 727 ILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMT 777
ILL D KVADFGL RL H + T +AGTFGY+ PEY T
Sbjct: 1049 ILLDGDFEPKVADFGLARLISACESH-VSTVIAGTFGYIPPEYGQSARATT 1098
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 239 bits (609), Expect = 8e-62, Method: Compositional matrix adjust.
Identities = 225/767 (29%), Positives = 356/767 (46%), Gaps = 87/767 (11%)
Query: 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDN 122
+ +T + + G + G +P S S L L + N +G++P +L + L+ + N
Sbjct: 316 DTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFN 375
Query: 123 NFT-SVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATG-LQRFSANGANITGTIPDF 180
F+ +P SL T+ L N+F ++P ++ LQ TG IP
Sbjct: 376 EFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPT 435
Query: 181 LGGDTIPGLMHLHLAFNFLQGPIPLSFG---KSSIQTLWLNGQKGDSKLNGSVAVIQNMT 237
L L+ LHL+FN+L G IP S G K LWLN +G+ + +
Sbjct: 436 LS--NCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIP-----QELMYVK 488
Query: 238 SLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLF 296
+L L L N TG +P LS ++L S+ +N+LTG +P + L +LA++ L+NN F
Sbjct: 489 TLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSF 548
Query: 297 QGQTPK-----------------FNSPVRFDMAKGSNSFCL-------------DDAGVA 326
G P FN + M K S D
Sbjct: 549 SGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKE 608
Query: 327 CDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWK------GVSCDAGGNITVVNLKNL 380
C G N+L + G + NPCN + + D G++ +++
Sbjct: 609 CHGAGNLL----EFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYN 664
Query: 381 GLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQN 440
LSG I + L L L N+++G+IP E+ L L +LD+S+N L G++P
Sbjct: 665 MLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSA 724
Query: 441 VIVKTDGN----------PDIGKDSSSFTPK---SPPGSSPTP-PGGDSGGNGSSGGANK 486
+ + T+ + P++G+ +F P + PG P P D + + G A+
Sbjct: 725 LTMLTEIDLSNNNLSGPIPEMGQ-FETFPPAKFLNNPGLCGYPLPRCDP--SNADGYAHH 781
Query: 487 NSNTGK----IVGSVVGVVCGAFIVGLGFCLYTRKRKRSGRVQSPNAVVIHPSNGGDGNA 542
+ G+ + GSV + +F+ G L R+ ++ R + + +G G+
Sbjct: 782 QRSHGRRPASLAGSVAMGLLFSFVCIFGLILVGREMRKRRRKKEAELEMYAEGHGNSGDR 841
Query: 543 VKITVTESSVTGGGSESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGG 602
T +TG E+ S+ +L E ++ L TN F ++++G GG
Sbjct: 842 TA-NNTNWKLTGV-KEALSI------NLAAFEKPLRKLTFADLLQATNGFHNDSLIGSGG 893
Query: 603 FGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662
FG VYK L DG+ +A+K++ VS +G EF +E+ + K++HR+LV LLGYC G+E
Sbjct: 894 FGDVYKAILKDGSAVAIKKL--IHVSGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGDE 951
Query: 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDL 722
RLLVYE+M G+L L + K+ G+K L W+ R IA+ ARG+ +LH IHRD+
Sbjct: 952 RLLVYEFMKYGSLEDVLHDPKKAGVK-LNWSTRRKIAIGSARGLAFLHHNCSPHIIHRDM 1010
Query: 723 KPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEY 769
K SN+LL +++ A+V+DFG+ RL H + LAGT GY+ PEY
Sbjct: 1011 KSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEY 1057
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 233 bits (595), Expect = 4e-60, Method: Compositional matrix adjust.
Identities = 225/741 (30%), Positives = 345/741 (46%), Gaps = 96/741 (12%)
Query: 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQ-----EVLFD 120
R+T + + NI G++P L + S+L VL++ N+ TG++PS G SLQ E L
Sbjct: 352 RITNLYLPFNNISGSVPISLTNCSNLRVLDLSSNEFTGEVPS--GFCSLQSSSVLEKLLI 409
Query: 121 DNNFTS--VPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIP 178
NN+ S VP + K SL+TI L +N+ + +IP+ + L N+TG IP
Sbjct: 410 ANNYLSGTVPVELGK-CKSLKTIDLSFNAL-TGLIPKEIWTLPKLSDLVMWANNLTGGIP 467
Query: 179 DFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTS 238
+ + D L L L N L G +P S K + LW++
Sbjct: 468 ESICVDG-GNLETLILNNNLLTGSLPESISKCT-NMLWIS-------------------- 505
Query: 239 LTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
L N TG +P + L L + +N LTG +PS L N +L ++L +N
Sbjct: 506 -----LSSNLLTGEIPVGIGKLEKLAILQLGNNSLTGNIPSELGNCKNLIWLDLNSNNLT 560
Query: 298 GQTPKFNSPVRFDMAKGSNS-----FCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWK 352
G P + + GS S F ++ G C G +V+ G A E +
Sbjct: 561 GNLPGELASQAGLVMPGSVSGKQFAFVRNEGGTDCRGAG----GLVEFEGIRAERLEHFP 616
Query: 353 GNNPC--NSDWKGVSC---DAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELT 407
+ C + G++ + G++ ++L +SG+I + + L+ L L N LT
Sbjct: 617 MVHSCPKTRIYSGMTMYMFSSNGSMIYLDLSYNAVSGSIPLGYGAMGYLQVLNLGHNLLT 676
Query: 408 GTIPKELTTLPSLEMLDVSNNHLFGKVP------NFRQNVIVKTD---GNPDIGKDSSSF 458
GTIP L ++ +LD+S+N L G +P +F ++ V + G G ++F
Sbjct: 677 GTIPDSFGGLKAIGVLDLSHNDLQGFLPGSLGGLSFLSDLDVSNNNLTGPIPFGGQLTTF 736
Query: 459 TPKSPPGSS-----PTPPGGDSGGNGSSGGANKNSN---TGKIVGSVVGVVCGAFIVGLG 510
+S P PP SG + A+ TG G V +C IV L
Sbjct: 737 PLTRYANNSGLCGVPLPP-CSSGSRPTRSHAHPKKQSIATGMSAGIVFSFMC---IVMLI 792
Query: 511 FCLYTRKRKRSGRVQSPNAVVIHPSNGGDGNAVKITVTESSVTGGGSES--QSLTSSGPS 568
LY ++ + Q + P++G + S+ E + LT +
Sbjct: 793 MALYRARKVQKKEKQREKYIESLPTSGSSSWKLSSVHEPLSINVATFEKPLRKLTFA--- 849
Query: 569 DLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVS 628
H++EA TN FS ++++G GGFG VYK +L DG+ +A+K++ V+
Sbjct: 850 --HLLEA-------------TNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKL--IQVT 892
Query: 629 EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLK 688
+G EF +E+ + K++HR+LV LLGYC G ERLLVYEYM G+L L + ++G
Sbjct: 893 GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKTKKGGI 952
Query: 689 PLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748
L+W+ R IA+ ARG+ +LH IHRD+K SN+LL D A+V+DFG+ RL
Sbjct: 953 FLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMARLVSA 1012
Query: 749 NGKHSIETRLAGTFGYLAPEY 769
H + LAGT GY+ PEY
Sbjct: 1013 LDTHLSVSTLAGTPGYVPPEY 1033
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 232 bits (591), Expect = 1e-59, Method: Compositional matrix adjust.
Identities = 232/751 (30%), Positives = 334/751 (44%), Gaps = 116/751 (15%)
Query: 67 VTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQ-----EVLFDD 121
+T + + NI G++P L + S+L VL++ N TG +PS G SLQ E +
Sbjct: 353 ITYLYVAYNNISGSVPISLTNCSNLRVLDLSSNGFTGNVPS--GFCSLQSSPVLEKILIA 410
Query: 122 NNFTS--VPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD 179
NN+ S VP + K SL+TI L +N + IP+ + L N+TGTIP+
Sbjct: 411 NNYLSGTVPMELGK-CKSLKTIDLSFNEL-TGPIPKEIWMLPNLSDLVMWANNLTGTIPE 468
Query: 180 FLGGDTIPG--LMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMT 237
G + G L L L N L G IP S I T
Sbjct: 469 ---GVCVKGGNLETLILNNNLLTGSIPES--------------------------ISRCT 499
Query: 238 SLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLF 296
++ + L N TG +P + LS L + +N L+G VP L N SL ++L +N
Sbjct: 500 NMIWISLSSNRLTGKIPSGIGNLSKLAILQLGNNSLSGNVPRQLGNCKSLIWLDLNSNNL 559
Query: 297 QGQTPKFNSPVRFDMAKGSNS-----FCLDDAGVACDG----------------RVNVLL 335
G P + + GS S F ++ G C G R+ ++
Sbjct: 560 TGDLPGELASQAGLVMPGSVSGKQFAFVRNEGGTDCRGAGGLVEFEGIRAERLERLPMVH 619
Query: 336 SIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDA--------GGNITVVNLKNLG---LSG 384
S + Y + ++ N + + +S +A GN+ + + NLG ++G
Sbjct: 620 SCPATRIYSGMTMYTFSANG--SMIYFDISYNAVSGFIPPGYGNMGYLQVLNLGHNRITG 677
Query: 385 TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQNVIVK 444
TI +F L ++ L LS N L G +P L +L L LDVSNN+L G +P Q
Sbjct: 678 TIPDSFGGLKAIGVLDLSHNNLQGYLPGSLGSLSFLSDLDVSNNNLTGPIPFGGQLTTFP 737
Query: 445 TDGNPDIGKDSSSFTPKSPPGSSPTPPGGDSGGNGSSGGANKNS-NTGKIVGSVVGVVCG 503
+ P P GS+P P S A K + T I G +C
Sbjct: 738 VSRYAN--NSGLCGVPLRPCGSAPRRP------ITSRIHAKKQTVATAVIAGIAFSFMCF 789
Query: 504 AFIVGLGFCLYTRKRKRSGRVQSPNAVVIHPSNGGDGNAVKITVTESSVTGGGSESQSLT 563
+V LY R RK + Q + S+ GS S L
Sbjct: 790 VMLV---MALY-RVRKVQKKEQKREKYI------------------ESLPTSGSCSWKL- 826
Query: 564 SSGPSDLHV----VEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAV 619
SS P L + E ++ L TN FS E ++G GGFG VYK +L DG+ +A+
Sbjct: 827 SSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQLRDGSVVAI 886
Query: 620 KRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHL 679
K++ ++ +G EF +E+ + K++HR+LV LLGYC G ERLLVYEYM G+L L
Sbjct: 887 KKL--IRITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVL 944
Query: 680 FNRK-EEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 738
+ ++G L W R IA+ ARG+ +LH IHRD+K SN+LL +D A+V+
Sbjct: 945 HEKSSKKGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVS 1004
Query: 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEY 769
DFG+ RL H + LAGT GY+ PEY
Sbjct: 1005 DFGMARLVSALDTHLSVSTLAGTPGYVPPEY 1035
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 224 bits (570), Expect = 3e-57, Method: Compositional matrix adjust.
Identities = 227/803 (28%), Positives = 350/803 (43%), Gaps = 170/803 (21%)
Query: 67 VTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPS-LSGLSSLQEVLFDDNNFT 125
+ ++ + G N+ G LP L +L+ L L + N L G+IPS ++ L+ + + NNF+
Sbjct: 164 LVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFS 223
Query: 126 SVPSDFFKGLTSLQTISLDYNSFDSWV------------------------IPESLKDAT 161
V L+SL+ + + YN F + IP +L + +
Sbjct: 224 GVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNIS 283
Query: 162 GLQRFSANGANITGTIPDF---------------LGGDT------------IPGLMHLHL 194
L+R N N+TG+IP F LG D+ L L +
Sbjct: 284 TLERLGMNENNLTGSIPTFGNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGI 343
Query: 195 AFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAV-IQNMTSLTQLWLHGNSFTGPL 253
N L G +P+S S + + L+ G + ++GS+ I N+ +L +L L N +GPL
Sbjct: 344 GRNRLGGDLPISIANLSAKLVTLD--LGGTLISGSIPYDIGNLINLQKLILDQNMLSGPL 401
Query: 254 P-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTP----------- 301
P L L +L+ S+ N+L+G +P+ + N+ L ++L+NN F+G P
Sbjct: 402 PTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLE 461
Query: 302 ------KFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNN 355
K N + ++ K LD +G + G + + ++++G ++ G
Sbjct: 462 LWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKL 521
Query: 356 PCNSDWKGVSCDAGGNITVVNLKNLGLSGTISS----NFSRLTSLRQLMLSGNELTGTIP 411
P GN + +++L L G + + L ++++ LS N+L+G+IP
Sbjct: 522 P----------QTLGN--CLTMESLFLEGNLFYGDIPDLKGLVGVKEVDLSNNDLSGSIP 569
Query: 412 KELTTLPSLEMLDVSNNHLFGKVPN---FRQNVIVKTDGNPDIGKDSSSFTPKSPPGSSP 468
+ + LE L++S N+L GKVP F V GN D+ F K +P
Sbjct: 570 EYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAP 629
Query: 469 TPPGGDSGGNGSSGGANKNSNTGKIVGSVVGVVCGAFIVGLGF-----CLYTRKRKRSGR 523
+ K+S+ K V V+GV G ++ L F ++ RKRK++
Sbjct: 630 SV-------------VKKHSSRLKKV--VIGVSVGITLLLLLFMASVTLIWLRKRKKNKE 674
Query: 524 VQSPNAVVIHPSNGGDGNAVKITVTESSVTGGGSESQSLTSSGPSDLHVVEAGSMVISIQ 583
+P PS L V+ IS
Sbjct: 675 TNNPT--------------------------------------PSTLEVLHEK---ISYG 693
Query: 584 VLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAEFKSEIAVL 642
LRN TN FS N++G G FGTVYK L K+ AVK + + F +E L
Sbjct: 694 DLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLN--MQRRGAMKSFMAECESL 751
Query: 643 TKVRHRHLVGLLGYC----LDGNE-RLLVYEYMPQGTLSRHLFNRKEEGL----KPLEWT 693
+RHR+LV LL C GNE R L+YE+MP G+L L + E + + L
Sbjct: 752 KDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLL 811
Query: 694 RRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753
RL IA+DVA ++YLH H+ H DLKPSN+LL DD+ A V+DFGL RL + S
Sbjct: 812 ERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEES 871
Query: 754 IETRLA-----GTFGYLAPEYAA 771
+L+ GT GY APEY
Sbjct: 872 FFNQLSSAGVRGTIGYAAPEYGV 894
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGJ1|Y1743_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g74360 OS=Arabidopsis thaliana GN=At1g74360 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 223 bits (569), Expect = 4e-57, Method: Compositional matrix adjust.
Identities = 221/776 (28%), Positives = 339/776 (43%), Gaps = 153/776 (19%)
Query: 70 IQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSG-LSSLQEVLFDDNNFTS-V 127
+ +G +P+ L +L++L L++ +NK G I + G + ++ ++ N++ +
Sbjct: 305 LYLGNNTFSRDIPETLLNLTNLVFLDLSRNKFGGDIQEIFGRFTQVKYLVLHANSYVGGI 364
Query: 128 PSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIP 187
S L +L + L YN+F S +P + L+ N +G IP G +P
Sbjct: 365 NSSNILKLPNLSRLDLGYNNF-SGQLPTEISQIQSLKFLILAYNNFSGDIPQEYG--NMP 421
Query: 188 GLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGN 247
GL L L+FN L G IP SFGK +TSL L L N
Sbjct: 422 GLQALDLSFNKLTGSIPASFGK--------------------------LTSLLWLMLANN 455
Query: 248 SFTGPLP-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSP 306
S +G +P ++ +SL F+V +NQL+G L + G P SP
Sbjct: 456 SLSGEIPREIGNCTSLLWFNVANNQLSGRFHPELTRM--------------GSNP---SP 498
Query: 307 VRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGV-- 364
F++ + + D +A G + + + P + C S W V
Sbjct: 499 T-FEVNRQNK-----DKIIAGSGECLAMKRWIPAEFPPFNFVYAILTKKSCRSLWDHVLK 552
Query: 365 ------SCDAGGNI------TVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPK 412
C AG + + L SG I ++ S++ L L L NE G +P
Sbjct: 553 GYGLFPVCSAGSTVRTLKISAYLQLSGNKFSGEIPASISQMDRLSTLHLGFNEFEGKLPP 612
Query: 413 ELTTLPSLEMLDVSNNHLFGKVP-----------------NFRQNVIVKTDGNPDIGKDS 455
E+ LP L L+++ N+ G++P NF N + ++ K +
Sbjct: 613 EIGQLP-LAFLNLTRNNFSGEIPQEIGNLKCLQNLDLSFNNFSGNFPTSLNDLNELSKFN 671
Query: 456 SSFTPKSPPGSSPTPPGGDSGGNGSSGGA----------NKNSNTGKIVGSVVG------ 499
S+ P G+ PT + S G +NT KI V+G
Sbjct: 672 ISYNP-FISGAIPTTGQVATFDKDSFLGNPLLRFPSFFNQSGNNTRKISNQVLGNRPRTL 730
Query: 500 -------VVCGAFIVGL---GFCLYTRKRKRSGRVQSPNAVVIHPSNGGDGNAVKITVTE 549
+ AFI L G L K R + DG+ + +T
Sbjct: 731 LLIWISLALALAFIACLVVSGIVLMVVKASREAEIDLL-----------DGSKTRHDMTS 779
Query: 550 SSVTGGGSESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKG 609
SS GG S S + V+ + + T+NFSEE V+GRGG+GTVY+G
Sbjct: 780 SS--GGSSPWLS------GKIKVIRLDKSTFTYADILKATSNFSEERVVGRGGYGTVYRG 831
Query: 610 ELHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLT-----KVRHRHLVGLLGYCLDGNER 663
L DG ++AVK+++ +EK EF++E+ VL+ H +LV L G+CLDG+E+
Sbjct: 832 VLPDGREVAVKKLQREGTEAEK---EFRAEMEVLSANAFGDWAHPNLVRLYGWCLDGSEK 888
Query: 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLK 723
+LV+EYM G+L + ++ + L+W +R+ IA DVARG+ +LH + S +HRD+K
Sbjct: 889 ILVHEYMGGGSLEELITDKTK-----LQWKKRIDIATDVARGLVFLHHECYPSIVHRDVK 943
Query: 724 PSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMTWQ 779
SN+LL A+V DFGL RL + G + T +AGT GY+APEY G TWQ
Sbjct: 944 ASNVLLDKHGNARVTDFGLARLL-NVGDSHVSTVIAGTIGYVAPEY-----GQTWQ 993
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 779 | ||||||
| 255573218 | 935 | receptor protein kinase, putative [Ricin | 0.970 | 0.808 | 0.662 | 0.0 | |
| 224101923 | 931 | predicted protein [Populus trichocarpa] | 0.973 | 0.814 | 0.654 | 0.0 | |
| 224108223 | 930 | predicted protein [Populus trichocarpa] | 0.947 | 0.793 | 0.655 | 0.0 | |
| 359472575 | 937 | PREDICTED: probable receptor protein kin | 0.964 | 0.801 | 0.670 | 0.0 | |
| 449450141 | 950 | PREDICTED: probable receptor protein kin | 0.940 | 0.771 | 0.634 | 0.0 | |
| 449445063 | 953 | PREDICTED: probable receptor protein kin | 0.979 | 0.800 | 0.634 | 0.0 | |
| 224069210 | 945 | predicted protein [Populus trichocarpa] | 0.976 | 0.805 | 0.623 | 0.0 | |
| 7672732 | 945 | LRR receptor-like protein kinase [Nicoti | 0.943 | 0.777 | 0.658 | 0.0 | |
| 359476563 | 889 | PREDICTED: probable receptor protein kin | 0.911 | 0.798 | 0.633 | 0.0 | |
| 351727489 | 941 | NAK-type protein kinase precursor [Glyci | 0.969 | 0.802 | 0.621 | 0.0 |
| >gi|255573218|ref|XP_002527538.1| receptor protein kinase, putative [Ricinus communis] gi|223533088|gb|EEF34847.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1008 bits (2606), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 515/777 (66%), Positives = 606/777 (77%), Gaps = 21/777 (2%)
Query: 1 MKKRHLGVSLFLLSLLSATLSVNSQSSSDAAAMQALKTSLGNPASLGWTDPDPC--KWKH 58
MKKRH GVSL + NSQ + DA+ M LK SLGNP+ W+ DPC KW H
Sbjct: 1 MKKRHPGVSLIPFFFMGFLSLANSQQNGDASVMLKLKESLGNPSF--WSGSDPCNDKWDH 58
Query: 59 IQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVL 118
+ C SNRVT IQIG QN+ GTLP EL+ L++L LEVM N L+G +PSLSGLSSLQ VL
Sbjct: 59 VTCDSSNRVTDIQIGRQNLVGTLPPELSKLTALKRLEVMFNNLSGPVPSLSGLSSLQVVL 118
Query: 119 FDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIP 178
+N F+S PSDFF GL S+ T+SLDYN F W IP SL +A+ L+ FSAN A+ITG IP
Sbjct: 119 LHNNEFSSFPSDFFNGLNSITTVSLDYNPFTPWEIPVSLTNASTLKEFSANKASITGKIP 178
Query: 179 DFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKS-SIQTLWLNGQKGDSKLNGSVAVIQNMT 237
DF D PGL LHLA N L+G +P SF +S +I +LWLNGQ+ LNG+++V+QNMT
Sbjct: 179 DFFNNDVFPGLESLHLAMNSLEGELPGSFSRSPTITSLWLNGQR----LNGTISVLQNMT 234
Query: 238 SLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
LT++WLH N FTGPLP+ + + LQ S+RDN+ TGIVP SLV L +L+VVNLTNNL Q
Sbjct: 235 GLTEIWLHMNQFTGPLPEFNDFNGLQKLSLRDNRFTGIVPESLVKLPTLSVVNLTNNLLQ 294
Query: 298 GQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPC 357
G TP+F VR DM SN FC + GVACD RV VLLSIVK GYPA LA++W+GN+PC
Sbjct: 295 GPTPEFPDSVRVDMTSESNRFCTPNPGVACDHRVEVLLSIVKDFGYPANLADNWEGNDPC 354
Query: 358 NSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTL 417
+ WKG++C GGNITV+N + +GL+GTIS NFS + SL++L+L+ N L GTIP ELTT+
Sbjct: 355 -AQWKGITCSPGGNITVINFQGMGLTGTISPNFSLIPSLQKLILANNSLNGTIPSELTTM 413
Query: 418 PSLEMLDVSNNHLFGKVPNFRQNVIVKTDGNPDIGKDSSSFTPKSPPGSSP--TPPGGDS 475
PSL +L+V+NN L+GK+P+F+Q V V TDGNPDIGKD+SS PPGS+P TP G
Sbjct: 414 PSLSLLNVANNQLYGKLPSFKQ-VQVITDGNPDIGKDTSS---SIPPGSTPGSTPSGKPG 469
Query: 476 GGNGSSGGANKNSNTGKIVGSVVGVVCGAFIVGLGFCLYTRKRKRSGRVQSPNAVVIHPS 535
GG+ S NKNS+TGKI+GSVVG VCG +VGLG Y+RK+KR +VQSPN +VIHP
Sbjct: 470 GGSNSDATGNKNSSTGKIIGSVVGAVCGLCVVGLGVFFYSRKQKRYSKVQSPNMMVIHPR 529
Query: 536 NGGDGNAVKITVTESSVTGGGSESQSLT-SSGPSDLHVVEAGSMVISIQVLRNVTNNFSE 594
+ G+ +AVKITV ESS G ++S T SSGPSD+HVVEAG+MVISIQVLRNVTN+FSE
Sbjct: 530 HSGNQDAVKITVAESSTVG---RAESCTDSSGPSDIHVVEAGNMVISIQVLRNVTNDFSE 586
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
+N+LGRGGFGTVYKGELHDGTKIAVKRMES V+SEKG AEF SEIAVL KVRHRHLV LL
Sbjct: 587 DNILGRGGFGTVYKGELHDGTKIAVKRMESGVLSEKGLAEFTSEIAVLNKVRHRHLVALL 646
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
GYCLDGNERLLVYEYMPQGTLS+ LFN KEEG+KPL+WTRRLTIALDVARGVEYLHGLAH
Sbjct: 647 GYCLDGNERLLVYEYMPQGTLSKFLFNWKEEGVKPLDWTRRLTIALDVARGVEYLHGLAH 706
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAA 771
QSFIHRDLKPSNILLGDD+RAKVADFGLVRLAP+ GK SIETRLAGTFGYLAPEYA
Sbjct: 707 QSFIHRDLKPSNILLGDDLRAKVADFGLVRLAPE-GKASIETRLAGTFGYLAPEYAV 762
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224101923|ref|XP_002312477.1| predicted protein [Populus trichocarpa] gi|222852297|gb|EEE89844.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 966 bits (2498), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 504/770 (65%), Positives = 601/770 (78%), Gaps = 12/770 (1%)
Query: 6 LGVSLFLLS--LLSATLSVNSQSSSDAAAMQALKTSLGNPASLGWTDPDPCKWKHIQCSP 63
+GV LF+ + LLS +SQ + DAA M L+ SL ++LGW+ DPC+W H+ C+
Sbjct: 1 MGVWLFIHTSLLLSLLCIAHSQQNDDAAVMLKLRDSLVKSSTLGWSASDPCQWAHVGCT- 59
Query: 64 SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNN 123
+NRV RIQIG QN++GTLP EL +L+ LT EVM N LTG +PSLSGLSSLQ +L NN
Sbjct: 60 NNRVDRIQIGYQNLQGTLPPELRNLTQLTRFEVMSNNLTGSLPSLSGLSSLQVLLLHTNN 119
Query: 124 FTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGG 183
F+S+P DFF G+TSL ++SLD N F+SW IPESLKDAT L+ FSAN AN+ G IP+F
Sbjct: 120 FSSIPPDFFTGMTSLTSVSLDTNPFESWEIPESLKDATSLKEFSANDANVAGKIPEFFNN 179
Query: 184 DTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLW 243
D PGL LHLAFN+L+G +PL+F S+I++LWLNGQK +S+LNG+++++QNMTSLT++W
Sbjct: 180 DVFPGLESLHLAFNYLEGELPLNFSGSTIRSLWLNGQKSNSRLNGTLSILQNMTSLTEIW 239
Query: 244 LHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKF 303
LHGNS TGPLPDLSG+ SL+D S+RDN LTG+VP SLVN+ +L VN TNN QG TPKF
Sbjct: 240 LHGNSLTGPLPDLSGMISLEDLSLRDNSLTGVVPPSLVNISTLRAVNFTNNKLQGPTPKF 299
Query: 304 NSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSD-WK 362
V DM G+N+FCLD GVACD V+VLLS+ K+ GYPA LA+ WKGN+PC+S+ WK
Sbjct: 300 ADRVSVDMNPGTNNFCLDKPGVACDATVDVLLSVAKNFGYPASLADFWKGNDPCSSNTWK 359
Query: 363 GVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEM 422
G++C G +I V+NLK GL+GTISS+F +++L++L LS N LTGTIP ELT L L +
Sbjct: 360 GIAC-VGKDILVINLKKAGLTGTISSDFFLISTLQELFLSDNMLTGTIPDELTNLSDLTI 418
Query: 423 LDVSNNHLFGKVPNFRQNVIVKTDGNPDIGKDSSSFTPKSPPGSSPTPPGGDSGGNGSSG 482
LDVSNN L+G +P FR NV V+ GNPDIGK+ S + P + PG++P P G G S G
Sbjct: 419 LDVSNNRLYGNIPKFRNNVQVEYAGNPDIGKNGSVYPPPATPGTAPGSPSGTVG--DSDG 476
Query: 483 GANKNSNTGKIVGSVVGVVCGAFIVGLGFCLYTRKRKRSGRVQSPNAVVIHPSNGGDGNA 542
NKN TGKIVGSV+G VCG +VGLG Y RK+KRS +VQSPN ++IHP + GD +A
Sbjct: 477 SGNKNLATGKIVGSVIGFVCGLCMVGLGVFFYNRKQKRSSKVQSPNMMIIHPRHSGDQDA 536
Query: 543 VKITVTESSVTGGGSESQSLTSS-GPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRG 601
VKITV SS G ++S T S GPSD+++ +MVISIQVL NVTNNFSEEN+LGRG
Sbjct: 537 VKITVAGSSANIG---AESFTDSVGPSDINLARTENMVISIQVLSNVTNNFSEENILGRG 593
Query: 602 GFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN 661
GFGTVYKGELHDGTKIAVKRMES VVSEKG AEF SEIAVLTKVRHRHLV L+GYCLDGN
Sbjct: 594 GFGTVYKGELHDGTKIAVKRMESGVVSEKGLAEFMSEIAVLTKVRHRHLVALIGYCLDGN 653
Query: 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRD 721
ERLLVYEYMPQGTLSRHLF KEEG+K LEWTRRLTI LDVARGVEYLHGLAHQ FIHRD
Sbjct: 654 ERLLVYEYMPQGTLSRHLFCWKEEGVKSLEWTRRLTIGLDVARGVEYLHGLAHQCFIHRD 713
Query: 722 LKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAA 771
LKPSNILLGDDMRAKVADFGLVR AP+ GK SIETRLAGTFGYLAPEYA
Sbjct: 714 LKPSNILLGDDMRAKVADFGLVRPAPE-GKTSIETRLAGTFGYLAPEYAV 762
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224108223|ref|XP_002314766.1| predicted protein [Populus trichocarpa] gi|222863806|gb|EEF00937.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 963 bits (2490), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 493/752 (65%), Positives = 589/752 (78%), Gaps = 14/752 (1%)
Query: 23 NSQSSSDAAAMQALKTSLGNPASLGWTDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLP 82
NSQ + DAAAM L+ SLGNP++LGW+ DPC W H+ C NRVTRIQIG QN++GTLP
Sbjct: 21 NSQQNDDAAAMMKLRGSLGNPSTLGWSGSDPCNWLHVGCL-DNRVTRIQIGNQNLQGTLP 79
Query: 83 KELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTIS 142
EL L+ LT EVM N+L G +PSLSGLS LQ + +N F+S+P DFF G+TSL ++
Sbjct: 80 PELKDLTQLTRFEVMNNQLMGALPSLSGLSFLQVLFLHNNTFSSIPPDFFAGMTSLTSVY 139
Query: 143 LDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGP 202
LDYN F+SW IPESLKDA+ L+ FSANGAN+ G IP+F D PG+ LHLAFN+ +G
Sbjct: 140 LDYNPFESWEIPESLKDASALKEFSANGANVAGKIPEFFNSDVFPGMETLHLAFNYFEGG 199
Query: 203 IPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSL 262
+PL+F S+IQ+LWLNGQK +S+LNG+++++QNMTSL ++WL GN FTGPLPDLSG+ SL
Sbjct: 200 LPLNFSGSTIQSLWLNGQKSNSRLNGTISILQNMTSLKEIWLQGNHFTGPLPDLSGMISL 259
Query: 263 QDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDD 322
+D ++RDN LTG+VP SL+N+ +L VVN TNN QG TP F V DM G+N+FCLD+
Sbjct: 260 EDLNLRDNSLTGVVPPSLLNISTLRVVNFTNNKLQGPTPSFARTVDADMIPGTNNFCLDN 319
Query: 323 AGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSD--WKGVSCDAGGNITVVNLKNL 380
GVACD VNVLLS+ K+ GYPA LA+ WKGN+PC S WKG++C GG+I V+NLK
Sbjct: 320 PGVACDSTVNVLLSVAKNFGYPASLADLWKGNDPCTSTQAWKGITC-GGGDILVINLKKA 378
Query: 381 GLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQN 440
GLSGTISS+FS ++ L++L+LS N LTGTIP EL +L +L +LDVSNN L G++P FR N
Sbjct: 379 GLSGTISSDFSLISRLQKLILSDNMLTGTIPDELISLSNLALLDVSNNKLSGQIPKFRSN 438
Query: 441 VIVKTDGNPDIGKDSSSFTPKSPPGSSPTPPGGDSGGNGSSGGANKNSNTGKIVGSVVGV 500
V V+ GNPDIGK ++S+ +PPG+ + G GS G NKNS +GKIVGSV+G
Sbjct: 439 VQVEYGGNPDIGKINTSY---APPGAPGS--TPSGTGGGSDGSGNKNSASGKIVGSVIGA 493
Query: 501 VCGAFIVGLGFCLYTRKRKRSGRVQSPNAVVIHPSNGGDGNAVKITVTESSVTGGGSESQ 560
V +VGLG Y++K+KRS +VQSPN ++IHP D + VKITV SS G +
Sbjct: 494 VGVVCVVGLGVFFYSKKQKRSSKVQSPNMMIIHPRRSWDQDEVKITVAGSSANSG---VE 550
Query: 561 SLTSS-GPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAV 619
S T S GPSD+ VV +MVISIQVLRNVTNNFSEEN+LGRGGFGTVYKGELHDGTKIAV
Sbjct: 551 SFTDSVGPSDIQVVRTENMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAV 610
Query: 620 KRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHL 679
KRMES V+SEKG AEF SEIAVLTKVRHRHLV LLGYCLDGNERLLVYEYMP+GTLS HL
Sbjct: 611 KRMESGVISEKGLAEFMSEIAVLTKVRHRHLVALLGYCLDGNERLLVYEYMPRGTLSSHL 670
Query: 680 FNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 739
F+ KEEG+KPL+WTRRLTI LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD
Sbjct: 671 FSWKEEGVKPLDWTRRLTIGLDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 730
Query: 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAA 771
FGLVRLAP+ GK SIETRLAGTFGYLAPEYA
Sbjct: 731 FGLVRLAPE-GKASIETRLAGTFGYLAPEYAV 761
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359472575|ref|XP_002281552.2| PREDICTED: probable receptor protein kinase TMK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 962 bits (2486), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 516/770 (67%), Positives = 598/770 (77%), Gaps = 19/770 (2%)
Query: 8 VSLFLLSLLSATLSVNSQSSS-DAAAMQALKTSLGNPASLGWTDPDPCKWKHIQCSPSNR 66
+ + L+ LL+ TL+V SQSSS DA MQ LK +L P+ LGW+D DPCKW + C R
Sbjct: 5 LCVVLVCLLALTLNVQSQSSSGDADVMQVLKKNLNQPSDLGWSDSDPCKWDGVSCDGDRR 64
Query: 67 VTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTS 126
VTRIQIGG+N++G+LP L L++L +LEV N+L+G +PSLS LS LQ +L +NNFTS
Sbjct: 65 VTRIQIGGKNLKGSLPSNLTDLTALEILEVQYNQLSGPLPSLSRLSLLQRLLLSNNNFTS 124
Query: 127 VPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTI 186
VPS FF G+TSLQT++LD N F WV P SL+ A L+ FSAN A I+G P+ +
Sbjct: 125 VPSGFFDGMTSLQTVALDNNPFSPWVFPVSLQAAGSLKSFSANSAGISGKFPEIF--EAF 182
Query: 187 PGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHG 246
P L LHLAFN L+G +P SF SSIQTLWLNGQ+ SKLNG++ V+QNMTSLTQ+WL+
Sbjct: 183 PSLTDLHLAFNSLEGGLPSSFSGSSIQTLWLNGQESASKLNGTIEVLQNMTSLTQVWLNM 242
Query: 247 NSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSP 306
NSFTGPLPD S L++LQD ++RDN TG VPS+L+NL SL VNLTNNL QG P+F S
Sbjct: 243 NSFTGPLPDFSSLTNLQDLNLRDNGFTGPVPSTLLNLKSLKTVNLTNNLLQGPMPEFASS 302
Query: 307 VRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSC 366
V DM G N FCL + G C VN LL + KS+GYP+ LA++WKGN+PC+ W G++C
Sbjct: 303 VAADMV-GVNMFCLPEPG-PCSQTVNTLLEVAKSMGYPSSLAKNWKGNDPCDQ-WFGLTC 359
Query: 367 DAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVS 426
D GG I VVNL+ +GLSGTISSNFS L SL++L+L+ N LTGTIP ELT L +L LDVS
Sbjct: 360 DDGG-IAVVNLQKMGLSGTISSNFSTLGSLQKLILADNNLTGTIPAELTNLQNLRELDVS 418
Query: 427 NNHLFGKVPNFRQNVIVKTDGNPDIGK----DSSSFTPKSPPGSSPTPPGGDSGGNGSSG 482
NN L+G++PNFR NVIVKT+GNPDIGK D + TP P SPT P DS GNG
Sbjct: 419 NNQLYGQIPNFRSNVIVKTEGNPDIGKEGGDDPNPGTPSGGPPDSPTSPDADSPGNGG-- 476
Query: 483 GANKNSNTGKIVGSVVGVVCGAFIVGL-GFCLYTRKRKRSGRVQSPNAVVIHPSNGG-DG 540
K SNT IVGSVVG V F++GL GFC Y ++K GRVQSPN +VIHP + G D
Sbjct: 477 ---KKSNTVVIVGSVVGSVGAVFLIGLVGFCFYRTRQKHFGRVQSPNTMVIHPRHSGSDN 533
Query: 541 NAVKITVTESSVTGGGSESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGR 600
+AVKIT+ SSV GGGSE+ S SSGPSD+ ++EAGSMVISIQVLRNVTNNFSEENVLGR
Sbjct: 534 DAVKITIANSSVNGGGSETYSHASSGPSDIQMIEAGSMVISIQVLRNVTNNFSEENVLGR 593
Query: 601 GGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG 660
GGFGTVYKGELHDGTKIAVKRMES VVSEKG EFKSEIAVLTKVRHRHLV LLGYCLDG
Sbjct: 594 GGFGTVYKGELHDGTKIAVKRMESGVVSEKGLTEFKSEIAVLTKVRHRHLVALLGYCLDG 653
Query: 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHR 720
NERLLVYEYMPQGTLSRHLFN KEEG+KPLEW +RL+IALDVARGVEYLHGLAHQSFIHR
Sbjct: 654 NERLLVYEYMPQGTLSRHLFNWKEEGMKPLEWMKRLSIALDVARGVEYLHGLAHQSFIHR 713
Query: 721 DLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYA 770
DLKPSNILLGDDMRAKVADFGLVRLAP+ GK SIETRLAGTFGYLAPEYA
Sbjct: 714 DLKPSNILLGDDMRAKVADFGLVRLAPE-GKASIETRLAGTFGYLAPEYA 762
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449450141|ref|XP_004142822.1| PREDICTED: probable receptor protein kinase TMK1-like [Cucumis sativus] gi|449526311|ref|XP_004170157.1| PREDICTED: probable receptor protein kinase TMK1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 946 bits (2446), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 473/745 (63%), Positives = 571/745 (76%), Gaps = 12/745 (1%)
Query: 29 DAAAMQALKTSLGNPASLGWTDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSL 88
D + M LK S+G P+SLGWT D C+W H++C +RV +IQIG QN++G+LPKEL SL
Sbjct: 37 DGSVMNLLKNSVGAPSSLGWTGSDYCQWNHVKCDSQSRVVKIQIGNQNLKGSLPKELFSL 96
Query: 89 SSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSF 148
S+L LEV N+L G P+L+ SLQ +L DN FTS+P+DFF ++LQTI +D N F
Sbjct: 97 SALVQLEVQSNQLGGPFPNLA--DSLQILLAHDNLFTSMPADFFAKKSALQTIDIDNNPF 154
Query: 149 DSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFG 208
+W IP++++DA+ LQ+ SAN NITG IP G T P L +LHLA NFL+G +P S
Sbjct: 155 SAWQIPDNIRDASALQQLSANRVNITGIIPGIFDGATFPTLTNLHLAGNFLEGELPASLA 214
Query: 209 KSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVR 268
SSIQ+LWLNGQ+ SKLNGS+A++QNMT+L ++WLH N F+GPLPD S L L S+R
Sbjct: 215 GSSIQSLWLNGQQSSSKLNGSIAILQNMTNLQEVWLHMNQFSGPLPDFSNLQGLAKLSLR 274
Query: 269 DNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACD 328
DNQLTGIVPSSLVNL SL VVNLTNNL QG TP F+ V+ DM +N FCLD G CD
Sbjct: 275 DNQLTGIVPSSLVNLKSLMVVNLTNNLLQGPTPAFDPNVQLDMKPQTNKFCLDSPGEPCD 334
Query: 329 GRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAG-GNITVVNLKNLGLSGTIS 387
RVN LLS+ +S+G+P A+ W GN+PC +KG+SC NI+V+NLKN+GL+G+IS
Sbjct: 335 PRVNALLSVAESMGFPTAFAQGWAGNDPCQG-FKGISCIGNPTNISVINLKNMGLAGSIS 393
Query: 388 SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQNVIVKTDG 447
+FS LTS+++L LS N L+GTIP EL T+PSL LDVSNN L GKVP FR+NVIV T G
Sbjct: 394 PSFSLLTSVQKLFLSNNFLSGTIPNELATMPSLTELDVSNNRLHGKVPVFRKNVIVNTQG 453
Query: 448 NPDIGKDSSSF-TPKSPPGSSPTPPGGDSGGNGSSGGANKNSNTGKIVGSVVGVVCGAFI 506
NPDIGKD++S P SP G SP+ GDS GN K SN G +VG+++GV+ G +
Sbjct: 454 NPDIGKDNASPPVPGSPTGRSPSDGSGDSAGNDE-----KKSNAGVVVGAIIGVIVGLLV 508
Query: 507 VG-LGFCLYTRKRKRSGRVQSPNAVVIHPSNGGDGNAVKITVTESSVTGGGSESQSLTSS 565
VG + F L RK++R RVQSPN VV+HPS+ GD N+VKIT+TE+ G E+ + +
Sbjct: 509 VGTVIFFLCKRKKRRGNRVQSPNTVVVHPSHSGDQNSVKITITEARSDGSAPETSRVPIA 568
Query: 566 GPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESA 625
GPSD+HVVEAG++VISIQVLR+VTNNFS EN+LG+GGFGTVYKGELHDGT IAVKRMES
Sbjct: 569 GPSDVHVVEAGNLVISIQVLRSVTNNFSPENILGKGGFGTVYKGELHDGTMIAVKRMESG 628
Query: 626 VVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE 685
V+ EKG EFK+EIAVLTKVRHR+LV LLGYCLDGNERLLVYEYMPQGT SR LFN KEE
Sbjct: 629 VIGEKGLNEFKAEIAVLTKVRHRNLVALLGYCLDGNERLLVYEYMPQGTFSRFLFNWKEE 688
Query: 686 GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745
G++PLEW RRL + LDVARGVEYLH LAHQSFIHRDLKPSNILLGDD+RAKVADFGLVRL
Sbjct: 689 GIRPLEWKRRLIVVLDVARGVEYLHSLAHQSFIHRDLKPSNILLGDDLRAKVADFGLVRL 748
Query: 746 APDNGKHSIETRLAGTFGYLAPEYA 770
AP+ GK SIETRLAGTFGYLAPEYA
Sbjct: 749 APE-GKASIETRLAGTFGYLAPEYA 772
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449445063|ref|XP_004140293.1| PREDICTED: probable receptor protein kinase TMK1-like [Cucumis sativus] gi|449479894|ref|XP_004155738.1| PREDICTED: probable receptor protein kinase TMK1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 943 bits (2438), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 496/782 (63%), Positives = 584/782 (74%), Gaps = 19/782 (2%)
Query: 2 KKRHLGVSLFL-LSLLSATLSVNSQS-SSDAAAMQALKTSLGNPASLGWTDPDPCKWKHI 59
KK H FL L++ S SV Q S DA AM ALK SL SLGW+DP+PCKW H+
Sbjct: 4 KKTHFVNKHFLILAIFSIFHSVEPQELSPDAPAMTALKKSLNPTESLGWSDPNPCKWNHV 63
Query: 60 QCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLF 119
CS NRVTRIQIG QN++G LP L +L++L LE+ NK++G +PSLSGL+SLQ +L
Sbjct: 64 LCSDDNRVTRIQIGRQNLQGMLPLNLQNLTALERLELQWNKISGPLPSLSGLTSLQVLLL 123
Query: 120 DDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD 179
N FTS+PSDFF G+TSLQ + +D N F +W IP SL++A+ LQ FSAN AN+TG IP+
Sbjct: 124 SGNQFTSIPSDFFAGMTSLQAVEIDENPFSAWEIPASLRNASTLQNFSANSANVTGRIPE 183
Query: 180 FLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSL 239
FLGG+ IPGL +LHLAFN L+G +P SF S +++LW+NGQ KL+GS+ V+QNMTSL
Sbjct: 184 FLGGEDIPGLTNLHLAFNNLEGGLPSSFSGSQLESLWVNGQNSADKLSGSIDVLQNMTSL 243
Query: 240 TQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQ 299
++WLH NSF+GPLPD S L LQ S+RDN+ TG VPSSLVN SL VVNLTNNL QG
Sbjct: 244 IEVWLHSNSFSGPLPDFSRLKDLQALSLRDNKFTGPVPSSLVNSPSLKVVNLTNNLLQGP 303
Query: 300 TPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNS 359
P F + V DM SNSFCL D G CD RVN LLSIVK +GYP AE+WKGN+PC +
Sbjct: 304 IPLFKTGVVVDMTNDSNSFCLQDPG-ECDSRVNTLLSIVKFMGYPQRFAENWKGNDPC-A 361
Query: 360 DWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPS 419
+W G+SC +IT+VN + +GLSG IS F+ L L +L+L+ N LTG+IP+ELTTLP
Sbjct: 362 EWIGISC-RNQSITIVNFQKMGLSGMISPEFASLKGLERLVLADNHLTGSIPEELTTLPF 420
Query: 420 LEMLDVSNNHLFGKVPNFRQNVIVKTDGNPDIGKDSSSFTPKSPPGSSPTPPGGDSG--- 476
L LDVSNN L GK+P FR NV++ GNPDIGK+ T S G+SP+ D+
Sbjct: 421 LTELDVSNNQLSGKIPKFRSNVMMTITGNPDIGKEK---TDSSSNGASPSASSNDTKEAG 477
Query: 477 ----GNGSSGGANKNSNTGKIVGSVVGVVCGAFIVGL-GFCLYTRKRKRSGRVQSPNAVV 531
GN G +S G IV SVVG V F++GL C+Y K+KR +VQSPNA+V
Sbjct: 478 SNGGGNSGDGEKKPSSMVGVIVLSVVGGVFVLFLIGLVVLCVYKMKQKRFSQVQSPNAMV 537
Query: 532 IHPSN-GGDGNAVKITVTESSV-TGGGSESQSLTSSGPSDLHVVEAGSMVISIQVLRNVT 589
IHP + G D +VKITV SSV G SE+Q+ SS D+ +VEAG+MVISIQVL+NVT
Sbjct: 538 IHPRHSGSDNESVKITVAGSSVRVGAISETQNGASSETGDIQMVEAGNMVISIQVLKNVT 597
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
NNFSEEN+LG+GGFGTVYKGELHDGTKIAVKRMES V+ KG EFKSEIAVLTKVRHRH
Sbjct: 598 NNFSEENILGQGGFGTVYKGELHDGTKIAVKRMESGVIKGKGLTEFKSEIAVLTKVRHRH 657
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
LV LLGYCLDGNE+LLVYEYMPQGTLSRHLFN EEGLKPLEWT+RLTIALDVARGVEYL
Sbjct: 658 LVALLGYCLDGNEKLLVYEYMPQGTLSRHLFNWPEEGLKPLEWTKRLTIALDVARGVEYL 717
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEY 769
HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP+ GK SIETR+AGTFGYLAPEY
Sbjct: 718 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE-GKGSIETRIAGTFGYLAPEY 776
Query: 770 AA 771
A
Sbjct: 777 AV 778
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224069210|ref|XP_002302927.1| predicted protein [Populus trichocarpa] gi|222844653|gb|EEE82200.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 936 bits (2419), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 487/781 (62%), Positives = 585/781 (74%), Gaps = 20/781 (2%)
Query: 1 MKKRHLGVSLFLLSLLSATLSV----NSQSSSDAAAMQALKTSLGNPASLGWTDPDPCKW 56
MK+R + LL L S+ NSQ+S DA M +LK SL P SLGW+DPDPC W
Sbjct: 1 MKRRSHRRTKLLLVFLVGFSSIFHFANSQTSPDAEVMFSLKKSLNVPDSLGWSDPDPCNW 60
Query: 57 KHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQE 116
H+ CS RVTRIQIG QN++GTLP L +L+ L LE+ N ++G +PSL+GLSSLQ
Sbjct: 61 NHVVCSDEKRVTRIQIGRQNLQGTLPSNLRNLAQLERLELQYNNISGPLPSLNGLSSLQV 120
Query: 117 VLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGT 176
+L DN F SVPSDFF GL+SLQ++ +D N F +WVIPES+K+A+ LQ FSAN ANI+G+
Sbjct: 121 ILLSDNKFISVPSDFFTGLSSLQSVEIDNNPFSNWVIPESIKNASALQNFSANSANISGS 180
Query: 177 IPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNM 236
IP F G D+ PGL L LAFN L+G +P SF S +Q+LWLNGQK L+G + VIQNM
Sbjct: 181 IPGFFGPDSFPGLTILRLAFNDLEGELPASFSGSQVQSLWLNGQK----LSGGIDVIQNM 236
Query: 237 TSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLF 296
T L ++WLH N F+GPLPD SGL L+ S+RDN TG+VP SLVNL SL VNL+NNL
Sbjct: 237 TLLREVWLHSNGFSGPLPDFSGLKDLESLSLRDNSFTGLVPESLVNLESLKFVNLSNNLL 296
Query: 297 QGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNP 356
QG P F S V DM K SN FCL + CD RVN LLSIVKS+ YP LA+SWKGN+P
Sbjct: 297 QGPMPVFKSSVSVDMVKDSNRFCLPTPDL-CDSRVNTLLSIVKSMDYPQRLADSWKGNDP 355
Query: 357 CNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTT 416
C +DW G++C+ GNITVVN + +GL+G+IS +F+ + SL +L+L+ N LTG+IP+E+TT
Sbjct: 356 C-ADWIGITCN-NGNITVVNFEKMGLTGSISPDFASVKSLERLVLANNNLTGSIPQEITT 413
Query: 417 LPSLEMLDVSNNHLFGKVPNFRQNVIVKTDGNPDIGKDSSSFTPKSPPGSSPTPPGGDSG 476
LP L++LDVSNNHL+G+VP F NVIV T+GNP+IGKD + S S +P
Sbjct: 414 LPGLKVLDVSNNHLYGRVPAFTSNVIVNTNGNPNIGKDVN--ISTSSESPSASPSANTGS 471
Query: 477 GNGSSGGANKNSNTGKIVGSVVGVVCGAFIVGL----GFCLYTRKRKRSGRVQSPNAVVI 532
G+G S + ++ IV + V+ G F++ L FCLY +K+KR RVQSPN +VI
Sbjct: 472 GSGGSSRKSGKKSSTLIVVIIFSVIGGVFLLSLIGLLVFCLYKKKQKRFSRVQSPNEMVI 531
Query: 533 HPSNGG-DGNAVKITVTESSVTGGG-SESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTN 590
HP + G D +VKITV SS++ G SE+ ++ +S D+ +VEAG+MVISIQVLRNVTN
Sbjct: 532 HPRHSGSDNESVKITVAGSSISVGAISETHTIPASEQGDIQMVEAGNMVISIQVLRNVTN 591
Query: 591 NFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
NFSEEN+LG GGFG VYKGELHDGTKIAVKRMES V+S KG EFKSEIAVLTKVRHRHL
Sbjct: 592 NFSEENILGWGGFGVVYKGELHDGTKIAVKRMESGVISGKGLTEFKSEIAVLTKVRHRHL 651
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
V LLGYCLDGNE+LLVYEYMPQGTLSRH+FN EEGLKPLEWTRRLTIALDVARGVEYLH
Sbjct: 652 VALLGYCLDGNEKLLVYEYMPQGTLSRHIFNWAEEGLKPLEWTRRLTIALDVARGVEYLH 711
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYA 770
GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP+ GK SIETR+AGTFGYLAPEYA
Sbjct: 712 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE-GKGSIETRIAGTFGYLAPEYA 770
Query: 771 A 771
Sbjct: 771 V 771
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|7672732|gb|AAF66615.1| LRR receptor-like protein kinase [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 933 bits (2412), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 493/749 (65%), Positives = 572/749 (76%), Gaps = 14/749 (1%)
Query: 26 SSSDAAAMQALKTSLGNPASLGWTDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKEL 85
+++DAA MQ LK + P+SLGW DPDPCKW +QC+ RVTRIQIG Q ++G+LP L
Sbjct: 32 AANDAAVMQELKKRINPPSSLGWNDPDPCKWGKVQCTKDGRVTRIQIGNQGLKGSLPPNL 91
Query: 86 NSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145
N+L+ L V EV N LTG +PS SGL SLQ +L ++N FTS+P+DFF GLTSLQ++ LD
Sbjct: 92 NNLTELLVFEVQNNGLTGSLPSFSGLDSLQSLLLNNNGFTSIPTDFFDGLTSLQSVYLDK 151
Query: 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPL 205
N F W IPESLK AT +Q FSA ANITGTIPDF D L +LHL+FN L G +P
Sbjct: 152 NQFSPWSIPESLKSATSIQTFSAVSANITGTIPDFF--DAFASLTNLHLSFNNLGGSLPS 209
Query: 206 SFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQL-WLHGNSFTGPLPDLSGLSSLQD 264
SF S IQ+LWLNG KG +LNGS+AVIQNMT LT+ N+F+ PLPD SGLS LQ+
Sbjct: 210 SFSGSQIQSLWLNGLKG--RLNGSIAVIQNMTQLTRTSGCKANAFSSPLPDFSGLSQLQN 267
Query: 265 FSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAG 324
S+RDN LTG VP+SLVNL SL VV LTNN QG TPKF S V+ DM +NSFCL G
Sbjct: 268 CSLRDNSLTGPVPNSLVNLPSLKVVVLTNNFLQGPTPKFPSSVQVDMLADTNSFCLSQPG 327
Query: 325 VACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG 384
V CD RVN LL++ K VGYP AE+WKGN+PC S W G++CD GGNITV+N + +GL+G
Sbjct: 328 VPCDSRVNTLLAVAKDVGYPREFAENWKGNDPC-SPWMGITCD-GGNITVLNFQKMGLTG 385
Query: 385 TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQNVIVK 444
TIS N+S +TSL++L+L+ N L GTIP EL LP+L LDVSNN L+GK+P F+ NV++K
Sbjct: 386 TISPNYSSITSLQKLILANNNLIGTIPNELALLPNLRELDVSNNQLYGKIPPFKSNVLLK 445
Query: 445 TDGNPDIGKDSSSFTPKSPPGSSPTPPGGDSGGNGSSGGANKNSNTGKIVGSVVGVVCGA 504
T GN +IGKD+ P S SGG + + K S+TG +VGSV+G VC A
Sbjct: 446 TQGNVNIGKDNPPPPAPGTPSGSTPGSSDGSGGGQTHANSGKKSSTGVVVGSVIGGVCAA 505
Query: 505 FIVG--LGFCLYTRKRKRSGRVQSPNAVVIHPSNGG-DGNAVKITVTESSVTGGGSESQS 561
++ FCLY KRKRSGRVQSP+ VVIHP + G D +AVKIT+ SSV GG S
Sbjct: 506 VVLAGLFVFCLYRTKRKRSGRVQSPHTVVIHPHHSGSDQDAVKITIAGSSVNGGDSCG-- 563
Query: 562 LTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKR 621
+SS P DLH+VEAG+MVISIQVLR+VTNNFSE N+LGRGGFGTVYKGELHDGTK+AVKR
Sbjct: 564 -SSSAPGDLHIVEAGNMVISIQVLRDVTNNFSEVNILGRGGFGTVYKGELHDGTKMAVKR 622
Query: 622 MESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFN 681
MES V+SEKG EFKSEIAVLTKVRHRHLV LLGYCLDGNERLLVYEYMPQGTLSR+LFN
Sbjct: 623 MESGVMSEKGLDEFKSEIAVLTKVRHRHLVTLLGYCLDGNERLLVYEYMPQGTLSRYLFN 682
Query: 682 RKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741
KEEGLKPLEWTRRLTIALDVARGVEYLHGLA QSFIHRDLKPSNILLGDDMRAKVADFG
Sbjct: 683 WKEEGLKPLEWTRRLTIALDVARGVEYLHGLAQQSFIHRDLKPSNILLGDDMRAKVADFG 742
Query: 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYA 770
LVRLAPD K S+ TRLAGTFGYLAPEYA
Sbjct: 743 LVRLAPD-PKASVVTRLAGTFGYLAPEYA 770
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359476563|ref|XP_002265087.2| PREDICTED: probable receptor protein kinase TMK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 931 bits (2406), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 470/742 (63%), Positives = 567/742 (76%), Gaps = 32/742 (4%)
Query: 33 MQALKTSLGNPASLGWTDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLT 92
M ALK SL N SLGW+ PDPC+WKH+ CS RVTRIQ+G Q ++GTLP L +L+ L
Sbjct: 1 MLALKDSLSNSESLGWSGPDPCEWKHVVCSEDKRVTRIQVGRQGLQGTLPSSLGNLTELE 60
Query: 93 VLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWV 152
LE+ N ++G +PSL GLSSLQ ++ +N FT +P DFF GL+SLQ++ +D N F +W
Sbjct: 61 RLELQWNNISGPLPSLKGLSSLQVLMLSNNQFTYIPVDFFSGLSSLQSVEIDNNPFSAWE 120
Query: 153 IPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSI 212
IP+SLK+A+ LQ FSAN ANITG IPDFLG PGL++LHLAFN L G +P + S I
Sbjct: 121 IPQSLKNASALQNFSANSANITGNIPDFLGPVAFPGLVNLHLAFNALVGGLPSALSGSLI 180
Query: 213 QTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQL 272
++LW+NGQ + KL+G++ VIQNMTSL ++WLH N+F+GPLPD SGL LQ S+RDN
Sbjct: 181 ESLWVNGQMSEEKLSGTIDVIQNMTSLKEVWLHSNAFSGPLPDFSGLKDLQSLSLRDNLF 240
Query: 273 TGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVN 332
TG+VP SLVNL SL VNLTNN QG P+F + V DM NSFCL G CD RVN
Sbjct: 241 TGVVPVSLVNLGSLEAVNLTNNFLQGPVPEFKNSVAVDMTPDGNSFCLPKPG-ECDPRVN 299
Query: 333 VLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSR 392
+LLSIVKS GYP A++WKGN+PC ++W G++C+ GNITVVN + +GL+GTISSNFS
Sbjct: 300 ILLSIVKSFGYPTKFAKNWKGNDPC-TEWFGITCN-NGNITVVNFQKMGLTGTISSNFSS 357
Query: 393 LTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQNVIVKTDGNPDIG 452
L SL++L+L+ N +TG+IPKELTTLP+L LDVSNN L+GK+P+F+ NV+V +G+ D
Sbjct: 358 LISLQKLVLADNNITGSIPKELTTLPALTQLDVSNNQLYGKIPSFKGNVLVNANGSQD-- 415
Query: 453 KDSSSFTPKSPPGSSPTPPGGDSGGNGSSGGANKNSNTGKIVGSVVGVVCGAFIVG-LGF 511
G+ +GG +S G IV SV+G V F++G L F
Sbjct: 416 -----------------------SGSSMNGGKKSSSLIGIIVFSVIGGVFVIFLIGLLVF 452
Query: 512 CLYTRKRKRSGRVQSPNAVVIHPSN-GGDGNAVKITVTESSVTGGG-SESQSLTSSGPSD 569
CLY RK+KR RVQSPNA+VIHP + G D ++VKITV SSV+ G SE+ + SS P+D
Sbjct: 453 CLYKRKQKRFTRVQSPNAMVIHPRHSGSDNDSVKITVAGSSVSVGAISETHTHPSSEPND 512
Query: 570 LHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSE 629
+ +VEAG+MVISIQVLRNVTNNFSEEN+LG+GGFGTVY+GELHDGTKIAVKRMES V++
Sbjct: 513 IQMVEAGNMVISIQVLRNVTNNFSEENILGQGGFGTVYRGELHDGTKIAVKRMESGVITG 572
Query: 630 KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKP 689
KG AEFKSEIAVLTKVRHRHLV LLGYCLDGNE+LLVYEYMPQGTLSRHLF+ EEG+KP
Sbjct: 573 KGLAEFKSEIAVLTKVRHRHLVALLGYCLDGNEKLLVYEYMPQGTLSRHLFSWPEEGIKP 632
Query: 690 LEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
LEWTRRL IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP+
Sbjct: 633 LEWTRRLAIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE- 691
Query: 750 GKHSIETRLAGTFGYLAPEYAA 771
GK SIETR+AGTFGYLAPEYA
Sbjct: 692 GKGSIETRIAGTFGYLAPEYAV 713
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351727489|ref|NP_001238698.1| NAK-type protein kinase precursor [Glycine max] gi|223452361|gb|ACM89508.1| NAK-type protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 931 bits (2405), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 479/771 (62%), Positives = 586/771 (76%), Gaps = 16/771 (2%)
Query: 9 SLFLLSLLSATLSVNSQSSSD---AAAMQALKTSLGNPASLGWTDPDPCKWKHIQCSPSN 65
+L LL+++ TL V SQ D A+ M ALK SL P GW+DPDPCKW + CS
Sbjct: 3 ALALLAIIVFTLLVRSQEEEDYDDASVMLALKNSLNPP---GWSDPDPCKWARVLCSDDK 59
Query: 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFT 125
RVTRIQIG N++GTLP L L+ L LE+ N ++G +PSL+GL+SL+ L +N F+
Sbjct: 60 RVTRIQIGRLNLQGTLPTTLQKLTHLEHLELQYNNISGPLPSLNGLTSLRVFLASNNRFS 119
Query: 126 SVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDT 185
+VP+DFF G++ LQ + +D N F+ W IP+SL++A+GLQ FSAN AN+ G+IP+F G D
Sbjct: 120 AVPADFFAGMSQLQAVEIDSNPFEPWEIPQSLRNASGLQNFSANSANVGGSIPEFFGSDV 179
Query: 186 IPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLH 245
PGL LHLA N L+G +PLSF S IQ+LWLNGQK +KL GSV V+QNMT LT +WL
Sbjct: 180 FPGLTLLHLAMNNLEGTLPLSFSGSQIQSLWLNGQKSVNKLGGSVEVLQNMTFLTDVWLQ 239
Query: 246 GNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVP-SSLVNLHSLAVVNLTNNLFQGQTPKFN 304
N+FTGPLPDLSGL SL+D S+RDN+ TG VP +S V L +L VVNLTNNLFQG P F
Sbjct: 240 SNAFTGPLPDLSGLKSLRDLSLRDNRFTGPVPVASFVGLKTLKVVNLTNNLFQGPMPVFG 299
Query: 305 SPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGV 364
V D K SNSFCL G CD RV+VLLS+V +GYP AESWKGN+PC + W G+
Sbjct: 300 DGVVVDNVKDSNSFCLPSPG-DCDPRVDVLLSVVGVMGYPPRFAESWKGNDPC-AYWIGI 357
Query: 365 SCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLD 424
+C + G ITVVN + + LSG IS F++L SL++++L+ N LTG+IP+EL TLP+L L+
Sbjct: 358 TC-SNGYITVVNFQKMELSGVISPEFAKLKSLQRIVLADNNLTGSIPEELATLPALTQLN 416
Query: 425 VSNNHLFGKVPNFRQNVIVKTDGNPDIGKDSSSFTPKS-PPGSSPTPPGGDSGGNGSSGG 483
V+NN L+GKVP+FR+NV+V T+GN DIGKD SS +P+ P +P G DSGG GG
Sbjct: 417 VANNQLYGKVPSFRKNVVVSTNGNTDIGKDKSSLSPQGLVPPMAPNAKG-DSGGVSGIGG 475
Query: 484 ANKNSNTGKIVGSVVGVVCGAFIVG-LGFCLYTRKRKRSGRVQSPNAVVIHPSNGG-DGN 541
+S+ G IV SV+G V ++G L FCL+ K+K+ RVQSPNA+VIHP + G D
Sbjct: 476 KKSSSHVGVIVFSVIGAVFVVSMIGFLVFCLFRMKQKKLSRVQSPNALVIHPRHSGSDNE 535
Query: 542 AVKITVTESSVT-GGGSESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGR 600
+VKITV SSV+ G SE++++ S SD+ +VEAG+MVISIQVL+NVT+NFSE+NVLG+
Sbjct: 536 SVKITVAGSSVSVGAASETRTVPGSEASDIQMVEAGNMVISIQVLKNVTDNFSEKNVLGQ 595
Query: 601 GGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG 660
GGFGTVY+GELHDGT+IAVKRME ++ KG AEFKSEIAVLTKVRHRHLV LLGYCLDG
Sbjct: 596 GGFGTVYRGELHDGTRIAVKRMECGAIAGKGAAEFKSEIAVLTKVRHRHLVSLLGYCLDG 655
Query: 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHR 720
NE+LLVYEYMPQGTLSRHLF+ EEGL+PLEW RRLTIALDVARGVEYLHGLAHQSFIHR
Sbjct: 656 NEKLLVYEYMPQGTLSRHLFDWPEEGLEPLEWNRRLTIALDVARGVEYLHGLAHQSFIHR 715
Query: 721 DLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAA 771
DLKPSNILLGDDMRAKVADFGLVRLAP+ GK SIETR+AGTFGYLAPEYA
Sbjct: 716 DLKPSNILLGDDMRAKVADFGLVRLAPE-GKASIETRIAGTFGYLAPEYAV 765
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 779 | ||||||
| TAIR|locus:2013825 | 942 | TMK1 "transmembrane kinase 1" | 0.930 | 0.769 | 0.582 | 3.2e-223 | |
| TAIR|locus:2059703 | 943 | AT2G01820 [Arabidopsis thalian | 0.930 | 0.768 | 0.576 | 2.6e-221 | |
| TAIR|locus:2095188 | 928 | AT3G23750 [Arabidopsis thalian | 0.916 | 0.769 | 0.472 | 5.2e-168 | |
| TAIR|locus:2024016 | 886 | AT1G24650 [Arabidopsis thalian | 0.519 | 0.457 | 0.540 | 1.3e-109 | |
| TAIR|locus:2156992 | 946 | AT5G49770 [Arabidopsis thalian | 0.242 | 0.199 | 0.484 | 1.7e-61 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.234 | 0.146 | 0.420 | 2.7e-61 | |
| UNIPROTKB|Q8RZV7 | 1294 | P0413C03.22 "Putative extra sp | 0.264 | 0.159 | 0.416 | 1.1e-59 | |
| TAIR|locus:2157042 | 953 | AT5G49760 [Arabidopsis thalian | 0.242 | 0.198 | 0.474 | 4.9e-59 | |
| TAIR|locus:2097310 | 1002 | BAM2 "BARELY ANY MERISTEM 2" [ | 0.232 | 0.180 | 0.429 | 2.4e-58 | |
| TAIR|locus:2154709 | 1036 | PSKR2 "phytosylfokine-alpha re | 0.258 | 0.194 | 0.436 | 4.4e-58 |
| TAIR|locus:2013825 TMK1 "transmembrane kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2155 (763.7 bits), Expect = 3.2e-223, P = 3.2e-223
Identities = 432/741 (58%), Positives = 526/741 (70%)
Query: 36 LKTSLGNPASLGWTDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLE 95
LK SL P+S GW+DPDPCKW HI C+ + RVTRIQIG ++GTL +L +LS L LE
Sbjct: 35 LKKSLNPPSSFGWSDPDPCKWTHIVCTGTKRVTRIQIGHSGLQGTLSPDLRNLSELERLE 94
Query: 96 VMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPE 155
+ N ++G +PSLSGL+SLQ ++ +NNF S+PSD F+GLTSLQ++ +D N F SW IPE
Sbjct: 95 LQWNNISGPVPSLSGLASLQVLMLSNNNFDSIPSDVFQGLTSLQSVEIDNNPFKSWEIPE 154
Query: 156 SLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTL 215
SL++A+ LQ FSAN AN++G++P FLG D PGL LHLAFN L+G +P+S S +Q+L
Sbjct: 155 SLRNASALQNFSANSANVSGSLPGFLGPDEFPGLSILHLAFNNLEGELPMSLAGSQVQSL 214
Query: 216 WLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTXXXXXXXXXXXXQDFSVRDNQLTGI 275
WLNGQK L G + V+QNMT L ++WLH N F+ + S+RDN TG
Sbjct: 215 WLNGQK----LTGDITVLQNMTGLKEVWLHSNKFSGPLPDFSGLKELESLSLRDNSFTGP 270
Query: 276 VPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLL 335
VP+SL++L SL VVNLTNN QG P F S V D+ K SNSFCL G CD RV LL
Sbjct: 271 VPASLLSLESLKVVNLTNNHLQGPVPVFKSSVSVDLDKDSNSFCLSSPG-ECDPRVKSLL 329
Query: 336 SIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTS 395
I S YP LAESWKGN+PC ++W G++C + GNITV++L+ + L+GTIS F + S
Sbjct: 330 LIASSFDYPPRLAESWKGNDPC-TNWIGIAC-SNGNITVISLEKMELTGTISPEFGAIKS 387
Query: 396 LRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQNVIVKTDGNPDIGKDX 455
L++++L N LTG IP+ELTTLP+L+ LDVS+N LFGKVP FR NV+V T+GNPDIGKD
Sbjct: 388 LQRIILGINNLTGMIPQELTTLPNLKTLDVSSNKLFGKVPGFRSNVVVNTNGNPDIGKDK 447
Query: 456 XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXIVGSVVGVVCGAFIVGL-GFCLY 514
IVGSV+G + F++GL FC Y
Sbjct: 448 SSLSSPGSSSPSGGSGSGINGDKDRRGMKSSTFIGI-IVGSVLGGLLSIFLIGLLVFCWY 506
Query: 515 TRKRKRSGRVQSPNAVVIHPSNGG-DGNAVKIXXXXXXXXXXXXXXQSLTSSGPSD---- 569
+++KR +S NAVV+HP + G D +VKI + T G S+
Sbjct: 507 KKRQKRFSGSESSNAVVVHPRHSGSDNESVKITVAGSSVSVGGIS-DTYTLPGTSEVGDN 565
Query: 570 LHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSE 629
+ +VEAG+M+ISIQVLR+VTNNFS +N+LG GGFG VYKGELHDGTKIAVKRME+ V++
Sbjct: 566 IQMVEAGNMLISIQVLRSVTNNFSSDNILGSGGFGVVYKGELHDGTKIAVKRMENGVIAG 625
Query: 630 KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKP 689
KGFAEFKSEIAVLTKVRHRHLV LLGYCLDGNE+LLVYEYMPQGTLSRHLF EEGLKP
Sbjct: 626 KGFAEFKSEIAVLTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQGTLSRHLFEWSEEGLKP 685
Query: 690 LEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
L W +RLT+ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP+
Sbjct: 686 LLWKQRLTLALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE- 744
Query: 750 GKHSIETRLAGTFGYLAPEYA 770
GK SIETR+AGTFGYLAPEYA
Sbjct: 745 GKGSIETRIAGTFGYLAPEYA 765
|
|
| TAIR|locus:2059703 AT2G01820 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2137 (757.3 bits), Expect = 2.6e-221, P = 2.6e-221
Identities = 425/737 (57%), Positives = 526/737 (71%)
Query: 36 LKTSLGNPASLGWTDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLE 95
LK+SL + + W++P+PCKW+ +QC SNRVT+IQ+ + I GTLP L SLS L +LE
Sbjct: 36 LKSSLNLTSDVDWSNPNPCKWQSVQCDGSNRVTKIQLKQKGIRGTLPTNLQSLSELVILE 95
Query: 96 VMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPE 155
+ N+++G IP LSGLS LQ + DN FTSVP + F G++SLQ + L+ N FD WVIP+
Sbjct: 96 LFLNRISGPIPDLSGLSRLQTLNLHDNLFTSVPKNLFSGMSSLQEMYLENNPFDPWVIPD 155
Query: 156 SLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTL 215
++K+AT LQ + + +I G IPDF G ++P L +L L+ N L+G +P+SF +SIQ+L
Sbjct: 156 TVKEATSLQNLTLSNCSIIGKIPDFFGSQSLPSLTNLKLSQNGLEGELPMSFAGTSIQSL 215
Query: 216 WLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTXXXXXXXXXXXXQDFSVRDNQLTGI 275
+LNGQK LNGS++V+ NMTSL ++ L GN F+ + F+VR+NQLTG+
Sbjct: 216 FLNGQK----LNGSISVLGNMTSLVEVSLQGNQFSGPIPDLSGLVSLRVFNVRENQLTGV 271
Query: 276 VPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLL 335
VP SLV+L SL VNLTNN QG TP F V D+ NSFC + AG ACD RV+ L+
Sbjct: 272 VPQSLVSLSSLTTVNLTNNYLQGPTPLFGKSVGVDIVNNMNSFCTNVAGEACDPRVDTLV 331
Query: 336 SIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTS 395
S+ +S GYP LAESWKGNNPC +W G++C +GGNITVVN++ LSGTIS + ++LTS
Sbjct: 332 SVAESFGYPVKLAESWKGNNPC-VNWVGITC-SGGNITVVNMRKQDLSGTISPSLAKLTS 389
Query: 396 LRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQNVIVKTDGNPDIGKDX 455
L + L+ N+L+G IP ELTTL L +LDVSNN +G P FR V + T+GN ++GK+
Sbjct: 390 LETINLADNKLSGHIPDELTTLSKLRLLDVSNNDFYGIPPKFRDTVTLVTEGNANMGKNG 449
Query: 456 XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXIVGSVVGVVCGAFIVGLGFCLYT 515
+VG VVG +C +VGLG CLY
Sbjct: 450 PNKTSDAPGASPGSKPSGGSDGSETSKKSSNVKIIVPVVGGVVGALC---LVGLGVCLYA 506
Query: 516 RKRKRSGRVQSPNA-VVIHPSNGGDGNAVKIXXXXXXXXXXXXXXQ-SLTSSGPSDLHVV 573
+KRKR RVQSP++ +VIHP + GD + +K+ S + S SD+HVV
Sbjct: 507 KKRKRPARVQSPSSNMVIHPHHSGDNDDIKLTVAASSLNSGGGSDSYSHSGSAASDIHVV 566
Query: 574 EAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFA 633
EAG++VISIQVLRNVTNNFSEEN+LGRGGFGTVYKGELHDGTKIAVKRMES+VVS+KG
Sbjct: 567 EAGNLVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMESSVVSDKGLT 626
Query: 634 EFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWT 693
EFKSEI VLTK+RHRHLV LLGYCLDGNERLLVYEYMPQGTLS+HLF+ KEEG KPL+WT
Sbjct: 627 EFKSEITVLTKMRHRHLVALLGYCLDGNERLLVYEYMPQGTLSQHLFHWKEEGRKPLDWT 686
Query: 694 RRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753
RRL IALDVARGVEYLH LAHQSFIHRDLKPSNILLGDDMRAKV+DFGLVRLAPD GK+S
Sbjct: 687 RRLAIALDVARGVEYLHTLAHQSFIHRDLKPSNILLGDDMRAKVSDFGLVRLAPD-GKYS 745
Query: 754 IETRLAGTFGYLAPEYA 770
IETR+AGTFGYLAPEYA
Sbjct: 746 IETRVAGTFGYLAPEYA 762
|
|
| TAIR|locus:2095188 AT3G23750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1634 (580.3 bits), Expect = 5.2e-168, P = 5.2e-168
Identities = 347/735 (47%), Positives = 456/735 (62%)
Query: 42 NPASLGWTDP-DPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNK 100
NP W+ D CKW ++C+ RVT I + +++ G + E+++LS L + + +NK
Sbjct: 38 NPPPSDWSSTTDFCKWSGVRCT-GGRVTTISLADKSLTGFIAPEISTLSELKSVSIQRNK 96
Query: 101 LTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL-DYNSFDSWVIPESLKD 159
L+G IPS + LSSLQE+ D+NNF V + F GLTSLQ +SL D N+ +W P L D
Sbjct: 97 LSGTIPSFAKLSSLQEIYMDENNFVGVETGAFAGLTSLQILSLSDNNNITTWSFPSELVD 156
Query: 160 ATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNG 219
+T L + NI G +PD D++ L +L L++N + G +P S GKSSIQ LW+N
Sbjct: 157 STSLTTIYLDNTNIAGVLPDIF--DSLASLQNLRLSYNNITGVLPPSLGKSSIQNLWINN 214
Query: 220 QKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTXXXXXXXXXXXXQDFSVRDNQLTGIVPSS 279
Q D ++G++ V+ +MTSL+Q WLH N F D +RDN LTGIVP +
Sbjct: 215 Q--DLGMSGTIEVLSSMTSLSQAWLHKNHFFGPIPDLSKSENLFDLQLRDNDLTGIVPPT 272
Query: 280 LVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVK 339
L+ L SL ++L NN FQG P F+ V+ + N FC AG +C +V LL++
Sbjct: 273 LLTLASLKNISLDNNKFQGPLPLFSPEVKVTI--DHNVFCTTKAGQSCSPQVMTLLAVAG 330
Query: 340 SVGYPAVLAESWKGNNPCNSDWKGVSCD-AGGNITVVNLKNLGLSGTISSNFSRLTSLRQ 398
+GYP++LAESW+G++ C S W VSCD AG N+ +NL G +G IS + LTSL+
Sbjct: 331 GLGYPSMLAESWQGDDAC-SGWAYVSCDSAGKNVVTLNLGKHGFTGFISPAIANLTSLKS 389
Query: 399 LMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQNVIVK-TDGNPDIGKDXXX 457
L L+GN+LTG IPKELT + SL+++DVSNN+L G++P F V GN +G +
Sbjct: 390 LYLNGNDLTGVIPKELTFMTSLQLIDVSNNNLRGEIPKFPATVKFSYKPGNALLGTNGGD 449
Query: 458 XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXIVGSVVGVVCGAFIVGLGFCLYTRK 517
+ +++G V F++ + + R
Sbjct: 450 GSSPGTGGASGGPGGSSGGGGSKVGVIVGVIVAVLVFLAILGFVVYKFVMKRKYGRFNRT 509
Query: 518 R-KRSGRVQSPNAVVIHPSNGGDGNAVKIXXXXXXXXXXXXXXQSLTSSGPSDLHVVEAG 576
++ G++ +AV SNGG GN S +S SD ++E G
Sbjct: 510 DPEKVGKILVSDAV----SNGGSGNG---GYANGHGANNFNALNSPSSGDNSDRFLLEGG 562
Query: 577 SMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFK 636
S+ I ++VLR VTNNFSE+N+LGRGGFG VY GELHDGTK AVKRME A + KG +EF+
Sbjct: 563 SVTIPMEVLRQVTNNFSEDNILGRGGFGVVYAGELHDGTKTAVKRMECAAMGNKGMSEFQ 622
Query: 637 SEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRL 696
+EIAVLTKVRHRHLV LLGYC++GNERLLVYEYMPQG L +HLF E G PL W +R+
Sbjct: 623 AEIAVLTKVRHRHLVALLGYCVNGNERLLVYEYMPQGNLGQHLFEWSELGYSPLTWKQRV 682
Query: 697 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIET 756
+IALDVARGVEYLH LA QSFIHRDLKPSNILLGDDMRAKVADFGLV+ APD GK+S+ET
Sbjct: 683 SIALDVARGVEYLHSLAQQSFIHRDLKPSNILLGDDMRAKVADFGLVKNAPD-GKYSVET 741
Query: 757 RLAGTFGYLAPEYAA 771
RLAGTFGYLAPEYAA
Sbjct: 742 RLAGTFGYLAPEYAA 756
|
|
| TAIR|locus:2024016 AT1G24650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1064 (379.6 bits), Expect = 1.3e-109, Sum P(2) = 1.3e-109
Identities = 225/416 (54%), Positives = 278/416 (66%)
Query: 36 LKTSLGNPASLGWTDPDPCKWK-HIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVL 94
LK S GNP W+ DPCKW I+C SNRVT IQIG + I G LP +L L+SLT
Sbjct: 34 LKLS-GNP---NWSGSDPCKWSMFIKCDASNRVTAIQIGDRGISGKLPPDLGKLTSLTKF 89
Query: 95 EVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIP 154
EVM+N+LTG IPSL+GL SL V +DN+FTSVP DFF GL+SLQ +SLD N FDSWVIP
Sbjct: 90 EVMRNRLTGPIPSLAGLKSLVTVYANDNDFTSVPEDFFSGLSSLQHVSLDNNPFDSWVIP 149
Query: 155 ESLKDATGLQRFSANGANITGTIPDFL-GGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQ 213
SL++AT L FSA N++G IPD+L G L L L++N L P++F S +Q
Sbjct: 150 PSLENATSLVDFSAVNCNLSGKIPDYLFEGKDFSSLTTLKLSYNSLVCEFPMNFSDSRVQ 209
Query: 214 TLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTXXXXXXXXXXXXQDFSVRDNQLT 273
L LNGQKG KL+GS++ +Q MTSLT + L GNSF+ + F+VR+NQL+
Sbjct: 210 VLMLNGQKGREKLHGSISFLQKMTSLTNVTLQGNSFSGPLPDFSGLVSLKSFNVRENQLS 269
Query: 274 GIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSP-VRFDMAKGSNSFCLDDAGVACDGRVN 332
G+VPSSL L SL+ V L NNL QG TP F +P ++ D+ G NSFCLD G +CD RVN
Sbjct: 270 GLVPSSLFELQSLSDVALGNNLLQGPTPNFTAPDIKPDL-NGLNSFCLDTPGTSCDPRVN 328
Query: 333 VLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSR 392
LLSIV++ GYP AE WKGN+PC S W G++C G +ITV+N KNLGL+GTIS F+
Sbjct: 329 TLLSIVEAFGYPVNFAEKWKGNDPC-SGWVGITC-TGTDITVINFKNLGLNGTISPRFAD 386
Query: 393 LTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQNVIVKTDGN 448
SLR + LS N L GTIP+EL L +L+ LDVS N L G+VP F IV T GN
Sbjct: 387 FASLRVINLSQNNLNGTIPQELAKLSNLKTLDVSKNRLCGEVPRFN-TTIVNTTGN 441
|
|
| TAIR|locus:2156992 AT5G49770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 454 (164.9 bits), Expect = 1.7e-61, Sum P(3) = 1.7e-61
Identities = 94/194 (48%), Positives = 129/194 (66%)
Query: 576 GSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEF 635
G+ + + L TNNFS+ N +G GG+G VYKG L +G IA+KR + S +G EF
Sbjct: 618 GTKAFTFEELSKCTNNFSDANDVGGGGYGQVYKGTLPNGQVIAIKRAQQG--SMQGAFEF 675
Query: 636 KSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRR 695
K+EI +L++V H+++V LLG+C D E++LVYEY+P G+L L + G+K L+WTRR
Sbjct: 676 KTEIELLSRVHHKNVVKLLGFCFDQKEQMLVYEYIPNGSLRDGLSGKN--GVK-LDWTRR 732
Query: 696 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE 755
L IAL +G+ YLH LA IHRD+K +NILL + + AKVADFGL +L D K +
Sbjct: 733 LKIALGSGKGLAYLHELADPPIIHRDVKSNNILLDEHLTAKVADFGLSKLVGDPEKAHVT 792
Query: 756 TRLAGTFGYLAPEY 769
T++ GT GYL PEY
Sbjct: 793 TQVKGTMGYLDPEY 806
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 370 (135.3 bits), Expect = 2.7e-61, Sum P(2) = 2.7e-61
Identities = 82/195 (42%), Positives = 120/195 (61%)
Query: 585 LRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRM--ESAVVSEKGFAEFKSEIAVL 642
+ T+N SEE ++G GG G VYK EL +G +AVK++ + ++S K F+ E+ L
Sbjct: 944 IMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSR---EVKTL 1000
Query: 643 TKVRHRHLVGLLGYCLDGNE--RLLVYEYMPQGTLSRHLFNRK---EEGLKPLEWTRRLT 697
++RHRHLV L+GYC +E LL+YEYM G++ L K E+ K L+W RL
Sbjct: 1001 GRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLR 1060
Query: 698 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE-- 755
IA+ +A+GVEYLH +HRD+K SN+LL +M A + DFGL ++ +N + +
Sbjct: 1061 IAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSN 1120
Query: 756 TRLAGTFGYLAPEYA 770
T A ++GY+APEYA
Sbjct: 1121 TWFACSYGYIAPEYA 1135
|
|
| UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 407 (148.3 bits), Expect = 1.1e-59, Sum P(2) = 1.1e-59
Identities = 87/209 (41%), Positives = 124/209 (59%)
Query: 569 DLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVS 628
+L E + ++ + T NFS+ +++G GGFGTVYK L +G ++A+KR+
Sbjct: 979 NLATFEHALLRVTADDILKATENFSKVHIIGDGGFGTVYKAALPEGRRVAIKRLHGGHQF 1038
Query: 629 EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLK 688
+ G EF +E+ + KV+H +LV LLGYC+ G+ER L+YEYM G+L L NR + L+
Sbjct: 1039 Q-GDREFLAEMETIGKVKHPNLVPLLGYCVCGDERFLIYEYMENGSLEMWLRNRAD-ALE 1096
Query: 689 PLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748
L W RL I L ARG+ +LH IHRD+K SNILL ++ +V+DFGL R+
Sbjct: 1097 ALGWPDRLKICLGSARGLAFLHHGFVPHIIHRDMKSSNILLDENFEPRVSDFGLARIISA 1156
Query: 749 NGKHSIETRLAGTFGYLAPEYAAETSGMT 777
H + T +AGTFGY+ PEY T
Sbjct: 1157 CETH-VSTDIAGTFGYIPPEYGLTMKSTT 1184
|
|
| TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 450 (163.5 bits), Expect = 4.9e-59, Sum P(3) = 4.9e-59
Identities = 92/194 (47%), Positives = 131/194 (67%)
Query: 576 GSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEF 635
G+ + + L+ T+NFSE N +G GG+G VY+G L +G IA+KR + S +G EF
Sbjct: 615 GAKAFTFEELKKCTDNFSEANDVGGGGYGKVYRGILPNGQLIAIKRAQQG--SLQGGLEF 672
Query: 636 KSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRR 695
K+EI +L++V H+++V LLG+C D NE++LVYEY+ G+L L + G++ L+WTRR
Sbjct: 673 KTEIELLSRVHHKNVVRLLGFCFDRNEQMLVYEYISNGSLKDSLSGKS--GIR-LDWTRR 729
Query: 696 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE 755
L IAL +G+ YLH LA IHRD+K +NILL +++ AKVADFGL +L D K +
Sbjct: 730 LKIALGSGKGLAYLHELADPPIIHRDIKSNNILLDENLTAKVADFGLSKLVGDPEKTHVT 789
Query: 756 TRLAGTFGYLAPEY 769
T++ GT GYL PEY
Sbjct: 790 TQVKGTMGYLDPEY 803
|
|
| TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 389 (142.0 bits), Expect = 2.4e-58, Sum P(2) = 2.4e-58
Identities = 79/184 (42%), Positives = 112/184 (60%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR 646
+V ++ E+N++G+GG G VYKG + G +AVKR+ + F +EI L ++R
Sbjct: 685 DVLDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLATMSHGSSHDHGFNAEIQTLGRIR 744
Query: 647 HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706
HRH+V LLG+C + LLVYEYMP G+L L +K G L W R IAL+ A+G+
Sbjct: 745 HRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKG-G--HLHWNTRYKIALEAAKGL 801
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLA 766
YLH +HRD+K +NILL + A VADFGL + D+G + +AG++GY+A
Sbjct: 802 CYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIA 861
Query: 767 PEYA 770
PEYA
Sbjct: 862 PEYA 865
|
|
| TAIR|locus:2154709 PSKR2 "phytosylfokine-alpha receptor 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 419 (152.6 bits), Expect = 4.4e-58, Sum P(2) = 4.4e-58
Identities = 90/206 (43%), Positives = 123/206 (59%)
Query: 566 GPSDLHVVEA-GSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMES 624
GPS + + + G +S++ L TNNFS+ N++G GGFG VYK DG+K AVKR+
Sbjct: 727 GPSKIVLFHSCGCKDLSVEELLKSTNNFSQANIIGCGGFGLVYKANFPDGSKAAVKRLSG 786
Query: 625 AVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKE 684
+ EF++E+ L++ H++LV L GYC GN+RLL+Y +M G+L L R +
Sbjct: 787 DCGQME--REFQAEVEALSRAEHKNLVSLQGYCKHGNDRLLIYSFMENGSLDYWLHERVD 844
Query: 685 EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
G L W RL IA ARG+ YLH + + IHRD+K SNILL + A +ADFGL R
Sbjct: 845 -GNMTLIWDVRLKIAQGAARGLAYLHKVCEPNVIHRDVKSSNILLDEKFEAHLADFGLAR 903
Query: 745 LAPDNGKHSIETRLAGTFGYLAPEYA 770
L H + T L GT GY+ PEY+
Sbjct: 904 LLRPYDTH-VTTDLVGTLGYIPPEYS 928
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.VIII.2922.1 | hypothetical protein (927 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 779 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-44 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-43 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-39 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-29 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-28 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-27 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-25 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-23 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-23 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-23 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-23 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-20 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-20 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-20 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-19 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-19 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-19 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-19 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-17 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-16 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-16 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-15 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-12 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-12 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 8e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-10 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 9e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 7e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-04 | |
| PRK15387 | 788 | PRK15387, PRK15387, E3 ubiquitin-protein ligase Ss | 4e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-04 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 6e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.001 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.002 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.002 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 0.002 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.004 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.004 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 1e-44
Identities = 67/173 (38%), Positives = 86/173 (49%), Gaps = 12/173 (6%)
Query: 598 LGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
LG GGFGTVY G K+A+K + S E EI +L K+ H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII-KKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 657 CLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS 716
D N LV EY G+L L + L L I L + G+EYLH
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENE----GKLSEDEILRILLQILEGLEYLH---SNG 112
Query: 717 FIHRDLKPSNILLG-DDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
IHRDLKP NILL D+ + K+ADFGL +L + S+ + GT Y+APE
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK--SLLKTIVGTPAYMAPE 163
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 5e-43
Identities = 63/173 (36%), Positives = 84/173 (48%), Gaps = 11/173 (6%)
Query: 597 VLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLG 655
LG G FGTVYK + G +AVK ++ K + EI +L ++ H ++V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ 715
D + LV EY G L +L PL IAL + RG+EYLH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGG-----PLSEDEAKKIALQILRGLEYLHS---N 117
Query: 716 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
IHRDLKP NILL ++ K+ADFGL + + T GT Y+APE
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL--TTFVGTPWYMAPE 168
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 7e-43
Identities = 58/178 (32%), Positives = 82/178 (46%), Gaps = 13/178 (7%)
Query: 592 FSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
+ LG G FG VY + G +A+K ++ + + EI +L K++H ++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD-RERILREIKILKKLKHPNI 59
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
V L D ++ LV EY G L L +K L + R + +EYLH
Sbjct: 60 VRLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRL-SEDEARF--YLRQILSALEYLH 114
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
+ +HRDLKP NILL +D K+ADFGL R K T GT Y+APE
Sbjct: 115 S---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL---TTFVGTPEYMAPE 166
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 60/164 (36%), Positives = 85/164 (51%), Gaps = 14/164 (8%)
Query: 596 NVLGRGGFGTVYKGELHDG----TKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
LG G FG VYKG+L T++AVK + E A SE+ +F E V+ K+ H ++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA--SEEERKDFLKEARVMKKLGHPNV 58
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHL----FNRKEEGLKPLEWTRRLTIALDVARGV 706
V LLG C + LV EYM G L +L L L+ A+ +A+G+
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750
EYL + F+HRDL N L+G+D+ K++DFGL R D+
Sbjct: 119 EYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 63/181 (34%), Positives = 94/181 (51%), Gaps = 17/181 (9%)
Query: 595 ENVLGRGGFGTVYKGEL-----HDGTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHR 648
LG G FG VYKG L ++AVK + E A + EF E ++ K+ H
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQI--EEFLREARIMRKLDHP 61
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
++V LLG C + ++V EYMP G L +L + + L + L+ AL +ARG+EY
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSD---LLSFALQIARGMEY 118
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG-KHSIETRLAGTFGYLAP 767
L ++FIHRDL N L+G+++ K++DFGL R D+ +L ++AP
Sbjct: 119 LE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAP 173
Query: 768 E 768
E
Sbjct: 174 E 174
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (367), Expect = 5e-39
Identities = 60/160 (37%), Positives = 87/160 (54%), Gaps = 15/160 (9%)
Query: 595 ENVLGRGGFGTVYKGEL-----HDGTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHR 648
LG G FG VYKG+L ++AVK + E A SE+ EF E ++ K+ H
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA--SEQQIEEFLREARIMRKLDHP 61
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
++V LLG C + +V EYM G L +L + + L + L+ AL +ARG+EY
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK----LSLSDLLSFALQIARGMEY 117
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748
L ++FIHRDL N L+G+++ K++DFGL R D
Sbjct: 118 LE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 154
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 61/155 (39%), Positives = 84/155 (54%), Gaps = 15/155 (9%)
Query: 597 VLGRGGFGTVYKGELHD-----GTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
LG G FG VYKG L TK+AVK + E A SE+ EF E +++ K+ H ++
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGA--SEEEREEFLEEASIMKKLSHPNI 63
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
V LLG C G +V EYMP G L L E L L +AL +A+G+EYL
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE----KLTLKDLLQMALQIAKGMEYLE 119
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745
++F+HRDL N L+ +++ K++DFGL R
Sbjct: 120 S---KNFVHRDLAARNCLVTENLVVKISDFGLSRD 151
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 5e-37
Identities = 57/176 (32%), Positives = 86/176 (48%), Gaps = 11/176 (6%)
Query: 596 NVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
+LGRG FG+VY D G +AVK +E + SE+ + EI +L+ ++H ++V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 655 GYCLD--GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
G D N + EY+ G+LS L +K L R+ T + G+ YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPV-IRKYTR--QILEGLAYLHS- 119
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
+HRD+K +NIL+ D K+ADFG + D + GT ++APE
Sbjct: 120 --NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 54/179 (30%), Positives = 94/179 (52%), Gaps = 15/179 (8%)
Query: 592 FSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
F +G+GGFG VYK G ++A+K ++ + S++ + +EI +L K +H ++
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK--LESKEKKEKIINEIQILKKCKHPNI 59
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
V G L +E +V E+ G+L L + + L ++ + ++ +G+EYLH
Sbjct: 60 VKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLH 115
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNGKHSIETRLAGTFGYLAPE 768
IHRD+K +NILL D K+ DFGL +L+ ++++ GT ++APE
Sbjct: 116 S---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM----VGTPYWMAPE 167
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 9e-29
Identities = 109/366 (29%), Positives = 174/366 (47%), Gaps = 51/366 (13%)
Query: 77 IEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFT-SVPSDFFKG 134
+ G +P ++ S SSL VL++ N L G+IP SL+ L+SL+ + N +P + +
Sbjct: 152 LSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQ- 210
Query: 135 LTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHL 194
+ SL+ I L YN N++G IP +GG T L HL L
Sbjct: 211 MKSLKWIYLGYN-------------------------NLSGEIPYEIGGLT--SLNHLDL 243
Query: 195 AFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVA-VIQNMTSLTQLWLHGNSFTGP 252
+N L GPIP S G ++Q L+L +KL+G + I ++ L L L NS +G
Sbjct: 244 VYNNLTGPIPSSLGNLKNLQYLFLY----QNKLSGPIPPSIFSLQKLISLDLSDNSLSGE 299
Query: 253 LPDL-SGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDM 311
+P+L L +L+ + N TG +P +L +L L V+ L +N F G+ PK ++
Sbjct: 300 IPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK-------NL 352
Query: 312 AKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGN 371
K +N LD + G + L ++ + + S +G P S A +
Sbjct: 353 GKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIP-------KSLGACRS 405
Query: 372 ITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLF 431
+ V L++ SG + S F++L + L +S N L G I +PSL+ML ++ N F
Sbjct: 406 LRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFF 465
Query: 432 GKVPNF 437
G +P+
Sbjct: 466 GGLPDS 471
|
Length = 968 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 64/174 (36%), Positives = 96/174 (55%), Gaps = 21/174 (12%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657
+G+G FG V G+ G K+AVK ++ F +E +V+T +RH +LV LLG
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDS---TAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 658 LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSF 717
L GN +V EYM +G+L +L +R G + ++L ALDV G+EYL ++F
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSR---GRAVITLAQQLGFALDVCEGMEYLEE---KNF 123
Query: 718 IHRDLKPSNILLGDDMRAKVADFGL---VRLAPDNGKHSIETRLAGTFGYLAPE 768
+HRDL N+L+ +D+ AKV+DFGL D+GK ++ + APE
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK--------WTAPE 169
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 8e-28
Identities = 117/378 (30%), Positives = 164/378 (43%), Gaps = 66/378 (17%)
Query: 70 IQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFT-SV 127
I +G N+ G +P E+ L+SL L+++ N LTG IP SL L +LQ + N + +
Sbjct: 217 IYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPI 276
Query: 128 PSDFFKGLTSLQTISLDY-NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTI 186
P F L L ISLD ++ S IPE + L+ N TG IP L ++
Sbjct: 277 PPSIF-SLQKL--ISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALT--SL 331
Query: 187 PGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHG 246
P L L L N G IP + GK N +LT L L
Sbjct: 332 PRLQVLQLWSNKFSGEIPKNLGK------------------------HN--NLTVLDLST 365
Query: 247 NSFTGPLPDL---SG-LSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK 302
N+ TG +P+ SG L L FS N L G +P SL SL V L +N F G+ P
Sbjct: 366 NNLTGEIPEGLCSSGNLFKLILFS---NSLEGEIPKSLGACRSLRRVRLQDNSFSGELPS 422
Query: 303 FNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWK 362
+ K + LD + GR+N + S+ ++ + G P + K
Sbjct: 423 -------EFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSK 475
Query: 363 GVSCDAGGNITVVNLKNLGL-----SGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTL 417
L+NL L SG + L+ L QL LS N+L+G IP EL++
Sbjct: 476 -------------RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSC 522
Query: 418 PSLEMLDVSNNHLFGKVP 435
L LD+S+N L G++P
Sbjct: 523 KKLVSLDLSHNQLSGQIP 540
|
Length = 968 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 60/175 (34%), Positives = 82/175 (46%), Gaps = 14/175 (8%)
Query: 598 LGRGGFGTVYK-GELHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLG 655
LG+G FG V + G A+K ++ ++ K +E +L+++ H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 656 YCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
Y E+L LV EY P G L HL +EG E R A ++ +EYLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARF--YAAEIVLALEYLHS--- 111
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEY 769
I+RDLKP NILL D K+ DFGL + G + GT YLAPE
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT--NTFCGTPEYLAPEV 164
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 9e-27
Identities = 66/192 (34%), Positives = 89/192 (46%), Gaps = 14/192 (7%)
Query: 591 NFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRH-R 648
++ LG G FG VY D +A+K + + S+ E F EI +L + H
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
++V L + D LV EY+ G+L L +G PL + L I + +EY
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKG--PLSESEALFILAQILSALEY 116
Query: 709 LHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFGLVRLAPDNGKHSIETRLA----GTFG 763
LH + IHRD+KP NILL D K+ DFGL +L PD G S L GT G
Sbjct: 117 LH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 764 YLAPEYAAETSG 775
Y+APE S
Sbjct: 174 YMAPEVLLGLSL 185
|
Length = 384 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-26
Identities = 113/441 (25%), Positives = 187/441 (42%), Gaps = 77/441 (17%)
Query: 2 KKRHLGVSLFLLSLLSATLSVNSQSSSDAAAMQALKTSLGNPASL--GW-TDPDPCKWKH 58
KK + L L+ + + + + + K+S+ +P W + D C W+
Sbjct: 3 KKGPQHCPYLIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQG 62
Query: 59 IQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQE 116
I C+ S+RV I + G+NI G + + L + + + N+L+G IP + SSL+
Sbjct: 63 ITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRY 122
Query: 117 VLFDDNNFT-SVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITG 175
+ +NNFT S+P + +L+T+ L N S IP + + L+ G + G
Sbjct: 123 LNLSNNNFTGSIPRGS---IPNLETLDLSNNML-SGEIPNDIGSFSSLKVLDLGGNVLVG 178
Query: 176 TIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQN 235
IP+ L + L L LA N L G IP G+
Sbjct: 179 KIPNSLT--NLTSLEFLTLASNQLVGQIPRELGQ-------------------------- 210
Query: 236 MTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
M SL ++L N+ +G +P ++ GL+SL + N LTG +PSSL NL +L + L N
Sbjct: 211 MKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQN 270
Query: 295 LFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGN 354
G P P F + LD + + G + L+ ++
Sbjct: 271 KLSGPIP----PSIFSL---QKLISLDLSDNSLSGEIPELVIQLQ--------------- 308
Query: 355 NPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKEL 414
N+ +++L + +G I + L L+ L L N+ +G IPK L
Sbjct: 309 ----------------NLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNL 352
Query: 415 TTLPSLEMLDVSNNHLFGKVP 435
+L +LD+S N+L G++P
Sbjct: 353 GKHNNLTVLDLSTNNLTGEIP 373
|
Length = 968 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 55/163 (33%), Positives = 81/163 (49%), Gaps = 19/163 (11%)
Query: 597 VLGRGGFGTVYKGEL------HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
LG G FG V+ GE +D +AVK ++ S +F+ E +LT +H ++
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENI 70
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHL------FNR-KEEGLKPLEWTRR--LTIALD 701
V G C +G+ ++V+EYM G L++ L K E T L IA+
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 702 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
+A G+ Y LA Q F+HRDL N L+G D+ K+ DFG+ R
Sbjct: 131 IASGMVY---LASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 56/152 (36%), Positives = 86/152 (56%), Gaps = 9/152 (5%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657
LG G FG V+ G + TK+AVK ++ +S + F + E ++ K+RH LV L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQ---EAQIMKKLRHDKLVQLYAVC 70
Query: 658 LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSF 717
+ +V EYM +G+L L + EG K L + + +A +A G+ YL +++
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFL--KSGEG-KKLRLPQLVDMAAQIAEGMAYLE---SRNY 124
Query: 718 IHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
IHRDL NIL+G+++ K+ADFGL RL D+
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDD 156
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 57/157 (36%), Positives = 86/157 (54%), Gaps = 8/157 (5%)
Query: 592 FSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
F+ E LG G FG V++G + ++A+K ++S +F+ E+ L ++RH+HL+
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLI 65
Query: 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHG 711
L C G ++ E M +G+L F R EG + L + +A VA G+ YL
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSL--LAFLRSPEG-QVLPVASLIDMACQVAEGMAYLE- 121
Query: 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748
Q+ IHRDL NIL+G+D+ KVADFGL RL +
Sbjct: 122 --EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 56/185 (30%), Positives = 91/185 (49%), Gaps = 23/185 (12%)
Query: 591 NFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
N+ +++GRG FG VYKG L G +A+K++ + E+ EI +L ++H +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHL--FNRKEEGLKPLEWTRRLTIALDVA---R 704
+V +G + ++ EY G+L + + F E L +A+ V +
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL----------VAVYVYQVLQ 110
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNGKHSIETRLAGTFG 763
G+ YLH Q IHRD+K +NIL D K+ADFG+ +L N + + GT
Sbjct: 111 GLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKL---NDVSKDDASVVGTPY 164
Query: 764 YLAPE 768
++APE
Sbjct: 165 WMAPE 169
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 53/159 (33%), Positives = 85/159 (53%), Gaps = 14/159 (8%)
Query: 597 VLGRGGFGTVYKGELH--DGT--KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVG 652
+LG G FG+V +G+L DG+ K+AVK M+ + + EF SE A + H +++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 653 LLGYCLDGNER------LLVYEYMPQGTLSRHLF-NRKEEGLKPLEWTRRLTIALDVARG 705
L+G C + + +++ +M G L L +R + L L +D+A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
+EYL ++++FIHRDL N +L +DM VADFGL +
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 57/152 (37%), Positives = 76/152 (50%), Gaps = 10/152 (6%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657
LG G FG V+ G+ +A+K + +SE F E E V+ K+ H +LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIE---EAKVMMKLSHPNLVQLYGVC 68
Query: 658 LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSF 717
+V EYM G L +L R+ +G EW L + DV +EYL F
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYL--RERKGKLGTEWL--LDMCSDVCEAMEYLE---SNGF 121
Query: 718 IHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
IHRDL N L+G+D KV+DFGL R D+
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 57/172 (33%), Positives = 86/172 (50%), Gaps = 25/172 (14%)
Query: 592 FSEENVLGRGGFGTVYKGEL------HDGTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTK 644
F EE LG G FG VYKGEL T +A+K + E+A + EF+ E +++
Sbjct: 9 FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQ--QEFRQEAELMSD 64
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-----------KEEGLKPLEWT 693
++H ++V LLG C +++EY+ G L L E L+ +
Sbjct: 65 LQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCS 124
Query: 694 RRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745
L IA+ +A G+EY L+ F+HRDL N L+G+ + K++DFGL R
Sbjct: 125 DFLHIAIQIAAGMEY---LSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRD 173
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 53/152 (34%), Positives = 79/152 (51%), Gaps = 10/152 (6%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657
+G G FG V+ G + K+A+K + +SE+ +F E V+ K+ H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 658 LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSF 717
+ + LV+E+M G LS +L R + G L + LDV G+ YL +
Sbjct: 69 TERSPICLVFEFMEHGCLSDYL--RAQRGK--FSQETLLGMCLDVCEGMAYLE---SSNV 121
Query: 718 IHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
IHRDL N L+G++ KV+DFG+ R D+
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 56/163 (34%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 598 LGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
LG G FG V+ E H D +AVK ++ A SE +F+ E +LT ++H+H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIV 70
Query: 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNR----------KEEGLKPLEWTRRLTIALD 701
G C +G L+V+EYM G L+R L + ++ L + L IA
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 702 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
+A G+ YL L F+HRDL N L+G + K+ DFG+ R
Sbjct: 131 IASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 17/184 (9%)
Query: 591 NFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
+ +G+G FG VY DG +K ++ + +SEK + +E+ +L K+ H +
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKP-----LEWTRRLTIALDVAR 704
++ + + +V EY G LS+ + +K+EG L+W +L +AL
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK--- 117
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
YLH + +HRD+KP NI L + K+ DFG+ ++ + + GT Y
Sbjct: 118 ---YLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA--KTVVGTPYY 169
Query: 765 LAPE 768
L+PE
Sbjct: 170 LSPE 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 6e-23
Identities = 56/153 (36%), Positives = 88/153 (57%), Gaps = 12/153 (7%)
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
+G+G FG V G+ + G K+AVK +++ ++ F +E +V+T++RH +LV LL
Sbjct: 11 LQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNLVQLL 65
Query: 655 GYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
G ++ L +V EYM +G+L +L +R G L L +LDV +EYL
Sbjct: 66 GVIVEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEA-- 120
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746
+F+HRDL N+L+ +D AKV+DFGL + A
Sbjct: 121 -NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 152
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 6e-23
Identities = 62/192 (32%), Positives = 97/192 (50%), Gaps = 24/192 (12%)
Query: 581 SIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIA 640
SIQ+LR LG G FG V++G ++ T +AVK ++ + K +F +E
Sbjct: 7 SIQLLRK----------LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK---DFLAEAQ 53
Query: 641 VLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIAL 700
++ K+RH L+ L C +V E M G+L +L + + L+ + + +A
Sbjct: 54 IMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYL---QGGAGRALKLPQLIDMAA 110
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAG 760
VA G+ YL Q++IHRDL N+L+G++ KVADFGL R+ ++ E R
Sbjct: 111 QVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKED---IYEAREGA 164
Query: 761 TF--GYLAPEYA 770
F + APE A
Sbjct: 165 KFPIKWTAPEAA 176
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 3e-22
Identities = 52/160 (32%), Positives = 82/160 (51%), Gaps = 17/160 (10%)
Query: 596 NVLGRGGFGTVYKGE---LHDGT--KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
LG G FG V L D T ++AVK + + E+ ++F+ EI +L + H ++
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE-EQHRSDFEREIEILRTLDHENI 68
Query: 651 VGLLGYCLD--GNERLLVYEYMPQGTLSRHL-FNRKEEGLKPLEWTRRLTIALDVARGVE 707
V G C G L+ EY+P G+L +L +R + LK L L + + +G++
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRL-----LLFSSQICKGMD 123
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747
YL Q +IHRDL NIL+ + K++DFGL ++ P
Sbjct: 124 YLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 4e-22
Identities = 59/176 (33%), Positives = 88/176 (50%), Gaps = 13/176 (7%)
Query: 598 LGRGGFGTVYKGELHDGT----KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGL 653
LG G FG V +GE +AVK ++S +S+ +F E A++ + H +L+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDI-MDDFLKEAAIMHSLDHENLIRL 61
Query: 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
G L + ++V E P G+L L +++ L + A+ +A G+ YL
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSL---LDRLRKDALGHFLISTLCDYAVQIANGMRYLE--- 114
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSI-ETRLAGTFGYLAPE 768
+ FIHRDL NILL D + K+ DFGL+R P N H + E L F + APE
Sbjct: 115 SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE 170
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 6e-22
Identities = 60/151 (39%), Positives = 85/151 (56%), Gaps = 12/151 (7%)
Query: 597 VLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
++G G FG V +GE + G K+AVK ++ V ++ F E AV+TK+ H++LV LLG
Sbjct: 13 IIGEGEFGAVLQGE-YTGQKVAVKNIKCDVTAQA----FLEETAVMTKLHHKNLVRLLGV 67
Query: 657 CLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS 716
L N +V E M +G L L R G + + L +LDVA G+EYL +
Sbjct: 68 ILH-NGLYIVMELMSKGNLVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLES---KK 120
Query: 717 FIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747
+HRDL NIL+ +D AKV+DFGL R+
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGS 151
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (241), Expect = 6e-22
Identities = 49/160 (30%), Positives = 78/160 (48%), Gaps = 21/160 (13%)
Query: 592 FSEENVLGRGGFGTVYKG-ELHDGTKIAVK--RMESAVVSEKGFAEFKS----EIAVLTK 644
+ + LG G +G VYK + G +A+K R+++ E+G S EI++L +
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN---EEEGI---PSTALREISLLKE 54
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
++H ++V LL + LV+EY L + +++ L + I + R
Sbjct: 55 LKHPNIVKLLDVIHTERKLYLVFEYCDM-DL-KKYLDKRPGPL-SPNLIKS--IMYQLLR 109
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
G+ Y H +HRDLKP NIL+ D K+ADFGL R
Sbjct: 110 GLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 57/161 (35%), Positives = 87/161 (54%), Gaps = 19/161 (11%)
Query: 598 LGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
LG G FG V+ E + D +AVK ++ A S+ +F E +LT ++H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIV 70
Query: 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNR------KEEGLKPLEWTRR--LTIALDVA 703
G C++G+ ++V+EYM G L++ L EG +P E T+ L IA +A
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
G+ Y LA Q F+HRDL N L+G+++ K+ DFG+ R
Sbjct: 131 AGMVY---LASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 56/172 (32%), Positives = 81/172 (47%), Gaps = 10/172 (5%)
Query: 598 LGRGGFGTVYK-GELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
+G G G V+K + G +A+K++ + + EI L +H ++V LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 657 CLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS 716
G+ +LV EYMP LS L R EE P + L +GV Y+H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVL--RDEERPLPEAQVKSYMRML--LKGVAYMHAN---G 119
Query: 717 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
+HRDLKP+N+L+ D K+ADFGL RL + + + T Y APE
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLF-SEEEPRLYSHQVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 51/147 (34%), Positives = 83/147 (56%), Gaps = 8/147 (5%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657
+G+G FG VYKG L T++AVK S + + +F E +L + H ++V L+G C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK-RKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 658 LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSF 717
+ +V E +P G+L L RK++ ++ + L ++LD A G+EYL ++
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVK--KLLQMSLDAAAGMEYLES---KNC 114
Query: 718 IHRDLKPSNILLGDDMRAKVADFGLVR 744
IHRDL N L+G++ K++DFG+ R
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 5e-21
Identities = 62/176 (35%), Positives = 97/176 (55%), Gaps = 17/176 (9%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657
LG+G FG V+ G + T++A+K ++ +S + F + E V+ K+RH LV L Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQL--YA 68
Query: 658 LDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS 716
+ E + +V EYM +G+L L K E K L + + +A +A G+ Y+ + +
Sbjct: 69 VVSEEPIYIVTEYMSKGSLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVERM---N 122
Query: 717 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF--GYLAPEYA 770
++HRDL+ +NIL+G+++ KVADFGL RL DN R F + APE A
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIEDN---EYTARQGAKFPIKWTAPEAA 175
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 9e-21
Identities = 60/180 (33%), Positives = 95/180 (52%), Gaps = 11/180 (6%)
Query: 591 NFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
+F LG+G +G+VYK + L D A+K ++ +S+K + +EI +L V H +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
++ LDGN+ +V EY P G LS+ + RK++ K + I + + RG++ L
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKR-KLIPEQEIWRIFIQLLRGLQAL 119
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN-GKHSIETRLAGTFGYLAPE 768
H Q +HRDLK +NILL + K+ D G+ ++ N K I GT Y+APE
Sbjct: 120 H---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-----GTPHYMAPE 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 9e-21
Identities = 54/178 (30%), Positives = 78/178 (43%), Gaps = 15/178 (8%)
Query: 596 NVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
N +G G FG VY L G +AVK + K E E+ VL ++H +LV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
G + + + EY GTL L + + R T+ L G+ YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL---EHGRILDEHVIRVYTLQL--LEGLAYLH---S 117
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNGKHSIETRLAGTFG---YLAPE 768
+HRD+KP+NI L + K+ DFG V+L N ++ + G Y+APE
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK--NNTTTMGEEVQSLAGTPAYMAPE 173
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 51/157 (32%), Positives = 84/157 (53%), Gaps = 12/157 (7%)
Query: 595 ENVLGRGGFGTVYKG--ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVG 652
++ LG G +G VY+G + + T +AVK ++ + + EF E AV+ +++H +LV
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLT-VAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQ 66
Query: 653 LLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
LLG C ++ E+M G L +L + + + L +A ++ +EYL
Sbjct: 67 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE-- 121
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
++FIHRDL N L+G++ KVADFGL RL +
Sbjct: 122 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 1e-20
Identities = 62/179 (34%), Positives = 88/179 (49%), Gaps = 29/179 (16%)
Query: 590 NNFSEENVLGRGGFGTVYKGEL------HDGTKIAVKRM-ESAVVSEKGFAEFKSEIAVL 642
NN +G+G FG V++ T +AVK + E A S A+F+ E A++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALM 62
Query: 643 TKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLS---RHLFNRKEEGLK----------- 688
+ H ++V LLG C G L++EYM G L+ RH R + L
Sbjct: 63 AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122
Query: 689 ---PLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
PL T +L IA VA G+ YL + + F+HRDL N L+G++M K+ADFGL R
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 59/153 (38%), Positives = 89/153 (58%), Gaps = 12/153 (7%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657
LG G FG V+ G + TK+AVK ++ +S + F E E ++ K+RH LV L Y
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLE---EAQIMKKLRHDKLVQL--YA 68
Query: 658 LDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS 716
+ E + +V EYM +G+L F + EG + L+ + +A VA G+ Y+ + +
Sbjct: 69 VVSEEPIYIVTEYMSKGSLL--DFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERM---N 122
Query: 717 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
+IHRDL+ +NIL+GD + K+ADFGL RL DN
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 57/163 (34%), Positives = 79/163 (48%), Gaps = 18/163 (11%)
Query: 596 NVLGRGGFGTVYKG----ELHDGT---KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR 648
N LG G FG VY+G L G+ ++AVK + ++ EF E +++ H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLKEAHLMSNFNHP 59
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKP--LEWTRRLTIALDVARGV 706
++V LLG CL + ++ E M G L +L + + E P L L I LDVA+G
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 707 EYLHGLAHQSFIHRDLKPSNILL----GDDMR-AKVADFGLVR 744
YL + FIHRDL N L+ D R K+ DFGL R
Sbjct: 120 VYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 56/165 (33%), Positives = 79/165 (47%), Gaps = 22/165 (13%)
Query: 598 LGRGGFGTVYKGEL-----HDGT-KIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHL 650
LG G FG V K E + T +AVK M +EK ++ SE+ ++ + +H+++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVK-MLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLK-----PLEWTRRLT------IA 699
+ LLG C +V EY G L L R+ G P LT A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 700 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
VARG+E+L A + IHRDL N+L+ +D K+ADFGL R
Sbjct: 139 YQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 53/159 (33%), Positives = 85/159 (53%), Gaps = 17/159 (10%)
Query: 598 LGRGGFGTVYKGELHD------GTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
LG+G FG VY+G T++A+K + E+A + E+ EF +E +V+ + H+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASVMKEFNCHHV 71
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE-----GLKPLEWTRRLTIALDVARG 705
V LLG G L+V E M +G L +L +R+ E GL P + + +A ++A G
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
+ YL F+HRDL N ++ +D+ K+ DFG+ R
Sbjct: 132 MAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 52/164 (31%), Positives = 86/164 (52%), Gaps = 22/164 (13%)
Query: 598 LGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
LG G FG V+ E + D +AVK ++ ++ + +F+ E +LT ++H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHEHIV 70
Query: 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGL-----KPLE------WTRRLTIAL 700
G C DG+ ++V+EYM G L++ L + + +P + ++ L IA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
+A G+ Y LA Q F+HRDL N L+G ++ K+ DFG+ R
Sbjct: 131 QIASGMVY---LASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 4e-20
Identities = 59/201 (29%), Positives = 87/201 (43%), Gaps = 31/201 (15%)
Query: 590 NNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKV-R 646
++F ++G G F TV E + A+K ++ ++ EK K E VLT++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 647 HRHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARG 705
H ++ L Y E L V EY P G L +++ ++ G + TR A ++
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTR--FYAAEILLA 114
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLA------ 759
+EYLH IHRDLKP NILL DM K+ DFG ++ N A
Sbjct: 115 LEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 760 ------------GTFGYLAPE 768
GT Y++PE
Sbjct: 172 IEKNRRRFASFVGTAEYVSPE 192
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 5e-20
Identities = 61/176 (34%), Positives = 97/176 (55%), Gaps = 17/176 (9%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657
LG+G FG V+ G + TK+A+K ++ + + F + E ++ K+RH LV L Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQ---EAQIMKKLRHDKLVPL--YA 68
Query: 658 LDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS 716
+ E + +V E+M +G+L L KE K L+ + + +A +A G+ Y+ + +
Sbjct: 69 VVSEEPIYIVTEFMGKGSLLDFL---KEGDGKYLKLPQLVDMAAQIADGMAYIERM---N 122
Query: 717 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF--GYLAPEYA 770
+IHRDL+ +NIL+GD++ K+ADFGL RL DN R F + APE A
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLARLIEDN---EYTARQGAKFPIKWTAPEAA 175
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 6e-20
Identities = 55/182 (30%), Positives = 81/182 (44%), Gaps = 29/182 (15%)
Query: 597 VLGRGGFGTVYKGELHDGTK--IAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
VLG+G G VYK H T A+K++ E + E+ L ++V
Sbjct: 8 VLGQGSSGVVYKV-RHKPTGKIYALKKIHVDGDEEFR-KQLLRELKTLRSCESPYVVKCY 65
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKP--LEWTRRLTIALDVARGVEYLHGL 712
G E +V EYM G+L+ L +K + L IA + +G++YLH
Sbjct: 66 GAFYKEGEISIVLEYMDGGSLADLL--KKVGKIPEPVLA-----YIARQILKGLDYLHTK 118
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLA------GTFGYLA 766
H IHRD+KPSN+L+ K+ADFG+ + +E L GT Y++
Sbjct: 119 RHI--IHRDIKPSNLLINSKGEVKIADFGISK--------VLENTLDQCNTFVGTVTYMS 168
Query: 767 PE 768
PE
Sbjct: 169 PE 170
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 6e-20
Identities = 54/152 (35%), Positives = 76/152 (50%), Gaps = 10/152 (6%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657
LG G FG V+ G+ K+A+K + +SE+ F E E V+ K+ H LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIE---EAKVMMKLSHPKLVQLYGVC 68
Query: 658 LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSF 717
+V E+M G L +L R+ + K + L++ DV G+EYL SF
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDM----LLSMCQDVCEGMEYLE---RNSF 121
Query: 718 IHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
IHRDL N L+ KV+DFG+ R D+
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 7e-20
Identities = 56/165 (33%), Positives = 78/165 (47%), Gaps = 22/165 (13%)
Query: 597 VLGRGGFGTVYKG---ELHDGTKI--AVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
VLG G FGTVYKG + KI A+K + S K E E V+ V H H+V
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVV 72
Query: 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE--GLKPLEWTRRLTIALDVARGVEYL 709
LLG CL ++ L+ + MP G L ++ N K+ L W + +A+G+ YL
Sbjct: 73 RLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYL 125
Query: 710 --HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752
L +HRDL N+L+ K+ DFGL +L + K
Sbjct: 126 EEKRL-----VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 7e-20
Identities = 63/170 (37%), Positives = 88/170 (51%), Gaps = 19/170 (11%)
Query: 590 NNFSEENVLGRGGFGTVYKGELH-DGTKI--AVKRMESAVVSEKGFAEFKSEIAVLTKV- 645
N+ ++V+G G FG V K + DG ++ A+KRM+ S+ +F E+ VL K+
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLG 65
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTL------SRHL-----FNRKEEGLKPLEWTR 694
H +++ LLG C L EY P G L SR L F L +
Sbjct: 66 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 695 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
L A DVARG++YL + + FIHRDL NIL+G++ AK+ADFGL R
Sbjct: 126 LLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 7e-20
Identities = 68/191 (35%), Positives = 99/191 (51%), Gaps = 29/191 (15%)
Query: 592 FSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFK-SEIAVLTKVR--- 646
+ E +G G +GTVYK +L+ G +A+K++ +SE+G EIA+L ++
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKV-RVPLSEEGIPLSTLREIALLKQLESFE 59
Query: 647 HRHLVGLLGYCLDGNER------LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIAL 700
H ++V LL C G LV+E++ Q L+ +L + GL P E + L L
Sbjct: 60 HPNIVRLLDVC-HGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPP-ETIKDLMRQL 116
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAG 760
RGV++LH +H +HRDLKP NIL+ D + K+ADFGL R +S E L
Sbjct: 117 --LRGVDFLH--SH-RIVHRDLKPQNILVTSDGQVKIADFGLAR------IYSFEMALTS 165
Query: 761 ---TFGYLAPE 768
T Y APE
Sbjct: 166 VVVTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 60/195 (30%), Positives = 102/195 (52%), Gaps = 33/195 (16%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFA-----EFKSEIAVLTKVRHRHLV 651
LG G FG+VY+G L DG AVK E ++ + + + EIA+L+K++H ++V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVK--EVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 652 GLLGYCLDGNERLLVY-EYMPQGTLSRHL--FNRKEEGLKPLEWTRRLTIALDVARGVEY 708
LG + + L ++ E +P G+L++ L + E + L +TR++ + G+EY
Sbjct: 66 QYLGTEREE-DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRL-YTRQILL------GLEY 117
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLA----GTFGY 764
LH ++ +HRD+K +NIL+ + K+ADFG+ K +E A G+ +
Sbjct: 118 LHD---RNTVHRDIKGANILVDTNGVVKLADFGM-------AKQVVEFSFAKSFKGSPYW 167
Query: 765 LAPEYAAETSGMTWQ 779
+APE A+ G
Sbjct: 168 MAPEVIAQQGGYGLA 182
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 60/186 (32%), Positives = 96/186 (51%), Gaps = 21/186 (11%)
Query: 598 LGRGGFGTVYK---GELHDGTK--IAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVG 652
LG+G FG+V L D T +AVK+++ + + + +F+ EI +L ++H ++V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVK 69
Query: 653 LLGYCLDGNER--LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
G C R LV EY+P G+L +L +E L+ + L A + +G+EYL
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER----LDHRKLLLYASQICKGMEYL- 124
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAG---TFGYLAP 767
+ ++HRDL NIL+ + R K+ DFGL ++ P + K + R G F Y AP
Sbjct: 125 --GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD-KEYYKVREPGESPIFWY-AP 180
Query: 768 EYAAET 773
E E+
Sbjct: 181 ESLTES 186
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 1e-19
Identities = 49/155 (31%), Positives = 72/155 (46%), Gaps = 21/155 (13%)
Query: 598 LGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEK-GFA-EFKSEIAVLTKVRHRHLVGLL 654
+G G +G VYK G +A+K++ + +EK GF EI +L K+RH ++V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 655 GYCLD--GNERLLVYEYMP---QGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+V+EYM G L E +K + G++YL
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIK--------CYMKQLLEGLQYL 116
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
H +HRD+K SNIL+ +D K+ADFGL R
Sbjct: 117 H---SNGILHRDIKGSNILINNDGVLKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 60/186 (32%), Positives = 98/186 (52%), Gaps = 16/186 (8%)
Query: 596 NVLGRGGFGTVYKGELHDGTKIAVKRME----SAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
VLG+G +GTVY G + G IAVK++E + + +EK + + + E+ +L ++H ++V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHG 711
LG CLD N + E++P G++S L G P + T + GV YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYT--KQILDGVAYLH- 119
Query: 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR---LAPDNGKHS-IETRLAGTFGYLAP 767
+ +HRD+K +N++L + K+ DFG R +G HS + + GT ++AP
Sbjct: 120 --NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 768 EYAAET 773
E E+
Sbjct: 178 EVINES 183
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 56/186 (30%), Positives = 90/186 (48%), Gaps = 23/186 (12%)
Query: 589 TNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH 647
+ +G G G VYK + G ++A+K+M + ++ +EI ++ +H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR---LRKQNKELIINEILIMKDCKH 74
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLS---RHLFNRKEEGLKPLEWTRRLTIALDVAR 704
++V L G+E +V EYM G+L+ F R E + + +V +
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEP-------QIAYVCREVLQ 127
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNGK-HSIETRLAGTF 762
G+EYLH Q+ IHRD+K NILL D K+ADFG +L + K +S+ GT
Sbjct: 128 GLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV----VGTP 180
Query: 763 GYLAPE 768
++APE
Sbjct: 181 YWMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 56/191 (29%), Positives = 88/191 (46%), Gaps = 32/191 (16%)
Query: 591 NFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAE---FKS--EIAVLTK 644
+ + LG G + VYK G +A+K+++ + K + F + EI +L +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIK--LGERKEAKDGINFTALREIKLLQE 58
Query: 645 VRHRHLVGLLG-YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLE---WTRRLTIAL 700
++H +++GLL + N L V+E+M T + K L P + +
Sbjct: 59 LKHPNIIGLLDVFGHKSNINL-VFEFME--TDLEKVIKDKSIVLTPADIKSYMLMTL--- 112
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK---HSIETR 757
RG+EYLH +HRDLKP+N+L+ D K+ADFGL R + H + TR
Sbjct: 113 ---RGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTR 166
Query: 758 LAGTFGYLAPE 768
Y APE
Sbjct: 167 W-----YRAPE 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-19
Identities = 58/164 (35%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 595 ENVLGRGGFGTVYKGELH-DGTKI-AVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLV 651
E+V+G G FG V + + DG K+ A +M SE +F E+ VL K+ H +++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 652 GLLGYCLDGNERLLVYEYMPQGTL------SRHL-----FNRKEEGLKPLEWTRRLTIAL 700
LLG C + + EY P G L SR L F ++ L + L A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
DVA G++YL + + FIHRDL N+L+G+++ +K+ADFGL R
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 55/180 (30%), Positives = 81/180 (45%), Gaps = 13/180 (7%)
Query: 591 NFSEENVLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKG-FAEFKSEIAVLTKVRHR 648
+F V+G+G FG V + D K+ A+K M EKG +E +L ++ H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
LV L D LV + + G L HL + +K E + I ++ +EY
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHL----SQKVKFSEEQVKFWIC-EIVLALEY 115
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
LH + IHRD+KP NILL + + DF + + T +GT GY+APE
Sbjct: 116 LH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGTPGYMAPE 169
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 53/161 (32%), Positives = 77/161 (47%), Gaps = 17/161 (10%)
Query: 596 NVLGRGGFGTVYKGEL----HDGTKIAVK---RMESAVVSEKGFAEFKSEIAVLTKVRHR 648
LG G FG VY+G D ++ V ES SE+ ++F E +++K H+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQ 69
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRR--LTIALDVARGV 706
++V L+G + R ++ E M G L L + +P T + L A DVA+G
Sbjct: 70 NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 707 EYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVR 744
+YL FIHRD+ N LL G AK+ADFG+ R
Sbjct: 130 KYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 58/172 (33%), Positives = 89/172 (51%), Gaps = 9/172 (5%)
Query: 597 VLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
+LG+G FG V+KG L D T +AVK + + E +F SE +L + H ++V L+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI-KFLSEARILKQYDHPNIVKLIGV 60
Query: 657 CLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS 716
C +V E +P G L +K+E L+ + + ALD A G+ YL ++
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDE----LKTKQLVKFALDAAAGMAYLES---KN 113
Query: 717 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
IHRDL N L+G++ K++DFG+ R D+G +S + APE
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPE 164
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 4e-19
Identities = 64/180 (35%), Positives = 93/180 (51%), Gaps = 13/180 (7%)
Query: 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE-KGFAEFKSEIAVLTKVRHRH 649
F + VLG+GGFG V ++ G A KR+E + + KG + +E +L KV +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 650 LVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
+V L Y + + L LV M G L H++N G E R L A ++ G+E
Sbjct: 62 VVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF---EEERALFYAAEILCGLED 117
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
LH ++ ++RDLKP NILL D +++D GL P+ SI R+ GT GY+APE
Sbjct: 118 LH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--ESIRGRV-GTVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 4e-19
Identities = 54/159 (33%), Positives = 82/159 (51%), Gaps = 19/159 (11%)
Query: 598 LGRGGFGTVYKG--ELHDGTKI--AVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRHLVG 652
LG G FG+V KG + G ++ AVK + + + + K EF E +V+ ++ H +V
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLDHPCIVR 60
Query: 653 LLGYCLDGNERLLVYEYMPQGTLSRHLFNRKE-EGLKPLEWTRRLTIALDVARGVEYLHG 711
L+G C G +LV E P G L ++L R+E E A VA G+ YL
Sbjct: 61 LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLES 113
Query: 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPDN 749
+ F+HRDL N+LL + +AK++DFG+ R L +
Sbjct: 114 ---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS 149
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 56/157 (35%), Positives = 78/157 (49%), Gaps = 19/157 (12%)
Query: 596 NVLGRGGFGTVYKGELHDG----TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
V+G+G FG VY G L D AVK + + + + +F E ++ H +++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL-NRITDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 652 GLLGYCLDGN-ERLLVYEYMPQGTLSRHLFNRKEE---GLKPLEWTRRLTIALDVARGVE 707
LLG CL L+V YM G L R+ F R E +K L + L VA+G+E
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDL-RN-FIRSETHNPTVKDL-----IGFGLQVAKGME 112
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
YL A + F+HRDL N +L + KVADFGL R
Sbjct: 113 YL---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 62/180 (34%), Positives = 94/180 (52%), Gaps = 13/180 (7%)
Query: 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE-KGFAEFKSEIAVLTKVRHRH 649
F + VLG+GGFG V ++ G A K++E + + KG + +E +L KV R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 650 LVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
+V L Y + + L LV M G L H+++ E G E R + A ++ G+E
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGF---EEGRAVFYAAEICCGLED 117
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
LH + ++RDLKP NILL D +++D GL P+ +I+ R+ GT GY+APE
Sbjct: 118 LH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIKGRV-GTVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 8e-19
Identities = 70/241 (29%), Positives = 111/241 (46%), Gaps = 12/241 (4%)
Query: 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNN 123
N +T + + N+ G +P+ L S +L L + N L G+IP SL SL+ V DN+
Sbjct: 356 NNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNS 415
Query: 124 FT-SVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLG 182
F+ +PS+F K L + + + N+ I D LQ S G +PD G
Sbjct: 416 FSGELPSEFTK-LPLVYFLDISNNNL-QGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG 473
Query: 183 GDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQ 241
L +L L+ N G +P G S + L L+ K ++ ++ + + SL
Sbjct: 474 SKR---LENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLD- 529
Query: 242 LWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQT 300
L N +G +P S + L + NQL+G +P +L N+ SL VN+++N G
Sbjct: 530 --LSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSL 587
Query: 301 P 301
P
Sbjct: 588 P 588
|
Length = 968 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 8e-19
Identities = 55/152 (36%), Positives = 74/152 (48%), Gaps = 10/152 (6%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657
LG G FG V G+ +A+K ++ +SE EF E V+ K+ H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 658 LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSF 717
+V EYM G L +L E K + ++ L + DV G+ YL + Q F
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYL----REHGKRFQPSQLLEMCKDVCEGMAYLE--SKQ-F 121
Query: 718 IHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
IHRDL N L+ D KV+DFGL R D+
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 55/173 (31%), Positives = 89/173 (51%), Gaps = 16/173 (9%)
Query: 598 LGRGGFGTVYKGELHDGT---KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
LG G FG+V +G+L+ K+AVK M+ A+ + +F SE + + H +++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 655 GYCLDGNER------LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIAL--DVARGV 706
G CL E +++ +M G L L + G P ++ + D+A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRL-GDCPQYLPTQMLVKFMTDIASGM 125
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLA 759
EYL + +SFIHRDL N +L ++M VADFGL + NG + + R+A
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK-KIYNGDYYRQGRIA 174
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 54/184 (29%), Positives = 90/184 (48%), Gaps = 20/184 (10%)
Query: 596 NVLGRGGFGTVYK-GELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
+G+G FGTV K DG + K ++ ++EK + SE+ +L +++H ++V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 655 GYCLD-GNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLE----W--TRRLTIALDVARGV 706
+D N+ L +V EY G L++ + K+E K +E W +L +AL
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKER-KYIEEEFIWRILTQLLLALY----- 119
Query: 707 EYLHGLAH--QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
H + + +HRDLKP+NI L + K+ DFGL ++ + S GT Y
Sbjct: 120 -ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--SSFAKTYVGTPYY 176
Query: 765 LAPE 768
++PE
Sbjct: 177 MSPE 180
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 51/153 (33%), Positives = 87/153 (56%), Gaps = 12/153 (7%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657
LG G FG V+ G + TK+A+K ++ +S + F E ++ +++H LV L Y
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLA---EANLMKQLQHPRLVRL--YA 68
Query: 658 LDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS 716
+ E + ++ EYM G+L L + EG+K L + + +A +A G+ ++ ++
Sbjct: 69 VVTQEPIYIITEYMENGSLVDFL--KTPEGIK-LTINKLIDMAAQIAEGMAFIE---RKN 122
Query: 717 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
+IHRDL+ +NIL+ + + K+ADFGL RL DN
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDN 155
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 49/157 (31%), Positives = 74/157 (47%), Gaps = 26/157 (16%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKS--------EIAVLTKV-RH 647
LG G FG+VY G +A+K+M+ +F S E+ L K+ H
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK---------KKFYSWEECMNLREVKSLRKLNEH 57
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
++V L + +E V+EYM +G L L K+ KP + +I + +G+
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYM-EGNL-YQLM--KDRKGKPFSESVIRSIIYQILQGLA 113
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
++H F HRDLKP N+L+ K+ADFGL R
Sbjct: 114 HIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 6e-18
Identities = 48/152 (31%), Positives = 84/152 (55%), Gaps = 9/152 (5%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657
LG G FG V+ G ++ TK+AVK ++ +S + F E E ++ ++H LV L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLE---EANLMKTLQHDKLVRLYAVV 70
Query: 658 LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSF 717
++ EYM +G+L F + +EG K + + + + +A G+ Y+ +++
Sbjct: 71 TKEEPIYIITEYMAKGSLLD--FLKSDEGGK-VLLPKLIDFSAQIAEGMAYIE---RKNY 124
Query: 718 IHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
IHRDL+ +N+L+ + + K+ADFGL R+ DN
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDN 156
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 7e-18
Identities = 45/154 (29%), Positives = 83/154 (53%), Gaps = 12/154 (7%)
Query: 595 ENVLGRGGFGTVYKGELHDGTK----IAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
E V+G G FG V +G L K +A+K +++ S+K +F +E +++ + H ++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNI 67
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
+ L G +++ EYM G+L + L R+ +G + + + +A G++YL
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFL--RENDG--KFTVGQLVGMLRGIASGMKYL- 122
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
+ +++HRDL NIL+ ++ KV+DFGL R
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 7e-18
Identities = 53/159 (33%), Positives = 82/159 (51%), Gaps = 17/159 (10%)
Query: 597 VLGRGGFGTV--YKGE-LHDGTK--IAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
VLG G FG V Y + +DGT +AVK ++ ++ + +K EI +L + H ++V
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIV 69
Query: 652 GLLGYCLDGNER--LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
G C + + L+ EY+P G+L +L + + L L L A + G+ YL
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQL-----LLFAQQICEGMAYL 123
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748
H Q +IHRDL N+LL +D K+ DFGL + P+
Sbjct: 124 HS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 9e-18
Identities = 51/189 (26%), Positives = 91/189 (48%), Gaps = 12/189 (6%)
Query: 589 TNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMES-AVVSEKGFAEFKSEIAVLTKVR 646
NF E +G+G F VYK L DG +A+K+++ ++ K + EI +L ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 647 HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706
H +++ L ++ NE +V E G LSR + + K++ + + + + +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQK-RLIPERTIWKYFVQLCSAL 119
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL--APDNGKHSIETRLAGTFGY 764
E++H + +HRD+KP+N+ + K+ D GL R + HS L GT Y
Sbjct: 120 EHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS----LVGTPYY 172
Query: 765 LAPEYAAET 773
++PE E
Sbjct: 173 MSPERIHEN 181
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 51/184 (27%), Positives = 77/184 (41%), Gaps = 18/184 (9%)
Query: 590 NNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRM----ESAVVSEKGFAEFKSEIAVLTK 644
N + V+G G +G V K G +A+K+ + V + E+ VL +
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTAL----REVKVLRQ 56
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
+RH ++V L LV+EY+ + L L GL P + R L +
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEYVERTLL--ELLEASPGGLPP-DAVRSYIWQL--LQ 111
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
+ Y H + IHRD+KP NIL+ + K+ DFG R + +A T Y
Sbjct: 112 AIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWY 167
Query: 765 LAPE 768
APE
Sbjct: 168 RAPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 62/180 (34%), Positives = 92/180 (51%), Gaps = 13/180 (7%)
Query: 592 FSEENVLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSE-KGFAEFKSEIAVLTKVRHRH 649
F VLG+GGFG V ++ K+ A K++E + + KG A +E +L KV R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 650 LVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
+V L Y + + L LV M G L H++N G + R + A ++ G+E
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGF---DEERAVFYAAEITCGLED 117
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
LH + ++RDLKP NILL D +++D GL P+ +I R+ GT GY+APE
Sbjct: 118 LH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--ETIRGRV-GTVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 56/188 (29%), Positives = 90/188 (47%), Gaps = 24/188 (12%)
Query: 592 FSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
+ +G G +G VYK ++ G +A+K + + F + EI++L + RH ++
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVI--KLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIAL---DVARGVE 707
V G L ++ +V EY G+L ++ L L+ IA + +G+
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQ-DIYQVTRGPLSELQ------IAYVCRETLKGLA 115
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNGKHSIETR--LAGTFGY 764
YLH IHRD+K +NILL +D K+ADFG+ +L +I R GT +
Sbjct: 116 YLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQL-----TATIAKRKSFIGTPYW 167
Query: 765 LAPEYAAE 772
+APE AA
Sbjct: 168 MAPEVAAV 175
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 64/181 (35%), Positives = 80/181 (44%), Gaps = 15/181 (8%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKI-AVKRMESA-VVSEKGFAEFKSEIAVLTKVRH 647
++F LG G FG V K A+K + A +V K +E +L +RH
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
LV L G D + LV EY+P G L HL RK G P R A V +E
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL--RKS-GRFPEPVAR--FYAAQVVLALE 115
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
YLH ++RDLKP N+LL D K+ DFG + T L GT YLAP
Sbjct: 116 YLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYT-LCGTPEYLAP 167
Query: 768 E 768
E
Sbjct: 168 E 168
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 59/163 (36%), Positives = 81/163 (49%), Gaps = 17/163 (10%)
Query: 596 NVLGRGGFGTVYKGELH-DGTKI-AVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVG 652
+V+G G FG V K + DG ++ A + S+ +F E+ VL K+ H +++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 653 LLGYCLDGNERLLVYEYMPQGTL------SRHL-----FNRKEEGLKPLEWTRRLTIALD 701
LLG C L EY P G L SR L F L + L A D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 702 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
VARG++YL + + FIHRDL NIL+G++ AK+ADFGL R
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 5e-17
Identities = 90/339 (26%), Positives = 140/339 (41%), Gaps = 50/339 (14%)
Query: 77 IEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFT-SVPSDFFKG 134
+ G +P+ + L +L +L + N TG+IP +L+ L LQ + N F+ +P + K
Sbjct: 296 LSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKH 355
Query: 135 LTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHL 194
+L + L N+ + IPE L + L + ++ G IP LG L + L
Sbjct: 356 -NNLTVLDLSTNNL-TGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLG--ACRSLRRVRL 411
Query: 195 AFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQ-NMTSLTQLWLHGNSFTGPL 253
N G +P F K + ++ L G + + +M SL L L N F G L
Sbjct: 412 QDNSFSGELPSEFTKLPLVYFL---DISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGL 468
Query: 254 PDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAK 313
PD G L++ + NQ +G VP L +L L + L+ N G+ P S
Sbjct: 469 PDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELS-------- 520
Query: 314 GSNSFCLDDAGVACDGRVNVLLSIVKSVGY-PAVLAESWKGNNPCNSDWKGVSCDAGGNI 372
+C V++ LS + G PA +E P S
Sbjct: 521 ------------SCKKLVSLDLSHNQLSGQIPASFSEM-----PVLSQ------------ 551
Query: 373 TVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIP 411
++L LSG I N + SL Q+ +S N L G++P
Sbjct: 552 --LDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588
|
Length = 968 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 57/174 (32%), Positives = 84/174 (48%), Gaps = 13/174 (7%)
Query: 598 LGRGGFGTVYKGELHDGTKI-AVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLG 655
LG+GGFG V ++ K+ A K+++ + KG +E +L KV R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 656 YCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
Y + + L LV M G L H++N E G R + A + G+E+LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPE---ARAIFYAAQIICGLEHLH---Q 113
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
+ ++RDLKP N+LL D +++D GL K AGT GY+APE
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPE 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 6e-17
Identities = 57/181 (31%), Positives = 88/181 (48%), Gaps = 20/181 (11%)
Query: 598 LGRGGFGTVYKGELHDGTK--IAVKRMESAVVSEKG-FAEFKSEIAVLTKVRHRHLVGLL 654
+ +G +G V+ + T A+K ++ A + K + +E +L++ + ++V L
Sbjct: 1 ISKGAYGRVFLAK-KKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 655 GYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
Y G + L LV EY+P G L+ L N G + R + IA ++ +EYLH
Sbjct: 60 -YSFQGKKNLYLVMEYLPGGDLASLLEN---VGSLDEDVAR-IYIA-EIVLALEYLHSN- 112
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGL-----VRLAPDNGKHSIET-RLAGTFGYLAP 767
IHRDLKP NIL+ + K+ DFGL VR + E R+ GT Y+AP
Sbjct: 113 --GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 768 E 768
E
Sbjct: 171 E 171
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 51/159 (32%), Positives = 84/159 (52%), Gaps = 17/159 (10%)
Query: 598 LGRGGFGTVY----KGELHDG--TKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
LG+G FG VY KG + D T++A+K + E+A + E+ EF +E +V+ + H+
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRER--IEFLNEASVMKEFNCHHV 71
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE-----GLKPLEWTRRLTIALDVARG 705
V LLG G L++ E M +G L +L + + E P + + +A ++A G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
+ YL+ F+HRDL N ++ +D K+ DFG+ R
Sbjct: 132 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 8e-17
Identities = 51/179 (28%), Positives = 82/179 (45%), Gaps = 25/179 (13%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRM----ESAVVSEKGFAEFKSEIAVLTKVRHRHLVG 652
+G G +G VYK + G +A+K++ ES + + EI +L ++ H +++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTAL----REIKLLKELNHPNIIK 62
Query: 653 LLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
LL + LV+E+M L ++ GL P + L +G+ + H
Sbjct: 63 LLDVFRHKGDLYLVFEFMDTDLY--KLIKDRQRGL-PESLIKSYLYQL--LQGLAFCH-- 115
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPDNG--KHSIETRLAGTFGYLAPE 768
+H +HRDLKP N+L+ + K+ADFGL R H + TR Y APE
Sbjct: 116 SH-GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW-----YRAPE 168
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 52/170 (30%), Positives = 87/170 (51%), Gaps = 23/170 (13%)
Query: 592 FSEENVLGRGGFGTVYKGELH-----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR 646
F EE LG FG +YKG L+ +A+K ++ + + + + EF+ E +++ ++
Sbjct: 9 FMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKD-INNPQQWGEFQQEASLMAELH 65
Query: 647 HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRK----------EEGL--KPLEWTR 694
H ++V LLG +++EY+ QG L L R E+G L+
Sbjct: 66 HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGD 125
Query: 695 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
L IA+ +A G+EYL + F+H+DL NIL+G+ + K++D GL R
Sbjct: 126 FLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 55/180 (30%), Positives = 85/180 (47%), Gaps = 18/180 (10%)
Query: 592 FSEENVLGRGGFGTVYKGELH--DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
F LG G +G+VYK +H G +A+K + E+ E EI++L + +
Sbjct: 5 FDILEKLGEGSYGSVYKA-IHKETGQVVAIKVVPV----EEDLQEIIKEISILKQCDSPY 59
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+V G + +V EY G++S + + L E I +G+EYL
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVS-DIMKITNKTLTEEEIA---AILYQTLKGLEYL 115
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV-RLAPDNGKHSIETRLAGTFGYLAPE 768
H IHRD+K NILL ++ +AK+ADFG+ +L K T + GT ++APE
Sbjct: 116 H---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK--RNT-VIGTPFWMAPE 169
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 60/180 (33%), Positives = 90/180 (50%), Gaps = 13/180 (7%)
Query: 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE-KGFAEFKSEIAVLTKVRHRH 649
F VLG+GGFG V ++ G A K++E + + KG A +E +L KV R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 650 LVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
+V L Y + + L LV M G L H++N G + R + A ++ G+E
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF---DEQRAIFYAAELCCGLED 117
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
L + ++RDLKP NILL D +++D GL P+ ++ R+ GT GY+APE
Sbjct: 118 LQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--ETVRGRV-GTVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 66/194 (34%), Positives = 91/194 (46%), Gaps = 26/194 (13%)
Query: 584 VLRNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVK--RMESAVVSEKGFAEFKS--E 638
R+VT F + N +G G +G VY+ + G +A+K RM++ E+ S E
Sbjct: 2 RCRSVTE-FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDN----ERDGIPISSLRE 56
Query: 639 IAVLTKVRHRHLVGLL----GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTR 694
I +L +RH ++V L G LD LV EY Q L+ L N P ++
Sbjct: 57 ITLLLNLRHPNIVELKEVVVGKHLD--SIFLVMEYCEQ-DLASLLDNMP----TPFSESQ 109
Query: 695 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSI 754
+ L + RG++YLH IHRDLK SN+LL D K+ADFGL R K
Sbjct: 110 VKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT 166
Query: 755 ETRLAGTFGYLAPE 768
+ T Y APE
Sbjct: 167 PKVV--TLWYRAPE 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 49/151 (32%), Positives = 72/151 (47%), Gaps = 13/151 (8%)
Query: 598 LGRGGFGTVYKGELHDGTKIA---VKRME-SAVVSEKGFAEFKSEIAVLTKVRHRHLVGL 653
+G G FG V GE H G A VK + SA E+ F E+ ++ H +++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQ--LLFLQEVQPYRELNHPNVLQC 60
Query: 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLT--IALDVARGVEYLHG 711
LG C++ LLV E+ P G L +L R G+ + + +A +VA G+ +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYL--RSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742
FIH DL N L D+ K+ D+GL
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGL 146
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 54/167 (32%), Positives = 86/167 (51%), Gaps = 24/167 (14%)
Query: 598 LGRGGFGTVYKGEL--------HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHR 648
LG G FG V E + TK+AVK ++S +EK ++ SE+ ++ + +H+
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHK 84
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGL-----------KPLEWTRRLT 697
+++ LLG C ++ EY +G L +L R+ G+ + L + ++
Sbjct: 85 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144
Query: 698 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
A VARG+EYL A + IHRDL N+L+ +D K+ADFGL R
Sbjct: 145 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 56/193 (29%), Positives = 89/193 (46%), Gaps = 25/193 (12%)
Query: 596 NVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKS---EIAVLTKVRHRHLV 651
V+G G VY L + K+A+KR++ EK E+ +++ H ++V
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDL----EKCQTSVDELRKEVQAMSQCNHPNVV 62
Query: 652 GLLGYCLDGNERLLVYEYMPQGTLS---RHLFNRK--EEGLKPLEWTRRLTIALDVARGV 706
+ G+E LV Y+ G+L + + R +E + T+ +V +G+
Sbjct: 63 KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA-------TVLKEVLKGL 115
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR--LAGTFGY 764
EYLH IHRD+K NILLG+D K+ADFG+ D G + + R GT +
Sbjct: 116 EYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCW 172
Query: 765 LAPEYAAETSGMT 777
+APE + G
Sbjct: 173 MAPEVMEQVHGYD 185
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 49/155 (31%), Positives = 77/155 (49%), Gaps = 19/155 (12%)
Query: 592 FSEENVLGRGGFGTVYKG-ELHDGTKIAVKR--MESAVVSEKGFAEFKSEIAVLTKVRHR 648
F+ +G+G FG VYK + +A+K +E +E + + EI L++ R
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSP 59
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKP--LEWTRRLTIALDVARGV 706
++ G L G++ ++ EY G+ L LKP L+ T I +V G+
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSC-LDL-------LKPGKLDETYIAFILREVLLGL 111
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741
EYLH + IHRD+K +NILL ++ K+ADFG
Sbjct: 112 EYLHE---EGKIHRDIKAANILLSEEGDVKLADFG 143
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 20/178 (11%)
Query: 596 NVLGRGGFGTVYKGELH--DGTKIAVKRMESAVVSEKGFAEFK---SEIAVLTKVRHRHL 650
LG G G V K LH G +AVK + + A K E+ +L K ++
Sbjct: 7 GELGAGNSGVVSKV-LHRPTGKIMAVKTIRLEINE----AIQKQILRELDILHKCNSPYI 61
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
VG G + + + EYM G+L + ++ +G P ++ +A V +G+ YLH
Sbjct: 62 VGFYGAFYNNGDISICMEYMDGGSLDK--ILKEVQGRIPERILGKIAVA--VLKGLTYLH 117
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
IHRD+KPSNIL+ + K+ DFG+ + S+ GT Y+APE
Sbjct: 118 EKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN----SLAKTFVGTSSYMAPE 169
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 49/167 (29%), Positives = 82/167 (49%), Gaps = 24/167 (14%)
Query: 598 LGRGGFGTVYKGEL--------HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHR 648
LG G FG V E + +AVK ++ +EK ++ SE+ ++ + +H+
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHK 81
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLK-----------PLEWTRRLT 697
+++ LLG C ++ EY +G L +L R+ G++ + + ++
Sbjct: 82 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141
Query: 698 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
VARG+EYL A Q IHRDL N+L+ ++ K+ADFGL R
Sbjct: 142 CTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 4e-16
Identities = 56/170 (32%), Positives = 77/170 (45%), Gaps = 28/170 (16%)
Query: 614 GTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL--GYCLDGNERLL-VYEY 669
G ++A+K + A E A F+ E A+ ++ H ++V LL G G L V+EY
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG--LLFAVFEY 60
Query: 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH---QSFIHRDLKPSN 726
+P TL L +G P T RL + + L LA Q +HRDLKP N
Sbjct: 61 VPGRTLREVLAA---DGALPAGETGRLML--------QVLDALACAHNQGIVHRDLKPQN 109
Query: 727 ILL---GDDMRAKVADFGLVRLAPDNGKH-----SIETRLAGTFGYLAPE 768
I++ G AKV DFG+ L P + T + GT Y APE
Sbjct: 110 IMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 4e-16
Identities = 54/159 (33%), Positives = 81/159 (50%), Gaps = 17/159 (10%)
Query: 598 LGRGGFGTVYKGELHD------GTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
LG+G FG VY+G D T++AVK + ESA + E+ EF +E +V+ H+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER--IEFLNEASVMKGFTCHHV 71
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE-----GLKPLEWTRRLTIALDVARG 705
V LLG G L+V E M G L +L + + E G P + +A ++A G
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
+ YL+ + F+HRDL N ++ D K+ DFG+ R
Sbjct: 132 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-16
Identities = 61/180 (33%), Positives = 85/180 (47%), Gaps = 22/180 (12%)
Query: 598 LGRGGFGTVY------KGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
LG+GGFG V G+L+ K+ KR++ KG+ E +L KV R +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK----RKGYEGAMVEKRILAKVHSRFIV 56
Query: 652 GLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
L Y L LV M G L H++N EE R + G+E+LH
Sbjct: 57 SL-AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEEN-PGFPEPRACFYTAQIISGLEHLH 114
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNGKHSIETR-LAGTFGYLAPE 768
+ I+RDLKP N+LL +D +++D GL V L K T+ AGT G++APE
Sbjct: 115 ---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK----TKGYAGTPGFMAPE 167
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 7e-16
Identities = 51/164 (31%), Positives = 86/164 (52%), Gaps = 14/164 (8%)
Query: 592 FSEENVLGRGGFGTVYKGEL--HDGT--KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH 647
F+ +LG+G FG+V + +L DG+ K+AVK +++ + S EF E A + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 648 RHLVGLLGYCLDGNER------LLVYEYMPQGTLSRHLF-NRKEEGLKPLEWTRRLTIAL 700
+++ L+G L + +++ +M G L L +R E L + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
D+A G+EYL + ++FIHRDL N +L ++M VADFGL +
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 7e-16
Identities = 61/178 (34%), Positives = 95/178 (53%), Gaps = 16/178 (8%)
Query: 597 VLGRGGFGTVYKGELHDGT---KI-AVKRMESA--VVSEKGFAEFKSEIAVLTKVRHRHL 650
VLG+GG+G V++ G KI A+K ++ A V ++K A K+E +L V+H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
V L+ G + L+ EY+ G L HL + EG+ +E T ++ +++ +E+LH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIF-MEDTACFYLS-EISLALEHLH 117
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
Q I+RDLKP NILL K+ DFGL + + G ++ GT Y+APE
Sbjct: 118 ---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--TVTHTFCGTIEYMAPE 170
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 8e-16
Identities = 56/201 (27%), Positives = 80/201 (39%), Gaps = 37/201 (18%)
Query: 597 VLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGF-AEFKSEIAVLTKVRHRHLVGLL 654
V+GRG FG V+ + G A+K + + + ++ A ++E +L +V L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY 67
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
D LV EYMP G L L + + P E R L +A ++ +H L
Sbjct: 68 YSFQDEEHLYLVMEYMPGGDLMNLLIRK---DVFPEETARFYIAELVLA--LDSVHKLG- 121
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGL-----------------VRLAPDNGKHSIETR 757
FIHRD+KP NIL+ D K+ADFGL L +
Sbjct: 122 --FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179
Query: 758 L----------AGTFGYLAPE 768
GT Y+APE
Sbjct: 180 HKQRRVRANSTVGTPDYIAPE 200
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 8e-16
Identities = 53/161 (32%), Positives = 78/161 (48%), Gaps = 18/161 (11%)
Query: 592 FSEENVLGRGGFGTVYKG-ELHDGTKI----AVKRMESAVVSEKGFAEFKSEIAVLTKVR 646
F + VLG G FGTVYKG + +G K+ A+K + A S K E E V+ V
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVD 67
Query: 647 HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE--GLKPLEWTRRLTIALDVAR 704
+ H+ LLG CL +L + + MP G L ++ K+ L W + +A+
Sbjct: 68 NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 120
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745
G+ YL + +HRDL N+L+ K+ DFGL +L
Sbjct: 121 GMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 8e-16
Identities = 48/165 (29%), Positives = 89/165 (53%), Gaps = 14/165 (8%)
Query: 590 NNFSEENVLGRGGFGTVYKGELH-DGTK---IAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
++ +++ V+G G FG V++G L G K +A+K ++ +EK +F SE +++ +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQF 63
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEG-LKPLEWTRRLTIALDVAR 704
H +++ L G +++ EYM G L ++L R +G + L +A
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYL--RDHDGEFSSYQLVGMLR---GIAA 118
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
G++YL + +++HRDL NIL+ ++ KV+DFGL R+ D+
Sbjct: 119 GMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 52/162 (32%), Positives = 81/162 (50%), Gaps = 15/162 (9%)
Query: 597 VLGRGGFGTVYKG-ELHDGTKI----AVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
+LG G FGTV+KG + +G I A+K ++ + F E + + + H ++V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIV 72
Query: 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHG 711
LLG C G LV + P G+L H+ ++ L P R L + +A+G+ YL
Sbjct: 73 RLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRD-SLDP---QRLLNWCVQIAKGMYYLE- 126
Query: 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-PDNGKH 752
+HR+L NILL D ++ADFG+ L PD+ K+
Sbjct: 127 --EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY 166
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 60/182 (32%), Positives = 89/182 (48%), Gaps = 17/182 (9%)
Query: 598 LGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKG---FAEFKSEIAVLTKVRHRHLVGL 653
LG+GGFG V ++ + G A K+++ + +K A + EI L KV +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 654 LGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
Y + L LV M G L H++N E GL E R + + + G+ +LH +
Sbjct: 59 -AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL---EMERVIHYSAQITCGILHLHSM 114
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAE 772
++RD+KP N+LL D +++D GL D GK T+ AGT GY+APE E
Sbjct: 115 ---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD-GKTI--TQRAGTNGYMAPEILKE 168
Query: 773 TS 774
Sbjct: 169 EP 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 51/180 (28%), Positives = 78/180 (43%), Gaps = 22/180 (12%)
Query: 597 VLGRGGFGTVYKGELHD--GTKIAV-----KRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
+G G FG VY+G KIAV K S V EK F E ++ + H H
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK----FLQEAYIMRQFDHPH 68
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+V L+G + N +V E P G L +L K L+ + + ++ + YL
Sbjct: 69 IVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYS----LDLASLILYSYQLSTALAYL 123
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG-KHSIETRLAGTFGYLAPE 768
+ F+HRD+ N+L+ K+ DFGL R D + + +L ++APE
Sbjct: 124 ES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP--IKWMAPE 178
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 47/164 (28%), Positives = 79/164 (48%), Gaps = 14/164 (8%)
Query: 591 NFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTK 644
N E LGRG FG V+ + T + VK ++ E +EF+ E+ + K
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK-TKDENLQSEFRRELDMFRK 64
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLF--NRKEEGLK--PLEWTRRLTIAL 700
+ H+++V LLG C + ++ EY G L + L K+E LK PL +++ +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
+A G+++ L++ F+HRDL N L+ KV+ L +
Sbjct: 125 QIALGMDH---LSNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 3e-15
Identities = 58/196 (29%), Positives = 93/196 (47%), Gaps = 34/196 (17%)
Query: 598 LGRGGFGTVYKGELHDGTK--------IAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHR 648
LG G FG V + E + K +AVK ++ ++K A+ SE+ ++ + +H+
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHK 78
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGL-----------KPLEWTRRLT 697
+++ LLG C ++ EY +G L L R+ G + L + ++
Sbjct: 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 698 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR 757
A VARG+EYL + IHRDL N+L+ +D K+ADFGL R G H I+
Sbjct: 139 CAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLAR-----GVHDIDYY 190
Query: 758 LAGTFG-----YLAPE 768
+ G ++APE
Sbjct: 191 KKTSNGRLPVKWMAPE 206
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 58/183 (31%), Positives = 89/183 (48%), Gaps = 11/183 (6%)
Query: 598 LGRGGFGTVYKGELHDG---TKIAVKRME-SAVVSEKGFAEFKSEIAVLTKVRHRHLVGL 653
+G G FG V GE++ G ++ VK + SA V E+ +F E ++H +L+
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQ--MKFLEEAQPYRSLQHSNLLQC 60
Query: 654 LGYCLDGNERLLVYEYMPQGTLSRHLFN-RKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
LG C + LLV E+ P G L +L + RK E + P + T +A ++A G+ +LH
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTP-DPTTLQRMACEIALGLLHLH-- 117
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAE 772
+FIH DL N LL D+ K+ D+GL + +L ++APE E
Sbjct: 118 -KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176
Query: 773 TSG 775
G
Sbjct: 177 VHG 179
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-15
Identities = 51/167 (30%), Positives = 83/167 (49%), Gaps = 24/167 (14%)
Query: 598 LGRGGFGTVYKGEL--------HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHR 648
LG G FG V E + +AVK ++ ++K ++ SE+ ++ + +H+
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHK 78
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGL-----------KPLEWTRRLT 697
+++ LLG C ++ EY +G L +L R+ G+ + L + ++
Sbjct: 79 NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138
Query: 698 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
A VARG+EYL A Q IHRDL N+L+ +D K+ADFGL R
Sbjct: 139 CAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 52/154 (33%), Positives = 77/154 (50%), Gaps = 14/154 (9%)
Query: 597 VLGRGGFGTVYKG-ELHDGTKIAVK---RMESAVVSEKGFAEFKSEIAVLTKVRHRHLVG 652
VLG G FGTVYKG + +G + + ++ + K EF E ++ + H HLV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 653 LLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE-GLKPLEWTRRLTIALDVARGVEYLHG 711
LLG CL +L V + MP G L ++ K+ G + L L + +A+G+ YL
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLL-----LNWCVQIAKGMMYLE- 126
Query: 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745
+ +HRDL N+L+ K+ DFGL RL
Sbjct: 127 --ERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 5e-15
Identities = 56/174 (32%), Positives = 79/174 (45%), Gaps = 15/174 (8%)
Query: 598 LGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHRHLVGLLG 655
LG GGFG V ++ A+K ++ + E G E SE +L + H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ 715
D ++ EY G L L ++ GL E+T R IA V EYLH ++
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTIL---RDRGLFD-EYTARFYIAC-VVLAFEYLH---NR 112
Query: 716 SFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPDNGKHSIETRLAGTFGYLAPE 768
I+RDLKP N+LL + K+ DFG + L + GT Y+APE
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF----CGTPEYVAPE 162
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 6e-15
Identities = 55/163 (33%), Positives = 79/163 (48%), Gaps = 16/163 (9%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHD------GTKIAVKRM-ESAVVSEKGFAEFKSEIAVL 642
NN S LG G FG V + + K+AVK + +A SE+ SE+ ++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER--EALMSELKIM 92
Query: 643 TKV-RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALD 701
+ + H ++V LLG C G L++ EY G L L RK E L L+ +
Sbjct: 93 SHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESF--LTLEDLLSFSYQ 149
Query: 702 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
VA+G+ +L A ++ IHRDL N+LL K+ DFGL R
Sbjct: 150 VAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 7e-15
Identities = 54/183 (29%), Positives = 90/183 (49%), Gaps = 22/183 (12%)
Query: 597 VLGRGGFGTVYKG-ELHDGTKIAVKRM----ESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
LG G F + Y+ ++ GT +AVK++ ++ E+ + EI ++ ++ H H++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 652 GLLG-YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
+LG C D + L V E+M G++S L + + + RG+ YLH
Sbjct: 67 RMLGATCEDSHFNLFV-EWMAGGSVSHLLSK-----YGAFKEAVIINYTEQLLRGLSYLH 120
Query: 711 GLAHQSFIHRDLKPSNILL---GDDMRAKVADFG-LVRLAPD-NGKHSIETRLAGTFGYL 765
IHRD+K +N+L+ G +R +ADFG RLA G + +L GT ++
Sbjct: 121 ---ENQIIHRDVKGANLLIDSTGQRLR--IADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 766 APE 768
APE
Sbjct: 176 APE 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 8e-15
Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 19/186 (10%)
Query: 589 TNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH 647
+ E VLG+G +G VY +L +IA+K + + EIA+ + ++H
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIP--ERDSRYVQPLHEEIALHSYLKH 64
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIAL---DVAR 704
R++V LG + + E +P G+LS L R + G PL+ TI +
Sbjct: 65 RNIVQYLGSDSENGFFKIFMEQVPGGSLSALL--RSKWG--PLK-DNEQTIIFYTKQILE 119
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLV-RLAPDNGKHSIETRLAGTF 762
G++YLH +HRD+K N+L+ K++DFG RLA G + GT
Sbjct: 120 GLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA---GINPCTETFTGTL 173
Query: 763 GYLAPE 768
Y+APE
Sbjct: 174 QYMAPE 179
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-15
Identities = 52/174 (29%), Positives = 77/174 (44%), Gaps = 31/174 (17%)
Query: 597 VLGRGGFGTVYKGE------LHDGTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRH 649
LG G FG V K T +AVK + E+A SE + SE +L +V H H
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE--LRDLLSEFNLLKQVNHPH 64
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHL-FNRKEE------------------GLKPL 690
++ L G C LL+ EY G+L L +RK + L
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 691 EWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
++ A ++RG++YL A +HRDL N+L+ + + K++DFGL R
Sbjct: 125 TMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 58/185 (31%), Positives = 89/185 (48%), Gaps = 15/185 (8%)
Query: 590 NNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKS---EIAVLTKV 645
N+ +LG+G FG VY ++ G ++AVK++ S + E + EI +L +
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 646 RHRHLVGLLGYCLDGNERLLVY-EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
+H +V G CL +E L ++ EYMP G++ L K G TR+ T +
Sbjct: 62 QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL---KAYGALTETVTRKYT--RQILE 115
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV-RLAPDNGKHSIETRLAGTFG 763
GVEYLH +HRD+K +NIL K+ DFG RL + + GT
Sbjct: 116 GVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPY 172
Query: 764 YLAPE 768
+++PE
Sbjct: 173 WMSPE 177
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 51/178 (28%), Positives = 90/178 (50%), Gaps = 35/178 (19%)
Query: 598 LGRGGFGTVYKGELHDGTK-----------------IAVKRMESAVVSEKGFAEFKSEIA 640
LG G FG V+ E+ + +AVK + ++ +F E+
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILR-PDANKNARNDFLKEVK 71
Query: 641 VLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTL-----SRHLFNRKEEG--------- 686
+L++++ +++ LLG C+D + ++ EYM G L S HL +++E G
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 687 LKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
L + ++ L +AL +A G++YL L +F+HRDL N L+G+++ K+ADFG+ R
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 53/184 (28%), Positives = 92/184 (50%), Gaps = 15/184 (8%)
Query: 595 ENVLGRGGFGTVYKGEL-HDGTK---IAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
E V+G G FG V +G L G + +A+K ++S +EK +F SE +++ + H ++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNI 67
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
+ L G +++ E+M G L F R+ +G + + + + +A G++YL
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDS--FLRQNDGQFTV--IQLVGMLRGIAAGMKYL- 122
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAG---TFGYLAP 767
+ +++HRDL NIL+ ++ KV+DFGL R D+ T G + AP
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 768 EYAA 771
E A
Sbjct: 181 EAIA 184
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 48/155 (30%), Positives = 81/155 (52%), Gaps = 10/155 (6%)
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
E LG G FG V+ + TK+AVK M+ +S + F E V+ ++H LV L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA---EANVMKTLQHDKLV-KL 66
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
+ ++ E+M +G+L F + +EG K + + + +A G+ ++
Sbjct: 67 HAVVTKEPIYIITEFMAKGSLLD--FLKSDEGSK-QPLPKLIDFSAQIAEGMAFIE---Q 120
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
+++IHRDL+ +NIL+ + K+ADFGL R+ DN
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 35/198 (17%)
Query: 592 FSEENVLGRGGFGTVYKG---ELHDGTKIAVKRMESAVVSEKGFAEFKS---EIAVLTKV 645
+ E +GRG +G VYK DG + A+K+ + G ++ S EIA+L ++
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQ--SACREIALLREL 59
Query: 646 RHRHLVGLLGYCLDGNERL--LVYEYMPQGTLSRHLFNRKEEG-------LKPLEWTRRL 696
+H ++V L+ L+ ++ L+++Y F+R+ + +K L W
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW---- 115
Query: 697 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILL-GDDM---RAKVADFGLVRL--APDNG 750
+ GV YLH +HRDLKP+NIL+ G+ K+ D GL RL AP
Sbjct: 116 ----QILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168
Query: 751 KHSIETRLAGTFGYLAPE 768
+ T Y APE
Sbjct: 169 LAD-LDPVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 57/192 (29%), Positives = 94/192 (48%), Gaps = 24/192 (12%)
Query: 597 VLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKS-------EIAVLTKVRHR 648
++G G FG+VY G G +AVK++E VS +S EIA+L +++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
++V LG LD + + EY+P G+++ L N E T + +G+ Y
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN-----YGAFEETLVRNFVRQILKGLNY 121
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR------LAPDNGKHSIETRLAGTF 762
LH ++ IHRD+K +NIL+ + K++DFG+ + L+ L G+
Sbjct: 122 LH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGA--RPSLQGSV 176
Query: 763 GYLAPEYAAETS 774
++APE +TS
Sbjct: 177 FWMAPEVVKQTS 188
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 53/180 (29%), Positives = 91/180 (50%), Gaps = 18/180 (10%)
Query: 598 LGRGGFGTV----YKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVG 652
LG G FG V Y E + G ++AVK ++ A+ K EI +L + H ++V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVK 70
Query: 653 LLGYCLD--GNERLLVYEYMPQGTLSRHL-FNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
G C + GN L+ E++P G+L +L N+ + LK L A+ + +G++YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQ-----LKYAVQICKGMDYL 125
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPDNGKHSIETRLAGTFGYLAPE 768
+ ++HRDL N+L+ + + K+ DFGL + + D ++++ L + APE
Sbjct: 126 ---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 48/182 (26%), Positives = 82/182 (45%), Gaps = 17/182 (9%)
Query: 598 LGRGGFGTVYKGELHDG--TKIAVKRM--------ESAVVSEKGFAEFKSEIAVLTK-VR 646
LG G FG VYK + +A+K + + +K + SE+ ++ + +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 647 HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706
H ++V L+ + +V + + L H + KE+ + R I + + +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKK-QRFTEERIWNIFVQMVLAL 126
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLA 766
YLH + +HRDL P+NI+LG+D + + DFGL + K T + GT Y
Sbjct: 127 RYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL---TSVVGTILYSC 181
Query: 767 PE 768
PE
Sbjct: 182 PE 183
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 52/172 (30%), Positives = 78/172 (45%), Gaps = 17/172 (9%)
Query: 600 RGGFGTVYKGELH-DGTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657
+G FG+VY + G A+K + +S ++++ K+E A++ V L Y
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 658 LDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS 716
+ L LV EY+ G + + K G P +W + +V GVE LH +
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAK--QYIAEVVLGVEDLHQ---RG 117
Query: 717 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
IHRD+KP N+L+ K+ DFGL R + GT YLAPE
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPE 163
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 3e-14
Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 32/199 (16%)
Query: 588 VTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRM----ESAVVSEKGFAEFKSEIAVL 642
+TN + + +G G FG V + G +A+K++ + V++++ + E K +L
Sbjct: 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK----LL 63
Query: 643 TKVRHRHLVGLLGYCLDGNERL-LVYEYMPQGT-LSRHLFNRKEEGLKPLEWTRRLTIAL 700
+RH +++ L + E + V E + GT L R L +R PLE
Sbjct: 64 KHLRHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSR------PLEKQFIQYFLY 115
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAG 760
+ RG++Y+H +HRDLKPSNIL+ ++ K+ DFGL R+ + TR
Sbjct: 116 QILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-- 170
Query: 761 TFGYLAPEYAAETSGMTWQ 779
Y APE +TWQ
Sbjct: 171 ---YRAPEIM-----LTWQ 181
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 47/183 (25%), Positives = 84/183 (45%), Gaps = 17/183 (9%)
Query: 591 NFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
+ + V+GRG FG V+ D + +K++ +++ ++E VL + H +
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKP---LEWTRRLTIALDVARGV 706
++ L+ ++V EY P GTL+ ++ R L L + ++ +A
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------- 113
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYL 765
LH + + +HRDLK NILL M K+ DFG+ ++ S + GT Y+
Sbjct: 114 --LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL---SSKSKAYTVVGTPCYI 168
Query: 766 APE 768
+PE
Sbjct: 169 SPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 62/176 (35%), Positives = 89/176 (50%), Gaps = 15/176 (8%)
Query: 597 VLGRGGFGTVYKGELH-DGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTK-VRHRHLVGL 653
V+G+G FG V + DG AVK ++ A++ +K +E VL K V+H LVGL
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 654 LGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
Y ++L V +Y+ G L HL R+ +P R A ++A + YLH L
Sbjct: 62 -HYSFQTADKLYFVLDYVNGGELFFHL-QRERSFPEP----RARFYAAEIASALGYLHSL 115
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
+ I+RDLKP NILL + DFGL + ++ K + + GT YLAPE
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT--STFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 57/188 (30%), Positives = 78/188 (41%), Gaps = 26/188 (13%)
Query: 597 VLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAE-FKSEIAVL---TKVRHRHLV 651
VLGRG FG V E G A+K ++ + + E E + RH LV
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 652 GLLGYCLDGNERL-LVYEYMPQGTLSRHL----FNRKEEGLKPLEWTRRLTIALDVARGV 706
L C + + V EY G L H+ F+ R + A V G+
Sbjct: 66 NLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP----------RAVFYAACVVLGL 114
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLA 766
+YLH ++RDLK N+LL + K+ADFGL + G + GT +LA
Sbjct: 115 QYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPEFLA 169
Query: 767 PEYAAETS 774
PE ETS
Sbjct: 170 PEVLTETS 177
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 52/173 (30%), Positives = 74/173 (42%), Gaps = 15/173 (8%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLG 655
+G G FG V+ + A+K M V+ K +E VL +V H ++ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ 715
D ++ EY+P G L +L N + L A ++ +EYLH
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYLRNSGR-----FSNSTGLFYASEIVCALEYLHSK--- 120
Query: 716 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
++RDLKP NILL + K+ DFG + D L GT YLAPE
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAPE 168
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 54/184 (29%), Positives = 90/184 (48%), Gaps = 23/184 (12%)
Query: 597 VLGRGGFGTVYKG-ELHDGTKIAVKRME-SAVVSEKG-------FAEFKSEIAVLTKVRH 647
++G+G +G VY + G +AVK++E A ++ + +SEI L + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 648 RHLVGLLGYCLDGNERLLVY-EYMPQGTLSRHL--FNRKEEGLKPLEWTRRLTIALDVAR 704
++V LG E L ++ EY+P G++ L + R EE L R T V
Sbjct: 68 LNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL-----VRFFT--EQVLE 119
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
G+ YLH + +HRDLK N+L+ D K++DFG+ + + D + + G+ +
Sbjct: 120 GLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176
Query: 765 LAPE 768
+APE
Sbjct: 177 MAPE 180
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 5e-14
Identities = 53/199 (26%), Positives = 87/199 (43%), Gaps = 38/199 (19%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRM---ESAVVSEKGFAEFKSEIAVL 642
+V + + +G G +G V G K+A+K++ E ++ E K +L
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----IL 57
Query: 643 TKVRHRHLVGLL------GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRL 696
+ +H +++G+L + N+ +V E M E L L T+ L
Sbjct: 58 RRFKHENIIGILDIIRPPSFE-SFNDVYIVQELM-------------ETDLYKLIKTQHL 103
Query: 697 T------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750
+ + RG++Y+H + +HRDLKPSN+LL + K+ DFGL R+A
Sbjct: 104 SNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160
Query: 751 KHSIE-TRLAGTFGYLAPE 768
H+ T T Y APE
Sbjct: 161 DHTGFLTEYVATRWYRAPE 179
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 46/169 (27%), Positives = 80/169 (47%), Gaps = 26/169 (15%)
Query: 598 LGRGGFGTVYKGEL---------------HDGTKIAVKRMESAVVSEKGFAEFKSEIAVL 642
LG G FG V+ E +AVK + + V +F EI ++
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK-TARNDFLKEIKIM 71
Query: 643 TKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-------KEEGLKPLEWTRR 695
+++++ +++ LLG C+ + ++ EYM G L++ L R + +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 696 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
L +A+ +A G++YL L +F+HRDL N L+G+ K+ADFG+ R
Sbjct: 132 LYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSR 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 57/183 (31%), Positives = 88/183 (48%), Gaps = 21/183 (11%)
Query: 598 LGRGGFGTVYKGELHDGTKI--AVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL- 654
LG G FG VYK + H T + A K ++ + SE+ +F EI +L++ +H ++VGL
Sbjct: 13 LGDGAFGKVYKAQ-HKETGLFAAAKIIQ--IESEEELEDFMVEIDILSECKHPNIVGLYE 69
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
Y + +L+ E+ G L + E + L + + + + +LH
Sbjct: 70 AYFYENKLWILI-EFCDGGALD----SIMLELERGLTEPQIRYVCRQMLEALNFLH---S 121
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR--LAGTFGYLAPEY-AA 771
IHRDLK NILL D K+ADFG+ K +++ R GT ++APE A
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADFGVSAK----NKSTLQKRDTFIGTPYWMAPEVVAC 177
Query: 772 ETS 774
ET
Sbjct: 178 ETF 180
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 49/176 (27%), Positives = 78/176 (44%), Gaps = 27/176 (15%)
Query: 591 NFSEENVLGRGGFGTVYKGELHDGTKIAVK----------------RMESAVVSEKGFAE 634
NF E+ LG G FG V+ E + K ++ S+ +
Sbjct: 8 NFVEK--LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65
Query: 635 FKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE------GLK 688
F E+ +L+++ ++ LLG C ++ EYM G L++ L E K
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 689 PLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
L ++ L +A +A G+ YL L +F+HRDL N L+G + K+ADFG+ R
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-14
Identities = 55/186 (29%), Positives = 92/186 (49%), Gaps = 17/186 (9%)
Query: 592 FSEENVLGRGGFGTVYKG-ELHDGTKIAVK--RMESAVVSEKGFAEFKSEIAVLTKVRHR 648
F++ +G+G FG VYKG + +A+K +E A E + + EI VL++
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSP 62
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
++ G L G + ++ EY+ G+ L + G PLE T TI ++ +G++Y
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGGGSALDLL----KPG--PLEETYIATILREILKGLDY 116
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
LH + IHRD+K +N+LL + K+ADFG+ D GT ++APE
Sbjct: 117 LHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKRNTFVGTPFWMAPE 171
Query: 769 YAAETS 774
+++
Sbjct: 172 VIKQSA 177
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 59/176 (33%), Positives = 88/176 (50%), Gaps = 30/176 (17%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEK-GFA-EFKSEIAVL 642
R V F +G G +G VYK D G +A+K++ + +EK GF EI +L
Sbjct: 4 RCVDK-FDIIGQIGEGTYGQVYKARDKDTGELVALKKVR--LDNEKEGFPITAIREIKIL 60
Query: 643 TKVRHRHLVGLLGYCLDGNERL----------LVYEYMPQ---GTLSRHLFNRKEEGLKP 689
++ HR++V L D + L LV+EYM G L L + E+ +K
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120
Query: 690 LEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745
++L L+ G+ Y H ++F+HRD+K SNILL + + K+ADFGL RL
Sbjct: 121 F--MKQL---LE---GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARL 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 49/174 (28%), Positives = 85/174 (48%), Gaps = 11/174 (6%)
Query: 597 VLGRGGFG--TVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
VLG+G FG T+Y+ D + + K + +SEK + +EI +L+ ++H +++
Sbjct: 7 VLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
+ +D N L+ EY GTL + R++ L E L + V Y+H
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMV--LWYLFQIVSAVSYIH---K 119
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
+HRD+K NI L K+ DFG+ ++ ++S+ + GT Y++PE
Sbjct: 120 AGILHRDIKTLNIFLTKAGLIKLGDFGISKIL--GSEYSMAETVVGTPYYMSPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 52/169 (30%), Positives = 90/169 (53%), Gaps = 16/169 (9%)
Query: 595 ENVLGRGGFGTVYKGELHDGTK----IAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
E V+G G FG V G L K +A+K +++ +EK +F SE +++ + H ++
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNI 67
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWT--RRLTIALDVARGVEY 708
+ L G ++V EYM G+L F RK +G ++T + + + +A G++Y
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDA--FLRKHDG----QFTVIQLVGMLRGIASGMKY 121
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR 757
L + ++HRDL NIL+ ++ KV+DFGL R+ D+ + + TR
Sbjct: 122 L---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR 167
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 56/180 (31%), Positives = 83/180 (46%), Gaps = 18/180 (10%)
Query: 592 FSEENVLGRGGFGTVYKG-ELHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKVRHRH 649
F++ +G G FG VY ++ +A+K+M S S + + + E+ L ++RH +
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+ G L + LV EY G+ S L K KPL+ I +G+ YL
Sbjct: 77 TIEYKGCYLREHTAWLVMEYC-LGSASDILEVHK----KPLQEVEIAAICHGALQGLAYL 131
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL-APDNGKHSIETRLAGTFGYLAPE 768
H IHRD+K NILL + K+ADFG L +P N GT ++APE
Sbjct: 132 HSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS-------FVGTPYWMAPE 181
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 48/156 (30%), Positives = 78/156 (50%), Gaps = 10/156 (6%)
Query: 591 NFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFK-SEIAVLTKVRHR 648
NF + LG G + TVYKG G +A+K E + +E+G EI+++ +++H
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALK--EIHLDAEEGTPSTAIREISLMKELKHE 58
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
++V L N+ +LV+EYM + L +++ G + T L +G+ +
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQL--LKGIAF 115
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
H +HRDLKP N+L+ K+ADFGL R
Sbjct: 116 CH---ENRVLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 58/196 (29%), Positives = 91/196 (46%), Gaps = 34/196 (17%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKR--MESAVVSEKGFAEFKS--EIA 640
R+V + + + N + G +G VY+ + G +A+K+ ME ++GF S EI
Sbjct: 2 RSV-DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEK---EKEGFP-ITSLREIN 56
Query: 641 VLTKVRHRHLVGL----LGYCLDGNERLLVYEYMPQGTLSRH----LFNRKEEGLKPLEW 692
+L K++H ++V + +G LD + +V EY+ H L ++ E
Sbjct: 57 ILLKLQHPNIVTVKEVVVGSNLD--KIYMVMEYV------EHDLKSLMETMKQPFLQSE- 107
Query: 693 TRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752
+ L + GV +LH +HRDLK SN+LL + K+ DFGL R K
Sbjct: 108 --VKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP 162
Query: 753 SIETRLAGTFGYLAPE 768
T+L T Y APE
Sbjct: 163 Y--TQLVVTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 4e-13
Identities = 49/183 (26%), Positives = 90/183 (49%), Gaps = 11/183 (6%)
Query: 592 FSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
F++ +G+G FG V+KG + K+ ++ +E + + EI VL++ ++
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHG 711
G L + ++ EY+ G+ + E G PL+ T+ TI ++ +G++YLH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPG--PLDETQIATILREILKGLDYLHS 119
Query: 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAA 771
+ IHRD+K +N+LL + K+ADFG+ D GT ++APE
Sbjct: 120 ---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QIKRNTFVGTPFWMAPEVIK 174
Query: 772 ETS 774
+++
Sbjct: 175 QSA 177
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 53/174 (30%), Positives = 89/174 (51%), Gaps = 18/174 (10%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
+G+G GTVY ++ G ++A+K+M +K +EI V+ + +H ++V L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKHPNIVNYLDS 84
Query: 657 CLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ 715
L G+E +V EY+ G+L+ + +EG + + + + +E+LH
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALEFLHS---N 134
Query: 716 SFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNGKHSIETRLAGTFGYLAPE 768
IHRD+K NILLG D K+ DFG ++ P+ K S + GT ++APE
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST---MVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 54/185 (29%), Positives = 95/185 (51%), Gaps = 10/185 (5%)
Query: 591 NFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMES-AVVSEKGFAEFKSEIAVLTKVRHR 648
NF E +GRG F VY+ L DG +A+K+++ ++ K A+ EI +L ++ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFN-RKEEGLKPLEWTRRLTIALDVARGVE 707
+++ ++ NE +V E G LSR + + +K++ L P + + + L A +E
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA--LE 120
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
++H + +HRD+KP+N+ + K+ D GL R + K + L GT Y++P
Sbjct: 121 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSP 175
Query: 768 EYAAE 772
E E
Sbjct: 176 ERIHE 180
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 47/155 (30%), Positives = 80/155 (51%), Gaps = 8/155 (5%)
Query: 591 NFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
NF + +G G +G VYK G +A+K++ +E + EI++L ++ H +
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+V LL N+ LV+E++ Q L + + G+ PL + L +G+ +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGI-PLPLIKSYLFQL--LQGLAFC 116
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
H +H+ +HRDLKP N+L+ + K+ADFGL R
Sbjct: 117 H--SHR-VLHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 21/201 (10%)
Query: 580 ISIQVLRNVTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSE 638
I + LR+ F V+G G +G VYKG + G A+K M+ V+E E K E
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTEDEEEEIKLE 62
Query: 639 IAVLTKV-RHRHLVGLLGYCL------DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLE 691
I +L K HR++ G + ++ LV E+ G+++ + N K LK +
Sbjct: 63 INMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE-D 121
Query: 692 WTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNG 750
W I ++ RG+ +LH AH+ IHRD+K N+LL ++ K+ DFG+ +L G
Sbjct: 122 WIA--YICREILRGLAHLH--AHK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 176
Query: 751 KHSIETRLAGTFGYLAPEYAA 771
+ + GT ++APE A
Sbjct: 177 RRNT---FIGTPYWMAPEVIA 194
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 9e-13
Identities = 54/194 (27%), Positives = 81/194 (41%), Gaps = 44/194 (22%)
Query: 596 NVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKS---------EIAVLTKV 645
+G G +G V G K+A+K++ + F EI +L +
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNV---------FDDLIDAKRILREIKLLRHL 56
Query: 646 RHRHLVGLL-----GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIAL 700
RH +++GLL D N+ +V E M + L + + + + PL
Sbjct: 57 RHENIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQ-----PLTDDHIQYFLY 110
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE----- 755
+ RG++YLH A+ IHRDLKPSNIL+ + K+ DFGL R +
Sbjct: 111 QILRGLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167
Query: 756 -TRLAGTFGYLAPE 768
TR Y APE
Sbjct: 168 VTRW-----YRAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 53/155 (34%), Positives = 75/155 (48%), Gaps = 16/155 (10%)
Query: 597 VLGRGGFGTVYKG-ELHDGTKI----AVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
VLG G FGTVYKG + DG + A+K + S K E E V+ V ++
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVC 72
Query: 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLF-NRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
LLG CL +L V + MP G L ++ N+ G + L L + +A+G+ YL
Sbjct: 73 RLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDL-----LNWCVQIAKGMSYLE 126
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745
+ +HRDL N+L+ K+ DFGL RL
Sbjct: 127 EV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 65/178 (36%), Positives = 87/178 (48%), Gaps = 19/178 (10%)
Query: 597 VLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTK-VRHRHLVGL 653
V+G+G FG V + DG+ AVK ++ + +K +E VL K ++H LVGL
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 654 LGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
Y E+L V +Y+ G L HL R+ L+P R A +VA + YLH L
Sbjct: 62 -HYSFQTAEKLYFVLDYVNGGELFFHL-QRERCFLEP----RARFYAAEVASAIGYLHSL 115
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIET--RLAGTFGYLAPE 768
+ I+RDLKP NILL + DFGL + G ET GT YLAPE
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCK----EGVEPEETTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 53/187 (28%), Positives = 92/187 (49%), Gaps = 14/187 (7%)
Query: 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMES-AVVSEKGFAEFKSEIAVLTKVRHR 648
NF E +GRG F VY+ D +A+K+++ ++ K + EI +L ++ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHL-FNRKEEGLKPLEWTRRLTIALDVARGVE 707
+++ L ++ NE +V E G LS+ + + +K++ L P + + L A VE
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA--VE 120
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL--APDNGKHSIETRLAGTFGYL 765
++H + +HRD+KP+N+ + K+ D GL R + HS L GT Y+
Sbjct: 121 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS----LVGTPYYM 173
Query: 766 APEYAAE 772
+PE E
Sbjct: 174 SPERIHE 180
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 48/179 (26%), Positives = 84/179 (46%), Gaps = 9/179 (5%)
Query: 591 NFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
+F N +G+G FG V+K D A+K+++ + ++ + E E VL K+ +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
++ LD + +V EY G L + L K + +PL + + + G+ +L
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLL---KMQRGRPLPEDQVWRFFIQILLGLAHL 117
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
H + +HRD+K N+ L K+ D G+ +L DN + + GT YL+PE
Sbjct: 118 HS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNFANTIVGTPYYLSPE 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 44/169 (26%), Positives = 76/169 (44%), Gaps = 36/169 (21%)
Query: 596 NVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKS-------------EIAV 641
LG G +G V K G +A+K+++ +S + + E+ +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEIS-NDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 642 LTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLT---- 697
+ +++H +++GL+ ++G+ LV + M L + + +RK RLT
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRK----------IRLTESQV 121
Query: 698 --IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
I L + G+ LH F+HRDL P+NI + K+ADFGL R
Sbjct: 122 KCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 59/204 (28%), Positives = 88/204 (43%), Gaps = 41/204 (20%)
Query: 585 LRNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLT 643
L + T F V+G G +G VYK G +A+K M+ E+ E K E +L
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE---EIKEEYNILR 57
Query: 644 KV-RHRHLVGLLGYCL------DGNERLLVYEYMPQGTLS------RHLFNRKEEGLKPL 690
K H ++ G + + ++ LV E G+++ R R +E
Sbjct: 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKE----- 112
Query: 691 EWTRRLTIAL---DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LA 746
EW IA + RG+ YLH ++ IHRD+K NILL + K+ DFG+ L
Sbjct: 113 EW-----IAYILRETLRGLAYLH--ENK-VIHRDIKGQNILLTKNAEVKLVDFGVSAQLD 164
Query: 747 PDNGKH--SIETRLAGTFGYLAPE 768
G+ I GT ++APE
Sbjct: 165 STLGRRNTFI-----GTPYWMAPE 183
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 2e-12
Identities = 56/185 (30%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 598 LGRGGFGTVYKGELHDGT---KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
+GRG +G VYK + DG + A+K++E +S EIA+L +++H +++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC----REIALLRELKHPNVIALQ 64
Query: 655 GYCLDGNER--LLVYEYMPQGTLSRHLFNRKEEG-LKPLEWTRRLTIAL--DVARGVEYL 709
L ++R L+++Y F+R + KP++ R + +L + G+ YL
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 710 HGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRL--APDNGKHSIETRLAGTFG 763
H +HRDLKP+NIL+ + R K+AD G RL +P ++ + TF
Sbjct: 125 HA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 180
Query: 764 YLAPE 768
Y APE
Sbjct: 181 YRAPE 185
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 57/177 (32%), Positives = 85/177 (48%), Gaps = 22/177 (12%)
Query: 598 LGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
LG G FG VYK + + G A K +E+ SE+ ++ EI +L H ++V LLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGA 77
Query: 657 CLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLT---IALDVARGVEYLHGLA 713
+ ++ E+ P G + + LE R LT I + + +E L L
Sbjct: 78 FYWDGKLWIMIEFCPGGAVDAIM----------LELDRGLTEPQIQVICRQMLEALQYLH 127
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR--LAGTFGYLAPE 768
IHRDLK N+LL D K+ADFG ++ N K +++ R GT ++APE
Sbjct: 128 SMKIIHRDLKAGNVLLTLDGDIKLADFG---VSAKNVK-TLQRRDSFIGTPYWMAPE 180
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 51/201 (25%), Positives = 86/201 (42%), Gaps = 48/201 (23%)
Query: 588 VTNNFSEENVLGRGGFGTVYKGELHD-GTKIAVKRM----ESAVVSEKGFAEFKSEIAVL 642
V + + + +G G +G V G K+A+K++ +SA+ +++ + E+ +L
Sbjct: 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY----RELRLL 68
Query: 643 TKVRHRHLVGLLGYCLDGNERL-------LVYEYMPQ--GTLSRHLFNRKEEGLKPLEWT 693
+ H +++GLL L LV M + +
Sbjct: 69 KHMDHENVIGLLD-VFTPASSLEDFQDVYLVTHLMGADLNNIVK---------------C 112
Query: 694 RRLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747
++L+ + + RG++Y+H A IHRDLKPSNI + +D K+ DFGL R
Sbjct: 113 QKLSDDHIQFLVYQILRGLKYIHS-AG--IIHRDLKPSNIAVNEDCELKILDFGLARHTD 169
Query: 748 DNGKHSIETRLAGTFGYLAPE 768
D + TR Y APE
Sbjct: 170 DEMTGYVATRW-----YRAPE 185
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 49/177 (27%), Positives = 77/177 (43%), Gaps = 27/177 (15%)
Query: 589 TNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEK-GFA-EFKSEIAVLTKV 645
++ LG G FG VYK ++ G +A+K++ + +EK GF EI +L K+
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI--LMHNEKDGFPITALREIKILKKL 64
Query: 646 RHRHLVGLLGYCLD-----GNERLLVYEYMP------QGTLSRHLFNRKEEGLKPLEWTR 694
+H ++V L+ ++ +R VY P G L E +K
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK------ 118
Query: 695 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK 751
L + G+ YLH +HRD+K +NIL+ + K+ADFGL R
Sbjct: 119 --CYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 48/177 (27%), Positives = 77/177 (43%), Gaps = 19/177 (10%)
Query: 597 VLGRGGFGTVYKGELHD-GTKIAVKRM----ESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
++G G +G V K + + G +A+K+ + +V + EI +L ++RH +LV
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM----REIRMLKQLRHENLV 63
Query: 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHG 711
L+ LV+E++ L + GL R+ + RG+E+ H
Sbjct: 64 NLIEVFRRKKRLYLVFEFVDHTVLDD--LEKYPNGLD-ESRVRK--YLFQILRGIEFCH- 117
Query: 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
+ IHRD+KP NIL+ K+ DFG R + T T Y APE
Sbjct: 118 --SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL--AAPGEVYTDYVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 53/182 (29%), Positives = 84/182 (46%), Gaps = 12/182 (6%)
Query: 590 NNFSEENVLGRGGFGTVY-KGELHDGTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRH 647
+F ++++GRG FG V E G A+K M +S +++++ + F+ E +L+
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
+ L D + LV EY P G L L NR E+ + +A V
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDL-LSLLNRYED---QFDED---MAQFYLAELVL 113
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG-LVRLAPDNGKHSIETRLAGTFGYLA 766
+H + ++HRD+KP N+L+ K+ADFG RL + K GT Y+A
Sbjct: 114 AIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN--KMVNSKLPVGTPDYIA 171
Query: 767 PE 768
PE
Sbjct: 172 PE 173
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 6e-12
Identities = 47/176 (26%), Positives = 84/176 (47%), Gaps = 29/176 (16%)
Query: 592 FSEENVLGRGGFGTVYKGE---LHDGTK--------------IAVKRMESAVVSEKGFAE 634
F E+ LG G FG V+ E + +AVK M ++ +
Sbjct: 9 FKEK--LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVK-MLREDANKNARND 65
Query: 635 FKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTL----SRHLFNR--KEEGLK 688
F EI ++++++ +++ LL C+ + ++ EYM G L SRH ++ +
Sbjct: 66 FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125
Query: 689 PLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
+ ++ + +A +A G++YL L +F+HRDL N L+G + K+ADFG+ R
Sbjct: 126 TISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 57/177 (32%), Positives = 81/177 (45%), Gaps = 23/177 (12%)
Query: 598 LGRGGFGTVYKGELHDGTKI-AVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLG 655
+G+GG+G V+ + D +I A+KRM +S + +E +LT + LV LL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ 715
D L EY+P G R L N G+ + R + A V+ LH L
Sbjct: 69 AFQDDEYLYLAMEYVPGGDF-RTLLNNL--GVLSEDHARFYMAEMFEA--VDALHELG-- 121
Query: 716 SFIHRDLKPSNILLGDDMRAKVADFGL----VRLAPDNGKHSIETRLAGTFGYLAPE 768
+IHRDLKP N L+ K+ DFGL V A +S+ G+ Y+APE
Sbjct: 122 -YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYA-----NSV----VGSPDYMAPE 168
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 53/157 (33%), Positives = 75/157 (47%), Gaps = 14/157 (8%)
Query: 591 NFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAE---FKSEIAVLTKVR 646
N+ +LGRG FG VY + G ++AVK++ S++ E + EI +L +R
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 647 HRHLVGLLGYCLDGNERLL--VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
H +V G D E+ L EYMP G++ L K G TRR T + +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTRRYT--RQILQ 117
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741
GV YLH +HRD+K +NIL K+ DFG
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFG 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 9e-12
Identities = 60/196 (30%), Positives = 93/196 (47%), Gaps = 21/196 (10%)
Query: 585 LRNVTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLT 643
LR+ F ++G G +G VYKG + G A+K M+ E+ E K EI +L
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE---EIKQEINMLK 57
Query: 644 KV-RHRHLVGLLGYCLDGN------ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRL 696
K HR++ G + N + LV E+ G+++ + N K LK EW
Sbjct: 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE-EWIA-- 114
Query: 697 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNGKHSIE 755
I ++ RG+ +LH IHRD+K N+LL ++ K+ DFG+ +L G+ +
Sbjct: 115 YICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT- 170
Query: 756 TRLAGTFGYLAPEYAA 771
GT ++APE A
Sbjct: 171 --FIGTPYWMAPEVIA 184
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 61/190 (32%), Positives = 96/190 (50%), Gaps = 20/190 (10%)
Query: 598 LGRGGFGTVYKG-ELHDGTK-IAVKRMESAVVSEKGFAEFKSEIAVLTKVR---HRHLVG 652
+G G +G V+K +L +G + +A+KR+ E E+AVL + H ++V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 653 LLGYCL----DGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
L C D +L LV+E++ Q L+ +L E G+ P E + + L RG++
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV-PTETIKDMMFQL--LRGLD 124
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
+LH +H+ +HRDLKP NIL+ + K+ADFGL R+ T + T Y AP
Sbjct: 125 FLH--SHR-VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAP 178
Query: 768 EYAAETSGMT 777
E ++S T
Sbjct: 179 EVLLQSSYAT 188
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 62/177 (35%), Positives = 88/177 (49%), Gaps = 17/177 (9%)
Query: 597 VLGRGGFGTVYKGELHDGTKI-AVKRMES-AVVSEKGFAEFKSEIAVLTK-VRHRHLVGL 653
V+G+G FG V K AVK ++ A++ +K SE VL K V+H LVGL
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 654 LGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
+ ++L V +Y+ G L HL R+ L+P R A ++A + YLH L
Sbjct: 62 -HFSFQTADKLYFVLDYINGGELFYHL-QRERCFLEP----RARFYAAEIASALGYLHSL 115
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH-SIETRLAGTFGYLAPE 768
+ ++RDLKP NILL + DFGL + +N +H + GT YLAPE
Sbjct: 116 ---NIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 568 SDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAV 626
SD ++E ++S+ + F + +G+G GTVY ++ G ++A+++M
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57
Query: 627 VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEE 685
+K +EI V+ + ++ ++V L L G+E +V EY+ G+L+ + +E
Sbjct: 58 QPKKEL--IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE 115
Query: 686 GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VR 744
G + + + + +E+LH IHRD+K NILLG D K+ DFG +
Sbjct: 116 G-------QIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165
Query: 745 LAPDNGKHSIETRLAGTFGYLAPE 768
+ P+ K S + GT ++APE
Sbjct: 166 ITPEQSKRS---TMVGTPYWMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 56/186 (30%), Positives = 88/186 (47%), Gaps = 18/186 (9%)
Query: 591 NFSEENVLGRGGFGTVY----KGELHDGTKIAVKRMESA-VVSEKGFAEF-KSEIAVLTK 644
NF VLG G +G V+ G G A+K ++ A +V + AE ++E VL
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 645 VRHRHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVA 703
VR + L Y + +L L+ +Y+ G L HL+ R+ E R+ IA ++
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE----HFTESEVRVYIA-EIV 115
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPDNGKHSIETRLAGTF 762
+++LH L I+RD+K NILL + + DFGL + + + + GT
Sbjct: 116 LALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS--FCGTI 170
Query: 763 GYLAPE 768
Y+APE
Sbjct: 171 EYMAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-11
Identities = 51/177 (28%), Positives = 74/177 (41%), Gaps = 32/177 (18%)
Query: 32 AMQALKTSLGNPASLGWTDPDPC-----KWKHIQCSPSNRVTRIQIGGQNIEGTLPKELN 86
A+Q LK+SLG P GW + DPC W C + + I G ++
Sbjct: 376 ALQTLKSSLGLPLRFGW-NGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLD-------- 426
Query: 87 SLSSLTVLEVMKNKLTGQIPS-LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145
L G IP+ +S L LQ + N+ +TSL+ + L Y
Sbjct: 427 -----------NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSY 475
Query: 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGP 202
NSF+ IPESL T L+ + NG +++G +P LGG + +FNF
Sbjct: 476 NSFNG-SIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHR-----ASFNFTDNA 526
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-11
Identities = 40/113 (35%), Positives = 57/113 (50%), Gaps = 11/113 (9%)
Query: 331 VNVLLSIVKSVGYPAVLAESWKGNNPC---NSDWKGVSC---DAGGN--ITVVNLKNLGL 382
V+ L ++ S+G P W G+ PC W G C G I + L N GL
Sbjct: 374 VSALQTLKSSLGLPLRFG--WNGD-PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGL 430
Query: 383 SGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVP 435
G I ++ S+L L+ + LSGN + G IP L ++ SLE+LD+S N G +P
Sbjct: 431 RGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483
|
Length = 623 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 50/176 (28%), Positives = 90/176 (51%), Gaps = 15/176 (8%)
Query: 598 LGRGGFGTVYKGELHDGTK---IAVKRMESAVVSEKGFA-EFKSEIAVLTKVRHRHLVGL 653
LG G FG V KG K +A+K +++ +EK E E ++ ++ + ++V +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE--NEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
+G C + +LV E G L++ L +K+E + + + + V+ G++YL G
Sbjct: 61 IGVC-EAEALMLVMEMASGGPLNKFLSGKKDE----ITVSNVVELMHQVSMGMKYLEG-- 113
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPDNGKHSIETRLAGTFGYLAPE 768
++F+HRDL N+LL + AK++DFGL + L D+ + + + APE
Sbjct: 114 -KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPE 168
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 56/185 (30%), Positives = 91/185 (49%), Gaps = 22/185 (11%)
Query: 598 LGRGGFGTVYKGELHDGTK---IAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
+GRG +G VYK + DG A+K++E +S EIA+L +++H +++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC----REIALLRELKHPNVISLQ 64
Query: 655 GYCLDGNER--LLVYEYMPQGTLSRHLFNRKEEG-LKPLEWTRRLTIAL--DVARGVEYL 709
L +R L+++Y F+R + KP++ R + +L + G+ YL
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 710 HGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRL--APDNGKHSIETRLAGTFG 763
H +HRDLKP+NIL+ + R K+AD G RL +P ++ + TF
Sbjct: 125 HA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 180
Query: 764 YLAPE 768
Y APE
Sbjct: 181 YRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 14/157 (8%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKG-FAEFKSEIAVLTKVRH 647
++F V+GRG FG V + D I A+K++ + + EK A ++E +L + +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 648 RHLVGLLGYC--LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARG 705
+V L Y D N L+ EY+P G + L K++ E R IA +
Sbjct: 61 PWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLM--KKDTFT--EEETRFYIA-ETILA 113
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742
++ +H L +IHRD+KP N+LL K++DFGL
Sbjct: 114 IDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 52/174 (29%), Positives = 87/174 (50%), Gaps = 18/174 (10%)
Query: 598 LGRGGFGTV-YKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
+G G G V E H G ++AVK+M+ + ++ +E+ ++ H ++V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMD--LRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 657 CLDGNERLLVYEYMPQGTLSRHLFNRK--EEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
L G+E +V E++ G L+ + + + EE + T+ L V R + YLH +
Sbjct: 88 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--------TVCLSVLRALSYLH---N 136
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
Q IHRD+K +ILL D R K++DFG A + + L GT ++APE
Sbjct: 137 QGVIHRDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYWMAPE 188
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 53/184 (28%), Positives = 84/184 (45%), Gaps = 23/184 (12%)
Query: 591 NFSEENVLGRGGFGTVYKGELHDGTKIAVKR------MESAVVSEKGFAEFKSEIAVLTK 644
+F + LG G G V K LH + + + R ++ A+ ++ E+ VL +
Sbjct: 2 DFEKLGELGAGNGGVVTK-VLHRPSGLIMARKLIHLEIKPAIRNQ-----IIRELKVLHE 55
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
++VG G E + E+M G+L + L K+ G P +++IA V R
Sbjct: 56 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKISIA--VLR 110
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
G+ YL +HRD+KPSNIL+ K+ DFG+ D S+ GT Y
Sbjct: 111 GLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSY 164
Query: 765 LAPE 768
++PE
Sbjct: 165 MSPE 168
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 55/191 (28%), Positives = 79/191 (41%), Gaps = 30/191 (15%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
E + LG G G+V K L + I + + + + E+ + + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 650 LVGLLGYCLDGNERLL--VYEYMPQGTLSRHLFNRKEEGL----KPLEWTRRLTIALDVA 703
+V G LD + + EY G+L K+ G K L IA V
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVL-----GKIAESVL 115
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE--TRLAGT 761
+G+ YLH + IHRD+KPSNILL + K+ DFG+ S E LAGT
Sbjct: 116 KGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGV----------SGELVNSLAGT 162
Query: 762 FG----YLAPE 768
F Y+APE
Sbjct: 163 FTGTSFYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 47/151 (31%), Positives = 79/151 (52%), Gaps = 14/151 (9%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVK--RMESAVVSEKGFAEFK-SEIAVLTKVRHRHLVGL 653
+G G +G VYK + G +A+K R+E+ ++G EI++L ++ H ++V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLET---EDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
L N+ LV+E++ L +++ + GL P + L +G+ Y H
Sbjct: 64 LDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDP-PLIKSYLYQL--LQGIAYCHS-- 117
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
H+ +HRDLKP N+L+ + K+ADFGL R
Sbjct: 118 HR-VLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 56/187 (29%), Positives = 86/187 (45%), Gaps = 15/187 (8%)
Query: 598 LGRGGFGTVYKGELHDGTKI-AVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRH---LVG 652
+G+G FG VY+ D +I A+K + + +V++K A E +L + +VG
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 653 LLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
L ++ LV +YM G L HL ++EG E + IA ++ +E+LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHL---QKEGRFS-EDRAKFYIA-ELVLALEHLH-- 113
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAE 772
++RDLKP NILL + DFGL + + + GT YLAPE +
Sbjct: 114 -KYDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLD 170
Query: 773 TSGMTWQ 779
G T
Sbjct: 171 EKGYTKH 177
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 55/178 (30%), Positives = 88/178 (49%), Gaps = 18/178 (10%)
Query: 597 VLGRGGFGTVY-----KGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
VLG+G FG V+ G G A+K ++ A + + K E +L +V H +V
Sbjct: 3 VLGQGSFGKVFLVRKITGP-DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 652 GLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
L Y +L L+ +++ G L F R + + E + +A ++A +++LH
Sbjct: 62 KL-HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLA-ELALALDHLH 115
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
L I+RDLKP NILL ++ K+ DFGL + + D+ K + GT Y+APE
Sbjct: 116 SLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPE 168
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 53/179 (29%), Positives = 84/179 (46%), Gaps = 13/179 (7%)
Query: 597 VLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFK-SEIAVLTKVRHRHLVGLL 654
VLG+G FG V L G AVK ++ V+ + E +E +L+ R+ + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 655 GYCLDGNERLL-VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
C +RL V E++ G L H+ + + + R A ++ + +LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHI-----QKSRRFDEARARFYAAEITSALMFLH--- 113
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAE 772
+ I+RDLK N+LL + K+ADFG+ + NGK + + GT Y+APE E
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT--STFCGTPDYIAPEILQE 170
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 53/181 (29%), Positives = 80/181 (44%), Gaps = 30/181 (16%)
Query: 595 ENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGL 653
+ +LG G GTVYK L +AVK + + E + SE+ +L K +++G
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ-KQIMSELEILYKCDSPYIIGF 64
Query: 654 LGYCLDGNERLLVYEYMPQGTLS------RHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
G N + E+M G+L H+ R IA+ V +G+
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGR---------------IAVAVVKGLT 109
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
YL L +HRD+KPSN+L+ + K+ DFG+ + SI GT Y+AP
Sbjct: 110 YLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----SIAKTYVGTNAYMAP 162
Query: 768 E 768
E
Sbjct: 163 E 163
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 51/176 (28%), Positives = 79/176 (44%), Gaps = 19/176 (10%)
Query: 598 LGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFK---SEIAVLTKVRHRHLVGL 653
+G G +G V+K + G +A+K+ V SE K EI +L +++H +LV L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKF---VESEDDPVIKKIALREIRMLKQLKHPNLVNL 65
Query: 654 LGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
+ +L LV+EY L + + G+ P +++ + V + H
Sbjct: 66 I-EVFRRKRKLHLVFEYCDHTVL--NELEKNPRGV-PEHLIKKII--WQTLQAVNFCH-- 117
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
H IHRD+KP NIL+ + K+ DFG R+ G T T Y APE
Sbjct: 118 KHNC-IHRDVKPENILITKQGQIKLCDFGFARIL--TGPGDDYTDYVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 43/151 (28%), Positives = 77/151 (50%), Gaps = 13/151 (8%)
Query: 598 LGRGGFGTVYKGE-LHDGTKIAVK--RMESAVVSEKGFAEFK-SEIAVLTKVRHRHLVGL 653
+G G +G VYKG G +A+K R+ES E+G EI++L +++H ++V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLES---EEEGVPSTAIREISLLKELQHPNIVCL 64
Query: 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
+ + L++E++ L ++L + + E + + +G+ + H
Sbjct: 65 QDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYL--YQILQGILFCH--- 118
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
+ +HRDLKP N+L+ + K+ADFGL R
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 47/152 (30%), Positives = 73/152 (48%), Gaps = 9/152 (5%)
Query: 598 LGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
+GRG FG V+ G L D T +AVK + + A+F E +L + H ++V L+G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLK-AKFLQEARILKQYSHPNIVRLIGV 61
Query: 657 CLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS 716
C +V E + G L + EG + L+ + + + A G+EYL +
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFL---RTEGPR-LKVKELIQMVENAAAGMEYLES---KH 114
Query: 717 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748
IHRDL N L+ + K++DFG+ R D
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSREEED 146
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 56/180 (31%), Positives = 84/180 (46%), Gaps = 18/180 (10%)
Query: 592 FSEENVLGRGGFGTVYKG-ELHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKVRHRH 649
FS+ +G G FG VY ++ + +A+K+M S S + + + E+ L K+RH +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+ G L + LV EY G+ S L K KPL+ + +G+ YL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYL 131
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL-APDNGKHSIETRLAGTFGYLAPE 768
H + IHRD+K NILL + K+ DFG + AP N GT ++APE
Sbjct: 132 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-------FVGTPYWMAPE 181
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 5e-11
Identities = 51/174 (29%), Positives = 89/174 (51%), Gaps = 18/174 (10%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
+G+G GTVY ++ G ++A+K+M +K +EI V+ + ++ ++V L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDS 84
Query: 657 CLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ 715
L G+E +V EY+ G+L+ + +EG + + + + +++LH
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALDFLHS---N 134
Query: 716 SFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNGKHSIETRLAGTFGYLAPE 768
IHRD+K NILLG D K+ DFG ++ P+ K S + GT ++APE
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST---MVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 52/190 (27%), Positives = 85/190 (44%), Gaps = 26/190 (13%)
Query: 588 VTNNFSEENVLGRGGFGTV-YKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR 646
V + + + +G G +GTV + G K+A+K++ SE E+ +L ++
Sbjct: 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK 72
Query: 647 HRHLVGLLGY-----CLDG-NERLLVYEYMPQ--GTLSRHLFNRKEEGLKPLEWTRRLTI 698
H +++GLL LD ++ LV +M G L +H + L R +
Sbjct: 73 HENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH---------EKLSEDRIQFL 123
Query: 699 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRL 758
+ +G++Y+H IHRDLKP N+ + +D K+ DFGL R + TR
Sbjct: 124 VYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRW 180
Query: 759 AGTFGYLAPE 768
Y APE
Sbjct: 181 -----YRAPE 185
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 7e-11
Identities = 54/179 (30%), Positives = 84/179 (46%), Gaps = 16/179 (8%)
Query: 592 FSEENVLGRGGFGTVY-KGELHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKVRHRH 649
F++ +G G FG VY ++ +A+K+M S S + + + E+ L +++H +
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+ G L + LV EY G+ S L K KPL+ I +G+ YL
Sbjct: 87 SIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHK----KPLQEVEIAAITHGALQGLAYL 141
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
H + IHRD+K NILL + + K+ADFG +A S GT ++APE
Sbjct: 142 HS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIA------SPANSFVGTPYWMAPE 191
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 19/153 (12%)
Query: 598 LGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
+G G +GTV+K + + +A+KR+ E + EI +L +++H+++V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 657 CLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY--LHGLAH 714
+ LV+EY Q LK + I ++ + + L GLA
Sbjct: 68 LHSDKKLTLVFEYCDQ-------------DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAF 114
Query: 715 ---QSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
+ +HRDLKP N+L+ + K+ADFGL R
Sbjct: 115 CHSHNVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 45/183 (24%), Positives = 87/183 (47%), Gaps = 11/183 (6%)
Query: 592 FSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
F++ +G+G FG V+KG + ++ ++ +E + + EI VL++ ++
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHG 711
G L G + ++ EY+ G+ L P + + T+ ++ +G++YLH
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLL------RAGPFDEFQIATMLKEILKGLDYLHS 119
Query: 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAA 771
+ IHRD+K +N+LL + K+ADFG+ D GT ++APE
Sbjct: 120 ---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKRNTFVGTPFWMAPEVIQ 174
Query: 772 ETS 774
+++
Sbjct: 175 QSA 177
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 9e-11
Identities = 57/196 (29%), Positives = 81/196 (41%), Gaps = 47/196 (23%)
Query: 591 NFSE---ENVLGRGGFGTVYKGELHDGT------KIAVKRMESAVVSEKGFAEFKSEIAV 641
+ SE N +G G GTVYK +H T K+ E V + EI +
Sbjct: 72 SLSELERVNRIGSGAGGTVYK-VIHRPTGRLYALKVIYGNHEDTVRRQ-----ICREIEI 125
Query: 642 LTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALD 701
L V H ++V E ++ E+M G+L E+ L D
Sbjct: 126 LRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIA-DEQFLA------------D 172
Query: 702 VAR----GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-----LAPDNGKH 752
VAR G+ YLH + +HRD+KPSN+L+ K+ADFG+ R + P N
Sbjct: 173 VARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS- 228
Query: 753 SIETRLAGTFGYLAPE 768
GT Y++PE
Sbjct: 229 ------VGTIAYMSPE 238
|
Length = 353 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 49/160 (30%), Positives = 74/160 (46%), Gaps = 14/160 (8%)
Query: 591 NFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRME---SAVVSEKGFAEFKSEIAVLTKVR 646
N+ +LG+G FG VY + G ++AVK+++ + + K + EI +L +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 647 HRHLVGLLGYCLDGNERLL--VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
H +V G D ER L E+MP G++ L K G TR+ T +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYGALTENVTRKYT--RQILE 117
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
GV YLH +HRD+K +NIL K+ DFG +
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 27/194 (13%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYK------GELHDGTKIAVKRMESAVVSEKGFAEFKSEI 639
RN +F +G G +G VYK GEL I V ++E + FA + EI
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGEL---AAIKVIKLEPG----EDFAVVQQEI 57
Query: 640 AVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSR--HLFNRKEEGLKPLEWTRRLT 697
++ +H ++V G L ++ + E+ G+L H+ PL ++
Sbjct: 58 IMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG-------PLSESQIAY 110
Query: 698 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR 757
++ + +G+ YLH + +HRD+K +NILL D+ K+ADFG+ A +
Sbjct: 111 VSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKS 165
Query: 758 LAGTFGYLAPEYAA 771
GT ++APE AA
Sbjct: 166 FIGTPYWMAPEVAA 179
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 57/183 (31%), Positives = 84/183 (45%), Gaps = 17/183 (9%)
Query: 597 VLGRGGFGTVYKGELHDGTK--IAVKRMESAVVSEKGFAEF-KSEIAVLTKV-RHRHLVG 652
VLG+G FG V EL GT AVK ++ V+ + E +E VL +H L
Sbjct: 2 VLGKGSFGKVLLAELK-GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 653 LLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHG 711
L C +RL V EY+ G L H+ + G R A ++ G+++LH
Sbjct: 61 LHS-CFQTKDRLFFVMEYVNGGDLMFHI---QRSGRFDEPRAR--FYAAEIVLGLQFLH- 113
Query: 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAA 771
+ I+RDLK N+LL + K+ADFG+ + G + + GT Y+APE +
Sbjct: 114 --ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT--STFCGTPDYIAPEILS 169
Query: 772 ETS 774
Sbjct: 170 YQP 172
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 56/180 (31%), Positives = 86/180 (47%), Gaps = 19/180 (10%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR---HRHLVGL 653
+G G +GTVYK + H G +A+K + + E+A+L ++ H ++V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 654 LGYC----LDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
+ C D ++ LV+E++ Q L +L GL P E + L RG+++
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGL-PAETIKDLMRQF--LRGLDF 123
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
LH +HRDLKP NIL+ + K+ADFGL R+ T + T Y APE
Sbjct: 124 LHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPE 177
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 47/157 (29%), Positives = 75/157 (47%), Gaps = 14/157 (8%)
Query: 591 NFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRME---SAVVSEKGFAEFKSEIAVLTKVR 646
N+ +LG+G FG VY ++ G ++A K+++ + + K + + EI +L ++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 647 HRHLVGLLGYCLDGNERLLV--YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
H +V G D E+ L EYMP G++ L K G TR+ T +
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTRKYT--RQILE 117
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741
G+ YLH +HRD+K +NIL K+ DFG
Sbjct: 118 GMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFG 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 53/181 (29%), Positives = 81/181 (44%), Gaps = 16/181 (8%)
Query: 595 ENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGL 653
+ V+G+G +G V + H G K+A+K++ EI +L +RH +V +
Sbjct: 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 64
Query: 654 LGYCLDGNER-----LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
L + R +V+E M H + + L P L L R ++Y
Sbjct: 65 KHIMLPPSRREFKDIYVVFELMES---DLHQVIKANDDLTPEHHQFFLYQLL---RALKY 118
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSI-ETRLAGTFGYLAP 767
+H + HRDLKP NIL D + K+ DFGL R+A ++ +I T T Y AP
Sbjct: 119 IHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
Query: 768 E 768
E
Sbjct: 176 E 176
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 53/180 (29%), Positives = 86/180 (47%), Gaps = 17/180 (9%)
Query: 595 ENVLGRGGFGTVYKGELHDGTK----IAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
E +LG G FG + +G L +K +A+ A S+K F +E L + H ++
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIH-TLRAGCSDKQRRGFLAEALTLGQFDHSNI 68
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
V L G GN ++V EYM G L F RK EG L + + + +A G++Y
Sbjct: 69 VRLEGVITRGNTMMIVTEYMSNGALDS--FLRKHEG--QLVAGQLMGMLPGLASGMKY-- 122
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYL--APE 768
L+ ++H+ L +L+ D+ K++ F RL ++ +I T ++G L APE
Sbjct: 123 -LSEMGYVHKGLAAHKVLVNSDLVCKISGFR--RL-QEDKSEAIYTTMSGKSPVLWAAPE 178
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 51/202 (25%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 569 DLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVV 627
D ++E ++SI + ++ +G+G GTV+ ++ G ++A+K++
Sbjct: 1 DEEIMEKLRTIVSIG---DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ 57
Query: 628 SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGL 687
+K +EI V+ ++++ ++V L L G+E +V EY+ G+L+ +
Sbjct: 58 PKKEL--IINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE------ 109
Query: 688 KPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLA 746
++ + + + + +E+LH IHRD+K N+LLG D K+ DFG ++
Sbjct: 110 TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166
Query: 747 PDNGKHSIETRLAGTFGYLAPE 768
P+ K S + GT ++APE
Sbjct: 167 PEQSKRST---MVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 2e-10
Identities = 62/187 (33%), Positives = 91/187 (48%), Gaps = 35/187 (18%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVS-EKGFAEFKS---------EIAVLTKVR- 646
LG+G +G V+K A+ R VV+ +K F F++ EI L ++
Sbjct: 15 LGKGAYGIVWK---------AIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD 65
Query: 647 HRHLVGLLGYCLDGNER--LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
H ++V LL N++ LV+EYM + L H R + LE + I + +
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYM-ETDL--HAVIRA--NI--LEDVHKRYIMYQLLK 118
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA---PDNGKHSIETRLAGT 761
++Y+H + IHRDLKPSNILL D R K+ADFGL R +N ++ + T T
Sbjct: 119 ALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 762 FGYLAPE 768
Y APE
Sbjct: 176 RWYRAPE 182
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 60/176 (34%), Positives = 85/176 (48%), Gaps = 15/176 (8%)
Query: 597 VLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTK-VRHRHLVGL 653
V+G+G FG V + DG AVK ++ +V + K +E VL K V+H LVGL
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 654 LGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
Y E+L V +++ G L HL ++E E R A ++A + YLH +
Sbjct: 62 -HYSFQTTEKLYFVLDFVNGGELFFHL--QRERSFP--EPRARFYAA-EIASALGYLHSI 115
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
+ ++RDLKP NILL + DFGL + + T GT YLAPE
Sbjct: 116 ---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT--TTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 56/191 (29%), Positives = 88/191 (46%), Gaps = 21/191 (10%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKG--FAEFKSEIAVL 642
RN +++ +G G +G VYK LH G AVK + E G F+ + EI ++
Sbjct: 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVK----IIKLEPGDDFSLIQQEIFMV 60
Query: 643 TKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSR--HLFNRKEEGLKPLEWTRRLTIAL 700
+ +H ++V G L + + EY G+L H+ PL + +
Sbjct: 61 KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG-------PLSELQIAYVCR 113
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAG 760
+ +G+ YLH +HRD+K +NILL D+ K+ADFG+ A + G
Sbjct: 114 ETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSFIG 168
Query: 761 TFGYLAPEYAA 771
T ++APE AA
Sbjct: 169 TPYWMAPEVAA 179
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 53/173 (30%), Positives = 79/173 (45%), Gaps = 16/173 (9%)
Query: 598 LGRGGFGTVY-KGELHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLG 655
+G G FG VY H +AVK+M S + + + + E+ L +++H + + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ 715
L + LV EY G+ S L K KPL+ I +G+ YLH
Sbjct: 89 CYLKEHTAWLVMEYC-LGSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHS---H 140
Query: 716 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
+ IHRD+K NILL + + K+ADFG + S GT ++APE
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSASKS------SPANSFVGTPYWMAPE 187
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 55/196 (28%), Positives = 80/196 (40%), Gaps = 12/196 (6%)
Query: 582 IQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESA--VVSEKGFAEFKSEI 639
I+ LR ++ V+GRG FG V K+ ++ S ++ A F E
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 640 AVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIA 699
++ +V L D +V EYMP G L + N P +W R T
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD----VPEKWARFYTAE 150
Query: 700 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLA 759
+ +A L + FIHRD+KP N+LL K+ADFG G +T +
Sbjct: 151 VVLA-----LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV- 204
Query: 760 GTFGYLAPEYAAETSG 775
GT Y++PE G
Sbjct: 205 GTPDYISPEVLKSQGG 220
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 50/179 (27%), Positives = 84/179 (46%), Gaps = 28/179 (15%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
+G G G V + G ++AVK+M+ + ++ +E+ ++ +H ++V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMD--LRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84
Query: 657 CLDGNERLLVYEYMPQGTLS---RHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
L G+E +V E++ G L+ H EE + T+ L V + + +LH
Sbjct: 85 YLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIA--------TVCLAVLKALSFLHA-- 133
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIET----RLAGTFGYLAPE 768
Q IHRD+K +ILL D R K++DFG + S E L GT ++APE
Sbjct: 134 -QGVIHRDIKSDSILLTSDGRVKLSDFGFC------AQVSKEVPRRKSLVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 55/175 (31%), Positives = 76/175 (43%), Gaps = 14/175 (8%)
Query: 597 VLGRGGFGTV-YKGELHDGTKIAVKRMESAVVSEKG-FAEFKSEIAVLTKVRHRHLVGLL 654
+LG+G FG V E G A+K ++ V+ K A +E VL RH L L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL- 60
Query: 655 GYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
Y ++RL V EY G L HL E + + R ++ + YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRAR--FYGAEIVSALGYLH--- 112
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
++RDLK N++L D K+ DFGL + +G GT YLAPE
Sbjct: 113 SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 57/195 (29%), Positives = 85/195 (43%), Gaps = 36/195 (18%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSE-KGFAEFKSEIAVLTK------VRHRHL 650
+G G FG V E++ T +A VV E K A K + L + ++H ++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVA-----RVVVKELKANASSKEQNEFLQQGDPYRILQHPNI 57
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLT-------IALDVA 703
+ LG C++ LLV+EY G L +L +W RR + +A ++A
Sbjct: 58 LQCLGQCVEAIPYLLVFEYCELGDLKSYLSQE--------QWHRRNSQLLLLQRMACEIA 109
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS-IET--RLAG 760
GV ++H +F+H DL N L D+ KV D+G + P K IET
Sbjct: 110 AGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYG---IGPSRYKEDYIETEDDKCV 163
Query: 761 TFGYLAPEYAAETSG 775
+LAPE E G
Sbjct: 164 PLRWLAPELVGEFHG 178
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 54/198 (27%), Positives = 96/198 (48%), Gaps = 19/198 (9%)
Query: 578 MVISIQVLRNVTNNFSEENVLGRGGFGTV-YKGELHDGTKIAVKRMESAVVSEKGFAEFK 636
MV+ R++ N+ + +G G G V E H G ++AVK M+ + ++
Sbjct: 12 MVVDQGDPRSLLENYIK---IGEGSTGIVCIAREKHSGRQVAVKMMD--LRKQQRRELLF 66
Query: 637 SEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRL 696
+E+ ++ +H+++V + L G E ++ E++ G L+ + + L +
Sbjct: 67 NEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR------LNEEQIA 120
Query: 697 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNGKHSIE 755
T+ V + + YLH Q IHRD+K +ILL D R K++DFG +++ D K
Sbjct: 121 TVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK-- 175
Query: 756 TRLAGTFGYLAPEYAAET 773
L GT ++APE + T
Sbjct: 176 -SLVGTPYWMAPEVISRT 192
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 54/178 (30%), Positives = 88/178 (49%), Gaps = 25/178 (14%)
Query: 598 LGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKS----EIAVLTKVRHRHLVG 652
LG G G+V K + + GT +A K VV + + E+ ++ + R ++V
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKK-----VVHIGAKSSVRKQILRELQIMHECRSPYIVS 67
Query: 653 LLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
G L+ N + E+M G+L R K+ G P+E + IA+ V G+ YL+ +
Sbjct: 68 FYGAFLNENNICMCMEFMDCGSLDRIY---KKGGPIPVEILGK--IAVAVVEGLTYLYNV 122
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK--HSIETRLAGTFGYLAPE 768
+HRD+KPSNIL+ + K+ DFG+ +G+ +SI GT Y++PE
Sbjct: 123 HR--IMHRDIKPSNILVNSRGQIKLCDFGV------SGELINSIADTFVGTSTYMSPE 172
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 5e-10
Identities = 51/175 (29%), Positives = 83/175 (47%), Gaps = 13/175 (7%)
Query: 598 LGRGGFGTVYKG--ELHDGTK-IAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
LG G FGTV KG ++ K +AVK +++ E E V+ ++ + ++V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
G C + +LV E G L++ L K K + + V+ G++YL
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNI-----TELVHQVSMGMKYLE---E 113
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPDNGKHSIETRLAGTFGYLAPE 768
+F+HRDL N+LL AK++DFGL + L D + +T + APE
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE 168
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 53/179 (29%), Positives = 80/179 (44%), Gaps = 13/179 (7%)
Query: 597 VLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAEFK-SEIAVLTKVRHRHLVGLL 654
VLG+G FG V EL ++ A+K ++ V+ + + +E +L + L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 655 GYCLDGNERLL-VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
C +RL V EY+ G L +F + + + R A +V + +LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDL---MFQIQRS--RKFDEPRSRFYAAEVTLALMFLH--- 113
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAE 772
I+RDLK NILL + K+ADFG+ + NG T GT Y+APE E
Sbjct: 114 RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAPEILQE 170
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 6e-10
Identities = 59/186 (31%), Positives = 83/186 (44%), Gaps = 26/186 (13%)
Query: 591 NFSEENVLGRGGFGTV----YKGELHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKV 645
+F+ LG G FG V YK E D +A+KR E S ++ +K SE +L +
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNE--DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI 88
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARG 705
H V L G D + LV E++ G F R+ K A +
Sbjct: 89 NHPFCVNLYGSFKDESYLYLVLEFVIGGEF--FTFLRRN---KRFPNDVGCFYAAQIVLI 143
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR---LAGTF 762
EYL L + ++RDLKP N+LL D K+ DFG ++ ++TR L GT
Sbjct: 144 FEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRTYTLCGTP 192
Query: 763 GYLAPE 768
Y+APE
Sbjct: 193 EYIAPE 198
|
Length = 340 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 49/176 (27%), Positives = 78/176 (44%), Gaps = 29/176 (16%)
Query: 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAE------FKSEIAVL 642
T F EE LG FG VYKG L GT + A+ + K AE FK E +
Sbjct: 6 TVRFMEE--LGEDRFGKVYKGHLF-GTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMR 62
Query: 643 TKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRK--------------EEGLK 688
++++H ++V LLG +++ Y L L R + L+
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 689 PLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
P ++ + I +A G+E+L + +H+DL N+L+ D + K++D GL R
Sbjct: 123 PADF---VHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 56/175 (32%), Positives = 85/175 (48%), Gaps = 13/175 (7%)
Query: 597 VLGRGGFGTV-YKGELHDGTKIAVKRMESAVVSEKG-FAEFKSEIAVLTKVRHRHLVGLL 654
+LG+G FG V E G A+K ++ V+ K A +E VL RH L L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL- 60
Query: 655 GYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
Y ++RL V EY G L HL +R+ + R ++ ++YLH +
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHL-SRE----RVFSEDRARFYGAEIVSALDYLH--S 113
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
++ ++RDLK N++L D K+ DFGL + +G +++T GT YLAPE
Sbjct: 114 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKT-FCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 8e-10
Identities = 40/142 (28%), Positives = 77/142 (54%), Gaps = 21/142 (14%)
Query: 598 LGRGGFGTVYKG---ELHDG-----TKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHR 648
LG+G F ++KG E+ D T++ +K ++ S + ++E F ++++++ H+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK---SHRNYSESFFEAASMMSQLSHK 59
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
HLV G C+ G+E ++V EY+ G+L +L +K + L + W L+VA+ + +
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWK------LEVAKQLAW 111
Query: 709 -LHGLAHQSFIHRDLKPSNILL 729
LH L + H ++ N+LL
Sbjct: 112 ALHFLEDKGLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 56/183 (30%), Positives = 82/183 (44%), Gaps = 21/183 (11%)
Query: 591 NFSEENVLGRGGFGTV----YKGELHDGTKIAVKRMES-AVVSEKGFAEFKSEIAVLTKV 645
+F LG G FG V +KG G A+K ++ ++ K E ++L ++
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARG 705
H +V ++ D N + E++ G L HL ++ G P + + L +A
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL---RKAGRFPNDVAKFYHAELVLA-- 130
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYL 765
EYLH I+RDLKP N+LL + KV DFG + PD L GT YL
Sbjct: 131 FEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLCGTPEYL 182
Query: 766 APE 768
APE
Sbjct: 183 APE 185
|
Length = 329 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 48/181 (26%), Positives = 84/181 (46%), Gaps = 26/181 (14%)
Query: 597 VLGRGGFGTVYKGELHDGTK--IAVKRMESAVVSEKGFAEFKSEIAVLTKVRH---RHLV 651
++GRG +G VY+G H T +A+K + + ++ + E+A+L+++R ++
Sbjct: 8 LIGRGAYGAVYRG-KHVPTGRVVALKIINLDTPDDD-VSDIQREVALLSQLRQSQPPNIT 65
Query: 652 GLLGYCLDGNERLLVYEYMPQG---TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
G L G ++ EY G TL + P+ I +V ++Y
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLMK---------AGPIAEKYISVIIREVLVALKY 116
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNGKHSIETRLAGTFGYLAP 767
+H IHRD+K +NIL+ + K+ DFG+ L ++ K S GT ++AP
Sbjct: 117 IH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST---FVGTPYWMAP 170
Query: 768 E 768
E
Sbjct: 171 E 171
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 58/191 (30%), Positives = 88/191 (46%), Gaps = 25/191 (13%)
Query: 588 VTNNFSEENVLGRGGFGTVYKGELHD--GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
+ + +GRG FGTV K LH GT +AVKR+ S V EK ++ V+ +
Sbjct: 2 TAEDLKDLGEIGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVD-EKEQKRLLMDLDVVMRS 59
Query: 646 RH-RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR----KEEGLKPLEWTRRLTIAL 700
++V G + + E M +S F + + + P E ++ +A
Sbjct: 60 SDCPYIVKFYGALFREGDCWICMELM---DISLDKFYKYVYEVLKSVIPEEILGKIAVA- 115
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK--HSI-ETR 757
+ + YL IHRD+KPSNILL + K+ DFG+ +G+ SI +TR
Sbjct: 116 -TVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGI------SGQLVDSIAKTR 166
Query: 758 LAGTFGYLAPE 768
AG Y+APE
Sbjct: 167 DAGCRPYMAPE 177
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 47/181 (25%), Positives = 83/181 (45%), Gaps = 12/181 (6%)
Query: 591 NFSEENVLGRGGFGTVY--KGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR 648
+ +G G FG +Y K + D +K ++ + K K E+ +L K++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
++V + +V EY G L + + NR+ L + L+ + ++ G+++
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVL--FSEDQILSWFVQISLGLKH 116
Query: 709 LHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
+H + +HRD+K NI L + M AK+ DFG+ R N + GT YL+P
Sbjct: 117 IH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--NDSMELAYTCVGTPYYLSP 171
Query: 768 E 768
E
Sbjct: 172 E 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 56/175 (32%), Positives = 82/175 (46%), Gaps = 14/175 (8%)
Query: 597 VLGRGGFGTV-YKGELHDGTKIAVKRMESAVVSEKG-FAEFKSEIAVLTKVRHRHLVGLL 654
+LG+G FG V E G A+K + V+ K A +E VL RH L L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL- 60
Query: 655 GYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
Y ++RL V EY G L HL +R+ + R ++ +EYLH
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHL-SRE----RVFTEERARFYGAEIVSALEYLHS-- 113
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
+ ++RD+K N++L D K+ DFGL + +G +++T GT YLAPE
Sbjct: 114 -RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKT-FCGTPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 57/195 (29%), Positives = 88/195 (45%), Gaps = 22/195 (11%)
Query: 591 NFSEENVLGRGGFGTVY---KGELHDGTKI-AVKRMESA--VVSEKGFAEFKSEIAVLTK 644
NF VLG G +G V+ K HD K+ A+K ++ A V K ++E VL
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 645 VRHRHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNR---KEEGLKPLEWTRRLTIAL 700
VR + L Y +L L+ +Y+ G + HL+ R E+ ++ ++ + +AL
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRF--YSGEIILAL 118
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAG 760
E+LH L ++RD+K NILL + + DFGL + K + G
Sbjct: 119 ------EHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCG 168
Query: 761 TFGYLAPEYAAETSG 775
T Y+APE G
Sbjct: 169 TIEYMAPEIIRGKGG 183
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 50/155 (32%), Positives = 80/155 (51%), Gaps = 22/155 (14%)
Query: 597 VLGRGGFGTVYKG-ELHDGTKIAVK--RMESAVVSEKGFAEFKS--EIAVLTKVRHRHLV 651
LG G + TVYKG G +A+K R+E E+G A F + E ++L ++H ++V
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEH----EEG-APFTAIREASLLKDLKHANIV 66
Query: 652 GLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIAL-DVARGVEYL 709
L + + L LV+EY+ L +++ + GL + + L + RG+ Y
Sbjct: 67 -TLHDIIHTKKTLTLVFEYL-DTDLKQYM-DDCGGGLSM----HNVRLFLFQLLRGLAYC 119
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
H + +HRDLKP N+L+ + K+ADFGL R
Sbjct: 120 H---QRRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-09
Identities = 35/106 (33%), Positives = 58/106 (54%), Gaps = 4/106 (3%)
Query: 333 VLLSIVKSVGYPAVLAESWKGNNP-CNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFS 391
+LLS S+ P +W + C W+G++C+ + ++L +SG ISS
Sbjct: 33 LLLSFKSSINDPLKYLSNWNSSADVCL--WQGITCNNSSRVVSIDLSGKNISGKISSAIF 90
Query: 392 RLTSLRQLMLSGNELTGTIPKEL-TTLPSLEMLDVSNNHLFGKVPN 436
RL ++ + LS N+L+G IP ++ TT SL L++SNN+ G +P
Sbjct: 91 RLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR 136
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 57/196 (29%), Positives = 88/196 (44%), Gaps = 20/196 (10%)
Query: 244 LHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPS-SLVNLHSLAVVNLTNNLFQGQT 300
L N +GP+PD + SSL+ ++ +N TG +P S+ NL +L +L+NN+ G+
Sbjct: 100 LSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETL---DLSNNMLSGEI 156
Query: 301 PKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSD 360
P D+ S+ LD G G++ L+ + S+ + + + G P
Sbjct: 157 PN-------DIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIP---- 205
Query: 361 WKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSL 420
++ + L LSG I LTSL L L N LTG IP L L +L
Sbjct: 206 ---RELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNL 262
Query: 421 EMLDVSNNHLFGKVPN 436
+ L + N L G +P
Sbjct: 263 QYLFLYQNKLSGPIPP 278
|
Length = 968 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 58/196 (29%), Positives = 81/196 (41%), Gaps = 20/196 (10%)
Query: 579 VISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTK--IAVKRM---ESAVVSEKGFA 633
I LR +F V+GRG FG V + H +K A+K + E S+ F
Sbjct: 32 AEKITKLRMKAEDFDVIKVIGRGAFGEV-QLVRHKSSKQVYAMKLLSKFEMIKRSDSAF- 89
Query: 634 EFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWT 693
F E ++ +V L D +V EYMP G L + N P +W
Sbjct: 90 -FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD----IPEKWA 144
Query: 694 RRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNGKH 752
R T A V L + FIHRD+KP N+LL K+ADFG +++ +
Sbjct: 145 RFYT-----AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR 199
Query: 753 SIETRLAGTFGYLAPE 768
GT Y++PE
Sbjct: 200 C--DTAVGTPDYISPE 213
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 25/157 (15%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
+G G +G VYK + IA+K++ E + EI++L +++H ++V L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD- 68
Query: 657 CLDGNERL-LVYEYMPQGTLSRHL-----FNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
+ +RL LV+EY+ L +H+ F + +K + + RG+ Y H
Sbjct: 69 VVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLY--------QILRGIAYCH 119
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRA---KVADFGLVR 744
+H+ +HRDLKP N+L+ D R K+ADFGL R
Sbjct: 120 --SHR-VLHRDLKPQNLLI--DRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 56/193 (29%), Positives = 89/193 (46%), Gaps = 26/193 (13%)
Query: 591 NFSEENVLGRGGFGTVY---KGELHDGTKI-AVKRMESAVVSEKG--FAEFKSEIAVLTK 644
NF VLG G +G V+ K HD K+ A+K ++ A + +K ++E VL
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 645 VRHRHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLE-WTRRLTIALDV 702
+R + L Y + +L L+ +Y+ G L HL R+ + ++ ++ + +AL
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLAL-- 118
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLA--- 759
E+LH L I+RD+K NILL + + DFGL + H E A
Sbjct: 119 ----EHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF-----HEDEVERAYSF 166
Query: 760 -GTFGYLAPEYAA 771
GT Y+AP+
Sbjct: 167 CGTIEYMAPDIVR 179
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 53/180 (29%), Positives = 81/180 (45%), Gaps = 15/180 (8%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657
LG G FG VYK + + +A ++ SE+ ++ EI +L H ++V LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 658 LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSF 717
N ++ E+ G + + E +PL + + + YLH
Sbjct: 72 YYENNLWILIEFCAGGAVDAVML----ELERPLTEPQIRVVCKQTLEALNYLH---ENKI 124
Query: 718 IHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR--LAGTFGYLAPEYA-AETS 774
IHRDLK NIL D K+ADFG ++ N + +I+ R GT ++APE ETS
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFG---VSAKNTR-TIQRRDSFIGTPYWMAPEVVMCETS 180
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 49/157 (31%), Positives = 82/157 (52%), Gaps = 12/157 (7%)
Query: 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR 648
+++ + LG G + TVYKG+ +G +A+K + F + E ++L ++H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63
Query: 649 HLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
++V LL + E L LV+EY+ L +++ ++ GL P L + RG+
Sbjct: 64 NIV-LLHDIIHTKETLTLVFEYV-HTDLCQYM-DKHPGGLHPENVKLFL---FQLLRGLS 117
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
Y+H + +HRDLKP N+L+ D K+ADFGL R
Sbjct: 118 YIH---QRYILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 61/175 (34%), Positives = 82/175 (46%), Gaps = 16/175 (9%)
Query: 598 LGRGGFGTVYKGELHDGTKI-AVKRMESA-VVSEKGFAEFKSEIAVLTKVRHRHLVGLLG 655
+G+G FG V + D +I A+K + A +VS +E VL +V +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 656 YCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
+ E+L LV ++ G L HL + EG L R T L A +E LH
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHL---QREGRFDLSRARFYTAELLCA--LENLHKF-- 112
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR-LAGTFGYLAPE 768
+ I+RDLKP NILL + DFGL +L N K +T GT YLAPE
Sbjct: 113 -NVIYRDLKPENILLDYQGHIALCDFGLCKL---NMKDDDKTNTFCGTPEYLAPE 163
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 30/182 (16%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRM----ESAVVSEKGFAEFKSEIAVLTKVRHRHLVG 652
+G G +G+V + G ++AVK++ +S + +++ + E + +L ++H +++G
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR----LLKHMKHENVIG 80
Query: 653 LLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLT------IALDVARGV 706
LL D E L HL L + ++LT + + RG+
Sbjct: 81 LL----DVFTPARSLEEFNDVYLVTHLMGAD---LNNIVKCQKLTDDHVQFLIYQILRGL 133
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLA 766
+Y+H IHRDLKPSN+ + +D K+ DFGL R D + TR Y A
Sbjct: 134 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW-----YRA 185
Query: 767 PE 768
PE
Sbjct: 186 PE 187
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 58/177 (32%), Positives = 81/177 (45%), Gaps = 17/177 (9%)
Query: 597 VLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAEFKS-EIAVLT-KVRHRHLVGL 653
VLG+G FG V EL + A+K ++ VV E E E VL H L L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 654 LGYC-LDGNERLL-VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHG 711
+C E L V EY+ G L H+ + + R A ++ G+++LH
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHI-----QSSGRFDEARARFYAAEIICGLQFLH- 113
Query: 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
+ I+RDLK N+LL D K+ADFG+ + NG+ T GT Y+APE
Sbjct: 114 --KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENM-NGEGKAST-FCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 44/172 (25%), Positives = 73/172 (42%), Gaps = 28/172 (16%)
Query: 598 LGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
LG G G V+ D ++AVK++ + + EI ++ ++ H ++V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKI--VLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 657 CLDGNERL--------------LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDV 702
L +V EYM L N E+G E R L
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLSEEHARLFMYQL-- 123
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFGLVRLAPDNGKHS 753
RG++Y+H + +HRDLKP+N+ + +D+ K+ DFGL R+ + H
Sbjct: 124 LRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHK 172
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 58/180 (32%), Positives = 81/180 (45%), Gaps = 27/180 (15%)
Query: 598 LGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH----LVG 652
+G G G VYK G +AVK+M E E K + L V H +V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE----ENKRILMDLDVVLKSHDCPYIVK 78
Query: 653 LLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL--- 709
GY + ++ + E M T L R + + P + ++T+A + + + YL
Sbjct: 79 CYGYFITDSDVFICMELM--STCLDKLLKRIQGPI-PEDILGKMTVA--IVKALHYLKEK 133
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV-RLAPDNGKHSIETRLAGTFGYLAPE 768
HG+ IHRD+KPSNILL K+ DFG+ RL K TR AG Y+APE
Sbjct: 134 HGV-----IHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK----TRSAGCAAYMAPE 184
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 52/151 (34%), Positives = 84/151 (55%), Gaps = 16/151 (10%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKG--FAEFKSEIAVLTKVRHRHLVGLL 654
LG G + TVYKG +G +A+K + ++ +E+G F + E ++L ++H ++V LL
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVI--SMKTEEGVPFTAIR-EASLLKGLKHANIV-LL 68
Query: 655 GYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
+ E L V+EYM L++++ + GL P + RL + + RG+ Y+H
Sbjct: 69 HDIIHTKETLTFVFEYM-HTDLAQYM-IQHPGGLHP--YNVRLFM-FQLLRGLAYIH--- 120
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
Q +HRDLKP N+L+ K+ADFGL R
Sbjct: 121 GQHILHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 3e-09
Identities = 53/177 (29%), Positives = 79/177 (44%), Gaps = 21/177 (11%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLG 655
+G G F V K G A+K M+ S + EI L ++ H +++ L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRLIE 65
Query: 656 YCLD-GNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
D RL LV+E M L + RK +PL R + + + ++++H
Sbjct: 66 VLFDRKTGRLALVFELM-DMNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHR-- 118
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS--IETRLAGTFGYLAPE 768
+ F HRD+KP NIL+ DD K+ADFG R ++ I TR Y APE
Sbjct: 119 NGIF-HRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTRW-----YRAPE 168
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 59/215 (27%), Positives = 80/215 (37%), Gaps = 70/215 (32%)
Query: 595 ENVLGRGGFGTVYKGELHDGTK------IAVKRM-ESAVVSEKGFAEFKSEIAVLTKV-R 646
LGRG FG V + K +AVK + E A SE + +E+ +L +
Sbjct: 12 GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASE--YKALMTELKILIHIGH 69
Query: 647 HRHLVGLLGYCLDGNERLLV-YEYMPQGTLS------RHLFN-------RKEEGLKPLEW 692
H ++V LLG C L+V EY G LS R F+ RK E +
Sbjct: 70 HLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGK 129
Query: 693 TRRLT-------------------------------------------IALDVARGVEYL 709
+RL + VARG+E+L
Sbjct: 130 KQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL 189
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
A + IHRDL NILL ++ K+ DFGL R
Sbjct: 190 ---ASRKCIHRDLAARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 53/175 (30%), Positives = 85/175 (48%), Gaps = 16/175 (9%)
Query: 598 LGRGGFGTVYKGELHDGTKI--AVK--RMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGL 653
LG+G +G+VYK LH T + A+K R+E + E F + E+ +L K ++V
Sbjct: 9 LGKGNYGSVYKV-LHRPTGVTMAMKEIRLE---LDESKFNQIIMELDILHKAVSPYIVDF 64
Query: 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
G + EYM G+L + P + RR+T A V +G+++L
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYA--VVKGLKFLK--E 120
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
+ IHRD+KP+N+L+ + + K+ DFG+ N S+ G Y+APE
Sbjct: 121 EHNIIHRDVKPTNVLVNGNGQVKLCDFGV----SGNLVASLAKTNIGCQSYMAPE 171
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 41/163 (25%), Positives = 73/163 (44%), Gaps = 12/163 (7%)
Query: 596 NVLGRGGFGTVYKGELHDGTKIAVKRMESAVV----SEKGFAEFKSEIAVLTKVRHRHLV 651
++L G FG ++ G L D + + V SE E +L + H++++
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 652 GLLGYCLDGNERLLV-YEYMPQGTLSRHLFNRKE-EGLKPLEWTRRLTI--ALDVARGVE 707
+L C++ E V Y YM G L L + E P + + + A+ +A G+
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPDN 749
YLH IH+D+ N ++ ++++ K+ D L R L P +
Sbjct: 132 YLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 5e-09
Identities = 53/181 (29%), Positives = 87/181 (48%), Gaps = 24/181 (13%)
Query: 598 LGRGGFGTVYK-GELHDGTKIAVKRM----ESAVVSEKGFAEFKSEIAVLTKVRHRHLVG 652
+G G FG V+ + DG ++A+K+M ++ V ++ F E K +L +H +++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELK----MLCFFKHDNVLS 63
Query: 653 LLGYC----LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
L +D E + V + Q L + + + + PL + RG++Y
Sbjct: 64 ALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQ-----PLSSDHVKVFLYQILRGLKY 118
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL-APDNGKHSIETRLAGTFGYLAP 767
LH A +HRD+KP N+L+ + K+ DFGL R+ PD KH T+ T Y AP
Sbjct: 119 LHS-AG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHM--TQEVVTQYYRAP 173
Query: 768 E 768
E
Sbjct: 174 E 174
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 53/179 (29%), Positives = 82/179 (45%), Gaps = 11/179 (6%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
++F + LG G G V K + I +++ + + E+ VL + +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+VG G E + E+M G+L + L KE P E +++IA V RG+ YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIA--VLRGLAYL 119
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
HQ +HRD+KPSNIL+ K+ DFG+ D S+ GT Y++PE
Sbjct: 120 RE-KHQ-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPE 172
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 52/188 (27%), Positives = 80/188 (42%), Gaps = 31/188 (16%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKR--MESAVVSEKGFAEFK-SEIAVLTKVRHRHLVGL 653
+G+G FG V+K +A+K+ ME+ ++GF EI +L ++H ++V L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENE---KEGFPITALREIKILQLLKHENVVNL 76
Query: 654 LGYC----LDGNER----LLVYEYMPQ---GTLSRHLFNRKEEGLKPLEWTRRLTIALDV 702
+ C N LV+E+ G LS +K + +
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIK--------KVMKML 128
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR--LAPDNGKHSIETRLAG 760
G+ Y+H +HRD+K +NIL+ D K+ADFGL R N K + T
Sbjct: 129 LNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185
Query: 761 TFGYLAPE 768
T Y PE
Sbjct: 186 TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 7e-09
Identities = 54/200 (27%), Positives = 86/200 (43%), Gaps = 37/200 (18%)
Query: 598 LGRGGFGTVYKGELHD---GTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRHLVGL 653
+G+GG G VY +D ++A+K++ E + F E + + H +V +
Sbjct: 10 IGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 654 LGYCLDGNERLLVYEYMP--QGTLSRHLFN--RKEEGL-KPLEWTRR----LTIALDVAR 704
C DG+ VY MP +G + L ++E L K L L+I +
Sbjct: 68 YSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-------------VRLAPDNGK 751
+EY+H + +HRDLKP NILLG + D+G + + N
Sbjct: 125 TIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 752 HS---IETRLAGTFGYLAPE 768
+S I ++ GT Y+APE
Sbjct: 182 YSSMTIPGKIVGTPDYMAPE 201
|
Length = 932 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-08
Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 25/186 (13%)
Query: 594 EENVLGRGGFGTVYKGE-LHDGTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
EENV+ RG G YKG+ + +G + VK + + + SEIA + K++H ++V
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS-------SEIADMGKLQHPNIV 746
Query: 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHG 711
L+G C L++EY+ LS E L+ L W RR IA+ +A+ + +LH
Sbjct: 747 KLIGLCRSEKGAYLIHEYIEGKNLS--------EVLRNLSWERRRKIAIGIAKALRFLHC 798
Query: 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAA 771
+ + +L P I++ D +RL+ G +T+ + Y+APE
Sbjct: 799 RCSPAVVVGNLSPEKIII------DGKDEPHLRLSLP-GLLCTDTKCFISSAYVAPE-TR 850
Query: 772 ETSGMT 777
ET +T
Sbjct: 851 ETKDIT 856
|
Length = 968 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 55/184 (29%), Positives = 78/184 (42%), Gaps = 29/184 (15%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKS--------EIAVLTKVRHRH 649
LG+G FGTVY L K AV V+ E E E +L+K+ H
Sbjct: 8 LGKGSFGTVY---LVKDKK-AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLK-----PLEWTRRLTIALDVAR 704
+V L+ + ++ EY L L K G EW +L +
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------ 117
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
GV Y+H + +HRDLK NI L +++ K+ DFG+ RL G + T GT Y
Sbjct: 118 GVHYMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL--MGSCDLATTFTGTPYY 171
Query: 765 LAPE 768
++PE
Sbjct: 172 MSPE 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 49/163 (30%), Positives = 71/163 (43%), Gaps = 26/163 (15%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKI-AVKRM-ESAVVSEKGFAEFKSEIAVLTKVRH 647
+F V+G+G FG V + D KI A+K + +S + + A K+E VL +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR--- 704
+V L D L+ E++P G L L T + DV R
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYD-------------TFSEDVTRFYM 107
Query: 705 -----GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742
+E +H L FIHRD+KP NIL+ K++DFGL
Sbjct: 108 AECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 47/150 (31%), Positives = 69/150 (46%), Gaps = 16/150 (10%)
Query: 598 LGRGGFGTVYKGELHDGTKI-AVKRMESA-VVSEKGFAEFKSEIAVLTKVRHRHLVGLLG 655
+G G FG V D + A+K + A V+ A K+E +L + + +V L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY- 67
Query: 656 YCLDGNERL-LVYEYMPQGTLSRHLFNRK--EEGLKPLEWTRRLTIALDVARGVEYLHGL 712
Y + L V +Y+P G + L EE L R IA ++ +E +H +
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA------RFYIA-ELTCAIESVHKM 120
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGL 742
FIHRD+KP NIL+ D K+ DFGL
Sbjct: 121 G---FIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 42/157 (26%), Positives = 69/157 (43%), Gaps = 16/157 (10%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR-HLVGLLG 655
+G G +G VYK + + G +A+K+ + E EI++L + ++V LL
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL- 67
Query: 656 YCLDGNER-------LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
++ E LV+EY+ N + G +PL + + +GV +
Sbjct: 68 -DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPG-RPLPAKTIKSFMYQLLKGVAH 125
Query: 709 LHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFGLVR 744
H +HRDLKP N+L+ K+AD GL R
Sbjct: 126 CHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGR 159
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 53/200 (26%), Positives = 84/200 (42%), Gaps = 12/200 (6%)
Query: 578 MVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESA--VVSEKGFAEF 635
+V I+ L+ ++ V+GRG FG V K+ ++ S ++ A F
Sbjct: 31 IVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFF 90
Query: 636 KSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRR 695
E ++ +V L D +V EYMP G L + N P +W +
Sbjct: 91 WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD----VPEKWAKF 146
Query: 696 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE 755
T +V ++ +H + IHRD+KP N+LL K+ADFG + G +
Sbjct: 147 YTA--EVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD 201
Query: 756 TRLAGTFGYLAPEYAAETSG 775
T + GT Y++PE G
Sbjct: 202 TAV-GTPDYISPEVLKSQGG 220
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 35/151 (23%), Positives = 66/151 (43%), Gaps = 17/151 (11%)
Query: 597 VLGR----GGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVG 652
++G+ + K + T +AVK++ S++ + EI +++H +++
Sbjct: 5 LIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 653 LLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIAL---DVARGVEYL 709
+ + +E +V M G+ L EGL L IA DV ++Y+
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP------ELAIAFILKDVLNALDYI 117
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740
H + FIHR +K S+ILL D + ++
Sbjct: 118 H---SKGFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 51/190 (26%), Positives = 85/190 (44%), Gaps = 46/190 (24%)
Query: 598 LGRGGFGTV---YKGELHDGTKIAVKRM----ESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
+G G +G+V Y L K+AVK++ +S + + + + E + +L ++H ++
Sbjct: 23 VGSGAYGSVCSAYDTRLRQ--KVAVKKLSRPFQSLIHARRTYRELR----LLKHMKHENV 76
Query: 651 VGLLGYCL------DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLT------I 698
+GLL + NE LV M L + ++L+ +
Sbjct: 77 IGLLDVFTPATSIENFNEVYLVTNLMGAD-------------LNNIVKCQKLSDEHVQFL 123
Query: 699 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRL 758
+ RG++Y+H IHRDLKPSN+ + +D ++ DFGL R A D + TR
Sbjct: 124 IYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRW 180
Query: 759 AGTFGYLAPE 768
Y APE
Sbjct: 181 -----YRAPE 185
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 54/207 (26%), Positives = 80/207 (38%), Gaps = 47/207 (22%)
Query: 597 VLGRGGFGTVYKGELHD-GTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
+LG+G G V+ L G A+K ++ ++ +E +L + H L L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL- 66
Query: 655 GYC-LDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTR----RLTIALDVARGVEY 708
Y L LV +Y P G L R L R+ E R + +AL EY
Sbjct: 67 -YASFQTETYLCLVMDYCPGGELFR-LLQRQPGKCLSEEVARFYAAEVLLAL------EY 118
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL---------------VRLAPDNGKHS 753
LH L ++RDLKP NILL + ++DF L + + + +S
Sbjct: 119 LHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 754 IETRLA------------GTFGYLAPE 768
I + GT Y+APE
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPE 202
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 46/197 (23%), Positives = 81/197 (41%), Gaps = 34/197 (17%)
Query: 588 VTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKS------EIA 640
V + + +G G +G V + G K+A+K++ A F E+
Sbjct: 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHA------FDVPTLAKRTLRELK 56
Query: 641 VLTKVRHRHLVGLLGYCL----DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRL 696
+L +H +++ + D + +V + M + L + + + PL
Sbjct: 57 ILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQ-----PLTEEHIR 110
Query: 697 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE- 755
+ RG++Y+H + IHRDLKPSN+L+ +D ++ DFG+ R + E
Sbjct: 111 YFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS---PTEH 164
Query: 756 ----TRLAGTFGYLAPE 768
T T Y APE
Sbjct: 165 KYFMTEYVATRWYRAPE 181
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 49/179 (27%), Positives = 82/179 (45%), Gaps = 11/179 (6%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
++F + + LG G G V+K I +++ + + E+ VL + +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+VG G E + E+M G+L + L K+ G P + +++IA V +G+ YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIA--VIKGLTYL 119
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
+HRD+KPSNIL+ K+ DFG+ D S+ GT Y++PE
Sbjct: 120 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPE 172
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 49/184 (26%), Positives = 86/184 (46%), Gaps = 31/184 (16%)
Query: 597 VLGRGGFGTVY------KGELH-----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
++GRGGFG VY G+++ D +I +K+ E+ ++E+ + L
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNER-------IMLSLVST 53
Query: 646 RHRHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
+ + Y ++L + + M G L HL K + + A ++
Sbjct: 54 GDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-----YATEIIL 108
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
G+E++H ++ ++RDLKP+NILL + +++D G LA D K + GT GY
Sbjct: 109 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLG---LACDFSKKKPHASV-GTHGY 161
Query: 765 LAPE 768
+APE
Sbjct: 162 MAPE 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 55/191 (28%), Positives = 86/191 (45%), Gaps = 46/191 (24%)
Query: 598 LGRGGFGTVYKGELH--DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLG 655
LGRG +G V K H GT +AVKR+ + V S++ + R L+
Sbjct: 9 LGRGAYGVVDK-MRHVPTGTIMAVKRIRATVNSQE---------------QKRLLMD--- 49
Query: 656 YCLDGNERLLVYEYMPQ--GTLSRH--------LFNRKEEGLKPLEWTRRLTI------- 698
LD + R + Y G L R + + + + + LTI
Sbjct: 50 --LDISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGK 107
Query: 699 -ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR 757
A+ + + +EYLH + S IHRD+KPSN+L+ + + K+ DFG+ D+ +I+
Sbjct: 108 IAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID-- 163
Query: 758 LAGTFGYLAPE 768
AG Y+APE
Sbjct: 164 -AGCKPYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 4e-08
Identities = 54/175 (30%), Positives = 78/175 (44%), Gaps = 14/175 (8%)
Query: 597 VLGRGGFGTV-YKGELHDGTKIAVKRMESAVVSEKG-FAEFKSEIAVLTKVRHRHLVGLL 654
+LG+G FG V E G A+K ++ V+ K A +E VL RH L L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL- 60
Query: 655 GYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
Y +RL V EY+ G L HL + R ++ ++YLH
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRER-----VFSEDRTRFYGAEIVSALDYLHS-- 113
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
++RDLK N++L D K+ DFGL + + +++T GT YLAPE
Sbjct: 114 -GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMKT-FCGTPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 53/197 (26%), Positives = 92/197 (46%), Gaps = 21/197 (10%)
Query: 575 AGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFA 633
A MV+ R +NF + +G G G V + G +AVK+M+ + ++
Sbjct: 8 ALQMVVDPGDPRTYLDNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMD--LRKQQRRE 62
Query: 634 EFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRK--EEGLKPLE 691
+E+ ++ +H ++V + L G+E +V E++ G L+ + + + EE +
Sbjct: 63 LLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--- 119
Query: 692 WTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK 751
+ L V + + LH Q IHRD+K +ILL D R K++DFG A + +
Sbjct: 120 -----AVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKE 169
Query: 752 HSIETRLAGTFGYLAPE 768
L GT ++APE
Sbjct: 170 VPRRKSLVGTPYWMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 59/214 (27%), Positives = 81/214 (37%), Gaps = 71/214 (33%)
Query: 597 VLGRGGFGTVYKGE---LHDGTK---IAVKRM-ESAVVSEKGFAEFKSEIAVLTKV-RHR 648
VLG G FG V + + + +AVK + E A SE SE+ +L + H
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEH--KALMSELKILIHIGNHL 71
Query: 649 HLVGLLGYCLDGNERLLV-YEYMPQGTLS------------------------------- 676
++V LLG C N L+V E+ G LS
Sbjct: 72 NVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQS 131
Query: 677 -----------RHLFNR----KEEGLKPLE-----WTRRLTI------ALDVARGVEYLH 710
LF+R P + W LT+ + VARG+E+L
Sbjct: 132 RVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL- 190
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
A + IHRDL NILL ++ K+ DFGL R
Sbjct: 191 --ASRKCIHRDLAARNILLSENNVVKICDFGLAR 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 5e-08
Identities = 27/65 (41%), Positives = 36/65 (55%), Gaps = 5/65 (7%)
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFG 763
RG++Y+H + +HRDLKPSN+LL + K+ DFGL R + K T T
Sbjct: 119 RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRW 173
Query: 764 YLAPE 768
Y APE
Sbjct: 174 YRAPE 178
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 50/181 (27%), Positives = 78/181 (43%), Gaps = 29/181 (16%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
+G G +G+V + G K+A+K++ SE E+ +L ++H +++GLL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 657 ---CLDGNERLLVYEYMP------QGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
+ G+E Y MP Q + L K + L + G++
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYL-----------VYQMLCGLK 131
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
Y+H IHRDLKP N+ + +D K+ DFGL R A + TR Y AP
Sbjct: 132 YIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-----YRAP 183
Query: 768 E 768
E
Sbjct: 184 E 184
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 59/187 (31%), Positives = 84/187 (44%), Gaps = 37/187 (19%)
Query: 597 VLGRGGFGTVYKGELH-DGTKIAVKRMESAVV----------SEKGFAEFKSEIAVLTKV 645
VLG+G FG V EL G AVK ++ VV EK E LT
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLT-- 59
Query: 646 RHRHLVGLLGYC-LDGNERLL-VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVA 703
HL YC E L V E++ G L H+ +++G + R A ++
Sbjct: 60 ---HL-----YCTFQTKEHLFFVMEFLNGGDLMFHI---QDKG--RFDLYRATFYAAEIV 106
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN--GKHSIETRLAGT 761
G+++LH + I+RDLK N++L D K+ADFG+ + +N G + T GT
Sbjct: 107 CGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCK---ENVFGDNRAST-FCGT 159
Query: 762 FGYLAPE 768
Y+APE
Sbjct: 160 PDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 50/189 (26%), Positives = 86/189 (45%), Gaps = 41/189 (21%)
Query: 597 VLGRGGFGTVY------KGELH-----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
++GRGGFG VY G+++ D +I +K+ E+ ++E+ + L
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNER-------IMLSLVST 53
Query: 646 RHRHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHL-----FNRKEEGLKPLEWTRRLTIA 699
+ + Y ++L + + M G L HL F+ E A
Sbjct: 54 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF----------YA 103
Query: 700 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLA 759
++ G+E++H ++ ++RDLKP+NILL + +++D G LA D K +
Sbjct: 104 AEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLG---LACDFSKKKPHASV- 156
Query: 760 GTFGYLAPE 768
GT GY+APE
Sbjct: 157 GTHGYMAPE 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 8e-08
Identities = 57/194 (29%), Positives = 91/194 (46%), Gaps = 38/194 (19%)
Query: 591 NFSEENVLGRGGFGTVYKGELHDGTKI----------AVKRMESAVVSEKGFAEFKSEIA 640
+F V+GRG FG V +L + K+ +KR E+A F+ E
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC--------FREERD 53
Query: 641 VLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTR----RL 696
VL ++ + L D N LV +Y G L L ++ E+ L P + R +
Sbjct: 54 VLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLT-LLSKFEDRL-PEDMARFYLAEM 111
Query: 697 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG-LVRLAPDNGKHSIE 755
IA+D V LH ++HRD+KP NIL+ + ++ADFG ++L D +++
Sbjct: 112 VIAID---SVHQLH------YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG---TVQ 159
Query: 756 TRLA-GTFGYLAPE 768
+ +A GT Y++PE
Sbjct: 160 SSVAVGTPDYISPE 173
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 10/155 (6%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEK-GFAEFKSEIAVLTKVRH 647
++F V+GRG FG V + D I A+K + A + EK A ++E +L +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
+V + D L+ E++P G + L K++ L E + IA + ++
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLS--EEATQFYIA-ETVLAID 115
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742
+H L FIHRD+KP N+LL K++DFGL
Sbjct: 116 AIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 52/190 (27%), Positives = 86/190 (45%), Gaps = 28/190 (14%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKI----------AVKRMESAVVSEKGFAEFKSEI 639
++F V+GRG FG V ++ +I +KR E+A F+ E
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETAC--------FREER 52
Query: 640 AVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIA 699
VL + + L D N LV +Y G L L ++ E+ L P + R
Sbjct: 53 NVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLT-LLSKFEDRL-PEDMAR----- 105
Query: 700 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLA 759
+A V +H + ++HRD+KP N+LL + ++ADFG +G ++++ +A
Sbjct: 106 FYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG--TVQSSVA 163
Query: 760 -GTFGYLAPE 768
GT Y++PE
Sbjct: 164 VGTPDYISPE 173
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 52/185 (28%), Positives = 87/185 (47%), Gaps = 15/185 (8%)
Query: 591 NFSEENVLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAEFKS-EIAVLTKVRHR 648
+F+ VLG+G FG V E ++ A+K ++ VV + E E VL
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 649 HLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
+ L C +RL V EY+ G L H+ + + + + + A +++ G+
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI-----QQVGKFKEPQAVFYAAEISVGLF 115
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR-LAGTFGYLA 766
+LH + I+RDLK N++L + K+ADFG+ + ++ + TR GT Y+A
Sbjct: 116 FLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIA 169
Query: 767 PEYAA 771
PE A
Sbjct: 170 PEIIA 174
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 56/178 (31%), Positives = 81/178 (45%), Gaps = 19/178 (10%)
Query: 597 VLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKS-EIAVLTKV-RHRHLVGL 653
+LG+G FG V+ EL A+K ++ VV E E VL+ H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 654 LGYC-LDGNERLL-VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHG 711
YC E L V EY+ G L H+ + + R A ++ G+++LH
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHI-----QSCHKFDLPRATFYAAEIICGLQFLHS 114
Query: 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIET-RLAGTFGYLAPE 768
+ ++RDLK NILL D K+ADFG+ + +N +T GT Y+APE
Sbjct: 115 ---KGIVYRDLKLDNILLDTDGHIKIADFGMCK---ENMLGDAKTCTFCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 47/156 (30%), Positives = 73/156 (46%), Gaps = 26/156 (16%)
Query: 598 LGRGGFGTVYKGELH-DGTKIAVK--RMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGL- 653
LG G + TV+KG +A+K R+E E E+++L ++H ++V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEH---EEGAPCTAIREVSLLKNLKHANIVTLH 69
Query: 654 ----LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIAL-DVARGVEY 708
CL LV+EY+ L ++L N L + I + + RG+ Y
Sbjct: 70 DIIHTERCLT-----LVFEYL-DSDLKQYLDN-----CGNLMSMHNVKIFMFQLLRGLSY 118
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
H + +HRDLKP N+L+ + K+ADFGL R
Sbjct: 119 CH---KRKILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 48/157 (30%), Positives = 67/157 (42%), Gaps = 52/157 (33%)
Query: 148 FDS----WVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHL---HLAFNFLQ 200
FDS W I D GL + + G IP+ I L HL +L+ N ++
Sbjct: 411 FDSTKGKWFI-----DGLGL-----DNQGLRGFIPN-----DISKLRHLQSINLSGNSIR 455
Query: 201 GPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGL 259
G IP S G ++TSL L L NSF G +P+ L L
Sbjct: 456 GNIPPSLG--------------------------SITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 260 SSLQDFSVRDNQLTGIVPSSLVN--LHSLAVVNLTNN 294
+SL+ ++ N L+G VP++L LH A N T+N
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGRLLHR-ASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 56/186 (30%), Positives = 86/186 (46%), Gaps = 17/186 (9%)
Query: 591 NFSEENVLGRGGFGTVYKGELHDGTK--IAVKRMESAVVSEKGFAEFK-SEIAVLTKVRH 647
+F+ VLG+G FG V E GT A+K ++ V+ + E E VL
Sbjct: 1 DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK 59
Query: 648 RHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706
+ L C +RL V EY+ G L H+ ++ G + + A ++A G+
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI---QQVG--KFKEPHAVFYAAEIAIGL 114
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR-LAGTFGYL 765
+LH + I+RDLK N++L + K+ADFG+ + +N TR GT Y+
Sbjct: 115 FFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRTFCGTPDYI 168
Query: 766 APEYAA 771
APE A
Sbjct: 169 APEIIA 174
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 52/176 (29%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 597 VLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAEF-KSEIAVL-TKVRHRHLVGL 653
V+GRG + V EL +I A+K ++ +V++ ++ ++E V T H LVGL
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 654 LGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
C RL V E++ G L H+ +++ L P E R + + +A L+ L
Sbjct: 62 HS-CFQTESRLFFVIEFVSGGDLMFHM--QRQRKL-PEEHARFYSAEISLA-----LNFL 112
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
+ I+RDLK N+LL + K+ D+G+ + G + + GT Y+APE
Sbjct: 113 HERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT--STFCGTPNYIAPE 166
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 52/183 (28%), Positives = 87/183 (47%), Gaps = 23/183 (12%)
Query: 598 LGRGGFGTVYKG---ELHDGTKIAVKRMESAVVSEKGFAEFK-SEIAVLTKVR-HRHLVG 652
LG+G +G V E + +A+K++ + V S+K A+ E+ +L R H+++
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKI-TNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 653 LLGYCLD-----GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
L Y +D L +YE + + L H R + PL + + G++
Sbjct: 67 L--YDMDIVFPGNFNELYLYEELMEADL--HQIIRSGQ---PLTDAHFQSFIYQILCGLK 119
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPDNGKHS-IETRLAGTFGYL 765
Y+H + +HRDLKP N+L+ D K+ DFGL R + + G+++ T T Y
Sbjct: 120 YIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYR 176
Query: 766 APE 768
APE
Sbjct: 177 APE 179
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 45/151 (29%), Positives = 70/151 (46%), Gaps = 16/151 (10%)
Query: 598 LGRGGFGTVYKG--ELHDGTKIAVK--RMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGL 653
LG G + TVYKG +L D +A+K R+E E E+++L ++H ++V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEH---EEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
LV+EY L + L ++ + + RG+ Y H
Sbjct: 70 HDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH--- 121
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
+ +HRDLKP N+L+ + K+ADFGL R
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 46/177 (25%), Positives = 84/177 (47%), Gaps = 19/177 (10%)
Query: 598 LGRGGFG-TVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
+G G FG + DG + +K + + +S K E + E+AVL+ ++H ++V
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 657 CLDGNERLLVYEYMPQGTLSRHLFNRK-----EEGLKPLEWTRRLTIALDVARGVEYLHG 711
+ +V +Y G L + + ++ E+ + L+W ++ +AL +++H
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI--LDWFVQICLAL------KHVH- 118
Query: 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
+ +HRD+K NI L D K+ DFG+ R+ N + GT YL+PE
Sbjct: 119 --DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL--NSTVELARTCIGTPYYLSPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 52/184 (28%), Positives = 85/184 (46%), Gaps = 30/184 (16%)
Query: 597 VLGRGGFGTVYKGELHDGTKI----------AVKRMESAVVSEKGFAEFKSEIAVLTKVR 646
V+GRG FG V ++ + ++ +KR E+A F+ E VL
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETAC--------FREERDVLVNGD 59
Query: 647 HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706
R + L D N LV +Y G L L ++ E+ L P + R +A V
Sbjct: 60 RRWITNLHYAFQDENNLYLVMDYYVGGDLLT-LLSKFEDRL-PEDMAR-----FYLAEMV 112
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG-LVRLAPDNGKHSIETRLA-GTFGY 764
+ + ++HRD+KP N+LL + ++ADFG +RL D ++++ +A GT Y
Sbjct: 113 LAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG---TVQSNVAVGTPDY 169
Query: 765 LAPE 768
++PE
Sbjct: 170 ISPE 173
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 10/154 (6%)
Query: 591 NFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEK-GFAEFKSEIAVLTKVRHR 648
+F V+GRG FG V + D G A+K + A + EK ++E +L +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
+V + D L+ E++P G + L K++ L E + IA + ++
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLT--EEETQFYIA-ETVLAIDS 116
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742
+H L FIHRD+KP N+LL K++DFGL
Sbjct: 117 IHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 30/95 (31%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 635 FKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTR 694
F +++++V H HL + G C+ G+E ++V E++ G L L RKE+G P+ W
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCL--RKEKGRVPVAW-- 118
Query: 695 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 729
++T+A +A + YL ++ +H ++ NILL
Sbjct: 119 KITVAQQLASALSYLE---DKNLVHGNVCAKNILL 150
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-07
Identities = 45/150 (30%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 600 RGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAE-FKSEIAVLTKVRHRHLVGLLGYC 657
RG FG VY G + +K+ AVK ++ A + K ++E L + +V L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 658 LDGNERLLVYEYMPQGTLSR--HLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ 715
N LV EY+ G + H++ +E + +++ + +ALD YLH
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA-VKYISEVALALD------YLH---RH 123
Query: 716 SFIHRDLKPSNILLGDDMRAKVADFGLVRL 745
IHRDLKP N+L+ ++ K+ DFGL ++
Sbjct: 124 GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 6e-07
Identities = 28/64 (43%), Positives = 35/64 (54%), Gaps = 6/64 (9%)
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
G+++LH IHRDLKPSNI++ D K+ DFGL R A G + T T Y
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 183
Query: 765 LAPE 768
APE
Sbjct: 184 RAPE 187
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-07
Identities = 48/176 (27%), Positives = 87/176 (49%), Gaps = 27/176 (15%)
Query: 579 VISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGT-KIAVKRMESAVVSEKGFAEFKS 637
+I + R+ ++ N++G G FG VY+ D + K+A+K+ V+ + +
Sbjct: 55 MIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKK----VLQDPQYK--NR 108
Query: 638 EIAVLTKVRHRHLVGLLGY----CLDGNERLL----VYEYMPQGTLSRHL--FNRKEEGL 687
E+ ++ + H +++ L Y C NE+ + V E++PQ T+ +++ + R L
Sbjct: 109 ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHAL 167
Query: 688 KPLEWTRRLTIALDVARGVEYLHGLAHQSFI-HRDLKPSNILLGDDMRA-KVADFG 741
PL + + L R + Y+H FI HRDLKP N+L+ + K+ DFG
Sbjct: 168 -PLFLVKLYSYQL--CRALAYIH----SKFICHRDLKPQNLLIDPNTHTLKLCDFG 216
|
Length = 440 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 51/176 (28%), Positives = 85/176 (48%), Gaps = 15/176 (8%)
Query: 597 VLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAEF-KSEIAVLTKV-RHRHLVGL 653
V+GRG + V L +I A+K ++ +V++ ++ ++E V + H LVGL
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 654 LGYCLDGNERLL-VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
C RL V EY+ G L +F+ + + P E R + + +A + YLH
Sbjct: 62 HS-CFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLA--LNYLH-- 113
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
+ I+RDLK N+LL + K+ D+G+ + G + + GT Y+APE
Sbjct: 114 -ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--STFCGTPNYIAPE 166
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 8e-07
Identities = 47/178 (26%), Positives = 85/178 (47%), Gaps = 18/178 (10%)
Query: 597 VLGRGGFGTV-YKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLG 655
V+G+G +G V DG + +K++ S + + E +L++++H ++V
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV-AYR 65
Query: 656 YCLDGNERLL--VYEYMPQGTLSRHLFNRKEEGL---KPLEWTRRLTIALDVARGVEYLH 710
+G + LL V + G L L +K + L + +EW ++ +AL +YLH
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL------QYLH 119
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
+ +HRDLK N+ L KV D G+ R+ + + + + L GT Y++PE
Sbjct: 120 ---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCDMASTLIGTPYYMSPE 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 16/151 (10%)
Query: 598 LGRGGFGTVYKG--ELHDGTKIAVK--RMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGL 653
LG G + TV+KG +L + +A+K R+E E E+++L ++H ++V L
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEH---EEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
LV+EY L + L ++ + + RG+ Y H
Sbjct: 70 HDIVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH--- 121
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
+ +HRDLKP N+L+ + K+ADFGL R
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 51/179 (28%), Positives = 82/179 (45%), Gaps = 15/179 (8%)
Query: 597 VLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAEFKS-EIAVLTKVRHRHLVGLL 654
VLG+G FG V E ++ A+K ++ VV + E E VL + L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 655 GYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
C +RL V EY+ G L + + + + + A ++A G+ +LH
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQI-----QQVGRFKEPHAVFYAAEIAIGLFFLHS-- 119
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR-LAGTFGYLAPEYAA 771
+ I+RDLK N++L + K+ADFG+ + +N + T+ GT Y+APE A
Sbjct: 120 -KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTPDYIAPEIIA 174
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 47/153 (30%), Positives = 67/153 (43%), Gaps = 10/153 (6%)
Query: 592 FSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESA-VVSEKGFAEFKSEIAVLTKVRHRH 649
F + LG G FG V D A+K + V+ A K+E +L + +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+V L D + V +Y+P G + L G+ P + R L A VE +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM---GIFPEDLARFYIAELTCA--VESV 117
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742
H + FIHRD+KP NIL+ D K+ DFGL
Sbjct: 118 HKM---GFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 52/207 (25%), Positives = 88/207 (42%), Gaps = 42/207 (20%)
Query: 232 VIQNMTSLTQLWLHGNSFTGPL-PDLSGLSSLQDFSVRDNQLTGIVPSSLVNL-HSLAVV 289
N + + + L G + +G + + L +Q ++ +NQL+G +P + SL +
Sbjct: 64 TCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYL 123
Query: 290 NLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAE 349
NL+NN F G P+ + P N LD + G + + S+
Sbjct: 124 NLSNNNFTGSIPRGSIP---------NLETLDLSNNMLSGEIPNDIGSFSSLKV------ 168
Query: 350 SWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGT 409
D GGN+ L G I ++ + LTSL L L+ N+L G
Sbjct: 169 ----------------LDLGGNV---------LVGKIPNSLTNLTSLEFLTLASNQLVGQ 203
Query: 410 IPKELTTLPSLEMLDVSNNHLFGKVPN 436
IP+EL + SL+ + + N+L G++P
Sbjct: 204 IPRELGQMKSLKWIYLGYNNLSGEIPY 230
|
Length = 968 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 45/153 (29%), Positives = 70/153 (45%), Gaps = 10/153 (6%)
Query: 592 FSEENVLGRGGFGTV-YKGELHDGTKIAVKRMESA-VVSEKGFAEFKSEIAVLTKVRHRH 649
F + LG G FG V ++ A+K + V++ A K+E +L + +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+V L D + V +Y+P G + L + P E R IA ++ +E +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM---EVFP-EVLARFYIA-ELTLAIESV 117
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742
H + FIHRD+KP NIL+ D K+ DFGL
Sbjct: 118 HKMG---FIHRDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 48/181 (26%), Positives = 81/181 (44%), Gaps = 12/181 (6%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTK--IAVKRMESAVVSEKGFAEFKSEIAVLTKVRH 647
N F V+G G +G V K H TK +A+K+ + + +E+ E+ +L ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCR-HKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQ 59
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
++V L + LV+EY+ + L L G+ P E R L ++
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEKNML--ELLEEMPNGVPP-EKVRSYIYQL-----IK 111
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
+H +HRD+KP N+L+ + K+ DFG R + G ++ T T Y +P
Sbjct: 112 AIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE-GSNANYTEYVATRWYRSP 170
Query: 768 E 768
E
Sbjct: 171 E 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 3e-06
Identities = 19/60 (31%), Positives = 33/60 (55%), Gaps = 1/60 (1%)
Query: 90 SLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSF 148
+L L++ N+LT + GL +L+ + NN TS+ + F GL SL+++ L N+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 46/167 (27%), Positives = 72/167 (43%), Gaps = 32/167 (19%)
Query: 614 GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQG 673
G +AVK++ ++ E+ +L V H++++ LL + PQ
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV------------FTPQK 93
Query: 674 TLS--RHLFNRKEEGLKPLEWTRRLTIALDVAR----------GVEYLHGLAHQSFIHRD 721
+L + ++ E L + + + LD R G+++LH IHRD
Sbjct: 94 SLEEFQDVYLVME--LMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHS---AGIIHRD 148
Query: 722 LKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
LKPSNI++ D K+ DFGL R A N + T T Y APE
Sbjct: 149 LKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYYRAPE 192
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 48/175 (27%), Positives = 81/175 (46%), Gaps = 13/175 (7%)
Query: 597 VLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAEF-KSEIAVLTKVRHRHLVGLL 654
V+GRG + V L +I A+K ++ +V + ++ ++E V + + L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 655 GYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
C RL LV EY+ G L H+ +++ P E R A ++ + +LH
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRK---LPEEHAR--FYAAEICIALNFLH--- 113
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
+ I+RDLK N+LL D K+ D+G+ + G + + GT Y+APE
Sbjct: 114 ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT--STFCGTPNYIAPE 166
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 4e-06
Identities = 24/60 (40%), Positives = 34/60 (56%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
N+ ++L N L+ F L +L+ L LSGN LT P+ + LPSL LD+S N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 44/164 (26%), Positives = 72/164 (43%), Gaps = 32/164 (19%)
Query: 617 IAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLS 676
+A+K++ ++ E+ ++ V H++++GLL + PQ +L
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLE 99
Query: 677 --RHLFNRKEEGLKPLEWTRRLTIALDVAR----------GVEYLHGLAHQSFIHRDLKP 724
+ ++ E L + + + LD R G+++LH IHRDLKP
Sbjct: 100 EFQDVYIVME--LMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKP 154
Query: 725 SNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
SNI++ D K+ DFGL R A G + T T Y APE
Sbjct: 155 SNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPE 195
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 42/162 (25%), Positives = 67/162 (41%), Gaps = 28/162 (17%)
Query: 617 IAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLS 676
+A+K++ ++ E+ ++ V H++++ LL + PQ +L
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV------------FTPQKSLE 92
Query: 677 RHLFNRKEEGLKPLEWTRRLTIALDVAR----------GVEYLHGLAHQSFIHRDLKPSN 726
L + + + LD R G+++LH IHRDLKPSN
Sbjct: 93 EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSN 149
Query: 727 ILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
I++ D K+ DFGL R A G + T T Y APE
Sbjct: 150 IVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPE 188
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 5e-06
Identities = 46/181 (25%), Positives = 73/181 (40%), Gaps = 13/181 (7%)
Query: 597 VLGRGGFGTV-YKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGL-- 653
VLG G GTV + DG AVK ++ +SE ++E+ L +V
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98
Query: 654 -LGYCLDGNERL-----LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
N LV +Y G L + + +R + + + + V V
Sbjct: 99 DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTN-RTFREHEAGLLFIQVLLAVH 157
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
++H + IHRD+K +NILL + K+ DFG ++ + GT Y+AP
Sbjct: 158 HVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAP 214
Query: 768 E 768
E
Sbjct: 215 E 215
|
Length = 496 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 8e-06
Identities = 28/81 (34%), Positives = 42/81 (51%), Gaps = 7/81 (8%)
Query: 668 EYMPQGTLSRHLFNRKE----EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLK 723
E P + S + K+ E PL+ L + VA+G+++L A ++ IHRD+
Sbjct: 183 EMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVA 239
Query: 724 PSNILLGDDMRAKVADFGLVR 744
N+LL D AK+ DFGL R
Sbjct: 240 ARNVLLTDGRVAKICDFGLAR 260
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 9e-06
Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 16/140 (11%)
Query: 598 LGRGGFGTVYKGELHD--GTKIAVKRMESAVV------SEKGFAEFKSEIAVLTKVRHRH 649
LG+G F +YKG L I E +VV + F ++++++ H+H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
LV L G C+ +E ++V EY+ G L L +E+ L W +L +A +A + YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFL--HREKNNVSLHW--KLDVAKQLASALHYL 117
Query: 710 HGLAHQSFIHRDLKPSNILL 729
+ +H ++ NIL+
Sbjct: 118 E---DKKLVHGNVCGKNILV 134
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 25/67 (37%), Positives = 39/67 (58%), Gaps = 2/67 (2%)
Query: 375 VNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKV 434
+NL N +G+I + +L L LS N L+G IP ++ + SL++LD+ N L GK+
Sbjct: 123 LNLSNNNFTGSIPRGS--IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180
Query: 435 PNFRQNV 441
PN N+
Sbjct: 181 PNSLTNL 187
|
Length = 968 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 43/200 (21%), Positives = 83/200 (41%), Gaps = 35/200 (17%)
Query: 63 PSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDN 122
+ + + + IE +LP L +L +L L++ N L+ LS LS+L + N
Sbjct: 138 LKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGN 196
Query: 123 NFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLG 182
+ +P + L++L+ + L NS + SL + L + + +P+ +G
Sbjct: 197 KISDLP-PEIELLSALEELDLSNNSIIE--LLSSLSNLKNLSGLELSNNKLE-DLPESIG 252
Query: 183 GDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQL 242
S+++TL L+ S++ + ++T+L +L
Sbjct: 253 NL-------------------------SNLETLDLSN-----NQISSISSLGSLTNLREL 282
Query: 243 WLHGNSFTGPLPDLSGLSSL 262
L GNS + LP ++ L L
Sbjct: 283 DLSGNSLSNALPLIALLLLL 302
|
Length = 394 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 29/87 (33%), Positives = 38/87 (43%), Gaps = 12/87 (13%)
Query: 688 KPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL-- 745
+PL + L I + G+ YLH Q IHRD+K NI + D + + D G +
Sbjct: 152 RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208
Query: 746 -APDNGKHSIETRLAGTFGYLAPEYAA 771
AP LAGT APE A
Sbjct: 209 VAPA------FLGLAGTVETNAPEVLA 229
|
Length = 357 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 39/140 (27%), Positives = 64/140 (45%), Gaps = 4/140 (2%)
Query: 629 EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLK 688
E+ A +SE+ L H +V ++ LL+ EY G L++ + R +E L
Sbjct: 106 ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLP 165
Query: 689 PLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748
E+ L + + ++ +H + +HRDLK +NI L K+ DFG + D
Sbjct: 166 FQEYEVGL-LFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221
Query: 749 NGKHSIETRLAGTFGYLAPE 768
+ + + GT YLAPE
Sbjct: 222 SVSLDVASSFCGTPYYLAPE 241
|
Length = 478 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 23/57 (40%), Positives = 32/57 (56%), Gaps = 3/57 (5%)
Query: 688 KPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
K L + + VA+G+E+L A + IHRDL NILL ++ K+ DFGL R
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR 227
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 54/201 (26%), Positives = 87/201 (43%), Gaps = 37/201 (18%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGT--KIAVKRMESAVVS-----EKGFAEFKSEIAVL 642
+F ++ G +G VY H T + A+K++ + ++ F E +L
Sbjct: 1 EDFETIKLISNGAYGAVYLVR-HKETRQRFAMKKINKQNLILRNQIQQVFVERD----IL 55
Query: 643 TKVRHRHLVGLLGYCLDGNERLL--VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIAL 700
T + +V + +C +R L V EY+ G + L K G P++ R+ A
Sbjct: 56 TFAENPFVVSM--FCSFETKRHLCMVMEYVEGGDCATLL---KNIGALPVD-MARMYFAE 109
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN-------GKHS 753
V +EYLH +HRDLKP N+L+ K+ DFGL ++ + G
Sbjct: 110 TVL-ALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIE 165
Query: 754 IETR------LAGTFGYLAPE 768
+TR + GT Y+APE
Sbjct: 166 KDTREFLDKQVCGTPEYIAPE 186
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 27/78 (34%), Positives = 39/78 (50%), Gaps = 6/78 (7%)
Query: 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSN 726
Y+ + L + EGL L+ L+ VARG+E+L A ++ +HRDL N
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDL---LSFTYQVARGMEFL---ASKNCVHRDLAARN 267
Query: 727 ILLGDDMRAKVADFGLVR 744
+LL K+ DFGL R
Sbjct: 268 VLLAQGKIVKICDFGLAR 285
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 41/173 (23%), Positives = 76/173 (43%), Gaps = 22/173 (12%)
Query: 595 ENVLGRGGFGTVYKGEL---HDGTKIAVKRMES----AVVSE----KGFAEFKSEIAVLT 643
+ ++G GGFG VY+ + H AV ++E+ +V E + +IA+
Sbjct: 17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYD-IDKIALWK 75
Query: 644 KVRHRHLVGLLGY--CLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRL--TIA 699
+ + +G+ Y C + Y ++ L + + N KE + ++L I
Sbjct: 76 NIHNIDHLGIPKYYGCGSFKRCRMYYRFI---LLEKLVENTKEIFKRIKCKNKKLIKNIM 132
Query: 700 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752
D+ +EY+H H D+KP NI++ + R + D+G+ +GKH
Sbjct: 133 KDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKH 182
|
Length = 294 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (109), Expect = 7e-05
Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 42/202 (20%)
Query: 598 LGRGGFGTVYKGELHDGTK--IAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLG 655
+G G FG V+ + H T+ K + + E+ ++ E+ V+ +++H+++V +
Sbjct: 21 IGNGRFGEVFLVK-HKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYID 79
Query: 656 YCLD-GNERL-LVYEYMPQGTLSRH------LFNRKEEGLKPLEWTRRLTIALDVARGVE 707
L+ N++L ++ E+ G LSR+ +F + EE ++ TR+L AL
Sbjct: 80 RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEH-AIVDITRQLLHAL------A 132
Query: 708 YLHGLAH----QSFIHRDLKPSNILLGDDMR-----------------AKVADFGLVRLA 746
Y H L + +HRDLKP NI L +R AK+ DFGL +
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK-- 190
Query: 747 PDNGKHSIETRLAGTFGYLAPE 768
+ G S+ GT Y +PE
Sbjct: 191 -NIGIESMAHSCVGTPYYWSPE 211
|
Length = 1021 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 1e-04
Identities = 20/61 (32%), Positives = 29/61 (47%), Gaps = 3/61 (4%)
Query: 238 SLTQLWLHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNL 295
+L L L N T +PD GL +L+ + N LT I P + L SL ++L+ N
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 296 F 296
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 38/213 (17%)
Query: 577 SMVISIQVLRNVTNNFSEENVLGRGGFGTVYK-GELHDGTKIAVKRMESAVVSEKGFAEF 635
S ++ ++ L + T+ + +G+G +G VYK DG+ AVK ++ ++ E
Sbjct: 9 SSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE---EI 65
Query: 636 KSEIAVLTKV-RHRHLVGLLG--YCLD---GNERLLVYEYMPQGTLSRHLFNRKEEGLKP 689
++E +L + H ++V G Y D G + LV E G+++ + +GL
Sbjct: 66 EAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGL-- 118
Query: 690 LEWTRRLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743
L +RL I G+++LH + IHRD+K +NILL + K+ DFG+
Sbjct: 119 LICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGV- 174
Query: 744 RLAPDNGKHSIETRL-----AGTFGYLAPEYAA 771
TRL GT ++APE A
Sbjct: 175 ------SAQLTSTRLRRNTSVGTPFWMAPEVIA 201
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 3e-04
Identities = 17/61 (27%), Positives = 31/61 (50%), Gaps = 1/61 (1%)
Query: 113 SLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGAN 172
+L+ + +N T +P FKGL +L+ + L N+ S + PE+ L+ +G N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTS-ISPEAFSGLPSLRSLDLSGNN 59
Query: 173 I 173
+
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 21/49 (42%), Positives = 29/49 (59%), Gaps = 3/49 (6%)
Query: 696 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
L+ + VA+G+ +L A ++ IHRDL NILL K+ DFGL R
Sbjct: 217 LSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 262
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|185285 PRK15387, PRK15387, E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (102), Expect = 4e-04
Identities = 97/352 (27%), Positives = 140/352 (39%), Gaps = 109/352 (30%)
Query: 25 QSSSDAAAMQALKTSLGNPASL------GWTDPDPCKWKHIQ--CSPSNRVTRIQIGGQN 76
+S AA +Q ++ L N ++ G T C HI P N +T +
Sbjct: 184 ESRGRAAVVQKMRACLNNGNAVLNVGESGLTTLPDCLPAHITTLVIPDNNLTSLP----- 238
Query: 77 IEGTLPKEL-------NSLSSLTVL-------EVMKNKLTGQIPSL-SGLSSL------- 114
LP EL N L+SL VL + N LT +P+L SGL L
Sbjct: 239 ---ALPPELRTLEVSGNQLTSLPVLPPGLLELSIFSNPLT-HLPALPSGLCKLWIFGNQL 294
Query: 115 ----------QEVLFDDNNFTSVPS---------DFFKGLTSLQTISLDYNSFDSWVIPE 155
QE+ DN S+P+ + LTSL T+
Sbjct: 295 TSLPVLPPGLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLPTLP------------- 341
Query: 156 SLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTL 215
+GLQ S + N ++P T+P ++ A+N +P S ++ L
Sbjct: 342 -----SGLQELSVSD-NQLASLP------TLPSELYKLWAYNNRLTSLPAL--PSGLKEL 387
Query: 216 WLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDL-SGLSSLQDFSVRDNQLTG 274
++G + S + V+ + L +L + GN T LP L SGL SL SV NQLT
Sbjct: 388 IVSGNRLTS-----LPVLP--SELKELMVSGNRLTS-LPMLPSGLLSL---SVYRNQLTR 436
Query: 275 IVPSSLVNLHSLAVVNLTNNLFQGQT----------PKFNSP-VRFDMAKGS 315
+ P SL++L S VNL N +T P ++ P +RFDMA S
Sbjct: 437 L-PESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGAS 487
|
Length = 788 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 50/184 (27%), Positives = 84/184 (45%), Gaps = 22/184 (11%)
Query: 598 LGRGGFGTVYK-GELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLG 655
+G+G +G V+K +G+K AVK ++ ++ E ++E +L + H ++V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE---EIEAEYNILKALSDHPNVVKFYG 82
Query: 656 Y-----CLDGNERLLVYEYMPQGT---LSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
+G++ LV E G+ L + R E +P+ IA + +
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI-------IAYILHEALM 135
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
L L IHRD+K +NILL + K+ DFG V + + T + GT ++AP
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG-VSAQLTSTRLRRNTSV-GTPFWMAP 193
Query: 768 EYAA 771
E A
Sbjct: 194 EVIA 197
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 47/179 (26%), Positives = 83/179 (46%), Gaps = 22/179 (12%)
Query: 597 VLGRGGFGT--VYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
V+G G FG + + D K A+K + S + + E +L K++H ++V
Sbjct: 7 VVGEGSFGRALLVQHVNSD-QKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAF- 63
Query: 655 GYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKP----LEWTRRLTIALDVARGVEYL 709
+ + L +V EY G L + + ++ + L P L+W ++ + GV+++
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGK-LFPEDTILQWFVQMCL------GVQHI 116
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
H + +HRD+K NI L + + K+ DFG RL G ++ GT Y+ PE
Sbjct: 117 H---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA--CTYVGTPYYVPPE 170
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 37.7 bits (88), Expect = 6e-04
Identities = 13/42 (30%), Positives = 18/42 (42%), Gaps = 5/42 (11%)
Query: 26 SSSDAAAMQALKTSLGNP---ASLGW--TDPDPCKWKHIQCS 62
+ D A+ A K+SL A W + DPC W + C
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 7e-04
Identities = 34/146 (23%), Positives = 58/146 (39%), Gaps = 28/146 (19%)
Query: 60 QCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPS-LSGLSSLQEVL 118
S R+ + + G +P++L SLS L L++ +NKL+G+IP LS L +
Sbjct: 470 DSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLD 529
Query: 119 FDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIP 178
N + F + L + L N ++G IP
Sbjct: 530 LSHNQLSGQIPASFSEMPVLSQLDLSQN-------------------------QLSGEIP 564
Query: 179 DFLGGDTIPGLMHLHLAFNFLQGPIP 204
LG + L+ ++++ N L G +P
Sbjct: 565 KNLGN--VESLVQVNISHNHLHGSLP 588
|
Length = 968 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 35/137 (25%), Positives = 53/137 (38%), Gaps = 24/137 (17%)
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHL---FNRKEEGLKPLEWTRRLTIALDVARG 705
++V L Y + + LV ++ G L H+ N EE +K W + +ALD
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVK--RWAAEMVVALD---- 99
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG-LVRLAPDNGKHSIETRLAGTFGY 764
L + + RDL P+NILL D ++ F + ++E Y
Sbjct: 100 -----ALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------Y 148
Query: 765 LAPEYAA---ETSGMTW 778
APE ET W
Sbjct: 149 CAPEVGGISEETEACDW 165
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.001
Identities = 28/87 (32%), Positives = 36/87 (41%), Gaps = 16/87 (18%)
Query: 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ 715
Y +D + L+V EY+ G L LK R + +V R V LH
Sbjct: 67 YDVDPDNGLIVMEYIE-GEL-----------LKDALEEARPDLLREVGRLVGKLH---KA 111
Query: 716 SFIHRDLKPSNILLGDDMRAKVADFGL 742
+H DL SNI+L R DFGL
Sbjct: 112 GIVHGDLTTSNIILSGG-RIYFIDFGL 137
|
Length = 204 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 29/102 (28%), Positives = 53/102 (51%), Gaps = 8/102 (7%)
Query: 590 NNFSEENVLGRGGFGTVYK------GELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLT 643
+N LG G FG V + G+ + ++AVK ++++ +++ A SE+ +L+
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREA-LMSELKILS 96
Query: 644 KV-RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKE 684
+ +H+++V LLG C G L++ EY G L L + E
Sbjct: 97 HLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAE 138
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 36.3 bits (85), Expect = 0.002
Identities = 17/37 (45%), Positives = 25/37 (67%), Gaps = 2/37 (5%)
Query: 394 TSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
T+L L LS N++T +P L+ LP+LE LD+S N +
Sbjct: 1 TNLETLDLSNNQIT-DLP-PLSNLPNLETLDLSGNKI 35
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.002
Identities = 27/115 (23%), Positives = 42/115 (36%), Gaps = 14/115 (12%)
Query: 635 FKSEIAVLTKVRHRHLVG--LLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEW 692
+ E+A+L + + L +L L+ E++ TL KE+
Sbjct: 38 REREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEVSEEEKED------- 90
Query: 693 TRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747
IA +A + LH L H DL P NIL+ D + D+ P
Sbjct: 91 -----IAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 20/102 (19%), Positives = 27/102 (26%), Gaps = 10/102 (9%)
Query: 647 HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706
H L RL + + E L L +A +A
Sbjct: 106 HSVPPEALPLARRLRRRLKLLRQLAAALRRL----VAAELLDRLAELWERLLAALLALLP 161
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMR-AKVADFGLVRLAP 747
+H DL P N+L+ R V DF L
Sbjct: 162 AL-----PLVLVHGDLHPGNLLVDPGGRVTGVIDFEDAGLGD 198
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 35.5 bits (83), Expect = 0.004
Identities = 14/39 (35%), Positives = 21/39 (53%), Gaps = 1/39 (2%)
Query: 237 TSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGI 275
T+L L L N T LP LS L +L+ + N++T +
Sbjct: 1 TNLETLDLSNNQITD-LPPLSNLPNLETLDLSGNKITDL 38
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 35/148 (23%), Positives = 68/148 (45%), Gaps = 22/148 (14%)
Query: 598 LGRGGFGTVYKGELHDGT-------------KIAVKRMESAVVSEKGFAEFKSEIAVLTK 644
LGRG +Y G L+ K+ +K ++ + + A F++ +++ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETA-SMMRQ 60
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
V H+H+V L G C+ E ++V E++ G L LF ++ + W + +A +A
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPW--KFKVAKQLAS 116
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDD 732
+ YL + +H ++ NILL +
Sbjct: 117 ALSYLE---DKDLVHGNVCTKNILLARE 141
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.004
Identities = 43/175 (24%), Positives = 72/175 (41%), Gaps = 32/175 (18%)
Query: 601 GGFGTVY--KGELHDGT-KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657
G FG V K H T K+ V++ ++ K F + + L K + + + L Y
Sbjct: 27 GKFGKVSVLK---HKPTQKLFVQK----IIKAKNFNAIEPMVHQLMK-DNPNFIKLY-YS 77
Query: 658 LDG-NERLLVYEYMPQGTLSRHLFN--RKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
+ +L+ +Y+ G L F+ +KE L E ++ I + + LH H
Sbjct: 78 VTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAE-VKK--IIRQLVEALNDLH--KH 128
Query: 715 QSFIHRDLKPSNILLGDDM-RAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
IH D+K N+L R + D+GL ++ + GT Y +PE
Sbjct: 129 N-IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------GTLDYFSPE 176
|
Length = 267 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 779 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.98 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.97 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.97 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.97 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.96 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.96 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.96 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.96 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.96 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.96 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.96 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.96 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.96 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.95 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.95 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.95 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.95 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.95 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.95 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.95 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.95 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.95 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.95 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.95 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.95 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.95 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.95 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.95 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.94 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.94 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.94 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.94 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.94 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.94 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.94 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.94 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.94 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.94 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.94 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.94 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.94 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.94 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.94 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.94 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.94 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.94 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.94 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.94 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.94 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.94 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.94 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.94 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.94 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.94 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.93 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.93 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.93 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.93 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.93 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.93 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.93 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.93 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.93 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.93 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.93 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.93 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.93 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.93 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.93 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.93 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.93 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.93 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.93 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.93 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.93 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.93 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.93 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.93 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.93 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.93 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.93 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.93 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.93 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.93 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.92 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.92 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.92 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.92 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.92 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.92 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.92 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.92 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.92 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.92 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.92 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.92 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.92 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.92 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.92 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.92 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.92 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.92 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.92 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.92 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.92 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.91 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.91 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.91 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.91 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.91 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.91 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.91 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.91 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.91 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.91 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.91 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.91 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.91 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.91 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.91 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.91 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.91 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.91 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.91 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.91 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.91 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.91 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.91 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.91 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.91 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.91 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.91 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.91 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.91 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.91 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.91 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.91 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.91 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.91 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.91 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.91 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.91 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.91 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.91 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.91 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.91 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.91 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.91 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.91 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.91 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.91 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.91 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.91 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.91 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.9 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.9 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.9 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.9 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.9 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.9 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.9 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.9 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.9 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.9 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.9 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.9 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.9 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.9 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.9 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.9 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.9 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.9 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.9 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.9 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.9 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.9 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.9 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.9 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.9 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.9 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.9 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.9 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.9 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.9 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.9 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.9 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.9 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.9 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.9 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.9 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.9 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.9 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.9 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.89 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.89 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.89 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.89 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.89 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.89 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.89 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.89 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.89 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.89 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.89 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.89 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.89 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.89 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.89 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.89 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.89 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.89 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.89 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.89 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.89 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.89 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.89 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.89 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.89 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.89 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.89 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.89 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.88 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.88 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.88 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.88 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.88 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.88 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.88 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.88 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.88 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.88 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.88 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.88 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.88 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.88 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.88 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.88 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.88 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.88 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.88 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.88 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.88 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.88 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.87 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.87 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.87 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.87 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.87 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.87 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.87 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.87 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.86 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.86 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.86 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.86 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.86 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.86 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.86 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.86 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.85 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.85 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.85 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.84 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.84 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.83 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.83 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.83 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.82 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.82 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.81 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.81 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.8 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.8 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.79 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.76 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.75 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.74 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.74 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.73 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.73 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.69 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.65 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.63 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.56 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.55 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.5 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.44 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.43 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.4 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.39 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.37 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.37 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.34 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.32 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.26 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.25 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.24 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.2 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.17 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.14 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.13 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.13 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.12 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.1 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.09 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.08 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.04 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.03 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.02 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.01 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.99 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.96 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.96 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.94 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.91 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.9 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.89 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.85 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.83 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.81 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.79 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.73 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.72 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.71 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.67 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.61 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.59 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.5 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.5 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.47 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.43 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.41 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.39 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.34 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.29 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.25 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.24 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.22 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-71 Score=673.32 Aligned_cols=667 Identities=27% Similarity=0.430 Sum_probs=362.5
Q ss_pred ChhHHHHHHHHHHHcCCCCC--CCCC-CCCCCcceeeEeCCCCcEEEEEecCCCccccCCccccCCCCCcEEEcccCccc
Q 004020 26 SSSDAAAMQALKTSLGNPAS--LGWT-DPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLT 102 (779)
Q Consensus 26 ~~~~~~~l~~~k~~~~~~~~--~~w~-~~~~C~w~gv~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 102 (779)
++.|..||++||+++.++.. .+|. ..|||.|.||+|+..++|+.|+|++|+++|.+|..|..+++|++|+|++|++.
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~ 106 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLS 106 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCCCCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccC
Confidence 66899999999999976653 4786 45899999999998889999999999999999988999999999999999888
Q ss_pred cCCC-C-CCCCCCccEEecCCCCCCC----------------------CCcccccCCCCccEEEcccCCCCCCCCccccc
Q 004020 103 GQIP-S-LSGLSSLQEVLFDDNNFTS----------------------VPSDFFKGLTSLQTISLDYNSFDSWVIPESLK 158 (779)
Q Consensus 103 ~~~~-~-~~~l~~L~~L~l~~N~l~~----------------------~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~ 158 (779)
+.+| . +.++++|++|+|++|++++ ..+..+.++++|++|+|++|.+.+ .+|..+.
T Consensus 107 ~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~ 185 (968)
T PLN00113 107 GPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVG-KIPNSLT 185 (968)
T ss_pred CcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccc-cCChhhh
Confidence 7666 3 4466666666666666553 333345555555555555555543 3455555
Q ss_pred CCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCcccc-CCcceeeccCCCCCCCCCC---------
Q 004020 159 DATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNG--------- 228 (779)
Q Consensus 159 ~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~L~~l~l~~n~~~~~~~~--------- 228 (779)
++++|++|++++|++++.+|..++ .+++|++|+|++|++++.+|..++. .+|+.|++++|.+....+.
T Consensus 186 ~l~~L~~L~L~~n~l~~~~p~~l~--~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 263 (968)
T PLN00113 186 NLTSLEFLTLASNQLVGQIPRELG--QMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQ 263 (968)
T ss_pred hCcCCCeeeccCCCCcCcCChHHc--CcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCC
Confidence 555555555555555555555443 4455555555555555555544443 3455555554443322111
Q ss_pred ------------chhhhcCCCCccEEEeecCcccCCCCC-CCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCcc
Q 004020 229 ------------SVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNL 295 (779)
Q Consensus 229 ------------~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 295 (779)
.+..+..+++|+.|+|++|.+++.+|. +..+++|+.|++++|.+.+.+|..+..+++|+.|+|++|+
T Consensus 264 ~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~ 343 (968)
T PLN00113 264 YLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNK 343 (968)
T ss_pred EEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCC
Confidence 112233344444444444444444442 3444444444444444444444444444444444444444
Q ss_pred ccccCCCCCCCc----ccccc----------------------cCCC---------------CcccCCCCcccCccc---
Q 004020 296 FQGQTPKFNSPV----RFDMA----------------------KGSN---------------SFCLDDAGVACDGRV--- 331 (779)
Q Consensus 296 l~g~~p~~~~~~----~~~~~----------------------~~~~---------------~~~~~~~~~~~~~~~--- 331 (779)
+++.+|..+... .+++. ...| +..+....+...+..
T Consensus 344 l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~ 423 (968)
T PLN00113 344 FSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSE 423 (968)
T ss_pred CcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChh
Confidence 444444211110 00000 0000 000000000000000
Q ss_pred ---------------------hhhhhhcccCC------------Cch-----hcccccCCCCCCC---------------
Q 004020 332 ---------------------NVLLSIVKSVG------------YPA-----VLAESWKGNNPCN--------------- 358 (779)
Q Consensus 332 ---------------------~~~~~~~~~~~------------~~~-----~~~~~~~~~~~~~--------------- 358 (779)
+........+. .+. .+.......+.-.
T Consensus 424 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~ 503 (968)
T PLN00113 424 FTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQ 503 (968)
T ss_pred HhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCE
Confidence 00000000000 000 0000000000000
Q ss_pred -----CCCCcc---ccCCCCCeEEEEccCccccccccccccccccCCeEeccCccccccCCccCCCCCCCCceeccCCcc
Q 004020 359 -----SDWKGV---SCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430 (779)
Q Consensus 359 -----~~~~~~---~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l 430 (779)
+...+. ......+|+.|+|++|.++|.+|..|+.+++|+.|+|++|+++|.+|..+..+++|++|++++|++
T Consensus 504 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l 583 (968)
T PLN00113 504 LKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHL 583 (968)
T ss_pred EECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcc
Confidence 000000 112233455555555555555555555555555555555555555555555555555555555555
Q ss_pred cccCCCCCC---cceeeeCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccEEEehhHHHHHHHHH
Q 004020 431 FGKVPNFRQ---NVIVKTDGNPDIGKDSSSFTPKSPPGSSPTPPGGDSGGNGSSGGANKNSNTGKIVGSVVGVVCGAFIV 507 (779)
Q Consensus 431 ~g~iP~~~~---~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~i~g~v~g~~~~~~~~ 507 (779)
+|.+|.... .....+.||+.+|+..... ..+++ .. ..+....+.++++++++++.++++
T Consensus 584 ~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~--------~~~~c--------~~--~~~~~~~~~~~~~~~~~~~~~~~~ 645 (968)
T PLN00113 584 HGSLPSTGAFLAINASAVAGNIDLCGGDTTS--------GLPPC--------KR--VRKTPSWWFYITCTLGAFLVLALV 645 (968)
T ss_pred eeeCCCcchhcccChhhhcCCccccCCcccc--------CCCCC--------cc--ccccceeeeehhHHHHHHHHHHHH
Confidence 555554221 1123345555555432100 00000 00 001111222333333332222222
Q ss_pred HHheeeEEeecccCCCCCCCCcceecCCCCCCCCceeeEeecccccCCCCCccccCCCCCCCCcccc-cCceeeeHHHHH
Q 004020 508 GLGFCLYTRKRKRSGRVQSPNAVVIHPSNGGDGNAVKITVTESSVTGGGSESQSLTSSGPSDLHVVE-AGSMVISIQVLR 586 (779)
Q Consensus 508 ~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 586 (779)
+++++++ |+|++. +... .. . ..+. ....... .....++ ..
T Consensus 646 ~~~~~~~-~~~~~~-~~~~-----~~-~--~~~~--------------------------~~~~~~~~~~~~~~~---~~ 686 (968)
T PLN00113 646 AFGFVFI-RGRNNL-ELKR-----VE-N--EDGT--------------------------WELQFFDSKVSKSIT---IN 686 (968)
T ss_pred HHHHHHH-Hhhhcc-cccc-----cc-c--cccc--------------------------ccccccccccchhhh---HH
Confidence 2222222 222111 1000 00 0 0000 0000000 0001122 22
Q ss_pred HhhcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
.....|...+.||+|+||.||+|+. .++..||||++..... ...+|++.+++++|||||++++++.+.+..|+
T Consensus 687 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~l 760 (968)
T PLN00113 687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYL 760 (968)
T ss_pred HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEE
Confidence 3345677889999999999999986 4789999999864321 12356889999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||||+++|+|.++++ .++|.++.+|+.||++||+|||..+..+|+||||||+||+++.++.+++. ||.+..
T Consensus 761 v~Ey~~~g~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~ 831 (968)
T PLN00113 761 IHEYIEGKNLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL 831 (968)
T ss_pred EEeCCCCCcHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence 999999999999983 37899999999999999999997556799999999999999999888875 666543
Q ss_pred cCCCCCcccccccccCCccccccccccc
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.... ....||+.|||||++.+.
T Consensus 832 ~~~~------~~~~~t~~y~aPE~~~~~ 853 (968)
T PLN00113 832 LCTD------TKCFISSAYVAPETRETK 853 (968)
T ss_pred cccC------CCccccccccCcccccCC
Confidence 3211 223688999999998754
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=309.35 Aligned_cols=176 Identities=33% Similarity=0.511 Sum_probs=157.3
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
...+|...+.||+|+||+||+|+++ ++.+||||.+.+.....+..+-+..|+++|+.++|||||.+++++..++..|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 4568999999999999999999876 689999999988876777788899999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCC------CcEEEEee
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD------MRAKVADF 740 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~------~~~kl~DF 740 (779)
||||.||+|.+|++.+. .+++..+..++.|++.||++||+ ++||||||||+|||++.. -.+||+||
T Consensus 88 MEyC~gGDLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG-----RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred EEeCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 99999999999997764 58999999999999999999996 899999999999999764 46899999
Q ss_pred ccceecCCCCCcccccccccCCcccccccccccC
Q 004020 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 741 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
|+||...+. ......+|++.|||||+++...
T Consensus 160 GfAR~L~~~---~~a~tlcGSplYMAPEV~~~~~ 190 (429)
T KOG0595|consen 160 GFARFLQPG---SMAETLCGSPLYMAPEVIMSQQ 190 (429)
T ss_pred chhhhCCch---hHHHHhhCCccccCHHHHHhcc
Confidence 999988753 2345678999999999996443
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=311.33 Aligned_cols=189 Identities=55% Similarity=0.952 Sum_probs=165.6
Q ss_pred ceeeeHHHHHHhhcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeE
Q 004020 577 SMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656 (779)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 656 (779)
...|++++++.++++|.....||+|+||.||+|...++..||||++....... ..+|.+|++++.+++|||+|+++||
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 44699999999999999999999999999999999999999999887654221 4569999999999999999999999
Q ss_pred EEeCC-eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcE
Q 004020 657 CLDGN-ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 735 (779)
Q Consensus 657 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 735 (779)
|.+.+ +.++|+|||++|+|.++++..... +++|.+|++||.++|+||+|||+.+...||||||||+|||+|+++++
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 99998 599999999999999999875532 68999999999999999999999777789999999999999999999
Q ss_pred EEEeeccceecCC-CCCcccccccccCCcccccccccc
Q 004020 736 KVADFGLVRLAPD-NGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 736 kl~DFG~a~~~~~-~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
||+|||+|+..+. ... ..+...||.+|+|||+++.
T Consensus 217 KlsDFGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~ 252 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTS--VSTTVMGTFGYLAPEYAST 252 (361)
T ss_pred EccCccCcccCCccccc--eeeecCCCCccCChhhhcc
Confidence 9999999976654 211 1111179999999999864
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=285.36 Aligned_cols=172 Identities=30% Similarity=0.451 Sum_probs=151.3
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC-eEEEEEE
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN-ERLLVYE 668 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e 668 (779)
+.+..+.||+|..|+||+|+++ +++.+|+|.+... .+....+++.+|++++++++||+||.+|+.|+..+ +..++||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 3444678999999999999886 6888999999433 35666788999999999999999999999999998 5999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
||++|+|++++... .++++...-+|+.+|++||.|||. .++||||||||+|||++..|+|||||||.++.+..
T Consensus 159 YMDgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 159 YMDGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred hcCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 99999999998544 258999999999999999999996 48999999999999999999999999999987754
Q ss_pred CCCcccccccccCCcccccccccccC
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
. ....++||..|||||.+++..
T Consensus 232 S----~a~tfvGT~~YMsPERi~g~~ 253 (364)
T KOG0581|consen 232 S----IANTFVGTSAYMSPERISGES 253 (364)
T ss_pred h----hcccccccccccChhhhcCCc
Confidence 3 446789999999999998864
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=286.75 Aligned_cols=176 Identities=30% Similarity=0.468 Sum_probs=151.1
Q ss_pred hhcCCcccceecccccEEEEEEE-EcCCcEEEEEEecccccChh-----HHHHHHHHHHHHHcCCCCccceEeeEEEeCC
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEK-----GFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN 661 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 661 (779)
..+.|.+.+.||+|+||.|-+|. .++|+.||||++.+...... .....++|+++|++++|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 56678899999999999999995 45899999999976543221 2234679999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCC---CcEEEE
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD---MRAKVA 738 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~---~~~kl~ 738 (779)
+.||||||++||+|.+.+-..+ .+.+.....+++|++.|+.|||+ +||+||||||+|||+..+ ..+||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk-----~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK-----YLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc-----ccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEec
Confidence 9999999999999999885543 46677778999999999999996 899999999999999755 789999
Q ss_pred eeccceecCCCCCcccccccccCCcccccccccccC
Q 004020 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 739 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
|||+|+.... .......+|||.|.|||++.++.
T Consensus 322 DFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg 354 (475)
T KOG0615|consen 322 DFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKG 354 (475)
T ss_pred ccchhhcccc---ceehhhhcCCccccChhheecCC
Confidence 9999998753 34556789999999999997654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=282.32 Aligned_cols=183 Identities=27% Similarity=0.449 Sum_probs=158.5
Q ss_pred hcCCcccceecccccEEEEEEE-EcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEee-EEEeCCe-EEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLG-YCLDGNE-RLL 665 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~-~~~~~~~-~~l 665 (779)
..+|++.++||+|+||.||++. ..+|..+|.|.+.-..++.+..++...|+.+|++++|||||++++ .+.++.+ .++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 3468889999999999999995 568999999999977778888899999999999999999999998 4444455 789
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-CcEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ-SFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
|||||.+|+|..+++..+.+. +.+++..+|+++.|++.||+++|+.-++ -|+||||||.||+++.+|.|||+|||+++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qk-r~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQK-RLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHhhcccCHHHHHHHHHhcc-ccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 999999999999998776554 4799999999999999999999973222 38899999999999999999999999999
Q ss_pred ecCCCCCcccccccccCCcccccccccccC
Q 004020 745 LAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
.+... .......+|||.||+||.+.+..
T Consensus 177 ~l~s~--~tfA~S~VGTPyYMSPE~i~~~~ 204 (375)
T KOG0591|consen 177 FLSSK--TTFAHSLVGTPYYMSPERIHESG 204 (375)
T ss_pred Hhcch--hHHHHhhcCCCcccCHHHHhcCC
Confidence 88653 34456789999999999987653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=281.80 Aligned_cols=176 Identities=30% Similarity=0.477 Sum_probs=154.8
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccCh-hHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE-KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
.++|++.++||+|+||+||.++.+ +++.+|+|++++....+ ...+....|..++.+++||+||+++-.|++.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 467999999999999999999765 68899999998765433 4667789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
+||+.||.|..++.+.. .+++..+.-++.+|+.||.|||+ ++||||||||+|||+|.+|+++|+|||+++..
T Consensus 104 ld~~~GGeLf~hL~~eg-----~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG-----RFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EeccCCccHHHHHHhcC-----CcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 99999999999985433 58899999999999999999996 89999999999999999999999999999865
Q ss_pred CCCCCcccccccccCCcccccccccccC
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
...+. .+...+||+.|||||++.++.
T Consensus 176 ~~~~~--~t~tfcGT~eYmAPEil~~~g 201 (357)
T KOG0598|consen 176 LKDGD--ATRTFCGTPEYMAPEILLGKG 201 (357)
T ss_pred ccCCC--ccccccCCccccChHHHhcCC
Confidence 44322 234579999999999998873
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=294.82 Aligned_cols=173 Identities=30% Similarity=0.529 Sum_probs=155.4
Q ss_pred cCCcccceecccccEEEEEEEE-cCCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.+|...+.||+|||+.||+++. .+|+.||+|++.+... +....+.+.+||++.+.|+|||||+++++|++.+++|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999987 7899999999987543 3455678999999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
|+|+.++|..+++.++ ++++.++..+++||+.||.|||+ .+|+|||||..|++++++.+|||+|||+|....
T Consensus 98 ELC~~~sL~el~Krrk-----~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK-----PLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EecCCccHHHHHHhcC-----CCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeec
Confidence 9999999999986443 68999999999999999999996 889999999999999999999999999999887
Q ss_pred CCCCcccccccccCCcccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
.+++. ....+|||.|.|||++..
T Consensus 170 ~~~Er--k~TlCGTPNYIAPEVl~k 192 (592)
T KOG0575|consen 170 YDGER--KKTLCGTPNYIAPEVLNK 192 (592)
T ss_pred Ccccc--cceecCCCcccChhHhcc
Confidence 55332 355789999999999983
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=272.50 Aligned_cols=177 Identities=24% Similarity=0.350 Sum_probs=150.9
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
+.|+...++|+|+||.||+|+.+ +|+.||||++....-+..-.+-.+||+++|++++|||+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888899999999999999876 69999999997665334444567999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
||+..-|. .+.... ..++...+.++++|+++|+.|+|+ +++|||||||+||||+.+|.+||||||+|+.+..
T Consensus 82 ~~dhTvL~-eLe~~p----~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDHTVLH-ELERYP----NGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecchHHHH-HHHhcc----CCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 99875444 343332 247888999999999999999995 8999999999999999999999999999998875
Q ss_pred CCCcccccccccCCcccccccccccCCC
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAETSGM 776 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~~~~ 776 (779)
.++ ..+.++.|.+|+|||++.|...|
T Consensus 154 pgd--~YTDYVATRWYRaPELLvGDtqY 179 (396)
T KOG0593|consen 154 PGD--NYTDYVATRWYRAPELLVGDTQY 179 (396)
T ss_pred Ccc--hhhhhhhhhhccChhhhcccCcC
Confidence 433 34778899999999999885433
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=264.88 Aligned_cols=178 Identities=27% Similarity=0.434 Sum_probs=156.3
Q ss_pred cCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
.+|...+++|+|.||.||+|+. .+|+.||||+++.....+.......||++.|+.++|+||+.++++|.+.+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4788899999999999999964 589999999998776555555678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
||+. +|+..+++.. ..++..++..++.++++|++|||+ +.|+||||||.|+||+.+|.+||+|||+|+.+..
T Consensus 82 fm~t-dLe~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN----IILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred eccc-cHHHHhcccc----cccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 9974 9999886554 368999999999999999999996 8999999999999999999999999999998876
Q ss_pred CCCcccccccccCCcccccccccccCCCC
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
..... +..+-|.+|+|||++.|...|+
T Consensus 154 p~~~~--~~~V~TRWYRAPELLfGsr~Yg 180 (318)
T KOG0659|consen 154 PNRIQ--THQVVTRWYRAPELLFGSRQYG 180 (318)
T ss_pred CCccc--ccceeeeeccChHHhccchhcC
Confidence 54332 3347899999999999887664
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=287.04 Aligned_cols=182 Identities=27% Similarity=0.367 Sum_probs=157.5
Q ss_pred hhcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC--CeEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--NERL 664 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 664 (779)
..+.|+.+++||+|.||.||+|+. .+|+.||+|++......+....-..+||.+|++++||||+++.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 345688899999999999999964 5899999999987765566666778999999999999999999998877 6899
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
||+|||++ +|.-++... .-.+++.++..++.|++.||+|||+ ++|+|||||.+|||||.+|.+||+|||+|+
T Consensus 195 lVFeYMdh-DL~GLl~~p----~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr 266 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSP----GVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLAR 266 (560)
T ss_pred EEEecccc-hhhhhhcCC----CcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEecccccee
Confidence 99999987 777776432 2358999999999999999999996 899999999999999999999999999999
Q ss_pred ecCCCCCcccccccccCCcccccccccccCCCCC
Q 004020 745 LAPDNGKHSIETRLAGTFGYLAPEYAAETSGMTW 778 (779)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t~ 778 (779)
++...... ..+..+-|.+|+|||++.|...|+.
T Consensus 267 ~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~ 299 (560)
T KOG0600|consen 267 FYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGT 299 (560)
T ss_pred eccCCCCc-ccccceEEeeccChHHhcCCccccc
Confidence 88765433 3466678999999999999988764
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=288.17 Aligned_cols=178 Identities=40% Similarity=0.609 Sum_probs=152.1
Q ss_pred cccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC-eEEEEEEecC
Q 004020 593 SEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN-ERLLVYEYMP 671 (779)
Q Consensus 593 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~ 671 (779)
...+.+|+|+||+||+|.++....||||++.....+....++|.+|+.++.+++|||||+++|++.+.. ..++||||++
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 345669999999999999985555999999876655555779999999999999999999999999887 7899999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-cEEcCCCCCCEEEcCCC-cEEEEeeccceecCCC
Q 004020 672 QGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS-FIHRDLKPSNILLGDDM-RAKVADFGLVRLAPDN 749 (779)
Q Consensus 672 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~-ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~ 749 (779)
+|+|.++++.. ....+++..+++++.|||+||+|||+ .+ ||||||||+|||++.++ ++||+|||+++.....
T Consensus 124 ~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 124 GGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 99999999774 12369999999999999999999997 56 99999999999999997 9999999999876543
Q ss_pred CCcccccccccCCccccccccccc-CCCCC
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAET-SGMTW 778 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~-~~~t~ 778 (779)
. ...+...||+.|||||++.+. ..+|.
T Consensus 198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~~ 225 (362)
T KOG0192|consen 198 K--TSMTSVAGTYRWMAPEVLRGEKSPYTE 225 (362)
T ss_pred c--ccccCCCCCccccChhhhcCCCCcCCc
Confidence 2 223446899999999999974 44443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-33 Score=286.29 Aligned_cols=179 Identities=27% Similarity=0.408 Sum_probs=157.8
Q ss_pred hhcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCC-eEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGN-ERL 664 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~-~~~ 664 (779)
+.++|...++||.|+||.||+|+. .+++.||||+|++...+-++. .-.||++.|+++. |||||++.+++.+.+ ..|
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 457899999999999999999965 478999999999877553332 3468999999998 999999999999988 899
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
+|||||+ .+|.++++++. +.+++..+..|+.||++||+|+|. +|+.|||+||+|||+.....+||+|||+||
T Consensus 87 fVfE~Md-~NLYqLmK~R~----r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKDRN----RLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAR 158 (538)
T ss_pred eeHHhhh-hhHHHHHhhcC----CcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccc
Confidence 9999996 59999997763 479999999999999999999994 999999999999999988899999999999
Q ss_pred ecCCCCCcccccccccCCcccccccccccCCCCC
Q 004020 745 LAPDNGKHSIETRLAGTFGYLAPEYAAETSGMTW 778 (779)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t~ 778 (779)
..... ...+.++.|.+|+|||++.....|++
T Consensus 159 ev~Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~ 189 (538)
T KOG0661|consen 159 EVRSK---PPYTEYVSTRWYRAPEVLLRSGYYSS 189 (538)
T ss_pred ccccC---CCcchhhhcccccchHHhhhccccCC
Confidence 87653 34577899999999999999988875
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-32 Score=259.83 Aligned_cols=172 Identities=32% Similarity=0.453 Sum_probs=153.7
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccc-cChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
++|+..+.||.|+||+|.+++.+ +|..+|+|++.+.. ...+..+....|..+|+.+.||+++++++.|.+.+..||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 47888999999999999999876 68899999997654 34456677889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||++||.|..++++.. ++++..+..++.||+.||+|||+ .+|++||+||+|||+|.+|++||+|||+|+...
T Consensus 124 eyv~GGElFS~Lrk~~-----rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG-----RFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred eccCCccHHHHHHhcC-----CCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 9999999999996543 58999999999999999999996 899999999999999999999999999999875
Q ss_pred CCCCcccccccccCCcccccccccccC
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
.. +...+|||.|+|||+++.+.
T Consensus 196 ~r-----T~TlCGTPeYLAPEii~sk~ 217 (355)
T KOG0616|consen 196 GR-----TWTLCGTPEYLAPEIIQSKG 217 (355)
T ss_pred Cc-----EEEecCCccccChHHhhcCC
Confidence 43 34578999999999998764
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=323.22 Aligned_cols=320 Identities=26% Similarity=0.400 Sum_probs=259.6
Q ss_pred CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEc
Q 004020 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 143 (779)
.+++.|+|++|++.+.+|..+..+++|++|+|++|.+.+.+| .+.++++|+.|+|++|.+++..+..+..+++|+.|+|
T Consensus 284 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~L 363 (968)
T PLN00113 284 QKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDL 363 (968)
T ss_pred cCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEEC
Confidence 468999999999999999999999999999999999998887 7899999999999999999877778999999999999
Q ss_pred ccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCcccc-CCcceeeccCCCC
Q 004020 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKG 222 (779)
Q Consensus 144 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~L~~l~l~~n~~ 222 (779)
++|++.+ .+|..+..+++|+.|++++|++++.+|..+. .+++|+.|+|++|++++.+|..+.. ..|+.|++++|.+
T Consensus 364 s~n~l~~-~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~--~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l 440 (968)
T PLN00113 364 STNNLTG-EIPEGLCSSGNLFKLILFSNSLEGEIPKSLG--ACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNL 440 (968)
T ss_pred CCCeeEe-eCChhHhCcCCCCEEECcCCEecccCCHHHh--CCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcc
Confidence 9999976 6788888899999999999999999998886 6889999999999999988888876 6788999999887
Q ss_pred CCCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCC
Q 004020 223 DSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK 302 (779)
Q Consensus 223 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~ 302 (779)
...... .+..+++|+.|+|++|++.+.+|.....++|+.|++++|++++.+|..+.++++|+.|+|++|++++.+|+
T Consensus 441 ~~~~~~---~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 517 (968)
T PLN00113 441 QGRINS---RKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPD 517 (968)
T ss_pred cCccCh---hhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCCh
Confidence 765443 34568889999999999988888766778899999999999888888888899999999999999888886
Q ss_pred CCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccc
Q 004020 303 FNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGL 382 (779)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l 382 (779)
.+.... ++..+....+...+ .........++|+.|+|++|++
T Consensus 518 ~~~~l~-------~L~~L~Ls~N~l~~-------------------------------~~p~~~~~l~~L~~L~Ls~N~l 559 (968)
T PLN00113 518 ELSSCK-------KLVSLDLSHNQLSG-------------------------------QIPASFSEMPVLSQLDLSQNQL 559 (968)
T ss_pred HHcCcc-------CCCEEECCCCcccc-------------------------------cCChhHhCcccCCEEECCCCcc
Confidence 443221 01011110000000 0001123345899999999999
Q ss_pred cccccccccccccCCeEeccCccccccCCccCCCCCCCCceeccCCc
Q 004020 383 SGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNH 429 (779)
Q Consensus 383 ~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~ 429 (779)
+|.+|..+.+++.|+.|+|++|+++|.+|.. +.+..+....+.+|.
T Consensus 560 ~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~ 605 (968)
T PLN00113 560 SGEIPKNLGNVESLVQVNISHNHLHGSLPST-GAFLAINASAVAGNI 605 (968)
T ss_pred cccCChhHhcCcccCEEeccCCcceeeCCCc-chhcccChhhhcCCc
Confidence 9999999999999999999999999999964 444455566667776
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=278.01 Aligned_cols=173 Identities=31% Similarity=0.484 Sum_probs=157.0
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+....+++.+.+++|+++++.++|||||.++++|+...+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888999999999999999755 68899999998887778888999999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+.| +|..++.+.. .+++..+..|+.|++.||.|||+ .+|+|||+||.|||++..|.+|++|||+|+.+..
T Consensus 82 ~a~g-~L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG-----KLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred hhhh-hHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 9987 9999996554 58999999999999999999996 8999999999999999999999999999998766
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+ ....+...|||.|||||++.+.
T Consensus 153 ~--t~vltsikGtPlYmAPElv~e~ 175 (808)
T KOG0597|consen 153 N--TSVLTSIKGTPLYMAPELVEEQ 175 (808)
T ss_pred C--ceeeeeccCcccccCHHHHcCC
Confidence 3 3455677899999999999854
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=268.43 Aligned_cols=173 Identities=29% Similarity=0.481 Sum_probs=147.7
Q ss_pred CcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcC--CCCccceEeeEEEeCC----eEEE
Q 004020 592 FSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV--RHRHLVGLLGYCLDGN----ERLL 665 (779)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~----~~~l 665 (779)
.+..+++|+|.||.||||.+. ++.||||++.. ...+.|..|-++++.. +|+||++++++-.... ++++
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 445678999999999999986 59999999863 3456777787777764 7999999999877665 8899
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcC------CCCCcEEcCCCCCCEEEcCCCcEEEEe
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL------AHQSFIHRDLKPSNILLGDDMRAKVAD 739 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~------~~~~ivHrDlkp~NIll~~~~~~kl~D 739 (779)
|+||.+.|+|.+|+... .++|....+|+..|++||+|||+. .+.+|+|||||.+||||..|+.+.|+|
T Consensus 286 Vt~fh~kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred EeeeccCCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 99999999999999654 589999999999999999999974 346799999999999999999999999
Q ss_pred eccceecCCCCCcccccccccCCcccccccccccCCC
Q 004020 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSGM 776 (779)
Q Consensus 740 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 776 (779)
||+|..+............+||.+|||||++.|..+.
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl 396 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINL 396 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhccc
Confidence 9999988765444444557899999999999887654
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=264.86 Aligned_cols=184 Identities=25% Similarity=0.424 Sum_probs=160.7
Q ss_pred hcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.++|++.++||.|..++||+|+. ..++.||||++.-...... .+.+++|+..++.++||||++++..|..+.+.|+||
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 45799999999999999999975 4689999999987765444 788999999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
.||.+|++.++++.....+ +++..+..|.+++++||.|||. +|.||||||+.||||+.+|.|||+|||.+..+.
T Consensus 104 pfMa~GS~ldIik~~~~~G---l~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDG---LEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred hhhcCCcHHHHHHHHcccc---ccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 9999999999998877654 8899999999999999999995 899999999999999999999999999876554
Q ss_pred CCCCcc-cc-cccccCCccccccc-ccccCCCCCC
Q 004020 748 DNGKHS-IE-TRLAGTFGYLAPEY-AAETSGMTWQ 779 (779)
Q Consensus 748 ~~~~~~-~~-~~~~gt~~y~APE~-l~~~~~~t~~ 779 (779)
+.+... .. ..++||+.|||||+ .+.-.+|++|
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfK 212 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFK 212 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccch
Confidence 444221 22 55689999999999 6666888875
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=259.62 Aligned_cols=179 Identities=29% Similarity=0.382 Sum_probs=152.9
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC--CeEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--NERLL 665 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 665 (779)
.+.|+....|++|+||.||+|+.+ +++.||+|+++.......-.-.-.|||.+|.+++|||||.+.++.... +.+|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 356888899999999999999765 789999999987653333334568999999999999999999887644 67999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
|||||+. +|...+..-+ +++...++..++.|+++|++|||. ..|+||||||+|+|+.+.|.+||+|||+||.
T Consensus 155 VMe~~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLARE 226 (419)
T ss_pred eHHHHHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhh
Confidence 9999986 8988886554 368899999999999999999995 8999999999999999999999999999999
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCC
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
+... ....+..+-|.+|+|||++.|...|+
T Consensus 227 ygsp--~k~~T~lVVTLWYRaPELLLG~~tys 256 (419)
T KOG0663|consen 227 YGSP--LKPYTPLVVTLWYRAPELLLGAKTYS 256 (419)
T ss_pred hcCC--cccCcceEEEeeecCHHHhcCCcccC
Confidence 8765 23456778999999999999887654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=271.89 Aligned_cols=181 Identities=30% Similarity=0.464 Sum_probs=156.1
Q ss_pred HHhhcCCcccceecccccEEEEEEEE-cCCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCe
Q 004020 586 RNVTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNE 662 (779)
Q Consensus 586 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 662 (779)
.....+|..++.||+|+|++||+|+. .++++||||++.+... .+...+-..+|-.+|.+| .||.|++++-.|++...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 45567899999999999999999965 4799999999976643 344456678899999999 79999999999999999
Q ss_pred EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecc
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 742 (779)
.|+|+||+++|+|.++|++.. .+++..+..++.||+.||+|||+ +|||||||||+|||+|++|++||.|||.
T Consensus 149 LYFvLe~A~nGdll~~i~K~G-----sfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGs 220 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG-----SFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGS 220 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC-----cchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccc
Confidence 999999999999999997653 58999999999999999999996 8999999999999999999999999999
Q ss_pred ceecCCCCCc-----------ccccccccCCcccccccccccC
Q 004020 743 VRLAPDNGKH-----------SIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 743 a~~~~~~~~~-----------~~~~~~~gt~~y~APE~l~~~~ 774 (779)
|+.+.+.... .....++||..|.+||++.+..
T Consensus 221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~ 263 (604)
T KOG0592|consen 221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP 263 (604)
T ss_pred cccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCC
Confidence 9987543221 1124589999999999997653
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=274.65 Aligned_cols=178 Identities=29% Similarity=0.470 Sum_probs=153.0
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccC---hhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCCe
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS---EKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNE 662 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 662 (779)
..+.|.+.+.||+|+||.|+.|+.. +++.||+|++.+.... ....+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4568999999999999999999654 7899999987765222 123456778999999999 9999999999999999
Q ss_pred EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCC-CcEEEEeec
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFG 741 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DFG 741 (779)
.|+||||+.+|+|.+++.+.. ++.+..+.++++|++.|++|+|+ +||+||||||+|||+|.+ +++||+|||
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g-----~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKG-----RLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred EEEEEEecCCccHHHHHHHcC-----CCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 999999999999999997632 57889999999999999999996 899999999999999999 999999999
Q ss_pred cceecCCCCCcccccccccCCcccccccccccCC
Q 004020 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 742 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
++..... ........+||+.|+|||++.+...
T Consensus 167 ~s~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~ 198 (370)
T KOG0583|consen 167 LSAISPG--EDGLLKTFCGSPAYAAPEVLSGKGT 198 (370)
T ss_pred cccccCC--CCCcccCCCCCcccCCHHHhCCCCC
Confidence 9987741 1223355689999999999998763
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=261.87 Aligned_cols=177 Identities=25% Similarity=0.451 Sum_probs=157.6
Q ss_pred hhcCCcccceecccccEEEEEEEE-cCCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
..-+|++.+.||+|.||.|-+|.. ..|+.||||.+++... ++++.-.+++|+++|..++||||+.+|++|+..+...+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 345789999999999999999964 6799999999987654 44566789999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||||..+|.|++|+.++. .+++.++.++++||+.|+.|+| +++++|||||.+|||+|+++++||+|||++..
T Consensus 131 vMEYaS~GeLYDYiSer~-----~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNl 202 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERG-----SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNL 202 (668)
T ss_pred EEEecCCccHHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhh
Confidence 999999999999997664 5899999999999999999999 58999999999999999999999999999987
Q ss_pred cCCCCCcccccccccCCcccccccccccCC
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
+... ..-+.++|+|-|.+||++.|...
T Consensus 203 y~~~---kfLqTFCGSPLYASPEIvNG~PY 229 (668)
T KOG0611|consen 203 YADK---KFLQTFCGSPLYASPEIVNGTPY 229 (668)
T ss_pred hccc---cHHHHhcCCcccCCccccCCCCC
Confidence 7653 33466899999999999987643
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=280.80 Aligned_cols=325 Identities=23% Similarity=0.277 Sum_probs=239.5
Q ss_pred CCcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEE
Q 004020 64 SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTIS 142 (779)
Q Consensus 64 ~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 142 (779)
.++++.|+|.+|.|+..-.+++..++.|+.||||.|.|+.++. +|..-.+|++|+|++|+|+.+..+.|.++.+|.+|.
T Consensus 124 sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlk 203 (873)
T KOG4194|consen 124 SGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLK 203 (873)
T ss_pred ccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeee
Confidence 4578888888888877777778888888888888888876653 777777888888888888888888888888888888
Q ss_pred cccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCcc-ccCCcceeeccCCC
Q 004020 143 LDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSF-GKSSIQTLWLNGQK 221 (779)
Q Consensus 143 Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~~~L~~l~l~~n~ 221 (779)
|+.|+++. ..+..|++|++|+.|+|..|+|.-.---.|. .+++|+.|.|..|++...-...| +..++++|+|..|+
T Consensus 204 LsrNritt-Lp~r~Fk~L~~L~~LdLnrN~irive~ltFq--gL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~ 280 (873)
T KOG4194|consen 204 LSRNRITT-LPQRSFKRLPKLESLDLNRNRIRIVEGLTFQ--GLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNR 280 (873)
T ss_pred cccCcccc-cCHHHhhhcchhhhhhccccceeeehhhhhc--CchhhhhhhhhhcCcccccCcceeeecccceeecccch
Confidence 88888865 5556777788888888888887622233343 57788888888888875544444 33677888888877
Q ss_pred CCCCCCCchhhhcCCCCccEEEeecCcccCCCCC-CCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccC
Q 004020 222 GDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQT 300 (779)
Q Consensus 222 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~ 300 (779)
+.....|+ +.++++|+.|+||.|.|..+-++ +.-..+|++|+|++|+|+...+.+|..+..|++|+|++|+++..-
T Consensus 281 l~~vn~g~---lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~ 357 (873)
T KOG4194|consen 281 LQAVNEGW---LFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLA 357 (873)
T ss_pred hhhhhccc---ccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHH
Confidence 76665554 45777888888888888775554 666678888888888888777778888888888888888776322
Q ss_pred CCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCc
Q 004020 301 PKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNL 380 (779)
Q Consensus 301 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n 380 (779)
-. .++..++|..|||++|
T Consensus 358 e~--------------------------------------------------------------af~~lssL~~LdLr~N 375 (873)
T KOG4194|consen 358 EG--------------------------------------------------------------AFVGLSSLHKLDLRSN 375 (873)
T ss_pred hh--------------------------------------------------------------HHHHhhhhhhhcCcCC
Confidence 11 1223458999999999
Q ss_pred ccccccc---ccccccccCCeEeccCccccccCCccCCCCCCCCceeccCCcccccCCC-CCCc--ceeeeCCCCCCCCC
Q 004020 381 GLSGTIS---SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPN-FRQN--VIVKTDGNPDIGKD 454 (779)
Q Consensus 381 ~l~g~~p---~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~-~~~~--~~~~~~~n~~~~~~ 454 (779)
.|++.|- ..|..|+.|+.|+|.+|+|...--.+|..+.+|+.|||.+|.+-.--|+ |... ..+.+..-..+|.+
T Consensus 376 ~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDC 455 (873)
T KOG4194|consen 376 ELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDC 455 (873)
T ss_pred eEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEec
Confidence 9998774 3688899999999999999944346899999999999999998776665 3322 22334455567776
Q ss_pred CC
Q 004020 455 SS 456 (779)
Q Consensus 455 ~~ 456 (779)
..
T Consensus 456 ql 457 (873)
T KOG4194|consen 456 QL 457 (873)
T ss_pred cH
Confidence 54
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=260.64 Aligned_cols=182 Identities=29% Similarity=0.443 Sum_probs=150.0
Q ss_pred HHHHHhhcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHc--CCCCccceEeeEEEeC
Q 004020 583 QVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTK--VRHRHLVGLLGYCLDG 660 (779)
Q Consensus 583 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~ 660 (779)
-..+.+..+..+.+.||+|.||.||+|+++ |+.||||++... +.+.+.+|.++++. ++|+||+.+++.-..+
T Consensus 204 LVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~ 277 (513)
T KOG2052|consen 204 LVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKD 277 (513)
T ss_pred HhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence 345667778889999999999999999997 899999998643 23457777777765 5999999999876544
Q ss_pred C----eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHc-----CCCCCcEEcCCCCCCEEEcC
Q 004020 661 N----ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHG-----LAHQSFIHRDLKPSNILLGD 731 (779)
Q Consensus 661 ~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-----~~~~~ivHrDlkp~NIll~~ 731 (779)
. +.|+|++|.+.|||.||+... .++....++++..+|.||++||. +.+..|.|||||++||||.+
T Consensus 278 ~gs~TQLwLvTdYHe~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk 351 (513)
T KOG2052|consen 278 NGSWTQLWLVTDYHEHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 351 (513)
T ss_pred CCceEEEEEeeecccCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc
Confidence 3 679999999999999999553 58889999999999999999994 35678999999999999999
Q ss_pred CCcEEEEeeccceecCCCCC--cccccccccCCcccccccccccCCC
Q 004020 732 DMRAKVADFGLVRLAPDNGK--HSIETRLAGTFGYLAPEYAAETSGM 776 (779)
Q Consensus 732 ~~~~kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~ 776 (779)
++.+.|+|+|+|........ .......+||.+|||||++.+..+.
T Consensus 352 n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~ 398 (513)
T KOG2052|consen 352 NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINM 398 (513)
T ss_pred CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcCh
Confidence 99999999999976654321 1123456899999999999876543
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-30 Score=256.61 Aligned_cols=182 Identities=26% Similarity=0.388 Sum_probs=151.6
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCc-cceEeeEEEeCC-----
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH-LVGLLGYCLDGN----- 661 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~----- 661 (779)
...|+..++||+|+||+||+|+.. +|+.||+|++......+.......+|+.+++.++|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345777888999999999999754 7899999999766533334456789999999999999 999999999877
Q ss_pred -eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEee
Q 004020 662 -ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (779)
Q Consensus 662 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF 740 (779)
..++|+||++ .+|.+++....... ..++...+..+++||++||+|||+ ++|+||||||+||||+++|.+||+||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeecc
Confidence 7889999996 59999997655322 346668899999999999999996 89999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccCCcccccccccccCCCC
Q 004020 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 741 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
|+|+...-... ..+..++|.+|+|||++.|...|+
T Consensus 165 GlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys 199 (323)
T KOG0594|consen 165 GLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYS 199 (323)
T ss_pred chHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCC
Confidence 99996653322 245678999999999999886553
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-30 Score=265.70 Aligned_cols=152 Identities=26% Similarity=0.412 Sum_probs=136.4
Q ss_pred HHhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeE
Q 004020 586 RNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (779)
Q Consensus 586 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 663 (779)
+.-.++|+..++||+|+||.||+|+-+ +|..+|+|++++..+ .....+..+.|-.+|...++|+||+++-.|++.++.
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 445688999999999999999999765 699999999987653 334567789999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccc
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 743 (779)
||||||++||++..+|.... .+++..+..++.+++-|++-||. .|+|||||||+|+|||..|++||+|||++
T Consensus 217 YLiMEylPGGD~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs 288 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKD-----TLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLS 288 (550)
T ss_pred EEEEEecCCccHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeecccccc
Confidence 99999999999999985442 68899999999999999999994 89999999999999999999999999998
Q ss_pred ee
Q 004020 744 RL 745 (779)
Q Consensus 744 ~~ 745 (779)
.-
T Consensus 289 ~g 290 (550)
T KOG0605|consen 289 TG 290 (550)
T ss_pred ch
Confidence 53
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-31 Score=274.31 Aligned_cols=230 Identities=20% Similarity=0.274 Sum_probs=183.9
Q ss_pred cEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCC-CCccEEecCCCCCCCCCcccccCCCCccEEEcc
Q 004020 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGL-SSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (779)
Q Consensus 66 ~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l-~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 144 (779)
.+..||+++|.|+.+-+..|.++++|++++|..|.|+ .+|.|+.. .+|+.|+|.+|.|+.+..+.+..++.|++||||
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 5788999999999888888999999999999999998 55655554 459999999999999999999999999999999
Q ss_pred cCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCcccc-CCcceeeccCCCCC
Q 004020 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGD 223 (779)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~L~~l~l~~n~~~ 223 (779)
.|.|.. +.-..|..-.++++|+|++|.|+..--+.|. .+.+|.+|.|+.|+++...+..|.. .+|+.|+|..|++.
T Consensus 158 rN~is~-i~~~sfp~~~ni~~L~La~N~It~l~~~~F~--~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~ir 234 (873)
T KOG4194|consen 158 RNLISE-IPKPSFPAKVNIKKLNLASNRITTLETGHFD--SLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIR 234 (873)
T ss_pred hchhhc-ccCCCCCCCCCceEEeecccccccccccccc--ccchheeeecccCcccccCHHHhhhcchhhhhhcccccee
Confidence 999976 4446778888999999999999977677775 7889999999999999555556663 67999999888876
Q ss_pred CCCCCchhhhcCCCCccEEEeecCcccCCCCC-CCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCC
Q 004020 224 SKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK 302 (779)
Q Consensus 224 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~ 302 (779)
..-. -.|+.+++|+.|.|..|.+...-.. |.++.++++|+|..|++...-..++.++++|+.|+||+|.|+..-++
T Consensus 235 ive~---ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d 311 (873)
T KOG4194|consen 235 IVEG---LTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHID 311 (873)
T ss_pred eehh---hhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecc
Confidence 4311 1255677777778888877765553 77777777788877777766667777777777777777777755443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=259.50 Aligned_cols=181 Identities=30% Similarity=0.459 Sum_probs=147.4
Q ss_pred HHhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChh------------HHHHHHHHHHHHHcCCCCccce
Q 004020 586 RNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEK------------GFAEFKSEIAVLTKVRHRHLVG 652 (779)
Q Consensus 586 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~------------~~~~~~~E~~~l~~l~h~niv~ 652 (779)
+...++|++.+.||+|.||.|-+|+.. +++.||||++.+...... ..++..+||.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 445689999999999999999999765 789999999975432211 2357899999999999999999
Q ss_pred EeeEEEeC--CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEc
Q 004020 653 LLGYCLDG--NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG 730 (779)
Q Consensus 653 ~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~ 730 (779)
++++..+. +..|||+|||..|.+...= .....+++.++++|+++++.||+|||. ++||||||||+|+|++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLS 244 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEc
Confidence 99998875 5789999999998875332 111128899999999999999999996 8999999999999999
Q ss_pred CCCcEEEEeeccceecCCCC---CcccccccccCCcccccccccccC
Q 004020 731 DDMRAKVADFGLVRLAPDNG---KHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 731 ~~~~~kl~DFG~a~~~~~~~---~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
++|+|||+|||.+..+.... ....-...+|||.|||||...+..
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~ 291 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGN 291 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCC
Confidence 99999999999988663321 111123468999999999987744
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=256.06 Aligned_cols=175 Identities=27% Similarity=0.437 Sum_probs=143.9
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC---e--EE
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN---E--RL 664 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~--~~ 664 (779)
.|...+++|.|+||.||+|... +++.||||+.-.... --.+|.++|++++|||||++.-+|.... + ..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 4667899999999999999765 578999999864431 1247999999999999999998887543 2 24
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCC-CcEEEEeeccc
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFGLV 743 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a 743 (779)
+|||||+. +|.++++..... ...++...+.-++.||.+||.|||+ .+|+||||||.|+|+|.+ |.+||||||.|
T Consensus 99 lVleymP~-tL~~~~r~~~~~-~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRA-NQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhc-CCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 89999986 899988754322 2357778889999999999999996 899999999999999966 99999999999
Q ss_pred eecCCCCCcccccccccCCcccccccccccCCCCCC
Q 004020 744 RLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMTWQ 779 (779)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t~~ 779 (779)
+....+.. ...+..|..|+|||.+.|...||++
T Consensus 174 K~L~~~ep---niSYicSRyYRaPELifga~~Yt~~ 206 (364)
T KOG0658|consen 174 KVLVKGEP---NISYICSRYYRAPELIFGATEYTTS 206 (364)
T ss_pred eeeccCCC---ceeEEEeccccCHHHHcCccccCce
Confidence 98866432 2456789999999999999999874
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=255.33 Aligned_cols=174 Identities=32% Similarity=0.513 Sum_probs=146.9
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC--eEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN--ERLLV 666 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv 666 (779)
.+|...+.||+|+||.||++... +|+..|||.+.... ....+.+.+|+.+|++++|||||+++|.....+ .+++.
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 45778899999999999999765 48999999987652 222677899999999999999999999865555 58899
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC-CCcEEEEeecccee
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLVRL 745 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~ 745 (779)
|||+++|+|.+++.+... .+++..+.++++||++||+|||+ +|||||||||+|||++. ++.+||+|||+++.
T Consensus 95 mEy~~~GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred eeccCCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccc
Confidence 999999999999965432 48999999999999999999996 89999999999999999 79999999999987
Q ss_pred cCCCC-CcccccccccCCcccccccccc
Q 004020 746 APDNG-KHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 746 ~~~~~-~~~~~~~~~gt~~y~APE~l~~ 772 (779)
..... .........||+.|||||++..
T Consensus 168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~ 195 (313)
T KOG0198|consen 168 LESKGTKSDSELSVQGTPNYMAPEVIRN 195 (313)
T ss_pred cccccccccccccccCCccccCchhhcC
Confidence 65311 1122345689999999999984
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-30 Score=239.79 Aligned_cols=177 Identities=32% Similarity=0.515 Sum_probs=153.8
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccC-hhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
.++|++++.||+|-||.||.|+.+ ++..||+|++.+.... ....+++.+|+++-+.++||||+++|++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 468999999999999999999765 6788999999765432 23446799999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
+||.++|++...+...+. ..+++.....++.|+|.|+.|+|. ++||||||||+|+|++..+..||+|||.+...
T Consensus 101 lEya~~gel~k~L~~~~~---~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRM---KRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEecCCchHHHHHHhccc---ccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 999999999999975443 357888899999999999999995 89999999999999999999999999998776
Q ss_pred CCCCCcccccccccCCcccccccccccCC
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
+.+ .....+||.-|.+||+..+...
T Consensus 175 p~~----kR~tlcgt~dyl~pEmv~~~~h 199 (281)
T KOG0580|consen 175 PSN----KRKTLCGTLDYLPPEMVEGRGH 199 (281)
T ss_pred CCC----CceeeecccccCCHhhcCCCCc
Confidence 533 2345689999999999987654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=264.02 Aligned_cols=175 Identities=27% Similarity=0.475 Sum_probs=152.8
Q ss_pred HhhcCCcccceecccccEEEEEEE-EcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
+....|...++||+|+.|.||.|+ ..+++.||||++.... ....+-+.+|+.+|+..+|+|||.+++.|..+++.|+
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~--Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV 347 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK--QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV 347 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc--CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence 345678888999999999999995 4578999999997654 3334568899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
|||||+||+|.|.+... .+++.++..|++++++||+|||. ++|+|||||.+|||++.+|.+||+|||++..
T Consensus 348 VMEym~ggsLTDvVt~~------~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaq 418 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKT------RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQ 418 (550)
T ss_pred EEeecCCCchhhhhhcc------cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeec
Confidence 99999999999998543 48899999999999999999996 8999999999999999999999999999988
Q ss_pred cCCCCCcccccccccCCcccccccccccC
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
+..... .....+|||+|||||+...+.
T Consensus 419 i~~~~~--KR~TmVGTPYWMAPEVvtrk~ 445 (550)
T KOG0578|consen 419 ISEEQS--KRSTMVGTPYWMAPEVVTRKP 445 (550)
T ss_pred cccccC--ccccccCCCCccchhhhhhcc
Confidence 766432 345678999999999987654
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=262.48 Aligned_cols=183 Identities=28% Similarity=0.528 Sum_probs=155.6
Q ss_pred HHHHHhhcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCe
Q 004020 583 QVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (779)
Q Consensus 583 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 662 (779)
++.....+.+.+.+.||+|+||+||+|++. ..||||+++.....++..+.|+.|+.++++-+|.||+-+.||+..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 455556667788899999999999999986 479999999888788889999999999999999999999999998877
Q ss_pred EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecc
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 742 (779)
.||+.+|+|.+|+.+++..+. .++..+.+.|++||++|+.|||+ ++|||||||..||++.++++|||+|||+
T Consensus 463 -AIiTqwCeGsSLY~hlHv~et----kfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQET----KFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred -eeeehhccCchhhhhccchhh----hhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccc
Confidence 899999999999999987653 58899999999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCCCcccccccccCCcccccccccccCC
Q 004020 743 VRLAPDNGKHSIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 743 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
+..-..-..........|...|||||+++.+..
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~ 567 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDD 567 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhccc
Confidence 754321111111222357889999999975543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=248.39 Aligned_cols=181 Identities=29% Similarity=0.461 Sum_probs=156.4
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEe-----CC
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD-----GN 661 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~ 661 (779)
+...|...+.||+|+||.|+.|... +|+.||+|++..........++..+|+++++.++|+||+.+.+.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 4456777899999999999999654 79999999998777667788899999999999999999999999876 24
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeec
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 741 (779)
..|+|+|+| +.+|...++... .++...+..+++|+++||+|+|+ .+|+|||+||+|++++.+..+||+|||
T Consensus 100 DvYiV~elM-etDL~~iik~~~-----~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQ-----DLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCc-----cccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEecccc
Confidence 689999999 568988885442 48889999999999999999997 899999999999999999999999999
Q ss_pred cceecCCCCCcccccccccCCcccccccccccCCCC
Q 004020 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 742 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
+||...........+..+.|.+|+|||++.....||
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt 206 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYT 206 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhcccccc
Confidence 999886543333457788999999999998777765
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=264.05 Aligned_cols=177 Identities=30% Similarity=0.460 Sum_probs=153.4
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccc-cChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCCeEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERL 664 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 664 (779)
..++|...++||+|+||+|++|..+ +++.+|||.+++.. ..+++.+..+.|.+++.... ||.++.++..|+..++.|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3468999999999999999999876 68899999998764 45667788899999988885 999999999999999999
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
.||||+.||++..+.+. ..+++..+..|+..|+.||+|||+ ++|||||||.+|||+|.+|++||+|||+++
T Consensus 446 fvmey~~Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEecCCCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEeccccccc
Confidence 99999999995444322 258999999999999999999995 999999999999999999999999999998
Q ss_pred ecCCCCCcccccccccCCcccccccccccCC
Q 004020 745 LAPDNGKHSIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
.....+. .+..++|||.|||||++.+..+
T Consensus 517 e~m~~g~--~TsTfCGTpey~aPEil~e~~Y 545 (694)
T KOG0694|consen 517 EGMGQGD--RTSTFCGTPEFLAPEVLTEQSY 545 (694)
T ss_pred ccCCCCC--ccccccCChhhcChhhhccCcc
Confidence 7553332 4467899999999999987754
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=257.88 Aligned_cols=172 Identities=34% Similarity=0.540 Sum_probs=146.8
Q ss_pred CcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecC
Q 004020 592 FSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMP 671 (779)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 671 (779)
+...+.||+|-||.||.|+++....||+|.++.... ..++|.+|+++|++++|++||+++++|..++..|||||||+
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m---~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM---SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecccc---ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 345688999999999999999888999999987643 33578899999999999999999999999889999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCC
Q 004020 672 QGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK 751 (779)
Q Consensus 672 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 751 (779)
.|+|.+++.... ...+...+.+.++.|||+|++||++ +++|||||.++||||+++..+||+|||+||...++ .
T Consensus 285 ~GsLl~yLr~~~---~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~ 357 (468)
T KOG0197|consen 285 KGSLLDYLRTRE---GGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD-E 357 (468)
T ss_pred cCcHHHHhhhcC---CCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCC-c
Confidence 999999997632 2367889999999999999999996 89999999999999999999999999999955443 3
Q ss_pred cccccccccCCccccccccccc
Q 004020 752 HSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 752 ~~~~~~~~gt~~y~APE~l~~~ 773 (779)
........-...|.|||.+...
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~ 379 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYG 379 (468)
T ss_pred eeecCCCCCCceecCHHHHhhC
Confidence 3333333346789999998643
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=261.47 Aligned_cols=177 Identities=27% Similarity=0.394 Sum_probs=155.3
Q ss_pred hcCCcccceecccccEEEEEEEE-cCCcEEEEEEeccc-ccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESA-VVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
.+-|+.++.||+|+.|.|-.|++ .+|+.+|||++.+. ...+.....+.+|+-+|+.+.||||+++|++|++..+.|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 34688899999999999999975 58999999999876 34455567899999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
.||+++|.|.+++..+. ++++.++.++++||+.|+.|+|. .+|+|||+||+|+|+|..+++||+|||+|...
T Consensus 91 lEyv~gGELFdylv~kG-----~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe 162 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKG-----PLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLE 162 (786)
T ss_pred EEecCCchhHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecc
Confidence 99999999999996553 58889999999999999999996 89999999999999999999999999999865
Q ss_pred CCCCCcccccccccCCcccccccccccCCC
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAETSGM 776 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 776 (779)
.++ ..-...+|+|.|.|||+++|....
T Consensus 163 ~~g---klLeTSCGSPHYA~PEIV~G~pYd 189 (786)
T KOG0588|consen 163 VPG---KLLETSCGSPHYAAPEIVSGRPYD 189 (786)
T ss_pred cCC---ccccccCCCcccCCchhhcCCCCC
Confidence 443 223445899999999999987654
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-30 Score=240.83 Aligned_cols=176 Identities=27% Similarity=0.446 Sum_probs=154.7
Q ss_pred hhcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
+.+.|++.++||+|.|+.||++.. .+|+.+|+|++.....+....+++.+|+++.+.++||||+++++.+.+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 456788999999999999999954 5799999999987777777889999999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC---CCcEEEEeeccc
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVADFGLV 743 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DFG~a 743 (779)
+|+|.|++|..-+-.+. .+++..+-.+++||+++|.|+|. ++|||||+||+|+++.. .--+||+|||+|
T Consensus 89 Fe~m~G~dl~~eIV~R~-----~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVARE-----FYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred EecccchHHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceE
Confidence 99999999988776553 57889999999999999999996 89999999999999953 345999999999
Q ss_pred eecCCCCCcccccccccCCcccccccccccC
Q 004020 744 RLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
..... .......+|||+|||||++....
T Consensus 161 i~l~~---g~~~~G~~GtP~fmaPEvvrkdp 188 (355)
T KOG0033|consen 161 IEVND---GEAWHGFAGTPGYLSPEVLKKDP 188 (355)
T ss_pred EEeCC---ccccccccCCCcccCHHHhhcCC
Confidence 98863 24456788999999999987553
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=268.51 Aligned_cols=182 Identities=30% Similarity=0.535 Sum_probs=153.0
Q ss_pred hcCCcccceecccccEEEEEEEEc------CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCe
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 662 (779)
..+.+..+.||+|+||+||+|+.. +...||||.++... +.+..++|++|++++..++|||||+++|+|..++.
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 345556789999999999999753 35679999998654 44577899999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhHhhhcccCC---------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEEG---------LKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 733 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~~---------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 733 (779)
.+||+|||..|||.++|..+.... ..+++..+.+.||.|||.|++||-+ +.+|||||..+|+||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhceeccce
Confidence 999999999999999997654332 2238889999999999999999996 7899999999999999999
Q ss_pred cEEEEeeccceecCCCCCcccccccccCCcccccccccccC
Q 004020 734 RAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 734 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
.|||+|||++|.......+.......-..+|||||.++...
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k 681 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK 681 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc
Confidence 99999999999776654444433334467999999987543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-31 Score=264.93 Aligned_cols=370 Identities=23% Similarity=0.320 Sum_probs=266.4
Q ss_pred cEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEccc
Q 004020 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145 (779)
Q Consensus 66 ~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 145 (779)
-+++|++.+|++. .+|++++.+..++.|+.++|++...++++..+.+|..|+.+.|.+..++++ +..+-.|+.|+..+
T Consensus 69 ~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~~s~n~~~el~~~-i~~~~~l~dl~~~~ 146 (565)
T KOG0472|consen 69 CLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLSELPEQIGSLISLVKLDCSSNELKELPDS-IGRLLDLEDLDATN 146 (565)
T ss_pred ceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhhccccceeecCch-HHHHhhhhhhhccc
Confidence 4899999999999 899999999999999999999998888999999999999999999999987 66788999999999
Q ss_pred CCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCcccc-CCcceeeccCCCCCC
Q 004020 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDS 224 (779)
Q Consensus 146 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~L~~l~l~~n~~~~ 224 (779)
|++.+ .|+.+..+.+|..+++.+|+++...|+.+ .++.|++||+-.|.++ .+|+.+|. .+|+.|++..|++..
T Consensus 147 N~i~s--lp~~~~~~~~l~~l~~~~n~l~~l~~~~i---~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~ 220 (565)
T KOG0472|consen 147 NQISS--LPEDMVNLSKLSKLDLEGNKLKALPENHI---AMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRF 220 (565)
T ss_pred ccccc--CchHHHHHHHHHHhhccccchhhCCHHHH---HHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhccccc
Confidence 99976 89999999999999999999996666655 4889999999999988 78888876 678899999888765
Q ss_pred CCCCchhhhcCCCCccEEEeecCcccCCCCC-CCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCC
Q 004020 225 KLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKF 303 (779)
Q Consensus 225 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~ 303 (779)
.. .|..|..|++|+++.|++...+.+ ...++++..|||++|++. ..|+.++-+.+|++||+|+|.+++.+++.
T Consensus 221 lP-----ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sL 294 (565)
T KOG0472|consen 221 LP-----EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSL 294 (565)
T ss_pred CC-----CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCccc
Confidence 42 355778888888888888855544 457888888888888887 68888888888888888888888887765
Q ss_pred CCCcccccccCCCCcccCCCCcccCccchhhhhhc------------------------------------ccCCC----
Q 004020 304 NSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIV------------------------------------KSVGY---- 343 (779)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------------------~~~~~---- 343 (779)
.+.....+....|.+..-.......+ ...+..+. +.+.+
T Consensus 295 gnlhL~~L~leGNPlrTiRr~ii~~g-T~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~q 373 (565)
T KOG0472|consen 295 GNLHLKFLALEGNPLRTIRREIISKG-TQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQ 373 (565)
T ss_pred ccceeeehhhcCCchHHHHHHHHccc-HHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccc
Confidence 54422222222221100000000000 00000000 00000
Q ss_pred -chhccccc-------------CCCCCC---------------------CCCCCccccCCCCCeEEEEccCccccccccc
Q 004020 344 -PAVLAESW-------------KGNNPC---------------------NSDWKGVSCDAGGNITVVNLKNLGLSGTISS 388 (779)
Q Consensus 344 -~~~~~~~~-------------~~~~~~---------------------~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~ 388 (779)
...-.+.| ..++-| .-.|.+......++|+.|+|++|-+. .+|.
T Consensus 374 lt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~ 452 (565)
T KOG0472|consen 374 LTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPE 452 (565)
T ss_pred cccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcch
Confidence 00000001 111111 12355556667788888999888887 6888
Q ss_pred cccccccCCeEeccCcccc----------------------ccCCcc-CCCCCCCCceeccCCcccccCCCCCC---cce
Q 004020 389 NFSRLTSLRQLMLSGNELT----------------------GTIPKE-LTTLPSLEMLDVSNNHLFGKVPNFRQ---NVI 442 (779)
Q Consensus 389 ~~~~l~~L~~L~Ls~N~l~----------------------g~iP~~-l~~l~~L~~L~Ls~N~l~g~iP~~~~---~~~ 442 (779)
+++.+..|+.||||+|+|. |.+|.+ +.+|.+|.+|||.+|.+...+|..+. ...
T Consensus 453 e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~h 532 (565)
T KOG0472|consen 453 EMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRH 532 (565)
T ss_pred hhhhhhhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeE
Confidence 8888888999999988875 345444 77788888888888888766665433 335
Q ss_pred eeeCCCCCC
Q 004020 443 VKTDGNPDI 451 (779)
Q Consensus 443 ~~~~~n~~~ 451 (779)
+.+.|||+.
T Consensus 533 LeL~gNpfr 541 (565)
T KOG0472|consen 533 LELDGNPFR 541 (565)
T ss_pred EEecCCccC
Confidence 666777654
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-29 Score=258.62 Aligned_cols=174 Identities=30% Similarity=0.459 Sum_probs=148.7
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccc-cChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
.|...+.||.|+||.||-|+.. +.+.||||++.-.. .+....+++.+|++.|.+++|||++.+.|+|......|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4666788999999999999754 67889999997543 234567889999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
||- |+-.|++.-.+ +++.+..+..|..+.+.||+|||+ .+.||||||..|||+.+.|.|||+|||.|....+
T Consensus 107 YCl-GSAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP 178 (948)
T ss_pred HHh-ccHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCc
Confidence 995 57778775554 368888999999999999999997 7899999999999999999999999999877644
Q ss_pred CCCcccccccccCCcccccccccccCCCCC
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAETSGMTW 778 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~~~~t~ 778 (779)
. ..++|||+|||||++......-|
T Consensus 179 A------nsFvGTPywMAPEVILAMDEGqY 202 (948)
T KOG0577|consen 179 A------NSFVGTPYWMAPEVILAMDEGQY 202 (948)
T ss_pred h------hcccCCccccchhHheecccccc
Confidence 2 56799999999999865544433
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=256.80 Aligned_cols=177 Identities=26% Similarity=0.418 Sum_probs=158.8
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCe-EEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE-RLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~ 667 (779)
++|...+.+|+|+||.++.++++ ++..||+|++...............|+.++++++|||||.+.+.|..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57899999999999999999765 67899999998887777777789999999999999999999999999988 89999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
+||+||++.+.+.+.+. ..+++.++..++.||+.|+.|||+ .+|+|||||+.||+++.++.|||.|||+|+.+.
T Consensus 84 ~Y~eGg~l~~~i~~~k~---~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKG---VLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eecCCCCHHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 99999999999977662 368999999999999999999995 899999999999999999999999999999887
Q ss_pred CCCCcccccccccCCcccccccccccC
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
... .....++||+.||+||++.+..
T Consensus 158 ~~~--~~a~tvvGTp~YmcPEil~d~p 182 (426)
T KOG0589|consen 158 PED--SLASTVVGTPYYMCPEILSDIP 182 (426)
T ss_pred Cch--hhhheecCCCcccCHHHhCCCC
Confidence 643 2345678999999999987654
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=257.98 Aligned_cols=180 Identities=26% Similarity=0.340 Sum_probs=151.1
Q ss_pred HHHHhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC
Q 004020 584 VLRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN 661 (779)
Q Consensus 584 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 661 (779)
.+....++|++.+.||+|+||.||+|+.. +++.||+|.+.+... .....+.+.+|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34445678999999999999999999875 588999999865322 2233456889999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeec
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 741 (779)
..|+||||+++|+|.+++... .+++..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG 187 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFG 187 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecc
Confidence 999999999999999988532 36788899999999999999996 899999999999999999999999999
Q ss_pred cceecCCCCCcccccccccCCccccccccccc
Q 004020 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 742 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+|+....... .......||+.|||||++.+.
T Consensus 188 ~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~ 218 (370)
T cd05621 188 TCMKMDETGM-VRCDTAVGTPDYISPEVLKSQ 218 (370)
T ss_pred cceecccCCc-eecccCCCCcccCCHHHHhcc
Confidence 9987643322 122345799999999998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=231.44 Aligned_cols=179 Identities=31% Similarity=0.474 Sum_probs=152.3
Q ss_pred HHHHhhcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccC------hhHHHHHHHHHHHHHcC-CCCccceEee
Q 004020 584 VLRNVTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVS------EKGFAEFKSEIAVLTKV-RHRHLVGLLG 655 (779)
Q Consensus 584 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l-~h~niv~~~~ 655 (779)
.-....+.|...+.+|+|..+.|-++.. .+|.++|+|++...... ..-.++-.+|+.+|+++ .||+|+++.+
T Consensus 11 aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D 90 (411)
T KOG0599|consen 11 AAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD 90 (411)
T ss_pred hHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence 3445667888899999999999999855 47899999998643211 12235578899999998 5999999999
Q ss_pred EEEeCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcE
Q 004020 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 735 (779)
Q Consensus 656 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 735 (779)
+|+.+...++|+|.|+.|.|.|++...- .+++....+|++|+.+|++|||. +.||||||||+|||+|++.++
T Consensus 91 ~yes~sF~FlVFdl~prGELFDyLts~V-----tlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i 162 (411)
T KOG0599|consen 91 VYESDAFVFLVFDLMPRGELFDYLTSKV-----TLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNI 162 (411)
T ss_pred eccCcchhhhhhhhcccchHHHHhhhhe-----eecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccce
Confidence 9999999999999999999999995543 68999999999999999999996 899999999999999999999
Q ss_pred EEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 736 KVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 736 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
||+|||+|+.+..... -...+|||+|.|||.+.-.
T Consensus 163 ~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~ 197 (411)
T KOG0599|consen 163 KISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCS 197 (411)
T ss_pred EEeccceeeccCCchh---HHHhcCCCcccChhheeee
Confidence 9999999998876532 3567899999999998544
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=256.85 Aligned_cols=176 Identities=26% Similarity=0.418 Sum_probs=147.6
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
++|++.+.||+|+||.||+|+.. +++.||+|++..... .......+.+|+.++.+++||||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999765 688999999975432 2234467889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMKKD-----TLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 9999999999986432 57899999999999999999996 899999999999999999999999999987543
Q ss_pred CCCCc---------------------------------ccccccccCCccccccccccc
Q 004020 748 DNGKH---------------------------------SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~---------------------------------~~~~~~~gt~~y~APE~l~~~ 773 (779)
..... ......+||+.|+|||++.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~ 211 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT 211 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC
Confidence 21100 001235799999999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=257.13 Aligned_cols=148 Identities=28% Similarity=0.414 Sum_probs=131.0
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47889999999999999999764 789999999865432 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 81 E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~ 150 (377)
T cd05629 81 EFLPGGDLMTMLIKYD-----TFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTG 150 (377)
T ss_pred eCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccc
Confidence 9999999999885432 57888899999999999999996 8999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-30 Score=266.71 Aligned_cols=223 Identities=30% Similarity=0.428 Sum_probs=193.9
Q ss_pred CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCC--CCCcccccCCCCccEEE
Q 004020 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFT--SVPSDFFKGLTSLQTIS 142 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~--~~~~~~~~~l~~L~~L~ 142 (779)
.+++-|.|...++. .+|++++.|.+|++|.+++|+|..+-..++.|+.|+.+++.+|+|. +||++.| .|..|++||
T Consensus 32 t~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF-~l~dLt~lD 109 (1255)
T KOG0444|consen 32 TQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLISVHGELSDLPRLRSVIVRDNNLKNSGIPTDIF-RLKDLTILD 109 (1255)
T ss_pred hheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHhhhhhhccchhhHHHhhhccccccCCCCchhc-ccccceeee
Confidence 47999999999998 8999999999999999999999988889999999999999999998 6888866 699999999
Q ss_pred cccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCcccc-CCcceeeccCCC
Q 004020 143 LDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQK 221 (779)
Q Consensus 143 Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~L~~l~l~~n~ 221 (779)
||+|++.. .|..+..-+++-.|+|++|+|. +||..++ .++..|-.||||+|+|. .+|..+.. ..|++|.|++|.
T Consensus 110 LShNqL~E--vP~~LE~AKn~iVLNLS~N~Ie-tIPn~lf-inLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NP 184 (1255)
T KOG0444|consen 110 LSHNQLRE--VPTNLEYAKNSIVLNLSYNNIE-TIPNSLF-INLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNP 184 (1255)
T ss_pred cchhhhhh--cchhhhhhcCcEEEEcccCccc-cCCchHH-HhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCCh
Confidence 99999986 8999999999999999999998 7787665 37899999999999999 56666655 789999999997
Q ss_pred CCCCCCCchhhhcCCCCccEEEeecCcccC--CCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccc
Q 004020 222 GDSKLNGSVAVIQNMTSLTQLWLHGNSFTG--PLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQG 298 (779)
Q Consensus 222 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g 298 (779)
+... -+.++-.+++|++|.+++.+-+- .++.+..+.+|..+||+.|.+. .+|+.+.++++|+.|+||+|+|+-
T Consensus 185 L~hf---QLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~ite 259 (1255)
T KOG0444|consen 185 LNHF---QLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITE 259 (1255)
T ss_pred hhHH---HHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceee
Confidence 6543 12334467788899999887653 4557899999999999999998 899999999999999999999874
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=249.37 Aligned_cols=178 Identities=27% Similarity=0.452 Sum_probs=154.9
Q ss_pred HhhcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
-......+.++||+|-||.|..|....+..||||+++... ......+|.+|+++|.+++||||++++++|..++.+++|
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 3445677889999999999999999888999999998764 344568899999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
+|||++|+|.+++.....+. .+-....+|+.||+.|++||.+ .++||||+.+.|+|+|.++++||+|||++|.+
T Consensus 614 ~EYmEnGDLnqFl~aheapt---~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPT---AETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred HHHHhcCcHHHHHHhccCcc---cccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCccccccc
Confidence 99999999999997664322 3455667899999999999997 78999999999999999999999999999977
Q ss_pred CCCCCcccccccccCCccccccccc
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAA 771 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~ 771 (779)
.....+......+-..+|||||.+.
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsil 712 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESIL 712 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHH
Confidence 7665666666667788999999874
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=249.61 Aligned_cols=180 Identities=24% Similarity=0.359 Sum_probs=159.5
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
....|.+.+.||+|.|+.|..|++. ++..||+|.+.+........+.+.+|+++|+.++|||||+++.+.......|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3467899999999999999999765 799999999998887777777799999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+.+|.+.+++.... .+.+..+..++.|+++|++|||+ +.|||||||++|||++.++++||+|||++..+
T Consensus 134 ~eya~~ge~~~yl~~~g-----r~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG-----RMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred EEeccCchhHHHHHhcc-----cchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceee
Confidence 99999999999997654 34557888999999999999996 89999999999999999999999999999888
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCC
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAETSGMTW 778 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t~ 778 (779)
... ......+|++.|.|||+++|......
T Consensus 206 ~~~---~~lqt~cgsppyAaPEl~~g~~y~gp 234 (596)
T KOG0586|consen 206 DYG---LMLQTFCGSPPYAAPELFNGKKYDGP 234 (596)
T ss_pred ccc---ccccccCCCCCccChHhhcCcccCCc
Confidence 643 23355689999999999999875543
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-27 Score=251.46 Aligned_cols=171 Identities=29% Similarity=0.434 Sum_probs=148.3
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccC-hhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
++|++.+.||+|+||.||+|+.. +++.||+|++...... ......+.+|++++..++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47899999999999999999876 5889999999765322 234467889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 81 EYVPGGDFRTLLNNLG-----VLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred eCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 9999999999985432 57888999999999999999996 899999999999999999999999999987654
Q ss_pred CCCCcccccccccCCccccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
. ......||+.|+|||++.+.
T Consensus 153 ~-----~~~~~~gt~~y~aPE~~~~~ 173 (333)
T cd05600 153 T-----YANSVVGSPDYMAPEVLRGK 173 (333)
T ss_pred c-----ccCCcccCccccChhHhcCC
Confidence 3 12345799999999998765
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-29 Score=239.48 Aligned_cols=171 Identities=30% Similarity=0.478 Sum_probs=149.9
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
-|.+.++||+|+||.||+|.++ +|+.+|+|.+... .+.+++.+|+.++++++.|++|++||.|......|+||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 4667889999999999999654 7999999998643 4678899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
|..|++.+.++.++ +++.+.++..+.+..+.||+|||. ..-||||||..|||++.+|.+||+|||.|-.+.+.
T Consensus 110 CGAGSiSDI~R~R~----K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT 182 (502)
T KOG0574|consen 110 CGAGSISDIMRARR----KPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT 182 (502)
T ss_pred cCCCcHHHHHHHhc----CCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence 99999999997665 479999999999999999999995 67899999999999999999999999999776543
Q ss_pred CCcccccccccCCcccccccccccC
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
. .....+.|||.|||||++++-.
T Consensus 183 M--AKRNTVIGTPFWMAPEVI~EIG 205 (502)
T KOG0574|consen 183 M--AKRNTVIGTPFWMAPEVIEEIG 205 (502)
T ss_pred H--HhhCccccCcccccHHHHHHhc
Confidence 2 2235578999999999987543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-27 Score=251.61 Aligned_cols=173 Identities=29% Similarity=0.450 Sum_probs=149.0
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 357899999999999999999875 688999999875432 223456789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++++|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++..
T Consensus 97 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 168 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV 168 (329)
T ss_pred EcCCCCChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence 99999999999886432 47888899999999999999996 89999999999999999999999999999876
Q ss_pred CCCCCcccccccccCCcccccccccccC
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
.... ....||+.|+|||++.+..
T Consensus 169 ~~~~-----~~~~gt~~y~aPE~~~~~~ 191 (329)
T PTZ00263 169 PDRT-----FTLCGTPEYLAPEVIQSKG 191 (329)
T ss_pred CCCc-----ceecCChhhcCHHHHcCCC
Confidence 4321 2346999999999987653
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=242.78 Aligned_cols=170 Identities=29% Similarity=0.494 Sum_probs=147.6
Q ss_pred cceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCCC
Q 004020 595 ENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQG 673 (779)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 673 (779)
.++||+|-||+||-|.++ +|+.||||++.+.....+....++.|+.+|+.++||.||.+.-.|+..+..|+|||-+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 489999999999999764 79999999999887777777889999999999999999999999999999999999995 5
Q ss_pred ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCC---CcEEEEeeccceecCCCC
Q 004020 674 TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD---MRAKVADFGLVRLAPDNG 750 (779)
Q Consensus 674 sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~---~~~kl~DFG~a~~~~~~~ 750 (779)
+..+++...... ++++..-..+..||+.||.|||. ++|+|+||||+|||+... -++||||||+||.+.+.
T Consensus 648 DMLEMILSsEkg---RL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk- 720 (888)
T KOG4236|consen 648 DMLEMILSSEKG---RLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK- 720 (888)
T ss_pred hHHHHHHHhhcc---cchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchh-
Confidence 776766554432 57888778889999999999995 899999999999999643 57999999999998653
Q ss_pred CcccccccccCCcccccccccccC
Q 004020 751 KHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 751 ~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
+....++|||.|.|||+++.+.
T Consensus 721 --sFRrsVVGTPAYLaPEVLrnkG 742 (888)
T KOG4236|consen 721 --SFRRSVVGTPAYLAPEVLRNKG 742 (888)
T ss_pred --hhhhhhcCCccccCHHHHhhcc
Confidence 4556789999999999998764
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-27 Score=247.20 Aligned_cols=181 Identities=28% Similarity=0.490 Sum_probs=147.6
Q ss_pred hcCCcccceecccccEEEEEEEEcC-----------------CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccc
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHD-----------------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 651 (779)
.++|.+.+.||+|+||.||+|++++ +..||+|.+.... ......++.+|++++.+++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 3578899999999999999997532 3469999987543 344556799999999999999999
Q ss_pred eEeeEEEeCCeEEEEEEecCCCChhhHhhhcccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCc
Q 004020 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE--------------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSF 717 (779)
Q Consensus 652 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~i 717 (779)
++++++.+.+..++||||+++++|.+++...... ....+++..++.++.||+.||+|||+ .+|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i 159 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNF 159 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCc
Confidence 9999999999999999999999999988653211 11246788899999999999999996 899
Q ss_pred EEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 718 IHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 718 vHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+||||||+||++++++.+||+|||+++...............++..|+|||++.+.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 215 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG 215 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC
Confidence 99999999999999999999999999866443222222334568899999987653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-27 Score=253.00 Aligned_cols=181 Identities=29% Similarity=0.465 Sum_probs=145.0
Q ss_pred hcCCcccceecccccEEEEEEEE------cCCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCC
Q 004020 589 TNNFSEENVLGRGGFGTVYKGEL------HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGN 661 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 661 (779)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... .......+.+|+.++.++ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 46799999999999999999964 235689999987543 234456789999999999 8999999999887654
Q ss_pred -eEEEEEEecCCCChhhHhhhcccC-------------------------------------------------------
Q 004020 662 -ERLLVYEYMPQGTLSRHLFNRKEE------------------------------------------------------- 685 (779)
Q Consensus 662 -~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 685 (779)
..++||||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 578999999999999998653210
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCcccccccccCCc
Q 004020 686 --GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFG 763 (779)
Q Consensus 686 --~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~ 763 (779)
...++++..+..++.||++||+|||+ ++|+||||||+||++++++.+||+|||+++...............+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 01347788899999999999999996 8999999999999999999999999999986543222222223346788
Q ss_pred cccccccccc
Q 004020 764 YLAPEYAAET 773 (779)
Q Consensus 764 y~APE~l~~~ 773 (779)
|+|||++.+.
T Consensus 242 y~aPE~~~~~ 251 (338)
T cd05102 242 WMAPESIFDK 251 (338)
T ss_pred ccCcHHhhcC
Confidence 9999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-27 Score=255.08 Aligned_cols=149 Identities=26% Similarity=0.446 Sum_probs=132.3
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
++|++.+.||+|+||.||+|+.. +++.||||++..... .......+.+|+++++.++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999875 689999999975432 2234456889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+
T Consensus 81 E~~~~g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 151 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-----TFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151 (364)
T ss_pred CCCCCcHHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceec
Confidence 9999999999986432 47899999999999999999996 89999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-28 Score=248.67 Aligned_cols=176 Identities=28% Similarity=0.464 Sum_probs=151.3
Q ss_pred cCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
..|...+.||+|+||.||+|.. .+++.||+|++.... .+...+++++|+.++..++++||.++|+.|..+...|++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 4577789999999999999965 478999999998654 34556789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
||.||++.+.+.... .+++..+..|+++++.|+.|||+ ++.+|||||+.||++..+|.+|++|||.+.....
T Consensus 92 y~~gGsv~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGN-----ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred HhcCcchhhhhccCC-----CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeec
Confidence 999999999884432 34777788899999999999996 8899999999999999999999999999987765
Q ss_pred CCCcccccccccCCcccccccccccCCCC
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
.. .....++|||.|||||++.+ .+|+
T Consensus 164 ~~--~rr~tfvGTPfwMAPEVI~~-~~Y~ 189 (467)
T KOG0201|consen 164 TV--KRRKTFVGTPFWMAPEVIKQ-SGYD 189 (467)
T ss_pred hh--hccccccccccccchhhhcc-cccc
Confidence 42 22366899999999999994 4444
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-27 Score=251.25 Aligned_cols=172 Identities=29% Similarity=0.404 Sum_probs=147.3
Q ss_pred hcCCcccceecccccEEEEEEEEcC--CcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHD--GTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
.++|++.+.||+|+||.||+|.... +..||+|++..... .....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3579999999999999999997543 36899999865432 23345678899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 109 v~Ey~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 999999999999986432 57889999999999999999996 8999999999999999999999999999987
Q ss_pred cCCCCCcccccccccCCccccccccccc
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.... .....||+.|||||++.+.
T Consensus 181 ~~~~-----~~~~~gt~~y~aPE~~~~~ 203 (340)
T PTZ00426 181 VDTR-----TYTLCGTPEYIAPEILLNV 203 (340)
T ss_pred cCCC-----cceecCChhhcCHHHHhCC
Confidence 6432 1335799999999998654
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-27 Score=248.21 Aligned_cols=172 Identities=30% Similarity=0.401 Sum_probs=147.7
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47889999999999999999765 689999999865432 2234466889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++++|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+||++++++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 81 EYVPGGELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred eCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 9999999999986532 47888999999999999999996 899999999999999999999999999988654
Q ss_pred CCCCcccccccccCCcccccccccccC
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
.. .....||+.|+|||++.+..
T Consensus 153 ~~-----~~~~~gt~~y~aPE~~~~~~ 174 (291)
T cd05612 153 DR-----TWTLCGTPEYLAPEVIQSKG 174 (291)
T ss_pred CC-----cccccCChhhcCHHHHcCCC
Confidence 32 12346899999999987653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.6e-27 Score=253.55 Aligned_cols=182 Identities=27% Similarity=0.353 Sum_probs=152.3
Q ss_pred HHHHHHhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccc-cChhHHHHHHHHHHHHHcCCCCccceEeeEEEe
Q 004020 582 IQVLRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD 659 (779)
Q Consensus 582 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 659 (779)
+.+.....++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3444555689999999999999999999876 68899999986532 222334567899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEe
Q 004020 660 GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 739 (779)
Q Consensus 660 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 739 (779)
++..++||||+++|+|.+++... .+++..+..++.||+.||+|||+ ++|+||||||+||+++.++++||+|
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~D 185 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD 185 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEe
Confidence 99999999999999999988532 36788889999999999999996 8999999999999999999999999
Q ss_pred eccceecCCCCCcccccccccCCccccccccccc
Q 004020 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 740 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
||+++....... .......||+.|||||++.+.
T Consensus 186 fG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~ 218 (371)
T cd05622 186 FGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQ 218 (371)
T ss_pred CCceeEcCcCCc-ccccCcccCccccCHHHHhcc
Confidence 999987654322 122345799999999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-27 Score=255.06 Aligned_cols=147 Identities=27% Similarity=0.379 Sum_probs=130.5
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
.|+..+.||+|+||.||+|+.. +++.||+|++..... .......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999764 688999999976432 23445678999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
|+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+++.
T Consensus 82 ~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~ 150 (381)
T cd05626 82 YIPGGDMMSLLIRME-----VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTG 150 (381)
T ss_pred cCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence 999999999985432 47888899999999999999996 8999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-28 Score=235.34 Aligned_cols=187 Identities=28% Similarity=0.389 Sum_probs=153.8
Q ss_pred HhhcCCcccceecccccEEEEEEEEc---C--CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEe-C
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGELH---D--GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD-G 660 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~ 660 (779)
.....|+..+.||+|.||.||+|.-. + ...+|+|+++...-...-....-+|+.+++.++|||++.+..++.. +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 34567899999999999999999432 2 3378999998653212222456789999999999999999999887 7
Q ss_pred CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCC----CcEE
Q 004020 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD----MRAK 736 (779)
Q Consensus 661 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~----~~~k 736 (779)
...++++||.+. +|.++++-.+....+.++...+..|+.||+.|+.|||+ +=|+||||||.|||+..+ |.||
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeE
Confidence 789999999986 89888877665555678999999999999999999996 778999999999999877 8999
Q ss_pred EEeeccceecCCCCCcc-cccccccCCcccccccccccCCCC
Q 004020 737 VADFGLVRLAPDNGKHS-IETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 737 l~DFG~a~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
|+|||+||.+...-... ....++-|.+|+|||++.|..-||
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT 218 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYT 218 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhccccccc
Confidence 99999999886543322 234567899999999999988776
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-27 Score=236.66 Aligned_cols=149 Identities=30% Similarity=0.389 Sum_probs=133.2
Q ss_pred cCCcccceecccccEEEEEEEEcC-CcEEEEEEecccccC-hhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
++|+..+.||+|.-|.||+|+.++ +..+|+|++.+.... .+...+.+.|.+||+.++||.++.+|+.|+.++..|+||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 356778899999999999998874 588999999876543 556678899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
|||+||+|....+++.. +.+++..+..++.+|+-||+|||- .|||.|||||+||||.++|++.|+||.++.
T Consensus 157 eyCpGGdL~~LrqkQp~---~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPG---KRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSL 227 (459)
T ss_pred ecCCCccHHHHHhhCCC---CccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccc
Confidence 99999999888765443 468999999999999999999995 899999999999999999999999999864
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=248.20 Aligned_cols=168 Identities=29% Similarity=0.419 Sum_probs=142.4
Q ss_pred ceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCCC
Q 004020 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQG 673 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 673 (779)
+.||+|+||.||+|+.. +++.||+|+++.... .......+.+|++++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999764 689999999976432 2334567889999999999999999999999999999999999999
Q ss_pred ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCcc
Q 004020 674 TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753 (779)
Q Consensus 674 sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 753 (779)
+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-- 150 (323)
T cd05571 81 ELFFHLSRER-----VFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-- 150 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--
Confidence 9998885432 57899999999999999999996 8999999999999999999999999999875432211
Q ss_pred cccccccCCccccccccccc
Q 004020 754 IETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 754 ~~~~~~gt~~y~APE~l~~~ 773 (779)
.....+||+.|+|||++.+.
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~ 170 (323)
T cd05571 151 TMKTFCGTPEYLAPEVLEDN 170 (323)
T ss_pred cccceecCccccChhhhcCC
Confidence 12345799999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=248.87 Aligned_cols=176 Identities=28% Similarity=0.400 Sum_probs=147.0
Q ss_pred CCcccceecccccEEEEEEEE----cCCcEEEEEEeccccc--ChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCCeE
Q 004020 591 NFSEENVLGRGGFGTVYKGEL----HDGTKIAVKRMESAVV--SEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNER 663 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 663 (779)
+|++.+.||+|+||.||+|+. .+++.||+|++.+... .....+.+.+|+.++..++ ||+|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488899999999999999975 3588999999875432 1233456889999999995 99999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccc
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 743 (779)
++||||+++|+|.+++..+. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD-----NFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 99999999999999886532 47889999999999999999996 89999999999999999999999999998
Q ss_pred eecCCCCCcccccccccCCcccccccccccCC
Q 004020 744 RLAPDNGKHSIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
+........ ......||+.|+|||++.+...
T Consensus 153 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~ 183 (332)
T cd05614 153 KEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGG 183 (332)
T ss_pred ccccccCCC-ccccccCCccccCHHHhcCCCC
Confidence 865432221 2234579999999999876543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=247.44 Aligned_cols=175 Identities=26% Similarity=0.367 Sum_probs=147.8
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccc-cChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
++|++.+.||+|+||.||+++.. +++.||+|++.+.. ......+.+.+|+.++..++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999865 68899999987532 22334466889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++|+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153 (331)
T ss_pred ecCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence 9999999999985432 247888999999999999999996 899999999999999999999999999987664
Q ss_pred CCCCcccccccccCCcccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
..... ......||+.|+|||++.+
T Consensus 154 ~~~~~-~~~~~~gt~~y~aPE~~~~ 177 (331)
T cd05597 154 ADGTV-QSNVAVGTPDYISPEILQA 177 (331)
T ss_pred CCCCc-cccceeccccccCHHHHhh
Confidence 43221 1223469999999999864
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=253.84 Aligned_cols=147 Identities=28% Similarity=0.383 Sum_probs=129.9
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
+|++.+.||+|+||.||+|+.. +++.||+|++..... .......+.+|++++++++||||+++++.+.+++..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5889999999999999999764 688999999875432 23345678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
|+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~ 150 (382)
T cd05625 82 YIPGGDMMSLLIRMG-----IFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (382)
T ss_pred CCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence 999999999885432 47888899999999999999996 8999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=253.65 Aligned_cols=147 Identities=28% Similarity=0.397 Sum_probs=129.8
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.+|++.+.||+|+||.||+|+.. +++.||+|++..... .......+.+|++++++++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999765 689999999865432 2233466889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+|.
T Consensus 81 E~~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~ 149 (376)
T cd05598 81 DYIPGGDMMSLLIRLG-----IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (376)
T ss_pred eCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence 9999999999985432 47888889999999999999996 899999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=247.21 Aligned_cols=175 Identities=25% Similarity=0.331 Sum_probs=147.8
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccc-cChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
++|++.+.||+|+||.||+++.. +++.||+|.+.... ........+.+|..++..++|++|+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999865 67889999987532 22233456888999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 81 Ey~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN 153 (331)
T ss_pred eCCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999986532 257888999999999999999996 899999999999999999999999999998765
Q ss_pred CCCCcccccccccCCcccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
..... ......||+.|+|||++.+
T Consensus 154 ~~~~~-~~~~~~gt~~y~aPE~~~~ 177 (331)
T cd05624 154 QDGTV-QSSVAVGTPDYISPEILQA 177 (331)
T ss_pred CCCce-eeccccCCcccCCHHHHhc
Confidence 43221 1223469999999999865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=241.43 Aligned_cols=174 Identities=32% Similarity=0.481 Sum_probs=146.5
Q ss_pred CCcccceecccccEEEEEEEE-cCCcEEEEEEecccccCh-hHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 591 NFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSE-KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
.|+..+.||+|+||.||+|.. .+++.||+|.+....... .....+.+|++++++++|++|+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377789999999999999976 478999999987543222 233467899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++|+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 81 ~~~~g~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 81 IMNGGDLKFHIYNMGN---PGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred ecCCCcHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 9999999888754322 257899999999999999999996 8999999999999999999999999999987643
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. ......||+.|+|||++.+.
T Consensus 155 ~~---~~~~~~g~~~y~aPE~~~~~ 176 (285)
T cd05631 155 GE---TVRGRVGTVGYMAPEVINNE 176 (285)
T ss_pred CC---eecCCCCCCCccCHhhhcCC
Confidence 21 12345699999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=246.84 Aligned_cols=174 Identities=28% Similarity=0.462 Sum_probs=151.9
Q ss_pred HhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccC-hhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCCeE
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNER 663 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 663 (779)
.....|++.+.||+|.||.||+|+.+ +|+.+|+|.+.+.... ......+.+|+.+|+++. |||||.+++.|++....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 35567899999999999999999876 5999999999776533 234578999999999998 99999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC----CCcEEEEe
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD----DMRAKVAD 739 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~----~~~~kl~D 739 (779)
++|||++.||.|.+.+... .+++..+..++.|++.+++|||+ .||+|||+||+|+|+.. ++.+|++|
T Consensus 112 ~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred EEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEee
Confidence 9999999999999998665 28899999999999999999996 89999999999999963 35799999
Q ss_pred eccceecCCCCCcccccccccCCcccccccccc
Q 004020 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 740 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
||+|...... ......+||+.|+|||++.+
T Consensus 183 FGla~~~~~~---~~~~~~~Gtp~y~APEvl~~ 212 (382)
T KOG0032|consen 183 FGLAKFIKPG---ERLHTIVGTPEYVAPEVLGG 212 (382)
T ss_pred CCCceEccCC---ceEeeecCCccccCchhhcC
Confidence 9999987652 23356789999999999985
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=248.00 Aligned_cols=175 Identities=26% Similarity=0.367 Sum_probs=149.5
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
++|++.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47899999999999999999765 689999999976543 2334566889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++|+|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 81 EYQPGGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLT 153 (330)
T ss_pred CCCCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECC
Confidence 9999999999986542 258899999999999999999996 899999999999999999999999999998765
Q ss_pred CCCCcccccccccCCcccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
..... ......||+.|+|||++..
T Consensus 154 ~~~~~-~~~~~~gt~~y~aPE~~~~ 177 (330)
T cd05601 154 ANKMV-NSKLPVGTPDYIAPEVLTT 177 (330)
T ss_pred CCCce-eeecccCCccccCHHHhcc
Confidence 43222 2233468999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=252.55 Aligned_cols=176 Identities=27% Similarity=0.359 Sum_probs=148.4
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
..++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+++..|+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4568999999999999999999765 688999999865432 22334557899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||||+++|+|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 121 v~Ey~~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 99999999999988542 36778888999999999999996 8999999999999999999999999999987
Q ss_pred cCCCCCcccccccccCCccccccccccc
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
...... .......||+.|+|||++.+.
T Consensus 192 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~ 218 (370)
T cd05596 192 MDANGM-VRCDTAVGTPDYISPEVLKSQ 218 (370)
T ss_pred ccCCCc-ccCCCCCCCcCeECHHHhccC
Confidence 644322 122345799999999998754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=242.75 Aligned_cols=177 Identities=25% Similarity=0.399 Sum_probs=146.2
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
++|++.+.||+|+||.||+|+.. +++.||+|+++.... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 57999999999999999999765 688999999865431 2233567899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++ +|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+||++++++.+||+|||+++....
T Consensus 84 ~~~~-~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 84 YLDS-DLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred CCCc-CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 9975 8888875432 246888999999999999999996 8999999999999999999999999999876543
Q ss_pred CCCcccccccccCCcccccccccccCCCC
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
... ......|++.|+|||++.+...++
T Consensus 156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~ 182 (288)
T cd07871 156 PTK--TYSNEVVTLWYRPPDVLLGSTEYS 182 (288)
T ss_pred CCc--cccCceecccccChHHhcCCcccC
Confidence 211 123346899999999987654433
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=249.62 Aligned_cols=176 Identities=26% Similarity=0.428 Sum_probs=147.2
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
++|+..+.||+|+||.||+|+.. +++.||+|++..... .......+.+|+.++..++||+|+++++.+.+.+..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999765 689999999875432 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 9999999999985432 57889999999999999999996 899999999999999999999999999987543
Q ss_pred CCCCc---------------------------------ccccccccCCccccccccccc
Q 004020 748 DNGKH---------------------------------SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~---------------------------------~~~~~~~gt~~y~APE~l~~~ 773 (779)
..... ......+||+.|+|||++.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~ 211 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT 211 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC
Confidence 21100 001235799999999998654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=245.35 Aligned_cols=168 Identities=29% Similarity=0.430 Sum_probs=141.8
Q ss_pred ceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCCC
Q 004020 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQG 673 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 673 (779)
+.||+|+||.||+|+.. ++..||+|++..... .......+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999764 689999999976532 2334566788999999999999999999999999999999999999
Q ss_pred ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCcc
Q 004020 674 TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753 (779)
Q Consensus 674 sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 753 (779)
+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-- 150 (323)
T cd05595 81 ELFFHLSRER-----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-- 150 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--
Confidence 9988875432 57899999999999999999996 8999999999999999999999999999875432211
Q ss_pred cccccccCCccccccccccc
Q 004020 754 IETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 754 ~~~~~~gt~~y~APE~l~~~ 773 (779)
......||+.|+|||++.+.
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~ 170 (323)
T cd05595 151 TMKTFCGTPEYLAPEVLEDN 170 (323)
T ss_pred ccccccCCcCcCCcccccCC
Confidence 12335699999999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=250.54 Aligned_cols=176 Identities=29% Similarity=0.437 Sum_probs=150.3
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccCh-hHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE-KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
++|++.+.||+|+||.||+|+.. +++.||+|++....... .....+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999875 68999999997654322 34567889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 81 EYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 999999999998654 257889999999999999999996 899999999999999999999999999988654
Q ss_pred CCC---------------------------CcccccccccCCccccccccccc
Q 004020 748 DNG---------------------------KHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~---------------------------~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
... .........||+.|+|||++.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 205 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT 205 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC
Confidence 432 00112345699999999998765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=245.19 Aligned_cols=168 Identities=29% Similarity=0.427 Sum_probs=142.2
Q ss_pred ceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCCC
Q 004020 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQG 673 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 673 (779)
+.||+|+||.||+|+.. +++.||+|++..... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999765 689999999976532 2334567889999999999999999999999999999999999999
Q ss_pred ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCcc
Q 004020 674 TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753 (779)
Q Consensus 674 sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 753 (779)
+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~ 150 (328)
T cd05593 81 ELFFHLSRER-----VFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--A 150 (328)
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--c
Confidence 9988875432 57899999999999999999996 899999999999999999999999999987543221 1
Q ss_pred cccccccCCccccccccccc
Q 004020 754 IETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 754 ~~~~~~gt~~y~APE~l~~~ 773 (779)
......||+.|+|||++.+.
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~ 170 (328)
T cd05593 151 TMKTFCGTPEYLAPEVLEDN 170 (328)
T ss_pred ccccccCCcCccChhhhcCC
Confidence 12345799999999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=239.35 Aligned_cols=181 Identities=30% Similarity=0.462 Sum_probs=155.7
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccCh-hHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE-KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
..+.|..-++||+|+||.||-++.+ +|+.||+|++.++.... ........|-.++.++..+.||.+--.|++.+..++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 3466888899999999999999765 79999999997765433 344557899999999999999999989999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||..|.||+|.-+|.+... ..+++..+..++.+|+.||++||. .+||.||+||+|||+|+.|+++|+|.|+|..
T Consensus 263 VLtlMNGGDLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred EEEeecCCceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEe
Confidence 9999999999888855443 468999999999999999999995 8999999999999999999999999999998
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCC
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAAETSGMTW 778 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t~ 778 (779)
+..... ....+||.+|||||+++++. |+|
T Consensus 337 i~~g~~---~~~rvGT~GYMAPEvl~ne~-Y~~ 365 (591)
T KOG0986|consen 337 IPEGKP---IRGRVGTVGYMAPEVLQNEV-YDF 365 (591)
T ss_pred cCCCCc---cccccCcccccCHHHHcCCc-ccC
Confidence 876432 23448999999999998876 554
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=245.04 Aligned_cols=175 Identities=26% Similarity=0.350 Sum_probs=146.8
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
++|++.+.||+|+||.||+++.+ +++.||+|++.+... .......+.+|+.++..++|++|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47899999999999999999876 578899999865322 2233455888999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++|+|.+++.+.. ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 ey~~~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred eccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 9999999999986532 257888999999999999999996 899999999999999999999999999987654
Q ss_pred CCCCcccccccccCCcccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
.... .......||+.|+|||++.+
T Consensus 154 ~~~~-~~~~~~~gt~~y~aPE~~~~ 177 (332)
T cd05623 154 EDGT-VQSSVAVGTPDYISPEILQA 177 (332)
T ss_pred cCCc-ceecccccCccccCHHHHhc
Confidence 3322 12233569999999999863
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-26 Score=243.90 Aligned_cols=169 Identities=29% Similarity=0.430 Sum_probs=141.8
Q ss_pred ceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCCC
Q 004020 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQG 673 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 673 (779)
+.||+|+||.||+|+.. +++.||+|++..... ......++.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999764 789999999976532 2234566788999999999999999999999999999999999999
Q ss_pred ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCcc
Q 004020 674 TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753 (779)
Q Consensus 674 sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 753 (779)
+|.+++.... .+++..+..++.||+.||+|||+ ..+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-- 151 (325)
T cd05594 81 ELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-- 151 (325)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--
Confidence 9988875432 57899999999999999999995 36999999999999999999999999999875433211
Q ss_pred cccccccCCccccccccccc
Q 004020 754 IETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 754 ~~~~~~gt~~y~APE~l~~~ 773 (779)
......||+.|+|||++.+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~ 171 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDN 171 (325)
T ss_pred ccccccCCcccCCHHHHccC
Confidence 12335699999999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=242.48 Aligned_cols=177 Identities=26% Similarity=0.390 Sum_probs=146.2
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 468999999999999999999876 688999999875432 222345778999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||++ +++.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++...
T Consensus 83 e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 83 EYVH-TDLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred ECCC-cCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 9996 57877775432 247888899999999999999996 899999999999999999999999999987653
Q ss_pred CCCCcccccccccCCcccccccccccCCC
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAETSGM 776 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 776 (779)
... .......||+.|+|||++.+...+
T Consensus 155 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~ 181 (303)
T cd07869 155 VPS--HTYSNEVVTLWYRPPDVLLGSTEY 181 (303)
T ss_pred CCC--ccCCCCcccCCCCChHHHcCCCCC
Confidence 321 112335689999999998765443
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-26 Score=256.57 Aligned_cols=177 Identities=24% Similarity=0.320 Sum_probs=147.9
Q ss_pred CCcccceecccccEEEEEEEEc-C-CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-D-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
.|.+.+.||+|+||.||+|... + ++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 4888999999999999999654 4 6788888764332 3344567889999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++|+|.+++...... ..++++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 146 ~~~gg~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKE-HLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred CCCCCCHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 99999999988654322 2357889999999999999999996 8999999999999999999999999999987654
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
..........+||+.|+|||++.+.
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~ 246 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERK 246 (478)
T ss_pred ccccccccccCCCccccCHhHhCCC
Confidence 3222223455799999999998764
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=243.43 Aligned_cols=166 Identities=29% Similarity=0.384 Sum_probs=141.1
Q ss_pred ecccccEEEEEEEEc-CCcEEEEEEecccc-cChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCCCCh
Q 004020 598 LGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTL 675 (779)
Q Consensus 598 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 675 (779)
||+|+||.||+|+.. +++.||+|++.... ........+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999775 58899999987543 2234456788999999999999999999999999999999999999999
Q ss_pred hhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCcccc
Q 004020 676 SRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE 755 (779)
Q Consensus 676 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 755 (779)
.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~ 150 (312)
T cd05585 81 FHHLQREG-----RFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKT 150 (312)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccc
Confidence 99885432 47889999999999999999996 899999999999999999999999999987543321 122
Q ss_pred cccccCCccccccccccc
Q 004020 756 TRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 756 ~~~~gt~~y~APE~l~~~ 773 (779)
....||+.|+|||++.+.
T Consensus 151 ~~~~gt~~y~aPE~~~~~ 168 (312)
T cd05585 151 NTFCGTPEYLAPELLLGH 168 (312)
T ss_pred ccccCCcccCCHHHHcCC
Confidence 345799999999998764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=256.60 Aligned_cols=182 Identities=25% Similarity=0.333 Sum_probs=152.5
Q ss_pred hhcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC-----
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN----- 661 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 661 (779)
..++|.+.+.||+|+||.||+|+. .+++.||||++............+.+|+.++..++|+||+++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 456899999999999999999975 47899999999776655666678899999999999999999988775432
Q ss_pred ---eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEE
Q 004020 662 ---ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 738 (779)
Q Consensus 662 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 738 (779)
..++||||+++|+|.+++..+... ...+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~-~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKT-NRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEE
Confidence 367999999999999998765432 2368899999999999999999996 899999999999999999999999
Q ss_pred eeccceecCCCCCcccccccccCCccccccccccc
Q 004020 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 739 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
|||+++...............||+.|+|||++.+.
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~ 220 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK 220 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCC
Confidence 99999876543222223445799999999998764
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=245.32 Aligned_cols=175 Identities=30% Similarity=0.469 Sum_probs=145.5
Q ss_pred cCCcccceecccccEEEEEEEEcC--C---cEEEEEEecc-cccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHD--G---TKIAVKRMES-AVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~--~---~~vavK~~~~-~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 663 (779)
++....++||+|+||.||+|++.. + ..||+|..+. .........++.+|+++|++++|||||++||++......
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 344556899999999999997653 2 2389999885 335677788999999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccc
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 743 (779)
++|||+|.||+|.+++.+... .++..++..++.+.+.||+|||+ +++|||||-.+|+|++.++.+||+|||++
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccc
Confidence 999999999999999976543 58899999999999999999996 89999999999999999999999999998
Q ss_pred eecCCCCCcccccccccCCccccccccccc
Q 004020 744 RLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+.-.... .......-...|+|||.+...
T Consensus 310 ~~~~~~~--~~~~~~klPirWLAPEtl~~~ 337 (474)
T KOG0194|consen 310 RAGSQYV--MKKFLKKLPIRWLAPETLNTG 337 (474)
T ss_pred cCCccee--eccccccCcceecChhhhccC
Confidence 7643111 111111245789999998755
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=238.92 Aligned_cols=179 Identities=25% Similarity=0.326 Sum_probs=157.9
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
+..-|...+.||+|.|++|-+|++- +|+.||||++.+...+......+.+|++.|+.++|||||++|++.......|+|
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 4566888899999999999999754 899999999998887777778899999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEc-CCCcEEEEeecccee
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFGLVRL 745 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~-~~~~~kl~DFG~a~~ 745 (779)
+|.-++|+|.+|+.+... .+.+..+.+++.||+.|+.|+|. ..+|||||||+||++- +-|-|||.|||++..
T Consensus 96 LELGD~GDl~DyImKHe~----Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNk 168 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEE----GLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNK 168 (864)
T ss_pred EEecCCchHHHHHHhhhc----cccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeecccccc
Confidence 999999999999977654 47888899999999999999995 7899999999999875 568999999999987
Q ss_pred cCCCCCcccccccccCCcccccccccccCCC
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAAETSGM 776 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 776 (779)
+.+... -+..+|+..|.|||++.|.+..
T Consensus 169 f~PG~k---L~TsCGSLAYSAPEILLGDsYD 196 (864)
T KOG4717|consen 169 FQPGKK---LTTSCGSLAYSAPEILLGDSYD 196 (864)
T ss_pred CCCcch---hhcccchhhccCchhhhcCccC
Confidence 766432 2456899999999999987654
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-26 Score=242.58 Aligned_cols=168 Identities=32% Similarity=0.510 Sum_probs=140.7
Q ss_pred ceecccccEEEEEEEE----cCCcEEEEEEeccccc--ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 596 NVLGRGGFGTVYKGEL----HDGTKIAVKRMESAVV--SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
+.||+|+||.||+|+. .+++.||+|.++.... .......+.+|+++++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999975 3578999999875432 123345678999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+++++|.+++.... .+.+..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 82 LSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 99999999885432 46788888999999999999996 89999999999999999999999999998754332
Q ss_pred CCcccccccccCCccccccccccc
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. ......||+.|+|||++.+.
T Consensus 154 ~~--~~~~~~gt~~y~aPE~~~~~ 175 (323)
T cd05584 154 GT--VTHTFCGTIEYMAPEILMRS 175 (323)
T ss_pred CC--cccccCCCccccChhhccCC
Confidence 21 22345699999999998754
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=255.17 Aligned_cols=179 Identities=32% Similarity=0.423 Sum_probs=146.3
Q ss_pred CCcccceecccccEEEEEEEEcCC-cEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeE-EEe------CC
Q 004020 591 NFSEENVLGRGGFGTVYKGELHDG-TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGY-CLD------GN 661 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~-~~~------~~ 661 (779)
++++.+.|.+|||+.||.|+...+ .+||+|++-.. ++...+.+.+|+++|++|. |+|||.+++. ... .-
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 567889999999999999987765 99999998765 5677888999999999997 9999999993 322 13
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeec
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 741 (779)
+++|.||||++|.|-|++..+... .+++.++++|+.|+++|+++||.+ +.+|||||||-+||||+.+++.||||||
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~---~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQT---RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhc---cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence 678999999999999999877654 489999999999999999999975 5789999999999999999999999999
Q ss_pred cceecCCCCCccc-------ccccccCCcccccccccccCC
Q 004020 742 LVRLAPDNGKHSI-------ETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 742 ~a~~~~~~~~~~~-------~~~~~gt~~y~APE~l~~~~~ 775 (779)
.|.-......... .-....|+.|+|||++.-..+
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg 232 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSG 232 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcC
Confidence 9763221111000 111247999999999865443
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-26 Score=242.78 Aligned_cols=168 Identities=28% Similarity=0.401 Sum_probs=142.9
Q ss_pred ceecccccEEEEEEEE----cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecC
Q 004020 596 NVLGRGGFGTVYKGEL----HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMP 671 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 671 (779)
+.||+|+||.||+++. .+++.||+|++............+.+|++++++++||||+++++++...+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999865 357899999997654434445667889999999999999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCC
Q 004020 672 QGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK 751 (779)
Q Consensus 672 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 751 (779)
+++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~- 152 (318)
T cd05582 82 GGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE- 152 (318)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-
Confidence 99999988543 257899999999999999999996 899999999999999999999999999987654321
Q ss_pred cccccccccCCccccccccccc
Q 004020 752 HSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 752 ~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.......||+.|+|||++.+.
T Consensus 153 -~~~~~~~g~~~y~aPE~~~~~ 173 (318)
T cd05582 153 -KKAYSFCGTVEYMAPEVVNRR 173 (318)
T ss_pred -CceecccCChhhcCHHHHcCC
Confidence 122345799999999998654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-27 Score=250.13 Aligned_cols=178 Identities=32% Similarity=0.466 Sum_probs=148.8
Q ss_pred CCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC------eE
Q 004020 591 NFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN------ER 663 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~ 663 (779)
-|...+.||+|+||.||+++. .+|+.||||.++... .....++..+|++++++++|||||++++.-.... ..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 345568899999999999985 579999999997654 3445677899999999999999999998765543 56
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEc--CCCc--EEEEe
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDMR--AKVAD 739 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~--~~~~--~kl~D 739 (779)
.+|||||.+|||...+.+-. ....+++.+.+.+...++.||.|||+ ++|+||||||.||++- .+|+ -||+|
T Consensus 93 vlvmEyC~gGsL~~~L~~PE--N~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPE--NAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred eEEEeecCCCcHHHHhcCcc--cccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeec
Confidence 89999999999999996543 33468999999999999999999995 8999999999999984 3343 69999
Q ss_pred eccceecCCCCCcccccccccCCcccccccccccCCCC
Q 004020 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 740 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
||.|+..+++. ..+.++||..|.+||++.....|+
T Consensus 168 fG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~ 202 (732)
T KOG4250|consen 168 FGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYT 202 (732)
T ss_pred ccccccCCCCC---eeeeecCchhhcChHHHhhccCcC
Confidence 99999987753 456789999999999998644443
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-26 Score=239.24 Aligned_cols=176 Identities=22% Similarity=0.351 Sum_probs=146.7
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
++|++.+.||+|+||.||+|+.+ +++.||+|++..........+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47899999999999999999876 67899999987654334445678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|++++.+..+. ... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~~~~l~~~~-~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLE-EMP----NGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHH-hcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 99987765443 221 257889999999999999999996 8999999999999999999999999999987643
Q ss_pred CCCcccccccccCCcccccccccccC
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
... .......||+.|+|||++.+..
T Consensus 153 ~~~-~~~~~~~~~~~y~aPE~~~~~~ 177 (287)
T cd07848 153 GSN-ANYTEYVATRWYRSPELLLGAP 177 (287)
T ss_pred ccc-ccccccccccccCCcHHHcCCC
Confidence 221 1223456899999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=241.48 Aligned_cols=173 Identities=28% Similarity=0.403 Sum_probs=148.8
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.++|++.+.||+|+||.||+|+.. ++..||+|.+.... ......++.+|++++++++||||+++++++..++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 368999999999999999999876 68889999887543 3344567999999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++++|.+++.... .+++..+..++.|++.||.|||+ +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 83 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 83 EHMDGGSLDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred ecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 9999999999985532 47888999999999999999996 3479999999999999999999999999987654
Q ss_pred CCCCcccccccccCCccccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. ......||+.|+|||++.+.
T Consensus 156 ~~----~~~~~~g~~~y~aPE~~~~~ 177 (331)
T cd06649 156 DS----MANSFVGTRSYMSPERLQGT 177 (331)
T ss_pred cc----ccccCCCCcCcCCHhHhcCC
Confidence 32 12345699999999998764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-28 Score=256.20 Aligned_cols=296 Identities=22% Similarity=0.310 Sum_probs=164.4
Q ss_pred EEEEEecCCCcc-ccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEccc
Q 004020 67 VTRIQIGGQNIE-GTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145 (779)
Q Consensus 67 v~~l~l~~~~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 145 (779)
++.+++.+|++. .-||+.++.|..|+.||||+|+|...|..+...+++-+|+||+|+|.+||...|.+|+.|-.||||+
T Consensus 80 LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~ 159 (1255)
T KOG0444|consen 80 LRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSN 159 (1255)
T ss_pred hHHHhhhccccccCCCCchhcccccceeeecchhhhhhcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhcccc
Confidence 344444444442 2345555555555555555555555444555555555555555555555555555555555555555
Q ss_pred CCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCC-CcCCCcccc-CCcceeeccCCCCC
Q 004020 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQ-GPIPLSFGK-SSIQTLWLNGQKGD 223 (779)
Q Consensus 146 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~-~~L~~l~l~~n~~~ 223 (779)
|++.. +|..+..+..|+.|.|++|.+..---..+- .+.+|++|++++.+=+ ..+|.++.. .+|..++++.|.+
T Consensus 160 NrLe~--LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLP--smtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~L- 234 (1255)
T KOG0444|consen 160 NRLEM--LPPQIRRLSMLQTLKLSNNPLNHFQLRQLP--SMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNL- 234 (1255)
T ss_pred chhhh--cCHHHHHHhhhhhhhcCCChhhHHHHhcCc--cchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCC-
Confidence 55543 455555555555555555554321111111 2344555555544422 244544433 4455555555432
Q ss_pred CCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccc-cCCC
Q 004020 224 SKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQG-QTPK 302 (779)
Q Consensus 224 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g-~~p~ 302 (779)
+..+..+-++.+|+.|+||+|+|+..--......+|++|+|++|+++ .+|++++.+++|+.|.+.+|+|+= -||+
T Consensus 235 ---p~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPS 310 (1255)
T KOG0444|consen 235 ---PIVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPS 310 (1255)
T ss_pred ---CcchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCcc
Confidence 22334444555555555555555544333444455555555666555 455556666666655555555431 0111
Q ss_pred CCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccc
Q 004020 303 FNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGL 382 (779)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l 382 (779)
. +....+|+++.+++|.|
T Consensus 311 G--------------------------------------------------------------IGKL~~Levf~aanN~L 328 (1255)
T KOG0444|consen 311 G--------------------------------------------------------------IGKLIQLEVFHAANNKL 328 (1255)
T ss_pred c--------------------------------------------------------------hhhhhhhHHHHhhcccc
Confidence 0 11123566777777777
Q ss_pred cccccccccccccCCeEeccCccccccCCccCCCCCCCCceeccCCcccccCC
Q 004020 383 SGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVP 435 (779)
Q Consensus 383 ~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP 435 (779)
. ..|..++.+..|+.|.|++|+|- ++|+.+--|+.|+.|||..|.=--.+|
T Consensus 329 E-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 329 E-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred c-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCC
Confidence 6 67888888888888888888888 888888888888888888876444444
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-26 Score=247.39 Aligned_cols=181 Identities=29% Similarity=0.447 Sum_probs=146.7
Q ss_pred hcCCcccceecccccEEEEEEEE------cCCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCC
Q 004020 589 TNNFSEENVLGRGGFGTVYKGEL------HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGN 661 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 661 (779)
.++|++.+.||+|+||.||+|.. .++..||+|+++... .....+.+.+|+++++.+ +||||+++++++...+
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 35788899999999999999963 246689999987543 233456788999999999 8999999999999999
Q ss_pred eEEEEEEecCCCChhhHhhhcccC--------------------------------------------------------
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEE-------------------------------------------------------- 685 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 685 (779)
..++||||+++|+|.+++......
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 999999999999999998653210
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCC
Q 004020 686 --------------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK 751 (779)
Q Consensus 686 --------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 751 (779)
....+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 11247888999999999999999996 8999999999999999999999999999987654322
Q ss_pred cccccccccCCccccccccccc
Q 004020 752 HSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 752 ~~~~~~~~gt~~y~APE~l~~~ 773 (779)
........++..|+|||++.+.
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~ 291 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNC 291 (375)
T ss_pred ccccCCCCCCcceeChhHhcCC
Confidence 2222223456789999998654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.8e-26 Score=241.31 Aligned_cols=173 Identities=28% Similarity=0.388 Sum_probs=144.2
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCC-CccceEeeEEEeCCeEEEEE
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRH-RHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~ 667 (779)
+|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+..|.+++..+.| ++|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5888999999999999999765 578999999876432 23345678889999999976 46888999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 81 EYVNGGDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152 (324)
T ss_pred cCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence 9999999998885432 47889999999999999999996 899999999999999999999999999987543
Q ss_pred CCCCcccccccccCCccccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.... ......||+.|+|||++.+.
T Consensus 153 ~~~~--~~~~~~gt~~y~aPE~~~~~ 176 (324)
T cd05587 153 FGGK--TTRTFCGTPDYIAPEIIAYQ 176 (324)
T ss_pred CCCC--ceeeecCCccccChhhhcCC
Confidence 2211 12345699999999998764
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-27 Score=244.14 Aligned_cols=160 Identities=32% Similarity=0.534 Sum_probs=141.0
Q ss_pred ccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCCC
Q 004020 594 EENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQG 673 (779)
Q Consensus 594 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 673 (779)
..+-||.|+.|.||+|+++ ++.||||+++.- -..+|+-|++|+||||+.|.|+|.....++||||||..|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 4578999999999999997 789999987532 236889999999999999999999999999999999999
Q ss_pred ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCcc
Q 004020 674 TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753 (779)
Q Consensus 674 sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 753 (779)
-|..+++..+ ++.......|..+||.|+.|||. +.|||||||.-||||..+..|||+|||.++...+. +
T Consensus 198 qL~~VLka~~-----~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---S 266 (904)
T KOG4721|consen 198 QLYEVLKAGR-----PITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---S 266 (904)
T ss_pred cHHHHHhccC-----ccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh---h
Confidence 9999996554 57778888999999999999996 78999999999999999999999999999877653 4
Q ss_pred cccccccCCcccccccccccC
Q 004020 754 IETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 754 ~~~~~~gt~~y~APE~l~~~~ 774 (779)
....++||..|||||++..+.
T Consensus 267 TkMSFaGTVaWMAPEvIrneP 287 (904)
T KOG4721|consen 267 TKMSFAGTVAWMAPEVIRNEP 287 (904)
T ss_pred hhhhhhhhHhhhCHHHhhcCC
Confidence 456789999999999997653
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-26 Score=247.08 Aligned_cols=181 Identities=29% Similarity=0.496 Sum_probs=146.1
Q ss_pred hcCCcccceecccccEEEEEEEEc------CCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCC
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGN 661 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 661 (779)
.++|++.+.||+|+||.||+|+.. ++..||+|++.... .......+.+|+++++.+ +||||+++++++...+
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 457899999999999999998642 34579999997543 233456788999999999 8999999999999999
Q ss_pred eEEEEEEecCCCChhhHhhhccc---------------------------------------------------------
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKE--------------------------------------------------------- 684 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 684 (779)
..++||||+++|+|.+++.....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 99999999999999999864321
Q ss_pred --------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCccccc
Q 004020 685 --------EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIET 756 (779)
Q Consensus 685 --------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 756 (779)
....++++..+++++.||+.||+|||+ ++|+||||||+||++++++.+||+|||+++............
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 011247888899999999999999996 899999999999999999999999999998664432222222
Q ss_pred ccccCCccccccccccc
Q 004020 757 RLAGTFGYLAPEYAAET 773 (779)
Q Consensus 757 ~~~gt~~y~APE~l~~~ 773 (779)
...++..|||||++.+.
T Consensus 273 ~~~~~~~y~aPE~~~~~ 289 (374)
T cd05106 273 NARLPVKWMAPESIFDC 289 (374)
T ss_pred CCCCccceeCHHHhcCC
Confidence 23456789999988643
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=207.80 Aligned_cols=176 Identities=24% Similarity=0.355 Sum_probs=148.3
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
+|...++||+|.||+||+|+.. +++.||+|+++...-++.......+|+.+++.++|.|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 5777899999999999999765 688999999976654444556789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
|. .+|..+...-. ..++.+.+..++.|+++||.|+|+ +++.|||+||.|.+|+.+|+.|++|||+|+.+.-.
T Consensus 83 cd-qdlkkyfdsln----g~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLN----GDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred hh-HHHHHHHHhcC----CcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 95 47777764433 257888999999999999999997 88999999999999999999999999999877543
Q ss_pred CCcccccccccCCcccccccccccCCC
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAETSGM 776 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~~~~ 776 (779)
.. -....+-|.+|++|.++.|..-|
T Consensus 155 vr--cysaevvtlwyrppdvlfgakly 179 (292)
T KOG0662|consen 155 VR--CYSAEVVTLWYRPPDVLFGAKLY 179 (292)
T ss_pred eE--eeeceeeeeeccCcceeeeeehh
Confidence 21 22345679999999999876544
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=240.11 Aligned_cols=173 Identities=27% Similarity=0.403 Sum_probs=148.0
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.++|++.+.||+|+||.||+|... ++..+|+|.+.... .......+.+|++++++++||||+++++++.+++..++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 368999999999999999999876 68889999886543 3445567899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++++|.+++.... .+++..+..++.|++.||.|||+ ..+|+||||||+||++++++.+||+|||++....
T Consensus 83 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 83 EHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred ecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 9999999999985432 47888899999999999999996 3579999999999999999999999999987653
Q ss_pred CCCCcccccccccCCccccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. ......|+..|+|||++.+.
T Consensus 156 ~~----~~~~~~~~~~y~aPE~~~~~ 177 (333)
T cd06650 156 DS----MANSFVGTRSYMSPERLQGT 177 (333)
T ss_pred hh----ccccCCCCccccCHHHhcCC
Confidence 32 12334689999999998764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.7e-26 Score=241.34 Aligned_cols=171 Identities=32% Similarity=0.468 Sum_probs=141.2
Q ss_pred CcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHH---HcCCCCccceEeeEEEeCCeEEEE
Q 004020 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVL---TKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
|++.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+.+|++++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999765 689999999975432 223345666776665 566799999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++++|..++.. ..+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 999999999887743 258899999999999999999996 89999999999999999999999999998754
Q ss_pred CCCCCcccccccccCCccccccccccc
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.... .......|++.|+|||++.+.
T Consensus 152 ~~~~--~~~~~~~g~~~y~aPE~~~~~ 176 (324)
T cd05589 152 MGFG--DRTSTFCGTPEFLAPEVLTET 176 (324)
T ss_pred CCCC--CcccccccCccccCHhHhcCC
Confidence 3221 122345799999999998764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=242.78 Aligned_cols=173 Identities=27% Similarity=0.437 Sum_probs=142.6
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC-----eEE
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN-----ERL 664 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 664 (779)
+|++.+.||+|+||.||+|+.. +++.||+|++...........++.+|++++++++||||+++++++.... ..|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999765 6899999998754433444567889999999999999999999886432 479
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
+||||++ ++|.+++.... .+++..+..++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 81 VVFELME-SDLHQVIKAND-----DLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEecCC-CCHHHHHHhcc-----cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 9999995 68888875432 47899999999999999999996 899999999999999999999999999997
Q ss_pred ecCCCCC-cccccccccCCcccccccccc
Q 004020 745 LAPDNGK-HSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 745 ~~~~~~~-~~~~~~~~gt~~y~APE~l~~ 772 (779)
....... ........||+.|+|||++.+
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 180 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGS 180 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhc
Confidence 6433211 112234579999999999865
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=239.72 Aligned_cols=168 Identities=26% Similarity=0.432 Sum_probs=140.7
Q ss_pred ceecccccEEEEEEEEc-CCcEEEEEEecccccC-hhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEEEEEEecCC
Q 004020 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 672 (779)
+.||+|+||.||+|+.. +++.||+|+++..... ......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 6789999999765322 23445678899988877 799999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCc
Q 004020 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (779)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 752 (779)
|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~- 151 (329)
T cd05618 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD- 151 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-
Confidence 9998887543 257899999999999999999996 8999999999999999999999999999875432211
Q ss_pred ccccccccCCccccccccccc
Q 004020 753 SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 753 ~~~~~~~gt~~y~APE~l~~~ 773 (779)
......||+.|+|||++.+.
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~ 171 (329)
T cd05618 152 -TTSTFCGTPNYIAPEILRGE 171 (329)
T ss_pred -ccccccCCccccCHHHHcCC
Confidence 12345799999999998764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.9e-26 Score=244.63 Aligned_cols=168 Identities=27% Similarity=0.409 Sum_probs=141.0
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
++|+..+.||+|+||.||+|+.. +++.||+|++.... .......+.+|++++++++|+||+++++++...+..++|||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 35667789999999999999765 68999999986443 23445678999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++++|.+.. ...+..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 153 ~~~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 153 FMDGGSLEGTH---------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred cCCCCcccccc---------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 99999986432 34567788999999999999996 8999999999999999999999999999987643
Q ss_pred CCCcccccccccCCcccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
... ......||..|+|||++..
T Consensus 221 ~~~--~~~~~~gt~~y~aPE~~~~ 242 (353)
T PLN00034 221 TMD--PCNSSVGTIAYMSPERINT 242 (353)
T ss_pred ccc--cccccccCccccCcccccc
Confidence 211 1234579999999998853
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=240.19 Aligned_cols=168 Identities=26% Similarity=0.427 Sum_probs=141.5
Q ss_pred ceecccccEEEEEEEEc-CCcEEEEEEecccccC-hhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEEEEEEecCC
Q 004020 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 672 (779)
+.||+|+||.||+|+.. +++.||+|+++..... ......+.+|..++.++ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999765 6889999999765432 23445688999999998 699999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCc
Q 004020 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (779)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 752 (779)
|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~- 151 (329)
T cd05588 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD- 151 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC-
Confidence 9998887543 258899999999999999999996 8999999999999999999999999999875322211
Q ss_pred ccccccccCCccccccccccc
Q 004020 753 SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 753 ~~~~~~~gt~~y~APE~l~~~ 773 (779)
......||+.|+|||++.+.
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~ 171 (329)
T cd05588 152 -TTSTFCGTPNYIAPEILRGE 171 (329)
T ss_pred -ccccccCCccccCHHHHcCC
Confidence 22345799999999998764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=238.72 Aligned_cols=168 Identities=30% Similarity=0.447 Sum_probs=138.8
Q ss_pred ceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEEEEEEecCC
Q 004020 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 672 (779)
+.||+|+||.||+|+.. +++.||+|.++.... .....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999765 578899999876432 223345566677777654 799999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCc
Q 004020 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (779)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 752 (779)
|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-- 150 (316)
T cd05592 81 GDLMFHIQSSG-----RFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-- 150 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--
Confidence 99998885432 47888999999999999999996 899999999999999999999999999998653322
Q ss_pred ccccccccCCccccccccccc
Q 004020 753 SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 753 ~~~~~~~gt~~y~APE~l~~~ 773 (779)
.......||+.|+|||++.+.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~ 171 (316)
T cd05592 151 GKASTFCGTPDYIAPEILKGQ 171 (316)
T ss_pred CccccccCCccccCHHHHcCC
Confidence 222345799999999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7e-27 Score=261.37 Aligned_cols=187 Identities=26% Similarity=0.331 Sum_probs=160.9
Q ss_pred eHHHHHHhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccC-hhHHHHHHHHHHHHHcCCCCccceEeeEEE
Q 004020 581 SIQVLRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCL 658 (779)
Q Consensus 581 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 658 (779)
....++.-.++|.+.++||+|+||.|..++++ +++.||+|++.+..+- .....-|+.|-.+|..-+.+-|+.++-.|+
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 45666777889999999999999999999876 6888999999875432 344566899999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEE
Q 004020 659 DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 738 (779)
Q Consensus 659 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 738 (779)
+..+.|+|||||+||+|-.++.+.. ++++..+..++..|+-||.-||+ .|+|||||||+|||+|..|++||+
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLA 217 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLA 217 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeec
Confidence 9999999999999999999985543 58888899999999999999996 899999999999999999999999
Q ss_pred eeccceecCCCCCcccccccccCCcccccccccccCCC
Q 004020 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSGM 776 (779)
Q Consensus 739 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 776 (779)
|||.+-.+..+|.. .....+|||-|++||+++...++
T Consensus 218 DFGsClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~ 254 (1317)
T KOG0612|consen 218 DFGSCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDG 254 (1317)
T ss_pred cchhHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCC
Confidence 99998877665443 33456899999999999765543
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=238.99 Aligned_cols=173 Identities=28% Similarity=0.379 Sum_probs=144.1
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEEEEE
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 667 (779)
+|++.+.||+|+||.||+|+.. +++.||+|++..... .......+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5788999999999999999765 578999999876532 223345577788888877 5899999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 9999999998885432 47889999999999999999996 899999999999999999999999999987643
Q ss_pred CCCCcccccccccCCccccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.... ......||+.|+|||++.+.
T Consensus 153 ~~~~--~~~~~~gt~~y~aPE~~~~~ 176 (323)
T cd05616 153 WDGV--TTKTFCGTPDYIAPEIIAYQ 176 (323)
T ss_pred CCCC--ccccCCCChhhcCHHHhcCC
Confidence 2211 22345799999999998764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=239.70 Aligned_cols=168 Identities=30% Similarity=0.468 Sum_probs=140.6
Q ss_pred ceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEEEEEEecCC
Q 004020 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 672 (779)
+.||+|+||.||+|+.. +++.||+|++..... .....+.+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 688999999875432 233456677888888877 699999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCc
Q 004020 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (779)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 752 (779)
|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~- 151 (320)
T cd05590 81 GDLMFHIQKSR-----RFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK- 151 (320)
T ss_pred chHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-
Confidence 99998885432 47889999999999999999996 8999999999999999999999999999876432211
Q ss_pred ccccccccCCccccccccccc
Q 004020 753 SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 753 ~~~~~~~gt~~y~APE~l~~~ 773 (779)
......||+.|+|||++.+.
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~ 171 (320)
T cd05590 152 -TTSTFCGTPDYIAPEILQEM 171 (320)
T ss_pred -cccccccCccccCHHHHcCC
Confidence 22345799999999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=256.27 Aligned_cols=182 Identities=24% Similarity=0.365 Sum_probs=148.7
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccC-hhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
++|++.++||+|+||.||+|... +++.||+|++...... ....+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999765 6899999998754322 234567899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccC------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeec
Q 004020 668 EYMPQGTLSRHLFNRKEE------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 741 (779)
||+++++|.+++...... .....++..++.++.||++||+|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988643211 11235677889999999999999996 899999999999999999999999999
Q ss_pred cceecCCCCC----------------cccccccccCCcccccccccccC
Q 004020 742 LVRLAPDNGK----------------HSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 742 ~a~~~~~~~~----------------~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
+++....... .......+||+.|||||++.+..
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~ 207 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP 207 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC
Confidence 9986621110 00112346999999999987653
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=243.82 Aligned_cols=181 Identities=28% Similarity=0.446 Sum_probs=147.4
Q ss_pred hcCCcccceecccccEEEEEEEEc------CCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCC
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGN 661 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 661 (779)
.++|++.+.||+|+||.||+|... .+..||+|++.... .....+.+.+|+++++++. ||||+++++++...+
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 467889999999999999999753 23579999986543 3344567999999999996 999999999999999
Q ss_pred eEEEEEEecCCCChhhHhhhcccC--------------------------------------------------------
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEE-------------------------------------------------------- 685 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 685 (779)
..|+||||+++|+|.+++......
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 999999999999999988654210
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEc
Q 004020 686 -----------------------------------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG 730 (779)
Q Consensus 686 -----------------------------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~ 730 (779)
....+++..+..++.||++||+|||+ .+|+||||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEe
Confidence 01247788889999999999999996 8999999999999999
Q ss_pred CCCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 731 DDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 731 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+++.+||+|||+++...............+++.|+|||++.+.
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 314 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN 314 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC
Confidence 9999999999999866443222222334577889999988654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=239.11 Aligned_cols=168 Identities=30% Similarity=0.444 Sum_probs=140.4
Q ss_pred ceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEEEEEEecCC
Q 004020 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 672 (779)
+.||+|+||.||+|+.. +++.||+|++..... .....+.+..|.+++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999765 578999999876432 233445677899998876 799999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCc
Q 004020 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (779)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 752 (779)
++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~- 151 (321)
T cd05591 81 GDLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV- 151 (321)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-
Confidence 99998885432 47888999999999999999996 8999999999999999999999999999876433221
Q ss_pred ccccccccCCccccccccccc
Q 004020 753 SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 753 ~~~~~~~gt~~y~APE~l~~~ 773 (779)
......||+.|+|||++.+.
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~ 171 (321)
T cd05591 152 -TTTTFCGTPDYIAPEILQEL 171 (321)
T ss_pred -cccccccCccccCHHHHcCC
Confidence 22345699999999998654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-27 Score=246.77 Aligned_cols=174 Identities=28% Similarity=0.409 Sum_probs=147.2
Q ss_pred hhcCCcccceecccccEEEEEEEEcCCc-EEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELHDGT-KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
..+.|.++..||.|+||.||+|..++.. ..|.|++... +....+++.-||++|+.++||+||++++.|+..+..||+
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 3456788899999999999999876443 4466777544 366778999999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
.|||.||-+..++..-. ..+.+.++..+++|++.||.|||+ +.|||||||..|||++-+|.++|+|||.+...
T Consensus 108 iEFC~GGAVDaimlEL~----r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELG----RVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKN 180 (1187)
T ss_pred EeecCCchHhHHHHHhc----cccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccc
Confidence 99999999988875543 268999999999999999999997 89999999999999999999999999987543
Q ss_pred CCCCCcccccccccCCcccccccccc
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
.. .......+.|||+|||||+.+-
T Consensus 181 ~~--t~qkRDsFIGTPYWMAPEVvmC 204 (1187)
T KOG0579|consen 181 KS--TRQKRDSFIGTPYWMAPEVVMC 204 (1187)
T ss_pred hh--HHhhhccccCCcccccchheee
Confidence 32 1223456789999999999863
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=244.13 Aligned_cols=176 Identities=26% Similarity=0.423 Sum_probs=146.1
Q ss_pred CCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC-----eEE
Q 004020 591 NFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN-----ERL 664 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 664 (779)
+|+..+.||+|+||.||+|.. .+++.||+|++..........+++.+|+++++.++||||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999976 47899999998755433445567899999999999999999999998776 789
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
+||||+. ++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~l~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-----QPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEeeccc-cCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEecccccee
Confidence 9999996 5777776432 258899999999999999999996 899999999999999999999999999998
Q ss_pred ecCCCCCcccccccccCCcccccccccccCCC
Q 004020 745 LAPDNGKHSIETRLAGTFGYLAPEYAAETSGM 776 (779)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 776 (779)
....... .......+++.|+|||++.+...+
T Consensus 152 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~ 182 (372)
T cd07853 152 VEEPDES-KHMTQEVVTQYYRAPEILMGSRHY 182 (372)
T ss_pred ecccCcc-ccCCCCCcCCCcCCHHHHcCCCCC
Confidence 6543321 122344689999999998875543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=233.52 Aligned_cols=170 Identities=31% Similarity=0.467 Sum_probs=142.0
Q ss_pred ecccccEEEEEEEEc-CCcEEEEEEecccccC-hhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCCCCh
Q 004020 598 LGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTL 675 (779)
Q Consensus 598 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 675 (779)
||+|+||.||+|... +++.||+|++...... ....+.+..|++++++++||||+++++++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999765 6889999998754322 22346678899999999999999999999999999999999999999
Q ss_pred hhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCcccc
Q 004020 676 SRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE 755 (779)
Q Consensus 676 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 755 (779)
.+++..... ....+++..++.++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++....... ..
T Consensus 81 ~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~ 154 (280)
T cd05608 81 RYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KT 154 (280)
T ss_pred HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--cc
Confidence 888754332 22358899999999999999999996 8999999999999999999999999999986644321 12
Q ss_pred cccccCCccccccccccc
Q 004020 756 TRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 756 ~~~~gt~~y~APE~l~~~ 773 (779)
....||+.|+|||++.+.
T Consensus 155 ~~~~g~~~y~aPE~~~~~ 172 (280)
T cd05608 155 KGYAGTPGFMAPELLQGE 172 (280)
T ss_pred cccCCCcCccCHHHhcCC
Confidence 345789999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=243.70 Aligned_cols=167 Identities=23% Similarity=0.285 Sum_probs=140.9
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
..+|++.+.||+|+||.||+|... +++.||+|.... ..+.+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 467999999999999999999764 688999996432 34678999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
|++. ++|.+++.... .+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+|+...
T Consensus 163 e~~~-~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 163 PRYK-TDLYCYLAAKR-----NIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred ecCC-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 9995 68888775432 47889999999999999999996 799999999999999999999999999987543
Q ss_pred CCCCcccccccccCCccccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
... ........||+.|+|||++.+.
T Consensus 234 ~~~-~~~~~~~~gt~~y~aPE~~~~~ 258 (391)
T PHA03212 234 DIN-ANKYYGWAGTIATNAPELLARD 258 (391)
T ss_pred ccc-ccccccccCccCCCChhhhcCC
Confidence 221 1122345799999999998764
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=238.62 Aligned_cols=168 Identities=32% Similarity=0.469 Sum_probs=137.0
Q ss_pred ceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHH-HHHcCCCCccceEeeEEEeCCeEEEEEEecCC
Q 004020 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIA-VLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 672 (779)
+.||+|+||.||+|+.. +++.||+|++..... ......++.+|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 688999999875432 2223344555554 67889999999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCc
Q 004020 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (779)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 752 (779)
++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 150 (321)
T cd05603 81 GELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-- 150 (321)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--
Confidence 9998887543 247788899999999999999996 899999999999999999999999999987532221
Q ss_pred ccccccccCCccccccccccc
Q 004020 753 SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 753 ~~~~~~~gt~~y~APE~l~~~ 773 (779)
.......||+.|+|||++.+.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~ 171 (321)
T cd05603 151 ETTSTFCGTPEYLAPEVLRKE 171 (321)
T ss_pred CccccccCCcccCCHHHhcCC
Confidence 122345799999999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=238.62 Aligned_cols=173 Identities=28% Similarity=0.383 Sum_probs=143.8
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCCeEEEEE
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 667 (779)
+|+..+.||+|+||.||+|+.. +++.||+|++..... .....+.+..|..++..+. |++|+++++++...+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677899999999999999765 688999999875432 2334466788999998886 577888999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+||++++++.+||+|||+++...
T Consensus 81 Ey~~~g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 9999999998885432 58899999999999999999996 899999999999999999999999999987543
Q ss_pred CCCCcccccccccCCccccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.... ......||+.|+|||++.+.
T Consensus 153 ~~~~--~~~~~~gt~~y~aPE~~~~~ 176 (323)
T cd05615 153 VDGV--TTRTFCGTPDYIAPEIIAYQ 176 (323)
T ss_pred CCCc--cccCccCCccccCHHHHcCC
Confidence 3211 12345699999999998754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=238.64 Aligned_cols=168 Identities=32% Similarity=0.476 Sum_probs=137.7
Q ss_pred ceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHH-HHHcCCCCccceEeeEEEeCCeEEEEEEecCC
Q 004020 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIA-VLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 672 (779)
+.||+|+||.||+|+.. +++.||+|++..... ......++.+|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999764 689999999875432 2233345556655 46778999999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCc
Q 004020 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (779)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 752 (779)
|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-- 150 (325)
T cd05604 81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-- 150 (325)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--
Confidence 9998887543 257899999999999999999996 899999999999999999999999999987543221
Q ss_pred ccccccccCCccccccccccc
Q 004020 753 SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 753 ~~~~~~~gt~~y~APE~l~~~ 773 (779)
.......||+.|+|||++.+.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~ 171 (325)
T cd05604 151 DTTTTFCGTPEYLAPEVIRKQ 171 (325)
T ss_pred CCcccccCChhhCCHHHHcCC
Confidence 122345799999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=238.11 Aligned_cols=168 Identities=32% Similarity=0.482 Sum_probs=137.6
Q ss_pred ceecccccEEEEEEEEc-CCcEEEEEEecccccC-hhHHHHHHHHHH-HHHcCCCCccceEeeEEEeCCeEEEEEEecCC
Q 004020 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIA-VLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 672 (779)
+.||+|+||.||+|+.. +++.||+|++...... .....++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999875 6899999998754321 223344555555 56789999999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCc
Q 004020 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (779)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 752 (779)
|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 150 (323)
T cd05575 81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-- 150 (323)
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--
Confidence 99998885432 57888999999999999999996 899999999999999999999999999987543221
Q ss_pred ccccccccCCccccccccccc
Q 004020 753 SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 753 ~~~~~~~gt~~y~APE~l~~~ 773 (779)
.......||+.|+|||++.+.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~ 171 (323)
T cd05575 151 KTTSTFCGTPEYLAPEVLRKQ 171 (323)
T ss_pred CccccccCChhhcChhhhcCC
Confidence 122345799999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=232.27 Aligned_cols=174 Identities=33% Similarity=0.482 Sum_probs=146.1
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccCh-hHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE-KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
.|++.+.||+|+||.||++... +++.||+|++....... .....+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999764 68999999987543222 223457789999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++++|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 999999998875432 1358899999999999999999996 8999999999999999999999999999987643
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
... .....|++.|+|||++.+.
T Consensus 155 ~~~---~~~~~~~~~y~aPE~~~~~ 176 (285)
T cd05605 155 GET---IRGRVGTVGYMAPEVVKNE 176 (285)
T ss_pred CCc---cccccCCCCccCcHHhcCC
Confidence 221 1234689999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=239.05 Aligned_cols=170 Identities=29% Similarity=0.414 Sum_probs=138.2
Q ss_pred ecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcC---CCCccceEeeEEEeCCeEEEEEEecCC
Q 004020 598 LGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKV---RHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (779)
Q Consensus 598 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~ 672 (779)
||+|+||.||+|+.. +++.||+|++..... ..........|..++... +||||+++++++...+..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999765 689999999865432 222334456677777665 699999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCc
Q 004020 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (779)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 752 (779)
|+|.+++... ..+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-- 150 (330)
T cd05586 81 GELFWHLQKE-----GRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-- 150 (330)
T ss_pred ChHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--
Confidence 9999888543 257899999999999999999996 899999999999999999999999999987543321
Q ss_pred ccccccccCCcccccccccccCCCC
Q 004020 753 SIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 753 ~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
.......||+.|+|||++.+...++
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~ 175 (330)
T cd05586 151 KTTNTFCGTTEYLAPEVLLDEKGYT 175 (330)
T ss_pred CCccCccCCccccCHHHHcCCCCCC
Confidence 1223457999999999987655443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=244.30 Aligned_cols=173 Identities=26% Similarity=0.405 Sum_probs=143.8
Q ss_pred ccceecccccEEEEEEEE-cCCcEEEEEEecccc--cChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCe--EEEEEE
Q 004020 594 EENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAV--VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE--RLLVYE 668 (779)
Q Consensus 594 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~lv~e 668 (779)
..++||+|+|-+||||-+ .+|.+||--.++... .+....++|..|+.+|+.|+||||+++|++|.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 346899999999999955 368888765443322 234456899999999999999999999999988765 678999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC-CCcEEEEeeccceecC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLVRLAP 747 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~~ 747 (779)
.+..|+|..|.++.+ .++...+..|++||++||.|||++ ..+|||||||-+||+|+. .|.|||+|.|+|....
T Consensus 124 L~TSGtLr~Y~kk~~-----~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHR-----RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred cccCCcHHHHHHHhc-----cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 999999999997765 467788999999999999999985 579999999999999975 5999999999998764
Q ss_pred CCCCcccccccccCCcccccccccccCCC
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAETSGM 776 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 776 (779)
.. .....+|||.|||||++....+.
T Consensus 198 ~s----~aksvIGTPEFMAPEmYEE~YnE 222 (632)
T KOG0584|consen 198 KS----HAKSVIGTPEFMAPEMYEENYNE 222 (632)
T ss_pred cc----ccceeccCccccChHHHhhhcch
Confidence 42 23447899999999999866554
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-26 Score=223.83 Aligned_cols=177 Identities=29% Similarity=0.422 Sum_probs=153.1
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
..++|+..++||+|.||.|.+++-+ +++.+|+|++++... ..+....-..|-++|+..+||.+..+--.|+..+..+.
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3467889999999999999999755 789999999988754 34455667899999999999999999889999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||||..||.|.-++.+.+ .+++.....+...|+.||.|||+ ++||.||+|.+|.++|++|++||.|||+++.
T Consensus 246 VMeyanGGeLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKE 317 (516)
T ss_pred EEEEccCceEeeehhhhh-----cccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchh
Confidence 999999999988775432 58888889999999999999997 8999999999999999999999999999986
Q ss_pred cCCCCCcccccccccCCcccccccccccC
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
-...+. ....++|||.|.|||++....
T Consensus 318 ~I~~g~--t~kTFCGTPEYLAPEVleDnD 344 (516)
T KOG0690|consen 318 EIKYGD--TTKTFCGTPEYLAPEVLEDND 344 (516)
T ss_pred cccccc--eeccccCChhhcCchhhcccc
Confidence 544332 345689999999999997654
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=237.87 Aligned_cols=168 Identities=30% Similarity=0.447 Sum_probs=136.0
Q ss_pred ceecccccEEEEEEEEc-CCcEEEEEEecccccC-hhHHHHHHHHHH-HHHcCCCCccceEeeEEEeCCeEEEEEEecCC
Q 004020 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIA-VLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 672 (779)
+.||+|+||.||+|+.. +++.||+|++...... ......+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999775 5788999998754321 222334444444 56788999999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCc
Q 004020 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (779)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 752 (779)
++|.+++.... .+.+..+..++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-- 150 (325)
T cd05602 81 GELFYHLQRER-----CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-- 150 (325)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--
Confidence 99999885432 46788888999999999999996 899999999999999999999999999987543221
Q ss_pred ccccccccCCccccccccccc
Q 004020 753 SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 753 ~~~~~~~gt~~y~APE~l~~~ 773 (779)
.......||+.|+|||++.+.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~ 171 (325)
T cd05602 151 GTTSTFCGTPEYLAPEVLHKQ 171 (325)
T ss_pred CCcccccCCccccCHHHHcCC
Confidence 122345799999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=236.90 Aligned_cols=168 Identities=29% Similarity=0.442 Sum_probs=139.2
Q ss_pred ceecccccEEEEEEEEc-CCcEEEEEEecccccC-hhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEEEEEEecCC
Q 004020 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 672 (779)
+.||+|+||.||+|+.. +++.||+|.++..... ......+..|..++... +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999875 6889999999765321 23345567788888765 899999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCc
Q 004020 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (779)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 752 (779)
|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~L~~~i~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 150 (316)
T cd05620 81 GDLMFHIQDKG-----RFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-- 150 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--
Confidence 99998885432 47888999999999999999996 899999999999999999999999999987532211
Q ss_pred ccccccccCCccccccccccc
Q 004020 753 SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 753 ~~~~~~~gt~~y~APE~l~~~ 773 (779)
.......||+.|+|||++.+.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~ 171 (316)
T cd05620 151 NRASTFCGTPDYIAPEILQGL 171 (316)
T ss_pred CceeccCCCcCccCHHHHcCC
Confidence 122345799999999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-25 Score=235.58 Aligned_cols=168 Identities=29% Similarity=0.443 Sum_probs=139.1
Q ss_pred ceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEEEEEEecCC
Q 004020 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 672 (779)
+.||+|+||.||+|+.. +++.||+|+++.... .......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 578999999976532 123345567788888764 899999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCc
Q 004020 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (779)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 752 (779)
|+|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 151 (316)
T cd05619 81 GDLMFHIQSCH-----KFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA- 151 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-
Confidence 99999885432 47888999999999999999996 8999999999999999999999999999875432211
Q ss_pred ccccccccCCccccccccccc
Q 004020 753 SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 753 ~~~~~~~gt~~y~APE~l~~~ 773 (779)
......||+.|+|||++.+.
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~ 171 (316)
T cd05619 152 -KTCTFCGTPDYIAPEILLGQ 171 (316)
T ss_pred -ceeeecCCccccCHHHHcCC
Confidence 12345699999999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=240.35 Aligned_cols=170 Identities=29% Similarity=0.385 Sum_probs=145.4
Q ss_pred CCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-C-----CccceEeeEEEeCCeE
Q 004020 591 NFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-H-----RHLVGLLGYCLDGNER 663 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~ 663 (779)
+|++.+.||+|+||+|-+|.. ++++.||||+++.. .....+...|+.+|..++ | -|+|+++++|..+++.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 899999999999999999965 57999999999764 344567788999999997 4 3899999999999999
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCC--CcEEEEeec
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD--MRAKVADFG 741 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~--~~~kl~DFG 741 (779)
|||+|.++ .+|.++++..+. ..++...+..|+.||+.||.+||+ .+|||+||||+|||+.+. ..+||+|||
T Consensus 264 ciVfELL~-~NLYellK~n~f---~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 264 CIVFELLS-TNLYELLKNNKF---RGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred eeeehhhh-hhHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecc
Confidence 99999985 599999976554 458899999999999999999995 899999999999999643 479999999
Q ss_pred cceecCCCCCcccccccccCCcccccccccccCC
Q 004020 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 742 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
.|+...... ..++-+..|+|||++.|-..
T Consensus 337 SSc~~~q~v-----ytYiQSRfYRAPEVILGlpY 365 (586)
T KOG0667|consen 337 SSCFESQRV-----YTYIQSRFYRAPEVILGLPY 365 (586)
T ss_pred cccccCCcc-----eeeeeccccccchhhccCCC
Confidence 998765431 24567889999999988654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-26 Score=257.61 Aligned_cols=182 Identities=29% Similarity=0.465 Sum_probs=148.0
Q ss_pred HHhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEe-----
Q 004020 586 RNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD----- 659 (779)
Q Consensus 586 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----- 659 (779)
.+...+|+..+.||+||||.||+|+.+ ||+.||||++.... ++.....+.+|++.+++++|||||+++..|.+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 456778999999999999999999987 89999999998776 66777889999999999999999999854321
Q ss_pred --------------------------------------------------C-----------------------------
Q 004020 660 --------------------------------------------------G----------------------------- 660 (779)
Q Consensus 660 --------------------------------------------------~----------------------------- 660 (779)
.
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence 0
Q ss_pred -----------------------------------CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHH
Q 004020 661 -----------------------------------NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARG 705 (779)
Q Consensus 661 -----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~ 705 (779)
-..||-||||+...+.+++.+..... .....+++++||++|
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREILEG 709 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHHHH
Confidence 01378899999888877775543211 456789999999999
Q ss_pred HHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC----------------CCCcccccccccCCccccccc
Q 004020 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD----------------NGKHSIETRLAGTFGYLAPEY 769 (779)
Q Consensus 706 L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~----------------~~~~~~~~~~~gt~~y~APE~ 769 (779)
|.|+|+ +|||||||||.||++|+++.|||+|||+|+.... .......+..+||.-|+|||+
T Consensus 710 LaYIH~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 710 LAYIHD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHHHh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 999996 8999999999999999999999999999986210 001113466789999999999
Q ss_pred ccccCC
Q 004020 770 AAETSG 775 (779)
Q Consensus 770 l~~~~~ 775 (779)
+.+...
T Consensus 787 l~~~~~ 792 (1351)
T KOG1035|consen 787 LSDTSS 792 (1351)
T ss_pred hccccc
Confidence 988873
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=236.80 Aligned_cols=168 Identities=27% Similarity=0.428 Sum_probs=141.3
Q ss_pred ceecccccEEEEEEEEc-CCcEEEEEEecccccC-hhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEEEEEEecCC
Q 004020 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 672 (779)
+.||+|+||.||+|+.. +++.||+|+++..... ....+.+.+|+.++.++ +||+|+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999765 5789999999765432 23456688999999888 599999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCc
Q 004020 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (779)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 752 (779)
++|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 151 (327)
T cd05617 81 GDLMFHMQRQR-----KLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD- 151 (327)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-
Confidence 99988875432 58899999999999999999996 8999999999999999999999999999875332211
Q ss_pred ccccccccCCccccccccccc
Q 004020 753 SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 753 ~~~~~~~gt~~y~APE~l~~~ 773 (779)
.....+||+.|+|||++.+.
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~ 171 (327)
T cd05617 152 -TTSTFCGTPNYIAPEILRGE 171 (327)
T ss_pred -ceecccCCcccCCHHHHCCC
Confidence 12345799999999998754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-25 Score=232.65 Aligned_cols=174 Identities=29% Similarity=0.419 Sum_probs=140.0
Q ss_pred cCCcccceecccccEEEEEEEEc--CCcEEEEEEecccccChhHHHHHHHHHHHHHcC---CCCccceEeeEEEe-----
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH--DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV---RHRHLVGLLGYCLD----- 659 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~----- 659 (779)
++|++.+.||+|+||.||+|+.. +++.||+|++............+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 37899999999999999999763 467899999875543333334566777777766 69999999998863
Q ss_pred CCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEe
Q 004020 660 GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 739 (779)
Q Consensus 660 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 739 (779)
....++||||++ ++|.+++..... ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEcc
Confidence 346899999996 589888854332 247889999999999999999996 8999999999999999999999999
Q ss_pred eccceecCCCCCcccccccccCCccccccccccc
Q 004020 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 740 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
||+++..... .......||+.|+|||++.+.
T Consensus 154 fg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~ 184 (290)
T cd07862 154 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQS 184 (290)
T ss_pred ccceEeccCC---cccccccccccccChHHHhCC
Confidence 9999876433 122345689999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-26 Score=244.21 Aligned_cols=172 Identities=30% Similarity=0.526 Sum_probs=147.4
Q ss_pred CCcccceecccccEEEEEEEEc----CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 591 NFSEENVLGRGGFGTVYKGELH----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
...+.++||.|.||.||+|+++ ....||||.++... .++...+|..|+.||.++.||||+++.|+.......+||
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 3567899999999999999876 24579999998654 566778899999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
+|||++|+|+.+++.+.. .+.+.+...+.++|+.|++||-. .++|||||.++|||++.+..+|++|||++|.+
T Consensus 709 TEyMENGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred hhhhhCCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeec
Confidence 999999999999966542 48888999999999999999995 89999999999999999999999999999988
Q ss_pred CCCCCccccccccc--CCccccccccc
Q 004020 747 PDNGKHSIETRLAG--TFGYLAPEYAA 771 (779)
Q Consensus 747 ~~~~~~~~~~~~~g--t~~y~APE~l~ 771 (779)
.++... ..+...| ..+|.|||.+.
T Consensus 782 edd~~~-~ytt~GGKIPiRWTAPEAIa 807 (996)
T KOG0196|consen 782 EDDPEA-AYTTLGGKIPIRWTAPEAIA 807 (996)
T ss_pred ccCCCc-cccccCCccceeecChhHhh
Confidence 665422 1222222 46899999875
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-25 Score=229.67 Aligned_cols=175 Identities=23% Similarity=0.389 Sum_probs=144.5
Q ss_pred cCCcccceecccccEEEEEEEEc----CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
++|++.+.||+|+||.||+|.++ .+..||+|.++... .......+.+|+..+++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 46889999999999999999753 35689999987653 23445678999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+|++|||.+..
T Consensus 84 v~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEeCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 999999999999986432 257899999999999999999996 8999999999999999999999999998765
Q ss_pred cCCCCCcccccccccCCccccccccccc
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
..... ........++..|+|||++.+.
T Consensus 157 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~ 183 (266)
T cd05064 157 DKSEA-IYTTMSGKSPVLWAAPEAIQYH 183 (266)
T ss_pred ccccc-hhcccCCCCceeecCHHHHhhC
Confidence 43221 1111223456789999988653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-25 Score=234.59 Aligned_cols=176 Identities=25% Similarity=0.396 Sum_probs=145.2
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
++|.+.+.||+|+||.||+|+.. +++.||+|.++.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 57899999999999999999765 678899999875432 2233457789999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++ ++.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 85 YLDK-DLKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred CCCC-CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 9975 7887775432 247888999999999999999996 8999999999999999999999999999876533
Q ss_pred CCCcccccccccCCcccccccccccCCC
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAETSGM 776 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~~~~ 776 (779)
... ......+|+.|+|||++.+...+
T Consensus 157 ~~~--~~~~~~~~~~y~aPE~~~~~~~~ 182 (309)
T cd07872 157 PTK--TYSNEVVTLWYRPPDVLLGSSEY 182 (309)
T ss_pred Ccc--ccccccccccccCCHHHhCCCCC
Confidence 211 12234688999999998765443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-25 Score=245.26 Aligned_cols=176 Identities=23% Similarity=0.369 Sum_probs=139.8
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC------
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG------ 660 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 660 (779)
...+|++.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 3467999999999999999999764 68899999885432 2345799999999999999999887542
Q ss_pred --CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC-cEEE
Q 004020 661 --NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKV 737 (779)
Q Consensus 661 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kl 737 (779)
...++||||+++ ++.+++...... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~-~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARN-NHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceee
Confidence 135689999975 677766543222 2358899999999999999999996 8999999999999998664 7999
Q ss_pred EeeccceecCCCCCcccccccccCCcccccccccccCCCC
Q 004020 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 738 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
+|||+|+....... .....||+.|+|||++.+...++
T Consensus 213 ~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~ 249 (440)
T PTZ00036 213 CDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYT 249 (440)
T ss_pred eccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCC
Confidence 99999986643221 23457899999999987765544
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-25 Score=228.44 Aligned_cols=170 Identities=36% Similarity=0.585 Sum_probs=146.0
Q ss_pred CcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEec
Q 004020 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYM 670 (779)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 670 (779)
|++.+.||+|+||.||+|+.. +++.||+|++..............+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 678899999999999999876 4678999999876544444445567999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCC
Q 004020 671 PQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750 (779)
Q Consensus 671 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 750 (779)
++++|.+++... ..+++..++.++.||++||+|||+ .+|+|+||||+||+++.++.++|+|||.+......
T Consensus 81 ~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~- 151 (260)
T PF00069_consen 81 PGGSLQDYLQKN-----KPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN- 151 (260)
T ss_dssp TTEBHHHHHHHH-----SSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTST-
T ss_pred cccccccccccc-----cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc-
Confidence 999999999622 257899999999999999999997 89999999999999999999999999998864221
Q ss_pred CcccccccccCCccccccccc
Q 004020 751 KHSIETRLAGTFGYLAPEYAA 771 (779)
Q Consensus 751 ~~~~~~~~~gt~~y~APE~l~ 771 (779)
........++..|+|||++.
T Consensus 152 -~~~~~~~~~~~~y~aPE~~~ 171 (260)
T PF00069_consen 152 -NENFNPFVGTPEYMAPEVLQ 171 (260)
T ss_dssp -TSEBSSSSSSGGGSCHHHHT
T ss_pred -cccccccccccccccccccc
Confidence 22334567899999999987
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-25 Score=228.67 Aligned_cols=173 Identities=27% Similarity=0.407 Sum_probs=138.7
Q ss_pred ceecccccEEEEEEEEcC---CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCC
Q 004020 596 NVLGRGGFGTVYKGELHD---GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 672 (779)
+.||+|+||.||+|...+ ...+|+|.+.... .......+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 358999999999996543 3567888775432 334456788999999999999999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCc
Q 004020 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (779)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 752 (779)
|+|.+++...........++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 999999876543323345678889999999999999996 89999999999999999999999999998754332221
Q ss_pred ccccccccCCcccccccccc
Q 004020 753 SIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 753 ~~~~~~~gt~~y~APE~l~~ 772 (779)
.......+++.|+|||++..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~ 176 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEI 176 (269)
T ss_pred eccCCCCCcccccCHHHHhh
Confidence 11233346778999999754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.5e-25 Score=229.94 Aligned_cols=180 Identities=30% Similarity=0.545 Sum_probs=148.0
Q ss_pred cCCcccceecccccEEEEEEEEcC------CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHD------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 663 (779)
++|++.+.||+|+||.||+|.... ...||+|.+.... ......++.+|++++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 478889999999999999997642 2579999887543 334456789999999999999999999999998999
Q ss_pred EEEEEecCCCChhhHhhhcccCCC-----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCC
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGL-----------KPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 732 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~ 732 (779)
+++|||+++++|.+++........ ..+++..++.++.|++.||+|||+ .+++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCC
Confidence 999999999999999865432111 357888999999999999999996 899999999999999999
Q ss_pred CcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 733 MRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 733 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+.+||+|||+++...............+++.|+|||++.+.
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 201 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG 201 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccC
Confidence 99999999999865433222223344578899999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-25 Score=242.24 Aligned_cols=169 Identities=25% Similarity=0.335 Sum_probs=142.5
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
...|.+.+.||+|+||.||+|... +++.||+|.... ..+.+|++++++++||||+++++++...+..++||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 447999999999999999999775 578899996321 23568999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
|++. ++|.+++.... ..+++.+++.|+.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 240 e~~~-~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 240 PKYR-SDLYTYLGARL----RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311 (461)
T ss_pred EccC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence 9995 68888875432 258999999999999999999996 899999999999999999999999999998764
Q ss_pred CCCCcccccccccCCccccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
............||+.|+|||++.+.
T Consensus 312 ~~~~~~~~~~~~GT~~Y~APE~~~~~ 337 (461)
T PHA03211 312 GSWSTPFHYGIAGTVDTNAPEVLAGD 337 (461)
T ss_pred cccccccccccCCCcCCcCHHHHcCC
Confidence 43222223345799999999998765
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.4e-25 Score=234.24 Aligned_cols=175 Identities=31% Similarity=0.490 Sum_probs=142.6
Q ss_pred cCCcccceecccccEEEEEEEEc-CCc----EEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGT----KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 664 (779)
.+|+..+.||+|+||.||+|++. +++ .||+|.++... .....+++.+|+.+++.++||||+++++++... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 46899999999999999999754 333 48999986432 334557789999999999999999999998764 567
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
+|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++
T Consensus 85 ~v~e~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 85 LITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred eeeecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccc
Confidence 9999999999999986543 247888899999999999999996 899999999999999999999999999998
Q ss_pred ecCCCCCcccccccccCCccccccccccc
Q 004020 745 LAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
...............++..|+|||++.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~ 186 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHR 186 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccC
Confidence 76543222222223356789999998654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-25 Score=212.55 Aligned_cols=185 Identities=28% Similarity=0.344 Sum_probs=152.8
Q ss_pred hcCCcccceecccccEEEEEEE-EcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC-----Ce
Q 004020 589 TNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG-----NE 662 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 662 (779)
.++|.+.+.+|+|||+.||.++ ..+++.||+|++.... .++.+..++|++..++++|||+++++++...+ ..
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 3689999999999999999996 5678999999997654 56678899999999999999999999887543 35
Q ss_pred EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecc
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 742 (779)
.|++++|...|+|.+.+...+.++. .+++.+++.|+.+|++||++||+.. .+++||||||.||++.+++.++|.|||.
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~-~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGN-FVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCC-ccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccC
Confidence 8999999999999999987766543 6899999999999999999999732 3599999999999999999999999999
Q ss_pred ceecCCCCCc-------ccccccccCCcccccccccccCCCC
Q 004020 743 VRLAPDNGKH-------SIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 743 a~~~~~~~~~-------~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
++...-.-.. ........|..|+|||++.-+.+-|
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~t 217 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCT 217 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcc
Confidence 8754321111 1123345789999999997665544
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-25 Score=237.62 Aligned_cols=176 Identities=28% Similarity=0.410 Sum_probs=145.9
Q ss_pred HHhhcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC----
Q 004020 586 RNVTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG---- 660 (779)
Q Consensus 586 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---- 660 (779)
-.+.++|++.+.||+|+||.||+|.. .+++.||+|++............+.+|++++++++||||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 34567899999999999999999976 4688999999876543334456688999999999999999999987643
Q ss_pred --CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEE
Q 004020 661 --NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 738 (779)
Q Consensus 661 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 738 (779)
...+++||++ +++|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEc
Confidence 3468999988 6788877632 248899999999999999999996 899999999999999999999999
Q ss_pred eeccceecCCCCCcccccccccCCcccccccccccCCC
Q 004020 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSGM 776 (779)
Q Consensus 739 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 776 (779)
|||+++..... .....||+.|+|||++.+...+
T Consensus 161 Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~ 193 (343)
T cd07878 161 DFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHY 193 (343)
T ss_pred CCccceecCCC-----cCCccccccccCchHhcCCccC
Confidence 99999865432 2345689999999998764433
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.6e-25 Score=226.28 Aligned_cols=173 Identities=31% Similarity=0.459 Sum_probs=145.4
Q ss_pred cCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
++|++.+.||+|+||.||+|+.+++..+|+|.+..... ...++.+|++++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM---SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc---cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 46888899999999999999988888999998764432 235688999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+||++++++.+||+|||.++.....
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 81 MENGCLLNYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred CCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 99999999886432 247889999999999999999995 89999999999999999999999999998765432
Q ss_pred CCcccccccccCCccccccccccc
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. .......++..|+|||++.+.
T Consensus 154 ~~-~~~~~~~~~~~y~aPE~~~~~ 176 (256)
T cd05114 154 EY-TSSSGAKFPVKWSPPEVFNFS 176 (256)
T ss_pred ce-eccCCCCCchhhCChhhcccC
Confidence 11 112223456789999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.8e-25 Score=227.22 Aligned_cols=173 Identities=28% Similarity=0.421 Sum_probs=140.6
Q ss_pred ceecccccEEEEEEEEcC---CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCC
Q 004020 596 NVLGRGGFGTVYKGELHD---GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 672 (779)
+.||+|+||.||+|...+ +..+|+|.++.... ......+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 368999999999997643 45789998865432 23345788999999999999999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCc
Q 004020 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (779)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 752 (779)
|+|.+++...........++..+..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||+++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 999999976543333346777888999999999999996 89999999999999999999999999998754433222
Q ss_pred ccccccccCCcccccccccc
Q 004020 753 SIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 753 ~~~~~~~gt~~y~APE~l~~ 772 (779)
.......|+..|+|||++.+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~ 176 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDE 176 (269)
T ss_pred ecCCCcCCcccccCHhHhcc
Confidence 22233457889999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=226.49 Aligned_cols=168 Identities=32% Similarity=0.468 Sum_probs=140.1
Q ss_pred ecccccEEEEEEEEc-CCcEEEEEEecccccCh-hHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCCCCh
Q 004020 598 LGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE-KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTL 675 (779)
Q Consensus 598 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 675 (779)
||+|+||.||+++.+ +|+.||+|.+....... .....+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999765 68999999987543222 2234566799999999999999999999999999999999999999
Q ss_pred hhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCcccc
Q 004020 676 SRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE 755 (779)
Q Consensus 676 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 755 (779)
.+++..... ..+++..+..++.||+.||+|||+ .+|+||||||+||++++++.++|+|||++....... ..
T Consensus 81 ~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~ 151 (277)
T cd05607 81 KYHIYNVGE---RGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TI 151 (277)
T ss_pred HHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---ee
Confidence 988754332 347889999999999999999996 899999999999999999999999999988764422 12
Q ss_pred cccccCCcccccccccccC
Q 004020 756 TRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 756 ~~~~gt~~y~APE~l~~~~ 774 (779)
....|+..|+|||++.+..
T Consensus 152 ~~~~~~~~y~aPE~~~~~~ 170 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEP 170 (277)
T ss_pred eccCCCCCccCHHHHccCC
Confidence 3346899999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=236.89 Aligned_cols=173 Identities=29% Similarity=0.393 Sum_probs=143.4
Q ss_pred HhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC----
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN---- 661 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 661 (779)
.+.++|++.+.||+|+||.||+|... +++.||+|++...........++.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 34578999999999999999999764 6899999999765544555677889999999999999999999986543
Q ss_pred --eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEe
Q 004020 662 --ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 739 (779)
Q Consensus 662 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 739 (779)
..|+||||+++ ++.+.+.. .+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~D 166 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILD 166 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEec
Confidence 46999999975 56555521 36788889999999999999996 8999999999999999999999999
Q ss_pred eccceecCCCCCcccccccccCCccccccccccc
Q 004020 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 740 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
||+++..... .......||+.|+|||++.+.
T Consensus 167 fg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~ 197 (359)
T cd07876 167 FGLARTACTN---FMMTPYVVTRYYRAPEVILGM 197 (359)
T ss_pred CCCccccccC---ccCCCCcccCCCCCchhccCC
Confidence 9998764332 122345789999999998764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=228.10 Aligned_cols=180 Identities=27% Similarity=0.499 Sum_probs=146.8
Q ss_pred cCCcccceecccccEEEEEEEE-----cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGEL-----HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 664 (779)
++|++.+.||+|+||.||+|.. .++..||+|.+.... ......++.+|++++++++||||+++++++..++..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 4678889999999999999974 246789999987543 2344567899999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCC
Q 004020 665 LVYEYMPQGTLSRHLFNRKEE------------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 732 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~ 732 (779)
+||||+++++|.+++..+... ....+++.++..++.|++.||+|||+ ++++||||||+||+++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCC
Confidence 999999999999998543210 12247888899999999999999996 899999999999999999
Q ss_pred CcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 733 MRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 733 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+.+||+|||+++...............++..|+|||++.+.
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 201 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG 201 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccC
Confidence 99999999999865433222222334467789999998643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.92 E-value=9e-25 Score=233.13 Aligned_cols=168 Identities=30% Similarity=0.452 Sum_probs=140.5
Q ss_pred ceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEEEEEEecCC
Q 004020 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 672 (779)
+.||+|+||.||+|+.. +++.||+|++..... .......+.+|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999775 578999999976532 223445678899999888 699999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCc
Q 004020 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (779)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 752 (779)
++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 151 (318)
T cd05570 81 GDLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV- 151 (318)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-
Confidence 99998875432 58899999999999999999996 8999999999999999999999999999875332211
Q ss_pred ccccccccCCccccccccccc
Q 004020 753 SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 753 ~~~~~~~gt~~y~APE~l~~~ 773 (779)
......||+.|+|||++.+.
T Consensus 152 -~~~~~~g~~~y~aPE~~~~~ 171 (318)
T cd05570 152 -TTSTFCGTPDYIAPEILSYQ 171 (318)
T ss_pred -cccceecCccccCHHHhcCC
Confidence 12334689999999998764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=228.21 Aligned_cols=182 Identities=27% Similarity=0.472 Sum_probs=146.5
Q ss_pred hhcCCcccceecccccEEEEEEEEc------CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN 661 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 661 (779)
..++|++.+.||+|+||.||+|... ++..||+|++.... ......++.+|+.+++.++||||+++++++..++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4567999999999999999998753 35679999886432 2334567889999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhHhhhcccC-----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEE
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEE-----GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 736 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 736 (779)
..++||||+++++|.+++...... .....++..+..++.|++.||+|||+ .+++||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEE
Confidence 999999999999999998653321 11245788899999999999999996 8999999999999999999999
Q ss_pred EEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 737 VADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 737 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
|+|||+++...............+++.|+|||++.+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 196 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG 196 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC
Confidence 9999998765432221112223457889999998653
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=228.25 Aligned_cols=181 Identities=30% Similarity=0.536 Sum_probs=149.0
Q ss_pred cCCcccceecccccEEEEEEEEc------CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 663 (779)
++|.+.+.||+|+||.||+|... +++.||+|.++... .....+.+.+|++++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 46888899999999999999764 34789999987543 233457899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhhccc---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCc
Q 004020 664 LLVYEYMPQGTLSRHLFNRKE---------EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 734 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~---------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 734 (779)
++||||+++++|.+++..... .....+++..+..++.|++.|++|||+ .+++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence 999999999999999865421 122357888999999999999999996 89999999999999999999
Q ss_pred EEEEeeccceecCCCCCcccccccccCCcccccccccccC
Q 004020 735 AKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 735 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
+||+|||+++...............+++.|+|||++.+..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 200 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK 200 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCC
Confidence 9999999998654332222223345678999999986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=236.90 Aligned_cols=181 Identities=27% Similarity=0.449 Sum_probs=146.3
Q ss_pred hcCCcccceecccccEEEEEEEEc------CCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCC
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGN 661 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 661 (779)
.++|.+.+.||+|+||.||+|++. .+..||+|+++... .....+.+.+|++++.++. ||||+++++++...+
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 346778899999999999999854 34689999997643 2333457889999999997 999999999999999
Q ss_pred eEEEEEEecCCCChhhHhhhccc---------------------------------------------------------
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKE--------------------------------------------------------- 684 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 684 (779)
..++||||+++|+|.++++....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999965421
Q ss_pred ------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEE
Q 004020 685 ------------------------------------EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 728 (779)
Q Consensus 685 ------------------------------------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIl 728 (779)
.....+++..+..++.||+.||+|||+ .+|+||||||+||+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEE
Confidence 011246777889999999999999996 89999999999999
Q ss_pred EcCCCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 729 LGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 729 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+++++.+||+|||+++...............+++.|+|||++.+.
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 316 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN 316 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC
Confidence 999999999999999865432221122234578899999988654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=226.94 Aligned_cols=164 Identities=17% Similarity=0.311 Sum_probs=138.9
Q ss_pred ceecccccEEEEEEEEcCCcEEEEEEecccccChh-HHHHHHHHHHHHHcCCCCccceEeeEEEe----CCeEEEEEEec
Q 004020 596 NVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEK-GFAEFKSEIAVLTKVRHRHLVGLLGYCLD----GNERLLVYEYM 670 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~ 670 (779)
..||+|++|.||+|.. +|+.||||+++....... ..+.+.+|+.++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999988 589999999976543222 24678899999999999999999999877 34678999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCC
Q 004020 671 PQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750 (779)
Q Consensus 671 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 750 (779)
++|+|.+++.... .+++..+..++.|++.||.|||+ ..+++||||||+||++++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 105 TRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCcHHHHHhhCC-----CCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 9999999986532 57889999999999999999996 3478899999999999999999999999988654321
Q ss_pred CcccccccccCCcccccccccc
Q 004020 751 KHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 751 ~~~~~~~~~gt~~y~APE~l~~ 772 (779)
....|+..|+|||++.+
T Consensus 178 -----~~~~~~~~y~aPE~~~~ 194 (283)
T PHA02988 178 -----FKNVNFMVYFSYKMLND 194 (283)
T ss_pred -----ccccCcccccCHHHhhh
Confidence 23468899999999875
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=224.03 Aligned_cols=176 Identities=27% Similarity=0.465 Sum_probs=146.3
Q ss_pred cCCcccceecccccEEEEEEEEc----CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
++|++.+.||+|+||.||+|.+. +...||+|.++... ......++.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 57889999999999999999874 24579999886543 34445678999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||||+++++|.+++.... ..+++..++.++.|++.|++|||+ ++|+||||||+||++++++.+||+|||+++.
T Consensus 83 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 83 ITEYMENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred EEEcCCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 999999999999986533 257899999999999999999995 8999999999999999999999999999987
Q ss_pred cCCCCCcccccccccCCccccccccccc
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
..............++..|+|||++.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~ 183 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYR 183 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccC
Confidence 6522221122223456789999988654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=227.16 Aligned_cols=179 Identities=25% Similarity=0.386 Sum_probs=148.0
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
+|++.+.||+|++|.||+|+.. ++..||+|++............+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5788899999999999999865 689999999875543333446788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
++ ++|.+++..... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 81 LS-MDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred CC-CCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 97 588888754332 2358899999999999999999996 89999999999999999999999999998765432
Q ss_pred CCcccccccccCCcccccccccccCCCC
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
. .......+++.|+|||++.+...++
T Consensus 155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~ 180 (285)
T cd07861 155 V--RVYTHEVVTLWYRAPEVLLGSPRYS 180 (285)
T ss_pred c--ccccCCcccccccChHHhcCCCCcC
Confidence 1 1123345789999999987655433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=237.21 Aligned_cols=170 Identities=25% Similarity=0.318 Sum_probs=142.5
Q ss_pred hhcCCcccceecccccEEEEEEEEc---CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH---DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 664 (779)
...+|.+.+.||+|+||.||+|... .+..||+|.+... ....+|++++++++||||+++++++......+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 3468999999999999999999653 3578999987543 23468999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
+|||++. ++|.+++... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 163 lv~e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~ 233 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAAC 233 (392)
T ss_pred EEehhcC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCcccc
Confidence 9999996 6888887322 258899999999999999999996 899999999999999999999999999997
Q ss_pred ecCCCCCcccccccccCCccccccccccc
Q 004020 745 LAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
...............||+.|+|||++.+.
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 262 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPELLALD 262 (392)
T ss_pred ccCcccccccccccccccCccCHhHhcCC
Confidence 66543222223346799999999998754
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-24 Score=225.20 Aligned_cols=173 Identities=34% Similarity=0.478 Sum_probs=145.2
Q ss_pred CcccceecccccEEEEEEEEc-CCcEEEEEEecccccCh-hHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE-KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
|+..+.||+|+||.||+|... +++.||+|.+....... .....+.+|++++++++|++|+++++++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999764 68899999987553322 2335578899999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+++++|.+++.... ...+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 82 MNGGDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred ccCccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 99999998875432 2258999999999999999999996 89999999999999999999999999998765432
Q ss_pred CCcccccccccCCccccccccccc
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. .....|+..|+|||++.+.
T Consensus 156 ~~---~~~~~g~~~~~aPE~~~~~ 176 (285)
T cd05632 156 ES---IRGRVGTVGYMAPEVLNNQ 176 (285)
T ss_pred Cc---ccCCCCCcCccChHHhcCC
Confidence 11 1334689999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=227.14 Aligned_cols=179 Identities=30% Similarity=0.537 Sum_probs=147.2
Q ss_pred cCCcccceecccccEEEEEEEEc------CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 663 (779)
.+|.+.+.||+|+||.||++... ++..+|+|.+.... ....+.+.+|++++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 46888999999999999999742 34568999886542 44556799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhhccc--------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcE
Q 004020 664 LLVYEYMPQGTLSRHLFNRKE--------EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 735 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~--------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 735 (779)
++||||+++++|.+++..... .....+++..++.++.|++.||+|||+ ++++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcE
Confidence 999999999999999865431 122358999999999999999999995 899999999999999999999
Q ss_pred EEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 736 KVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 736 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
||+|||+++...............++..|+|||++.+.
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 197 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR 197 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccC
Confidence 99999998865433222222334467889999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=224.59 Aligned_cols=175 Identities=26% Similarity=0.466 Sum_probs=147.8
Q ss_pred hcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
.++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..+++||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 35788999999999999999998888899999876532 234678999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++++|.+++..... ..+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++....
T Consensus 82 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 82 YMAKGSLLDFLKSDEG---GKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred cCCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 9999999999865432 257888899999999999999996 8999999999999999999999999999987654
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
... .......++..|+|||++.+.
T Consensus 156 ~~~-~~~~~~~~~~~y~aPE~~~~~ 179 (261)
T cd05072 156 NEY-TAREGAKFPIKWTAPEAINFG 179 (261)
T ss_pred Cce-eccCCCccceecCCHHHhccC
Confidence 321 112233467789999998654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=227.89 Aligned_cols=181 Identities=28% Similarity=0.438 Sum_probs=149.4
Q ss_pred hcCCcccceecccccEEEEEEEEcC-----------------CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccc
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHD-----------------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 651 (779)
.++|++.+.||+|+||.||+|+... +..||+|.+.... .....+.+.+|++++++++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 3578999999999999999987542 2468999887543 234567889999999999999999
Q ss_pred eEeeEEEeCCeEEEEEEecCCCChhhHhhhcccC------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCC
Q 004020 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPS 725 (779)
Q Consensus 652 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~ 725 (779)
++++++..++..+++|||+++++|.+++...... ....+++..++.++.|++.||+|||+ .+|+||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchh
Confidence 9999999999999999999999999998665421 12258899999999999999999996 89999999999
Q ss_pred CEEEcCCCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 726 NILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 726 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
||+++.++.++|+|||+++...............+++.|+|||++.+.
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 207 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG 207 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC
Confidence 999999999999999998865443322223344567899999988653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-24 Score=225.03 Aligned_cols=173 Identities=33% Similarity=0.501 Sum_probs=145.2
Q ss_pred CcccceecccccEEEEEEEEc-CCcEEEEEEecccccCh-hHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE-KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
|+..+.||+|+||.||+|... +++.||+|.+....... .....+.+|+.++++++|++|+.+++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677889999999999999765 68899999987543222 2335577899999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+++++|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++......
T Consensus 82 ~~g~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 82 MNGGDLKFHIYHMGE---AGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred cCCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 999999998854322 357889999999999999999996 89999999999999999999999999998765432
Q ss_pred CCcccccccccCCccccccccccc
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. .....|+..|+|||++.+.
T Consensus 156 ~~---~~~~~g~~~y~aPE~~~~~ 176 (285)
T cd05630 156 QT---IKGRVGTVGYMAPEVVKNE 176 (285)
T ss_pred cc---ccCCCCCccccChHHHcCC
Confidence 21 1234689999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=251.52 Aligned_cols=184 Identities=23% Similarity=0.380 Sum_probs=149.4
Q ss_pred HHhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC--Ce
Q 004020 586 RNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--NE 662 (779)
Q Consensus 586 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 662 (779)
....++|++.+.||+|+||.||+|+.. ++..||+|.+............+..|+.++++++||||++++++|... ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 345578999999999999999999765 577899999876655556667899999999999999999999988654 56
Q ss_pred EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCC----CCCcEEcCCCCCCEEEcC-------
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA----HQSFIHRDLKPSNILLGD------- 731 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~----~~~ivHrDlkp~NIll~~------- 731 (779)
.|+||||+++++|.+++...... ...+++..++.|+.||+.||+|||+.. ..+||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 89999999999999998654322 235899999999999999999999632 145999999999999964
Q ss_pred ----------CCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 732 ----------DMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 732 ----------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.+.+||+|||+++...... ......||+.|+|||++.+.
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge 216 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHE 216 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhcc
Confidence 2358999999998664321 22345799999999998643
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=228.87 Aligned_cols=181 Identities=29% Similarity=0.494 Sum_probs=147.8
Q ss_pred hcCCcccceecccccEEEEEEEEc--------CCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEe
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH--------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLD 659 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 659 (779)
.++|.+.+.||+|+||.||+|+.. ++..||+|.+.... ......++.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 457888999999999999999642 24579999886543 234557789999999999 79999999999999
Q ss_pred CCeEEEEEEecCCCChhhHhhhcccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEE
Q 004020 660 GNERLLVYEYMPQGTLSRHLFNRKEEG-----------LKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 728 (779)
Q Consensus 660 ~~~~~lv~e~~~~gsL~~~l~~~~~~~-----------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIl 728 (779)
....++||||+++++|.+++......+ ...+++.++..++.||++||+|||+ ++++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEE
Confidence 999999999999999999997643211 1357888899999999999999996 89999999999999
Q ss_pred EcCCCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 729 LGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 729 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+++++.+||+|||+++...............+++.|+|||++.+.
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 214 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR 214 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC
Confidence 999999999999999876543222222333467789999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=228.80 Aligned_cols=181 Identities=28% Similarity=0.473 Sum_probs=146.2
Q ss_pred hcCCcccceecccccEEEEEEEEcC---------------CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHD---------------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGL 653 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 653 (779)
.++|++.+.||+|+||.||+|+... ...||+|.+.... .......+.+|++++++++||||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 3579999999999999999986532 2358999987543 34455679999999999999999999
Q ss_pred eeEEEeCCeEEEEEEecCCCChhhHhhhcccC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCC
Q 004020 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE-------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSN 726 (779)
Q Consensus 654 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~N 726 (779)
++++...+..++||||+++++|.+++...... ....+++..++.++.|++.||+|||+ .+++||||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhh
Confidence 99999999999999999999999998653211 11236788999999999999999996 899999999999
Q ss_pred EEEcCCCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 727 ILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 727 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
|++++++.+||+|||+++...............++..|+|||++.+.
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 206 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG 206 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC
Confidence 99999999999999998765433222222233457789999987643
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=233.11 Aligned_cols=181 Identities=28% Similarity=0.476 Sum_probs=144.7
Q ss_pred hcCCcccceecccccEEEEEEEEc------CCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeC-
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDG- 660 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~- 660 (779)
.++|++.+.||+|+||.||+|+.. +++.||+|+++... .....+.+.+|+.++.++ +||||+++++++...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 357999999999999999999532 35789999987543 234456788999999999 799999999988755
Q ss_pred CeEEEEEEecCCCChhhHhhhcccC-------------------------------------------------------
Q 004020 661 NERLLVYEYMPQGTLSRHLFNRKEE------------------------------------------------------- 685 (779)
Q Consensus 661 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 685 (779)
...+++|||+++++|.+++......
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 4678999999999999988643211
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCcccccccccCCcc
Q 004020 686 -GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764 (779)
Q Consensus 686 -~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y 764 (779)
....+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++.+.............++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 01257899999999999999999996 89999999999999999999999999999876433222222234567889
Q ss_pred ccccccccc
Q 004020 765 LAPEYAAET 773 (779)
Q Consensus 765 ~APE~l~~~ 773 (779)
+|||++.+.
T Consensus 242 ~aPE~~~~~ 250 (337)
T cd05054 242 MAPESIFDK 250 (337)
T ss_pred cCcHHhcCC
Confidence 999988654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-24 Score=223.19 Aligned_cols=172 Identities=28% Similarity=0.445 Sum_probs=145.9
Q ss_pred hcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.++++++||||+++++++...+..++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 45799999999999999999986 468899999986443 223456789999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++...
T Consensus 86 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 86 EYCGGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred eCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 9999999999885432 47889999999999999999996 899999999999999999999999999988664
Q ss_pred CCCCcccccccccCCcccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
.... ......|++.|+|||.+.+
T Consensus 158 ~~~~--~~~~~~~~~~y~~PE~~~~ 180 (267)
T cd06646 158 ATIA--KRKSFIGTPYWMAPEVAAV 180 (267)
T ss_pred cccc--ccCccccCccccCHhHccc
Confidence 3211 1233468899999998853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=246.81 Aligned_cols=262 Identities=23% Similarity=0.299 Sum_probs=211.3
Q ss_pred cEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEccc
Q 004020 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145 (779)
Q Consensus 66 ~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 145 (779)
.-..|+|++++|+ .+|+.+. ++|+.|++++|+|+.++. .+++|++|+|++|+|+.+|.. .++|++|+|++
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~LP~---lp~~Lk~LdLs~N~LtsLP~l----p~sL~~L~Ls~ 271 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA---LPPELRTLEVSGNQLTSLPVL----PPGLLELSIFS 271 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCCCCC---CCCCCcEEEecCCccCcccCc----ccccceeeccC
Confidence 3567899999999 7888886 489999999999997553 258999999999999999752 57999999999
Q ss_pred CCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCC
Q 004020 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSK 225 (779)
Q Consensus 146 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~ 225 (779)
|.|.. +|..+ .+|+.|++++|+++ .+|.. +++|+.|+|++|+|++ +|... ..|..|++++|.+...
T Consensus 272 N~L~~--Lp~lp---~~L~~L~Ls~N~Lt-~LP~~-----p~~L~~LdLS~N~L~~-Lp~lp--~~L~~L~Ls~N~L~~L 337 (788)
T PRK15387 272 NPLTH--LPALP---SGLCKLWIFGNQLT-SLPVL-----PPGLQELSVSDNQLAS-LPALP--SELCKLWAYNNQLTSL 337 (788)
T ss_pred Cchhh--hhhch---hhcCEEECcCCccc-ccccc-----ccccceeECCCCcccc-CCCCc--ccccccccccCccccc
Confidence 99975 55533 57889999999998 45642 4689999999999995 55422 3588899999887653
Q ss_pred CCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCCCC
Q 004020 226 LNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNS 305 (779)
Q Consensus 226 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~ 305 (779)
. .. ..+|+.|+|++|+|++.++ + ..+|+.|++++|+|+. +|.. ..+|+.|+|++|+|++ +|..
T Consensus 338 P-~l------p~~Lq~LdLS~N~Ls~LP~-l--p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l-- 400 (788)
T PRK15387 338 P-TL------PSGLQELSVSDNQLASLPT-L--PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL-- 400 (788)
T ss_pred c-cc------ccccceEecCCCccCCCCC-C--Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc--
Confidence 2 11 2479999999999997543 2 3578899999999984 6754 3579999999999985 3321
Q ss_pred CcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCcccccc
Q 004020 306 PVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGT 385 (779)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ 385 (779)
.++|+.|++++|+|++
T Consensus 401 ---------------------------------------------------------------~s~L~~LdLS~N~Lss- 416 (788)
T PRK15387 401 ---------------------------------------------------------------PSELKELMVSGNRLTS- 416 (788)
T ss_pred ---------------------------------------------------------------ccCCCEEEccCCcCCC-
Confidence 1268899999999995
Q ss_pred ccccccccccCCeEeccCccccccCCccCCCCCCCCceeccCCcccccCCC
Q 004020 386 ISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPN 436 (779)
Q Consensus 386 ~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~ 436 (779)
+|..+ .+|+.|+|++|+|+ .+|..++.+++|+.|+|++|+|+|.+|.
T Consensus 417 IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 417 LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 77643 56889999999999 8999999999999999999999999886
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=230.26 Aligned_cols=175 Identities=29% Similarity=0.418 Sum_probs=137.0
Q ss_pred cceecccccEEEEEEEEc---CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEe--CCeEEEEEEe
Q 004020 595 ENVLGRGGFGTVYKGELH---DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD--GNERLLVYEY 669 (779)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~ 669 (779)
.++||+|+||.||+|+.. +++.||+|.+..... ...+.+|++++++++||||+++++++.. +...++||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999764 467899999865432 2356789999999999999999999864 3567899999
Q ss_pred cCCCChhhHhhhccc----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEE----cCCCcEEEEeec
Q 004020 670 MPQGTLSRHLFNRKE----EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFG 741 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~----~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll----~~~~~~kl~DFG 741 (779)
++ +++.+++..... .....+++..+..++.||+.||+|||+ .+|+||||||+|||+ +..+.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 86 478777653221 112357889999999999999999996 899999999999999 456789999999
Q ss_pred cceecCCCCCc-ccccccccCCcccccccccccCCCC
Q 004020 742 LVRLAPDNGKH-SIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 742 ~a~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
+++........ .......||+.|+|||++.+...++
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 194 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYT 194 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcC
Confidence 99876443211 1223457899999999997755443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-24 Score=223.70 Aligned_cols=179 Identities=29% Similarity=0.493 Sum_probs=142.7
Q ss_pred CcccceecccccEEEEEEEEcCC-c--EEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC------Ce
Q 004020 592 FSEENVLGRGGFGTVYKGELHDG-T--KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG------NE 662 (779)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~~~-~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~ 662 (779)
|.+.+.||+|+||.||+|+..+. . .+|+|.++.........+.+.+|+++++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 34678999999999999987543 2 689999876655566677899999999999999999999987532 24
Q ss_pred EEEEEEecCCCChhhHhhhcc-cCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeec
Q 004020 663 RLLVYEYMPQGTLSRHLFNRK-EEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 741 (779)
.+++|||+++|+|.+++.... ......+++..+..++.||+.||+|||+ ++|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999998874332 2223358899999999999999999996 899999999999999999999999999
Q ss_pred cceecCCCCCcccccccccCCccccccccccc
Q 004020 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 742 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+++...............+++.|+|||++.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~ 189 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADR 189 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCC
Confidence 99876543221112223467789999998654
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-24 Score=227.40 Aligned_cols=172 Identities=28% Similarity=0.379 Sum_probs=146.6
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
++|++.+.||+|+||.||++... ++..+|+|.+.... ......++.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 46899999999999999999765 67888999886543 23445678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++++|.+++... ..+++..+..++.|+++||.|||+ ..+++||||||+||++++++.+||+|||++.....
T Consensus 80 y~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 80 HMDGGSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred ccCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 99999999998643 257888999999999999999996 35899999999999999999999999999876533
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. .....|+..|+|||++.+.
T Consensus 153 ~~----~~~~~~~~~~~aPE~~~~~ 173 (308)
T cd06615 153 SM----ANSFVGTRSYMSPERLQGT 173 (308)
T ss_pred cc----cccCCCCcCccChhHhcCC
Confidence 21 2335689999999998654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-24 Score=221.02 Aligned_cols=175 Identities=27% Similarity=0.444 Sum_probs=150.7
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
+|+..+.||+|++|.||+|... +++.|++|.+..........+++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999765 689999999876555556677899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+++++|.+++..... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~l~~~~~---~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQRG---RPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 999999999865422 357889999999999999999996 89999999999999999999999999998876543
Q ss_pred CCcccccccccCCccccccccccc
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. ......|++.|+|||++.+.
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~ 176 (256)
T cd08529 155 TN--FANTIVGTPYYLSPELCEDK 176 (256)
T ss_pred cc--hhhccccCccccCHHHhcCC
Confidence 22 12334688999999998754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-24 Score=222.94 Aligned_cols=178 Identities=26% Similarity=0.421 Sum_probs=148.9
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccc-cChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
++|++.+.||+|+||.||+|+.. +++.||+|.+.... .......++.+|+++++.++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999764 78999999876432 23344567889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++++|.+++...... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQ-KRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 999999999888543322 2357888999999999999999996 899999999999999999999999999988765
Q ss_pred CCCCcccccccccCCccccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.... ......|++.|+|||++.+.
T Consensus 158 ~~~~--~~~~~~~~~~~~aPE~~~~~ 181 (267)
T cd08228 158 SKTT--AAHSLVGTPYYMSPERIHEN 181 (267)
T ss_pred chhH--HHhcCCCCccccChhhhccC
Confidence 4221 12234688999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-25 Score=215.80 Aligned_cols=166 Identities=27% Similarity=0.422 Sum_probs=140.4
Q ss_pred ceecccccEEEEEEE-EcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCCeEEEEEEecCCC
Q 004020 596 NVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLLVYEYMPQG 673 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g 673 (779)
+.||+|+|+.|--+. ..+|.+||||++.+.. .....+..+|++++..++ |+||++++++|+++..+|+|||-|.||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG 161 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence 789999999999884 6789999999998653 445678999999999996 999999999999999999999999999
Q ss_pred ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC---cEEEEeeccceecCCCC
Q 004020 674 TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAKVADFGLVRLAPDNG 750 (779)
Q Consensus 674 sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~---~~kl~DFG~a~~~~~~~ 750 (779)
.|..++++++ .+++.++.++..+|+.||.|||. +||.|||+||+|||-.+.. -+||+||.++.-+..+.
T Consensus 162 plLshI~~~~-----~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~ 233 (463)
T KOG0607|consen 162 PLLSHIQKRK-----HFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN 233 (463)
T ss_pred hHHHHHHHhh-----hccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence 9999998775 58899999999999999999995 9999999999999986543 48999999875443322
Q ss_pred Cccc-----ccccccCCccccccccc
Q 004020 751 KHSI-----ETRLAGTFGYLAPEYAA 771 (779)
Q Consensus 751 ~~~~-----~~~~~gt~~y~APE~l~ 771 (779)
..+. -...+|+..|||||+..
T Consensus 234 ~~spastP~L~tPvGSAEfMAPEVVd 259 (463)
T KOG0607|consen 234 DCSPASTPELLTPVGSAEFMAPEVVD 259 (463)
T ss_pred CCCCCCCccccCcccchhhcchhHHh
Confidence 2111 12357999999999864
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=234.90 Aligned_cols=173 Identities=27% Similarity=0.371 Sum_probs=143.7
Q ss_pred HhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC----
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN---- 661 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 661 (779)
...++|++.+.||+|+||.||+|... +++.||+|++............+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35578999999999999999999764 6889999999765544555677889999999999999999999886543
Q ss_pred --eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEe
Q 004020 662 --ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 739 (779)
Q Consensus 662 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 739 (779)
..++||||+++ ++.+.+.. .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~D 162 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILD 162 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEee
Confidence 46899999975 66665521 36788899999999999999996 8999999999999999999999999
Q ss_pred eccceecCCCCCcccccccccCCccccccccccc
Q 004020 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 740 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
||+++..... .......||+.|+|||++.+.
T Consensus 163 fg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~ 193 (355)
T cd07874 163 FGLARTAGTS---FMMTPYVVTRYYRAPEVILGM 193 (355)
T ss_pred CcccccCCCc---cccCCccccCCccCHHHHcCC
Confidence 9999865432 122345789999999998764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-24 Score=221.61 Aligned_cols=175 Identities=30% Similarity=0.466 Sum_probs=146.5
Q ss_pred hcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
.++|++.+.||+|++|.||+|...+++.||+|.++... ...+++.+|++++++++||||+++++++...+..++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 35688999999999999999988778899999987543 234568899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++++|.+++.... ...+++..+..++.|++.|+.|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 82 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 82 LMKYGSLLEYLQGGA---GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred cccCCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 999999999986543 2357899999999999999999996 8999999999999999999999999999987653
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
... ........+..|+|||++.+.
T Consensus 156 ~~~-~~~~~~~~~~~y~aPE~~~~~ 179 (261)
T cd05068 156 DIY-EAREGAKFPIKWTAPEAALYN 179 (261)
T ss_pred Ccc-cccCCCcCceeccCccccccC
Confidence 211 111122234579999988653
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-24 Score=225.84 Aligned_cols=182 Identities=29% Similarity=0.479 Sum_probs=145.7
Q ss_pred hhcCCcccceecccccEEEEEEEEc------CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN 661 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 661 (779)
..++|++.+.||+|+||.||+|..+ .+..||+|.+.... ......++.+|+.++++++||||+++++++...+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3568999999999999999999653 24579999876443 2233456889999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhHhhhcccC-----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEE
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEE-----GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 736 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 736 (779)
..++||||+++|+|.+++...... +....++..+..++.|++.||.|||+ ++|+||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEE
Confidence 999999999999999999653321 12345677889999999999999996 8999999999999999999999
Q ss_pred EEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 737 VADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 737 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
|+|||+++...............++..|+|||++.+.
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~ 196 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG 196 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccC
Confidence 9999998865432221112223457789999998654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-24 Score=220.67 Aligned_cols=170 Identities=29% Similarity=0.433 Sum_probs=139.0
Q ss_pred ceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCCCC
Q 004020 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGT 674 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 674 (779)
+.||+|+||.||+|+.. +++.||+|.+.... .......+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 46999999999999765 78899999876443 34445678999999999999999999999999999999999999999
Q ss_pred hhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCccc
Q 004020 675 LSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSI 754 (779)
Q Consensus 675 L~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 754 (779)
|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..........
T Consensus 80 L~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 80 FLTFLRTEG----PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 999985432 247899999999999999999995 8999999999999999999999999999875443211111
Q ss_pred ccccccCCccccccccccc
Q 004020 755 ETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 755 ~~~~~gt~~y~APE~l~~~ 773 (779)
.....++..|+|||++.+.
T Consensus 153 ~~~~~~~~~y~aPE~~~~~ 171 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYG 171 (252)
T ss_pred CCCCCCceeecCchhhcCC
Confidence 1111234579999998654
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=232.44 Aligned_cols=181 Identities=28% Similarity=0.447 Sum_probs=143.3
Q ss_pred hcCCcccceecccccEEEEEEEE------cCCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeC-
Q 004020 589 TNNFSEENVLGRGGFGTVYKGEL------HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDG- 660 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~- 660 (779)
.++|++.+.||+|+||.||+|.. .+++.||||+++... .......+.+|+.++.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 35799999999999999999963 357889999987543 233456788999999999 689999999988654
Q ss_pred CeEEEEEEecCCCChhhHhhhcccC-------------------------------------------------------
Q 004020 661 NERLLVYEYMPQGTLSRHLFNRKEE------------------------------------------------------- 685 (779)
Q Consensus 661 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 685 (779)
...++||||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 4578999999999999998653210
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCccccccc
Q 004020 686 -------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRL 758 (779)
Q Consensus 686 -------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 758 (779)
....+++.++..++.||++||+|||+ ++|+||||||+||++++++.+||+|||+++..............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 01246788889999999999999996 89999999999999999999999999998765332221112223
Q ss_pred ccCCccccccccccc
Q 004020 759 AGTFGYLAPEYAAET 773 (779)
Q Consensus 759 ~gt~~y~APE~l~~~ 773 (779)
.+++.|+|||++.+.
T Consensus 242 ~~~~~y~aPE~~~~~ 256 (343)
T cd05103 242 RLPLKWMAPETIFDR 256 (343)
T ss_pred CCCcceECcHHhcCC
Confidence 456789999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=243.13 Aligned_cols=183 Identities=19% Similarity=0.275 Sum_probs=138.4
Q ss_pred HHhhcCCcccceecccccEEEEEEEEcC--CcEEEEEE--------------eccc-ccChhHHHHHHHHHHHHHcCCCC
Q 004020 586 RNVTNNFSEENVLGRGGFGTVYKGELHD--GTKIAVKR--------------MESA-VVSEKGFAEFKSEIAVLTKVRHR 648 (779)
Q Consensus 586 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~--------------~~~~-~~~~~~~~~~~~E~~~l~~l~h~ 648 (779)
..+.++|++.+.||+|+||.||+|..+. +..++.|. +.+. .........+.+|+.++++++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 3456789999999999999999986542 22222221 1111 11122345688999999999999
Q ss_pred ccceEeeEEEeCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEE
Q 004020 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 728 (779)
Q Consensus 649 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIl 728 (779)
||+++++++...+..|+|+|++. +++.+++...............+..|+.||+.||+|||+ ++||||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEE
Confidence 99999999999999999999985 577777654332212223456678899999999999996 89999999999999
Q ss_pred EcCCCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 729 LGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 729 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
++.++.+||+|||+++.+..... .......||+.|+|||++.+.
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~ 343 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGD 343 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCC
Confidence 99999999999999987654322 222345799999999998764
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-24 Score=222.01 Aligned_cols=173 Identities=32% Similarity=0.475 Sum_probs=144.2
Q ss_pred cCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
.+|++.+.||+|+||.||+|+.+++..+|+|.+..... ...++.+|++++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 35788899999999999999888778899999865432 234678899999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+++++|.+++.... ..+++..++.++.|++.|++|||+ .+++||||||+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 81 MANGCLLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred CCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 99999999986433 257899999999999999999996 89999999999999999999999999998865432
Q ss_pred CCcccccccccCCccccccccccc
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. .......++..|+|||++.+.
T Consensus 154 ~~-~~~~~~~~~~~y~~Pe~~~~~ 176 (256)
T cd05059 154 QY-TSSQGTKFPVKWAPPEVFDYS 176 (256)
T ss_pred cc-cccCCCCCCccccCHHHhccC
Confidence 11 111222345679999998754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=221.83 Aligned_cols=173 Identities=31% Similarity=0.455 Sum_probs=145.2
Q ss_pred cCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
++|++.+.||+|+||.||+|+..++..+|+|.+..... ...++.+|+.++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 46888899999999999999887777899998875432 235688999999999999999999999988889999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+++++|.+++.... ..+++..++.++.||+.||+|||+ .+++|+||||+||++++++.+||+|||.++.....
T Consensus 81 ~~~~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 81 MSNGCLLNYLREHG----KRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred CCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 99999999885432 157899999999999999999996 89999999999999999999999999998865443
Q ss_pred CCcccccccccCCccccccccccc
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. .......++..|+|||++.+.
T Consensus 154 ~~-~~~~~~~~~~~y~~pe~~~~~ 176 (256)
T cd05113 154 EY-TSSVGSKFPVRWSPPEVLLYS 176 (256)
T ss_pred ce-eecCCCccChhhCCHHHHhcC
Confidence 21 111223456789999998653
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=222.18 Aligned_cols=179 Identities=30% Similarity=0.483 Sum_probs=145.5
Q ss_pred CcccceecccccEEEEEEEEcC----CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCe-----
Q 004020 592 FSEENVLGRGGFGTVYKGELHD----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE----- 662 (779)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 662 (779)
|++.+.||+|+||.||+|.... +..||+|+++...........+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999997642 4679999988665555566789999999999999999999998876554
Q ss_pred -EEEEEEecCCCChhhHhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEee
Q 004020 663 -RLLVYEYMPQGTLSRHLFNRKEE-GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (779)
Q Consensus 663 -~~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF 740 (779)
.+++|||+++++|.+++...... ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 78999999999999988654322 22358899999999999999999996 89999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccCCccccccccccc
Q 004020 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 741 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
|+++...............++..|+|||++.+.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~ 190 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR 190 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccC
Confidence 999876543222222223356789999987544
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.3e-24 Score=222.41 Aligned_cols=167 Identities=28% Similarity=0.419 Sum_probs=143.0
Q ss_pred cCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
++|++.+.||+|+||.||+|.. .+++.||+|.+.... ......++.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 3678889999999999999975 478899999986542 23445678999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|++++++..+. .+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||++.....
T Consensus 80 ~~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 80 FMDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred cCCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 99999986542 36788889999999999999996 8999999999999999999999999999876543
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
. ......||..|+|||++.+.
T Consensus 148 ~----~~~~~~~~~~y~aPE~~~~~ 168 (279)
T cd06619 148 S----IAKTYVGTNAYMAPERISGE 168 (279)
T ss_pred c----cccCCCCChhhcCceeecCC
Confidence 2 12345789999999998754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.6e-24 Score=218.77 Aligned_cols=175 Identities=26% Similarity=0.410 Sum_probs=151.0
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
+|+..+.||+|+||.||.++.. +++.+++|.+...........++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999999754 688999999876655566677889999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+++++|.+++..... ..+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||.++.....
T Consensus 81 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQKG---QLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 999999999865431 257889999999999999999996 79999999999999999999999999999876543
Q ss_pred CCcccccccccCCccccccccccc
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. ......|++.|+|||++.+.
T Consensus 155 ~~--~~~~~~~~~~y~ape~~~~~ 176 (256)
T cd08221 155 YS--MAETVVGTPYYMSPELCQGV 176 (256)
T ss_pred cc--cccccCCCccccCHhhcCCC
Confidence 21 22345689999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-24 Score=225.80 Aligned_cols=181 Identities=30% Similarity=0.487 Sum_probs=147.5
Q ss_pred hcCCcccceecccccEEEEEEEEc------CCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCC
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGN 661 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 661 (779)
.++|++.+.||+|+||.||++... ....+|+|.+.... ......++.+|+++++++ +||||+++++++..++
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 457888999999999999999764 23678999887543 234456788999999999 7999999999999999
Q ss_pred eEEEEEEecCCCChhhHhhhccc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEc
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKE-----------EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG 730 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~ 730 (779)
..+++|||+++++|.+++..+.. .....+++..++.++.|++.||+|||+ .+|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEc
Confidence 99999999999999999865421 123468899999999999999999996 8999999999999999
Q ss_pred CCCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 731 DDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 731 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+++.+||+|||+++...............++..|+|||++.+.
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 209 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR 209 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccC
Confidence 9999999999999876543222222223456789999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-24 Score=234.14 Aligned_cols=186 Identities=27% Similarity=0.417 Sum_probs=156.2
Q ss_pred eHHHHHHhhcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEE
Q 004020 581 SIQVLRNVTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCL 658 (779)
Q Consensus 581 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 658 (779)
.++.+...++-|++.++||+|.+|.||+++. ++++.+|+|++.... +..+++..|.++++.. .|||++.++++|.
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 4455566678899999999999999999975 478899999886543 3346678899999988 5999999999987
Q ss_pred e-----CCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC
Q 004020 659 D-----GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 733 (779)
Q Consensus 659 ~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 733 (779)
. +++.|+|||||.+|+..|+++... ...+.|..+..|++.++.|+.+||. ..++|||||=.|||++.++
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~ 160 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENA 160 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccC
Confidence 4 468999999999999999998776 2368999999999999999999994 8899999999999999999
Q ss_pred cEEEEeeccceecCCCCCcccccccccCCcccccccccccCCCC
Q 004020 734 RAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 734 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
.||++|||.+...... .......+|||.|||||++..++..+
T Consensus 161 ~VKLvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d 202 (953)
T KOG0587|consen 161 EVKLVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPD 202 (953)
T ss_pred cEEEeeeeeeeeeecc--cccccCcCCCcccccceeeecccCCC
Confidence 9999999998877543 22335568999999999997665433
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-24 Score=223.98 Aligned_cols=176 Identities=26% Similarity=0.369 Sum_probs=147.1
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
++|+..+.||+|+||.||+|+.. +++.||+|++..........+.+.+|++++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46889999999999999999876 58999999986543223334567899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|++++.+..+.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 81 YCDHTVLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred ccCccHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 99998887765322 247899999999999999999996 8999999999999999999999999999987654
Q ss_pred CCCcccccccccCCcccccccccccCC
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
... ......++..|+|||++.+...
T Consensus 153 ~~~--~~~~~~~~~~~~aPE~~~~~~~ 177 (286)
T cd07847 153 PGD--DYTDYVATRWYRAPELLVGDTQ 177 (286)
T ss_pred Ccc--cccCcccccccCCHHHHhCCCC
Confidence 321 1223457889999999876443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=227.58 Aligned_cols=180 Identities=32% Similarity=0.497 Sum_probs=145.7
Q ss_pred cCCcccceecccccEEEEEEEEc--------CCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeC
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH--------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDG 660 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 660 (779)
++|.+.+.||+|+||.||+|+.. +...+|+|.+.... ......++.+|+++++++ +||||+++++++...
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 57899999999999999999753 23579999987543 334456788999999999 799999999999999
Q ss_pred CeEEEEEEecCCCChhhHhhhcccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEE
Q 004020 661 NERLLVYEYMPQGTLSRHLFNRKEEG-----------LKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 729 (779)
Q Consensus 661 ~~~~lv~e~~~~gsL~~~l~~~~~~~-----------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll 729 (779)
+..|+||||+++++|.+++..+...+ ...+++.+++.++.|++.||+|||+ .+++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEE
Confidence 99999999999999999997653211 1247889999999999999999996 899999999999999
Q ss_pred cCCCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 730 GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 730 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
++++.+||+|||.++...............+++.|+|||++.+.
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 217 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 217 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC
Confidence 99999999999998765432111111222345789999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-24 Score=223.59 Aligned_cols=175 Identities=29% Similarity=0.474 Sum_probs=141.6
Q ss_pred cCCcccceecccccEEEEEEEEc-CCc----EEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGT----KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 664 (779)
++|++.+.||+|+||.||+|.+. +++ .+++|.+.... ......++..|+..+++++||||+++++++. ....+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence 46888899999999999999764 344 47777775332 2344567888999999999999999999875 45578
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
+++||+++|+|.+++.... ..+++..+..++.||+.||+|||+ ++++||||||+||++++++.+||+|||+++
T Consensus 85 ~i~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred EEEEeCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccce
Confidence 9999999999999986543 257899999999999999999996 889999999999999999999999999998
Q ss_pred ecCCCCCcccccccccCCccccccccccc
Q 004020 745 LAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
...............++..|+|||++.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~ 186 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFG 186 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccC
Confidence 76443222222344577899999998653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-24 Score=221.40 Aligned_cols=174 Identities=36% Similarity=0.641 Sum_probs=141.3
Q ss_pred ccceecccccEEEEEEEEc-----CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 594 EENVLGRGGFGTVYKGELH-----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 594 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
..+.||.|.||.||+|.+. .+..|+||.++.. ......+.+.+|++.+++++||||+++++++...+..++|||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeeccccccccccccccccccccccccccccccc
Confidence 4678999999999999876 3678999999653 234457889999999999999999999999998888999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++|+|.+++..... ..+++..+..|+.||++||+|||+ .+++|+||+++||++++++.+||+|||+++....
T Consensus 82 ~~~~g~L~~~L~~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNK---EPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp --TTEBHHHHHHHTCT---TTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccccc---cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 9999999999977622 358899999999999999999997 7899999999999999999999999999987733
Q ss_pred CCCcccccccccCCcccccccccccC
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
...........+...|+|||++.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~ 181 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGE 181 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSE
T ss_pred cccccccccccccccccccccccccc
Confidence 22222223345778999999986543
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=226.74 Aligned_cols=176 Identities=24% Similarity=0.384 Sum_probs=151.9
Q ss_pred cCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 668 (779)
..|++.+.||+||.+.||++...+.+.||+|++.....+......|..|+..|.+++ |.+||++++|-..++..|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 468999999999999999999988899999998877777788889999999999996 9999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|= ..+|..++.++... ...| .++.+..||+.|+.++|. .||||.||||.|+|+- .|.+||+|||+|..+..
T Consensus 441 ~G-d~DL~kiL~k~~~~---~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSI---DPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred cc-cccHHHHHHhccCC---CchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 74 56999999765432 2223 677899999999999995 8999999999999995 56899999999998877
Q ss_pred CCCcccccccccCCcccccccccccC
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
+...-.....+||+.|||||.+....
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~ 537 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMS 537 (677)
T ss_pred cccceeeccccCcccccCHHHHhhcc
Confidence 65544556679999999999986554
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=248.71 Aligned_cols=179 Identities=35% Similarity=0.574 Sum_probs=148.8
Q ss_pred cCCcccceecccccEEEEEEEEcC--C----cEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHD--G----TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~--~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 663 (779)
...+..+.||+|.||.||+|...+ + ..||+|.+++.. +.+...+|.+|..+|++++|||||+++|++.+....
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 345667899999999999997653 3 348999887653 566778999999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeec
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEG--LKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 741 (779)
++++|||++|+|..++++.+... ...+...+.+.++.|||+|+.||++ +++|||||..+|+|++....|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999997764322 3357888999999999999999996 899999999999999999999999999
Q ss_pred cceecCCCCCcccccccccCCcccccccccc
Q 004020 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 742 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
+|+.+.............-...|||||.+.+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d 878 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKD 878 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhh
Confidence 9996654433322222223468999999985
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.3e-24 Score=223.81 Aligned_cols=176 Identities=30% Similarity=0.434 Sum_probs=150.2
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
+|++.+.||+|+||.||+|... +++.||+|++..........+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5888999999999999999864 689999999876554444557789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+ +++|.+++.... ..+++.+++.++.||++||+|||+ .+++|+||||+||++++++.++|+|||.+......
T Consensus 81 ~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 999999886543 358999999999999999999996 89999999999999999999999999998876543
Q ss_pred CCcccccccccCCcccccccccccCC
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
.. .......|+..|+|||++.+...
T Consensus 153 ~~-~~~~~~~~~~~y~aPE~~~~~~~ 177 (286)
T cd07832 153 EP-RLYSHQVATRWYRAPELLYGARK 177 (286)
T ss_pred CC-CccccccCcccccCceeeecccc
Confidence 22 11233468999999999876543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-24 Score=227.03 Aligned_cols=176 Identities=26% Similarity=0.407 Sum_probs=145.3
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
++|++.+.||+|+||.||+|+.. +++.||+|.+..... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 57899999999999999999765 688999999864431 2233457789999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|++ ++|.+++.... ..+++..+..++.|+++||+|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 85 ~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 85 YLD-KDLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred ccc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 997 58888875432 247888999999999999999996 8999999999999999999999999999876433
Q ss_pred CCCcccccccccCCcccccccccccCCC
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAETSGM 776 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~~~~ 776 (779)
... ......+++.|+|||++.+...+
T Consensus 157 ~~~--~~~~~~~~~~y~~PE~~~~~~~~ 182 (301)
T cd07873 157 PTK--TYSNEVVTLWYRPPDILLGSTDY 182 (301)
T ss_pred CCC--cccccceeecccCcHHHhCCCCC
Confidence 211 12234578999999998765443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=233.24 Aligned_cols=172 Identities=27% Similarity=0.380 Sum_probs=143.1
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC------
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG------ 660 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 660 (779)
..++|++.+.||+|+||.||+|... .++.||||++...........++.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999764 688999999976554445567788999999999999999999987643
Q ss_pred CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEee
Q 004020 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (779)
Q Consensus 661 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF 740 (779)
...|+||||+++ ++.+.+.. .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeC
Confidence 357999999975 67666631 36788899999999999999996 89999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccCCccccccccccc
Q 004020 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 741 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
|+++..... .......||+.|+|||++.+.
T Consensus 171 G~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~ 200 (364)
T cd07875 171 GLARTAGTS---FMMTPYVVTRYYRAPEVILGM 200 (364)
T ss_pred CCccccCCC---CcccCCcccCCcCCHHHHhCC
Confidence 999765432 122345789999999998764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-24 Score=223.83 Aligned_cols=171 Identities=33% Similarity=0.471 Sum_probs=147.8
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
++|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46889999999999999999765 689999999865432 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 81 EYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152 (290)
T ss_pred ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence 999999999998554 257889999999999999999996 899999999999999999999999999988764
Q ss_pred CCCCcccccccccCCccccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. .....|++.|+|||++.+.
T Consensus 153 ~~-----~~~~~~~~~y~aPE~~~~~ 173 (290)
T cd05580 153 GR-----TYTLCGTPEYLAPEIILSK 173 (290)
T ss_pred CC-----CCCCCCCccccChhhhcCC
Confidence 43 2334689999999998654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-24 Score=222.23 Aligned_cols=171 Identities=28% Similarity=0.453 Sum_probs=145.6
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.++|++.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 357888899999999999999764 68899999986543 234456789999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++++|.+++.... .+++.+++.++.|++.|++|||+ .+++|+||||+||+++.++.+||+|||++....
T Consensus 86 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 86 EFCGGGSLQDIYHVTG-----PLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred eccCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 9999999999885432 57899999999999999999996 799999999999999999999999999987654
Q ss_pred CCCCcccccccccCCccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAA 771 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~ 771 (779)
... .......|+..|+|||++.
T Consensus 158 ~~~--~~~~~~~~~~~y~aPE~~~ 179 (267)
T cd06645 158 ATI--AKRKSFIGTPYWMAPEVAA 179 (267)
T ss_pred Ccc--cccccccCcccccChhhhc
Confidence 321 1123456899999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=224.41 Aligned_cols=179 Identities=27% Similarity=0.452 Sum_probs=144.5
Q ss_pred CCcccceecccccEEEEEEEEc------CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEE
Q 004020 591 NFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 664 (779)
+|++.+.||+|+||.||+|... ....+++|.+.... ......++.+|+.+++.++||||+++++.+...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 4778899999999999999753 23568888876543 2344567899999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhhccc-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCC
Q 004020 665 LVYEYMPQGTLSRHLFNRKE-------------------EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPS 725 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~-------------------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~ 725 (779)
++|||+++++|.+++..... .....+++..++.++.|++.||+|||+ .+|+||||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhh
Confidence 99999999999999865321 112357889999999999999999996 89999999999
Q ss_pred CEEEcCCCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 726 NILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 726 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
||++++++.+||+|||+++...............++..|+|||++.+.
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~ 204 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH 204 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC
Confidence 999999999999999998865433222222233467789999987544
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.5e-24 Score=229.63 Aligned_cols=167 Identities=25% Similarity=0.336 Sum_probs=140.0
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
..+|++.+.||+|+||.||+|+.. +++.||+|..... ....|+.++++++||||+++++++...+..++||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 457999999999999999999775 5778999975432 2346899999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+. ++|.+++.... ..+++..+..|+.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 137 e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 137 PHYS-SDLYTYLTKRS----RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EccC-CcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 9995 58888875432 358899999999999999999996 899999999999999999999999999987533
Q ss_pred CCCCcccccccccCCcccccccccccC
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
.. .......||+.|+|||++.+..
T Consensus 209 ~~---~~~~~~~gt~~y~aPE~~~~~~ 232 (357)
T PHA03209 209 VA---PAFLGLAGTVETNAPEVLARDK 232 (357)
T ss_pred cC---cccccccccccccCCeecCCCC
Confidence 21 1123456999999999987643
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-24 Score=223.43 Aligned_cols=181 Identities=29% Similarity=0.496 Sum_probs=147.7
Q ss_pred hcCCcccceecccccEEEEEEEEc------CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCe
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 662 (779)
.++|++.+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 457889999999999999999764 24689999986443 23345678899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhHhhhcccCC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEE
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEEG-----LKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 737 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 737 (779)
.++||||+++++|.+++....... ...+++..++.++.|++.||.|||+ .+|+||||||+||++++++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEE
Confidence 999999999999999986543221 2246888999999999999999995 89999999999999999999999
Q ss_pred EeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 738 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+|||+++...............++..|+|||++.+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 196 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG 196 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcC
Confidence 999998765443222222334567899999988643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.9e-24 Score=220.07 Aligned_cols=178 Identities=27% Similarity=0.434 Sum_probs=150.1
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
++|++.+.||+|+||.||+|... +++.||+|.++.... .....+++.+|++++++++|++|+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999876 789999998865332 2334677899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++++|.+++...... ...+++.+++.++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||+++...
T Consensus 82 e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQ-KRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhccc-CCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 999999999988653322 2357899999999999999999996 899999999999999999999999999987654
Q ss_pred CCCCcccccccccCCccccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.... ......|++.|+|||++.+.
T Consensus 158 ~~~~--~~~~~~~~~~y~apE~~~~~ 181 (267)
T cd08224 158 SKTT--AAHSLVGTPYYMSPERIHEN 181 (267)
T ss_pred CCCc--ccceecCCccccCHHHhccC
Confidence 3221 12334688999999988654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-24 Score=224.16 Aligned_cols=180 Identities=29% Similarity=0.509 Sum_probs=147.2
Q ss_pred cCCcccceecccccEEEEEEEEc------CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 663 (779)
.+|.+.+.||+|+||.||+|... ++..+++|.+.... ....+.+.+|++++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 46888899999999999999642 34568899886543 33446789999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhhccc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCC
Q 004020 664 LLVYEYMPQGTLSRHLFNRKE-----------EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 732 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~ 732 (779)
++||||+++++|.+++..... .....+++..++.++.||+.|++|||+ ++|+||||||+||+++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccC
Confidence 999999999999999865431 112247899999999999999999996 899999999999999999
Q ss_pred CcEEEEeeccceecCCCCCcccccccccCCcccccccccccC
Q 004020 733 MRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 733 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
+.+||+|||+++...............++..|+|||++.+..
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 201 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK 201 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCC
Confidence 999999999997654432222233445788999999886543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=217.17 Aligned_cols=174 Identities=25% Similarity=0.385 Sum_probs=147.5
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
+|++.+.||+|+||.||++... +++.+|+|.++... .....+.+.+|+.+++.++||||+++++.+.+++..++||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 5788999999999999999765 68899999986443 234556788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
++++++.+++..... ..+++..++.++.|++.||.|||+ ++|+|+||||+||++++++.++++|||.++.....
T Consensus 80 ~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 80 CDGGDLMQKIKLQRG---KLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred CCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 999999988854322 247888999999999999999996 89999999999999999999999999998866543
Q ss_pred CCcccccccccCCccccccccccc
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. ......|++.|+|||++.+.
T Consensus 154 ~~--~~~~~~~~~~~~aPE~~~~~ 175 (255)
T cd08219 154 GA--YACTYVGTPYYVPPEIWENM 175 (255)
T ss_pred cc--ccccccCCccccCHHHHccC
Confidence 22 12345689999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=224.52 Aligned_cols=173 Identities=29% Similarity=0.423 Sum_probs=138.7
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcC---CCCccceEeeEEEeC-----C
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV---RHRHLVGLLGYCLDG-----N 661 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~-----~ 661 (779)
+|++.+.||+|+||.||+|+.. +++.||+|.++...........+.+|+++++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999765 688999999875433332334556777777665 699999999988642 3
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeec
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 741 (779)
..++||||+++ +|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP---PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccC
Confidence 57899999974 88888754332 247899999999999999999996 899999999999999999999999999
Q ss_pred cceecCCCCCcccccccccCCccccccccccc
Q 004020 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 742 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+++...... ......||..|+|||++.+.
T Consensus 154 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~ 182 (288)
T cd07863 154 LARIYSCQM---ALTPVVVTLWYRAPEVLLQS 182 (288)
T ss_pred ccccccCcc---cCCCccccccccCchHhhCC
Confidence 998664321 12345689999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=224.87 Aligned_cols=179 Identities=25% Similarity=0.385 Sum_probs=145.1
Q ss_pred CCcccceecccccEEEEEEEEc------CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEE
Q 004020 591 NFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 664 (779)
+|.+.+.||+|+||.||+|... ++..||+|++.... .....+.+.+|+.++..++||||+++++++...+..+
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 4777889999999999999753 25789999987543 2334467889999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhhccc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC
Q 004020 665 LVYEYMPQGTLSRHLFNRKE-----------EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 733 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 733 (779)
+++||+++++|.+++..+.. .....+++..+..++.|++.||+|+|+ ++|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCC
Confidence 99999999999999853321 112347888899999999999999996 8999999999999999999
Q ss_pred cEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 734 RAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 734 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.+||+|||+++...............+++.|+|||++.+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 201 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG 201 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcC
Confidence 9999999998865443222222334567899999998543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-25 Score=254.09 Aligned_cols=182 Identities=30% Similarity=0.438 Sum_probs=154.9
Q ss_pred HHHhhcCCcccceecccccEEEEEEE-EcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeE
Q 004020 585 LRNVTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (779)
Q Consensus 585 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 663 (779)
++.+.-+|+....||.|.||.||-|. ..+|+..|+|.++...........+.+|+.++..++|||+|++||+-.+++..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 45566788999999999999999995 45789999999976655556667889999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccc
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 743 (779)
+|.||||++|+|.+.+...+ ..++.....+..|++.|+.|||+ .|||||||||+||+++.+|.+|++|||.|
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gr-----i~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccce
Confidence 99999999999999985543 35666667788999999999995 89999999999999999999999999999
Q ss_pred eecCCCCCc--ccccccccCCcccccccccccC
Q 004020 744 RLAPDNGKH--SIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 744 ~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~ 774 (779)
..+..+... ..-....||+.|||||++.+..
T Consensus 1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~ 1414 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTK 1414 (1509)
T ss_pred eEecCchhcCCHHHHhhcCCchhcCchhhcccc
Confidence 887654211 1123468999999999998764
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=218.11 Aligned_cols=177 Identities=28% Similarity=0.423 Sum_probs=147.1
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccC---hhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS---EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
++|++.+.||+|++|.||+|... +++.||+|.+...... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46889999999999999999764 6899999998654322 1234578899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||||+++++|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||+++.
T Consensus 82 v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEEECCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 999999999999885432 47888899999999999999996 8999999999999999999999999999876
Q ss_pred cCCCCCcc-cccccccCCcccccccccccC
Q 004020 746 APDNGKHS-IETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 746 ~~~~~~~~-~~~~~~gt~~y~APE~l~~~~ 774 (779)
........ ......|+..|+|||++.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 183 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEG 183 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCC
Confidence 54321111 112345788999999987653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-24 Score=222.56 Aligned_cols=176 Identities=33% Similarity=0.548 Sum_probs=149.2
Q ss_pred hhcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
...+|++.+.||+|+||.||+|...++..+|+|.+.... .....++.+|+.+++.++||||+++++++...+..++||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 356789999999999999999998889999999987553 234467889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++++|.+++..... ..+++..+..++.|++.||+|||+ ++++||||||+||++++++.+||+|||.+....
T Consensus 82 e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 82 ELMEKGSLLAFLRSPEG---QVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIK 155 (261)
T ss_pred eecccCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcC
Confidence 99999999999965432 357899999999999999999996 899999999999999999999999999987664
Q ss_pred CCCCcccccccccCCccccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.... ......++..|+|||++.+.
T Consensus 156 ~~~~--~~~~~~~~~~~~~PE~~~~~ 179 (261)
T cd05148 156 EDVY--LSSDKKIPYKWTAPEAASHG 179 (261)
T ss_pred Cccc--cccCCCCceEecCHHHHccC
Confidence 3211 11233467789999987653
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-24 Score=224.10 Aligned_cols=180 Identities=24% Similarity=0.451 Sum_probs=145.3
Q ss_pred hcCCcccceecccccEEEEEEEEc-----------------CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccc
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-----------------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 651 (779)
.++|++.+.||+|+||.||+|+.. ++..||+|.+.... ......++.+|+.+++.++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 357999999999999999998532 23468999887542 344556889999999999999999
Q ss_pred eEeeEEEeCCeEEEEEEecCCCChhhHhhhcccCC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCC
Q 004020 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEG------LKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPS 725 (779)
Q Consensus 652 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~ 725 (779)
++++++...+..++||||+++++|.+++....... ...+++.++..++.|++.||+|||+ .+++||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChh
Confidence 99999999999999999999999999986643211 1247788899999999999999996 89999999999
Q ss_pred CEEEcCCCcEEEEeeccceecCCCCCcccccccccCCcccccccccc
Q 004020 726 NILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 726 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
||++++++.++|+|||+++...............+++.|+|||+..+
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 206 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL 206 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc
Confidence 99999999999999999886543322222222345678999997654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.9e-24 Score=221.22 Aligned_cols=171 Identities=27% Similarity=0.418 Sum_probs=135.9
Q ss_pred eecccccEEEEEEEEcCCc---EEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCCC
Q 004020 597 VLGRGGFGTVYKGELHDGT---KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQG 673 (779)
Q Consensus 597 ~lg~G~~g~Vy~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 673 (779)
.||+|+||.||+|+..++. .+++|.+.... .....+.+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 5999999999999755433 45566654332 2344578999999999999999999999999999999999999999
Q ss_pred ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCcc
Q 004020 674 TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753 (779)
Q Consensus 674 sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 753 (779)
+|.+++.+.... ....++..+..++.||++||+|||+ .+++||||||+||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 81 DLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred cHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 999998654322 2346677788999999999999996 899999999999999999999999999976432221111
Q ss_pred cccccccCCcccccccccc
Q 004020 754 IETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 754 ~~~~~~gt~~y~APE~l~~ 772 (779)
......|+..|+|||++..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~ 175 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGE 175 (268)
T ss_pred cccCCcCcccccCchhccc
Confidence 2234468899999999853
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-24 Score=225.83 Aligned_cols=176 Identities=23% Similarity=0.356 Sum_probs=145.6
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
+|+..+.||+|+||.||+|+.. +|+.||+|++............+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999875 689999999875443333345678899999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
++ ++|.+++.... ..+++..++.++.||++||.|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 81 CD-QDLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred CC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 97 47877765432 258899999999999999999996 89999999999999999999999999998765432
Q ss_pred CCcccccccccCCcccccccccccCCC
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAETSGM 776 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~~~~ 776 (779)
.. ......+++.|+|||++.+...+
T Consensus 153 ~~--~~~~~~~~~~y~aPE~~~~~~~~ 177 (284)
T cd07839 153 VR--CYSAEVVTLWYRPPDVLFGAKLY 177 (284)
T ss_pred CC--CcCCCccccCCcChHHHhCCccc
Confidence 11 12234578999999998775543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=8e-24 Score=223.64 Aligned_cols=168 Identities=29% Similarity=0.269 Sum_probs=131.0
Q ss_pred HhhcCCcccceecccccEEEEEEEEc--CCcEEEEEEeccccc---ChhHHHHHHHHHHHHHcCCCCccce-EeeEEEeC
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGELH--DGTKIAVKRMESAVV---SEKGFAEFKSEIAVLTKVRHRHLVG-LLGYCLDG 660 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~ 660 (779)
...++|++.+.||+|+||+||+|+.. +++.||||++..... .....+.+.+|++++++++|+|++. +++ .
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~ 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----T 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----c
Confidence 45678999999999999999999765 577789998753311 2334567999999999999999985 443 2
Q ss_pred CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCC-CCCCEEEcCCCcEEEEe
Q 004020 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDL-KPSNILLGDDMRAKVAD 739 (779)
Q Consensus 661 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDl-kp~NIll~~~~~~kl~D 739 (779)
+..|+||||+++++|.... . .. ...++.|+++||+|||+ +||+|||| ||+|||++.++++||+|
T Consensus 91 ~~~~LVmE~~~G~~L~~~~----~-----~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR----P-----HG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred CCcEEEEEccCCCCHHHhC----c-----cc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEE
Confidence 4579999999999996321 0 11 14678899999999996 89999999 99999999999999999
Q ss_pred eccceecCCCCCccc------ccccccCCccccccccccc
Q 004020 740 FGLVRLAPDNGKHSI------ETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 740 FG~a~~~~~~~~~~~------~~~~~gt~~y~APE~l~~~ 773 (779)
||+|+.+...+.... -+...+++.|+|||++..+
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999997755432111 1345689999999998654
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.3e-24 Score=219.99 Aligned_cols=176 Identities=28% Similarity=0.471 Sum_probs=144.8
Q ss_pred cCCcccceecccccEEEEEEEEc----CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
.+|++.+.||+|+||.||+|+.. .+..+|+|.++... .....+.+.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46888999999999999999764 23479999886543 23445688999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||||+++++|.+++.... ..+++.+++.++.|++.|++|||+ .+++||||||+||+++.++.++|+|||+++.
T Consensus 83 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 83 VTEYMENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred EEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 999999999999985432 247889999999999999999996 8999999999999999999999999999987
Q ss_pred cCCCCCccc-ccccccCCccccccccccc
Q 004020 746 APDNGKHSI-ETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 746 ~~~~~~~~~-~~~~~gt~~y~APE~l~~~ 773 (779)
......... .....++..|+|||++.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~ 184 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccC
Confidence 654322111 1122345689999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.4e-24 Score=222.77 Aligned_cols=175 Identities=25% Similarity=0.414 Sum_probs=147.6
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
++|++.+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.++++++||||+++++.+...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 46888999999999999999876 78999999886542 34445778999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++++|.+++..... ...+++..+..++.|++.||.|||+ +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 80 YMDAGSLDKLYAGGVA--TEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred ecCCCCHHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 9999999888854321 2358899999999999999999996 35899999999999999999999999999876533
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. .....|++.|+|||++.+.
T Consensus 156 ~~----~~~~~~~~~y~aPE~~~~~ 176 (286)
T cd06622 156 SL----AKTNIGCQSYMAPERIKSG 176 (286)
T ss_pred Cc----cccCCCccCccCcchhcCC
Confidence 21 1234588899999998543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9e-24 Score=225.19 Aligned_cols=181 Identities=29% Similarity=0.491 Sum_probs=145.5
Q ss_pred hcCCcccceecccccEEEEEEEEc--------CCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEe
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH--------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLD 659 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 659 (779)
.++|.+.+.||+|+||.||+|+.. ....+|+|.+.... ......++.+|+++++++ +||||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 357888999999999999999642 24578999887543 234556788999999999 59999999999999
Q ss_pred CCeEEEEEEecCCCChhhHhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEE
Q 004020 660 GNERLLVYEYMPQGTLSRHLFNRKEE-----------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 728 (779)
Q Consensus 660 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIl 728 (779)
.+..++||||+++|+|.+++...... ....+++..+..++.|++.||+|||+ ++++||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEE
Confidence 99999999999999999999764321 12357889999999999999999996 89999999999999
Q ss_pred EcCCCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 729 LGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 729 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+++++.+||+|||.++...............++..|+|||++.+.
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 211 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR 211 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccC
Confidence 999999999999999865432211111222345689999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.4e-24 Score=219.24 Aligned_cols=174 Identities=32% Similarity=0.515 Sum_probs=143.4
Q ss_pred hcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
.++|++.++||+|+||.||+|+..++..||+|++..... ..+++.+|++++++++||||+++++++. .+..++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE 80 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEE
Confidence 357999999999999999999887777899999875432 2356889999999999999999999874 456799999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++++|.+++..... ..+++..+..++.|+++||+|+|+ .+++||||||+||++++++.+||+|||.++....
T Consensus 81 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 81 YMSKGSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred cCCCCcHHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 9999999999865321 247889999999999999999996 8999999999999999999999999999986644
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
... .......++..|+|||+..+.
T Consensus 155 ~~~-~~~~~~~~~~~y~~PE~~~~~ 178 (262)
T cd05071 155 NEY-TARQGAKFPIKWTAPEAALYG 178 (262)
T ss_pred ccc-ccccCCcccceecCHhHhccC
Confidence 321 111233467789999987543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-27 Score=239.82 Aligned_cols=264 Identities=24% Similarity=0.386 Sum_probs=208.7
Q ss_pred cEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEccc
Q 004020 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145 (779)
Q Consensus 66 ~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 145 (779)
.+..+++++|+++ .+.+.+.+|..|++|++++|++...+|+++.+..++.|+.++|++..+|+. ...+.+|..|+.++
T Consensus 46 ~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~~lp~aig~l~~l~~l~vs~n~ls~lp~~-i~s~~~l~~l~~s~ 123 (565)
T KOG0472|consen 46 DLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLSQLPAAIGELEALKSLNVSHNKLSELPEQ-IGSLISLVKLDCSS 123 (565)
T ss_pred chhhhhhccCchh-hccHhhhcccceeEEEeccchhhhCCHHHHHHHHHHHhhcccchHhhccHH-Hhhhhhhhhhhccc
Confidence 3678899999998 666778999999999999999998889999999999999999999999987 67888999999999
Q ss_pred CCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCC
Q 004020 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSK 225 (779)
Q Consensus 146 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~ 225 (779)
|.+.. .|..++.+..|..++..+|+++ +.|+.++ .+.+|..|++.+|+++...|..+
T Consensus 124 n~~~e--l~~~i~~~~~l~dl~~~~N~i~-slp~~~~--~~~~l~~l~~~~n~l~~l~~~~i------------------ 180 (565)
T KOG0472|consen 124 NELKE--LPDSIGRLLDLEDLDATNNQIS-SLPEDMV--NLSKLSKLDLEGNKLKALPENHI------------------ 180 (565)
T ss_pred cceee--cCchHHHHhhhhhhhccccccc-cCchHHH--HHHHHHHhhccccchhhCCHHHH------------------
Confidence 99975 8888999999999999999998 5566555 68889999999999985444333
Q ss_pred CCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCCCC
Q 004020 226 LNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNS 305 (779)
Q Consensus 226 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~ 305 (779)
+|+.|++||..+|-++..||+++++.+|.-|||++|+|. .+| +|..+..|..|+++.|++.-.+.+
T Consensus 181 ---------~m~~L~~ld~~~N~L~tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae--- 246 (565)
T KOG0472|consen 181 ---------AMKRLKHLDCNSNLLETLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAE--- 246 (565)
T ss_pred ---------HHHHHHhcccchhhhhcCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHH---
Confidence 488899999999999988889999999999999999998 677 888999999999999988622111
Q ss_pred CcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCcccccc
Q 004020 306 PVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGT 385 (779)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ 385 (779)
.++..+++.+|||.+|++. .
T Consensus 247 -----------------------------------------------------------~~~~L~~l~vLDLRdNklk-e 266 (565)
T KOG0472|consen 247 -----------------------------------------------------------HLKHLNSLLVLDLRDNKLK-E 266 (565)
T ss_pred -----------------------------------------------------------Hhcccccceeeeccccccc-c
Confidence 1222335566666666666 4
Q ss_pred ccccccccccCCeEeccCccccccCCccCCCCCCCCceeccCCcc
Q 004020 386 ISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430 (779)
Q Consensus 386 ~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l 430 (779)
.|+++.-+.+|+.||||+|.|+ .+|.+++++ .|+.|.|.+|++
T Consensus 267 ~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPl 309 (565)
T KOG0472|consen 267 VPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPL 309 (565)
T ss_pred CchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCch
Confidence 6666666666666666666666 556666666 666666666655
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.4e-24 Score=221.12 Aligned_cols=176 Identities=30% Similarity=0.442 Sum_probs=142.6
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCc----EEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGT----KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 663 (779)
.++|++.+.||+|+||.||+|++. +++ .||+|.+.... ......++.+|+.+++.+.||||+++++++.. ...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV 83 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence 357888999999999999999753 444 48999886543 33445678899999999999999999999875 457
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccc
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 743 (779)
+++|||+++|+|.+++.... ..+++..++.++.||+.||+|||+ ++|+||||||+||++++++.+||+|||++
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~ 156 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLA 156 (279)
T ss_pred EEEEEcCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCce
Confidence 89999999999999986532 257899999999999999999996 89999999999999999999999999999
Q ss_pred eecCCCCCcccccccccCCccccccccccc
Q 004020 744 RLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+...............+++.|+|||++.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 186 (279)
T cd05109 157 RLLDIDETEYHADGGKVPIKWMALESILHR 186 (279)
T ss_pred eecccccceeecCCCccchhhCCHHHhccC
Confidence 876543221111223356789999998654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=225.84 Aligned_cols=174 Identities=19% Similarity=0.282 Sum_probs=142.0
Q ss_pred ccceeccc--ccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEec
Q 004020 594 EENVLGRG--GFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYM 670 (779)
Q Consensus 594 ~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 670 (779)
+.++||+| +|++||+++. .+++.||+|++..........+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7899999976 47899999999766544455567888999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCC
Q 004020 671 PQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750 (779)
Q Consensus 671 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 750 (779)
++++|.+++..... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.++++||+.+......+
T Consensus 82 ~~~~l~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 82 AYGSAKDLICTHFM---DGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred CCCcHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 99999999865432 247899999999999999999996 899999999999999999999999998754332211
Q ss_pred Ccc-----cccccccCCccccccccccc
Q 004020 751 KHS-----IETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 751 ~~~-----~~~~~~gt~~y~APE~l~~~ 773 (779)
... ......++..|+|||++.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 183 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQN 183 (327)
T ss_pred ccccccccccccccceecccChHHhhcc
Confidence 100 11223567889999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=227.35 Aligned_cols=175 Identities=22% Similarity=0.331 Sum_probs=146.5
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc------ChhHHHHHHHHHHHHHcCC---CCccceEeeEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV------SEKGFAEFKSEIAVLTKVR---HRHLVGLLGYCL 658 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~ 658 (779)
..+|...+.+|+|+||.|+.|.++ ....|++|.+.+... .+...-..--|+.+|+.++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 346899999999999999999776 466789998876542 1222234567999999997 999999999999
Q ss_pred eCCeEEEEEEecC-CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEE
Q 004020 659 DGNERLLVYEYMP-QGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 737 (779)
Q Consensus 659 ~~~~~~lv~e~~~-~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 737 (779)
+++.+|++||-.. +.+|.+++..+ ..+++..+..|++||+.|+++||+ ++|||||||-+|+.++.+|-+||
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~k-----p~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~kl 711 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFK-----PRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKL 711 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhcc-----CccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEE
Confidence 9999999999764 44888888443 368999999999999999999996 89999999999999999999999
Q ss_pred EeeccceecCCCCCcccccccccCCcccccccccccCC
Q 004020 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 738 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
+|||.|...... ....++||..|.|||++.|+..
T Consensus 712 idfgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y 745 (772)
T KOG1152|consen 712 IDFGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKY 745 (772)
T ss_pred eeccchhhhcCC----CcceeeeeccccchhhhCCCcc
Confidence 999998766543 2345789999999999987653
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.4e-24 Score=227.08 Aligned_cols=180 Identities=29% Similarity=0.478 Sum_probs=145.5
Q ss_pred cCCcccceecccccEEEEEEEEc--------CCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeC
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH--------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDG 660 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 660 (779)
.+|++.+.||+|+||.||+|+.. .+..||+|.+.... .....+++.+|+++++++ +||||+++++++...
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 46889999999999999999642 12368999876432 344567889999999999 799999999999999
Q ss_pred CeEEEEEEecCCCChhhHhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEE
Q 004020 661 NERLLVYEYMPQGTLSRHLFNRKEE-----------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 729 (779)
Q Consensus 661 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll 729 (779)
+..+++|||+++|+|.+++..+... ....+++.+++.++.|++.||+|||+ ++++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEE
Confidence 9999999999999999998764321 12347888999999999999999996 899999999999999
Q ss_pred cCCCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 730 GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 730 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
++++.+||+|||+++...............++..|+|||++.+.
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 211 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR 211 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC
Confidence 99999999999999866443222112223345789999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.5e-24 Score=218.80 Aligned_cols=165 Identities=23% Similarity=0.408 Sum_probs=134.5
Q ss_pred ceecccccEEEEEEEEcC-------------CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCe
Q 004020 596 NVLGRGGFGTVYKGELHD-------------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 662 (779)
+.||+|+||.||+|...+ ...|++|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 468999999999997532 2358888876543 3344578889999999999999999999999999
Q ss_pred EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCc-------E
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR-------A 735 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~-------~ 735 (779)
.++||||+++++|..++.... ..+++..++.++.||++||+|||+ ++|+||||||+||+++.++. +
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred CEEEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCcee
Confidence 999999999999988875432 257889999999999999999996 89999999999999987654 8
Q ss_pred EEEeeccceecCCCCCcccccccccCCcccccccccccCC
Q 004020 736 KVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 736 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
|++|||++...... ....++..|+|||++.+...
T Consensus 152 ~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~ 185 (262)
T cd05077 152 KLSDPGIPITVLSR------QECVERIPWIAPECVEDSKN 185 (262)
T ss_pred EeCCCCCCccccCc------ccccccccccChhhhcCCCC
Confidence 99999998654322 22457889999998864443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=221.09 Aligned_cols=175 Identities=27% Similarity=0.533 Sum_probs=144.2
Q ss_pred CCcccceecccccEEEEEEEE-----cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC--CeE
Q 004020 591 NFSEENVLGRGGFGTVYKGEL-----HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--NER 663 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 663 (779)
-|++.+.||+|+||.||+|+. .++..||+|.++... .......+.+|++++++++||||+++++++... ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 467889999999999999974 357889999986543 234456799999999999999999999998875 568
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccc
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 743 (779)
++||||+++++|.+++.... ..+++..+..++.||+.||+|||+ ++++||||||+||+++.++.+||+|||++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccc
Confidence 89999999999999985432 257899999999999999999996 89999999999999999999999999998
Q ss_pred eecCCCCCc-ccccccccCCccccccccccc
Q 004020 744 RLAPDNGKH-SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 744 ~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~ 773 (779)
+........ .......++..|+|||++.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~ 187 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccC
Confidence 866443221 112234577789999987654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.7e-24 Score=223.88 Aligned_cols=179 Identities=29% Similarity=0.455 Sum_probs=146.6
Q ss_pred hcCCcccceecccccEEEEEEEEc------CCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCC
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGN 661 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 661 (779)
.++|.+.+.||+|+||.||+|... ++..||+|.++... .....+.+.+|+++++++ +||||+++++++...+
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 357889999999999999999642 35579999887543 233456789999999999 7999999999999999
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeec
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 741 (779)
..++||||+++++|.+++..... ..+++.++..++.|++.||+|||+ ++|+|+||||+||+++.++.+|++|||
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCc
Confidence 99999999999999999865332 237899999999999999999996 899999999999999999999999999
Q ss_pred cceecCCCCCcccccccccCCcccccccccccC
Q 004020 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 742 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
+++...............++..|+|||++.+..
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 219 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCV 219 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCC
Confidence 998664432211222334678899999886543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.4e-24 Score=223.79 Aligned_cols=175 Identities=27% Similarity=0.427 Sum_probs=147.5
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
++|++.+.||+|+||.||+|... +++.||+|++..........+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999875 58999999987654333345678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|++++++.++.... ..+++..++.++.||++||+|||+ .+++||||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 99998888765332 247899999999999999999996 7999999999999999999999999999886644
Q ss_pred CCCcccccccccCCcccccccccccC
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
.. .......++..|+|||++.+..
T Consensus 153 ~~--~~~~~~~~~~~y~aPE~~~~~~ 176 (286)
T cd07846 153 PG--EVYTDYVATRWYRAPELLVGDT 176 (286)
T ss_pred Cc--cccCcccceeeccCcHHhcccc
Confidence 32 1223356889999999987644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=220.52 Aligned_cols=175 Identities=29% Similarity=0.554 Sum_probs=142.7
Q ss_pred cCCcccceecccccEEEEEEEEc-----CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC--Ce
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--NE 662 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 662 (779)
.+|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 47888999999999999999743 57899999986543 44557789999999999999999999987543 46
Q ss_pred EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecc
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 742 (779)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcc
Confidence 789999999999999985432 247899999999999999999996 8999999999999999999999999999
Q ss_pred ceecCCCCCcc-cccccccCCccccccccccc
Q 004020 743 VRLAPDNGKHS-IETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 743 a~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~ 773 (779)
++......... ......++..|+|||++.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 186 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTES 186 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhccC
Confidence 98765432211 11122344569999998654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=218.66 Aligned_cols=174 Identities=31% Similarity=0.490 Sum_probs=144.9
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
.+|++.+.||+|+||.||+|... +++.||+|.+... .....++.+|++++++++||||+++++++...+..+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 45788899999999999999765 5889999988643 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++++|.+++..... ..+++..++.++.|+++||+|||+ .+++||||||+||++++++.+||+|||+++....
T Consensus 83 ~~~~~~L~~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 83 FMTYGNLLDYLRECNR---QEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred eCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 9999999999855332 357889999999999999999996 8999999999999999999999999999886644
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
... .......++..|+|||++.+.
T Consensus 157 ~~~-~~~~~~~~~~~y~aPE~~~~~ 180 (263)
T cd05052 157 DTY-TAHAGAKFPIKWTAPESLAYN 180 (263)
T ss_pred cee-eccCCCCCccccCCHHHhccC
Confidence 211 111222346789999988654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.6e-24 Score=222.24 Aligned_cols=184 Identities=25% Similarity=0.341 Sum_probs=149.6
Q ss_pred eeHHHHHHhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEE
Q 004020 580 ISIQVLRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYC 657 (779)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 657 (779)
+.++.+....++|++.+.||+|+||.||+|... +++.+|+|++.... ....++.+|+.+++++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 445666678889999999999999999999764 57899999876432 2235678899999999 699999999988
Q ss_pred E-----eCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCC
Q 004020 658 L-----DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 732 (779)
Q Consensus 658 ~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~ 732 (779)
. .++..++||||+++++|.+++...... ...+++..+..++.|+++||.|||+ .+|+||||||+||+++++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~ 160 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR-GERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTE 160 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhcc-CccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCC
Confidence 4 345689999999999999987643222 2357889999999999999999996 899999999999999999
Q ss_pred CcEEEEeeccceecCCCCCcccccccccCCcccccccccc
Q 004020 733 MRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 733 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
+.+||+|||+++....... ......|++.|+|||++..
T Consensus 161 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~ 198 (286)
T cd06638 161 GGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIAC 198 (286)
T ss_pred CCEEEccCCceeecccCCC--ccccccCCCcccChhhhch
Confidence 9999999999887643221 1233468999999999853
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=207.08 Aligned_cols=175 Identities=27% Similarity=0.425 Sum_probs=142.7
Q ss_pred cccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCCeEEEEEEec
Q 004020 593 SEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLLVYEYM 670 (779)
Q Consensus 593 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 670 (779)
+....||.|+.|+|++++.+ +|...|||.+.+.. .....+++...++++.+.+ .|+||+.+|||..+...++.||.|
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 34567999999999999876 58889999998765 3556678888888877775 999999999999999999999998
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCC
Q 004020 671 PQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750 (779)
Q Consensus 671 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 750 (779)
.. -.+.++ .+.. .++++..+-++...++.||.||.+ +++|+|||+||+|||+|+.|++|+||||++-.+.+..
T Consensus 174 s~-C~ekLl-krik---~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 174 ST-CAEKLL-KRIK---GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HH-HHHHHH-HHhc---CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 42 333333 3322 368888888999999999999998 7899999999999999999999999999987665432
Q ss_pred CcccccccccCCcccccccccccCCCCC
Q 004020 751 KHSIETRLAGTFGYLAPEYAAETSGMTW 778 (779)
Q Consensus 751 ~~~~~~~~~gt~~y~APE~l~~~~~~t~ 778 (779)
..+..+|.+.|||||.+.-+....|
T Consensus 247 ---AhtrsAGC~~YMaPERidp~~~~kY 271 (391)
T KOG0983|consen 247 ---AHTRSAGCAAYMAPERIDPPDKPKY 271 (391)
T ss_pred ---ccccccCCccccCccccCCCCCCcc
Confidence 2355679999999999987655444
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=215.61 Aligned_cols=169 Identities=33% Similarity=0.512 Sum_probs=140.4
Q ss_pred ceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCCCCh
Q 004020 596 NVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTL 675 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 675 (779)
+.||+|+||.||+|...++..+|+|.+.... .......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 4689999999999998888999999987543 233445788999999999999999999999999999999999999999
Q ss_pred hhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCcccc
Q 004020 676 SRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE 755 (779)
Q Consensus 676 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 755 (779)
.+++.... ..+++..+..++.|++.||.|+|+ ++++||||||+||++++++.+||+|||++....... ....
T Consensus 80 ~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~ 151 (250)
T cd05085 80 LSFLRKKK----DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSS 151 (250)
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccc-cccC
Confidence 99885432 247899999999999999999995 899999999999999999999999999987643321 1111
Q ss_pred cccccCCccccccccccc
Q 004020 756 TRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 756 ~~~~gt~~y~APE~l~~~ 773 (779)
....++..|+|||++.+.
T Consensus 152 ~~~~~~~~y~aPE~~~~~ 169 (250)
T cd05085 152 GLKQIPIKWTAPEALNYG 169 (250)
T ss_pred CCCCCcccccCHHHhccC
Confidence 222346789999998654
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-23 Score=219.92 Aligned_cols=173 Identities=28% Similarity=0.426 Sum_probs=146.5
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.+.|++.+.||+|+||.||+|+.. ++..|++|.+.... ....+.+.+|+++++.++||||+++++++..++..++||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 467899999999999999999875 58899999986542 445677899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||++++++..++.+.. ..+++..+..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 89 e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 89 EFCPGGAVDAIMLELD----RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred ecCCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 9999999988775432 247899999999999999999995 899999999999999999999999999987543
Q ss_pred CCCCcccccccccCCcccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
... .......+++.|+|||++.+
T Consensus 162 ~~~--~~~~~~~~~~~y~aPE~~~~ 184 (292)
T cd06644 162 KTL--QRRDSFIGTPYWMAPEVVMC 184 (292)
T ss_pred ccc--cccceecCCccccCceeecc
Confidence 321 11233468899999999853
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=217.29 Aligned_cols=174 Identities=35% Similarity=0.564 Sum_probs=146.3
Q ss_pred ceecccccEEEEEEEEcC----CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecC
Q 004020 596 NVLGRGGFGTVYKGELHD----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMP 671 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 671 (779)
+.||+|+||.||+|.... +..|++|.+....... ..+++.+|++.++.++|+||+++++++......++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 469999999999997753 7889999987654322 46789999999999999999999999999999999999999
Q ss_pred CCChhhHhhhcccC----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 672 QGTLSRHLFNRKEE----GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 672 ~gsL~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
+++|.+++...... ....+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||.++...
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999998665211 02368999999999999999999995 899999999999999999999999999998776
Q ss_pred CCCCcccccccccCCccccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
............++..|+|||.+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~ 182 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDG 182 (262)
T ss_pred cccccccccCCCcCccccCHHHhccC
Confidence 54322223345678899999988764
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=221.92 Aligned_cols=181 Identities=34% Similarity=0.507 Sum_probs=147.1
Q ss_pred hcCCcccceecccccEEEEEEEEc------CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCe
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 662 (779)
.++|++.+.||+|+||.||+|... ++..||+|.+.... ......++.+|+.++++++||||+++++++..++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 357899999999999999999753 46789999887543 23445678999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhHhhhccc-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCC
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKE-----------------EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPS 725 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~-----------------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~ 725 (779)
.++||||+++++|.+++..... .....+++..++.++.|++.||+|||+ ++++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHh
Confidence 9999999999999999965321 112347888899999999999999996 89999999999
Q ss_pred CEEEcCCCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 726 NILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 726 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
||++++++.+||+|||+++...............++..|+|||++.+.
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 207 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN 207 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC
Confidence 999999999999999998765432211112223456789999987654
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=198.71 Aligned_cols=177 Identities=28% Similarity=0.411 Sum_probs=144.9
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 666 (779)
.++......||+|++|.|-+.++. +|...|+|++.... ..+..++..+|+.+..+. .+|.+|++||.+......|+.
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 344555678999999999988764 78999999998665 355667788888887665 699999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
||.|. .+|..+..+-...+ ..+++...-+|+..+++||.|||+ +..+||||+||+||||+.+|++|+||||++-.+
T Consensus 124 ME~M~-tSldkfy~~v~~~g-~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 124 MELMD-TSLDKFYRKVLKKG-GTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred HHHhh-hhHHHHHHHHHhcC-CcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence 99995 47776655433333 368889999999999999999998 689999999999999999999999999998876
Q ss_pred CCCCCcccccccccCCccccccccccc
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.+.- ..+-..|...|||||.+..+
T Consensus 200 ~dSi---Akt~daGCkpYmaPEri~~e 223 (282)
T KOG0984|consen 200 VDSI---AKTMDAGCKPYMAPERINPE 223 (282)
T ss_pred hhhh---HHHHhcCCCccCChhhcCcc
Confidence 5432 12334688999999998755
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=218.93 Aligned_cols=170 Identities=28% Similarity=0.433 Sum_probs=143.7
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
-|++.+.||+|+||.||+|... ++..+++|.+.... ....+.+.+|+++++.++||||+++++++..++..++||||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 3677889999999999999876 57788999886432 44557788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+++++|..++.... ..+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 156 (282)
T cd06643 84 CAGGAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 156 (282)
T ss_pred cCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccc
Confidence 99999988875422 258899999999999999999996 89999999999999999999999999998765332
Q ss_pred CCcccccccccCCccccccccc
Q 004020 750 GKHSIETRLAGTFGYLAPEYAA 771 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~ 771 (779)
. .......|++.|+|||++.
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~ 176 (282)
T cd06643 157 I--QRRDSFIGTPYWMAPEVVM 176 (282)
T ss_pred c--cccccccccccccCHhhcc
Confidence 1 1123346899999999985
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-26 Score=215.99 Aligned_cols=180 Identities=26% Similarity=0.398 Sum_probs=145.6
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC--------
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG-------- 660 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-------- 660 (779)
..|+...+||+|.||.||+|+.+ +++.||+|++-.............+|++++..++|+|++.+++.|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 35667789999999999999765 578889987754433333345678999999999999999999887542
Q ss_pred CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEee
Q 004020 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (779)
Q Consensus 661 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF 740 (779)
..+|+||++|+. +|.-++.++. ..++..++.+++.++..||.|+|. ..|+|||+||+|+||+.+|.+||+||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecc
Confidence 347999999976 8888875543 358889999999999999999995 88999999999999999999999999
Q ss_pred ccceecCCC--CCcccccccccCCcccccccccccCCCC
Q 004020 741 GLVRLAPDN--GKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 741 G~a~~~~~~--~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
|+|+.+... ......+..+-|.+|++||.+.|...++
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg 207 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYG 207 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccC
Confidence 999765432 2222345556799999999999887765
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.7e-24 Score=221.91 Aligned_cols=173 Identities=29% Similarity=0.440 Sum_probs=147.7
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.++|++.+.||+|+||.||+|... ++..+|+|.+... .....+.+.+|++++++++||||+++++++..+...++||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 467999999999999999999765 6889999998644 2445577899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++++|.+++.... ..+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 82 EFCDGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred eccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 9999999999885532 258899999999999999999996 899999999999999999999999999976553
Q ss_pred CCCCcccccccccCCcccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
.... ......|++.|+|||++..
T Consensus 155 ~~~~--~~~~~~~~~~y~~PE~~~~ 177 (280)
T cd06611 155 STLQ--KRDTFIGTPYWMAPEVVAC 177 (280)
T ss_pred cccc--ccceeecchhhcCHHHHhh
Confidence 3211 1233468999999999853
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-23 Score=215.52 Aligned_cols=175 Identities=24% Similarity=0.393 Sum_probs=147.0
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC-CeEEEEEE
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG-NERLLVYE 668 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e 668 (779)
+|++.+.||+|++|.||++... +++.||+|++..........+.+.+|++++++++|||++++++.+... ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4888999999999999999765 578899999876554455567789999999999999999999987644 45789999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++++|.+++..... ..+++.+++.++.|++.|++|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~l~~~~~---~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQKG---KLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 9999999999865332 257899999999999999999996 8999999999999999999999999999987644
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
... ......|++.|+|||++.+.
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~ 177 (257)
T cd08223 155 QCD--MASTLIGTPYYMSPELFSNK 177 (257)
T ss_pred cCC--ccccccCCcCccChhHhcCC
Confidence 321 22334688999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=217.54 Aligned_cols=174 Identities=33% Similarity=0.522 Sum_probs=144.1
Q ss_pred hcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
.++|++.+.||+|+||.||+|...++..+|+|.+..... ..+++.+|+.++++++|+||+++++++. .+..+++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 357889999999999999999888888999999876442 2356889999999999999999999875 456899999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++++|.+++..... ..+++.+++.++.|++.||+|||+ .+++||||||+||++++++.++|+|||.+.....
T Consensus 81 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 81 YMSKGSLLDFLKDGEG---RALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred ecCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 9999999999865322 247899999999999999999996 8999999999999999999999999999987644
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.... ......++..|+|||++.+.
T Consensus 155 ~~~~-~~~~~~~~~~y~aPE~~~~~ 178 (260)
T cd05070 155 NEYT-ARQGAKFPIKWTAPEAALYG 178 (260)
T ss_pred cccc-cccCCCCCccccChHHHhcC
Confidence 3211 11223456789999987543
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=217.48 Aligned_cols=175 Identities=33% Similarity=0.542 Sum_probs=146.2
Q ss_pred CCcccceecccccEEEEEEEEcCCcEEEEEEeccccc----ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 591 NFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVV----SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
+|+..+.||+|+||.||+|...+++.+|+|.+..... .......+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 5788899999999999999888899999998864421 123345688999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++++|.+++.+.. .+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.++|+|||+++..
T Consensus 81 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 99999999999985432 47888999999999999999996 78999999999999999999999999998754
Q ss_pred CCCCC----cccccccccCCccccccccccc
Q 004020 747 PDNGK----HSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 747 ~~~~~----~~~~~~~~gt~~y~APE~l~~~ 773 (779)
..... ........|+..|+|||++.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~ 183 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCC
Confidence 32111 1112234689999999998654
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=222.78 Aligned_cols=177 Identities=36% Similarity=0.542 Sum_probs=142.0
Q ss_pred cCCcccceecccccEEEEEEEEc-CCc--EEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGT--KIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 665 (779)
++|++.+.||+|+||.||+|+.+ ++. .+|+|.+.... .......+.+|++++.++ +||||+++++++..++..|+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 57888999999999999999865 444 45777765432 344556788999999999 89999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCc
Q 004020 666 VYEYMPQGTLSRHLFNRKEE-----------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 734 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 734 (779)
||||+++++|.+++...... ....+++.+++.++.||+.|++|||+ ++++||||||+||++++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCc
Confidence 99999999999998654311 12357899999999999999999995 89999999999999999999
Q ss_pred EEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 735 AKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 735 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+||+|||+++..... .......++..|+|||++.+.
T Consensus 163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~ 198 (303)
T cd05088 163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYS 198 (303)
T ss_pred EEeCccccCcccchh---hhcccCCCcccccCHHHHhcc
Confidence 999999998643211 111122346789999987654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=224.10 Aligned_cols=174 Identities=28% Similarity=0.412 Sum_probs=135.9
Q ss_pred cceecccccEEEEEEEEc---CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEe--CCeEEEEEEe
Q 004020 595 ENVLGRGGFGTVYKGELH---DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD--GNERLLVYEY 669 (779)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~ 669 (779)
..+||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 368999999999999865 45789999886543 22457789999999999999999999854 4567899999
Q ss_pred cCCCChhhHhhhccc----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEE----cCCCcEEEEeec
Q 004020 670 MPQGTLSRHLFNRKE----EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFG 741 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~----~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll----~~~~~~kl~DFG 741 (779)
+++ ++.+++..... .....+++..+..++.||+.||+|||+ .+|+||||||+||++ ++++.+||+|||
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 875 77777643221 112357888999999999999999996 899999999999999 566799999999
Q ss_pred cceecCCCCCc-ccccccccCCcccccccccccCCC
Q 004020 742 LVRLAPDNGKH-SIETRLAGTFGYLAPEYAAETSGM 776 (779)
Q Consensus 742 ~a~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~ 776 (779)
+++........ .......||+.|+|||++.+...+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 193 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHY 193 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCcc
Confidence 99876443211 112345789999999998765443
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=224.61 Aligned_cols=181 Identities=27% Similarity=0.398 Sum_probs=145.5
Q ss_pred CCcccceecccccEEEEEEEEc---CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC--CeEE
Q 004020 591 NFSEENVLGRGGFGTVYKGELH---DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--NERL 664 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 664 (779)
+|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+.+|+.++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999765 478999999876431 122335678899999999999999999999988 7899
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC----CCcEEEEee
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD----DMRAKVADF 740 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~----~~~~kl~DF 740 (779)
+||||+++ ++.+.+..........+++..++.++.||+.||+|||+ .+|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 67676654433333368899999999999999999996 89999999999999999 899999999
Q ss_pred ccceecCCCCC-cccccccccCCcccccccccccCC
Q 004020 741 GLVRLAPDNGK-HSIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 741 G~a~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
|+++....... ........+++.|+|||++.+...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 192 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARH 192 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCC
Confidence 99886644322 112234568899999998876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=219.84 Aligned_cols=163 Identities=24% Similarity=0.396 Sum_probs=132.2
Q ss_pred eecccccEEEEEEEEcC-------------------------CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccc
Q 004020 597 VLGRGGFGTVYKGELHD-------------------------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651 (779)
Q Consensus 597 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 651 (779)
.||+|+||.||+|.... ...||+|.+.... .....++.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 59999999999986421 2358888886543 23346788899999999999999
Q ss_pred eEeeEEEeCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC
Q 004020 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 731 (779)
Q Consensus 652 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~ 731 (779)
++++++......++||||+++++|..++.... ..+++..+..++.||++||+|||+ ++|+||||||+||++++
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~ 152 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLAR 152 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEec
Confidence 99999999999999999999999988885432 257889999999999999999996 89999999999999976
Q ss_pred CC-------cEEEEeeccceecCCCCCcccccccccCCcccccccccccC
Q 004020 732 DM-------RAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 732 ~~-------~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
.+ .+|++|||.+...... ....++..|+|||++.+..
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~ 196 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGN 196 (274)
T ss_pred cCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCC
Confidence 43 4899999987644221 1235778899999887643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=218.64 Aligned_cols=176 Identities=29% Similarity=0.488 Sum_probs=143.6
Q ss_pred cCCcccceecccccEEEEEEEEcC-C---cEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHD-G---TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
.+|++.+.||+|+||.||+|.... + ..||+|.+.... ......++..|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 357889999999999999997652 3 369999987543 34456789999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||||+++++|.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.
T Consensus 83 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 83 ITEFMENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred EEecCCCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccc
Confidence 999999999999885432 247889999999999999999996 8999999999999999999999999999876
Q ss_pred cCCCCCccccc-ccc--cCCccccccccccc
Q 004020 746 APDNGKHSIET-RLA--GTFGYLAPEYAAET 773 (779)
Q Consensus 746 ~~~~~~~~~~~-~~~--gt~~y~APE~l~~~ 773 (779)
........... ... .+..|+|||++.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 186 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccC
Confidence 54322211111 111 24579999998654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=218.83 Aligned_cols=178 Identities=27% Similarity=0.433 Sum_probs=148.9
Q ss_pred cCCcccceecccccEEEEEEEE-cCCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
++|++.+.||+|+||.||+|+. .+++.+|||.+..... ......++.+|+++++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4788899999999999999975 4789999998865332 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++++|.+++..... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 99999999998864322 22357899999999999999999996 899999999999999999999999999987664
Q ss_pred CCCCcccccccccCCccccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.... ......|+..|+|||++.+.
T Consensus 158 ~~~~--~~~~~~~~~~~~ape~~~~~ 181 (267)
T cd08229 158 SKTT--AAHSLVGTPYYMSPERIHEN 181 (267)
T ss_pred cCCc--ccccccCCcCccCHHHhcCC
Confidence 3321 12234688999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-23 Score=220.87 Aligned_cols=179 Identities=26% Similarity=0.336 Sum_probs=145.1
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCCe-----
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNE----- 662 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~----- 662 (779)
++|++.+.||+|+||.||+|... +++.||+|++............+.+|+.+++++. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999865 6899999998655433333467888999999995 6999999999987665
Q ss_pred EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC-CCcEEEEeec
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFG 741 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DFG 741 (779)
.|+||||+++ ++.+++..........+++..++.++.||+.||+|||+ ++|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 88888865443323468999999999999999999996 89999999999999998 8999999999
Q ss_pred cceecCCCCCcccccccccCCcccccccccccC
Q 004020 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 742 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
+++....... ......+++.|+|||++.+..
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~ 187 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGST 187 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCC
Confidence 9886543211 112335788999999886543
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=220.54 Aligned_cols=176 Identities=27% Similarity=0.386 Sum_probs=143.3
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.++|.+.+.||+|+||.||+|... +++.||+|.+..... ......+.+|+.+++.++|+||+++++++..++..++||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 468999999999999999999764 688999999865432 222345678999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+. +++.+++.... ..+.+..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 83 e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 83 EYMH-TDLAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred eccc-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 9996 67776664332 246778888999999999999996 799999999999999999999999999987643
Q ss_pred CCCCcccccccccCCcccccccccccCC
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
.... ......+++.|+|||++.+..+
T Consensus 155 ~~~~--~~~~~~~~~~y~aPE~~~~~~~ 180 (291)
T cd07870 155 IPSQ--TYSSEVVTLWYRPPDVLLGATD 180 (291)
T ss_pred CCCC--CCCCccccccccCCceeecCCC
Confidence 3221 1223457899999999876543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=219.36 Aligned_cols=180 Identities=32% Similarity=0.531 Sum_probs=146.6
Q ss_pred cCCcccceecccccEEEEEEEEc------CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 663 (779)
.+|+..++||+|+||.||+|... ++..+|+|.+.... ....+.+.+|+++++.++|+||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 46778899999999999999642 35678999876443 44557899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcccC----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEE----------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 733 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 733 (779)
+++|||+++++|.+++...... ....+++..++.++.|++.|++|||+ .+++||||||+||++++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCC
Confidence 9999999999999998654321 11347889999999999999999996 8999999999999999999
Q ss_pred cEEEEeeccceecCCCCCcccccccccCCcccccccccccC
Q 004020 734 RAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 734 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
.+||+|||+++...............+++.|+|||++.+..
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 200 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK 200 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC
Confidence 99999999987654332212222334578899999887543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=221.45 Aligned_cols=176 Identities=26% Similarity=0.402 Sum_probs=144.6
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.++|++.+.||+|++|.||+|..+ +++.||+|.+..... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc-cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 367999999999999999999765 689999999875432 122245678999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++ +|.+++.... ..+++..+..++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 83 e~~~~-~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 83 EYLDT-DLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKS 154 (291)
T ss_pred ecCCC-CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccC
Confidence 99975 8988875432 257889999999999999999996 899999999999999999999999999987543
Q ss_pred CCCCcccccccccCCcccccccccccCC
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
.... ......++..|+|||++.+...
T Consensus 155 ~~~~--~~~~~~~~~~~~aPE~~~~~~~ 180 (291)
T cd07844 155 VPSK--TYSNEVVTLWYRPPDVLLGSTE 180 (291)
T ss_pred CCCc--cccccccccccCCcHHhhcCcc
Confidence 2211 1122346889999999876543
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=219.22 Aligned_cols=175 Identities=29% Similarity=0.418 Sum_probs=141.6
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHH-HHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAV-LTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
++|++.+.||+|+||.||+|+.. +|+.||+|+++....... ..++..|+.. ++..+||||+++++++..++..+++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 47889999999999999999775 689999999876543222 3445556664 56678999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||++ ++|.+++....... ..+++..++.++.||+.||+|||+ +.+++||||||+||+++.++.+||+|||+++...
T Consensus 80 e~~~-~~l~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKG-LTIPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhhc-ccHHHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 9996 68888776543222 468999999999999999999996 2389999999999999999999999999988654
Q ss_pred CCCCcccccccccCCcccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
... ......|+..|+|||++.+
T Consensus 156 ~~~---~~~~~~~~~~y~aPE~~~~ 177 (283)
T cd06617 156 DSV---AKTIDAGCKPYMAPERINP 177 (283)
T ss_pred ccc---ccccccCCccccChhhcCC
Confidence 321 1233468899999999865
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=221.64 Aligned_cols=174 Identities=29% Similarity=0.423 Sum_probs=146.0
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccC---hhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS---EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
+|+..+.||+|+||.||+|... +++.||+|++...... ......+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999765 6899999999765433 22345677899999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+ +++|.+++.... ..+++..+..++.||++||+|||+ .+|+|+||||+||+++.++.+||+|||+++..
T Consensus 81 ~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred Eccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 9999 889999985432 258899999999999999999996 89999999999999999999999999999876
Q ss_pred CCCCCcccccccccCCcccccccccccC
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
..... ......+++.|+|||++.+..
T Consensus 153 ~~~~~--~~~~~~~~~~y~aPE~~~~~~ 178 (298)
T cd07841 153 GSPNR--KMTHQVVTRWYRAPELLFGAR 178 (298)
T ss_pred cCCCc--cccccccceeeeCHHHHhCCC
Confidence 54321 112335688999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-23 Score=216.13 Aligned_cols=180 Identities=29% Similarity=0.492 Sum_probs=151.4
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
++|++.+.||+|+||.||+|... ++..+|+|++....... ..+.+.+|++.++.++|+||+++++.+..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 47899999999999999999754 67899999987544333 56788999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++++|.+++..... ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++.....
T Consensus 80 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 80 YLSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred ccCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 9999999999865432 1257899999999999999999995 8999999999999999999999999999876654
Q ss_pred CCCcc--cccccccCCcccccccccccCC
Q 004020 749 NGKHS--IETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 749 ~~~~~--~~~~~~gt~~y~APE~l~~~~~ 775 (779)
..... ......|+..|+|||++.....
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~ 183 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183 (267)
T ss_pred CccccccccccccCChhhcChHHHccccC
Confidence 33221 2234568999999999876533
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=215.20 Aligned_cols=173 Identities=29% Similarity=0.481 Sum_probs=147.1
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc---ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV---SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
+|+..+.||+|+||.||+|... +++.|++|.+..... ..+..+.+.+|+++++.++||||+++++++...+..+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999876 789999998865331 233556789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++++|.+++... ..+++..+..++.|++.|++|||+ .+++|+||+|+||+++.++.+||+|||.+...
T Consensus 81 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 81 LELVPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceec
Confidence 9999999999998543 247888999999999999999996 89999999999999999999999999998765
Q ss_pred CCCCCcccccccccCCcccccccccccC
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
.... ......|+..|+|||.+....
T Consensus 153 ~~~~---~~~~~~~~~~y~~pe~~~~~~ 177 (258)
T cd06632 153 VEFS---FAKSFKGSPYWMAPEVIAQQG 177 (258)
T ss_pred cccc---cccccCCCcceeCHHHhcCCC
Confidence 4432 123456889999999986554
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=218.89 Aligned_cols=181 Identities=29% Similarity=0.441 Sum_probs=144.4
Q ss_pred hcCCcccceecccccEEEEEEEEc------CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCe
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 662 (779)
.++|++.+.||+|+||.||+|... .+..||+|.+.... .......+.+|+.++++++|+||+++++++.+.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 457889999999999999999765 35678999876433 23344678999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhHhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC---cEEE
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEE--GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAKV 737 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~---~~kl 737 (779)
.++||||+++++|.+++...... ....+++..++.++.||+.||+|||+ ++++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEe
Confidence 99999999999999998665321 12358899999999999999999996 7899999999999998654 5999
Q ss_pred EeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 738 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+|||+++................+..|+|||++.+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 196 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG 196 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcC
Confidence 999999866332111111122345689999998654
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=242.25 Aligned_cols=173 Identities=25% Similarity=0.367 Sum_probs=147.6
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccc-cChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
.++|.+.+.||+|+||.||+|... +++.||+|+++... ........+.+|+.+++.++||||+++++++...+..|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367999999999999999999876 68999999987543 2334456789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++++|.+++.... .+++..++.|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 83 mEy~~g~~L~~li~~~~-----~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~ 154 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG-----YFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154 (669)
T ss_pred EeCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCccc
Confidence 99999999999985432 47888899999999999999996 79999999999999999999999999999876
Q ss_pred CCCCCcccccccccCCccccccccc
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAA 771 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~ 771 (779)
.... .......+|+.|+|||...
T Consensus 155 ~~~~--~~~~~~~~t~~~~~pe~~~ 177 (669)
T cd05610 155 LNRE--LNMMDILTTPSMAKPKNDY 177 (669)
T ss_pred cCCc--ccccccccCccccCccccc
Confidence 4332 1223457899999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=218.35 Aligned_cols=174 Identities=32% Similarity=0.505 Sum_probs=142.4
Q ss_pred cCCcccceecccccEEEEEEEEc-CCc----EEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGT----KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 664 (779)
.+|++.+.||+|+||.||+|... +++ .+|+|.+.... ......++.+|+.++++++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 57888999999999999999764 233 58999876553 23455678999999999999999999999987 7889
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
+||||+++|+|.+++..... .+++..+..++.||+.||+|||+ .+++||||||+||++++++.+||+|||.++
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKD----NIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred EEEecCCCCcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccc
Confidence 99999999999999865432 47899999999999999999996 899999999999999999999999999998
Q ss_pred ecCCCCCcccccccccCCcccccccccc
Q 004020 745 LAPDNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
...............++..|+|||.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 185 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILH 185 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhc
Confidence 7654322211122234578999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=233.58 Aligned_cols=175 Identities=24% Similarity=0.317 Sum_probs=136.9
Q ss_pred HHHHHhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCC------CccceEee
Q 004020 583 QVLRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH------RHLVGLLG 655 (779)
Q Consensus 583 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~ 655 (779)
+++....++|++.+.||+|+||.||+|... +++.||||+++... ....++..|+++++.++| ++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~ 198 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQR 198 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence 334445688999999999999999999764 57889999986421 223445667777777654 45888999
Q ss_pred EEEeC-CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC-
Q 004020 656 YCLDG-NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM- 733 (779)
Q Consensus 656 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~- 733 (779)
++... +..++|||++ +++|.+++.+.. .+++..+..|+.||+.||+|||+ +.+||||||||+|||++.++
T Consensus 199 ~~~~~~~~~~iv~~~~-g~~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~ 270 (467)
T PTZ00284 199 YFQNETGHMCIVMPKY-GPCLLDWIMKHG-----PFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDT 270 (467)
T ss_pred EEEcCCceEEEEEecc-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCc
Confidence 88765 4688999988 678888875432 58899999999999999999995 35999999999999998765
Q ss_pred ---------------cEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 734 ---------------RAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 734 ---------------~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.+||+|||.+..... .....+||+.|||||++.+.
T Consensus 271 ~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~ 320 (467)
T PTZ00284 271 VVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGL 320 (467)
T ss_pred ccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcC
Confidence 499999998754321 12446799999999998765
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=220.34 Aligned_cols=177 Identities=27% Similarity=0.367 Sum_probs=148.0
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
++|++.+.||+|+||.||+|... +++.||+|+++.........+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999876 58899999987654444455778999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|++++.+..+.... ..+++..+..++.||+.||+|||+ .+++||||+|+||++++++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 81 YVERTLLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred cCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 99987666554221 247889999999999999999996 8999999999999999999999999999887654
Q ss_pred CCCcccccccccCCcccccccccccCC
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
... .......++..|+|||++.+...
T Consensus 153 ~~~-~~~~~~~~~~~~~~PE~~~~~~~ 178 (288)
T cd07833 153 RPA-SPLTDYVATRWYRAPELLVGDTN 178 (288)
T ss_pred Ccc-ccccCcccccCCcCCchhcCCCC
Confidence 322 12234568899999999877633
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=221.10 Aligned_cols=175 Identities=28% Similarity=0.392 Sum_probs=146.2
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC--CeEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--NERLLV 666 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv 666 (779)
++|++.+.||+|+||.||+|... +++.+|+|.++.....+.....+.+|+.++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57889999999999999999876 588999999976543333345677899999999999999999999877 789999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++ +|.+++.... ..+++..++.++.||+.||+|||+ .+++||||||+||+++.++.+||+|||+++..
T Consensus 85 ~e~~~~-~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 85 MEYVEH-DLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred ehhcCc-CHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 999974 8988875433 258899999999999999999996 79999999999999999999999999998876
Q ss_pred CCCCCcccccccccCCcccccccccccC
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
..... ......+++.|+|||++.+..
T Consensus 157 ~~~~~--~~~~~~~~~~~~aPE~~~~~~ 182 (293)
T cd07843 157 GSPLK--PYTQLVVTLWYRAPELLLGAK 182 (293)
T ss_pred cCCcc--ccccccccccccCchhhcCCc
Confidence 54321 123345788999999987654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=220.58 Aligned_cols=173 Identities=26% Similarity=0.437 Sum_probs=147.4
Q ss_pred hhcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
...+|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 456899999999999999999976 478999999986543 22346688999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++++|.+++.+. .+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++...
T Consensus 95 ~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~ 165 (297)
T cd06656 95 MEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (297)
T ss_pred ecccCCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEc
Confidence 9999999999988432 46888999999999999999996 89999999999999999999999999998765
Q ss_pred CCCCCcccccccccCCccccccccccc
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
..... ......+++.|+|||++.+.
T Consensus 166 ~~~~~--~~~~~~~~~~y~aPE~~~~~ 190 (297)
T cd06656 166 TPEQS--KRSTMVGTPYWMAPEVVTRK 190 (297)
T ss_pred cCCcc--CcCcccCCccccCHHHHcCC
Confidence 44321 12334688999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=216.93 Aligned_cols=176 Identities=27% Similarity=0.443 Sum_probs=145.2
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccC--------hhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS--------EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN 661 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 661 (779)
+|...+.||+|+||.||+|... +++.||+|.++..... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778899999999999999754 6899999988642211 112356788999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeec
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 741 (779)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecc
Confidence 999999999999999988544 257888999999999999999996 899999999999999999999999999
Q ss_pred cceecCCCCCcccccccccCCcccccccccccC
Q 004020 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 742 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
+++...............|+..|+|||++....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 186 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhcccc
Confidence 987654322112223346889999999987543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=216.42 Aligned_cols=175 Identities=33% Similarity=0.553 Sum_probs=147.4
Q ss_pred hcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
.++|++.+.||+|+||.||+|..+++..||+|.+..... ..+++.+|+.++++++||||+++++++......++|||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 468999999999999999999988888999999875432 34578899999999999999999999998889999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++++|.+++..... ..+++..+..++.|++.|++|||+ .+++|+||||+||++++++.+||+|||.++....
T Consensus 82 ~~~~~~L~~~i~~~~~---~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 82 YMSKGSLLDFLKSGEG---KKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred ccCCCCHHHHHhcccc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 9999999999865431 257899999999999999999996 8999999999999999999999999999887653
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. ........++..|+|||.+.+.
T Consensus 156 ~~-~~~~~~~~~~~~y~~PE~~~~~ 179 (261)
T cd05034 156 DE-YTAREGAKFPIKWTAPEAANYG 179 (261)
T ss_pred hh-hhhhhccCCCccccCHHHhccC
Confidence 21 1111222356789999988754
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=220.54 Aligned_cols=173 Identities=26% Similarity=0.433 Sum_probs=146.4
Q ss_pred hhcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
...+|++.+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|+.+++.++||||+++++.+..++..++|
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 346899999999999999999975 4688999998875442 2346788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++++|.+++... .+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 96 ~e~~~~~~L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~ 166 (296)
T cd06654 96 MEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (296)
T ss_pred ecccCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhc
Confidence 9999999999988432 36888999999999999999996 89999999999999999999999999998765
Q ss_pred CCCCCcccccccccCCccccccccccc
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
..... ......|++.|+|||++.+.
T Consensus 167 ~~~~~--~~~~~~~~~~y~aPE~~~~~ 191 (296)
T cd06654 167 TPEQS--KRSTMVGTPYWMAPEVVTRK 191 (296)
T ss_pred ccccc--ccCcccCCccccCHHHHcCC
Confidence 43211 12234688999999988654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=216.14 Aligned_cols=174 Identities=28% Similarity=0.463 Sum_probs=144.7
Q ss_pred hcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
.++|++.++||+|+||.||+|..++++.||+|.+..... ...++.+|+.++++++||||+++++++. .+..+++||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 467899999999999999999988899999999875442 2357889999999999999999999864 467899999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++++|.+++.... ...+++.++..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 81 YMENGSLVDFLKTPE---GIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred cCCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 999999999885433 2357889999999999999999995 8999999999999999999999999999877653
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
... .......++..|+|||++.+.
T Consensus 155 ~~~-~~~~~~~~~~~y~~pe~~~~~ 178 (260)
T cd05067 155 NEY-TAREGAKFPIKWTAPEAINYG 178 (260)
T ss_pred CCc-ccccCCcccccccCHHHhccC
Confidence 211 112233467789999987543
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=218.19 Aligned_cols=181 Identities=23% Similarity=0.411 Sum_probs=147.6
Q ss_pred hcCCcccceecccccEEEEEEEEcC-----CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEe-CCe
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHD-----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD-GNE 662 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~ 662 (779)
.++|++.+.||+|+||.||+|.... +..|++|++.... .......+.+|+.++++++||||+++++++.. +..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 4678899999999999999998765 6889999886432 34456778999999999999999999998776 467
Q ss_pred EEEEEEecCCCChhhHhhhcccC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEe
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEE---GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 739 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 739 (779)
.++++||+++++|.+++...... ....+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998654322 11358899999999999999999995 8999999999999999999999999
Q ss_pred eccceecCCCCCcccccccccCCccccccccccc
Q 004020 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 740 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
||+++.+.............++..|+|||++.+.
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~ 194 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNK 194 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcC
Confidence 9999865433222222233467789999988654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=218.70 Aligned_cols=175 Identities=29% Similarity=0.440 Sum_probs=145.0
Q ss_pred HhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeC----
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDG---- 660 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~---- 660 (779)
.+.+.|++.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++.++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 35677889999999999999999765 68889999986442 2335678899999998 699999999998753
Q ss_pred --CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEE
Q 004020 661 --NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 738 (779)
Q Consensus 661 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 738 (779)
...|+||||+++++|.+++..... ..+++..+..++.|++.|++|||+ ++|+||||||+||++++++.+||+
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~ 153 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLV 153 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEc
Confidence 457899999999999999865322 357899999999999999999996 799999999999999999999999
Q ss_pred eeccceecCCCCCcccccccccCCcccccccccc
Q 004020 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 739 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
|||+++...... .......|++.|+|||++.+
T Consensus 154 Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~ 185 (272)
T cd06637 154 DFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIAC 185 (272)
T ss_pred cCCCceeccccc--ccCCcccccccccCHhHhcc
Confidence 999988654321 12234568999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=215.14 Aligned_cols=176 Identities=26% Similarity=0.378 Sum_probs=143.3
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc---ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC--CeE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV---SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--NER 663 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 663 (779)
.+|++.+.||+|+||.||+|... ++..||+|.+..... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47889999999999999999764 589999998854321 123456788999999999999999999988764 457
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccc
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 743 (779)
+++|||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~ 153 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG-----ALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGAS 153 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccc
Confidence 89999999999999885432 46788889999999999999996 89999999999999999999999999998
Q ss_pred eecCCCCC-cccccccccCCccccccccccc
Q 004020 744 RLAPDNGK-HSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 744 ~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+....... ........|+..|+|||++.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 184 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGE 184 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCC
Confidence 75532111 1112234588999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.6e-24 Score=223.77 Aligned_cols=148 Identities=27% Similarity=0.405 Sum_probs=129.6
Q ss_pred hcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccc-cChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
..-|..++.||-|+||+|.+++. ++...||+|.+++.. ...........|-+||+..+.+-||++|-.|++++..|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 45688899999999999999964 456778999987653 3344556678899999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
|||++||++..++.+.. .+++..+..++.++..|+++.| +.|+|||||||+|||||.+|++||.|||++.
T Consensus 708 MdYIPGGDmMSLLIrmg-----IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCT 777 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMG-----IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 777 (1034)
T ss_pred EeccCCccHHHHHHHhc-----cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccc
Confidence 99999999999885432 5788888889999999999999 5999999999999999999999999999985
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=220.95 Aligned_cols=178 Identities=28% Similarity=0.370 Sum_probs=148.3
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccCh-hHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE-KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
++|+..+.||+|+||.||+|... +++.||+|.+....... ...+.+.+|+++++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46889999999999999999775 58999999997654332 35567899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+.+++|.+++..... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQPG---KCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhCCC---CccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 99999999998864321 357889999999999999999996 899999999999999999999999999987543
Q ss_pred CCCCc---------------------------ccccccccCCccccccccccc
Q 004020 748 DNGKH---------------------------SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~---------------------------~~~~~~~gt~~y~APE~l~~~ 773 (779)
..... .......||..|+|||++.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 207 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD 207 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC
Confidence 22110 011234689999999998654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=215.12 Aligned_cols=173 Identities=32% Similarity=0.502 Sum_probs=142.4
Q ss_pred cCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
++|.+.+.||+|++|.||+|....+..+|+|.+.... ...+.+.+|++++++++|||++++++++. .+..++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 5688899999999999999988877789999876543 23356889999999999999999998875 4568899999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+++++|.+++..... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||.++.....
T Consensus 82 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 82 MGKGSLLDFLKEGDG---KYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred CCCCCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 999999999865322 247889999999999999999995 89999999999999999999999999999876433
Q ss_pred CCcccccccccCCccccccccccc
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. .......++..|+|||+..+.
T Consensus 156 ~~-~~~~~~~~~~~y~~Pe~~~~~ 178 (260)
T cd05069 156 EY-TARQGAKFPIKWTAPEAALYG 178 (260)
T ss_pred cc-cccCCCccchhhCCHHHhccC
Confidence 21 111223467789999987643
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=214.44 Aligned_cols=167 Identities=28% Similarity=0.410 Sum_probs=137.3
Q ss_pred eecccccEEEEEEEEc---CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCCC
Q 004020 597 VLGRGGFGTVYKGELH---DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQG 673 (779)
Q Consensus 597 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 673 (779)
.||+|+||.||+|.++ ++..+|+|+++.........+++.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999653 5788999998765544455678999999999999999999999875 45678999999999
Q ss_pred ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCcc
Q 004020 674 TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753 (779)
Q Consensus 674 sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 753 (779)
+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 81 PLNKFLQKNK-----HVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 9999885432 47889999999999999999996 899999999999999999999999999998664432211
Q ss_pred -cccccccCCcccccccccc
Q 004020 754 -IETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 754 -~~~~~~gt~~y~APE~l~~ 772 (779)
......++..|+|||++..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~ 172 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNY 172 (257)
T ss_pred eecCCCCCCccccCHhHhcc
Confidence 1122234678999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=214.36 Aligned_cols=174 Identities=27% Similarity=0.460 Sum_probs=145.2
Q ss_pred hcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
.++|++.+.||+|+||.||+|...++..+|+|.+... ....+.+.+|++++++++|+||+++++++.. ...+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 4688999999999999999998877888999988643 2334678899999999999999999999887 77899999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++++|.+++..... ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||.++....
T Consensus 81 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 81 FMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred eCCCCcHHHHHHhCCc---cccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 9999999999865332 247888899999999999999996 8999999999999999999999999999876643
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
... .......++..|+|||++.+.
T Consensus 155 ~~~-~~~~~~~~~~~y~~PE~~~~~ 178 (260)
T cd05073 155 NEY-TAREGAKFPIKWTAPEAINFG 178 (260)
T ss_pred CCc-ccccCCcccccccCHhHhccC
Confidence 221 112223456789999998653
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-24 Score=226.24 Aligned_cols=168 Identities=27% Similarity=0.439 Sum_probs=140.5
Q ss_pred ceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCCCC
Q 004020 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGT 674 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 674 (779)
-+||+|.||+||.|+.. +...+|||.+.... ....+-+..|+.+-++++|.|||+++|.+..++.+-+.||-++||+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 47999999999999865 46678999987554 4455678999999999999999999999999998899999999999
Q ss_pred hhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEc-CCCcEEEEeeccceecCCCCCcc
Q 004020 675 LSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFGLVRLAPDNGKHS 753 (779)
Q Consensus 675 L~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~ 753 (779)
|.+++...- +.-.-.+.++-.+.+||++||.|||. ..|||||||-+||||+ -.|.+||+|||.++.+..- ..
T Consensus 659 LSsLLrskW--GPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP 731 (1226)
T KOG4279|consen 659 LSSLLRSKW--GPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NP 731 (1226)
T ss_pred HHHHHHhcc--CCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccC--Cc
Confidence 999985533 21122677888999999999999996 8899999999999996 5799999999999876432 22
Q ss_pred cccccccCCcccccccccc
Q 004020 754 IETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 754 ~~~~~~gt~~y~APE~l~~ 772 (779)
.+..+.||..|||||++..
T Consensus 732 ~TETFTGTLQYMAPEvIDq 750 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQ 750 (1226)
T ss_pred cccccccchhhhChHhhcc
Confidence 3345679999999999853
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-24 Score=217.74 Aligned_cols=177 Identities=29% Similarity=0.432 Sum_probs=145.8
Q ss_pred hcCCcccceecccccEEEEEE-EEcCCcEEEEEEecccc--cC---hhHHHHHHHHHHHHHcCCCCccceEeeEEEe-CC
Q 004020 589 TNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAV--VS---EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD-GN 661 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~--~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~ 661 (779)
.++|-....||+|||+.||+| .....+.||||+-.... .+ ....+...+|.++-+.+.||.||++|+||.- .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 467888899999999999999 45567889999754321 11 1123557899999999999999999999974 46
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEc---CCCcEEEE
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG---DDMRAKVA 738 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~---~~~~~kl~ 738 (779)
.++-|+|||+|.+|.-|++..+ .+++.++..|+.||+.||.||.+. +.+|||-||||.|||+. .-|.+||.
T Consensus 542 sFCTVLEYceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred cceeeeeecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence 7889999999999999987664 588999999999999999999975 47999999999999995 35889999
Q ss_pred eeccceecCCCCCcc-----cccccccCCccccccccc
Q 004020 739 DFGLVRLAPDNGKHS-----IETRLAGTFGYLAPEYAA 771 (779)
Q Consensus 739 DFG~a~~~~~~~~~~-----~~~~~~gt~~y~APE~l~ 771 (779)
|||+++.+.++...+ .+....||.+|.+||.+-
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFv 653 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFV 653 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceee
Confidence 999999887654332 234568999999999975
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=213.88 Aligned_cols=170 Identities=36% Similarity=0.599 Sum_probs=145.2
Q ss_pred hcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
.++|++.+.||+|+||.||+|... ++.||+|.+..... ..+++.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 357888999999999999999875 78999999876542 45778999999999999999999999999899999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++++|.+++..... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||.++....
T Consensus 81 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 81 YMAKGSLVDYLRSRGR---AVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred ecCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccc
Confidence 9999999999865432 257899999999999999999996 8999999999999999999999999999886633
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. ....++..|+|||++.+.
T Consensus 155 ~~-----~~~~~~~~~~ape~~~~~ 174 (256)
T cd05039 155 GQ-----DSGKLPVKWTAPEALREK 174 (256)
T ss_pred cc-----ccCCCcccccCchhhcCC
Confidence 21 122346789999987643
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.1e-23 Score=213.33 Aligned_cols=174 Identities=29% Similarity=0.453 Sum_probs=148.5
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.++|++.+.||+|+||.||+|... +++.+++|.+.... ....+.+.+|++++++++||||+++++++...+..+++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 367899999999999999999764 57889999987543 235578899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||.+....
T Consensus 80 e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 80 EYCGGGSLQDIYQVTR----GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLT 152 (262)
T ss_pred eCCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhh
Confidence 9999999999885532 257889999999999999999995 899999999999999999999999999987654
Q ss_pred CCCCcccccccccCCccccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.... ......++..|+|||++.+.
T Consensus 153 ~~~~--~~~~~~~~~~y~~Pe~~~~~ 176 (262)
T cd06613 153 ATIA--KRKSFIGTPYWMAPEVAAVE 176 (262)
T ss_pred hhhh--ccccccCCccccCchhhccc
Confidence 3211 12335688999999998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=217.62 Aligned_cols=174 Identities=30% Similarity=0.510 Sum_probs=140.9
Q ss_pred cCC-cccceecccccEEEEEEEE-----cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC--C
Q 004020 590 NNF-SEENVLGRGGFGTVYKGEL-----HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--N 661 (779)
Q Consensus 590 ~~~-~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~ 661 (779)
++| +..+.||+|+||.||++.. .++..||+|.+.... .......+.+|++++++++||||+++++++... .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 345 8889999999999988643 357889999987543 233456788999999999999999999988754 3
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeec
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 741 (779)
..++||||+++++|.+++... .+++.+++.++.|++.||+|||+ ++|+||||||+||++++++.+||+|||
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg 152 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFG 152 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecc
Confidence 578999999999999988542 47899999999999999999996 899999999999999999999999999
Q ss_pred cceecCCCCCc-ccccccccCCccccccccccc
Q 004020 742 LVRLAPDNGKH-SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 742 ~a~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~ 773 (779)
+++........ .......++..|+|||++.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~ 185 (283)
T cd05080 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN 185 (283)
T ss_pred cccccCCcchhhccCCCCCCCceeeCHhHhccc
Confidence 98866542211 111223456789999988653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.1e-23 Score=218.48 Aligned_cols=176 Identities=23% Similarity=0.366 Sum_probs=144.5
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccC-hhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
++|++.+.||+|+||.||++... +++.||+|.+...... ......+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36889999999999999999765 5789999998755322 234467889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 81 EYVEGGDCATLLKNIG-----ALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred ecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence 9999999999985432 57888999999999999999996 899999999999999999999999999986421
Q ss_pred CCCC-------------cccccccccCCccccccccccc
Q 004020 748 DNGK-------------HSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~-------------~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.... ........|+..|+|||++.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 191 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ 191 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCC
Confidence 1100 0011124578899999987653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-25 Score=210.20 Aligned_cols=177 Identities=27% Similarity=0.341 Sum_probs=143.2
Q ss_pred CcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEEEEEEe
Q 004020 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
.+....||.|+||+|+|..++ .|+..|||++..... ..+.+++..|.+...+- +.||||++||.....+..|+.||.
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 344577999999999999765 699999999987653 56677888888876655 699999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
|+ .++..+.+.-..-....+++...-+|+...+.||.||.. ...|||||+||+|||+|..|.+||||||++-.+.+.
T Consensus 145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 95 477655433222223467888888899999999999997 578999999999999999999999999998765432
Q ss_pred CCcccccccccCCcccccccccccCC
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
...+..+|...|||||.+.....
T Consensus 222 ---iAkT~daGCrpYmAPERi~p~~~ 244 (361)
T KOG1006|consen 222 ---IAKTVDAGCRPYMAPERIDPSDK 244 (361)
T ss_pred ---HHhhhccCCccccChhccCCccC
Confidence 23355679999999999976654
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=215.29 Aligned_cols=161 Identities=25% Similarity=0.447 Sum_probs=134.1
Q ss_pred ceecccccEEEEEEEEcCCc-----------EEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEE
Q 004020 596 NVLGRGGFGTVYKGELHDGT-----------KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 664 (779)
+.||+|+||.||+|...+.. .+++|.+.... .....+.+|+.++++++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 46999999999999876432 47777765432 125778899999999999999999999988 7789
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC-------cEEE
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-------RAKV 737 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-------~~kl 737 (779)
+||||+++++|.+++..... .+++..+..++.||+.||+|||+ ++|+||||||+||+++.++ .+||
T Consensus 77 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKN----NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred EEEEcCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEe
Confidence 99999999999999865432 57889999999999999999996 8999999999999999887 7999
Q ss_pred EeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 738 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+|||+++..... ....++..|+|||++.+.
T Consensus 150 ~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~ 179 (259)
T cd05037 150 SDPGIPITVLSR------EERVERIPWIAPECIRNG 179 (259)
T ss_pred CCCCcccccccc------cccccCCCccChhhhcCC
Confidence 999998765431 223567889999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-23 Score=212.82 Aligned_cols=175 Identities=23% Similarity=0.408 Sum_probs=148.6
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
+|++.+.||+|+||.||+++.. +++.||+|++..........+++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999764 688999999876544455567889999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+++++|.+++..... ..+++.++..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 81 CEGGDLYKKINAQRG---VLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred CCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 999999998864332 246888999999999999999996 89999999999999999999999999998866443
Q ss_pred CCcccccccccCCccccccccccc
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. ......|++.|+|||++.+.
T Consensus 155 ~~--~~~~~~~~~~~~~pe~~~~~ 176 (256)
T cd08218 155 VE--LARTCIGTPYYLSPEICENR 176 (256)
T ss_pred hh--hhhhccCCccccCHHHhCCC
Confidence 21 12234588999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-23 Score=214.22 Aligned_cols=175 Identities=31% Similarity=0.536 Sum_probs=144.7
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccCh-------hHHHHHHHHHHHHHcCCCCccceEeeEEEeCCe
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE-------KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 662 (779)
+|.+.+.||+|++|.||+|... +++.||+|.+....... ...+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999764 68899999886543211 223568899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecc
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 742 (779)
.++||||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~ 152 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG-----AFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGI 152 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCC
Confidence 999999999999999985432 47888899999999999999996 8999999999999999999999999999
Q ss_pred ceecCCCCCcc----cccccccCCccccccccccc
Q 004020 743 VRLAPDNGKHS----IETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 743 a~~~~~~~~~~----~~~~~~gt~~y~APE~l~~~ 773 (779)
++......... ......|+..|+|||++.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~ 187 (267)
T cd06628 153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT 187 (267)
T ss_pred CcccccccccCCccccccccCCCcCccChhHhccC
Confidence 88665321111 11234588999999998654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.5e-23 Score=213.90 Aligned_cols=181 Identities=27% Similarity=0.429 Sum_probs=149.9
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEe--CCeEEEEE
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD--GNERLLVY 667 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 667 (779)
+|++.+.||.|+||.||+|... ++..||+|.+..........+++..|++++++++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999754 68899999987665556666789999999999999999999998764 34678999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA--HQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||+++++|.+++...... ...+++..++.++.||+.||.|||..+ ..+++|+||||+||+++.++.+||+|||++..
T Consensus 81 e~~~~~~L~~~l~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKE-RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred hhccCCCHHHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999998664322 236889999999999999999999332 37899999999999999999999999999887
Q ss_pred cCCCCCcccccccccCCcccccccccccC
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
...... ......|++.|+|||++.+..
T Consensus 160 ~~~~~~--~~~~~~~~~~~~~pE~~~~~~ 186 (265)
T cd08217 160 LGHDSS--FAKTYVGTPYYMSPEQLNHMS 186 (265)
T ss_pred ccCCcc--cccccccCCCccChhhhcCCC
Confidence 654321 123346899999999986643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-23 Score=213.06 Aligned_cols=168 Identities=26% Similarity=0.448 Sum_probs=135.6
Q ss_pred eecccccEEEEEEEEc---CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCCC
Q 004020 597 VLGRGGFGTVYKGELH---DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQG 673 (779)
Q Consensus 597 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 673 (779)
.||+|+||.||+|.+. ++..||+|++.... .....+++.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 3899999999999764 35579999886543 3344567999999999999999999999875 45689999999999
Q ss_pred ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCcc
Q 004020 674 TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753 (779)
Q Consensus 674 sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 753 (779)
+|.+++.... ..+++..+++++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 80 PLNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 9999885432 257899999999999999999996 899999999999999999999999999987654332211
Q ss_pred -cccccccCCccccccccccc
Q 004020 754 -IETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 754 -~~~~~~gt~~y~APE~l~~~ 773 (779)
......++..|+|||++.+.
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~ 173 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFR 173 (257)
T ss_pred eccCCCCCCcccCCHHHHccC
Confidence 11222345789999987653
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=218.61 Aligned_cols=175 Identities=27% Similarity=0.409 Sum_probs=145.5
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
+|+..+.||+|++|.||+|+.. +++.||+|++............+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999765 689999999875543333446788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+. ++|.+++..... ..+++..+..++.|++.||+|||+ .+++||||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~-~~l~~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 81 LH-QDLKKFMDASPL---SGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred cc-cCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 96 588888754322 357899999999999999999996 89999999999999999999999999998765432
Q ss_pred CCcccccccccCCcccccccccccC
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
.. ......+++.|+|||++.+..
T Consensus 154 ~~--~~~~~~~~~~y~aPE~~~~~~ 176 (284)
T cd07860 154 VR--TYTHEVVTLWYRAPEILLGCK 176 (284)
T ss_pred cc--ccccccccccccCCeEEecCC
Confidence 11 122335788999999887654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=214.16 Aligned_cols=170 Identities=35% Similarity=0.564 Sum_probs=141.6
Q ss_pred ceecccccEEEEEEEEcC--C--cEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecC
Q 004020 596 NVLGRGGFGTVYKGELHD--G--TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMP 671 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 671 (779)
+.||+|++|.||+|.+.+ + ..||+|.+...... ...+++.+|++++++++||||+++++++.. ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999997643 2 36899999876543 556789999999999999999999999988 88999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCC
Q 004020 672 QGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK 751 (779)
Q Consensus 672 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 751 (779)
+++|.+++.+... ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 79 LGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccccc
Confidence 9999999866432 357899999999999999999996 8999999999999999999999999999987654322
Q ss_pred cc-cccccccCCccccccccccc
Q 004020 752 HS-IETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 752 ~~-~~~~~~gt~~y~APE~l~~~ 773 (779)
.. ......++..|+|||++.+.
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~ 175 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTR 175 (257)
T ss_pred ceecccCCCCCceecCHHHhccc
Confidence 11 12234577899999987653
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-23 Score=217.87 Aligned_cols=177 Identities=32% Similarity=0.504 Sum_probs=141.5
Q ss_pred cCCcccceecccccEEEEEEEEcC-Cc--EEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHD-GT--KIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 665 (779)
++|++.+.||+|+||.||+|...+ +. .+++|.++... .....+.+.+|++++.++ +||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 578899999999999999997653 33 46888776432 334456789999999999 69999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCc
Q 004020 666 VYEYMPQGTLSRHLFNRKEE-----------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 734 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 734 (779)
||||+++++|.+++...... ....+++..++.++.|++.||+|||+ ++|+||||||+||++++++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCe
Confidence 99999999999998653311 11247889999999999999999996 89999999999999999999
Q ss_pred EEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 735 AKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 735 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+||+|||++...... ........+..|+|||++.+.
T Consensus 158 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~ 193 (297)
T cd05089 158 SKIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYS 193 (297)
T ss_pred EEECCcCCCccccce---eccCCCCcCccccCchhhccC
Confidence 999999998643211 011112235679999988654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=219.99 Aligned_cols=178 Identities=32% Similarity=0.421 Sum_probs=145.1
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC--CeEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--NERLL 665 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 665 (779)
.++|++.+.||+|+||.||+|... +++.||+|++............+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999765 689999999875443333334567899999999999999999998765 46899
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||||+++ +|.+++.... ..+++..+..++.||+.||+|||+ .+++||||||+||++++++.+||+|||.++.
T Consensus 86 v~e~~~~-~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEecCCC-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeee
Confidence 9999974 7888775432 358899999999999999999996 8999999999999999999999999999987
Q ss_pred cCCCCCcccccccccCCcccccccccccCCC
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAAETSGM 776 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 776 (779)
...... ......+++.|+|||++.+...+
T Consensus 158 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~ 186 (309)
T cd07845 158 YGLPAK--PMTPKVVTLWYRAPELLLGCTTY 186 (309)
T ss_pred cCCccC--CCCcccccccccChhhhcCCCCc
Confidence 654321 12233467889999998765443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=215.74 Aligned_cols=179 Identities=27% Similarity=0.459 Sum_probs=145.6
Q ss_pred cCCcccceecccccEEEEEEEEc------CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 663 (779)
++|++.+.||+|+||.||+|+.+ +.+.|++|.+.... .....+++.+|++++++++||||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 57888999999999999999864 34678999876432 223456789999999999999999999999998999
Q ss_pred EEEEEecCCCChhhHhhhcccCC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEe
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEG----LKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 739 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 739 (779)
++||||+++++|.+++....... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999986544211 1257899999999999999999996 8999999999999999999999999
Q ss_pred eccceecCCCCCcccccccccCCccccccccccc
Q 004020 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 740 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
||+++...... ........++..|+|||.+.+.
T Consensus 161 ~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~ 193 (275)
T cd05046 161 LSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQED 193 (275)
T ss_pred cccccccCccc-ccccCCceeEEeecChhhhccC
Confidence 99987543221 1122333567889999987654
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.5e-23 Score=216.54 Aligned_cols=176 Identities=27% Similarity=0.414 Sum_probs=145.8
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
+|++.+.||+|++|.||+|+.. +++.||+|++..... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 5888999999999999999875 688999999875432 22345677899999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+++ +|.+++..... ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++.....
T Consensus 80 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 80 MDK-DLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP 153 (284)
T ss_pred CCc-cHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence 985 88888755432 2358999999999999999999996 79999999999999999999999999998755432
Q ss_pred CCcccccccccCCcccccccccccCC
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
.. ......++..|+|||++.+...
T Consensus 154 ~~--~~~~~~~~~~y~~PE~~~~~~~ 177 (284)
T cd07836 154 VN--TFSNEVVTLWYRAPDVLLGSRT 177 (284)
T ss_pred cc--ccccccccccccChHHhcCCCC
Confidence 11 1123457899999999876543
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.2e-23 Score=212.54 Aligned_cols=173 Identities=31% Similarity=0.504 Sum_probs=144.6
Q ss_pred cCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
.+|++.+.||+|+||.||+|...++..+|+|.+...... ..++.+|++++++++||||+++++++......++||||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 467888999999999999998877889999998754432 34688999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+++++|.+++.... ..+++..++.++.|++.|++|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 81 MEHGCLSDYLRAQR----GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred CCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 99999999885432 247888999999999999999996 79999999999999999999999999998765432
Q ss_pred CCcccccccccCCccccccccccc
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
. ........++..|+|||++.+.
T Consensus 154 ~-~~~~~~~~~~~~~~aPe~~~~~ 176 (256)
T cd05112 154 Q-YTSSTGTKFPVKWSSPEVFSFS 176 (256)
T ss_pred c-ccccCCCccchhhcCHhHhccC
Confidence 1 1111223356789999988653
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.6e-23 Score=211.22 Aligned_cols=174 Identities=26% Similarity=0.444 Sum_probs=148.1
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
+|+..+.||+|+||.||+|... +++.+|+|.+............+.+|++++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999764 688999999876655555667899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCC-CcEEEEeeccceecCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFGLVRLAPD 748 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~ 748 (779)
+++++|.+++..... ..+++..+..++.|+++|++|||+ ++++|+||||+||+++++ +.+||+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKRCN---SLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 999999999865432 247889999999999999999996 899999999999999855 4689999999987654
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
... .....|+..|+|||++.+.
T Consensus 155 ~~~---~~~~~~~~~y~aPE~~~~~ 176 (256)
T cd08220 155 KSK---AYTVVGTPCYISPELCEGK 176 (256)
T ss_pred Ccc---ccccccCCcccCchhccCC
Confidence 321 1234688999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.2e-23 Score=213.53 Aligned_cols=175 Identities=26% Similarity=0.403 Sum_probs=142.6
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.+.+.....||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++|+||+++++++..++..++|+
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 344555678999999999999754 67889999886543 334567899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC-CCcEEEEeeccceec
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLVRLA 746 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~ 746 (779)
||+++++|.+++...... ...++..+..++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||.+...
T Consensus 85 e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 85 EQVPGGSLSALLRSKWGP--LKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred ecCCCCCHHHHHHHhccc--CCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 999999999998654211 112778888999999999999996 89999999999999976 679999999998765
Q ss_pred CCCCCcccccccccCCcccccccccc
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
..... ......|++.|+|||++.+
T Consensus 160 ~~~~~--~~~~~~~~~~~~aPE~~~~ 183 (268)
T cd06624 160 AGINP--CTETFTGTLQYMAPEVIDK 183 (268)
T ss_pred ccCCC--ccccCCCCccccChhhhcc
Confidence 43211 1223458899999999854
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.8e-23 Score=212.53 Aligned_cols=176 Identities=26% Similarity=0.400 Sum_probs=143.6
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc---ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC--CeE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV---SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--NER 663 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 663 (779)
.+|+..+.||+|+||.||+|... ++..||+|++..... .......+.+|+.++++++||||+++++++... +..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36889999999999999999764 688999998864432 123446788999999999999999999988753 567
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccc
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 743 (779)
+++|||+++++|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~ 153 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCc
Confidence 89999999999999885432 47888899999999999999996 89999999999999999999999999998
Q ss_pred eecCCCCC-cccccccccCCccccccccccc
Q 004020 744 RLAPDNGK-HSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 744 ~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+....... ........++..|+|||++.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 184 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCC
Confidence 76533111 1111234588999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.2e-23 Score=217.25 Aligned_cols=177 Identities=27% Similarity=0.380 Sum_probs=143.6
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
++|++.+.||+|++|.||+|... +++.||+|++............+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999765 68899999986554333344678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC-CCcEEEEeeccceecC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLVRLAP 747 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~~ 747 (779)
|++ +++.+++..... ..+++..+..++.||+.||+|||+ ++++||||||+||++++ ++.+||+|||+++...
T Consensus 82 ~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD---FAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhCCC---CCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 996 578777643321 235788888999999999999996 89999999999999985 5679999999987653
Q ss_pred CCCCcccccccccCCcccccccccccCC
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
... .......+++.|+|||++.+...
T Consensus 155 ~~~--~~~~~~~~~~~y~~PE~~~~~~~ 180 (294)
T PLN00009 155 IPV--RTFTHEVVTLWYRAPEILLGSRH 180 (294)
T ss_pred CCc--cccccCceeecccCHHHHhCCCC
Confidence 321 11233467899999999876443
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=215.55 Aligned_cols=173 Identities=28% Similarity=0.427 Sum_probs=148.3
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccCh-hHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE-KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
+|++.+.||+|+||.||+|+.. +++.||+|.+....... ...+.+.+|++++++++||||+++++++..++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4888999999999999999875 68999999997654322 456789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++++|.+++... ..+++..+..++.|+++||.|||+ .+++|+||||+||++++++.++|+|||.+.....
T Consensus 81 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 81 LLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 99999999988543 257889999999999999999996 8999999999999999999999999999876644
Q ss_pred CCCcccccccccCCcccccccccccC
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
.. ......|+..|+|||++.+..
T Consensus 153 ~~---~~~~~~~~~~y~~PE~~~~~~ 175 (258)
T cd05578 153 DT---LTTSTSGTPGYMAPEVLCRQG 175 (258)
T ss_pred Cc---cccccCCChhhcCHHHHcccC
Confidence 32 123345888999999986543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-23 Score=211.51 Aligned_cols=170 Identities=32% Similarity=0.506 Sum_probs=140.6
Q ss_pred ceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCCCCh
Q 004020 596 NVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTL 675 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 675 (779)
++||+|+||.||+|...+++.||+|.+...... .....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 469999999999998777999999998765432 3556789999999999999999999999999999999999999999
Q ss_pred hhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCcccc
Q 004020 676 SRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE 755 (779)
Q Consensus 676 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 755 (779)
.+++.... ..+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++...........
T Consensus 80 ~~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 80 LTFLRKKK----NRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 99985432 246888899999999999999995 89999999999999999999999999998765432111111
Q ss_pred cccccCCccccccccccc
Q 004020 756 TRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 756 ~~~~gt~~y~APE~l~~~ 773 (779)
....++..|+|||++.+.
T Consensus 153 ~~~~~~~~y~~PE~~~~~ 170 (251)
T cd05041 153 GLKQIPIKWTAPEALNYG 170 (251)
T ss_pred ccCcceeccCChHhhccC
Confidence 122345679999988654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.1e-23 Score=214.34 Aligned_cols=173 Identities=29% Similarity=0.440 Sum_probs=148.4
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
++|++.+.||.|++|.||+|+.. +++.||+|.+.... .......+.+|+++++.++||||+++++++.++...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 46888899999999999999765 68899999986543 23345678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++++|.+++... .+++..+..++.|++.|+.|||+ ++++||||+|+||++++++.++|+|||+++....
T Consensus 80 ~~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 80 YCGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred eeCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 99999999988542 57899999999999999999996 8999999999999999999999999999987754
Q ss_pred CCCcccccccccCCcccccccccccC
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
.. .......|++.|+|||++.+..
T Consensus 151 ~~--~~~~~~~~~~~y~~PE~~~~~~ 174 (274)
T cd06609 151 TM--SKRNTFVGTPFWMAPEVIKQSG 174 (274)
T ss_pred cc--cccccccCCccccChhhhccCC
Confidence 32 1123446889999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.2e-23 Score=212.57 Aligned_cols=168 Identities=35% Similarity=0.537 Sum_probs=140.2
Q ss_pred cCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEE-eCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCL-DGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e 668 (779)
++|++.+.||+|+||.||++... +..||+|.+.... ..+.+.+|+.++++++|+|++++++++. .++..++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 47888999999999999999765 7889999886432 3457889999999999999999999765 4467899999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++++|.+++..... ..+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 81 YMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred CCCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 9999999999865432 247889999999999999999996 8999999999999999999999999999876543
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. ....++..|+|||++.+.
T Consensus 155 ~~-----~~~~~~~~y~aPE~~~~~ 174 (256)
T cd05082 155 TQ-----DTGKLPVKWTAPEALREK 174 (256)
T ss_pred cC-----CCCccceeecCHHHHccC
Confidence 21 222356789999988654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-25 Score=211.53 Aligned_cols=175 Identities=27% Similarity=0.418 Sum_probs=143.7
Q ss_pred cccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC-----eEEEE
Q 004020 593 SEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN-----ERLLV 666 (779)
Q Consensus 593 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv 666 (779)
+-.+.||-|+||.||.+.+ ++|+.||.|++..-..+-...+++.+|++++..++|.|++..++..+-.. +.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3457899999999999965 47999999999765544456688999999999999999999988876543 56788
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
+|.|. .+|..++- ....++...+.-+.+||++||+|||+ .+|.||||||.|.|++.+..+||||||+|+..
T Consensus 136 TELmQ-SDLHKIIV-----SPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 136 TELMQ-SDLHKIIV-----SPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHH-hhhhheec-----cCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEeccccccccc
Confidence 88885 47766652 23467888888999999999999997 89999999999999999999999999999976
Q ss_pred CCCCCcccccccccCCcccccccccccCCCC
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
+.+... ..+..+-|.+|+|||+++|..-|+
T Consensus 207 e~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs 236 (449)
T KOG0664|consen 207 DQRDRL-NMTHEVVTQYYRAPELLMGARRYT 236 (449)
T ss_pred chhhhh-hhHHHHHHHHhccHHHhhcchhhc
Confidence 554332 334556799999999999886654
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=216.59 Aligned_cols=165 Identities=23% Similarity=0.418 Sum_probs=135.1
Q ss_pred ceecccccEEEEEEEEcC--------CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 596 NVLGRGGFGTVYKGELHD--------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
+.||+|+||.||+|.... ..+||+|.+.... ....+++.+|+.+++.+.||||+++++++..++..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 469999999999997542 2347888775432 334467889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCc--------EEEEe
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR--------AKVAD 739 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~--------~kl~D 739 (779)
||+++|+|.+++..... .+++..++.++.||+.||+|||+ ++|+||||||+||+++.++. ++++|
T Consensus 79 e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 79 EYVKFGSLDTYLKKNKN----LINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred ecCCCCcHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecc
Confidence 99999999999865432 47888999999999999999996 89999999999999987765 69999
Q ss_pred eccceecCCCCCcccccccccCCcccccccccccCC
Q 004020 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 740 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
||++...... ....+++.|+|||++.+...
T Consensus 152 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~ 181 (258)
T cd05078 152 PGISITVLPK------EILLERIPWVPPECIENPQN 181 (258)
T ss_pred cccccccCCc------hhccccCCccCchhccCCCC
Confidence 9987654321 23457889999999976443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-23 Score=219.19 Aligned_cols=175 Identities=31% Similarity=0.506 Sum_probs=140.8
Q ss_pred cCCcccceecccccEEEEEEEEc-CCc----EEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGT----KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 664 (779)
++|+..+.||+|+||.||+|... +++ .||+|.+.... ......++.+|+.++++++||||+++++++... ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 56788899999999999999764 444 57888876543 233345688999999999999999999998754 467
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
+++||+++|+|.+++.... ..+++..++.++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++
T Consensus 85 ~v~e~~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred eeehhcCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccc
Confidence 9999999999999986432 247888999999999999999996 899999999999999999999999999998
Q ss_pred ecCCCCCcccccccccCCccccccccccc
Q 004020 745 LAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
...............++..|+|||++.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 186 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYR 186 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccC
Confidence 66433222122233467789999988654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-23 Score=217.13 Aligned_cols=172 Identities=25% Similarity=0.457 Sum_probs=146.3
Q ss_pred hcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
..+|++.+.||.|++|.||+|.. .+++.||+|.+.... ....+.+.+|+++++.++||||+++++++...+..++|+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 35699999999999999999975 478999999986543 233467889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++++|.+++... .+++.++..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 96 e~~~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~ 166 (296)
T cd06655 96 EYLAGGSLTDVVTET------CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166 (296)
T ss_pred EecCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence 999999999987432 47899999999999999999996 899999999999999999999999999987654
Q ss_pred CCCCcccccccccCCccccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.... ......|+..|+|||.+.+.
T Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~ 190 (296)
T cd06655 167 PEQS--KRSTMVGTPYWMAPEVVTRK 190 (296)
T ss_pred cccc--cCCCcCCCccccCcchhcCC
Confidence 3321 12234688999999988654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.7e-23 Score=215.92 Aligned_cols=173 Identities=27% Similarity=0.382 Sum_probs=143.9
Q ss_pred CCcccceecccccEEEEEEEE----cCCcEEEEEEecccccC--hhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeE
Q 004020 591 NFSEENVLGRGGFGTVYKGEL----HDGTKIAVKRMESAVVS--EKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNER 663 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 663 (779)
+|++.+.||+|+||.||+|+. .+|+.||+|++...... ....+.+.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999975 36889999998754321 22346678899999999 599999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccc
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 743 (779)
++||||+++++|.+++.... .+++..+..++.|+++||.|||+ .+++||||||+||+++.++.+||+|||++
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE-----RFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccc
Confidence 99999999999999985432 47788899999999999999996 89999999999999999999999999998
Q ss_pred eecCCCCCcccccccccCCcccccccccc
Q 004020 744 RLAPDNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
+....... .......|+..|+|||++.+
T Consensus 153 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~ 180 (290)
T cd05613 153 KEFHEDEV-ERAYSFCGTIEYMAPDIVRG 180 (290)
T ss_pred eecccccc-cccccccCCcccCChhhccC
Confidence 86543221 11223468999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.5e-23 Score=211.91 Aligned_cols=176 Identities=30% Similarity=0.446 Sum_probs=149.7
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
+|+..+.||+|+||.||+|... +++.|++|.+..........+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5888899999999999999764 688999999876654445678899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+++++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 81 CSGGTLEELLEHGR-----ILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred CCCCcHHHHHhhcC-----CCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 99999999985432 46788899999999999999996 89999999999999999999999999998776543
Q ss_pred CCccc--ccccccCCcccccccccccC
Q 004020 750 GKHSI--ETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 750 ~~~~~--~~~~~gt~~y~APE~l~~~~ 774 (779)
..... .....+++.|+|||++.+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~ 179 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGK 179 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCC
Confidence 22111 11346789999999987654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=217.22 Aligned_cols=172 Identities=27% Similarity=0.380 Sum_probs=145.8
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
++|++.+.||+|+||.||+|... +++.||+|++.... .....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 57888899999999999999765 68899999876543 23445778999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++++|.+++... ..+++..+..++.|++.||.|||+ ..+++||||||+||++++++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 84 FMDCGSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred cCCCCCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 99999999887543 257899999999999999999996 35899999999999999999999999999865432
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. .....|+..|+|||++.+.
T Consensus 157 ~~----~~~~~~~~~~~aPE~~~~~ 177 (284)
T cd06620 157 SI----ADTFVGTSTYMSPERIQGG 177 (284)
T ss_pred hc----cCccccCcccCCHHHHccC
Confidence 21 1234689999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.4e-23 Score=214.52 Aligned_cols=172 Identities=26% Similarity=0.492 Sum_probs=146.0
Q ss_pred CCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCC---CCccceEeeEEEeCCeEEEE
Q 004020 591 NFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR---HRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv 666 (779)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... .....+++.+|+.++++++ |||++++++++..+...++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 477889999999999999986 478999999986543 2334567889999999997 99999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++++|.+++... .+++..++.++.|++.||.|||+ .+|+|+||+|+||++++++.++|+|||.+...
T Consensus 81 ~e~~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 81 MEYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred EecCCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 9999999999887432 47899999999999999999996 89999999999999999999999999998876
Q ss_pred CCCCCcccccccccCCcccccccccccC
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
..... ......|+..|+|||++.+..
T Consensus 152 ~~~~~--~~~~~~~~~~y~aPE~~~~~~ 177 (277)
T cd06917 152 NQNSS--KRSTFVGTPYWMAPEVITEGK 177 (277)
T ss_pred CCCcc--ccccccCCcceeCHHHhccCC
Confidence 54321 123346899999999986544
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.6e-23 Score=216.64 Aligned_cols=184 Identities=26% Similarity=0.352 Sum_probs=149.5
Q ss_pred eeHHHHHHhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEE
Q 004020 580 ISIQVLRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYC 657 (779)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 657 (779)
+..+++..+.++|++.+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.+++++ +|||++++++++
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~ 88 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMF 88 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence 344556667889999999999999999999764 68899999986432 2235677899999999 799999999998
Q ss_pred EeC-----CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCC
Q 004020 658 LDG-----NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 732 (779)
Q Consensus 658 ~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~ 732 (779)
... +..++||||+++++|.++++..... ...+++..++.++.|++.||+|||+ .+++||||||+||+++++
T Consensus 89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~ 164 (291)
T cd06639 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLIC-GQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTE 164 (291)
T ss_pred EeccccCCCeeEEEEEECCCCcHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCC
Confidence 754 3579999999999999988643222 2357899999999999999999996 899999999999999999
Q ss_pred CcEEEEeeccceecCCCCCcccccccccCCcccccccccc
Q 004020 733 MRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 733 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
+.+||+|||+++........ .....|+..|+|||++..
T Consensus 165 ~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~ 202 (291)
T cd06639 165 GGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIAC 202 (291)
T ss_pred CCEEEeecccchhccccccc--ccCccCCccccChhhhcC
Confidence 99999999998765432211 123468899999999754
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.1e-23 Score=213.32 Aligned_cols=174 Identities=26% Similarity=0.426 Sum_probs=141.7
Q ss_pred cCCcccceecccccEEEEEEEEcC----CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHD----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
++|.+.+.||+|+||.||+|...+ ...||+|...... .....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 468888999999999999997643 3468999886543 23455678999999999999999999998875 55789
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.
T Consensus 84 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 84 VMELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEcCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeee
Confidence 999999999999985432 247899999999999999999996 8999999999999999999999999999887
Q ss_pred cCCCCCcccccccccCCccccccccccc
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
...... .......++..|+|||++.+.
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 183 (270)
T cd05056 157 LEDESY-YKASKGKLPIKWMAPESINFR 183 (270)
T ss_pred cccccc-eecCCCCccccccChhhhccC
Confidence 654321 112233355789999987544
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.8e-23 Score=212.79 Aligned_cols=176 Identities=27% Similarity=0.509 Sum_probs=143.7
Q ss_pred cCCcccceecccccEEEEEEEEc-CC---cEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DG---TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
++|+..+.||+|+||.||+|+.. ++ ..+|+|.+.... .....+++..|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 46788899999999999999765 33 378999886543 23445678999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||||+++++|.+++.... ..+++.++..++.|++.|++|||+ .+++||||||+||++++++.+||+|||++..
T Consensus 84 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 84 ITEYMENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCcccee
Confidence 999999999999985432 257899999999999999999996 8999999999999999999999999999876
Q ss_pred cCCCCCccc-ccccccCCccccccccccc
Q 004020 746 APDNGKHSI-ETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 746 ~~~~~~~~~-~~~~~gt~~y~APE~l~~~ 773 (779)
......... ......+..|+|||++.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 185 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcC
Confidence 643221111 1112234679999988654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-25 Score=221.18 Aligned_cols=244 Identities=23% Similarity=0.343 Sum_probs=196.8
Q ss_pred eeEeCCC----------CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCC-CCCC
Q 004020 58 HIQCSPS----------NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDD-NNFT 125 (779)
Q Consensus 58 gv~c~~~----------~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~-N~l~ 125 (779)
-|.|+.. ...++|+|..|.|+.+-|.+|..+.+|++||||+|+|+.+-| +|.+|.+|..|-+-+ |+|+
T Consensus 50 ~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~ 129 (498)
T KOG4237|consen 50 IVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT 129 (498)
T ss_pred eEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh
Confidence 3788753 368999999999997778899999999999999999998888 899999988887766 9999
Q ss_pred CCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCC-CccCCCCCcccEEEccCCCCC----
Q 004020 126 SVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD-FLGGDTIPGLMHLHLAFNFLQ---- 200 (779)
Q Consensus 126 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~-~~~~~~l~~L~~L~L~~N~l~---- 200 (779)
.+|.++|.+|..|+-|.+.-|++.. .....|..|++|..|.+.+|.+. .++. +|. .+..++++++..|.+-
T Consensus 130 ~l~k~~F~gL~slqrLllNan~i~C-ir~~al~dL~~l~lLslyDn~~q-~i~~~tf~--~l~~i~tlhlA~np~icdCn 205 (498)
T KOG4237|consen 130 DLPKGAFGGLSSLQRLLLNANHINC-IRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQ--GLAAIKTLHLAQNPFICDCN 205 (498)
T ss_pred hhhhhHhhhHHHHHHHhcChhhhcc-hhHHHHHHhhhcchhcccchhhh-hhcccccc--chhccchHhhhcCccccccc
Confidence 9999999999999999999999987 67789999999999999999998 4554 554 6888999999988721
Q ss_pred --------CcCCCcccc-----------------------CCccee--ecc-CCCCCCCCCCchhhhcCCCCccEEEeec
Q 004020 201 --------GPIPLSFGK-----------------------SSIQTL--WLN-GQKGDSKLNGSVAVIQNMTSLTQLWLHG 246 (779)
Q Consensus 201 --------~~~p~~~~~-----------------------~~L~~l--~l~-~n~~~~~~~~~~~~~~~l~~L~~L~L~~ 246 (779)
...|-.++- ..++.+ .++ .+... .......|..+++|+.|+|++
T Consensus 206 L~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d--~~cP~~cf~~L~~L~~lnlsn 283 (498)
T KOG4237|consen 206 LPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPD--SICPAKCFKKLPNLRKLNLSN 283 (498)
T ss_pred cchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcC--CcChHHHHhhcccceEeccCC
Confidence 122222211 001111 011 11111 122335688899999999999
Q ss_pred CcccCCCC-CCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCCCCCc
Q 004020 247 NSFTGPLP-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPV 307 (779)
Q Consensus 247 N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~ 307 (779)
|+++++-+ .|.++..+++|+|..|+|...--..|.++..|++|+|.+|+|+..-|..|...
T Consensus 284 N~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~ 345 (498)
T KOG4237|consen 284 NKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTL 345 (498)
T ss_pred CccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEeccccccc
Confidence 99999877 49999999999999999987777889999999999999999999888776654
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.5e-23 Score=222.14 Aligned_cols=178 Identities=30% Similarity=0.447 Sum_probs=145.6
Q ss_pred HhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeC--Ce
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDG--NE 662 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~ 662 (779)
.+.++|++.+.||+|+||.||+|... +++.+|+|++............+.+|+.+++++ +||||+++++++... ..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 35678999999999999999999865 688999999865433344456678899999999 999999999998654 36
Q ss_pred EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecc
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 742 (779)
.++||||++ ++|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~ 153 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGL 153 (337)
T ss_pred EEEEecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccc
Confidence 799999997 5888877432 46788899999999999999996 8999999999999999999999999999
Q ss_pred ceecCCCCCc---ccccccccCCcccccccccccC
Q 004020 743 VRLAPDNGKH---SIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 743 a~~~~~~~~~---~~~~~~~gt~~y~APE~l~~~~ 774 (779)
++........ .......|+..|+|||++.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 188 (337)
T cd07852 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGST 188 (337)
T ss_pred hhccccccccccCcchhcccccccccCceeeeccc
Confidence 8866443221 1223456899999999886543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.3e-23 Score=218.32 Aligned_cols=178 Identities=25% Similarity=0.372 Sum_probs=142.7
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC------
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN------ 661 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 661 (779)
.++|++.+.||+|+||.||+|... +++.||+|++............+.+|++++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457999999999999999999765 6899999998654333333345678999999999999999999987654
Q ss_pred --eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEe
Q 004020 662 --ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 739 (779)
Q Consensus 662 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 739 (779)
..++||||+++ ++.+++.... ..+++.+++.++.||+.||+|||+ .+++|+||||+||+++.++.+||+|
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECc
Confidence 35999999964 7877774432 257899999999999999999996 7999999999999999999999999
Q ss_pred eccceecCCCCCc--ccccccccCCcccccccccccC
Q 004020 740 FGLVRLAPDNGKH--SIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 740 FG~a~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~ 774 (779)
||++......... .......++..|+|||++.+..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 199 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGER 199 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCc
Confidence 9998766432211 1112345788999999986654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.4e-23 Score=213.38 Aligned_cols=175 Identities=27% Similarity=0.481 Sum_probs=144.9
Q ss_pred CCcccceecccccEEEEEEEE-cCCcEEEEEEecccccC----hhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 591 NFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVS----EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
+|+..+.||+|++|.||+|.. .+++.||+|.+...... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999975 57899999998643311 1235678999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC-cEEEEeeccce
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVR 744 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~ 744 (779)
||||+++++|.+++.+.. ++++..+..++.|++.||.|||+ ++++|+||||+||+++.++ .+||+|||.+.
T Consensus 81 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred EEeccCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 999999999999885432 57889999999999999999996 8999999999999998775 59999999987
Q ss_pred ecCCCCCc--ccccccccCCccccccccccc
Q 004020 745 LAPDNGKH--SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 745 ~~~~~~~~--~~~~~~~gt~~y~APE~l~~~ 773 (779)
........ .......|+..|+|||++.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~ 183 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE 183 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccC
Confidence 66543111 112234688999999998654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.4e-23 Score=213.74 Aligned_cols=164 Identities=27% Similarity=0.391 Sum_probs=132.2
Q ss_pred eecccccEEEEEEEEc-CCcEEEEEEecccccChh-HHHHHHHHHHHHH---cCCCCccceEeeEEEeCCeEEEEEEecC
Q 004020 597 VLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEK-GFAEFKSEIAVLT---KVRHRHLVGLLGYCLDGNERLLVYEYMP 671 (779)
Q Consensus 597 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~---~l~h~niv~~~~~~~~~~~~~lv~e~~~ 671 (779)
.||+|+||.||++... +++.+|+|.+........ ....+.+|..+++ ..+||+|+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999764 688999999875433222 1223344444333 3479999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCC
Q 004020 672 QGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK 751 (779)
Q Consensus 672 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 751 (779)
+++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~- 151 (279)
T cd05633 81 GGDLHYHLSQHG-----VFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (279)
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-
Confidence 999998885432 58999999999999999999996 899999999999999999999999999987654321
Q ss_pred cccccccccCCcccccccccc
Q 004020 752 HSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 752 ~~~~~~~~gt~~y~APE~l~~ 772 (779)
.....|+..|+|||++.+
T Consensus 152 ---~~~~~~~~~y~aPE~~~~ 169 (279)
T cd05633 152 ---PHASVGTHGYMAPEVLQK 169 (279)
T ss_pred ---ccCcCCCcCccCHHHhcC
Confidence 123468999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.5e-23 Score=213.10 Aligned_cols=179 Identities=29% Similarity=0.468 Sum_probs=143.1
Q ss_pred CcccceecccccEEEEEEEEc----CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC------
Q 004020 592 FSEENVLGRGGFGTVYKGELH----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN------ 661 (779)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 661 (779)
|.+.+.||+|+||.||+|... +++.||+|++..........+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999753 4688999999876655566778999999999999999999999886542
Q ss_pred eEEEEEEecCCCChhhHhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEee
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKE-EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF 740 (779)
..++++||+++|+|.+++..... .....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 24788999999999888754321 122347888999999999999999996 89999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccCCccccccccccc
Q 004020 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 741 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
|+++...............+++.|++||.+.+.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~ 190 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADN 190 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcC
Confidence 998865433222222233456789999987644
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-23 Score=217.91 Aligned_cols=170 Identities=28% Similarity=0.439 Sum_probs=142.0
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
.|.....||+|+||.||++... ++..||+|++.... ....+.+.+|+.++++++||||+++++.+..++..++||||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 3444567999999999999764 68899999886433 33456788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+++++|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||++......
T Consensus 101 ~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (292)
T cd06658 101 LEGGALTDIVTHT------RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE 171 (292)
T ss_pred CCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence 9999999887432 47888999999999999999996 79999999999999999999999999998755332
Q ss_pred CCcccccccccCCccccccccccc
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
. .......|+..|+|||++.+.
T Consensus 172 ~--~~~~~~~~~~~y~aPE~~~~~ 193 (292)
T cd06658 172 V--PKRKSLVGTPYWMAPEVISRL 193 (292)
T ss_pred c--ccCceeecCccccCHHHHccC
Confidence 1 112335689999999988553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=210.63 Aligned_cols=176 Identities=28% Similarity=0.412 Sum_probs=143.8
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccc---cChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC--CeE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV---VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--NER 663 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 663 (779)
.+|++.+.||+|+||.||+|... ++..||+|.+.... ........+.+|++++++++||||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47889999999999999999764 68999999875321 1233456789999999999999999999998764 457
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccc
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 743 (779)
+++|||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 153 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG-----ALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccc
Confidence 89999999999999885432 47788899999999999999996 89999999999999999999999999998
Q ss_pred eecCCCCC-cccccccccCCccccccccccc
Q 004020 744 RLAPDNGK-HSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 744 ~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+....... ........|+..|+|||++.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 184 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGE 184 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCC
Confidence 76532111 1111234688999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=213.63 Aligned_cols=176 Identities=28% Similarity=0.519 Sum_probs=144.8
Q ss_pred cCCcccceecccccEEEEEEEEc-----CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEe--CCe
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD--GNE 662 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~ 662 (779)
++|+..+.||+|+||.||+|+.. ++..||+|.+...... ...+.+.+|+++++.+.||||+++++++.. +..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 46778899999999999999754 3688999998765432 346789999999999999999999999887 557
Q ss_pred EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecc
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 742 (779)
.++||||+++++|.+++..... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||.
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRD----QINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCcc----ccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccc
Confidence 8999999999999999865432 48899999999999999999996 8999999999999999999999999999
Q ss_pred ceecCCCCCcc-cccccccCCccccccccccc
Q 004020 743 VRLAPDNGKHS-IETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 743 a~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~ 773 (779)
+.......... ......++..|+|||++.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~ 187 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTS 187 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccC
Confidence 98765332211 11123456679999987654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.8e-23 Score=210.75 Aligned_cols=171 Identities=30% Similarity=0.462 Sum_probs=147.6
Q ss_pred cCCcccceecccccEEEEEEEEcC-CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
++|+..+.||+|+||.||+|...+ ++.+++|.+.... ..+++.+|++++++++||||+++++++......++++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 578999999999999999998764 7899999986542 25789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++++|.+++.... ..+++..+..++.|++.|+.|||+ .+++||||+|+||++++++.+||+|||++.....
T Consensus 79 ~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 79 YCGAGSVSDIMKITN----KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred cCCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 999999999985432 357899999999999999999996 8999999999999999999999999999886654
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
... ......|+..|+|||++.+.
T Consensus 152 ~~~--~~~~~~~~~~y~~PE~~~~~ 174 (256)
T cd06612 152 TMA--KRNTVIGTPFWMAPEVIQEI 174 (256)
T ss_pred Ccc--ccccccCCccccCHHHHhcC
Confidence 321 12334588999999998655
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.5e-24 Score=204.20 Aligned_cols=170 Identities=26% Similarity=0.383 Sum_probs=138.4
Q ss_pred hhcCCccc-ceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEe----C
Q 004020 588 VTNNFSEE-NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLD----G 660 (779)
Q Consensus 588 ~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~ 660 (779)
++++|.+. ++||-|-.|.|..+..+ +++++|+|++... ...++|+++--.. .|||||.++++|.. .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 55667653 67999999999999654 7899999987532 3567888876665 59999999999864 3
Q ss_pred CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEc---CCCcEEE
Q 004020 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG---DDMRAKV 737 (779)
Q Consensus 661 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~---~~~~~kl 737 (779)
....+|||+|+||.|...+.++.. ..+++.++..|+.||+.|+.|||+ .+|.||||||+|+|.. .+..+||
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~---~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKL 205 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGD---QAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKL 205 (400)
T ss_pred eeeEeeeecccchHHHHHHHHccc---ccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEe
Confidence 456799999999999999876653 468999999999999999999996 8999999999999996 4567999
Q ss_pred EeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 738 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+|||+|+.....+. ....+.||+|.|||++..+
T Consensus 206 tDfGFAK~t~~~~~---L~TPc~TPyYvaPevlg~e 238 (400)
T KOG0604|consen 206 TDFGFAKETQEPGD---LMTPCFTPYYVAPEVLGPE 238 (400)
T ss_pred cccccccccCCCcc---ccCCcccccccCHHHhCch
Confidence 99999987654322 2344689999999998644
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.4e-23 Score=216.97 Aligned_cols=180 Identities=29% Similarity=0.401 Sum_probs=145.7
Q ss_pred HhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC----
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN---- 661 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 661 (779)
...++|++.+.||+|+||.||+|... +++.||+|+++...........+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35578999999999999999999875 5889999998765433334456788999999999999999999987654
Q ss_pred ------eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcE
Q 004020 662 ------ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 735 (779)
Q Consensus 662 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 735 (779)
..++|+||+++ ++.+.+... ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcE
Confidence 78999999976 676666433 1258899999999999999999996 899999999999999999999
Q ss_pred EEEeeccceecCCCCCcccccccccCCcccccccccccCC
Q 004020 736 KVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 736 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
||+|||.+........ .......++..|+|||++.+...
T Consensus 156 kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~ 194 (302)
T cd07864 156 KLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEER 194 (302)
T ss_pred EeCcccccccccCCcc-cccccceeccCccChHHhcCCCC
Confidence 9999999886654322 11222346788999998865443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.5e-23 Score=219.91 Aligned_cols=173 Identities=28% Similarity=0.438 Sum_probs=144.3
Q ss_pred HHhhcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC---
Q 004020 586 RNVTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN--- 661 (779)
Q Consensus 586 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--- 661 (779)
..+.++|++.+.||+|+||.||+|.. .++..||+|++............+.+|++++++++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 34678899999999999999999975 47899999998654433444567889999999999999999999987653
Q ss_pred ---eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEE
Q 004020 662 ---ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 738 (779)
Q Consensus 662 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 738 (779)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+ .+|+||||||+||+++.++.+||+
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEe
Confidence 458999998 6788887742 247899999999999999999996 899999999999999999999999
Q ss_pred eeccceecCCCCCcccccccccCCccccccccccc
Q 004020 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 739 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
|||++...... .....+++.|+|||++.+.
T Consensus 161 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~ 190 (343)
T cd07880 161 DFGLARQTDSE-----MTGYVVTRWYRAPEVILNW 190 (343)
T ss_pred ecccccccccC-----ccccccCCcccCHHHHhCC
Confidence 99998765432 1234578999999998653
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=208.99 Aligned_cols=173 Identities=35% Similarity=0.600 Sum_probs=143.9
Q ss_pred CcccceecccccEEEEEEEEcC-----CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 592 FSEENVLGRGGFGTVYKGELHD-----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
+++.+.||+|+||.||+|+... +..||+|.+.... .....+.+..|+++++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3567899999999999997753 4889999986543 222567889999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++++|.+++...... .+++.++..++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++..
T Consensus 80 ~e~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPK---ELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred EeccCCCCHHHHHHhhhhc---cCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceec
Confidence 9999999999998654321 27899999999999999999996 89999999999999999999999999999876
Q ss_pred CCCCCcccccccccCCcccccccccc
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
....... .....+++.|+|||.+.+
T Consensus 154 ~~~~~~~-~~~~~~~~~y~~Pe~~~~ 178 (258)
T smart00219 154 YDDDYYK-KKGGKLPIRWMAPESLKD 178 (258)
T ss_pred ccccccc-cccCCCcccccChHHhcc
Confidence 5432211 112337789999998743
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-23 Score=215.37 Aligned_cols=172 Identities=30% Similarity=0.497 Sum_probs=145.0
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
+.|+..+.||+|+||.||+|... +++.||+|.+.... .....+.+.+|++++++++||||+++++++..+...++|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 35677788999999999999764 57889999886443 23345678999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++++|.+++.. ..+++..+..++.|+++|+.|||+ ++++|+||+|+||++++++.++|+|||++.....
T Consensus 83 ~~~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 83 YLGGGSALDLLKP------GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred ccCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccC
Confidence 9999999988743 247889999999999999999995 8999999999999999999999999999876543
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. .......|+..|+|||++.+.
T Consensus 154 ~~--~~~~~~~~~~~y~aPE~~~~~ 176 (277)
T cd06642 154 TQ--IKRNTFVGTPFWMAPEVIKQS 176 (277)
T ss_pred cc--hhhhcccCcccccCHHHhCcC
Confidence 21 112234688999999998764
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=213.87 Aligned_cols=170 Identities=31% Similarity=0.470 Sum_probs=142.9
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccc-cChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
.+.|+..+.||+|+||.||+|... +++.||+|++.... ......+++.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888999999999999999765 68999999886433 2234456789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||++ |++.+++.... ..+++..+..++.|++.||.|||+ .+|+||||+|+||++++++.+||+|||++...
T Consensus 94 ~e~~~-g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 94 MEYCL-GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred HHhhC-CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceec
Confidence 99997 57766664322 257899999999999999999996 89999999999999999999999999998765
Q ss_pred CCCCCcccccccccCCcccccccccc
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
... ....|++.|+|||++.+
T Consensus 166 ~~~------~~~~~~~~y~aPE~~~~ 185 (307)
T cd06607 166 SPA------NSFVGTPYWMAPEVILA 185 (307)
T ss_pred CCC------CCccCCccccCceeeec
Confidence 432 23468889999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=210.57 Aligned_cols=171 Identities=36% Similarity=0.543 Sum_probs=136.1
Q ss_pred ceecccccEEEEEEEEcC-Cc--EEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEEEEEEecC
Q 004020 596 NVLGRGGFGTVYKGELHD-GT--KIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLVYEYMP 671 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 671 (779)
+.||+|+||.||+|+..+ +. .+++|.++... .....+.+.+|++++.++ +||||+++++++...+..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 368999999999998753 43 46888876432 334556788999999999 79999999999999999999999999
Q ss_pred CCChhhHhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEee
Q 004020 672 QGTLSRHLFNRKEE-----------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (779)
Q Consensus 672 ~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF 740 (779)
+++|.+++...... ....+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCC
Confidence 99999998654321 12247889999999999999999996 89999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccCCccccccccccc
Q 004020 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 741 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
|+++..... ........+..|+|||++...
T Consensus 157 gl~~~~~~~---~~~~~~~~~~~y~apE~~~~~ 186 (270)
T cd05047 157 GLSRGQEVY---VKKTMGRLPVRWMAIESLNYS 186 (270)
T ss_pred CCccccchh---hhccCCCCccccCChHHHccC
Confidence 998632211 011112345679999987543
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.6e-23 Score=220.21 Aligned_cols=177 Identities=28% Similarity=0.478 Sum_probs=142.8
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC-----
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN----- 661 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 661 (779)
+.++|++.+.||+|+||.||+|... +++.||+|++.... ......++.+|+.++++++||||+++++++....
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 3578999999999999999999754 68999999986432 2234466888999999999999999999876543
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeec
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 741 (779)
..++|+||+++ ++.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg 151 (336)
T cd07849 82 DVYIVQELMET-DLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFG 151 (336)
T ss_pred eEEEEehhccc-CHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECccc
Confidence 57999999964 77777633 258889999999999999999996 899999999999999999999999999
Q ss_pred cceecCCCCCc-ccccccccCCcccccccccccCC
Q 004020 742 LVRLAPDNGKH-SIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 742 ~a~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
+++........ .......|++.|+|||++.+...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 186 (336)
T cd07849 152 LARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKG 186 (336)
T ss_pred ceeeccccccccCCcCCcCcCCCccChHHhhCCCC
Confidence 98865432211 11233568999999998765443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-22 Score=206.89 Aligned_cols=174 Identities=30% Similarity=0.509 Sum_probs=150.2
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
+|++.+.||+|++|.||+|... +++.|++|.+..........+.+.+|++++++++|||++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999765 678999999987665445667899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+++++|.+++... ..+++..+..++.|++.|+.|||+ .+|+||||||+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 9999999988544 258899999999999999999996 89999999999999999999999999999876543
Q ss_pred CCcccccccccCCcccccccccccC
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
... .....++..|+|||+..+..
T Consensus 153 ~~~--~~~~~~~~~y~~pe~~~~~~ 175 (254)
T cd06627 153 SKD--DASVVGTPYWMAPEVIEMSG 175 (254)
T ss_pred ccc--ccccccchhhcCHhhhcCCC
Confidence 221 23346889999999876543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.7e-23 Score=217.07 Aligned_cols=169 Identities=27% Similarity=0.409 Sum_probs=142.0
Q ss_pred CcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEec
Q 004020 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYM 670 (779)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 670 (779)
|+....||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 444567999999999999764 68999999986543 233456889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCC
Q 004020 671 PQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750 (779)
Q Consensus 671 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 750 (779)
++++|.+++.. ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 101 QGGALTDIVSQ------TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred CCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence 99999887743 247889999999999999999996 899999999999999999999999999987554322
Q ss_pred CcccccccccCCccccccccccc
Q 004020 751 KHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 751 ~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
. ......|+..|+|||++.+.
T Consensus 172 ~--~~~~~~~~~~y~aPE~~~~~ 192 (297)
T cd06659 172 P--KRKSLVGTPYWMAPEVISRT 192 (297)
T ss_pred c--cccceecCccccCHHHHccC
Confidence 1 12335689999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=219.91 Aligned_cols=172 Identities=28% Similarity=0.396 Sum_probs=143.0
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC------
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG------ 660 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 660 (779)
+.++|+..+.||+|+||.||+|+.. +++.||+|++...........++.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 5678999999999999999999765 789999999876544444556788999999999999999999988644
Q ss_pred CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEee
Q 004020 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (779)
Q Consensus 661 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF 740 (779)
...|+||||+. ++|.+.+.. .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccC
Confidence 24699999996 478777632 26788899999999999999996 89999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccCCccccccccccc
Q 004020 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 741 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
|+++...... ......++..|+|||++.+.
T Consensus 163 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~ 192 (353)
T cd07850 163 GLARTAGTSF---MMTPYVVTRYYRAPEVILGM 192 (353)
T ss_pred ccceeCCCCC---CCCCCcccccccCHHHHhCC
Confidence 9998764321 12334688999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=212.22 Aligned_cols=177 Identities=29% Similarity=0.410 Sum_probs=146.7
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCC----
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGN---- 661 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~---- 661 (779)
..++|++.+.||+|++|.||+|... +++.+++|++.... ...+++.+|+.+++++ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 4678999999999999999999875 57899999886543 2346789999999999 6999999999997644
Q ss_pred --eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEe
Q 004020 662 --ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 739 (779)
Q Consensus 662 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 739 (779)
..++||||+++++|.+++...... ...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKK-GKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECC
Confidence 489999999999999988653311 2358899999999999999999996 8999999999999999999999999
Q ss_pred eccceecCCCCCcccccccccCCccccccccccc
Q 004020 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 740 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
||.+....... .......|+..|+|||++...
T Consensus 157 ~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~ 188 (275)
T cd06608 157 FGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACD 188 (275)
T ss_pred Cccceecccch--hhhcCccccccccCHhHhccc
Confidence 99987654322 112334689999999998643
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=210.53 Aligned_cols=171 Identities=29% Similarity=0.484 Sum_probs=144.6
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
-|++.+.||+|+||.||+|... +++.||+|.+.... .....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 4677889999999999999764 68899999876443 233456789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+++++|.+++... .+++..+..++.|++.|+.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 84 LGGGSALDLLEPG------PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred CCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 9999999888432 47889999999999999999995 89999999999999999999999999998766432
Q ss_pred CCcccccccccCCccccccccccc
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
. .......|+..|+|||++.+.
T Consensus 155 ~--~~~~~~~~~~~y~~PE~~~~~ 176 (277)
T cd06641 155 Q--IKRNTFVGTPFWMAPEVIKQS 176 (277)
T ss_pred h--hhhccccCCccccChhhhccC
Confidence 1 112334688999999998654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6e-23 Score=220.82 Aligned_cols=176 Identities=24% Similarity=0.395 Sum_probs=144.0
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEe----CCeE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD----GNER 663 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~ 663 (779)
.++|++.+.||+|+||.||+|... +++.||+|++..........+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999764 68999999987654333445678889999999999999999998763 3467
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccc
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 743 (779)
++||||+. ++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||++
T Consensus 84 ~lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred EEEEehhh-hhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccc
Confidence 99999996 5888887432 248899999999999999999996 89999999999999999999999999998
Q ss_pred eecCCCCCc--ccccccccCCccccccccccc
Q 004020 744 RLAPDNGKH--SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 744 ~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~ 773 (779)
+........ .......|+..|+|||++.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 186 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSL 186 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcCC
Confidence 765432211 112234689999999998653
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=212.57 Aligned_cols=180 Identities=31% Similarity=0.462 Sum_probs=146.5
Q ss_pred HHHHHHhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEe
Q 004020 582 IQVLRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLD 659 (779)
Q Consensus 582 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 659 (779)
..++....+.|++.+.||+|+||.||+|+.. +++.+|+|.+... .....++..|+.+++++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 3444556678999999999999999999764 6889999987543 23445688899999998 69999999999863
Q ss_pred ------CCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC
Q 004020 660 ------GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 733 (779)
Q Consensus 660 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 733 (779)
.+..+++|||+++++|.+++..... ..+++..++.++.|++.|+.|||+ .+|+||||||+||++++++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~ 158 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENA 158 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCC
Confidence 4578999999999999998865432 247788889999999999999996 8999999999999999999
Q ss_pred cEEEEeeccceecCCCCCcccccccccCCcccccccccc
Q 004020 734 RAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 734 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
.++|+|||+++....... ......|++.|+|||++..
T Consensus 159 ~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~ 195 (282)
T cd06636 159 EVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIAC 195 (282)
T ss_pred CEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCc
Confidence 999999999875532211 1233568999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=213.27 Aligned_cols=174 Identities=27% Similarity=0.398 Sum_probs=144.7
Q ss_pred CcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEec
Q 004020 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYM 670 (779)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 670 (779)
|++.+.||+|++|.||+|... +|..||+|++............+.+|+++++.++|||++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 667889999999999999764 7999999998765433334466888999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCC
Q 004020 671 PQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750 (779)
Q Consensus 671 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 750 (779)
+ ++|.+++..... ..+++..++.++.|+++||+|||+ .+++||||+|+||++++++.++|+|||+++......
T Consensus 81 ~-~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 81 D-LDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred C-cCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 5 689888855432 257899999999999999999996 799999999999999999999999999987654321
Q ss_pred CcccccccccCCcccccccccccC
Q 004020 751 KHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 751 ~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
. ......++..|+|||++.+..
T Consensus 154 ~--~~~~~~~~~~~~aPE~~~~~~ 175 (283)
T cd07835 154 R--TYTHEVVTLWYRAPEILLGSR 175 (283)
T ss_pred c--ccCccccccCCCCCceeecCc
Confidence 1 112335788999999886643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=211.14 Aligned_cols=172 Identities=27% Similarity=0.481 Sum_probs=146.1
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
..|+..+.||+|+||.||+|... ++..||+|.+.... .......+.+|+++++++.||||+++++++.++...++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 46778899999999999999765 58899999886543 23455788999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++++|.+++... .+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 83 YLGGGSALDLLRAG------PFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred cCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 99999999988432 47888899999999999999996 8999999999999999999999999999976644
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
... ......++..|+|||++.+.
T Consensus 154 ~~~--~~~~~~~~~~y~apE~~~~~ 176 (277)
T cd06640 154 TQI--KRNTFVGTPFWMAPEVIQQS 176 (277)
T ss_pred Ccc--ccccccCcccccCHhHhccC
Confidence 321 12334688899999998654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=213.19 Aligned_cols=177 Identities=28% Similarity=0.388 Sum_probs=146.2
Q ss_pred CcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC--CeEEEEEE
Q 004020 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--NERLLVYE 668 (779)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 668 (779)
|++.+.||+|+||.||+|+.. +++.+|+|++............+.+|++++++++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 667889999999999999876 588999999986542334446788999999999999999999999988 78999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++ +|.+++.... ..+++..++.++.||++||+|||+ .+++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 81 YMDH-DLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred cccc-cHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 9975 8888875432 258899999999999999999996 7999999999999999999999999999987654
Q ss_pred CCCcccccccccCCcccccccccccCCCC
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
... .......++..|+|||.+.+...++
T Consensus 153 ~~~-~~~~~~~~~~~y~~PE~~~~~~~~~ 180 (287)
T cd07840 153 RNS-ADYTNRVITLWYRPPELLLGATRYG 180 (287)
T ss_pred CCc-ccccccccccccCCceeeEccccCC
Confidence 321 1123345788999999887654433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=218.44 Aligned_cols=178 Identities=28% Similarity=0.423 Sum_probs=146.3
Q ss_pred HHHHHHhhcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC
Q 004020 582 IQVLRNVTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG 660 (779)
Q Consensus 582 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 660 (779)
..++..+.++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 455667789999999999999999999975 4789999999876543334456788999999999999999999988643
Q ss_pred ------CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCc
Q 004020 661 ------NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 734 (779)
Q Consensus 661 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 734 (779)
...+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||++++++.
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCC
Confidence 3467888877 7789877642 147889999999999999999996 89999999999999999999
Q ss_pred EEEEeeccceecCCCCCcccccccccCCcccccccccccC
Q 004020 735 AKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 735 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
+||+|||+++..... .....|+..|+|||++.+..
T Consensus 159 ~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~ 193 (345)
T cd07877 159 LKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWM 193 (345)
T ss_pred EEEeccccccccccc-----ccccccCCCccCHHHHhCcc
Confidence 999999998764322 13346889999999986643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=212.23 Aligned_cols=168 Identities=32% Similarity=0.451 Sum_probs=140.2
Q ss_pred ecccccEEEEEEEEc-CCcEEEEEEecccccC-hhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCCCCh
Q 004020 598 LGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTL 675 (779)
Q Consensus 598 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 675 (779)
||+|+||.||+|... +++.||+|.+...... ......+.+|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999754 6889999998754322 22345677899999999999999999999999999999999999999
Q ss_pred hhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCcccc
Q 004020 676 SRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE 755 (779)
Q Consensus 676 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 755 (779)
.+++..... ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||.++...... ..
T Consensus 81 ~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~ 151 (277)
T cd05577 81 KYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KI 151 (277)
T ss_pred HHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cc
Confidence 998865432 357899999999999999999996 899999999999999999999999999987654321 11
Q ss_pred cccccCCcccccccccccC
Q 004020 756 TRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 756 ~~~~gt~~y~APE~l~~~~ 774 (779)
....++..|+|||++.+..
T Consensus 152 ~~~~~~~~y~~PE~~~~~~ 170 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEV 170 (277)
T ss_pred ccccCCCCcCCHHHhcCCC
Confidence 2345788999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=211.41 Aligned_cols=165 Identities=25% Similarity=0.370 Sum_probs=132.7
Q ss_pred eecccccEEEEEEEEc-CCcEEEEEEecccccChhH-HHHHHHHH---HHHHcCCCCccceEeeEEEeCCeEEEEEEecC
Q 004020 597 VLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKG-FAEFKSEI---AVLTKVRHRHLVGLLGYCLDGNERLLVYEYMP 671 (779)
Q Consensus 597 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~~E~---~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 671 (779)
.||+|+||.||+|+.. +++.||+|.+......... ...+..|. +.++...||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999764 6889999998764322211 12233343 34445679999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCC
Q 004020 672 QGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK 751 (779)
Q Consensus 672 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 751 (779)
+++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~- 151 (278)
T cd05606 81 GGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (278)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-
Confidence 99999887532 258999999999999999999996 899999999999999999999999999987654321
Q ss_pred cccccccccCCccccccccccc
Q 004020 752 HSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 752 ~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.....|+..|+|||++.+.
T Consensus 152 ---~~~~~~~~~y~aPE~~~~~ 170 (278)
T cd05606 152 ---PHASVGTHGYMAPEVLQKG 170 (278)
T ss_pred ---CcCcCCCcCCcCcHHhcCC
Confidence 1234689999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=208.34 Aligned_cols=168 Identities=32% Similarity=0.504 Sum_probs=136.4
Q ss_pred ceecccccEEEEEEEEcC----CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecC
Q 004020 596 NVLGRGGFGTVYKGELHD----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMP 671 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 671 (779)
++||+|+||.||+|.... +..+|+|.+...... ...+++.+|+++++++.||||+++++++. .+..++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 469999999999996532 368999998765432 34567899999999999999999999876 456899999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCC
Q 004020 672 QGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK 751 (779)
Q Consensus 672 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 751 (779)
+++|.+++.... .+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||.++.......
T Consensus 79 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 79 LGPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 999999986543 47899999999999999999996 7899999999999999999999999999886644322
Q ss_pred ccc-ccccccCCccccccccccc
Q 004020 752 HSI-ETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 752 ~~~-~~~~~gt~~y~APE~l~~~ 773 (779)
... .....++..|+|||.+.+.
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~ 173 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYG 173 (257)
T ss_pred ccccccCccccccccCHHHhcCC
Confidence 111 1112245689999988644
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=209.65 Aligned_cols=170 Identities=31% Similarity=0.495 Sum_probs=134.7
Q ss_pred ceecccccEEEEEEEEc----CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEe-CCeEEEEEEec
Q 004020 596 NVLGRGGFGTVYKGELH----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD-GNERLLVYEYM 670 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~ 670 (779)
+.||+|+||.||+|... +...||+|++.... .....+.+.+|+.+++.++||||+++++++.. ++..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 46899999999999753 24579999875422 23445678899999999999999999998764 45678999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCC
Q 004020 671 PQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750 (779)
Q Consensus 671 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 750 (779)
.+++|.+++..... ..++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 80 ~~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 80 KHGDLRNFIRSETH----NPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred CCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 99999999864322 35677788999999999999995 899999999999999999999999999987654322
Q ss_pred Ccc--cccccccCCccccccccccc
Q 004020 751 KHS--IETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 751 ~~~--~~~~~~gt~~y~APE~l~~~ 773 (779)
... ......++..|+|||++.+.
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~ 177 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQ 177 (262)
T ss_pred ceeecccccCcCCccccChhHhccC
Confidence 111 11233467789999987654
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.7e-23 Score=212.85 Aligned_cols=173 Identities=29% Similarity=0.416 Sum_probs=147.6
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
++|+..+.||+|+||.||+|... +++.+|+|.+..... ....+++.+|++++++++||||+++++++...+..++++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 36788899999999999999876 688999999876542 3455678999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++++|.+++.... ..+++..+..++.|++.|++|||+ ..+++|+||||+||++++++.++|+|||.+.....
T Consensus 80 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 80 YMDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred ecCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence 999999999986543 357889999999999999999995 37999999999999999999999999999875533
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
... ....++..|+|||++.+.
T Consensus 154 ~~~----~~~~~~~~y~~PE~~~~~ 174 (265)
T cd06605 154 SLA----KTFVGTSSYMAPERIQGN 174 (265)
T ss_pred HHh----hcccCChhccCHHHHcCC
Confidence 211 125688999999998665
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-22 Score=207.17 Aligned_cols=178 Identities=27% Similarity=0.474 Sum_probs=152.1
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
+|++.+.||+|+||.||++... ++..||+|++..........+++.+|+++++.++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788899999999999999765 688999999987655556667889999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+++++|.+++...... ...+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKE-GKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhcc-CCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 9999999998765421 2368999999999999999999996 79999999999999999999999999998876543
Q ss_pred CCcccccccccCCcccccccccccC
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
. .......|++.|+|||.+.+..
T Consensus 157 ~--~~~~~~~~~~~y~~pe~~~~~~ 179 (258)
T cd08215 157 V--DLAKTVVGTPYYLSPELCQNKP 179 (258)
T ss_pred c--ceecceeeeecccChhHhccCC
Confidence 2 1223346889999999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-22 Score=208.13 Aligned_cols=174 Identities=28% Similarity=0.427 Sum_probs=149.2
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
++|++.+.||+|++|.||+|... +++.|++|++...... .....+.+|++.+.+++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 36888999999999999999876 5899999998765422 455789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++++|.+++... ..+++..++.++.|+++|++|||+ ..+++||||+|+||+++.++.++|+|||.+.....
T Consensus 80 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 80 YMDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred ecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999998654 257899999999999999999994 27999999999999999999999999999887654
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.... .....++..|+|||.+.+.
T Consensus 153 ~~~~--~~~~~~~~~y~~pE~~~~~ 175 (264)
T cd06623 153 TLDQ--CNTFVGTVTYMSPERIQGE 175 (264)
T ss_pred CCCc--ccceeecccccCHhhhCCC
Confidence 3221 1234688999999988665
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=213.63 Aligned_cols=177 Identities=30% Similarity=0.384 Sum_probs=141.0
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 667 (779)
++|+..+.||+|+||.||++... +++.||+|.+..... ......+.+|+.++.++. ||||+++++++..++..+++|
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD-EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC-hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 35666789999999999999765 689999999875432 244567889999999996 999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||++. ++.++...........+++..+..++.|++.||+|||+ ..+++||||||+||+++.++.+||+|||+++...
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 99864 55544322111112368899999999999999999996 3589999999999999999999999999987654
Q ss_pred CCCCcccccccccCCccccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.... .....|++.|+|||++.+.
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~ 182 (288)
T cd06616 160 DSIA---KTRDAGCRPYMAPERIDPS 182 (288)
T ss_pred cCCc---cccccCccCccCHHHhccc
Confidence 3211 1233588999999998765
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=208.69 Aligned_cols=167 Identities=37% Similarity=0.569 Sum_probs=139.1
Q ss_pred cCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
++|++.+.||+|+||.||++.. +++.||+|.+.... ..+.+.+|+.++++++||||+++++++... ..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 4688999999999999999875 57889999986432 335788999999999999999999998764 47999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+++++|.+++..... ..+++..++.++.|++.|+.|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 80 MSKGNLVNFLRTRGR---ALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred CCCCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 999999999865432 247888999999999999999995 89999999999999999999999999998764322
Q ss_pred CCcccccccccCCccccccccccc
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
. .....+..|+|||++.+.
T Consensus 154 ~-----~~~~~~~~y~~pe~~~~~ 172 (254)
T cd05083 154 V-----DNSKLPVKWTAPEALKHK 172 (254)
T ss_pred C-----CCCCCCceecCHHHhccC
Confidence 1 122345789999988643
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.8e-23 Score=212.12 Aligned_cols=174 Identities=33% Similarity=0.512 Sum_probs=139.4
Q ss_pred ceecccccEEEEEEEEcC-------CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 596 NVLGRGGFGTVYKGELHD-------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
+.||+|+||.||+|+..+ +..+|+|.+.... ......++.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 368999999999997642 2578999876432 23345678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC-----cEEEEeec
Q 004020 669 YMPQGTLSRHLFNRKEE--GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-----RAKVADFG 741 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-----~~kl~DFG 741 (779)
|+++++|.+++...... ....+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++ .++++|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 99999999999754322 12347889999999999999999996 7899999999999999877 89999999
Q ss_pred cceecCCCCCcccccccccCCccccccccccc
Q 004020 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 742 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+++...............++..|+|||++.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 188 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDG 188 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccC
Confidence 98765432221122223467889999988643
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-22 Score=208.84 Aligned_cols=177 Identities=27% Similarity=0.486 Sum_probs=145.2
Q ss_pred CCcccceecccccEEEEEEEEcC--CcEEEEEEecccc--------cChhHHHHHHHHHHHHHc-CCCCccceEeeEEEe
Q 004020 591 NFSEENVLGRGGFGTVYKGELHD--GTKIAVKRMESAV--------VSEKGFAEFKSEIAVLTK-VRHRHLVGLLGYCLD 659 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~--------~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~ 659 (779)
+|++.+.||+|+||.||+|.... ++.+|+|.+.... .......++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999998764 6889999875332 123344667789988875 789999999999999
Q ss_pred CCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEe
Q 004020 660 GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 739 (779)
Q Consensus 660 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 739 (779)
++..++||||+++++|.+++...... ...+++..++.++.|++.||.|||+ ..+++|+||||+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999887543222 2358889999999999999999995 36899999999999999999999999
Q ss_pred eccceecCCCCCcccccccccCCccccccccccc
Q 004020 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 740 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
||.+....... ......|+..|+|||++.+.
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~ 188 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNE 188 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCC
Confidence 99998755432 22345688999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-24 Score=220.91 Aligned_cols=174 Identities=27% Similarity=0.344 Sum_probs=150.1
Q ss_pred cCCcccceecccccEEEEEEEEcCCc-EEEEEEecccc-cChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHDGT-KIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.+++....||-|+||.|-+++.+... .+|+|++++.. .+.+..+.+..|-.+|..++.|.||++|..|.+.++.|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34556678999999999999876433 48999987653 44455567889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
|-|-||.++..+.++. .++...+..++..+++|++|||+ ++||.|||||+|.++|.+|.+||.|||+|+.+.
T Consensus 500 EaClGGElWTiLrdRg-----~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG-----SFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred HhhcCchhhhhhhhcC-----CcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 9999999999997654 57888889999999999999996 899999999999999999999999999999987
Q ss_pred CCCCcccccccccCCcccccccccccC
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
.... +..++|||.|.|||++..+.
T Consensus 572 ~g~K---TwTFcGTpEYVAPEIILnKG 595 (732)
T KOG0614|consen 572 SGRK---TWTFCGTPEYVAPEIILNKG 595 (732)
T ss_pred cCCc---eeeecCCcccccchhhhccC
Confidence 6533 35679999999999987653
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=212.32 Aligned_cols=172 Identities=27% Similarity=0.452 Sum_probs=145.5
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.++|++.+.||+|+||.||++... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++...+..|+|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 368889999999999999999754 67899999986432 233467889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++++|.+++.+. .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 96 e~~~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~ 166 (293)
T cd06647 96 EYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (293)
T ss_pred ecCCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence 999999999988532 36788899999999999999996 899999999999999999999999999987654
Q ss_pred CCCCcccccccccCCccccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.... ......|++.|+|||++.+.
T Consensus 167 ~~~~--~~~~~~~~~~y~~PE~~~~~ 190 (293)
T cd06647 167 PEQS--KRSTMVGTPYWMAPEVVTRK 190 (293)
T ss_pred cccc--ccccccCChhhcCchhhccC
Confidence 4322 12234688999999988653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=208.63 Aligned_cols=175 Identities=33% Similarity=0.500 Sum_probs=150.1
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
+|++.+.||+|+||.||++... +++.+|+|.+...........++.+|++++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999654 688999999976655555667788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+++++|.+++.+.... ...+++..++.++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKK-RKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 9999999998664322 2357899999999999999999996 89999999999999999999999999998876543
Q ss_pred CCcccccccccCCccccccccccc
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
......|++.|+|||++.+.
T Consensus 157 ----~~~~~~~~~~~~~Pe~~~~~ 176 (256)
T cd08530 157 ----MAKTQIGTPHYMAPEVWKGR 176 (256)
T ss_pred ----CcccccCCccccCHHHHCCC
Confidence 11234588999999998654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-23 Score=211.36 Aligned_cols=175 Identities=28% Similarity=0.383 Sum_probs=146.0
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccCh-hHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE-KGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 665 (779)
..+|....+||+|+||.|.+|..+ +.+.+|||++++...-+ ++.+--+.|-++|+.- +-|.+++++.+|+.-+..|.
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 357888999999999999999655 57789999998876433 3444456777888776 47899999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||||+.||+|.-.+++.. .+.+..+..+|.+|+-||-|||+ +|||.||||.+||++|.+|++||+|||+++.
T Consensus 428 VMEyvnGGDLMyhiQQ~G-----kFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVG-----KFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred EEEEecCchhhhHHHHhc-----ccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccc
Confidence 999999999988875543 46778889999999999999996 8999999999999999999999999999986
Q ss_pred cCCCCCcccccccccCCccccccccccc
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
-.-.+ ..+..++|||.|+|||++.-+
T Consensus 500 ni~~~--~TTkTFCGTPdYiAPEIi~Yq 525 (683)
T KOG0696|consen 500 NIFDG--VTTKTFCGTPDYIAPEIIAYQ 525 (683)
T ss_pred cccCC--cceeeecCCCcccccceEEec
Confidence 44332 234568999999999998643
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.6e-22 Score=205.46 Aligned_cols=175 Identities=30% Similarity=0.432 Sum_probs=150.4
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC--CeEEEEE
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--NERLLVY 667 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 667 (779)
+|+..+.||+|++|.||+|... +++.|++|++..........+.+.+|++++++++||||+++++.+... +..++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999876 689999999876654445677899999999999999999999999988 8899999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++++|.+++.... .+++..++.++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 9999999999986543 58899999999999999999996 899999999999999999999999999988775
Q ss_pred CCCCcccccccccCCccccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
............++..|+|||++.+.
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~ 178 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAPEVIRGE 178 (260)
T ss_pred cccccccccCCCCCccccCHhhhcCC
Confidence 54321112335688999999988655
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=208.76 Aligned_cols=175 Identities=24% Similarity=0.441 Sum_probs=146.2
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
+|+..+.||+|+||.||+|... ++..+|+|.+..........+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788899999999999999765 588999999876543344556788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC-cEEEEeeccceecCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVRLAPD 748 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~ 748 (779)
+++++|.+++..... ..+++..+..++.|+++||+|||+ .+++|+||||+||++++++ .+||+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQRG---VLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 999999998865332 247899999999999999999996 8999999999999999875 469999999876644
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
... ......|++.|+|||++.+.
T Consensus 155 ~~~--~~~~~~~~~~~~ape~~~~~ 177 (257)
T cd08225 155 SME--LAYTCVGTPYYLSPEICQNR 177 (257)
T ss_pred Ccc--cccccCCCccccCHHHHcCC
Confidence 321 11234588999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=218.06 Aligned_cols=175 Identities=27% Similarity=0.451 Sum_probs=143.9
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC-----C
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG-----N 661 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~ 661 (779)
+.++|.+.+.||+|+||.||+|+.. +++.||+|.+...........++.+|+.+++.++||||+++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 3467999999999999999999764 689999999876543344456778899999999999999999988654 3
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeec
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 741 (779)
..++||||+. ++|.+++... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg 153 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFG 153 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCc
Confidence 4799999996 6888877432 258899999999999999999996 899999999999999999999999999
Q ss_pred cceecCCCCCcccccccccCCccccccccccc
Q 004020 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 742 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+++...... .......++..|+|||++.+.
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~ 183 (337)
T cd07858 154 LARTTSEKG--DFMTEYVVTRWYRAPELLLNC 183 (337)
T ss_pred cccccCCCc--ccccccccccCccChHHHhcC
Confidence 998664432 112334688999999988653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-22 Score=210.01 Aligned_cols=175 Identities=28% Similarity=0.353 Sum_probs=144.5
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC--CeEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--NERLLV 666 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv 666 (779)
++|+..+.||.|++|.||+|... +++.+|+|.+.... ......++.+|++++++++||||+++++++... +..++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC-chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 46888999999999999999875 68899999887543 234457789999999999999999999998654 468999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++++|.+++..... ....+++..+..++.||+.||.|||+ .+++|+||+|+||+++.++.++|+|||++...
T Consensus 80 ~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence 999999999988754332 22357888999999999999999996 89999999999999999999999999998755
Q ss_pred CCCCCcccccccccCCccccccccccc
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.... .....++..|+|||.+.+.
T Consensus 156 ~~~~----~~~~~~~~~y~~pE~~~~~ 178 (287)
T cd06621 156 VNSL----AGTFTGTSFYMAPERIQGK 178 (287)
T ss_pred cccc----cccccCCccccCHHHhcCC
Confidence 3321 1234578899999988654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=206.48 Aligned_cols=165 Identities=28% Similarity=0.358 Sum_probs=140.8
Q ss_pred ecccccEEEEEEEEc-CCcEEEEEEecccccC-hhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCCCCh
Q 004020 598 LGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTL 675 (779)
Q Consensus 598 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 675 (779)
||+|++|.||+|+.. +++.||+|.+...... ....+.+.+|+.+++.++||||+++++++.+++..++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999875 5889999998764432 23456799999999999999999999999999999999999999999
Q ss_pred hhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCcccc
Q 004020 676 SRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE 755 (779)
Q Consensus 676 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 755 (779)
.+++.... .+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||.++...... ..
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~ 149 (262)
T cd05572 81 WTILRDRG-----LFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KT 149 (262)
T ss_pred HHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cc
Confidence 99985532 47888999999999999999996 899999999999999999999999999988765432 12
Q ss_pred cccccCCccccccccccc
Q 004020 756 TRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 756 ~~~~gt~~y~APE~l~~~ 773 (779)
....|++.|+|||++.+.
T Consensus 150 ~~~~~~~~~~~PE~~~~~ 167 (262)
T cd05572 150 WTFCGTPEYVAPEIILNK 167 (262)
T ss_pred ccccCCcCccChhHhcCC
Confidence 234688999999998654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=214.93 Aligned_cols=173 Identities=29% Similarity=0.462 Sum_probs=143.5
Q ss_pred HhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEe-CCeEE
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD-GNERL 664 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~ 664 (779)
.+.++|++.+.||+|+||.||+|... +++.||+|++..........+.+.+|++++++++||||+++++++.. .+..+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 46788999999999999999999755 78999999886554334445678899999999999999999999876 45788
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
++|||+ +++|.+++... .+++..+..++.|+++||+|||+ .+|+||||||+||++++++.+||+|||.++
T Consensus 87 lv~e~~-~~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 87 FVTELL-GTDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEeehh-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 999998 56888777422 46778888999999999999996 899999999999999999999999999987
Q ss_pred ecCCCCCcccccccccCCcccccccccccC
Q 004020 745 LAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
..... .....++..|+|||++.+..
T Consensus 157 ~~~~~-----~~~~~~~~~y~aPE~~~~~~ 181 (328)
T cd07856 157 IQDPQ-----MTGYVSTRYYRAPEIMLTWQ 181 (328)
T ss_pred ccCCC-----cCCCcccccccCceeeeccC
Confidence 54322 12345788999999876533
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=214.89 Aligned_cols=176 Identities=25% Similarity=0.370 Sum_probs=140.3
Q ss_pred CCcccceecccccEEEEEEEEc-C--CcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeC----Ce
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-D--GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDG----NE 662 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~----~~ 662 (779)
+|++.+.||+|+||.||+|+.. + +..||+|++..........+.+.+|+++++++ .||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999865 3 77899999875443333456788999999999 499999999875432 45
Q ss_pred EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecc
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 742 (779)
.++++||+. ++|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG-----QPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 788999986 6888887432 257899999999999999999996 8999999999999999999999999999
Q ss_pred ceecCCCCCc--ccccccccCCcccccccccccCC
Q 004020 743 VRLAPDNGKH--SIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 743 a~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
++........ .......||..|+|||++.+...
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 186 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQS 186 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCCC
Confidence 9865432211 11233568999999998865443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.5e-22 Score=210.66 Aligned_cols=168 Identities=30% Similarity=0.477 Sum_probs=141.0
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
..|+..+.||+|+||.||+|+.. ++..||+|++..... ......++.+|++++++++|||++++++++.+++..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34777899999999999999764 688999999864322 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++ ++.+.+.... ..+++.++..++.|++.|+.|||+ .+|+||||+|+||+++.++.+||+|||++....
T Consensus 105 e~~~g-~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 105 EYCLG-SASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176 (317)
T ss_pred eCCCC-CHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccC
Confidence 99974 7777764332 257899999999999999999996 899999999999999999999999999987543
Q ss_pred CCCCcccccccccCCccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAA 771 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~ 771 (779)
.. ....|++.|+|||++.
T Consensus 177 ~~------~~~~~~~~y~aPE~~~ 194 (317)
T cd06635 177 PA------NSFVGTPYWMAPEVIL 194 (317)
T ss_pred Cc------ccccCCccccChhhhh
Confidence 32 2346889999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=5e-22 Score=208.29 Aligned_cols=169 Identities=28% Similarity=0.380 Sum_probs=137.9
Q ss_pred CcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeC--CeEEEEE
Q 004020 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDG--NERLLVY 667 (779)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~ 667 (779)
|++.+.||+|+||.||+|... +++.||+|+++....... .....+|+.++.++. ||||+++++++.+. +..++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 567889999999999999764 688999999876532222 234457889999885 99999999999987 8899999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||++ +++.+.+.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++. +.+||+|||+++...
T Consensus 80 e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 80 ELMD-MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIY 150 (282)
T ss_pred ecCC-ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccc
Confidence 9997 57877775432 258899999999999999999996 89999999999999999 999999999988664
Q ss_pred CCCCcccccccccCCccccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.... .....++..|+|||++.+.
T Consensus 151 ~~~~---~~~~~~~~~y~aPE~~~~~ 173 (282)
T cd07831 151 SKPP---YTEYISTRWYRAPECLLTD 173 (282)
T ss_pred cCCC---cCCCCCCcccCChhHhhcC
Confidence 3221 1234578999999987543
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=213.67 Aligned_cols=172 Identities=20% Similarity=0.330 Sum_probs=139.5
Q ss_pred ceeccc--ccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCC
Q 004020 596 NVLGRG--GFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (779)
Q Consensus 596 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 672 (779)
+.||+| +||+||+|+.. +++.||+|++..........+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456776 99999999764 799999999876554455567899999999999999999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCc
Q 004020 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (779)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 752 (779)
+++.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 84 GSANSLLKTYFP---EGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 999998865432 247889999999999999999996 89999999999999999999999999865433221111
Q ss_pred c-----cccccccCCccccccccccc
Q 004020 753 S-----IETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 753 ~-----~~~~~~gt~~y~APE~l~~~ 773 (779)
. ......++..|+|||++.+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~ 183 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQD 183 (328)
T ss_pred ccccccccccccCccCccChhhhcCC
Confidence 0 01112356779999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=213.88 Aligned_cols=172 Identities=28% Similarity=0.520 Sum_probs=143.3
Q ss_pred cCCcccceecccccEEEEEEEEcC---Cc--EEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHD---GT--KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~---~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 664 (779)
+..+..++||.|-||.||+|.+.+ |+ .||||..+... ..+..+.|..|..+|+.++||||++++|+|.+ ...|
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~W 466 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMW 466 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-ccee
Confidence 344567899999999999997543 33 47888877544 34457889999999999999999999999976 4689
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
+|||.++.|.|..|+...+. .++......++.||+.||.|||+ .++|||||..+|||+....-||++|||++|
T Consensus 467 ivmEL~~~GELr~yLq~nk~----sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKD----SLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred EEEecccchhHHHHHHhccc----cchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhh
Confidence 99999999999999976653 58888999999999999999997 899999999999999999999999999999
Q ss_pred ecCCCCCcccccccccCCccccccccc
Q 004020 745 LAPDNGKHSIETRLAGTFGYLAPEYAA 771 (779)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~APE~l~ 771 (779)
.+.+...... +...-...|||||-+.
T Consensus 540 ~~ed~~yYka-S~~kLPIKWmaPESIN 565 (974)
T KOG4257|consen 540 YLEDDAYYKA-SRGKLPIKWMAPESIN 565 (974)
T ss_pred hccccchhhc-cccccceeecCccccc
Confidence 8877644332 2333457899999763
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.6e-22 Score=202.51 Aligned_cols=172 Identities=31% Similarity=0.513 Sum_probs=148.4
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
+|+..+.||+|++|.||++... +++.+++|++..... ...+.+.+|++.+++++||+|+++++++...+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 4778899999999999999875 688999999876542 3557889999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+++++|.+++.... ..+++..+..++.|+++||+|||. .+++||||+|+||++++++.++|+|||.+......
T Consensus 79 ~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 79 CSGGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred CCCCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 99999999886542 358999999999999999999995 89999999999999999999999999998776543
Q ss_pred CCcccccccccCCcccccccccccC
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
.. .....|+..|+|||++.+..
T Consensus 152 ~~---~~~~~~~~~~~~PE~~~~~~ 173 (253)
T cd05122 152 KA---RNTMVGTPYWMAPEVINGKP 173 (253)
T ss_pred cc---ccceecCCcccCHHHHcCCC
Confidence 21 23456889999999986543
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-22 Score=210.49 Aligned_cols=176 Identities=31% Similarity=0.471 Sum_probs=148.1
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCCeEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 666 (779)
++|.+.+.||+|+||.||+|... ++..||+|++..... .....+.+.+|.+++++++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47889999999999999999765 789999999876432 2344567889999999998 99999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++++|.+++.... .+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++++|||++...
T Consensus 81 ~e~~~~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred EcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 99999999999985532 58999999999999999999996 89999999999999999999999999998765
Q ss_pred CCCCCc------------------ccccccccCCccccccccccc
Q 004020 747 PDNGKH------------------SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 747 ~~~~~~------------------~~~~~~~gt~~y~APE~l~~~ 773 (779)
...... .......|+..|+|||++.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~ 197 (280)
T cd05581 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK 197 (280)
T ss_pred CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCC
Confidence 432210 112234578999999987654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=214.08 Aligned_cols=178 Identities=29% Similarity=0.384 Sum_probs=142.2
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC------
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN------ 661 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 661 (779)
.++|++.+.||+|+||.||+|... +++.+|+|++......+.....+.+|++++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999765 6889999998755433333456778999999999999999999875443
Q ss_pred --eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEe
Q 004020 662 --ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 739 (779)
Q Consensus 662 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 739 (779)
..++||||+++ ++...+.... ..+++..+..++.|+++||+|||+ .+|+||||||+||++++++.+||+|
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS----VKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECc
Confidence 46999999975 6766664322 258999999999999999999996 8999999999999999999999999
Q ss_pred eccceecCCCCCcc---------cccccccCCcccccccccccC
Q 004020 740 FGLVRLAPDNGKHS---------IETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 740 FG~a~~~~~~~~~~---------~~~~~~gt~~y~APE~l~~~~ 774 (779)
||+++......... ..+...|++.|+|||++.+..
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 202 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGER 202 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCC
Confidence 99987654322111 112346788999999886544
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6e-23 Score=200.89 Aligned_cols=176 Identities=24% Similarity=0.404 Sum_probs=151.0
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChh-HHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEK-GFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 665 (779)
.++|...++||+|+|+.|..+++. +.+.||+|++++....++ ...-.+.|-.+..+. +||.+|.++.+|+.....++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 468999999999999999999865 678899999988765443 445567788888776 59999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
|.||++||+|.-++.+.+ .++++.+..+..+|+-||.|||+ +|||.||+|.+|+|+|..|++|+.|+|+++.
T Consensus 329 vieyv~ggdlmfhmqrqr-----klpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEecCcceeeehhhhh-----cCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhc
Confidence 999999999977765443 58899999999999999999996 8999999999999999999999999999986
Q ss_pred cCCCCCcccccccccCCcccccccccccC
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
--..+. .+..++|||.|+|||+++|+.
T Consensus 401 ~l~~gd--~tstfcgtpnyiapeilrgee 427 (593)
T KOG0695|consen 401 GLGPGD--TTSTFCGTPNYIAPEILRGEE 427 (593)
T ss_pred CCCCCc--ccccccCCCcccchhhhcccc
Confidence 544333 346689999999999999874
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.9e-22 Score=211.90 Aligned_cols=174 Identities=20% Similarity=0.253 Sum_probs=140.1
Q ss_pred cccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCC
Q 004020 593 SEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (779)
Q Consensus 593 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 672 (779)
.+.+.+|.|+++.||++.. +++.||+|++..........+.+.+|+++++.++||||+++++++...+..+++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3445555566666665544 689999999976544555667899999999999999999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCc
Q 004020 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (779)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 752 (779)
+++.+++..... ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||.+.........
T Consensus 84 ~~l~~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 84 GSCEDLLKTHFP---EGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred CCHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence 999999865432 247888899999999999999996 89999999999999999999999999998755432211
Q ss_pred -----ccccccccCCccccccccccc
Q 004020 753 -----SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 753 -----~~~~~~~gt~~y~APE~l~~~ 773 (779)
.......++..|+|||++.+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~ 183 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVLQQN 183 (314)
T ss_pred ccccccccccccccccccCHHHhcCC
Confidence 111234578899999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.8e-22 Score=207.80 Aligned_cols=174 Identities=29% Similarity=0.451 Sum_probs=148.4
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
..+.|+..+.||+|++|.||+|... ++..|++|++..... ..+.+.+|++.++.++|+||+++++++...+..++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 4567888899999999999999876 688999999875432 456788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
+||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++...
T Consensus 94 ~e~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 94 MEYMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred EeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 99999999999986643 258899999999999999999996 89999999999999999999999999997655
Q ss_pred CCCCCcccccccccCCccccccccccc
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
..... ......++..|+|||++.+.
T Consensus 167 ~~~~~--~~~~~~~~~~y~~PE~~~~~ 191 (286)
T cd06614 167 TKEKS--KRNSVVGTPYWMAPEVIKRK 191 (286)
T ss_pred ccchh--hhccccCCcccCCHhHhcCC
Confidence 43211 12234578899999988654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=9e-22 Score=206.68 Aligned_cols=170 Identities=26% Similarity=0.428 Sum_probs=142.6
Q ss_pred CCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 591 NFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
.|...+.||+|++|.||++.. .+++.+++|++.... ....+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 345567999999999999975 468899999885432 33445688999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+++++|.+++.. ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||.+......
T Consensus 98 ~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~ 168 (285)
T cd06648 98 LEGGALTDIVTH------TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168 (285)
T ss_pred cCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence 999999998854 147888999999999999999996 89999999999999999999999999988755432
Q ss_pred CCcccccccccCCccccccccccc
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
. .......|++.|+|||++.+.
T Consensus 169 ~--~~~~~~~~~~~y~aPE~~~~~ 190 (285)
T cd06648 169 V--PRRKSLVGTPYWMAPEVISRL 190 (285)
T ss_pred C--cccccccCCccccCHHHhcCC
Confidence 1 112234689999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-21 Score=204.10 Aligned_cols=172 Identities=20% Similarity=0.268 Sum_probs=138.2
Q ss_pred HHHHHHhhcCCccccee--cccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEE
Q 004020 582 IQVLRNVTNNFSEENVL--GRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYC 657 (779)
Q Consensus 582 ~~~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 657 (779)
..+.....++|++.+.+ |+|+||.||+++.+ ++..+|+|.+........ |+.....+ +||||+++++++
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~ 78 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSV 78 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEE
Confidence 34455566777777777 99999999999764 688899999865432111 22222222 699999999999
Q ss_pred EeCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC-cEE
Q 004020 658 LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAK 736 (779)
Q Consensus 658 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-~~k 736 (779)
...+..++||||+++++|.+++.... .+++..+..++.||++||+|||+ .+++||||||+||+++.++ .++
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~ 150 (267)
T PHA03390 79 TTLKGHVLIMDYIKDGDLFDLLKKEG-----KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIY 150 (267)
T ss_pred ecCCeeEEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEE
Confidence 99999999999999999999985432 58999999999999999999996 8899999999999999988 999
Q ss_pred EEeeccceecCCCCCcccccccccCCcccccccccccC
Q 004020 737 VADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 737 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
|+|||+++..... ....|+..|+|||++.+..
T Consensus 151 l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~ 182 (267)
T PHA03390 151 LCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHN 182 (267)
T ss_pred EecCccceecCCC------ccCCCCCcccChhhhcCCC
Confidence 9999998765432 2235889999999987643
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=206.42 Aligned_cols=169 Identities=28% Similarity=0.452 Sum_probs=141.2
Q ss_pred ecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCCCCh
Q 004020 598 LGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTL 675 (779)
Q Consensus 598 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 675 (779)
||+|+||.||+|+.. +++.+++|.+..... .....+.+.+|++++++++||||+++++.+..+...|++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999876 489999999875432 224556789999999999999999999999999999999999999999
Q ss_pred hhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCC----
Q 004020 676 SRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK---- 751 (779)
Q Consensus 676 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---- 751 (779)
.+++.... .+++..+..++.||++||+|||+ .+++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 81 ASLLENVG-----SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 99986532 57899999999999999999996 8999999999999999999999999999875433211
Q ss_pred --cccccccccCCcccccccccccC
Q 004020 752 --HSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 752 --~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
........++..|+|||+..+..
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~ 177 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQG 177 (265)
T ss_pred cccccccCcccCccccCHHHhcCCC
Confidence 01223346888999999886543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.2e-22 Score=208.95 Aligned_cols=174 Identities=28% Similarity=0.387 Sum_probs=143.4
Q ss_pred CCcccceecccccEEEEEEEE----cCCcEEEEEEecccccC--hhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeE
Q 004020 591 NFSEENVLGRGGFGTVYKGEL----HDGTKIAVKRMESAVVS--EKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNER 663 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 663 (779)
+|++.+.||+|++|.||+|+. .+++.||+|.++..... ....+.+.+|++++.++ +||||+++++.+..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999864 25788999998754221 22345688999999999 599999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccc
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 743 (779)
++||||+++++|.+++... ..+++..+..++.|+++||+|||+ .+++||||||+||+++.++.++|+|||++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccc
Confidence 9999999999999988543 247888999999999999999996 89999999999999999999999999998
Q ss_pred eecCCCCCcccccccccCCccccccccccc
Q 004020 744 RLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+....... .......|+..|+|||++.+.
T Consensus 153 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 181 (288)
T cd05583 153 KEFLAEEE-ERAYSFCGTIEYMAPEVIRGG 181 (288)
T ss_pred cccccccc-cccccccCCccccCHHHhcCC
Confidence 76543321 112234688999999998654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.2e-22 Score=208.28 Aligned_cols=175 Identities=27% Similarity=0.414 Sum_probs=146.9
Q ss_pred CcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEec
Q 004020 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYM 670 (779)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 670 (779)
|++.+.||+|++|.||+|... +++.+++|++............+.+|++++++++|+||+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999765 6889999998766544445567889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCC
Q 004020 671 PQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750 (779)
Q Consensus 671 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 750 (779)
++ ++.+++.... ..+++..+..++.|+++||+|||+ .+|+|+||||+||++++++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 81 DT-DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred CC-CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 75 8888775432 258899999999999999999996 899999999999999999999999999988765532
Q ss_pred CcccccccccCCcccccccccccCCC
Q 004020 751 KHSIETRLAGTFGYLAPEYAAETSGM 776 (779)
Q Consensus 751 ~~~~~~~~~gt~~y~APE~l~~~~~~ 776 (779)
.......++..|+|||.+.+....
T Consensus 153 --~~~~~~~~~~~~~~PE~~~~~~~~ 176 (283)
T cd05118 153 --RPYTHYVVTRWYRAPELLLGDKGY 176 (283)
T ss_pred --ccccCccCcccccCcHHHhcCCCC
Confidence 122334688899999998765333
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.8e-22 Score=213.33 Aligned_cols=179 Identities=26% Similarity=0.387 Sum_probs=142.5
Q ss_pred hhcCCc-ccceecccccEEEEEEEEc-CCcEEEEEEecccccChh------------HHHHHHHHHHHHHcCCCCccceE
Q 004020 588 VTNNFS-EENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEK------------GFAEFKSEIAVLTKVRHRHLVGL 653 (779)
Q Consensus 588 ~~~~~~-~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~------------~~~~~~~E~~~l~~l~h~niv~~ 653 (779)
+.++|. +.+.||+|+||.||+|... +++.||+|++........ ....+.+|+++++.++||||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 345665 4577999999999999765 689999999865432210 01247789999999999999999
Q ss_pred eeEEEeCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC
Q 004020 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 733 (779)
Q Consensus 654 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 733 (779)
++++...+..++||||++ ++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~ 156 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKG 156 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCC
Confidence 999999999999999997 5888887543 247889999999999999999996 8999999999999999999
Q ss_pred cEEEEeeccceecCCCCC------------cccccccccCCcccccccccccCC
Q 004020 734 RAKVADFGLVRLAPDNGK------------HSIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 734 ~~kl~DFG~a~~~~~~~~------------~~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
.+||+|||.++....... ........+++.|+|||++.+...
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 210 (335)
T PTZ00024 157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEK 210 (335)
T ss_pred CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCC
Confidence 999999999876541110 011122346889999999876543
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=214.70 Aligned_cols=175 Identities=29% Similarity=0.446 Sum_probs=146.4
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC-----eEE
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN-----ERL 664 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 664 (779)
+|++.+.||+|++|.||+|+.. +++.||+|++..........+.+.+|+++++.++||||+++++++...+ ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999875 5899999998765433445577899999999999999999999988775 789
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
+||||++ ++|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++.
T Consensus 81 lv~e~~~-~~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred EEecchh-hhHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 9999997 47888875432 58899999999999999999996 899999999999999999999999999998
Q ss_pred ecCCCCCc-ccccccccCCcccccccccccC
Q 004020 745 LAPDNGKH-SIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 745 ~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~ 774 (779)
........ .......++..|+|||++.+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 182 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSS 182 (330)
T ss_pred eecccccccccccccccccCcCCceeeeccc
Confidence 76543210 1123346889999999988764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.3e-22 Score=218.40 Aligned_cols=181 Identities=21% Similarity=0.280 Sum_probs=133.1
Q ss_pred hhcCCcccceecccccEEEEEEEE-----------------cCCcEEEEEEecccccCh------------hHHHHHHHH
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGEL-----------------HDGTKIAVKRMESAVVSE------------KGFAEFKSE 638 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~------------~~~~~~~~E 638 (779)
..++|++.++||+|+||.||+|.. ..++.||||++....... ...+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999853 235689999986432100 011224457
Q ss_pred HHHHHcCCCCcc-----ceEeeEEEe--------CCeEEEEEEecCCCChhhHhhhcccC-------------------C
Q 004020 639 IAVLTKVRHRHL-----VGLLGYCLD--------GNERLLVYEYMPQGTLSRHLFNRKEE-------------------G 686 (779)
Q Consensus 639 ~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~ 686 (779)
+.++.+++|.++ ++++++|.. .+..|+||||+++++|.++++..... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888876554 667777653 35689999999999999998653210 0
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCcccccccccCCcccc
Q 004020 687 LKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLA 766 (779)
Q Consensus 687 ~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~A 766 (779)
....++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++........ ......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 1234677889999999999999996 79999999999999999999999999998765432111 1112235899999
Q ss_pred cccccc
Q 004020 767 PEYAAE 772 (779)
Q Consensus 767 PE~l~~ 772 (779)
||++..
T Consensus 379 PE~l~~ 384 (507)
T PLN03224 379 PEELVM 384 (507)
T ss_pred hhhhcC
Confidence 999864
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=7e-22 Score=207.34 Aligned_cols=172 Identities=31% Similarity=0.465 Sum_probs=142.9
Q ss_pred CcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCCeEEEEEEe
Q 004020 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
|++.+.||+|++|.||+|... +++.|++|++...... .......+|+..+++++ ||||+++++++..++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 667889999999999999876 5788999998755422 22234567999999999 99999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+ ++++.+++.... ...+++..+..++.|++.+|.|||+ .+++|+||||+||++++++.++|+|||.++.....
T Consensus 80 ~-~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 80 M-EGNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred C-CCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 9 789988886543 1357899999999999999999996 89999999999999999999999999998866443
Q ss_pred CCcccccccccCCcccccccccccC
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
.. .....++..|+|||++.+..
T Consensus 153 ~~---~~~~~~~~~~~aPE~~~~~~ 174 (283)
T cd07830 153 PP---YTDYVSTRWYRAPEILLRST 174 (283)
T ss_pred CC---cCCCCCcccccCceeeecCc
Confidence 21 13346889999999886544
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.5e-22 Score=208.39 Aligned_cols=166 Identities=27% Similarity=0.429 Sum_probs=140.0
Q ss_pred ccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCC
Q 004020 594 EENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (779)
Q Consensus 594 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 672 (779)
....||+|+||.||++... +++.||+|++.... ......+.+|+.+++.++|+||+++++++...+..++||||+++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 3467999999999999764 78999999875432 33456788999999999999999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCc
Q 004020 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (779)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 752 (779)
++|.+++... .+++..+..++.|++.|++|||+ .+++||||||+||++++++.++|+|||++........
T Consensus 102 ~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~- 171 (292)
T cd06657 102 GALTDIVTHT------RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 171 (292)
T ss_pred CcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc-
Confidence 9999877432 46888999999999999999996 7999999999999999999999999999876543211
Q ss_pred ccccccccCCcccccccccc
Q 004020 753 SIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 753 ~~~~~~~gt~~y~APE~l~~ 772 (779)
......|++.|+|||++.+
T Consensus 172 -~~~~~~~~~~y~~pE~~~~ 190 (292)
T cd06657 172 -RRKSLVGTPYWMAPELISR 190 (292)
T ss_pred -cccccccCccccCHHHhcC
Confidence 1233568899999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.4e-24 Score=224.24 Aligned_cols=173 Identities=31% Similarity=0.473 Sum_probs=149.8
Q ss_pred HhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
+..++|+....+|.|.||.||||+.. +++..|+|.++... ....+-+++|+-+++.++|||||.+++.|...+..|+
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep--~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccC--CccccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 45678999999999999999999764 78899999997654 3455678899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
.||||.+|+|++..+-. .++++.++..+.+..++|++|||+ ++-+|||||-.||++++.|.+|++|||.+..
T Consensus 90 cMEycgggslQdiy~~T-----gplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaq 161 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQ 161 (829)
T ss_pred EEEecCCCcccceeeec-----ccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhh
Confidence 99999999999876433 368899999999999999999997 7889999999999999999999999999766
Q ss_pred cCCCCCcccccccccCCccccccccc
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAA 771 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~ 771 (779)
+... ......+.||++|||||+..
T Consensus 162 itat--i~KrksfiGtpywmapEvaa 185 (829)
T KOG0576|consen 162 ITAT--IAKRKSFIGTPYWMAPEVAA 185 (829)
T ss_pred hhhh--hhhhhcccCCccccchhHHH
Confidence 5432 11235578999999999974
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.1e-22 Score=213.08 Aligned_cols=170 Identities=28% Similarity=0.453 Sum_probs=140.0
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC-----
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN----- 661 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 661 (779)
+.++|...+.||+|+||.||+|... +++.||+|++............+.+|++++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 3578999999999999999999764 6899999998765433334456889999999999999999999987543
Q ss_pred -eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEee
Q 004020 662 -ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (779)
Q Consensus 662 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF 740 (779)
..++|+||+.. ++..+.. ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+||
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~df 161 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDF 161 (342)
T ss_pred ceEEEEeccccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeC
Confidence 46899999964 6665541 147888999999999999999996 89999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccCCccccccccccc
Q 004020 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 741 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
|+++..... .....++..|+|||++.+.
T Consensus 162 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~ 189 (342)
T cd07879 162 GLARHADAE-----MTGYVVTRWYRAPEVILNW 189 (342)
T ss_pred CCCcCCCCC-----CCCceeeecccChhhhcCc
Confidence 998764321 1234678999999998653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-21 Score=206.02 Aligned_cols=167 Identities=31% Similarity=0.479 Sum_probs=139.6
Q ss_pred CcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
|...+.||+|+||.||+|+.. +++.|++|++..... .....+.+.+|+++++.++|||++++++++.+.+..|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666788999999999999764 688999999865432 233446788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+. +++.+++.... ..+++.++..++.||+.|++|||+ .+++||||||+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~- 173 (313)
T cd06633 103 CL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP- 173 (313)
T ss_pred CC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC-
Confidence 96 57777764432 257899999999999999999996 8999999999999999999999999999764322
Q ss_pred CCcccccccccCCcccccccccc
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
.....|+..|+|||++..
T Consensus 174 -----~~~~~~~~~y~aPE~~~~ 191 (313)
T cd06633 174 -----ANSFVGTPYWMAPEVILA 191 (313)
T ss_pred -----CCCccccccccChhhccc
Confidence 123468899999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=202.08 Aligned_cols=165 Identities=27% Similarity=0.401 Sum_probs=134.7
Q ss_pred ceecccccEEEEEEEEc-CCcEEEEEEecccccC-hhHHHHHHHHHHHH-HcCCCCccceEeeEEEeCCeEEEEEEecCC
Q 004020 596 NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVL-TKVRHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 672 (779)
+.||+|+||.||+|... +++.||+|.+...... ......+..|..++ ...+||||+++++++..++..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999764 6889999998654321 22233445555544 445899999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCc
Q 004020 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (779)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 752 (779)
++|.+++.... .+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 82 GDCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 99999885432 47888999999999999999996 7999999999999999999999999999876433
Q ss_pred ccccccccCCcccccccccccC
Q 004020 753 SIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 753 ~~~~~~~gt~~y~APE~l~~~~ 774 (779)
.....|+..|+|||++.+..
T Consensus 150 --~~~~~~~~~y~~pe~~~~~~ 169 (260)
T cd05611 150 --NKKFVGTPDYLAPETILGVG 169 (260)
T ss_pred --cccCCCCcCccChhhhcCCC
Confidence 12345889999999987654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.4e-22 Score=214.78 Aligned_cols=172 Identities=28% Similarity=0.431 Sum_probs=144.6
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCe----
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE---- 662 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 662 (779)
+.++|++.+.||+|++|.||+|+.. +++.||+|++..........+.+.+|+.++++++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999875 57899999987654334445678889999999999999999998876654
Q ss_pred --EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEee
Q 004020 663 --RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (779)
Q Consensus 663 --~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF 740 (779)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||++++++.+||+||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccc
Confidence 89999998 5699888743 258899999999999999999996 89999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccCCcccccccccccC
Q 004020 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 741 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
|++...... .....++..|+|||.+.+..
T Consensus 163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~ 191 (343)
T cd07851 163 GLARHTDDE-----MTGYVATRWYRAPEIMLNWM 191 (343)
T ss_pred ccccccccc-----ccCCcccccccCHHHHhCCC
Confidence 998765432 23346788999999986543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.2e-22 Score=224.64 Aligned_cols=247 Identities=25% Similarity=0.319 Sum_probs=198.8
Q ss_pred CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcc
Q 004020 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 144 (779)
.+++.|++++|+|+ .+|. .+++|++|+|++|+|+.+++. .++|+.|+|++|.|+.+|.. +.+|+.|+|+
T Consensus 222 ~~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~LtsLP~l---p~sL~~L~Ls~N~L~~Lp~l----p~~L~~L~Ls 290 (788)
T PRK15387 222 AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTSLPVL---PPGLLELSIFSNPLTHLPAL----PSGLCKLWIF 290 (788)
T ss_pred cCCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccCcccCc---ccccceeeccCCchhhhhhc----hhhcCEEECc
Confidence 37899999999999 5665 358999999999999976542 46899999999999988752 3679999999
Q ss_pred cCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCC
Q 004020 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDS 224 (779)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~ 224 (779)
+|+++. +|.. +++|+.|++++|+|++ +|.. ...|+.|++++|+|++ +|... .+|+.|++++|++..
T Consensus 291 ~N~Lt~--LP~~---p~~L~~LdLS~N~L~~-Lp~l-----p~~L~~L~Ls~N~L~~-LP~lp--~~Lq~LdLS~N~Ls~ 356 (788)
T PRK15387 291 GNQLTS--LPVL---PPGLQELSVSDNQLAS-LPAL-----PSELCKLWAYNNQLTS-LPTLP--SGLQELSVSDNQLAS 356 (788)
T ss_pred CCcccc--cccc---ccccceeECCCCcccc-CCCC-----cccccccccccCcccc-ccccc--cccceEecCCCccCC
Confidence 999975 5543 4789999999999995 5553 3468899999999984 66422 479999999999886
Q ss_pred CCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCCC
Q 004020 225 KLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFN 304 (779)
Q Consensus 225 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~ 304 (779)
... ..++|+.|++++|+|+. +|.+ ..+|+.|++++|+|++ +|.. .++|+.|+|++|+|++ +|..
T Consensus 357 LP~-------lp~~L~~L~Ls~N~L~~-LP~l--~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l- 420 (788)
T PRK15387 357 LPT-------LPSELYKLWAYNNRLTS-LPAL--PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPML- 420 (788)
T ss_pred CCC-------CCcccceehhhcccccc-Cccc--ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcc-
Confidence 322 13578899999999996 4543 3679999999999995 6654 3679999999999985 3431
Q ss_pred CCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccc
Q 004020 305 SPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG 384 (779)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g 384 (779)
..+|+.|+|++|+|+
T Consensus 421 ----------------------------------------------------------------~~~L~~L~Ls~NqLt- 435 (788)
T PRK15387 421 ----------------------------------------------------------------PSGLLSLSVYRNQLT- 435 (788)
T ss_pred ----------------------------------------------------------------hhhhhhhhhccCccc-
Confidence 115778999999998
Q ss_pred cccccccccccCCeEeccCccccccCCccCCCC
Q 004020 385 TISSNFSRLTSLRQLMLSGNELTGTIPKELTTL 417 (779)
Q Consensus 385 ~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l 417 (779)
.+|..|.++++|+.|+|++|.|+|.+|..+..+
T Consensus 436 ~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l 468 (788)
T PRK15387 436 RLPESLIHLSSETTVNLEGNPLSERTLQALREI 468 (788)
T ss_pred ccChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence 789999999999999999999999988876443
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-21 Score=203.86 Aligned_cols=172 Identities=33% Similarity=0.464 Sum_probs=140.4
Q ss_pred CcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcC---CCCccceEeeEEEeCCe-----
Q 004020 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV---RHRHLVGLLGYCLDGNE----- 662 (779)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~----- 662 (779)
|++.+.||+|+||.||+|+.+ +++.||+|++............+.+|+.+++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 677899999999999999876 489999999975543333345566788777666 59999999999998776
Q ss_pred EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecc
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 742 (779)
.+++|||+.+ +|.+++..... ..+++..++.++.|+++||+|||+ .+++|+||||+||++++++.+||+|||.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCc
Confidence 8999999974 88888754332 257899999999999999999996 8999999999999999999999999999
Q ss_pred ceecCCCCCcccccccccCCccccccccccc
Q 004020 743 VRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 743 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+........ .....++..|+|||++.+.
T Consensus 154 ~~~~~~~~~---~~~~~~~~~~~~PE~~~~~ 181 (287)
T cd07838 154 ARIYSFEMA---LTSVVVTLWYRAPEVLLQS 181 (287)
T ss_pred ceeccCCcc---cccccccccccChHHhccC
Confidence 887644321 1233578899999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.5e-22 Score=206.17 Aligned_cols=174 Identities=32% Similarity=0.427 Sum_probs=145.6
Q ss_pred CcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEec
Q 004020 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYM 670 (779)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 670 (779)
|+..+.||+|++|.||+|... +++.||+|.+..........+.+..|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999776 5899999999765433444567889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCC
Q 004020 671 PQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750 (779)
Q Consensus 671 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 750 (779)
+ ++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||+|+||++++++.+||+|||.++......
T Consensus 81 ~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 81 D-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred C-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 7 58999986543 258899999999999999999996 799999999999999999999999999987664432
Q ss_pred CcccccccccCCcccccccccccCC
Q 004020 751 KHSIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 751 ~~~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
. ......++..|+|||++.+...
T Consensus 153 ~--~~~~~~~~~~~~aPE~~~~~~~ 175 (282)
T cd07829 153 R--TYTHEVVTLWYRAPEILLGSKH 175 (282)
T ss_pred c--ccCccccCcCcCChHHhcCCcC
Confidence 1 1223456788999999876533
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-21 Score=206.32 Aligned_cols=168 Identities=31% Similarity=0.483 Sum_probs=140.8
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccc-cChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
+.|+..+.||+|+||.||+|+.. +++.+|+|.+.... .......++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777889999999999999865 57889999886432 23344567889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+. |++.+++.... ..+++..+..++.|++.|+.|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 95 e~~~-~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 95 EYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EccC-CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 9996 57877764332 247889999999999999999996 899999999999999999999999999987654
Q ss_pred CCCCcccccccccCCccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAA 771 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~ 771 (779)
.. ....|++.|+|||++.
T Consensus 167 ~~------~~~~~~~~y~aPE~~~ 184 (308)
T cd06634 167 PA------NXFVGTPYWMAPEVIL 184 (308)
T ss_pred Cc------ccccCCccccCHHHHh
Confidence 32 2345889999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.6e-22 Score=228.41 Aligned_cols=181 Identities=24% Similarity=0.385 Sum_probs=119.1
Q ss_pred cEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEccc
Q 004020 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145 (779)
Q Consensus 66 ~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 145 (779)
+.+.|++++++++ .+|..+. ++|+.|+|++|+|+..+..+. ++|++|++++|+|+.+|.... .+|+.|+|++
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~LtsLP~~l~--~nL~~L~Ls~N~LtsLP~~l~---~~L~~L~Ls~ 250 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELKSLPENLQ--GNIKTLYANSNQLTSIPATLP---DTIQEMELSI 250 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCcCChhhc--cCCCEEECCCCccccCChhhh---ccccEEECcC
Confidence 5678888888888 5676554 478888888888886655443 478888888888888776432 3688888888
Q ss_pred CCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCC
Q 004020 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSK 225 (779)
Q Consensus 146 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~ 225 (779)
|++.. +|..+. .+|+.|++++|+|+ .+|+.+. ++|+.|+|++|+|+ .+|..+.
T Consensus 251 N~L~~--LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~----~sL~~L~Ls~N~Lt-~LP~~lp----------------- 303 (754)
T PRK15370 251 NRITE--LPERLP--SALQSLDLFHNKIS-CLPENLP----EELRYLSVYDNSIR-TLPAHLP----------------- 303 (754)
T ss_pred CccCc--CChhHh--CCCCEEECcCCccC-ccccccC----CCCcEEECCCCccc-cCcccch-----------------
Confidence 88864 565553 47888888888887 4676552 47888888888887 3554432
Q ss_pred CCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCcccc
Q 004020 226 LNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297 (779)
Q Consensus 226 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 297 (779)
++|+.|+|++|+++..++.+. ++|+.|++++|.+++ +|..+. ++|+.|+|++|+|+
T Consensus 304 -----------~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~ 359 (754)
T PRK15370 304 -----------SGITHLNVQSNSLTALPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT 359 (754)
T ss_pred -----------hhHHHHHhcCCccccCCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC
Confidence 245555566666554332222 456666666666653 454442 45666666666554
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-22 Score=213.73 Aligned_cols=172 Identities=30% Similarity=0.517 Sum_probs=144.0
Q ss_pred CcccceecccccEEEEEEEEc--CC--cEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 592 FSEENVLGRGGFGTVYKGELH--DG--TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
....++||+|.||.|++|.|. .| ..||||.++...... ...+|.+|+.+|.+|+|||++++||+..+ ....|||
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 345688999999999999775 33 468999998765433 67899999999999999999999999887 6678999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
|+++.|+|.+.+++... ..+-......++.|||.|+.||.+ +++|||||..+|+++.....|||+|||+.|.+.
T Consensus 190 ELaplGSLldrLrka~~---~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKAKK---AILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhcccchHHHHHhhccc---cceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 99999999999977322 357778889999999999999997 899999999999999999899999999999887
Q ss_pred CCCCcccccc-cccCCccccccccc
Q 004020 748 DNGKHSIETR-LAGTFGYLAPEYAA 771 (779)
Q Consensus 748 ~~~~~~~~~~-~~gt~~y~APE~l~ 771 (779)
.+...+.... ..-.+.|+|||.+.
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLr 288 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLR 288 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhc
Confidence 7655443322 23456899999875
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-22 Score=210.72 Aligned_cols=173 Identities=31% Similarity=0.493 Sum_probs=145.6
Q ss_pred hcCCcccceecccccEEEEEEEEcC-CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
..+.....+||-|-||.||.|.|+. .-.||||.++... ...++|.+|+.+|+.++|||+|+++|+|.....+|||+
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiT 342 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIIT 342 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEE
Confidence 3455667899999999999998874 5679999987653 45689999999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
|||..|+|.+|+++.... .++....++++.||..|++||.. +++|||||..+|.|+.++..||++|||+++.+.
T Consensus 343 EfM~yGNLLdYLRecnr~---ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNRS---EVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred ecccCccHHHHHHHhchh---hcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 999999999999765433 45666778999999999999994 899999999999999999999999999999886
Q ss_pred CCCCcccccccccCCccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAA 771 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~ 771 (779)
.+. +.......-.+.|.|||-+.
T Consensus 417 gDT-YTAHAGAKFPIKWTAPEsLA 439 (1157)
T KOG4278|consen 417 GDT-YTAHAGAKFPIKWTAPESLA 439 (1157)
T ss_pred CCc-eecccCccCcccccCccccc
Confidence 542 21222223457899999874
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-22 Score=220.54 Aligned_cols=170 Identities=30% Similarity=0.480 Sum_probs=140.9
Q ss_pred cccceecccccEEEEEEEE-cCC----cEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 593 SEENVLGRGGFGTVYKGEL-HDG----TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 593 ~~~~~lg~G~~g~Vy~~~~-~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
...++||+|+||+||+|.+ ..| -+||+|++.... ..+..+++.+|+-+|.+++|||++++++++.... ..||+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 3468999999999999965 334 468889876543 3455678999999999999999999999998776 77999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
+|++.|.|.++++..+. .+-....+.|..||++||.|||. +++|||||-.+|||+.....+||.|||+|+...
T Consensus 777 q~mP~G~LlDyvr~hr~----~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRD----NIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HhcccchHHHHHHHhhc----cccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 99999999999977553 57788899999999999999995 899999999999999999999999999999887
Q ss_pred CCCCcccccccccCCccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAA 771 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~ 771 (779)
.++.........-.+.|||=|.+.
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~ 873 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIR 873 (1177)
T ss_pred cccccccccccccCcHHHHHHHhh
Confidence 665443333333456788877764
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=204.13 Aligned_cols=174 Identities=28% Similarity=0.432 Sum_probs=140.8
Q ss_pred hcCCcccceecccccEEEEEEEEcC-CcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 666 (779)
.++|++.+.||+|+||.||+|...+ ++.||||.++.... .....++.+|+.++.+.. ||||+++++++.+....++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 3578889999999999999998764 89999999875432 233456677887777775 99999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||++ +++.+++.... ..+++..+..++.|++.||+|||+ ..+|+||||+|+||++++++.+||+|||++...
T Consensus 93 ~e~~~-~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 93 MELMS-TCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred eeccC-cCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 99985 46766654322 258889999999999999999996 358999999999999999999999999998765
Q ss_pred CCCCCcccccccccCCccccccccccc
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
..... .....++..|+|||++.+.
T Consensus 166 ~~~~~---~~~~~~~~~y~aPE~~~~~ 189 (296)
T cd06618 166 VDSKA---KTRSAGCAAYMAPERIDPP 189 (296)
T ss_pred cCCCc---ccCCCCCccccCHhhcCCC
Confidence 43221 1233578899999998755
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.1e-21 Score=202.57 Aligned_cols=177 Identities=19% Similarity=0.246 Sum_probs=126.5
Q ss_pred hcCCcccceecccccEEEEEEEEcC----CcEEEEEEecccccCh--h-H------HHHHHHHHHHHHcCCCCccceEee
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHD----GTKIAVKRMESAVVSE--K-G------FAEFKSEIAVLTKVRHRHLVGLLG 655 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~--~-~------~~~~~~E~~~l~~l~h~niv~~~~ 655 (779)
.++|++.+.||+|+||.||+|...+ +..+|+|+........ + . ......+...+..+.|++|+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4689999999999999999998654 3456666543221100 0 0 011233444566778999999998
Q ss_pred EEEeCC----eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC
Q 004020 656 YCLDGN----ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 731 (779)
Q Consensus 656 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~ 731 (779)
++.... ..++++|++.. ++.+.+.... ..++..+..++.|++.||+|||+ .+|+||||||+|||++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK-----CKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDG 161 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhhc-----cCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcC
Confidence 776543 34678887743 5655553321 24677888999999999999996 89999999999999999
Q ss_pred CCcEEEEeeccceecCCCCCc-----ccccccccCCcccccccccccC
Q 004020 732 DMRAKVADFGLVRLAPDNGKH-----SIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 732 ~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~ 774 (779)
++.++|+|||+|+.....+.. .......||+.|+|||+..+..
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~ 209 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC 209 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC
Confidence 999999999999876432211 1112346999999999887543
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-23 Score=229.48 Aligned_cols=355 Identities=23% Similarity=0.311 Sum_probs=209.1
Q ss_pred cEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEccc
Q 004020 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145 (779)
Q Consensus 66 ~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 145 (779)
+++.||+++|.+. ..|..+..+.+|+.|+++.|.|...+-+..++.+|++|.|.+|++...|.+ +..+.+|++||+|+
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~~vp~s~~~~~~l~~lnL~~n~l~~lP~~-~~~lknl~~LdlS~ 123 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIRSVPSSCSNMRNLQYLNLKNNRLQSLPAS-ISELKNLQYLDLSF 123 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHhhCchhhhhhhcchhheeccchhhcCchh-HHhhhcccccccch
Confidence 4899999999887 888999999999999999999997777899999999999999999999876 88899999999999
Q ss_pred CCCCCCCCcccccCCCCCceEeccCc-------------------eeEeecCCCccCCCCCcccE-EEccCCCCCCcCCC
Q 004020 146 NSFDSWVIPESLKDATGLQRFSANGA-------------------NITGTIPDFLGGDTIPGLMH-LHLAFNFLQGPIPL 205 (779)
Q Consensus 146 N~l~~~~~p~~~~~l~~L~~L~l~~n-------------------~l~~~~p~~~~~~~l~~L~~-L~L~~N~l~~~~p~ 205 (779)
|++. .+|..+..++.+..+.+++| .+.+.++..+. .|++ |+|.+|++....-.
T Consensus 124 N~f~--~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~-----~l~~~ldLr~N~~~~~dls 196 (1081)
T KOG0618|consen 124 NHFG--PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIY-----NLTHQLDLRYNEMEVLDLS 196 (1081)
T ss_pred hccC--CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchh-----hhheeeecccchhhhhhhh
Confidence 9996 46766665555555555555 34444443332 3333 77777776621111
Q ss_pred cccc------------------CCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEc
Q 004020 206 SFGK------------------SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSV 267 (779)
Q Consensus 206 ~~~~------------------~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l 267 (779)
.+.. .+++.|+.+.|.++...... .-.+|+++|+++|++++.+..++.+.+|+.+..
T Consensus 197 ~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~p-----~p~nl~~~dis~n~l~~lp~wi~~~~nle~l~~ 271 (1081)
T KOG0618|consen 197 NLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVHP-----VPLNLQYLDISHNNLSNLPEWIGACANLEALNA 271 (1081)
T ss_pred hccchhhhhhhhcccceEEecCcchheeeeccCcceeecccc-----ccccceeeecchhhhhcchHHHHhcccceEecc
Confidence 1111 12233333333332111111 124566677777777765533566666677766
Q ss_pred cCCccccccCh-----------------------hhhCCCCCCEEEccCccccccCCCCCCCccc--ccccCCCCcccCC
Q 004020 268 RDNQLTGIVPS-----------------------SLVNLHSLAVVNLTNNLFQGQTPKFNSPVRF--DMAKGSNSFCLDD 322 (779)
Q Consensus 268 ~~N~l~~~~p~-----------------------~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~--~~~~~~~~~~~~~ 322 (779)
.+|+|+ .+|. ....++.|++|+|..|+|...++.++..... +....+. ..+..
T Consensus 272 n~N~l~-~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~-n~l~~ 349 (1081)
T KOG0618|consen 272 NHNRLV-ALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSS-NKLST 349 (1081)
T ss_pred cchhHH-hhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhh-ccccc
Confidence 666664 4444 4444555555555555554433322222110 0000000 00000
Q ss_pred CCcccCccchhhhhhcccCCCchhcccccCCC----CCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCe
Q 004020 323 AGVACDGRVNVLLSIVKSVGYPAVLAESWKGN----NPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQ 398 (779)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~ 398 (779)
.. ...... ...+...+..+ +.| |. .+....+|++|+|++|+|.......+.++..|+.
T Consensus 350 lp-~~~e~~------------~~~Lq~LylanN~Ltd~c---~p--~l~~~~hLKVLhLsyNrL~~fpas~~~kle~Lee 411 (1081)
T KOG0618|consen 350 LP-SYEENN------------HAALQELYLANNHLTDSC---FP--VLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEE 411 (1081)
T ss_pred cc-cccchh------------hHHHHHHHHhcCcccccc---hh--hhccccceeeeeecccccccCCHHHHhchHHhHH
Confidence 00 000000 00000000000 011 10 1223457888888888887433345677777777
Q ss_pred EeccCccccc----------------------cCCccCCCCCCCCceeccCCcccc-cCCC---CCCcceeeeCCCCCCC
Q 004020 399 LMLSGNELTG----------------------TIPKELTTLPSLEMLDVSNNHLFG-KVPN---FRQNVIVKTDGNPDIG 452 (779)
Q Consensus 399 L~Ls~N~l~g----------------------~iP~~l~~l~~L~~L~Ls~N~l~g-~iP~---~~~~~~~~~~~n~~~~ 452 (779)
|+||+|+|+- ..| ++..++.|+.+|||.|+|+- .+|. +.....+++.||.++-
T Consensus 412 L~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~ 490 (1081)
T KOG0618|consen 412 LNLSGNKLTTLPDTVANLGRLHTLRAHSNQLLSFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLV 490 (1081)
T ss_pred HhcccchhhhhhHHHHhhhhhHHHhhcCCceeech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccc
Confidence 7777777761 445 67788999999999999973 4443 3455678889998755
Q ss_pred CCC
Q 004020 453 KDS 455 (779)
Q Consensus 453 ~~~ 455 (779)
.+.
T Consensus 491 ~d~ 493 (1081)
T KOG0618|consen 491 FDH 493 (1081)
T ss_pred cch
Confidence 443
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=5e-21 Score=196.83 Aligned_cols=166 Identities=33% Similarity=0.468 Sum_probs=141.1
Q ss_pred ecccccEEEEEEEEc-CCcEEEEEEecccccC-hhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCCCCh
Q 004020 598 LGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTL 675 (779)
Q Consensus 598 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 675 (779)
||+|+||.||++... +++.+|+|.+...... ......+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999765 5899999998765432 23456789999999999999999999999999999999999999999
Q ss_pred hhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCcccc
Q 004020 676 SRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE 755 (779)
Q Consensus 676 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 755 (779)
.+++.... .+++..+..++.|+++|+.|||+ .+++|+||||+||+++.++.++|+|||.+....... ...
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~ 150 (250)
T cd05123 81 FSHLSKEG-----RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRT 150 (250)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC--Ccc
Confidence 99985432 47899999999999999999996 899999999999999999999999999987764431 112
Q ss_pred cccccCCccccccccccc
Q 004020 756 TRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 756 ~~~~gt~~y~APE~l~~~ 773 (779)
....++..|+|||...+.
T Consensus 151 ~~~~~~~~~~~Pe~~~~~ 168 (250)
T cd05123 151 NTFCGTPEYLAPEVLLGK 168 (250)
T ss_pred cCCcCCccccChHHhCCC
Confidence 345688999999998654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=208.58 Aligned_cols=174 Identities=25% Similarity=0.394 Sum_probs=138.8
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC-------
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG------- 660 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------- 660 (779)
..+|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~--~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC--CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 468999999999999999999764 68899999986543 23456788999999999999999999876654
Q ss_pred -------CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEc-CC
Q 004020 661 -------NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DD 732 (779)
Q Consensus 661 -------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~-~~ 732 (779)
...++||||++ ++|.+++... .+++..++.++.||+.||+|||+ .+|+||||||+||+++ ++
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~ 151 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTED 151 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCC
Confidence 35789999997 5888776321 47889999999999999999996 8999999999999997 45
Q ss_pred CcEEEEeeccceecCCCCCcc-cccccccCCcccccccccccC
Q 004020 733 MRAKVADFGLVRLAPDNGKHS-IETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 733 ~~~kl~DFG~a~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~ 774 (779)
+.+||+|||.++......... ......|+..|+|||++.+..
T Consensus 152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 194 (342)
T cd07854 152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPN 194 (342)
T ss_pred ceEEECCcccceecCCccccccccccccccccccCHHHHhCcc
Confidence 678999999987654321111 112335788999999876543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.85 E-value=3e-21 Score=199.86 Aligned_cols=176 Identities=26% Similarity=0.383 Sum_probs=140.2
Q ss_pred CCcccceecccccEEEEEEEEcC-CcEEEEEEeccc---ccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 591 NFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESA---VVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
+|.+.+.||+|+||.||+++... +..+++|.++.. ........++.+|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58888999999999999997653 444555555432 22223345677899999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++++|.+++...... ...+++..++.++.|+++||.|||+ .+++|+||||+||++++ +.+||+|||.++..
T Consensus 81 ~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHT-GKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeec
Confidence 9999999999988653322 2368999999999999999999996 89999999999999975 56999999998876
Q ss_pred CCCCCcccccccccCCccccccccccc
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
..... ......|++.|+|||++.+.
T Consensus 156 ~~~~~--~~~~~~~~~~~~~pe~~~~~ 180 (260)
T cd08222 156 MGSCD--LATTFTGTPYYMSPEALKHQ 180 (260)
T ss_pred CCCcc--cccCCCCCcCccCHHHHccC
Confidence 44322 12334588999999987543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.5e-21 Score=210.32 Aligned_cols=173 Identities=29% Similarity=0.421 Sum_probs=136.1
Q ss_pred CcccceecccccEE-EEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCCeEEEEEEe
Q 004020 592 FSEENVLGRGGFGT-VYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 592 ~~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
|.-.+++|.|+.|+ ||+|... ++.||||++-.. ...-.++|+..++.-+ |||||++++.-.++...|+..|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 44457899998875 8999886 889999988643 3345789999999885 99999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC---C--CcEEEEeeccce
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---D--MRAKVADFGLVR 744 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~--~~~kl~DFG~a~ 744 (779)
|. .+|.+++..... ..........+.+..|++.||++||+ .+||||||||.||||+. + .+++|+|||+++
T Consensus 585 C~-~sL~dlie~~~~-d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 585 CA-CSLQDLIESSGL-DVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred hh-hhHHHHHhcccc-chhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 95 699999976411 11111114457888999999999997 78999999999999975 3 579999999999
Q ss_pred ecCCCCC-cccccccccCCcccccccccccCC
Q 004020 745 LAPDNGK-HSIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 745 ~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
.+..... ........||-+|+|||++.+...
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~ 691 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRK 691 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhcccc
Confidence 8765432 222345679999999999987643
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.1e-22 Score=185.65 Aligned_cols=171 Identities=19% Similarity=0.374 Sum_probs=142.8
Q ss_pred hcCCcccceecccccEEEEEEE-EcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCC--eEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGN--ERL 664 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~--~~~ 664 (779)
.++|++.+++|+|.++.||.|. ..+.++++||++++- ..+.+.+|++++..+. ||||+++++...+.. ...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 4689999999999999999996 456889999998753 3467889999999997 999999999998765 457
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC-CCcEEEEeeccc
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLV 743 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DFG~a 743 (779)
+|+||+.+.+..... ..++...+..++.|++.||.|+|+ +||+|||+||.|++||. .-.++|+|+|+|
T Consensus 112 LiFE~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
T ss_pred hHhhhhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchH
Confidence 999999988776654 246677888999999999999997 89999999999999995 457999999999
Q ss_pred eecCCCCCcccccccccCCcccccccccccCCCCC
Q 004020 744 RLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMTW 778 (779)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t~ 778 (779)
.++.+..+. ...+.+..|.-||++-....++|
T Consensus 181 EFYHp~~eY---nVRVASRyfKGPELLVdy~~YDY 212 (338)
T KOG0668|consen 181 EFYHPGKEY---NVRVASRYFKGPELLVDYQMYDY 212 (338)
T ss_pred hhcCCCcee---eeeeehhhcCCchheeechhccc
Confidence 988665443 23356788999999987776665
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.9e-21 Score=187.99 Aligned_cols=142 Identities=18% Similarity=0.221 Sum_probs=109.0
Q ss_pred cceecccccEEEEEEEEcCCcEEEEEEecccccChhH------------------------HHHHHHHHHHHHcCCCCcc
Q 004020 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKG------------------------FAEFKSEIAVLTKVRHRHL 650 (779)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~E~~~l~~l~h~ni 650 (779)
.+.||+|+||.||+|...+|+.||+|+++........ .....+|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999998888999999999754321111 1123459999999988877
Q ss_pred ceEeeEEEeCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCcEEcCCCCCCEEE
Q 004020 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL-HGLAHQSFIHRDLKPSNILL 729 (779)
Q Consensus 651 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~L-H~~~~~~ivHrDlkp~NIll 729 (779)
.....+.. ...++||||++++++....... ..++...+..++.|++.+|.|+ |+ .+|+||||||+||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEE
Confidence 54443322 2238999999987765443221 2578889999999999999999 64 799999999999999
Q ss_pred cCCCcEEEEeeccceecC
Q 004020 730 GDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 730 ~~~~~~kl~DFG~a~~~~ 747 (779)
+ ++.++|+|||+|....
T Consensus 152 ~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 152 H-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred E-CCcEEEEEccccccCC
Confidence 8 4789999999987553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-20 Score=215.70 Aligned_cols=227 Identities=20% Similarity=0.268 Sum_probs=141.0
Q ss_pred CCChhHHHHHHHHHHHcCCCCC-----CCCCC-CCCCccee----------------eEeCCCCcEEEEEecCCCccccC
Q 004020 24 SQSSSDAAAMQALKTSLGNPAS-----LGWTD-PDPCKWKH----------------IQCSPSNRVTRIQIGGQNIEGTL 81 (779)
Q Consensus 24 ~~~~~~~~~l~~~k~~~~~~~~-----~~w~~-~~~C~w~g----------------v~c~~~~~v~~l~l~~~~l~~~~ 81 (779)
...+++.+.+.+..+.+..|.- ..|.+ .|.|.-.. |.|.+ +.|+.+..-+.......
T Consensus 59 ~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~-~~vt~l~~~g~~~~~~~ 137 (754)
T PRK15370 59 TASPEEIKSKFECLRMLAFPAYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGGG-KSVTYTRVTESEQASSA 137 (754)
T ss_pred CCCHHHHHHHHHHHHHhcCCchhhccccccCCCCcccccCCcchhhheeeecCCceEEecCC-CcccccccccccccccC
Confidence 4568889999999999876652 24864 47885433 66653 35666655442111000
Q ss_pred ---------------------C-------ccc-----cCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCC
Q 004020 82 ---------------------P-------KEL-----NSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVP 128 (779)
Q Consensus 82 ---------------------p-------~~l-----~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~ 128 (779)
+ .++ +-..+.+.|+++++.++..+..+. +.|+.|+|++|+|+.+|
T Consensus 138 ~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~LtsLP~~Ip--~~L~~L~Ls~N~LtsLP 215 (754)
T PRK15370 138 SGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLTTIPACIP--EQITTLILDNNELKSLP 215 (754)
T ss_pred CCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcCcCCcccc--cCCcEEEecCCCCCcCC
Confidence 0 000 111345666666666665443332 45666677777766666
Q ss_pred cccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccc
Q 004020 129 SDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFG 208 (779)
Q Consensus 129 ~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 208 (779)
...+ ++|++|+|++|+|++ +|..+. .+|+.|+|++|+++ .+|..+. .+|+.|+|++|+|+ .+|..+
T Consensus 216 ~~l~---~nL~~L~Ls~N~Lts--LP~~l~--~~L~~L~Ls~N~L~-~LP~~l~----s~L~~L~Ls~N~L~-~LP~~l- 281 (754)
T PRK15370 216 ENLQ---GNIKTLYANSNQLTS--IPATLP--DTIQEMELSINRIT-ELPERLP----SALQSLDLFHNKIS-CLPENL- 281 (754)
T ss_pred hhhc---cCCCEEECCCCcccc--CChhhh--ccccEEECcCCccC-cCChhHh----CCCCEEECcCCccC-cccccc-
Confidence 5533 366666666666654 444332 35666666666665 4555442 35666666666666 345432
Q ss_pred cCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCE
Q 004020 209 KSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAV 288 (779)
Q Consensus 209 ~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~ 288 (779)
.++|+.|+|++|+|++.++.+. ++|+.|++++|+++. +|..+. ++|+.
T Consensus 282 ---------------------------~~sL~~L~Ls~N~Lt~LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~ 329 (754)
T PRK15370 282 ---------------------------PEELRYLSVYDNSIRTLPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKT 329 (754)
T ss_pred ---------------------------CCCCcEEECCCCccccCcccch--hhHHHHHhcCCcccc-CCcccc--cccee
Confidence 2579999999999997655443 579999999999984 665543 68999
Q ss_pred EEccCcccccc
Q 004020 289 VNLTNNLFQGQ 299 (779)
Q Consensus 289 L~Ls~N~l~g~ 299 (779)
|++++|.+++.
T Consensus 330 L~Ls~N~Lt~L 340 (754)
T PRK15370 330 LEAGENALTSL 340 (754)
T ss_pred ccccCCccccC
Confidence 99999999863
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.7e-21 Score=193.04 Aligned_cols=172 Identities=24% Similarity=0.329 Sum_probs=142.2
Q ss_pred HhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCC--C----ccceEeeEEEe
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH--R----HLVGLLGYCLD 659 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~~~~~~~~ 659 (779)
...++|.+...+|+|.||.|-++..+ .+..||+|+++.- .+..+..+-|+++++++.+ | -+|.+.+||..
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 34789999999999999999999654 5789999998643 3445677889999999942 2 37888999999
Q ss_pred CCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC--------
Q 004020 660 GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-------- 731 (779)
Q Consensus 660 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-------- 731 (779)
.++.++|+|.+ |-++.+++... +..+++...+..|++|++++++|||+ .+++|-||||+|||+.+
T Consensus 163 rghiCivfell-G~S~~dFlk~N---~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKEN---NYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred cCceEEEEecc-ChhHHHHhccC---CccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEec
Confidence 99999999988 56999999543 44578999999999999999999996 89999999999999932
Q ss_pred ------------CCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 732 ------------DMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 732 ------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+..+||+|||.|+..... ....+.|..|+|||++.|-
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgL 284 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGL 284 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheecc
Confidence 235899999999875432 1456789999999999864
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.4e-21 Score=215.20 Aligned_cols=174 Identities=22% Similarity=0.258 Sum_probs=120.4
Q ss_pred hhcCCcccceecccccEEEEEEEEc-C----CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeE------
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-D----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY------ 656 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~------ 656 (779)
..++|++.+.||+|+||.||+|+.. + +..||+|++..... .+....| .+....+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 4578999999999999999999875 4 68999998764321 1111111 1111122222222111
Q ss_pred EEeCCeEEEEEEecCCCChhhHhhhcccC---------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcC
Q 004020 657 CLDGNERLLVYEYMPQGTLSRHLFNRKEE---------------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRD 721 (779)
Q Consensus 657 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrD 721 (779)
.......++||||+++++|.+++...... .........+..++.||+.||+|||+ ++|+|||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRD 280 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRD 280 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCc
Confidence 23456789999999999999988643210 00011233456799999999999996 8999999
Q ss_pred CCCCCEEEcC-CCcEEEEeeccceecCCCCCcccccccccCCccccccccc
Q 004020 722 LKPSNILLGD-DMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAA 771 (779)
Q Consensus 722 lkp~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~ 771 (779)
|||+|||+++ ++.+||+|||+|+....... .......||+.|||||.+.
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~ 330 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYI 330 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhh
Confidence 9999999985 58999999999986543322 2234567899999999764
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=191.68 Aligned_cols=153 Identities=21% Similarity=0.208 Sum_probs=126.8
Q ss_pred cccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCCCChhhHh
Q 004020 601 GGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHL 679 (779)
Q Consensus 601 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l 679 (779)
|.+|.||+|+.. +++.||+|++.... .+.+|...+....||||+++++++...+..++||||+++++|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 889999999764 68899999986542 2334555556667999999999999999999999999999999988
Q ss_pred hhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCcccccccc
Q 004020 680 FNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLA 759 (779)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 759 (779)
.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.++++|||.+...... .....
T Consensus 77 ~~~~-----~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~ 143 (237)
T cd05576 77 SKFL-----NIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEA 143 (237)
T ss_pred HHhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCC
Confidence 5432 47899999999999999999995 89999999999999999999999999987655432 12234
Q ss_pred cCCccccccccccc
Q 004020 760 GTFGYLAPEYAAET 773 (779)
Q Consensus 760 gt~~y~APE~l~~~ 773 (779)
++..|+|||++.+.
T Consensus 144 ~~~~y~aPE~~~~~ 157 (237)
T cd05576 144 VENMYCAPEVGGIS 157 (237)
T ss_pred cCccccCCcccCCC
Confidence 67789999987543
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.1e-20 Score=226.37 Aligned_cols=306 Identities=19% Similarity=0.218 Sum_probs=222.2
Q ss_pred CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCC-CCCCCcccccCCCCccEEEc
Q 004020 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNN-FTSVPSDFFKGLTSLQTISL 143 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~L~L 143 (779)
..++.|++.++.+. .+|..| ...+|++|+|++|++...+..+..+++|+.|+|++|. ++.+|. +..+++|++|+|
T Consensus 589 ~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~--ls~l~~Le~L~L 664 (1153)
T PLN03210 589 PKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEKLWDGVHSLTGLRNIDLRGSKNLKEIPD--LSMATNLETLKL 664 (1153)
T ss_pred cccEEEEecCCCCC-CCCCcC-CccCCcEEECcCccccccccccccCCCCCEEECCCCCCcCcCCc--cccCCcccEEEe
Confidence 36899999999887 778777 5799999999999998776688999999999999865 666663 788999999999
Q ss_pred ccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCC
Q 004020 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGD 223 (779)
Q Consensus 144 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~ 223 (779)
++|.... .+|..+.++++|+.|++++|.....+|..+ .+++|+.|+|++|...+.+|... .+|+.|++++|.+.
T Consensus 665 ~~c~~L~-~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i---~l~sL~~L~Lsgc~~L~~~p~~~--~nL~~L~L~~n~i~ 738 (1153)
T PLN03210 665 SDCSSLV-ELPSSIQYLNKLEDLDMSRCENLEILPTGI---NLKSLYRLNLSGCSRLKSFPDIS--TNISWLDLDETAIE 738 (1153)
T ss_pred cCCCCcc-ccchhhhccCCCCEEeCCCCCCcCccCCcC---CCCCCCEEeCCCCCCcccccccc--CCcCeeecCCCccc
Confidence 9886544 589999999999999999987667888766 58999999999998776777543 46899999998875
Q ss_pred CCCCCchhhhcCCCCccEEEeecCcccC-------CCCC-CCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCcc
Q 004020 224 SKLNGSVAVIQNMTSLTQLWLHGNSFTG-------PLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNL 295 (779)
Q Consensus 224 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~-------~~~~-~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 295 (779)
..... ..+++|+.|++.++.... ..+. ...+++|+.|++++|...+.+|.+++++++|+.|+|++|.
T Consensus 739 ~lP~~-----~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~ 813 (1153)
T PLN03210 739 EFPSN-----LRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCI 813 (1153)
T ss_pred ccccc-----ccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCC
Confidence 43221 157888888887743321 1221 2345789999999998888899999999999999999986
Q ss_pred ccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEE
Q 004020 296 FQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVV 375 (779)
Q Consensus 296 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L 375 (779)
.-+.+|.......+.....++ |.. . ...+....+|+.|
T Consensus 814 ~L~~LP~~~~L~sL~~L~Ls~----------------------------------------c~~-L-~~~p~~~~nL~~L 851 (1153)
T PLN03210 814 NLETLPTGINLESLESLDLSG----------------------------------------CSR-L-RTFPDISTNISDL 851 (1153)
T ss_pred CcCeeCCCCCccccCEEECCC----------------------------------------CCc-c-ccccccccccCEe
Confidence 555566432111100000000 000 0 0001112367777
Q ss_pred EccCccccccccccccccccCCeEeccC-ccccccCCccCCCCCCCCceeccCCc
Q 004020 376 NLKNLGLSGTISSNFSRLTSLRQLMLSG-NELTGTIPKELTTLPSLEMLDVSNNH 429 (779)
Q Consensus 376 ~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~-N~l~g~iP~~l~~l~~L~~L~Ls~N~ 429 (779)
+|++|.++ .+|.++..+++|+.|+|++ |+|. .+|..+..+++|+.|+++++.
T Consensus 852 ~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 852 NLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred ECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 77777776 4677777777777777777 4444 577777777777777777663
|
syringae 6; Provisional |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.1e-20 Score=180.84 Aligned_cols=144 Identities=22% Similarity=0.234 Sum_probs=111.9
Q ss_pred cceecccccEEEEEEEEcCCcEEEEEEecccccChh------------------------HHHHHHHHHHHHHcCCCCcc
Q 004020 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEK------------------------GFAEFKSEIAVLTKVRHRHL 650 (779)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------~~~~~~~E~~~l~~l~h~ni 650 (779)
.+.||+|+||.||+|+..+|+.||||+++....... ....+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 468999999999999877899999999875421100 01234689999999999988
Q ss_pred ceEeeEEEeCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEc
Q 004020 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG 730 (779)
Q Consensus 651 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~ 730 (779)
.....+... ..++||||++++++....... ..++...+..++.|++.++.++|+ ..||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE
Confidence 655544433 248999999987554332111 146778889999999999999995 37999999999999998
Q ss_pred CCCcEEEEeeccceecCC
Q 004020 731 DDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 731 ~~~~~kl~DFG~a~~~~~ 748 (779)
++.++|+|||+|+....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 78999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.8e-22 Score=201.10 Aligned_cols=296 Identities=23% Similarity=0.257 Sum_probs=211.2
Q ss_pred EEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcc-
Q 004020 67 VTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD- 144 (779)
Q Consensus 67 v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls- 144 (779)
=..++.++.+++ .+|..+-. ..++++|..|+|+.+++ +|+.+++|++||||+|+|+.|-+++|.++++|.+|-+-
T Consensus 48 g~~VdCr~~GL~-eVP~~LP~--~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg 124 (498)
T KOG4237|consen 48 GGIVDCRGKGLT-EVPANLPP--ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYG 124 (498)
T ss_pred CceEEccCCCcc-cCcccCCC--cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhc
Confidence 466788999998 78876643 78899999999999888 89999999999999999999999999999999887765
Q ss_pred cCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCC-cccc-CCcceeeccCCCC
Q 004020 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPL-SFGK-SSIQTLWLNGQKG 222 (779)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~-~~L~~l~l~~n~~ 222 (779)
+|+|+. .....|.+|.+|+.|.+.-|++.....+.|. .+++|..|.|.+|.+. .++. .+.. ..++.+++..|.+
T Consensus 125 ~NkI~~-l~k~~F~gL~slqrLllNan~i~Cir~~al~--dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~ 200 (498)
T KOG4237|consen 125 NNKITD-LPKGAFGGLSSLQRLLLNANHINCIRQDALR--DLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPF 200 (498)
T ss_pred CCchhh-hhhhHhhhHHHHHHHhcChhhhcchhHHHHH--Hhhhcchhcccchhhh-hhccccccchhccchHhhhcCcc
Confidence 599987 4557899999999999999999988888886 7999999999999998 5555 4443 4567777766652
Q ss_pred CCCCC---------CchhhhcCCCCccEEEeecCcccCCCCC-C-CCCCCCcEEEccCCccccccC-hhhhCCCCCCEEE
Q 004020 223 DSKLN---------GSVAVIQNMTSLTQLWLHGNSFTGPLPD-L-SGLSSLQDFSVRDNQLTGIVP-SSLVNLHSLAVVN 290 (779)
Q Consensus 223 ~~~~~---------~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~-~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~L~~L~ 290 (779)
-.... ..+..++.........|.++++....+. | +.+.++..=..+.+...+.-| ..|..+++|+.|+
T Consensus 201 icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~ln 280 (498)
T KOG4237|consen 201 ICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLN 280 (498)
T ss_pred ccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEec
Confidence 11100 0111122222233333444444433332 1 222222221222222323334 5677788888888
Q ss_pred ccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCC
Q 004020 291 LTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGG 370 (779)
Q Consensus 291 Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (779)
|++|+++++-+.+|... .
T Consensus 281 lsnN~i~~i~~~aFe~~--------------------------------------------------------------a 298 (498)
T KOG4237|consen 281 LSNNKITRIEDGAFEGA--------------------------------------------------------------A 298 (498)
T ss_pred cCCCccchhhhhhhcch--------------------------------------------------------------h
Confidence 88888876655433221 2
Q ss_pred CeEEEEccCccccccccccccccccCCeEeccCccccccCCccCCCCCCCCceeccCCccc
Q 004020 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLF 431 (779)
Q Consensus 371 ~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~ 431 (779)
.++.|.|..|+|.-.-...|.++..|+.|+|.+|+|+-.-|..|..+.+|.+|+|-.|.+.
T Consensus 299 ~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 299 ELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred hhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence 5677777777777666667888888888888888888777888888888888888888774
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.2e-19 Score=220.85 Aligned_cols=314 Identities=17% Similarity=0.171 Sum_probs=231.3
Q ss_pred CcEEEEEecCC------CccccCCccccCCC-CCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCC
Q 004020 65 NRVTRIQIGGQ------NIEGTLPKELNSLS-SLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTS 137 (779)
Q Consensus 65 ~~v~~l~l~~~------~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 137 (779)
.+++.|.+..+ ++...+|..|..++ +|+.|++.+|.+...+..| ...+|+.|+|++|++..++.+ +..+++
T Consensus 558 ~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~~lP~~f-~~~~L~~L~L~~s~l~~L~~~-~~~l~~ 635 (1153)
T PLN03210 558 RNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLRCMPSNF-RPENLVKLQMQGSKLEKLWDG-VHSLTG 635 (1153)
T ss_pred ccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCCCCCCcC-CccCCcEEECcCccccccccc-cccCCC
Confidence 46788888654 34557888888875 6999999999998666666 579999999999999998765 678999
Q ss_pred ccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeec
Q 004020 138 LQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWL 217 (779)
Q Consensus 138 L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l 217 (779)
|++|+|++|.... .+| .+..+++|+.|++++|.....+|..+. .+++|+.|++++|...+.+|..+...+|+.|++
T Consensus 636 Lk~L~Ls~~~~l~-~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~--~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~L 711 (1153)
T PLN03210 636 LRNIDLRGSKNLK-EIP-DLSMATNLETLKLSDCSSLVELPSSIQ--YLNKLEDLDMSRCENLEILPTGINLKSLYRLNL 711 (1153)
T ss_pred CCEEECCCCCCcC-cCC-ccccCCcccEEEecCCCCccccchhhh--ccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeC
Confidence 9999999876433 355 488899999999999988788999987 799999999999876668888776678999999
Q ss_pred cCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCcc-------ccccChhhhCCCCCCEEE
Q 004020 218 NGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQL-------TGIVPSSLVNLHSLAVVN 290 (779)
Q Consensus 218 ~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l-------~~~~p~~l~~l~~L~~L~ 290 (779)
++|.....++. ..++|+.|+|++|.+... |....+++|+.|++.++.. ....|......++|+.|+
T Consensus 712 sgc~~L~~~p~------~~~nL~~L~L~~n~i~~l-P~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~ 784 (1153)
T PLN03210 712 SGCSRLKSFPD------ISTNISWLDLDETAIEEF-PSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLF 784 (1153)
T ss_pred CCCCCcccccc------ccCCcCeeecCCCccccc-cccccccccccccccccchhhccccccccchhhhhccccchhee
Confidence 99865433322 246899999999999754 4434688899999987442 222233344467999999
Q ss_pred ccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCC
Q 004020 291 LTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGG 370 (779)
Q Consensus 291 Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (779)
|++|...+.+|..+..+. ++..+.... | ..+. ..| .....+
T Consensus 785 Ls~n~~l~~lP~si~~L~-------~L~~L~Ls~--C-----------~~L~-----------~LP--------~~~~L~ 825 (1153)
T PLN03210 785 LSDIPSLVELPSSIQNLH-------KLEHLEIEN--C-----------INLE-----------TLP--------TGINLE 825 (1153)
T ss_pred CCCCCCccccChhhhCCC-------CCCEEECCC--C-----------CCcC-----------eeC--------CCCCcc
Confidence 999998888886443221 000000000 0 0000 000 000235
Q ss_pred CeEEEEccCccccccccccccccccCCeEeccCccccccCCccCCCCCCCCceeccC-CcccccCC
Q 004020 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSN-NHLFGKVP 435 (779)
Q Consensus 371 ~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~-N~l~g~iP 435 (779)
+|+.|+|++|..-..+|.. .++|+.|+|++|.|+ .+|.++..+++|++|+|++ |+|.+ +|
T Consensus 826 sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~-l~ 886 (1153)
T PLN03210 826 SLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQR-VS 886 (1153)
T ss_pred ccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCc-cC
Confidence 7899999998766666653 368999999999999 8999999999999999998 55554 44
|
syringae 6; Provisional |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.2e-20 Score=210.88 Aligned_cols=177 Identities=31% Similarity=0.453 Sum_probs=145.4
Q ss_pred CCcccceecccccEEEEEEEEc--------CCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCC
Q 004020 591 NFSEENVLGRGGFGTVYKGELH--------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGN 661 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 661 (779)
+..+.+.+|+|.||.|++|... ....||||..+..... ...+.+..|+++|+.+. ||||+.+++++..++
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 3455569999999999999643 1457999998876544 67788999999999995 999999999999999
Q ss_pred eEEEEEEecCCCChhhHhhhcc---------cCCC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEc
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRK---------EEGL--KPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG 730 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~---------~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~ 730 (779)
..++|+||++.|+|.++++..+ .... ..+...+.+.++.|||.|++||++ .++||||+-.+|||+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEec
Confidence 9999999999999999998776 1111 137888999999999999999996 7899999999999999
Q ss_pred CCCcEEEEeeccceecCCCCCccccccccc--CCcccccccccc
Q 004020 731 DDMRAKVADFGLVRLAPDNGKHSIETRLAG--TFGYLAPEYAAE 772 (779)
Q Consensus 731 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~g--t~~y~APE~l~~ 772 (779)
++..+||+|||+|+........... ...| ...|||||.+..
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~ 495 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFD 495 (609)
T ss_pred CCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhcc
Confidence 9999999999999976554333211 1222 345999999887
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.4e-21 Score=186.43 Aligned_cols=171 Identities=26% Similarity=0.370 Sum_probs=143.2
Q ss_pred hcCCcccceecccccEEEEEEE-EcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC------
Q 004020 589 TNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN------ 661 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 661 (779)
..+|.-.+.+|.|.- .|..|. .-.++.||+|++..+.......++..+|..++..+.|+||++++.+|.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 357777888999988 555553 336899999999877655666788899999999999999999999987543
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeec
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 741 (779)
+.|+|||||. .+|...+.. .++..++..|..|++.|++|||+ .||+||||||+||++..++.+||.|||
T Consensus 95 e~y~v~e~m~-~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVILM-------ELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred hHHHHHHhhh-hHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccch
Confidence 5799999995 588888752 36778899999999999999996 899999999999999999999999999
Q ss_pred cceecCCCCCcccccccccCCcccccccccccC
Q 004020 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 742 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
+|+..... ...+.++.|..|+|||++.+..
T Consensus 164 ~ar~e~~~---~~mtpyVvtRyyrapevil~~~ 193 (369)
T KOG0665|consen 164 LARTEDTD---FMMTPYVVTRYYRAPEVILGMG 193 (369)
T ss_pred hhcccCcc---cccCchhheeeccCchheeccC
Confidence 99865432 3457788999999999998775
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.7e-19 Score=179.55 Aligned_cols=171 Identities=36% Similarity=0.496 Sum_probs=144.3
Q ss_pred CcccceecccccEEEEEEEEcC-CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEec
Q 004020 592 FSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYM 670 (779)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 670 (779)
|...+.||+|++|.||++...+ ++.+|+|.+...... ...+.+.+|++.+++++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 5667899999999999998764 889999998765422 24578899999999999999999999999989999999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCC
Q 004020 671 PQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750 (779)
Q Consensus 671 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 750 (779)
++++|.+++..... .+++..+..++.+++.++.|||+ .+++|+|++|+||+++.++.++|+|||.+.......
T Consensus 80 ~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 80 EGGDLFDYLRKKGG----KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred CCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 99999999865432 16888999999999999999996 799999999999999999999999999988765432
Q ss_pred CcccccccccCCccccccccc
Q 004020 751 KHSIETRLAGTFGYLAPEYAA 771 (779)
Q Consensus 751 ~~~~~~~~~gt~~y~APE~l~ 771 (779)
. .......++..|++||.+.
T Consensus 153 ~-~~~~~~~~~~~~~~pe~~~ 172 (225)
T smart00221 153 A-ALLKTVKGTPFYLAPEVLL 172 (225)
T ss_pred c-ccccceeccCCcCCHhHhc
Confidence 1 1123345788999999874
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.7e-22 Score=218.41 Aligned_cols=264 Identities=27% Similarity=0.339 Sum_probs=202.5
Q ss_pred CCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEec
Q 004020 89 SSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSA 168 (779)
Q Consensus 89 ~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l 168 (779)
++|+.|+.++|.++...+.+ .-.+|+++++++|+++.+| +++..+.+|+.|+..+|+|.. +|..+..+++|++|.+
T Consensus 219 ~~l~~L~a~~n~l~~~~~~p-~p~nl~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~~--lp~ri~~~~~L~~l~~ 294 (1081)
T KOG0618|consen 219 PSLTALYADHNPLTTLDVHP-VPLNLQYLDISHNNLSNLP-EWIGACANLEALNANHNRLVA--LPLRISRITSLVSLSA 294 (1081)
T ss_pred cchheeeeccCcceeecccc-ccccceeeecchhhhhcch-HHHHhcccceEecccchhHHh--hHHHHhhhhhHHHHHh
Confidence 44555555555555322222 2257999999999999999 889999999999999999964 8899999999999999
Q ss_pred cCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCcccc---CCcceeeccCCCCCCCCCCchhhhcCCCCccEEEee
Q 004020 169 NGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK---SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLH 245 (779)
Q Consensus 169 ~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~---~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~ 245 (779)
..|.+. -+|.... .++.|++|+|..|+|. .+|+.+-. ..+..|+.+.|++....... =..++.|+.|+|.
T Consensus 295 ~~nel~-yip~~le--~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~---e~~~~~Lq~Lyla 367 (1081)
T KOG0618|consen 295 AYNELE-YIPPFLE--GLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYE---ENNHAALQELYLA 367 (1081)
T ss_pred hhhhhh-hCCCccc--ccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhcccccccccc---chhhHHHHHHHHh
Confidence 999998 5666665 6889999999999998 66665433 34666777766665443221 1246779999999
Q ss_pred cCcccC-CCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCC
Q 004020 246 GNSFTG-PLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAG 324 (779)
Q Consensus 246 ~N~l~~-~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 324 (779)
+|.|+. .+|.+.+++.|+.|+|++|++.......+.++..|+.|+||+|+|+... +.
T Consensus 368 nN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~Lp-~t--------------------- 425 (1081)
T KOG0618|consen 368 NNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTTLP-DT--------------------- 425 (1081)
T ss_pred cCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhhhh-HH---------------------
Confidence 999997 5678999999999999999998555567889999999999999998432 21
Q ss_pred cccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccCc
Q 004020 325 VACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGN 404 (779)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N 404 (779)
....+.|++|..-+|+|. .+| ++..+++|+.+|||.|
T Consensus 426 -----------------------------------------va~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N 462 (1081)
T KOG0618|consen 426 -----------------------------------------VANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCN 462 (1081)
T ss_pred -----------------------------------------HHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccc
Confidence 111236778888888888 677 8999999999999999
Q ss_pred ccc-ccCCccCCCCCCCCceeccCCc
Q 004020 405 ELT-GTIPKELTTLPSLEMLDVSNNH 429 (779)
Q Consensus 405 ~l~-g~iP~~l~~l~~L~~L~Ls~N~ 429 (779)
+|+ +.+|..+. .++|++|||++|.
T Consensus 463 ~L~~~~l~~~~p-~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 463 NLSEVTLPEALP-SPNLKYLDLSGNT 487 (1081)
T ss_pred hhhhhhhhhhCC-CcccceeeccCCc
Confidence 998 34454433 3899999999997
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.7e-20 Score=199.23 Aligned_cols=169 Identities=30% Similarity=0.389 Sum_probs=139.0
Q ss_pred hhcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 665 (779)
+.++|.....+|.|+|+.|-.+.. .+++..++|++.+.. .+..+|+.++.+. .||||+++++.+.++.+.|+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCceeee
Confidence 567888999999999999999865 468889999987652 2345678777766 59999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEE-cCCCcEEEEeeccce
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVR 744 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll-~~~~~~kl~DFG~a~ 744 (779)
|||++.++-+.+.+...+ .....+..|+++|+.|+.|||+ +||||||+||+|||+ ++.++++|+|||.++
T Consensus 394 v~e~l~g~ell~ri~~~~------~~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKP------EFCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWS 464 (612)
T ss_pred eehhccccHHHHHHHhcc------hhHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhh
Confidence 999999998877764433 2226677899999999999996 899999999999999 589999999999998
Q ss_pred ecCCCCCcccccccccCCcccccccccccCCCC
Q 004020 745 LAPDNGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
..... ....+-|..|.|||++. ..++|
T Consensus 465 ~~~~~-----~~tp~~t~~y~APEvl~-~~~yt 491 (612)
T KOG0603|consen 465 ELERS-----CDTPALTLQYVAPEVLA-IQEYT 491 (612)
T ss_pred hCchh-----hcccchhhcccChhhhc-cCCCC
Confidence 77543 12335688999999998 44444
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.2e-20 Score=176.64 Aligned_cols=174 Identities=25% Similarity=0.400 Sum_probs=137.2
Q ss_pred HhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeE-EEeCCeE
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGY-CLDGNER 663 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~-~~~~~~~ 663 (779)
...+.|.+.+.+|+|.||.+-+|+++ +...+|+|.+.... ...++|.+|...--.+. |.||+.-|+. |+..+.+
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 34567999999999999999999876 56789999887654 34568889988766674 8999988765 5667788
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEc--CCCcEEEEeec
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFG 741 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~--~~~~~kl~DFG 741 (779)
+.++||++.|+|..-+.. ..+-+....+++.|++.|+.|||+ +++||||||.+||||- +..++|+||||
T Consensus 98 vF~qE~aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG 168 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFG 168 (378)
T ss_pred EEeeccCccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecc
Confidence 899999999999887633 236778889999999999999997 8999999999999993 44689999999
Q ss_pred cceecCCCCCcccccccccCCcccccccccccCCCC
Q 004020 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 742 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
..+....... ...-+..|.|||+.....+..
T Consensus 169 ~t~k~g~tV~-----~~~~~~~y~~pe~~~~~~ne~ 199 (378)
T KOG1345|consen 169 LTRKVGTTVK-----YLEYVNNYHAPELCDTVVNEK 199 (378)
T ss_pred cccccCceeh-----hhhhhcccCCcHHHhhccccc
Confidence 9876543211 122456799999876554433
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.4e-20 Score=185.63 Aligned_cols=148 Identities=22% Similarity=0.374 Sum_probs=128.9
Q ss_pred HHHHHHhhcCCcccceecccccEEEEEEEEc----CCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeE
Q 004020 582 IQVLRNVTNNFSEENVLGRGGFGTVYKGELH----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGY 656 (779)
Q Consensus 582 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~ 656 (779)
.+.+..+.+.|..+++||+|.|+.||++... ..+.||+|.+.... ...++..|+++|..+. +.||+++.++
T Consensus 28 ~q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~ 103 (418)
T KOG1167|consen 28 RQDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGC 103 (418)
T ss_pred HhhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhh
Confidence 3456677888999999999999999999543 46789999986543 3457889999999996 9999999999
Q ss_pred EEeCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC-CCcE
Q 004020 657 CLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRA 735 (779)
Q Consensus 657 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-~~~~ 735 (779)
+..++...+|+||++.....++.. .++...+..+++.+..||+++|. .|||||||||+|++.+. .++-
T Consensus 104 ~rnnd~v~ivlp~~~H~~f~~l~~--------~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg 172 (418)
T KOG1167|consen 104 FRNNDQVAIVLPYFEHDRFRDLYR--------SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRG 172 (418)
T ss_pred hccCCeeEEEecccCccCHHHHHh--------cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCc
Confidence 999999999999999988888773 36678899999999999999995 99999999999999984 5778
Q ss_pred EEEeeccce
Q 004020 736 KVADFGLVR 744 (779)
Q Consensus 736 kl~DFG~a~ 744 (779)
.|+|||+|.
T Consensus 173 ~LvDFgLA~ 181 (418)
T KOG1167|consen 173 VLVDFGLAQ 181 (418)
T ss_pred eEEechhHH
Confidence 999999987
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.8e-18 Score=172.21 Aligned_cols=166 Identities=39% Similarity=0.606 Sum_probs=140.4
Q ss_pred ecccccEEEEEEEEcC-CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCCCChh
Q 004020 598 LGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLS 676 (779)
Q Consensus 598 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 676 (779)
||+|++|.||++.... ++.+++|++....... ..+.+.+|++.++.++|++|+++++++......+++|||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999998764 8999999987654221 3467899999999999999999999999999999999999999999
Q ss_pred hHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC-CCcEEEEeeccceecCCCCCcccc
Q 004020 677 RHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLVRLAPDNGKHSIE 755 (779)
Q Consensus 677 ~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~ 755 (779)
+++.... ..+++..+..++.+++++++|||+ .+++|+||+|.||+++. ++.++|+|||.+........ ..
T Consensus 80 ~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~ 150 (215)
T cd00180 80 DLLKENE----GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LL 150 (215)
T ss_pred HHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hh
Confidence 9986542 257889999999999999999996 79999999999999999 89999999999887654321 12
Q ss_pred cccccCCccccccccccc
Q 004020 756 TRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 756 ~~~~gt~~y~APE~l~~~ 773 (779)
....+...|++||.+...
T Consensus 151 ~~~~~~~~~~~pe~~~~~ 168 (215)
T cd00180 151 KTIVGTPAYMAPEVLLGK 168 (215)
T ss_pred hcccCCCCccChhHhccc
Confidence 334578899999998664
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.6e-19 Score=167.55 Aligned_cols=170 Identities=24% Similarity=0.374 Sum_probs=136.1
Q ss_pred hhcCCcccceecccccEEEEEEE-EcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCC-CccceEeeEEEeCCeEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH-RHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~l 665 (779)
+.+.|.+.++||.|+||.+|.|. ..+|++||+|.-.... ...++..|.++...++| ..|..+..++.++..-.+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC----CCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 45689999999999999999995 5689999999765433 23467889999999974 678888888888888899
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC---CCcEEEEeecc
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVADFGL 742 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DFG~ 742 (779)
|||.+ |.+|++.+.-.. ..++..+++..+-||+.-++|+|. +++|||||||+|+|..- ..++.++|||+
T Consensus 89 VMdLL-GPsLEdLfnfC~----R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFCS----RRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred eeecc-CccHHHHHHHHh----hhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccc
Confidence 99988 679988774332 358889999999999999999995 89999999999999963 34689999999
Q ss_pred ceecCCCCCc-----ccccccccCCccccccc
Q 004020 743 VRLAPDNGKH-----SIETRLAGTFGYLAPEY 769 (779)
Q Consensus 743 a~~~~~~~~~-----~~~~~~~gt~~y~APE~ 769 (779)
|+.+.+.... .......||..|.+--.
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinA 192 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINA 192 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhh
Confidence 9877553221 12344679999977543
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-21 Score=174.93 Aligned_cols=182 Identities=23% Similarity=0.408 Sum_probs=145.8
Q ss_pred CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcc
Q 004020 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 144 (779)
.+++.|.|++|.++ .+|+.+.+|.+|+.|++++|+|+..+++++.+++|+.|+++-|++..+|.+ |+.++.|+.|||.
T Consensus 33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~~lprg-fgs~p~levldlt 110 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLNILPRG-FGSFPALEVLDLT 110 (264)
T ss_pred hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhhcCccc-cCCCchhhhhhcc
Confidence 47899999999999 788899999999999999999998888999999999999999999888876 8999999999999
Q ss_pred cCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCC
Q 004020 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDS 224 (779)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~ 224 (779)
+|++..-..|+.|..|+.|+.|+|++|.+. .+|..++ .+.+|+.|.+..|.+- .+|..++
T Consensus 111 ynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg--~lt~lqil~lrdndll-~lpkeig---------------- 170 (264)
T KOG0617|consen 111 YNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVG--KLTNLQILSLRDNDLL-SLPKEIG---------------- 170 (264)
T ss_pred ccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhh--hhcceeEEeeccCchh-hCcHHHH----------------
Confidence 999988778888888888888888888887 6677776 6888888888888876 5666554
Q ss_pred CCCCchhhhcCCCCccEEEeecCcccCCCCCCCCC---CCCcEEEccCCccccccCh
Q 004020 225 KLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGL---SSLQDFSVRDNQLTGIVPS 278 (779)
Q Consensus 225 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l---~~L~~L~l~~N~l~~~~p~ 278 (779)
.++.|+.|++.+|+++-.+|+++.+ .+-+.+.+.+|.+...|.+
T Consensus 171 ----------~lt~lrelhiqgnrl~vlppel~~l~l~~~k~v~r~E~NPwv~pIae 217 (264)
T KOG0617|consen 171 ----------DLTRLRELHIQGNRLTVLPPELANLDLVGNKQVMRMEENPWVNPIAE 217 (264)
T ss_pred ----------HHHHHHHHhcccceeeecChhhhhhhhhhhHHHHhhhhCCCCChHHH
Confidence 4777777788888887777765443 2334555556655544443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-18 Score=170.49 Aligned_cols=170 Identities=20% Similarity=0.344 Sum_probs=137.2
Q ss_pred cCCcccceecccccEEEEEEE-EcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 667 (779)
-.|.+.++||+|+||+++.|. +-+++.||||.-.... ...++..|.+..+.|. .+.|...|-+...+.+-.|||
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 478999999999999999995 4579999999754332 3356788888888885 789999998888888889999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCC-----CcEEEEeecc
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-----MRAKVADFGL 742 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~-----~~~kl~DFG~ 742 (779)
|.+ |.+|+|+..-.. ..++..++..+|.||+.-++|+|+ +.+|.|||||+|+||... ..+.|+|||+
T Consensus 104 dLL-GPSLEDLFD~Cg----R~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCG----RRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhh-CcCHHHHHHHhc----CcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccc
Confidence 988 679988764322 368999999999999999999996 889999999999999754 3589999999
Q ss_pred ceecCCCCCc-----ccccccccCCccccccccc
Q 004020 743 VRLAPDNGKH-----SIETRLAGTFGYLAPEYAA 771 (779)
Q Consensus 743 a~~~~~~~~~-----~~~~~~~gt~~y~APE~l~ 771 (779)
|+.+.+.... .......||.+||+=-.-.
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHl 209 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHL 209 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccc
Confidence 9987654321 1234567999999854433
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=2e-18 Score=176.20 Aligned_cols=159 Identities=36% Similarity=0.526 Sum_probs=135.7
Q ss_pred ccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCCCChhhHhh
Q 004020 602 GFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLF 680 (779)
Q Consensus 602 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~ 680 (779)
+||.||+|... +++.+|+|++........ .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999876 489999999876543221 5789999999999999999999999999999999999999999999885
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCccccccccc
Q 004020 681 NRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAG 760 (779)
Q Consensus 681 ~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~g 760 (779)
... .+++..++.++.++++++.|||. .+++|+||+|+||++++++.++|+|||.+....... ......+
T Consensus 80 ~~~-----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~ 148 (244)
T smart00220 80 KRG-----RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVG 148 (244)
T ss_pred hcc-----CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccC
Confidence 432 27889999999999999999996 799999999999999999999999999988765432 2234568
Q ss_pred CCcccccccccc
Q 004020 761 TFGYLAPEYAAE 772 (779)
Q Consensus 761 t~~y~APE~l~~ 772 (779)
+..|+|||.+.+
T Consensus 149 ~~~~~~pE~~~~ 160 (244)
T smart00220 149 TPEYMAPEVLLG 160 (244)
T ss_pred CcCCCCHHHHcc
Confidence 899999998763
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.8e-18 Score=168.31 Aligned_cols=138 Identities=20% Similarity=0.278 Sum_probs=105.2
Q ss_pred cccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcC-----CCCccceEeeEEEeCC---eEE
Q 004020 593 SEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-----RHRHLVGLLGYCLDGN---ERL 664 (779)
Q Consensus 593 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~---~~~ 664 (779)
...+.||+|+||.||. .-.++.. +||++.... ....+.+.+|+++++.+ .||||+++++++.++. ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 4457899999999996 2234444 688886542 22346789999999999 5799999999999873 434
Q ss_pred -EEEEe--cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHH-HHHHcCCCCCcEEcCCCCCCEEEcC----CCcEE
Q 004020 665 -LVYEY--MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV-EYLHGLAHQSFIHRDLKPSNILLGD----DMRAK 736 (779)
Q Consensus 665 -lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L-~~LH~~~~~~ivHrDlkp~NIll~~----~~~~k 736 (779)
+|||| +++++|.+++.+. .+++. ..++.|++.++ +|||+ .+|+||||||+|||++. +++++
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~ 149 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPV 149 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEE
Confidence 78999 5579999999542 24444 35678888887 99996 89999999999999974 34799
Q ss_pred EEe-ecccee
Q 004020 737 VAD-FGLVRL 745 (779)
Q Consensus 737 l~D-FG~a~~ 745 (779)
|+| ||....
T Consensus 150 LiDg~G~~~~ 159 (210)
T PRK10345 150 VCDNIGESTF 159 (210)
T ss_pred EEECCCCcce
Confidence 999 555444
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.2e-18 Score=172.78 Aligned_cols=190 Identities=20% Similarity=0.297 Sum_probs=149.4
Q ss_pred eHHHHHHhhcCCcccceecccccEEEEEEEEc------CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEe
Q 004020 581 SIQVLRNVTNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654 (779)
Q Consensus 581 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 654 (779)
..+++..-..+++....+-+|.||.||+|.++ +.+.|-+|.++... ++-....+..|...+..+.|||+..+.
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCcccee
Confidence 34555566677888899999999999999554 34556677765443 445567789999999999999999999
Q ss_pred eEEEeC-CeEEEEEEecCCCChhhHhhhccc---CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEc
Q 004020 655 GYCLDG-NERLLVYEYMPQGTLSRHLFNRKE---EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG 730 (779)
Q Consensus 655 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~---~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~ 730 (779)
+++.+. +..++++.++.-|+|..++...+. ...+.++..+...++.|++.|++|||. ++|||.||..+|.+||
T Consensus 354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVID 430 (563)
T ss_pred EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceeh
Confidence 988765 567889999999999999974332 223456778888999999999999995 8999999999999999
Q ss_pred CCCcEEEEeeccceecCCCCCcccccccccCCcccccccccccC
Q 004020 731 DDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 731 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
+..++||+|=.++|..-+...+-..........||+||.+..+.
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ 474 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH 474 (563)
T ss_pred hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhh
Confidence 99999999999998765543333333334567899999987653
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.5e-18 Score=179.61 Aligned_cols=183 Identities=22% Similarity=0.268 Sum_probs=149.4
Q ss_pred eeeHHHHHHhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCC------CCccc
Q 004020 579 VISIQVLRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR------HRHLV 651 (779)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv 651 (779)
.+.++..+..-.+|.+....|+|-|+.|.+|... .|..||||+|.... --.+.=.+|+++|++|. --+++
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE---~M~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE---VMHKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch---HHhhhhhHHHHHHHHhhccCchhhhHHH
Confidence 4566666677789999999999999999999754 58899999997543 22244578999999995 24789
Q ss_pred eEeeEEEeCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC
Q 004020 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 731 (779)
Q Consensus 652 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~ 731 (779)
+++..|...++.|||+|-+. .+|.++++..... ..+....+..++.|+.-||..|. +.+|+|.||||.|||+++
T Consensus 498 rl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~n--vGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE 571 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRN--VGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNE 571 (752)
T ss_pred HHHHHhhhcceeEEEehhhh-chHHHHHHHhCcc--cceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEecc
Confidence 99999999999999999884 5899999775433 24677888999999999999999 489999999999999986
Q ss_pred C-CcEEEEeeccceecCCCCCcccccccccCCcccccccccccC
Q 004020 732 D-MRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 732 ~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
. ..+||||||.|.....+.. +.+.-+..|+|||++.|-.
T Consensus 572 ~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~ 611 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLP 611 (752)
T ss_pred CcceeeeccCccccccccccc----cHHHHHHhccCcceeecCc
Confidence 5 5689999999987765432 4455678899999998764
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.3e-17 Score=163.73 Aligned_cols=143 Identities=16% Similarity=0.203 Sum_probs=116.4
Q ss_pred HhhcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhH-HHH------HHHHHHHHHcCCCCccceEeeEEEe
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKG-FAE------FKSEIAVLTKVRHRHLVGLLGYCLD 659 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-~~~------~~~E~~~l~~l~h~niv~~~~~~~~ 659 (779)
...++|...+.+|.|+||.||.+.. ++..+|+|.+.......+. .+. +.+|+..+.++.||+|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3568899999999999999999766 5778999999765433322 222 6899999999999999999988764
Q ss_pred C--------CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC
Q 004020 660 G--------NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 731 (779)
Q Consensus 660 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~ 731 (779)
. ...++||||++|.+|.++. .++. ....+++.++..+|. .|++|||+||+||++++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~---------~~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP---------EISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSK 170 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh---------hccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeC
Confidence 4 3578999999999997763 1222 245699999999995 89999999999999999
Q ss_pred CCcEEEEeeccceecC
Q 004020 732 DMRAKVADFGLVRLAP 747 (779)
Q Consensus 732 ~~~~kl~DFG~a~~~~ 747 (779)
+| ++|+|||..+...
T Consensus 171 ~g-i~liDfg~~~~~~ 185 (232)
T PRK10359 171 NG-LRIIDLSGKRCTA 185 (232)
T ss_pred CC-EEEEECCCccccc
Confidence 88 9999999877653
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=168.67 Aligned_cols=146 Identities=16% Similarity=0.152 Sum_probs=111.7
Q ss_pred cCCcccceecccccEEEEEEE--EcCCcEEEEEEecccccCh--------------------h--HHHHHHHHHHHHHcC
Q 004020 590 NNFSEENVLGRGGFGTVYKGE--LHDGTKIAVKRMESAVVSE--------------------K--GFAEFKSEIAVLTKV 645 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~--------------------~--~~~~~~~E~~~l~~l 645 (779)
..|.+.+.||+|+||.||+|. ..+|+.||+|++....... . ....+.+|++.+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358889999999999999998 5689999999987532100 0 112467899999999
Q ss_pred CCCc--cceEeeEEEeCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-cEEcCC
Q 004020 646 RHRH--LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS-FIHRDL 722 (779)
Q Consensus 646 ~h~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~-ivHrDl 722 (779)
.+.. +.+++++ ...++||||+++.++....... ......++..++.||+.++++||. .+ |+||||
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Di 175 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLYK---EGELVHGDL 175 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCC
Confidence 7533 3444432 2358999999998876654221 134556678999999999999996 78 999999
Q ss_pred CCCCEEEcCCCcEEEEeeccceecCC
Q 004020 723 KPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 723 kp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
||+||+++ +++++|+|||.|.....
T Consensus 176 kp~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 176 SEYNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred ChhhEEEE-CCCEEEEEChhhhccCC
Confidence 99999999 88999999999886544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.1e-17 Score=157.31 Aligned_cols=136 Identities=20% Similarity=0.198 Sum_probs=106.8
Q ss_pred ccceecccccEEEEEEEEcCCcEEEEEEeccccc--ChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCCeEEEEEEec
Q 004020 594 EENVLGRGGFGTVYKGELHDGTKIAVKRMESAVV--SEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLLVYEYM 670 (779)
Q Consensus 594 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 670 (779)
+...|++|+||+||.+.. ++.+++.+.+..... ..-....+.+|+++|+++. |++|++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999998765 678888777654321 1112235789999999996 5889999886 4469999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCC-CCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 671 PQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDL-KPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 671 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDl-kp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
.|.+|.+.... ....++.|++++|+++|+ .||+|||| ||+|||++.++.++|+|||+|......
T Consensus 81 ~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 81 AGAAMYQRPPR------------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred cCccHHhhhhh------------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 99888654310 113577899999999996 89999999 799999999999999999999865543
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.6e-20 Score=195.49 Aligned_cols=280 Identities=21% Similarity=0.256 Sum_probs=176.7
Q ss_pred EEEecCCCcc-ccCCccccCCCCCcEEEcccCccccC----CC-CCCCCCCccEEecCCCCCCCC------CcccccCCC
Q 004020 69 RIQIGGQNIE-GTLPKELNSLSSLTVLEVMKNKLTGQ----IP-SLSGLSSLQEVLFDDNNFTSV------PSDFFKGLT 136 (779)
Q Consensus 69 ~l~l~~~~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~----~~-~~~~l~~L~~L~l~~N~l~~~------~~~~~~~l~ 136 (779)
.|+|.+++++ ......+..+.+|++|+++++.++.. ++ .+...+.|++|+++++.+... .+..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4666667666 34445556667788888888777432 22 455667777777777776631 223456677
Q ss_pred CccEEEcccCCCCCCCCcccccCCCC---CceEeccCceeEee----cCCCccCCCC-CcccEEEccCCCCCCcCCCccc
Q 004020 137 SLQTISLDYNSFDSWVIPESLKDATG---LQRFSANGANITGT----IPDFLGGDTI-PGLMHLHLAFNFLQGPIPLSFG 208 (779)
Q Consensus 137 ~L~~L~Ls~N~l~~~~~p~~~~~l~~---L~~L~l~~n~l~~~----~p~~~~~~~l-~~L~~L~L~~N~l~~~~p~~~~ 208 (779)
+|++|++++|.+.. ..+..+..+.. |+.|++++|+++.. +...+. .+ ++|+.|+|++|.+++.....+
T Consensus 82 ~L~~L~l~~~~~~~-~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~--~~~~~L~~L~L~~n~l~~~~~~~~- 157 (319)
T cd00116 82 GLQELDLSDNALGP-DGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLK--DLPPALEKLVLGRNRLEGASCEAL- 157 (319)
T ss_pred ceeEEEccCCCCCh-hHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHH--hCCCCceEEEcCCCcCCchHHHHH-
Confidence 77777777777754 34444444444 77777777777631 222222 34 677888888888775322222
Q ss_pred cCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCC----CC-CCCCCCCCcEEEccCCccccc----cChh
Q 004020 209 KSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGP----LP-DLSGLSSLQDFSVRDNQLTGI----VPSS 279 (779)
Q Consensus 209 ~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~----~~-~~~~l~~L~~L~l~~N~l~~~----~p~~ 279 (779)
...+..+++|++|+|++|.+++. ++ .+..+++|+.|++++|.+.+. ++..
T Consensus 158 ---------------------~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~ 216 (319)
T cd00116 158 ---------------------AKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAET 216 (319)
T ss_pred ---------------------HHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHH
Confidence 12344567888888888888742 11 245567888888888888643 3455
Q ss_pred hhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCC
Q 004020 280 LVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNS 359 (779)
Q Consensus 280 l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (779)
+..+++|++|++++|++++..... +...
T Consensus 217 ~~~~~~L~~L~ls~n~l~~~~~~~---------------------------------l~~~------------------- 244 (319)
T cd00116 217 LASLKSLEVLNLGDNNLTDAGAAA---------------------------------LASA------------------- 244 (319)
T ss_pred hcccCCCCEEecCCCcCchHHHHH---------------------------------HHHH-------------------
Confidence 667788999999988876421110 0000
Q ss_pred CCCccccCCCCCeEEEEccCcccc----ccccccccccccCCeEeccCcccccc----CCccCCCC-CCCCceeccCCcc
Q 004020 360 DWKGVSCDAGGNITVVNLKNLGLS----GTISSNFSRLTSLRQLMLSGNELTGT----IPKELTTL-PSLEMLDVSNNHL 430 (779)
Q Consensus 360 ~~~~~~~~~~~~L~~L~Ls~n~l~----g~~p~~~~~l~~L~~L~Ls~N~l~g~----iP~~l~~l-~~L~~L~Ls~N~l 430 (779)
.......|+.|++++|.++ +.++..+..+++|+++++++|.++.. +...+-.. +.|++||+.+|++
T Consensus 245 -----~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 245 -----LLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred -----HhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 0001136888888888886 23455666678888889999888844 55555555 6788888888864
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.3e-17 Score=175.55 Aligned_cols=175 Identities=25% Similarity=0.344 Sum_probs=135.3
Q ss_pred CCcccceecccccEEEEEEEEcCC--cEEEEEEecccccChhHHHHHHHHHHHHHcCCC----CccceEeeEE-EeCCeE
Q 004020 591 NFSEENVLGRGGFGTVYKGELHDG--TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH----RHLVGLLGYC-LDGNER 663 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~-~~~~~~ 663 (779)
+|.+.+.||+|+||.||.|..... ..+|+|......... . ..+..|+.++..+.. +++..+++.+ ......
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~-~-~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK-P-SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC-C-ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 799999999999999999986643 478888765432111 1 257788888888863 6899999998 477788
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCC-----CcEEEE
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-----MRAKVA 738 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~-----~~~kl~ 738 (779)
|+||+.+ |.+|.++..... ...++..++.+|+.|++.+|++||+ .|++||||||+|+.+... ..+.|.
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred EEEEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEE
Confidence 9999987 779998764443 3468999999999999999999996 899999999999999854 469999
Q ss_pred eeccce--ecCCCCC----ccc--ccccccCCcccccccccccC
Q 004020 739 DFGLVR--LAPDNGK----HSI--ETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 739 DFG~a~--~~~~~~~----~~~--~~~~~gt~~y~APE~l~~~~ 774 (779)
|||+|+ .+..... ... .....||..|++++.-.+..
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e 213 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE 213 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc
Confidence 999998 3322211 111 23356999999998765543
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=8.9e-20 Score=162.73 Aligned_cols=163 Identities=29% Similarity=0.479 Sum_probs=120.3
Q ss_pred ccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCc
Q 004020 85 LNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQ 164 (779)
Q Consensus 85 l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~ 164 (779)
+.++.+.+.|-||+|+++..+|.+..|.+|+.|++++|+++.+|.. +..+++|+.|+++-|++.
T Consensus 29 Lf~~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie~lp~~-issl~klr~lnvgmnrl~--------------- 92 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIEELPTS-ISSLPKLRILNVGMNRLN--------------- 92 (264)
T ss_pred ccchhhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhhhcChh-hhhchhhhheecchhhhh---------------
Confidence 4556666667777777776666666666666666666666666654 555666666666666653
Q ss_pred eEeccCceeEeecCCCccCCCCCcccEEEccCCCCCC-cCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEE
Q 004020 165 RFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQG-PIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLW 243 (779)
Q Consensus 165 ~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~ 243 (779)
.+|..|+ .+|.|+.|||.+|++.. .+|.. +..++.|+.|+
T Consensus 93 -----------~lprgfg--s~p~levldltynnl~e~~lpgn--------------------------ff~m~tlraly 133 (264)
T KOG0617|consen 93 -----------ILPRGFG--SFPALEVLDLTYNNLNENSLPGN--------------------------FFYMTTLRALY 133 (264)
T ss_pred -----------cCccccC--CCchhhhhhccccccccccCCcc--------------------------hhHHHHHHHHH
Confidence 4566665 56777777777777753 23333 23577888899
Q ss_pred eecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCC
Q 004020 244 LHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKF 303 (779)
Q Consensus 244 L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~ 303 (779)
|++|.|.-.+|+++.+++||.|.+++|.+- .+|..++.++.|+.|.+.+|+++-.+|+.
T Consensus 134 l~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~vlppel 192 (264)
T KOG0617|consen 134 LGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTVLPPEL 192 (264)
T ss_pred hcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceeeecChhh
Confidence 999999988889999999999999999987 68999999999999999999999888764
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.5e-17 Score=161.68 Aligned_cols=137 Identities=23% Similarity=0.366 Sum_probs=114.4
Q ss_pred ceecccccEEEEEEEEcCCcEEEEEEecccccChh------HHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 596 NVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEK------GFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
+.||+|++|.||+|+. ++..+++|+......... ...++.+|++++..+.|++|+....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 678899998654332111 224678999999999999998888888778888999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
++|++|.+++... .. .+..++.+++.+|.++|+ .+++|||++|+||+++ ++.++|+|||.++..
T Consensus 81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999887432 12 678999999999999996 8999999999999999 788999999998764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.2e-17 Score=160.33 Aligned_cols=146 Identities=21% Similarity=0.161 Sum_probs=111.5
Q ss_pred HHHhhcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccCh--------------------hHHHHHHHHHHHHHc
Q 004020 585 LRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSE--------------------KGFAEFKSEIAVLTK 644 (779)
Q Consensus 585 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~E~~~l~~ 644 (779)
+.....-|.+.+.||+|+||.||++...+|+.||||++....... .......+|..++.+
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 333333478889999999999999988889999999875432100 011236788999999
Q ss_pred CCCCc--cceEeeEEEeCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCC
Q 004020 645 VRHRH--LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDL 722 (779)
Q Consensus 645 l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDl 722 (779)
+.|++ ++..++ ....++||||+++++|..... ......++.+++.++.++|+ .+|+||||
T Consensus 90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~-----------~~~~~~~~~~i~~~l~~lh~---~gi~H~Dl 151 (198)
T cd05144 90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV-----------LEDPEEVLDEILEEIVKAYK---HGIIHGDL 151 (198)
T ss_pred HHHcCCCCCceee----cCCceEEEEEeCCcchhhccc-----------cccHHHHHHHHHHHHHHHHH---CCCCcCCC
Confidence 98774 444443 245589999999999876531 02345788999999999996 89999999
Q ss_pred CCCCEEEcCCCcEEEEeeccceecCC
Q 004020 723 KPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 723 kp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
||+||+++++++++|+|||.+.....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.8e-16 Score=163.70 Aligned_cols=133 Identities=28% Similarity=0.385 Sum_probs=111.0
Q ss_pred cCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-----C---CccceEeeEEEeC
Q 004020 590 NNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-----H---RHLVGLLGYCLDG 660 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~~~~ 660 (779)
.+|.+.++||-|-|++||+|.. ...+.||+|+.+.. +...+....||++|++++ | .+||++++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 7899999999999999999965 46788999998754 234456789999999984 3 3699999999854
Q ss_pred ----CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC
Q 004020 661 ----NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 731 (779)
Q Consensus 661 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~ 731 (779)
.+++||+|++ |-+|..+|....- +.++...+.+|++||+.||.|||. +.||||-||||+|||+..
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~Y---rGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl~~ 223 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNY---RGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLLCS 223 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCC---CCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeeeec
Confidence 4789999999 5578777755433 358899999999999999999998 579999999999999953
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-16 Score=157.72 Aligned_cols=134 Identities=22% Similarity=0.354 Sum_probs=108.2
Q ss_pred eecccccEEEEEEEEcCCcEEEEEEecccccCh------hHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEec
Q 004020 597 VLGRGGFGTVYKGELHDGTKIAVKRMESAVVSE------KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYM 670 (779)
Q Consensus 597 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 670 (779)
.||+|+||.||+|.+ ++..+++|......... ....++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 57889999865432111 12356789999999999887766666666777789999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 671 PQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 671 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
+|++|.+.+.... ..++.|++.+|.++|+ .+++|||++|+||+++ ++.++++|||.++...
T Consensus 80 ~g~~l~~~~~~~~------------~~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEGN------------DELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhcH------------HHHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 9999988763321 0788999999999996 8999999999999999 7899999999987653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-16 Score=181.24 Aligned_cols=142 Identities=23% Similarity=0.319 Sum_probs=113.4
Q ss_pred hhcCCcccceecccccEEEEEEEEcCCcEEEEEEe-cccccC-----hhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRM-ESAVVS-----EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN 661 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 661 (779)
....|...+.||+|+||.||++.+.... +++|+. .+.... ....+++.+|+++++.++|++++....++...+
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 3345566789999999999999876443 444432 221111 112356889999999999999998888888877
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeec
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 741 (779)
..++||||+++++|.+++. ....++.|++++|.|||+ .+++|||+||+||++ +++.++|+|||
T Consensus 410 ~~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFG 472 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFG 472 (535)
T ss_pred CCEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCc
Confidence 8899999999999988873 346789999999999996 899999999999999 67789999999
Q ss_pred cceecC
Q 004020 742 LVRLAP 747 (779)
Q Consensus 742 ~a~~~~ 747 (779)
+++...
T Consensus 473 la~~~~ 478 (535)
T PRK09605 473 LGKYSD 478 (535)
T ss_pred ccccCC
Confidence 998754
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.7e-16 Score=166.72 Aligned_cols=175 Identities=35% Similarity=0.557 Sum_probs=145.1
Q ss_pred CcccceecccccEEEEEEEEcCCcEEEEEEecccccChh-HHHHHHHHHHHHHcCCCC-ccceEeeEEEeCCeEEEEEEe
Q 004020 592 FSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEK-GFAEFKSEIAVLTKVRHR-HLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~ 669 (779)
|...+.||.|+||.||++... ..+++|.+........ ....+.+|+.+++.+.|+ +|+++.+.+......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999876 8889999877654433 567899999999999988 799999999877778999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC-cEEEEeeccceecCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVRLAPD 748 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~ 748 (779)
+.++++.+++...... ..+.......++.|++.+++|+|+ .+++|||+||+||+++..+ .++++|||.++....
T Consensus 80 ~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 80 VDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred CCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 9999999666443211 257888899999999999999996 7899999999999999888 799999999986554
Q ss_pred CCCcc----cccccccCCccccccccccc
Q 004020 749 NGKHS----IETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~----~~~~~~gt~~y~APE~l~~~ 773 (779)
..... ......||..|+|||.+.+.
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~ 183 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGL 183 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCC
Confidence 33221 23556799999999998773
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.9e-18 Score=182.32 Aligned_cols=259 Identities=20% Similarity=0.212 Sum_probs=183.3
Q ss_pred EEEcccCccccCC-C-CCCCCCCccEEecCCCCCCCC----CcccccCCCCccEEEcccCCCCC-----CCCcccccCCC
Q 004020 93 VLEVMKNKLTGQI-P-SLSGLSSLQEVLFDDNNFTSV----PSDFFKGLTSLQTISLDYNSFDS-----WVIPESLKDAT 161 (779)
Q Consensus 93 ~L~Ls~N~l~~~~-~-~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~-----~~~p~~~~~l~ 161 (779)
.|+|..+.+++.- . .+..+.+|++|+++++.++.. .+..+...++|++|++++|.+.. ..++..+.+++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 5788888887432 3 567788899999999998642 23346677889999999988752 11334667788
Q ss_pred CCceEeccCceeEeecCCCccCCCCC---cccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCC-C
Q 004020 162 GLQRFSANGANITGTIPDFLGGDTIP---GLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNM-T 237 (779)
Q Consensus 162 ~L~~L~l~~n~l~~~~p~~~~~~~l~---~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l-~ 237 (779)
+|+.|++++|.+.+..+..+. .+. +|++|++++|++++.....+ ...+..+ +
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~--~l~~~~~L~~L~ls~~~~~~~~~~~l----------------------~~~l~~~~~ 137 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLE--SLLRSSSLQELKLNNNGLGDRGLRLL----------------------AKGLKDLPP 137 (319)
T ss_pred ceeEEEccCCCCChhHHHHHH--HHhccCcccEEEeeCCccchHHHHHH----------------------HHHHHhCCC
Confidence 888888888888765555443 233 38888888888763111111 1223456 8
Q ss_pred CccEEEeecCcccCCCC-----CCCCCCCCcEEEccCCcccc----ccChhhhCCCCCCEEEccCccccccCCCCCCCcc
Q 004020 238 SLTQLWLHGNSFTGPLP-----DLSGLSSLQDFSVRDNQLTG----IVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVR 308 (779)
Q Consensus 238 ~L~~L~L~~N~l~~~~~-----~~~~l~~L~~L~l~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~ 308 (779)
+|+.|+|++|.+++... .+..+++|++|++++|.+++ .++..+..+++|+.|+|++|.+++.....+
T Consensus 138 ~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l---- 213 (319)
T cd00116 138 ALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASAL---- 213 (319)
T ss_pred CceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHH----
Confidence 99999999999995322 25677899999999999984 345566777899999999999874321100
Q ss_pred cccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccc
Q 004020 309 FDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISS 388 (779)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~ 388 (779)
...+...++|++|++++|.+++....
T Consensus 214 ------------------------------------------------------~~~~~~~~~L~~L~ls~n~l~~~~~~ 239 (319)
T cd00116 214 ------------------------------------------------------AETLASLKSLEVLNLGDNNLTDAGAA 239 (319)
T ss_pred ------------------------------------------------------HHHhcccCCCCEEecCCCcCchHHHH
Confidence 00112234899999999999874444
Q ss_pred cccc-----cccCCeEeccCcccc----ccCCccCCCCCCCCceeccCCccccc
Q 004020 389 NFSR-----LTSLRQLMLSGNELT----GTIPKELTTLPSLEMLDVSNNHLFGK 433 (779)
Q Consensus 389 ~~~~-----l~~L~~L~Ls~N~l~----g~iP~~l~~l~~L~~L~Ls~N~l~g~ 433 (779)
.+.. .+.|+.|++++|.++ ..++..+..+++|+++|+++|.++..
T Consensus 240 ~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~ 293 (319)
T cd00116 240 ALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEE 293 (319)
T ss_pred HHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHH
Confidence 4332 379999999999997 34556677779999999999999854
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.5e-16 Score=177.44 Aligned_cols=155 Identities=29% Similarity=0.539 Sum_probs=116.6
Q ss_pred CCCChhHHHHHHHHHHHcCCCCCCCCCCCCCC-----cceeeEeCCC-----CcEEEEEecCCCccccCCccccCCCCCc
Q 004020 23 NSQSSSDAAAMQALKTSLGNPASLGWTDPDPC-----KWKHIQCSPS-----NRVTRIQIGGQNIEGTLPKELNSLSSLT 92 (779)
Q Consensus 23 ~~~~~~~~~~l~~~k~~~~~~~~~~w~~~~~C-----~w~gv~c~~~-----~~v~~l~l~~~~l~~~~p~~l~~l~~L~ 92 (779)
..+.+.|.+||+++|+++.++...+|.+ |+| .|.||.|+.. ..|+.|+|++|++.|.+|..|..+++|+
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~~~~~W~g-~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~ 445 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLPLRFGWNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQ 445 (623)
T ss_pred cccCchHHHHHHHHHHhcCCcccCCCCC-CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCC
Confidence 3456789999999999998766568975 455 6999999631 2599999999999999999999999999
Q ss_pred EEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCc
Q 004020 93 VLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGA 171 (779)
Q Consensus 93 ~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n 171 (779)
.|+|++|+|.|.+| .++.+++|+.|+|++|++++..|+.+.++++|++|+|++|++.
T Consensus 446 ~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~---------------------- 503 (623)
T PLN03150 446 SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLS---------------------- 503 (623)
T ss_pred EEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCccc----------------------
Confidence 99999999998887 6888888888888888887766666666666666666666664
Q ss_pred eeEeecCCCccCCCCCcccEEEccCCCCCCcCC
Q 004020 172 NITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIP 204 (779)
Q Consensus 172 ~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p 204 (779)
|.+|..++. ...++..+++.+|......|
T Consensus 504 ---g~iP~~l~~-~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 504 ---GRVPAALGG-RLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred ---ccCChHHhh-ccccCceEEecCCccccCCC
Confidence 455555431 23345567777776544344
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.2e-15 Score=143.50 Aligned_cols=136 Identities=23% Similarity=0.213 Sum_probs=113.3
Q ss_pred ccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCC--CccceEeeEEEeCCeEEEEEEecC
Q 004020 594 EENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH--RHLVGLLGYCLDGNERLLVYEYMP 671 (779)
Q Consensus 594 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~ 671 (779)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++| ..+++++.++...+..+++|||++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 35789999999999998764 7899998865432 4578899999999976 589999988888888999999998
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 672 QGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 672 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
++.+..+ +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.++..
T Consensus 77 g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 77 GETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred CeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 8766432 34556778899999999999744458999999999999999899999999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=2e-15 Score=147.81 Aligned_cols=141 Identities=19% Similarity=0.190 Sum_probs=99.8
Q ss_pred cceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHH----------------------HHHHHHHHHcCCCCc--c
Q 004020 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAE----------------------FKSEIAVLTKVRHRH--L 650 (779)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~----------------------~~~E~~~l~~l~h~n--i 650 (779)
.+.||+|+||.||+|...+++.||||++............ ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999998888999999998754322111111 135666666665433 4
Q ss_pred ceEeeEEEeCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEc
Q 004020 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG 730 (779)
Q Consensus 651 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~ 730 (779)
.+.+++ ...++||||++++.+......... .. ..+..++.+++.++.++|. ..+|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE
Confidence 444433 245899999998544221111100 01 4577899999999999995 37999999999999999
Q ss_pred CCCcEEEEeeccceecCC
Q 004020 731 DDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 731 ~~~~~kl~DFG~a~~~~~ 748 (779)
++.++++|||.+.....
T Consensus 150 -~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 -DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred -CCcEEEEECcccccccC
Confidence 88999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=6.1e-16 Score=177.84 Aligned_cols=179 Identities=24% Similarity=0.253 Sum_probs=136.4
Q ss_pred HhhcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCC---CCccceEeeEEEeCCeE
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR---HRHLVGLLGYCLDGNER 663 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~ 663 (779)
.-.+.|.+.+.||+|+||.||+|...+|+.||+|+-+....- +|.--.+++.+|+ -+.|..+...+...+..
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W-----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW-----EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce-----eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 345678899999999999999998888999999987765421 1112222333333 34566666777777888
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEc-------CCCcEE
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-------DDMRAK 736 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~-------~~~~~k 736 (779)
++|+||.+.|+|.+++. ..+.++|..++.+..||++.+++||. .+|||+||||+|++|. +..-++
T Consensus 770 ~lv~ey~~~Gtlld~~N-----~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN-----TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred eeeeeccccccHHHhhc-----cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceE
Confidence 99999999999999985 33468999999999999999999996 8999999999999994 234589
Q ss_pred EEeeccceecCCCCCcccccccccCCcccccccccccCCCCCC
Q 004020 737 VADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMTWQ 779 (779)
Q Consensus 737 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t~~ 779 (779)
|+|||.+-.+.--.........++|-.+-.+|+..|. +||||
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr-pWtYq 883 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR-PWTYQ 883 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCC-CCchh
Confidence 9999998654332222233556789999999987775 46775
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.9e-14 Score=145.39 Aligned_cols=138 Identities=19% Similarity=0.197 Sum_probs=105.4
Q ss_pred ceec-ccccEEEEEEEEcCCcEEEEEEeccccc-----------ChhHHHHHHHHHHHHHcCCCCcc--ceEeeEEEeCC
Q 004020 596 NVLG-RGGFGTVYKGELHDGTKIAVKRMESAVV-----------SEKGFAEFKSEIAVLTKVRHRHL--VGLLGYCLDGN 661 (779)
Q Consensus 596 ~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~ 661 (779)
..|| .|+.|+||++... +..+++|.+..... ......++.+|++++.+++|++| +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5687 8889999998775 77899998864221 11223568899999999998875 66776654332
Q ss_pred ----eEEEEEEecCC-CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEE
Q 004020 662 ----ERLLVYEYMPQ-GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 736 (779)
Q Consensus 662 ----~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 736 (779)
..++||||+++ .+|.+++... .++.. .+.|++.++.+||+ .||+||||||+|||++.++.++
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEE
Confidence 23599999997 6888887431 23332 35789999999996 8999999999999999989999
Q ss_pred EEeeccceecC
Q 004020 737 VADFGLVRLAP 747 (779)
Q Consensus 737 l~DFG~a~~~~ 747 (779)
|+|||.++...
T Consensus 183 LIDfg~~~~~~ 193 (239)
T PRK01723 183 LIDFDRGELRT 193 (239)
T ss_pred EEECCCcccCC
Confidence 99999987754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.4e-15 Score=170.13 Aligned_cols=174 Identities=24% Similarity=0.314 Sum_probs=133.2
Q ss_pred cccceecccccEEEEEEEEc-CCcEEEEEEec----ccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 593 SEENVLGRGGFGTVYKGELH-DGTKIAVKRME----SAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 593 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~----~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
...+.+|.|++|.|+.+... ..+..+.|.+. ...........+..|..+-..+.|||++.....+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34678999999977777433 33444444433 11111122233777888888999999998888877777666679
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
|||++ +|...+... ..+...++-.++.|++.|++|+|+ .||.|||+||+|+++..+|.+||+|||.+..+.
T Consensus 401 E~~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hcccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeec
Confidence 99999 999888543 146777888999999999999996 899999999999999999999999999987655
Q ss_pred CCCCc--ccccccccCCcccccccccccCC
Q 004020 748 DNGKH--SIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 748 ~~~~~--~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
...+. ......+|+..|+|||++.+...
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~y 501 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEY 501 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCccccccccc
Confidence 44333 44567889999999999987654
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.6e-14 Score=166.02 Aligned_cols=85 Identities=29% Similarity=0.454 Sum_probs=73.4
Q ss_pred CeEEEEccCccccccccccccccccCCeEeccCccccccCCccCCCCCCCCceeccCCcccccCCCC-----CCcceeee
Q 004020 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNF-----RQNVIVKT 445 (779)
Q Consensus 371 ~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~-----~~~~~~~~ 445 (779)
+|+.|+|++|.|+|.+|..++.+++|+.|+|++|+|+|.+|..++.+++|++|||++|+|+|.+|.. .....+.+
T Consensus 443 ~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~ 522 (623)
T PLN03150 443 HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNF 522 (623)
T ss_pred CCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEe
Confidence 6888888888888889999999999999999999999999999999999999999999999999962 12235778
Q ss_pred CCCCCCCCCC
Q 004020 446 DGNPDIGKDS 455 (779)
Q Consensus 446 ~~n~~~~~~~ 455 (779)
.+|+.+|+.+
T Consensus 523 ~~N~~lc~~p 532 (623)
T PLN03150 523 TDNAGLCGIP 532 (623)
T ss_pred cCCccccCCC
Confidence 8999999754
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.1e-14 Score=174.23 Aligned_cols=122 Identities=17% Similarity=0.179 Sum_probs=85.9
Q ss_pred CCC-CccceEeeEEE-------eCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 004020 645 VRH-RHLVGLLGYCL-------DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS 716 (779)
Q Consensus 645 l~h-~niv~~~~~~~-------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ 716 (779)
+.| +||+.++++|. ..+.++.+|||+ +++|.+++.... ..+++.+++.++.||++||+|||+ ++
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~g 100 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAHS---QG 100 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHHh---CC
Confidence 345 57777777762 234567788987 569999985432 358899999999999999999996 89
Q ss_pred cEEcCCCCCCEEEcCC-------------------CcEEEEeeccceecCCCCC--------------cccccccccCCc
Q 004020 717 FIHRDLKPSNILLGDD-------------------MRAKVADFGLVRLAPDNGK--------------HSIETRLAGTFG 763 (779)
Q Consensus 717 ivHrDlkp~NIll~~~-------------------~~~kl~DFG~a~~~~~~~~--------------~~~~~~~~gt~~ 763 (779)
|+||||||+||||+.. +.+|++|||+++....... .......+||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 9999999999999654 4455666666553211000 000112458999
Q ss_pred ccccccccccC
Q 004020 764 YLAPEYAAETS 774 (779)
Q Consensus 764 y~APE~l~~~~ 774 (779)
|||||++.+..
T Consensus 181 Y~APE~~~~~~ 191 (793)
T PLN00181 181 YTSPEEDNGSS 191 (793)
T ss_pred eEChhhhccCC
Confidence 99999987653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.2e-13 Score=149.60 Aligned_cols=148 Identities=24% Similarity=0.304 Sum_probs=103.2
Q ss_pred hcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChh--------------------------------------
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEK-------------------------------------- 630 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------------------------------------- 630 (779)
...|+ .+.||.|++|+||+|+.++|+.||||+.++.....-
T Consensus 117 F~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~ 195 (437)
T TIGR01982 117 FAEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLR 195 (437)
T ss_pred HhhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHH
Confidence 33444 368999999999999999999999999865421100
Q ss_pred HHHHHHHHHHHHHcCC-----CCccceEeeEE-EeCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHH
Q 004020 631 GFAEFKSEIAVLTKVR-----HRHLVGLLGYC-LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704 (779)
Q Consensus 631 ~~~~~~~E~~~l~~l~-----h~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~ 704 (779)
..-++.+|++.+.+++ ++++ .+-.++ ......++||||++|+++.+....... .. .+..++.+++.
T Consensus 196 ~Eldf~~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~ 267 (437)
T TIGR01982 196 RELDLRREAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLAR 267 (437)
T ss_pred HHHCHHHHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHH
Confidence 0012455666666652 3333 322222 234457999999999999887643211 11 23456666666
Q ss_pred -HHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 705 -GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 705 -~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
.+..+|. .|++|+|+||.||+++++++++++|||++..+..
T Consensus 268 ~~l~ql~~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 268 SFLNQVLR---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHh---CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 4677885 8999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.1e-14 Score=156.59 Aligned_cols=162 Identities=26% Similarity=0.323 Sum_probs=132.9
Q ss_pred eecccccEEEEEEEE----cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCCeEEEEEEecC
Q 004020 597 VLGRGGFGTVYKGEL----HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLLVYEYMP 671 (779)
Q Consensus 597 ~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 671 (779)
.+|+|+||.|+.++. +.+.-+|+|..++.............|..++..++ ||.+++++-.++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998742 34777899988765433333335667888899997 9999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCC
Q 004020 672 QGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK 751 (779)
Q Consensus 672 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 751 (779)
+|.+...+.+.. .+++.....+...++-+++++|. .+|+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred cchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 999987764432 46667777788899999999995 8999999999999999999999999999987654321
Q ss_pred cccccccccCCcccccccccc
Q 004020 752 HSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 752 ~~~~~~~~gt~~y~APE~l~~ 772 (779)
.+||..|||||++.+
T Consensus 153 ------~cgt~eymApEI~~g 167 (612)
T KOG0603|consen 153 ------ACGTYEYRAPEIING 167 (612)
T ss_pred ------cccchhhhhhHhhhc
Confidence 289999999999983
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.9e-15 Score=156.72 Aligned_cols=90 Identities=23% Similarity=0.327 Sum_probs=42.7
Q ss_pred CCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCccc
Q 004020 111 LSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLM 190 (779)
Q Consensus 111 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~ 190 (779)
+..-...||+.|++..+|.+ +..+-.|+.|.|..|.+.. +|..+.++..|.+|+|+.|+++ .+|..++ .--|+
T Consensus 74 ltdt~~aDlsrNR~~elp~~-~~~f~~Le~liLy~n~~r~--ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC---~lpLk 146 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFSELPEE-ACAFVSLESLILYHNCIRT--IPEAICNLEALTFLDLSSNQLS-HLPDGLC---DLPLK 146 (722)
T ss_pred ccchhhhhccccccccCchH-HHHHHHHHHHHHHhcccee--cchhhhhhhHHHHhhhccchhh-cCChhhh---cCcce
Confidence 33444445555555555443 3344445555555555542 4444555555555555555544 3444433 12255
Q ss_pred EEEccCCCCCCcCCCccc
Q 004020 191 HLHLAFNFLQGPIPLSFG 208 (779)
Q Consensus 191 ~L~L~~N~l~~~~p~~~~ 208 (779)
.|-+++|+++ .+|+.++
T Consensus 147 vli~sNNkl~-~lp~~ig 163 (722)
T KOG0532|consen 147 VLIVSNNKLT-SLPEEIG 163 (722)
T ss_pred eEEEecCccc-cCCcccc
Confidence 5555555555 4444443
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.4e-13 Score=149.53 Aligned_cols=152 Identities=22% Similarity=0.258 Sum_probs=97.7
Q ss_pred HHhhcCCcccceecccccEEEEEEEEcC-CcEEEEEEecccccCh--------------------------------hHH
Q 004020 586 RNVTNNFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSE--------------------------------KGF 632 (779)
Q Consensus 586 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~--------------------------------~~~ 632 (779)
.....+|+. +.||+|++|+||+|+.++ |+.||||++++..... +..
T Consensus 116 ~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~ 194 (537)
T PRK04750 116 EEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE 194 (537)
T ss_pred HHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence 344566776 899999999999999987 9999999997542100 001
Q ss_pred ------HHHHHHHHHHHcCC----CCccceEeeEEEe-CCeEEEEEEecCCCChhhHhhhcccC-CCCCCCHHHHHHHHH
Q 004020 633 ------AEFKSEIAVLTKVR----HRHLVGLLGYCLD-GNERLLVYEYMPQGTLSRHLFNRKEE-GLKPLEWTRRLTIAL 700 (779)
Q Consensus 633 ------~~~~~E~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~~~~~~i~~ 700 (779)
-++.+|+..+.+++ +...+.+-.++.+ ....++||||++|+.+.++-.-.... ....+....+..++.
T Consensus 195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~ 274 (537)
T PRK04750 195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT 274 (537)
T ss_pred HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence 12445555555542 3333443333332 45678999999999997743111110 000122222222333
Q ss_pred HHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC----cEEEEeeccceecCC
Q 004020 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM----RAKVADFGLVRLAPD 748 (779)
Q Consensus 701 qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~----~~kl~DFG~a~~~~~ 748 (779)
|+ + ..|++|+|+||.||+++.++ +++++|||++..+..
T Consensus 275 Qi-------f---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 275 QV-------F---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HH-------H---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33 3 36899999999999999888 999999999887654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=8.1e-14 Score=133.71 Aligned_cols=170 Identities=21% Similarity=0.391 Sum_probs=134.2
Q ss_pred cccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCC
Q 004020 593 SEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (779)
Q Consensus 593 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 672 (779)
....+|.+...|..|+|+++ |..+++|++...........+|..|.-.++-+.||||+.+++.|.......++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 34457888899999999997 56677788876555555567899999999999999999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEE--eeccceecCCCC
Q 004020 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA--DFGLVRLAPDNG 750 (779)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~--DFG~a~~~~~~~ 750 (779)
|+|+..+++... ...+..++.+++.+|++|++|||+.. .-|..--+....++||++.+++|. |--++.. .
T Consensus 272 gslynvlhe~t~---vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfq--e-- 343 (448)
T KOG0195|consen 272 GSLYNVLHEQTS---VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--E-- 343 (448)
T ss_pred hHHHHHHhcCcc---EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeee--c--
Confidence 999999976543 35778899999999999999999853 334455788999999999887764 3222211 1
Q ss_pred CcccccccccCCcccccccccccCCC
Q 004020 751 KHSIETRLAGTFGYLAPEYAAETSGM 776 (779)
Q Consensus 751 ~~~~~~~~~gt~~y~APE~l~~~~~~ 776 (779)
......|.||+||.++.+...
T Consensus 344 -----~gr~y~pawmspealqrkped 364 (448)
T KOG0195|consen 344 -----VGRAYSPAWMSPEALQRKPED 364 (448)
T ss_pred -----cccccCcccCCHHHHhcCchh
Confidence 122356899999999877653
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.7e-14 Score=150.49 Aligned_cols=213 Identities=22% Similarity=0.306 Sum_probs=158.0
Q ss_pred EecCCCCCCCCCccccc-CCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEcc
Q 004020 117 VLFDDNNFTSVPSDFFK-GLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLA 195 (779)
Q Consensus 117 L~l~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~ 195 (779)
|.|++-++...|-+.+. .+..-...||+.|++.. +|..+..+..|+.+.|+.|.+. .+|..++ .+..|++|||+
T Consensus 55 l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~e--lp~~~~~f~~Le~liLy~n~~r-~ip~~i~--~L~~lt~l~ls 129 (722)
T KOG0532|consen 55 LLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFSE--LPEEACAFVSLESLILYHNCIR-TIPEAIC--NLEALTFLDLS 129 (722)
T ss_pred cccccchhhcCCCccccccccchhhhhcccccccc--CchHHHHHHHHHHHHHHhccce-ecchhhh--hhhHHHHhhhc
Confidence 44555555555554433 45556688999999975 8999999999999999999998 7888887 79999999999
Q ss_pred CCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccc
Q 004020 196 FNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGI 275 (779)
Q Consensus 196 ~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~ 275 (779)
.|+++ .+|..++. --|+.|-+++|+++-.+++++.+..|..||.+.|.+. .
T Consensus 130 ~NqlS-~lp~~lC~---------------------------lpLkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~-s 180 (722)
T KOG0532|consen 130 SNQLS-HLPDGLCD---------------------------LPLKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQ-S 180 (722)
T ss_pred cchhh-cCChhhhc---------------------------CcceeEEEecCccccCCcccccchhHHHhhhhhhhhh-h
Confidence 99999 77776653 2366777777777766666777777777888888776 5
Q ss_pred cChhhhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCC
Q 004020 276 VPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNN 355 (779)
Q Consensus 276 ~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (779)
+|..++.+.+|+.|.+..|++...+++...
T Consensus 181 lpsql~~l~slr~l~vrRn~l~~lp~El~~-------------------------------------------------- 210 (722)
T KOG0532|consen 181 LPSQLGYLTSLRDLNVRRNHLEDLPEELCS-------------------------------------------------- 210 (722)
T ss_pred chHHhhhHHHHHHHHHhhhhhhhCCHHHhC--------------------------------------------------
Confidence 777777777777777777777654443110
Q ss_pred CCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccCccccccCCccCCCCCC---CCceeccCCc
Q 004020 356 PCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPS---LEMLDVSNNH 429 (779)
Q Consensus 356 ~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~---L~~L~Ls~N~ 429 (779)
=.|..||+|.|+++ .||..|.+|+.|++|-|.+|-|. ..|.+++..-. .++|+..-.+
T Consensus 211 --------------LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 211 --------------LPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred --------------CceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 03667777777777 68888888888888888888888 77777765433 3566666664
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.6e-13 Score=146.13 Aligned_cols=213 Identities=23% Similarity=0.378 Sum_probs=145.2
Q ss_pred CcceeeEeCCCCcEE--EEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCC-CccEEecCCCCCCCCCcc
Q 004020 54 CKWKHIQCSPSNRVT--RIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLS-SLQEVLFDDNNFTSVPSD 130 (779)
Q Consensus 54 C~w~gv~c~~~~~v~--~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~-~L~~L~l~~N~l~~~~~~ 130 (779)
+.+.+..+....... .++++.+.+...+ ..+..++.++.|++.+|.++.+++....++ +|+.|++++|++..++.
T Consensus 80 ~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~~l~~- 157 (394)
T COG4886 80 ISSLDGSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPS- 157 (394)
T ss_pred cccccccccccCCCCCceeeccccccccCc-hhhhcccceeEEecCCcccccCccccccchhhcccccccccchhhhhh-
Confidence 555555554332222 4666666664222 345555777777777777776666666663 77777777777777752
Q ss_pred cccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccC
Q 004020 131 FFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKS 210 (779)
Q Consensus 131 ~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~ 210 (779)
.+..+++|+.|++++|++.. +|.....++.|+.|++++|+++ .+|..+. .+..|++|.+++|.+. .++.
T Consensus 158 ~~~~l~~L~~L~l~~N~l~~--l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~--~~~~L~~l~~~~N~~~-~~~~----- 226 (394)
T COG4886 158 PLRNLPNLKNLDLSFNDLSD--LPKLLSNLSNLNNLDLSGNKIS-DLPPEIE--LLSALEELDLSNNSII-ELLS----- 226 (394)
T ss_pred hhhccccccccccCCchhhh--hhhhhhhhhhhhheeccCCccc-cCchhhh--hhhhhhhhhhcCCcce-ecch-----
Confidence 25667777777777777764 5555556677777777777766 4555432 2444666777666432 2222
Q ss_pred CcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEE
Q 004020 211 SIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVN 290 (779)
Q Consensus 211 ~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~ 290 (779)
.+..++++..|.+.+|++...+..+..++++++|++++|+++. ++. ++.+.+|+.|+
T Consensus 227 ---------------------~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~ 283 (394)
T COG4886 227 ---------------------SLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQISS-ISS-LGSLTNLRELD 283 (394)
T ss_pred ---------------------hhhhcccccccccCCceeeeccchhccccccceeccccccccc-ccc-ccccCccCEEe
Confidence 2346788888889999998765568888899999999999984 444 99999999999
Q ss_pred ccCccccccCCC
Q 004020 291 LTNNLFQGQTPK 302 (779)
Q Consensus 291 Ls~N~l~g~~p~ 302 (779)
+++|.+...+|.
T Consensus 284 ~s~n~~~~~~~~ 295 (394)
T COG4886 284 LSGNSLSNALPL 295 (394)
T ss_pred ccCccccccchh
Confidence 999999988775
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.1e-12 Score=144.52 Aligned_cols=48 Identities=33% Similarity=0.511 Sum_probs=32.4
Q ss_pred cccccccccCCeEeccCccccccCCccCCCCCCCCceeccCCcccccCCC
Q 004020 387 SSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPN 436 (779)
Q Consensus 387 p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~ 436 (779)
+..++.++.++.|++++|+++ .++. +..+.+|+.||+++|.++..+|.
T Consensus 248 ~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 248 PESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred cchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchh
Confidence 445566666777777777777 5554 66777777777777777766664
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.9e-12 Score=130.94 Aligned_cols=119 Identities=32% Similarity=0.433 Sum_probs=87.0
Q ss_pred CCCccceEeeEEEe---------------------------CCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHH
Q 004020 646 RHRHLVGLLGYCLD---------------------------GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTI 698 (779)
Q Consensus 646 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i 698 (779)
+|||||++.++|.+ +...|+||..++ .+|.+++..+. .+.....-+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~------~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH------RSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC------CchHHHHHH
Confidence 59999999987754 124689998885 48999885543 345566778
Q ss_pred HHHHHHHHHHHHcCCCCCcEEcCCCCCCEEE--cCCC--cEEEEeeccceecCCCCC----cccccccccCCcccccccc
Q 004020 699 ALDVARGVEYLHGLAHQSFIHRDLKPSNILL--GDDM--RAKVADFGLVRLAPDNGK----HSIETRLAGTFGYLAPEYA 770 (779)
Q Consensus 699 ~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll--~~~~--~~kl~DFG~a~~~~~~~~----~~~~~~~~gt~~y~APE~l 770 (779)
..|+++|+.||| ++||.|||+|++|||+ |+|+ ...|+|||.+---+..+- .+......|...-||||+.
T Consensus 347 laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 889999999999 4899999999999999 3443 478999998643322111 1112334688899999998
Q ss_pred cccC
Q 004020 771 AETS 774 (779)
Q Consensus 771 ~~~~ 774 (779)
....
T Consensus 424 ta~P 427 (598)
T KOG4158|consen 424 TAVP 427 (598)
T ss_pred hcCC
Confidence 6543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.9e-11 Score=117.47 Aligned_cols=132 Identities=18% Similarity=0.160 Sum_probs=95.8
Q ss_pred cceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCcc-ceEeeEEEeCCeEEEEEEecCCC
Q 004020 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL-VGLLGYCLDGNERLLVYEYMPQG 673 (779)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g 673 (779)
.+.++.|.++.||+++.. +..|++|....... ....+.+|+++++.+.+.++ .+++.+. ....++||||+++.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCC
Confidence 367899999999999865 78899998754321 12346789999998865554 3454443 33458999999998
Q ss_pred ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 674 TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA--HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 674 sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
++.+.. . ....++.+++++|+.||+.. ..+++|+|++|.||+++ ++.++++|||.+...
T Consensus 77 ~l~~~~----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 77 ELLTED----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred cccccc----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 775320 0 11245678999999999632 12369999999999998 668999999998653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.25 E-value=6.5e-11 Score=114.01 Aligned_cols=139 Identities=14% Similarity=0.139 Sum_probs=98.8
Q ss_pred cceecccccEEEEEEEEcC-------CcEEEEEEeccccc-----------C---------hhHHHH----HHHHHHHHH
Q 004020 595 ENVLGRGGFGTVYKGELHD-------GTKIAVKRMESAVV-----------S---------EKGFAE----FKSEIAVLT 643 (779)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~-----------~---------~~~~~~----~~~E~~~l~ 643 (779)
...||.|--+.||.|...+ +..+|||+.+.... + ....+. ..+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999997543 47999998753211 0 001122 348999999
Q ss_pred cCCC--CccceEeeEEEeCCeEEEEEEecCCCChhh-HhhhcccCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCcEE
Q 004020 644 KVRH--RHLVGLLGYCLDGNERLLVYEYMPQGTLSR-HLFNRKEEGLKPLEWTRRLTIALDVARGVEYL-HGLAHQSFIH 719 (779)
Q Consensus 644 ~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~L-H~~~~~~ivH 719 (779)
++.. -++++++++ ...++||||+.+..+.. .+.+ ..++..+...+..+++.+|.++ |. .++||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~---~glVH 148 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVH 148 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHh---CCeec
Confidence 9963 466666654 45689999997654322 1211 1234455677889999999999 74 79999
Q ss_pred cCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 720 RDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 720 rDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
+|+++.||+++ ++.+.|+|||.+....
T Consensus 149 GDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 149 ADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999999997 4679999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.24 E-value=7e-11 Score=120.03 Aligned_cols=172 Identities=24% Similarity=0.353 Sum_probs=107.6
Q ss_pred CcccceecccccEEEEEEEEc-CCcEEEEEEecccc-cChhHHHHHHHHHHHHHcCCC----------CccceEeeEEE-
Q 004020 592 FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRH----------RHLVGLLGYCL- 658 (779)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h----------~niv~~~~~~~- 658 (779)
+...+.||.|+++.||.+++. +++++|+|++.... ......+++.+|.-....+.+ -.++..++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 455789999999999999876 68999999886443 223356777777766655432 12222233222
Q ss_pred --------eC---C-----eEEEEEEecCCCChhhHhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEc
Q 004020 659 --------DG---N-----ERLLVYEYMPQGTLSRHLFNRKEEG--LKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHR 720 (779)
Q Consensus 659 --------~~---~-----~~~lv~e~~~~gsL~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHr 720 (779)
.. . ..+++|+-+ .++|.+++..-.... ........++.+..|+++.+++||+ .|++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEec
Confidence 11 1 235678877 468887754211111 1123445567777999999999997 899999
Q ss_pred CCCCCCEEEcCCCcEEEEeeccceecCCCCCcccccccccCCcccccccccc
Q 004020 721 DLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 721 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
||||+|++++++|.++|+||+........ . .. ...+..|.+||....
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~---~-~~-~~~~~~~~PPe~~~~ 216 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTR---Y-RC-SEFPVAFTPPELESC 216 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEE---E-EG-GGS-TTTS-HHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCce---e-ec-cCCCcccCChhhhhh
Confidence 99999999999999999999987665331 1 11 234578999997654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.1e-10 Score=106.10 Aligned_cols=135 Identities=25% Similarity=0.337 Sum_probs=102.8
Q ss_pred ceecccccEEEEEEEEcCCcEEEEEEecccccChh------HHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 596 NVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEK------GFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
..+++|+-+.+|.+.+. |.++++|.-.++..... ...+..+|++++.+++--.|...+=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 45789999999999775 44566665443332222 224577899999999866666666677788888999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
++|..|.+++... ...++..+-.-+.-||. .||+|+|+.++||++..+. +.++|||++....
T Consensus 81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 81 IEGELLKDALEEA------------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred eCChhHHHHHHhc------------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 9998888887432 23566677777888994 8999999999999997664 9999999987543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=5.6e-12 Score=142.63 Aligned_cols=173 Identities=20% Similarity=0.237 Sum_probs=127.3
Q ss_pred CCcccceecccccEEEEEEEEcCCcEEEEEEecccc--cChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 591 NFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAV--VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
+|...+.||++.|=+|.+|+++.|. |+||++-+.. .+-....+..+|++ ...++|||.+.+.-+-......|||=+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5677889999999999999998887 8899885443 23334455555666 666789999999888777777788888
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec--
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-- 746 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~-- 746 (779)
|..+ +|.|.+..+. -+...+.+.|+.|++.||..+|. .||+|||||.+||||+.=.=+.|+||..-+..
T Consensus 102 yvkh-nLyDRlSTRP-----FL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRP-----FLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHhh-hhhhhhccch-----HHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccC
Confidence 8865 8888774432 35677788899999999999995 89999999999999987777899999764432
Q ss_pred CCCCCccc---ccccccCCcccccccccccC
Q 004020 747 PDNGKHSI---ETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 747 ~~~~~~~~---~~~~~gt~~y~APE~l~~~~ 774 (779)
+.+..... ......-..|.|||.+-...
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~ 203 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSAL 203 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccc
Confidence 22111100 01111234799999987644
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=6.7e-12 Score=142.30 Aligned_cols=177 Identities=24% Similarity=0.320 Sum_probs=140.5
Q ss_pred CCcccceecccccEEEEEEEEc--CCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCCeEEEEE
Q 004020 591 NFSEENVLGRGGFGTVYKGELH--DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 667 (779)
.|...+.||+|+|+.|-.+... ....+|+|.+...............|..+-+.+. |+|++++++...+.+..++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 5666778999999999888553 3455677777655433444556677888888887 999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC-cEEEEeeccceec
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVRLA 746 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~ 746 (779)
||..++++.+.+. .......+...+-.++.|+..++.|+|. ..++.|||+||+|.+++..+ ..+++|||+|..+
T Consensus 101 ~~s~g~~~f~~i~---~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 101 SYSDGGSLFSKIS---HPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred Ccccccccccccc---cCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 9999999988773 1111134555677899999999999994 38999999999999999999 9999999999877
Q ss_pred CC-CCCccccccccc-CCcccccccccc
Q 004020 747 PD-NGKHSIETRLAG-TFGYLAPEYAAE 772 (779)
Q Consensus 747 ~~-~~~~~~~~~~~g-t~~y~APE~l~~ 772 (779)
.. .+........+| ++.|+|||...+
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~ 203 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSG 203 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccc
Confidence 66 444444455678 999999999877
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=8.2e-10 Score=101.44 Aligned_cols=146 Identities=23% Similarity=0.264 Sum_probs=108.6
Q ss_pred ccceecccccEEEEEEEEcCCcEEEEEEecccccChh------HHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 594 EENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEK------GFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 594 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
....+-+|+-+.|+++.+. |+.+.||.-..+..... ..++..+|++.+.+++--.|....=++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4578999999999999876 77777775543322221 3356789999999997666666666677777778999
Q ss_pred EecCC-CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC---cEEEEeeccc
Q 004020 668 EYMPQ-GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAKVADFGLV 743 (779)
Q Consensus 668 e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~---~~kl~DFG~a 743 (779)
||+++ .++.+++....... ........++.+|-+.+.-||. .+|||+||..+||++..++ .+.++|||++
T Consensus 90 E~~~g~~~vk~~i~~~~~~~---~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE---SEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EeccchhHHHHHHHHHccCc---ccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecch
Confidence 99976 47788876654332 2223336788889999999995 8999999999999996554 3589999997
Q ss_pred eec
Q 004020 744 RLA 746 (779)
Q Consensus 744 ~~~ 746 (779)
...
T Consensus 164 ~~s 166 (229)
T KOG3087|consen 164 SVS 166 (229)
T ss_pred hcc
Confidence 643
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.2e-11 Score=120.59 Aligned_cols=186 Identities=24% Similarity=0.256 Sum_probs=121.9
Q ss_pred CCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCC-----------------------cccccCCCC
Q 004020 81 LPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVP-----------------------SDFFKGLTS 137 (779)
Q Consensus 81 ~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~-----------------------~~~~~~l~~ 137 (779)
+|-.+.-+.+|..+.+|.+.-..+..-...-+.|+++...+.-++..| .........
T Consensus 206 l~f~l~~f~~l~~~~~s~~~~~~i~~~~~~kptl~t~~v~~s~~~~~~~l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq~ 285 (490)
T KOG1259|consen 206 LSFNLNAFRNLKTLKFSALSTENIVDIELLKPTLQTICVHNTTIQDVPSLLPETILADPSGSEPSTSNGSALVSADTWQE 285 (490)
T ss_pred cccchHHhhhhheeeeeccchhheeceeecCchhheeeeecccccccccccchhhhcCccCCCCCccCCceEEecchHhh
Confidence 343444556666666666543222221122244555555554443211 111223457
Q ss_pred ccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeec
Q 004020 138 LQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWL 217 (779)
Q Consensus 138 L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l 217 (779)
|++||||+|.|+. +.++..-++.++.|+++.|.|+.. . .++ .+++|++||||+|.++.... +
T Consensus 286 LtelDLS~N~I~~--iDESvKL~Pkir~L~lS~N~i~~v-~-nLa--~L~~L~~LDLS~N~Ls~~~G-w----------- 347 (490)
T KOG1259|consen 286 LTELDLSGNLITQ--IDESVKLAPKLRRLILSQNRIRTV-Q-NLA--ELPQLQLLDLSGNLLAECVG-W----------- 347 (490)
T ss_pred hhhccccccchhh--hhhhhhhccceeEEeccccceeee-h-hhh--hcccceEeecccchhHhhhh-h-----------
Confidence 8888888888875 778888888888888888888733 2 244 68888888888888873221 1
Q ss_pred cCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccC-hhhhCCCCCCEEEccCccc
Q 004020 218 NGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVP-SSLVNLHSLAVVNLTNNLF 296 (779)
Q Consensus 218 ~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l 296 (779)
-..+-++++|.|++|.+. .+..+..+-+|..||+++|+|..... ..++++|.|++|.|.+|++
T Consensus 348 ---------------h~KLGNIKtL~La~N~iE-~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl 411 (490)
T KOG1259|consen 348 ---------------HLKLGNIKTLKLAQNKIE-TLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPL 411 (490)
T ss_pred ---------------HhhhcCEeeeehhhhhHh-hhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCc
Confidence 124677888888888876 34456777888899999998874332 5788899999999999998
Q ss_pred cccC
Q 004020 297 QGQT 300 (779)
Q Consensus 297 ~g~~ 300 (779)
++.+
T Consensus 412 ~~~v 415 (490)
T KOG1259|consen 412 AGSV 415 (490)
T ss_pred cccc
Confidence 8653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.12 E-value=5.1e-10 Score=112.67 Aligned_cols=144 Identities=20% Similarity=0.277 Sum_probs=109.7
Q ss_pred ceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCC--CccceEeeEEEeCC---eEEEEEEec
Q 004020 596 NVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH--RHLVGLLGYCLDGN---ERLLVYEYM 670 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~---~~~lv~e~~ 670 (779)
+.++.|.++.||+++..+|+.+++|........ ....++.+|+++++.+.+ ..+.+++.+..... ..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 678999999999998877789999987654321 134568899999999975 34577777766542 568999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-------------------------------------
Q 004020 671 PQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA------------------------------------- 713 (779)
Q Consensus 671 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~------------------------------------- 713 (779)
+|.++.+.+.. ..++..+...++.+++++|.+||+..
T Consensus 83 ~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 83 DGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred CCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99888765421 13566777788888888888888521
Q ss_pred ----------------CCCcEEcCCCCCCEEEcC--CCcEEEEeeccceec
Q 004020 714 ----------------HQSFIHRDLKPSNILLGD--DMRAKVADFGLVRLA 746 (779)
Q Consensus 714 ----------------~~~ivHrDlkp~NIll~~--~~~~kl~DFG~a~~~ 746 (779)
...++|+|++|.||+++. ++.+.|+||+.+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 245799999999999998 667899999987653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.10 E-value=7.7e-12 Score=128.46 Aligned_cols=162 Identities=19% Similarity=0.228 Sum_probs=94.5
Q ss_pred CCCCCccEEecCCCCCCCCCc-ccccCCCCccEEEcccCCCCCCCC-cccccCCCCCceEeccCceeEeecCCCccCCCC
Q 004020 109 SGLSSLQEVLFDDNNFTSVPS-DFFKGLTSLQTISLDYNSFDSWVI-PESLKDATGLQRFSANGANITGTIPDFLGGDTI 186 (779)
Q Consensus 109 ~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~-p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l 186 (779)
+++++|+...|.+..+..++. .....|++++.||||.|-|..+.. -.....+++|+.|+++.|++..-...... ..+
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~-~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTT-LLL 196 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccch-hhh
Confidence 557888888888888877664 466788888888888888865322 23345566666666666666532222222 235
Q ss_pred CcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCC-CCCCCCCCcEE
Q 004020 187 PGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDF 265 (779)
Q Consensus 187 ~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L 265 (779)
++|+.|.|+.|.|+..--.+ .+..+|+|..|+|..|...+.-. ...-+..|++|
T Consensus 197 ~~lK~L~l~~CGls~k~V~~-------------------------~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~L 251 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQW-------------------------ILLTFPSLEVLYLEANEIILIKATSTKILQTLQEL 251 (505)
T ss_pred hhhheEEeccCCCCHHHHHH-------------------------HHHhCCcHHHhhhhcccccceecchhhhhhHHhhc
Confidence 55666666666655211111 12246677777777775221111 23445666777
Q ss_pred EccCCccccccC--hhhhCCCCCCEEEccCcccc
Q 004020 266 SVRDNQLTGIVP--SSLVNLHSLAVVNLTNNLFQ 297 (779)
Q Consensus 266 ~l~~N~l~~~~p--~~l~~l~~L~~L~Ls~N~l~ 297 (779)
+|++|++-. .+ ...+.++.|+.|+++.+.+.
T Consensus 252 dLs~N~li~-~~~~~~~~~l~~L~~Lnls~tgi~ 284 (505)
T KOG3207|consen 252 DLSNNNLID-FDQGYKVGTLPGLNQLNLSSTGIA 284 (505)
T ss_pred cccCCcccc-cccccccccccchhhhhccccCcc
Confidence 777776652 33 44555666666666666554
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.09 E-value=6.7e-11 Score=111.66 Aligned_cols=81 Identities=26% Similarity=0.493 Sum_probs=16.4
Q ss_pred EEEEEecCCCccccCCcccc-CCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEccc
Q 004020 67 VTRIQIGGQNIEGTLPKELN-SLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145 (779)
Q Consensus 67 v~~l~l~~~~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 145 (779)
+++|+|.+|.|+. + +.++ .+++|+.|+|++|.|+. ++.+..++.|++|++++|+|+.+.+.....+++|++|+|++
T Consensus 21 ~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~-l~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~ 97 (175)
T PF14580_consen 21 LRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITK-LEGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSN 97 (175)
T ss_dssp -----------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS---S-CHHHHHH-TT--EEE-TT
T ss_pred ccccccccccccc-c-cchhhhhcCCCEEECCCCCCcc-ccCccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcC
Confidence 4445555555542 2 1233 34445555555555542 22344445555555555555544332222344555555555
Q ss_pred CCCCC
Q 004020 146 NSFDS 150 (779)
Q Consensus 146 N~l~~ 150 (779)
|+|..
T Consensus 98 N~I~~ 102 (175)
T PF14580_consen 98 NKISD 102 (175)
T ss_dssp S---S
T ss_pred CcCCC
Confidence 55443
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.08 E-value=6.3e-11 Score=111.81 Aligned_cols=110 Identities=27% Similarity=0.370 Sum_probs=41.1
Q ss_pred cccCCCCCcEEEcccCccccCCCCCC-CCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccc-cCCC
Q 004020 84 ELNSLSSLTVLEVMKNKLTGQIPSLS-GLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESL-KDAT 161 (779)
Q Consensus 84 ~l~~l~~L~~L~Ls~N~l~~~~~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~-~~l~ 161 (779)
.+.+..++++|+|.+|+|+. +..++ .+.+|+.|+|++|.|+.+.. +..++.|++|+|++|+|+. +.+.+ ..++
T Consensus 14 ~~~n~~~~~~L~L~~n~I~~-Ie~L~~~l~~L~~L~Ls~N~I~~l~~--l~~L~~L~~L~L~~N~I~~--i~~~l~~~lp 88 (175)
T PF14580_consen 14 QYNNPVKLRELNLRGNQIST-IENLGATLDKLEVLDLSNNQITKLEG--LPGLPRLKTLDLSNNRISS--ISEGLDKNLP 88 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S--TT------TT--EEE--SS---S---CHHHHHH-T
T ss_pred cccccccccccccccccccc-ccchhhhhcCCCEEECCCCCCccccC--ccChhhhhhcccCCCCCCc--cccchHHhCC
Confidence 35566689999999999985 45565 68999999999999999863 7889999999999999986 44444 4689
Q ss_pred CCceEeccCceeEeecC-CCccCCCCCcccEEEccCCCCC
Q 004020 162 GLQRFSANGANITGTIP-DFLGGDTIPGLMHLHLAFNFLQ 200 (779)
Q Consensus 162 ~L~~L~l~~n~l~~~~p-~~~~~~~l~~L~~L~L~~N~l~ 200 (779)
+|+.|++++|+|...-. ..+. .+++|++|+|.+|.++
T Consensus 89 ~L~~L~L~~N~I~~l~~l~~L~--~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 89 NLQELYLSNNKISDLNELEPLS--SLPKLRVLSLEGNPVC 126 (175)
T ss_dssp T--EEE-TTS---SCCCCGGGG--G-TT--EEE-TT-GGG
T ss_pred cCCEEECcCCcCCChHHhHHHH--cCCCcceeeccCCccc
Confidence 99999999999974221 2333 6889999999999887
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1e-10 Score=132.60 Aligned_cols=138 Identities=30% Similarity=0.485 Sum_probs=92.2
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
..+|..++.|..|+||.||.++++ +.+.+|+|+-+... +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l--------ilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL--------ILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccch--------hhhc--cccccCCccee----------------
Confidence 357888999999999999999877 46678884332221 1111 23333344433
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
|+-...++.- + +++. +++.+++|+|+ .+|+|||+||+|.+|+.-|++|+.|||+++..-
T Consensus 136 -----gDc~tllk~~---g--~lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 136 -----GDCATLLKNI---G--PLPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred -----chhhhhcccC---C--CCcc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhh
Confidence 3433444221 1 2221 33788999996 899999999999999999999999999986431
Q ss_pred CCCC------------c-ccccccccCCccccccccccc
Q 004020 748 DNGK------------H-SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~------------~-~~~~~~~gt~~y~APE~l~~~ 773 (779)
.... + .....++||+.|+|||++..+
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq 233 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ 233 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhh
Confidence 1100 0 112346899999999998765
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.9e-11 Score=133.35 Aligned_cols=196 Identities=25% Similarity=0.314 Sum_probs=95.6
Q ss_pred CCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceE
Q 004020 87 SLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRF 166 (779)
Q Consensus 87 ~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L 166 (779)
.+..++.+.+..|.+......+..+++|+.|++.+|+|..+... +..+++|++|+|++|.|.. -..+..++.|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~~~~~~l~~~~~l~~l~l~~n~i~~i~~~-l~~~~~L~~L~ls~N~I~~---i~~l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAKILNHLSKLKSLEALDLYDNKIEKIENL-LSSLVNLQVLDLSFNKITK---LEGLSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhhhhhcccccccceeeeeccccchhhcccc-hhhhhcchheecccccccc---ccchhhccchhhh
Confidence 34444444455555543223345555555555555555554432 3445555555555555533 2333444445555
Q ss_pred eccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCC-ccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEee
Q 004020 167 SANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPL-SFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLH 245 (779)
Q Consensus 167 ~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~ 245 (779)
++.+|.|+ .+... . .+..|+.+++++|++...-+. .-...+++.+++.+|.+... ..+..+..+..+++.
T Consensus 146 ~l~~N~i~-~~~~~-~--~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~i-----~~~~~~~~l~~~~l~ 216 (414)
T KOG0531|consen 146 NLSGNLIS-DISGL-E--SLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIREI-----EGLDLLKKLVLLSLL 216 (414)
T ss_pred eeccCcch-hccCC-c--cchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchhcc-----cchHHHHHHHHhhcc
Confidence 55555554 22221 1 255556666666665533221 01113344444444433221 112233445555777
Q ss_pred cCcccCCCCCCCCCC--CCcEEEccCCccccccChhhhCCCCCCEEEccCcccc
Q 004020 246 GNSFTGPLPDLSGLS--SLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297 (779)
Q Consensus 246 ~N~l~~~~~~~~~l~--~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 297 (779)
.|.++..-+ +..+. .|+.+++++|.+. .++..+..+.++..|++++|++.
T Consensus 217 ~n~i~~~~~-l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~ 268 (414)
T KOG0531|consen 217 DNKISKLEG-LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRIS 268 (414)
T ss_pred cccceeccC-cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccc
Confidence 777764322 22222 3677777777776 44456666677777777777665
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.02 E-value=6.4e-10 Score=107.49 Aligned_cols=80 Identities=29% Similarity=0.274 Sum_probs=66.1
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCc
Q 004020 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (779)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 752 (779)
|+|.+++..+. ..+++.+++.|+.||+.||+|||+ .+ ||+||+++.++.+|+ ||.++.....
T Consensus 1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~--- 62 (176)
T smart00750 1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPE--- 62 (176)
T ss_pred CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeeccc---
Confidence 68888886542 258999999999999999999996 44 999999999999999 9998876432
Q ss_pred ccccccccCCcccccccccccC
Q 004020 753 SIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 753 ~~~~~~~gt~~y~APE~l~~~~ 774 (779)
...||+.|||||++.+..
T Consensus 63 ----~~~g~~~y~aPE~~~~~~ 80 (176)
T smart00750 63 ----QSRVDPYFMAPEVIQGQS 80 (176)
T ss_pred ----cCCCcccccChHHhcCCC
Confidence 125889999999997653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.01 E-value=3e-11 Score=124.25 Aligned_cols=185 Identities=16% Similarity=0.180 Sum_probs=108.9
Q ss_pred cCCCCCcEEEcccCccccCCC--CCCCCCCccEEecCCCCCCCCCc--ccccCCCCccEEEcccCCCCCCCCcccccCCC
Q 004020 86 NSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDNNFTSVPS--DFFKGLTSLQTISLDYNSFDSWVIPESLKDAT 161 (779)
Q Consensus 86 ~~l~~L~~L~Ls~N~l~~~~~--~~~~l~~L~~L~l~~N~l~~~~~--~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~ 161 (779)
.++.+|+...|.+..+..... ....|++++.||||+|-+....+ .....|++|+.|+|+.|++....-...-..++
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 356677777777766654332 45567777777777777775322 34456777777788777775422222233567
Q ss_pred CCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccE
Q 004020 162 GLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQ 241 (779)
Q Consensus 162 ~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~ 241 (779)
.|+.|.|++|.++..--..+. ..+|+|+.|+|..|...+...... ..+..|+.
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~-~~fPsl~~L~L~~N~~~~~~~~~~--------------------------~i~~~L~~ 250 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWIL-LTFPSLEVLYLEANEIILIKATST--------------------------KILQTLQE 250 (505)
T ss_pred hhheEEeccCCCCHHHHHHHH-HhCCcHHHhhhhcccccceecchh--------------------------hhhhHHhh
Confidence 778888888887632222222 257788888888885321111111 12445666
Q ss_pred EEeecCcccCCC--CCCCCCCCCcEEEccCCccccc-cChh-----hhCCCCCCEEEccCcccc
Q 004020 242 LWLHGNSFTGPL--PDLSGLSSLQDFSVRDNQLTGI-VPSS-----LVNLHSLAVVNLTNNLFQ 297 (779)
Q Consensus 242 L~L~~N~l~~~~--~~~~~l~~L~~L~l~~N~l~~~-~p~~-----l~~l~~L~~L~Ls~N~l~ 297 (779)
|||++|++-... +..+.++.|..|+++.+.+... .|+. ...+++|++|+++.|++.
T Consensus 251 LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 251 LDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred ccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence 666666666544 3456666666666666666532 2222 234566777777777664
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.4e-11 Score=116.82 Aligned_cols=130 Identities=20% Similarity=0.256 Sum_probs=91.7
Q ss_pred CCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCccc
Q 004020 111 LSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLM 190 (779)
Q Consensus 111 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~ 190 (779)
-..|++||||+|.|+.+... ..-+|.++.|++|+|.|.. -..+..+.+|+.|+|++|.++. +.++- ..+.+++
T Consensus 283 Wq~LtelDLS~N~I~~iDES-vKL~Pkir~L~lS~N~i~~---v~nLa~L~~L~~LDLS~N~Ls~-~~Gwh--~KLGNIK 355 (490)
T KOG1259|consen 283 WQELTELDLSGNLITQIDES-VKLAPKLRRLILSQNRIRT---VQNLAELPQLQLLDLSGNLLAE-CVGWH--LKLGNIK 355 (490)
T ss_pred Hhhhhhccccccchhhhhhh-hhhccceeEEeccccceee---ehhhhhcccceEeecccchhHh-hhhhH--hhhcCEe
Confidence 34567777777777766543 4556677777777777642 3346677777777777777663 33332 2577888
Q ss_pred EEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCC--CCCCCCCCcEEEcc
Q 004020 191 HLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP--DLSGLSSLQDFSVR 268 (779)
Q Consensus 191 ~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~l~~L~~L~l~ 268 (779)
+|.|+.|.|.. +..+..+-+|..||+++|++...-. .+++++-|+.+.|.
T Consensus 356 tL~La~N~iE~----------------------------LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~ 407 (490)
T KOG1259|consen 356 TLKLAQNKIET----------------------------LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLT 407 (490)
T ss_pred eeehhhhhHhh----------------------------hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhc
Confidence 99999998862 1124467789999999999987543 58999999999999
Q ss_pred CCccccc
Q 004020 269 DNQLTGI 275 (779)
Q Consensus 269 ~N~l~~~ 275 (779)
+|.+.+.
T Consensus 408 ~NPl~~~ 414 (490)
T KOG1259|consen 408 GNPLAGS 414 (490)
T ss_pred CCCcccc
Confidence 9999854
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.96 E-value=4.6e-10 Score=87.09 Aligned_cols=60 Identities=37% Similarity=0.584 Sum_probs=46.6
Q ss_pred CCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCC
Q 004020 89 SSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSF 148 (779)
Q Consensus 89 ~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 148 (779)
++|++|+|++|+|+.+++ .|.++++|++|++++|+++.++++.|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 467788888888877766 677788888888888888888777788888888888887764
|
... |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=4.4e-11 Score=119.87 Aligned_cols=196 Identities=21% Similarity=0.286 Sum_probs=120.3
Q ss_pred CCcEEEEEecCCCccc----cCCccccCCCCCcEEEcccCcccc----CCC--------CCCCCCCccEEecCCCCCCCC
Q 004020 64 SNRVTRIQIGGQNIEG----TLPKELNSLSSLTVLEVMKNKLTG----QIP--------SLSGLSSLQEVLFDDNNFTSV 127 (779)
Q Consensus 64 ~~~v~~l~l~~~~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~----~~~--------~~~~l~~L~~L~l~~N~l~~~ 127 (779)
...++.|+|++|.+.. .+.+.+.+.++|++.++|+= ++| .+| ++.++++|++||||+|.|..-
T Consensus 29 ~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~ 107 (382)
T KOG1909|consen 29 MDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM-FTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPK 107 (382)
T ss_pred cCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh-hcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCcc
Confidence 3568888888888753 24455677788888888873 233 222 255667888888888877632
Q ss_pred --C--cccccCCCCccEEEcccCCCCCCCCcccccCC-CCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCc
Q 004020 128 --P--SDFFKGLTSLQTISLDYNSFDSWVIPESLKDA-TGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGP 202 (779)
Q Consensus 128 --~--~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l-~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~ 202 (779)
+ .+.+.++..|++|+|.+|.+. |..=+.+ ..|..|. .|+. +| .-+.|+++..+.|++...
T Consensus 108 g~~~l~~ll~s~~~L~eL~L~N~Glg----~~ag~~l~~al~~l~--~~kk---~~------~~~~Lrv~i~~rNrlen~ 172 (382)
T KOG1909|consen 108 GIRGLEELLSSCTDLEELYLNNCGLG----PEAGGRLGRALFELA--VNKK---AA------SKPKLRVFICGRNRLENG 172 (382)
T ss_pred chHHHHHHHHhccCHHHHhhhcCCCC----hhHHHHHHHHHHHHH--HHhc---cC------CCcceEEEEeeccccccc
Confidence 1 134556677777777777662 1111110 0111111 1111 11 345677777777777521
Q ss_pred CCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCC-----CCCCCCCCCcEEEccCCccccc--
Q 004020 203 IPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPL-----PDLSGLSSLQDFSVRDNQLTGI-- 275 (779)
Q Consensus 203 ~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-----~~~~~l~~L~~L~l~~N~l~~~-- 275 (779)
.... ....++..+.|+.+.+++|.+...- ..+..+++|+.|||++|-|+..
T Consensus 173 ga~~----------------------~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs 230 (382)
T KOG1909|consen 173 GATA----------------------LAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGS 230 (382)
T ss_pred cHHH----------------------HHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHH
Confidence 1111 1234566788888888888885321 1367788899999999988632
Q ss_pred --cChhhhCCCCCCEEEccCcccc
Q 004020 276 --VPSSLVNLHSLAVVNLTNNLFQ 297 (779)
Q Consensus 276 --~p~~l~~l~~L~~L~Ls~N~l~ 297 (779)
+...++.+++|+.|+++++.+.
T Consensus 231 ~~LakaL~s~~~L~El~l~dcll~ 254 (382)
T KOG1909|consen 231 VALAKALSSWPHLRELNLGDCLLE 254 (382)
T ss_pred HHHHHHhcccchheeecccccccc
Confidence 4466777888999999988876
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.2e-09 Score=118.30 Aligned_cols=126 Identities=28% Similarity=0.457 Sum_probs=101.7
Q ss_pred HHcCCCCccceEeeEEEeCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcC
Q 004020 642 LTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRD 721 (779)
Q Consensus 642 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrD 721 (779)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+.... ..+++.....+.++|+.||+|+|. ..-..|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~----~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED----IKLDYFFILSFIRDISKGLAYLHN--SPIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc----cCccHHHHHHHHHHHHHHHHHHhc--Ccceeeee
Confidence 356789999999999999999999999999999999996632 358899999999999999999996 23339999
Q ss_pred CCCCCEEEcCCCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 722 LKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 722 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+++.|.++|....+||.|||+.................-..-|.|||.+.+.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~ 126 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGA 126 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhccc
Confidence 9999999999999999999997766421111111122234679999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.5e-08 Score=97.51 Aligned_cols=128 Identities=23% Similarity=0.271 Sum_probs=83.4
Q ss_pred EEEEEEEcCCcEEEEEEecccccC------------------------hhHHHHHHHHHHHHHcCCCC--ccceEeeEEE
Q 004020 605 TVYKGELHDGTKIAVKRMESAVVS------------------------EKGFAEFKSEIAVLTKVRHR--HLVGLLGYCL 658 (779)
Q Consensus 605 ~Vy~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~ 658 (779)
.||.|...+|..+|+|+.+..... ........+|.+.|.++..- ++++++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999889999999987532110 01124578999999999755 566666542
Q ss_pred eCCeEEEEEEecC--CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHH-HHcCCCCCcEEcCCCCCCEEEcCCCcE
Q 004020 659 DGNERLLVYEYMP--QGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY-LHGLAHQSFIHRDLKPSNILLGDDMRA 735 (779)
Q Consensus 659 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~-LH~~~~~~ivHrDlkp~NIll~~~~~~ 735 (779)
...+||||++ |..+..+. +.. ++......++.+++..+.. +| ..||+|+|+.+.||+++++ .+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~-~~~------~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLK-DVD------LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHH-HCG------GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CE
T ss_pred ---CCEEEEEecCCCccchhhHH-hcc------ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eE
Confidence 3479999998 55554432 211 1123345677788886665 46 4899999999999999887 89
Q ss_pred EEEeeccceecC
Q 004020 736 KVADFGLVRLAP 747 (779)
Q Consensus 736 kl~DFG~a~~~~ 747 (779)
.|+|||.+....
T Consensus 146 ~iIDf~qav~~~ 157 (188)
T PF01163_consen 146 YIIDFGQAVDSS 157 (188)
T ss_dssp EE--GTTEEETT
T ss_pred EEEecCcceecC
Confidence 999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.90 E-value=2.3e-10 Score=121.27 Aligned_cols=105 Identities=32% Similarity=0.461 Sum_probs=86.4
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeec
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 741 (779)
+.|+.|++|...+|.+++..++... .-++.....++.|++.|++| ++.+|||+||.||+...+.++||.|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e--~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGE--ERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCccc--ccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhh
Confidence 5789999999999999997555433 35777889999999999999 479999999999999999999999999
Q ss_pred cceecCCCC----CcccccccccCCcccccccccccC
Q 004020 742 LVRLAPDNG----KHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 742 ~a~~~~~~~----~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
+........ .....+..+||..||+||.+.+.+
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~ 438 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ 438 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhh
Confidence 987665543 112235568999999999998764
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.8e-08 Score=101.49 Aligned_cols=143 Identities=15% Similarity=0.131 Sum_probs=99.7
Q ss_pred ceecccccEEEEEEEEcCCcEEEEEEecccccCh---------hHHHHHHHHHHHHHcCCCCcc--ceEeeEEEe-----
Q 004020 596 NVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSE---------KGFAEFKSEIAVLTKVRHRHL--VGLLGYCLD----- 659 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~----- 659 (779)
+.+-+-....|+++.. +|+.|.||......... .....+.+|...+.++..-+| +..++++..
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444445667665 47889999775432111 011147789999988854333 344555543
Q ss_pred CCeEEEEEEecCCC-ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC-------
Q 004020 660 GNERLLVYEYMPQG-TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD------- 731 (779)
Q Consensus 660 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~------- 731 (779)
....++|||++++. +|.+++..... ...+...+..++.+++..+.-||. .||+|+|++++|||++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCC
Confidence 23578999999886 78888743211 134556677899999999999995 89999999999999975
Q ss_pred CCcEEEEeecccee
Q 004020 732 DMRAKVADFGLVRL 745 (779)
Q Consensus 732 ~~~~kl~DFG~a~~ 745 (779)
++.+.++||+.++.
T Consensus 181 ~~~~~LIDl~r~~~ 194 (268)
T PRK15123 181 DLKLSVIDLHRAQI 194 (268)
T ss_pred CceEEEEECCcccc
Confidence 46899999998864
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.2e-09 Score=84.69 Aligned_cols=61 Identities=25% Similarity=0.526 Sum_probs=47.6
Q ss_pred CCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCcee
Q 004020 112 SSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANI 173 (779)
Q Consensus 112 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l 173 (779)
++|++|++++|+|+.+++++|.++++|++|++++|++.. ..|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~-i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTS-IPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESE-EETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCc-cCHHHHcCCCCCCEEeCcCCcC
Confidence 578889999999999888888888888888888888865 4555666666666666666654
|
... |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.83 E-value=4.5e-10 Score=112.71 Aligned_cols=208 Identities=15% Similarity=0.205 Sum_probs=149.6
Q ss_pred cEEEEEecCC---CccccCCc-------cccCCCCCcEEEcccCccccC--CC---CCCCCCCccEEecCCCCCCCCCcc
Q 004020 66 RVTRIQIGGQ---NIEGTLPK-------ELNSLSSLTVLEVMKNKLTGQ--IP---SLSGLSSLQEVLFDDNNFTSVPSD 130 (779)
Q Consensus 66 ~v~~l~l~~~---~l~~~~p~-------~l~~l~~L~~L~Ls~N~l~~~--~~---~~~~l~~L~~L~l~~N~l~~~~~~ 130 (779)
.++..++++- ++...+|+ ++...++|++||||+|.|.-. .+ -+.++..|+.|.|.+|.+.-.-..
T Consensus 59 ~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~ 138 (382)
T KOG1909|consen 59 ELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGG 138 (382)
T ss_pred cceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHH
Confidence 5777777652 33334443 455667999999999998532 22 267799999999999998843222
Q ss_pred -------------cccCCCCccEEEcccCCCCCCC---CcccccCCCCCceEeccCceeEee----cCCCccCCCCCccc
Q 004020 131 -------------FFKGLTSLQTISLDYNSFDSWV---IPESLKDATGLQRFSANGANITGT----IPDFLGGDTIPGLM 190 (779)
Q Consensus 131 -------------~~~~l~~L~~L~Ls~N~l~~~~---~p~~~~~l~~L~~L~l~~n~l~~~----~p~~~~~~~l~~L~ 190 (779)
....-++|++++.++|++.... +...|...+.|+.+.+..|.|... +-..+. .+++|+
T Consensus 139 ~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~--~~~~Le 216 (382)
T KOG1909|consen 139 RLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALE--HCPHLE 216 (382)
T ss_pred HHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHH--hCCcce
Confidence 2345679999999999996522 335678889999999999988521 112233 689999
Q ss_pred EEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCC-----CC-CCCCCCcE
Q 004020 191 HLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-----DL-SGLSSLQD 264 (779)
Q Consensus 191 ~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-----~~-~~l~~L~~ 264 (779)
+|||..|-|+..-...++ ..+..++.|+.|+++++.+...-. .+ ...++|++
T Consensus 217 vLdl~DNtft~egs~~La----------------------kaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~v 274 (382)
T KOG1909|consen 217 VLDLRDNTFTLEGSVALA----------------------KALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEV 274 (382)
T ss_pred eeecccchhhhHHHHHHH----------------------HHhcccchheeecccccccccccHHHHHHHHhccCCCCce
Confidence 999999999854433333 345578889999999999875322 22 34789999
Q ss_pred EEccCCccccc----cChhhhCCCCCCEEEccCcccc
Q 004020 265 FSVRDNQLTGI----VPSSLVNLHSLAVVNLTNNLFQ 297 (779)
Q Consensus 265 L~l~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~ 297 (779)
|.|.+|.|+.. +-..+...+.|..|+|++|++.
T Consensus 275 l~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 275 LELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred eccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 99999998732 3445667899999999999994
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.9e-09 Score=115.36 Aligned_cols=178 Identities=23% Similarity=0.228 Sum_probs=137.1
Q ss_pred cCCcccceecc--cccEEEEEEEE---cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCCeE
Q 004020 590 NNFSEENVLGR--GGFGTVYKGEL---HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNER 663 (779)
Q Consensus 590 ~~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 663 (779)
..|...+.+|. |.+|.||.++. .++..+|+|+-+..........+=.+|+...++++ |++.++.+..+..++..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34566788999 99999999976 46888999986544432333334456777777786 99999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHH----HHHHHHcCCCCCcEEcCCCCCCEEEcCC-CcEEEE
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR----GVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVA 738 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~----~L~~LH~~~~~~ivHrDlkp~NIll~~~-~~~kl~ 738 (779)
|+-+|++. .++.++.+.... .++....+.+..+... |+.++|+ ..++|-|+||+||+...+ ...+++
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred eeeecccc-chhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecC
Confidence 99999985 677777654432 3566777788888888 9999997 899999999999999998 889999
Q ss_pred eeccceecCCCCCccc---ccccccCCcccccccccccCC
Q 004020 739 DFGLVRLAPDNGKHSI---ETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 739 DFG~a~~~~~~~~~~~---~~~~~gt~~y~APE~l~~~~~ 775 (779)
|||+...+.+...... .....|...|++||...+-..
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~ 305 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLAT 305 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhccccc
Confidence 9999988766542211 122357788999999876543
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.4e-09 Score=119.89 Aligned_cols=216 Identities=22% Similarity=0.260 Sum_probs=114.9
Q ss_pred cEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEccc
Q 004020 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145 (779)
Q Consensus 66 ~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 145 (779)
.+..+++..|.+.. +-..+..+++|+.|++.+|+|..+...+..+++|++|+|++|+|+.+.. +..++.|+.|++++
T Consensus 73 ~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~ 149 (414)
T KOG0531|consen 73 SLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSG 149 (414)
T ss_pred hHHhhccchhhhhh-hhcccccccceeeeeccccchhhcccchhhhhcchheeccccccccccc--hhhccchhhheecc
Confidence 34445555555552 3334666667777777777766444446666777777777777766654 44555677777777
Q ss_pred CCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCC
Q 004020 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSK 225 (779)
Q Consensus 146 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~ 225 (779)
|.|+. ...+..+++|+.+++++|.++..-++.. ..+.+|+.+++.+|.+........ ...+..+.+..|++...
T Consensus 150 N~i~~---~~~~~~l~~L~~l~l~~n~i~~ie~~~~--~~~~~l~~l~l~~n~i~~i~~~~~-~~~l~~~~l~~n~i~~~ 223 (414)
T KOG0531|consen 150 NLISD---ISGLESLKSLKLLDLSYNRIVDIENDEL--SELISLEELDLGGNSIREIEGLDL-LKKLVLLSLLDNKISKL 223 (414)
T ss_pred Ccchh---ccCCccchhhhcccCCcchhhhhhhhhh--hhccchHHHhccCCchhcccchHH-HHHHHHhhcccccceec
Confidence 77643 3445556667777777777664333101 145666666676666652221111 11223334444443322
Q ss_pred CCCchhhhcCCCC--ccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCcccc
Q 004020 226 LNGSVAVIQNMTS--LTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297 (779)
Q Consensus 226 ~~~~~~~~~~l~~--L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 297 (779)
-+ +..+.. |+.+++++|.+......+..+..+..|++.+|++... ..+...+.+..+.+..|++.
T Consensus 224 ~~-----l~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 224 EG-----LNELVMLHLRELYLSGNRISRSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLA 290 (414)
T ss_pred cC-----cccchhHHHHHHhcccCccccccccccccccccccchhhcccccc--ccccccchHHHhccCcchhc
Confidence 11 111222 5666666666664434455556666666666666532 22333444455555555544
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=5.8e-08 Score=107.33 Aligned_cols=149 Identities=21% Similarity=0.300 Sum_probs=98.5
Q ss_pred hcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccCh--------------------------------h------
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSE--------------------------------K------ 630 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------------~------ 630 (779)
...|+. +.|+.++-|+||+|++++|+.||||+.++..... +
T Consensus 125 F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~ 203 (517)
T COG0661 125 FSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR 203 (517)
T ss_pred HHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence 334443 7899999999999999999999999986543210 0
Q ss_pred HHHHHHHHHHHHHcCC-----CCccceEeeEEEeCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHH
Q 004020 631 GFAEFKSEIAVLTKVR-----HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARG 705 (779)
Q Consensus 631 ~~~~~~~E~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~ 705 (779)
..-++.+|+.-+.+++ .+++.-..=|+.......++|||++|..+.+...... . ..+ +..++..++++
T Consensus 204 ~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~---g~d---~k~ia~~~~~~ 276 (517)
T COG0661 204 EELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-A---GID---RKELAELLVRA 276 (517)
T ss_pred HHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-c---CCC---HHHHHHHHHHH
Confidence 0012455666666553 3444333333344567789999999998888753332 1 233 22333333332
Q ss_pred -HHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 706 -VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 706 -L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
+..+- ..|++|.|.+|.||+++.+|++.+.|||+...+.+
T Consensus 277 f~~q~~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 277 FLRQLL---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHH---hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 12222 26899999999999999999999999999876654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.72 E-value=6.7e-08 Score=105.77 Aligned_cols=125 Identities=15% Similarity=0.169 Sum_probs=102.1
Q ss_pred EEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCCCChhhHhhhcccCCCCC
Q 004020 610 ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKP 689 (779)
Q Consensus 610 ~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~ 689 (779)
+..++.+|.|..++.... .......+-++.++.++||||+++++.+...+..|+|+|.+. -|..++.+.
T Consensus 33 ~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------- 101 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------- 101 (690)
T ss_pred eeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------
Confidence 445688888888765542 334557788899999999999999999999999999999985 466666432
Q ss_pred CCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 690 LEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 690 ~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
....+..-+.||+.||.|||. +.+++|++|.-+-|+|+..|+.||++|-++.....
T Consensus 102 -~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~ 157 (690)
T KOG1243|consen 102 -GKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASG 157 (690)
T ss_pred -HHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEecccc
Confidence 245566778999999999997 57899999999999999999999999998765443
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.3e-08 Score=119.78 Aligned_cols=207 Identities=23% Similarity=0.274 Sum_probs=144.2
Q ss_pred ccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCC--CCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCC
Q 004020 85 LNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNN--FTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATG 162 (779)
Q Consensus 85 l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~--l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~ 162 (779)
..+....+.+.+.+|.+.-..... ..++|++|-+..|. +..++.++|..++.|..|||++|.= ...+|..+++|-+
T Consensus 519 ~~~~~~~rr~s~~~~~~~~~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~-l~~LP~~I~~Li~ 596 (889)
T KOG4658|consen 519 VKSWNSVRRMSLMNNKIEHIAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSS-LSKLPSSIGELVH 596 (889)
T ss_pred ccchhheeEEEEeccchhhccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCc-cCcCChHHhhhhh
Confidence 334467888888888876444333 33478899999887 7888888899999999999998654 3368999999999
Q ss_pred CceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccc-cCCcceeeccCCCCCCCCCCchhhhcCCCCccE
Q 004020 163 LQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFG-KSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQ 241 (779)
Q Consensus 163 L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~ 241 (779)
|++|++++..++ .+|..+. .++.|.+|++..+.-...+|..+. -.+|++|.+.... ..........+..+.+|+.
T Consensus 597 LryL~L~~t~I~-~LP~~l~--~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~-~~~~~~~l~el~~Le~L~~ 672 (889)
T KOG4658|consen 597 LRYLDLSDTGIS-HLPSGLG--NLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA-LSNDKLLLKELENLEHLEN 672 (889)
T ss_pred hhcccccCCCcc-ccchHHH--HHHhhheeccccccccccccchhhhcccccEEEeeccc-cccchhhHHhhhcccchhh
Confidence 999999999988 7888887 788999999998886656655554 3677887775543 2222233455566777777
Q ss_pred EEeecCcccCCCCCCCCCCCC----cEEEccCCccccccChhhhCCCCCCEEEccCcccccc
Q 004020 242 LWLHGNSFTGPLPDLSGLSSL----QDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQ 299 (779)
Q Consensus 242 L~L~~N~l~~~~~~~~~l~~L----~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ 299 (779)
|....... ..+.++..+..| +.+.+..+... ..+.++..+.+|+.|.+.++.+...
T Consensus 673 ls~~~~s~-~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~ 732 (889)
T KOG4658|consen 673 LSITISSV-LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEI 732 (889)
T ss_pred heeecchh-HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchh
Confidence 77755554 222233333333 23443334433 5677888899999999998887643
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.3e-07 Score=93.14 Aligned_cols=139 Identities=22% Similarity=0.181 Sum_probs=98.3
Q ss_pred CCcccceecccccEEEEEEEEcCCcEEEEEEeccccc------------------C--hhHHHHHHHHHHHHHcCCCC--
Q 004020 591 NFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVV------------------S--EKGFAEFKSEIAVLTKVRHR-- 648 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~--~~~~~~~~~E~~~l~~l~h~-- 648 (779)
-+.+...||.|--+.||.|....|.++|||.=+.... + .-.....++|.++|.++...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 3456789999999999999999999999996422110 0 01234568999999999744
Q ss_pred ccceEeeEEEeCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEE
Q 004020 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 728 (779)
Q Consensus 649 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIl 728 (779)
.+++.+++ +...+||||++|-.|...- ++....-.++..|++-+..+-. .||||+|+.+=||+
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIl 234 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNIL 234 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEE
Confidence 67777765 4557999999986664321 1122233444444444443332 79999999999999
Q ss_pred EcCCCcEEEEeeccceec
Q 004020 729 LGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 729 l~~~~~~kl~DFG~a~~~ 746 (779)
++++|.+.++||--+...
T Consensus 235 V~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 235 VTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred EecCCCEEEEeCcccccC
Confidence 999999999999766544
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.61 E-value=3.8e-07 Score=90.22 Aligned_cols=108 Identities=27% Similarity=0.349 Sum_probs=83.4
Q ss_pred HHHHHHHHHHHHcCCCC--ccceEeeEEEeCC----eEEEEEEecCCC-ChhhHhhhcccCCCCCCCHHHHHHHHHHHHH
Q 004020 632 FAEFKSEIAVLTKVRHR--HLVGLLGYCLDGN----ERLLVYEYMPQG-TLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704 (779)
Q Consensus 632 ~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~ 704 (779)
..+..+|...+..+... .+++.+++..... ..++|+|++++. +|.+++..... .+......++.+++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-----~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-----LDPSQRRELLRALAR 129 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-----cchhhHHHHHHHHHH
Confidence 34677888888887533 3456666665532 458999999884 78888854321 345567789999999
Q ss_pred HHHHHHcCCCCCcEEcCCCCCCEEEcCCC---cEEEEeeccceecC
Q 004020 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAKVADFGLVRLAP 747 (779)
Q Consensus 705 ~L~~LH~~~~~~ivHrDlkp~NIll~~~~---~~kl~DFG~a~~~~ 747 (779)
.+.-||. .||+|+|+++.|||++.+. .+.++||+-++...
T Consensus 130 ~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 130 LIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999996 8999999999999999887 89999999887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.59 E-value=3.5e-08 Score=107.08 Aligned_cols=153 Identities=21% Similarity=0.272 Sum_probs=121.9
Q ss_pred HHHhhcCCcccceecccccEEEEEEEEc--CCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCC
Q 004020 585 LRNVTNNFSEENVLGRGGFGTVYKGELH--DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGN 661 (779)
Q Consensus 585 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 661 (779)
......+|.....||.|.|+.|+++..+ ++..|++|..............-..|+.+...+. |.+++.++..|...+
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 4455678899999999999999998644 6788999988766544433334456777777764 888998888887777
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCC-CcEEEEee
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVADF 740 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DF 740 (779)
..|+-.|||++++....+.- ...+++..++++..|++.++.++|+ +.++|+|+||+||++..+ +..++.||
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~-----~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~ 411 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVT-----SQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDF 411 (524)
T ss_pred cccCchhhhcCcchhhhhHH-----HHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccc
Confidence 78899999999988766511 1246777889999999999999996 899999999999999875 78899999
Q ss_pred cccee
Q 004020 741 GLVRL 745 (779)
Q Consensus 741 G~a~~ 745 (779)
|.+..
T Consensus 412 ~~~t~ 416 (524)
T KOG0601|consen 412 GCWTR 416 (524)
T ss_pred ccccc
Confidence 98753
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.50 E-value=7.4e-07 Score=94.58 Aligned_cols=142 Identities=19% Similarity=0.256 Sum_probs=108.6
Q ss_pred cEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEe----CCeEEEEEEecCC-CChh
Q 004020 603 FGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD----GNERLLVYEYMPQ-GTLS 676 (779)
Q Consensus 603 ~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~-gsL~ 676 (779)
-.+.||+.. .||..|++|+++... .........-++.++++.|+|+|++.+++.. +...++|++|++. ++|.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r--~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDR--DQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred cceeEeeeeccCCceeeeeeecccc--ccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 357899954 489999999994332 1112223456788999999999999998873 3467899999986 4777
Q ss_pred hHhhhcccCC----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 677 RHLFNRKEEG----------LKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 677 ~~l~~~~~~~----------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
++........ ....++...|.++.|+..||.++|+ .|..-+-|.|.+|+++.+.+++|+..|+....
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeee
Confidence 7654432221 2246778899999999999999996 89999999999999999999999999987665
Q ss_pred CCC
Q 004020 747 PDN 749 (779)
Q Consensus 747 ~~~ 749 (779)
..+
T Consensus 444 ~~d 446 (655)
T KOG3741|consen 444 QED 446 (655)
T ss_pred cCC
Confidence 443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.6e-06 Score=83.72 Aligned_cols=141 Identities=21% Similarity=0.198 Sum_probs=102.0
Q ss_pred eecccccEEEEEEEEcCCcEEEEEEeccccc-C---hhHHHHHHHHHHHHHcCCCCc--cceEeeEEE-e--C--CeEEE
Q 004020 597 VLGRGGFGTVYKGELHDGTKIAVKRMESAVV-S---EKGFAEFKSEIAVLTKVRHRH--LVGLLGYCL-D--G--NERLL 665 (779)
Q Consensus 597 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~---~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~-~--~--~~~~l 665 (779)
--|+||.+-|++.... |..+-+|+...... + .-....|.+|+..+.++..-+ +.+.. ++. . + -..++
T Consensus 25 N~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 25 NYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred CcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 3567999999998765 44688888752211 1 234567999999999986332 44444 332 1 1 23579
Q ss_pred EEEecCC-CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCc--EEEEeecc
Q 004020 666 VYEYMPQ-GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR--AKVADFGL 742 (779)
Q Consensus 666 v~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~--~kl~DFG~ 742 (779)
|+|-+++ .+|.+++.+.. ..+.+...+..+..+++..+.-||. .|+.|+|+.+.||+++.++. ++++||.-
T Consensus 103 VTe~L~g~~~L~~~l~~~~---~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk 176 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHA---VSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEK 176 (216)
T ss_pred EEEeCCCCccHHHHHhcCC---cCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence 9997764 48887774432 2245677778999999999999995 89999999999999986666 99999987
Q ss_pred cee
Q 004020 743 VRL 745 (779)
Q Consensus 743 a~~ 745 (779)
++.
T Consensus 177 ~r~ 179 (216)
T PRK09902 177 SRR 179 (216)
T ss_pred cch
Confidence 664
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.1e-06 Score=86.00 Aligned_cols=133 Identities=20% Similarity=0.213 Sum_probs=85.1
Q ss_pred ceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCc--cceEeeEEEeCCeEEEEEEecCCC
Q 004020 596 NVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH--LVGLLGYCLDGNERLLVYEYMPQG 673 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g 673 (779)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 57999999999984 25567888876432 2245688999998886433 467777777777788999999986
Q ss_pred C-hhhHhhhcccCCCCCCCHHHHHHHHHHHHHH---------------------------------------HHHHHcC-
Q 004020 674 T-LSRHLFNRKEEGLKPLEWTRRLTIALDVARG---------------------------------------VEYLHGL- 712 (779)
Q Consensus 674 s-L~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~---------------------------------------L~~LH~~- 712 (779)
+ +...+.. +......++.++++. .++|...
T Consensus 80 ~~~~~~~~~---------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~ 150 (226)
T TIGR02172 80 RSFSRIISD---------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVP 150 (226)
T ss_pred cchhhhhcC---------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCC
Confidence 3 2111100 000011111111111 1222211
Q ss_pred CCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 713 ~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
....++|+|+.|.||++++++ +.|+||+.+..
T Consensus 151 ~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 151 DTSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 124578999999999999888 99999998754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.3e-06 Score=96.25 Aligned_cols=142 Identities=18% Similarity=0.211 Sum_probs=90.4
Q ss_pred ceecccccEEEEEEEEcCCcEEEEEEecccccCh-----------------------------hH------HHHHHHHHH
Q 004020 596 NVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSE-----------------------------KG------FAEFKSEIA 640 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------------------~~------~~~~~~E~~ 640 (779)
+.||.-+.|+||+|+.++|+.||||+.++..... +- .-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 7899999999999999999999999876543210 00 012445555
Q ss_pred HHHcC----CCCc------cceEeeEEEeCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 004020 641 VLTKV----RHRH------LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710 (779)
Q Consensus 641 ~l~~l----~h~n------iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH 710 (779)
-..++ +|-+ |.++|- .......++||||+|..+.|.-.-.+. .++...+.. .+.++.. +
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~----gi~~~~i~~---~l~~~~~--~ 315 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKR----GISPHDILN---KLVEAYL--E 315 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHc----CCCHHHHHH---HHHHHHH--H
Confidence 44433 3444 333322 223467899999999877665322221 244443333 3333211 1
Q ss_pred cCCCCCcEEcCCCCCCEEEcC----CCcEEEEeeccceecCC
Q 004020 711 GLAHQSFIHRDLKPSNILLGD----DMRAKVADFGLVRLAPD 748 (779)
Q Consensus 711 ~~~~~~ivHrDlkp~NIll~~----~~~~kl~DFG~a~~~~~ 748 (779)
..-..|++|+|-+|.||++.. ++++.+.|||+...+..
T Consensus 316 qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 316 QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 111268999999999999983 67899999999876543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.2e-07 Score=92.70 Aligned_cols=130 Identities=22% Similarity=0.319 Sum_probs=93.4
Q ss_pred HHHHHcCCCCccceEeeEEEeCC-----eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCC
Q 004020 639 IAVLTKVRHRHLVGLLGYCLDGN-----ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713 (779)
Q Consensus 639 ~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ 713 (779)
..-+-.+.|.|||+++.|+.+.. +..++.|||..|++..++++.+... +.+......+|+-||+.||.|||+.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-~a~~~~~wkkw~tqIlsal~yLhs~- 195 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-KALFQKAWKKWCTQILSALSYLHSC- 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-hhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence 33455567999999999987654 4678999999999999998765543 3567777889999999999999985
Q ss_pred CCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC--CCCcccccccccCCcccccccc
Q 004020 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD--NGKHSIETRLAGTFGYLAPEYA 770 (779)
Q Consensus 714 ~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~--~~~~~~~~~~~gt~~y~APE~l 770 (779)
...|+|+++.-+-|++..+|-+|+.----...... ...........+-++|.|||+=
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg 254 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESG 254 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcC
Confidence 68999999999999999998888643211110000 0000011122466889999863
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.39 E-value=4e-06 Score=81.33 Aligned_cols=140 Identities=21% Similarity=0.258 Sum_probs=90.0
Q ss_pred hhcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChh-HH------HHHHHHHHHHHcCCCC---ccceEeeEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEK-GF------AEFKSEIAVLTKVRHR---HLVGLLGYC 657 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~------~~~~~E~~~l~~l~h~---niv~~~~~~ 657 (779)
..++|...+++-......|.+... +|..+++|.........+ .. ....+++..+.+++.. ....++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 456788888888777666666555 478899998765432211 11 1223444444444322 222222222
Q ss_pred E-----eCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCC
Q 004020 658 L-----DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 732 (779)
Q Consensus 658 ~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~ 732 (779)
. -....+++|||++|..|.+.. .++. .++..+++++.-+|. .|++|+|..|.|++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~---------~i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE---------DIDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch---------hcCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC
Confidence 2 223457899999998876543 1222 244567788999995 899999999999999865
Q ss_pred CcEEEEeecccee
Q 004020 733 MRAKVADFGLVRL 745 (779)
Q Consensus 733 ~~~kl~DFG~a~~ 745 (779)
+ ++++||+..+.
T Consensus 172 ~-i~iID~~~k~~ 183 (229)
T PF06176_consen 172 G-IRIIDTQGKRM 183 (229)
T ss_pred c-EEEEECccccc
Confidence 4 99999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.34 E-value=5.8e-06 Score=80.93 Aligned_cols=156 Identities=23% Similarity=0.273 Sum_probs=104.5
Q ss_pred eeHHHHHHhhcCCcccceec---ccccEEEEEEEEcCCcEEEEEEecccccChhH----------------------HHH
Q 004020 580 ISIQVLRNVTNNFSEENVLG---RGGFGTVYKGELHDGTKIAVKRMESAVVSEKG----------------------FAE 634 (779)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~lg---~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------------------~~~ 634 (779)
.++..+.....+..+.+..| .|.-+.||+|...++..+|+|+++.....-.. ..-
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 45666777777776665554 56667899998888999999998643221110 112
Q ss_pred HHHHHHHHHcCC--CCccceEeeEEEeCCeEEEEEEecCCCCh-hhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHc
Q 004020 635 FKSEIAVLTKVR--HRHLVGLLGYCLDGNERLLVYEYMPQGTL-SRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHG 711 (779)
Q Consensus 635 ~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~ 711 (779)
..+|..-|.++. +-.+.+.+++.. -.+||||+..... .-.+.+ .++.......+..++++.+.-|-.
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD------v~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD------VPLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCccc------CCcCchhHHHHHHHHHHHHHHHHH
Confidence 356777777774 444455555432 3699999965311 111111 122333566778888888888774
Q ss_pred CCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 712 ~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
..++||+||..=|||+. ++.+.|+|||-|.....
T Consensus 185 --~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 185 --EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred --hcCcccccchhhheEEE-CCeEEEEECccccccCC
Confidence 47999999999999999 78999999998876543
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=3.3e-08 Score=86.16 Aligned_cols=63 Identities=21% Similarity=0.316 Sum_probs=51.7
Q ss_pred cCCCCccEEEeecCcccCCCCCCC-CCCCCcEEEccCCccccccChhhhCCCCCCEEEccCcccc
Q 004020 234 QNMTSLTQLWLHGNSFTGPLPDLS-GLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297 (779)
Q Consensus 234 ~~l~~L~~L~L~~N~l~~~~~~~~-~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 297 (779)
.....|+..+|++|.|...++.|. .++.++.|+|++|.|+ .+|..+..++.|+.|++++|+|.
T Consensus 50 ~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~ 113 (177)
T KOG4579|consen 50 SKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN 113 (177)
T ss_pred hCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc
Confidence 345678888999999998888754 4568899999999998 68888999999999888888875
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.9e-06 Score=101.82 Aligned_cols=52 Identities=29% Similarity=0.367 Sum_probs=32.2
Q ss_pred CCeEEEEccCccccccccccccccccCCeEeccCcccccc-CCccCCCCCCCC
Q 004020 370 GNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGT-IPKELTTLPSLE 421 (779)
Q Consensus 370 ~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~-iP~~l~~l~~L~ 421 (779)
++|+.|.+........+.+....+..+..+-+..+.+.|. .-.++..++++.
T Consensus 770 ~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~ 822 (889)
T KOG4658|consen 770 PHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLY 822 (889)
T ss_pred CcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeE
Confidence 4677777777776666666666666666677777777655 233344443333
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.24 E-value=7.5e-09 Score=112.74 Aligned_cols=125 Identities=30% Similarity=0.303 Sum_probs=85.5
Q ss_pred CccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCC-ccccCCccee
Q 004020 137 SLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPL-SFGKSSIQTL 215 (779)
Q Consensus 137 ~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~~~L~~l 215 (779)
.|.+.+.++|.+.. ...++.-++.|+.|+|++|+++..- .+. .++.|++|||++|.|+ .+|. ....+.|+.|
T Consensus 165 ~L~~a~fsyN~L~~--mD~SLqll~ale~LnLshNk~~~v~--~Lr--~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L 237 (1096)
T KOG1859|consen 165 KLATASFSYNRLVL--MDESLQLLPALESLNLSHNKFTKVD--NLR--RLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLL 237 (1096)
T ss_pred hHhhhhcchhhHHh--HHHHHHHHHHhhhhccchhhhhhhH--HHH--hcccccccccccchhc-cccccchhhhhheee
Confidence 67778888888863 6677777888888888888887332 443 6888888888888888 4443 2222456677
Q ss_pred eccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCC--CCCCCCCCcEEEccCCccc
Q 004020 216 WLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP--DLSGLSSLQDFSVRDNQLT 273 (779)
Q Consensus 216 ~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~l~~L~~L~l~~N~l~ 273 (779)
++.+|-++.. ..+.++.+|+.|||+.|-|.+.-. .++.+..|..|+|.+|.+-
T Consensus 238 ~lrnN~l~tL-----~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 238 NLRNNALTTL-----RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred eecccHHHhh-----hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 7766655432 234567777778888887776332 3566677777777777764
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.22 E-value=2.3e-08 Score=87.06 Aligned_cols=138 Identities=13% Similarity=0.243 Sum_probs=97.0
Q ss_pred EeCCCCcEEEEEecCCCccccCCcccc---CCCCCcEEEcccCccccCCCCC-CCCCCccEEecCCCCCCCCCcccccCC
Q 004020 60 QCSPSNRVTRIQIGGQNIEGTLPKELN---SLSSLTVLEVMKNKLTGQIPSL-SGLSSLQEVLFDDNNFTSVPSDFFKGL 135 (779)
Q Consensus 60 ~c~~~~~v~~l~l~~~~l~~~~p~~l~---~l~~L~~L~Ls~N~l~~~~~~~-~~l~~L~~L~l~~N~l~~~~~~~~~~l 135 (779)
+|+..-..-.+||+.+.|- .+++++. ...+|+..+|++|.+...++.| ...+.++.|+|++|.|+.+|.+ +..+
T Consensus 22 rcedakE~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisdvPeE-~Aam 99 (177)
T KOG4579|consen 22 RCEDAKELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISDVPEE-LAAM 99 (177)
T ss_pred hhHHHHHhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhhchHH-Hhhh
Confidence 3544445677888888776 5665544 4456777799999998777755 4456889999999999999988 8899
Q ss_pred CCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCC
Q 004020 136 TSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIP 204 (779)
Q Consensus 136 ~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p 204 (779)
+.|+.|++++|.|.. .|..+..|.+|.+|+..+|.+. .+|-.+.-+..+.| .++.++-+.+.-+
T Consensus 100 ~aLr~lNl~~N~l~~--~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al--~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 100 PALRSLNLRFNPLNA--EPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPAL--IKLGNEPLGDETK 163 (177)
T ss_pred HHhhhcccccCcccc--chHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHH--HHhcCCcccccCc
Confidence 999999999999864 7787777888888888888876 44433331222333 3345555554433
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 779 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-38 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-37 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-33 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-33 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-32 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-31 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-16 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 7e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-16 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-14 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-12 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 8e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 9e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 9e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-07 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 8e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-06 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-06 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-06 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-06 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 7e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 8e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 9e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 9e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-05 | ||
| 3zyn_A | 321 | Crystal Structure Of The N-Terminal Leucine Rich Re | 8e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-04 | ||
| 3zyo_A | 411 | Crystal Structure Of The N-Terminal Leucine Rich Re | 2e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-04 | ||
| 2o6r_A | 177 | Structural Diversity Of The Hagfish Variable Lympho | 4e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3ZYO|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats And Immunoglobulin Domain Of Netrin-G Ligand-3 Length = 411 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2O6R|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B61 Length = 177 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 293 bits (753), Expect = 2e-93
Identities = 81/215 (37%), Positives = 123/215 (57%), Gaps = 6/215 (2%)
Query: 557 SESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTK 616
S++ + + S ++V S + + L TNNF + ++G G FG VYKG L DG K
Sbjct: 6 SKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK 65
Query: 617 IAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLS 676
+A+KR S +G EF++EI L+ RH HLV L+G+C + NE +L+Y+YM G L
Sbjct: 66 VALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123
Query: 677 RHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 736
RHL+ + + W +RL I + ARG+ YLH ++ IHRD+K NILL ++ K
Sbjct: 124 RHLY-GSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPK 179
Query: 737 VADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAA 771
+ DFG+ + + + + T + GT GY+ PEY
Sbjct: 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFI 214
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 292 bits (751), Expect = 3e-93
Identities = 83/209 (39%), Positives = 115/209 (55%), Gaps = 14/209 (6%)
Query: 569 DLHVVEAGSMVISIQVLRNVTNNFSEE------NVLGRGGFGTVYKGELHDGTKIAVKRM 622
L V + S L+NVTNNF E N +G GGFG VYKG + + T +AVK++
Sbjct: 4 SLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKL 62
Query: 623 ESAVV--SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLF 680
+ V +E+ +F EI V+ K +H +LV LLG+ DG++ LVY YMP G+L L
Sbjct: 63 AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122
Query: 681 NRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740
G PL W R IA A G+ +LH IHRD+K +NILL + AK++DF
Sbjct: 123 CLD--GTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDF 177
Query: 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEY 769
GL R + + + +R+ GT Y+APE
Sbjct: 178 GLARASEKFAQTVMTSRIVGTTAYMAPEA 206
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 284 bits (729), Expect = 9e-90
Identities = 84/195 (43%), Positives = 120/195 (61%), Gaps = 8/195 (4%)
Query: 585 LRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTK 644
L+ ++NFS +N+LGRGGFG VYKG L DGT +AVKR+ ++ G +F++E+ +++
Sbjct: 25 LQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL-KEERTQGGELQFQTEVEMISM 83
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
HR+L+ L G+C+ ERLLVY YM G+++ L R E PL+W +R IAL AR
Sbjct: 84 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSAR 142
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
G+ YLH IHRD+K +NILL ++ A V DFGL +L H + T + GT G+
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGH 201
Query: 765 LAPEYAAETSGMTWQ 779
+APEY T +
Sbjct: 202 IAPEYL-----STGK 211
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 4e-62
Identities = 51/235 (21%), Positives = 85/235 (36%), Gaps = 33/235 (14%)
Query: 556 GSESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGT 615
G +S + L + V RG FG V+K +
Sbjct: 2 GHHHHHHSSGVDLGT------------ENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNE 48
Query: 616 KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN----ERLLVYEYMP 671
+AVK ++ + + + E+ L ++H +++ +G G + L+ +
Sbjct: 49 YVAVKIFPIQ--DKQSW-QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHE 105
Query: 672 QGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH-------GLAHQSFIHRDLKP 724
+G+LS L + W IA +ARG+ YLH + HRD+K
Sbjct: 106 KGSLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKS 159
Query: 725 SNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMTWQ 779
N+LL +++ A +ADFGL GT Y+APE
Sbjct: 160 KNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRD 214
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 7e-58
Identities = 61/181 (33%), Positives = 96/181 (53%), Gaps = 9/181 (4%)
Query: 591 NFSE---ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH 647
+ + + +G G FGTV++ E H G+ +AVK + + EF E+A++ ++RH
Sbjct: 35 PWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
++V +G +V EY+ +G+L R L K + L+ RRL++A DVA+G+
Sbjct: 94 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL--HKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
YLH + +HR+LK N+L+ KV DFGL RL S AGT ++AP
Sbjct: 152 YLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS--KSAAGTPEWMAP 208
Query: 768 E 768
E
Sbjct: 209 E 209
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 1e-57
Identities = 77/431 (17%), Positives = 154/431 (35%), Gaps = 81/431 (18%)
Query: 17 SATLSVNSQSSSDAAAMQALKTSLGNPASL-GWT-DPDPCKWKHIQCSPSNRVTRIQIGG 74
S S + + + + K L + L W+ + +PC + + C ++VT I +
Sbjct: 1 SFQASPSQSLYREIHQLISFKDVLPDKNLLPDWSSNKNPCTFDGVTCR-DDKVTSIDLSS 59
Query: 75 QNIE---GTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFT-SVPSD 130
+ + + L SL+ L L + + + G + +SL + N+ + V +
Sbjct: 60 KPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTL 119
Query: 131 F-FKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD-FLGGDTIPG 188
+ L+ +++ N+ D L+ + +I+G ++ D
Sbjct: 120 TSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGE 179
Query: 189 LMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNS 248
L HL ++ N + G + +S +L L + N+
Sbjct: 180 LKHLAISGNKISGDVDVS----------------------------RCVNLEFLDVSSNN 211
Query: 249 FTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSP-- 306
F+ +P L S+LQ + N+L+G ++ L ++N+++N F G P
Sbjct: 212 FSTGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSL 271
Query: 307 VRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSC 366
+ N F G + P L+ +
Sbjct: 272 QYLSL--AENKF---------TGEI------------PDFLSGACD-------------- 294
Query: 367 DAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDV 425
+T ++L G + F + L L LS N +G +P + L + L++LD+
Sbjct: 295 ----TLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDL 350
Query: 426 SNNHLFGKVPN 436
S N G++P
Sbjct: 351 SFNEFSGELPE 361
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 4e-53
Identities = 99/382 (25%), Positives = 168/382 (43%), Gaps = 31/382 (8%)
Query: 76 NIEGTLPKE-LNSLSSLTVLEVMKNKLTGQIP-SLSGLS-SLQEVLFDDNNFT-SVPSDF 131
N G LP + L + L VL++ N+ +G++P SL+ LS SL + NNF+ + +
Sbjct: 329 NFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNL 388
Query: 132 FKG-LTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLM 190
+ +LQ + L N F + IP +L + + L + ++GTIP LG ++ L
Sbjct: 389 CQNPKNTLQELYLQNNGF-TGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG--SLSKLR 445
Query: 191 HLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSV-AVIQNMTSLTQLWLHGNS 248
L L N L+G IP +++TL L+ L G + + + N T+L + L N
Sbjct: 446 DLKLWLNMLEGEIPQELMYVKTLETLILDFND----LTGEIPSGLSNCTNLNWISLSNNR 501
Query: 249 FTGPLP-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK--FNS 305
TG +P + L +L + +N +G +P+ L + SL ++L NLF G P F
Sbjct: 502 LTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ 561
Query: 306 PVRFDMAKGSNS----FCLDDAGVACDGRVNVLL---SIVKSVGYPAVLAESWKGNNPCN 358
+ + D C G N+L + + + +
Sbjct: 562 SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSR--- 618
Query: 359 SDWKGVSCDAGGNITVVNLKNLG---LSGTISSNFSRLTSLRQLMLSGNELTGTIPKELT 415
+ G + N + ++ LSG I + L L L N+++G+IP E+
Sbjct: 619 -VYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVG 677
Query: 416 TLPSLEMLDVSNNHLFGKVPNF 437
L L +LD+S+N L G++P
Sbjct: 678 DLRGLNILDLSSNKLDGRIPQA 699
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-51
Identities = 92/389 (23%), Positives = 151/389 (38%), Gaps = 42/389 (10%)
Query: 76 NIEGTLPKELNSLS-SLTVLEVMKNKLTGQIPSLSG---LSSLQEVLFDDNNFT-SVPSD 130
G LP+ L +LS SL L++ N +G I ++LQE+ +N FT +P
Sbjct: 354 EFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPT 413
Query: 131 FFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLM 190
+ L ++ L +N S IP SL + L+ + G IP L + L
Sbjct: 414 LSN-CSELVSLHLSFNYL-SGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELM--YVKTLE 469
Query: 191 HLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSV-AVIQNMTSLTQLWLHGNS 248
L L FN L G IP +++ + L +++L G + I + +L L L NS
Sbjct: 470 TLILDFNDLTGEIPSGLSNCTNLNWISL----SNNRLTGEIPKWIGRLENLAILKLSNNS 525
Query: 249 FTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPV 307
F+G +P L SL + N G +P+++ N
Sbjct: 526 FSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKK 585
Query: 308 RFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNP-CNSDWKGVSC 366
A F G + L+ + + + + + G+ + +
Sbjct: 586 ECHGAGNLLEF---------QGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMF 636
Query: 367 -DAGGN---------------ITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTI 410
D N + ++NL + +SG+I L L L LS N+L G I
Sbjct: 637 LDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRI 696
Query: 411 PKELTTLPSLEMLDVSNNHLFGKVPNFRQ 439
P+ ++ L L +D+SNN+L G +P Q
Sbjct: 697 PQAMSALTMLTEIDLSNNNLSGPIPEMGQ 725
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-48
Identities = 90/387 (23%), Positives = 148/387 (38%), Gaps = 67/387 (17%)
Query: 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDNNFT 125
T + + G + G +P S S L L + N +G++P +L + L+ + N F+
Sbjct: 297 TGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFS 356
Query: 126 -SVPSDFFKGLTSLQTISLDYNSFDSWVIPESL--KDATGLQRFSANGANITGTIPDFLG 182
+P SL T+ L N+F I +L LQ TG IP L
Sbjct: 357 GELPESLTNLSASLLTLDLSSNNFSG-PILPNLCQNPKNTLQELYLQNNGFTGKIPPTLS 415
Query: 183 GDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSV-AVIQNMTSLT 240
L+ LHL+FN+L G IP S G S ++ L L + L G + + + +L
Sbjct: 416 N--CSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKL----WLNMLEGEIPQELMYVKTLE 469
Query: 241 QLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQ 299
L L N TG +P LS ++L S+ +N+LTG +P + L +LA++ L+NN F G
Sbjct: 470 TLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGN 529
Query: 300 TP----KFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNN 355
P S + D+ +N F G +I PA + +
Sbjct: 530 IPAELGDCRSLIWLDLN--TNLF----NG-----------TI------PAAMFKQSG--- 563
Query: 356 PCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGN--ELTGTIPKE 413
+ ++G ++ +GN E G ++
Sbjct: 564 --------------------KIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQ 603
Query: 414 LTTLPSLEMLDVSNNHLFGKVPNFRQN 440
L L + ++++ G N
Sbjct: 604 LNRLSTRNPCNITSRVYGGHTSPTFDN 630
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 1e-46
Identities = 86/373 (23%), Positives = 139/373 (37%), Gaps = 84/373 (22%)
Query: 76 NIEGTLPKEL---NSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFT-SVPSDF 131
+I G + L L + NK++G + +S +L+ + NNF+ +P
Sbjct: 162 SISGANVVGWVLSDGCGELKHLAISGNKISGDVD-VSRCVNLEFLDVSSNNFSTGIPF-- 218
Query: 132 FKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMH 191
++LQ + + N S ++ T L+ + + G IP + L +
Sbjct: 219 LGDCSALQHLDISGNKL-SGDFSRAISTCTELKLLNISSNQFVGPIPPLP----LKSLQY 273
Query: 192 LHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTG 251
L LA N G IP +LT L L GN F G
Sbjct: 274 LSLAENKFTGEIPDFLS-------------------------GACDTLTGLDLSGNHFYG 308
Query: 252 PLPD-LSGLSSLQDFSVRDNQLTGIVP-SSLVNLHSLAVVNLTNNLFQGQTPK--FNSP- 306
+P S L+ ++ N +G +P +L+ + L V++L+ N F G+ P+ N
Sbjct: 309 AVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSA 368
Query: 307 --VRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGV 364
+ D++ SN+F G + L NP N
Sbjct: 369 SLLTLDLS--SNNF---------SGPI------------LPNL-----CQNPKN------ 394
Query: 365 SCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLD 424
+ + L+N G +G I S + L L LS N L+GTIP L +L L L
Sbjct: 395 ------TLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLK 448
Query: 425 VSNNHLFGKVPNF 437
+ N L G++P
Sbjct: 449 LWLNMLEGEIPQE 461
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-32
Identities = 55/243 (22%), Positives = 97/243 (39%), Gaps = 23/243 (9%)
Query: 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFT- 125
I + + G +PK + L +L +L++ N +G IP L SL + + N F
Sbjct: 493 NWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG 552
Query: 126 SVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRF--SANGANITGTIPDFLGG 183
++P+ FK Q+ + N + +K+ + + N G + L
Sbjct: 553 TIPAAMFK-----QSGKIAANFI-AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLN- 605
Query: 184 DTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSV-AVIQNMTSLTQ 241
+ ++ G +F S+ L + + L+G + I +M L
Sbjct: 606 -RLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDM----SYNMLSGYIPKEIGSMPYLFI 660
Query: 242 LWLHGNSFTGPLPD-LSGLSSLQ--DFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQG 298
L L N +G +PD + L L D S N+L G +P ++ L L ++L+NN G
Sbjct: 661 LNLGHNDISGSIPDEVGDLRGLNILDLS--SNKLDGRIPQAMSALTMLTEIDLSNNNLSG 718
Query: 299 QTP 301
P
Sbjct: 719 PIP 721
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-30
Identities = 47/241 (19%), Positives = 101/241 (41%), Gaps = 15/241 (6%)
Query: 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFT- 125
+ + ++ G +P L++ ++L + + N+LTG+IP + L +L + +N+F+
Sbjct: 469 ETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSG 528
Query: 126 SVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDT 185
++P++ SL + L+ N F + IP ++ Q I G ++ D
Sbjct: 529 NIPAELGD-CRSLIWLDLNTNLF-NGTIPAAM----FKQSGKIAANFIAGKRYVYIKNDG 582
Query: 186 IPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSV-AVIQNMTSLTQLW 243
+ H QG + S+ + G N S+ L
Sbjct: 583 MKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNI----TSRVYGGHTSPTFDNNGSMMFLD 638
Query: 244 LHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK 302
+ N +G +P + + L ++ N ++G +P + +L L +++L++N G+ P+
Sbjct: 639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQ 698
Query: 303 F 303
Sbjct: 699 A 699
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-17
Identities = 32/128 (25%), Positives = 50/128 (39%), Gaps = 14/128 (10%)
Query: 315 SNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITV 374
S S L L+S + +L W N + + GV+C +T
Sbjct: 5 SPSQSLYREIHQ-------LISFKDVLPDKNLLP-DWSSNKNPCT-FDGVTCR-DDKVTS 54
Query: 375 VNLKNLGLS---GTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLF 431
++L + L+ +SS+ LT L L LS + + G++ SL LD+S N L
Sbjct: 55 IDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLS 113
Query: 432 GKVPNFRQ 439
G V
Sbjct: 114 GPVTTLTS 121
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 8e-13
Identities = 20/77 (25%), Positives = 37/77 (48%), Gaps = 9/77 (11%)
Query: 370 GNITVVNLKNL--------GLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLE 421
G++ V NL S I ++L+ L +SGN+L+G + ++T L+
Sbjct: 192 GDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELK 250
Query: 422 MLDVSNNHLFGKVPNFR 438
+L++S+N G +P
Sbjct: 251 LLNISSNQFVGPIPPLP 267
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 1e-12
Identities = 32/123 (26%), Positives = 42/123 (34%), Gaps = 13/123 (10%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
N+ ++L N L+G I RL +L L LS N +G IP EL SL LD++ N
Sbjct: 491 NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLF 550
Query: 431 FGKVPNFRQNVIVKTDGNPDIGKDSSSFTPKSPPGSSPTPPGGDSGGNGSSGGANKNSNT 490
G +P + K S G D G N
Sbjct: 551 NGTIP-------------AAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQ 597
Query: 491 GKI 493
G
Sbjct: 598 GIR 600
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 3e-10
Identities = 34/198 (17%), Positives = 61/198 (30%), Gaps = 35/198 (17%)
Query: 9 SLFLLSLLSATLSVNSQSSSDAAAMQALKTSLGNPASLGWTDPDPCKWKHIQCSPSNRVT 68
++F S A + + K G L + + +
Sbjct: 557 AMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLS-----TRN 611
Query: 69 RIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFT-S 126
I + G ++ S+ L++ N L+G IP + + L + N+ + S
Sbjct: 612 PCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGS 671
Query: 127 VPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTI 186
+P + L L + L N + G IP + +
Sbjct: 672 IPDE-VGDLRGLNILDLSSN-------------------------KLDGRIPQAMSA--L 703
Query: 187 PGLMHLHLAFNFLQGPIP 204
L + L+ N L GPIP
Sbjct: 704 TMLTEIDLSNNNLSGPIP 721
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 1e-06
Identities = 26/105 (24%), Positives = 42/105 (40%), Gaps = 8/105 (7%)
Query: 67 VTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFT 125
+ + + + G +PKE+ S+ L +L + N ++G IP + L L + N
Sbjct: 634 MMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLD 693
Query: 126 -SVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSAN 169
+P LT L I L N+ S IPE + F
Sbjct: 694 GRIPQ-AMSALTMLTEIDLSNNNL-SGPIPEM----GQFETFPPA 732
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 6e-54
Identities = 59/180 (32%), Positives = 84/180 (46%), Gaps = 15/180 (8%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
E V+GRG FG V K + +A+K++ES E F E+ L++V H +
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES----ESERKAFIVELRQLSRVNHPN 62
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+V L G CL N LV EY G+L L E L ++ L ++GV YL
Sbjct: 63 IVKLYGACL--NPVCLVMEYAEGGSLYNVL--HGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMR-AKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
H + ++ IHRDLKP N+LL K+ DFG + T G+ ++APE
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPE 173
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 4e-53
Identities = 72/291 (24%), Positives = 127/291 (43%), Gaps = 22/291 (7%)
Query: 26 SSSDAAAMQALKTSLGNPASL-GW---TDPDPCKWKHIQCSP---SNRVTRIQIGGQNIE 78
+ D A+ +K LGNP +L W TD W + C + RV + + G N+
Sbjct: 4 NPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 79 GT--LPKELNSLSSLTVLEVMK-NKLTGQIP-SLSGLSSLQEVLFDDNNFT-SVPSDFFK 133
+P L +L L L + N L G IP +++ L+ L + N + ++P +
Sbjct: 64 KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
Query: 134 GLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLM-HL 192
+ +L T+ YN+ S +P S+ L + +G I+G IPD G L +
Sbjct: 124 -IKTLVTLDFSYNAL-SGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS--FSKLFTSM 179
Query: 193 HLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSV-AVIQNMTSLTQLWLHGNSFTG 251
++ N L G IP +F ++ + L + L G + + + ++ L NS
Sbjct: 180 TISRNRLTGKIPPTFANLNLAFVDL----SRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235
Query: 252 PLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK 302
L + +L +R+N++ G +P L L L +N++ N G+ P+
Sbjct: 236 DLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 36/113 (31%), Positives = 52/113 (46%), Gaps = 8/113 (7%)
Query: 332 NVLLSIVKSVGYPAVLAESWKGNNP-CNSDWKGVSCDAGGN---ITVVNLKNLGLSGT-- 385
LL I K +G P L+ SW CN W GV CD + ++L L L
Sbjct: 9 QALLQIKKDLGNPTTLS-SWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP 67
Query: 386 ISSNFSRLTSLRQLMLSG-NELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNF 437
I S+ + L L L + G N L G IP + L L L +++ ++ G +P+F
Sbjct: 68 IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF 120
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 21/66 (31%), Positives = 33/66 (50%), Gaps = 1/66 (1%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
N ++L L+ + +L L L N + GT+P+ LT L L L+VS N+L
Sbjct: 222 NTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280
Query: 431 FGKVPN 436
G++P
Sbjct: 281 CGEIPQ 286
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 17/67 (25%), Positives = 32/67 (47%), Gaps = 1/67 (1%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
N+ V+L L G S F + +++ L+ N L + ++ +L LD+ NN +
Sbjct: 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRI 256
Query: 431 FGKVPNF 437
+G +P
Sbjct: 257 YGTLPQG 263
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 21/69 (30%), Positives = 32/69 (46%), Gaps = 9/69 (13%)
Query: 376 NLKNLG--------LSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSL-EMLDVS 426
+K L LSGT+ + S L +L + GN ++G IP + L + +S
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTIS 182
Query: 427 NNHLFGKVP 435
N L GK+P
Sbjct: 183 RNRLTGKIP 191
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 7e-09
Identities = 17/75 (22%), Positives = 27/75 (36%), Gaps = 4/75 (5%)
Query: 233 IQNMTSLTQLWLHGNSFTGPL---PDLSGLSSLQDFSVRD-NQLTGIVPSSLVNLHSLAV 288
+ L L G + P L+ L L + N L G +P ++ L L
Sbjct: 46 DTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHY 105
Query: 289 VNLTNNLFQGQTPKF 303
+ +T+ G P F
Sbjct: 106 LYITHTNVSGAIPDF 120
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 1e-08
Identities = 13/56 (23%), Positives = 24/56 (42%), Gaps = 1/56 (1%)
Query: 382 LSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNF 437
L+G I F+ L +L + LS N L G + + + + ++ N L +
Sbjct: 186 LTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKV 240
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 5e-06
Identities = 17/48 (35%), Positives = 21/48 (43%)
Query: 76 NIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNN 123
I GTLP+ L L L L V N L G+IP L + +N
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 2e-05
Identities = 18/68 (26%), Positives = 29/68 (42%), Gaps = 10/68 (14%)
Query: 370 GNI-TVVNLKNL--------GLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSL 420
++ V KNL + GT+ ++L L L +S N L G IP+ L
Sbjct: 235 FDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG-NLQRF 293
Query: 421 EMLDVSNN 428
++ +NN
Sbjct: 294 DVSAYANN 301
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 1e-52
Identities = 54/202 (26%), Positives = 81/202 (40%), Gaps = 27/202 (13%)
Query: 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR 648
+N ++GRG +G VYKG L +AVK A + + F K I + + H
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFA--NRQNFINEK-NIYRVPLMEHD 67
Query: 649 HLVGLLGYCLDGN-----ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVA 703
++ + E LLV EY P G+L ++L +W +A V
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH------TSDWVSSCRLAHSVT 121
Query: 704 RGVEYLH------GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR------LAPDNGK 751
RG+ YLH + HRDL N+L+ +D ++DFGL L +
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181
Query: 752 HSIETRLAGTFGYLAPEYAAET 773
+ GT Y+APE
Sbjct: 182 DNAAISEVGTIRYMAPEVLEGA 203
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-51
Identities = 39/183 (21%), Positives = 74/183 (40%), Gaps = 17/183 (9%)
Query: 591 NFSE---ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH 647
+F + L G ++KG G I VK ++ S + +F E L H
Sbjct: 8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 648 RHLVGLLGYCLDGNERLL--VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARG 705
+++ +LG C + +MP G+L L ++ ++ + ALD+ARG
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN---FVVDQSQAVKFALDMARG 123
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYL 765
+ +LH L L ++++ +DM A+++ + G+ ++
Sbjct: 124 MAFLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-------MYAPAWV 175
Query: 766 APE 768
APE
Sbjct: 176 APE 178
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-51
Identities = 58/190 (30%), Positives = 97/190 (51%), Gaps = 23/190 (12%)
Query: 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRM-----ESAVVSEKGFAEFKSEIAVLT 643
N E +G+GGFG V+KG + D + +A+K + E + F EF+ E+ +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 644 KVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVA 703
+ H ++V L G + +V E++P G L L ++ P++W+ +L + LD+A
Sbjct: 79 NLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIA 132
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILL-----GDDMRAKVADFGLVRLAPDNGKHSIETRL 758
G+EY+ + +HRDL+ NI L + AKVADFGL + + L
Sbjct: 133 LGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGL 186
Query: 759 AGTFGYLAPE 768
G F ++APE
Sbjct: 187 LGNFQWMAPE 196
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-51
Identities = 57/174 (32%), Positives = 87/174 (50%), Gaps = 10/174 (5%)
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
+G G FGTVYKG+ H +AVK + + + FK+E+ VL K RH +++ +
Sbjct: 29 GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
GY +V ++ +L HL + E + + IA ARG++YLH
Sbjct: 87 GYSTAPQ-LAIVTQWCEGSSLYHHLHASE----TKFEMKKLIDIARQTARGMDYLHA--- 138
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
+S IHRDLK +NI L +D K+ DFGL +L+G+ ++APE
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 3e-51
Identities = 46/184 (25%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 591 NFSE---ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH 647
F + ++G+G FG VY G H ++A++ ++ +E FK E+ + RH
Sbjct: 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
++V +G C+ ++ TL + + K L+ + IA ++ +G+
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMG 144
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRL---AGTFGY 764
YLH + +H+DLK N+ D+ + + DFGL ++ E +L G +
Sbjct: 145 YLHA---KGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200
Query: 765 LAPE 768
LAPE
Sbjct: 201 LAPE 204
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 5e-51
Identities = 57/191 (29%), Positives = 88/191 (46%), Gaps = 24/191 (12%)
Query: 591 NFSE---ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSE--KGFAEFKSEIAVLTKV 645
+F+E E ++G GGFG VY+ G ++AVK + + + E + +
Sbjct: 5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARG 705
+H +++ L G CL LV E+ G L+R L ++ + + A+ +ARG
Sbjct: 64 KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR------IPPDILVNWAVQIARG 117
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMR--------AKVADFGLVRLAPDNGKHSIETR 757
+ YLH A IHRDLK SNIL+ + K+ DFGL R K
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----MS 173
Query: 758 LAGTFGYLAPE 768
AG + ++APE
Sbjct: 174 AAGAYAWMAPE 184
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 5e-47
Identities = 50/187 (26%), Positives = 80/187 (42%), Gaps = 22/187 (11%)
Query: 595 ENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGL 653
VLG+G FG K + G + +K + E+ F E+ V+ + H +++
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKF 72
Query: 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
+G + EY+ GTL + + W++R++ A D+A G+ YLH
Sbjct: 73 IGVLYKDKRLNFITEYIKGGTLRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLH--- 125
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR------------LAGT 761
+ IHRDL N L+ ++ VADFGL RL D R + G
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 762 FGYLAPE 768
++APE
Sbjct: 186 PYWMAPE 192
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 5e-45
Identities = 47/198 (23%), Positives = 82/198 (41%), Gaps = 25/198 (12%)
Query: 584 VLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSE--IAV 641
+ R V + + +G+G +G V++G G +AVK + S + + E +
Sbjct: 2 MQRTVARDITLLECVGKGRYGEVWRGSWQ-GENVAVK-----IFSSRDEKSWFRETELYN 55
Query: 642 LTKVRHRHLVGLLGYCLDGN----ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLT 697
+RH +++G + + + L+ Y G+L +L L+ L
Sbjct: 56 TVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL------TTLDTVSCLR 109
Query: 698 IALDVARGVEYLHGLAHQSF-----IHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752
I L +A G+ +LH + HRDLK NIL+ + + +AD GL + +
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169
Query: 753 --SIETRLAGTFGYLAPE 768
GT Y+APE
Sbjct: 170 LDVGNNPRVGTKRYMAPE 187
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-44
Identities = 45/185 (24%), Positives = 77/185 (41%), Gaps = 21/185 (11%)
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
+G+G +G V+ G+ G K+AVK + +E+ ++EI +RH +++G +
Sbjct: 42 VKQIGKGRYGEVWMGKWR-GEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFI 97
Query: 655 GYCLDGNER----LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
+ G L+ +Y G+L +L + L+ L +A G+ +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLH 151
Query: 711 GLAHQSF-----IHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS--IETRLAGTFG 763
+ HRDLK NIL+ + +AD GL + GT
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 764 YLAPE 768
Y+ PE
Sbjct: 212 YMPPE 216
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-41
Identities = 48/185 (25%), Positives = 78/185 (42%), Gaps = 21/185 (11%)
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
+ +G+G FG V++G+ G ++AVK S E+ ++EI +RH +++G +
Sbjct: 47 QESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFI 102
Query: 655 GYCLDGN----ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
N + LV +Y G+L +L + + +AL A G+ +LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLH 156
Query: 711 GLAHQS-----FIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS--IETRLAGTFG 763
+ HRDLK NIL+ + +AD GL GT
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 764 YLAPE 768
Y+APE
Sbjct: 217 YMAPE 221
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-40
Identities = 73/385 (18%), Positives = 132/385 (34%), Gaps = 29/385 (7%)
Query: 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTS 126
T + +G I P+ L L VL + N+L+ + + ++L E+ N+
Sbjct: 52 TSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQK 111
Query: 127 VPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTI 186
+ ++ F +L T+ L +N S + LQ + I + L
Sbjct: 112 IKNNPFVKQKNLITLDLSHNGLSS-TKLGTQVQLENLQELLLSNNKIQALKSEELDIFAN 170
Query: 187 PGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLH 245
L L L+ N ++ P F + L+LN + L + + TS+ L L
Sbjct: 171 SSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLS 230
Query: 246 GNSFTGPLPD-LSGL--SSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK 302
+ + GL ++L + N L + S L L L N Q
Sbjct: 231 NSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSH 290
Query: 303 FNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSV-GYPAVLAE-SWKGNNPCNSD 360
L + + L I + L + + N+
Sbjct: 291 S-----LHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDI---- 341
Query: 361 WKGVSCDAGGNITVVNLKNLGLSG------TISSN-FSRL--TSLRQLMLSGNELTGTIP 411
G+ + + NLK L LS T+++ F L + L L L+ N+++
Sbjct: 342 -PGIKSNMFTGLI--NLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIES 398
Query: 412 KELTTLPSLEMLDVSNNHLFGKVPN 436
+ L LE+LD+ N + ++
Sbjct: 399 DAFSWLGHLEVLDLGLNEIGQELTG 423
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 6e-36
Identities = 62/375 (16%), Positives = 117/375 (31%), Gaps = 60/375 (16%)
Query: 76 NIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFK- 133
+I+ +L L++ N L+ + L +LQE+L +N ++ S+
Sbjct: 108 SIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDI 167
Query: 134 -GLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD-FLGGDTIPGLMH 191
+SL+ + L N P L N + ++ + + +
Sbjct: 168 FANSSLKKLELSSNQIKE-FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRN 226
Query: 192 LHLAFNFLQGPIPLSFG---KSSIQTLWLNGQKGDSKLNG-SVAVIQNMTSLTQLWLHGN 247
L L+ + L +F +++ L L + LN + L +L N
Sbjct: 227 LSLSNSQLSTTSNTTFLGLKWTNLTMLDL----SYNNLNVVGNDSFAWLPQLEYFFLEYN 282
Query: 248 SFTGPLPD-LSGLSSLQ---------DFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
+ L GL +++ S+ L I S L L +N+ +N
Sbjct: 283 NIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDN--- 339
Query: 298 GQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESW-KGNNP 356
N L L+ S+
Sbjct: 340 ----DIPGIKSNMFTGLINLKYLS-------------------------LSNSFTSLRTL 370
Query: 357 CNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIP-KELT 415
N + ++ + ++NL +S S FS L L L L NE+ + +E
Sbjct: 371 TNETFVSLA---HSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWR 427
Query: 416 TLPSLEMLDVSNNHL 430
L ++ + +S N
Sbjct: 428 GLENIFEIYLSYNKY 442
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 7e-34
Identities = 60/387 (15%), Positives = 114/387 (29%), Gaps = 83/387 (21%)
Query: 60 QCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVL 118
+C+ S+ V + +P +L +++TVL + N+L + + S L +
Sbjct: 1 KCTVSHEV--ADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLD 55
Query: 119 FDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIP 178
N + + + + L L+ ++L +N + ++ T L +I
Sbjct: 56 VGFNTISKLEPELCQKLPMLKVLNLQHNELSQ-LSDKTFAFCTNLTELHLMSNSIQKIKN 114
Query: 179 DFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTS 238
+ L+ L L+ N L + + +
Sbjct: 115 NPFVK--QKNLITLDLSHNGLSSTKLGTQV--------------------------QLEN 146
Query: 239 LTQLWLHGNSFTGPLPD---LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNL 295
L +L L N + + SSL+ + NQ+ P + L + L N
Sbjct: 147 LQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQ 206
Query: 296 FQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVL-LSIVKSVGYPAVLAESWKGN 354
+ CL+ A + L LS
Sbjct: 207 LGPSLTE--------------KLCLELANT----SIRNLSLS------------------ 230
Query: 355 NPCNSDWKGVSCDAGGNITVVNLKNLGLS-----GTISSNFSRLTSLRQLMLSGNELTGT 409
NS S + NL L LS + +F+ L L L N +
Sbjct: 231 ---NSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHL 287
Query: 410 IPKELTTLPSLEMLDVSNNHLFGKVPN 436
L L ++ L++ + +
Sbjct: 288 FSHSLHGLFNVRYLNLKRSFTKQSISL 314
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-33
Identities = 69/412 (16%), Positives = 133/412 (32%), Gaps = 62/412 (15%)
Query: 76 NIEGTLPKELNSLSSLTVLEVMKNKLTGQIP----------SLSGLSSLQEVLFDDNNFT 125
NI+ L+ L ++ L + ++ I S L L+ + +DN+
Sbjct: 283 NIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIP 342
Query: 126 SVPSDFFKGLTSLQTISLDYNSFDSWVIPESL---KDATGLQRFSANGANITGTIPDFLG 182
+ S+ F GL +L+ +SL + + + L + I+ D
Sbjct: 343 GIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFS 402
Query: 183 GDTIPGLMHLHLAFNFLQGPIPLS-FGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLT 240
+ L L L N + + + +I ++L+ K S + SL
Sbjct: 403 W--LGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNS---FALVPSLQ 457
Query: 241 QLWLHGNSFTG---PLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
+L L + L +L + +N + I L L L +++L +N
Sbjct: 458 RLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA 517
Query: 298 GQTPKFNSPVRFDMAKGSNSFC-LDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNP 356
N KG + L+ L N
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILN-------------LE----------------SNG- 547
Query: 357 CNSDWKGVSCDAGGN---ITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKE 413
+ + + + + +++L L+ +S F+ SL+ L L N +T K
Sbjct: 548 ----FDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKV 603
Query: 414 L-TTLPSLEMLDVSNNHLFGKVPNFRQNVIVKTDGNPDIGKDSSSFTPKSPP 464
+L LD+ N + V + + +I + SS + +PP
Sbjct: 604 FGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPP 655
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 9e-24
Identities = 49/257 (19%), Positives = 93/257 (36%), Gaps = 24/257 (9%)
Query: 64 SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDN 122
T+ I ++ L L L + N + G +GL +L+ + ++
Sbjct: 304 KRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNS 363
Query: 123 --NFTSVPSDFFKGL--TSLQTISLDYNSFDSWVIPESLKDATGLQ--RFSANGANITGT 176
+ ++ ++ F L + L ++L N + ++ L+ N I
Sbjct: 364 FTSLRTLTNETFVSLAHSPLHILNLTKNKISK-IESDAFSWLGHLEVLDLGLN--EIGQE 420
Query: 177 IP-DFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQ 234
+ G + + ++L++N SF S+Q L L ++ S + Q
Sbjct: 421 LTGQEWRG--LENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVAL-KNVDSSPSPFQ 477
Query: 235 NMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLT--------GIVPSSLVNLHS 285
+ +LT L L N+ D L GL L+ ++ N L G L L
Sbjct: 478 PLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSH 537
Query: 286 LAVVNLTNNLFQGQTPK 302
L ++NL +N F +
Sbjct: 538 LHILNLESNGFDEIPVE 554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 6e-21
Identities = 47/268 (17%), Positives = 76/268 (28%), Gaps = 52/268 (19%)
Query: 76 NIEGTLPKELNSLSSLTVLEVMKNKLTG--QIPS-LSGLSSLQEVLFDDNNFTSVPSDFF 132
+ SL L + + L PS L +L + +NN ++ D
Sbjct: 441 KYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDML 500
Query: 133 KGLTSLQTISLDYNSFDS-------WVIPESLKDATGLQRFSANGANITGTIPDFLGGDT 185
+GL L+ + L +N+ LK + L + +
Sbjct: 501 EGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKD-- 558
Query: 186 IPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLH 245
+ L + L N L F N SL L L
Sbjct: 559 LFELKIIDLGLNNLNTLPASVFN--------------------------NQVSLKSLNLQ 592
Query: 246 GNSFTGPLPDL--SGLSSLQDFSVRDNQLTGIVPS-----SLVNLHSLAVVNLTNNLFQG 298
N T + +L + +R N S + +N + L+++
Sbjct: 593 KNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCN 652
Query: 299 QTPKF-NSPVR-FDMAKGSNSFCLDDAG 324
P + PVR FD S C D A
Sbjct: 653 TPPHYHGFPVRLFD-----TSSCKDSAH 675
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 24/117 (20%), Positives = 38/117 (32%), Gaps = 5/117 (4%)
Query: 64 SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDN 122
N + R+ G L LS L +L + N L L+ + N
Sbjct: 513 HNNLARLWKHA--NPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLN 570
Query: 123 NFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDA-TGLQRFSANGANITGTIP 178
N ++P+ F SL++++L N S V + A L T
Sbjct: 571 NLNTLPASVFNNQVSLKSLNLQKNLITS-VEKKVFGPAFRNLTELDMRFNPFDCTCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 9e-05
Identities = 19/72 (26%), Positives = 33/72 (45%), Gaps = 5/72 (6%)
Query: 371 NITVVNLKNLGLSGTISSNFS---RLTSLRQLMLSGNELTGTIPKELTTL--PSLEMLDV 425
+ + L N+ L +++ TS+R L LS ++L+ T L +L MLD+
Sbjct: 196 RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255
Query: 426 SNNHLFGKVPNF 437
S N+L +
Sbjct: 256 SYNNLNVVGNDS 267
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 14/79 (17%), Positives = 25/79 (31%), Gaps = 9/79 (11%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGN---------ELTGTIPKELTTLPSLE 421
+ L+ + S + L ++R L L + L L LE
Sbjct: 273 QLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLE 332
Query: 422 MLDVSNNHLFGKVPNFRQN 440
L++ +N + G N
Sbjct: 333 HLNMEDNDIPGIKSNMFTG 351
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-37
Identities = 70/386 (18%), Positives = 134/386 (34%), Gaps = 45/386 (11%)
Query: 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTS 126
+ + I+ SLS L+ L + N + + SGLSSLQ+++ + N S
Sbjct: 55 QVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114
Query: 127 VPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDT- 185
+ + L +L+ +++ +N S+ +PE + T L+ + I L
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174
Query: 186 -IPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSV--AVIQNMTSLTQL 242
+ L L+ N + P +F + + L L ++ + +V IQ + L
Sbjct: 175 MPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR----NNFDSLNVMKTCIQGLAGLEVH 230
Query: 243 WLHGNSFTG----PLPDLSGLSSLQDFSVRDNQLTGI------VPSSLVNLHSLAVVNLT 292
L F D S L L + ++ + +L + + L +++ +L
Sbjct: 231 RLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLV 290
Query: 293 NNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWK 352
+ F G L + P + +S K
Sbjct: 291 SV-------TIERVKDFSYNFGWQHLELVN---------CKFGQF------PTLKLKSLK 328
Query: 353 GNNPCNSDWKGVSCDAG-GNITVVNLKN--LGLSGTISSNFSRLTSLRQLMLSGNELTGT 409
++ + ++ ++L L G S + TSL+ L LS N + T
Sbjct: 329 RLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-T 387
Query: 410 IPKELTTLPSLEMLDVSNNHLFGKVP 435
+ L LE LD +++L
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSE 413
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-33
Identities = 64/427 (14%), Positives = 130/427 (30%), Gaps = 91/427 (21%)
Query: 76 NIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVP-SDFFK 133
I+ + LSSL L ++ L + L +L+E+ N S ++F
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 134 GLTSLQTISLDYNSFDSWVIPESLKDATGLQRF------SANGANITGTIPDFLGGDTIP 187
LT+L+ + L N S + L+ + S N + P
Sbjct: 147 NLTNLEHLDLSSNKIQS-IYCTDLRVLHQMPLLNLSLDLSLN--PMNFIQPGAFKE---I 200
Query: 188 GLMHLHLAFNFLQGPIPLSFGKS----SIQTLWLNGQKGDSKL----------------- 226
L L L NF + + + + L L + + L
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 227 -----------NGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGI 275
+ + + +T+++ L + + D S Q + + +
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQF 319
Query: 276 VPS-------------------SLVNLHSLAVVNLTNN--LFQGQTPKFNSP----VRFD 310
S V+L SL ++L+ N F+G + + D
Sbjct: 320 PTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 311 MAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGG 370
++ N ++++ + L ++ + +
Sbjct: 380 LSF------------------NGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNH 429
N+ +++ + + F+ L+SL L ++GN + T L +L LD+S
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481
Query: 430 LFGKVPN 436
L P
Sbjct: 482 LEQLSPT 488
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-29
Identities = 55/363 (15%), Positives = 100/363 (27%), Gaps = 81/363 (22%)
Query: 81 LPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
+P L S L++ N L S LQ + ++ ++ L+ L
Sbjct: 22 IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFL 199
T+ L N S + + + LQ+ A N+ +G + L L++A N +
Sbjct: 80 TLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGH--LKTLKELNVAHNLI 136
Query: 200 QG-PIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLS 257
Q +P F N+T+L L L N DL
Sbjct: 137 QSFKLPEYFS--------------------------NLTNLEHLDLSSNKIQSIYCTDLR 170
Query: 258 GLSSLQDFSVR----DNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAK 313
L + ++ N + I P + + L + L NN
Sbjct: 171 VLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVM----KTCIQGLA 225
Query: 314 GSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNIT 373
G L G + + A +
Sbjct: 226 GLEVHRLVL------------------------------GEFRNEGNLEKFDKSALEGLC 255
Query: 374 VVNLKNLGLS------GTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSN 427
+ ++ L+ I F+ LT++ L + + + L++ N
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVN 313
Query: 428 NHL 430
Sbjct: 314 CKF 316
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-27
Identities = 43/253 (16%), Positives = 87/253 (34%), Gaps = 33/253 (13%)
Query: 76 NIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFK-- 133
+ N L++++ ++ + ++ S Q + + F P+ K
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSL 327
Query: 134 -----------------GLTSLQTISLDYNSF-DSWVIPESLKDATGLQRFSANGANITG 175
L SL+ + L N +S T L+ + +
Sbjct: 328 KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387
Query: 176 TIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK--SSIQTLWLNGQKGDSKLNGSVA-V 232
+FLG + L HL + L+ S ++ L ++ + + +
Sbjct: 388 MSSNFLG---LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS----HTHTRVAFNGI 440
Query: 233 IQNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVN 290
++SL L + GNSF + L +L + QL + P++ +L SL V+N
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 500
Query: 291 LTNNLFQGQTPKF 303
+++N F
Sbjct: 501 MSHNNFFSLDTFP 513
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-27
Identities = 44/225 (19%), Positives = 79/225 (35%), Gaps = 16/225 (7%)
Query: 86 NSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDN--NFTSVPSDFFKGLTSLQTISL 143
L SL L NK S L SL+ + N +F S G TSL+ + L
Sbjct: 322 LKLKSLKRLTFTSNKGGN-AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIP-DFLGGDTIPGLMHLHLAFNFLQGP 202
+N + + + L+ +N+ + L++L ++ +
Sbjct: 381 SFNGVIT--MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS--LRNLIYLDISHTHTRVA 436
Query: 203 IPLSFGK-SSIQTLWLNGQKGDSKLNGSV--AVIQNMTSLTQLWLHGNSFTGPLPD-LSG 258
F SS++ L + G + + + + +LT L L P +
Sbjct: 437 FNGIFNGLSSLEVLKMAG----NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492
Query: 259 LSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKF 303
LSSLQ ++ N + L+SL V++ + N +
Sbjct: 493 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 537
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-24
Identities = 36/221 (16%), Positives = 71/221 (32%), Gaps = 15/221 (6%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTS 137
T+ L L L+ + L L +L + + + F GL+S
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446
Query: 138 LQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFN 197
L+ + + NSF +P+ + L + + P + L L+++ N
Sbjct: 447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS--LSSLQVLNMSHN 504
Query: 198 FLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSV--AVIQNMTSLTQLWLHGNSFTG--P 252
+ +S+Q L + + S + +SL L L N F
Sbjct: 505 NFFSLDTFPYKCLNSLQVLDYSLN----HIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560
Query: 253 LPDLSG-LSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLT 292
+ + V ++ PS + + +N+T
Sbjct: 561 HQSFLQWIKDQRQLLVEVERMECATPSDKQGM-PVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 6e-09
Identities = 20/71 (28%), Positives = 32/71 (45%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
N+T ++L L + F+ L+SL+ L +S N L SL++LD S NH+
Sbjct: 471 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 530
Query: 431 FGKVPNFRQNV 441
Q+
Sbjct: 531 MTSKKQELQHF 541
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 13/67 (19%), Positives = 25/67 (37%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+ V++L + + L+ L L+L+GN + + L SL+ L +L
Sbjct: 53 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNL 112
Query: 431 FGKVPNF 437
Sbjct: 113 ASLENFP 119
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 8e-08
Identities = 16/71 (22%), Positives = 32/71 (45%), Gaps = 1/71 (1%)
Query: 371 NITVVNLKNLGLSGTISSN-FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNH 429
++ V+ + + F+ L +L L LS +L P +L SL++L++S+N+
Sbjct: 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN 505
Query: 430 LFGKVPNFRQN 440
F +
Sbjct: 506 FFSLDTFPYKC 516
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 6e-07
Identities = 15/63 (23%), Positives = 29/63 (46%), Gaps = 1/63 (1%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLP-SLEMLDVSNNH 429
++ V+N+ + + + L SL+ L S N + + +EL P SL L+++ N
Sbjct: 495 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 554
Query: 430 LFG 432
Sbjct: 555 FAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 5e-05
Identities = 15/71 (21%), Positives = 21/71 (29%), Gaps = 3/71 (4%)
Query: 366 CDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDV 425
C L I N S + L LS N L + P L++LD+
Sbjct: 3 CVEVVPNITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59
Query: 426 SNNHLFGKVPN 436
S +
Sbjct: 60 SRCEIQTIEDG 70
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 63/226 (27%), Positives = 101/226 (44%), Gaps = 26/226 (11%)
Query: 555 GGSESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGE-LHD 613
G S SSG +L+ ++ I ++ LG GGF V E LHD
Sbjct: 2 GSSHHHHHHSSGRENLYFQ---GHMVIID-----NKHYLFIQKLGEGGFSYVDLVEGLHD 53
Query: 614 GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD----GNERLLVYEY 669
G A+KR+ ++ E + E + H +++ L+ YCL +E L+ +
Sbjct: 54 GHFYALKRI--LCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPF 111
Query: 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 729
+GTL + K++G L + L + L + RG+E +H + + HRDLKP+NILL
Sbjct: 112 FKRGTLWNEIERLKDKG-NFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILL 167
Query: 730 GDDMRAKVADFGLVRLAPDNGKHSIETRLA-------GTFGYLAPE 768
GD+ + + D G + A + + S + T Y APE
Sbjct: 168 GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 2e-36
Identities = 55/155 (35%), Positives = 78/155 (50%), Gaps = 10/155 (6%)
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
+G G FG V+ G + K+A+K + +SE+ +F E V+ K+ H LV L
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLY 69
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
G CL+ LV E+M G LS +L R + GL L + LDV G+ YL
Sbjct: 70 GVCLEQAPICLVTEFMEHGCLSDYL--RTQRGL--FAAETLLGMCLDVCEGMAYL---EE 122
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
IHRDL N L+G++ KV+DFG+ R D+
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 55/160 (34%), Positives = 88/160 (55%), Gaps = 13/160 (8%)
Query: 595 ENVLGRGGFGTVYKGELHDG----TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
+LG G FG+V +G L K+AVK M+ S++ EF SE A + H ++
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 651 VGLLGYCLDGN-----ERLLVYEYMPQGTLSRHL-FNRKEEGLKPLEWTRRLTIALDVAR 704
+ LLG C++ + + +++ +M G L +L ++R E G K + L +D+A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
G+EYL ++++F+HRDL N +L DDM VADFGL +
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 50/161 (31%), Positives = 81/161 (50%), Gaps = 14/161 (8%)
Query: 595 ENVLGRGGFGTVYKGELHDG----TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
+LG+G FG+V + +L K+AVK +++ +++ EF E A + + H H+
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 651 VGLLGYCLDGNER------LLVYEYMPQGTLSRHL-FNRKEEGLKPLEWTRRLTIALDVA 703
L+G L + +++ +M G L L +R E L + +D+A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
G+EYL + ++FIHRDL N +L +DM VADFGL R
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 50/155 (32%), Positives = 71/155 (45%), Gaps = 10/155 (6%)
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
LG G FG V G+ +A+K ++ +SE EF E V+ + H LV L
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLY 85
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
G C ++ EYM G L +L R+ + + L + DV +EYL
Sbjct: 86 GVCTKQRPIFIITEYMANGCLLNYL--REMRH--RFQTQQLLEMCKDVCEAMEYL---ES 138
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
+ F+HRDL N L+ D KV+DFGL R D+
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 59/166 (35%), Positives = 80/166 (48%), Gaps = 21/166 (12%)
Query: 595 ENVLGRGGFGTVYKGELHDG---TKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKV-RHRH 649
++V+G G FG V K + A+KRM E A S+ +F E+ VL K+ H +
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPN 87
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRR-----------LTI 698
++ LLG C L EY P G L L + P L
Sbjct: 88 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 699 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
A DVARG++YL + + FIHRDL NIL+G++ AK+ADFGL R
Sbjct: 148 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-35
Identities = 54/387 (13%), Positives = 108/387 (27%), Gaps = 68/387 (17%)
Query: 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFT 125
+ + I + ++ K T + + N +T ++ L+ L++ ++ F
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFV 219
Query: 126 SVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDT 185
+ + + + +Y + L +P FL
Sbjct: 220 AEN-----ICEAWENENSEYAQQ-YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA-- 271
Query: 186 IPGLMHLHLAFNFL--------QGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSV-AVIQN 235
+P + +++A N IQ +++ + V +Q
Sbjct: 272 LPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKT---FPVETSLQK 328
Query: 236 MTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNL 295
M L L N G LP L ++ NQ+T I + + ++ +N
Sbjct: 329 MKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNK 388
Query: 296 FQG-----QTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAES 350
+ + D N V + + K +
Sbjct: 389 LKYIPNIFDAKSVSVMSAIDF--SYNEI----GSVDGKNFDPLDPTPFKGI--------- 433
Query: 351 WKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTG-- 408
N++ +NL N +S FS + L + L GN LT
Sbjct: 434 --------------------NVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIP 473
Query: 409 -----TIPKELTTLPSLEMLDVSNNHL 430
+ L +D+ N L
Sbjct: 474 KNSLKDENENFKNTYLLTSIDLRFNKL 500
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-33
Identities = 39/233 (16%), Positives = 78/233 (33%), Gaps = 19/233 (8%)
Query: 78 EGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTS 137
+ L + L +LE + N+L G++P+ L + N T +P++F
Sbjct: 319 TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQ 378
Query: 138 LQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPG-------LM 190
++ +S +N K + + + I + +
Sbjct: 379 VENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP--LDPTPFKGINVS 436
Query: 191 HLHLAFNFLQGPIPLSFGK-SSIQTLWLNG----QKGDSKLNGSVAVIQNMTSLTQLWLH 245
++L+ N + F S + ++ L G + + L +N LT + L
Sbjct: 437 SINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLR 496
Query: 246 GNSFTGPLPD---LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNL 295
N T L D + L L + N + P+ +N +L + N
Sbjct: 497 FNKLTK-LSDDFRATTLPYLVGIDLSYNSFSKF-PTQPLNSSTLKGFGIRNQR 547
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-33
Identities = 56/372 (15%), Positives = 112/372 (30%), Gaps = 64/372 (17%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
+ K + L+ L + + + + + E + + + L L
Sbjct: 197 FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYA---QQYKTEDLKWDN-LKDLT 252
Query: 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPG------LMHLH 193
+ + +P LK +Q + + + ++
Sbjct: 253 DVEVYNCPN-LTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIY 311
Query: 194 LAFNFLQ-GPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTG 251
+ +N L+ P+ S K + L ++L G + + L L L N T
Sbjct: 312 IGYNNLKTFPVETSLQKMKKLGMLEC----LYNQLEGKLPAFGSEIKLASLNLAYNQITE 367
Query: 252 PLPDLSG-LSSLQDFSVRDNQLTGIVPS-SLVNLHSLAVVNLTNNLFQGQTPKFNSPVRF 309
+ G +++ S N+L I ++ ++ ++ + N K P+
Sbjct: 368 IPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDP 427
Query: 310 DMAKGSN--SFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCD 367
KG N S L + N + K +
Sbjct: 428 TPFKGINVSSINLSN---------NQISKFPKELF----------STGS----------- 457
Query: 368 AGGNITVVNLKNLGLSG-------TISSNFSRLTSLRQLMLSGNELTGTIPKEL--TTLP 418
++ +NL L+ + NF L + L N+LT + + TTLP
Sbjct: 458 ---PLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLP 513
Query: 419 SLEMLDVSNNHL 430
L +D+S N
Sbjct: 514 YLVGIDLSYNSF 525
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-30
Identities = 60/386 (15%), Positives = 114/386 (29%), Gaps = 86/386 (22%)
Query: 76 NIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKG 134
T + ++L LT +EV ++P L L +Q + N S
Sbjct: 236 QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDW 295
Query: 135 --------LTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTI 186
+Q I + YN+ ++ + SL+ L + G +P F
Sbjct: 296 QALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGS---E 352
Query: 187 PGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHG 246
L L+LA+N + G + L
Sbjct: 353 IKLASLNLAYNQITEIPANFCG--------------------------FTEQVENLSFAH 386
Query: 247 NSFTG--PLPDLSGLSSLQDFSVRDNQLTGIV-------PSSLVNLHSLAVVNLTNNLFQ 297
N + D +S + N++ + + +++ +NL+NN
Sbjct: 387 NKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNN--- 443
Query: 298 GQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPC 357
+ + + + GS ++ G N+L I K S K N
Sbjct: 444 ----QISKFPKELFSTGSPLSSINLMG-------NMLTEIPK---------NSLKDENEN 483
Query: 358 NSDWKGVSCDAGGNITVVNLKNLGLSGTISS-NFSRLTSLRQLMLSGNELTGTIPKELTT 416
+ +T ++L+ L+ + L L + LS N + P +
Sbjct: 484 FKNTY--------LLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLN 534
Query: 417 LPSLEMLDVSN------NHLFGKVPN 436
+L+ + N N + P
Sbjct: 535 SSTLKGFGIRNQRDAQGNRTLREWPE 560
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-30
Identities = 57/441 (12%), Positives = 111/441 (25%), Gaps = 95/441 (21%)
Query: 16 LSATLSVNSQSSSDAAAMQALKTSLGNP--ASLGWTDPDPCKWKH------------IQC 61
+ LS ++ D A++ + +L + G+ W +
Sbjct: 18 VPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSL 77
Query: 62 SPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQI-----PSLSGLSSLQE 116
+ + RVT + + G G +P + L+ L VL + + +S S ++
Sbjct: 78 NSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ 137
Query: 117 VLFDDNNFTSVPSDFFKGLTSLQTISLDYNS-FDSWVIPESLKDATGLQRFSANGANITG 175
++ D+ I NS I +S + + NIT
Sbjct: 138 KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF 197
Query: 176 TIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQN 235
+ + + L ++ + ++
Sbjct: 198 -VSKAVMR--LTKLRQFYMGNSPFVAENICEAWENEN----------------------- 231
Query: 236 MTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLT-N 293
L L D V + +P+ L L + ++N+ N
Sbjct: 232 --------SEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACN 283
Query: 294 NLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKG 353
G+ K + D G + N L + L
Sbjct: 284 RGISGEQLKDDWQALADAPVGEKIQIIYIGY-------NNLKTF----PVETSL------ 326
Query: 354 NNPCNSDWKGVSCDAGGNITVVNLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGT 409
+ L L F L L L+ N++T
Sbjct: 327 ----------------QKMK--KLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEI 368
Query: 410 IPKELTTLPSLEMLDVSNNHL 430
+E L ++N L
Sbjct: 369 PANFCGFTEQVENLSFAHNKL 389
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 9e-28
Identities = 42/247 (17%), Positives = 83/247 (33%), Gaps = 31/247 (12%)
Query: 76 NIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSG-LSSLQEVLFDDNNFTSVPSDFFKG 134
+EG LP S L L + N++T + G ++ + F N +P+ F
Sbjct: 341 QLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAK 399
Query: 135 -LTSLQTISLDYNSFDS------WVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIP 187
++ + I YN S + + + + + I+ + T
Sbjct: 400 SVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFS--TGS 457
Query: 188 GLMHLHLAFNFLQG-------PIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQ--NMT 237
L ++L N L +F + ++ L +KL + +
Sbjct: 458 PLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDL----RFNKLTKLSDDFRATTLP 513
Query: 238 SLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRD------NQLTGIVPSSLVNLHSLAVVNL 291
L + L NSF+ S+L+ F +R+ N+ P + SL + +
Sbjct: 514 YLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQI 573
Query: 292 TNNLFQG 298
+N +
Sbjct: 574 GSNDIRK 580
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-27
Identities = 38/255 (14%), Positives = 76/255 (29%), Gaps = 28/255 (10%)
Query: 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTG---------QIPSLSGLSSLQEVL 118
T +++ LP L +L + ++ V N+ + +Q +
Sbjct: 252 TDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIY 311
Query: 119 FDDNNFTSVP-SDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTI 177
NN + P + + L + YN + + L + IT
Sbjct: 312 IGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG--KLPAFGSEIKLASLNLAYNQITEIP 369
Query: 178 PDFLGGDTIPGLMHLHLAFNFLQG-PIPLSFGK-SSIQTLWLNG----QKGDSKLNGSVA 231
+F G + +L A N L+ P S + + + +
Sbjct: 370 ANFCGF--TEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDP 427
Query: 232 VIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGI-------VPSSLVNL 283
+++ + L N + + S S L ++ N LT I + N
Sbjct: 428 TPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNT 487
Query: 284 HSLAVVNLTNNLFQG 298
+ L ++L N
Sbjct: 488 YLLTSIDLRFNKLTK 502
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-25
Identities = 38/238 (15%), Positives = 82/238 (34%), Gaps = 24/238 (10%)
Query: 80 TLPK--ELNSLSSLTVLEVMKNKLTGQI--------PSLSGLSSLQEVLFDDNNFTSVPS 129
+P + S+S ++ ++ N++ P+ ++ + +N + P
Sbjct: 391 YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPK 450
Query: 130 DFFKGLTSLQTISLDYNSFDS------WVIPESLKDATGLQRFSANGANITGTIPDFLGG 183
+ F + L +I+L N E+ K+ L +T + D
Sbjct: 451 ELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRA 509
Query: 184 DTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDS--KLNGSV-AVIQNMTSL 239
T+P L+ + L++N P S+++ + Q+ + I SL
Sbjct: 510 TTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSL 568
Query: 240 TQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
TQL + N + + ++ ++DN I S + + L + Q
Sbjct: 569 TQLQIGSNDIRK-VNE-KITPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-18
Identities = 43/331 (12%), Positives = 101/331 (30%), Gaps = 55/331 (16%)
Query: 132 FKGLTSLQTISLDYN-SFDSWVIPE--SLKDATGLQRFSANGANITGTIPDFLGGDTIPG 188
+G + + ++N D W SL + S G +G +PD +G +
Sbjct: 49 QQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQ--LTE 106
Query: 189 LMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVI-----QNMTSLTQLW 243
L L L + + L I + QK +++ + ++ + L +
Sbjct: 107 LEVLALGSHGEKVNERLFGP-KGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDC 165
Query: 244 LHGNSFTGPLPDLSGLS-SLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLT-NNLFQGQTP 301
++ + + S ++ N +T + +++ L L + +
Sbjct: 166 INSDPQQKSIKKSSRITLKDTQIGQLSNNITFV-SKAVMRLTKLRQFYMGNSPFVAENIC 224
Query: 302 KFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGY-PAVLAESWKGNNPCNSD 360
+ + A+ + D +V + ++ P L
Sbjct: 225 EAWENENSEYAQQYKT--EDLKWDNLKDLTDVEVYNCPNLTKLPTFL------------- 269
Query: 361 WKGVSCDAGGNITVVNLKNLGLS-------------GTISSNFSRLTSLRQLMLSGNEL- 406
+ ++ + ++ ++ ++ + + N L
Sbjct: 270 ---------KALP--EMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK 318
Query: 407 TGTIPKELTTLPSLEMLDVSNNHLFGKVPNF 437
T + L + L ML+ N L GK+P F
Sbjct: 319 TFPVETSLQKMKKLGMLECLYNQLEGKLPAF 349
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 9/62 (14%), Positives = 26/62 (41%), Gaps = 3/62 (4%)
Query: 376 NLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVP 435
+ + + SL QL + N++ + +++ P++ +LD+ +N
Sbjct: 548 DAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDL 604
Query: 436 NF 437
++
Sbjct: 605 SY 606
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 50/155 (32%), Positives = 72/155 (46%), Gaps = 10/155 (6%)
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
LG G FG V G+ +AVK ++ +SE EF E + K+ H LV
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFY 69
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
G C +V EY+ G L +L + + LE ++ L + DV G+ +L
Sbjct: 70 GVCSKEYPIYIVTEYISNGCLLNYLRSHGKG----LEPSQLLEMCYDVCEGMAFL---ES 122
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
FIHRDL N L+ D+ KV+DFG+ R D+
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 49/156 (31%), Positives = 69/156 (44%), Gaps = 9/156 (5%)
Query: 595 ENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGL 653
+GRG FG V+ G L D T +AVK + A+F E +L + H ++V L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
+G C +V E + G L R E L L + D A G+EYL
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFL--RTEGA--RLRVKTLLQMVGDAAAGMEYLES-- 231
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
+ IHRDL N L+ + K++DFG+ R D
Sbjct: 232 -KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 50/171 (29%), Positives = 81/171 (47%), Gaps = 26/171 (15%)
Query: 595 ENVLGRGGFGTVYKGELHD--------GTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKV 645
LG G FG V E +AVK + + A +EK ++ SE+ ++ +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMI 97
Query: 646 -RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRR--------- 695
+H++++ LLG C ++ EY +G L +L R+ G++ R
Sbjct: 98 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 696 --LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
++ +ARG+EY LA Q IHRDL N+L+ ++ K+ADFGL R
Sbjct: 158 DLVSCTYQLARGMEY---LASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 49/162 (30%), Positives = 84/162 (51%), Gaps = 16/162 (9%)
Query: 595 ENVLGRGGFGTVYKGELH-----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
LG+G FG+V G +AVK+++ + +E+ +F+ EI +L ++H +
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDN 103
Query: 650 LVGLLGYCLDGNER--LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
+V G C R L+ EY+P G+L +L KE ++ + L + +G+E
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGME 159
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
YL + +IHRDL NIL+ ++ R K+ DFGL ++ P +
Sbjct: 160 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 198
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 49/161 (30%), Positives = 82/161 (50%), Gaps = 17/161 (10%)
Query: 596 NVLGRGGFGTVYKGELHDG------TKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHR 648
LG+G FG VY+G T++A+K + E+A + E+ EF +E +V+ +
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER--IEFLNEASVMKEFNCH 88
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRK-----EEGLKPLEWTRRLTIALDVA 703
H+V LLG G L++ E M +G L +L + + L P ++ + +A ++A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
G+ YL F+HRDL N ++ +D K+ DFG+ R
Sbjct: 149 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 52/176 (29%), Positives = 77/176 (43%), Gaps = 31/176 (17%)
Query: 595 ENVLGRGGFGTVYKGELHDG------TKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRH 647
LG G FG V K T +AVK + E+A SE + SE VL +V H
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL--RDLLSEFNVLKQVNH 85
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGL-------------------K 688
H++ L G C LL+ EY G+L L ++ G +
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 689 PLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
L ++ A +++G++Y LA +HRDL NIL+ + + K++DFGL R
Sbjct: 146 ALTMGDLISFAWQISQGMQY---LAEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 52/176 (29%), Positives = 78/176 (44%), Gaps = 26/176 (14%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHD------GTKIAVKRM-ESAVVSEKGFAEFKSEIAVL 642
N S LG G FG V + + +AVK + SA ++E+ SE+ VL
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EALMSELKVL 80
Query: 643 TKV-RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRR------ 695
+ + H ++V LLG C G L++ EY G L L +++ +
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 696 -------LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
L+ + VA+G+ +L A ++ IHRDL NILL K+ DFGL R
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 193
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-35
Identities = 48/162 (29%), Positives = 81/162 (50%), Gaps = 16/162 (9%)
Query: 595 ENVLGRGGFGTVYKGELH-----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
LG+G FG+V G +AVK+++ + +F+ EI +L ++H +
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDN 72
Query: 650 LVGLLGYCLDGNER--LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
+V G C R L+ EY+P G+L +L KE ++ + L + +G+E
Sbjct: 73 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGME 128
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
YL + +IHRDL NIL+ ++ R K+ DFGL ++ P +
Sbjct: 129 YLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 167
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 6e-35
Identities = 49/171 (28%), Positives = 82/171 (47%), Gaps = 26/171 (15%)
Query: 595 ENVLGRGGFGTVYKGELHD--------GTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKV 645
LG G FG V E +AVK + + A +EK ++ SE+ ++ +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMI 143
Query: 646 -RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGL-----------KPLEWT 693
+H++++ LLG C ++ EY +G L +L R+ G+ + + +
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 694 RRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
++ +ARG+EY LA Q IHRDL N+L+ ++ K+ADFGL R
Sbjct: 204 DLVSCTYQLARGMEY---LASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-35
Identities = 48/167 (28%), Positives = 73/167 (43%), Gaps = 22/167 (13%)
Query: 595 ENVLGRGGFGTVYKGELHD------GTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKV-R 646
LG G FG V + K+AVK + +A EK SE+ +++ + +
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EALMSELKIMSHLGQ 108
Query: 647 HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRK---------EEGLKPLEWTRRLT 697
H ++V LLG C G L++ EY G L L + L
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 698 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
+ VA+G+ +L A ++ IHRD+ N+LL + AK+ DFGL R
Sbjct: 169 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 51/167 (30%), Positives = 85/167 (50%), Gaps = 22/167 (13%)
Query: 595 ENVLGRGGFGTVYKGELHDG------TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR 648
+ LG G FG V+ E ++ +AVK ++ ++ + +F+ E +LT ++H
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHE 77
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHL-----------FNRKEEGLKPLEWTRRLT 697
H+V G C DG+ ++V+EYM G L++ L + + L ++ L
Sbjct: 78 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 698 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
IA +A G+ Y LA Q F+HRDL N L+G ++ K+ DFG+ R
Sbjct: 138 IASQIASGMVY---LASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-34
Identities = 64/241 (26%), Positives = 102/241 (42%), Gaps = 22/241 (9%)
Query: 516 RKRKRSGRVQSPNAVVIHPSNGGDGNAVKITVTESSVTGGGSESQSLTSSGPSDLHVVEA 575
R S A ++ P + + S+ + S++L G + +H+ +
Sbjct: 10 HHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLS 69
Query: 576 GSMVISIQVLRNVTNNFSEENV-----LGRGGFGTVYKGELHDG----TKIAVKRM-ESA 625
+Q +++V S V +GRG FG VY G L D AVK +
Sbjct: 70 ALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT 129
Query: 626 VVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE-RLLVYEYMPQGTLSRHLFNRKE 684
++F +E ++ H +++ LLG CL L+V YM G L + N
Sbjct: 130 --DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 187
Query: 685 E-GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743
+K L + L VA+G+++L A + F+HRDL N +L + KVADFGL
Sbjct: 188 NPTVKDL-----IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 239
Query: 744 R 744
R
Sbjct: 240 R 240
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-34
Identities = 51/171 (29%), Positives = 79/171 (46%), Gaps = 26/171 (15%)
Query: 595 ENVLGRGGFGTVYKGELHD--------GTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKV 645
LG G FG V E TK+AVK + A + ++ SE+ ++ +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL--SDLISEMEMMKMI 131
Query: 646 -RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHL-----------FNRKEEGLKPLEWT 693
+H++++ LLG C ++ EY +G L +L +N + L
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 694 RRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
++ A VARG+EYL A + IHRDL N+L+ +D K+ADFGL R
Sbjct: 192 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 31/176 (17%)
Query: 595 ENVLGRGGFGTVYKGELHDG------TKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKV-R 646
VLG G FG V + ++AVK + E A SE+ SE+ ++T++
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER--EALMSELKMMTQLGS 107
Query: 647 HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRR----------- 695
H ++V LLG C L++EY G L +L +++E+ +
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 696 -------LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
L A VA+G+E+L +S +HRDL N+L+ K+ DFGL R
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 42/162 (25%), Positives = 76/162 (46%), Gaps = 15/162 (9%)
Query: 595 ENVLGRGGFGTVYKGELH-----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
LG G FG V G ++AVK ++ A+ K EI +L + H +
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHEN 84
Query: 650 LVGLLGYCLDGNER--LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
+V G C + L+ E++P G+L +L K + + ++L A+ + +G++
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK----INLKQQLKYAVQICKGMD 140
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
YL + ++HRDL N+L+ + + K+ DFGL + +
Sbjct: 141 YL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 51/156 (32%), Positives = 82/156 (52%), Gaps = 10/156 (6%)
Query: 595 ENVLGRGGFGTVYKGELHDG-TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGL 653
++ LG G +G VY+G +AVK ++ + + EF E AV+ +++H +LV L
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQL 74
Query: 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
LG C ++ E+M G L +L R+ + + L +A ++ +EYL
Sbjct: 75 LGVCTREPPFYIITEFMTYGNLLDYL--RECNR-QEVSAVVLLYMATQISSAMEYL---E 128
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
++FIHRDL N L+G++ KVADFGL RL +
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 54/151 (35%), Positives = 84/151 (55%), Gaps = 12/151 (7%)
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
+G+G FG V G+ G K+AVK +++ ++ F +E +V+T++RH +LV LL
Sbjct: 26 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLL 80
Query: 655 GYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
G ++ L +V EYM +G+L +L R L L +LDV +EYL
Sbjct: 81 GVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGR-SVLGGDCLLKFSLDVCEAMEYL---E 134
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
+F+HRDL N+L+ +D AKV+DFGL +
Sbjct: 135 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 56/202 (27%), Positives = 84/202 (41%), Gaps = 29/202 (14%)
Query: 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR 648
+F LGRGGFG V++ + D A+KR+ E + E+ L K+ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHP 63
Query: 649 HLVGLLGYCLDGNE---------RLLVY---EYMPQGTLSRHLFNRKEEGLKPLEWTRRL 696
+V L+ N ++ +Y + + L + R ++ E + L
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC--TIEERERSVCL 121
Query: 697 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL----------A 746
I L +A VE+LH + +HRDLKPSNI D KV DFGLV
Sbjct: 122 HIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 747 PDNGKHSIETRLAGTFGYLAPE 768
++ T GT Y++PE
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPE 200
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 5e-34
Identities = 50/156 (32%), Positives = 82/156 (52%), Gaps = 10/156 (6%)
Query: 595 ENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGL 653
++ LG G +G VY+G +AVK ++ + + EF E AV+ +++H +LV L
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQL 281
Query: 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
LG C ++ E+M G L +L R+ + + L +A ++ +EYL
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYL--RECNR-QEVSAVVLLYMATQISSAMEYL---E 335
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
++FIHR+L N L+G++ KVADFGL RL +
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-34
Identities = 56/166 (33%), Positives = 84/166 (50%), Gaps = 21/166 (12%)
Query: 595 ENVLGRGGFGTVYKGELHDG------TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR 648
+ LG G FG V+ E H+ +AVK ++ A SE +F+ E +LT ++H+
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQ 103
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR----------KEEGLKPLEWTRRLTI 698
H+V G C +G L+V+EYM G L+R L + ++ PL + L +
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 699 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
A VA G+ Y LA F+HRDL N L+G + K+ DFG+ R
Sbjct: 164 ASQVAAGMVY---LAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-34
Identities = 51/169 (30%), Positives = 77/169 (45%), Gaps = 25/169 (14%)
Query: 596 NVLGRGGFGTVYKGELHD------GTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKV-RH 647
LGRG FG V + + +AVK + E A SE SE+ +L + H
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKILIHIGHH 90
Query: 648 RHLVGLLGYCLDGNE-RLLVYEYMPQGTLSRHLFNRKEEGL-----------KPLEWTRR 695
++V LLG C +++ E+ G LS +L +++ E + L
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 696 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
+ + VA+G+E+L A + IHRDL NILL + K+ DFGL R
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-34
Identities = 48/162 (29%), Positives = 74/162 (45%), Gaps = 17/162 (10%)
Query: 595 ENVLGRGGFGTVYKGELHDG------TKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRH 647
LG G FG VY+G++ ++AVK + E ++ +F E +++K H
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE--LDFLMEALIISKFNH 92
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRR--LTIALDVARG 705
+++V +G L R ++ E M G L L + +P L +A D+A G
Sbjct: 93 QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 706 VEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVR 744
+Y L FIHRD+ N LL G AK+ DFG+ R
Sbjct: 153 CQY---LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 9e-34
Identities = 48/162 (29%), Positives = 74/162 (45%), Gaps = 17/162 (10%)
Query: 595 ENVLGRGGFGTVYKGELHDG------TKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRH 647
LG G FG VY+G++ ++AVK + E ++ +F E +++K H
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE--LDFLMEALIISKFNH 133
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRR--LTIALDVARG 705
+++V +G L R ++ E M G L L + +P L +A D+A G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 706 VEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVR 744
+Y L FIHRD+ N LL G AK+ DFG+ R
Sbjct: 194 CQY---LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 50/155 (32%), Positives = 81/155 (52%), Gaps = 10/155 (6%)
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
LG G FG V+ G + TK+AVK ++ +S F +E ++ +++H+ LV L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRLY 74
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
++ EYM G+L L + G L + L +A +A G+ ++
Sbjct: 75 AVVT-QEPIYIITEYMENGSLVDFL--KTPSG-IKLTINKLLDMAAQIAEGMAFI---EE 127
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
+++IHRDL+ +NIL+ D + K+ADFGL RL DN
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-33
Identities = 54/151 (35%), Positives = 85/151 (56%), Gaps = 12/151 (7%)
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
+G+G FG V G+ G K+AVK +++ ++ F +E +V+T++RH +LV LL
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLL 252
Query: 655 GYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
G ++ L +V EYM +G+L +L +R L L +LDV +EYL
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC---LLKFSLDVCEAMEYL---E 306
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
+F+HRDL N+L+ +D AKV+DFGL +
Sbjct: 307 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 38/181 (20%), Positives = 70/181 (38%), Gaps = 12/181 (6%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH-- 647
+S +G GG V++ A+K + + +++EIA L K++
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
++ L Y + +V E L+ L K++ + ++ V
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKS--YWKNMLEAVH 141
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
+H +H DLKP+N L+ D K+ DFG+ + ++ GT Y+ P
Sbjct: 142 TIH---QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
Query: 768 E 768
E
Sbjct: 198 E 198
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 44/159 (27%), Positives = 79/159 (49%), Gaps = 12/159 (7%)
Query: 595 ENVLGRGGFGTVYKGELHDG----TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
E ++G G G V G L +A+K +++ +E+ +F SE +++ + H ++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNI 112
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
+ L G G ++V EYM G+L L R +G + + + V G+ YL
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDG--QFTIMQLVGMLRGVGAGMRYL- 167
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
+ ++HRDL N+L+ ++ KV+DFGL R+ D+
Sbjct: 168 --SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 44/159 (27%), Positives = 76/159 (47%), Gaps = 12/159 (7%)
Query: 594 EENVLGRGGFGTVYKGELHDG---TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
E+ LG G FGTV KG +AVK +++ E +E V+ ++ + ++
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
V ++G C +LV E G L+++L + K + + + V+ G++YL
Sbjct: 81 VRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYL- 133
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
+F+HRDL N+LL AK++DFGL + +
Sbjct: 134 --EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 47/160 (29%), Positives = 86/160 (53%), Gaps = 13/160 (8%)
Query: 595 ENVLGRGGFGTVYKGELHDGT-----KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
+ V+G G FG VYKG L + +A+K +++ +EK +F E ++ + H +
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHN 107
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
++ L G +++ EYM G L + L R+++G + + + +A G++YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFL--REKDG--EFSVLQLVGMLRGIAAGMKYL 163
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
A+ +++HRDL NIL+ ++ KV+DFGL R+ D+
Sbjct: 164 ---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 43/168 (25%), Positives = 69/168 (41%), Gaps = 23/168 (13%)
Query: 595 ENVLGRGGFGTVYKGELHDG------TKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRH 647
LG FG VYKG L +A+K + + A EF+ E + +++H
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQH 71
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGL-----------KPLEWTRRL 696
++V LLG +++ Y G L L R LE +
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 697 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
+ +A G+EYL + +H+DL N+L+ D + K++D GL R
Sbjct: 132 HLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 56/176 (31%), Positives = 82/176 (46%), Gaps = 31/176 (17%)
Query: 595 ENVLGRGGFGTVYKGELHDG------TKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRH 647
+G G FG V++ T +AVK + E A S A+F+ E A++ + +
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDN 109
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRK-------------------EEGLK 688
++V LLG C G L++EYM G L+ L + G
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 689 PLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
PL +L IA VA G+ Y L+ + F+HRDL N L+G++M K+ADFGL R
Sbjct: 170 PLSCAEQLCIARQVAAGMAY---LSERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 53/157 (33%), Positives = 74/157 (47%), Gaps = 17/157 (10%)
Query: 595 ENVLGRGGFGTVYKGELHDG----TKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRH 649
V+GRG FG VY G L D AVK + ++F +E ++ H +
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPN 87
Query: 650 LVGLLGYCLDGNE-RLLVYEYMPQGTLSRHLFNRKEE-GLKPLEWTRRLTIALDVARGVE 707
++ LLG CL L+V YM G L + N +K L + L VA+G++
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMK 142
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
YL A + F+HRDL N +L + KVADFGL R
Sbjct: 143 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 51/161 (31%), Positives = 74/161 (45%), Gaps = 16/161 (9%)
Query: 595 ENVLGRGGFGTVYKGELHDG-----TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
VLG G FGTVYKG +A+K + A S K E E V+ V + H
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPH 78
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE-GLKPLEWTRRLTIALDVARGVEY 708
+ LLG CL + L+ + MP G L ++ K+ G + L L + +A+G+ Y
Sbjct: 79 VCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNY 132
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
L + +HRDL N+L+ K+ DFGL +L
Sbjct: 133 L---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 17/159 (10%)
Query: 594 EENVLGRGGFGTVYKGELHDG----TKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHR 648
+ V+G+G FG VY GE D + A+K + + + F E ++ + H
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQV--EAFLREGLLMRGLNHP 82
Query: 649 HLVGLLGYCLDGNERLL-VYEYMPQGTLSRHL-FNRKEEGLKPLEWTRRLTIALDVARGV 706
+++ L+G L + YM G L + + ++ +K L ++ L VARG+
Sbjct: 83 NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-----ISFGLQVARGM 137
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745
EYL A Q F+HRDL N +L + KVADFGL R
Sbjct: 138 EYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARD 173
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 49/162 (30%), Positives = 73/162 (45%), Gaps = 17/162 (10%)
Query: 595 ENVLGRGGFGTVYKGELHD-----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
LG G FG V G +AVK +++ + + +K EI +L + H H
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEH 94
Query: 650 LVGLLGYCLDGNER--LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
++ G C D LV EY+P G+L +L + + L A + G+
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS------IGLAQLLLFAQQICEGMA 148
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
YLH Q +IHRDL N+LL +D K+ DFGL + P+
Sbjct: 149 YLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 18/163 (11%)
Query: 595 ENVLGRGGFGTVYKGELH-----DGTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHR 648
+ LG+G FG+V G +AVK++ S ++ +F+ EI +L +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR---DFQREIQILKALHSD 84
Query: 649 HLVGLLGYCLDGNER--LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706
+V G + LV EY+P G L L + L+ +R L + + +G+
Sbjct: 85 FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR----LDASRLLLYSSQICKGM 140
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
EYL + +HRDL NIL+ + K+ADFGL +L P +
Sbjct: 141 EYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 52/160 (32%), Positives = 72/160 (45%), Gaps = 13/160 (8%)
Query: 595 ENVLGRGGFGTVYKGELH----DGTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRH 649
LG G FG V +GE +AVK + + + +F E+ + + HR+
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
L+ L G L +V E P G+L L RK +G L A+ VA G+ YL
Sbjct: 83 LIRLYGVVL-TPPMKMVTELAPLGSLLDRL--RKHQGHFLLG--TLSRYAVQVAEGMGYL 137
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
+ FIHRDL N+LL K+ DFGL+R P N
Sbjct: 138 ---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 9e-33
Identities = 55/155 (35%), Positives = 87/155 (56%), Gaps = 10/155 (6%)
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
E LG+G FG V+ G + T++A+K ++ +S + F E V+ K+RH LV L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLY 245
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
+ +V EYM +G+L L + E G K L + + +A +A G+ Y+
Sbjct: 246 AVVSE-EPIYIVTEYMSKGSLLDFL--KGETG-KYLRLPQLVDMAAQIASGMAYV---ER 298
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
+++HRDL+ +NIL+G+++ KVADFGL RL DN
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-33
Identities = 57/196 (29%), Positives = 92/196 (46%), Gaps = 32/196 (16%)
Query: 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR 648
+F E ++G GGFG V+K + DG +KR++ + + E+ L K+ H
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK------YNNEKAEREVKALAKLDHV 64
Query: 649 HLVGLLGYCLDGNERL----------------LVYEYMPQGTLSRHLFNRKEEGLKPLEW 692
++V G + + E+ +GTL + + R+ E L +
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL- 123
Query: 693 TRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752
L + + +GV+Y+H + I+RDLKPSNI L D + K+ DFGLV ++GK
Sbjct: 124 --ALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178
Query: 753 SIETRLAGTFGYLAPE 768
TR GT Y++PE
Sbjct: 179 ---TRSKGTLRYMSPE 191
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 58/181 (32%), Positives = 85/181 (46%), Gaps = 14/181 (7%)
Query: 590 NNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRH 647
+F LG+G FG VY E +A+K + A + + G + E+ + + +RH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
+++ L GY D L+ EY P GT+ R L +K E T ++A +
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFD--EQRTA-TYITELANALS 123
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
Y H + IHRD+KP N+LLG K+ADFG AP + + L GT YL P
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----LCGTLDYLPP 176
Query: 768 E 768
E
Sbjct: 177 E 177
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-32
Identities = 47/155 (30%), Positives = 80/155 (51%), Gaps = 10/155 (6%)
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
E LG G FG V+ + TK+AVK M+ +S + F +E V+ ++H LV L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE---AFLAEANVMKTLQHDKLVKLH 249
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
++ E+M +G+L L + +EG + + + +A G+ ++
Sbjct: 250 AVVT-KEPIYIITEFMAKGSLLDFL--KSDEG-SKQPLPKLIDFSAQIAEGMAFI---EQ 302
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
+++IHRDL+ +NIL+ + K+ADFGL R+ DN
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-32
Identities = 66/392 (16%), Positives = 127/392 (32%), Gaps = 43/392 (10%)
Query: 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTS 126
+ + IE K + L L+ L + N + P S SGL+SL+ ++ + S
Sbjct: 59 QWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS 118
Query: 127 VPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGG--D 184
+ S L +L+ +++ +N S +P + T L + I + L +
Sbjct: 119 LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRE 178
Query: 185 TIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWL 244
+ L ++ N + +F + L L G S + + +QN+ L L
Sbjct: 179 NPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKT--CLQNLAGLHVHRL 236
Query: 245 HGNSFTG-------PLPDLSGLSSLQ--DFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNL 295
F + GL + +F + L +++ ++L
Sbjct: 237 ILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVS 296
Query: 296 FQGQTPKFNSPVRFDMAKGSNSF------------CLDDAGVACDGRVNVLLSIVKSVGY 343
+ ++ L N K V
Sbjct: 297 IKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTM-------NKGSISFKKVAL 349
Query: 344 PAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG----TISSNFSRLTSLRQL 399
P+ L+ N + C + ++ +L++L LS +S+NF L L+ L
Sbjct: 350 PS-LSYLDLSRNALSF----SGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHL 404
Query: 400 MLSGNELTGTIPKE-LTTLPSLEMLDVSNNHL 430
+ L +L L LD+S +
Sbjct: 405 DFQHSTLKRVTEFSAFLSLEKLLYLDISYTNT 436
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-25
Identities = 65/362 (17%), Positives = 116/362 (32%), Gaps = 35/362 (9%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSL 138
+P ++ SS +++ N L S S S LQ + ++ + GL L
Sbjct: 25 KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHL 82
Query: 139 QTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNF 198
+ L N S P S T L+ A + +G + L L++A NF
Sbjct: 83 SNLILTGNPIQS-FSPGSFSGLTSLENLVAVETKLASLESFPIGQ--LITLKKLNVAHNF 139
Query: 199 LQG-PIPLSFGK-SSIQTLWLNGQKGDSKLNG-SVAVIQNMTSLTQ----LWLHGNSFTG 251
+ +P F +++ + L+ + + +V +Q + Q L + N
Sbjct: 140 IHSCKLPAYFSNLTNLVHVDLSY----NYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF 195
Query: 252 PLPDLSGLSSLQDFSVRDNQLTG-IVPSSLVNLHSLAVVNLTNNLFQGQTP-KFNSPVRF 309
L + ++R N + I+ + L NL L V L F+ + + P
Sbjct: 196 IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIM 255
Query: 310 DMAKGSNSFCLDDAGVACDGRVNVLLSIVKSV-GYPAVLAESWKGNNPCNSDWKGVSCDA 368
+ S A ++
Sbjct: 256 EGLCDVTIDEFRLTY-------TNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHF- 307
Query: 369 GGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNN 428
+++ L L L+ L L+ N+ +I + LPSL LD+S N
Sbjct: 308 --KWQSLSIIRCQLK---QFPTLDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRN 360
Query: 429 HL 430
L
Sbjct: 361 AL 362
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-25
Identities = 41/222 (18%), Positives = 77/222 (34%), Gaps = 10/222 (4%)
Query: 86 NSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFK--GLTSLQTISL 143
L L L + NK + L SL + N + + G SL+ + L
Sbjct: 325 LDLPFLKSLTLTMNKGS-ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDL 383
Query: 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPI 203
+N + + LQ + + + +F ++ L++L +++ +
Sbjct: 384 SFNGAII--MSANFMGLEELQHLDFQHSTLKR-VTEFSAFLSLEKLLYLDISYTNTKIDF 440
Query: 204 PLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSS 261
F +S+ TL + G +V N T+LT L L L
Sbjct: 441 DGIFLGLTSLNTLKMAGNSFKDNTLSNV--FANTTNLTFLDLSKCQLEQISWGVFDTLHR 498
Query: 262 LQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKF 303
LQ ++ N L + S L+SL+ ++ + N +
Sbjct: 499 LQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGIL 540
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-23
Identities = 44/225 (19%), Positives = 79/225 (35%), Gaps = 14/225 (6%)
Query: 79 GTLPKELNSLSSLTVLEVMKNKLTGQIP---SLSGLSSLQEVLFDDNNFTSVPSDFFKGL 135
G++ + +L SL+ L++ +N L+ S G +SL+ + N + + F GL
Sbjct: 340 GSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSA-NFMGL 398
Query: 136 TSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLA 195
LQ + +++ + L + N G + L L +A
Sbjct: 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLG--LTSLNTLKMA 456
Query: 196 FNFLQGPIPLSFGK--SSIQTLWLNGQKGDSKLNG-SVAVIQNMTSLTQLWLHGNSFTGP 252
N + + +++ L L+ +L S V + L L + N+
Sbjct: 457 GNSFKDNTLSNVFANTTNLTFLDLSK----CQLEQISWGVFDTLHRLQLLNMSHNNLLFL 512
Query: 253 LPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLF 296
+ L SL N++ SLA NLTNN
Sbjct: 513 DSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-22
Identities = 49/367 (13%), Positives = 102/367 (27%), Gaps = 64/367 (17%)
Query: 79 GTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGL-SSLQEVLFDDNNFTSVPSDFFKGLTS 137
G+L + + ++T M KL+ ++P + SS + + N + S F +
Sbjct: 2 GSLNPCIEVVPNITYQ-CMDQKLS-KVPD--DIPSSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 138 LQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFN 197
LQ + L + ++ L G I P G + L +L
Sbjct: 58 LQWLDLSRCEI-ETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSG--LTSLENLVAVET 114
Query: 198 FLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTG-PLPD- 255
L G + +L +L + N LP
Sbjct: 115 KLASLESFPIG--------------------------QLITLKKLNVAHNFIHSCKLPAY 148
Query: 256 LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVV----NLTNNLFQGQTPKFNSPVRF-- 309
S L++L + N + I + L L V +++ N + ++
Sbjct: 149 FSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHE 208
Query: 310 -DMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDA 368
+ N + + + G + +
Sbjct: 209 LTL--RGNFNSSNIMKTCLQNLAGLHVH------------RLILGEFKDERNLEIFEPSI 254
Query: 369 GGNITVVNLKNLGLSGT-----ISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEML 423
+ V + L+ T F L ++ + L+G + +++ + L
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSL 312
Query: 424 DVSNNHL 430
+ L
Sbjct: 313 SIIRCQL 319
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 6e-19
Identities = 35/224 (15%), Positives = 72/224 (32%), Gaps = 12/224 (5%)
Query: 76 NIEGTLPKELNSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDNNFTSVPSDFFK 133
N + L L L+ + L + L L + N F
Sbjct: 386 NGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFL 445
Query: 134 GLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLH 193
GLTSL T+ + NSF + + T L + + + L L+
Sbjct: 446 GLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDT--LHRLQLLN 503
Query: 194 LAFNFLQGPIPLSF-GKSSIQTLWLNGQKGDSKLNG-SVAVIQNMTSLTQLWLHGNSFTG 251
++ N L + S+ TL + +++ + SL L NS
Sbjct: 504 MSHNNLLFLDSSHYNQLYSLSTLDCSF----NRIETSKGILQHFPKSLAFFNLTNNSVAC 559
Query: 252 PLPDLSGLSS-LQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+ + +++ + + ++ V +++ V++ N+
Sbjct: 560 -ICEHQKFLQWVKEQKQFLVNVEQMTCATPVEMNTSLVLDFNNS 602
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 7e-11
Identities = 20/97 (20%), Positives = 33/97 (34%), Gaps = 2/97 (2%)
Query: 75 QNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFK 133
+ TL + ++LT L++ K +L L LQ + NN + S +
Sbjct: 459 SFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYN 518
Query: 134 GLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANG 170
L SL T+ +N L F+
Sbjct: 519 QLYSLSTLDCSFNRI-ETSKGILQHFPKSLAFFNLTN 554
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 8e-08
Identities = 18/70 (25%), Positives = 25/70 (35%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
N+T ++L L F L L+ L +S N L L SL LD S N +
Sbjct: 474 NLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRI 533
Query: 431 FGKVPNFRQN 440
+
Sbjct: 534 ETSKGILQHF 543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 14/60 (23%), Positives = 29/60 (48%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+ ++N+ + L SS++++L SL L S N + + SL +++NN +
Sbjct: 498 RLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 17/61 (27%), Positives = 32/61 (52%), Gaps = 1/61 (1%)
Query: 371 NITVVNL-KNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNH 429
++ + + N T+S+ F+ T+L L LS +L TL L++L++S+N+
Sbjct: 449 SLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNN 508
Query: 430 L 430
L
Sbjct: 509 L 509
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-32
Identities = 45/247 (18%), Positives = 85/247 (34%), Gaps = 26/247 (10%)
Query: 524 VQSPNAVVIHPSNGGDGNAVKITVTESSVTGGGSESQSLTSSGPSDLHVVEAGSMVISIQ 583
+ +V S + A K G++ SS ++ V+
Sbjct: 4 HHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGR------- 56
Query: 584 VLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLT 643
+S +G GG V++ A+K + + +++EIA L
Sbjct: 57 -------IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLN 109
Query: 644 KVRH--RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALD 701
K++ ++ L Y + +V E L+ L K++ + +
Sbjct: 110 KLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKS--YWKN 163
Query: 702 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGT 761
+ V +H +H DLKP+N L+ D K+ DFG+ + ++ G
Sbjct: 164 MLEAVHTIH---QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGA 219
Query: 762 FGYLAPE 768
Y+ PE
Sbjct: 220 VNYMPPE 226
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 48/161 (29%), Positives = 75/161 (46%), Gaps = 16/161 (9%)
Query: 595 ENVLGRGGFGTVYKGELHDG-----TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
VLG G FGTV+KG + +K +E + F + + + H H
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAH 76
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE-GLKPLEWTRRLTIALDVARGVEY 708
+V LLG C G+ LV +Y+P G+L H+ + G + L L + +A+G+ Y
Sbjct: 77 IVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLL-----LNWGVQIAKGMYY 130
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
L +HR+L N+LL + +VADFG+ L P +
Sbjct: 131 L---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 37/175 (21%), Positives = 68/175 (38%), Gaps = 12/175 (6%)
Query: 596 NVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH--RHLVGL 653
+G GG V++ A+K + + +++EIA L K++ ++ L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
Y + +V E L+ L K++ + ++ V +H
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKS--YWKNMLEAVHTIH--- 125
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
+H DLKP+N L+ D K+ DFG+ + ++ GT Y+ PE
Sbjct: 126 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-32
Identities = 46/159 (28%), Positives = 81/159 (50%), Gaps = 12/159 (7%)
Query: 595 ENVLGRGGFGTVYKGELHDGTK----IAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
+ V+G G FG V G L +K +A+K ++ +EK +F E +++ + H ++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNI 108
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
+ L G ++V EYM G+L L RK + + + + +A G++YL
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDA--QFTVIQLVGMLRGIASGMKYL- 163
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
+ ++HRDL NIL+ ++ KV+DFGL R+ D+
Sbjct: 164 --SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 54/181 (29%), Positives = 74/181 (40%), Gaps = 15/181 (8%)
Query: 591 NFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHR 648
+F + LG G +G V+K DG AVKR S K A +E+ KV +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
V L +G L E +L +H + G L + D + +
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHC---EAWG-ASLPEAQVWGYLRDTLLALAH 172
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPDNGKHSIETRLAGTFGYLAP 767
LH Q +H D+KP+NI LG R K+ DFGL+ L E G Y+AP
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE----GDPRYMAP 225
Query: 768 E 768
E
Sbjct: 226 E 226
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 5e-32
Identities = 58/175 (33%), Positives = 91/175 (52%), Gaps = 15/175 (8%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHRHLVGLLG 655
LG+G F VY+ +H G ++A+K ++ + + G + ++E+ + +++H ++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPL-EWTRRLTIALDVARGVEYLHGLAH 714
Y D N LV E G ++R+L NR KP E R + G+ YLH
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRV----KPFSENEAR-HFMHQIITGMLYLH---S 130
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNGKHSIETRLAGTFGYLAPE 768
+HRDL SN+LL +M K+ADFGL +L + KH T L GT Y++PE
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH--YT-LCGTPNYISPE 182
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 41/159 (25%), Positives = 76/159 (47%), Gaps = 12/159 (7%)
Query: 594 EENVLGRGGFGTVYKGELHDG---TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
+ LG G FG+V +G +A+K ++ + E E ++ ++ + ++
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYI 72
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
V L+G C +LV E G L + L ++EE + + + V+ G++YL
Sbjct: 73 VRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYL- 126
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
++F+HRDL N+LL + AK++DFGL + +
Sbjct: 127 --EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-32
Identities = 51/161 (31%), Positives = 74/161 (45%), Gaps = 16/161 (9%)
Query: 595 ENVLGRGGFGTVYKGELHDG-----TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
VLG G FGTVYKG +A+K + A S K E E V+ V + H
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPH 78
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE-GLKPLEWTRRLTIALDVARGVEY 708
+ LLG CL + L+ + MP G L ++ K+ G + L L + +A+G+ Y
Sbjct: 79 VCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNY 132
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
L + +HRDL N+L+ K+ DFGL +L
Sbjct: 133 L---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-31
Identities = 50/185 (27%), Positives = 85/185 (45%), Gaps = 20/185 (10%)
Query: 591 NFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRH 649
+F ++VLG G GT+ + D +AVKR+ + F+ E+ +L + H +
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI-----LPECFSFADREVQLLRESDEHPN 79
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
++ D + + E TL +K+ LE +T+ G+ +L
Sbjct: 80 VIRYFCTEKDRQFQYIAIELCA-ATLQE-YVEQKDFAHLGLE---PITLLQQTTSGLAHL 134
Query: 710 HGLAHQSFIHRDLKPSNILLGD-----DMRAKVADFGL-VRLAPDNGKHSIETRLAGTFG 763
H + +HRDLKP NIL+ ++A ++DFGL +LA S + + GT G
Sbjct: 135 H---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 764 YLAPE 768
++APE
Sbjct: 192 WIAPE 196
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-31
Identities = 55/155 (35%), Positives = 87/155 (56%), Gaps = 10/155 (6%)
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
E LG+G FG V+ G + T++A+K ++ +S + F E V+ K+RH LV L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLY 328
Query: 655 GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
+ +V EYM +G+L L + E G K L + + +A +A G+ Y+
Sbjct: 329 AVVSE-EPIYIVTEYMSKGSLLDFL--KGETG-KYLRLPQLVDMAAQIASGMAYV---ER 381
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
+++HRDL+ +NIL+G+++ KVADFGL RL DN
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 41/167 (24%), Positives = 79/167 (47%), Gaps = 25/167 (14%)
Query: 595 ENVLGRGGFGTVYKGELHD--------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR 646
LG+G F ++KG + T++ +K ++ A + F ++++K+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS--ESFFEAASMMSKLS 70
Query: 647 HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706
H+HLV G C+ G+E +LV E++ G+L +L +K + + W +L +A +A +
Sbjct: 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILW--KLEVAKQLAAAM 126
Query: 707 EYLHGLAHQSFIHRDLKPSNILL--------GDDMRAKVADFGLVRL 745
+ L + IH ++ NILL G+ K++D G+
Sbjct: 127 HF---LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 45/199 (22%), Positives = 87/199 (43%), Gaps = 29/199 (14%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRME-SAVVSEKGFAE-------------- 634
N++ L +G F + E D A+K+ E S + ++ F +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 635 FKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHL-----FNRKEEGLKP 689
FK+E+ ++T +++ + + G + +E ++YEYM ++ + ++ P
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 690 LEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
++ + I V Y+H ++ HRD+KPSNIL+ + R K++DFG D
Sbjct: 150 IQVIKC--IIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205
Query: 750 GKHSIETRLAGTFGYLAPE 768
GT+ ++ PE
Sbjct: 206 KIKG----SRGTYEFMPPE 220
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 51/181 (28%), Positives = 87/181 (48%), Gaps = 14/181 (7%)
Query: 590 NNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRH 647
++F LG+G FG VY E + +A+K + + + ++G + EI + + +RH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
+++ + Y D L+ E+ P+G L + L +K E + ++A +
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFD--EQRSATFME-ELADALH 128
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
Y H + IHRD+KP N+L+G K+ADFG AP + + + GT YL P
Sbjct: 129 YCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT----MCGTLDYLPP 181
Query: 768 E 768
E
Sbjct: 182 E 182
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 48/206 (23%), Positives = 79/206 (38%), Gaps = 36/206 (17%)
Query: 589 TNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH 647
++F E VLG+G FG V K D A+K++ +E+ + SE+ +L + H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNH 61
Query: 648 RHLVGLLGYCLDGNERL-------------LVYEYMPQGTLSRHLFNRKEEGLKPLEWTR 694
+++V L+ + + EY GTL + + +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN----LNQQRDE 117
Query: 695 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSI 754
+ + + Y+H Q IHRDLKP NI + + K+ DFGL + +
Sbjct: 118 YWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 755 E------------TRLAGTFGYLAPE 768
T GT Y+A E
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATE 200
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-31
Identities = 55/376 (14%), Positives = 110/376 (29%), Gaps = 66/376 (17%)
Query: 76 NIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGL 135
N + K + L+ L ++ + T ++ + + + L
Sbjct: 435 NRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSD----YAKQYENEELSWSNL 490
Query: 136 TSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPG------- 188
L + L +P+ L D LQ + +
Sbjct: 491 KDLTDVELYNCPN-MTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPK 549
Query: 189 LMHLHLAFNFLQG-PIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHG 246
+ ++ +N L+ P S K + L +K+ + LT L L
Sbjct: 550 IQIFYMGYNNLEEFPASASLQKMVKLGLLDCV----HNKVR-HLEAFGTNVKLTDLKLDY 604
Query: 247 NSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPS-SLVNLHSLAVVNLTNNLFQGQTPKF 303
N +P+ + ++ N+L I + +++ + V+ + N +
Sbjct: 605 NQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGR-- 661
Query: 304 NSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKG 363
N D KG N+ + + N + +
Sbjct: 662 NISCSMDDYKGINASTVTLSY-------NEIQKFPTELF----------ATGS------- 697
Query: 364 VSCDAGGNITVVNLKNLGLS-------GTISSNFSRLTSLRQLMLSGNELTGTIPKEL-- 414
I+ + L N ++ N+ L + L N+LT ++ +
Sbjct: 698 -------PISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRA 749
Query: 415 TTLPSLEMLDVSNNHL 430
TTLP L +DVS N
Sbjct: 750 TTLPYLSNMDVSYNCF 765
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 2e-30
Identities = 58/381 (15%), Positives = 107/381 (28%), Gaps = 68/381 (17%)
Query: 71 QIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSD 130
I + K+ T + + N++T ++ L+ LQ + F ++ FT
Sbjct: 407 AINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNI- 465
Query: 131 FFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLM 190
+ + DY S + L +PDFL +P L
Sbjct: 466 ----AVDWEDANSDYAKQYE-NEELSWSNLKDLTDVELYNCPNMTQLPDFLYD--LPELQ 518
Query: 191 HLHLAFNFLQGP---------IPLSFGK-SSIQTLWLNGQKGDSKLNG--SVAVIQNMTS 238
L++A N + IQ ++ + L + A +Q M
Sbjct: 519 SLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMG----YNNLEEFPASASLQKMVK 574
Query: 239 LTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQG 298
L L N L L D + NQ+ I + + ++N +
Sbjct: 575 LGLLDCVHNKVRH-LEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY 633
Query: 299 QTPKFNSPVRFDMAKGSN--SFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNP 356
P F+ S N + S +++
Sbjct: 634 ------IPNIFNAKSVYVMGSVDFSY---------NKIGSEGRNISCS------------ 666
Query: 357 CNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELT-------GT 409
+ G N + V L + + F+ + + ++LS N +T
Sbjct: 667 -------MDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKP 719
Query: 410 IPKELTTLPSLEMLDVSNNHL 430
L +D+ N L
Sbjct: 720 KDGNYKNTYLLTTIDLRFNKL 740
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-29
Identities = 40/230 (17%), Positives = 75/230 (32%), Gaps = 16/230 (6%)
Query: 80 TLPKE--LNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTS 137
P L + L +L+ + NK+ + + L ++ D N +P DF
Sbjct: 562 EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQ 620
Query: 138 LQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITG---TIPDFLGGDTIPGLMHLHL 194
++ + +N + K + + I I + + L
Sbjct: 621 VEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTL 680
Query: 195 AFNFLQGPIPLSFGK-SSIQTLWLNG----QKGDSKLNGSVAVIQNMTSLTQLWLHGNSF 249
++N +Q F S I T+ L+ ++ L +N LT + L N
Sbjct: 681 SYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL 740
Query: 250 TGPLPD---LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLF 296
T L D + L L + V N + P+ +N L + +
Sbjct: 741 TS-LSDDFRATTLPYLSNMDVSYNCFSSF-PTQPLNSSQLKAFGIRHQRD 788
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 8e-26
Identities = 36/254 (14%), Positives = 73/254 (28%), Gaps = 28/254 (11%)
Query: 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTG---------QIP-SLSGLSSLQEV 117
T +++ LP L L L L + N+ ++ +Q
Sbjct: 494 TDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIF 553
Query: 118 LFDDNNFTSVP-SDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGT 176
NN P S + + L + +N E+ L + I
Sbjct: 554 YMGYNNLEEFPASASLQKMVKLGLLDCVHNKV---RHLEAFGTNVKLTDLKLDYNQIE-E 609
Query: 177 IPDFLGGDTIPGLMHLHLAFNFLQG-PIPLSFGK-SSIQTLWL--NGQKGDSKLNGSVAV 232
IP+ T + L + N L+ P + + ++ N + +
Sbjct: 610 IPEDFCAFT-DQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMD 668
Query: 233 IQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGI-------VPSSLVNLH 284
+ + + L N + + S + + +N +T I + N +
Sbjct: 669 DYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTY 728
Query: 285 SLAVVNLTNNLFQG 298
L ++L N
Sbjct: 729 LLTTIDLRFNKLTS 742
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 3e-25
Identities = 51/426 (11%), Positives = 112/426 (26%), Gaps = 68/426 (15%)
Query: 19 TLSVNSQSSSDAAAMQALKTSLGNPASLGWTDPDPCKWKHIQCSPSNRVTRIQIGGQNIE 78
L ++ D A++A+ +L ++ + + + +
Sbjct: 260 QLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWG------- 312
Query: 79 GTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTS 137
+L++ +T L + G++P ++ L+ L+ + F ++ T F +
Sbjct: 313 DQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELT 372
Query: 138 LQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFN 197
+ L L I P+ I + L
Sbjct: 373 PDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR-NPEMKP---IKKDSRISLKDT 428
Query: 198 FLQG------PIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFT 250
+ I + + + +Q ++ S
Sbjct: 429 QIGNLTNRITFISKAIQRLTKLQIIYFAN----SPFTY----DNIAVDWEDANSDYAKQY 480
Query: 251 GPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRF 309
S L L D + + +P L +L L +N+ N R
Sbjct: 481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRL 540
Query: 310 DMAKGSNS----FCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVS 365
+ + F + N L A +
Sbjct: 541 ADDEDTGPKIQIFYMGY---------NNLEEFP---------ASASLQKMV--------- 573
Query: 366 CDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKEL-TTLPSLEMLD 424
+ +++ + + + + F L L L N++ IP++ +E L
Sbjct: 574 -----KLGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLG 625
Query: 425 VSNNHL 430
S+N L
Sbjct: 626 FSHNKL 631
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-23
Identities = 37/233 (15%), Positives = 76/233 (32%), Gaps = 22/233 (9%)
Query: 80 TLPK--ELNSLSSLTVLEVMKNKLTGQIPSLSG------LSSLQEVLFDDNNFTSVPSDF 131
+P S+ + ++ NK+ + ++S + V N P++
Sbjct: 633 YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTEL 692
Query: 132 FKGLTSLQTISLDYNSFDS------WVIPESLKDATGLQRFSANGANITGTIPDFLGGDT 185
F + + TI L N S + K+ L +T ++ D T
Sbjct: 693 FATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATT 751
Query: 186 IPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDS--KLNGSV-AVIQNMTSLTQ 241
+P L ++ +++N P S ++ + Q+ ++ I SL Q
Sbjct: 752 LPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQ 810
Query: 242 LWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
L + N + + L + DN I +S+ + L +
Sbjct: 811 LQIGSNDIRK-VDE-KLTPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYD 861
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 1e-21
Identities = 35/239 (14%), Positives = 70/239 (29%), Gaps = 34/239 (14%)
Query: 80 TLPKEL-NSLSSLTVLEVMKNKLTGQIP---SLSGLSSLQEVLFDDNNFTSVPSDFFKGL 135
+P++ + L NKL IP + + + V F N S + +
Sbjct: 609 EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSM 667
Query: 136 -----TSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDT----- 185
+ T++L YN E + + + +T +IP+
Sbjct: 668 DDYKGINASTVTLSYNEIQK-FPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYK 725
Query: 186 -IPGLMHLHLAFNFLQG-PIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQL 242
L + L FN L + + ++ + + N + L
Sbjct: 726 NTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSY----NCFSSFPTQPLNSSQLKAF 781
Query: 243 ------WLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
GN P ++ SL + N + + L+ L ++ +N
Sbjct: 782 GIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLTPQLYIL---DIADN 837
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 2e-18
Identities = 49/362 (13%), Positives = 99/362 (27%), Gaps = 67/362 (18%)
Query: 86 NSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNN-FTSVPSDFFKGLTSLQTISLD 144
N L+ + + + I L ++ E L N + S + +
Sbjct: 249 NKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFN--- 305
Query: 145 YNSFDSW--VIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGP 202
D W L + + S G G +PD +G + L L +
Sbjct: 306 -KELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQ--LTELKVLSFGTHSETVS 362
Query: 203 IPLSFGKSSIQTLWLNGQK----GDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSG 258
L + + + K+ N++ L Q ++ N P+ S
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422
Query: 259 LS-SLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNS 317
+S N++T I ++ L L ++ N
Sbjct: 423 ISLKDTQIGNLTNRITFI-SKAIQRLTKLQIIYFAN------------------------ 457
Query: 318 FCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNL 377
+ +V + ++ K W + ++T V L
Sbjct: 458 --------------SPFTYDNIAVDWEDANSDYAKQYENEELSWSNLK-----DLTDVEL 498
Query: 378 KNLGLSGTISSNFSRLTSLRQLMLSGNELTG---------TIPKELTTLPSLEMLDVSNN 428
N + L L+ L ++ N + + T P +++ + N
Sbjct: 499 YNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYN 558
Query: 429 HL 430
+L
Sbjct: 559 NL 560
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 4e-12
Identities = 30/253 (11%), Positives = 63/253 (24%), Gaps = 65/253 (25%)
Query: 209 KSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSV 267
+ W ++ D + + N +T L L G G +PD + L+ L+ S
Sbjct: 295 NTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSF 354
Query: 268 RDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVAC 327
+ T + + + + K D
Sbjct: 355 GTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKK-------------MFLDYDQRLNLS 401
Query: 328 DGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG--- 384
D + + + + ++LK+ +
Sbjct: 402 DLLQDAINRNPEMKPIK--------------------------KDSRISLKDTQIGNLTN 435
Query: 385 ---TISSNFSRLTSLRQLMLSGNELTG-------------------TIPKELTTLPSLEM 422
IS RLT L+ + + + T + L L
Sbjct: 436 RITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTD 495
Query: 423 LDVSNNHLFGKVP 435
+++ N ++P
Sbjct: 496 VELYNCPNMTQLP 508
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 3e-10
Identities = 17/95 (17%), Positives = 34/95 (35%), Gaps = 2/95 (2%)
Query: 344 PAVLAESWKGNNPCNS--DWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLML 401
+ + +W N + D GV D G +T ++L G G + +LT L+ L
Sbjct: 295 NTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSF 354
Query: 402 SGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPN 436
+ T + + +M + + +
Sbjct: 355 GTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKK 389
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 11/55 (20%), Positives = 26/55 (47%), Gaps = 3/55 (5%)
Query: 376 NLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+ + + + + SL QL + N++ + ++L P L +LD+++N
Sbjct: 788 DAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPN 839
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 14/65 (21%), Positives = 25/65 (38%), Gaps = 10/65 (15%)
Query: 376 NLKNLGLSG----TISSNFSRLTSLRQL------MLSGNELTGTIPKELTTLPSLEMLDV 425
L N+ +S + + + L+ GN + P +TT PSL L +
Sbjct: 754 YLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQI 813
Query: 426 SNNHL 430
+N +
Sbjct: 814 GSNDI 818
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 38/160 (23%), Positives = 66/160 (41%), Gaps = 15/160 (9%)
Query: 595 ENVLGRGGFGTVYKGELHDG----TKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRH 649
+G G FG V++G +A+K S+ +F E + + H H
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPH 77
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+V L+G N ++ E G L L + + L+ + A ++ + YL
Sbjct: 78 IVKLIGVIT-ENPVWIIMELCTLGELRSFL--QVRKY--SLDLASLILYAYQLSTALAYL 132
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
+ F+HRD+ N+L+ + K+ DFGL R D+
Sbjct: 133 ---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 42/160 (26%), Positives = 70/160 (43%), Gaps = 15/160 (9%)
Query: 595 ENVLGRGGFGTVYKGELHDG----TKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRH 649
+LG G FG VY+G + +AVK + + K +F SE ++ + H H
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDHPH 74
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+V L+G ++ E P G L +L + + L+ + +L + + + YL
Sbjct: 75 IVKLIGIIE-EEPTWIIMELYPYGELGHYL--ERNKN--SLKVLTLVLYSLQICKAMAYL 129
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
+ +HRD+ NIL+ K+ DFGL R D
Sbjct: 130 ---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 41/180 (22%), Positives = 78/180 (43%), Gaps = 9/180 (5%)
Query: 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR 648
+ +G G FG + DG + +K + + +S K E + E+AVL ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
++V + +V +Y G L + + + + + L + + +++
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI---NAQKGVLFQEDQILDWFVQICLALKH 140
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
+H + +HRD+K NI L D ++ DFG+ R+ N + GT YL+PE
Sbjct: 141 VH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTPYYLSPE 195
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 45/184 (24%), Positives = 79/184 (42%), Gaps = 8/184 (4%)
Query: 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR 648
++ +G G +G K DG + K ++ ++E SE+ +L +++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 649 HLVGLLGYCLDGNERLL--VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706
++V +D L V EY G L+ + +E + L+ L + + +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTLAL 124
Query: 707 EYLH--GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
+ H + +HRDLKP+N+ L K+ DFGL R+ N S GT Y
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTFVGTPYY 182
Query: 765 LAPE 768
++PE
Sbjct: 183 MSPE 186
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 14/174 (8%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHRHLVGLLG 655
LG+GGF ++ + A K + +++ + E EI++ + H+H+VG G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ 715
+ D + +V E + +L RK L E R + G +YLH
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPE-ARYYLRQI--VLGCQYLH---RN 134
Query: 716 SFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNGKHSIETRLAGTFGYLAPE 768
IHRDLK N+ L +D+ K+ DFGL ++ D + + L GT Y+APE
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--KV-LCGTPNYIAPE 185
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-30
Identities = 40/158 (25%), Positives = 76/158 (48%), Gaps = 12/158 (7%)
Query: 595 ENVLGRGGFGTVYKGELHDG---TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV 651
+ LG G FG+V +G +A+K ++ + E E ++ ++ + ++V
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIV 399
Query: 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHG 711
L+G C +LV E G L + L ++EE + + + V+ G++YL
Sbjct: 400 RLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYL-- 452
Query: 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
++F+HR+L N+LL + AK++DFGL + +
Sbjct: 453 -EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 14/174 (8%)
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHRHLVGLLG 655
LG+GGF ++ + A K + +++ + E EI++ + H+H+VG G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ 715
+ D + +V E + +L RK L E R + G +YLH
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPE-ARYYLRQI--VLGCQYLH---RN 160
Query: 716 SFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPDNGKHSIETRLAGTFGYLAPE 768
IHRDLK N+ L +D+ K+ DFGL ++ D + + L GT Y+APE
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--KV-LCGTPNYIAPE 211
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 9e-30
Identities = 61/395 (15%), Positives = 117/395 (29%), Gaps = 63/395 (15%)
Query: 49 TDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-S 107
+ C N+ + +P L +S LE N L +
Sbjct: 3 SSDQKC-----IEKEVNKT--YNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTT 52
Query: 108 LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFS 167
S L +L + + D F+ L T+ L N + +L L+
Sbjct: 53 FSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIF-MAETALSGPKALKHLF 111
Query: 168 ANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKL 226
I+ L L L+L N + ++ L
Sbjct: 112 FIQTGISSIDFIPLHN--QKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLS 169
Query: 227 NGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVN--LH 284
++ +Q T+L+ L L+GN G P + Q + Q ++ L N +
Sbjct: 170 KEDMSSLQQATNLS-LNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQ 228
Query: 285 SLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYP 344
SL + + + +P F+ + ++ L
Sbjct: 229 SLWLGTFEDMDDEDISPAV-----FEGLCEMSVESIN-------------LQ-------- 262
Query: 345 AVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG----TISSNFSRLTSLRQLM 400
+ + +S + + L+ L L+ + S L++L++L+
Sbjct: 263 --------KHY-----FFNISSNTFHCFS--GLQELDLTATHLSELPSGLVGLSTLKKLV 307
Query: 401 LSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVP 435
LS N+ + PSL L + N ++
Sbjct: 308 LSANKFENLCQISASNFPSLTHLSIKGNTKRLELG 342
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-25
Identities = 44/250 (17%), Positives = 87/250 (34%), Gaps = 15/250 (6%)
Query: 63 PSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDN 122
V I + + S L L++ L+ L GLS+L++++ N
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSAN 311
Query: 123 NFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQR--FSANGANITGTIPDF 180
F ++ SL +S+ N+ + L++ L+ S + +
Sbjct: 312 KFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQ 371
Query: 181 LGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNG--SVAVIQNMT 237
L + L L+L++N +F + ++ L L ++L + + QN+
Sbjct: 372 LRN--LSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF----TRLKVKDAQSPFQNLH 425
Query: 238 SLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIV---PSSLVNLHSLAVVNLTN 293
L L L + GL +LQ +++ N +SL L L ++ L+
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF 485
Query: 294 NLFQGQTPKF 303
Sbjct: 486 CDLSSIDQHA 495
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 8e-25
Identities = 41/236 (17%), Positives = 79/236 (33%), Gaps = 23/236 (9%)
Query: 76 NIEGTLPKE-LNSLSSLTVLEVMKNKLTGQIP---SLSGLSSLQEVLFDDNNFTSVPSDF 131
L L +L +L L++ + + L LS LQ + N S+ ++
Sbjct: 336 TKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEA 395
Query: 132 FKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMH 191
FK L+ + L + ++ L+ + + + + + G +P L H
Sbjct: 396 FKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDG--LPALQH 453
Query: 192 LHLAFNFLQGPIPLSFGK----SSIQTLWLNGQKGDSKLNG----SVAVIQNMTSLTQLW 243
L+L N ++ L L+ ++ + +
Sbjct: 454 LNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF-------CDLSSIDQHAFTSLKMMNHVD 506
Query: 244 LHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQG 298
L N T + LS L + ++ N ++ I+PS L L +NL N
Sbjct: 507 LSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-22
Identities = 38/232 (16%), Positives = 78/232 (33%), Gaps = 9/232 (3%)
Query: 71 QIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSD 130
Q +G + SL T ++ ++ + S++ + + F ++ S+
Sbjct: 213 QNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN 272
Query: 131 FFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLM 190
F + LQ + L +P L + L++ + P L
Sbjct: 273 TFHCFSGLQELDLTATHLSE--LPSGLVGLSTLKKLVLSANKFENLCQISASN--FPSLT 328
Query: 191 HLHLAFNFLQGPIPLSF--GKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNS 248
HL + N + + +++ L L+ + ++N++ L L L N
Sbjct: 329 HLSIKGNTKRLELGTGCLENLENLRELDLSHDD-IETSDCCNLQLRNLSHLQSLNLSYNE 387
Query: 249 FTG-PLPDLSGLSSLQDFSVRDNQLTGIVP-SSLVNLHSLAVVNLTNNLFQG 298
L+ + +L S NLH L V+NL+++L
Sbjct: 388 PLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI 439
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-18
Identities = 40/319 (12%), Positives = 75/319 (23%), Gaps = 70/319 (21%)
Query: 121 DNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDF 180
+ +P S + + +N + + + L I D
Sbjct: 21 NLGLNEIPGTLP---NSTECLEFSFNVLPT-IQNTTFSRLINLTFLDLTRCQIYWIHEDT 76
Query: 181 LGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLT 240
L L L N L + +L
Sbjct: 77 FQS--QHRLDTLVLTANPLIFMAETAL--------------------------SGPKALK 108
Query: 241 QLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQ 299
L+ + L +L+ + N ++ I L V++ NN
Sbjct: 109 HLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYL 168
Query: 300 TPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNS 359
+ + + + + L+ G N + I AV G
Sbjct: 169 SKED-----MSSLQQATNLSLNLNG-------NDIAGIEPGAFDSAVFQSLNFGGT---- 212
Query: 360 DWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLP- 418
+V K L S + SL + P L
Sbjct: 213 -----------QNLLVIFKGLK--------NSTIQSLWLGTFEDMDDEDISPAVFEGLCE 253
Query: 419 -SLEMLDVSNNHLFGKVPN 436
S+E +++ ++ F N
Sbjct: 254 MSVESINLQKHYFFNISSN 272
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 17/61 (27%), Positives = 27/61 (44%), Gaps = 6/61 (9%)
Query: 376 NLKNLGLSG------TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNH 429
L+ L L+ S F L L+ L LS + L + + LP+L+ L++ NH
Sbjct: 401 QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNH 460
Query: 430 L 430
Sbjct: 461 F 461
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 16/62 (25%), Positives = 28/62 (45%), Gaps = 2/62 (3%)
Query: 371 NITVVNLKN--LGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNN 428
N+ ++L + + S + L+ L+ L LS NE + P LE+LD++
Sbjct: 351 NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFT 410
Query: 429 HL 430
L
Sbjct: 411 RL 412
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 4e-06
Identities = 16/63 (25%), Positives = 29/63 (46%), Gaps = 8/63 (12%)
Query: 376 NLKNLGLSG--------TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSN 427
L++L L G +++ L L L+LS +L+ T+L + +D+S+
Sbjct: 450 ALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSH 509
Query: 428 NHL 430
N L
Sbjct: 510 NRL 512
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 6e-06
Identities = 19/63 (30%), Positives = 29/63 (46%), Gaps = 3/63 (4%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKE---LTTLPSLEMLDVSN 427
+ V+NL + L + F L +L+ L L GN ++ L TL LE+L +S
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF 485
Query: 428 NHL 430
L
Sbjct: 486 CDL 488
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-05
Identities = 14/61 (22%), Positives = 28/61 (45%), Gaps = 6/61 (9%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNH 429
+L++L LS ++ + F L L L+ L + L L++L++S++
Sbjct: 377 HLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSL 436
Query: 430 L 430
L
Sbjct: 437 L 437
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 16/70 (22%), Positives = 33/70 (47%), Gaps = 1/70 (1%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+ ++ L LS F+ L + + LS N LT + + L+ L + L++++NH+
Sbjct: 477 RLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHI 535
Query: 431 FGKVPNFRQN 440
+P+
Sbjct: 536 SIILPSLLPI 545
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 14/63 (22%), Positives = 30/63 (47%), Gaps = 3/63 (4%)
Query: 371 NITVVNLKNLGLSGTISSN-FSRLTSLRQLMLSGNELT--GTIPKELTTLPSLEMLDVSN 427
++T +++K + + L +LR+L LS +++ +L L L+ L++S
Sbjct: 326 SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSY 385
Query: 428 NHL 430
N
Sbjct: 386 NEP 388
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 7e-05
Identities = 13/60 (21%), Positives = 26/60 (43%), Gaps = 1/60 (1%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+ V+L + L+ + S L + L L+ N ++ +P L L +++ N L
Sbjct: 501 MMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPL 559
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 9e-30
Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 31/203 (15%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKS-EIAVLTK 644
+++ N E +LG G GTV G +AVKRM F + EI +LT+
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM------LIDFCDIALMEIKLLTE 64
Query: 645 V-RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRK--EEGLKPLEWTRRLTIALD 701
H +++ + E L + ++ +E LK + +++
Sbjct: 65 SDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 702 VARGVEYLHGLAHQSFIHRDLKPSNILL-------------GDDMRAKVADFGLVRLAPD 748
+A GV +LH IHRDLKP NIL+ +++R ++DFGL + D
Sbjct: 124 IASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL-D 179
Query: 749 NGKHSIETRL---AGTFGYLAPE 768
+G+ S T L +GT G+ APE
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPE 202
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 41/200 (20%), Positives = 66/200 (33%), Gaps = 28/200 (14%)
Query: 589 TNNFSEENVLGRGGFGTVYKGE------LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVL 642
+ ++LG G F VY+ + K +K + A E F + L
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWE--FYIGTQLMERL 121
Query: 643 TKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDV 702
+ L N +LV E GTL + K K + ++ A+ +
Sbjct: 122 KPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA-----------KVADFGL---VRLAPD 748
+E +H IH D+KP N +LG+ + D G ++L P
Sbjct: 182 LYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238
Query: 749 NGKHSIETRLAGTFGYLAPE 768
T T G+ E
Sbjct: 239 GTIF---TAKCETSGFQCVE 255
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 48/182 (26%), Positives = 82/182 (45%), Gaps = 16/182 (8%)
Query: 597 VLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLG 655
+GRG F TVYKG + ++A ++ +++ FK E +L ++H ++V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 656 YCLD---GNERLLVY-EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHG 711
G + +++ E M GTL +L K + ++ R + +G+++LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRS--WCRQILKGLQFLHT 147
Query: 712 LAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYA 770
IHRDLK NI + G K+ D GL L + ++ GT ++APE
Sbjct: 148 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV----IGTPEFMAPEMY 202
Query: 771 AE 772
E
Sbjct: 203 EE 204
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 48/193 (24%), Positives = 72/193 (37%), Gaps = 24/193 (12%)
Query: 595 ENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVG 652
VL GGF VY+ + + G + A+KR+ E+ E+ + K+ H ++V
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRL--LSNEEEKNRAIIQEVCFMKKLSGHPNIVQ 90
Query: 653 LLGYCLDGNER-------LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARG 705
G E L+ + +G L L + G PL L I R
Sbjct: 91 FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG--PLSCDTVLKIFYQTCRA 148
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLA------ 759
V+++H IHRDLK N+LL + K+ DFG +S +
Sbjct: 149 VQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 760 ----GTFGYLAPE 768
T Y PE
Sbjct: 208 ITRNTTPMYRTPE 220
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 49/181 (27%), Positives = 90/181 (49%), Gaps = 8/181 (4%)
Query: 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKVRH 647
NF E +GRG F VY+ L DG +A+K+++ ++ K A+ EI +L ++ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
+++ ++ NE +V E G LSR + + K++ + + + + +E
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK-RLIPERTVWKYFVQLCSALE 150
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
++H + +HRD+KP+N+ + K+ D GL R + K + L GT Y++P
Sbjct: 151 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSP 205
Query: 768 E 768
E
Sbjct: 206 E 206
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 45/189 (23%), Positives = 74/189 (39%), Gaps = 16/189 (8%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
+ + ++LG+G V++G G A+K + E VL K+
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-VDVQMREFEVLKKL 64
Query: 646 RHRHLVGLLGYCLDGNERL--LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVA 703
H+++V L + R L+ E+ P G+L L P + DV
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL--RDVV 122
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILLG----DDMRAKVADFGLVRLAPDNGKHSIETRLA 759
G+ +L +HR++KP NI+ K+ DFG R D+ + + L
Sbjct: 123 GGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVS-LY 176
Query: 760 GTFGYLAPE 768
GT YL P+
Sbjct: 177 GTEEYLHPD 185
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-28
Identities = 38/160 (23%), Positives = 67/160 (41%), Gaps = 15/160 (9%)
Query: 595 ENVLGRGGFGTVYKGELHDG----TKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKVRHRH 649
+G G FG V++G +A+K S+ +F E + + H H
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPH 452
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+V L+G + N ++ E G L L + + L+ + A ++ + YL
Sbjct: 453 IVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKF--SLDLASLILYAYQLSTALAYL 507
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
+ F+HRD+ N+L+ + K+ DFGL R D+
Sbjct: 508 ---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 47/178 (26%), Positives = 83/178 (46%), Gaps = 17/178 (9%)
Query: 598 LGRGGFGTVYKGELHD---GTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHRHLVGL 653
LG GG TVY D K+A+K + ++ + F+ E+ +++ H+++V +
Sbjct: 19 LGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
+ + + LV EY+ TLS ++ + G PL + + G+++ A
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYI---ESHG--PLSVDTAINFTNQILDGIKH----A 127
Query: 714 HQS-FIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYA 770
H +HRD+KP NIL+ + K+ DFG+ + + L GT Y +PE A
Sbjct: 128 HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-GTVQYFSPEQA 184
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 8e-28
Identities = 24/248 (9%), Positives = 47/248 (18%), Gaps = 43/248 (17%)
Query: 555 GGSESQSLTSSGPSDLHVVEA----GSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKG- 609
G ++L V + +L L G V+
Sbjct: 23 GYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVR 82
Query: 610 ELHDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHRHLVGLLGYC----------- 657
++ A+K + + E ++
Sbjct: 83 DVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142
Query: 658 ---------------LDGNERLLVYEYMPQGTLSR--HLFNRKEEGLKPLEWTRRLTIAL 700
LL+ L + +
Sbjct: 143 QSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTA 201
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAG 760
+ R L + +H P N+ + D R + D + G +
Sbjct: 202 QLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSV 253
Query: 761 TFGYLAPE 768
Y E
Sbjct: 254 PVTYAPRE 261
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-27
Identities = 52/352 (14%), Positives = 122/352 (34%), Gaps = 16/352 (4%)
Query: 87 SLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146
S + V + T IPS ++++ + N T + + +LQ + L +
Sbjct: 3 SCDASGVCDGRSRSFT-SIPS-GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSS 60
Query: 147 SFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQG-PIPL 205
+ + ++ L+ + +++ + G + L +L+L N Q +
Sbjct: 61 RI-NTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGP--LSSLKYLNLMGNPYQTLGVTS 117
Query: 206 SFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTG-PLPDLSGLSSLQ 263
F +++QTL + + S++ +TSL +L + S L + +
Sbjct: 118 LFPNLTNLQTLRIGNVETFSEIRRID--FAGLTSLNELEIKALSLRNYQSQSLKSIRDIH 175
Query: 264 DFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDA 323
++ ++ ++ L S+ + L + +F
Sbjct: 176 HLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVL 235
Query: 324 GVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLS 383
+ LL + + + G N V + G + V ++ L +
Sbjct: 236 TDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSE-LGKVETVTIRRLHIP 294
Query: 384 G-----TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+S+ +S L ++++ + +++ L SLE LD+S N +
Sbjct: 295 QFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLM 346
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-22
Identities = 53/372 (14%), Positives = 119/372 (31%), Gaps = 63/372 (16%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTS 137
+ +L++L L + + +I +GL+SL E+ + + S K +
Sbjct: 114 GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRD 173
Query: 138 LQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITG---------TIPDFLGGDTIPG 188
+ ++L + ++++ + ++ N+ + + G
Sbjct: 174 IHHLTLHLSES-AFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRG 232
Query: 189 LMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQN-----MTSLTQLW 243
+ +FN L + S ++ V+ ++ +L
Sbjct: 233 SVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLH 292
Query: 244 LHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK 302
+ L S L ++ +V ++++ + S +L SL ++L+ NL +
Sbjct: 293 IPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEY-- 350
Query: 303 FNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWK 362
+ + L N L S+
Sbjct: 351 LKNSACKGAWPSLQTLVLSQ---------NHLRSM------------------------- 376
Query: 363 GVSCDAGGNITVVNLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLP 418
+T+ NL +L +S + + +R L LS + + +
Sbjct: 377 --QKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQ 431
Query: 419 SLEMLDVSNNHL 430
+LE+LDVSNN+L
Sbjct: 432 TLEVLDVSNNNL 443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-21
Identities = 46/239 (19%), Positives = 79/239 (33%), Gaps = 24/239 (10%)
Query: 67 VTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNF 124
+ R+ I + L + L + + V +K+ +P L SL+ + +N
Sbjct: 288 IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLM 346
Query: 125 TSVP---SDFFKGLTSLQTISLDYNSFDS-WVIPESLKDATGLQR--FSANGANITGTIP 178
S SLQT+ L N S E L L S N +P
Sbjct: 347 VEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRN--TFH-PMP 403
Query: 179 DFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTS 238
D + L+L+ ++ +++ L ++ N + +
Sbjct: 404 DSCQW--PEKMRFLNLSSTGIRVVKTCIP--QTLEVLDVSN-------NNLDSFSLFLPR 452
Query: 239 LTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
L +L++ N LPD S L + NQL + L SL + L N +
Sbjct: 453 LQELYISRNKLKT-LPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-20
Identities = 58/383 (15%), Positives = 123/383 (32%), Gaps = 80/383 (20%)
Query: 80 TLPKE-LNSLSSLTVLEVMKNKLT--GQIPSLSGLSSLQEV-LFDDNNFTSVPSDFFKGL 135
+L LSSL L +M N G L++LQ + + + F+ + F GL
Sbjct: 88 SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGL 147
Query: 136 TSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLA 195
TSL + + S + +SLK + + + + + + D + + +L L
Sbjct: 148 TSLNELEIKALSLRN-YQSQSLKSIRDIHHLTLHLSESA-FLLEIFA-DILSSVRYLELR 204
Query: 196 FNFLQ----GPIPLSFGKSSIQTLWLNGQK-GDSKLNGSVAVIQNMTSLTQLWLHGNSFT 250
L P+P+ S ++ L G D N + +++ + L+++ +
Sbjct: 205 DTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLN 264
Query: 251 G----------PLPDLSGLS--SLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLT-NNLFQ 297
G + +L + +++ + L + + L + + + + +F
Sbjct: 265 GLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFL 324
Query: 298 GQTPKFNSPVRF---DMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGN 354
D+++ N+++
Sbjct: 325 VPCSFSQHLKSLEFLDLSE------------------NLMVEEY---------------- 350
Query: 355 NPCNSDWKGVSCDAGGNITVVNLKNLGLSG-------TISSNFSRLTSLRQLMLSGNELT 407
NS KG +L+ L LS L +L L +S N
Sbjct: 351 -LKNSACKG---------AWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH 400
Query: 408 GTIPKELTTLPSLEMLDVSNNHL 430
+P + L++S+ +
Sbjct: 401 -PMPDSCQWPEKMRFLNLSSTGI 422
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 4e-11
Identities = 36/263 (13%), Positives = 79/263 (30%), Gaps = 28/263 (10%)
Query: 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTS 126
++I ++ + L S+ + L + ++ + LSS++ + D N
Sbjct: 151 NELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR 210
Query: 127 VPSDFFKGLTSLQTISLDYNSFDSWV------IPESLKDATGLQRFSANGANITG----- 175
+ + + L+ L + + G
Sbjct: 211 FQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFN 270
Query: 176 ----TIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNG-S 229
+ LG + LH+ +L + + ++ + + +SK+
Sbjct: 271 PSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVE----NSKVFLVP 326
Query: 230 VAVIQNMTSLTQLWLHGNSFT----GPLPDLSGLSSLQDFSVRDNQLTGI--VPSSLVNL 283
+ Q++ SL L L N SLQ + N L + L+ L
Sbjct: 327 CSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTL 386
Query: 284 HSLAVVNLTNNLFQGQTPKFNSP 306
+L ++++ N F P
Sbjct: 387 KNLTSLDISRNTFHPMPDSCQWP 409
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 9e-05
Identities = 19/67 (28%), Positives = 33/67 (49%), Gaps = 6/67 (8%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTG-TIPKELTTLPSLEMLDVSNNH 429
+L++L LS ++SS+ F L+SL+ L L GN + L +L+ L + N
Sbjct: 75 SLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVE 134
Query: 430 LFGKVPN 436
F ++
Sbjct: 135 TFSEIRR 141
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 17/56 (30%), Positives = 30/56 (53%), Gaps = 3/56 (5%)
Query: 376 NLKNLGLSG-TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L+ L +S + S L L++L +S N+L T+P + + P L ++ +S N L
Sbjct: 432 TLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLP-DASLFPVLLVMKISRNQL 485
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 45/181 (24%), Positives = 77/181 (42%), Gaps = 17/181 (9%)
Query: 595 ENVLGRGGFGTVYKGELHD---GTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHRHL 650
++GRGG G VY+ D +A+K M + S+ F + E +++ H+
Sbjct: 39 RRLVGRGGMGDVYEA--EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHV 96
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
V + + + + + L+ L + +G PL R + I + ++
Sbjct: 97 VPIHDFGEIDGQLYVDMRLINGVDLAAML---RRQG--PLAPPRAVAIVRQIGSALDA-- 149
Query: 711 GLAHQS-FIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEY 769
AH + HRD+KP NIL+ D A + DFG+ D + + GT Y+APE
Sbjct: 150 --AHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPER 206
Query: 770 A 770
Sbjct: 207 F 207
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-27
Identities = 58/182 (31%), Positives = 88/182 (48%), Gaps = 10/182 (5%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKI-AVKRME-SAVVSEKGFAEFKSEIAVLTKVRH 647
+ F + VLGRGGFG V+ ++ K+ A K++ + KG+ E +L KV
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 648 RHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706
R +V L Y + L LV M G + H++N E+ E A + G+
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA-QIVSGL 302
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLA 766
E+LH ++ I+RDLKP N+LL DD +++D GL + AGT G++A
Sbjct: 303 EHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGY-AGTPGFMA 357
Query: 767 PE 768
PE
Sbjct: 358 PE 359
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-27
Identities = 45/191 (23%), Positives = 76/191 (39%), Gaps = 20/191 (10%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
+ + ++LG+G V++G G A+K + E VL K+
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-VDVQMREFEVLKKL 64
Query: 646 RHRHLVGLLGYCLDGNERL--LVYEYMPQGTLSRHLFNR--KEEGLKPLEWTRRLTIALD 701
H+++V L + R L+ E+ P G L+ + L + L + D
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCG----SLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 702 VARGVEYLHGLAHQSFIHRDLKPSNILLG----DDMRAKVADFGLVRLAPDNGKHSIETR 757
V G+ +L +HR++KP NI+ K+ DFG R D+ + +
Sbjct: 121 VVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVS- 174
Query: 758 LAGTFGYLAPE 768
L GT YL P+
Sbjct: 175 LYGTEEYLHPD 185
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 46/191 (24%), Positives = 81/191 (42%), Gaps = 25/191 (13%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
++N+ + LG+G F V + G + A K + + +S + F + + E + K+
Sbjct: 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTL-----SRHLFNRKEEGLKPLEWTRRLTIAL 700
+H ++V L + + LV++ + G L +R ++ +
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD--------ASHCI--Q 112
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHSIETR 757
+ + Y H +HR+LKP N+LL K+ADFGL D+
Sbjct: 113 QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HG 166
Query: 758 LAGTFGYLAPE 768
AGT GYL+PE
Sbjct: 167 FAGTPGYLSPE 177
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 5e-27
Identities = 53/191 (27%), Positives = 80/191 (41%), Gaps = 19/191 (9%)
Query: 588 VTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR 646
+ + LG GGFG V + G ++A+K+ + S K + EI ++ K+
Sbjct: 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLN 70
Query: 647 HRHLVGLL------GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIAL 700
H ++V + LL EY G L ++L N+ E E R T+
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL-NQFENCCGLKEGPIR-TLLS 128
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHSIETR 757
D++ + YLH IHRDLKP NI+L + K+ D G +
Sbjct: 129 DISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL--CTEF 183
Query: 758 LAGTFGYLAPE 768
+ GT YLAPE
Sbjct: 184 V-GTLQYLAPE 193
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 35/214 (16%), Positives = 67/214 (31%), Gaps = 41/214 (19%)
Query: 597 VLGRGGFGTVYKG-ELHDGTKIAVK--------------RMESAVVSEKGFAEFKSEIAV 641
VLG+ + + G V +M+ V+ + K++
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 642 LTKVR------------HRHLVGLLGYCLDGN--ERLLVYEYMPQ--GTLSRHLFNRKEE 685
+R + ++ + D R +Y M T L +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 686 GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745
K L RL + L V R + LH H +H L+P +I+L + F +
Sbjct: 200 H-KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV- 254
Query: 746 APDNGKHSIETRLAGTFGYLAPEYAAETSGMTWQ 779
+ + + G+ PE A + +++
Sbjct: 255 -----RDGARVVSSVSRGFEPPELEARRATISYH 283
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 20/234 (8%)
Query: 540 GNAVKITVTESSVTGGGSESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLG 599
G A + + + G ++ Q L + V+ + R + + + +G
Sbjct: 8 GQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVG 67
Query: 600 RGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCL 658
RG FG V++ + G + AVK++ V + E+ + +V L G
Sbjct: 68 RGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGAVR 120
Query: 659 DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFI 718
+G + E + G+L + + K+ G L R L G+EYLH + +
Sbjct: 121 EGPWVNIFMELLEGGSLGQLI---KQMG--CLPEDRALYYLGQALEGLEYLHT---RRIL 172
Query: 719 HRDLKPSNILLGDD-MRAKVADFGL-VRLAPDNGKHSIETR--LAGTFGYLAPE 768
H D+K N+LL D RA + DFG + L PD S+ T + GT ++APE
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 54/186 (29%), Positives = 82/186 (44%), Gaps = 20/186 (10%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKI-AVKRME-SAVVSEKGFAEFKSEIAVLTKVRH 647
+F +LG G F TV ++ A+K +E ++ E E V++++ H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 648 RHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTR----RLTIALDV 702
V L D +E+L Y G L +++ ++ G TR + AL
Sbjct: 90 PFFVKLYFTFQD-DEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSAL-- 143
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF 762
EYLHG IHRDLKP NILL +DM ++ DFG ++ K + GT
Sbjct: 144 ----EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196
Query: 763 GYLAPE 768
Y++PE
Sbjct: 197 QYVSPE 202
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-27
Identities = 51/216 (23%), Positives = 87/216 (40%), Gaps = 29/216 (13%)
Query: 566 GPSDLHVVEAGSMVISIQVLRNVTNNFSEE----NVLGRGGFGTVYKG-ELHDGTKIAVK 620
GP + M + + N + FS+ LG+G F V + G + A K
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60
Query: 621 RMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTL----- 675
+ + +S + F + + E + K++H ++V L + + LV++ + G L
Sbjct: 61 IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120
Query: 676 SRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDD 732
+R ++ + + + Y H +HR+LKP N+LL
Sbjct: 121 AREFYSEAD--------ASHCI--QQILESIAYCH---SNGIVHRNLKPENLLLASKAKG 167
Query: 733 MRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
K+ADFGL D+ AGT GYL+PE
Sbjct: 168 AAVKLADFGLAIEVNDSEAW---HGFAGTPGYLSPE 200
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-27
Identities = 64/272 (23%), Positives = 105/272 (38%), Gaps = 38/272 (13%)
Query: 517 KRKRSGRVQSPNAVVIHPSNGGDGNAVKITVTESSVTGGGSESQSLTSSGPSDLHVVEAG 576
++R + + + S +E++ L + P +
Sbjct: 16 NKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQ 75
Query: 577 SMVISIQVLR-NVTNNFSEE----NVLGRGGFGTVYKG-ELHDGTKIAVKRME------S 624
SM ++ F ++ +V+GRG V + G + AVK ME S
Sbjct: 76 SMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLS 135
Query: 625 AVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR- 682
E+ + E +L +V H H++ L+ + LV++ M +G L F+
Sbjct: 136 PEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYL 191
Query: 683 KEEGLKPLEWTRRLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 736
E+ L+ I + V +LH + +HRDLKP NILL D+M+ +
Sbjct: 192 TEKV--------ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIR 240
Query: 737 VADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
++DFG K L GT GYLAPE
Sbjct: 241 LSDFGFSCHLEPGEKL---RELCGTPGYLAPE 269
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-26
Identities = 62/182 (34%), Positives = 91/182 (50%), Gaps = 13/182 (7%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKI-AVKRME-SAVVSEKGFAEFKSEIAVLTKVRH 647
N F + VLG+GGFG V ++ K+ A K++E + KG A +E +L KV
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 648 RHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706
R +V L Y + + L LV M G L H+++ + G E A ++ G+
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP--EARAVFYAA-EICCGL 299
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLA 766
E LH + ++RDLKP NILL D +++D GL P+ I+ R GT GY+A
Sbjct: 300 EDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGR-VGTVGYMA 353
Query: 767 PE 768
PE
Sbjct: 354 PE 355
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 53/177 (29%), Positives = 85/177 (48%), Gaps = 17/177 (9%)
Query: 597 VLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLG 655
VLG+G +G VY G +L + +IA+K + + EIA+ ++H+++V LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIP--ERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLT--IALDVARGVEYLHGLA 713
+ + E +P G+LS L R + G PL+ + + G++YLH
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALL--RSKWG--PLKDNEQTIGFYTKQILEGLKYLHD-- 140
Query: 714 HQSFIHRDLKPSNILLGDDM-RAKVADFGL-VRLAPDNGKHSIETRLAGTFGYLAPE 768
+HRD+K N+L+ K++DFG RLA G + GT Y+APE
Sbjct: 141 -NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA---GINPCTETFTGTLQYMAPE 193
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 51/183 (27%), Positives = 79/183 (43%), Gaps = 21/183 (11%)
Query: 598 LGRGGFGTVYKGELHD---GTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHRHLVGL 653
LG GG V+ D +AVK + + + + F F+ E + H +V +
Sbjct: 20 LGFGGMSEVHLA--RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 654 LGYCLD-GNERLLVY---EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
L Y EY+ TL + EG P+ R + + D + + +
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEG--PMTPKRAIEVIADACQALNF- 131
Query: 710 HGLAHQS-FIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLA-GTFGYLAP 767
+HQ+ IHRD+KP+NI++ KV DFG+ R D+G +T GT YL+P
Sbjct: 132 ---SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 768 EYA 770
E A
Sbjct: 189 EQA 191
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 46/214 (21%), Positives = 83/214 (38%), Gaps = 20/214 (9%)
Query: 83 KELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTIS 142
L +L+ + L + N + LS ++ L + ++ V LT L ++S
Sbjct: 126 SPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLS 183
Query: 143 LDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGP 202
L+YN + L T L F+A IT P + + L L + N +
Sbjct: 184 LNYNQIEDI---SPLASLTSLHYFTAYVNQITDITP--VAN--MTRLNSLKIGNNKITDL 236
Query: 203 IPLSFGKSSIQTLWLNGQKGDSKLNG--SVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLS 260
PL+ S + L + N + ++++T L L + N + + L+ LS
Sbjct: 237 SPLA-NLSQLTWLEIGT-------NQISDINAVKDLTKLKMLNVGSNQISD-ISVLNNLS 287
Query: 261 SLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
L + +NQL + L +L + L+ N
Sbjct: 288 QLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQN 321
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 39/220 (17%), Positives = 84/220 (38%), Gaps = 19/220 (8%)
Query: 76 NIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGL 135
N + L++++ L L V ++K+ + ++ L+ L + + N + L
Sbjct: 142 NHNLSDLSPLSNMTGLNYLTVTESKVKD-VTPIANLTDLYSLSLNYNQIEDISP--LASL 198
Query: 136 TSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLA 195
TSL + N + + T L IT P L + L L +
Sbjct: 199 TSLHYFTAYVNQITD---ITPVANMTRLNSLKIGNNKITDLSP--LAN--LSQLTWLEIG 251
Query: 196 FNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD 255
N + + + ++ L + +++ ++V+ N++ L L+L+ N +
Sbjct: 252 TNQISDINAVK-DLTKLKMLNVGSN----QIS-DISVLNNLSQLNSLFLNNNQLGNEDME 305
Query: 256 -LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+ GL++L + N +T I L +L + + N
Sbjct: 306 VIGGLTNLTTLFLSQNHITDI--RPLASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 40/230 (17%), Positives = 100/230 (43%), Gaps = 20/230 (8%)
Query: 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNF 124
+T++ + G+ + + + L++L L + N++T I LS L L + N
Sbjct: 44 ESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITD-ISPLSNLVKLTNLYIGTNKI 100
Query: 125 TSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGD 184
T + + + LT+L+ + L+ ++ L + T + + + +
Sbjct: 101 TDISA--LQNLTNLRELYLNEDNISD---ISPLANLTKMYSLNLGANHNLSDLSPL---S 152
Query: 185 TIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWL 244
+ GL +L + + ++ P++ + + +L L +++ ++ + ++TSL
Sbjct: 153 NMTGLNYLTVTESKVKDVTPIA-NLTDLYSLSL----NYNQIE-DISPLASLTSLHYFTA 206
Query: 245 HGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+ N T + ++ ++ L + +N++T + S L NL L + + N
Sbjct: 207 YVNQITD-ITPVANMTRLNSLKIGNNKITDL--SPLANLSQLTWLEIGTN 253
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 49/212 (23%), Positives = 97/212 (45%), Gaps = 18/212 (8%)
Query: 83 KELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTIS 142
L++L LT L + NK+T I +L L++L+E+ +++N + + LT + +++
Sbjct: 82 SPLSNLVKLTNLYIGTNKIT-DISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLN 138
Query: 143 LDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGP 202
L N S L + TGL + + + + + L L L +N ++
Sbjct: 139 LGANHNLS--DLSPLSNMTGLNYLTVTESKVKD-VTPI---ANLTDLYSLSLNYNQIEDI 192
Query: 203 IPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSL 262
PL+ +S+ +++ + + NMT L L + N T L L+ LS L
Sbjct: 193 SPLA-SLTSLHYFTA----YVNQIT-DITPVANMTRLNSLKIGNNKITD-LSPLANLSQL 245
Query: 263 QDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+ NQ++ I +++ +L L ++N+ +N
Sbjct: 246 TWLEIGTNQISDI--NAVKDLTKLKMLNVGSN 275
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 6e-22
Identities = 40/210 (19%), Positives = 78/210 (37%), Gaps = 18/210 (8%)
Query: 85 LNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144
L+ + K +T + + L S+ +++ S+ + LT+L+ ++L+
Sbjct: 18 DADLAEGIRAVLQKASVTD-VVTQEELESITKLVVAGEKVASIQG--IEYLTNLEYLNLN 74
Query: 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIP 204
N L + L IT I + L L+L + + P
Sbjct: 75 GNQITD---ISPLSNLVKLTNLYIGTNKIT-DISAL---QNLTNLRELYLNEDNISDISP 127
Query: 205 LSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQD 264
L+ + + +L L + ++ + NMT L L + + + ++ L+ L
Sbjct: 128 LA-NLTKMYSLNLGA----NHNLSDLSPLSNMTGLNYLTVTESKVKD-VTPIANLTDLYS 181
Query: 265 FSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
S+ NQ+ I S L +L SL N
Sbjct: 182 LSLNYNQIEDI--SPLASLTSLHYFTAYVN 209
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 3e-20
Identities = 38/190 (20%), Positives = 74/190 (38%), Gaps = 15/190 (7%)
Query: 84 ELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143
+ +L+ L L + N++ I L+ L+SL N T + +T L ++ +
Sbjct: 172 PIANLTDLYSLSLNYNQIED-ISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKI 228
Query: 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPI 203
N L + + L I+ I + L L++ N +
Sbjct: 229 GNNKITD---LSPLANLSQLTWLEIGTNQIS-DINAV---KDLTKLKMLNVGSNQISDIS 281
Query: 204 PLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQ 263
L+ S + +L+LN + ++ + VI +T+LT L+L N T + L+ LS +
Sbjct: 282 VLN-NLSQLNSLFLNNNQLGNE---DMEVIGGLTNLTTLFLSQNHITD-IRPLASLSKMD 336
Query: 264 DFSVRDNQLT 273
+ +
Sbjct: 337 SADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 3e-11
Identities = 33/204 (16%), Positives = 65/204 (31%), Gaps = 63/204 (30%)
Query: 91 LTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDS 150
L + + QI + L+ + + T V + + L S+ + +
Sbjct: 2 AATLATLPAPIN-QIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEK--- 55
Query: 151 WVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKS 210
+ G++ L +L+L N + PLS
Sbjct: 56 ------VASIQGIEYL--------------------TNLEYLNLNGNQITDISPLS---- 85
Query: 211 SIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDN 270
N+ LT L++ N T + L L++L++ + ++
Sbjct: 86 ------------------------NLVKLTNLYIGTNKITD-ISALQNLTNLRELYLNED 120
Query: 271 QLTGIVPSSLVNLHSLAVVNLTNN 294
++ I S L NL + +NL N
Sbjct: 121 NISDI--SPLANLTKMYSLNLGAN 142
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 4e-08
Identities = 18/58 (31%), Positives = 28/58 (48%), Gaps = 3/58 (5%)
Query: 376 NLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
LK L + IS S + L+ L L L+ N+L + + L +L L +S NH+
Sbjct: 266 KLKMLNVGSNQISDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHI 323
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 49.8 bits (120), Expect = 2e-06
Identities = 14/58 (24%), Positives = 25/58 (43%), Gaps = 4/58 (6%)
Query: 376 NLKNLGLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
NL+ L L+ + S + LT + L L N + L+ + L L V+ + +
Sbjct: 111 NLRELYLNEDNISDISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKV 167
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 2e-06
Identities = 17/67 (25%), Positives = 28/67 (41%), Gaps = 5/67 (7%)
Query: 376 NLKNLGLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFG 432
L NL + T S LT+LR+L L+ + ++ P L L + L++ NH
Sbjct: 89 KLTNLYIGTNKITDISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS 146
Query: 433 KVPNFRQ 439
+
Sbjct: 147 DLSPLSN 153
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 2e-06
Identities = 13/58 (22%), Positives = 23/58 (39%), Gaps = 5/58 (8%)
Query: 376 NLKNLGLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+L T + + +T L L + N++T P L L L L++ N +
Sbjct: 200 SLHYFTAYVNQITDITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI 255
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 3e-06
Identities = 15/58 (25%), Positives = 25/58 (43%), Gaps = 5/58 (8%)
Query: 376 NLKNLGLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+L +L L+ S + LTSL N++T P + + L L + NN +
Sbjct: 178 DLYSLSLNYNQIEDISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKI 233
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 5e-06
Identities = 17/58 (29%), Positives = 28/58 (48%), Gaps = 5/58 (8%)
Query: 376 NLKNLGLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
NL+ L L+G T S S L L L + N++ T L L +L L ++ +++
Sbjct: 67 NLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNI 122
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 1e-05
Identities = 14/58 (24%), Positives = 23/58 (39%), Gaps = 5/58 (8%)
Query: 376 NLKNLGLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L L ++ + + LT L L L+ N++ P L +L SL N +
Sbjct: 156 GLNYLTVTESKVKDVTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQI 211
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 1e-05
Identities = 16/60 (26%), Positives = 25/60 (41%), Gaps = 2/60 (3%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+ + L N L LT+L L LS N +T P L +L ++ D +N +
Sbjct: 288 QLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 9e-05
Identities = 17/58 (29%), Positives = 30/58 (51%), Gaps = 5/58 (8%)
Query: 376 NLKNLGLSGT-ISS--NFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
++ L ++G ++S LT+L L L+GN++T P L+ L L L + N +
Sbjct: 45 SITKLVVAGEKVASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI 100
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 1e-04
Identities = 14/64 (21%), Positives = 25/64 (39%), Gaps = 5/64 (7%)
Query: 376 NLKNLGLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFG 432
L L + + + LT L+ L + N+++ L L L L ++NN L
Sbjct: 244 QLTWLEIGTNQISDINAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGN 301
Query: 433 KVPN 436
+
Sbjct: 302 EDME 305
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 8e-04
Identities = 11/58 (18%), Positives = 25/58 (43%), Gaps = 5/58 (8%)
Query: 376 NLKNLGLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L T L S+ +L+++G ++ + + L +LE L+++ N +
Sbjct: 23 EGIRAVLQKASVTDVVTQEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQI 78
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-26
Identities = 68/379 (17%), Positives = 130/379 (34%), Gaps = 41/379 (10%)
Query: 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFT 125
+ + I+ SLS L+ L + N + + SGLSSLQ+++ + N
Sbjct: 55 QVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA 113
Query: 126 SVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGG-- 183
S+ + L +L+ +++ +N S+ +PE + T L+ + I L
Sbjct: 114 SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLH 173
Query: 184 DTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLW 243
+ L L+ N + P +F + + L L LN IQ + L
Sbjct: 174 QMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNF--DSLNVMKTCIQGLAGLEVHR 231
Query: 244 LHGNSFTG----PLPDLSGLSSLQDFSVRDNQLTGI------VPSSLVNLHSLAVVNLTN 293
L F D S L L + ++ + +L + + L +++ +L +
Sbjct: 232 LVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVS 291
Query: 294 NLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKG 353
+ + + + F +
Sbjct: 292 VTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFT------------------ 333
Query: 354 NNPCNSDWKGVSCDAGGNITVVNLKN--LGLSGTISSNFSRLTSLRQLMLSGNELTGTIP 411
+N + + V ++ ++L L G S + TSL+ L LS N + T+
Sbjct: 334 SNKGGNAFSEVDL---PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMS 389
Query: 412 KELTTLPSLEMLDVSNNHL 430
L LE LD +++L
Sbjct: 390 SNFLGLEQLEHLDFQHSNL 408
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 68/374 (18%), Positives = 120/374 (32%), Gaps = 53/374 (14%)
Query: 80 TLPKE-LNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVP-SDFFKGLT 136
+L + LSSL L ++ L + L +L+E+ N S ++F LT
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 137 SLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAF 196
+L+ + L N S + L+ + + L L+
Sbjct: 150 NLEHLDLSSNKIQS-IYCTDLRVLHQMPLL----------------------NLSLDLSL 186
Query: 197 NFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTG----P 252
N + P +F + + L L LN IQ + L L F
Sbjct: 187 NPMNFIQPGAFKEIRLHKLTLRNNF--DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 244
Query: 253 LPDLSGLSSLQDFSVRDNQLTGI------VPSSLVNLHSLAVVNLTNNLFQGQTPKFNSP 306
D S L L + ++ + +L + + L +++ +L + + +
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF 304
Query: 307 VRFDMAKGSNSFCLDDAGVACDGRV-----NVLLSIVKSVGYPAVLAESWKGNNPCNSDW 361
+ + F + N + V P+ L N +
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPS-LEFLDLSRNGLSF-- 361
Query: 362 KGVSCDAGGNITVVNLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKE-LTT 416
C + + +LK L LS T+SSNF L L L + L +
Sbjct: 362 --KGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419
Query: 417 LPSLEMLDVSNNHL 430
L +L LD+S+ H
Sbjct: 420 LRNLIYLDISHTHT 433
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-23
Identities = 46/219 (21%), Positives = 81/219 (36%), Gaps = 16/219 (7%)
Query: 86 NSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFT--SVPSDFFKGLTSLQTISL 143
L SL L NK S L SL+ + N + S G TSL+ + L
Sbjct: 322 LKLKSLKRLTFTSNKGGN-AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPI 203
+N + + + L+ +N+ + +F ++ L++L ++ +
Sbjct: 381 SFNGVIT--MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAF 437
Query: 204 PLSFGK-SSIQTLWLNGQKGDSKLNGSV--AVIQNMTSLTQLWLHGNSFTGPLPD--LSG 258
F SS++ L + G + + + + +LT L L L +
Sbjct: 438 NGIFNGLSSLEVLKMAG----NSFQENFLPDIFTELRNLTFLDLSQCQLEQ-LSPTAFNS 492
Query: 259 LSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
LSSLQ ++ NQL + L SL + L N +
Sbjct: 493 LSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 6e-22
Identities = 62/349 (17%), Positives = 115/349 (32%), Gaps = 24/349 (6%)
Query: 89 SSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146
S L++ N L + S LQ + ++ ++ L+ L T+ L N
Sbjct: 28 FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 147 SFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQ-GPIPL 205
S + + + LQ+ A N+ +G + L L++A N +Q +P
Sbjct: 87 PIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGH--LKTLKELNVAHNLIQSFKLPE 143
Query: 206 SFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMT-SLTQLWLHGNSFTGPLPDLSGLSSLQ 263
F ++++ L L+ K S + V+ M L L N P L
Sbjct: 144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLH 203
Query: 264 DFSVRDNQLTG-IVPSSLVNLHSLAVVNLTNNLFQGQTP-KFNSPVRFDMAKGSNSFCLD 321
++R+N + ++ + + L L V L F+ + + +
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263
Query: 322 DAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLG 381
A + + + L + + + + L N
Sbjct: 264 LAYLD--------YYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCK 315
Query: 382 LSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+L SL++L + N+ LPSLE LD+S N L
Sbjct: 316 FG---QFPTLKLKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGL 359
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-20
Identities = 53/394 (13%), Positives = 113/394 (28%), Gaps = 74/394 (18%)
Query: 76 NIEGTLPKELNSLSSLTVLEVMKNKLT--GQIPSLSGLSSLQEVLFDDNNFTSVPSDFFK 133
N+ + L +L L V N + S L++L+ + N S+ +
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170
Query: 134 GLTSLQ----TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGL 189
L + ++ L N + I L + + + + + GL
Sbjct: 171 VLHQMPLLNLSLDLSLNPMNF--IQPGAFKEIRLHKLTLRNNFDSLNVMKTCI-QGLAGL 227
Query: 190 MHLHLAFNFLQGPIPLSF-------GKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQL 242
L + L G ++ D L+ + + +T+++
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF 287
Query: 243 WLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSL-------------------VNL 283
L + + D S Q + + + L V+L
Sbjct: 288 SLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDL 346
Query: 284 HSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGY 343
SL ++L+ N + S ++ LD N ++++
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQS-----DFGTTSLKYLD-----LSF--NGVITM------ 388
Query: 344 PAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSN-FSRLTSLRQLMLS 402
+S++ G+ + ++ ++ L + F L +L L +S
Sbjct: 389 --------------SSNFLGLE-----QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429
Query: 403 GNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPN 436
L SLE+L ++ N
Sbjct: 430 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 463
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 9e-16
Identities = 54/325 (16%), Positives = 107/325 (32%), Gaps = 39/325 (12%)
Query: 121 DNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDF 180
+ NF +P + S + + L +N + S LQ + I
Sbjct: 16 ELNFYKIPDNLP---FSTKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGA 71
Query: 181 LGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNG-SVAVIQNMTS 238
+ L L L N +Q +F SS+Q L ++ L I ++ +
Sbjct: 72 YQS--LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV----ETNLASLENFPIGHLKT 125
Query: 239 LTQLWLHGNSFT-GPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLT---- 292
L +L + N LP+ S L++L+ + N++ I + L LH + ++NL+
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185
Query: 293 -NNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESW 351
N + Q F + +N L+ G L +
Sbjct: 186 LNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAG--LEVH----------RLV 233
Query: 352 KGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG------TISSNFSRLTSLRQLMLSGNE 405
G + + A + + ++ L+ I F+ LT++ L
Sbjct: 234 LGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT 293
Query: 406 LTGTIPKELTTLPSLEMLDVSNNHL 430
+ + + + + L++ N
Sbjct: 294 IE-RVK-DFSYNFGWQHLELVNCKF 316
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 8e-10
Identities = 28/74 (37%), Positives = 38/74 (51%), Gaps = 3/74 (4%)
Query: 78 EGTLPKELNSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDNNFTSVPSDFFKGL 135
E LP L +LT L++ + +L Q+ + + LSSLQ + N SVP F L
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRL 517
Query: 136 TSLQTISLDYNSFD 149
TSLQ I L N +D
Sbjct: 518 TSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 8e-06
Identities = 15/61 (24%), Positives = 28/61 (45%), Gaps = 1/61 (1%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNH 429
N+ +++ + + F+ L+SL L ++GN + T L +L LD+S
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481
Query: 430 L 430
L
Sbjct: 482 L 482
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 17/61 (27%), Positives = 32/61 (52%), Gaps = 6/61 (9%)
Query: 376 NLKNLGLSG------TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNH 429
+L+ L ++G + F+ L +L L LS +L P +L SL++L++++N
Sbjct: 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQ 505
Query: 430 L 430
L
Sbjct: 506 L 506
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 9e-05
Identities = 18/61 (29%), Positives = 30/61 (49%), Gaps = 7/61 (11%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNH 429
NL L LS +S F+ L+SL+ L ++ N+L ++P L SL+ + + N
Sbjct: 471 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNP 529
Query: 430 L 430
Sbjct: 530 W 530
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-26
Identities = 56/376 (14%), Positives = 104/376 (27%), Gaps = 49/376 (13%)
Query: 76 NIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGL 135
+ +L + L +L + N L + L LS+L+ + ++N +
Sbjct: 45 PLSQISAADLAPFTKLELLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQELL-----VG 98
Query: 136 TSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLA 195
S++T+ N+ + S G + IT G + +L L
Sbjct: 99 PSIETLHAANNNISR--VSCSR--GQGKKNIYLANNKITMLRDLDEGC--RSRVQYLDLK 152
Query: 196 FNFLQG-PIPLSFGK-SSIQTLWLNGQKGDSKLNG--SVAVIQNMTSLTQLWLHGNSFTG 251
N + +++ L L N V L L L N
Sbjct: 153 LNEIDTVNFAELAASSDTLEHLNLQY-------NFIYDVKGQVVFAKLKTLDLSSNKLAF 205
Query: 252 PLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKF---NSPVR 308
P+ + + S+R+N+L I +L +L +L N F T + +
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLVLI-EKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264
Query: 309 FDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDA 368
+AK + C PA A+
Sbjct: 265 QTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLI---------------- 308
Query: 369 GGNITVVNLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLD 424
+ L G + R++ + I + + L+
Sbjct: 309 --ALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLE 366
Query: 425 VSNNHLFGKVPNFRQN 440
L +V N R+
Sbjct: 367 QKKKALDEQVSNGRRA 382
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 7e-20
Identities = 40/339 (11%), Positives = 84/339 (24%), Gaps = 44/339 (12%)
Query: 83 KELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTIS 142
+EL S+ L N ++ ++ S + + +N T + + +Q +
Sbjct: 93 QELLVGPSIETLHAANNNIS-RVSC-SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLD 150
Query: 143 LDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGP 202
L N D+ E + L+ + I + + L L L+ N L
Sbjct: 151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV---VFAKLKTLDLSSNKLAF- 205
Query: 203 IPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSL 262
+ F + +T + L N L +L
Sbjct: 206 MGPEFQ--------------------------SAAGVTWISLRNNKLVLIEKALRFSQNL 239
Query: 263 QDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDD 322
+ F +R N + V + + T + ++C +D
Sbjct: 240 EHFDLRGNGFHCGTLRDFF-SKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCED 298
Query: 323 AGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGL 382
R+ L + ++ + ++
Sbjct: 299 LPAPFADRLIALKR----------KEHALLSGQGSETERLECERENQARQREIDALKEQY 348
Query: 383 SGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLE 421
I R + L L + L+
Sbjct: 349 RTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELD 387
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 8e-12
Identities = 25/166 (15%), Positives = 58/166 (34%), Gaps = 14/166 (8%)
Query: 129 SDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPG 188
+ + + + +S + + A ++ +G ++ L
Sbjct: 3 HEIKQNGNRYKIEKVTDSSLKQ-ALASLRQSAWNVKELDLSGNPLSQISAADLAP--FTK 59
Query: 189 LMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNS 248
L L+L+ N L + L S+++TL LN N V + S+ L N+
Sbjct: 60 LELLNLSSNVLYETLDLE-SLSTLRTLDLNN-------N-YVQELLVGPSIETLHAANNN 110
Query: 249 FTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+ + S ++ + +N++T + + ++L N
Sbjct: 111 ISR-VS-CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLN 154
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 23/218 (10%), Positives = 60/218 (27%), Gaps = 5/218 (2%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSV-PSDFFKGLTSL 138
+ E S + +T + + NKL +L +L+ N F DFF +
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264
Query: 139 QTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNF 198
QT++ + E T + ++ D L L +
Sbjct: 265 QTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSE 324
Query: 199 LQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LS 257
+ ++ + + ++ + ++ V + L + + +
Sbjct: 325 TERLECERENQARQREIDALKEQYRTVIDQ---VTLRKQAKITLEQKKKALDEQVSNGRR 381
Query: 258 GLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNL 295
+ L + + ++ + +
Sbjct: 382 AHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRY 419
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 15/69 (21%), Positives = 32/69 (46%), Gaps = 1/69 (1%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+ + + L ++S ++++L LSGN L+ +L LE+L++S+N L
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 431 FGKVPNFRQ 439
+ +
Sbjct: 71 YE-TLDLES 78
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 22/219 (10%), Positives = 56/219 (25%), Gaps = 8/219 (3%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
+ K L +L ++ N + + + + T
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 140 TISLDYNSFDSWVIPES-LKDATGLQRFSANGANITGTIPDFLGGDTI--PGLMHLHLAF 196
+ +P L+R + G+ + L + +
Sbjct: 288 LGHYGAYCCED--LPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALK 345
Query: 197 NFLQGPIPLSF-GKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD 255
+ I K + TL + D +++ + Q + +
Sbjct: 346 EQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEE 405
Query: 256 LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
S L L+ R ++ V V +++ ++ +
Sbjct: 406 QSPLQLLRAIVKRYEEM--YVEQQSVQNNAIRDWDMYQH 442
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 16/67 (23%), Positives = 31/67 (46%), Gaps = 3/67 (4%)
Query: 232 VIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVN 290
+ Q+ ++ +L L GN + L+ + L+ ++ N L L +L +L ++
Sbjct: 29 LRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYET--LDLESLSTLRTLD 86
Query: 291 LTNNLFQ 297
L NN Q
Sbjct: 87 LNNNYVQ 93
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 7/45 (15%), Positives = 17/45 (37%)
Query: 386 ISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
I + ++ + L + + +++ LD+S N L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPL 46
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 53/193 (27%), Positives = 78/193 (40%), Gaps = 29/193 (15%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
++ +LG+G FG V K + + AVK + A K + E+ +L K+
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLT------I 698
H +++ L D + +V E G LF+ + R + I
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRK--------RFSEHDAARI 126
Query: 699 ALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHSIE 755
V G+ Y+H + +HRDLKP NILL D K+ DFGL N K
Sbjct: 127 IKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--- 180
Query: 756 TRLAGTFGYLAPE 768
GT Y+APE
Sbjct: 181 KDRIGTAYYIAPE 193
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 53/198 (26%), Positives = 77/198 (38%), Gaps = 34/198 (17%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVK-------RMESAVVSEKGFAEFKSE 638
N+ + +LGRG V + + AVK SA ++ E
Sbjct: 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73
Query: 639 IAVLTKV-RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRL 696
+ +L KV H +++ L LV++ M +G LF+ E+ L
Sbjct: 74 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG----ELFDYLTEKV--------TL 121
Query: 697 T------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750
+ I + + LH + +HRDLKP NILL DDM K+ DFG
Sbjct: 122 SEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 178
Query: 751 KHSIETRLAGTFGYLAPE 768
K + GT YLAPE
Sbjct: 179 KL---REVCGTPSYLAPE 193
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 3e-26
Identities = 34/206 (16%), Positives = 61/206 (29%), Gaps = 41/206 (19%)
Query: 597 VLGRGGFGTVYKGE-LHDGTKIAVK--------------RMESAVVSEKGFAEFKSEIAV 641
VLG+ + G V +M+ V+ + K++
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 642 LTKVR---------HRHLVGLLGYCLDGNERLLVYEY--MPQ-----GTLSRHLFNRKEE 685
+R ++ LD + ++ + P+ T L +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 686 GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745
K L RL + L V R + LH H +H L+P +I+L + F +
Sbjct: 205 H-KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 746 APDNGKHSIETRLAGTFGYLAPEYAA 771
+ G+ PE A
Sbjct: 261 DGAS------AVSPIGRGFAPPETTA 280
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 46/203 (22%), Positives = 74/203 (36%), Gaps = 31/203 (15%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
T F E +G G FG+V+K + DG A+KR + + E+ +
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 646 -RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
+H H+V + + L+ EY G+L+ + + + L V R
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIM-SYFKEAELKDLLLQVGR 126
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDD-------------------MRAKVADFGLVRL 745
G+ Y+H S +H D+KPSNI + + K+ D G V
Sbjct: 127 GLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 746 APDNGKHSIETRLAGTFGYLAPE 768
+ E G +LA E
Sbjct: 184 I--SSPQVEE----GDSRFLANE 200
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-26
Identities = 40/182 (21%), Positives = 70/182 (38%), Gaps = 27/182 (14%)
Query: 597 VLGRGGFGTVYKGELH--DGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHRHLVGL 653
+ GG G +Y +G + +K + + + +E L +V H +V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 654 LGYCLDGNERL-----LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
+ + +V EY+ +L R + L + L++ + Y
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG-------QKLPVAEAIAYLLEILPALSY 197
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
LH ++ DLKP NI+L ++ + K+ D G V G L GT G+ APE
Sbjct: 198 LH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG------YLYGTPGFQAPE 247
Query: 769 YA 770
Sbjct: 248 IV 249
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 58/234 (24%), Positives = 90/234 (38%), Gaps = 37/234 (15%)
Query: 550 SSVTGGGSESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEE----NVLGRGGFGT 605
S V G + S + S+V + + + S+ + LGRG
Sbjct: 9 SGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSI 68
Query: 606 VYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664
VY+ + A+K ++ V + ++EI VL ++ H +++ L E
Sbjct: 69 VYRCKQKGTQKPYALKVLKKTVDKKI----VRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124
Query: 665 LVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLT------IALDVARGVEYLHGLAHQSF 717
LV E + G LF+R E+G + + V YLH
Sbjct: 125 LVLELVTGG----ELFDRIVEKG--------YYSERDAADAVKQILEAVAYLH---ENGI 169
Query: 718 IHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
+HRDLKP N+L D K+ADFGL ++ + GT GY APE
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM---KTVCGTPGYCAPE 220
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 19/222 (8%)
Query: 549 ESSVTGGGSESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYK 608
SS G+E+ S + A MV+ + +G G G V
Sbjct: 7 HSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQG---DPRLLLDSYVKIGEGSTGIVCL 63
Query: 609 G-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667
E H G ++AVK M+ + ++ +E+ ++ +H ++V + L G E ++
Sbjct: 64 AREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLM 121
Query: 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNI 727
E++ G L+ + L + T+ V + + YLH Q IHRD+K +I
Sbjct: 122 EFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSI 172
Query: 728 LLGDDMRAKVADFGL-VRLAPDNGKHSIETRLAGTFGYLAPE 768
LL D R K++DFG +++ D K L GT ++APE
Sbjct: 173 LLTLDGRVKLSDFGFCAQISKDVPKR---KSLVGTPYWMAPE 211
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 54/193 (27%), Positives = 84/193 (43%), Gaps = 32/193 (16%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
N+ F VLG G F V+ + G A+K ++ + + ++EIAVL K+
Sbjct: 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD--SSLENEIAVLKKI 63
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLT------I 698
+H ++V L LV + + G LF+R E G T +
Sbjct: 64 KHENIVTLEDIYESTTHYYLVMQLVSGG----ELFDRILERG--------VYTEKDASLV 111
Query: 699 ALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHSIE 755
V V+YLH +HRDLKP N+L ++ + + DFGL ++ + I
Sbjct: 112 IQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IM 164
Query: 756 TRLAGTFGYLAPE 768
+ GT GY+APE
Sbjct: 165 STACGTPGYVAPE 177
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 52/200 (26%), Positives = 81/200 (40%), Gaps = 36/200 (18%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAE------FKSE 638
+ + + + LG G G V E K+A+K + + E ++E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 639 IAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLT 697
I +L K+ H ++ + + D + +V E M G LF++ RL
Sbjct: 66 IEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG----ELFDKVVGNK--------RLK 112
Query: 698 ------IALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPD 748
+ V+YLH IHRDLKP N+LL +D K+ DFG ++ +
Sbjct: 113 EATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
Query: 749 NGKHSIETRLAGTFGYLAPE 768
S+ L GT YLAPE
Sbjct: 170 T---SLMRTLCGTPTYLAPE 186
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-25
Identities = 42/195 (21%), Positives = 76/195 (38%), Gaps = 32/195 (16%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
T + LG+G F V + ++ G + A + + +S + + + E + +
Sbjct: 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTL-----SRHLFNRKEEGLKPLEWTRRLTIAL 700
+H ++V L + L+++ + G L +R ++ + A
Sbjct: 68 KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEAD--------------AS 113
Query: 701 DVAR----GVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHS 753
+ V + H +HR+LKP N+LL K+ADFGL +
Sbjct: 114 HCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ-- 168
Query: 754 IETRLAGTFGYLAPE 768
AGT GYL+PE
Sbjct: 169 AWFGFAGTPGYLSPE 183
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-25
Identities = 62/361 (17%), Positives = 130/361 (36%), Gaps = 66/361 (18%)
Query: 76 NIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGL 135
+ P L +L++L L++ NK++ I L+ L++L+ ++ +N + + L
Sbjct: 166 QVTDLKP--LANLTTLERLDISSNKVSD-ISVLAKLTNLESLIATNNQISDITP--LGIL 220
Query: 136 TSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLA 195
T+L +SL+ N +L T L I+ + + L L L
Sbjct: 221 TNLDELSLNGNQLKD---IGTLASLTNLTDLDLANNQISN-LAPL---SGLTKLTELKLG 273
Query: 196 FNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD 255
N + PL+ G +++ L LN ++L ++ I N+ +LT L L+ N+ + +
Sbjct: 274 ANQISNISPLA-GLTALTNLELNE----NQLE-DISPISNLKNLTYLTLYFNNISD-ISP 326
Query: 256 LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGS 315
+S L+ LQ +N+++ + SSL NL ++ ++ +N TP
Sbjct: 327 VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP-------------- 370
Query: 316 NSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVV 375
+ + + + + + N+++
Sbjct: 371 -------------------------LANLTRITQLGLNDQAWTNA----PVNYKANVSIP 401
Query: 376 NLKNLGLSGTIS-SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKV 434
N I+ + S S + ++ N + + T + G V
Sbjct: 402 NTVKNVTGALIAPATISDGGSYTEPDITWNLPSY-TNEVSYTFSQPVTIGKGTTTFSGTV 460
Query: 435 P 435
Sbjct: 461 T 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-22
Identities = 54/228 (23%), Positives = 96/228 (42%), Gaps = 22/228 (9%)
Query: 67 VTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTS 126
+ +G N+ T+ L +T L+ + + I + L++L ++ F +N T
Sbjct: 26 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTD 82
Query: 127 VPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTI 186
+ K LT L I ++ N L + T L + IT P L +
Sbjct: 83 ITP--LKNLTKLVDILMNNNQIAD---ITPLANLTNLTGLTLFNNQITDIDP--LKN--L 133
Query: 187 PGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHG 246
L L L+ N + LS G +S+Q L Q D K + N+T+L +L +
Sbjct: 134 TNLNRLELSSNTISDISALS-GLTSLQQLSFGNQVTDLK------PLANLTTLERLDISS 186
Query: 247 NSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
N + + L+ L++L+ +NQ++ I + L L +L ++L N
Sbjct: 187 NKVSD-ISVLAKLTNLESLIATNNQISDI--TPLGILTNLDELSLNGN 231
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-18
Identities = 50/217 (23%), Positives = 85/217 (39%), Gaps = 20/217 (9%)
Query: 85 LNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144
+L+ + K +T S + L + + D S+ + L +L I+
Sbjct: 20 DTALAEKMKTVLGKTNVTD-TVSQTDLDQVTTLQADRLGIKSIDG--VEYLNNLTQINFS 76
Query: 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIP 204
N LK+ T L N I P L + L L L N + P
Sbjct: 77 NNQLTD---ITPLKNLTKLVDILMNNNQIADITP--LAN--LTNLTGLTLFNNQITDIDP 129
Query: 205 LSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQD 264
L +++ L L+ + ++ ++ + +TSL QL GN T P L+ L++L+
Sbjct: 130 LK-NLTNLNRLELSS----NTIS-DISALSGLTSLQQLSF-GNQVTDLKP-LANLTTLER 181
Query: 265 FSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTP 301
+ N+++ I S L L +L + TNN TP
Sbjct: 182 LDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP 216
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-15
Identities = 37/206 (17%), Positives = 76/206 (36%), Gaps = 40/206 (19%)
Query: 90 SLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFD 149
L + ++ QI + + L+ + + N T S L + T+ D
Sbjct: 2 PLGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLG-- 57
Query: 150 SWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK 209
+K G++ + L ++ + N L PL
Sbjct: 58 -------IKSIDGVEYLNN--------------------LTQINFSNNQLTDITPLK-NL 89
Query: 210 SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRD 269
+ + + +N ++++ + + N+T+LT L L N T + L L++L +
Sbjct: 90 TKLVDILMN----NNQIA-DITPLANLTNLTGLTLFNNQITD-IDPLKNLTNLNRLELSS 143
Query: 270 NQLTGIVPSSLVNLHSLAVVNLTNNL 295
N ++ I S+L L SL ++ N +
Sbjct: 144 NTISDI--SALSGLTSLQQLSFGNQV 167
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 50/250 (20%), Positives = 94/250 (37%), Gaps = 50/250 (20%)
Query: 189 LMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNS 248
M L + + + + TL + ++G ++ + +LTQ+ N
Sbjct: 26 KMKTVLGKTNVTDTVSQT-DLDQVTTLQADRLGI-KSIDG----VEYLNNLTQINFSNNQ 79
Query: 249 FTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSP-- 306
T + L L+ L D + +NQ+ I + L NL +L + L NN P N
Sbjct: 80 LTD-ITPLKNLTKLVDILMNNNQIADI--TPLANLTNLTGLTLFNNQITDIDPLKNLTNL 136
Query: 307 VRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSC 366
R ++ SN+ +S + ++ L + GN +
Sbjct: 137 NRLEL--SSNT-----------------ISDISALSGLTSLQQLSFGNQVTDL------- 170
Query: 367 DAGGNITVVNLKNL---GLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSL 420
+ NL L +S + S ++LT+L L+ + N+++ P L L +L
Sbjct: 171 -----KPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILTNL 223
Query: 421 EMLDVSNNHL 430
+ L ++ N L
Sbjct: 224 DELSLNGNQL 233
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 14/69 (20%), Positives = 29/69 (42%), Gaps = 5/69 (7%)
Query: 376 NLKNLGLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFG 432
L+ L + S+ + LT++ L N+++ P L L + L +++
Sbjct: 332 KLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389
Query: 433 KVPNFRQNV 441
N++ NV
Sbjct: 390 APVNYKANV 398
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 47/194 (24%), Positives = 80/194 (41%), Gaps = 26/194 (13%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFA----EFKSEIAV 641
V +++ LG G F V K + G + A K ++ +S E + E+ +
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 642 LTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLTIAL 700
L ++RH +++ L + + +L+ E + G LF+ E+ T
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGE----LFDFLAEKE----SLTEDEATQF 113
Query: 701 --DVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRLAPDNGKHSI 754
+ GV YLH + H DLKP NI+L + R K+ DFG+ +
Sbjct: 114 LKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 170
Query: 755 ETRLAGTFGYLAPE 768
+ GT ++APE
Sbjct: 171 ---IFGTPEFVAPE 181
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 48/195 (24%), Positives = 78/195 (40%), Gaps = 26/195 (13%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVK----RMESAVVSEKGFAEFKSEIA 640
+ V + + LG G F V K E G + A K R A E + E++
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 641 VLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLTIA 699
+L +V H +++ L + + +L+ E + G LF+ ++ + +
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGG----ELFDFLAQKE----SLSEEEATS 119
Query: 700 L--DVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRLAPDNGKHS 753
+ GV YLH + H DLKP NI+L K+ DFGL D +
Sbjct: 120 FIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 754 IETRLAGTFGYLAPE 768
+ GT ++APE
Sbjct: 177 N---IFGTPEFVAPE 188
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 46/188 (24%), Positives = 78/188 (41%), Gaps = 21/188 (11%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
+V + + LG G FG V++ E G K + + +K K+EI+++ ++
Sbjct: 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMNQL 105
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLTIAL--DV 702
H L+ L D E +L+ E++ G LF+R E K + I
Sbjct: 106 HHPKLINLHDAFEDKYEMVLILEFLSGG----ELFDRIAAEDYK---MSEAEVINYMRQA 158
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRLAPDNGKHSIETRLAG 760
G++++H S +H D+KP NI+ K+ DFGL + +
Sbjct: 159 CEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTA 212
Query: 761 TFGYLAPE 768
T + APE
Sbjct: 213 TAEFAAPE 220
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-25
Identities = 55/223 (24%), Positives = 85/223 (38%), Gaps = 32/223 (14%)
Query: 560 QSLTSSGPSDLHVVEAGSMVISIQVLR---NVTNNFSEENVLGRGGFGTVYKG-ELHDGT 615
SSG +L+ + + +++ + LG G +G V +
Sbjct: 4 HHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHV 63
Query: 616 KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTL 675
+ A+K + VS ++ E+AVL + H +++ L + D LV E G
Sbjct: 64 ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE- 122
Query: 676 SRHLFNR-KEEGLKPLEWTRRLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNIL 728
LF+ + I V GV YLH + +HRDLKP N+L
Sbjct: 123 ---LFDEIIHRM--------KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLL 168
Query: 729 L---GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
L D K+ DFGL + + K GT Y+APE
Sbjct: 169 LESKEKDALIKIVDFGLSAVFENQKKM---KERLGTAYYIAPE 208
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 40/182 (21%), Positives = 72/182 (39%), Gaps = 19/182 (10%)
Query: 597 VLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAE---FKSEIAVLTKVRHRHLVG 652
V+G+G F V + G + AVK ++ A + K E ++ ++H H+V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 653 LLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLTIAL--DVARGVEYL 709
LL +V+E+M L + ++ + + + Y
Sbjct: 91 LLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 710 HGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLA 766
H + IHRD+KP +LL + K+ FG+ ++G + GT ++A
Sbjct: 147 H---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGTPHFMA 201
Query: 767 PE 768
PE
Sbjct: 202 PE 203
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 39/194 (20%), Positives = 71/194 (36%), Gaps = 32/194 (16%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTK 644
+ + + LGRG FG V++ E K ++ V K EI++L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNI 57
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLTIALDVA 703
RHR+++ L E ++++E++ +F R + E ++
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISGLD----IFERINTSAFELNE--------REIV 105
Query: 704 R-------GVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRLAPDNGKHSI 754
+++LH + H D++P NI+ K+ +FG R +
Sbjct: 106 SYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162
Query: 755 ETRLAGTFGYLAPE 768
L Y APE
Sbjct: 163 ---LFTAPEYYAPE 173
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 41/161 (25%), Positives = 70/161 (43%), Gaps = 10/161 (6%)
Query: 582 IQVLRNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIA 640
++ + + LG G FG VYK G A K +E SE+ ++ EI
Sbjct: 11 VRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYIVEIE 68
Query: 641 VLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIAL 700
+L H ++V LLG + ++ E+ P G + + E + L + +
Sbjct: 69 ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM----LELDRGLTEPQIQVVCR 124
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741
+ + +LH + IHRDLK N+L+ + ++ADFG
Sbjct: 125 QMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFG 162
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-25
Identities = 53/185 (28%), Positives = 87/185 (47%), Gaps = 19/185 (10%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKI-AVKRME-SAVVSEKGFAEFKSEIAVLTKV-- 645
N+FS ++GRGGFG VY D K+ A+K ++ + ++G +E +L+ V
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 646 -RHRHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVA 703
+V + Y ++L + + M G L HL + E R A ++
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFS--EADMRFYAA-EII 302
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFG 763
G+E++H ++RDLKP+NILL + +++D GL H+ GT G
Sbjct: 303 LGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHG 355
Query: 764 YLAPE 768
Y+APE
Sbjct: 356 YMAPE 360
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-25
Identities = 46/194 (23%), Positives = 77/194 (39%), Gaps = 26/194 (13%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFA----EFKSEIAV 641
V + + LG G F V K E G + A K ++ E + E+++
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 642 LTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLTIAL 700
L +V H +++ L + + +L+ E + G LF+ ++ + +
Sbjct: 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGG----ELFDFLAQKE----SLSEEEATSF 120
Query: 701 --DVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRLAPDNGKHSI 754
+ GV YLH + H DLKP NI+L K+ DFGL D +
Sbjct: 121 IKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 755 ETRLAGTFGYLAPE 768
+ GT ++APE
Sbjct: 178 ---IFGTPEFVAPE 188
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-25
Identities = 53/194 (27%), Positives = 78/194 (40%), Gaps = 29/194 (14%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTK 644
++ +LG+G FG V K + + AVK + A K + E+ +L K
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLT------ 697
+ H +++ L D + +V E G LF+ + R +
Sbjct: 78 LDHPNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRK--------RFSEHDAAR 125
Query: 698 IALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHSI 754
I V G+ Y+H + +HRDLKP NILL D K+ DFGL N K
Sbjct: 126 IIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-- 180
Query: 755 ETRLAGTFGYLAPE 768
GT Y+APE
Sbjct: 181 -KDRIGTAYYIAPE 193
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-25
Identities = 58/182 (31%), Positives = 89/182 (48%), Gaps = 17/182 (9%)
Query: 591 NFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
S+ +LG G FG V+K E G K+A K +++ + +K E K+EI+V+ ++ H +
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK--EEVKNEISVMNQLDHAN 147
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLTIALDVARGVEY 708
L+ L N+ +LV EY+ G LF+R +E E L + + G+ +
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGG----ELFDRIIDESYNLTELDTILFM-KQICEGIRH 202
Query: 709 LHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLA 766
+H +H DLKP NIL D + K+ DFGL R K + GT +LA
Sbjct: 203 MH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NFGTPEFLA 256
Query: 767 PE 768
PE
Sbjct: 257 PE 258
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 51/203 (25%), Positives = 100/203 (49%), Gaps = 19/203 (9%)
Query: 568 SDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAV 626
SD ++E ++S+ + ++ +G+G GTVY ++ G ++A+++M +
Sbjct: 1 SDEEILEKLRSIVSV---GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--L 55
Query: 627 VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEG 686
+ +EI V+ + ++ ++V L L G+E +V EY+ G+L+ +
Sbjct: 56 QQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----- 110
Query: 687 LKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRL 745
++ + + + + +E+LH IHRD+K NILLG D K+ DFG ++
Sbjct: 111 -TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166
Query: 746 APDNGKHSIETRLAGTFGYLAPE 768
P+ K + + GT ++APE
Sbjct: 167 TPEQSKR---STMVGTPYWMAPE 186
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 49/194 (25%), Positives = 78/194 (40%), Gaps = 26/194 (13%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVK----RMESAVVSEKGFAEFKSEIAV 641
NV + + LG G F V K E G + A K R + + + E+++
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 642 LTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLTIAL 700
L +++H +++ L + + +L+ E + G LF+ E+ T
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKE----SLTEEEATEF 119
Query: 701 --DVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRLAPDNGKHSI 754
+ GV YLH L H DLKP NI+L R K+ DFGL +
Sbjct: 120 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF-- 174
Query: 755 ETRLAGTFGYLAPE 768
+ GT ++APE
Sbjct: 175 -KNIFGTPEFVAPE 187
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-24
Identities = 75/375 (20%), Positives = 129/375 (34%), Gaps = 53/375 (14%)
Query: 82 PKELNSLSSLTVLEVMKNKLT--GQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLT--S 137
+L +LT L++ KN++ PS L+SL+ + F N V + L +
Sbjct: 116 DGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKT 175
Query: 138 LQTISLDYNSF-----DSWVIPESLKDATGLQRFSANGANITGTIPD----------FLG 182
L SL NS W + L+ +G T I
Sbjct: 176 LSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFS 235
Query: 183 GDTIPGLMHLHLAFNFLQGPIPLSFG---KSSIQTLWLNGQKGDSKLNGSVAVIQNMTSL 239
+M F+ ++ P +F +SS++ L L+ LN V + + L
Sbjct: 236 LILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLS-HGFVFSLNSRV--FETLKDL 292
Query: 240 TQLWLHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
L L N + D GL +LQ ++ N L + S+ L +A ++L N
Sbjct: 293 KVLNLAYNKINK-IADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA 351
Query: 298 GQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPC 357
+ F + + L D N L +I + + + + N
Sbjct: 352 IIQDQT-----FKFLEKLQTLDLRD---------NALTTI----HFIPSIPDIFLSGNKL 393
Query: 358 NSDWKGVSCDAGGNITVVNLKNLGLSG-TISSNFSRLTSLRQLMLSGNELTGTIPKEL-T 415
+ K +++L L I R+ L+ L+L+ N + + +
Sbjct: 394 VTLPKINL-----TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPS 448
Query: 416 TLPSLEMLDVSNNHL 430
PSLE L + N L
Sbjct: 449 ENPSLEQLFLGENML 463
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-24
Identities = 68/342 (19%), Positives = 121/342 (35%), Gaps = 39/342 (11%)
Query: 99 NKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLK 158
LT Q+P L++ + +L N +V + F L LQ + L + E+ +
Sbjct: 14 CNLT-QVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFR 70
Query: 159 DATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLN 218
+ L+ + I PD G + L L L F L
Sbjct: 71 NLPNLRILDLGSSKIYFLHPDAFQG--LFHLFELRLYFCGL------------------- 109
Query: 219 GQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFT--GPLPDLSGLSSLQDFSVRDNQLTGIV 276
S +N+ +LT+L L N P L+SL+ NQ+ +
Sbjct: 110 -----SDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVC 164
Query: 277 PSSLVNLH--SLAVVNLTNNLFQGQTPK-FNSPVRFDMAKGSNSFCLDDAGVACDGRVNV 333
L L +L+ +L N + + + + G D N
Sbjct: 165 EHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNF 224
Query: 334 LLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG----TISSN 389
+I KS + +LA G + K + + ++++L LS +++S
Sbjct: 225 SNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSR 284
Query: 390 -FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
F L L+ L L+ N++ + L +L++L++S N L
Sbjct: 285 VFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 5e-23
Identities = 54/374 (14%), Positives = 110/374 (29%), Gaps = 57/374 (15%)
Query: 67 VTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDNNF 124
R+ + I L L +LE+ I + L +L+ + +
Sbjct: 26 TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKI 85
Query: 125 TSVPSDFFKGLTSLQTISLDYNSFDSWVIPES-LKDATGLQRFSANGANITGTIPDFLGG 183
+ D F+GL L + L + V+ + ++ L R + I ++
Sbjct: 86 YFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIR-SLYLHPSF 144
Query: 184 DTIPGLMHLHLAFNFLQGPIPLSF---GKSSIQTLWLNGQKGDSKLNGSVAVIQNM---T 237
+ L + + N + ++ L S+++ N
Sbjct: 145 GKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNM 204
Query: 238 SLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
L L + GN +T + N ++ SL+ H + + +
Sbjct: 205 VLEILDVSGNGWTVDITGNF-----------SNAISKSQAFSLILAHHIMGAGFGFHNIK 253
Query: 298 GQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPC 357
F S+ LD + + S+ + ++
Sbjct: 254 DPDQNT-----FAGLARSSVRHLDLSH-------GFVFSL---------NSRVFETLK-- 290
Query: 358 NSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTL 417
++ V+NL ++ F L +L+ L LS N L L
Sbjct: 291 -------------DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGL 337
Query: 418 PSLEMLDVSNNHLF 431
P + +D+ NH+
Sbjct: 338 PKVAYIDLQKNHIA 351
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-22
Identities = 61/383 (15%), Positives = 116/383 (30%), Gaps = 39/383 (10%)
Query: 81 LPKELNSLSSLTVLEVMKNKLTG-QIPSLSGLS--SLQEVLFDDNNFTSVPSDFFKGL-- 135
L L+SL ++ N++ L L +L N+ S S +
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199
Query: 136 ----TSLQTISLDYNSFD-----------SWVIPESLKDATGLQRFSANGANITGTIPDF 180
L+ + + N + S SL A + NI +
Sbjct: 200 PFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNT 259
Query: 181 LGGDTIPGLMHLHLAFNFLQGPIPLSF-GKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSL 239
G + HL L+ F+ F ++ L L K +K+ + +L
Sbjct: 260 FAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKI-NKIADEA--FYGLDNL 316
Query: 240 TQLWLHGNSFTG-PLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQG 298
L L N + GL + ++ N + I + L L ++L +N
Sbjct: 317 QVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT- 375
Query: 299 QTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLA------ESWK 352
S + N +++ + ++++ L
Sbjct: 376 TIHFIPSIPDIFL--SGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILIL 433
Query: 353 GNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSN-----FSRLTSLRQLMLSGNELT 407
N +S + ++ + L L + F L+ L+ L L+ N L
Sbjct: 434 NQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN 493
Query: 408 GTIPKELTTLPSLEMLDVSNNHL 430
P + L +L L +++N L
Sbjct: 494 SLPPGVFSHLTALRGLSLNSNRL 516
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 3e-21
Identities = 71/380 (18%), Positives = 125/380 (32%), Gaps = 57/380 (15%)
Query: 77 IEGTLPKELNSLS--SLTVLEVMKNKLT-------------GQIPSLSGLSSLQEVLFDD 121
+ K +N L +L+V N T Q SL + F
Sbjct: 190 VSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGF 249
Query: 122 NNFTSVPSDFFKGL--TSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD 179
+N + F GL +S++ + L + S + + L+ + I +
Sbjct: 250 HNIKDPDQNTFAGLARSSVRHLDLSHGFVFS-LNSRVFETLKDLKVLNLAYNKINKIADE 308
Query: 180 FLGGDTIPGLMHLHLAFNFLQGPIPLSF-GKSSIQTLWLNGQKGDSKLNG-SVAVIQNMT 237
G + L L+L++N L +F G + + L + + + +
Sbjct: 309 AFYG--LDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK----NHIAIIQDQTFKFLE 362
Query: 238 SLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSL-VNLHSLAVVNLTNNLF 296
L L L N+ T + + S+ D + N+L + +L NL L+ L N
Sbjct: 363 KLQTLDLRDNALT----TIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDI 418
Query: 297 QGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVN-VLLSIVKSVGYPAVLAESWKGNN 355
+ + N F + L + G N
Sbjct: 419 LYFLLRVPHLQILILN--QNRFSSCSGDQTPSENPSLEQLFL---------------GEN 461
Query: 356 PCNSDWKGVSCDAGGNITVVNLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTI 410
W+ + +L+ L L+ ++ FS LT+LR L L+ N LT +
Sbjct: 462 MLQLAWET-ELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VL 519
Query: 411 PKELTTLPSLEMLDVSNNHL 430
+LE+LD+S N L
Sbjct: 520 SHN-DLPANLEILDISRNQL 538
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 2e-19
Identities = 50/242 (20%), Positives = 84/242 (34%), Gaps = 25/242 (10%)
Query: 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDNN 123
+ + + I + L +L VL + N L ++ + GL + + N+
Sbjct: 291 DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-ELYSSNFYGLPKVAYIDLQKNH 349
Query: 124 FTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGG 183
+ FK L LQT+ L N+ ++ + +G + T+P
Sbjct: 350 IAIIQDQTFKFLEKLQTLDLRDNAL------TTIHFIPSIPDIFLSGNKLV-TLPKIN-- 400
Query: 184 DTIPGLMHLHLAFNFLQGPIPLSFGK--SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQ 241
+HL+ N L+ L F +Q L LN + S SL Q
Sbjct: 401 ---LTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGD--QTPSENPSLEQ 455
Query: 242 LWLHGNSFTG------PLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNL 295
L+L N GLS LQ + N L + P +L +L ++L +N
Sbjct: 456 LFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNR 515
Query: 296 FQ 297
Sbjct: 516 LT 517
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 43/213 (20%), Positives = 71/213 (33%), Gaps = 37/213 (17%)
Query: 86 NSLSSLTVLEVMKNKLTGQIPS------LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
+ SL L + +N L + GLS LQ + + N S+P F LT+L+
Sbjct: 448 SENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALR 507
Query: 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFL 199
+SL+ N + + AN L L ++ N L
Sbjct: 508 GLSLNSNRLTV--LSHND--------LPAN-------------------LEILDISRNQL 538
Query: 200 QGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGL 259
P P F S+ + N + +L+ + + + P SG+
Sbjct: 539 LAPNPDVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYP-DSFSGV 597
Query: 260 SSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLT 292
SL S ++ S +L + V LT
Sbjct: 598 -SLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLT 629
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 13/72 (18%), Positives = 27/72 (37%), Gaps = 6/72 (8%)
Query: 365 SCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLD 424
SC G I + L+ + L + +L+LS N + L L++L+
Sbjct: 1 SCSFDGRI--AFYRFCNLT-QV---PQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLE 54
Query: 425 VSNNHLFGKVPN 436
+ + + +
Sbjct: 55 LGSQYTPLTIDK 66
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 48/193 (24%), Positives = 72/193 (37%), Gaps = 31/193 (16%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
++ ++ EN +GRG +G V + + A K++ V + FK EI ++ +
Sbjct: 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV--DRFKQEIEIMKSL 63
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLT------I 698
H +++ L D + LV E G LF R + I
Sbjct: 64 DHPNIIRLYETFEDNTDIYLVMELCTGG----ELFERVVHKR--------VFRESDAARI 111
Query: 699 ALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHSIE 755
DV V Y H + HRDLKP N L D K+ DFGL
Sbjct: 112 MKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--- 165
Query: 756 TRLAGTFGYLAPE 768
GT Y++P+
Sbjct: 166 RTKVGTPYYVSPQ 178
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-24
Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 26/195 (13%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAE------FKSE 638
+ + + + LG G G V E K+A++ + + E ++E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 639 IAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR--KEEGLKPLEWTRRL 696
I +L K+ H ++ + + D + +V E M G L F++ + LK +
Sbjct: 191 IEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNKRLKEAT-CKLY 244
Query: 697 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHS 753
+ V+YLH IHRDLKP N+LL +D K+ DFG ++ + S
Sbjct: 245 F--YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---S 296
Query: 754 IETRLAGTFGYLAPE 768
+ L GT YLAPE
Sbjct: 297 LMRTLCGTPTYLAPE 311
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 48/235 (20%), Positives = 82/235 (34%), Gaps = 46/235 (19%)
Query: 577 SMVISIQVLRNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVK---RMESAVVSEKGF 632
++ L + + + +G+G +G V E A+K + + ++ K
Sbjct: 13 NLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDV 72
Query: 633 AEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEW 692
K+E+ ++ K+ H ++ L D LV E G L L ++
Sbjct: 73 ERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAM 132
Query: 693 TRRLT-----------------------------------IALDVARGVEYLHGLAHQSF 717
T I + + YLH +Q
Sbjct: 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGI 189
Query: 718 IHRDLKPSNILLGDDMRA--KVADFGLVRL--APDNGKHSIETRLAGTFGYLAPE 768
HRD+KP N L + K+ DFGL + +NG++ T AGT ++APE
Sbjct: 190 CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 56/207 (27%), Positives = 85/207 (41%), Gaps = 25/207 (12%)
Query: 573 VEAGSMVISIQVLRNVTNNFS-EENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEK 630
V+ G+ + Q + N N + LGRG F V + G + A K ++ +
Sbjct: 11 VDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD 70
Query: 631 GFAEFKSEIAVLTKVRHR-HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR---KEEG 686
AE EIAVL + ++ L + +E +L+ EY G + F+ +
Sbjct: 71 CRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI----FSLCLPELAE 126
Query: 687 LKPLEWTRRLTIAL--DVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFG 741
+ + I L + GV YLH + +H DLKP NILL K+ DFG
Sbjct: 127 M----VSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179
Query: 742 LVRLAPDNGKHSIETRLAGTFGYLAPE 768
+ R + + GT YLAPE
Sbjct: 180 MSRKIGHACELRE---IMGTPEYLAPE 203
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-24
Identities = 50/195 (25%), Positives = 77/195 (39%), Gaps = 30/195 (15%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLT 643
++ + + VLG+G FG V + G + AVK + V + E+ +L
Sbjct: 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 644 KVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLT----- 697
++ H +++ L + D LV E G LF+ R +
Sbjct: 82 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRK--------RFSEVDAA 129
Query: 698 -IALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHS 753
I V G+ Y+H +HRDLKP N+LL D ++ DFGL + K
Sbjct: 130 RIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM- 185
Query: 754 IETRLAGTFGYLAPE 768
GT Y+APE
Sbjct: 186 --KDKIGTAYYIAPE 198
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-24
Identities = 56/262 (21%), Positives = 93/262 (35%), Gaps = 25/262 (9%)
Query: 516 RKRKRSGRVQSPNAVVIHPSNGGDGNAVKITVTESSVTGGGSESQSLTSSGPSDLHVVEA 575
R + QS P + + G + SS +
Sbjct: 81 RIIAENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIW 140
Query: 576 GSMVISIQVLR--NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGF 632
++ +V +++ LG G FG V++ E G A K + E
Sbjct: 141 KQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV--MTPHESDK 198
Query: 633 AEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR--KEEGLKPL 690
+ EI ++ +RH LV L D NE +++YE+M G LF + E
Sbjct: 199 ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG----ELFEKVADEHN---- 250
Query: 691 EWTRRLTIAL--DVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRLA 746
+ + + V +G+ ++H +++H DLKP NI+ K+ DFGL
Sbjct: 251 KMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307
Query: 747 PDNGKHSIETRLAGTFGYLAPE 768
+ GT + APE
Sbjct: 308 DPKQSVKV---TTGTAEFAAPE 326
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-24
Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 20/186 (10%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKI-AVKRME-SAVVSEKGFAEFKSEIAVLTKVRH 647
+F V+GRG FG V +L + K+ A+K + ++ A F+ E VL
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 648 RHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTR----RLTIALDV 702
+ + L Y + L LV +Y G L L K E P E R + IA+
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL--SKFEDRLPEEMARFYLAEMVIAI-- 188
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF 762
+ +H L ++HRD+KP NIL+ + ++ADFG ++G GT
Sbjct: 189 ----DSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTP 240
Query: 763 GYLAPE 768
Y++PE
Sbjct: 241 DYISPE 246
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-24
Identities = 53/182 (29%), Positives = 84/182 (46%), Gaps = 15/182 (8%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKI-AVKRME-SAVVSEKGFAEFKSEIAVLTKVRH 647
++F +G+G FG V + +D K+ A+K M V E+ ++ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 648 RHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706
LV L Y E + +V + + G L HL ++ K E T +L I ++ +
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFK--EETVKLFIC-ELVMAL 128
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLA 766
+YL Q IHRD+KP NILL + + DF + + P + T +AGT Y+A
Sbjct: 129 DYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMA 182
Query: 767 PE 768
PE
Sbjct: 183 PE 184
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 51/300 (17%), Positives = 96/300 (32%), Gaps = 39/300 (13%)
Query: 28 SDAAAMQALKTSLGNPASLGWTDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNS 87
+ A++ L D + Q + SN G+ ++ L
Sbjct: 20 QGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN-SNNPQIETRTGRALK-ATADLLED 77
Query: 88 LSS--LTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144
+ LE+ L Q P LS LQ + D +P + L+T++L
Sbjct: 78 ATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMELPDTMQQ-FAGLETLTLA 135
Query: 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPG-------LMHLHLAFN 197
N + +P S+ L+ S +P+ L G L L L +
Sbjct: 136 RNPLRA--LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWT 193
Query: 198 FLQGPIPLSFGK-SSIQTLWLNGQK--------------------GDSKLNGSVAVIQNM 236
++ +P S ++++L + G + L +
Sbjct: 194 GIRS-LPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGR 252
Query: 237 TSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNL 295
L +L L S LP + L+ L+ +R +PS + L + ++ + +L
Sbjct: 253 APLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL 312
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 24/208 (11%), Positives = 52/208 (25%), Gaps = 51/208 (24%)
Query: 233 IQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLT 292
+ + L+ G++ P D LS Q D N ++ + T
Sbjct: 8 HHHSSGRENLYFQGSTALRPYHD--VLSQWQRHYNADRNRWHS-AWRQANSNNPQIETRT 64
Query: 293 NNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWK 352
+ + + A L+ L
Sbjct: 65 GRALK------ATADLLEDATQPGRVALELRS-------VPLPQFPDQAF---------- 101
Query: 353 GNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTG 408
++ +L+++ + + + L L L+ N L
Sbjct: 102 ------------------RLS--HLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLR- 140
Query: 409 TIPKELTTLPSLEMLDVSNNHLFGKVPN 436
+P + +L L L + ++P
Sbjct: 141 ALPASIASLNRLRELSIRACPELTELPE 168
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 17/66 (25%), Positives = 31/66 (46%), Gaps = 5/66 (7%)
Query: 375 VNLKNLGLSGT----ISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
VNL++L L T + ++ + L +L+ L + + L+ + + LP LE LD+
Sbjct: 183 VNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTA 241
Query: 431 FGKVPN 436
P
Sbjct: 242 LRNYPP 247
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 17/67 (25%), Positives = 29/67 (43%), Gaps = 7/67 (10%)
Query: 376 NLKNLGLSG-----TISSNFSRLTSLRQLMLSG-NELTGTIPKELTTLPSLEMLDVSNNH 429
L+ L L G F L++L+L + L T+P ++ L LE LD+
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCV 288
Query: 430 LFGKVPN 436
++P+
Sbjct: 289 NLSRLPS 295
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 16/61 (26%), Positives = 25/61 (40%), Gaps = 5/61 (8%)
Query: 375 VNLKNLGLSG-----TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNH 429
LK L L T+ + RLT L +L L G +P + LP+ ++ V +
Sbjct: 253 APLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL 312
Query: 430 L 430
Sbjct: 313 Q 313
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 5e-06
Identities = 13/65 (20%), Positives = 21/65 (32%), Gaps = 4/65 (6%)
Query: 376 NLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLF 431
NLK+L + + L L +L L G P L+ L + +
Sbjct: 207 NLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL 266
Query: 432 GKVPN 436
+P
Sbjct: 267 LTLPL 271
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 13/69 (18%), Positives = 25/69 (36%), Gaps = 15/69 (21%)
Query: 376 NLKNLGLSG--------------TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLE 421
L+ L + S L +L+ L L + ++P + L +L+
Sbjct: 151 RLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLK 209
Query: 422 MLDVSNNHL 430
L + N+ L
Sbjct: 210 SLKIRNSPL 218
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 4e-04
Identities = 12/69 (17%), Positives = 26/69 (37%), Gaps = 13/69 (18%)
Query: 375 VNLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKEL---------TTLPSLE 421
L+ L L+ + ++ + L LR+L + +P+ L L +L+
Sbjct: 127 AGLETLTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQ 186
Query: 422 MLDVSNNHL 430
L + +
Sbjct: 187 SLRLEWTGI 195
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-24
Identities = 76/417 (18%), Positives = 130/417 (31%), Gaps = 107/417 (25%)
Query: 51 PDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP--SL 108
P C +CS +R + + +P+ + + +L++ KN++ +
Sbjct: 4 PPRC-----ECSAQDRA--VLCHRKRFV-AVPEGIPT--ETRLLDLGKNRIK-TLNQDEF 52
Query: 109 SGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSA 168
+ L+E+ ++N ++V F L +L+T+ L N + + L +
Sbjct: 53 ASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDI 111
Query: 169 NGANITGTIPD--FLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKL 226
+ I + D F + L L + N L I
Sbjct: 112 SENKIV-ILLDYMFQD---LYNLKSLEVGDNDL----------VYI-------------- 143
Query: 227 NGSVAVIQNMTSLTQLWLHGNSFTG-PLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHS 285
S + SL QL L + T P LS L L +R + I S L+
Sbjct: 144 --SHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYR 201
Query: 286 LAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPA 345
L V+ ++ + G LSI
Sbjct: 202 LKVLEIS----------------------HWPYLDTMTPNCLYGLNLTSLSI-------- 231
Query: 346 VLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG----TISSN-FSRLTSLRQLM 400
+ + V A ++ L+ L LS TI + L L+++
Sbjct: 232 -------THCNLTA----VPYLAVRHLV--YLRFLNLSYNPISTIEGSMLHELLRLQEIQ 278
Query: 401 LSGNELTGTIPKE-LTTLPSLEMLDVSNNHL-------FGKVPNFRQNVIVKTDGNP 449
L G +L + L L +L+VS N L F V N + D NP
Sbjct: 279 LVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLET---LILDSNP 331
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-22
Identities = 48/221 (21%), Positives = 86/221 (38%), Gaps = 13/221 (5%)
Query: 82 PKELNSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
L +L LEV N L I SGL+SL+++ + N TS+P++ L L
Sbjct: 121 DYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLI 179
Query: 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTI-PDFLGGDTIPGLMHLHLAFNF 198
+ L + + ++ + S K L+ + T+ P+ L G L L +
Sbjct: 180 VLRLRHLNINA-IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYG---LNLTSLSITHCN 235
Query: 199 LQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTG-PLPDL 256
L L+ ++ L L+ + + + L ++ L G
Sbjct: 236 LTAVPYLAVRHLVYLRFLNLSYNPISTIEGSM---LHELLRLQEIQLVGGQLAVVEPYAF 292
Query: 257 SGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
GL+ L+ +V NQLT + S ++ +L + L +N
Sbjct: 293 RGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 33/189 (17%), Positives = 61/189 (32%), Gaps = 44/189 (23%)
Query: 64 SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQI-PSLSGLSSLQEVLFDDN 122
+ I+ L L VLE+ + P+ +L +
Sbjct: 185 HLNINAIR----------DYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHC 234
Query: 123 NFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD--F 180
N T+VP + L L+ ++L YN S + L + LQ G + + F
Sbjct: 235 NLTAVPYLAVRHLVYLRFLNLSYNPI-STIEGSMLHELLRLQEIQLVGGQLA-VVEPYAF 292
Query: 181 LGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLT 240
G + L L+++ N L ++++ +V ++ +L
Sbjct: 293 RG---LNYLRVLNVSGNQL----------TTLEE----------------SVFHSVGNLE 323
Query: 241 QLWLHGNSF 249
L L N
Sbjct: 324 TLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 19/61 (31%), Positives = 32/61 (52%), Gaps = 7/61 (11%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKEL-TTLPSLEMLDVSNNH 429
L+ + L G + F L LR L +SGN+LT T+ + + ++ +LE L + +N
Sbjct: 273 RLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNP 331
Query: 430 L 430
L
Sbjct: 332 L 332
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 47/189 (24%), Positives = 73/189 (38%), Gaps = 18/189 (9%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
+ + F + LG G FG V+ E G + +K + + ++EI VL +
Sbjct: 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP-MEQIEAEIEVLKSL 77
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRRLTIAL--DV 702
H +++ + D + +V E G L R + + L +
Sbjct: 78 DHPNIIKIFEVFEDYHNMYIVMETCEGG----ELLERIVSAQARGKALSEGYVAELMKQM 133
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHSIETRLA 759
+ Y H Q +H+DLKP NIL K+ DFGL L + T A
Sbjct: 134 MNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAA 187
Query: 760 GTFGYLAPE 768
GT Y+APE
Sbjct: 188 GTALYMAPE 196
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 50/199 (25%), Positives = 86/199 (43%), Gaps = 23/199 (11%)
Query: 576 GSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTK--IAVKRMESAVVSEKGFA 633
+ +V ++F + + LG G G V+K H + +A K + +
Sbjct: 19 AFLTQKQKVGELKDDDFEKISELGAGNGGVVFKV-SHKPSGLVMARKLIHLEI-KPAIRN 76
Query: 634 EFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWT 693
+ E+ VL + ++VG G E + E+M G+L + L K+ G P +
Sbjct: 77 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQIL 133
Query: 694 RRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LVRLAPDN 749
+ +++ V +G+ YL +HRD+KPSNIL+ K+ DFG L+
Sbjct: 134 GK--VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----- 184
Query: 750 GKHSIETRLAGTFGYLAPE 768
S+ GT Y++PE
Sbjct: 185 ---SMANSFVGTRSYMSPE 200
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 50/187 (26%), Positives = 79/187 (42%), Gaps = 21/187 (11%)
Query: 590 NNFSEENVLGRGGFGTVYKGELH--DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTK-VR 646
+ + +GRG +G+V K +H G +AVKR+ + V EK + ++ V+ +
Sbjct: 22 EDLKDLGEIGRGAYGSVNKM-VHKPSGQIMAVKRIR-STVDEKEQKQLLMDLDVVMRSSD 79
Query: 647 HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706
++V G + + E M + + + I L + +
Sbjct: 80 CPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LVRLAPDNGKHSI-ETRLAGT 761
+L + IHRD+KPSNILL K+ DFG LV SI +TR AG
Sbjct: 139 NHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD--------SIAKTRDAGC 188
Query: 762 FGYLAPE 768
Y+APE
Sbjct: 189 RPYMAPE 195
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 65/355 (18%), Positives = 122/355 (34%), Gaps = 53/355 (14%)
Query: 76 NIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGL 135
++ T L++LT L+ + +T + + L+ L +++ NN T++
Sbjct: 29 EMQATDTISEEQLATLTSLDCHNSSIT-DMTGIEKLTGLTKLICTSNNITTLD---LSQN 84
Query: 136 TSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLA 195
T+L ++ D N + + + T L + + +T L P L +L+ A
Sbjct: 85 TNLTYLACDSNKLTN--LD--VTPLTKLTYLNCDTNKLTK-----LDVSQNPLLTYLNCA 135
Query: 196 FNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD 255
N L I +S + + L + K +KL+ + T LT L N T D
Sbjct: 136 RNTLT-EIDVS-HNTQLTELDCHLNKKITKLD-----VTPQTQLTTLDCSFNKITEL--D 186
Query: 256 LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGS 315
+S L + N +T + + + L L + ++N D+ +
Sbjct: 187 VSQNKLLNRLNCDTNNITKLDLNQNIQLTFL---DCSSNKLT----------EIDVTPLT 233
Query: 316 NSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVV 375
D C N L + V + L + D N ++
Sbjct: 234 QLTYFD-----CSV--NPLTEL--DVSTLSKLTTLHCIQT------DLLEIDLTHNTQLI 278
Query: 376 NLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+ G + + T L L +T + L+ P L L ++N L
Sbjct: 279 YFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTEL 330
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-21
Identities = 65/371 (17%), Positives = 117/371 (31%), Gaps = 66/371 (17%)
Query: 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNF 124
+T + +I + + L+ LT L N +T + LS ++L + D N
Sbjct: 42 ATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT-TLD-LSQNTNLTYLACDSNKL 97
Query: 125 TSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGD 184
T++ LT L ++ D N + S L + +T +
Sbjct: 98 TNLD---VTPLTKLTYLNCDTNKLTK--LDVS--QNPLLTYLNCARNTLT-----EIDVS 145
Query: 185 TIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWL 244
L L N + ++ ++ + TL + K ++L+ + L +L
Sbjct: 146 HNTQLTELDCHLNKKITKLDVT-PQTQLTTLDCSFNK-ITELD-----VSQNKLLNRLNC 198
Query: 245 HGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFN 304
N+ T DL+ L N+LT I + L L + + N
Sbjct: 199 DTNNITKL--DLNQNIQLTFLDCSSNKLTEIDVTPLTQLTYF---DCSVNPLT------- 246
Query: 305 SPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGV 364
D++ S L C LL I + + L
Sbjct: 247 ---ELDVSTLSKLTTLH-----CIQ--TDLLEI--DLTHNTQLIYFQAEGCRKIK----- 289
Query: 365 SCDAGGNITVVNLKNL---GLSGT-ISS-NFSRLTSLRQLMLSGNELTGTIPKELTTLPS 419
+ V + L I+ + S+ L L L+ ELT + ++
Sbjct: 290 ------ELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELT-ELD--VSHNTK 340
Query: 420 LEMLDVSNNHL 430
L+ L N H+
Sbjct: 341 LKSLSCVNAHI 351
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 7e-17
Identities = 47/238 (19%), Positives = 80/238 (33%), Gaps = 28/238 (11%)
Query: 57 KHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQE 116
I S + ++T + ++ + LT L+ NK+T ++ +S L
Sbjct: 140 TEIDVSHNTQLTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNKIT-ELD-VSQNKLLNR 195
Query: 117 VLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGT 176
+ D NN T + L + N I + T L F + +T
Sbjct: 196 LNCDTNNITKLD---LNQNIQLTFLDCSSNKLTE--ID--VTPLTQLTYFDCSVNPLT-E 247
Query: 177 IPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNM 236
+ T+ L LH L I L+ + + G + +L+ + +
Sbjct: 248 LDV----STLSKLTTLHCIQTDLLE-IDLTHN-TQLIYFQAEGCRKIKELD-----VTHN 296
Query: 237 TSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
T L L T L DLS L + + +LT + S L SL + N
Sbjct: 297 TQLYLLDCQAAGIT-EL-DLSQNPKLVYLYLNNTELTELDVSHNTKLKSL---SCVNA 349
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 10/60 (16%), Positives = 23/60 (38%), Gaps = 2/60 (3%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
N + T + + +L +L L + +T + + L L L ++N++
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNI 76
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 42/233 (18%), Positives = 88/233 (37%), Gaps = 21/233 (9%)
Query: 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDN 122
NR ++ +++ L S ++ L++ N L+ QI L+ + L+ + N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKLELLNLSSN 68
Query: 123 NFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLG 182
+ L++L+T+ L+ N + L ++ A NI+ +
Sbjct: 69 VLYETLD--LESLSTLRTLDLNNNYV------QELLVGPSIETLHAANNNIS-RVSC--- 116
Query: 183 GDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQ 241
G +++LA N + L G S +Q L L + +N + + + +L
Sbjct: 117 -SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI-DTVNFA-ELAASSDTLEH 173
Query: 242 LWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
L L N + + L+ + N+L + + + ++L NN
Sbjct: 174 LNLQYNFIYD-VKGQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNN 224
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 33/241 (13%), Positives = 68/241 (28%), Gaps = 36/241 (14%)
Query: 83 KELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTIS 142
+EL S+ L N ++ ++ S + + +N T + + +Q +
Sbjct: 93 QELLVGPSIETLHAANNNIS-RVSC-SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLD 150
Query: 143 LDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGP 202
L N D+ E + L+ + I + + L L L+ N L
Sbjct: 151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV---FAKLKTLDLSSNKLAF- 205
Query: 203 IPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSS 261
+ F + +T + L N + L +
Sbjct: 206 MGPEFQ--------------------------SAAGVTWISLRNNKLVL-IEKALRFSQN 238
Query: 262 LQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLD 321
L+ F +R N + V + + T + ++C +
Sbjct: 239 LEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE 297
Query: 322 D 322
D
Sbjct: 298 D 298
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 25/166 (15%), Positives = 58/166 (34%), Gaps = 14/166 (8%)
Query: 129 SDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPG 188
+ + + + +S + + A ++ +G ++ L
Sbjct: 3 HEIKQNGNRYKIEKVTDSSLKQ-ALASLRQSAWNVKELDLSGNPLSQISAADLAP--FTK 59
Query: 189 LMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNS 248
L L+L+ N L + L S+++TL LN N V + S+ L N+
Sbjct: 60 LELLNLSSNVLYETLDLE-SLSTLRTLDLNN-------N-YVQELLVGPSIETLHAANNN 110
Query: 249 FTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+ + S ++ + +N++T + + ++L N
Sbjct: 111 ISR-VS-CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLN 154
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 16/59 (27%), Positives = 22/59 (37%), Gaps = 5/59 (8%)
Query: 376 NLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
LK L LS + F + + L N+L I K L +LE D+ N
Sbjct: 192 KLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 15/69 (21%), Positives = 32/69 (46%), Gaps = 1/69 (1%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+ + + L ++S ++++L LSGN L+ +L LE+L++S+N L
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 431 FGKVPNFRQ 439
+ +
Sbjct: 71 -YETLDLES 78
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 20/117 (17%), Positives = 36/117 (30%), Gaps = 6/117 (5%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVP-SDFFKGLTSL 138
+ E S + +T + + NKL +L +L+ N F DFF +
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264
Query: 139 QTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLA 195
QT++ + ++ + G D + L H H
Sbjct: 265 QTVAKQTVKK----LTGQNEEECTVPTLGHYG-AYCCEDLPAPFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 18/58 (31%), Positives = 29/58 (50%), Gaps = 8/58 (13%)
Query: 376 NLKNLGLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L+ L LS + + L++LR L L+ N + EL PS+E L +NN++
Sbjct: 59 KLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI 111
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 13/59 (22%), Positives = 23/59 (38%), Gaps = 6/59 (10%)
Query: 376 NLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L++L L + L+ L LS N+L + E + + + + NN L
Sbjct: 170 TLEHLNLQYNFIYDVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 11/61 (18%), Positives = 24/61 (39%), Gaps = 6/61 (9%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTG-TIPKELTTLPSLEMLDVSNNH 429
KN+ L+ + + ++ L L NE+ + + +LE L++ N
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180
Query: 430 L 430
+
Sbjct: 181 I 181
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 17/67 (25%), Positives = 32/67 (47%), Gaps = 3/67 (4%)
Query: 232 VIQNMTSLTQLWLHGNSFTG-PLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVN 290
+ Q+ ++ +L L GN + DL+ + L+ ++ N L L +L +L ++
Sbjct: 29 LRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYET--LDLESLSTLRTLD 86
Query: 291 LTNNLFQ 297
L NN Q
Sbjct: 87 LNNNYVQ 93
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 12/61 (19%), Positives = 22/61 (36%), Gaps = 8/61 (13%)
Query: 376 NLKNLGLSG------TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNH 429
++ L L + + +L L L N + + L+ LD+S+N
Sbjct: 145 RVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNK 202
Query: 430 L 430
L
Sbjct: 203 L 203
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 11/57 (19%), Positives = 26/57 (45%), Gaps = 2/57 (3%)
Query: 376 NLKNLGLSGT-ISS-NFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+++ L + IS + SR + + L+ N++T + ++ LD+ N +
Sbjct: 100 SIETLHAANNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI 156
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 7/45 (15%), Positives = 17/45 (37%)
Query: 386 ISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
I + ++ + L + + +++ LD+S N L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPL 46
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 8/55 (14%), Positives = 20/55 (36%), Gaps = 3/55 (5%)
Query: 376 NLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L+ L L+ S+ L + N ++ + + + ++NN +
Sbjct: 81 TLRTLDLNNNYVQELLVGPSIETLHAANNNIS-RVSCS--RGQGKKNIYLANNKI 132
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 12/161 (7%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRM--ESAVVSEKGFAEFKSEIAVLT 643
+++ + V+G G V K+A+KR+ E + E EI ++
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK---CQTSMDELLKEIQAMS 68
Query: 644 KVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLS---RHLFNRKEEGLKPLEWTRRLTIAL 700
+ H ++V + +E LV + + G++ +H+ + E L+ + TI
Sbjct: 69 QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741
+V G+EYLH IHRD+K NILLG+D ++ADFG
Sbjct: 129 EVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFG 166
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 48/162 (29%), Positives = 71/162 (43%), Gaps = 12/162 (7%)
Query: 581 SIQVLRNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEI 639
+ + F LG G +G+VYK G +A+K++ E E EI
Sbjct: 20 EDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV----ESDLQEIIKEI 75
Query: 640 AVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIA 699
+++ + H+V G + +V EY G++S + R K L TI
Sbjct: 76 SIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN----KTLTEDEIATIL 131
Query: 700 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741
+G+EYLH IHRD+K NILL + AK+ADFG
Sbjct: 132 QSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFG 170
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 25/211 (11%)
Query: 566 GPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTK--IAVKRME 623
G S + G + I Q + N+ +G G G V+K T IAVK+M
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKM-RFRKTGHVIAVKQMR 59
Query: 624 SAVVSEKGFAEFKSEIAVLTK-VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR 682
+ +++ ++ V+ K ++V G + + + E M GT + +
Sbjct: 60 RSG-NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM--GTCA-EKLKK 115
Query: 683 KEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG- 741
+ +G P + + + + + + YL IHRD+KPSNILL + + K+ DFG
Sbjct: 116 RMQGPIPERILGK--MTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGI 171
Query: 742 ---LVRLAPDNGKHSI-ETRLAGTFGYLAPE 768
LV + R AG Y+APE
Sbjct: 172 SGRLVD--------DKAKDRSAGCAAYMAPE 194
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 48/158 (30%), Positives = 74/158 (46%), Gaps = 10/158 (6%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLT 643
+ FS+ +G G FG VY ++ + +A+K+M S S + + + E+ L
Sbjct: 50 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 644 KVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVA 703
K+RH + + G L + LV EY G+ S L K KPL+ +
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK----KPLQEVEIAAVTHGAL 164
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741
+G+ YLH + IHRD+K NILL + K+ DFG
Sbjct: 165 QGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFG 199
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-23
Identities = 53/200 (26%), Positives = 87/200 (43%), Gaps = 22/200 (11%)
Query: 577 SMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKI-AVKRME-SAVVSEKGFAE 634
+V+ ++ +R ++F V+GRG F V ++ ++ A+K M ++ +
Sbjct: 48 PIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC 107
Query: 635 FKSEIAVLTKVRHRHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWT 693
F+ E VL R + L + L LV EY G L L K P E
Sbjct: 108 FREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLL--SKFGERIPAEMA 164
Query: 694 R----RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
R + +A+ + +H L ++HRD+KP NILL ++ADFG
Sbjct: 165 RFYLAEIVMAI------DSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSC--LKLR 213
Query: 750 GKHSIETRLA-GTFGYLAPE 768
++ + +A GT YL+PE
Sbjct: 214 ADGTVRSLVAVGTPDYLSPE 233
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 4e-23
Identities = 39/191 (20%), Positives = 73/191 (38%), Gaps = 20/191 (10%)
Query: 589 TNNFSEENVLGRG--GFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
+ V+G+G TV G + V+R+ S + + E+ V
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIAL---DV 702
H ++V + NE +V +M G+ + +G+ E L IA V
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN--E----LAIAYILQGV 137
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK-----HSIETR 757
+ ++Y+H H ++HR +K S+IL+ D + ++ +G+ H
Sbjct: 138 LKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194
Query: 758 LAGTFGYLAPE 768
+L+PE
Sbjct: 195 SVKVLPWLSPE 205
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 5e-23
Identities = 47/187 (25%), Positives = 77/187 (41%), Gaps = 22/187 (11%)
Query: 590 NNFSEENVLGRGGFGTVYKGELH--DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTK-VR 646
++ LGRG +G V K H G +AVKR+ A V+ + ++ + + V
Sbjct: 7 DDLEPIMELGRGAYGVVEKM-RHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTVD 64
Query: 647 HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706
V G + + E M + + P + + IA+ + + +
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKAL 122
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LVRLAPDNGKHSI-ETRLAGT 761
E+LH IHRD+KPSN+L+ + K+ DFG LV + + AG
Sbjct: 123 EHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVD--------DVAKDIDAGC 172
Query: 762 FGYLAPE 768
Y+APE
Sbjct: 173 KPYMAPE 179
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 57/206 (27%), Positives = 87/206 (42%), Gaps = 54/206 (26%)
Query: 598 LGRGGFGTVYKGE-LHDGTKIAVKRME-SAVVSEKGFAEFKS------------------ 637
+G+G +G V +D T A+K + ++ + GF
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 638 -----EIAVLTKVRHRHLVGLLGYCLDGNERLL--VYEYMPQGTLSRHLFNRKEEGLKPL 690
EIA+L K+ H ++V L+ D NE L V+E + QG +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLK---- 132
Query: 691 EWTRRLTIALDVAR--------GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742
L+ D AR G+EYLH +Q IHRD+KPSN+L+G+D K+ADFG+
Sbjct: 133 ----PLSE--DQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 743 VRLAPDNGKHSIETRLAGTFGYLAPE 768
+ + GT ++APE
Sbjct: 184 SNEFKGSDAL-LSNT-VGTPAFMAPE 207
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-23
Identities = 49/184 (26%), Positives = 72/184 (39%), Gaps = 30/184 (16%)
Query: 595 ENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVG 652
+ LG G F K AVK ++S++ A + EI L H ++V
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVK-----IISKRMEANTQKEITALKLCEGHPNIVK 70
Query: 653 LLGYCLDGNERLLVYEYMPQGTL-----SRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
L D LV E + G L + F+ E I + V
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS----------YIMRKLVSAVS 120
Query: 708 YLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
++H +HRDLKP N+L D++ K+ DFG RL P + + ++T T Y
Sbjct: 121 HMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLKTP-CFTLHY 175
Query: 765 LAPE 768
APE
Sbjct: 176 AAPE 179
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-23
Identities = 50/189 (26%), Positives = 80/189 (42%), Gaps = 30/189 (15%)
Query: 595 ENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVG 652
E+VLG G V L + AVK +E + + E+ +L + + HR+++
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR--SRVFREVEMLYQCQGHRNVLE 75
Query: 653 LLGYCLDGNERLLVYEYMPQGTL-----SRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
L+ + + + LV+E M G++ R FN E + DVA ++
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS----------VVVQDVASALD 125
Query: 708 YLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGL-VRLAPDNGKHSIETRL----A 759
+LH ++ HRDLKP NIL K+ DF L + + I T
Sbjct: 126 FLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 760 GTFGYLAPE 768
G+ Y+APE
Sbjct: 183 GSAEYMAPE 191
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 49/204 (24%), Positives = 78/204 (38%), Gaps = 40/204 (19%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVK-----------RMESAVVSEKGFAE 634
+ ++ + LG G +G V E + ++ A+K + EK E
Sbjct: 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE 92
Query: 635 FKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWT 693
+EI++L + H +++ L D LV E+ G L F +
Sbjct: 93 IYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRH------- 141
Query: 694 RRLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVR 744
+ I + G+ YLH + +HRD+KP NILL + K+ DFGL
Sbjct: 142 -KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS 197
Query: 745 LAPDNGKHSIETRLAGTFGYLAPE 768
+ K GT Y+APE
Sbjct: 198 FFSKDYKL---RDRLGTAYYIAPE 218
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 49/224 (21%), Positives = 93/224 (41%), Gaps = 31/224 (13%)
Query: 557 SESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTK 616
+ + P D + + ++ V+G G FG V++ +L + +
Sbjct: 7 NAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE 66
Query: 617 IAVKRMESAVVSEKGFAEFKS-EIAVLTKVRHRHLVGLLGYCLDGNERL------LVYEY 669
+A+K++ FK+ E+ ++ V+H ++V L + ++ LV EY
Sbjct: 67 VAIKKVLQ-------DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119
Query: 670 MPQGTLSRHL--FNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNI 727
+P+ T+ R + + ++ + P+ + L R + Y+H + HRD+KP N+
Sbjct: 120 VPE-TVYRASRHYAKLKQTM-PMLLIKLYMYQL--LRSLAYIHSI---GICHRDIKPQNL 172
Query: 728 LL-GDDMRAKVADFGLVR-LAPDNGK-HSIETRLAGTFGYLAPE 768
LL K+ DFG + L I +R Y APE
Sbjct: 173 LLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPE 211
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 2e-22
Identities = 45/168 (26%), Positives = 77/168 (45%), Gaps = 29/168 (17%)
Query: 590 NNFSEENVLGRGGFGTVYKG-ELHDGTKIAVK--RMESAVVSEKGFAEFKS----EIAVL 642
+ F + LG G + TVYKG G +A+K +++S E+G S EI+++
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS----EEGTP---STAIREISLM 57
Query: 643 TKVRHRHLVGLLGYCLDGNERLLVYEYMPQ---GTLSRHLFNRKEEGLKPLE---WTRRL 696
+++H ++V L N+ LV+E+M + GL+ + +L
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 697 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
+G+ + H +HRDLKP N+L+ + K+ DFGL R
Sbjct: 118 L------QGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 49/170 (28%), Positives = 79/170 (46%), Gaps = 17/170 (10%)
Query: 580 ISIQVLRNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSE 638
I + LR+ F ++G G +G VYKG + G A+K M+ V+ E K E
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQE 70
Query: 639 IAVLTKV-RHRHLVGLLG-----YCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLE 691
I +L K HR++ G +++L LV E+ G+++ + K L+
Sbjct: 71 INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI---KNTKGNTLK 127
Query: 692 WTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741
I ++ RG+ +LH IHRD+K N+LL ++ K+ DFG
Sbjct: 128 EEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFG 174
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 52/222 (23%), Positives = 83/222 (37%), Gaps = 20/222 (9%)
Query: 82 PKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTI 141
P L L L + KN+L ++P +LQE+ +N T V F GL + +
Sbjct: 93 PGAFAPLVKLERLYLSKNQLK-ELPEKM-PKTLQELRVHENEITKVRKSVFNGLNQMIVV 150
Query: 142 SLDYNSFDSWVIPE-SLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQ 200
L N S I + + L NIT TIP P L LHL N +
Sbjct: 151 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ----GLPPSLTELHLDGNKIT 205
Query: 201 GPIPLSF-GKSSIQTLWLNGQKGDSKLNG-SVAVIQNMTSLTQLWLHGNSFTGPLPDLSG 258
S G +++ L L+ + ++ + N L +L L+ N L+
Sbjct: 206 KVDAASLKGLNNLAKLGLSF----NSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLAD 261
Query: 259 LSSLQDFSVRDNQLTGI------VPSSLVNLHSLAVVNLTNN 294
+Q + +N ++ I P S + V+L +N
Sbjct: 262 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN 303
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 54/254 (21%), Positives = 96/254 (37%), Gaps = 47/254 (18%)
Query: 54 CKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP--SLSGL 111
C + +QCS + ++ PK+L +L++ NK+T +I L
Sbjct: 31 CHLRVVQCS-DLGLEKV-----------PKDL--PPDTALLDLQNNKIT-EIKDGDFKNL 75
Query: 112 SSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGA 171
+L ++ +N + + F L L+ + L N +PE + LQ +
Sbjct: 76 KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE--LPEKM--PKTLQELRVHEN 131
Query: 172 NITGTIPD--FLGGDTIPGLMHLHLAFNFLQGPI--PLSF-GKSSIQTLWLNGQKGDSKL 226
IT + F G + ++ + L N L+ +F G + + +
Sbjct: 132 EIT-KVRKSVFNG---LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN----- 182
Query: 227 NGSVAVIQNM-----TSLTQLWLHGNSFTG-PLPDLSGLSSLQDFSVRDNQLTGIVPSSL 280
I + SLT+L L GN T L GL++L + N ++ + SL
Sbjct: 183 ------ITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSL 236
Query: 281 VNLHSLAVVNLTNN 294
N L ++L NN
Sbjct: 237 ANTPHLRELHLNNN 250
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 49/245 (20%), Positives = 82/245 (33%), Gaps = 59/245 (24%)
Query: 64 SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLT-GQIPS--LSGLSSLQEVLFD 120
N +T+++ N L+ + V+E+ N L I + G+ L +
Sbjct: 130 ENEITKVR----------KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIA 179
Query: 121 DNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD- 179
D N T++P LT L LD N V SLK L + + +I+ + +
Sbjct: 180 DTNITTIPQGLPPSLTEL---HLDGNKITK-VDAASLKGLNNLAKLGLSFNSIS-AVDNG 234
Query: 180 -FLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTS 238
P L LHL N L +P +
Sbjct: 235 SLAN---TPHLRELHLNNNKLVK-VPGGL--------------------------ADHKY 264
Query: 239 LTQLWLHGNSFT-------GPLPDLSGLSSLQDFSVRDNQL--TGIVPSSLVNLHSLAVV 289
+ ++LH N+ + P + +S S+ N + I PS+ ++ A V
Sbjct: 265 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 324
Query: 290 NLTNN 294
L N
Sbjct: 325 QLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 16/60 (26%), Positives = 30/60 (50%), Gaps = 6/60 (10%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
NL LGLS + + + LR+L L+ N+L +P L ++++ + NN++
Sbjct: 217 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 275
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 21/86 (24%), Positives = 30/86 (34%), Gaps = 12/86 (13%)
Query: 356 PCNSDWKGVSCDAGGNITVV------NLKNLGLSG----TISSN-FSRLTSLRQLMLSGN 404
C + V C + V + L L I F L +L L+L N
Sbjct: 28 RCQCHLRVVQCS-DLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINN 86
Query: 405 ELTGTIPKELTTLPSLEMLDVSNNHL 430
+++ P L LE L +S N L
Sbjct: 87 KISKISPGAFAPLVKLERLYLSKNQL 112
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 17/60 (28%), Positives = 26/60 (43%), Gaps = 5/60 (8%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+L L L G + + L +L +L LS N ++ L P L L ++NN L
Sbjct: 193 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 252
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 19/60 (31%), Positives = 29/60 (48%), Gaps = 8/60 (13%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
NL L L IS F+ L L +L LS N+L +P+++ +L+ L V N +
Sbjct: 77 NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEI 133
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 9e-05
Identities = 9/66 (13%), Positives = 23/66 (34%), Gaps = 12/66 (18%)
Query: 376 NLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKE-------LTTLPSLEMLD 424
+L+ L L+ + + ++ + L N ++ I T S +
Sbjct: 241 HLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVS 299
Query: 425 VSNNHL 430
+ +N +
Sbjct: 300 LFSNPV 305
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 9/62 (14%), Positives = 23/62 (37%), Gaps = 7/62 (11%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELT-GTIPKE-LTTLPSLEMLDVSNN 428
L+ L + + + F+ L + + L N L I + L + +++
Sbjct: 122 TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 181
Query: 429 HL 430
++
Sbjct: 182 NI 183
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 14/62 (22%), Positives = 25/62 (40%), Gaps = 10/62 (16%)
Query: 376 NLKNLGLSG------TISSN-FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNN 428
+ + L I + F + L + ++ +T TIP+ L PSL L + N
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGN 202
Query: 429 HL 430
+
Sbjct: 203 KI 204
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 40/185 (21%), Positives = 72/185 (38%), Gaps = 28/185 (15%)
Query: 597 VLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFK--SEIAVLTKVRHRHLVGL 653
+LG G +G V + + AVK ++ + E EI +L ++RH++++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 654 LGYCLDGNER--LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR------- 704
+ + ++ +V EY G + + E R + A
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEK--------RFPV--CQAHGYFCQLI 119
Query: 705 -GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFG 763
G+EYLH Q +H+D+KP N+LL K++ G+ G+
Sbjct: 120 DGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176
Query: 764 YLAPE 768
+ PE
Sbjct: 177 FQPPE 181
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 42/157 (26%), Positives = 79/157 (50%), Gaps = 11/157 (7%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTK 644
+ F++ +G+G FG V+KG + +A+K ++ ++ + + EI VL++
Sbjct: 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQ 76
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
++ G L + ++ EY+ G+ L PL+ T+ TI ++ +
Sbjct: 77 CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPG-----PLDETQIATILREILK 130
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741
G++YLH + IHRD+K +N+LL + K+ADFG
Sbjct: 131 GLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFG 164
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-22
Identities = 55/199 (27%), Positives = 84/199 (42%), Gaps = 22/199 (11%)
Query: 577 SMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKI-AVKRME-SAVVSEKGFAE 634
+ I+ LR ++ V+GRG FG V K+ A+K + ++ A
Sbjct: 56 DTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF 115
Query: 635 FKSEIAVLTKVRHRHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWT 693
F E ++ +V L Y + L +V EYMP G L + + P +W
Sbjct: 116 FWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM---SNYDV-PEKWA 170
Query: 694 R----RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
R + +AL + +H + FIHRD+KP N+LL K+ADFG
Sbjct: 171 RFYTAEVVLAL------DAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221
Query: 750 GKHSIETRLAGTFGYLAPE 768
G +T GT Y++PE
Sbjct: 222 GMVRCDT-AVGTPDYISPE 239
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 2e-22
Identities = 46/165 (27%), Positives = 78/165 (47%), Gaps = 26/165 (15%)
Query: 590 NNFSEENVLGRGGFGTVYKG-ELHDGTKIAVK--RMESAVVSEKGFAEFKS----EIAVL 642
NF + +G G +G VYK G +A+K R+++ +G S EI++L
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT---ETEGVP---STAIREISLL 56
Query: 643 TKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLE---WTRRLTIA 699
++ H ++V LL N+ LV+E++ Q L + + G+ + +L
Sbjct: 57 KELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL-- 113
Query: 700 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
+G+ + H +HRDLKP N+L+ + K+ADFGL R
Sbjct: 114 ----QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-22
Identities = 55/266 (20%), Positives = 101/266 (37%), Gaps = 28/266 (10%)
Query: 51 PDPC----KWKHIQCS-------PSN---RVTRIQIGGQNIEGTLPKELNSLSSLTVLEV 96
P C ++ + C P + + I+ L L +L++
Sbjct: 36 PSVCSCSNQFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQL 95
Query: 97 MKNKLTGQIP--SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIP 154
+N + I + +GL++L + DN T++P+ F L+ L+ + L N +S +
Sbjct: 96 SRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIES-IPS 153
Query: 155 ESLKDATGLQRFSANGANITGTIPD--FLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSI 212
+ L+R I + F G + L +L+LA L+ IP +
Sbjct: 154 YAFNRIPSLRRLDLGELKRLSYISEGAFEG---LSNLRYLNLAMCNLRE-IPNLTPLIKL 209
Query: 213 QTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTG-PLPDLSGLSSLQDFSVRDNQ 271
L L+G + GS Q + L +LW+ + L SL + ++ N
Sbjct: 210 DELDLSGNHLSAIRPGS---FQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNN 266
Query: 272 LTGIVPSSLVNLHSLAVVNLTNNLFQ 297
LT + LH L ++L +N +
Sbjct: 267 LTLLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 19/88 (21%), Positives = 37/88 (42%), Gaps = 17/88 (19%)
Query: 375 VNLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNN 428
+ L L LSG I F L L++L + +++ I + L SL +++++N
Sbjct: 207 IKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHN 265
Query: 429 HL-------FGKVPNFRQNVIVKTDGNP 449
+L F + + + + NP
Sbjct: 266 NLTLLPHDLFTPLHHLER---IHLHHNP 290
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 22/61 (36%), Positives = 29/61 (47%), Gaps = 7/61 (11%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNH 429
+L+ L LS TI F+ L +L L L N LT TIP L L+ L + NN
Sbjct: 89 HLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNP 147
Query: 430 L 430
+
Sbjct: 148 I 148
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 17/58 (29%), Positives = 27/58 (46%), Gaps = 3/58 (5%)
Query: 376 NLKNLGLSGT-ISS--NFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
NL+ L L+ + N + L L +L LSGN L+ P L L+ L + + +
Sbjct: 186 NLRYLNLAMCNLREIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI 243
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 22/85 (25%), Positives = 32/85 (37%), Gaps = 12/85 (14%)
Query: 357 CNSDWKGVSCDAGGNITVV------NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNE 405
C++ + V C N+ V N + L L I N F L L L LS N
Sbjct: 41 CSNQFSKVICV-RKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 406 LTGTIPKELTTLPSLEMLDVSNNHL 430
+ L +L L++ +N L
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRL 124
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 9e-05
Identities = 24/61 (39%), Positives = 31/61 (50%), Gaps = 8/61 (13%)
Query: 376 NLKNLGLSG-----TISSN-FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNH 429
+L+ L L IS F L++LR L L+ L IP LT L L+ LD+S NH
Sbjct: 161 SLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNH 218
Query: 430 L 430
L
Sbjct: 219 L 219
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 20/62 (32%), Positives = 28/62 (45%), Gaps = 8/62 (12%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKEL-TTLPSLEMLDVS-NN 428
NL L L TI + F L+ L++L L N + +IP +PSL LD+
Sbjct: 113 NLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELK 171
Query: 429 HL 430
L
Sbjct: 172 RL 173
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 4e-22
Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 25/175 (14%)
Query: 580 ISIQVLRNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVK--RMESAVVSEKGFAEFK 636
+++ V + + + LG G F TVYK + + +A+K ++ ++ G
Sbjct: 1 MALDVKSRA-KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGI---N 56
Query: 637 S----EIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLE- 691
EI +L ++ H +++GLL + LV+++M L + + L P
Sbjct: 57 RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSL-VLTPSHI 114
Query: 692 --WTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
+ +G+EYLH +HRDLKP+N+LL ++ K+ADFGL +
Sbjct: 115 KAYMLMTL------QGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 4e-22
Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 24/181 (13%)
Query: 597 VLGRGGFGTVY---KGELHDGTKI-AVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVG 652
VLG+G FG V+ K D ++ A+K ++ A + + K E +L +V H +V
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 653 LLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTR----RLTIALDVARGVE 707
L Y +L L+ +++ G L L +E + E + L +AL +
Sbjct: 91 LH-YAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALAL------D 140
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
+LH L I+RDLKP NILL ++ K+ DFGL + + D+ K + GT Y+AP
Sbjct: 141 HLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA--YSFCGTVEYMAP 195
Query: 768 E 768
E
Sbjct: 196 E 196
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-22
Identities = 48/205 (23%), Positives = 81/205 (39%), Gaps = 42/205 (20%)
Query: 582 IQVLRNVTNNFSEE----NVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFK 636
+Q L + F++ +G G + + + AVK ++ K +
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID------KSKRDPT 63
Query: 637 SEIAVLTK-VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTR 694
EI +L + +H +++ L DG +V E M G L ++ +
Sbjct: 64 EEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGG----ELLDKILRQK-------- 111
Query: 695 RLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGL-V 743
+ + + + VEYLH Q +HRDLKPSNIL G+ ++ DFG
Sbjct: 112 FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168
Query: 744 RLAPDNGKHSIETRLAGTFGYLAPE 768
+L +NG T ++APE
Sbjct: 169 QLRAENGLL---MTPCYTANFVAPE 190
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 7e-22
Identities = 52/229 (22%), Positives = 85/229 (37%), Gaps = 21/229 (9%)
Query: 550 SSVTGGGSESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKG 609
SS S + + + + + + + +LG GGFG+VY G
Sbjct: 3 SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG 62
Query: 610 E-LHDGTKIAVKRMESAVVSEKGFAEF----KSEIAVLTKVRHR--HLVGLLGYCLDGNE 662
+ D +A+K +E +S+ G E+ +L KV ++ LL + +
Sbjct: 63 IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122
Query: 663 RLLVYEY-MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRD 721
+L+ E P L + R L+ R V V + H + +HRD
Sbjct: 123 FVLILERPEPVQDLFDFITERGA--LQEEL-ARS--FFWQVLEAVRHCH---NCGVLHRD 174
Query: 722 LKPSNILL-GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEY 769
+K NIL+ + K+ DFG L D GT Y PE+
Sbjct: 175 IKDENILIDLNRGELKLIDFGSGALLKDTVYTD----FDGTRVYSPPEW 219
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 7e-22
Identities = 53/270 (19%), Positives = 102/270 (37%), Gaps = 36/270 (13%)
Query: 51 PDPC----KWKHIQCS-------PSN---RVTRIQIGGQNIEGTLPKELNSLSSLTVLEV 96
P C ++ + C+ P + + NI+ L L VL++
Sbjct: 47 PSVCSCSNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQL 106
Query: 97 MKNKLTGQIP--SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIP 154
+N + QI + +GL+SL + DN T +PS F+ L+ L+ + L N +
Sbjct: 107 GRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPI-ESIPS 164
Query: 155 ESLKDATGLQRFSANGANITGTIPD--FLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSI 212
+ L R I + F G + L +L+L ++ +P +
Sbjct: 165 YAFNRVPSLMRLDLGELKKLEYISEGAFEG---LFNLKYLNLGMCNIKD-MPNLTPLVGL 220
Query: 213 QTLWLNGQKGDSKLNG----SVAVIQNMTSLTQLWLHGNSFTG-PLPDLSGLSSLQDFSV 267
+ L ++G N ++SL +LW+ + + GL+SL + ++
Sbjct: 221 EELEMSG-------NHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNL 273
Query: 268 RDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
N L+ + L L ++L +N +
Sbjct: 274 AHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 21/88 (23%), Positives = 40/88 (45%), Gaps = 17/88 (19%)
Query: 375 VNLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNN 428
V L+ L +SG I F L+SL++L + ++++ I + L SL L++++N
Sbjct: 218 VGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHN 276
Query: 429 HL-------FGKVPNFRQNVIVKTDGNP 449
+L F + + + NP
Sbjct: 277 NLSSLPHDLFTPLRYLVE---LHLHHNP 301
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 20/61 (32%), Positives = 25/61 (40%), Gaps = 7/61 (11%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNH 429
+L+ L L I F+ L SL L L N LT IP L L L + NN
Sbjct: 100 HLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNP 158
Query: 430 L 430
+
Sbjct: 159 I 159
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 20/59 (33%), Positives = 26/59 (44%), Gaps = 5/59 (8%)
Query: 376 NLKNLGLSGT-ISS--NFSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNHL 430
NLK L L I N + L L +L +SGN I L SL+ L V N+ +
Sbjct: 197 NLKYLNLGMCNIKDMPNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQV 254
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 20/85 (23%), Positives = 32/85 (37%), Gaps = 12/85 (14%)
Query: 357 CNSDWKGVSCDAGGNITVV------NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNE 405
C++ + V C ++ V N + L L I ++ F L L L L N
Sbjct: 52 CSNQFSKVVCT-RRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 406 LTGTIPKELTTLPSLEMLDVSNNHL 430
+ L SL L++ +N L
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWL 135
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 20/61 (32%), Positives = 27/61 (44%), Gaps = 8/61 (13%)
Query: 376 NLKNLGLSG-----TISSN-FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNH 429
+L L L IS F L +L+ L L + +P LT L LE L++S NH
Sbjct: 172 SLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNH 229
Query: 430 L 430
Sbjct: 230 F 230
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 8e-04
Identities = 20/62 (32%), Positives = 27/62 (43%), Gaps = 8/62 (12%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVS-NN 428
+L L L I S F L+ LR+L L N + +IP +PSL LD+
Sbjct: 124 SLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELK 182
Query: 429 HL 430
L
Sbjct: 183 KL 184
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 50/170 (29%), Positives = 77/170 (45%), Gaps = 25/170 (14%)
Query: 590 NNFSEENVLGRGGFGTVYKG-ELHDGTKIAVK--RMESAVVSEKGFAEFKS----EIAVL 642
+ + +G G +GTVYK + H G +A+K R+ + G E+A+L
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPN---GGGGGGGLPISTVREVALL 65
Query: 643 ---TKVRHRHLVGLL----GYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTR 694
H ++V L+ D ++ LV+E++ Q L +L GL E +
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA-ETIK 123
Query: 695 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
L RG+++LH +HRDLKP NIL+ K+ADFGL R
Sbjct: 124 DLMRQF--LRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 46/162 (28%), Positives = 81/162 (50%), Gaps = 22/162 (13%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVK--RMESAVVSEKGFAEFKS--EIAVLTKV 645
+ + +G G +G VYK + G +A+K R+++ ++G + EI++L ++
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA---EDEGIP-STAIREISLLKEL 76
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLE---WTRRLTIALDV 702
H ++V L+ LV+E+M + L + L + + GL+ + + +L
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVL-DENKTGLQDSQIKIYLYQLL----- 129
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
RGV + H +HRDLKP N+L+ D K+ADFGL R
Sbjct: 130 -RGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 16/174 (9%)
Query: 598 LGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
+G+G F V + G ++A+K ++ ++ + E+ ++ + H ++V L +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 80
Query: 657 -CLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 714
++ + L L+ EY G + +L +K E R + V+Y H
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHG--RMKEKE-ARS--KFRQIVSAVQYCH---Q 132
Query: 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
+ +HRDLK N+LL DM K+ADFG GK ++ G Y APE
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--LDA-FCGAPPYAAPE 183
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-21
Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 32/196 (16%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKS-EIAVLT 643
R ++++ V+G G FG VY+ +L D G +A+K++ FK+ E+ ++
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-------DKRFKNRELQIMR 102
Query: 644 KVRHRHLVGLLGYCLDGNERL------LVYEYMPQGTLSRHL--FNRKEEGLKPLEWTRR 695
K+ H ++V L + E+ LV +Y+P+ T+ R ++R ++ L P+ + +
Sbjct: 103 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTL-PVIYVKL 160
Query: 696 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA-KVADFGLVR-LAPDNGKHS 753
L R + Y+H HRD+KP N+LL D K+ DFG + L S
Sbjct: 161 YMYQL--FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 215
Query: 754 -IETRLAGTFGYLAPE 768
I +R Y APE
Sbjct: 216 YICSRY-----YRAPE 226
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-21
Identities = 61/228 (26%), Positives = 92/228 (40%), Gaps = 13/228 (5%)
Query: 544 KITVTESSVTGGGSESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGF 603
I + + S PSD E + ++ R N F +LG+G F
Sbjct: 102 AIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTF 161
Query: 604 GTVYKGELHDGTKI-AVKRMESAVVSEKGFAEF-KSEIAVLTKVRHRHLVGLLGYCLDGN 661
G V + + A+K ++ V+ K +E VL RH L L Y +
Sbjct: 162 GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTH 220
Query: 662 ERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHR 720
+RL V EY G L HL E + + R ++ ++YLH ++ ++R
Sbjct: 221 DRLCFVMEYANGGELFFHL---SRERVFSEDRARFY--GAEIVSALDYLHS--EKNVVYR 273
Query: 721 DLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
DLK N++L D K+ DFGL + +G GT YLAPE
Sbjct: 274 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KTFCGTPEYLAPE 319
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 48/189 (25%), Positives = 76/189 (40%), Gaps = 29/189 (15%)
Query: 590 NNFSEENVLGRGGFGTVYKG-ELHDGTKIAVK--RMESAVVSEKGFAEFKS----EIAVL 642
+ + +G G +G V+K G +A+K + K EI +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED---DPVI---KKIALREIRML 56
Query: 643 TKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDV 702
+++H +LV LL LV+EY T+ H +R + G+ + +T
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TV-LHELDRYQRGVPEHL-VKSITWQT-- 111
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK---HSIETRLA 759
+ V + H + IHRD+KP NIL+ K+ DFG RL + TR
Sbjct: 112 LQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRW- 167
Query: 760 GTFGYLAPE 768
Y +PE
Sbjct: 168 ----YRSPE 172
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 3e-21
Identities = 50/180 (27%), Positives = 76/180 (42%), Gaps = 26/180 (14%)
Query: 598 LGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
LG G +G V +AVK ++ K EI + + H ++V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 657 CLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR--------GVEY 708
+GN + L EY G L F+R +E + A+ GV Y
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDR-------IEPDIGMPE--PDAQRFFHQLMAGVVY 120
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
LH HRD+KP N+LL + K++DFGL + N + + ++ GT Y+APE
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 50/189 (26%), Positives = 76/189 (40%), Gaps = 29/189 (15%)
Query: 590 NNFSEENVLGRGGFGTVYKG-ELHDGTKIAVK--RMESAVVSEKGFAEFKS----EIAVL 642
+ ++G G +G V K G +A+K +K K EI +L
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD---DKMV---KKIAMREIKLL 78
Query: 643 TKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDV 702
++RH +LV LL C LV+E++ T+ L GL ++ +
Sbjct: 79 KQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL-ELFPNGLDYQV-VQKYLFQI-- 133
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK---HSIETRLA 759
G+ + H + IHRD+KP NIL+ K+ DFG R G+ + TR
Sbjct: 134 INGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRW- 189
Query: 760 GTFGYLAPE 768
Y APE
Sbjct: 190 ----YRAPE 194
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 93.7 bits (234), Expect = 4e-21
Identities = 41/165 (24%), Positives = 78/165 (47%), Gaps = 27/165 (16%)
Query: 590 NNFSEENVLGRGGFGTVYKG-ELHDGTKIAVK--RMESAVVSEKGFAEFKS----EIAVL 642
+ + +G G +GTV+K +A+K R++ ++G S EI +L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVP---SSALREICLL 55
Query: 643 TKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLE---WTRRLTIA 699
+++H+++V L + LV+E+ Q L ++ + L P + +L
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNG-DLDPEIVKSFLFQLL-- 111
Query: 700 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
+G+ + H ++ +HRDLKP N+L+ + K+A+FGL R
Sbjct: 112 ----KGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-21
Identities = 54/198 (27%), Positives = 81/198 (40%), Gaps = 30/198 (15%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFA--EFKSEIAVL 642
R + F E + G+G FGTV G E G +A+K+ V+ + F E + L
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK----VIQDPRFRNREL-QIMQDL 73
Query: 643 TKVRHRHLVGLLGYCLDGNER-------LLVYEYMPQGTLSRHLFNRKEEGLK-PLEWTR 694
+ H ++V L Y ER +V EY+P TL R N + P +
Sbjct: 74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIK 132
Query: 695 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPDNGKHS 753
L R + LH + HRD+KP N+L+ D K+ DFG + + +
Sbjct: 133 VFLFQL--IRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-SPSEPN 188
Query: 754 IE---TRLAGTFGYLAPE 768
+ +R Y APE
Sbjct: 189 VAYICSRY-----YRAPE 201
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 6e-21
Identities = 42/224 (18%), Positives = 81/224 (36%), Gaps = 16/224 (7%)
Query: 85 LNSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSV-PSDFFKGLTSLQTI 141
+SL SL L++ N L+ + S LSSL + N + ++ + F LT LQ +
Sbjct: 96 FSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQIL 154
Query: 142 SLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD--FLGGDTIPGLMHLHLAFNFL 199
+ + + + T L+ + +++ + +I + HL L
Sbjct: 155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSL---KSIQNVSHLILHMKQH 210
Query: 200 QGPIPLSFGK-SSIQTLWLNGQKGDSK-----LNGSVAVIQNMTSLTQLWLHGNSFTGPL 253
+ + SS++ L L D+ G + + + + S +
Sbjct: 211 ILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVM 270
Query: 254 PDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
L+ +S L + NQL + L SL + L N +
Sbjct: 271 KLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 52/351 (14%), Positives = 110/351 (31%), Gaps = 98/351 (27%)
Query: 89 SSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146
++ L++ N++T I + L +LQ ++ N ++ D F L SL+ + L YN
Sbjct: 52 EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYN 110
Query: 147 SFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLS 206
+ + S F + L L+L N
Sbjct: 111 YLSN--LSSSW----------------------F---KPLSSLTFLNLLGN--------- 134
Query: 207 FGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQD 264
+TL G ++ ++T L L + + +GL+ L++
Sbjct: 135 ----PYKTL------------GETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEE 178
Query: 265 FSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAG 324
+ + L P SL ++ +++ + L
Sbjct: 179 LEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI--------------LLLEIFV------ 218
Query: 325 VACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG 384
D +V L ++ + G + I +N+ ++
Sbjct: 219 ---DVTSSVECLE---------LRDTDLDTFHFSELSTGET---NSLIKKFTFRNVKITD 263
Query: 385 ----TISSNFSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNHL 430
+ ++++ L +L S N+L ++P L SL+ + + N
Sbjct: 264 ESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 45/229 (19%), Positives = 82/229 (35%), Gaps = 26/229 (11%)
Query: 82 PKELNSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
+L +L L + N + I S L SL+ + N +++ S +FK L+SL
Sbjct: 69 NSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLT 127
Query: 140 TISLDYNSFDSWVIPES--LKDATGLQRFSANGANITGTIPD--FLGGDTIPGLMHLHLA 195
++L N + + + E+ T LQ + I F G + L L +
Sbjct: 128 FLNLLGNPYKT--LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAG---LTFLEELEID 182
Query: 196 FNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSF----- 249
+ LQ P S ++ L L+ ++ L + +S+ L L
Sbjct: 183 ASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEI---FVDVTSSVECLELRDTDLDTFHF 239
Query: 250 ----TGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
TG L + ++ + D L + L + L + + N
Sbjct: 240 SELSTGETNSLIKKFTFRNVKITDESLFQV-MKLLNQISGLLELEFSRN 287
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 49/334 (14%), Positives = 103/334 (30%), Gaps = 49/334 (14%)
Query: 78 EGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGL-SSLQEVLFDDNNFTSVPSDFFKGLT 136
E + + S + + L IPS GL +++ + +N T + + +
Sbjct: 20 EESSNQASLSCDRNGICKGSSGSLN-SIPS--GLTEAVKSLDLSNNRITYISNSDLQRCV 76
Query: 137 SLQTISLDYNSFDSWVIPE-SLKDATGLQRFSANGANITGTIPD--FLGGDTIPGLMHLH 193
+LQ + L N ++ I E S L+ + ++ + F + L L+
Sbjct: 77 NLQALVLTSNGINT--IEEDSFSSLGSLEHLDLSYNYLS-NLSSSWF---KPLSSLTFLN 130
Query: 194 LAFNFLQ--GPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTG 251
L N + G L + +Q L + +K+ +T L +L + +
Sbjct: 131 LLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKI--QRKDFAGLTFLEELEIDASDLQS 188
Query: 252 -PLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFD 310
L + ++ + Q ++ + S+ + L + S +
Sbjct: 189 YEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETN 248
Query: 311 MAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGG 370
+F NV ++ +L +
Sbjct: 249 SLIKKFTF------------RNVKITDESLFQVMKLL-------------------NQIS 277
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGN 404
+ + L F RLTSL+++ L N
Sbjct: 278 GLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 21/86 (24%), Positives = 32/86 (37%), Gaps = 2/86 (2%)
Query: 64 SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNN 123
+ + L + +++ L + L+ +S L E+ F N
Sbjct: 231 DTDLDTFHF--SELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQ 288
Query: 124 FTSVPSDFFKGLTSLQTISLDYNSFD 149
SVP F LTSLQ I L N +D
Sbjct: 289 LKSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 39/241 (16%), Positives = 82/241 (34%), Gaps = 30/241 (12%)
Query: 210 SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQDFSV 267
++++L L+ + + + S + +Q +L L L N + + S L SL+ +
Sbjct: 52 EAVKSLDLSNNR-ITYI--SNSDLQRCVNLQALVLTSNGINT-IEEDSFSSLGSLEHLDL 107
Query: 268 RDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ--GQTPKFNSPVRFDMAKGSNSFCLDDAGV 325
N L+ + S L SL +NL N ++ G+T F+ + + + N
Sbjct: 108 SYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKI-- 165
Query: 326 ACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGT 385
+ + L E + S + N++ + L
Sbjct: 166 ----QRKDFAGLTF-------LEELEIDASDLQSYEPKS-LKSIQNVSHLILHMKQHILL 213
Query: 386 ISSNFSRLTSLRQLMLSGNELTGTIPKELTT--------LPSLEMLDVSNNHLFGKVPNF 437
+ +S+ L L +L EL+T + + +++ LF +
Sbjct: 214 LEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLL 273
Query: 438 R 438
Sbjct: 274 N 274
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 7e-21
Identities = 55/191 (28%), Positives = 82/191 (42%), Gaps = 35/191 (18%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKI-AVKRME-SAVVSEKGFAEFKSEIAVLTKVRH 647
+F LG G FG V+ + A+K ++ VV K E +L+ V H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 648 RHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR-- 704
++ + G D +++ ++ +Y+ G L L RK +R VA+
Sbjct: 66 PFIIRMWGTFQD-AQQIFMIMDYIEGGELFSLL--RKS---------QRFPN--PVAKFY 111
Query: 705 ------GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR- 757
+EYLH + I+RDLKP NILL + K+ DFG + PD T
Sbjct: 112 AAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYT 162
Query: 758 LAGTFGYLAPE 768
L GT Y+APE
Sbjct: 163 LCGTPDYIAPE 173
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 54/187 (28%), Positives = 74/187 (39%), Gaps = 27/187 (14%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKI-AVKRME-SAVVSEKGFAEFKSEIAVLTKVRH 647
+ F LG G FG V + + A+K ++ VV K +E +L V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 648 RHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTR----RLTIALDV 702
LV L D N L +V EY+ G + HL R+ G R ++ +
Sbjct: 101 PFLVKLEFSFKD-NSNLYMVMEYVAGGEMFSHL--RRI-GRFSEPHARFYAAQIVLTF-- 154
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR-LAGT 761
EYLH I+RDLKP N+L+ +V DFG + T L GT
Sbjct: 155 ----EYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGT 201
Query: 762 FGYLAPE 768
LAPE
Sbjct: 202 PEALAPE 208
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 20/153 (13%), Positives = 48/153 (31%), Gaps = 18/153 (11%)
Query: 597 VLGRGGFGTVYKGELHD---GTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHRHLVG 652
G ++ D ++A+ ++ V + S L+++ +
Sbjct: 38 FHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 653 LLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
+L L+V E++ G+L + P+ + +A +
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPV---GAIRAMQSLAAAADA---- 144
Query: 713 AHQS-FIHRDLKPSNILLGDDMRAKVADFGLVR 744
AH++ PS + + D +A +
Sbjct: 145 AHRAGVALSIDHPSRVRVSIDGDVVLAYPATMP 177
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 41/220 (18%), Positives = 87/220 (39%), Gaps = 25/220 (11%)
Query: 80 TLPKE-LNSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLT 136
+ ++ L + N + +P + L ++ + N+ +S+P F
Sbjct: 83 EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTP 141
Query: 137 SLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAF 196
L T+S+ N+ + + ++ + T LQ + +T + IP L H ++++
Sbjct: 142 KLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLT-HVDL----SLIPSLFHANVSY 195
Query: 197 NFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNM--TSLTQLWLHGNSFTGPLP 254
N L + + +++ L + N S+ V++ LT L L N+ T
Sbjct: 196 NLLST-LAIP---IAVEELDASH-------N-SINVVRGPVNVELTILKLQHNNLT-DTA 242
Query: 255 DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
L L + + N+L I+ V + L + ++NN
Sbjct: 243 WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNN 282
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 4e-19
Identities = 41/218 (18%), Positives = 81/218 (37%), Gaps = 21/218 (9%)
Query: 80 TLPKE-LNSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDNNFTSVPSDFFKGLT 136
LP L+S + +L + ++ +I + + ++Q++ N +P F+ +
Sbjct: 59 KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVP 117
Query: 137 SLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAF 196
L + L+ N S + + L S + N+ I D T L +L L+
Sbjct: 118 LLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQAT-TSLQNLQLSS 174
Query: 197 NFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDL 256
N L + LS S+ ++ + + ++ +L NS +
Sbjct: 175 NRLTH-VDLS-LIPSLFHANVSYNLLST--------LAIPIAVEELDASHNSINV-VRGP 223
Query: 257 SGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
L ++ N LT + L+N L V+L+ N
Sbjct: 224 V-NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYN 258
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-18
Identities = 38/245 (15%), Positives = 91/245 (37%), Gaps = 27/245 (11%)
Query: 59 IQCSPSNRVTRI-----QIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPS--LSGL 111
+C SN I Q + E +L++ ++ + + ++P+ L
Sbjct: 10 YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSF 68
Query: 112 SSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGA 171
++ + +D + + F ++Q + + +N+ + P ++ L
Sbjct: 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERN 127
Query: 172 NITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSV 230
+++ ++P + + P L L ++ N L+ +F +S+Q L L+ N
Sbjct: 128 DLS-SLPRGIFHN-TPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSS-------NRLT 178
Query: 231 AV-IQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVV 289
V + + SL + N + L+ ++++ N + + V L L
Sbjct: 179 HVDLSLIPSLFHANVSYNLLS----TLAIPIAVEELDASHNSINVVRGPVNVELTIL--- 231
Query: 290 NLTNN 294
L +N
Sbjct: 232 KLQHN 236
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 43/235 (18%), Positives = 86/235 (36%), Gaps = 36/235 (15%)
Query: 80 TLPKEL-NSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGL- 135
+LP+ + ++ LT L + N L +I +SLQ + N T V L
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLF 189
Query: 136 ---------------TSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDF 180
+++ + +NS + + + L N+T
Sbjct: 190 HANVSYNLLSTLAIPIAVEELDASHNSINV--VRGPVN--VELTILKLQHNNLT-DTAWL 244
Query: 181 LGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSL 239
L PGL+ + L++N L+ + F K ++ L+++ ++L Q + +L
Sbjct: 245 LN---YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN----NRLVALNLYGQPIPTL 297
Query: 240 TQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
L L N + L++ + N + + S+ L +L L++N
Sbjct: 298 KVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNL---TLSHN 349
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 25/187 (13%), Positives = 54/187 (28%), Gaps = 36/187 (19%)
Query: 86 NSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145
LT+L++ N LT L L EV N + F + L+ + +
Sbjct: 223 PVNVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 281
Query: 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPL 205
N + + + L+ + ++ + L +L+L N +
Sbjct: 282 NRLVA--LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ--FDRLENLYLDHNSI------ 330
Query: 206 SFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDF 265
+++ + +L L L N + + ++
Sbjct: 331 ----VTLK-------------------LSTHHTLKNLTLSHNDWD-CNSLRALFRNVARP 366
Query: 266 SVRDNQL 272
+V D
Sbjct: 367 AVDDADQ 373
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 13/59 (22%), Positives = 25/59 (42%), Gaps = 5/59 (8%)
Query: 376 NLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L+ L +S ++ + +L+ L LS N L + + LE L + +N +
Sbjct: 273 RLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI 330
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 18/60 (30%), Positives = 31/60 (51%), Gaps = 6/60 (10%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L + LS I + F ++ L +L +S N L + +P+L++LD+S+NHL
Sbjct: 249 GLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL 307
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 9/66 (13%), Positives = 23/66 (34%), Gaps = 7/66 (10%)
Query: 371 NITVVNLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLD 424
+IT+ N K + + + + L L+ ++ I +++ L
Sbjct: 41 DITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLY 99
Query: 425 VSNNHL 430
+ N +
Sbjct: 100 MGFNAI 105
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 14/71 (19%), Positives = 29/71 (40%), Gaps = 5/71 (7%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSL 138
L + +L VL++ N L + + L+ + D N+ ++ L +L
Sbjct: 286 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNL 344
Query: 139 QTISLDYNSFD 149
+L +N +D
Sbjct: 345 ---TLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 19/60 (31%), Positives = 25/60 (41%), Gaps = 5/60 (8%)
Query: 375 VNLKNLGLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNHL 430
V L L L T ++ L ++ LS NEL I + LE L +SNN L
Sbjct: 226 VELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRL 284
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 17/59 (28%), Positives = 26/59 (44%), Gaps = 7/59 (11%)
Query: 376 NLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
LK L LS + N + L L L N + T+ L+T +L+ L +S+N
Sbjct: 296 TLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 15/61 (24%), Positives = 30/61 (49%), Gaps = 7/61 (11%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKEL-TTLPSLEMLDVSNNH 429
++ L + + + F + L L+L N+L+ ++P+ + P L L +SNN+
Sbjct: 94 TIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNN 152
Query: 430 L 430
L
Sbjct: 153 L 153
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 12/61 (19%), Positives = 27/61 (44%), Gaps = 7/61 (11%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNH 429
++ L L+ I + F+ ++++L + N + +P +P L +L + N
Sbjct: 70 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND 128
Query: 430 L 430
L
Sbjct: 129 L 129
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 16/61 (26%), Positives = 23/61 (37%), Gaps = 7/61 (11%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNH 429
L L L ++ F L L +S N L I + SL+ L +S+N
Sbjct: 118 LLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNR 176
Query: 430 L 430
L
Sbjct: 177 L 177
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 10/55 (18%), Positives = 25/55 (45%), Gaps = 3/55 (5%)
Query: 376 NLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+L + +S + S + ++ +L S N + + + L +L + +N+L
Sbjct: 187 SLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNL 238
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 9e-05
Identities = 6/57 (10%), Positives = 22/57 (38%), Gaps = 2/57 (3%)
Query: 375 VNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNHL 430
V++ L + + + + + +P L + +E+L++++ +
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQI 81
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 22/60 (36%), Positives = 29/60 (48%), Gaps = 8/60 (13%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L L +S I + F TSL+ L LS N LT + L+ +PSL +VS N L
Sbjct: 142 KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL 198
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 51/185 (27%), Positives = 76/185 (41%), Gaps = 25/185 (13%)
Query: 597 VLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAE----FKSEIAVLTKVR----H 647
+LG+GGFGTV+ G L D ++A+K + V E+A+L KV H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE--GLKPLEWTRRLTIALDVARG 705
++ LL + +LV E + LF+ E L +R V
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPA---QDLFDYITEKGPLGEGP-SRC--FFGQVVAA 151
Query: 706 VEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
+++ H + +HRD+K NIL+ AK+ DFG L D GT Y
Sbjct: 152 IQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD----FDGTRVY 204
Query: 765 LAPEY 769
PE+
Sbjct: 205 SPPEW 209
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 50/180 (27%), Positives = 77/180 (42%), Gaps = 26/180 (14%)
Query: 598 LGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGY 656
LG G +G V +AVK ++ + K EI + + H ++V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKFYGH 73
Query: 657 CLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR--------GVEY 708
+GN + L EY G L F+R +E + A+ GV Y
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDR-------IEPDIGMPE--PDAQRFFHQLMAGVVY 120
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
LH HRD+KP N+LL + K++DFGL + N + + ++ GT Y+APE
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 2e-20
Identities = 46/161 (28%), Positives = 79/161 (49%), Gaps = 20/161 (12%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVK--RMESAVVSEKGFAEFKS----EIAVLT 643
+ +G G +G VYK + + G A+K R+E ++G S EI++L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK---EDEGIP---STTIREISILK 55
Query: 644 KVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVA 703
+++H ++V L +LV+E++ Q L + L + GL+ + + + L
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEG-GLESVT-AKSFLLQL--L 110
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
G+ Y H + +HRDLKP N+L+ + K+ADFGL R
Sbjct: 111 NGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 54/215 (25%), Positives = 83/215 (38%), Gaps = 37/215 (17%)
Query: 82 PKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTI 141
K + L L L + KN L +IP + SSL E+ DN VP F GL ++ I
Sbjct: 95 EKAFSPLRKLQKLYISKNHLV-EIPP-NLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCI 152
Query: 142 SLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQG 201
+ N ++ D L + A +T IP D L LHL N
Sbjct: 153 EMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK----DLPETLNELHLDHN---- 203
Query: 202 PIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD--LSGL 259
IQ + + + + L +L L N + + LS L
Sbjct: 204 ---------KIQAI-------------ELEDLLRYSKLYRLGLGHNQIRM-IENGSLSFL 240
Query: 260 SSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+L++ + +N+L+ + P+ L +L L VV L N
Sbjct: 241 PTLRELHLDNNKLSRV-PAGLPDLKLLQVVYLHTN 274
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 52/260 (20%), Positives = 97/260 (37%), Gaps = 36/260 (13%)
Query: 43 PASLGWTDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLT 102
P + P C C +Q ++ +PKE++ T+L++ N ++
Sbjct: 20 PPTYSAMCPFGC-----HCHL----RVVQCSDLGLK-AVPKEISP--DTTLLDLQNNDIS 67
Query: 103 GQIP--SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDA 160
++ GL L ++ +N + + F L LQ + + N IP +L
Sbjct: 68 -ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVE--IPPNL--P 122
Query: 161 TGLQRFSANGANITGTIPD--FLGGDTIPGLMHLHLAFNFLQ-GPI-PLSFGKSSIQTLW 216
+ L + I +P F G + + + + N L+ P +F + L
Sbjct: 123 SSLVELRIHDNRIR-KVPKGVFSG---LRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLR 178
Query: 217 LNGQKGDSKLNGSVAVIQNM-TSLTQLWLHGNSFTG-PLPDLSGLSSLQDFSVRDNQLTG 274
++ + +++ +L +L L N L DL S L + NQ+
Sbjct: 179 ISE-------AKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRM 231
Query: 275 IVPSSLVNLHSLAVVNLTNN 294
I SL L +L ++L NN
Sbjct: 232 IENGSLSFLPTLRELHLDNN 251
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 59/332 (17%), Positives = 96/332 (28%), Gaps = 103/332 (31%)
Query: 113 SLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGAN 172
L+ V D +VP + T L L N + +
Sbjct: 34 HLRVVQCSDLGLKAVPKEISPDTTLL---DLQNNDISE--LRKD---------------- 72
Query: 173 ITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAV 232
DF G + L L L N + S I
Sbjct: 73 ------DFKG---LQHLYALVLVNNKI----------SKI----------------HEKA 97
Query: 233 IQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLT 292
+ L +L++ N P+L SSL + + DN++ + L ++ + +
Sbjct: 98 FSPLRKLQKLYISKNHLVEIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMG 155
Query: 293 NNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWK 352
N + NS G L + L I P L E
Sbjct: 156 GNPLE------NSGFEPGAFDGLKLNYLRISE-------AKLTGI--PKDLPETLNELHL 200
Query: 353 GNNPCNSDWKGVSCDAGGNITVV---------NLKNLGLSG----TISSN-FSRLTSLRQ 398
+N I + L LGL I + S L +LR+
Sbjct: 201 DHN---------------KIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRE 245
Query: 399 LMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L L N+L+ +P L L L+++ + N++
Sbjct: 246 LHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNI 276
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 40/245 (16%), Positives = 75/245 (30%), Gaps = 60/245 (24%)
Query: 64 SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLT-GQIPS--LSGLSSLQEVLFD 120
NR+ ++ + L ++ +E+ N L GL L +
Sbjct: 132 DNRIRKVP----------KGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK-LNYLRIS 180
Query: 121 DNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD- 179
+ T +P D +L + LD+N + + E L + L R I I +
Sbjct: 181 EAKLTGIPKDLP---ETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQIR-MIENG 235
Query: 180 -FLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTS 238
+P L LHL N L +P ++
Sbjct: 236 SLSF---LPTLRELHLDNNKLSR-VPAGL--------------------------PDLKL 265
Query: 239 LTQLWLHGNSFT-------GPLPDLSGLSSLQDFSVRDNQLT--GIVPSSLVNLHSLAVV 289
L ++LH N+ T P+ + S+ +N + + P++ + +
Sbjct: 266 LQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAI 325
Query: 290 NLTNN 294
N
Sbjct: 326 QFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 20/86 (23%), Positives = 33/86 (38%), Gaps = 12/86 (13%)
Query: 356 PCNSDWKGVSCDAGGNITVV------NLKNLGLSG----TISSN-FSRLTSLRQLMLSGN 404
C+ + V C + V + L L + + F L L L+L N
Sbjct: 30 GCHCHLRVVQCS-DLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNN 88
Query: 405 ELTGTIPKELTTLPSLEMLDVSNNHL 430
+++ K + L L+ L +S NHL
Sbjct: 89 KISKIHEKAFSPLRKLQKLYISKNHL 114
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 10/66 (15%), Positives = 20/66 (30%), Gaps = 12/66 (18%)
Query: 376 NLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKE-------LTTLPSLEMLD 424
L+ L L + + L L+ + L N +T + +
Sbjct: 242 TLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGIS 300
Query: 425 VSNNHL 430
+ NN +
Sbjct: 301 LFNNPV 306
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 3e-20
Identities = 56/181 (30%), Positives = 74/181 (40%), Gaps = 29/181 (16%)
Query: 598 LGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHRHLVGLLG 655
LG G FG V GE G K+AVK + + K EI L RH H++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR--------GVE 707
+ +V EY+ G L ++ R+ AR V+
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHG-----------RVEE--MEARRLFQQILSAVD 125
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
Y H +HRDLKP N+LL M AK+ADFGL + D + T G+ Y AP
Sbjct: 126 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF--LRTS-CGSPNYAAP 179
Query: 768 E 768
E
Sbjct: 180 E 180
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 49/187 (26%), Positives = 73/187 (39%), Gaps = 21/187 (11%)
Query: 591 NFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEF------KSEIAVLT 643
+S + LG G FG V+ ++ VK ++ V E + E EIA+L+
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 644 KVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNR--KEEGLKPLEWTRRLTIALD 701
+V H +++ +L + LV E G LF + L I
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSG---LDLFAFIDRHPRLDEPL-ASY--IFRQ 138
Query: 702 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGT 761
+ V YL + IHRD+K NI++ +D K+ DFG T GT
Sbjct: 139 LVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL--FYT-FCGT 192
Query: 762 FGYLAPE 768
Y APE
Sbjct: 193 IEYCAPE 199
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-20
Identities = 40/231 (17%), Positives = 78/231 (33%), Gaps = 42/231 (18%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIPSLSG--------------LSSLQEVLFDDNNFT 125
+P E ++ S T ++ P +G E+ ++ +
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84
Query: 126 SVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDT 185
S+P L+++ NS +PE + L + N ++ D
Sbjct: 85 SLPEL----PPHLESLVASCNSLTE--LPELPQSLKSLLVDNNNLKALS---------DL 129
Query: 186 IPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLH 245
P L +L ++ N L+ +P S ++ + ++ N + SL +
Sbjct: 130 PPLLEYLGVSNNQLEK-LPELQNSSFLKIIDVDN-------NSLKKLPDLPPSLEFIAAG 181
Query: 246 GNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLF 296
N LP+L L L +N L + P ++L S+ NN+
Sbjct: 182 NNQLEE-LPELQNLPFLTAIYADNNSLKKL-PDLPLSLESI---VAGNNIL 227
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 5e-20
Identities = 51/215 (23%), Positives = 87/215 (40%), Gaps = 29/215 (13%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
LP+ SL SL V L+ P L L +N +P + + L+
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLG------VSNNQLEKLPE--LQNSSFLK 156
Query: 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFL 199
I +D NS +P+ L+ +A + +P+ +P L ++ N L
Sbjct: 157 IIDVDNNSLKK--LPDLP---PSLEFIAAGNNQLE-ELPELQN---LPFLTAIYADNNSL 207
Query: 200 QGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGL 259
+ +P S++++ G++ L + +QN+ LT ++ N LPDL
Sbjct: 208 KK-LPDLPL--SLESIVA----GNNILE-ELPELQNLPFLTTIYADNNLLKT-LPDL--P 256
Query: 260 SSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
SL+ +VRDN LT + P +L L V +
Sbjct: 257 PSLEALNVRDNYLTDL-PELPQSLTFLDVSENIFS 290
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-17
Identities = 65/377 (17%), Positives = 117/377 (31%), Gaps = 104/377 (27%)
Query: 106 PSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKD------ 159
P + LQE L +N T +P + + S ++ ++ P + +
Sbjct: 5 PRNVSNTFLQEPLRHSSNLTEMPVEAEN-VKSKTEYYNAWSEWERNAPPGNGEQREMAVS 63
Query: 160 ------ATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK---- 209
N ++ ++P + P L L + N L +P
Sbjct: 64 RLRDCLDRQAHELELNNLGLS-SLP-----ELPPHLESLVASCNSLT-ELPELPQSLKSL 116
Query: 210 --------------SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD 255
++ L ++ +++L + +QN + L + + NS LPD
Sbjct: 117 LVDNNNLKALSDLPPLLEYLGVS----NNQLE-KLPELQNSSFLKIIDVDNNSLKK-LPD 170
Query: 256 LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGS 315
L SL+ + +NQL + L NL L + NN + S G+
Sbjct: 171 L--PPSLEFIAAGNNQLEEL--PELQNLPFLTAIYADNNSLKKLPDLPLSLESIVA--GN 224
Query: 316 NSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVV 375
N +L + + L + NN + +
Sbjct: 225 N-----------------ILEELPELQNLPFLTTIYADNN---------------LLKTL 252
Query: 376 -----NLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPK---------ELTTL 417
+L+ L + + LT L + L+ P E+ +L
Sbjct: 253 PDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSL 312
Query: 418 P----SLEMLDVSNNHL 430
SLE L+VSNN L
Sbjct: 313 CDLPPSLEELNVSNNKL 329
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 40/216 (18%), Positives = 78/216 (36%), Gaps = 35/216 (16%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
LP+ SL+ L V E + + L+ P+L L+ N S+ SL+
Sbjct: 271 DLPELPQSLTFLDVSENIFSGLSELPPNLYYLN------ASSNEIRSLCDL----PPSLE 320
Query: 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFL 199
+++ N +P L+R A+ ++ +P+ L LH+ +N L
Sbjct: 321 ELNVSNNKLIE--LPALP---PRLERLIASFNHLA-EVPELPQ-----NLKQLHVEYNPL 369
Query: 200 QGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGL 259
+ P S++ L +N + V + +L QL + N PD+
Sbjct: 370 RE-FPDIPE--SVEDLRMN--------SHLAEVPELPQNLKQLHVETNPLRE-FPDI--P 415
Query: 260 SSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNL 295
S++D + ++ + L ++
Sbjct: 416 ESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHH 451
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 46/218 (21%), Positives = 82/218 (37%), Gaps = 36/218 (16%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
EL +L LT + N L +P L SL+ + DN T +P + + LT L
Sbjct: 228 EELPELQNLPFLTTIYADNNLLK-TLPDL--PPSLEALNVRDNYLTDLP-ELPQSLTFLD 283
Query: 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFL 199
++ + E L +A+ I ++ D P L L+++ N L
Sbjct: 284 VSENIFSG-----LSELPP---NLYYLNASSNEIR-SLCDLP-----PSLEELNVSNNKL 329
Query: 200 QGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGL 259
+P + ++ L + N V + +L QL + N PD+
Sbjct: 330 IE-LPALPPR--LERLIASF-------NHLAEVPELPQNLKQLHVEYNPLRE-FPDI--P 376
Query: 260 SSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
S++D + ++ L + P NL L ++ N +
Sbjct: 377 ESVEDLRM-NSHLAEV-PELPQNLKQL---HVETNPLR 409
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 5e-05
Identities = 16/67 (23%), Positives = 27/67 (40%), Gaps = 8/67 (11%)
Query: 376 NLKNLGLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFG 432
L+ LG+S + L+ + + N L +P PSLE + NN L
Sbjct: 132 LLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDL---PPSLEFIAAGNNQL-E 186
Query: 433 KVPNFRQ 439
++P +
Sbjct: 187 ELPELQN 193
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 21/56 (37%), Positives = 25/56 (44%), Gaps = 5/56 (8%)
Query: 376 NLKNLGLSG-TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
NL L S I S SL +L +S N+L +P P LE L S NHL
Sbjct: 298 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHL 349
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 5e-20
Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 22/162 (13%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHD-GTKIAVK--RMESAVVSEKGFAEFKS----EIAVL 642
+ + + LG G + TVYKG+ +A+K R+E E+G E+++L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH----EEGAP---CTAIREVSLL 54
Query: 643 TKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDV 702
++H ++V L LV+EY+ + L ++L + + + L
Sbjct: 55 KDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL-DDCGNIINMHN-VKLFLFQL-- 109
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
RG+ Y H Q +HRDLKP N+L+ + K+ADFGL R
Sbjct: 110 LRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 5e-20
Identities = 50/185 (27%), Positives = 85/185 (45%), Gaps = 22/185 (11%)
Query: 598 LGRGGFGTVYKG---ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
+GRG +G VYK + D A+K++E +S EIA+L +++H +++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC----REIALLRELKHPNVISLQ 84
Query: 655 GYCLDGNERL--LVYEYMPQ---GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
L +R L+++Y + H ++ + L ++ + G+ YL
Sbjct: 85 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRA----KVADFGLVRL--APDNGKHSIETRLAGTFG 763
H +HRDLKP+NIL+ + K+AD G RL +P ++ + TF
Sbjct: 145 H---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 200
Query: 764 YLAPE 768
Y APE
Sbjct: 201 YRAPE 205
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 5e-20
Identities = 70/395 (17%), Positives = 117/395 (29%), Gaps = 91/395 (23%)
Query: 63 PSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFD 120
P++ V + + +I + L L L+V + I + GLSSL + D
Sbjct: 29 PAH-VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD 87
Query: 121 DNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDF 180
N F + + F GL +L+ ++L + D V+ + F
Sbjct: 88 YNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNF----------------------F 125
Query: 181 LGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLT 240
+ L L L N +I+ + NM
Sbjct: 126 ---KPLTSLEMLVLRDN-------------NIKKIQPAS------------FFLNMRRFH 157
Query: 241 QLWLHGNSFT----GPLPDLSG-------LSSLQDFSVRDNQLTGIVPSSLVNLHSLAVV 289
L L N L + G LSS+ + + L + S+ +
Sbjct: 158 VLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTL 217
Query: 290 NLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAE 349
+L+ N F+ ++ K + + +
Sbjct: 218 DLSGNGFK-ESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFK------ 270
Query: 350 SWKGNNPCNSDWKGVSCDAGGNITVV---------NLKNLGLSG----TISSN-FSRLTS 395
S K I + +L+ L L+ I N F LT
Sbjct: 271 -----GLEASGVKTCDLS-KSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTH 324
Query: 396 LRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L +L LS N L + L LE+LD+S NH+
Sbjct: 325 LLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHI 359
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-17
Identities = 57/349 (16%), Positives = 105/349 (30%), Gaps = 52/349 (14%)
Query: 100 KLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKD 159
L Q+P L + + V N+ + F L LQ + ++ + + + +
Sbjct: 21 GLH-QVPELP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRG 77
Query: 160 ATGLQRFSANGANITGTIPD--FLGGDTIPGLMHLHLAFNFLQGPI--PLSFGK-SSIQT 214
+ L + + F + + L L L L G + F +S++
Sbjct: 78 LSSLIILKLDYNQFL-QLETGAF---NGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEM 133
Query: 215 LWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFT----GPLPDLSG-------LSSLQ 263
L L + NM L L N L + G LSS+
Sbjct: 134 LVLRDNNIKKIQPA--SFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSIT 191
Query: 264 DFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDA 323
+ + L + S+ ++L+ N F + +
Sbjct: 192 LQDMNEYWLGWEKCGNPFKNTSITTLDLSGN-------GFKESMAKRFFDAIAGTKIQSL 244
Query: 324 GVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLS 383
++ + +P N +KG+ + +L +
Sbjct: 245 ILSNSYNMGSSFG-------------HTNFKDPDNFTFKGLEA---SGVKTCDLSKSKIF 288
Query: 384 GTISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNHL 430
+ + FS T L QL L+ NE+ I L L L++S N L
Sbjct: 289 -ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL 335
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 36/190 (18%), Positives = 58/190 (30%), Gaps = 60/190 (31%)
Query: 112 SSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGA 171
S ++ + ++ F T L+ ++L N
Sbjct: 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQN------------------------- 309
Query: 172 NITGTIPD--FLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGS 229
I I D F G + L+ L+L+ NFL F
Sbjct: 310 EIN-KIDDNAFWG---LTHLLKLNLSQNFLGSIDSRMF---------------------- 343
Query: 230 VAVIQNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLA 287
+N+ L L L N L D GL +L++ ++ NQL + L SL
Sbjct: 344 ----ENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQ 398
Query: 288 VVNLTNNLFQ 297
+ L N +
Sbjct: 399 KIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 24/117 (20%), Positives = 49/117 (41%), Gaps = 12/117 (10%)
Query: 86 NSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143
+ + L L + +N++ +I GL+ L ++ N S+ S F+ L L+ + L
Sbjct: 296 SHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354
Query: 144 DYNSFDSWVIPESLKDA-TGLQRFSANGANITGTIPD--FLGGDTIPGLMHLHLAFN 197
YN + + + L+ + + + ++PD F D + L + L N
Sbjct: 355 SYNHIRA--LGDQSFLGLPNLKELALDTNQLK-SVPDGIF---DRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 25/66 (37%), Positives = 34/66 (51%), Gaps = 3/66 (4%)
Query: 86 NSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143
+L L VL++ N + + S GL +L+E+ D N SVP F LTSLQ I L
Sbjct: 344 ENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWL 402
Query: 144 DYNSFD 149
N +D
Sbjct: 403 HTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 18/86 (20%), Positives = 29/86 (33%), Gaps = 12/86 (13%)
Query: 356 PCNSDWKGVSCDAGGNITVV-----NLKNLGLSGT-ISS----NFSRLTSLRQLMLSGNE 405
C+ C + V ++ + LS I+ +FSRL L+ L +
Sbjct: 7 ECSVIGYNAICI-NRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQT 65
Query: 406 LTGTIPKEL-TTLPSLEMLDVSNNHL 430
I L SL +L + N
Sbjct: 66 PGLVIRNNTFRGLSSLIILKLDYNQF 91
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 7e-20
Identities = 51/246 (20%), Positives = 83/246 (33%), Gaps = 45/246 (18%)
Query: 63 PSN---RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEV 117
P RI + G I + +LT+L + N L +I + +GL+ L+++
Sbjct: 27 PVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQL 85
Query: 118 LFDDNN-FTSVPSDFFKGLTSLQTISLDYNSFDSWVIPE-SLKDATGLQRFSANGANITG 175
DN SV F GL L T+ LD + + LQ +
Sbjct: 86 DLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE--LGPGLFRGLAALQYLYLQDNALQ- 142
Query: 176 TIPD--FLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVI 233
+PD F + L HL L N + +F
Sbjct: 143 ALPDDTFRD---LGNLTHLFLHGNRISSVPERAF-------------------------- 173
Query: 234 QNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNL 291
+ + SL +L LH N + L L + N L+ + +L L +L + L
Sbjct: 174 RGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRL 232
Query: 292 TNNLFQ 297
+N +
Sbjct: 233 NDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 17/61 (27%), Positives = 26/61 (42%), Gaps = 7/61 (11%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNH 429
NL +L L G ++ F L SL +L+L N + + L L L + N+
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANN 212
Query: 430 L 430
L
Sbjct: 213 L 213
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 15/61 (24%), Positives = 23/61 (37%), Gaps = 7/61 (11%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNH 429
L L L + F L +L+ L L N L +P + L +L L + N
Sbjct: 106 RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNR 164
Query: 430 L 430
+
Sbjct: 165 I 165
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 15/61 (24%), Positives = 25/61 (40%), Gaps = 5/61 (8%)
Query: 375 VNLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNH 429
L+ L L + + F L +L L L GN ++ + L SL+ L + N
Sbjct: 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNR 188
Query: 430 L 430
+
Sbjct: 189 V 189
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 15/62 (24%), Positives = 23/62 (37%), Gaps = 8/62 (12%)
Query: 376 NLKNLGLSG-----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNN 428
L+ L LS ++ F L L L L L + L +L+ L + +N
Sbjct: 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDN 139
Query: 429 HL 430
L
Sbjct: 140 AL 141
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 22/92 (23%), Positives = 32/92 (34%), Gaps = 13/92 (14%)
Query: 357 CNSDWKG-VSCDAGGNITVV------NLKNLGLSG----TISSN-FSRLTSLRQLMLSGN 404
C ++ K SC + V + + L G + + F +L L L N
Sbjct: 8 CYNEPKVTTSCP-QQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSN 66
Query: 405 ELTGTIPKELTTLPSLEMLDVSNNHLFGKVPN 436
L T L LE LD+S+N V
Sbjct: 67 VLARIDAAAFTGLALLEQLDLSDNAQLRSVDP 98
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 93.5 bits (232), Expect = 7e-20
Identities = 62/255 (24%), Positives = 102/255 (40%), Gaps = 22/255 (8%)
Query: 518 RKRSGRVQSPNAVVIHPSNGGDGNAVKITVTESSVTGGGSESQSLTSSGPSDLHVVEAGS 577
K + + V P G +GN E + G G+++ ++
Sbjct: 276 FKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNR 335
Query: 578 MVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAEF- 635
+ + +F+ VLG+G FG V E ++ AVK ++ VV + E
Sbjct: 336 DRMKLT-------DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT 388
Query: 636 KSEIAVLTKV-RHRHLVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWT 693
E VL + L L C +RL V EY+ G L H+ ++ G
Sbjct: 389 MVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI---QQVGRFKEPHA 444
Query: 694 RRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS 753
A ++A G+ +L + I+RDLK N++L + K+ADFG+ + +G +
Sbjct: 445 V--FYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT 499
Query: 754 IETRLAGTFGYLAPE 768
GT Y+APE
Sbjct: 500 --KTFCGTPDYIAPE 512
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 7e-20
Identities = 56/183 (30%), Positives = 89/183 (48%), Gaps = 26/183 (14%)
Query: 597 VLGRGGFGTVY---KGELHDGTKI-AVKRMESAVVSEKG--FAEFKSEIAVLTKVRHRHL 650
VLG+GG+G V+ K + KI A+K ++ A++ A K+E +L +V+H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 651 VGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTR----RLTIALDVARG 705
V L+ Y +L L+ EY+ G L L + EG+ + +++AL
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACFYLAEISMAL----- 134
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYL 765
+LH I+RDLKP NI+L K+ DFGL + + +G + GT Y+
Sbjct: 135 -GHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT--HTFCGTIEYM 188
Query: 766 APE 768
APE
Sbjct: 189 APE 191
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 8e-20
Identities = 39/151 (25%), Positives = 58/151 (38%), Gaps = 15/151 (9%)
Query: 628 SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGL 687
S +I + ++ VG L + + + L + R L
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC--SL 158
Query: 688 KPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR--- 744
+ E L I + +A VE+LH + +HRDLKPSNI D KV DFGLV
Sbjct: 159 EDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 215
Query: 745 -------LAPDNGKHSIETRLAGTFGYLAPE 768
+ ++ T GT Y++PE
Sbjct: 216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 18/63 (28%), Positives = 29/63 (46%), Gaps = 2/63 (3%)
Query: 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR 648
+F +GRGGFG V++ + D A+KR+ E + E+ L K+ H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKLEHP 64
Query: 649 HLV 651
+V
Sbjct: 65 GIV 67
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 8e-20
Identities = 54/179 (30%), Positives = 75/179 (41%), Gaps = 22/179 (12%)
Query: 597 VLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAEF-KSEIAVLTKVRHRHLVGLL 654
+LG+G FG V + A+K + V+ K +E VL RH L L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 655 GYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA 713
Y ++RL V EY G L HL E + E R ++ +EYLH
Sbjct: 72 -YAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFY--GAEIVSALEYLHSR- 124
Query: 714 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF-G---YLAPE 768
++RD+K N++L D K+ DFGL + +G TF G YLAPE
Sbjct: 125 --DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA------TMKTFCGTPEYLAPE 175
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 47/216 (21%), Positives = 81/216 (37%), Gaps = 32/216 (14%)
Query: 567 PSDLHVVEAGSMVISIQVLRNVTNNFSE-----ENVLGRGGFGTVYKG-ELHDGTKIAVK 620
H +G V+ Q ++ + VLG G G V + G K A+K
Sbjct: 2 AHHHHHHSSGLEVL-FQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK 60
Query: 621 RMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNER----LLVYEYMPQGTL 675
++ + + + E+ + H+V +L + + L++ E M G L
Sbjct: 61 -----LLYDS--PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL 113
Query: 676 SRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDD 732
+ R ++ E I D+ +++LH + HRD+KP N+L D
Sbjct: 114 FSRIQERGDQAFTEREAAE---IMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKD 167
Query: 733 MRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
K+ DFG + N + T Y+APE
Sbjct: 168 AVLKLTDFGFAKETTQNALQTP----CYTPYYVAPE 199
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 2e-19
Identities = 48/247 (19%), Positives = 89/247 (36%), Gaps = 26/247 (10%)
Query: 65 NRVTRIQIGGQNIEGTLPKE-LNSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDD 121
N + + LP L+S + +L + ++ +I + + ++Q++
Sbjct: 51 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGF 108
Query: 122 NNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFL 181
N +P F+ + L + L+ N S + + L S + N+ I D
Sbjct: 109 NAIRYLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLE-RIEDDT 166
Query: 182 GGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQ------- 234
T L +L L+ N L + LS S+ ++ S L +AV +
Sbjct: 167 FQAT-TSLQNLQLSSNRLTH-VDLS-LIPSLFHANVSYNLL-STLAIPIAVEELDASHNS 222
Query: 235 -------NMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLA 287
LT L L N+ T L L + + N+L I+ V + L
Sbjct: 223 INVVRGPVNVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLE 281
Query: 288 VVNLTNN 294
+ ++NN
Sbjct: 282 RLYISNN 288
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 85.4 bits (211), Expect = 2e-17
Identities = 43/235 (18%), Positives = 86/235 (36%), Gaps = 36/235 (15%)
Query: 80 TLPKEL-NSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLT 136
+LP+ + ++ LT L + N L +I +SLQ + N T V L
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLF 195
Query: 137 ----------------SLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDF 180
+++ + +NS + + + L N+T
Sbjct: 196 HANVSYNLLSTLAIPIAVEELDASHNSINV--VRGPV--NVELTILKLQHNNLT-DTAWL 250
Query: 181 LGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSL 239
L PGL+ + L++N L+ + F K ++ L+++ ++L Q + +L
Sbjct: 251 LN---YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN----NRLVALNLYGQPIPTL 303
Query: 240 TQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
L L N + L++ + N + + S+ L +L L++N
Sbjct: 304 KVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNL---TLSHN 355
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 1e-13
Identities = 40/238 (16%), Positives = 83/238 (34%), Gaps = 45/238 (18%)
Query: 72 IGGQ---NIEGTLPK----ELNSLSSLTVLEVMKNKLTGQIPSLS---GLSSLQEVLFDD 121
+GGQ N++ P+ + N +V + T + L++ + V F +
Sbjct: 1 VGGQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKN 60
Query: 122 NNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFL 181
+ +P+ ++ ++L+ + + + A +Q+ I +P +
Sbjct: 61 STMRKLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIR-YLPPHV 118
Query: 182 GGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQ 241
+ P L L L N + +L + N LT
Sbjct: 119 FQNV-PLLTVLVLERN-------------DLSSL-------------PRGIFHNTPKLTT 151
Query: 242 LWLHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
L + N+ + D +SLQ+ + N+LT + S + +L N++ NL
Sbjct: 152 LSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHA---NVSYNLLS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 13/59 (22%), Positives = 25/59 (42%), Gaps = 5/59 (8%)
Query: 376 NLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L+ L +S ++ + +L+ L LS N L + + LE L + +N +
Sbjct: 279 RLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI 336
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 18/60 (30%), Positives = 31/60 (51%), Gaps = 6/60 (10%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L + LS I + F ++ L +L +S N L + +P+L++LD+S+NHL
Sbjct: 255 GLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL 313
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 14/70 (20%), Positives = 27/70 (38%), Gaps = 3/70 (4%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
L + +L VL++ N L + L+ + D N+ ++ L +L
Sbjct: 292 ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLT 351
Query: 140 TISLDYNSFD 149
L +N +D
Sbjct: 352 ---LSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 19/60 (31%), Positives = 25/60 (41%), Gaps = 5/60 (8%)
Query: 375 VNLKNLGLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNHL 430
V L L L T ++ L ++ LS NEL I + LE L +SNN L
Sbjct: 232 VELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRL 290
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 9/66 (13%), Positives = 23/66 (34%), Gaps = 7/66 (10%)
Query: 371 NITVVNLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLD 424
+IT+ N K + + + + L L+ ++ I +++ L
Sbjct: 47 DITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLY 105
Query: 425 VSNNHL 430
+ N +
Sbjct: 106 MGFNAI 111
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 17/59 (28%), Positives = 26/59 (44%), Gaps = 7/59 (11%)
Query: 376 NLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
LK L LS + N + L L L N + T+ L+T +L+ L +S+N
Sbjct: 302 TLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDW 357
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 15/61 (24%), Positives = 30/61 (49%), Gaps = 7/61 (11%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKEL-TTLPSLEMLDVSNNH 429
++ L + + + F + L L+L N+L+ ++P+ + P L L +SNN+
Sbjct: 100 TIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNN 158
Query: 430 L 430
L
Sbjct: 159 L 159
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 12/61 (19%), Positives = 27/61 (44%), Gaps = 7/61 (11%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNH 429
++ L L+ I + F+ ++++L + N + +P +P L +L + N
Sbjct: 76 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND 134
Query: 430 L 430
L
Sbjct: 135 L 135
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 8e-05
Identities = 16/61 (26%), Positives = 23/61 (37%), Gaps = 7/61 (11%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNH 429
L L L ++ F L L +S N L I + SL+ L +S+N
Sbjct: 124 LLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNR 182
Query: 430 L 430
L
Sbjct: 183 L 183
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 6/57 (10%), Positives = 22/57 (38%), Gaps = 2/57 (3%)
Query: 375 VNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNHL 430
V++ L + + + + + +P L + +E+L++++ +
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQI 87
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 10/55 (18%), Positives = 25/55 (45%), Gaps = 3/55 (5%)
Query: 376 NLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+L + +S + S + ++ +L S N + + + L +L + +N+L
Sbjct: 193 SLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNL 244
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 22/60 (36%), Positives = 29/60 (48%), Gaps = 8/60 (13%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L L +S I + F TSL+ L LS N LT + L+ +PSL +VS N L
Sbjct: 148 KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL 204
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-19
Identities = 56/181 (30%), Positives = 78/181 (43%), Gaps = 29/181 (16%)
Query: 598 LGRGGFGTVYKGE-LHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLG 655
LG G FG V G+ G K+AVK + + S + + EI L RH H++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR--------GVE 707
++ +V EY+ G L ++ RL +R GV+
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNG-----------RLDE--KESRRLFQQILSGVD 130
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
Y H +HRDLKP N+LL M AK+ADFGL + D + T G+ Y AP
Sbjct: 131 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF--LRTS-CGSPNYAAP 184
Query: 768 E 768
E
Sbjct: 185 E 185
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 45/193 (23%), Positives = 80/193 (41%), Gaps = 27/193 (13%)
Query: 564 SSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVK-- 620
G + GSM +S + + LG G +G VYK + +A+K
Sbjct: 8 HMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI 67
Query: 621 RMESAVVSEKGFAEFKS----EIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLS 676
R+E E+G E+++L +++HR+++ L + L++EY L
Sbjct: 68 RLEHE---EEGVP---GTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLK 120
Query: 677 RHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL-----GD 731
+++ + + + + GV + H + +HRDLKP N+LL +
Sbjct: 121 KYM-----DKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASE 172
Query: 732 DMRAKVADFGLVR 744
K+ DFGL R
Sbjct: 173 TPVLKIGDFGLAR 185
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 55/268 (20%), Positives = 99/268 (36%), Gaps = 37/268 (13%)
Query: 54 CKWKHIQCS-------PSN---RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTG 103
C I+C+ P+ TR+++ ++ + L+ LT L + N L+
Sbjct: 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 104 Q---IPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDA 160
+ S G +SL+ + N ++ S+ F GL L+ + +++
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125
Query: 161 TGLQRFSANGANITGTIPD--FLGGDTIPGLMHLHLAFN-FLQGPIPLSFGK-SSIQTLW 216
L + + + F G + L L +A N F + +P F + ++ L
Sbjct: 126 RNLIYLDISHTHTR-VAFNGIFNG---LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 181
Query: 217 LNGQKGDSKLNG----SVAVIQNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQDFSVRDN 270
L+ S +++SL L + N+F L L+SLQ N
Sbjct: 182 LSQ-------CQLEQLSPTAFNSLSSLQVLNMSHNNFFS-LDTFPYKCLNSLQVLDYSLN 233
Query: 271 QLTGIVPSSLVNL-HSLAVVNLTNNLFQ 297
+ L + SLA +NLT N F
Sbjct: 234 HIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 21/73 (28%), Positives = 32/73 (43%), Gaps = 7/73 (9%)
Query: 364 VSCDAGGNITVVNLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKE--LTTL 417
C + + +LK L LS T+SSNF L L L + L + + +L
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSL 125
Query: 418 PSLEMLDVSNNHL 430
+L LD+S+ H
Sbjct: 126 RNLIYLDISHTHT 138
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 7e-06
Identities = 21/61 (34%), Positives = 31/61 (50%), Gaps = 7/61 (11%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNH 429
NL L LS +S F+ L+SL+ L +S N ++ L SL++LD S NH
Sbjct: 176 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNH 234
Query: 430 L 430
+
Sbjct: 235 I 235
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 9e-06
Identities = 18/61 (29%), Positives = 27/61 (44%), Gaps = 6/61 (9%)
Query: 376 NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNH 429
NL L +S + F+ L+SL L ++GN + T L +L LD+S
Sbjct: 127 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 186
Query: 430 L 430
L
Sbjct: 187 L 187
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 8e-05
Identities = 16/62 (25%), Positives = 32/62 (51%), Gaps = 8/62 (12%)
Query: 376 NLKNLGLSG-----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNN 428
+L+ L ++G + F+ L +L L LS +L + +L SL++L++S+N
Sbjct: 151 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHN 209
Query: 429 HL 430
+
Sbjct: 210 NF 211
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 22/88 (25%), Positives = 36/88 (40%), Gaps = 14/88 (15%)
Query: 356 PCNSDWKGVSCDAGGNITVV------NLKNLGLSG----TISSN-FSRLTSLRQLMLSGN 404
C+ + C+ +T V + L L ++ F +LT L +L LS N
Sbjct: 4 RCSCSGTEIRCN-SKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSN 62
Query: 405 ELT--GTIPKELTTLPSLEMLDVSNNHL 430
L+ G + SL+ LD+S N +
Sbjct: 63 GLSFKGCCSQSDFGTTSLKYLDLSFNGV 90
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 14/62 (22%), Positives = 22/62 (35%), Gaps = 8/62 (12%)
Query: 376 NLKNLGLSG----TISSN--FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNN 428
L++L +S F L +L L +S L SLE+L ++ N
Sbjct: 102 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGN 160
Query: 429 HL 430
Sbjct: 161 SF 162
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 90.8 bits (225), Expect = 4e-19
Identities = 39/221 (17%), Positives = 74/221 (33%), Gaps = 29/221 (13%)
Query: 75 QNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKG 134
+ + +N+ + ++ E+ + N +S+P +
Sbjct: 23 SGTYADYFSAWDKWEKQALPGENRNEAVSLLKE-CLINQFSELQLNRLNLSSLPDNLPPQ 81
Query: 135 LTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHL 194
+T L + N+ S +PE L+ A ++ T+P + L HL +
Sbjct: 82 ITVL---EITQNALIS--LPELP---ASLEYLDACDNRLS-TLP-----ELPASLKHLDV 127
Query: 195 AFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP 254
N L +P ++ + + N + + TSL L + N T LP
Sbjct: 128 DNNQLTM-LPELPA--LLEYINADN-------NQLTMLPELPTSLEVLSVRNNQLTF-LP 176
Query: 255 DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNL 295
+L SL+ V N L + P+ V H +
Sbjct: 177 EL--PESLEALDVSTNLLESL-PAVPVRNHHSEETEIFFRC 214
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 81.6 bits (201), Expect = 3e-16
Identities = 43/233 (18%), Positives = 79/233 (33%), Gaps = 46/233 (19%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
+LP+ +SL L+ N+L+ +P L +SL+ + D+N T +P L+
Sbjct: 94 SLPELP---ASLEYLDACDNRLS-TLPEL--PASLKHLDVDNNQLTMLPEL----PALLE 143
Query: 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFL 199
I+ D N +PE T L+ S +T +P+ L L ++ N L
Sbjct: 144 YINADNNQLTM--LPELP---TSLEVLSVRNNQLT-FLPELPES-----LEALDVSTNLL 192
Query: 200 QGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSG 258
+ +P + + + N T +P+ +
Sbjct: 193 ES-LPAVPVR----------------------NHHSEETEIFFRCRENRITH-IPENILS 228
Query: 259 LSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDM 311
L + DN L+ + SL + + F + N+ R
Sbjct: 229 LDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLA 281
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 18/56 (32%), Positives = 26/56 (46%), Gaps = 5/56 (8%)
Query: 376 NLKNLGLSGT-ISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L+ + ++ TSL L + N+LT +P+ SLE LDVS N L
Sbjct: 141 LLEYINADNNQLTMLPELPTSLEVLSVRNNQLT-FLPELPE---SLEALDVSTNLL 192
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 16/60 (26%), Positives = 27/60 (45%), Gaps = 7/60 (11%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+ + L L LS ++ N + L ++ N L ++P+ SLE LD +N L
Sbjct: 60 QFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPA---SLEYLDACDNRL 112
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 11/61 (18%), Positives = 24/61 (39%), Gaps = 9/61 (14%)
Query: 376 NLKNLGLSGTISSNFSR------LTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNH 429
+ L G + + +L L+ L+ ++P L P + +L+++ N
Sbjct: 35 KWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNA 91
Query: 430 L 430
L
Sbjct: 92 L 92
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 18/59 (30%), Positives = 28/59 (47%), Gaps = 11/59 (18%)
Query: 376 NLKNLGLSGTISSNFSRL----TSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+LK+L + + + L L + N+LT +P+ T SLE+L V NN L
Sbjct: 121 SLKHLDVDN---NQLTMLPELPALLEYINADNNQLT-MLPELPT---SLEVLSVRNNQL 172
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 9e-04
Identities = 18/73 (24%), Positives = 27/73 (36%), Gaps = 19/73 (26%)
Query: 376 NLKNLGLSGT-ISSNFSRLTSLRQLMLSGNELTGTIPKE-------------LTTLP--- 418
+ L ++ + S SL L N L+ T+P+ LT LP
Sbjct: 81 QITVLEITQNALISLPELPASLEYLDACDNRLS-TLPELPASLKHLDVDNNQLTMLPELP 139
Query: 419 -SLEMLDVSNNHL 430
LE ++ NN L
Sbjct: 140 ALLEYINADNNQL 152
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 5e-19
Identities = 50/171 (29%), Positives = 80/171 (46%), Gaps = 29/171 (16%)
Query: 590 NNFSEENVLGRGGFGTVYKG--ELHDGTKIAVK--RMESAVVSEKGFAEFKS----EIAV 641
+ +G G +G V+K + G +A+K R+++ E+G E+AV
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT---GEEGMP---LSTIREVAV 64
Query: 642 L---TKVRHRHLVGLL----GYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWT 693
L H ++V L D +L LV+E++ Q L+ +L E G+ E
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT-ETI 122
Query: 694 RRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
+ + L RG+++LH +HRDLKP NIL+ + K+ADFGL R
Sbjct: 123 KDMMFQL--LRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 6e-19
Identities = 61/233 (26%), Positives = 93/233 (39%), Gaps = 33/233 (14%)
Query: 548 TESSVTGGGSESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVY 607
+S GG Q LT + + + I NF VLG G +G V+
Sbjct: 19 AGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGI-------ENFELLKVLGTGAYGKVF 71
Query: 608 ---KGELHDGTKI-AVKRMESAVVSEKG--FAEFKSEIAVLTKVRHRH-LVGLLGYCLDG 660
K HD K+ A+K ++ A + +K ++E VL +R LV L Y
Sbjct: 72 LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQT 130
Query: 661 NERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTR----RLTIALDVARGVEYLHGLAHQ 715
+L L+ +Y+ G L HL + + + +AL E+LH L
Sbjct: 131 ETKLHLILDYINGGELFTHL---SQRERFTEHEVQIYVGEIVLAL------EHLHKL--- 178
Query: 716 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
I+RD+K NILL + + DFGL + + GT Y+AP+
Sbjct: 179 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAPD 230
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-19
Identities = 53/200 (26%), Positives = 84/200 (42%), Gaps = 39/200 (19%)
Query: 590 NNFSEENVLGRGGFGTVYKG-ELHDGTKIAVK--RMESAVVSEK-GFAEFKS----EIAV 641
+ + + +G+G FG V+K G K+A+K ME+ EK GF EI +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN----EKEGF---PITALREIKI 69
Query: 642 LTKVRHRHLVGLLGYCLDGNERL--------LVYEYMPQ---GTLSRHLFNRKEEGLKPL 690
L ++H ++V L+ C LV+++ G LS L +K
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK-- 127
Query: 691 EWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL--APD 748
+ + G+ Y+H +HRD+K +N+L+ D K+ADFGL R
Sbjct: 128 ------RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178
Query: 749 NGKHSIETRLAGTFGYLAPE 768
N + + T T Y PE
Sbjct: 179 NSQPNRYTNRVVTLWYRPPE 198
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 7e-19
Identities = 48/183 (26%), Positives = 69/183 (37%), Gaps = 35/183 (19%)
Query: 598 LGRGGFGTVYKGE-LHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLG 655
+G G FG +AVK +E A + E + EI +RH ++V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN----VQREIINHRSLRHPNIVRFKE 83
Query: 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR--------GVE 707
L ++ EY G L + N R + D AR GV
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICNAG-----------RFSE--DEARFFFQQLLSGVS 130
Query: 708 YLHGLAHQSFIHRDLKPSNILL--GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYL 765
Y H HRDLK N LL R K+ DFG + + + + ++ + GT Y+
Sbjct: 131 YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTV-GTPAYI 184
Query: 766 APE 768
APE
Sbjct: 185 APE 187
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 8e-19
Identities = 42/212 (19%), Positives = 85/212 (40%), Gaps = 23/212 (10%)
Query: 85 LNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144
+L++ + K+ +T + + L + + T++ + L +L + L
Sbjct: 15 DPALANAIKIAAGKSNVTD-TVTQADLDGITTLSAFGTGVTTIE--GVQYLNNLIGLELK 71
Query: 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIP 204
N LK+ T + +G + + + + L L + P
Sbjct: 72 DNQITD---LAPLKNLTKITELELSGNPLK-NVSAI---AGLQSIKTLDLTSTQITDVTP 124
Query: 205 LSFGKSSIQTLWLNGQKGDSKLNG--SVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSL 262
L+ G S++Q L+L+ N +++ + +T+L L + + L L+ LS L
Sbjct: 125 LA-GLSNLQVLYLDL-------NQITNISPLAGLTNLQYLSIGNAQVSD-LTPLANLSKL 175
Query: 263 QDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
DN+++ I S L +L +L V+L NN
Sbjct: 176 TTLKADDNKISDI--SPLASLPNLIEVHLKNN 205
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 50/239 (20%), Positives = 100/239 (41%), Gaps = 21/239 (8%)
Query: 67 VTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTS 126
+I G N+ T+ L +T L +T I + L++L + DN T
Sbjct: 21 AIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQITD 77
Query: 127 VPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTI 186
+ K LT + + L N + ++ ++ IT + +
Sbjct: 78 LAP--LKNLTKITELELSGNPLKN---VSAIAGLQSIKTLDLTSTQIT-DVTPL---AGL 128
Query: 187 PGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHG 246
L L+L N + PL+ G +++Q L + +++++ + + N++ LT L
Sbjct: 129 SNLQVLYLDLNQITNISPLA-GLTNLQYLSIG----NAQVS-DLTPLANLSKLTTLKADD 182
Query: 247 NSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNS 305
N + + L+ L +L + +++NQ++ + S L N +L +V LTN Q +N+
Sbjct: 183 NKISD-ISPLASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQPVFYNN 238
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 17/59 (28%), Positives = 29/59 (49%), Gaps = 5/59 (8%)
Query: 375 VNLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
NL L L I+ + LT + +L LSGN L + + L S++ LD+++ +
Sbjct: 63 NNLIGLELKDNQITDLAPLKNLTKITELELSGNPLK-NV-SAIAGLQSIKTLDLTSTQI 119
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 8e-05
Identities = 16/58 (27%), Positives = 30/58 (51%), Gaps = 5/58 (8%)
Query: 376 NLKNLGLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
++K L L+ T + + L++L+ L L N++T P L L +L+ L + N +
Sbjct: 108 SIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQV 163
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 9e-05
Identities = 16/58 (27%), Positives = 26/58 (44%), Gaps = 5/58 (8%)
Query: 376 NLKNLGLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
NL+ L L T S + LT+L+ L + +++ P L L L L +N +
Sbjct: 130 NLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKI 185
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 18/90 (20%), Positives = 37/90 (41%), Gaps = 8/90 (8%)
Query: 376 NLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFG 432
L L IS S + L +L ++ L N+++ P L +L ++ ++N +
Sbjct: 174 KLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231
Query: 433 KVPNFRQNVIVKTDGNPDIGKDSSSFTPKS 462
+ + N++V N G + P +
Sbjct: 232 QPVFYNNNLVVP---NVVKGPSGAPIAPAT 258
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 15/58 (25%), Positives = 29/58 (50%), Gaps = 5/58 (8%)
Query: 376 NLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
NL+ L + +S + + L+ L L N+++ I L +LP+L + + NN +
Sbjct: 152 NLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQI 207
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 16/58 (27%), Positives = 29/58 (50%), Gaps = 5/58 (8%)
Query: 376 NLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+ L LSG + S + L S++ L L+ ++T P L L +L++L + N +
Sbjct: 86 KITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQI 141
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 52/178 (29%), Positives = 85/178 (47%), Gaps = 19/178 (10%)
Query: 597 VLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAEF-KSEIAVLTKV-RHRHLVGL 653
V+GRG + V L +I A+K ++ +V++ ++ ++E V + H LVGL
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 654 LGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
C RL V EY+ G L H+ + + P E R A +++ + YLH
Sbjct: 76 H-SCFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHAR-FYSA-EISLALNYLHE- 128
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVR--LAPDNGKHSIETRLAGTFGYLAPE 768
+ I+RDLK N+LL + K+ D+G+ + L P + + GT Y+APE
Sbjct: 129 --RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST----FCGTPNYIAPE 180
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 52/181 (28%), Positives = 80/181 (44%), Gaps = 30/181 (16%)
Query: 598 LGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHRHLVGLLG 655
LG G FG V K+A+K + ++ + + EI+ L +RH H++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR--------GVE 707
+ ++V EY G L ++ +K R+T D R +E
Sbjct: 77 VITTPTDIVMVIEYA-GGELFDYIVEKK-----------RMTE--DEGRRFFQQIICAIE 122
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
Y H +HRDLKP N+LL D++ K+ADFGL + D ++T G+ Y AP
Sbjct: 123 YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF--LKT-SCGSPNYAAP 176
Query: 768 E 768
E
Sbjct: 177 E 177
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 3e-18
Identities = 49/215 (22%), Positives = 76/215 (35%), Gaps = 38/215 (17%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
+LP L L++ L L L N TS+P LQ
Sbjct: 95 SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLW------IFGNQLTSLPVL----PPGLQ 144
Query: 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFL 199
+S+ N S +P + L + A +T ++P GL L ++ N L
Sbjct: 145 ELSVSDNQLAS--LPALP---SELCKLWAYNNQLT-SLP-----MLPSGLQELSVSDNQL 193
Query: 200 QGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGL 259
+P + LW N ++ + L +L + GN T LP L
Sbjct: 194 AS-LPTLPS--ELYKLWAYN-------NRLTSLPALPSGLKELIVSGNRLTS-LPVL--P 240
Query: 260 SSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
S L++ V N+LT + P L SL ++ N
Sbjct: 241 SELKELMVSGNRLTSL-PMLPSGLLSL---SVYRN 271
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 1e-16
Identities = 53/235 (22%), Positives = 89/235 (37%), Gaps = 39/235 (16%)
Query: 60 QCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLF 119
C + + +G + TLP L + +T L + N LT +P+L L+ +
Sbjct: 36 ACLNNG-NAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPAL--PPELRTLEV 88
Query: 120 DDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD 179
N TS+P GL L S +P +GL + G +T ++P
Sbjct: 89 SGNQLTSLP-VLPPGLLELSIFSNPLTH-----LPALP---SGLCKLWIFGNQLT-SLP- 137
Query: 180 FLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSL 239
PGL L ++ N L +P + LW +++L ++ + L
Sbjct: 138 ----VLPPGLQELSVSDNQLAS-LPALPS--ELCKLWAY----NNQLT---SLPMLPSGL 183
Query: 240 TQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+L + N LP L S L +N+LT + P+ L L ++ N
Sbjct: 184 QELSVSDNQLAS-LPTL--PSELYKLWAYNNRLTSL-PALPSGLKEL---IVSGN 231
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 3e-13
Identities = 36/187 (19%), Positives = 65/187 (34%), Gaps = 31/187 (16%)
Query: 111 LSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANG 170
+ + ++ T++P +T+L + N+ S +P L+ +G
Sbjct: 39 NNGNAVLNVGESGLTTLPDCLPAHITTL---VIPDNNLTS--LPALP---PELRTLEVSG 90
Query: 171 ANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSV 230
+T ++P G L L +P S + LW+ G N
Sbjct: 91 NQLT-SLPVLPPGLL--ELSIFSNPLTHLP-ALP-----SGLCKLWIFG-------NQLT 134
Query: 231 AVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVN 290
++ L +L + N LP L S L +NQLT + P L L +
Sbjct: 135 SLPVLPPGLQELSVSDNQLAS-LPAL--PSELCKLWAYNNQLTSL-PMLPSGLQEL---S 187
Query: 291 LTNNLFQ 297
+++N
Sbjct: 188 VSDNQLA 194
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 5e-13
Identities = 51/243 (20%), Positives = 93/243 (38%), Gaps = 33/243 (13%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
+LP + L L N+LT +P L S LQE+ DN S+P+ + L
Sbjct: 155 SLPALPSELCKLWAYN---NQLT-SLPML--PSGLQELSVSDNQLASLPTL----PSELY 204
Query: 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFL 199
+ N S +P +GL+ +G +T ++P L L ++ N L
Sbjct: 205 KLWAYNNRLTS--LPALP---SGLKELIVSGNRLT-SLPVLPSE-----LKELMVSGNRL 253
Query: 200 QGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTG-PLPDLSG 258
+P+ + +L + ++L + +++S T + L GN + L L
Sbjct: 254 TS-LPMLPS--GLLSLSVY----RNQLTRLPESLIHLSSETTVNLEGNPLSERTLQALRE 306
Query: 259 LSSLQDFS---VRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGS 315
++S +S +R + P LH A L +G+ + F +
Sbjct: 307 ITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAR-EGEPAPADRWHMFGQEDNA 365
Query: 316 NSF 318
++F
Sbjct: 366 DAF 368
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 17/56 (30%), Positives = 28/56 (50%), Gaps = 2/56 (3%)
Query: 376 NLKNLGLSGT-ISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
LK L +SG ++S + L L + N+LT +P+ L L S +++ N L
Sbjct: 242 ELKELMVSGNRLTSLPMLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPL 296
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 15/62 (24%), Positives = 29/62 (46%), Gaps = 5/62 (8%)
Query: 369 GGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNN 428
+IT + + + L+ ++ + L +L +SGN+LT ++P L L +
Sbjct: 60 PAHITTLVIPDNNLT-SLPALPPELRTLE---VSGNQLT-SLPVLPPGLLELSIFSNPLT 114
Query: 429 HL 430
HL
Sbjct: 115 HL 116
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 17/73 (23%), Positives = 24/73 (32%), Gaps = 19/73 (26%)
Query: 376 NLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKELTTL-------------- 417
L+ L +SG ++ L L L +P L L
Sbjct: 82 ELRTLEVSGNQLTSLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIFGNQLTSLPVLP 140
Query: 418 PSLEMLDVSNNHL 430
P L+ L VS+N L
Sbjct: 141 PGLQELSVSDNQL 153
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 16/56 (28%), Positives = 29/56 (51%), Gaps = 5/56 (8%)
Query: 376 NLKNLGLSGT-ISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L+ L +S ++S + + L +L N+LT ++P + L+ L VS+N L
Sbjct: 142 GLQELSVSDNQLASLPALPSELCKLWAYNNQLT-SLPMLPS---GLQELSVSDNQL 193
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 9e-04
Identities = 20/56 (35%), Positives = 30/56 (53%), Gaps = 5/56 (8%)
Query: 376 NLKNLGLSGT-ISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
LK L +SG ++S + L++LM+SGN LT ++P + L L V N L
Sbjct: 222 GLKELIVSGNRLTSLPVLPSELKELMVSGNRLT-SLPMLPS---GLLSLSVYRNQL 273
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-18
Identities = 51/180 (28%), Positives = 83/180 (46%), Gaps = 23/180 (12%)
Query: 597 VLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAEF-KSEIAVLTKV-RHRHLVGL 653
V+GRG + V L +I A++ ++ +V++ ++ ++E V + H LVGL
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 654 LGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
C RL V EY+ G L H+ + + P E R A +++ + YLH
Sbjct: 119 H-SCFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHAR-FYSA-EISLALNYLHE- 171
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF-G---YLAPE 768
+ I+RDLK N+LL + K+ D+G+ + G TF G Y+APE
Sbjct: 172 --RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD------TTSTFCGTPNYIAPE 223
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-18
Identities = 59/181 (32%), Positives = 81/181 (44%), Gaps = 25/181 (13%)
Query: 597 VLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAEF-KSEIAVLTK-VRHRHLVGL 653
V+G+G FG V AVK ++ + +K + SE VL K V+H LVGL
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 654 LGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTR----RLTIALDVARGVEY 708
+ ++L V +Y+ G L HL + E R + AL Y
Sbjct: 105 H-FSFQTADKLYFVLDYINGGELFYHL---QRERCFLEPRARFYAAEIASAL------GY 154
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR-LAGTFGYLAP 767
LH L + ++RDLKP NILL + DFG L +N +H+ T GT YLAP
Sbjct: 155 LHSL---NIVYRDLKPENILLDSQGHIVLTDFG---LCKENIEHNSTTSTFCGTPEYLAP 208
Query: 768 E 768
E
Sbjct: 209 E 209
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 4e-18
Identities = 51/180 (28%), Positives = 80/180 (44%), Gaps = 23/180 (12%)
Query: 597 VLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAEF-KSEIAVLTKV-RHRHLVGL 653
VLG+G FG V + + + AVK ++ V+ + E +E +L+ H L L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 654 LGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
C +RL V E++ G L H+ ++ R A ++ + +LH
Sbjct: 90 F-CCFQTPDRLFFVMEFVNGGDLMFHI---QKSRRFDEARAR--FYAAEIISALMFLHD- 142
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF-G---YLAPE 768
+ I+RDLK N+LL + K+ADFG+ + NG TF G Y+APE
Sbjct: 143 --KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV------TTATFCGTPDYIAPE 194
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 4e-18
Identities = 53/180 (29%), Positives = 79/180 (43%), Gaps = 23/180 (12%)
Query: 597 VLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAEF-KSEIAVLTKV-RHRHLVGL 653
VLG+G FG V E ++ AVK ++ VV + E E VL + L L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 654 LGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
C +RL V EY+ G L H+ ++ G A ++A G+ +L
Sbjct: 87 H-SCFQTMDRLYFVMEYVNGGDLMYHI---QQVGRFKEPHAV--FYAAEIAIGLFFLQS- 139
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF-G---YLAPE 768
+ I+RDLK N++L + K+ADFG+ + +G TF G Y+APE
Sbjct: 140 --KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV------TTKTFCGTPDYIAPE 191
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 43/198 (21%), Positives = 78/198 (39%), Gaps = 29/198 (14%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKS--------- 637
+ + ++ + + G +G V G +G +A+KR+ + V +
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 638 EIAVLTKVRHRHLVGLL-----GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEW 692
EI +L H +++GL ++ LV E M + L++ + +++ +
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRI----VISP 133
Query: 693 TRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752
+ G+ LH A +HRDL P NILL D+ + DF L R +
Sbjct: 134 QHIQYFMYHILLGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANK 190
Query: 753 S--IETRLAGTFGYLAPE 768
+ + R Y APE
Sbjct: 191 THYVTHRW-----YRAPE 203
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 1e-17
Identities = 50/220 (22%), Positives = 73/220 (33%), Gaps = 75/220 (34%)
Query: 595 ENVLGRGGFGTVYKGELHD------GTKIAVKRM-ESAVVSEKGFAEFKSEIAVLTKV-R 646
LGRG FG V + + +AVK + E A SE SE+ +L +
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKILIHIGH 84
Query: 647 HRHLVGLLG--------------YCLDGN------------------------------- 661
H ++V LLG +C GN
Sbjct: 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGA 144
Query: 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRR-----------------LTIALDVAR 704
+ + + T S+ + K L + + VA+
Sbjct: 145 IPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAK 204
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
G+E+L A + IHRDL NILL + K+ DFGL R
Sbjct: 205 GMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 85.5 bits (211), Expect = 2e-17
Identities = 37/210 (17%), Positives = 84/210 (40%), Gaps = 19/210 (9%)
Query: 85 LNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144
++ + + K +T + + L+S+ +++ ++++ SV + L ++ + L+
Sbjct: 17 DDAFAETIKDNLKKKSVT-DAVTQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLN 73
Query: 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIP 204
N + L + L + I + + L L L N +
Sbjct: 74 GNKLTDI---KPLTNLKNLGWLFLDENKIK-DLSSL---KDLKKLKSLSLEHNGISDING 126
Query: 205 LSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQD 264
L +++L+L K + V+ +T L L L N + + L+GL+ LQ+
Sbjct: 127 LV-HLPQLESLYLGNNKITD-----ITVLSRLTKLDTLSLEDNQISD-IVPLAGLTKLQN 179
Query: 265 FSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+ N ++ + +L L +L V+ L +
Sbjct: 180 LYLSKNHISDL--RALAGLKNLDVLELFSQ 207
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 4e-05
Identities = 20/72 (27%), Positives = 35/72 (48%), Gaps = 5/72 (6%)
Query: 375 VNLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLF 431
L L L IS + LT L+ L LS N ++ + + L L +L++L++ +
Sbjct: 153 TKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECL 210
Query: 432 GKVPNFRQNVIV 443
K N + N++V
Sbjct: 211 NKPINHQSNLVV 222
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 8e-05
Identities = 20/58 (34%), Positives = 30/58 (51%), Gaps = 5/58 (8%)
Query: 376 NLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L++L L I+ + SRLT L L L N+++ I L L L+ L +S NH+
Sbjct: 132 QLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHI 187
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 17/59 (28%), Positives = 26/59 (44%), Gaps = 5/59 (8%)
Query: 375 VNLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
LK+L L IS + L L L L N++T L+ L L+ L + +N +
Sbjct: 109 KKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQI 165
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 14/58 (24%), Positives = 26/58 (44%), Gaps = 5/58 (8%)
Query: 376 NLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
N+ L L+G ++ + L +L L L N++ L L L+ L + +N +
Sbjct: 66 NVTKLFLNGNKLTDIKPLTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGI 121
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 7e-04
Identities = 20/59 (33%), Positives = 26/59 (44%), Gaps = 5/59 (8%)
Query: 375 VNLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
NL L L I S+ L L+ L L N ++ I L LP LE L + NN +
Sbjct: 87 KNLGWLFLDENKIKDLSSLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKI 143
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 7e-04
Identities = 16/58 (27%), Positives = 29/58 (50%), Gaps = 5/58 (8%)
Query: 376 NLKNLGLSGT-ISS--NFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
++ + + + I S L ++ +L L+GN+LT P LT L +L L + N +
Sbjct: 44 SIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKI 99
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 2e-17
Identities = 62/377 (16%), Positives = 120/377 (31%), Gaps = 72/377 (19%)
Query: 89 SSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146
T+L + +N ++ ++ + + LS L+ ++ N + FK L+ + L +N
Sbjct: 21 QKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79
Query: 147 SFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQG-PIPL 205
I L HL L+FN PI
Sbjct: 80 KLVK--------------------------ISC----HPTVNLKHLDLSFNAFDALPICK 109
Query: 206 SFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLS----GLS 260
FG S ++ L L+ + SV I ++ L + G ++
Sbjct: 110 EFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTE 166
Query: 261 SLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCL 320
SL + + I+ S+ + +L + N+ L + F S + +N
Sbjct: 167 SLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQ---TNPKLS 223
Query: 321 DDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNL 380
+ + N + I++ V + V S +G ++ +++ +
Sbjct: 224 NLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQV 283
Query: 381 G--------------------LSGTISSN-------FSRLTSLRQLMLSGNELTGTIPKE 413
+ T+S S+++ L S N LT T+ +
Sbjct: 284 VSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFEN 343
Query: 414 LTTLPSLEMLDVSNNHL 430
L LE L + N L
Sbjct: 344 CGHLTELETLILQMNQL 360
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 2e-16
Identities = 35/215 (16%), Positives = 67/215 (31%), Gaps = 33/215 (15%)
Query: 86 NSLSSLTVLEVMKNKLTG-QIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144
S++ + + + S +S + F +N T + LT L+T+ L
Sbjct: 297 EIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQ 356
Query: 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQ-GPI 203
N + L + + L L ++ N +
Sbjct: 357 MNQL------KELSKIAEM--T-----------------TQMKSLQQLDISQNSVSYDEK 391
Query: 204 PLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSL 262
S+ +L ++ + L ++ + L LH N + L +L
Sbjct: 392 KGDCSWTKSLLSLNMSS----NILTDTIF-RCLPPRIKVLDLHSNKIKSIPKQVVKLEAL 446
Query: 263 QDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
Q+ +V NQL + L SL + L N +
Sbjct: 447 QELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 3e-15
Identities = 56/426 (13%), Positives = 126/426 (29%), Gaps = 95/426 (22%)
Query: 54 CKWKHIQCSPSN---RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTG------- 103
+ P + + T + I I ++ SLS L +L + N++
Sbjct: 7 RSKNGLIHVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFK 66
Query: 104 -------------QIPSLS--GLSSLQEVLFDDNNFTSVPSD-FFKGLTSLQTISLDYNS 147
++ +S +L+ + N F ++P F ++ L+ + L
Sbjct: 67 FNQELEYLDLSHNKLVKISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTH 126
Query: 148 FDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSF 207
+ + + G + + + L F
Sbjct: 127 LEK-SSVLPIAHLNISKVLLVLGETYG----EKEDPEGLQDFNTESLHIVFPTNKEFHFI 181
Query: 208 GKSSIQTL--------------WLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPL 253
S++T+ + +L + NSF L
Sbjct: 182 LDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRIL 241
Query: 254 PDLSGLSSLQDFSVRDNQLTGIVPSSLV-----NLHSLAVVNLTNNLFQGQTPKFNSPVR 308
+ +++ FS+ + +L G + +L +L++ + +++F F
Sbjct: 242 QLVW-HTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG-----FPQSYI 295
Query: 309 FDMAKGSNSFCLDDAGVACDGRVNVL-LSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCD 367
+++ +N+ ++ + +
Sbjct: 296 YEIFS----------------NMNIKNFTVSGTRMVHML------------------CPS 321
Query: 368 AGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKE---LTTLPSLEMLD 424
++ N L+ T+ N LT L L+L N+L + K T + SL+ LD
Sbjct: 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLD 380
Query: 425 VSNNHL 430
+S N +
Sbjct: 381 ISQNSV 386
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 55/386 (14%), Positives = 120/386 (31%), Gaps = 50/386 (12%)
Query: 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLS----GLSSLQEVLFDDNN 123
+ + ++E + + L+ VL V+ + SL V +
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKE 177
Query: 124 FTSVPSDFFKGLTSLQTISLDYNSFDSWV-----IPESLKDATGLQRFSANGANITG--- 175
F + K + +L+ ++ D+ I L+ L + N T
Sbjct: 178 FHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSF 237
Query: 176 -TIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQ 234
I + T+ ++ + +S++ L ++ D + +
Sbjct: 238 IRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYE 297
Query: 235 NMTSLTQLWLHGNSFTG-PLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTN 293
+++ + + S +S +N LT V + +L L + L
Sbjct: 298 IFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQM 357
Query: 294 NLFQ------GQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVL 347
N + T + S + D+ NS D+ C + L
Sbjct: 358 NQLKELSKIAEMTTQMKSLQQLDI--SQNSVSYDEKKGDCSWTKS--------------L 401
Query: 348 AESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG----TISSNFSRLTSLRQLMLSG 403
+N ++ + +K L L +I +L +L++L ++
Sbjct: 402 LSLNMSSN-------ILTDTIFRCLPP-RIKVLDLHSNKIKSIPKQVVKLEALQELNVAS 453
Query: 404 NELTGTIPKE-LTTLPSLEMLDVSNN 428
N+L ++P L SL+ + + N
Sbjct: 454 NQLK-SVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 6e-11
Identities = 50/370 (13%), Positives = 99/370 (26%), Gaps = 48/370 (12%)
Query: 86 NSLSSLTVLEVMKNKLT--GQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143
+ +L L++ N +S L+ + + L + + +
Sbjct: 87 HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLV 146
Query: 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPI 203
++ PE L+D N + T+ L ++
Sbjct: 147 LGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKC 206
Query: 204 PLSFGKSS-------IQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-- 254
+ + L LN + + + T++ + G L
Sbjct: 207 SYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFR 266
Query: 255 ----DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLT-NNLFQGQTPKFNSPVRF 309
+ L +L V + ++ + N T + + F
Sbjct: 267 DFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPF 326
Query: 310 ---DMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSC 366
D +N C L N +S
Sbjct: 327 LHLDF--SNNLLTDTVFEN-CGHLTE--------------LETLILQMNQLKE----LSK 365
Query: 367 DAGGNITVVNLKNLGLSGT------ISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSL 420
A + +L+ L +S + S SL L +S N LT TI + L P +
Sbjct: 366 IAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRI 423
Query: 421 EMLDVSNNHL 430
++LD+ +N +
Sbjct: 424 KVLDLHSNKI 433
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 29/175 (16%), Positives = 59/175 (33%), Gaps = 38/175 (21%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIPSLSG----LSSLQEVLFDDNNFTSV-PSDFFKG 134
T+ + L+ L L + N+L ++ ++ + SLQ++ N+ +
Sbjct: 339 TVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSW 397
Query: 135 LTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHL 194
SL ++++ N + F I L L
Sbjct: 398 TKSLLSLNMSSNILTDTI-------------FRCLPPRIK----------------VLDL 428
Query: 195 AFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSF 249
N ++ ++Q L + + S +G +TSL ++WLH N +
Sbjct: 429 HSNKIKSIPKQVVKLEALQELNVASNQLKSVPDGI---FDRLTSLQKIWLHTNPW 480
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 41/186 (22%), Positives = 71/186 (38%), Gaps = 31/186 (16%)
Query: 595 ENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVG 652
VLG G G V + K A+K ++ + + E+ + + + H+V
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVR 119
Query: 653 LLGYCLDGNER----LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRR--LTIALDVARGV 706
++ + L+V E + G L + +R ++ T R I + +
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-----TEREASEIMKSIGEAI 174
Query: 707 EYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGL-VRLAPDNGKHSIETRLAGTF 762
+YLH + HRD+KP N+L + K+ DFG N + T
Sbjct: 175 QYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP----CYTP 227
Query: 763 GYLAPE 768
Y+APE
Sbjct: 228 YYVAPE 233
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 37/210 (17%), Positives = 84/210 (40%), Gaps = 19/210 (9%)
Query: 85 LNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144
++ + + K +T + + L+S+ +++ ++++ SV + L ++ + L+
Sbjct: 20 DDAFAETIKDNLKKKSVT-DAVTQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLN 76
Query: 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIP 204
N + L + L + + D + L L L N +
Sbjct: 77 GNKLTDI---KPLANLKNLGWLFLDENKVK----DLSSLKDLKKLKSLSLEHNGISDING 129
Query: 205 LSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQD 264
L +++L+L K + V+ +T L L L N + + L+GL+ LQ+
Sbjct: 130 LV-HLPQLESLYLGNNKITD-----ITVLSRLTKLDTLSLEDNQISD-IVPLAGLTKLQN 182
Query: 265 FSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+ N ++ + +L L +L V+ L +
Sbjct: 183 LYLSKNHISDL--RALAGLKNLDVLELFSQ 210
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 45/214 (21%), Positives = 79/214 (36%), Gaps = 19/214 (8%)
Query: 83 KELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTIS 142
+ + L ++T L + NKLT I L+ L +L + D+N + K L L+++S
Sbjct: 62 QGIQYLPNVTKLFLNGNKLT-DIKPLANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLS 118
Query: 143 LDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGP 202
L++N L L+ IT I + L L L N +
Sbjct: 119 LEHNGISDI---NGLVHLPQLESLYLGNNKIT-DITVL---SRLTKLDTLSLEDNQISDI 171
Query: 203 IPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTG-PLPDLSGLSS 261
+PL+ G + +Q L+L+ + + + +L L L P+ S L
Sbjct: 172 VPLA-GLTKLQNLYLSKNHISD-----LRALAGLKNLDVLELFSQECLNKPINHQSNLVV 225
Query: 262 LQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNL 295
D L + P + + N+ +L
Sbjct: 226 PNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHL 257
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 20/72 (27%), Positives = 34/72 (47%), Gaps = 5/72 (6%)
Query: 375 VNLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLF 431
L L L IS + LT L+ L LS N ++ + L L +L++L++ +
Sbjct: 156 TKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECL 213
Query: 432 GKVPNFRQNVIV 443
K N + N++V
Sbjct: 214 NKPINHQSNLVV 225
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 20/59 (33%), Positives = 30/59 (50%), Gaps = 5/59 (8%)
Query: 375 VNLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
L++L L I+ + SRLT L L L N+++ I L L L+ L +S NH+
Sbjct: 134 PQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHI 190
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 17/59 (28%), Positives = 26/59 (44%), Gaps = 5/59 (8%)
Query: 375 VNLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
LK+L L IS + L L L L N++T L+ L L+ L + +N +
Sbjct: 112 KKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQI 168
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 14/59 (23%), Positives = 26/59 (44%), Gaps = 5/59 (8%)
Query: 375 VNLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
N+ L L+G ++ + L +L L L N++ L L L+ L + +N +
Sbjct: 68 PNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGI 124
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 51/180 (28%), Positives = 74/180 (41%), Gaps = 23/180 (12%)
Query: 597 VLGRGGFGTVYKGELHDGTKI-AVKRMESAVVSEKGFAE-FKSEIAVLTKV-RHRHLVGL 653
+LG+G FG V+ E + A+K ++ VV E E VL+ H L +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83
Query: 654 LGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL 712
E L V EY+ G L H+ + L A ++ G+++LH
Sbjct: 84 F-CTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRAT--FYAAEIILGLQFLHSK 137
Query: 713 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF-G---YLAPE 768
++RDLK NILL D K+ADFG+ + TF G Y+APE
Sbjct: 138 ---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA------KTNTFCGTPDYIAPE 188
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 5e-17
Identities = 47/228 (20%), Positives = 83/228 (36%), Gaps = 66/228 (28%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKS-EIAVLTK 644
+ +S LG G FG V + ++ G + A+K++ +K+ E+ ++
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-------DPRYKNRELDIMKV 56
Query: 645 VRHRHLVGLLGYCLDGNERL--------------------------------------LV 666
+ H +++ L+ Y + ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 667 YEYMPQGTLSRHL--FNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKP 724
EY+P TL + L F R + P+ L R V ++H L HRD+KP
Sbjct: 117 MEYVPD-TLHKVLKSFIRSGRSI-PMNLISIYIYQL--FRAVGFIHSL---GICHRDIKP 169
Query: 725 SNILL-GDDMRAKVADFGLVRLAPDNGKHSIE---TRLAGTFGYLAPE 768
N+L+ D K+ DFG + + S+ +R Y APE
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKL-IPSEPSVAYICSRF-----YRAPE 211
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 9e-17
Identities = 50/281 (17%), Positives = 88/281 (31%), Gaps = 33/281 (11%)
Query: 45 SLGWTDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMK------ 98
S ++DP P C + V + GG+++E L + +++K
Sbjct: 14 SCNFSDPKPDWSSAFNCLGAADV-ELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKR 72
Query: 99 ---------NKLTGQIPSLSGLSSLQEVLFDDNNFTSV--PSDFFKGLTSLQTISLDYNS 147
+++ + G+S LQE+ ++ T P L ++L S
Sbjct: 73 LTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVS 132
Query: 148 ---FDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIP 204
D+W+ GL+ S A+ + + P L L L+ N G
Sbjct: 133 WATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVR--VFPALSTLDLSDNPELGERG 190
Query: 205 LS-----FGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDL--S 257
L ++Q L L ++ A+ L L L NS
Sbjct: 191 LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250
Query: 258 GLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQG 298
S L ++ L + L L +L+ N
Sbjct: 251 WPSQLNSLNLSFTGLKQVPKGLPAKLSVL---DLSYNRLDR 288
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 52/321 (16%), Positives = 92/321 (28%), Gaps = 75/321 (23%)
Query: 122 NNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITG-TIPDF 180
N + + + G SL+ + ++ + + L+R + A I +
Sbjct: 29 NCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGA 88
Query: 181 LGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLT 240
L I GL L L + G P +++ L
Sbjct: 89 LRVLGISGLQELTLENLEVTGTAPPPLLEAT------------------------GPDLN 124
Query: 241 QLWLHGNSFTGPLPDLSGLS-----SLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNL 295
L L S+ L+ L L+ S+ + +L+ ++L++N
Sbjct: 125 ILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNP 184
Query: 296 FQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNN 355
G+ ++ C + L + N
Sbjct: 185 ELGERGLISA--------------------LCPLKFPTLQVLALR-------------NA 211
Query: 356 PCNSDWKGVSCDAGGNITVVNLKNLGLSG------TISSNFSRLTSLRQLMLSGNELTGT 409
+ S A V L+ L LS + + + L L LS L
Sbjct: 212 GMETPSGVCSALAAAR---VQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-Q 267
Query: 410 IPKELTTLPSLEMLDVSNNHL 430
+PK L L +LD+S N L
Sbjct: 268 VPKGL--PAKLSVLDLSYNRL 286
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 32/211 (15%), Positives = 60/211 (28%), Gaps = 24/211 (11%)
Query: 78 EGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLS-----SLQEVLFDDNNFTSVPSDFF 132
P + L +L + + L+ L L+ + + + +
Sbjct: 110 TAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQV 169
Query: 133 KGLTSLQTISLDYNSFDSW------VIPESLKDATGLQRFSANGANITGTIPDFLGGDTI 186
+ +L T+ L N + P L +A +G
Sbjct: 170 RVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAA--R 227
Query: 187 PGLMHLHLAFNFLQGPIPLSF--GKSSIQTLWLNGQKGDSKLNGSVAVIQNM-TSLTQLW 243
L L L+ N L+ S + +L L+ G V + + L+ L
Sbjct: 228 VQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSF-------TGLKQVPKGLPAKLSVLD 280
Query: 244 LHGNSFTGPLPDLSGLSSLQDFSVRDNQLTG 274
L N P L + + S++ N
Sbjct: 281 LSYNRLDR-NPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 28/203 (13%), Positives = 55/203 (27%), Gaps = 41/203 (20%)
Query: 58 HIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-----SLSGLS 112
+Q + + I + +++ +L+ L++ N G+
Sbjct: 142 ELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFP 201
Query: 113 SLQEVLFDDNNFTSVP---SDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSAN 169
+LQ + + + S LQ + L +NS S + L + +
Sbjct: 202 TLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLS 261
Query: 170 GANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGS 229
+ +P L L L L++N L
Sbjct: 262 FTGLK-QVPKGLP----AKLSVLDLSYNRLD----------------------------R 288
Query: 230 VAVIQNMTSLTQLWLHGNSFTGP 252
+ + L L GN F
Sbjct: 289 NPSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 12/69 (17%), Positives = 30/69 (43%), Gaps = 4/69 (5%)
Query: 371 NITVVNLKNLGLSGTISSNFS----RLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVS 426
++ ++NL+N+ + + L+ L ++ +++ P+L LD+S
Sbjct: 122 DLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLS 181
Query: 427 NNHLFGKVP 435
+N G+
Sbjct: 182 DNPELGERG 190
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 3e-16
Identities = 51/259 (19%), Positives = 89/259 (34%), Gaps = 37/259 (14%)
Query: 538 GDGNAVKITVTESSVTGGGSESQSLTSSGPSDLHVVEAGSMVISIQVLRNVTNNFSEENV 597
G + +S T H + + + + + + ++
Sbjct: 1 GSSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHL 60
Query: 598 LGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKS---------EIAVLTKVRH 647
+G G +G V + + + +A+K++ F+ EIA+L ++ H
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRV---------FEDLIDCKRILREIAILNRLNH 111
Query: 648 RHLVGLL-----GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDV 702
H+V +L +E +V E + R L L T+ ++
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLF--RTPVYLTEL---HIKTLLYNL 165
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR----LAPDNGKHSIETRL 758
GV+Y+H +HRDLKP+N L+ D KV DFGL R N + I R
Sbjct: 166 LVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222
Query: 759 AGTFGYLAPEYAAETSGMT 777
P +T
Sbjct: 223 DDMNLVTFPHTKNLKRQLT 241
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 46/215 (21%), Positives = 82/215 (38%), Gaps = 11/215 (5%)
Query: 89 SSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146
S L++ N L + S LQ + ++ ++ L+ L T+ L N
Sbjct: 28 FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 147 SFDSWVIPESLKDA-TGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQG-PIP 204
S + + LQ+ A N+ ++ +F G + L L++A N +Q +P
Sbjct: 87 PIQS--LALGAFSGLSSLQKLVAVETNLA-SLENFPIGH-LKTLKELNVAHNLIQSFKLP 142
Query: 205 LSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLT-QLWLHGNSFTGPLPDLSGLSSL 262
F ++++ L L+ K S + V+ M L L L N P L
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRL 202
Query: 263 QDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
++ ++ NQL + L SL + L N +
Sbjct: 203 KELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 3e-05
Identities = 22/71 (30%), Positives = 32/71 (45%), Gaps = 8/71 (11%)
Query: 85 LNSLSSLTV----LEVMKNKLTGQIP--SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSL 138
L L + + L++ N + I + + L+E+ D N SVP F LTSL
Sbjct: 169 LRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIR-LKELALDTNQLKSVPDGIFDRLTSL 226
Query: 139 QTISLDYNSFD 149
Q I L N +D
Sbjct: 227 QKIWLHTNPWD 237
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 20/86 (23%), Positives = 29/86 (33%), Gaps = 14/86 (16%)
Query: 357 CNSDWKGVSCDAGGNITVV------NLKNLGLSG----TISSN-FSRLTSLRQLMLSGNE 405
C N + + KNL LS + S F L+ L LS E
Sbjct: 5 EVVPNITYQCM-ELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE 63
Query: 406 LTGTIPKEL-TTLPSLEMLDVSNNHL 430
+ TI +L L L ++ N +
Sbjct: 64 IQ-TIEDGAYQSLSHLSTLILTGNPI 88
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 17/62 (27%), Positives = 28/62 (45%), Gaps = 7/62 (11%)
Query: 375 VNLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKEL-TTLPSLEMLDVSNN 428
L+ L LS TI + L+ L L+L+GN + ++ + L SL+ L
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVET 110
Query: 429 HL 430
+L
Sbjct: 111 NL 112
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 47/209 (22%), Positives = 83/209 (39%), Gaps = 40/209 (19%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKS-------- 637
+V +N+ ++++GRG +G VY + + +A+K++ F+
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM---------FEDLIDCKRIL 73
Query: 638 -EIAVLTKVRHRHLVGLL-----GYCLDGNERLLVYEYMPQGT-LSRHLFNRKEEGLKPL 690
EI +L +++ +++ L L +E +V E + L + L
Sbjct: 74 REITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTPI-----FL 126
Query: 691 EWTRRLTIALDVARGVEYLH--GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748
TI ++ G ++H G+ IHRDLKP+N LL D KV DFGL R +
Sbjct: 127 TEEHIKTILYNLLLGENFIHESGI-----IHRDLKPANCLLNQDCSVKVCDFGLARTI-N 180
Query: 749 NGKHSIETRLAGTFGYLAPEYAAETSGMT 777
+ K + P +T
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLT 209
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 38/163 (23%), Positives = 66/163 (40%), Gaps = 31/163 (19%)
Query: 597 VLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLL 654
VLG G G V + K A+K ++ + + E+ + + + H+V ++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIV 77
Query: 655 GYCLDGNER----LLVYEYMPQGTLSRHLFNR-KEEGLKPLEWTRR--LTIALDVARGVE 707
+ L+V E + G LF+R ++ G + T R I + ++
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGG----ELFSRIQDRGDQAF--TEREASEIMKSIGEAIQ 131
Query: 708 YLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAP 747
YLH + HRD+KP N+L + K+ DFG A
Sbjct: 132 YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFG---FAK 168
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 5e-15
Identities = 48/257 (18%), Positives = 90/257 (35%), Gaps = 35/257 (13%)
Query: 50 DPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPS-- 107
PC +C + ++I+ +P + S L++++ L IPS
Sbjct: 4 SSPPC-----ECHQEEDFR---VTCKDIQ-RIP---SLPPSTQTLKLIETHLR-TIPSHA 50
Query: 108 LSGLSSLQEV-LFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRF 166
S L ++ + + D + S F L+ + I + +++ P++LK+ L+
Sbjct: 51 FSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110
Query: 167 SANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPL-SFGK--SSIQTLWLNGQKGD 223
+ PD + L + N IP+ +F + TL L
Sbjct: 111 GIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYN---- 165
Query: 224 SKLNGSVAVIQ----NMTSLTQLWLHGNSFTGPLPD--LSGL-SSLQDFSVRDNQLTGIV 276
NG +Q N T L ++L+ N + + G+ S V +T +
Sbjct: 166 ---NG-FTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALP 221
Query: 277 PSSLVNLHSLAVVNLTN 293
L +L L N
Sbjct: 222 SKGLEHLKELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 6e-04
Identities = 14/85 (16%), Positives = 31/85 (36%), Gaps = 13/85 (15%)
Query: 356 PCN-SDWKGVSCDAGGNITVV-----NLKNLGLSG----TISSN-FSRLTSLRQLMLSGN 404
PC + +I + + + L L TI S+ FS L ++ ++ +S +
Sbjct: 7 PCECHQEEDFRVT-CKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSID 65
Query: 405 ELTGTIPKEL-TTLPSLEMLDVSNN 428
+ L + +++ N
Sbjct: 66 VTLQQLESHSFYNLSKVTHIEIRNT 90
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 13/62 (20%), Positives = 25/62 (40%), Gaps = 7/62 (11%)
Query: 376 NLKNLGLSG-----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNN 428
N+ + +S + S+ F L+ + + + I + L LP L+ L + N
Sbjct: 56 NISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNT 115
Query: 429 HL 430
L
Sbjct: 116 GL 117
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 6e-15
Identities = 48/200 (24%), Positives = 79/200 (39%), Gaps = 43/200 (21%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKS-------- 637
V + +G G G V + +A+K++ F++
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---------FQNQTHAKRAY 109
Query: 638 -EIAVLTKVRHRHLVGLL------GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPL 690
E+ ++ V H++++ LL + + LV E M L + + L
Sbjct: 110 RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-------QMEL 161
Query: 691 EWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750
+ R + + G+++LH A IHRDLKPSNI++ D K+ DFGL R A +
Sbjct: 162 DHERMSYLLYQMLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218
Query: 751 K--HSIETRLAGTFGYLAPE 768
+ TR Y APE
Sbjct: 219 MMTPYVVTRY-----YRAPE 233
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 7e-15
Identities = 50/198 (25%), Positives = 82/198 (41%), Gaps = 40/198 (20%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKS-------- 637
V + + +G G +G V + G K+A+K++ F+S
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP---------FQSELFAKRAY 72
Query: 638 -EIAVLTKVRHRHLVGLL------GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPL 690
E+ +L +RH +++GLL D + LV +M L + + + + L
Sbjct: 73 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH------EKL 125
Query: 691 EWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750
R + + +G+ Y+H IHRDLKP N+ + +D K+ DFGL R A
Sbjct: 126 GEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM 182
Query: 751 KHSIETRLAGTFGYLAPE 768
+ TR Y APE
Sbjct: 183 TGYVVTRW-----YRAPE 195
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 8e-15
Identities = 45/198 (22%), Positives = 81/198 (40%), Gaps = 41/198 (20%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKS-------- 637
+ + +G G +G+V + G K+A+K++ F+S
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP---------FQSEIFAKRAY 71
Query: 638 -EIAVLTKVRHRHLVGLL------GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPL 690
E+ +L ++H +++GLL + + LV +M Q L + +
Sbjct: 72 RELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM-------GLKF 123
Query: 691 EWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750
+ + + +G++Y+H +HRDLKP N+ + +D K+ DFGL R A
Sbjct: 124 SEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM 180
Query: 751 KHSIETRLAGTFGYLAPE 768
+ TR Y APE
Sbjct: 181 TGYVVTRW-----YRAPE 193
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 48/198 (24%), Positives = 80/198 (40%), Gaps = 39/198 (19%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKS-------- 637
V + +G G G V + +A+K++ F++
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP---------FQNQTHAKRAY 72
Query: 638 -EIAVLTKVRHRHLVGLL------GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPL 690
E+ ++ V H++++GLL + + +V E M L + + L
Sbjct: 73 RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-------QMEL 124
Query: 691 EWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750
+ R + + G+++LH A IHRDLKPSNI++ D K+ DFGL R A +
Sbjct: 125 DHERMSYLLYQMLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181
Query: 751 KHSIETRLAGTFGYLAPE 768
+ T T Y APE
Sbjct: 182 ---MMTPYVVTRYYRAPE 196
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 51/210 (24%), Positives = 88/210 (41%), Gaps = 45/210 (21%)
Query: 583 QVLRNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKS---- 637
+++ N++++F +++LG G +G V G +A+K++E F
Sbjct: 4 RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP----------FDKPLFA 53
Query: 638 -----EIAVLTKVRHRHLVGLL-----GYCLDGNERLLVYEYMPQGT-LSRHLFNRKEEG 686
EI +L +H +++ + + NE ++ E M T L R +
Sbjct: 54 LRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVIST----- 106
Query: 687 LKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746
+ L R V+ LHG ++ IHRDLKPSN+L+ + KV DFGL R+
Sbjct: 107 -QMLSDDHIQYFIYQTLRAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARII 162
Query: 747 PDNGKHSIETRLAGTFG--------YLAPE 768
++ + E + Y APE
Sbjct: 163 DESAADNSEPTGQQSGMVEFVATRWYRAPE 192
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 32/218 (14%), Positives = 76/218 (34%), Gaps = 46/218 (21%)
Query: 583 QVLRNVT-NNFSEENVLGRGGFGTVYKGE---------LHDGTKIAVKRMESAVVSEKGF 632
VL + + + ++ R G +Y+ K ++K +++ + F
Sbjct: 34 TVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAK--DGRLF 90
Query: 633 AEFKS--------EIAVLTKVRHRHLVG---LLGYCLDGNE-RLLVYEYMPQGTLSRHLF 680
E ++ K+ L+ +G+ + ++ R LV + G +
Sbjct: 91 NEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSAL 148
Query: 681 NRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV--A 738
+ + + L +A + +E+LH ++H ++ NI + + +++V A
Sbjct: 149 DVSPKHVLSERSV--LQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLA 203
Query: 739 DFGLVRLAPDNGKHSIETR------LAGTFGYLAPEYA 770
+G +GKH + G E+
Sbjct: 204 GYGFAFRYCPSGKH-VAYVEGSRSPHEGD-----LEFI 235
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 2e-14
Identities = 48/353 (13%), Positives = 103/353 (29%), Gaps = 36/353 (10%)
Query: 82 PKELNSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
+++ LS L VL + N++ + L+ + N ++ + SL+
Sbjct: 69 MPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQNIS---CCPMASLR 124
Query: 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFL 199
+ L +N FD +P +F + L L L+
Sbjct: 125 HLDLSFNDFDV--LPVC---------------------KEF---GNLTKLTFLGLSAAKF 158
Query: 200 QGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGL 259
+ L + + L+ K + ++ T++ L H NS ++S +
Sbjct: 159 RQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMS-V 217
Query: 260 SSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFC 319
++L + + +L L+ S T Q + + +
Sbjct: 218 NALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRP 277
Query: 320 LDDAGV-ACD-GRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNL 377
++ + S L N + + + + L
Sbjct: 278 VEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALY-SVFAEMNIKML 336
Query: 378 KNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+S L + N T ++ + +TL L+ L + N L
Sbjct: 337 SISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL 389
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 6e-14
Identities = 39/240 (16%), Positives = 72/240 (30%), Gaps = 15/240 (6%)
Query: 64 SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSL-SGLSSLQEVLFDDN 122
+ + I + +L SL + V +L S + + + +
Sbjct: 280 YLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSIS 339
Query: 123 NFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLG 182
+ + +S ++ N F + + LQ +
Sbjct: 340 DTPFIHMVCPPSPSSFTFLNFTQNVFTD-SVFQGCSTLKRLQTLILQRNGLK-NFFK--V 395
Query: 183 GDTIPGLMHLHLAFNFLQGPIPLSF-----GKSSIQTLWLNGQKGDSKLNGSVAVIQNMT 237
+ L L ++ SI L L+ + L GSV
Sbjct: 396 ALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLS----SNMLTGSVF-RCLPP 450
Query: 238 SLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
+ L LH N D++ L +LQ+ +V NQL + L SL + L +N +
Sbjct: 451 KVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWD 510
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 8e-14
Identities = 57/374 (15%), Positives = 118/374 (31%), Gaps = 39/374 (10%)
Query: 88 LSSLTVLEVMKNKLT--GQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGL------TSLQ 139
++SL L++ N L+ L + F + L L
Sbjct: 120 MASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLV 179
Query: 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNF- 198
+ + +S IP + L + + + + L ++ L
Sbjct: 180 SYHIKGGETESLQIPNTTV----LHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENC 235
Query: 199 --LQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-- 254
L + ++ + L + K + + + L ++ + T +
Sbjct: 236 QRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDRE 295
Query: 255 ----DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLT-NNLFQGQTPKFNSPVRF 309
+ L SL V++ + + + L+ ++ SP F
Sbjct: 296 EFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSF 355
Query: 310 DMAKGSNSFCLDDAGVACDGRV---------NVLLSIVKSVGYPAVLAESWKGNNPCNSD 360
+ + D C N L + K ++ + NS
Sbjct: 356 TFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSL 415
Query: 361 WKGVS---CDAGGNITVVNLKNLGLSGTISSNFSRLT-SLRQLMLSGNELTGTIPKELTT 416
C +I V+NL + L+G++ F L ++ L L N + +IPK++T
Sbjct: 416 NSHAYDRTCAWAESILVLNLSSNMLTGSV---FRCLPPKVKVLDLHNNRIM-SIPKDVTH 471
Query: 417 LPSLEMLDVSNNHL 430
L +L+ L+V++N L
Sbjct: 472 LQALQELNVASNQL 485
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 3e-10
Identities = 52/375 (13%), Positives = 112/375 (29%), Gaps = 69/375 (18%)
Query: 87 SLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVL-FDDNNFTSVPSDFFKGLTSLQTISLDY 145
S ++++ LT +P L + L N+ + + L+ L+ + L +
Sbjct: 29 SNELESMVDYSNRNLT-HVPK--DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSH 85
Query: 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPL 205
N S + + F F L +L ++ N LQ +
Sbjct: 86 NRIRS--LDFHV--------F------------LFN-----QDLEYLDVSHNRLQN---I 115
Query: 206 SFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFT-GPLPDLSGL---- 259
S +S++ L L+ D N+T LT L L F L ++ L
Sbjct: 116 SCCPMASLRHLDLSFNDFDVL--PVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSC 173
Query: 260 --SSLQDFSVRDNQLTGIVPSSLVNLH------------------SLAVVNLTNNLFQGQ 299
L + ++ + + + LH +L + L+N +
Sbjct: 174 ILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDE 233
Query: 300 TPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNS 359
+ ++ +G L+ + + + + +P + N
Sbjct: 234 NCQRLMTFLSELTRGPTL--LNVTLQHIETTWKCSVKLFQFF-WPRPVEYLNIYNLTITE 290
Query: 360 DWKGVSCDAGGN----ITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELT 415
+ + ++KN + + +S + MLS ++
Sbjct: 291 RIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPP 350
Query: 416 TLPSLEMLDVSNNHL 430
+ S L+ + N
Sbjct: 351 SPSSFTFLNFTQNVF 365
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 47/253 (18%), Positives = 81/253 (32%), Gaps = 37/253 (14%)
Query: 54 CKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPS--LSGL 111
C + C ++VT I P +L + L + KL I SG
Sbjct: 9 CSNRVFLCQ-ESKVTEI-----------PSDL--PRNAIELRFVLTKLR-VIQKGAFSGF 53
Query: 112 SSLQEVLFDDNNFTS-VPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANG 170
L+++ N+ + +D F L L I ++ + ++ PE+ ++ LQ +
Sbjct: 54 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN 113
Query: 171 ANITGTIPDFLGGDTIPGLMHLHLAFNF-LQGPIPLSFGK--SSIQTLWLNGQKGDSKLN 227
I +PD + + L + N + SF LWLN N
Sbjct: 114 TGIK-HLPDVHKIHS-LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNK-------N 164
Query: 228 G----SVAVIQNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLV 281
G + N+ LP+ G S + ++ + L
Sbjct: 165 GIQEIHNSAFNGTQLDELNLSDNNNLEE-LPNDVFHGASGPVILDISRTRIHSLPSYGLE 223
Query: 282 NLHSLAVVNLTNN 294
NL L + N
Sbjct: 224 NLKKLRARSTYNL 236
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 31/212 (14%), Positives = 56/212 (26%), Gaps = 26/212 (12%)
Query: 234 QNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQDFSV-RDNQLTGIVPSSLVNLHSLAVVN 290
L ++ + N + S L L + + + N L I P + NL +L +
Sbjct: 51 SGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 110
Query: 291 LTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKS---VGYPAVL 347
++N LD N+ + ++ VG
Sbjct: 111 ISNT-------GIKHLPDVHKIHSLQKVLLDIQD-------NINIHTIERNSFVGLSFES 156
Query: 348 AESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSN-FSRLTSLRQLMLSGNEL 406
W N + + N L + ++ F + L +S +
Sbjct: 157 VILWLNKNGIQEIHNSA-FNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRI 214
Query: 407 TGTIPKELTTLPSLEMLDVSNNHLFGKVPNFR 438
L L L N K+P
Sbjct: 215 HSLPSYGLENLKKLRARSTYNLK---KLPTLE 243
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 43/333 (12%), Positives = 88/333 (26%), Gaps = 103/333 (30%)
Query: 113 SLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGAN 172
S + L ++ T +PSD + L I +
Sbjct: 10 SNRVFLCQESKVTEIPSDLPRNAIEL---RFVLTKLRV--IQKG---------------- 48
Query: 173 ITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAV 232
F G L + ++ N + I V
Sbjct: 49 ------AFSG---FGDLEKIEISQNDVLEVIEAD-------------------------V 74
Query: 233 IQNMTSLTQLWL-HGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVN 290
N+ L ++ + N+ P+ L +LQ + + + + ++ +++
Sbjct: 75 FSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLD 134
Query: 291 LTNNL---------FQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSV 341
+ +N+ F G + + S L+ N + I S
Sbjct: 135 IQDNINIHTIERNSFVGLSFE------------SVILWLNK---------NGIQEIHNSA 173
Query: 342 -GYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGT----ISSN-FSRLTS 395
+ + NN + + D + L +S T + S L
Sbjct: 174 FNGTQLDELNLSDNNN----LEELPNDVFHGAS--GPVILDISRTRIHSLPSYGLENLKK 227
Query: 396 LRQLMLSGNELTGTIPKELTTLPSLEMLDVSNN 428
LR + +P L L +L ++
Sbjct: 228 LRARSTYNLK---KLP-TLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 15/65 (23%), Positives = 28/65 (43%), Gaps = 7/65 (10%)
Query: 85 LNSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTIS 142
+ S +L++ + ++ +PS L L L+ N +P+ + L +L S
Sbjct: 198 FHGASGPVILDISRTRIH-SLPSYGLENLKKLR--ARSTYNLKKLPT--LEKLVALMEAS 252
Query: 143 LDYNS 147
L Y S
Sbjct: 253 LTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 12/65 (18%), Positives = 19/65 (29%), Gaps = 3/65 (4%)
Query: 85 LNSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTIS 142
N + N L ++P G S + S+PS + L L+ S
Sbjct: 174 FNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARS 232
Query: 143 LDYNS 147
Sbjct: 233 TYNLK 237
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-14
Identities = 47/198 (23%), Positives = 84/198 (42%), Gaps = 36/198 (18%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKS-------- 637
+V ++ + +G G +G V + + ++A+K++ F+
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP----------FEHQTYCQRTL 73
Query: 638 -EIAVLTKVRHRHLVGLL-----GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLE 691
EI +L + RH +++G+ + +V + M + L + L + L
Sbjct: 74 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKT------QHLS 126
Query: 692 WTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK 751
+ RG++Y+H + +HRDLKPSN+LL K+ DFGL R+A +
Sbjct: 127 NDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 752 HSIE-TRLAGTFGYLAPE 768
H+ T T Y APE
Sbjct: 184 HTGFLTEYVATRWYRAPE 201
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 38/210 (18%), Positives = 72/210 (34%), Gaps = 42/210 (20%)
Query: 85 LNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144
L++ + K +T + S LS +Q D++N S+ + T+L+ + L
Sbjct: 15 DPGLANAVKQNLGKQSVT-DLVSQKELSGVQNFNGDNSNIQSL--AGMQFFTNLKELHLS 71
Query: 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIP 204
+N LKD T L+ S N + + G+ L
Sbjct: 72 HNQISDL---SPLKDLTKLEELSVNRNRLK----------NLNGIPSACL---------- 108
Query: 205 LSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQD 264
L+L+ + + ++ +L L + N + L LS L+
Sbjct: 109 --------SRLFLDNNELRD-----TDSLIHLKNLEILSIRNNKLKS-IVMLGFLSKLEV 154
Query: 265 FSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+ N++T L L + ++LT
Sbjct: 155 LDLHGNEITNT--GGLTRLKKVNWIDLTGQ 182
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 38/196 (19%), Positives = 71/196 (36%), Gaps = 42/196 (21%)
Query: 99 NKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLK 158
+ Q+ GL++ + + T + S K L+ +Q + D ++ S ++
Sbjct: 7 TPIN-QVFPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQS---LAGMQ 60
Query: 159 DATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLN 218
T L+ + I+ + L L + ++ L +N
Sbjct: 61 FFTNLKELHLSHNQIS----------DLSPLKDL-----------------TKLEELSVN 93
Query: 219 GQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPS 278
+ LNG L++L+L N L L +L+ S+R+N+L I
Sbjct: 94 RNR-LKNLNGI-----PSACLSRLFLDNNELRD-TDSLIHLKNLEILSIRNNKLKSI--V 144
Query: 279 SLVNLHSLAVVNLTNN 294
L L L V++L N
Sbjct: 145 MLGFLSKLEVLDLHGN 160
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 8e-10
Identities = 38/257 (14%), Positives = 81/257 (31%), Gaps = 29/257 (11%)
Query: 67 VTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTS 126
+ +G Q++ + LS + + + + + ++L+E+ N +
Sbjct: 21 AVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAGMQFFTNLKELHLSHNQISD 77
Query: 127 VPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTI 186
+ K LT L+ +S++ N + S L R + + +
Sbjct: 78 L--SPLKDLTKLEELSVNRNRLKNLNGIPSAC----LSRLFLDNNELR-DTDSL---IHL 127
Query: 187 PGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNG--SVAVIQNMTSLTQLWL 244
L L + N L+ + L S ++ L L+G N + + + + + L
Sbjct: 128 KNLEILSIRNNKLKSIVMLG-FLSKLEVLDLHG-------NEITNTGGLTRLKKVNWIDL 179
Query: 245 HGNSFT-GPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK- 302
G P+ L +V+D I P + N S + L
Sbjct: 180 TGQKCVNEPVKYQPELYITN--TVKDPDGRWISPYYISNGGSYVDGCVLWELPVYTDEVS 237
Query: 303 --FNSPVRFDMAKGSNS 317
F+ + +
Sbjct: 238 YKFSEYINVGETEAIFD 254
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 17/63 (26%), Positives = 26/63 (41%), Gaps = 5/63 (7%)
Query: 371 NITVVNLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSN 427
I L L L + + L +L L + N+L +I L L LE+LD+
Sbjct: 102 GIPSACLSRLFLDNNELRDTDSLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHG 159
Query: 428 NHL 430
N +
Sbjct: 160 NEI 162
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 15/72 (20%), Positives = 29/72 (40%), Gaps = 5/72 (6%)
Query: 375 VNLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLF 431
NL+ L + + L+ L L L GNE+T LT L + +D++
Sbjct: 128 KNLEILSIRNNKLKSIVMLGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWIDLTGQKCV 185
Query: 432 GKVPNFRQNVIV 443
+ ++ + +
Sbjct: 186 NEPVKYQPELYI 197
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 7e-14
Identities = 47/217 (21%), Positives = 81/217 (37%), Gaps = 59/217 (27%)
Query: 82 PKELNSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
K + L+ L +L + NKL +P+ L +L+ + DN ++P F L +L
Sbjct: 54 SKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLA 112
Query: 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFL 199
+ LD N S +P + F D++ L +L L +N L
Sbjct: 113 ELRLDRNQLKS--LPPRV--------F-----------------DSLTKLTYLSLGYNEL 145
Query: 200 QGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD--LS 257
Q S+ V +TSL +L L+ N +P+
Sbjct: 146 Q----------SL----------------PKGVFDKLTSLKELRLYNNQLKR-VPEGAFD 178
Query: 258 GLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
L+ L+ + +NQL + + +L L ++ L N
Sbjct: 179 KLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 43/180 (23%), Positives = 69/180 (38%), Gaps = 19/180 (10%)
Query: 121 DNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDA-TGLQRFSANGANITGTIPD 179
T++PS+ + + L N S +P T L+ N + T+P
Sbjct: 25 SKKLTAIPSNIP---ADTKKLDLQSNKLSS--LPSKAFHRLTKLRLLYLNDNKLQ-TLPA 78
Query: 180 --FLGGDTIPGLMHLHLAFNFLQG-PIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNM 236
F + L L + N LQ PI + ++ L L+ + S V ++
Sbjct: 79 GIF---KELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPR---VFDSL 132
Query: 237 TSLTQLWLHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
T LT L L N LP L+SL++ + +NQL + + L L + L NN
Sbjct: 133 TKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNN 191
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 19/66 (28%), Positives = 32/66 (48%), Gaps = 3/66 (4%)
Query: 86 NSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143
+ L+SL L + N+L ++P L+ L+ + D+N VP F L L+ + L
Sbjct: 154 DKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212
Query: 144 DYNSFD 149
N +D
Sbjct: 213 QENPWD 218
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 23/90 (25%), Positives = 35/90 (38%), Gaps = 6/90 (6%)
Query: 210 SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQDFSV 267
+ + L L K S L +T L L+L+ N LP L +L+ V
Sbjct: 37 ADTKKLDLQSNK-LSSL--PSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWV 92
Query: 268 RDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
DN+L + L +LA + L N +
Sbjct: 93 TDNKLQALPIGVFDQLVNLAELRLDRNQLK 122
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 9e-14
Identities = 43/249 (17%), Positives = 79/249 (31%), Gaps = 62/249 (24%)
Query: 54 CKWKHIQCSPSN---RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSG 110
C +++ P + T + + + L + LT L + + +LT ++
Sbjct: 17 CDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDGT 75
Query: 111 LSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANG 170
L L + N S+P + L +L + + +N S +P
Sbjct: 76 LPVLGTLDLSHNQLQSLPL-LGQTLPALTVLDVSFNRLTS--LPLGA------------- 119
Query: 171 ANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSV 230
+ L L+L N L+ ++
Sbjct: 120 ---------L---RGLGELQELYLKGNELK----------TLPP---------------- 141
Query: 231 AVIQNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAV 288
++ L +L L N+ T LP L+GL +L +++N L I P H L
Sbjct: 142 GLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSLYTI-PKGFFGSHLLPF 199
Query: 289 VNLTNNLFQ 297
L N +
Sbjct: 200 AFLHGNPWL 208
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 46/192 (23%), Positives = 81/192 (42%), Gaps = 18/192 (9%)
Query: 107 SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRF 166
+S ++S EV D N T++P D + L N + +L T L +
Sbjct: 5 EVSKVASHLEVNCDKRNLTALPPDLP---KDTTILHLSENLLYT-FSLATLMPYTRLTQL 60
Query: 167 SANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSK 225
+ + A +T + T+P L L L+ N LQ +PL ++ L ++ ++
Sbjct: 61 NLDRAELT-KLQVD---GTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVS----FNR 111
Query: 226 LNG-SVAVIQNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLVN 282
L + ++ + L +L+L GN LP L+ L+ S+ +N LT + L
Sbjct: 112 LTSLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLANNNLTELPAGLLNG 170
Query: 283 LHSLAVVNLTNN 294
L +L + L N
Sbjct: 171 LENLDTLLLQEN 182
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 39/208 (18%), Positives = 64/208 (30%), Gaps = 57/208 (27%)
Query: 230 VAVIQNMTSLTQLWLHGNSFTGPLPDLSGL-SSLQDFSVRDNQLTGIVPSSLVNLHSLAV 288
+ + + S ++ + T LP L + +N L ++L+ L
Sbjct: 3 ICEVSKVASHLEVNCDKRNLTA-LP--PDLPKDTTILHLSENLLYTFSLATLMPYTRLTQ 59
Query: 289 VNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLA 348
+NL V + L N L S+ P +
Sbjct: 60 LNLDRAELT------KLQV-DGTLPVLGTLDLSH---------NQLQSL------PLLGQ 97
Query: 349 ESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG----TISSN-FSRLTSLRQLMLSG 403
+ L L +S ++ L L++L L G
Sbjct: 98 ----------------------TLP--ALTVLDVSFNRLTSLPLGALRGLGELQELYLKG 133
Query: 404 NELTGTIPKEL-TTLPSLEMLDVSNNHL 430
NEL T+P L T P LE L ++NN+L
Sbjct: 134 NELK-TLPPGLLTPTPKLEKLSLANNNL 160
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 18/62 (29%), Positives = 27/62 (43%), Gaps = 7/62 (11%)
Query: 375 VNLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKEL-TTLPSLEMLDVSNN 428
L+ L L G T+ + L +L L+ N LT +P L L +L+ L + N
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQEN 182
Query: 429 HL 430
L
Sbjct: 183 SL 184
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 15/59 (25%), Positives = 23/59 (38%), Gaps = 6/59 (10%)
Query: 375 VNLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNN 428
L+ L L+ + + + L +L L+L N L TIPK L + N
Sbjct: 148 PKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 50/198 (25%), Positives = 83/198 (41%), Gaps = 40/198 (20%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKS-------- 637
V + + +G G +G+V + G ++AVK++ F+S
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---------FQSIIHAKRTY 76
Query: 638 -EIAVLTKVRHRHLVGLL------GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPL 690
E+ +L ++H +++GLL + N+ LV M L+ + + L
Sbjct: 77 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC------QKL 129
Query: 691 EWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750
+ + RG++Y+H IHRDLKPSN+ + +D K+ DFGL R D
Sbjct: 130 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM 186
Query: 751 KHSIETRLAGTFGYLAPE 768
+ TR Y APE
Sbjct: 187 TGYVATRW-----YRAPE 199
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 46/214 (21%)
Query: 583 QVLRNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKS---- 637
+V R+V + LG+G +G V+K + G +AVK++ A F++
Sbjct: 2 RVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA---------FQNSTDA 52
Query: 638 -----EIAVLTKVR-HRHLVGLLGYCL--DGNERLLVYEYMPQGTLSRHLFNRKEEGLKP 689
EI +LT++ H ++V LL + + LV++YM E L
Sbjct: 53 QRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-------------ETDLHA 99
Query: 690 LEWTRRLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743
+ L + + + ++YLH +HRD+KPSNILL + KVADFGL
Sbjct: 100 VIRANILEPVHKQYVVYQLIKVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLS 156
Query: 744 RLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMT 777
R + + + L+ + + +T
Sbjct: 157 RSFVNIRRVTNNIPLSINENTENFDD--DQPILT 188
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 43/207 (20%), Positives = 82/207 (39%), Gaps = 45/207 (21%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRM--ESAVVSEKGFAEFKSEIAVLT 643
++ + + + LG GG G V+ + ++A+K++ + E K ++
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIK----IIR 63
Query: 644 KVRHRHLVGLL--------------GYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKP 689
++ H ++V + G + N +V EYM E L
Sbjct: 64 RLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-------------ETDLAN 110
Query: 690 LEWTRRLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGL 742
+ L + RG++Y+H + +HRDLKP+N+ + +D+ K+ DFGL
Sbjct: 111 VLEQGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGL 167
Query: 743 VRLAPDNGKHSIE-TRLAGTFGYLAPE 768
R+ + H + T Y +P
Sbjct: 168 ARIMDPHYSHKGHLSEGLVTKWYRSPR 194
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 5e-13
Identities = 35/215 (16%), Positives = 69/215 (32%), Gaps = 63/215 (29%)
Query: 89 SSLTVLEVMKNKLTGQIPS---LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145
S +L++ N L+ ++ + + L++L +L N+ + S+ F + +L+ + L
Sbjct: 39 SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97
Query: 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPL 205
N L F + L L L N +
Sbjct: 98 NH---------------LHTLDEF---------LFSD---LQALEVLLLYNNHIVVVDRN 130
Query: 206 SFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFT----GPLPDLSGLSS 261
+F ++M L +L+L N + + D + L
Sbjct: 131 AF--------------------------EDMAQLQKLYLSQNQISRFPVELIKDGNKLPK 164
Query: 262 LQDFSVRDNQLTGIVPSSLVNLHSLAV--VNLTNN 294
L + N+L + + L L + + L NN
Sbjct: 165 LMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 4e-12
Identities = 33/177 (18%), Positives = 64/177 (36%), Gaps = 14/177 (7%)
Query: 54 CKWKHIQCSPSN---RVTRIQIGGQNIEGTLPKE-LNSLSSLTVLEVMKNKLTGQIPS-- 107
C + + P + + + N+ + L++L L + N L I S
Sbjct: 25 CSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEA 83
Query: 108 LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFS 167
+ +L+ + N+ ++ F L +L+ + L N V + +D LQ+
Sbjct: 84 FVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLY 142
Query: 168 ANGANITGTIPD--FLGGDTIPGLMHLHLAFNFLQGPIPLSFG---KSSIQTLWLNG 219
+ I+ P G+ +P LM L L+ N L+ L+L+
Sbjct: 143 LSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 9e-06
Identities = 17/62 (27%), Positives = 28/62 (45%), Gaps = 7/62 (11%)
Query: 375 VNLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNN 428
NL+ L LS T+ FS L +L L+L N + + + + L+ L +S N
Sbjct: 88 PNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQN 146
Query: 429 HL 430
+
Sbjct: 147 QI 148
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 9e-06
Identities = 24/62 (38%), Positives = 34/62 (54%), Gaps = 7/62 (11%)
Query: 375 VNLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNN 428
NL +L LS ISS F + +LR L LS N L T+ + + L +LE+L + NN
Sbjct: 64 TNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNN 122
Query: 429 HL 430
H+
Sbjct: 123 HI 124
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 25/91 (27%), Positives = 40/91 (43%), Gaps = 18/91 (19%)
Query: 375 VNLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKE----LTTLPSLEMLDV 425
L+ L L + N F + L++L LS N+++ P E LP L +LD+
Sbjct: 112 QALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDL 170
Query: 426 SNNHL-------FGKVPNFRQNVIVKTDGNP 449
S+N L K+P + +N + NP
Sbjct: 171 SSNKLKKLPLTDLQKLPAWVKNGL-YLHNNP 200
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 24/184 (13%), Positives = 50/184 (27%), Gaps = 58/184 (31%)
Query: 113 SLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGAN 172
+ + +VP + + L +N+ L R A
Sbjct: 19 ASNILSCSKQQLPNVPQSLP---SYTALLDLSHNN---------------LSRLRAEWT- 59
Query: 173 ITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAV 232
+ L L L+ N + + S
Sbjct: 60 -------PTR---LTNLHSLLLSHN-------------HLNFI-------------SSEA 83
Query: 233 IQNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVN 290
+ +L L L N L + S L +L+ + +N + + ++ ++ L +
Sbjct: 84 FVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLY 142
Query: 291 LTNN 294
L+ N
Sbjct: 143 LSQN 146
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 17/87 (19%)
Query: 357 CNSDWKGVSCDAGGNITVV------NLKNLGLSG----TISSN--FSRLTSLRQLMLSGN 404
C S+ +SC + + V L LS + + +RLT+L L+LS N
Sbjct: 18 CASNI--LSC-SKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHN 74
Query: 405 ELTGTIPKE-LTTLPSLEMLDVSNNHL 430
L I E +P+L LD+S+NHL
Sbjct: 75 HLN-FISSEAFVPVPNLRYLDLSSNHL 100
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 9e-13
Identities = 19/188 (10%), Positives = 61/188 (32%), Gaps = 35/188 (18%)
Query: 107 SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRF 166
+ + ++SL + + N T + + +++ ++++ ++ + + L+R
Sbjct: 39 TEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHATNY---NPISGLSNLERL 93
Query: 167 SANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKL 226
G ++T L G + L L ++ +
Sbjct: 94 RIMGKDVTSDKIPNLSG--LTSLTLLDISHSAHD-------------------------- 125
Query: 227 NGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSL 286
+ + I + + + L N + L L L+ +++ + + + + L
Sbjct: 126 DSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDY--RGIEDFPKL 183
Query: 287 AVVNLTNN 294
+ +
Sbjct: 184 NQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 22/193 (11%), Positives = 50/193 (25%), Gaps = 56/193 (29%)
Query: 83 KELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTIS 142
+ ++ L + T +SGLS+L+ + + TS GLTSL +
Sbjct: 60 TGIEYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118
Query: 143 LDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGP 202
+ ++ +I + +P + + L++N
Sbjct: 119 ISHS-------------------------AHDDSILTKINT--LPKVNSIDLSYN----- 146
Query: 203 IPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSL 262
+ ++ + L L + + + L
Sbjct: 147 ----------------------GAITDIMPLKTLPELKSLNIQFDGVHD-YRGIEDFPKL 183
Query: 263 QDFSVRDNQLTGI 275
+ G
Sbjct: 184 NQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 8e-08
Identities = 16/59 (27%), Positives = 33/59 (55%), Gaps = 3/59 (5%)
Query: 375 VNLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
N+K+L ++ + + S L++L +L + G ++T L+ L SL +LD+S++
Sbjct: 66 HNIKDLTINNIHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAH 124
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 10/79 (12%), Positives = 26/79 (32%), Gaps = 2/79 (2%)
Query: 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSV 127
T + I + ++ ++N+L + +++ N I L L L+ + +
Sbjct: 115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDY 174
Query: 128 PSDFFKGLTSLQTISLDYN 146
+ L +
Sbjct: 175 --RGIEDFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 19/60 (31%), Positives = 31/60 (51%), Gaps = 5/60 (8%)
Query: 376 NLKNLGLSGT-IS----SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
NL+ L + G ++ N S LTSL L +S + +I ++ TLP + +D+S N
Sbjct: 89 NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 13/60 (21%), Positives = 30/60 (50%), Gaps = 1/60 (1%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
++T++++ + +I + + L + + LS N I L TLP L+ L++ + +
Sbjct: 113 SLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGV 171
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 6e-04
Identities = 9/58 (15%), Positives = 25/58 (43%), Gaps = 5/58 (8%)
Query: 376 NLKNLGLSGT-IS--SNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+L + L+ ++ + +++ L ++ T P ++ L +LE L + +
Sbjct: 45 SLTYITLANINVTDLTGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDV 100
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 8e-04
Identities = 9/59 (15%), Positives = 19/59 (32%), Gaps = 6/59 (10%)
Query: 376 NLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+ ++ LS T L L+ L + + + + P L L + +
Sbjct: 137 KVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTI 193
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 39/196 (19%), Positives = 81/196 (41%), Gaps = 42/196 (21%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
+++ LGRG + V++ + + K+ VK ++ V +K + K EI +L +
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--PVKKK---KIKREIKILENL 87
Query: 646 R-HRHLVGLLGYCLDGNER--LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDV 702
R +++ L D R LV+E++ + + LT D+
Sbjct: 88 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--------------QTLTDY-DI 132
Query: 703 A-------RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA-KVADFGLVRLAPDNGKHSI 754
+ ++Y H +HRD+KP N+++ + R ++ D+GL ++++
Sbjct: 133 RFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 189
Query: 755 E--TRLAGTFGYLAPE 768
+R + PE
Sbjct: 190 RVASRY-----FKGPE 200
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 39/206 (18%), Positives = 70/206 (33%), Gaps = 53/206 (25%)
Query: 598 LGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKG-----FAEFK--------SEIAVLTK 644
+G+GGFG +Y +++ + V E F E K +I +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSD-APCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 645 VRHRHLVG---LLGYCLDGNE----RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLT 697
R +G G L R ++ + G+ + ++ +R +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANA---------KRFS 150
Query: 698 ------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV--ADFGLVRLAPDN 749
++L + +EY+H ++H D+K SN+LL +V D+GL
Sbjct: 151 RKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207
Query: 750 GKHS-IETR----LAGTFGYLAPEYA 770
G H GT E+
Sbjct: 208 GVHKAYAADPKRCHDGT-----IEFT 228
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 48/203 (23%), Positives = 81/203 (39%), Gaps = 39/203 (19%)
Query: 581 SIQVLRNVTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEI 639
S+ VL V NF +G G FG + G+ L+ +A+K +E + + E
Sbjct: 1 SMGVLM-VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPM---KSRAPQLHLEY 55
Query: 640 AVLTKVRH-RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLT- 697
++ + + + G +V E + G LF+ + R +
Sbjct: 56 RFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCD---------RTFSL 104
Query: 698 -----IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK-----VADFGLVR--L 745
IA+ + +EY+H ++ I+RD+KP N L+G + DF L + +
Sbjct: 105 KTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161
Query: 746 APDNGKHSIETR----LAGTFGY 764
P+ KH I R L GT Y
Sbjct: 162 DPETKKH-IPYREHKSLTGTARY 183
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 48/209 (22%), Positives = 82/209 (39%), Gaps = 48/209 (22%)
Query: 576 GSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAE 634
GSM + + N + +G G FG +Y G + G ++A+K E +
Sbjct: 1 GSMELRVG------NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-------ECVKTK 47
Query: 635 FKS---EIAVLTKVRH-RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPL 690
E + ++ + + +G+ ++V E + G LFN
Sbjct: 48 HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCS------ 99
Query: 691 EWTRRLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK---VADFG 741
R+ + +A + +EY+H ++FIHRD+KP N L+G + + DFG
Sbjct: 100 ---RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFG 153
Query: 742 LVR--LAPDNGKHSIETR----LAGTFGY 764
L + +H I R L GT Y
Sbjct: 154 LAKKYRDARTHQH-IPYRENKNLTGTARY 181
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 8e-12
Identities = 38/181 (20%), Positives = 64/181 (35%), Gaps = 42/181 (23%)
Query: 598 LGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKG--FAEFK--------SEIAVLTKVR 646
+G GGFG +Y + K A + E G F+E K I + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 647 HRHLVGL-------LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLT-- 697
+G+ L + R +V E + G + +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISG----------QNGTFKKS 151
Query: 698 ----IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV--ADFGLVRLAPDNGK 751
+ + + +EY+H ++H D+K +N+LLG +V AD+GL NG
Sbjct: 152 TVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGN 208
Query: 752 H 752
H
Sbjct: 209 H 209
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 9e-12
Identities = 41/199 (20%), Positives = 78/199 (39%), Gaps = 44/199 (22%)
Query: 588 VTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAE---FKSEIAVLT 643
V ++ +G G FG +++G L + ++A+K E ++ + E
Sbjct: 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-------EPRRSDAPQLRDEYRTYK 60
Query: 644 KVRH-RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLT----- 697
+ + + + +G +LV + + +L L + R+ +
Sbjct: 61 LLAGCTGIPNVYYFGQEGLHNVLVIDLLGP-SLE-DLLDLCG---------RKFSVKTVA 109
Query: 698 -IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK-----VADFGLVR--LAPDN 749
A + V+ +H +S ++RD+KP N L+G V DFG+V+ P
Sbjct: 110 MAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166
Query: 750 GKHSIETR----LAGTFGY 764
+H I R L+GT Y
Sbjct: 167 KQH-IPYREKKNLSGTARY 184
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 65.3 bits (158), Expect = 2e-11
Identities = 33/201 (16%), Positives = 55/201 (27%), Gaps = 54/201 (26%)
Query: 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVK--RMESAVVSE----KGFAEFKSEIAVL 642
T +G G FG V++ D T +A+K +E + K F E EI +
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 643 TKV---------RHRHLVGLLGYCL------------------------------DGNER 663
++ R +GL ++
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLK 723
+V E+ G + K +I + + F HRDL
Sbjct: 138 FIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTASLAVAEASLR--FEHRDLH 189
Query: 724 PSNILLGDDMRAKVADFGLVR 744
N+LL K+ +
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGK 210
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 48/195 (24%), Positives = 88/195 (45%), Gaps = 38/195 (19%)
Query: 597 VLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVR-------- 646
LG G F TV+ + + + T +A+K V +K + E + EI +L +V
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMK----IVRGDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 647 ---HRHLVGLLGY----CLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIA 699
H++ LL + +G ++V+E + + L + + G+ PL + ++ I+
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGI-PLIYVKQ--IS 137
Query: 700 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA------KVADFGLVRLAPDNGKHS 753
+ G++Y+H IH D+KP N+L+ K+AD G ++ +S
Sbjct: 138 KQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 195
Query: 754 IETRLAGTFGYLAPE 768
I+TR Y +PE
Sbjct: 196 IQTRE-----YRSPE 205
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 43/162 (26%), Positives = 68/162 (41%), Gaps = 16/162 (9%)
Query: 92 TVLEVMKNKLTGQIPS-LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDS 150
L++ L + GL+ L + D N ++ + F LT L T+ L N S
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 151 WVIPESLKDA-TGLQRFSANGANITGTIPD--FLGGDTIPGLMHLHLAFNFLQGPIPLS- 206
+P + D T L + G + ++P F D + L L L N LQ IP
Sbjct: 98 --LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVF---DRLTKLKELRLNTNQLQS-IPAGA 150
Query: 207 FGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGN 247
F K +++QTL L+ + S +G+ + L + L GN
Sbjct: 151 FDKLTNLQTLSLSTNQLQSVPHGAFD---RLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 24/65 (36%), Positives = 32/65 (49%), Gaps = 3/65 (4%)
Query: 87 SLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144
L+ L L + N+L IP+ L++LQ + N SVP F L LQTI+L
Sbjct: 129 RLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLF 187
Query: 145 YNSFD 149
N FD
Sbjct: 188 GNQFD 192
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-10
Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 86 NSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145
L ++ L + NKL I +L L++L ++ N S+P+ F LT+L+ + L
Sbjct: 60 QYLPNVRYLALGGNKLH-DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVE 118
Query: 146 NSFDSWVIPESLKDA-TGLQRFSANGANITGTIPD--FLGGDTIPGLMHLHLAFNFLQGP 202
N S +P+ + D T L + + ++P F D + L L L++N LQ
Sbjct: 119 NQLQS--LPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVF---DKLTNLTELDLSYNQLQS- 171
Query: 203 IPLS-FGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGN 247
+P F K + ++ L L + S +G V +TSL +WLH N
Sbjct: 172 LPEGVFDKLTQLKDLRLYQNQLKSVPDG---VFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 47/210 (22%), Positives = 85/210 (40%), Gaps = 19/210 (9%)
Query: 90 SLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFD 149
+ K +T + + L+S+ +++ ++++ SV + L +++ ++L N
Sbjct: 20 ETIKANLKKKSVT-DAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKLH 76
Query: 150 SWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK 209
+ L + T L ++ + D L L L L N LQ F K
Sbjct: 77 DISALKELTNLTYLILTGNQLQSLPNGVFDKLTN-----LKELVLVENQLQSLPDGVFDK 131
Query: 210 -SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSG----LSSLQD 264
+++ L L + S G V +T+LT+L L N LP+ G L+ L+D
Sbjct: 132 LTNLTYLNLAHNQLQSLPKG---VFDKLTNLTELDLSYNQLQS-LPE--GVFDKLTQLKD 185
Query: 265 FSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+ NQL + L SL + L +N
Sbjct: 186 LRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 34/176 (19%), Positives = 58/176 (32%), Gaps = 47/176 (26%)
Query: 124 FTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGG 183
P D F +L S V L + + + ++
Sbjct: 10 KQIFPDDAF---AETIKANLKKKSVTDAVTQNELNSIDQIIANN----SDIKSVQGI--- 59
Query: 184 DTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLW 243
+P + +L L N L ++ ++ +T+LT L
Sbjct: 60 QYLPNVRYLALGGNKLH----------------------------DISALKELTNLTYLI 91
Query: 244 LHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGI---VPSSLVNLHSLAVVNLTNN 294
L GN LP+ L++L++ + +NQL + V L NL L NL +N
Sbjct: 92 LTGNQLQS-LPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYL---NLAHN 143
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 23/106 (21%), Positives = 37/106 (34%), Gaps = 7/106 (6%)
Query: 192 LHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTG 251
+L + +SI + N S V IQ + ++ L L GN
Sbjct: 24 ANLKKKSVTD-AVTQNELNSIDQIIANNSDIKS-----VQGIQYLPNVRYLALGGNKLH- 76
Query: 252 PLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
+ L L++L + NQL + L +L + L N Q
Sbjct: 77 DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ 122
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 33/135 (24%), Positives = 55/135 (40%), Gaps = 9/135 (6%)
Query: 89 SSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146
++T + + +N + IP S L+ + +N + + D F+GL SL ++ L N
Sbjct: 32 ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90
Query: 147 SFDSWVIPESL-KDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPL 205
+P+SL + LQ N I + + L L L N LQ
Sbjct: 91 KITE--LPKSLFEGLFSLQLLLLNANKIN-CLRVDA-FQDLHNLNLLSLYDNKLQTIAKG 146
Query: 206 SFGK-SSIQTLWLNG 219
+F +IQT+ L
Sbjct: 147 TFSPLRAIQTMHLAQ 161
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 33/187 (17%), Positives = 55/187 (29%), Gaps = 56/187 (29%)
Query: 112 SSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGA 171
++ E+ + N +P F L+ I L N + A
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE--LAP--------------DA 75
Query: 172 NITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVA 231
F + L L L N + +P S
Sbjct: 76 --------F---QGLRSLNSLVLYGNKITE-LPKS------------------------- 98
Query: 232 VIQNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVV 289
+ + + SL L L+ N L L +L S+ DN+L I + L ++ +
Sbjct: 99 LFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTM 157
Query: 290 NLTNNLF 296
+L N F
Sbjct: 158 HLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 9e-09
Identities = 27/121 (22%), Positives = 48/121 (39%), Gaps = 12/121 (9%)
Query: 82 PKELNSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
P + L +++ N+++ ++ GL SL ++ N T +P F+GL SLQ
Sbjct: 49 PGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQ 107
Query: 140 TISLDYNSFDSWVIPESLKDA-TGLQRFSANGANITGTIPD--FLGGDTIPGLMHLHLAF 196
+ L+ N + + L S + TI F + + +HLA
Sbjct: 108 LLLLNANKINC--LRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTF---SPLRAIQTMHLAQ 161
Query: 197 N 197
N
Sbjct: 162 N 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 21/73 (28%), Positives = 33/73 (45%), Gaps = 4/73 (5%)
Query: 80 TLPKEL-NSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDNNFTSVPSDFFKGLT 136
LPK L L SL +L + NK+ + + L +L + DN ++ F L
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152
Query: 137 SLQTISLDYNSFD 149
++QT+ L N F
Sbjct: 153 AIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 16/62 (25%), Positives = 31/62 (50%), Gaps = 7/62 (11%)
Query: 375 VNLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKEL-TTLPSLEMLDVSNN 428
+L +L L G + + F L SL+ L+L+ N++ + + L +L +L + +N
Sbjct: 80 RSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDN 138
Query: 429 HL 430
L
Sbjct: 139 KL 140
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 27/109 (24%), Positives = 49/109 (44%), Gaps = 7/109 (6%)
Query: 192 LHLAFNFLQGPIPLSF-GKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFT 250
+ L N ++ P +F ++ + L+ + Q + SL L L+GN T
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPD---AFQGLRSLNSLVLYGNKIT 93
Query: 251 GPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
LP GL SLQ + N++ + + +LH+L +++L +N Q
Sbjct: 94 E-LPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 49/197 (24%), Positives = 82/197 (41%), Gaps = 42/197 (21%)
Query: 588 VTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKS---EIAVLT 643
V N F +G G FG +Y G + ++A+K E + E +
Sbjct: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------ENVKTKHPQLLYESKIYR 57
Query: 644 KVR-HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLT----- 697
++ + + + ++G+ +LV + + +L LFN R+L+
Sbjct: 58 ILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLFNFCS---------RKLSLKTVL 106
Query: 698 -IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK---VADFGLVRL--APDNGK 751
+A + VE++H +SF+HRD+KP N L+G RA + DFGL + +
Sbjct: 107 MLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
Query: 752 HSIETR----LAGTFGY 764
H I R L GT Y
Sbjct: 164 H-IPYRENKNLTGTARY 179
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 36/216 (16%), Positives = 68/216 (31%), Gaps = 13/216 (6%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
++ + L E+ K T L LQE+ ++ + L L
Sbjct: 340 CWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLL 399
Query: 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFL 199
F +LK ++ + + + + + LHLA L
Sbjct: 400 YEKETLQYF------STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL 453
Query: 200 QGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGL 259
L + L L+ + L + + L L N+ + ++ L
Sbjct: 454 TVLCHLE-QLLLVTHLDLSHNR----LRALPPALAALRCLEVLQASDNALEN-VDGVANL 507
Query: 260 SSLQDFSVRDNQLTGI-VPSSLVNLHSLAVVNLTNN 294
LQ+ + +N+L LV+ L ++NL N
Sbjct: 508 PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 47/297 (15%), Positives = 86/297 (28%), Gaps = 23/297 (7%)
Query: 3 KRHLGVSLFLLSLLSATLSVNSQSSSDAAAMQALKTSLGN--PASLGWTDPDPC-KWKHI 59
+ H + +S A LSV + + + P S+ W PD + H+
Sbjct: 240 EPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHV 299
Query: 60 QCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLF 119
+ Q+ + +S +L+ + L + +
Sbjct: 300 WLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVE 359
Query: 120 DDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVI--PESLKDATGLQRFSANGANITGTI 177
S + LQ + + +I +L + + +
Sbjct: 360 KSTVLQS----ELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVD 415
Query: 178 PDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMT 237
P L FL L + ++ L L K + L ++ +
Sbjct: 416 PMRAA-------YLDDLRSKFLLENSVLKMEYADVRVLHLAH-KDLTVLCH----LEQLL 463
Query: 238 SLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+T L L N P L+ L L+ DN L + + NL L + L NN
Sbjct: 464 LVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNN 518
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 1e-07
Identities = 15/72 (20%), Positives = 31/72 (43%), Gaps = 7/72 (9%)
Query: 376 NLKNLGLSG-TISS--NFSRLTSLRQLMLSGNELTGTIP--KELTTLPSLEMLDVSNNHL 430
L+ L S + + + L L++L+L N L + L + P L +L++ N L
Sbjct: 487 CLEVLQASDNALENVDGVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSL 545
Query: 431 FGKVPNFRQNVI 442
+ ++ +
Sbjct: 546 -CQEEGIQERLA 556
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 2e-07
Identities = 16/60 (26%), Positives = 25/60 (41%), Gaps = 6/60 (10%)
Query: 375 VNLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+ + +L LS + + L L L S N L + + LP L+ L + NN L
Sbjct: 463 LLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRL 520
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 18/60 (30%), Positives = 31/60 (51%), Gaps = 3/60 (5%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
++ V++L + L+ + + +L + L LS N L +P L L LE+L S+N L
Sbjct: 442 DVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNAL 498
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 46/166 (27%), Positives = 69/166 (41%), Gaps = 43/166 (25%)
Query: 597 VLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHR------ 648
V+G+G FG V K +A+K V +EK F EI +L +R +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALK----MVRNEKRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 649 HLVGLLGY-------CLDGNERLLVYEYMPQGTLSRHLF----NRKEEGLKPLEWTRRLT 697
+++ +L C+ +E LS +L+ K +G L R+
Sbjct: 160 NVIHMLENFTFRNHICM-------TFEL-----LSMNLYELIKKNKFQGF-SLPLVRK-- 204
Query: 698 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA--KVADFG 741
A + + ++ LH IH DLKP NILL R+ KV DFG
Sbjct: 205 FAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG 247
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 38/177 (21%), Positives = 64/177 (36%), Gaps = 38/177 (21%)
Query: 125 TSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD--FLG 182
+P + L+ N F K L++ + + IT I + F
Sbjct: 24 NKIPEHIP---QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAF-- 77
Query: 183 GDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQL 242
+ G+ + L N L+ + + + + SL L
Sbjct: 78 -EGASGVNEILLTSNRLEN-VQHK-------------------------MFKGLESLKTL 110
Query: 243 WLHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
L N T + + GLSS++ S+ DNQ+T + P + LHSL+ +NL N F
Sbjct: 111 MLRSNRITC-VGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 36/160 (22%), Positives = 56/160 (35%), Gaps = 23/160 (14%)
Query: 54 CKWKHIQCS-------PSN---RVTRIQIGGQNIEGTLPK-ELNSLSSLTVLEVMKNKLT 102
C+ + CS P + +++ L L + NK+T
Sbjct: 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT 70
Query: 103 GQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDA 160
I G S + E+L N +V FKGL SL+T+ L N +
Sbjct: 71 -DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITC--VGNDSFIG 127
Query: 161 -TGLQRFSANGANITGTIPD--FLGGDTIPGLMHLHLAFN 197
+ ++ S IT T+ F DT+ L L+L N
Sbjct: 128 LSSVRLLSLYDNQIT-TVAPGAF---DTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 9e-08
Identities = 23/65 (35%), Positives = 34/65 (52%), Gaps = 3/65 (4%)
Query: 87 SLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144
L SL L + N++T + S GLSS++ + DN T+V F L SL T++L
Sbjct: 103 GLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLL 161
Query: 145 YNSFD 149
N F+
Sbjct: 162 ANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 14/62 (22%), Positives = 27/62 (43%), Gaps = 7/62 (11%)
Query: 375 VNLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKEL-TTLPSLEMLDVSNN 428
+ + L+ + F L SL+ LML N +T + + L S+ +L + +N
Sbjct: 81 SGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDN 139
Query: 429 HL 430
+
Sbjct: 140 QI 141
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 44/160 (27%), Positives = 73/160 (45%), Gaps = 27/160 (16%)
Query: 596 NVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHR----- 648
+++G+G FG V K + +A+K + ++K F + E+ +L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIK----IIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 649 -HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLF----NRKEEGLKPLEWTRRLTIALDVA 703
++V L + + N LV+E LS +L+ N G+ L TR+ A +
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEM-----LSYNLYDLLRNTNFRGV-SLNLTRK--FAQQMC 167
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA--KVADFG 741
+ +L S IH DLKP NILL + R+ K+ DFG
Sbjct: 168 TALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 1e-08
Identities = 23/122 (18%), Positives = 41/122 (33%), Gaps = 13/122 (10%)
Query: 51 PDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP--SL 108
PD C S+ + + G + L +LT L + + + L
Sbjct: 2 PDACC-----PHGSSGLRCTRDGALDS----LHHLPGAENLTELYIENQQHLQHLELRDL 52
Query: 109 SGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSA 168
GL L+ + + V D F L ++L +N+ +S + LQ
Sbjct: 53 RGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES--LSWKTVQGLSLQELVL 110
Query: 169 NG 170
+G
Sbjct: 111 SG 112
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 9e-07
Identities = 18/90 (20%), Positives = 28/90 (31%), Gaps = 16/90 (17%)
Query: 356 PCNSDWK-GVSCDAGGNITV-------VNLKNLGLSG-----TISSN-FSRLTSLRQLML 401
C G+ C G + NL L + + L LR L +
Sbjct: 4 ACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTI 63
Query: 402 SGNELTGTIPKE-LTTLPSLEMLDVSNNHL 430
+ L + + P L L++S N L
Sbjct: 64 VKSGLR-FVAPDAFHFTPRLSRLNLSFNAL 92
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 17/111 (15%), Positives = 36/111 (32%), Gaps = 7/111 (6%)
Query: 112 SSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGA 171
+ + G +L + ++ + L+ L+ + +
Sbjct: 8 HGSSGLRCTRDGALDSLHHL-PGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 172 NITGTIPD--FLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQ 220
+ + F P L L+L+FN L+ + S+Q L L+G
Sbjct: 67 GLR-FVAPDAFHF---TPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 5e-05
Identities = 14/64 (21%), Positives = 29/64 (45%), Gaps = 2/64 (3%)
Query: 233 IQNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVN 290
+ +LT+L++ L L GL L++ ++ + L + P + L+ +N
Sbjct: 27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86
Query: 291 LTNN 294
L+ N
Sbjct: 87 LSFN 90
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 9e-05
Identities = 16/61 (26%), Positives = 27/61 (44%), Gaps = 6/61 (9%)
Query: 375 VNLKNLGLSG----TISSN-FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNH 429
L+NL + ++ + F L +L LS N L ++ + SL+ L +S N
Sbjct: 56 GELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNP 114
Query: 430 L 430
L
Sbjct: 115 L 115
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 42/149 (28%), Positives = 65/149 (43%), Gaps = 24/149 (16%)
Query: 598 LGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEF-KSEIAVLTKVR--------H 647
LG G F TV+ + +A+K V S + + E EI +L VR
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMK----VVKSAEHYTETALDEIRLLKSVRNSDPNDPNR 100
Query: 648 RHLVGLLGY----CLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVA 703
+V LL ++G +V+E + L + + +GL PL ++ I V
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGL-PLPCVKK--IIQQVL 156
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILLGDD 732
+G++YLH IH D+KP NILL +
Sbjct: 157 QGLDYLHTKCR--IIHTDIKPENILLSVN 183
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 37/179 (20%), Positives = 61/179 (34%), Gaps = 40/179 (22%)
Query: 597 VLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHR-----H 649
+G G FG V + + + AVK V + K + K E +L K+++ +
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVK----VVRNIKKYTRSAKIEADILKKIQNDDINNNN 97
Query: 650 LVGLLGY-------CLDGNERLLVYEYMPQGTLSRHLF----NRKEEGLKPLEWTRRLTI 698
+V G CL ++E L L+ G +E +
Sbjct: 98 IVKYHGKFMYYDHMCL-------IFE-----PLGPSLYEIITRNNYNGF-HIEDIKL--Y 142
Query: 699 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETR 757
+++ + + YL + S H DLKP NILL D K +
Sbjct: 143 CIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 7e-07
Identities = 17/65 (26%), Positives = 30/65 (46%), Gaps = 3/65 (4%)
Query: 369 GGNITVVNLKNLGLSGT-ISS--NFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDV 425
G L+ L ++S N +L L++L LS N ++G + P+L L++
Sbjct: 36 GLTDEFEELEFLSTINVGLTSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95
Query: 426 SNNHL 430
S N +
Sbjct: 96 SGNKI 100
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-06
Identities = 17/88 (19%), Positives = 35/88 (39%), Gaps = 3/88 (3%)
Query: 210 SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRD 269
S ++ L L+ + S + L L T + +L L+ L+ + D
Sbjct: 17 SDVKELVLDNSR--SNEGKLEGLTDEFEELEFLSTINVGLTS-IANLPKLNKLKKLELSD 73
Query: 270 NQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
N+++G + +L +NL+ N +
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 20/90 (22%), Positives = 35/90 (38%), Gaps = 1/90 (1%)
Query: 75 QNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKG 134
++ EG L + L L + LT I +L L+ L+++ DN + +
Sbjct: 28 RSNEGKLEGLTDEFEELEFLSTINVGLT-SIANLPKLNKLKKLELSDNRVSGGLEVLAEK 86
Query: 135 LTSLQTISLDYNSFDSWVIPESLKDATGLQ 164
+L ++L N E LK L+
Sbjct: 87 CPNLTHLNLSGNKIKDLSTIEPLKKLENLK 116
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 6e-05
Identities = 20/119 (16%), Positives = 47/119 (39%), Gaps = 7/119 (5%)
Query: 133 KGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHL 192
+ + ++ + LD + + + + L+ S +T +I + + L L
Sbjct: 14 RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIANL---PKLNKLKKL 69
Query: 193 HLAFNFLQGPIP-LSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFT 250
L+ N + G + L+ ++ L L+G K ++ ++ + +L L L T
Sbjct: 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDL--STIEPLKKLENLKSLDLFNCEVT 126
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 27/107 (25%), Positives = 51/107 (47%), Gaps = 9/107 (8%)
Query: 54 CKWKHIQCSPSN---RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPS--L 108
C K ++ P VT + + G +PKEL++ LT++++ N+++ + +
Sbjct: 17 CSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSF 74
Query: 109 SGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPE 155
S ++ L ++ N +P F GL SL+ +SL N +PE
Sbjct: 75 SNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISV--VPE 119
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 23/106 (21%), Positives = 42/106 (39%), Gaps = 8/106 (7%)
Query: 192 LHLAFNFLQGPIPLSF-GKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFT 250
L+L N +P + + L+ + + N NMT L L L N
Sbjct: 36 LYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQ---SFSNMTQLLTLILSYNRLR 91
Query: 251 GPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+P GL SL+ S+ N ++ + + +L +L+ + + N
Sbjct: 92 C-IPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 29/129 (22%), Positives = 48/129 (37%), Gaps = 28/129 (21%)
Query: 92 TVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSW 151
T L + N+ T LS L + +N +++ + F +T L T+ L YN
Sbjct: 34 TELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC- 92
Query: 152 VIPESLKDA-TGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKS 210
IP D L+ S +G +I+ +P+ AFN L S
Sbjct: 93 -IPPRTFDGLKSLRLLSLHGNDIS-VVPEG--------------AFNDL----------S 126
Query: 211 SIQTLWLNG 219
++ L +
Sbjct: 127 ALSHLAIGA 135
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 9e-04
Identities = 16/61 (26%), Positives = 30/61 (49%), Gaps = 6/61 (9%)
Query: 237 TSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVP---SSLVNLHSLAVVNLTN 293
+T+L+L GN FT +LS L + +N+++ + S++ L +L L+
Sbjct: 31 RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTL---ILSY 87
Query: 294 N 294
N
Sbjct: 88 N 88
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 3e-06
Identities = 59/338 (17%), Positives = 102/338 (30%), Gaps = 113/338 (33%)
Query: 13 LSLLSATLSVNSQSSSDAAAMQALKTSLGNP-------ASLGWTDPDPCKW---KHIQCS 62
SLL L Q + L NP S+ W KH+ C
Sbjct: 304 KSLLLKYLDCRPQDLPR----EVLT---TNPRRLSIIAESI---RDGLATWDNWKHVNC- 352
Query: 63 PSNRVTRIQIGGQNIEGTL----PKELNSL-SSLTVLEVMKNKLTGQIPS--LSGL---- 111
+++T I IE +L P E + L+V + IP+ LS +
Sbjct: 353 --DKLTTI------IESSLNVLEPAEYRKMFDRLSVFP--PSA---HIPTILLSLIWFDV 399
Query: 112 --SSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD------------------YN---SF 148
S + V+ + ++ V + S+ +I L+ YN +F
Sbjct: 400 IKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTF 459
Query: 149 DSWVIPESLKDATGLQRFSANGANITGTIPDFLG--------GDTIPGLMHLHLAFNFLQ 200
DS + D +G + + + L F FL+
Sbjct: 460 DSDDLIPPYLD---------------QYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLE 504
Query: 201 GPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGL- 259
I + DS + I N L QL + P L
Sbjct: 505 QKI-----------------RHDSTAWNASGSILNT--LQQLKFYKPYICDNDPKYERLV 545
Query: 260 SSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
+++ DF + ++ S +L +A++ +F+
Sbjct: 546 NAILDFLPKIE--ENLICSKYTDLLRIALMAEDEAIFE 581
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 2e-05
Identities = 39/289 (13%), Positives = 83/289 (28%), Gaps = 86/289 (29%)
Query: 37 KTSLGNPASLGWTDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEV 96
KT + C +QC ++ + + N T+ + L L ++
Sbjct: 163 KTWVALDV---------CLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLL----YQI 209
Query: 97 MKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGL---TSLQTISLDYNSFDSWVI 153
N S + ++ + K L + L N ++
Sbjct: 210 DPN-------WTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL--LVLL-NVQNAKAW 259
Query: 154 PESLKDATGLQ-------RFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLS 206
+A L RF +T DFL T + ++
Sbjct: 260 -----NAFNLSCKILLTTRF----KQVT----DFLSAAT---------TTHISLDHHSMT 297
Query: 207 FGKS---SIQTLWLNGQKGD---SKLNGS---VAVI----QNMTSLTQLWLHGNSFTGPL 253
S+ +L+ + D L + +++I ++ + W H
Sbjct: 298 LTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKH-------- 349
Query: 254 PDLSGLSSLQDFSVRDNQLTGIVPSSLVNL-HSLAV----VNLTNNLFQ 297
+ L+++ + S+ N L P+ + L+V ++ L
Sbjct: 350 VNCDKLTTIIESSL--NVLE---PAEYRKMFDRLSVFPPSAHIPTILLS 393
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 2e-04
Identities = 69/431 (16%), Positives = 129/431 (29%), Gaps = 120/431 (27%)
Query: 67 VTRIQIGGQNI-EGTLPKELNSLSSLTVLEVMKNKLT--------GQIPSLSGLSSLQEV 117
Q ++I +++ V ++ K+ L+ ++SG L
Sbjct: 11 TGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWT 70
Query: 118 LFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWV---IPESLKDATGLQRFSANGANIT 174
L + F + + L+ +Y ++ I + + + R +
Sbjct: 71 LLSKQE--EMVQKFVEEV--LRI---NYK----FLMSPIKTEQRQPSMMTRMYIEQRDRL 119
Query: 175 GTIPDFLGGDTIP----------GLMHLHLAFN-FLQGPIPLSFGKSSIQTLWLNGQKGD 223
+ L+ L A N + G L GK+ + K
Sbjct: 120 YNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGV--LGSGKTWVALDVCLSYKVQ 177
Query: 224 SKLNGSVAVIQNMTSLTQLWLH-GNSFTG-----PLPDL-----SGLSSLQDFSVRDNQL 272
K++ + WL+ N + L L +S D S
Sbjct: 178 CKMDFKI-----------FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLR 226
Query: 273 TGIVPSSLVNL-------HSLAVV-NLTN----NLFQGQ-----TPKFNSPVRFDMAKGS 315
+ + L L + L V+ N+ N N F T +F F A +
Sbjct: 227 IHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATT 286
Query: 316 NSFCLDD--AGVACDGRVNVLLSIVK----------SVGYP---AVLAESWKGNNPCNSD 360
LD + D ++LL + P +++AES + + D
Sbjct: 287 THISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIR-DGLATWD 345
Query: 361 -WKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTS--LRQL--MLSGNELTGTI-PKEL 414
WK V+CD L+ I S+ + L R++ LS + P
Sbjct: 346 NWKHVNCDK-------------LTTIIESSLNVLEPAEYRKMFDRLS-------VFPPS- 384
Query: 415 TTLPS--LEML 423
+P+ L ++
Sbjct: 385 AHIPTILLSLI 395
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 32/131 (24%), Positives = 55/131 (41%), Gaps = 8/131 (6%)
Query: 92 TVLEVMKNKLTGQIPSL-SGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDS 150
+L + N++T P + L +L+E+ N ++P F LT L + L N
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTV 102
Query: 151 WVIPESLKDA-TGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK 209
+P ++ D L+ N +P G + + L HL L N L+ +F +
Sbjct: 103 --LPSAVFDRLVHLKELFMCC-NKLTELPR--GIERLTHLTHLALDQNQLKSIPHGAFDR 157
Query: 210 -SSIQTLWLNG 219
SS+ +L G
Sbjct: 158 LSSLTHAYLFG 168
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 34/181 (18%), Positives = 55/181 (30%), Gaps = 55/181 (30%)
Query: 115 QEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANIT 174
Q + DN T + F L +L+ + L N L
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSN---------------QLG---------- 77
Query: 175 GTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQ 234
+P G+ F+ L + + L L + + V
Sbjct: 78 -ALP--------VGV------FDSL----------TQLTVLDLGTNQLTVLPSA---VFD 109
Query: 235 NMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTN 293
+ L +L++ N T LP + L+ L ++ NQL I + L SL L
Sbjct: 110 RLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFG 168
Query: 294 N 294
N
Sbjct: 169 N 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 21/64 (32%), Positives = 29/64 (45%), Gaps = 2/64 (3%)
Query: 87 SLSSLTVLEVMKNKLTGQIPS-LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145
L L L + NKLT +P + L+ L + D N S+P F L+SL L
Sbjct: 110 RLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFG 168
Query: 146 NSFD 149
N +D
Sbjct: 169 NPWD 172
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 4e-06
Identities = 17/88 (19%), Positives = 36/88 (40%), Gaps = 3/88 (3%)
Query: 210 SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRD 269
++++ L L+ K S + +L L L + +L L L+ + +
Sbjct: 24 AAVRELVLDNCK--SNDGKIEGLTAEFVNLEFLSLINVGLIS-VSNLPKLPKLKKLELSE 80
Query: 270 NQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
N++ G + L +L +NL+ N +
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 5e-06
Identities = 21/59 (35%), Positives = 31/59 (52%), Gaps = 3/59 (5%)
Query: 375 VNLKNLGLSGT-ISS--NFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
VNL+ L L + S N +L L++L LS N + G + LP+L L++S N L
Sbjct: 49 VNLEFLSLINVGLISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL 107
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 16/90 (17%), Positives = 34/90 (37%), Gaps = 1/90 (1%)
Query: 75 QNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKG 134
++ +G + +L L ++ L + +L L L+++ +N +
Sbjct: 35 KSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSNLPKLPKLKKLELSENRIFGGLDMLAEK 93
Query: 135 LTSLQTISLDYNSFDSWVIPESLKDATGLQ 164
L +L ++L N E LK L+
Sbjct: 94 LPNLTHLNLSGNKLKDISTLEPLKKLECLK 123
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 3e-04
Identities = 20/117 (17%), Positives = 44/117 (37%), Gaps = 7/117 (5%)
Query: 135 LTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHL 194
+++ + LD + I + L+ S + ++ + +P L L L
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSNL---PKLPKLKKLEL 78
Query: 195 AFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFT 250
+ N + G + + K ++ L L+G K ++ ++ + L L L T
Sbjct: 79 SENRIFGGLDMLAEKLPNLTHLNLSGNKLKDI--STLEPLKKLECLKSLDLFNCEVT 133
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 15/61 (24%), Positives = 24/61 (39%), Gaps = 3/61 (4%)
Query: 373 TVVNLKNLGLSGT-ISS--NFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNH 429
T+ + S I F L L+ L+++ N + LP L L ++NN
Sbjct: 40 TLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS 99
Query: 430 L 430
L
Sbjct: 100 L 100
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 13/60 (21%), Positives = 20/60 (33%), Gaps = 1/60 (1%)
Query: 235 NMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+ + N L L L+ V +N++ I L L + LTNN
Sbjct: 40 TLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN 98
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 16/113 (14%), Positives = 39/113 (34%), Gaps = 13/113 (11%)
Query: 52 DPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGL 111
+ + + + ++ I+ N+ TL + ++ N++ ++ L
Sbjct: 17 NAVRDRELDLR-GYKIPVIE----NLGATLDQ-------FDAIDFSDNEIR-KLDGFPLL 63
Query: 112 SSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQ 164
L+ +L ++N + + L L + L NS + L L
Sbjct: 64 RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 116
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 37/178 (20%), Positives = 61/178 (34%), Gaps = 42/178 (23%)
Query: 597 VLGRGGFGTVYKGELHDGTK--IAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHR----- 648
LG G FG V + H K +A+K + + + E + EI VL K++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALK----IIRNVGKYREAARLEINVLKKIKEKDKENK 81
Query: 649 -HLVGLLGY-------CLDGNERLLVYEYMPQGTLSRHLF----NRKEEGLKPLEWTRRL 696
V + + C+ +E L ++ F + PL R
Sbjct: 82 FLCVLMSDWFNFHGHMCI-------AFE-----LLGKNTFEFLKENNFQPY-PLPHVRH- 127
Query: 697 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSI 754
+A + + +LH H DLKP NIL + + + SI
Sbjct: 128 -MAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 23/75 (30%), Positives = 35/75 (46%), Gaps = 11/75 (14%)
Query: 86 NSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143
L L LE+ +N+LTG I G S +QE+ +N + + F GL L+T++L
Sbjct: 51 GRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109
Query: 144 DYN--------SFDS 150
N SF+
Sbjct: 110 YDNQISCVMPGSFEH 124
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 17/65 (26%), Positives = 34/65 (52%), Gaps = 3/65 (4%)
Query: 232 VIQNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVV 289
+ + + +L L N + + GL L+ ++ DNQ++ ++P S +L+SL +
Sbjct: 73 AFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSL 131
Query: 290 NLTNN 294
NL +N
Sbjct: 132 NLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 18/65 (27%), Positives = 33/65 (50%), Gaps = 3/65 (4%)
Query: 87 SLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144
S + L++ +NK+ +I + GL L+ + DN + V F+ L SL +++L
Sbjct: 76 GASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLA 134
Query: 145 YNSFD 149
N F+
Sbjct: 135 SNPFN 139
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 40/178 (22%), Positives = 60/178 (33%), Gaps = 42/178 (23%)
Query: 597 VLGRGGFGTVYKGELH--DGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRHR----- 648
LG G FG V + H G +AVK V + + E +SEI VL +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVK----IVKNVDRYCEAARSEIQVLEHLNTTDPNST 76
Query: 649 -HLVGLLGY-------CLDGNERLLVYEYMPQGTLSRHLF----NRKEEGLKPLEWTRRL 696
V +L + C+ V+E L + L+ R+
Sbjct: 77 FRCVQMLEWFEHHGHICI-------VFE-----LLGLSTYDFIKENGFLPF-RLDHIRK- 122
Query: 697 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSI 754
+A + + V +LH H DLKP NIL + + + R I
Sbjct: 123 -MAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 8e-05
Identities = 65/386 (16%), Positives = 111/386 (28%), Gaps = 79/386 (20%)
Query: 89 SSLTVLEVMKNKLT--GQIPSLSGLSSLQEVLFDDNNFTSVP----SDFFKGLTSLQTIS 142
+ L++ +L+ L L Q V DD T S + +L ++
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 143 LDYNSFDSW---VIPESLKDA-TGLQRFSANGANITGT----IPDFLGGDTIPGLMHLHL 194
L N + + L+ +Q+ S +TG + L T+P L LHL
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLR--TLPTLQELHL 120
Query: 195 AFNFLQ--GPIPLSFG----KSSIQTLWLNGQKGDSKLNGSVA-VIQNMTSLTQLWLHGN 247
+ N L G L G + ++ L L + +A V++ +L + N
Sbjct: 121 SDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNN 180
Query: 248 SFTGP-LPDLS-GLS----SLQDFSVRDNQLT----GIVPSSLVNLHSLAVVNLTNNLFQ 297
+ L GL L+ + +T + + + SL + L +N
Sbjct: 181 DINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSN--- 237
Query: 298 GQTPKFNSPVRFDMAKGSNSFCLDDAGVA--CDGRVNVLLSIVKSVGYPAVLAESWKGNN 355
L D G+A C G ++ +
Sbjct: 238 ---------------------KLGDVGMAELCPGLLHPSSRLRTL---------WIWECG 267
Query: 356 PCNSDWKGVSCDAGGNITVVNLK----NLGLSGTIS---SNFSRLTSLRQLMLSGNELTG 408
+ ++ L LG G + L L + T
Sbjct: 268 ITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTA 327
Query: 409 T----IPKELTTLPSLEMLDVSNNHL 430
L L L +SNN L
Sbjct: 328 ACCSHFSSVLAQNRFLLELQISNNRL 353
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 73/423 (17%), Positives = 129/423 (30%), Gaps = 119/423 (28%)
Query: 62 SPSNRVTRIQIGGQNI--EG--TLPKELNSLSSLTVLEVMKNKLTGQ-IPSLSGL----- 111
+PS ++ ++ + + G L L +L +L L + N L + L
Sbjct: 82 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ 141
Query: 112 SSLQEVLFDDNNFTSVP----SDFFKGLTSLQTISLDYNSF-DSWV--IPESLKDAT-GL 163
L+++ + + ++ + + + +++ N ++ V + + LKD+ L
Sbjct: 142 CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQL 201
Query: 164 QRFSANGANITGTIPDFLGG--DTIPGLMHLHLAFNFL--QGPIPLSFG----KSSIQTL 215
+ +T L G + L L L N L G L G S ++TL
Sbjct: 202 EALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTL 261
Query: 216 WLN----GQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGP-LPDLSGL-----SSLQDF 265
W+ KG L V++ SL +L L GN L L+
Sbjct: 262 WIWECGITAKGCGDL---CRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESL 318
Query: 266 SVRDNQLTG----IVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLD 321
V+ T S L L + ++NN L+
Sbjct: 319 WVKSCSFTAACCSHFSSVLAQNRFLLELQISNN------------------------RLE 354
Query: 322 DAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLG 381
DAGV L + L+ L
Sbjct: 355 DAGVRE-------------------LCQGLGQPGS-------------------VLRVLW 376
Query: 382 LSG---------TISSNFSRLTSLRQLMLSGNELTGTIPKELTTL-----PSLEMLDVSN 427
L+ ++++ SLR+L LS N L +L LE L + +
Sbjct: 377 LADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYD 436
Query: 428 NHL 430
+
Sbjct: 437 IYW 439
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 42/163 (25%), Positives = 63/163 (38%), Gaps = 36/163 (22%)
Query: 89 SSLTVLEVMKNKLTGQIPS-LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNS 147
+ T L++ N L L+SL ++ N S+P+ F LTSL ++L N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87
Query: 148 FDSWVIPESLKDA-TGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPL- 205
S +P + D T L+ L L N LQ +P
Sbjct: 88 LQS--LPNGVFDKLTQLK--------------------------ELALNTNQLQS-LPDG 118
Query: 206 SFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGN 247
F K + ++ L L + S +G V +TSL +WLH N
Sbjct: 119 VFDKLTQLKDLRLYQNQLKSVPDG---VFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 9e-04
Identities = 23/67 (34%), Positives = 32/67 (47%), Gaps = 7/67 (10%)
Query: 87 SLSSLTVLEVMKNKLTGQIPSLSG----LSSLQEVLFDDNNFTSVPSDFFKGLTSLQTIS 142
L+ L L + N+L +P G L+ L+++ N SVP F LTSLQ I
Sbjct: 98 KLTQLKELALNTNQLQ-SLPD--GVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIW 154
Query: 143 LDYNSFD 149
L N +D
Sbjct: 155 LHDNPWD 161
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 27/168 (16%), Positives = 57/168 (33%), Gaps = 37/168 (22%)
Query: 84 ELNSLSSLTVLEV----MKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
E S+ + +V M + +LS L + + + NN + G+ +L+
Sbjct: 16 ERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLR 73
Query: 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFL 199
+SL N +K L + L L +++N +
Sbjct: 74 ILSLGRNL---------IKKIENLDAVADT-------------------LEELWISYNQI 105
Query: 200 QGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGN 247
+ +++ L+++ K + G + + + L L L GN
Sbjct: 106 ASLSGIE-KLVNLRVLYMSNNKITN--WGEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 14/62 (22%), Positives = 25/62 (40%), Gaps = 2/62 (3%)
Query: 234 QNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVP-SSLVNLHSLAVVNLT 292
+L +LW+ N L + L +L+ + +N++T L L L + L
Sbjct: 90 AVADTLEELWISYNQIAS-LSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLA 148
Query: 293 NN 294
N
Sbjct: 149 GN 150
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 5e-04
Identities = 27/67 (40%), Positives = 37/67 (55%), Gaps = 7/67 (10%)
Query: 87 SLSSLTVLEVMKNKLTGQIPSLSG----LSSLQEVLFDDNNFTSVPSDFFKGLTSLQTIS 142
L+ LT+L + +NKL +P+ G L+ L+E+ D N SVP F LTSLQ I
Sbjct: 74 KLTKLTILYLHENKLQ-SLPN--GVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIW 130
Query: 143 LDYNSFD 149
L N +D
Sbjct: 131 LHTNPWD 137
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 779 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.98 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.98 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.98 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.98 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.97 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.97 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.97 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.97 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.97 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.97 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.97 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.96 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.96 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.96 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.96 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.96 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.96 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.96 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.96 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.96 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.96 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.96 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.96 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.96 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.96 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.96 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.96 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.96 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.96 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.96 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.96 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.96 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.96 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.96 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.96 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.96 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.96 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.96 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.96 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.96 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.95 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.95 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.95 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.95 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.95 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.95 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.95 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.95 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.95 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.95 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.95 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.95 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.95 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.95 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.95 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.95 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.95 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.95 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.95 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.95 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.95 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.95 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.95 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.95 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.95 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.95 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.95 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.95 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.95 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.95 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.95 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.95 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.95 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.95 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.95 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.95 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.95 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.95 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.95 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.95 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.95 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.95 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.95 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.95 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.95 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.95 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.95 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.95 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.95 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.95 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.95 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.95 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.95 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.95 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.95 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.95 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.94 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.94 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.94 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.94 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.94 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.94 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.94 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.94 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.94 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.94 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.94 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.94 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.94 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.94 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.94 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.94 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.94 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.94 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.94 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.94 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.94 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.94 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.94 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.94 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.94 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.94 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.94 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.94 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.94 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.94 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.94 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.94 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.94 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.94 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.94 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.94 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.94 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.94 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.94 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.94 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.94 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.94 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.94 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.94 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.94 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.94 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.94 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.94 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.94 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.94 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.94 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.94 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.94 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.94 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.94 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.94 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.94 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.94 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.94 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.94 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.94 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.94 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.94 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.94 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.94 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.94 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.94 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.94 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.94 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.94 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.94 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.94 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.94 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.94 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.94 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.94 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.94 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.94 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.94 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.94 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.94 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.94 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.94 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.93 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.93 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.93 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.93 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.93 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.93 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.93 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.93 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.93 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.93 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.93 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.93 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.93 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.93 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.93 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.93 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.93 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.93 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.93 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.93 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.93 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.93 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.93 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.93 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.93 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.93 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.93 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.93 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.93 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.93 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.93 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.93 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.93 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.92 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.92 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.92 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.92 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.92 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.92 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.92 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.92 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.92 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.92 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.92 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.92 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.91 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.91 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.91 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.91 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.91 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.88 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.87 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.85 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.85 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.84 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.84 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.83 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.82 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.82 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.81 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.79 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.79 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.79 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.78 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.78 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.78 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.78 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.77 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.76 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.74 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.74 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.73 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.73 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.73 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.72 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.7 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.69 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.69 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.65 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.62 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.6 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.6 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.6 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.59 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.53 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.51 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.5 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.49 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.47 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.46 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.46 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.43 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.4 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.4 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.33 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.21 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.21 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.2 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.14 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.13 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.99 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.98 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.96 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.81 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.79 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.78 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.61 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.6 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.51 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.5 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.43 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.42 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.33 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.3 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.26 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.16 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.16 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.1 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.07 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.96 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.86 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.68 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.65 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.54 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.47 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.27 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.23 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.2 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.16 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.12 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.04 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.96 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.95 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.91 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.73 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.64 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.44 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.43 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.39 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.98 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.93 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.78 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 88.01 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 87.61 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 86.27 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.04 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 81.51 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 80.59 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=445.70 Aligned_cols=93 Identities=30% Similarity=0.405 Sum_probs=77.4
Q ss_pred CCCCeEEEEccCccccccccccccccccCCeEeccCccccccCCccCCCCCCCCceeccCCcccccCCCCCC---cceee
Q 004020 368 AGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQ---NVIVK 444 (779)
Q Consensus 368 ~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~~~---~~~~~ 444 (779)
..+.|+.|+|++|+++|.+|..|+++++|+.||||+|+|+|.||..+..+++|++|||++|+|+|.||...+ .....
T Consensus 654 ~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~ 733 (768)
T 3rgz_A 654 SMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAK 733 (768)
T ss_dssp GCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGG
T ss_pred ccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHH
Confidence 456788888888888888999999999999999999999999999999999999999999999999997443 33456
Q ss_pred eCCCCCCCCCCCCCCCCC
Q 004020 445 TDGNPDIGKDSSSFTPKS 462 (779)
Q Consensus 445 ~~~n~~~~~~~~~~~~~~ 462 (779)
+.||+.+|+.|.. +|.
T Consensus 734 ~~gN~~Lcg~~l~--~C~ 749 (768)
T 3rgz_A 734 FLNNPGLCGYPLP--RCD 749 (768)
T ss_dssp GCSCTEEESTTSC--CCC
T ss_pred hcCCchhcCCCCc--CCC
Confidence 8899999998753 554
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=417.87 Aligned_cols=417 Identities=18% Similarity=0.244 Sum_probs=292.6
Q ss_pred CCChhHHHHHHHHHHHcCCCC----------CCCCC-CCCCCcc---eeeEeCCCCcEEEEEecCCCccccCCccccCCC
Q 004020 24 SQSSSDAAAMQALKTSLGNPA----------SLGWT-DPDPCKW---KHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLS 89 (779)
Q Consensus 24 ~~~~~~~~~l~~~k~~~~~~~----------~~~w~-~~~~C~w---~gv~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~ 89 (779)
+....|..||.++++++..+. ..+|. +.|||.| .||+|+..+||+.|+|+++++.|.+|++|++|+
T Consensus 26 ~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~ 105 (636)
T 4eco_A 26 AEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLT 105 (636)
T ss_dssp CHHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCT
T ss_pred hhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCc
Confidence 345679999999999985432 12685 5689999 999998889999999999999999999999999
Q ss_pred CCcEEEcccC----------------------------------------------------------------------
Q 004020 90 SLTVLEVMKN---------------------------------------------------------------------- 99 (779)
Q Consensus 90 ~L~~L~Ls~N---------------------------------------------------------------------- 99 (779)
+|++|+|++|
T Consensus 106 ~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~ 185 (636)
T 4eco_A 106 ELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD 185 (636)
T ss_dssp TCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCT
T ss_pred cceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhh
Confidence 9999999998
Q ss_pred --------ccccCCCCCCCCCCccEEecCCCCCCC------------------CCccccc--CCCCccEEEcccCCCCCC
Q 004020 100 --------KLTGQIPSLSGLSSLQEVLFDDNNFTS------------------VPSDFFK--GLTSLQTISLDYNSFDSW 151 (779)
Q Consensus 100 --------~l~~~~~~~~~l~~L~~L~l~~N~l~~------------------~~~~~~~--~l~~L~~L~Ls~N~l~~~ 151 (779)
+++++++.|+++++|++|+|++|++++ +|. .+. ++++|++|+|++|++.+
T Consensus 186 l~l~~~~n~l~~ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~-~l~~~~l~~L~~L~L~~n~l~~- 263 (636)
T 4eco_A 186 TQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTE-DLKWDNLKDLTDVEVYNCPNLT- 263 (636)
T ss_dssp TTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS-CCCGGGCTTCCEEEEECCTTCS-
T ss_pred hhhccccCCCccCCHHHhcccCCCEEECcCCccccccccccccccccchhcccCch-hhhhcccCCCCEEEecCCcCCc-
Confidence 444533379999999999999999999 555 467 99999999999999977
Q ss_pred CCcccccCCCCCceEeccCce-eEe-ecCCCccCCCC------CcccEEEccCCCCCCcCCC--cccc-CCcceeeccCC
Q 004020 152 VIPESLKDATGLQRFSANGAN-ITG-TIPDFLGGDTI------PGLMHLHLAFNFLQGPIPL--SFGK-SSIQTLWLNGQ 220 (779)
Q Consensus 152 ~~p~~~~~l~~L~~L~l~~n~-l~~-~~p~~~~~~~l------~~L~~L~L~~N~l~~~~p~--~~~~-~~L~~l~l~~n 220 (779)
.+|..+.++++|+.|++++|+ ++| .+|..++ .+ ++|++|+|++|+++ .+|. .++. .+|+.|++++|
T Consensus 264 ~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~--~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N 340 (636)
T 4eco_A 264 KLPTFLKALPEMQLINVACNRGISGEQLKDDWQ--ALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYN 340 (636)
T ss_dssp SCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHH--HHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSC
T ss_pred cChHHHhcCCCCCEEECcCCCCCccccchHHHH--hhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCC
Confidence 789999999999999999998 998 8898876 44 89999999999999 8888 7876 67999999999
Q ss_pred CCCCCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCC-CcEEEccCCccccccChhhhCCC--CCCEEEccCcccc
Q 004020 221 KGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSS-LQDFSVRDNQLTGIVPSSLVNLH--SLAVVNLTNNLFQ 297 (779)
Q Consensus 221 ~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~-L~~L~l~~N~l~~~~p~~l~~l~--~L~~L~Ls~N~l~ 297 (779)
++...++ .+..+++|+.|+|++|+++..++.+..+++ |++|++++|+++ .+|..+..++ +|+.|+|++|+++
T Consensus 341 ~l~g~ip----~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~ 415 (636)
T 4eco_A 341 QLEGKLP----AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIG 415 (636)
T ss_dssp CCEEECC----CCEEEEEESEEECCSSEEEECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTT
T ss_pred cCccchh----hhCCCCCCCEEECCCCccccccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCC
Confidence 8874444 466788899999999999855556888888 999999999988 7888877655 8899999999998
Q ss_pred ccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCc---h----------------------hcccccC
Q 004020 298 GQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYP---A----------------------VLAESWK 352 (779)
Q Consensus 298 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~----------------------~~~~~~~ 352 (779)
+.+|..+...........+...+....+............+..+... . .+.....
T Consensus 416 ~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~L 495 (636)
T 4eco_A 416 SVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDL 495 (636)
T ss_dssp TTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEEC
T ss_pred CcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEEC
Confidence 88887555111111111111111111111111000000000111000 0 0001111
Q ss_pred CCCCCCCCCCcccc--CCCCCeEEEEccCccccccccccccccccCCeEec------cCccccccCCccCCCCCCCCcee
Q 004020 353 GNNPCNSDWKGVSC--DAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLML------SGNELTGTIPKELTTLPSLEMLD 424 (779)
Q Consensus 353 ~~~~~~~~~~~~~~--~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L------s~N~l~g~iP~~l~~l~~L~~L~ 424 (779)
..+... ... ... ...++|+.|+|++|++++ +|..++++++|+.|+| ++|++.+.+|..+..+++|++||
T Consensus 496 s~N~l~-~lp-~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~ 572 (636)
T 4eco_A 496 RFNKLT-KLS-DDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQ 572 (636)
T ss_dssp CSSCCC-BCC-GGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEE
T ss_pred cCCcCC-ccC-hhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEE
Confidence 111100 000 011 144566777777777776 6666667777777777 44666667777777777777777
Q ss_pred ccCCcccccCCC--CCCcceeeeCCCCCCCCC
Q 004020 425 VSNNHLFGKVPN--FRQNVIVKTDGNPDIGKD 454 (779)
Q Consensus 425 Ls~N~l~g~iP~--~~~~~~~~~~~n~~~~~~ 454 (779)
|++|++ +.||. +.....+.+.+|+..|.+
T Consensus 573 Ls~N~l-~~ip~~~~~~L~~L~Ls~N~l~~~~ 603 (636)
T 4eco_A 573 IGSNDI-RKVNEKITPNISVLDIKDNPNISID 603 (636)
T ss_dssp CCSSCC-CBCCSCCCTTCCEEECCSCTTCEEE
T ss_pred CCCCcC-CccCHhHhCcCCEEECcCCCCcccc
Confidence 777777 56665 223335555666665543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=416.97 Aligned_cols=412 Identities=18% Similarity=0.260 Sum_probs=288.5
Q ss_pred cCCCChhHHHHHHHHHHHcCCCCCCCCC------CCCC--Ccc------------eeeEeCCCCcEEEEEecCCCccccC
Q 004020 22 VNSQSSSDAAAMQALKTSLGNPASLGWT------DPDP--CKW------------KHIQCSPSNRVTRIQIGGQNIEGTL 81 (779)
Q Consensus 22 ~~~~~~~~~~~l~~~k~~~~~~~~~~w~------~~~~--C~w------------~gv~c~~~~~v~~l~l~~~~l~~~~ 81 (779)
.++....|.+||++||+++.++ +|. ..+| |.| .||+|+..++|+.|+|+++++.|.+
T Consensus 263 ~~~~~~~d~~ALl~~k~~l~~~---~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~i 339 (876)
T 4ecn_A 263 ETAEYIKDYKALKAIWEALDGK---NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRV 339 (876)
T ss_dssp CCCHHHHHHHHHHHHHHHTTGG---GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEE
T ss_pred ccccchHHHHHHHHHHHHcCCC---CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcC
Confidence 3445678999999999999776 563 2355 999 9999998899999999999999999
Q ss_pred CccccCCCCCcEEEc-ccCccccC--------------------------------------------------------
Q 004020 82 PKELNSLSSLTVLEV-MKNKLTGQ-------------------------------------------------------- 104 (779)
Q Consensus 82 p~~l~~l~~L~~L~L-s~N~l~~~-------------------------------------------------------- 104 (779)
|++|++|++|++|+| ++|.+.|.
T Consensus 340 p~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~ 419 (876)
T 4ecn_A 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKK 419 (876)
T ss_dssp CGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCC
T ss_pred chHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccc
Confidence 999999999999999 77765544
Q ss_pred --------------------CC-CCCCCCCccEEecCCCCCCC------------------CCccc-ccCCCCccEEEcc
Q 004020 105 --------------------IP-SLSGLSSLQEVLFDDNNFTS------------------VPSDF-FKGLTSLQTISLD 144 (779)
Q Consensus 105 --------------------~~-~~~~l~~L~~L~l~~N~l~~------------------~~~~~-~~~l~~L~~L~Ls 144 (779)
+| .|+++++|++|+|++|+|++ +|+.. |.++++|++|+|+
T Consensus 420 ~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls 499 (876)
T 4ecn_A 420 DSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELY 499 (876)
T ss_dssp CCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEE
T ss_pred ccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECc
Confidence 45 68899999999999999999 66653 4499999999999
Q ss_pred cCCCCCCCCcccccCCCCCceEeccCce-eEe-ecCCCccC-----CCCCcccEEEccCCCCCCcCCC--cccc-CCcce
Q 004020 145 YNSFDSWVIPESLKDATGLQRFSANGAN-ITG-TIPDFLGG-----DTIPGLMHLHLAFNFLQGPIPL--SFGK-SSIQT 214 (779)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~-l~~-~~p~~~~~-----~~l~~L~~L~L~~N~l~~~~p~--~~~~-~~L~~ 214 (779)
+|++.+ .+|..|.++++|+.|+|++|+ ++| .+|..++. ..+++|++|+|++|+++ .+|. .++. .+|+.
T Consensus 500 ~N~l~~-~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~ 577 (876)
T 4ecn_A 500 NCPNMT-QLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGL 577 (876)
T ss_dssp SCTTCC-SCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCE
T ss_pred CCCCCc-cChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCE
Confidence 999877 789999999999999999998 988 78876641 13459999999999999 8898 7876 67999
Q ss_pred eeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCC-CcEEEccCCccccccChhhhCCCC--CCEEEc
Q 004020 215 LWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSS-LQDFSVRDNQLTGIVPSSLVNLHS--LAVVNL 291 (779)
Q Consensus 215 l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~-L~~L~l~~N~l~~~~p~~l~~l~~--L~~L~L 291 (779)
|++++|.+. .++ .+..+++|+.|+|++|+++..++.+..+++ |+.|+|++|+|+ .+|..+..++. |+.|+|
T Consensus 578 L~Ls~N~l~-~lp----~~~~L~~L~~L~Ls~N~l~~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~L 651 (876)
T 4ecn_A 578 LDCVHNKVR-HLE----AFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDF 651 (876)
T ss_dssp EECTTSCCC-BCC----CCCTTSEESEEECCSSCCSCCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEEC
T ss_pred EECCCCCcc-cch----hhcCCCcceEEECcCCccccchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEEC
Confidence 999999887 333 577899999999999999944446888998 999999999998 78988887754 999999
Q ss_pred cCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCcc--ccCCC
Q 004020 292 TNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGV--SCDAG 369 (779)
Q Consensus 292 s~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 369 (779)
++|+++|.+|.+..... .....++..+....+........+...+..+........ .....|.. .+.+. .|...
T Consensus 652 s~N~l~g~ip~l~~~l~--~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N-~L~~ip~~-~~~~~~~~l~nl 727 (876)
T 4ecn_A 652 SYNKIGSEGRNISCSMD--DYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNN-LMTSIPEN-SLKPKDGNYKNT 727 (876)
T ss_dssp CSSCTTTTSSSCSSCTT--TCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSC-CCSCCCTT-SSSCTTSCCTTG
T ss_pred cCCcCCCccccchhhhc--cccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCC-cCCccChH-Hhcccccccccc
Confidence 99999998876431100 000001111111111111111111111111110000000 00000000 00000 01122
Q ss_pred CCeEEEEccCcccccccccccc--ccccCCeEeccCccccccCCccCCCCCCCCceeccC------CcccccCCC----C
Q 004020 370 GNITVVNLKNLGLSGTISSNFS--RLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSN------NHLFGKVPN----F 437 (779)
Q Consensus 370 ~~L~~L~Ls~n~l~g~~p~~~~--~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~------N~l~g~iP~----~ 437 (779)
++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|+|++ +|..+..+++|+.|+|++ |++++.+|. +
T Consensus 728 ~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L 805 (876)
T 4ecn_A 728 YLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTC 805 (876)
T ss_dssp GGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGC
T ss_pred CCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcC
Confidence 36777777777777 5666665 67777777777777775 677777777777777755 666666664 2
Q ss_pred CCcceeeeCCCCC
Q 004020 438 RQNVIVKTDGNPD 450 (779)
Q Consensus 438 ~~~~~~~~~~n~~ 450 (779)
.....+.+.+|..
T Consensus 806 ~~L~~L~Ls~N~L 818 (876)
T 4ecn_A 806 PSLIQLQIGSNDI 818 (876)
T ss_dssp SSCCEEECCSSCC
T ss_pred CCCCEEECCCCCC
Confidence 2333455555543
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=368.64 Aligned_cols=293 Identities=26% Similarity=0.478 Sum_probs=216.9
Q ss_pred CCChhHHHHHHHHHHHcCCCCC-CCCC-CCCCCc--ceeeEeCCC---CcEEEEEecCCCccc--cCCccccCCCCCcEE
Q 004020 24 SQSSSDAAAMQALKTSLGNPAS-LGWT-DPDPCK--WKHIQCSPS---NRVTRIQIGGQNIEG--TLPKELNSLSSLTVL 94 (779)
Q Consensus 24 ~~~~~~~~~l~~~k~~~~~~~~-~~w~-~~~~C~--w~gv~c~~~---~~v~~l~l~~~~l~~--~~p~~l~~l~~L~~L 94 (779)
.|.++|.+||++||+++.++.. .+|. +.|||. |.||+|+.. ++|++|+|++|+++| .+|+.|..+++|++|
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L 81 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEE
T ss_pred CCCHHHHHHHHHHHHhcCCcccccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCee
Confidence 4788999999999999987653 3785 468998 999999864 799999999999999 999999999999999
Q ss_pred Eccc-CccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCce
Q 004020 95 EVMK-NKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGAN 172 (779)
Q Consensus 95 ~Ls~-N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~ 172 (779)
+|++ |.+.+.+| .|.++++|++|+|++|++++..+..|.++++|++|+|++|++.+ .+|..+..+++|++|++++|+
T Consensus 82 ~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~ 160 (313)
T 1ogq_A 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSG-TLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEES-CCCGGGGGCTTCCEEECCSSC
T ss_pred eCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCC-cCChHHhcCCCCCeEECcCCc
Confidence 9995 99998877 78888888888888888886666667777777777777777654 455555555555555555555
Q ss_pred eEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCC
Q 004020 173 ITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGP 252 (779)
Q Consensus 173 l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~ 252 (779)
+++.+|..++ .++ ++|+.|+|++|++++.
T Consensus 161 l~~~~p~~l~--~l~-------------------------------------------------~~L~~L~L~~N~l~~~ 189 (313)
T 1ogq_A 161 ISGAIPDSYG--SFS-------------------------------------------------KLFTSMTISRNRLTGK 189 (313)
T ss_dssp CEEECCGGGG--CCC-------------------------------------------------TTCCEEECCSSEEEEE
T ss_pred ccCcCCHHHh--hhh-------------------------------------------------hcCcEEECcCCeeecc
Confidence 5555555544 333 1445555555555544
Q ss_pred CCC-CCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccc
Q 004020 253 LPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRV 331 (779)
Q Consensus 253 ~~~-~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (779)
+|. +..++ |++|++++|++++.+|..+..+++|+.|+|++|++++.+|.+
T Consensus 190 ~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~---------------------------- 240 (313)
T 1ogq_A 190 IPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKV---------------------------- 240 (313)
T ss_dssp CCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGC----------------------------
T ss_pred CChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcc----------------------------
Confidence 442 44444 666666666666666677777777777777777776554431
Q ss_pred hhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccCccccccCC
Q 004020 332 NVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIP 411 (779)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP 411 (779)
...++|++|+|++|+++|.+|..|..+++|++|+|++|+|+|.+|
T Consensus 241 -----------------------------------~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip 285 (313)
T 1ogq_A 241 -----------------------------------GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285 (313)
T ss_dssp -----------------------------------CCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC
T ss_pred -----------------------------------cccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCC
Confidence 011367777777778888888888999999999999999999999
Q ss_pred ccCCCCCCCCceeccCCc-cccc
Q 004020 412 KELTTLPSLEMLDVSNNH-LFGK 433 (779)
Q Consensus 412 ~~l~~l~~L~~L~Ls~N~-l~g~ 433 (779)
.. ..+++|+.|++++|+ +.|.
T Consensus 286 ~~-~~l~~L~~l~l~~N~~lc~~ 307 (313)
T 1ogq_A 286 QG-GNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp CS-TTGGGSCGGGTCSSSEEEST
T ss_pred CC-ccccccChHHhcCCCCccCC
Confidence 76 888899999998887 5553
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=349.12 Aligned_cols=341 Identities=20% Similarity=0.201 Sum_probs=257.3
Q ss_pred CCCCCccee--eEeCCC---------CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCC-C-CCCCCCCccE
Q 004020 50 DPDPCKWKH--IQCSPS---------NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQI-P-SLSGLSSLQE 116 (779)
Q Consensus 50 ~~~~C~w~g--v~c~~~---------~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-~-~~~~l~~L~~ 116 (779)
.++.|.|.+ |.|+.. .++++|+|++|++++..|..|..+++|++|+|++|.+.+.+ + .|.++++|++
T Consensus 4 ~~~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~ 83 (455)
T 3v47_A 4 GTSECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLII 83 (455)
T ss_dssp ---CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCE
T ss_pred ccceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCE
Confidence 346677766 888753 46999999999999998999999999999999999998655 3 7999999999
Q ss_pred EecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCccc--ccCCCCCceEeccCceeEeecCCC-ccCCCCCcccEEE
Q 004020 117 VLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPES--LKDATGLQRFSANGANITGTIPDF-LGGDTIPGLMHLH 193 (779)
Q Consensus 117 L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~--~~~l~~L~~L~l~~n~l~~~~p~~-~~~~~l~~L~~L~ 193 (779)
|+|++|+++.+++..|.++++|++|+|++|++.+ .++.. |..+++|+.|++++|++++..|.. +. .+++|++|+
T Consensus 84 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~--~l~~L~~L~ 160 (455)
T 3v47_A 84 LKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDG-AVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFL--NMRRFHVLD 160 (455)
T ss_dssp EECTTCTTCEECTTTTTTCTTCCEEECTTSCCBT-HHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGG--GCTTCCEEE
T ss_pred EeCCCCccCccChhhccCcccCCEEeCCCCCCCc-cccCcccccCcccCCEEECCCCccCccCcccccC--CCCcccEEe
Confidence 9999999999999999999999999999999975 33444 899999999999999999888876 54 799999999
Q ss_pred ccCCCCCCcCCCcccc---CCcceeeccCCCCCCCCCCch-----hhhcCCCCccEEEeecCcccCCCCC----------
Q 004020 194 LAFNFLQGPIPLSFGK---SSIQTLWLNGQKGDSKLNGSV-----AVIQNMTSLTQLWLHGNSFTGPLPD---------- 255 (779)
Q Consensus 194 L~~N~l~~~~p~~~~~---~~L~~l~l~~n~~~~~~~~~~-----~~~~~l~~L~~L~L~~N~l~~~~~~---------- 255 (779)
|++|++++..|..+.. ..++.|++++|.+........ ..+..+++|++|+|++|++++.+|.
T Consensus 161 L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~ 240 (455)
T 3v47_A 161 LTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTK 240 (455)
T ss_dssp CTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCC
T ss_pred CCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccc
Confidence 9999999999988866 468888888887765543322 1233557788888888877653321
Q ss_pred ----------------------------CC--CCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCCCC
Q 004020 256 ----------------------------LS--GLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNS 305 (779)
Q Consensus 256 ----------------------------~~--~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~ 305 (779)
+. ..++|+.|++++|++.+.+|..+..+++|+.|+|++|++++.+|..+.
T Consensus 241 L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 320 (455)
T 3v47_A 241 IQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFW 320 (455)
T ss_dssp EEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred eeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhc
Confidence 11 125788888888888888888888888888888888888877765432
Q ss_pred CcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCcccccc
Q 004020 306 PVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGT 385 (779)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ 385 (779)
. .++|+.|+|++|.+++.
T Consensus 321 ~--------------------------------------------------------------l~~L~~L~Ls~N~l~~~ 338 (455)
T 3v47_A 321 G--------------------------------------------------------------LTHLLKLNLSQNFLGSI 338 (455)
T ss_dssp T--------------------------------------------------------------CTTCCEEECCSSCCCEE
T ss_pred C--------------------------------------------------------------cccCCEEECCCCccCCc
Confidence 2 12566666666666666
Q ss_pred ccccccccccCCeEeccCccccccCCccCCCCCCCCceeccCCcccccCCC----CCCcceeeeCCCCCCCCCC
Q 004020 386 ISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPN----FRQNVIVKTDGNPDIGKDS 455 (779)
Q Consensus 386 ~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~----~~~~~~~~~~~n~~~~~~~ 455 (779)
.|..|+++++|++|+|++|++++..|..+..+++|++|+|++|++++..|. +.....+.+.+|+..|..+
T Consensus 339 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 339 DSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred ChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 666666666666666666666666666666666666666666666654443 1233355566666665544
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=328.44 Aligned_cols=177 Identities=28% Similarity=0.459 Sum_probs=156.0
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
++|++.+.||+|+||+||+|+.. +++.||||++.+... .....+.+.+|++++++++|||||+++++|.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999865 789999999976532 2334577999999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
|||++|+|.+++.+.. .+++..+..|+.||+.||+|||+ ++|+||||||+|||++.++++||+|||+|+.+.
T Consensus 112 Ey~~gG~L~~~i~~~~-----~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp CCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence 9999999999996543 58999999999999999999997 899999999999999999999999999999876
Q ss_pred CCCCcccccccccCCcccccccccccC
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
...........+||+.|||||++.+..
T Consensus 184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~ 210 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSPELLTEKS 210 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCHHHHHHSC
T ss_pred CCCCcccccCcccCcccCCHHHHcCCC
Confidence 544333445678999999999998754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=334.01 Aligned_cols=177 Identities=23% Similarity=0.399 Sum_probs=150.7
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
++|++.+.||+|+||.||+|+.. +|+.||||++..........+++.+|++++++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999875 69999999998776666777889999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
||++|+|.+++..++. ..+++.+++.|+.||+.||+|||+ ++||||||||+|||++++|.+||+|||+|+....
T Consensus 104 y~~gg~L~~~i~~~~~---~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG---VLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp CCTTCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred CCCCCcHHHHHHHcCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 9999999999965432 257899999999999999999997 8999999999999999999999999999987643
Q ss_pred CCCcccccccccCCcccccccccccC
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
. .......+||+.|||||++.+..
T Consensus 178 ~--~~~~~~~~GT~~YmAPE~l~~~~ 201 (350)
T 4b9d_A 178 T--VELARACIGTPYYLSPEICENKP 201 (350)
T ss_dssp H--HHHHHHHHSCCTTCCHHHHTTCC
T ss_pred C--cccccccCCCccccCHHHHCCCC
Confidence 2 12234567999999999998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=321.81 Aligned_cols=176 Identities=30% Similarity=0.541 Sum_probs=146.5
Q ss_pred hcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
.+++++.++||+|+||+||+|+++ ..||||+++....+....++|.+|++++++++|||||++++++.. +..++|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 357788999999999999999875 369999998666566677889999999999999999999998754 56899999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
||++|+|.++++... ..+++.++..|+.||++||+|||+ ++||||||||+|||+++++++||+|||+|+....
T Consensus 112 y~~gGsL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 112 WCEGSSLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp CCSSCBHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred cCCCCCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 999999999996543 258999999999999999999997 8999999999999999999999999999987654
Q ss_pred CCCcccccccccCCcccccccccccC
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
..........+||+.|||||++.+..
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~ 210 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQD 210 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCS
T ss_pred CCcceeecccccCCCccCHHHhhccC
Confidence 33333334568999999999997653
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=347.59 Aligned_cols=373 Identities=17% Similarity=0.169 Sum_probs=255.5
Q ss_pred CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEc
Q 004020 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 143 (779)
.++++|+|++|++++..+..|.++++|++|+|++|++++.+| .|.++++|++|+|++|+++.++++.|.++++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 468889999999988888788888999999999988888777 7888888999999988888888888888888888888
Q ss_pred ccCCCCCCCCcccccCCCCCceEeccCceeEe-ecCCCccCCCCCcccEEEccCCCCCCcCCCcccc-------------
Q 004020 144 DYNSFDSWVIPESLKDATGLQRFSANGANITG-TIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK------------- 209 (779)
Q Consensus 144 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~-~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~------------- 209 (779)
++|++.+ ..+..++++++|++|++++|.+++ .+|..++ .+++|++|+|++|++++..|..++.
T Consensus 112 ~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~--~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l 188 (606)
T 3vq2_A 112 VETKLAS-LESFPIGQLITLKKLNVAHNFIHSCKLPAYFS--NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDM 188 (606)
T ss_dssp TTSCCCC-SSSSCCTTCTTCCEEECCSSCCCCCCCCGGGG--TCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEEC
T ss_pred cCCcccc-ccccccCCCCCCCEEeCCCCcccceechHhHh--hcCCCCEEEccCCcceecChhhhhhhhccccccceeec
Confidence 8888876 455678888888888888888875 5677776 6888888888888887766654432
Q ss_pred ---------------CCcceeeccCCCCCC--------------------------------------------------
Q 004020 210 ---------------SSIQTLWLNGQKGDS-------------------------------------------------- 224 (779)
Q Consensus 210 ---------------~~L~~l~l~~n~~~~-------------------------------------------------- 224 (779)
.+|+.|++++|.+..
T Consensus 189 ~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l 268 (606)
T 3vq2_A 189 SLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRL 268 (606)
T ss_dssp TTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEE
T ss_pred cCCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheec
Confidence 134444444443210
Q ss_pred ----------------------------------------------------CCC-----------------CchhhhcC
Q 004020 225 ----------------------------------------------------KLN-----------------GSVAVIQN 235 (779)
Q Consensus 225 ----------------------------------------------------~~~-----------------~~~~~~~~ 235 (779)
.++ .....+..
T Consensus 269 ~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~l~~n~~~~~~~~~~ 348 (606)
T 3vq2_A 269 TYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVA 348 (606)
T ss_dssp CCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEEEESCSSCEECCCCC
T ss_pred cccccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCcccccCCCCccceeeccCCcCccchhhcc
Confidence 000 00002234
Q ss_pred CCCccEEEeecCcccCCC--C-CCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCC-CCCCC-cccc
Q 004020 236 MTSLTQLWLHGNSFTGPL--P-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTP-KFNSP-VRFD 310 (779)
Q Consensus 236 l~~L~~L~L~~N~l~~~~--~-~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~~-~~~~ 310 (779)
+++|++|+|++|.+++.. | .+..+++|++|++++|.+++ +|..+..+++|+.|+|++|++++.+| ..+.. ..+.
T Consensus 349 l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~ 427 (606)
T 3vq2_A 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLL 427 (606)
T ss_dssp CTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCC
T ss_pred CCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCC
Confidence 556666666666766652 3 36677888888888888874 66888888888888888888888776 33222 1111
Q ss_pred cccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccc
Q 004020 311 MAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNF 390 (779)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~ 390 (779)
....++ +......+........+. ......+..........+...++|+.|+|++|++++..|..|
T Consensus 428 ~L~l~~--------n~l~~~~~~~~~~l~~L~------~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 493 (606)
T 3vq2_A 428 YLDISY--------TNTKIDFDGIFLGLTSLN------TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVF 493 (606)
T ss_dssp EEECTT--------SCCEECCTTTTTTCTTCC------EEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTT
T ss_pred EEECcC--------CCCCccchhhhcCCCCCC------EEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhh
Confidence 111111 110000000000011110 000100000000000123345689999999999999999999
Q ss_pred cccccCCeEeccCccccccCCccCCCCCCCCceeccCCcccccCCC----CC-CcceeeeCCCCCCCCCCC
Q 004020 391 SRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPN----FR-QNVIVKTDGNPDIGKDSS 456 (779)
Q Consensus 391 ~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~----~~-~~~~~~~~~n~~~~~~~~ 456 (779)
+++++|++|+|++|++++.+|..+..+++|++|||++|+|+ .+|. +. ....+.+.+|++.|..+.
T Consensus 494 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 494 DTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp TTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred cccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 99999999999999999999999999999999999999999 4554 22 245678899999997664
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=362.02 Aligned_cols=397 Identities=19% Similarity=0.231 Sum_probs=251.0
Q ss_pred CCcceeeEeCCCCcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCC-C-CCCCCCCccEEecCCCCCCCCCcc
Q 004020 53 PCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQI-P-SLSGLSSLQEVLFDDNNFTSVPSD 130 (779)
Q Consensus 53 ~C~w~gv~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-~-~~~~l~~L~~L~l~~N~l~~~~~~ 130 (779)
.|.|..|.+ -..++++|||++|.|++..|..|.++++|++|+|++|.+.+.+ | .|.++++|++|+|++|+++.++++
T Consensus 13 ~~~L~~vP~-lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~ 91 (844)
T 3j0a_A 13 FCNLTQVPQ-VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91 (844)
T ss_dssp CCCSSCCCS-SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred CCCCCCCCC-CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence 356777777 5578999999999999888889999999999999999665544 4 789999999999999999998888
Q ss_pred cccCCCCccEEEcccCCCCCCCCcc--cccCCCCCceEeccCceeEeecC-CCccCCCCCcccEEEccCCCCCCcCCCcc
Q 004020 131 FFKGLTSLQTISLDYNSFDSWVIPE--SLKDATGLQRFSANGANITGTIP-DFLGGDTIPGLMHLHLAFNFLQGPIPLSF 207 (779)
Q Consensus 131 ~~~~l~~L~~L~Ls~N~l~~~~~p~--~~~~l~~L~~L~l~~n~l~~~~p-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~ 207 (779)
.|.++++|++|+|++|++.+ .+|. .|.++++|+.|+|++|.+++..+ ..++ .+++|++|+|++|.+++..|..+
T Consensus 92 ~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~--~L~~L~~L~Ls~N~i~~~~~~~l 168 (844)
T 3j0a_A 92 AFQGLFHLFELRLYFCGLSD-AVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFG--KLNSLKSIDFSSNQIFLVCEHEL 168 (844)
T ss_dssp SSCSCSSCCCEECTTCCCSS-CCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGG--TCSSCCEEEEESSCCCCCCSGGG
T ss_pred HccCCcccCEeeCcCCCCCc-ccccCccccccCCCCEEECCCCcccccccchhHh--hCCCCCEEECCCCcCCeeCHHHc
Confidence 89999999999999999876 3343 48889999999999998887655 3565 68888888888888877666554
Q ss_pred cc---CC------------------------------cceeeccCCCCCCCCCCc-------------------------
Q 004020 208 GK---SS------------------------------IQTLWLNGQKGDSKLNGS------------------------- 229 (779)
Q Consensus 208 ~~---~~------------------------------L~~l~l~~n~~~~~~~~~------------------------- 229 (779)
+. .+ |+.|++++|.+.......
T Consensus 169 ~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~ 248 (844)
T 3j0a_A 169 EPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFG 248 (844)
T ss_dssp HHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSS
T ss_pred ccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccccccc
Confidence 32 12 566666666433211110
Q ss_pred ----------------------------------hhhhcCCCCccEEEeecCcccCCCC-CCCCCCCCcEEEccCCcccc
Q 004020 230 ----------------------------------VAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDNQLTG 274 (779)
Q Consensus 230 ----------------------------------~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~ 274 (779)
...+..+++|+.|+|++|++++.+| .|.++++|++|+|++|++++
T Consensus 249 ~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~ 328 (844)
T 3j0a_A 249 FHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGE 328 (844)
T ss_dssp CSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSC
T ss_pred ccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCc
Confidence 1123344555555555555555544 25555556666666665555
Q ss_pred ccChhhhCCCCCCEEEccCccccccCCCCCCCc-ccccc-cCCCCccc-C---------CCCcccCccch----------
Q 004020 275 IVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPV-RFDMA-KGSNSFCL-D---------DAGVACDGRVN---------- 332 (779)
Q Consensus 275 ~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~-~~~~~-~~~~~~~~-~---------~~~~~~~~~~~---------- 332 (779)
..|..|..+++|+.|+|++|++++..+..+... .+... ...|.+.. . ...+... .++
T Consensus 329 ~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~-~l~~~~~~l~~L~ 407 (844)
T 3j0a_A 329 LYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLV-TLPKINLTANLIH 407 (844)
T ss_dssp CCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCC-CCCCCCTTCCEEE
T ss_pred cCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcc-cccccccccceee
Confidence 555555566666666666666555544433211 11110 00111000 0 0000000 000
Q ss_pred ------------hhhhhcccCCCch-------------------hcccccCCCCCCCCCCC-c---cccCCCCCeEEEEc
Q 004020 333 ------------VLLSIVKSVGYPA-------------------VLAESWKGNNPCNSDWK-G---VSCDAGGNITVVNL 377 (779)
Q Consensus 333 ------------~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~-~---~~~~~~~~L~~L~L 377 (779)
......+.+.... .+.......+.....|. + ..+...++|+.|+|
T Consensus 408 ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~L 487 (844)
T 3j0a_A 408 LSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYL 487 (844)
T ss_dssp CCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCC
T ss_pred cccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEEC
Confidence 0000000000000 00000000000000010 0 11234578899999
Q ss_pred cCccccccccccccccccCCeEeccCccccccCCccCCCCCCCCceeccCCcccccCCC-CCCcceeeeCCCCCCCCCCC
Q 004020 378 KNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPN-FRQNVIVKTDGNPDIGKDSS 456 (779)
Q Consensus 378 s~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~-~~~~~~~~~~~n~~~~~~~~ 456 (779)
++|+|++..|..|..+++|+.|+|++|+|++..|..+. ++|++|||++|+|+|.+|. +.....+.+.+||+.|..+.
T Consensus 488 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 488 NHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECEL 565 (844)
T ss_dssp CHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSSC
T ss_pred CCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEEEecCCCccccccc
Confidence 99999988888899999999999999999976666665 7899999999999999987 44555788899999997653
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=340.10 Aligned_cols=334 Identities=17% Similarity=0.189 Sum_probs=279.7
Q ss_pred cceeeEeCCC----------CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCC
Q 004020 55 KWKHIQCSPS----------NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNN 123 (779)
Q Consensus 55 ~w~gv~c~~~----------~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~ 123 (779)
.|..|.|+.. .+++.|+|++|++++..+..|..+++|++|+|++|.+++..| .|.++++|++|+|++|+
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 3678888742 368999999999998888999999999999999999999877 89999999999999999
Q ss_pred CCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcC
Q 004020 124 FTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPI 203 (779)
Q Consensus 124 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~ 203 (779)
++.+++..|.++++|++|+|++|++.+ ..|..|..+++|+.|++++|.+++..|..|. .+++|++|+|++|++++..
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~l~~n~l~~~~ 168 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVI-LLDYMFQDLYNLKSLEVGDNDLVYISHRAFS--GLNSLEQLTLEKCNLTSIP 168 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEEECCTTCCEECTTSST--TCTTCCEEEEESCCCSSCC
T ss_pred CCccCcccccCCCCCCEEECCCCcccc-CChhHccccccCCEEECCCCccceeChhhcc--CCCCCCEEECCCCcCcccC
Confidence 999999999999999999999999976 6788899999999999999999998888886 7999999999999999766
Q ss_pred CCcccc-CCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCC-CCCCCCCCcEEEccCCccccccChhhh
Q 004020 204 PLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDNQLTGIVPSSLV 281 (779)
Q Consensus 204 p~~~~~-~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~l~ 281 (779)
+..+.. .+|+.|++++|.+..... ..+..+++|+.|+|++|.+.+.+| ......+|+.|++++|++++..+..+.
T Consensus 169 ~~~l~~l~~L~~L~l~~n~i~~~~~---~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~ 245 (477)
T 2id5_A 169 TEALSHLHGLIVLRLRHLNINAIRD---YSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVR 245 (477)
T ss_dssp HHHHTTCTTCCEEEEESCCCCEECT---TCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHT
T ss_pred hhHhcccCCCcEEeCCCCcCcEeCh---hhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhc
Confidence 666665 679999999998876543 346678999999999998877666 455566999999999999965557899
Q ss_pred CCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCC
Q 004020 282 NLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDW 361 (779)
Q Consensus 282 ~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (779)
.+++|+.|+|++|++++..+..+.
T Consensus 246 ~l~~L~~L~Ls~n~l~~~~~~~~~-------------------------------------------------------- 269 (477)
T 2id5_A 246 HLVYLRFLNLSYNPISTIEGSMLH-------------------------------------------------------- 269 (477)
T ss_dssp TCTTCCEEECCSSCCCEECTTSCT--------------------------------------------------------
T ss_pred CccccCeeECCCCcCCccChhhcc--------------------------------------------------------
Confidence 999999999999999877664322
Q ss_pred CccccCCCCCeEEEEccCccccccccccccccccCCeEeccCccccccCCccCCCCCCCCceeccCCcccccCCC---CC
Q 004020 362 KGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPN---FR 438 (779)
Q Consensus 362 ~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~---~~ 438 (779)
..++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..|..+++|++|+|++|++++..+. +.
T Consensus 270 ------~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~ 343 (477)
T 2id5_A 270 ------ELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFR 343 (477)
T ss_dssp ------TCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHT
T ss_pred ------ccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHh
Confidence 123789999999999999999999999999999999999976677789999999999999999876542 11
Q ss_pred CcceeeeCCCCCCCCCCC
Q 004020 439 QNVIVKTDGNPDIGKDSS 456 (779)
Q Consensus 439 ~~~~~~~~~n~~~~~~~~ 456 (779)
......+.++...|..|.
T Consensus 344 ~~~~~~~~~~~~~C~~p~ 361 (477)
T 2id5_A 344 RRWRLNFNRQQPTCATPE 361 (477)
T ss_dssp TTTSSCCTTCCCBEEESG
T ss_pred hhhccccCccCceeCCch
Confidence 111234556666676554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=327.63 Aligned_cols=180 Identities=33% Similarity=0.563 Sum_probs=145.7
Q ss_pred cCCcccceecccccEEEEEEEEc------CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 663 (779)
++|.+.++||+|+||.||+|+++ +++.||||+++.. +....++|.+|++++++++|||||+++++|.+.+..
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 56788899999999999999864 4788999999754 355667899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcccC----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEE----------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 733 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 733 (779)
|+|||||++|+|.++++..... ...+++|.+++.|+.||++||+|||+ ++||||||||+|||+++++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCC
Confidence 9999999999999999765321 12468999999999999999999997 8999999999999999999
Q ss_pred cEEEEeeccceecCCCCCcccccccccCCcccccccccccC
Q 004020 734 RAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 734 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
.+||+|||+|+..............+||+.|||||++.+..
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~ 236 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK 236 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCC
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCC
Confidence 99999999998765543333445567999999999987654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=324.50 Aligned_cols=173 Identities=25% Similarity=0.405 Sum_probs=151.6
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.+.|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++|||||+++++|.+++..|+||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 357999999999999999999875 799999999975432 23356889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
|||++|+|.+++... .+++.++..|+.||+.||+|||+ ++||||||||+|||++.+|++||+|||+|+...
T Consensus 151 Ey~~gg~L~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 221 (346)
T 4fih_A 151 EFLEGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 221 (346)
T ss_dssp CCCTTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eCCCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecC
Confidence 999999999988542 48999999999999999999997 899999999999999999999999999999875
Q ss_pred CCCCcccccccccCCcccccccccccC
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
.... .....+||+.|||||++.+..
T Consensus 222 ~~~~--~~~~~~GTp~YmAPEvl~~~~ 246 (346)
T 4fih_A 222 KEVP--RRKSLVGTPYWMAPELISRLP 246 (346)
T ss_dssp SSSC--CBCCCCSCGGGCCHHHHTTCC
T ss_pred CCCC--cccccccCcCcCCHHHHCCCC
Confidence 4322 234568999999999987653
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=361.55 Aligned_cols=324 Identities=26% Similarity=0.396 Sum_probs=198.6
Q ss_pred CcEEEEEecCCCccccCCccccCCC-CCcEEEcccCccccCCC-CCCC--CCCccEEecCCCCCCCCCcccccCCCCccE
Q 004020 65 NRVTRIQIGGQNIEGTLPKELNSLS-SLTVLEVMKNKLTGQIP-SLSG--LSSLQEVLFDDNNFTSVPSDFFKGLTSLQT 140 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~~-~~~~--l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 140 (779)
.+++.|++++|.+++.+|..+..++ +|++|+|++|++++.++ .+.. +++|++|++++|++++..+..|.++++|++
T Consensus 343 ~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 422 (768)
T 3rgz_A 343 RGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVS 422 (768)
T ss_dssp TTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCE
T ss_pred CCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCE
Confidence 3566777777777766776666665 66666666666665444 3433 556666666666666555555666666666
Q ss_pred EEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCcccc-CCcceeeccC
Q 004020 141 ISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNG 219 (779)
Q Consensus 141 L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~L~~l~l~~ 219 (779)
|+|++|++.+ .+|..+.++++|+.|++++|.+++.+|..+. .+++|++|+|++|++++.+|..++. .+|+.|++++
T Consensus 423 L~Ls~N~l~~-~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 499 (768)
T 3rgz_A 423 LHLSFNYLSG-TIPSSLGSLSKLRDLKLWLNMLEGEIPQELM--YVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSN 499 (768)
T ss_dssp EECCSSEEES-CCCGGGGGCTTCCEEECCSSCCCSCCCGGGG--GCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCS
T ss_pred EECcCCcccC-cccHHHhcCCCCCEEECCCCcccCcCCHHHc--CCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccC
Confidence 6666666654 4566666666666666666666666666554 4566666666666666666666554 4566666666
Q ss_pred CCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCC-CCCCCCCcEEEccCCccccccChhhh-----------------
Q 004020 220 QKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLV----------------- 281 (779)
Q Consensus 220 n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~l~----------------- 281 (779)
|++....+ ..++.+++|++|+|++|++++.+|. +..+++|++|++++|+++|.+|..+.
T Consensus 500 N~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~ 576 (768)
T 3rgz_A 500 NRLTGEIP---KWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYV 576 (768)
T ss_dssp SCCCSCCC---GGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEE
T ss_pred CccCCcCC---hHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccc
Confidence 65554332 2344556666666666666655553 55566666666666666555554332
Q ss_pred -----------------------------------------------------CCCCCCEEEccCccccccCCCCCCCcc
Q 004020 282 -----------------------------------------------------NLHSLAVVNLTNNLFQGQTPKFNSPVR 308 (779)
Q Consensus 282 -----------------------------------------------------~l~~L~~L~Ls~N~l~g~~p~~~~~~~ 308 (779)
.+++|+.|||++|+++|.+|..+....
T Consensus 577 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~ 656 (768)
T 3rgz_A 577 YIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMP 656 (768)
T ss_dssp EEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCT
T ss_pred ccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccc
Confidence 234556666666666666664332211
Q ss_pred cccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccc
Q 004020 309 FDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISS 388 (779)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~ 388 (779)
+...+....+...+..+ ..+....+|+.|||++|+++|.+|.
T Consensus 657 -------~L~~L~Ls~N~l~g~ip-------------------------------~~l~~L~~L~~LdLs~N~l~g~ip~ 698 (768)
T 3rgz_A 657 -------YLFILNLGHNDISGSIP-------------------------------DEVGDLRGLNILDLSSNKLDGRIPQ 698 (768)
T ss_dssp -------TCCEEECCSSCCCSCCC-------------------------------GGGGGCTTCCEEECCSSCCEECCCG
T ss_pred -------cCCEEeCcCCccCCCCC-------------------------------hHHhCCCCCCEEECCCCcccCcCCh
Confidence 00001111110000000 0122335899999999999999999
Q ss_pred cccccccCCeEeccCccccccCCccCCCCCCCCceeccCCc-cccc
Q 004020 389 NFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNH-LFGK 433 (779)
Q Consensus 389 ~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~-l~g~ 433 (779)
.+++++.|++||||+|+|+|.||.. ..+..+..+.+.+|. |.|.
T Consensus 699 ~l~~l~~L~~L~ls~N~l~g~iP~~-~~~~~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 699 AMSALTMLTEIDLSNNNLSGPIPEM-GQFETFPPAKFLNNPGLCGY 743 (768)
T ss_dssp GGGGCCCCSEEECCSSEEEEECCSS-SSGGGSCGGGGCSCTEEEST
T ss_pred HHhCCCCCCEEECcCCcccccCCCc-hhhccCCHHHhcCCchhcCC
Confidence 9999999999999999999999965 456667777788885 6664
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=322.11 Aligned_cols=180 Identities=31% Similarity=0.540 Sum_probs=152.3
Q ss_pred cCCcccceecccccEEEEEEEEc------CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 663 (779)
++|.+.+.||+|+||.||+|++. ++..||||+++.. +....++|.+|++++++++|||||+++++|.+++..
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 57888999999999999999864 4788999999754 355667899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhhccc--------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcE
Q 004020 664 LLVYEYMPQGTLSRHLFNRKE--------EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 735 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~--------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 735 (779)
++|||||++|+|.++++.... .....++|.+++.|+.||++||+|||+ ++||||||||+|||+++++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcE
Confidence 999999999999999976431 223468999999999999999999997 899999999999999999999
Q ss_pred EEEeeccceecCCCCCcccccccccCCcccccccccccC
Q 004020 736 KVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 736 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
||+|||+|+...............||+.|||||++.+..
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~ 206 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK 206 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCC
Confidence 999999998765443333334457999999999997653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=312.63 Aligned_cols=169 Identities=28% Similarity=0.407 Sum_probs=146.3
Q ss_pred cccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEe----CCeEEEEE
Q 004020 593 SEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD----GNERLLVY 667 (779)
Q Consensus 593 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 667 (779)
++.++||+|+||.||+|++. +++.||+|++..........+++.+|++++++++|||||+++++|.+ ++..|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56678999999999999875 68999999998776666677889999999999999999999999875 24579999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--cEEcCCCCCCEEEc-CCCcEEEEeeccce
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLG-DDMRAKVADFGLVR 744 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~ 744 (779)
|||++|+|.+++.+.. .+++..+..|+.||+.||+|||+ ++ ||||||||+|||++ .++.+||+|||+|+
T Consensus 109 Ey~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp ECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 9999999999996543 58999999999999999999996 55 99999999999998 47999999999998
Q ss_pred ecCCCCCcccccccccCCccccccccccc
Q 004020 745 LAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
..... .....+||+.|||||++.+.
T Consensus 181 ~~~~~----~~~~~~GTp~YmAPE~~~~~ 205 (290)
T 3fpq_A 181 LKRAS----FAKAVIGTPEFMAPEMYEEK 205 (290)
T ss_dssp GCCTT----SBEESCSSCCCCCGGGGGTC
T ss_pred eCCCC----ccCCcccCccccCHHHcCCC
Confidence 64332 23456899999999998764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=311.60 Aligned_cols=176 Identities=28% Similarity=0.454 Sum_probs=139.4
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccCh-hHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE-KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
++|++.+.||+|+||+||+|+.. +++.||+|++.+..... ...+++.+|++++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999864 79999999997654332 34567999999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+ +|+|.+++.++. .+++.++..++.||+.||+|||+ ++|+||||||+|||+++++++||+|||+|+...
T Consensus 93 Ey~-~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp ECC-CEEHHHHHHHSC-----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred eCC-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 999 679999986542 58999999999999999999997 899999999999999999999999999998765
Q ss_pred CCCCcccccccccCCcccccccccccCCCC
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
... .....+||+.|||||++.+...++
T Consensus 164 ~~~---~~~~~~GT~~Y~APE~~~~~~y~~ 190 (275)
T 3hyh_A 164 DGN---FLKTSCGSPNYAAPEVISGKLYAG 190 (275)
T ss_dssp --------------CTTSCHHHHSSSSCCC
T ss_pred CCC---ccCCeeECcccCChhhhcCCCCCC
Confidence 432 224468999999999998876543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=341.07 Aligned_cols=376 Identities=17% Similarity=0.171 Sum_probs=247.7
Q ss_pred CCcceeeEeCCC------------CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEec
Q 004020 53 PCKWKHIQCSPS------------NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLF 119 (779)
Q Consensus 53 ~C~w~gv~c~~~------------~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l 119 (779)
.|.|.|+ |+.. .++++|+|++|++++..|.+|..+++|++|+|++|++++.+| .|.++++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 4888887 7632 379999999999999999999999999999999999999887 7999999999999
Q ss_pred CCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecC-CCccCCCCCcccEEEccCCC
Q 004020 120 DDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIP-DFLGGDTIPGLMHLHLAFNF 198 (779)
Q Consensus 120 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~~~l~~L~~L~L~~N~ 198 (779)
++|+++++++..|.++++|++|+|++|++.+...|..+.++++|+.|++++|.+.+.+| ..+. .+++|++|+|++|+
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~--~l~~L~~L~L~~n~ 159 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFA--GLTSLNELEIKALS 159 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTT--TCCEEEEEEEEETT
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhh--cccccCeeeccCCc
Confidence 99999999999999999999999999999875567889999999999999999555555 5665 78999999999999
Q ss_pred CCCcCCCcccc-------------------------CCcceeeccCCCCCCCCCCch-----------------------
Q 004020 199 LQGPIPLSFGK-------------------------SSIQTLWLNGQKGDSKLNGSV----------------------- 230 (779)
Q Consensus 199 l~~~~p~~~~~-------------------------~~L~~l~l~~n~~~~~~~~~~----------------------- 230 (779)
+++.+|..++. .+|+.|++++|++........
T Consensus 160 l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 239 (549)
T 2z81_A 160 LRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDES 239 (549)
T ss_dssp CCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHH
T ss_pred ccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhH
Confidence 99888877754 245556666665544210000
Q ss_pred -----hhh-----------------------------------------------------------cCCCCccEEEeec
Q 004020 231 -----AVI-----------------------------------------------------------QNMTSLTQLWLHG 246 (779)
Q Consensus 231 -----~~~-----------------------------------------------------------~~l~~L~~L~L~~ 246 (779)
..+ ..+++|+.|++++
T Consensus 240 ~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~ 319 (549)
T 2z81_A 240 FNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVEN 319 (549)
T ss_dssp HHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEES
T ss_pred HHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEecc
Confidence 000 0012233333333
Q ss_pred CcccCCCCCC-CCCCCCcEEEccCCccccccCh---hhhCCCCCCEEEccCccccccCC--CCCCCcccccccCCCCccc
Q 004020 247 NSFTGPLPDL-SGLSSLQDFSVRDNQLTGIVPS---SLVNLHSLAVVNLTNNLFQGQTP--KFNSPVRFDMAKGSNSFCL 320 (779)
Q Consensus 247 N~l~~~~~~~-~~l~~L~~L~l~~N~l~~~~p~---~l~~l~~L~~L~Ls~N~l~g~~p--~~~~~~~~~~~~~~~~~~~ 320 (779)
|.++..+..+ ..+++|++|++++|++++.+|. .++.+++|++|+|++|++++..+ ..+.. ..++..+
T Consensus 320 n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~-------l~~L~~L 392 (549)
T 2z81_A 320 SKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLT-------LKNLTSL 392 (549)
T ss_dssp SCCCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGG-------CTTCCEE
T ss_pred CccccCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhc-------CCCCCEE
Confidence 3333211122 2456666666666666665532 25566666666666666654321 00000 0000000
Q ss_pred CCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEe
Q 004020 321 DDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLM 400 (779)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~ 400 (779)
....+... ..+ ..+.....+.......+ ....+....+.+|+.|+|++|++++.+ ..+++|++|+
T Consensus 393 ~Ls~N~l~-~lp------~~~~~~~~L~~L~Ls~N----~l~~l~~~~~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~ 457 (549)
T 2z81_A 393 DISRNTFH-PMP------DSCQWPEKMRFLNLSST----GIRVVKTCIPQTLEVLDVSNNNLDSFS----LFLPRLQELY 457 (549)
T ss_dssp ECTTCCCC-CCC------SCCCCCTTCCEEECTTS----CCSCCCTTSCTTCSEEECCSSCCSCCC----CCCTTCCEEE
T ss_pred ECCCCCCc-cCC------hhhcccccccEEECCCC----CcccccchhcCCceEEECCCCChhhhc----ccCChhcEEE
Confidence 00000000 000 00000000000000000 011111112347889999999988753 4788999999
Q ss_pred ccCccccccCCccCCCCCCCCceeccCCcccccCCC----CCCcceeeeCCCCCCCCCC
Q 004020 401 LSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPN----FRQNVIVKTDGNPDIGKDS 455 (779)
Q Consensus 401 Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~----~~~~~~~~~~~n~~~~~~~ 455 (779)
|++|+|+ .+|. ...+++|++|||++|++++.+|. +.....+.+.+|++.|..+
T Consensus 458 Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 458 ISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp CCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred CCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 9999998 7886 46788999999999999988875 3344567888898887654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=326.85 Aligned_cols=173 Identities=25% Similarity=0.411 Sum_probs=151.9
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.+.|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||+++++|.+++..|+||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT--CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 467999999999999999999875 69999999997543 223356889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
|||++|+|.+++... .+++.++..|+.||+.||+|||+ ++||||||||+|||++.+|++||+|||+|+.+.
T Consensus 228 Ey~~gG~L~~~i~~~------~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~ 298 (423)
T 4fie_A 228 EFLEGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 298 (423)
T ss_dssp ECCTTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred eCCCCCcHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECC
Confidence 999999999998542 48999999999999999999997 899999999999999999999999999999875
Q ss_pred CCCCcccccccccCCcccccccccccC
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
.... .....+||+.|||||++.+..
T Consensus 299 ~~~~--~~~~~~GTp~YmAPEvl~~~~ 323 (423)
T 4fie_A 299 KEVP--RRKSLVGTPYWMAPELISRLP 323 (423)
T ss_dssp SSCC--CBCCCEECTTTCCHHHHTTCC
T ss_pred CCCc--cccccccCcCcCCHHHHCCCC
Confidence 4322 234568999999999987653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=320.57 Aligned_cols=175 Identities=27% Similarity=0.373 Sum_probs=145.1
Q ss_pred cCCcccceecccccEEEEEEEEc----CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
++|++.+.||+|+||+||+|+.. +++.||+|++++.........++.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999763 47899999997655444444578899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
|||||+||+|.+++.+.. .+++.++..++.||+.||+|||+ ++|+||||||+|||++.+|++||+|||+|+.
T Consensus 104 vmEy~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EECCCTTCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEcCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 999999999999996543 58999999999999999999997 8999999999999999999999999999986
Q ss_pred cCCCCCcccccccccCCcccccccccccC
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
..... ......+||+.|||||++.+..
T Consensus 176 ~~~~~--~~~~~~~GT~~YmAPE~~~~~~ 202 (304)
T 3ubd_A 176 SIDHE--KKAYSFCGTVEYMAPEVVNRRG 202 (304)
T ss_dssp -------CCCCSCCCCGGGCCHHHHHTSC
T ss_pred ccCCC--ccccccccCcccCCHHHhccCC
Confidence 54432 1234568999999999997654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.33 Aligned_cols=181 Identities=25% Similarity=0.403 Sum_probs=151.5
Q ss_pred cCCcccceecccccEEEEEEEEc------CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 663 (779)
.++++.+.||+|+||.||+|++. +++.||||+++... .....++|.+|+.++++++|||||+++++|.+++..
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 34667889999999999999863 46889999997543 334457899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCC
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEG-----------LKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 732 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~-----------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~ 732 (779)
++|||||++|+|.+++..+.... ...+++.++++|+.||++||+|||+ ++||||||||+|||++++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCC
Confidence 99999999999999997543211 2358999999999999999999997 899999999999999999
Q ss_pred CcEEEEeeccceecCCCCCcccccccccCCcccccccccccC
Q 004020 733 MRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 733 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
+++||+|||+|+..............+||+.|||||++.+..
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~ 223 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK 223 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCC
Confidence 999999999998765433333344567999999999987653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=313.33 Aligned_cols=180 Identities=31% Similarity=0.463 Sum_probs=141.1
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC------
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN------ 661 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 661 (779)
.++|++.+.||+|+||.||+|+.. +++.||||+++... .+...+++.+|++++++++|||||+++++|.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 456999999999999999999875 78999999997543 3445578999999999999999999999987654
Q ss_pred ------eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcE
Q 004020 662 ------ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 735 (779)
Q Consensus 662 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 735 (779)
..|+|||||++|+|.+++..+.. ....++..++.|+.||++||+|||+ ++||||||||+|||++.++.+
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~v 157 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVV 157 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCE
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcE
Confidence 36899999999999999965432 2235677788999999999999997 899999999999999999999
Q ss_pred EEEeeccceecCCCCCcc----------cccccccCCcccccccccccC
Q 004020 736 KVADFGLVRLAPDNGKHS----------IETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 736 kl~DFG~a~~~~~~~~~~----------~~~~~~gt~~y~APE~l~~~~ 774 (779)
||+|||+|+......... ..+..+||+.|||||++.+..
T Consensus 158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~ 206 (299)
T 4g31_A 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS 206 (299)
T ss_dssp EECCCCCC--------------------------CCCTTSCHHHHTTCC
T ss_pred EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCC
Confidence 999999998765432211 123457999999999998753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=315.70 Aligned_cols=170 Identities=26% Similarity=0.361 Sum_probs=144.3
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
+.|+..++||+|+||.||+|+.. +|+.||||+++.... ..+|+.++++++|||||++++++.+++..|+|||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 46888899999999999999875 689999999975432 2469999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC-cEEEEeeccceecC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVRLAP 747 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~ 747 (779)
||++|+|.+++.... .+++..+..|+.||+.||+|||+ ++||||||||+|||++.+| ++||+|||+|+...
T Consensus 131 y~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 131 LLEGGSLGQLIKQMG-----CLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp CCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred ccCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 999999999996543 58999999999999999999996 8999999999999999987 69999999999875
Q ss_pred CCCCcc---cccccccCCcccccccccccC
Q 004020 748 DNGKHS---IETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 748 ~~~~~~---~~~~~~gt~~y~APE~l~~~~ 774 (779)
..+... .....+||+.|||||++.+..
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~ 232 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTTCC
T ss_pred CCCcccceecCCccccCccccCHHHHCCCC
Confidence 432211 123357999999999998753
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=334.65 Aligned_cols=244 Identities=16% Similarity=0.179 Sum_probs=197.9
Q ss_pred ceeeEeCCC----------CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCC
Q 004020 56 WKHIQCSPS----------NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNF 124 (779)
Q Consensus 56 w~gv~c~~~----------~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l 124 (779)
+..+.|+.. ..++.|+|++|++++..|.+|..+++|++|+|++|++++..| .|.++++|++|+|++|++
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 445778642 479999999999999889999999999999999999998877 799999999999999999
Q ss_pred CCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCC
Q 004020 125 TSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIP 204 (779)
Q Consensus 125 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p 204 (779)
+.+++..|.++++|++|+|++|++.+ ..+..+.++++|++|++++|.+++..+..+. .+++|++|+|++|++++..|
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~-l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~L~~n~l~~~~~ 170 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISS-IDFIPLHNQKTLESLYLGSNHISSIKLPKGF--PTEKLKVLDFQNNAIHYLSK 170 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSC-GGGSCCTTCTTCCEEECCSSCCCCCCCCTTC--CCTTCCEEECCSSCCCEECH
T ss_pred cccChhhhcccccccEeeccccCccc-CCcchhccCCcccEEECCCCcccccCccccc--CCcccCEEEcccCcccccCh
Confidence 99999999999999999999999986 4578899999999999999999974433333 48899999999999998777
Q ss_pred Ccccc-CCcc--eeeccCCCCCCCCCCchh----------------------------------------------hhcC
Q 004020 205 LSFGK-SSIQ--TLWLNGQKGDSKLNGSVA----------------------------------------------VIQN 235 (779)
Q Consensus 205 ~~~~~-~~L~--~l~l~~n~~~~~~~~~~~----------------------------------------------~~~~ 235 (779)
..++. .+|+ .|++++|.+....+.... .+..
T Consensus 171 ~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~ 250 (606)
T 3t6q_A 171 EDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250 (606)
T ss_dssp HHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGG
T ss_pred hhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhch
Confidence 77765 4566 788888877654332211 0111
Q ss_pred CC--CccEEEeecCcccCCCCC-CCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCC
Q 004020 236 MT--SLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKF 303 (779)
Q Consensus 236 l~--~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~ 303 (779)
+. +|+.|++++|.+++.++. +..+++|++|++++|+++ .+|..+..+++|++|+|++|++++..|..
T Consensus 251 l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~ 320 (606)
T 3t6q_A 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQIS 320 (606)
T ss_dssp GGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGC
T ss_pred hhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhh
Confidence 11 678888888888887775 788888888888888887 67888888888888888888888776643
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=330.96 Aligned_cols=351 Identities=19% Similarity=0.184 Sum_probs=233.3
Q ss_pred ceeeEeCCCCcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccC
Q 004020 56 WKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKG 134 (779)
Q Consensus 56 w~gv~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~ 134 (779)
+.+|...-..++++|+|++|++++..|.+|..+++|++|+|++|+|++.+| .|.++++|++|+|++|+++.+|.. .
T Consensus 43 L~~ip~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~---~ 119 (562)
T 3a79_B 43 LTHVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCC---P 119 (562)
T ss_dssp CCSCCTTSCTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECSC---C
T ss_pred CccCCCCCCCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCcc---c
Confidence 333333323689999999999998888899999999999999999999877 799999999999999999999877 7
Q ss_pred CCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcc--cEEEccCCCC--CCcCCCccccC
Q 004020 135 LTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGL--MHLHLAFNFL--QGPIPLSFGKS 210 (779)
Q Consensus 135 l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L--~~L~L~~N~l--~~~~p~~~~~~ 210 (779)
+++|++|+|++|++.+..+|..|.++++|++|++++|.+++. .+. .+++| ++|+|++|++ ++..|..+...
T Consensus 120 l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~--~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l 194 (562)
T 3a79_B 120 MASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLL--PVAHLHLSCILLDLVSYHIKGGETESLQIP 194 (562)
T ss_dssp CTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTG--GGTTSCEEEEEEEESSCCCCSSSCCEEEEC
T ss_pred cccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chh--hhhhceeeEEEeecccccccccCccccccc
Confidence 999999999999998755678999999999999999999752 232 34555 8999999988 77777666541
Q ss_pred ---------------------------CcceeeccCCCCCC-CCCCch---------------------------hhhcC
Q 004020 211 ---------------------------SIQTLWLNGQKGDS-KLNGSV---------------------------AVIQN 235 (779)
Q Consensus 211 ---------------------------~L~~l~l~~n~~~~-~~~~~~---------------------------~~~~~ 235 (779)
+|+.+++++|+... .+.+.+ .....
T Consensus 195 ~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~ 274 (562)
T 3a79_B 195 NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFW 274 (562)
T ss_dssp CEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHT
T ss_pred CcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhh
Confidence 22233333221000 000000 00001
Q ss_pred CCCccEEEeecCcccCCCCC-C-----------------------------------------------------CCCCC
Q 004020 236 MTSLTQLWLHGNSFTGPLPD-L-----------------------------------------------------SGLSS 261 (779)
Q Consensus 236 l~~L~~L~L~~N~l~~~~~~-~-----------------------------------------------------~~l~~ 261 (779)
.++|++|++++|.++|.+|. + ..+++
T Consensus 275 ~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~ 354 (562)
T 3a79_B 275 PRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSS 354 (562)
T ss_dssp TSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCC
T ss_pred cccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCC
Confidence 12444455555555443332 1 45667
Q ss_pred CcEEEccCCccccccChhhhCCCCCCEEEccCccccccC--CCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcc
Q 004020 262 LQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQT--PKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVK 339 (779)
Q Consensus 262 L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~--p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (779)
|++|++++|++++.+|..+.++++|+.|+|++|++++.. |..+.... +...+....+....
T Consensus 355 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~-------~L~~L~l~~N~l~~---------- 417 (562)
T 3a79_B 355 FTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMS-------SLETLDVSLNSLNS---------- 417 (562)
T ss_dssp CCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCT-------TCCEEECTTSCCBS----------
T ss_pred ceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCC-------CCCEEECCCCcCCC----------
Confidence 777777777777666777777777777777777776532 22111100 00000000000000
Q ss_pred cCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccCccccccCCccCCCCCC
Q 004020 340 SVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPS 419 (779)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~ 419 (779)
......+...++|+.|+|++|++++.+|..+. ++|++|+|++|+|+ .+|..+..+++
T Consensus 418 --------------------~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~ 474 (562)
T 3a79_B 418 --------------------HAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQA 474 (562)
T ss_dssp --------------------CCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCC
T ss_pred --------------------ccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCC
Confidence 00000122345788888999888888777665 68888999999888 78888888888
Q ss_pred CCceeccCCcccccCCC--C---CCcceeeeCCCCCCCCCC
Q 004020 420 LEMLDVSNNHLFGKVPN--F---RQNVIVKTDGNPDIGKDS 455 (779)
Q Consensus 420 L~~L~Ls~N~l~g~iP~--~---~~~~~~~~~~n~~~~~~~ 455 (779)
|++|||++|+|++ +|. + .....+.+.+|++.|..+
T Consensus 475 L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 475 LQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp CSEEECCSSCCCC-CCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred CCEEECCCCCCCC-CCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 9999999998884 443 2 233456778888877643
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-35 Score=325.29 Aligned_cols=310 Identities=19% Similarity=0.233 Sum_probs=252.1
Q ss_pred CcEEEEEecCCCccccC-CccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCC--CcccccCCCCccE
Q 004020 65 NRVTRIQIGGQNIEGTL-PKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSV--PSDFFKGLTSLQT 140 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~--~~~~~~~l~~L~~ 140 (779)
.+++.|+|++|.+.+.+ +..|..+++|++|+|++|++++.+| .|.++++|++|+|++|++++. ....|..+++|++
T Consensus 54 ~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~ 133 (455)
T 3v47_A 54 QDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEM 133 (455)
T ss_dssp TTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCE
T ss_pred ccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCE
Confidence 57999999999998666 4679999999999999999998877 899999999999999999983 3445999999999
Q ss_pred EEcccCCCCCCCCccc-ccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccc---------cC
Q 004020 141 ISLDYNSFDSWVIPES-LKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFG---------KS 210 (779)
Q Consensus 141 L~Ls~N~l~~~~~p~~-~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~---------~~ 210 (779)
|+|++|++.+ ..|.. +.++++|++|++++|.+++..|..+......+|+.|++++|.+++..+..++ ..
T Consensus 134 L~L~~n~l~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~ 212 (455)
T 3v47_A 134 LVLRDNNIKK-IQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNT 212 (455)
T ss_dssp EECCSSBCCS-CCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTC
T ss_pred EECCCCccCc-cCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccc
Confidence 9999999987 45554 8999999999999999999888877632225666666666666654443322 13
Q ss_pred CcceeeccCCCCCCCCCCc----------------------------------hhhhc--CCCCccEEEeecCcccCCCC
Q 004020 211 SIQTLWLNGQKGDSKLNGS----------------------------------VAVIQ--NMTSLTQLWLHGNSFTGPLP 254 (779)
Q Consensus 211 ~L~~l~l~~n~~~~~~~~~----------------------------------~~~~~--~l~~L~~L~L~~N~l~~~~~ 254 (779)
+|+.|++++|++....... ...+. ..++|+.|+|++|.+++.+|
T Consensus 213 ~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 292 (455)
T 3v47_A 213 SITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLK 292 (455)
T ss_dssp EEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECT
T ss_pred eeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccch
Confidence 4566666665543211100 01111 23689999999999999888
Q ss_pred C-CCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchh
Q 004020 255 D-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNV 333 (779)
Q Consensus 255 ~-~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (779)
. +..+++|++|++++|++++..|..|..+++|++|+|++|++++.+|..+.
T Consensus 293 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---------------------------- 344 (455)
T 3v47_A 293 SVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFE---------------------------- 344 (455)
T ss_dssp TTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGT----------------------------
T ss_pred hhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhc----------------------------
Confidence 5 89999999999999999999999999999999999999999877664221
Q ss_pred hhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccCccccccCCcc
Q 004020 334 LLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKE 413 (779)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~ 413 (779)
..++|+.|+|++|++++..|..|..+++|++|+|++|+|++..+..
T Consensus 345 ----------------------------------~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 390 (455)
T 3v47_A 345 ----------------------------------NLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGI 390 (455)
T ss_dssp ----------------------------------TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred ----------------------------------CcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhH
Confidence 2347999999999999999999999999999999999999766677
Q ss_pred CCCCCCCCceeccCCcccccCCCC
Q 004020 414 LTTLPSLEMLDVSNNHLFGKVPNF 437 (779)
Q Consensus 414 l~~l~~L~~L~Ls~N~l~g~iP~~ 437 (779)
+..+++|++|+|++|++++.+|..
T Consensus 391 ~~~l~~L~~L~l~~N~l~~~~~~~ 414 (455)
T 3v47_A 391 FDRLTSLQKIWLHTNPWDCSCPRI 414 (455)
T ss_dssp TTTCTTCCEEECCSSCBCCCTTTT
T ss_pred hccCCcccEEEccCCCcccCCCcc
Confidence 899999999999999999999963
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=333.86 Aligned_cols=363 Identities=18% Similarity=0.203 Sum_probs=274.0
Q ss_pred CCCcce----eeEeCCC----------CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccE
Q 004020 52 DPCKWK----HIQCSPS----------NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQE 116 (779)
Q Consensus 52 ~~C~w~----gv~c~~~----------~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~ 116 (779)
++|.+. .|.|+.. ..+++|||++|+|++..+.+|..+++|++|+|++|+|+++++ +|.+|++|++
T Consensus 25 ~~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~ 104 (635)
T 4g8a_A 25 EPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLST 104 (635)
T ss_dssp CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred CCccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCE
Confidence 456543 5778742 369999999999998888899999999999999999999888 7999999999
Q ss_pred EecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEee-cCCCccCCCCCcccEEEcc
Q 004020 117 VLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGT-IPDFLGGDTIPGLMHLHLA 195 (779)
Q Consensus 117 L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~-~p~~~~~~~l~~L~~L~L~ 195 (779)
|+|++|+|+.+++++|.++++|++|+|++|++++ ..+..|+++++|++|++++|.+++. +|..++ .+++|++|+|+
T Consensus 105 L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~-l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~--~l~~L~~L~L~ 181 (635)
T 4g8a_A 105 LILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFS--NLTNLEHLDLS 181 (635)
T ss_dssp EECTTCCCCEECGGGGTTCTTCCEEECTTSCCCC-STTCCCTTCTTCCEEECCSSCCCCCCCCGGGG--GCTTCCEEECC
T ss_pred EEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCC-CChhhhhcCcccCeeccccCccccCCCchhhc--cchhhhhhccc
Confidence 9999999999999999999999999999999987 5667899999999999999999864 567775 78999999999
Q ss_pred CCCCCCcCCCcccc-C---------------------------CcceeeccCC---------------------------
Q 004020 196 FNFLQGPIPLSFGK-S---------------------------SIQTLWLNGQ--------------------------- 220 (779)
Q Consensus 196 ~N~l~~~~p~~~~~-~---------------------------~L~~l~l~~n--------------------------- 220 (779)
+|+|++..|..+.. . .+..+.+.+|
T Consensus 182 ~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~ 261 (635)
T 4g8a_A 182 SNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF 261 (635)
T ss_dssp SSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECC
T ss_pred CccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCccccccccccccc
Confidence 99998776655432 0 0111111111
Q ss_pred -----------------------------------------------------------------------------CCC
Q 004020 221 -----------------------------------------------------------------------------KGD 223 (779)
Q Consensus 221 -----------------------------------------------------------------------------~~~ 223 (779)
.+.
T Consensus 262 ~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~ 341 (635)
T 4g8a_A 262 RNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFG 341 (635)
T ss_dssp TTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEES
T ss_pred ccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhccccccc
Confidence 000
Q ss_pred CCCCC----------------chhhhcCCCCccEEEeecCcccC--------------------------CCCCCCCCCC
Q 004020 224 SKLNG----------------SVAVIQNMTSLTQLWLHGNSFTG--------------------------PLPDLSGLSS 261 (779)
Q Consensus 224 ~~~~~----------------~~~~~~~l~~L~~L~L~~N~l~~--------------------------~~~~~~~l~~ 261 (779)
..... .......+++|+.|++++|.+.. ..+.+..+++
T Consensus 342 ~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~ 421 (635)
T 4g8a_A 342 QFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQ 421 (635)
T ss_dssp SCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTT
T ss_pred CcCcccchhhhhcccccccCCCCcccccccccccchhhccccccccccccchhhhhhhhhhhcccccccccccccccccc
Confidence 00000 00011235667777777776642 2234667899
Q ss_pred CcEEEccCCccccccC-hhhhCCCCCCEEEccCccccccCCCCCCCcc-cccccCCCCcccCCCCcccCccchhhhhhcc
Q 004020 262 LQDFSVRDNQLTGIVP-SSLVNLHSLAVVNLTNNLFQGQTPKFNSPVR-FDMAKGSNSFCLDDAGVACDGRVNVLLSIVK 339 (779)
Q Consensus 262 L~~L~l~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (779)
|+.+++..|.+....+ ..+..+++|+.+++++|.+++..|..+.... +.....++ +...
T Consensus 422 L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~--------N~~~----------- 482 (635)
T 4g8a_A 422 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG--------NSFQ----------- 482 (635)
T ss_dssp CCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTT--------CEEG-----------
T ss_pred ccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhh--------cccc-----------
Confidence 9999999998876655 5678899999999999999988886544322 10000000 0000
Q ss_pred cCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccCccccccCCccCCCCCC
Q 004020 340 SVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPS 419 (779)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~ 419 (779)
.. .....+...++|++|+|++|+|++..|..|+++++|++|+|++|+|++..|..+..+++
T Consensus 483 ---------~~----------~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~ 543 (635)
T 4g8a_A 483 ---------EN----------FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNS 543 (635)
T ss_dssp ---------GG----------EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTT
T ss_pred ---------cc----------cCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCC
Confidence 00 00011233458999999999999999999999999999999999999888999999999
Q ss_pred CCceeccCCcccccCCCC-----CCcceeeeCCCCCCCCCC
Q 004020 420 LEMLDVSNNHLFGKVPNF-----RQNVIVKTDGNPDIGKDS 455 (779)
Q Consensus 420 L~~L~Ls~N~l~g~iP~~-----~~~~~~~~~~n~~~~~~~ 455 (779)
|++|||++|+|++.+|.. .....+.+.+||+.|.+.
T Consensus 544 L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 544 LQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp CCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred CCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 999999999999999863 234467889999999754
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=324.78 Aligned_cols=317 Identities=16% Similarity=0.167 Sum_probs=276.3
Q ss_pred EEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccC
Q 004020 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146 (779)
Q Consensus 68 ~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N 146 (779)
+.++.++++++ .+|..+. ++|++|+|++|+|++.++ .|.++++|++|+|++|+++.+++..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 47899999998 7787664 589999999999999887 8999999999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCcccc-CCcceeeccCCCCCCC
Q 004020 147 SFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSK 225 (779)
Q Consensus 147 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~L~~l~l~~n~~~~~ 225 (779)
++.. ..+..|.++++|++|++++|.+++..|..+. .+++|++|+|++|++++..|..+.. .+|+.|++++|++...
T Consensus 91 ~l~~-~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 167 (477)
T 2id5_A 91 RLKL-IPLGVFTGLSNLTKLDISENKIVILLDYMFQ--DLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSI 167 (477)
T ss_dssp CCCS-CCTTSSTTCTTCCEEECTTSCCCEECTTTTT--TCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSC
T ss_pred cCCc-cCcccccCCCCCCEEECCCCccccCChhHcc--ccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCccc
Confidence 9986 4556789999999999999999999898886 7999999999999999888888876 6799999999987653
Q ss_pred CCCchhhhcCCCCccEEEeecCcccCCCC-CCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCCC
Q 004020 226 LNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFN 304 (779)
Q Consensus 226 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~ 304 (779)
....+..+++|+.|+|++|.+++..+ .+..+++|+.|++++|.+.+.+|..+....+|+.|+|++|++++..+..
T Consensus 168 ---~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~- 243 (477)
T 2id5_A 168 ---PTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLA- 243 (477)
T ss_dssp ---CHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHH-
T ss_pred ---ChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHH-
Confidence 23457788999999999999998777 4888999999999999888888888888889999999999987533211
Q ss_pred CCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccc
Q 004020 305 SPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG 384 (779)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g 384 (779)
+...++|+.|+|++|.+++
T Consensus 244 -------------------------------------------------------------~~~l~~L~~L~Ls~n~l~~ 262 (477)
T 2id5_A 244 -------------------------------------------------------------VRHLVYLRFLNLSYNPIST 262 (477)
T ss_dssp -------------------------------------------------------------HTTCTTCCEEECCSSCCCE
T ss_pred -------------------------------------------------------------hcCccccCeeECCCCcCCc
Confidence 1223489999999999999
Q ss_pred cccccccccccCCeEeccCccccccCCccCCCCCCCCceeccCCcccccCCC----CCCcceeeeCCCCCCCCCC
Q 004020 385 TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPN----FRQNVIVKTDGNPDIGKDS 455 (779)
Q Consensus 385 ~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~----~~~~~~~~~~~n~~~~~~~ 455 (779)
..+..|..+++|+.|+|++|++++..|..+..+++|++|||++|+|++..|. +.....+.+.+|++.|...
T Consensus 263 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~ 337 (477)
T 2id5_A 263 IEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCR 337 (477)
T ss_dssp ECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGG
T ss_pred cChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccc
Confidence 8888999999999999999999999999999999999999999999987664 2334578889999988754
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=328.46 Aligned_cols=127 Identities=17% Similarity=0.224 Sum_probs=97.3
Q ss_pred CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEc
Q 004020 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 143 (779)
.++++|+|++|++++..|..|..+++|++|+|++|++++.+| .|.++++|++|+|++|+++.+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~---~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH---PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC---CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCcc---ccCCccEEec
Confidence 578888888888887777788888888888888888888766 788888888888888888887765 7888888888
Q ss_pred ccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcc--cEEEccCCCC
Q 004020 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGL--MHLHLAFNFL 199 (779)
Q Consensus 144 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L--~~L~L~~N~l 199 (779)
++|++.+..+|..|+++++|++|++++|.+++. .+. .+++| ++|+|++|++
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~---~~~--~l~~L~L~~L~l~~n~l 150 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEKS---SVL--PIAHLNISKVLLVLGET 150 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGG---GGG--GGTTSCEEEEEEEECTT
T ss_pred cCCccccccchhhhccCCcceEEEecCcccchh---hcc--ccccceeeEEEeecccc
Confidence 888887655778888888888888888877641 222 34444 5555555555
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-34 Score=334.89 Aligned_cols=372 Identities=19% Similarity=0.168 Sum_probs=264.7
Q ss_pred CcceeeEeCC----------CCcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCC
Q 004020 54 CKWKHIQCSP----------SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDN 122 (779)
Q Consensus 54 C~w~gv~c~~----------~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N 122 (779)
|.++.|.|+. ..+++.|+|++|++++..+..|..+++|++|+|++|++++.+| .|.++++|++|+|++|
T Consensus 4 ~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred eECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 4455566653 2479999999999998888889999999999999999999887 6899999999999999
Q ss_pred CCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCc
Q 004020 123 NFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGP 202 (779)
Q Consensus 123 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~ 202 (779)
+++.+++..|.++++|++|+|++|++.+ ..|..|.++++|++|++++|.+++..|..++ .+++|++|+|++|++++.
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~--~l~~L~~L~L~~n~l~~~ 160 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQK-IKNNPFVKQKNLITLDLSHNGLSSTKLGTQV--QLENLQELLLSNNKIQAL 160 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCC-CCSCTTTTCTTCCEEECCSSCCSCCCCCSSS--CCTTCCEEECCSSCCCCB
T ss_pred ccCccChhhhccCCCCCEEECCCCccCc-cChhHccccCCCCEEECCCCcccccCchhhc--ccccCCEEEccCCccccc
Confidence 9999999999999999999999999976 5668899999999999999999988888886 799999999999999987
Q ss_pred CCCcccc---CCcceeeccCCCCCCCCCCchhhhcC------------------------CCCccEEEeecCcccCCCCC
Q 004020 203 IPLSFGK---SSIQTLWLNGQKGDSKLNGSVAVIQN------------------------MTSLTQLWLHGNSFTGPLPD 255 (779)
Q Consensus 203 ~p~~~~~---~~L~~l~l~~n~~~~~~~~~~~~~~~------------------------l~~L~~L~L~~N~l~~~~~~ 255 (779)
.+..++. .+|+.|++++|.+....+.....+.+ .++|+.|+|++|.+++..|.
T Consensus 161 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~ 240 (680)
T 1ziw_A 161 KSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240 (680)
T ss_dssp CHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTT
T ss_pred CHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChh
Confidence 7776543 67999999999887765554332222 26788899999999887774
Q ss_pred -CCCCC--CCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCCCCCc-ccccccCCCCcc------------
Q 004020 256 -LSGLS--SLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPV-RFDMAKGSNSFC------------ 319 (779)
Q Consensus 256 -~~~l~--~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~-~~~~~~~~~~~~------------ 319 (779)
+..++ +|++|++++|++++..|..|..+++|++|+|++|++++.+|..+... .+......+...
T Consensus 241 ~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i 320 (680)
T 1ziw_A 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKI 320 (680)
T ss_dssp TTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEE
T ss_pred HhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhccccccccccc
Confidence 66664 49999999999998888889999999999999999998887654432 111111111000
Q ss_pred -------------cCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccc-----cCCCCCeEEEEccCcc
Q 004020 320 -------------LDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVS-----CDAGGNITVVNLKNLG 381 (779)
Q Consensus 320 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~L~~L~Ls~n~ 381 (779)
+....+............+..+ .......+.. ....+. .-...+|+.|+|++|+
T Consensus 321 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L------~~L~Ls~n~~--~~~~l~~~~f~~~~~~~L~~L~L~~n~ 392 (680)
T 1ziw_A 321 DDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINL------KYLSLSNSFT--SLRTLTNETFVSLAHSPLHILNLTKNK 392 (680)
T ss_dssp CTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTC------CEEECTTCBS--CCCEECTTTTGGGTTSCCCEEECTTSC
T ss_pred ChhhcccCCCCCEEECCCCccCCCChhHhccccCC------cEEECCCCch--hhhhcchhhhcccccCcCceEECCCCC
Confidence 0000000000000000000000 0000000000 000000 0011357777777777
Q ss_pred ccccccccccccccCCeEeccCccccccCC-ccCCCCCCCCceeccCCcccccCCC
Q 004020 382 LSGTISSNFSRLTSLRQLMLSGNELTGTIP-KELTTLPSLEMLDVSNNHLFGKVPN 436 (779)
Q Consensus 382 l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP-~~l~~l~~L~~L~Ls~N~l~g~iP~ 436 (779)
+++..|..|..+++|+.|+|++|++++.+| ..+..+++|++|+|++|++++..|.
T Consensus 393 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 448 (680)
T 1ziw_A 393 ISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRN 448 (680)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTT
T ss_pred CCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChh
Confidence 777777777777777777777777777665 5677777777777777777665543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=338.25 Aligned_cols=356 Identities=18% Similarity=0.195 Sum_probs=273.6
Q ss_pred CcceeeEeC--CCCcEEEEEecCCCccc-----------------cCCcccc--CCCCCcEEEcccCccccCCC-CCCCC
Q 004020 54 CKWKHIQCS--PSNRVTRIQIGGQNIEG-----------------TLPKELN--SLSSLTVLEVMKNKLTGQIP-SLSGL 111 (779)
Q Consensus 54 C~w~gv~c~--~~~~v~~l~l~~~~l~~-----------------~~p~~l~--~l~~L~~L~Ls~N~l~~~~~-~~~~l 111 (779)
|...|+.-. .-.+++.|+|++|+++| .+|+.++ ++++|++|+|++|++.+.+| .|.++
T Consensus 435 N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L 514 (876)
T 4ecn_A 435 NRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDL 514 (876)
T ss_dssp CEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGC
T ss_pred CcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCC
Confidence 455565421 23589999999999998 4999988 99999999999999999888 79999
Q ss_pred CCccEEecCCCC-CCC--CCcc------cccCCCCccEEEcccCCCCCCCCcc--cccCCCCCceEeccCceeEeecCCC
Q 004020 112 SSLQEVLFDDNN-FTS--VPSD------FFKGLTSLQTISLDYNSFDSWVIPE--SLKDATGLQRFSANGANITGTIPDF 180 (779)
Q Consensus 112 ~~L~~L~l~~N~-l~~--~~~~------~~~~l~~L~~L~Ls~N~l~~~~~p~--~~~~l~~L~~L~l~~n~l~~~~p~~ 180 (779)
++|++|+|++|+ +++ +|.. .+..+++|++|+|++|++. .+|. .+.++++|+.|+|++|+++ .+| .
T Consensus 515 ~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~--~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~ 590 (876)
T 4ecn_A 515 PELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE--EFPASASLQKMVKLGLLDCVHNKVR-HLE-A 590 (876)
T ss_dssp SSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC--BCCCHHHHTTCTTCCEEECTTSCCC-BCC-C
T ss_pred CCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC--ccCChhhhhcCCCCCEEECCCCCcc-cch-h
Confidence 999999999998 987 4442 2344569999999999998 4788 9999999999999999999 888 6
Q ss_pred ccCCCCCcccEEEccCCCCCCcCCCcccc-CC-cceeeccCCCCCCCCCCchhhhcCCC--CccEEEeecCcccCCCCCC
Q 004020 181 LGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SS-IQTLWLNGQKGDSKLNGSVAVIQNMT--SLTQLWLHGNSFTGPLPDL 256 (779)
Q Consensus 181 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~-L~~l~l~~n~~~~~~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~~ 256 (779)
++ .+++|++|+|++|+++ .+|..+.. .+ |+.|++++|.+.. ++ ..+..++ +|+.|+|++|++++.+|.+
T Consensus 591 ~~--~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~~-lp---~~~~~~~~~~L~~L~Ls~N~l~g~ip~l 663 (876)
T 4ecn_A 591 FG--TNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IP---NIFNAKSVYVMGSVDFSYNKIGSEGRNI 663 (876)
T ss_dssp CC--TTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCCS-CC---SCCCTTCSSCEEEEECCSSCTTTTSSSC
T ss_pred hc--CCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCCc-Cc---hhhhccccCCCCEEECcCCcCCCccccc
Confidence 65 7999999999999999 89988877 56 9999999999873 33 2334444 4999999999999988754
Q ss_pred C------CCCCCcEEEccCCccccccChhh-hCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCc
Q 004020 257 S------GLSSLQDFSVRDNQLTGIVPSSL-VNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDG 329 (779)
Q Consensus 257 ~------~l~~L~~L~l~~N~l~~~~p~~l-~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (779)
. .+++|+.|+|++|+++ .+|..+ ..+++|+.|+|++|+|+..++..+....-......++..+....+...
T Consensus 664 ~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~- 741 (876)
T 4ecn_A 664 SCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT- 741 (876)
T ss_dssp SSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-
T ss_pred hhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCc-
Confidence 3 4569999999999999 566655 589999999999999994433333221000000001111111000000
Q ss_pred cchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccC------
Q 004020 330 RVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSG------ 403 (779)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~------ 403 (779)
.-.........++|+.|+|++|++++ +|..++++++|+.|+|++
T Consensus 742 -----------------------------~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~ 791 (876)
T 4ecn_A 742 -----------------------------SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEG 791 (876)
T ss_dssp -----------------------------CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTC
T ss_pred -----------------------------cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCccc
Confidence 00000001245689999999999998 899999999999999976
Q ss_pred ccccccCCccCCCCCCCCceeccCCcccccCCC--CCCcceeeeCCCCCCCC
Q 004020 404 NELTGTIPKELTTLPSLEMLDVSNNHLFGKVPN--FRQNVIVKTDGNPDIGK 453 (779)
Q Consensus 404 N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~--~~~~~~~~~~~n~~~~~ 453 (779)
|++.+.+|..+..+++|+.|+|++|+| +.||. +.....+.+.+|+...-
T Consensus 792 N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~~~L~~LdLs~N~l~~i 842 (876)
T 4ecn_A 792 NRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLTPQLYILDIADNPNISI 842 (876)
T ss_dssp CBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCCSSSCEEECCSCTTCEE
T ss_pred ccccccChHHHhcCCCCCEEECCCCCC-CccCHhhcCCCCEEECCCCCCCcc
Confidence 889999999999999999999999999 88887 23344567777775543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=305.90 Aligned_cols=175 Identities=27% Similarity=0.388 Sum_probs=141.1
Q ss_pred hcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC----eEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN----ERL 664 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~ 664 (779)
.++|.+.+.||+|+||.||+|++ +|+.||||++.... .....+.+|+..+.+++|||||++++++.+++ ..|
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 35688899999999999999987 58999999986532 11223345666667889999999999998654 579
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCCcEEcCCCCCCEEEcCCCcEEEEe
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL-----AHQSFIHRDLKPSNILLGDDMRAKVAD 739 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-----~~~~ivHrDlkp~NIll~~~~~~kl~D 739 (779)
+|||||++|+|.++++.. .+++..+.+++.|+++||+|||+. ++.+||||||||+|||++.++++||+|
T Consensus 78 lV~Ey~~~gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D 151 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred EEecCCCCCcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence 999999999999999643 478999999999999999999963 124899999999999999999999999
Q ss_pred eccceecCCCCCcc--cccccccCCccccccccccc
Q 004020 740 FGLVRLAPDNGKHS--IETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 740 FG~a~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~ 773 (779)
||+|+......... .....+||+.|||||++.+.
T Consensus 152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~ 187 (303)
T 3hmm_A 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 187 (303)
T ss_dssp CTTCEEEETTTTEESCC-----CCGGGCCHHHHTTC
T ss_pred CCCCccccCCCCceeeecccccccccccCHHHhccc
Confidence 99998775543221 12345799999999999765
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=326.40 Aligned_cols=372 Identities=16% Similarity=0.139 Sum_probs=206.5
Q ss_pred cEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcc
Q 004020 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (779)
Q Consensus 66 ~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 144 (779)
+++.|+|++|++++..+.+|..+++|++|+|++|++++.++ .|.++++|++|+|++|+++.+++..|.++++|++|+|+
T Consensus 29 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 108 (570)
T 2z63_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (570)
T ss_dssp SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccc
Confidence 56666666666666666666666666666666666666555 56666666666666666666666666666666666666
Q ss_pred cCCCCCCCCcccccCCCCCceEeccCceeEe-ecCCCccCCCCCcccEEEccCCCCCCcCCCcccc-CCc----ceeecc
Q 004020 145 YNSFDSWVIPESLKDATGLQRFSANGANITG-TIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSI----QTLWLN 218 (779)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~-~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~L----~~l~l~ 218 (779)
+|++.. ..+..++++++|++|++++|.+++ .+|..++ .+++|++|++++|++++..|..++. .+| ..|+++
T Consensus 109 ~n~l~~-l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~--~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~ 185 (570)
T 2z63_A 109 ETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFS--NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185 (570)
T ss_dssp TSCCCC-STTCSCTTCTTCCEEECCSSCCCCCCCCGGGG--GCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECT
T ss_pred cccccc-CCCccccccccccEEecCCCccceecChhhhc--ccCCCCEEeCcCCccceecHHHccchhccchhhhhcccC
Confidence 666654 223346666666666666666654 3455554 4566666666666665544444432 222 333444
Q ss_pred CCCCCCCCC-----------------------------------------------------------------------
Q 004020 219 GQKGDSKLN----------------------------------------------------------------------- 227 (779)
Q Consensus 219 ~n~~~~~~~----------------------------------------------------------------------- 227 (779)
+|.+.....
T Consensus 186 ~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~ 265 (570)
T 2z63_A 186 LNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265 (570)
T ss_dssp TCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEE
T ss_pred CCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhh
Confidence 333221110
Q ss_pred -------CchhhhcCCCCccEEEeecCcccCCCCCCC------------------------------------------C
Q 004020 228 -------GSVAVIQNMTSLTQLWLHGNSFTGPLPDLS------------------------------------------G 258 (779)
Q Consensus 228 -------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~------------------------------------------~ 258 (779)
..+..+..+++|+.|++++|.+++.++.+. .
T Consensus 266 ~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~ 345 (570)
T 2z63_A 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVD 345 (570)
T ss_dssp ETTEEESCSTTTTGGGTTCSEEEEESCEECSCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCB
T ss_pred cchhhhhhchhhhcCcCcccEEEecCccchhhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCcccccccccc
Confidence 011234455667777777766664333333 3
Q ss_pred CCCCcEEEccCCcccccc--ChhhhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccch-hhh
Q 004020 259 LSSLQDFSVRDNQLTGIV--PSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVN-VLL 335 (779)
Q Consensus 259 l~~L~~L~l~~N~l~~~~--p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 335 (779)
+++|++|++++|++++.. |..+..+++|++|+|++|++++..+.+.....+ ..+....+....... ...
T Consensus 346 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L--------~~L~l~~n~l~~~~~~~~~ 417 (570)
T 2z63_A 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQL--------EHLDFQHSNLKQMSEFSVF 417 (570)
T ss_dssp CTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEEEETCTTC--------CEEECTTSEEESCTTSCTT
T ss_pred CCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccccccccCCC--------CEEEccCCccccccchhhh
Confidence 445555555555555332 455555556666666666555544321111111 011110000000000 000
Q ss_pred hhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCcccc-ccccccccccccCCeEeccCccccccCCccC
Q 004020 336 SIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLS-GTISSNFSRLTSLRQLMLSGNELTGTIPKEL 414 (779)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~-g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l 414 (779)
.....+ .......+.-. ......+...++|+.|+|++|.++ +.+|..+..+++|++|+|++|++++..|..+
T Consensus 418 ~~l~~L------~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~ 490 (570)
T 2z63_A 418 LSLRNL------IYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 490 (570)
T ss_dssp TTCTTC------CEEECTTSCCE-ECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTT
T ss_pred hcCCCC------CEEeCcCCccc-ccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhh
Confidence 000000 00000000000 000112234567888888888887 6788888888889999999998888888888
Q ss_pred CCCCCCCceeccCCcccccCCC-C---CCcceeeeCCCCCCCCCC
Q 004020 415 TTLPSLEMLDVSNNHLFGKVPN-F---RQNVIVKTDGNPDIGKDS 455 (779)
Q Consensus 415 ~~l~~L~~L~Ls~N~l~g~iP~-~---~~~~~~~~~~n~~~~~~~ 455 (779)
..+++|++|+|++|++++.+|. + .....+.+.+|++.|..+
T Consensus 491 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 491 NSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred hcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 8888899999998888887775 2 334467778888877654
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=330.73 Aligned_cols=308 Identities=16% Similarity=0.140 Sum_probs=214.7
Q ss_pred cEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcc
Q 004020 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (779)
Q Consensus 66 ~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 144 (779)
.++.++++++.+....+..|..+++|++|+|++|.|++.++ .|.++++|++|+|++|.++++++..|.++++|++|+|+
T Consensus 52 ~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 131 (597)
T 3oja_B 52 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 131 (597)
T ss_dssp CCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEee
Confidence 57889999999986666668899999999999999999887 89999999999999999999999999999999999999
Q ss_pred cCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCC
Q 004020 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDS 224 (779)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~ 224 (779)
+|.|.+ ..+..|.++++|++|+|++|.+++..|..++ .+++|++|+|++|.+++..+..+ ..|+.|++++|.+..
T Consensus 132 ~n~l~~-l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~l--~~L~~L~l~~n~l~~ 206 (597)
T 3oja_B 132 RNDLSS-LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQ--ATTSLQNLQLSSNRLTHVDLSLI--PSLFHANVSYNLLST 206 (597)
T ss_dssp SSCCCC-CCTTTTTTCTTCCEEECCSSCCCBCCTTTTT--TCTTCCEEECTTSCCSBCCGGGC--TTCSEEECCSSCCSE
T ss_pred CCCCCC-CCHHHhccCCCCCEEEeeCCcCCCCChhhhh--cCCcCcEEECcCCCCCCcChhhh--hhhhhhhcccCcccc
Confidence 999986 4556679999999999999999998888886 79999999999999997533332 467888888776653
Q ss_pred CCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCCC
Q 004020 225 KLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFN 304 (779)
Q Consensus 225 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~ 304 (779)
. ...++|+.|++++|.++..++.+. ++|+.|+|++|.+++ +..+..+++|+.|+|++|.+++.+|..+
T Consensus 207 l--------~~~~~L~~L~ls~n~l~~~~~~~~--~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~ 274 (597)
T 3oja_B 207 L--------AIPIAVEELDASHNSINVVRGPVN--VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPF 274 (597)
T ss_dssp E--------ECCTTCSEEECCSSCCCEEECSCC--SCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGG
T ss_pred c--------cCCchhheeeccCCcccccccccC--CCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHh
Confidence 2 234566666666666665444322 466666666666664 3556666666666666666666555422
Q ss_pred CCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccc
Q 004020 305 SPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG 384 (779)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g 384 (779)
.... ++..+....+...+ + .......++|+.|+|++|.++
T Consensus 275 ~~l~-------~L~~L~Ls~N~l~~-----------------l---------------~~~~~~l~~L~~L~Ls~N~l~- 314 (597)
T 3oja_B 275 VKMQ-------RLERLYISNNRLVA-----------------L---------------NLYGQPIPTLKVLDLSHNHLL- 314 (597)
T ss_dssp TTCS-------SCCEEECTTSCCCE-----------------E---------------ECSSSCCTTCCEEECCSSCCC-
T ss_pred cCcc-------CCCEEECCCCCCCC-----------------C---------------CcccccCCCCcEEECCCCCCC-
Confidence 2110 00000000000000 0 000011235666667766666
Q ss_pred cccccccccccCCeEeccCccccccCCccCCCCCCCCceeccCCccccc
Q 004020 385 TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGK 433 (779)
Q Consensus 385 ~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ 433 (779)
.+|..++.+++|+.|+|++|+|++ +| +..+++|++|+|++|++++.
T Consensus 315 ~i~~~~~~l~~L~~L~L~~N~l~~-~~--~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 315 HVERNQPQFDRLENLYLDHNSIVT-LK--LSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp CCGGGHHHHTTCSEEECCSSCCCC-CC--CCTTCCCSEEECCSSCEEHH
T ss_pred ccCcccccCCCCCEEECCCCCCCC-cC--hhhcCCCCEEEeeCCCCCCh
Confidence 456666666667777777776663 33 55566666677777766654
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=310.19 Aligned_cols=308 Identities=17% Similarity=0.136 Sum_probs=211.0
Q ss_pred CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEc
Q 004020 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 143 (779)
.+++.|+++++.++...+..|..+++|++|+|++|++++.++ .|.++++|++|+|++|+++.+++..|.++++|++|+|
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 468899999999985555557899999999999999998887 8999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCC
Q 004020 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGD 223 (779)
Q Consensus 144 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~ 223 (779)
++|++.. ..+..|.++++|++|++++|.+++..|..+. .+++|++|+|++|++++.....+ .+|+.|++++|.+.
T Consensus 125 ~~n~l~~-l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~l--~~L~~L~l~~n~l~ 199 (390)
T 3o6n_A 125 ERNDLSS-LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQ--ATTSLQNLQLSSNRLTHVDLSLI--PSLFHANVSYNLLS 199 (390)
T ss_dssp CSSCCCC-CCTTTTTTCTTCCEEECCSSCCCBCCTTTTS--SCTTCCEEECCSSCCSBCCGGGC--TTCSEEECCSSCCS
T ss_pred CCCccCc-CCHHHhcCCCCCcEEECCCCccCccChhhcc--CCCCCCEEECCCCcCCccccccc--cccceeeccccccc
Confidence 9999986 4445579999999999999999988888886 79999999999999996532222 46777888777654
Q ss_pred CCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCC
Q 004020 224 SKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKF 303 (779)
Q Consensus 224 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~ 303 (779)
.. ...++|+.|++++|.++..+... +++|+.|++++|++++. ..+..+++|+.|+|++|++++.+|..
T Consensus 200 ~~--------~~~~~L~~L~l~~n~l~~~~~~~--~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~ 267 (390)
T 3o6n_A 200 TL--------AIPIAVEELDASHNSINVVRGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHP 267 (390)
T ss_dssp EE--------ECCSSCSEEECCSSCCCEEECCC--CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGG
T ss_pred cc--------CCCCcceEEECCCCeeeeccccc--cccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhH
Confidence 32 23456666666666666543322 35666666666666643 45666666666666666666655432
Q ss_pred CCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCcccc
Q 004020 304 NSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLS 383 (779)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~ 383 (779)
+.... ++..+....+.... ........++|+.|+|++|+++
T Consensus 268 ~~~l~-------~L~~L~L~~n~l~~--------------------------------~~~~~~~l~~L~~L~L~~n~l~ 308 (390)
T 3o6n_A 268 FVKMQ-------RLERLYISNNRLVA--------------------------------LNLYGQPIPTLKVLDLSHNHLL 308 (390)
T ss_dssp GTTCS-------SCCEEECCSSCCCE--------------------------------EECSSSCCTTCCEEECCSSCCC
T ss_pred ccccc-------cCCEEECCCCcCcc--------------------------------cCcccCCCCCCCEEECCCCcce
Confidence 21110 00000000000000 0000011235666666666666
Q ss_pred ccccccccccccCCeEeccCccccccCCccCCCCCCCCceeccCCcccc
Q 004020 384 GTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFG 432 (779)
Q Consensus 384 g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g 432 (779)
.+|..++.+++|+.|+|++|+|+ .+| +..+++|++|+|++|++++
T Consensus 309 -~~~~~~~~l~~L~~L~L~~N~i~-~~~--~~~~~~L~~L~l~~N~~~~ 353 (390)
T 3o6n_A 309 -HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDC 353 (390)
T ss_dssp -CCGGGHHHHTTCSEEECCSSCCC-CCC--CCTTCCCSEEECCSSCEEH
T ss_pred -ecCccccccCcCCEEECCCCccc-eeC--chhhccCCEEEcCCCCccc
Confidence 35555666666666666666666 333 5556666666666666654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.28 Aligned_cols=190 Identities=26% Similarity=0.403 Sum_probs=157.4
Q ss_pred eHHHHHHhhcCCcccceecccccEEEEEEEEcC------CcEEEEEEecccccChhHHHHHHHHHHHHHcCCC-CccceE
Q 004020 581 SIQVLRNVTNNFSEENVLGRGGFGTVYKGELHD------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH-RHLVGL 653 (779)
Q Consensus 581 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~ 653 (779)
.....+...++|++.+.||+|+||.||+|++.. ++.||||++.... .....+++.+|++++++++| ||||++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 334445556889999999999999999997642 3689999997543 34456789999999999975 899999
Q ss_pred eeEEEeC-CeEEEEEEecCCCChhhHhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcC
Q 004020 654 LGYCLDG-NERLLVYEYMPQGTLSRHLFNRKEE-----------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRD 721 (779)
Q Consensus 654 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrD 721 (779)
+++|... +..++|||||++|+|.++++..... ....+++.+++.|+.|||+||+|||+ ++|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCc
Confidence 9999765 5689999999999999999764421 12358999999999999999999997 8999999
Q ss_pred CCCCCEEEcCCCcEEEEeeccceecCCCCCcccccccccCCcccccccccccC
Q 004020 722 LKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 722 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
|||+|||+++++.+||+|||+|+..............+||+.|||||++.+..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~ 263 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 263 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC
Confidence 99999999999999999999999776544444445567999999999997653
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=326.51 Aligned_cols=300 Identities=20% Similarity=0.210 Sum_probs=218.5
Q ss_pred cEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEccc
Q 004020 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145 (779)
Q Consensus 66 ~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 145 (779)
.++.|++++|++++..+..|..+++|++|+|++|+++..++.+.++++|++|++++|+++.+++..+..+++|++|++++
T Consensus 255 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 334 (606)
T 3t6q_A 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKG 334 (606)
T ss_dssp EEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCS
T ss_pred ceeEEEeecCccCccCHHHhccccCCCEEeccCCccCCCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCC
Confidence 68899999999988777788999999999999999986666888899999999999999998888888999999999999
Q ss_pred CCCCCCCCcccccCCCCCceEeccCceeEeec--CCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCC
Q 004020 146 NSFDSWVIPESLKDATGLQRFSANGANITGTI--PDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGD 223 (779)
Q Consensus 146 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~--p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~ 223 (779)
|.+.+...+..+..+++|++|++++|.+++.. |..+. .+++|++|+|++|++++..|..++
T Consensus 335 n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~--------------- 397 (606)
T 3t6q_A 335 NTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLR--NLSHLQSLNLSYNEPLSLKTEAFK--------------- 397 (606)
T ss_dssp CSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTT--TCTTCCEEECCSCSCEEECTTTTT---------------
T ss_pred CCcccccchhhhhccCcCCEEECCCCccccccCcchhcc--cCCCCCEEECCCCcCCcCCHHHhc---------------
Confidence 98875445566888999999999999988776 66675 788999999999998877777765
Q ss_pred CCCCCchhhhcCCCCccEEEeecCcccCCCC-C-CCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccC-
Q 004020 224 SKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-D-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQT- 300 (779)
Q Consensus 224 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~-~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~- 300 (779)
.+++|+.|+|++|++++..+ . +..+++|++|++++|.+.+..|..+..+++|+.|+|++|++++..
T Consensus 398 -----------~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 466 (606)
T 3t6q_A 398 -----------ECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNI 466 (606)
T ss_dssp -----------TCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEE
T ss_pred -----------CCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCcccc
Confidence 46666777777777666544 2 566667777777777776666666666777777777777665421
Q ss_pred CCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCc
Q 004020 301 PKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNL 380 (779)
Q Consensus 301 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n 380 (779)
|.. ..+...++|+.|+|++|
T Consensus 467 ~~~------------------------------------------------------------~~~~~l~~L~~L~Ls~n 486 (606)
T 3t6q_A 467 QKT------------------------------------------------------------NSLQTLGRLEILVLSFC 486 (606)
T ss_dssp CSS------------------------------------------------------------CGGGGCTTCCEEECTTS
T ss_pred ccc------------------------------------------------------------hhhccCCCccEEECCCC
Confidence 110 00111235666777777
Q ss_pred cccccccccccccccCCeEeccCccccccCCccCCCCCCCCceeccCCcccccCCC----CCCcceeeeCCCCCCCCC
Q 004020 381 GLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPN----FRQNVIVKTDGNPDIGKD 454 (779)
Q Consensus 381 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~----~~~~~~~~~~~n~~~~~~ 454 (779)
++++..|..|+.+++|+.|+|++|++++.+|..+..++.| +|||++|++++.+|. +.....+.+.+||+.|..
T Consensus 487 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 563 (606)
T 3t6q_A 487 DLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC 563 (606)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSG
T ss_pred ccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccC
Confidence 7776666666667777777777777776666667777667 677777777666554 123345566666666643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=311.05 Aligned_cols=180 Identities=23% Similarity=0.400 Sum_probs=152.4
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEe------CC
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD------GN 661 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~ 661 (779)
.++|++.+.||+|+||.||+|+.. +|+.||||+++.........+.+.+|+++|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 468999999999999999999875 79999999998766555666788999999999999999999998764 35
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeec
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 741 (779)
..|+|||||+ |+|.+++... ..+++..+..|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~-----~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFG 203 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSS-----QPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFG 203 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSS-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEEeCCC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecc
Confidence 7899999996 6899988543 268999999999999999999997 899999999999999999999999999
Q ss_pred cceecCCCCC--cccccccccCCcccccccccccCCCC
Q 004020 742 LVRLAPDNGK--HSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 742 ~a~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
+|+.+..... .......+||+.|||||++.+...++
T Consensus 204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~ 241 (398)
T 4b99_A 204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYT 241 (398)
T ss_dssp TCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCC
T ss_pred eeeecccCccccccccccceeChHhcCHHHhcCCCCCC
Confidence 9987643211 12234578999999999998876654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=327.30 Aligned_cols=358 Identities=15% Similarity=0.198 Sum_probs=267.6
Q ss_pred CCcceeeEeC--CCCcEEEEEecCCCcccc-----------------CCcccc--CCCCCcEEEcccCccccCCC-CCCC
Q 004020 53 PCKWKHIQCS--PSNRVTRIQIGGQNIEGT-----------------LPKELN--SLSSLTVLEVMKNKLTGQIP-SLSG 110 (779)
Q Consensus 53 ~C~w~gv~c~--~~~~v~~l~l~~~~l~~~-----------------~p~~l~--~l~~L~~L~Ls~N~l~~~~~-~~~~ 110 (779)
++...|+.-. .-.++++|+|++|.++|. +|+.++ ++++|++|+|++|++.+.+| .|.+
T Consensus 192 ~n~l~~ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~ 271 (636)
T 4eco_A 192 SNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA 271 (636)
T ss_dssp SCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTT
T ss_pred cCCCccCCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhc
Confidence 3455664321 235899999999999996 999999 99999999999999999888 8999
Q ss_pred CCCccEEecCCCC-CCC-CCcccccCC------CCccEEEcccCCCCCCCCcc--cccCCCCCceEeccCceeEeecCCC
Q 004020 111 LSSLQEVLFDDNN-FTS-VPSDFFKGL------TSLQTISLDYNSFDSWVIPE--SLKDATGLQRFSANGANITGTIPDF 180 (779)
Q Consensus 111 l~~L~~L~l~~N~-l~~-~~~~~~~~l------~~L~~L~Ls~N~l~~~~~p~--~~~~l~~L~~L~l~~n~l~~~~p~~ 180 (779)
+++|++|+|++|+ +++ ..|..+..+ ++|++|+|++|++. .+|. .+.++++|+.|++++|+++|.+| .
T Consensus 272 l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~--~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~ 348 (636)
T 4eco_A 272 LPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK--TFPVETSLQKMKKLGMLECLYNQLEGKLP-A 348 (636)
T ss_dssp CSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS--SCCCHHHHTTCTTCCEEECCSCCCEEECC-C
T ss_pred CCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC--ccCchhhhccCCCCCEEeCcCCcCccchh-h
Confidence 9999999999998 987 444446555 99999999999998 4788 99999999999999999999999 7
Q ss_pred ccCCCCCcccEEEccCCCCCCcCCCcccc-CC-cceeeccCCCCCCCCCCchhhhcC--CCCccEEEeecCcccCCCCC-
Q 004020 181 LGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SS-IQTLWLNGQKGDSKLNGSVAVIQN--MTSLTQLWLHGNSFTGPLPD- 255 (779)
Q Consensus 181 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~-L~~l~l~~n~~~~~~~~~~~~~~~--l~~L~~L~L~~N~l~~~~~~- 255 (779)
++ .+++|++|+|++|+++ .+|..++. .+ |+.|++++|.+.. ++. .+.. +++|+.|+|++|.+++.+|.
T Consensus 349 ~~--~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~~-lp~---~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 421 (636)
T 4eco_A 349 FG--SEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLKY-IPN---IFDAKSVSVMSAIDFSYNEIGSVDGKN 421 (636)
T ss_dssp CE--EEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCSS-CCS---CCCTTCSSCEEEEECCSSCTTTTTTCS
T ss_pred hC--CCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCcc-cch---hhhhcccCccCEEECcCCcCCCcchhh
Confidence 76 7999999999999999 89988877 56 9999999999883 332 3334 34899999999999998874
Q ss_pred CC-------CCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccC
Q 004020 256 LS-------GLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACD 328 (779)
Q Consensus 256 ~~-------~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (779)
+. .+++|++|++++|+++...+..+..+++|+.|+|++|+++...+..+....-......+...+....+...
T Consensus 422 l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~ 501 (636)
T 4eco_A 422 FDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT 501 (636)
T ss_dssp SCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC
T ss_pred hcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC
Confidence 76 78899999999999995444556679999999999999994444433321000000001111111111111
Q ss_pred ccchhhhh--hcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEc------cCccccccccccccccccCCeEe
Q 004020 329 GRVNVLLS--IVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNL------KNLGLSGTISSNFSRLTSLRQLM 400 (779)
Q Consensus 329 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~L------s~n~l~g~~p~~~~~l~~L~~L~ 400 (779)
.++.... .+..+ .......+.... ........++|+.|+| ++|++.+.+|..|+++++|++|+
T Consensus 502 -~lp~~~~~~~l~~L------~~L~Ls~N~l~~--ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~ 572 (636)
T 4eco_A 502 -KLSDDFRATTLPYL------VGIDLSYNSFSK--FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQ 572 (636)
T ss_dssp -BCCGGGSTTTCTTC------CEEECCSSCCSS--CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEE
T ss_pred -ccChhhhhccCCCc------CEEECCCCCCCC--cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEE
Confidence 1110000 11111 111111111111 1112334678999999 56889999999999999999999
Q ss_pred ccCccccccCCccCCCCCCCCceeccCCcccc
Q 004020 401 LSGNELTGTIPKELTTLPSLEMLDVSNNHLFG 432 (779)
Q Consensus 401 Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g 432 (779)
|++|+| +.+|..+. ++|++|||++|++..
T Consensus 573 Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 573 IGSNDI-RKVNEKIT--PNISVLDIKDNPNIS 601 (636)
T ss_dssp CCSSCC-CBCCSCCC--TTCCEEECCSCTTCE
T ss_pred CCCCcC-CccCHhHh--CcCCEEECcCCCCcc
Confidence 999999 69999877 799999999998763
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-34 Score=302.18 Aligned_cols=274 Identities=16% Similarity=0.226 Sum_probs=172.8
Q ss_pred CChhHHHHHHHHHHHcC-CCCCC--CCC-----CCCCCcceeeEeCC---------CCcEEEEEecCCCccccCCccccC
Q 004020 25 QSSSDAAAMQALKTSLG-NPASL--GWT-----DPDPCKWKHIQCSP---------SNRVTRIQIGGQNIEGTLPKELNS 87 (779)
Q Consensus 25 ~~~~~~~~l~~~k~~~~-~~~~~--~w~-----~~~~C~w~gv~c~~---------~~~v~~l~l~~~~l~~~~p~~l~~ 87 (779)
+-.+|.+||++||+++. ++..+ +|. ..++|.|.|+.|.. ..+|+.|+|++|+++ .+|+.++.
T Consensus 24 ~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~ 102 (328)
T 4fcg_A 24 ALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFR 102 (328)
T ss_dssp CCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGG
T ss_pred cCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhh
Confidence 44678999999999984 44443 573 45899999999952 357888888888887 77777888
Q ss_pred CCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEe
Q 004020 88 LSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFS 167 (779)
Q Consensus 88 l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~ 167 (779)
+++|++|+|++|.++..+..+.++++|++|+|++|+++.+|. .+.++++|++|+|++|++.+ .+|..+...
T Consensus 103 l~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~~lp~-~l~~l~~L~~L~L~~n~~~~-~~p~~~~~~------- 173 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLRALPA-SIASLNRLRELSIRACPELT-ELPEPLAST------- 173 (328)
T ss_dssp GTTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCCCCCG-GGGGCTTCCEEEEEEETTCC-CCCSCSEEE-------
T ss_pred CCCCCEEECCCCCccchhHHHhccCCCCEEECCCCccccCcH-HHhcCcCCCEEECCCCCCcc-ccChhHhhc-------
Confidence 888888888888887443467777777777777777775544 36666666666666655543 233322210
Q ss_pred ccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecC
Q 004020 168 ANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGN 247 (779)
Q Consensus 168 l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N 247 (779)
.+++.+. .+++|++|+|++|+++ .+|..++ .+++|++|+|++|
T Consensus 174 --------~~~~~~~--~l~~L~~L~L~~n~l~-~lp~~l~--------------------------~l~~L~~L~L~~N 216 (328)
T 4fcg_A 174 --------DASGEHQ--GLVNLQSLRLEWTGIR-SLPASIA--------------------------NLQNLKSLKIRNS 216 (328)
T ss_dssp --------C-CCCEE--ESTTCCEEEEEEECCC-CCCGGGG--------------------------GCTTCCEEEEESS
T ss_pred --------cchhhhc--cCCCCCEEECcCCCcC-cchHhhc--------------------------CCCCCCEEEccCC
Confidence 0111121 2444555555555554 3443332 3445555555555
Q ss_pred cccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCccc
Q 004020 248 SFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVAC 327 (779)
Q Consensus 248 ~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (779)
++++.++.+..+++|++|++++|.+.+.+|..+..+++
T Consensus 217 ~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~------------------------------------------ 254 (328)
T 4fcg_A 217 PLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAP------------------------------------------ 254 (328)
T ss_dssp CCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCC------------------------------------------
T ss_pred CCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCC------------------------------------------
Confidence 55544334444444444444444444444444444444
Q ss_pred CccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccCcccc
Q 004020 328 DGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELT 407 (779)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 407 (779)
|+.|+|++|.+.+.+|..++++++|++|+|++|++.
T Consensus 255 --------------------------------------------L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~ 290 (328)
T 4fcg_A 255 --------------------------------------------LKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290 (328)
T ss_dssp --------------------------------------------CCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTC
T ss_pred --------------------------------------------CCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCch
Confidence 455555555555566767788888888888888888
Q ss_pred ccCCccCCCCCCCCceeccCCccc
Q 004020 408 GTIPKELTTLPSLEMLDVSNNHLF 431 (779)
Q Consensus 408 g~iP~~l~~l~~L~~L~Ls~N~l~ 431 (779)
|.+|..+..+++|+.+++..|.+.
T Consensus 291 ~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 291 SRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CCCCGGGGGSCTTCEEECCGGGSC
T ss_pred hhccHHHhhccCceEEeCCHHHHH
Confidence 888888888888888888877553
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=302.31 Aligned_cols=181 Identities=23% Similarity=0.363 Sum_probs=150.8
Q ss_pred HHHHHhhcCCcccceecccccEEEEEEEEc----CCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEE
Q 004020 583 QVLRNVTNNFSEENVLGRGGFGTVYKGELH----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYC 657 (779)
Q Consensus 583 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 657 (779)
+.+..+.++|++.+.||+|+||.||+|+.+ +++.||+|++.... ...++.+|+++++.+ +||||+++++++
T Consensus 14 ~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~ 89 (361)
T 4f9c_A 14 EAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCF 89 (361)
T ss_dssp HHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEE
T ss_pred HhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence 344557789999999999999999999753 46889999986542 335678999999998 599999999999
Q ss_pred EeCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCC-CcEE
Q 004020 658 LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAK 736 (779)
Q Consensus 658 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~-~~~k 736 (779)
.+.+..|+||||+++|+|.+++. .+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ +.+|
T Consensus 90 ~~~~~~~lvmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~k 158 (361)
T 4f9c_A 90 RKNDHVVIAMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYA 158 (361)
T ss_dssp EETTEEEEEEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEE
T ss_pred EECCEEEEEEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEE
Confidence 99999999999999999999882 47899999999999999999997 899999999999999876 8999
Q ss_pred EEeeccceecCCCCCc--------------------------ccccccccCCcccccccccccCCCCC
Q 004020 737 VADFGLVRLAPDNGKH--------------------------SIETRLAGTFGYLAPEYAAETSGMTW 778 (779)
Q Consensus 737 l~DFG~a~~~~~~~~~--------------------------~~~~~~~gt~~y~APE~l~~~~~~t~ 778 (779)
|+|||+|+...+.... ...+..+||+.|||||++.+...++.
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~ 226 (361)
T 4f9c_A 159 LVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTT 226 (361)
T ss_dssp ECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCT
T ss_pred ECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCC
Confidence 9999999865432110 11233579999999999988766553
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-32 Score=319.63 Aligned_cols=356 Identities=19% Similarity=0.219 Sum_probs=197.9
Q ss_pred cEEEEEecCCCccccCCccccCCCC--CcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEE
Q 004020 66 RVTRIQIGGQNIEGTLPKELNSLSS--LTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTIS 142 (779)
Q Consensus 66 ~v~~l~l~~~~l~~~~p~~l~~l~~--L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 142 (779)
.++.|++++|.+++..|..|..++. |++|+|++|++++.++ .|.++++|++|+|++|+++++++..|.++++|++|+
T Consensus 223 ~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 302 (680)
T 1ziw_A 223 SIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLN 302 (680)
T ss_dssp CCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEE
T ss_pred cccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEe
Confidence 4555555555555555555555433 5555555555555544 455555555555555555555555555555555555
Q ss_pred cccCCCCCC----CCcc----cccCCCCCceEeccCceeEeecCCCccCCCCCc--------------------------
Q 004020 143 LDYNSFDSW----VIPE----SLKDATGLQRFSANGANITGTIPDFLGGDTIPG-------------------------- 188 (779)
Q Consensus 143 Ls~N~l~~~----~~p~----~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~-------------------------- 188 (779)
|++|...+. .+|. .|..+++|+.|++++|++++..|..+. .+++
T Consensus 303 L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~ 380 (680)
T 1ziw_A 303 LKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFT--GLINLKYLSLSNSFTSLRTLTNETFVSLAH 380 (680)
T ss_dssp CTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTT--TCTTCCEEECTTCBSCCCEECTTTTGGGTT
T ss_pred ccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhc--cccCCcEEECCCCchhhhhcchhhhccccc
Confidence 554433210 1121 444455555555555555544444443 3444
Q ss_pred --ccEEEccCCCCCCcCCCcccc-CCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCC-CCCCCCCCcE
Q 004020 189 --LMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQD 264 (779)
Q Consensus 189 --L~~L~L~~N~l~~~~p~~~~~-~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~ 264 (779)
|++|+|++|++++..|..+.. .+|+.|++++|.+...++. ..+..+++|++|+|++|++++..+ .+..+++|+.
T Consensus 381 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~ 458 (680)
T 1ziw_A 381 SPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG--QEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQR 458 (680)
T ss_dssp SCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCS--GGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCE
T ss_pred CcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCc--ccccCcccccEEecCCCCcceeChhhhhcCccccc
Confidence 444555555555444444443 3455555555544322211 223445555555555555555444 2555555555
Q ss_pred EEccCCccc--cccChhhhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCC
Q 004020 265 FSVRDNQLT--GIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVG 342 (779)
Q Consensus 265 L~l~~N~l~--~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (779)
|++++|.+. +.+|..+..+++|+.|+|++|++++.+|..+.... +...+....+.
T Consensus 459 L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~-------~L~~L~Ls~N~---------------- 515 (680)
T 1ziw_A 459 LMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLE-------KLEILDLQHNN---------------- 515 (680)
T ss_dssp EECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCT-------TCCEEECCSSC----------------
T ss_pred chhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhcccc-------ccCEEeCCCCC----------------
Confidence 555555554 34555566666666666666666655554332211 00000000000
Q ss_pred CchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccCccccccCCccCCCCCCCCc
Q 004020 343 YPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEM 422 (779)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~ 422 (779)
+...+....|-. ....+...++|+.|+|++|+++...+..|.++++|+.|+|++|+|++..|..+..+++|++
T Consensus 516 ----l~~~~~~~~~~~---~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~ 588 (680)
T 1ziw_A 516 ----LARLWKHANPGG---PIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKS 588 (680)
T ss_dssp ----CGGGGSTTSTTS---CCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred ----ccccchhhccCC---cchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCE
Confidence 000000000000 0011344568999999999999544457999999999999999999666667889999999
Q ss_pred eeccCCcccccCCC-----CCCcceeeeCCCCCCCCCC
Q 004020 423 LDVSNNHLFGKVPN-----FRQNVIVKTDGNPDIGKDS 455 (779)
Q Consensus 423 L~Ls~N~l~g~iP~-----~~~~~~~~~~~n~~~~~~~ 455 (779)
|+|++|+|++.+|. +.....+.+.+||+.|...
T Consensus 589 L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 589 LNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp EECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred EECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 99999999998874 3455678899999999865
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=298.53 Aligned_cols=233 Identities=27% Similarity=0.452 Sum_probs=190.4
Q ss_pred cccCCCCccEEEcc-cCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCcccc
Q 004020 131 FFKGLTSLQTISLD-YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK 209 (779)
Q Consensus 131 ~~~~l~~L~~L~Ls-~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 209 (779)
.|.++++|++|+|+ +|.+.+ .+|..|.++++|++|++++|++++.+|..+. .+++|++|+|++|++++.+|..++
T Consensus 71 ~l~~l~~L~~L~L~~~n~l~~-~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~- 146 (313)
T 1ogq_A 71 SLANLPYLNFLYIGGINNLVG-PIPPAIAKLTQLHYLYITHTNVSGAIPDFLS--QIKTLVTLDFSYNALSGTLPPSIS- 146 (313)
T ss_dssp GGGGCTTCSEEEEEEETTEES-CCCGGGGGCTTCSEEEEEEECCEEECCGGGG--GCTTCCEEECCSSEEESCCCGGGG-
T ss_pred hHhCCCCCCeeeCCCCCcccc-cCChhHhcCCCCCEEECcCCeeCCcCCHHHh--CCCCCCEEeCCCCccCCcCChHHh-
Confidence 34555555555555 255544 4566666666666666666677777888776 688888888888888887877665
Q ss_pred CCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCC-CCCCCC-CCcEEEccCCccccccChhhhCCCCCC
Q 004020 210 SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLS-SLQDFSVRDNQLTGIVPSSLVNLHSLA 287 (779)
Q Consensus 210 ~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~-~L~~L~l~~N~l~~~~p~~l~~l~~L~ 287 (779)
.+++|++|+|++|++++.+| .+..++ +|++|++++|++++.+|..+..++ |+
T Consensus 147 -------------------------~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~ 200 (313)
T 1ogq_A 147 -------------------------SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LA 200 (313)
T ss_dssp -------------------------GCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CS
T ss_pred -------------------------cCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-cc
Confidence 58889999999999998777 488887 999999999999999999999998 99
Q ss_pred EEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccC
Q 004020 288 VVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCD 367 (779)
Q Consensus 288 ~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (779)
.|+|++|++++.+|..+.
T Consensus 201 ~L~Ls~N~l~~~~~~~~~-------------------------------------------------------------- 218 (313)
T 1ogq_A 201 FVDLSRNMLEGDASVLFG-------------------------------------------------------------- 218 (313)
T ss_dssp EEECCSSEEEECCGGGCC--------------------------------------------------------------
T ss_pred EEECcCCcccCcCCHHHh--------------------------------------------------------------
Confidence 999999999987765322
Q ss_pred CCCCeEEEEccCccccccccccccccccCCeEeccCccccccCCccCCCCCCCCceeccCCcccccCCCCCC---cceee
Q 004020 368 AGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQ---NVIVK 444 (779)
Q Consensus 368 ~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~~~---~~~~~ 444 (779)
..++|+.|+|++|.+++.+|. +..+++|++|+|++|+|+|.+|..+..+++|++|+|++|+++|.+|.... ...+.
T Consensus 219 ~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~ 297 (313)
T 1ogq_A 219 SDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSA 297 (313)
T ss_dssp TTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGG
T ss_pred cCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHH
Confidence 224799999999999988877 88999999999999999999999999999999999999999999998533 33567
Q ss_pred eCCCCCCCCCCC
Q 004020 445 TDGNPDIGKDSS 456 (779)
Q Consensus 445 ~~~n~~~~~~~~ 456 (779)
+.+|+++|+.|.
T Consensus 298 l~~N~~lc~~p~ 309 (313)
T 1ogq_A 298 YANNKCLCGSPL 309 (313)
T ss_dssp TCSSSEEESTTS
T ss_pred hcCCCCccCCCC
Confidence 889999998764
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-32 Score=315.87 Aligned_cols=154 Identities=21% Similarity=0.260 Sum_probs=139.2
Q ss_pred EEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccC
Q 004020 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146 (779)
Q Consensus 68 ~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N 146 (779)
+++++++++++ .+|..+. ++|++|+|++|++++.++ .|.++++|++|+|++|+++.+++..|.++++|++|+|++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n 90 (606)
T 3vq2_A 14 ITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90 (606)
T ss_dssp TEEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred CceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCC
Confidence 46888889998 7787665 799999999999999888 8999999999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCC-cCCCcccc-CCcceeeccCCCCCC
Q 004020 147 SFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQG-PIPLSFGK-SSIQTLWLNGQKGDS 224 (779)
Q Consensus 147 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~-~~L~~l~l~~n~~~~ 224 (779)
++.+ ..|..|.++++|++|++++|.+++..|..++ .+++|++|+|++|++++ .+|..++. .+|+.|++++|++..
T Consensus 91 ~l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~ 167 (606)
T 3vq2_A 91 PIQS-FSPGSFSGLTSLENLVAVETKLASLESFPIG--QLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167 (606)
T ss_dssp CCCC-CCTTSSTTCTTCCEEECTTSCCCCSSSSCCT--TCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCE
T ss_pred cccc-cChhhcCCcccCCEEEccCCccccccccccC--CCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCccee
Confidence 9987 6789999999999999999999987778886 79999999999999986 67998987 689999999998775
Q ss_pred CCC
Q 004020 225 KLN 227 (779)
Q Consensus 225 ~~~ 227 (779)
...
T Consensus 168 ~~~ 170 (606)
T 3vq2_A 168 ITV 170 (606)
T ss_dssp ECT
T ss_pred cCh
Confidence 433
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=315.47 Aligned_cols=177 Identities=25% Similarity=0.368 Sum_probs=149.9
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChh----HHHHHHHHHHHHHcCCCCccceEeeEEEeCCeE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEK----GFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 663 (779)
.++|++.++||+|+||.||+|+.. +|+.||||++.+...... .......++.+++.++|||||+++++|.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 468999999999999999999875 699999999975432211 122334456777788999999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccc
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 743 (779)
|+|||||+||+|.+++.... .+++..+..|+.||+.||+|||+ ++||||||||+|||++.+|++||+|||+|
T Consensus 268 ylVmEy~~GGdL~~~l~~~~-----~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA 339 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLA 339 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEeccccee
Confidence 99999999999999996542 58999999999999999999996 89999999999999999999999999999
Q ss_pred eecCCCCCcccccccccCCcccccccccccCCCC
Q 004020 744 RLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
+...... ....+||+.|||||++.+..+|+
T Consensus 340 ~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~ 369 (689)
T 3v5w_A 340 CDFSKKK----PHASVGTHGYMAPEVLQKGVAYD 369 (689)
T ss_dssp EECSSCC----CCSCCSCGGGCCHHHHSTTCCCC
T ss_pred eecCCCC----CCCccCCcCccCHHHHhCCCCCC
Confidence 8875432 23468999999999997655554
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=318.92 Aligned_cols=286 Identities=18% Similarity=0.214 Sum_probs=226.5
Q ss_pred CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEc
Q 004020 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 143 (779)
.+++.|+|++|.+++..|..|..+++|++|+|++|.|++.+| .|+++++|++|+|++|.|+.+|+..|.++++|++|+|
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 379999999999999888899999999999999999999888 6899999999999999999999999999999999999
Q ss_pred ccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCC
Q 004020 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGD 223 (779)
Q Consensus 144 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~ 223 (779)
++|.+.+ ..|..|..+++|+.|++++|.+++.. +. .+++|++|++++|.+++... ...|+.|++++|.+.
T Consensus 155 s~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~---~~--~l~~L~~L~l~~n~l~~l~~----~~~L~~L~ls~n~l~ 224 (597)
T 3oja_B 155 SNNNLER-IEDDTFQATTSLQNLQLSSNRLTHVD---LS--LIPSLFHANVSYNLLSTLAI----PIAVEELDASHNSIN 224 (597)
T ss_dssp CSSCCCB-CCTTTTTTCTTCCEEECTTSCCSBCC---GG--GCTTCSEEECCSSCCSEEEC----CTTCSEEECCSSCCC
T ss_pred eCCcCCC-CChhhhhcCCcCcEEECcCCCCCCcC---hh--hhhhhhhhhcccCccccccC----CchhheeeccCCccc
Confidence 9999987 67888999999999999999998653 22 57889999999999985311 136888999888876
Q ss_pred CCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCC
Q 004020 224 SKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKF 303 (779)
Q Consensus 224 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~ 303 (779)
...... .++|+.|+|++|.+++. +.+..+++|+.|+|++|.+++.+|..|..+++|+.|+|++|++++..+..
T Consensus 225 ~~~~~~------~~~L~~L~L~~n~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~ 297 (597)
T 3oja_B 225 VVRGPV------NVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYG 297 (597)
T ss_dssp EEECSC------CSCCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEEECSS
T ss_pred cccccc------CCCCCEEECCCCCCCCC-hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCCCccc
Confidence 543322 36788999999988874 56788889999999999998888888989999999999999888854432
Q ss_pred CCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCcccc
Q 004020 304 NSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLS 383 (779)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~ 383 (779)
.....+.. +....+.... ++ ......++|+.|+|++|.++
T Consensus 298 ~~l~~L~~--------L~Ls~N~l~~-i~-------------------------------~~~~~l~~L~~L~L~~N~l~ 337 (597)
T 3oja_B 298 QPIPTLKV--------LDLSHNHLLH-VE-------------------------------RNQPQFDRLENLYLDHNSIV 337 (597)
T ss_dssp SCCTTCCE--------EECCSSCCCC-CG-------------------------------GGHHHHTTCSEEECCSSCCC
T ss_pred ccCCCCcE--------EECCCCCCCc-cC-------------------------------cccccCCCCCEEECCCCCCC
Confidence 21111111 1110000000 00 00112347999999999998
Q ss_pred ccccccccccccCCeEeccCccccccC
Q 004020 384 GTISSNFSRLTSLRQLMLSGNELTGTI 410 (779)
Q Consensus 384 g~~p~~~~~l~~L~~L~Ls~N~l~g~i 410 (779)
+. | ++.+++|+.|+|++|.+++..
T Consensus 338 ~~-~--~~~~~~L~~L~l~~N~~~~~~ 361 (597)
T 3oja_B 338 TL-K--LSTHHTLKNLTLSHNDWDCNS 361 (597)
T ss_dssp CC-C--CCTTCCCSEEECCSSCEEHHH
T ss_pred Cc-C--hhhcCCCCEEEeeCCCCCChh
Confidence 65 3 778899999999999999754
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=312.69 Aligned_cols=356 Identities=18% Similarity=0.206 Sum_probs=231.9
Q ss_pred EEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccC
Q 004020 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146 (779)
Q Consensus 68 ~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N 146 (779)
+.||+++|+++ .+|..+. ++|++|+|++|++++.+| .|.++++|++|+|++|++++++++.|.++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 57999999999 6888777 899999999999999887 8999999999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCceEeccCceeEe-ecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCc--ceeeccCCCC-
Q 004020 147 SFDSWVIPESLKDATGLQRFSANGANITG-TIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSI--QTLWLNGQKG- 222 (779)
Q Consensus 147 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~-~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L--~~l~l~~n~~- 222 (779)
++.. +|.. .+++|++|++++|.+++ .+|..++ .+++|++|+|++|++++.....+ ..| +.|++++|.+
T Consensus 80 ~l~~--lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~--~l~~L~~L~L~~n~l~~~~~~~l--~~L~L~~L~l~~n~l~ 151 (520)
T 2z7x_B 80 KLVK--ISCH--PTVNLKHLDLSFNAFDALPICKEFG--NMSQLKFLGLSTTHLEKSSVLPI--AHLNISKVLLVLGETY 151 (520)
T ss_dssp CCCE--EECC--CCCCCSEEECCSSCCSSCCCCGGGG--GCTTCCEEEEEESSCCGGGGGGG--TTSCEEEEEEEECTTT
T ss_pred ceee--cCcc--ccCCccEEeccCCccccccchhhhc--cCCcceEEEecCcccchhhcccc--ccceeeEEEeeccccc
Confidence 9975 6666 89999999999999997 4788887 79999999999999986322222 345 8888888877
Q ss_pred -CCCCCCchhh-----------------------------------------------------hcC-------------
Q 004020 223 -DSKLNGSVAV-----------------------------------------------------IQN------------- 235 (779)
Q Consensus 223 -~~~~~~~~~~-----------------------------------------------------~~~------------- 235 (779)
....+..+.. +..
T Consensus 152 ~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~ 231 (520)
T 2z7x_B 152 GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIE 231 (520)
T ss_dssp TSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEE
T ss_pred ccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccc
Confidence 3222221111 111
Q ss_pred --------------CCCccEEEeecCcccCCCCC-C-----CCCCCCcEEEccCCccccccC-hh---------------
Q 004020 236 --------------MTSLTQLWLHGNSFTGPLPD-L-----SGLSSLQDFSVRDNQLTGIVP-SS--------------- 279 (779)
Q Consensus 236 --------------l~~L~~L~L~~N~l~~~~~~-~-----~~l~~L~~L~l~~N~l~~~~p-~~--------------- 279 (779)
+++|++|+|++|+++|.+|. + ..+++|+.+++++|.+ .+| ..
T Consensus 232 l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l 309 (520)
T 2z7x_B 232 TTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTV 309 (520)
T ss_dssp EEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEE
T ss_pred cCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEc
Confidence 23677888888888876664 4 5555555555555555 233 11
Q ss_pred ----------hhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCc--cchhhhhhcccCCCchhc
Q 004020 280 ----------LVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDG--RVNVLLSIVKSVGYPAVL 347 (779)
Q Consensus 280 ----------l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 347 (779)
+..+++|++|+|++|++++.+|..+.... +...+....+.... ..+.....+..+.
T Consensus 310 ~~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~-------~L~~L~L~~N~l~~l~~~~~~~~~l~~L~----- 377 (520)
T 2z7x_B 310 SGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLT-------ELETLILQMNQLKELSKIAEMTTQMKSLQ----- 377 (520)
T ss_dssp ESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCCCS-------SCCEEECCSSCCCBHHHHHHHHTTCTTCC-----
T ss_pred CCCccccccchhhCCcccEEEeECCccChhhhhhhccCC-------CCCEEEccCCccCccccchHHHhhCCCCC-----
Confidence 15667777777777777776665433221 11111111111110 0000000011110
Q ss_pred ccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccCccccccCCccCCCCCCCCceeccC
Q 004020 348 AESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSN 427 (779)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~ 427 (779)
......+..........+...++|+.|+|++|++++.+|..+. ++|+.|+|++|+|+ .+|..+..+++|++|+|++
T Consensus 378 -~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~ 453 (520)
T 2z7x_B 378 -QLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVAS 453 (520)
T ss_dssp -EEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCS
T ss_pred -EEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCC
Confidence 0001110000000001123345677777777777776666554 67777777777777 7777666777777777777
Q ss_pred CcccccCCC--C---CCcceeeeCCCCCCCC
Q 004020 428 NHLFGKVPN--F---RQNVIVKTDGNPDIGK 453 (779)
Q Consensus 428 N~l~g~iP~--~---~~~~~~~~~~n~~~~~ 453 (779)
|+|++ +|. + .....+.+.+|++.|.
T Consensus 454 N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~ 483 (520)
T 2z7x_B 454 NQLKS-VPDGIFDRLTSLQKIWLHTNPWDCS 483 (520)
T ss_dssp SCCCC-CCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CcCCc-cCHHHhccCCcccEEECcCCCCccc
Confidence 77773 443 2 2333556666666664
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-32 Score=310.75 Aligned_cols=336 Identities=15% Similarity=0.166 Sum_probs=242.5
Q ss_pred EEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEccc
Q 004020 67 VTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145 (779)
Q Consensus 67 v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 145 (779)
.+.+++++++++ .+|..+. ++|++|+|++|+|++.++ .|.++++|++|+|++|++++++++.|.++++|++|+|++
T Consensus 33 ~~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 109 (562)
T 3a79_B 33 ESMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSH 109 (562)
T ss_dssp CCEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTT
T ss_pred CcEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCC
Confidence 389999999999 4887765 899999999999999887 899999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccccCCCCCceEeccCceeEe-ecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCC--
Q 004020 146 NSFDSWVIPESLKDATGLQRFSANGANITG-TIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKG-- 222 (779)
Q Consensus 146 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~-~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~-- 222 (779)
|+|.. +|.. .+++|++|++++|++++ .+|..++ .+++|++|+|++|++++.....+....|+.|++++|.+
T Consensus 110 N~l~~--lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~--~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~L~~n~l~~ 183 (562)
T 3a79_B 110 NRLQN--ISCC--PMASLRHLDLSFNDFDVLPVCKEFG--NLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHI 183 (562)
T ss_dssp SCCCE--ECSC--CCTTCSEEECCSSCCSBCCCCGGGG--GCTTCCEEEEECSBCCTTTTGGGTTSCEEEEEEEESSCCC
T ss_pred CcCCc--cCcc--ccccCCEEECCCCCccccCchHhhc--ccCcccEEecCCCccccCchhhhhhceeeEEEeecccccc
Confidence 99985 6665 89999999999999997 3467887 79999999999999986433333333459999999988
Q ss_pred CCCCCCchhh-----------------------hcCCCCccEEEeecCcc-----cCCCC--------------------
Q 004020 223 DSKLNGSVAV-----------------------IQNMTSLTQLWLHGNSF-----TGPLP-------------------- 254 (779)
Q Consensus 223 ~~~~~~~~~~-----------------------~~~l~~L~~L~L~~N~l-----~~~~~-------------------- 254 (779)
....+..+.. +..+++|+.|++++|+. .+.++
T Consensus 184 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~ 263 (562)
T 3a79_B 184 KGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTW 263 (562)
T ss_dssp CSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECH
T ss_pred cccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcH
Confidence 5444433322 22455677777777631 11000
Q ss_pred -------CCCCCCCCcEEEccCCccccccChhh-----------------------------------------------
Q 004020 255 -------DLSGLSSLQDFSVRDNQLTGIVPSSL----------------------------------------------- 280 (779)
Q Consensus 255 -------~~~~l~~L~~L~l~~N~l~~~~p~~l----------------------------------------------- 280 (779)
.....++|++|++++|+++|.+|..+
T Consensus 264 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~ 343 (562)
T 3a79_B 264 KCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPF 343 (562)
T ss_dssp HHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCC
T ss_pred HHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCc
Confidence 01112488999999999998888765
Q ss_pred ------hCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCC
Q 004020 281 ------VNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGN 354 (779)
Q Consensus 281 ------~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (779)
..+++|++|+|++|++++.+|..+.... +...+....+.... ....
T Consensus 344 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-------~L~~L~L~~N~l~~-~~~~-------------------- 395 (562)
T 3a79_B 344 IHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLK-------RLQTLILQRNGLKN-FFKV-------------------- 395 (562)
T ss_dssp CCCCCCSSCCCCCEEECCSSCCCTTTTTTCCSCS-------SCCEEECCSSCCCB-TTHH--------------------
T ss_pred ccccCccCCCCceEEECCCCccccchhhhhcccC-------CCCEEECCCCCcCC-cccc--------------------
Confidence 6789999999999999998876543321 01111110000000 0000
Q ss_pred CCCCCCCCccccCCCCCeEEEEccCccccccccc-cccccccCCeEeccCccccccCCccCCCCCCCCceeccCCccccc
Q 004020 355 NPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISS-NFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGK 433 (779)
Q Consensus 355 ~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~-~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ 433 (779)
.......++|+.|+|++|++++.+|. .+..+++|++|+|++|+|++.+|..+. ++|++|||++|+++ .
T Consensus 396 --------~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ 464 (562)
T 3a79_B 396 --------ALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-S 464 (562)
T ss_dssp --------HHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-C
T ss_pred --------hhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-c
Confidence 00122345788888888888875665 477788888888888888887777665 67888888888887 4
Q ss_pred CCC-C---CCcceeeeCCCCC
Q 004020 434 VPN-F---RQNVIVKTDGNPD 450 (779)
Q Consensus 434 iP~-~---~~~~~~~~~~n~~ 450 (779)
+|. + .....+.+.+|..
T Consensus 465 ip~~~~~l~~L~~L~L~~N~l 485 (562)
T 3a79_B 465 IPKDVTHLQALQELNVASNQL 485 (562)
T ss_dssp CCTTTTSSCCCSEEECCSSCC
T ss_pred cChhhcCCCCCCEEECCCCCC
Confidence 554 2 2333555666643
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.6e-31 Score=293.10 Aligned_cols=212 Identities=19% Similarity=0.166 Sum_probs=183.6
Q ss_pred CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcc
Q 004020 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 144 (779)
.++++|++++|++++. | .+..+++|++|+|++|+|++.+ ++.+++|++|++++|++++++ +.++++|++|+|+
T Consensus 42 ~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~~--~~~l~~L~~L~Ls~N~l~~~~---~~~l~~L~~L~L~ 114 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTLD--LSQNTNLTYLACDSNKLTNLD---VTPLTKLTYLNCD 114 (457)
T ss_dssp TTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECC
T ss_pred CCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeEc--cccCCCCCEEECcCCCCceee---cCCCCcCCEEECC
Confidence 5799999999999964 5 7999999999999999999863 899999999999999999985 8899999999999
Q ss_pred cCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCcccc-CCcceeeccCCCCC
Q 004020 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGD 223 (779)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~L~~l~l~~n~~~ 223 (779)
+|++.+ +| +..+++|++|++++|++++. + ++ .+++|++|++++|+..+.++ ++. .+|+.|++++|++.
T Consensus 115 ~N~l~~--l~--~~~l~~L~~L~l~~N~l~~l-~--l~--~l~~L~~L~l~~n~~~~~~~--~~~l~~L~~L~ls~n~l~ 183 (457)
T 3bz5_A 115 TNKLTK--LD--VSQNPLLTYLNCARNTLTEI-D--VS--HNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183 (457)
T ss_dssp SSCCSC--CC--CTTCTTCCEEECTTSCCSCC-C--CT--TCTTCCEEECTTCSCCCCCC--CTTCTTCCEEECCSSCCC
T ss_pred CCcCCe--ec--CCCCCcCCEEECCCCcccee-c--cc--cCCcCCEEECCCCCcccccc--cccCCcCCEEECCCCccc
Confidence 999986 44 88999999999999999974 3 44 68999999999997666663 444 67999999999887
Q ss_pred CCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCC
Q 004020 224 SKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKF 303 (779)
Q Consensus 224 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~ 303 (779)
... +..+++|+.|++++|++++. ++..+++|+.|++++|++++ +| +..+++|+.|++++|++++.++..
T Consensus 184 ~l~------l~~l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~ 252 (457)
T 3bz5_A 184 ELD------VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVST 252 (457)
T ss_dssp CCC------CTTCTTCCEEECCSSCCSCC--CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTT
T ss_pred eec------cccCCCCCEEECcCCcCCee--ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHH
Confidence 742 56889999999999999986 48889999999999999997 66 889999999999999999976654
Q ss_pred CC
Q 004020 304 NS 305 (779)
Q Consensus 304 ~~ 305 (779)
+.
T Consensus 253 l~ 254 (457)
T 3bz5_A 253 LS 254 (457)
T ss_dssp CT
T ss_pred CC
Confidence 43
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.4e-31 Score=306.62 Aligned_cols=375 Identities=20% Similarity=0.189 Sum_probs=244.6
Q ss_pred EEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccC
Q 004020 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146 (779)
Q Consensus 68 ~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N 146 (779)
+.++.++.+++ .+|..+. +++++|+|++|++++.++ .|.++++|++|+|++|++++++++.|.++++|++|+|++|
T Consensus 10 ~~~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 86 (570)
T 2z63_A 10 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86 (570)
T ss_dssp TEEECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred cEEEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCC
Confidence 34667777777 6777654 589999999999999887 8999999999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCC-cCCCcccc-CCcceeeccCCCCCC
Q 004020 147 SFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQG-PIPLSFGK-SSIQTLWLNGQKGDS 224 (779)
Q Consensus 147 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~-~~L~~l~l~~n~~~~ 224 (779)
++.+ ..|..|.++++|++|++++|++++..+..++ .+++|++|+|++|.+++ .+|..++. .+|+.|++++|++..
T Consensus 87 ~l~~-~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~--~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~ 163 (570)
T 2z63_A 87 PIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIG--HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163 (570)
T ss_dssp CCCE-ECTTTTTTCTTCCEEECTTSCCCCSTTCSCT--TCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCE
T ss_pred cCCc-cCHhhhcCccccccccccccccccCCCcccc--ccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccce
Confidence 9976 5678999999999999999999976665675 79999999999999997 47999987 689999999999876
Q ss_pred CCCCchhhhcCCCCc-cEEEeecCcccCCCCC------------------------------------------------
Q 004020 225 KLNGSVAVIQNMTSL-TQLWLHGNSFTGPLPD------------------------------------------------ 255 (779)
Q Consensus 225 ~~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~------------------------------------------------ 255 (779)
.....+..+.+++.+ +.|++++|.+++..|.
T Consensus 164 ~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l 243 (570)
T 2z63_A 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL 243 (570)
T ss_dssp ECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSC
T ss_pred ecHHHccchhccchhhhhcccCCCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhh
Confidence 654444433333221 5677777766655443
Q ss_pred ----------------------------------CCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCC
Q 004020 256 ----------------------------------LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTP 301 (779)
Q Consensus 256 ----------------------------------~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p 301 (779)
+..+++|+.|++++|.+. .+|..+..+ +|+.|++++|.+. .+|
T Consensus 244 ~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~ 320 (570)
T 2z63_A 244 EKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFP 320 (570)
T ss_dssp EECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCC
T ss_pred hhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccC
Confidence 233455555555555555 345555554 5555555555554 222
Q ss_pred CC-CCC-ccccccc-----------CCCCcccCCCCcccCccc--hhhhhhcccCCCc---h--------------hccc
Q 004020 302 KF-NSP-VRFDMAK-----------GSNSFCLDDAGVACDGRV--NVLLSIVKSVGYP---A--------------VLAE 349 (779)
Q Consensus 302 ~~-~~~-~~~~~~~-----------~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~---~--------------~~~~ 349 (779)
.. +.. ..+.+.. ..+...+....+...... .........+... . .+..
T Consensus 321 ~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~ 400 (570)
T 2z63_A 321 TLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEH 400 (570)
T ss_dssp BCBCSSCCEEEEESCBSCCBCCCCBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEEEETCTTCCE
T ss_pred cccccccCEEeCcCCccccccccccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccccccccCCCCE
Confidence 11 000 0000000 000011111111000000 0000001111000 0 0000
Q ss_pred ccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccCcccc-ccCCccCCCCCCCCceeccCC
Q 004020 350 SWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELT-GTIPKELTTLPSLEMLDVSNN 428 (779)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~-g~iP~~l~~l~~L~~L~Ls~N 428 (779)
.....+..........+...++|+.|++++|.+.+.+|..|..+++|++|+|++|+++ +.+|..+..+++|++|+|++|
T Consensus 401 L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n 480 (570)
T 2z63_A 401 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480 (570)
T ss_dssp EECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTS
T ss_pred EEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCC
Confidence 0000000000000012345568888899999888888888888899999999999987 678888888999999999999
Q ss_pred cccccCCC-C---CCcceeeeCCCCCC
Q 004020 429 HLFGKVPN-F---RQNVIVKTDGNPDI 451 (779)
Q Consensus 429 ~l~g~iP~-~---~~~~~~~~~~n~~~ 451 (779)
++++.+|. + .....+.+.+|...
T Consensus 481 ~l~~~~~~~~~~l~~L~~L~l~~n~l~ 507 (570)
T 2z63_A 481 QLEQLSPTAFNSLSSLQVLNMASNQLK 507 (570)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred ccccCChhhhhcccCCCEEeCCCCcCC
Confidence 99888775 2 23445666666443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=295.46 Aligned_cols=284 Identities=17% Similarity=0.260 Sum_probs=235.7
Q ss_pred CCCCCcceeeEeCCCCcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCC
Q 004020 50 DPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVP 128 (779)
Q Consensus 50 ~~~~C~w~gv~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~ 128 (779)
...+|.|.++ | ++++++++ .+|..+. ++|++|+|++|++++.++ .|.++++|++|+|++|++++++
T Consensus 26 ~~~~C~~~~~-c---------~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 92 (353)
T 2z80_A 26 ASLSCDRNGI-C---------KGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIE 92 (353)
T ss_dssp -CCEECTTSE-E---------ECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEEC
T ss_pred cCCCCCCCeE-e---------eCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccC
Confidence 3567888876 5 45678888 6787666 499999999999998887 7999999999999999999999
Q ss_pred cccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCC--CccCCCCCcccEEEccCCC-CCCcCCC
Q 004020 129 SDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD--FLGGDTIPGLMHLHLAFNF-LQGPIPL 205 (779)
Q Consensus 129 ~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~--~~~~~~l~~L~~L~L~~N~-l~~~~p~ 205 (779)
+..|.++++|++|+|++|++.+ ..+..|.++++|++|++++|++++ +|. .+. .+++|++|++++|+ +++..|.
T Consensus 93 ~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~--~l~~L~~L~l~~n~~~~~~~~~ 168 (353)
T 2z80_A 93 EDSFSSLGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFS--HLTKLQILRVGNMDTFTKIQRK 168 (353)
T ss_dssp TTTTTTCTTCCEEECCSSCCSS-CCHHHHTTCTTCSEEECTTCCCSS-SCSSCSCT--TCTTCCEEEEEESSSCCEECTT
T ss_pred HhhcCCCCCCCEEECCCCcCCc-CCHhHhCCCccCCEEECCCCCCcc-cCchhhhc--cCCCCcEEECCCCccccccCHH
Confidence 9999999999999999999986 445569999999999999999984 554 564 79999999999995 6655555
Q ss_pred ccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCC-CCCCCCCCcEEEccCCccccccChhhhCCC
Q 004020 206 SFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLH 284 (779)
Q Consensus 206 ~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~ 284 (779)
.++ .+++|++|+|++|++++.+| .+..+++|++|++++|++....+..+..++
T Consensus 169 ~~~--------------------------~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~ 222 (353)
T 2z80_A 169 DFA--------------------------GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTS 222 (353)
T ss_dssp TTT--------------------------TCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTT
T ss_pred Hcc--------------------------CCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcc
Confidence 554 68999999999999999877 589999999999999999754444556799
Q ss_pred CCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCcc
Q 004020 285 SLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGV 364 (779)
Q Consensus 285 ~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (779)
+|+.|+|++|++++..+..+...
T Consensus 223 ~L~~L~L~~n~l~~~~~~~l~~~--------------------------------------------------------- 245 (353)
T 2z80_A 223 SVECLELRDTDLDTFHFSELSTG--------------------------------------------------------- 245 (353)
T ss_dssp TEEEEEEESCBCTTCCCC--------------------------------------------------------------
T ss_pred cccEEECCCCccccccccccccc---------------------------------------------------------
Confidence 99999999999987655421110
Q ss_pred ccCCCCCeEEEEccCccccc----cccccccccccCCeEeccCccccccCCcc-CCCCCCCCceeccCCcccccCCC
Q 004020 365 SCDAGGNITVVNLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKE-LTTLPSLEMLDVSNNHLFGKVPN 436 (779)
Q Consensus 365 ~~~~~~~L~~L~Ls~n~l~g----~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~-l~~l~~L~~L~Ls~N~l~g~iP~ 436 (779)
.....++.++|+++.+++ .+|..+..+++|+.|+|++|+|+ .+|.. +..+++|++|+|++|++++..|.
T Consensus 246 --~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~~ 319 (353)
T 2z80_A 246 --ETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 319 (353)
T ss_dssp ---CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred --cccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence 012357778888888887 57889999999999999999999 78777 58999999999999999998874
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=314.72 Aligned_cols=344 Identities=19% Similarity=0.182 Sum_probs=253.4
Q ss_pred CCcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCC-cccccCCCCccEE
Q 004020 64 SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVP-SDFFKGLTSLQTI 141 (779)
Q Consensus 64 ~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L 141 (779)
-.++++|+|++|++++..|.+|..+++|++|+|++|++++.++ .|+++++|++|+|++|+++.++ +..|.++++|++|
T Consensus 49 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L 128 (549)
T 2z81_A 49 CANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL 128 (549)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred CCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEE
Confidence 3579999999999999888999999999999999999999888 5999999999999999999763 4578999999999
Q ss_pred EcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccC----------------------CCCCcccEEEccCCCC
Q 004020 142 SLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGG----------------------DTIPGLMHLHLAFNFL 199 (779)
Q Consensus 142 ~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~----------------------~~l~~L~~L~L~~N~l 199 (779)
+|++|++.+...+..|.++++|+.|++++|.+++..|..++. ..+++|++|+|++|++
T Consensus 129 ~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l 208 (549)
T 2z81_A 129 RIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNL 208 (549)
T ss_dssp EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBC
T ss_pred ECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCcc
Confidence 999999544344578999999999999999999988887752 1367888888999988
Q ss_pred CCcC--CCcccc--C-----------------------------------------------------------------
Q 004020 200 QGPI--PLSFGK--S----------------------------------------------------------------- 210 (779)
Q Consensus 200 ~~~~--p~~~~~--~----------------------------------------------------------------- 210 (779)
++.. |..+.. .
T Consensus 209 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l 288 (549)
T 2z81_A 209 ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTI 288 (549)
T ss_dssp TTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEE
T ss_pred ccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccc
Confidence 8742 111100 1
Q ss_pred ----------------------CcceeeccCCCCCCCCCCchhhh-cCCCCccEEEeecCcccCCCC----CCCCCCCCc
Q 004020 211 ----------------------SIQTLWLNGQKGDSKLNGSVAVI-QNMTSLTQLWLHGNSFTGPLP----DLSGLSSLQ 263 (779)
Q Consensus 211 ----------------------~L~~l~l~~n~~~~~~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~----~~~~l~~L~ 263 (779)
+|+.|++++|++.. .+..+ ..+++|++|+|++|++++.+| .+..+++|+
T Consensus 289 ~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~----ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~ 364 (549)
T 2z81_A 289 RRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFL----VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQ 364 (549)
T ss_dssp ESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCC----CCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCC
T ss_pred cccccchhhhcccchhhhhhcccceEEEeccCcccc----CCHHHHhcCccccEEEccCCccccccccchhhhhccccCc
Confidence 23334444443321 22233 578999999999999998653 377899999
Q ss_pred EEEccCCccccccC--hhhhCCCCCCEEEccCccccccCCCCCCCccccccc-CCCCcccCCCCcccCccchhhhhhccc
Q 004020 264 DFSVRDNQLTGIVP--SSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAK-GSNSFCLDDAGVACDGRVNVLLSIVKS 340 (779)
Q Consensus 264 ~L~l~~N~l~~~~p--~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (779)
+|++++|++++..+ ..+..+++|++|+|++|++++.++.+.....+.... ..|.+. ... ... ..
T Consensus 365 ~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~~~~L~~L~Ls~N~l~--~l~-------~~~---~~- 431 (549)
T 2z81_A 365 TLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIR--VVK-------TCI---PQ- 431 (549)
T ss_dssp EEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCCCCCSCCCCCTTCCEEECTTSCCS--CCC-------TTS---CT-
T ss_pred EEEccCCcccccccchhhhhcCCCCCEEECCCCCCccCChhhcccccccEEECCCCCcc--ccc-------chh---cC-
Confidence 99999999986543 568999999999999999995433322222211111 111110 000 000 00
Q ss_pred CCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccCccccccCCccCCCCCCC
Q 004020 341 VGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSL 420 (779)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L 420 (779)
.+.......+ ...+. ....++|+.|+|++|+++ .+|. ...+++|++|+|++|+|++.+|..+..+++|
T Consensus 432 -----~L~~L~Ls~N----~l~~~-~~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 499 (549)
T 2z81_A 432 -----TLEVLDVSNN----NLDSF-SLFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSL 499 (549)
T ss_dssp -----TCSEEECCSS----CCSCC-CCCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTC
T ss_pred -----CceEEECCCC----Chhhh-cccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCccc
Confidence 0111111111 11111 134568999999999999 6776 5789999999999999999889899999999
Q ss_pred CceeccCCcccccCCC
Q 004020 421 EMLDVSNNHLFGKVPN 436 (779)
Q Consensus 421 ~~L~Ls~N~l~g~iP~ 436 (779)
++|+|++|++++..|.
T Consensus 500 ~~L~l~~N~~~~~~~~ 515 (549)
T 2z81_A 500 QKIWLHTNPWDCSCPR 515 (549)
T ss_dssp CEEECCSSCBCCCHHH
T ss_pred CEEEecCCCccCCCcc
Confidence 9999999999999884
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=283.54 Aligned_cols=284 Identities=19% Similarity=0.250 Sum_probs=180.7
Q ss_pred EEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccC
Q 004020 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146 (779)
Q Consensus 68 ~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N 146 (779)
+.+++++++++ .+|..+. ++|++|+|++|.+++.++ .|.++++|++|+|++|+++.+++..|.++++|++|+|++|
T Consensus 36 ~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 36 RVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred CEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 34455555555 5555553 467777777777766655 5677777777777777777776666777777777777777
Q ss_pred CCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCC--CcCCCccccCCcceeeccCCCCCC
Q 004020 147 SFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQ--GPIPLSFGKSSIQTLWLNGQKGDS 224 (779)
Q Consensus 147 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~~~L~~l~l~~n~~~~ 224 (779)
++.. +|..+. ++|++|++++|.+++..+..+. .+++|++|+|++|.++ +..|..+...+|+.|++++|++..
T Consensus 113 ~l~~--l~~~~~--~~L~~L~l~~n~i~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~ 186 (332)
T 2ft3_A 113 HLVE--IPPNLP--SSLVELRIHDNRIRKVPKGVFS--GLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG 186 (332)
T ss_dssp CCCS--CCSSCC--TTCCEEECCSSCCCCCCSGGGS--SCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSS
T ss_pred cCCc--cCcccc--ccCCEEECCCCccCccCHhHhC--CCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCc
Confidence 7653 444433 6677777777777654444454 5667777777777764 255555554566666666665554
Q ss_pred CCCCchhhhcCCCCccEEEeecCcccCCCC-CCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCC
Q 004020 225 KLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKF 303 (779)
Q Consensus 225 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~ 303 (779)
..... .++|+.|+|++|.+++.++ .+..+++|+.|++++|++++..|..+..+++|+.|+|++|+++ .+|..
T Consensus 187 l~~~~------~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~ 259 (332)
T 2ft3_A 187 IPKDL------PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAG 259 (332)
T ss_dssp CCSSS------CSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTT
T ss_pred cCccc------cCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChh
Confidence 22211 2567777777777777665 4777777777777777777666667777777777777777776 33321
Q ss_pred CCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCcccc
Q 004020 304 NSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLS 383 (779)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~ 383 (779)
+. ..++|+.|+|++|.++
T Consensus 260 l~--------------------------------------------------------------~l~~L~~L~l~~N~l~ 277 (332)
T 2ft3_A 260 LP--------------------------------------------------------------DLKLLQVVYLHTNNIT 277 (332)
T ss_dssp GG--------------------------------------------------------------GCTTCCEEECCSSCCC
T ss_pred hh--------------------------------------------------------------cCccCCEEECCCCCCC
Confidence 10 1235777777777777
Q ss_pred cccccccccc------ccCCeEeccCcccc--ccCCccCCCCCCCCceeccCCc
Q 004020 384 GTISSNFSRL------TSLRQLMLSGNELT--GTIPKELTTLPSLEMLDVSNNH 429 (779)
Q Consensus 384 g~~p~~~~~l------~~L~~L~Ls~N~l~--g~iP~~l~~l~~L~~L~Ls~N~ 429 (779)
+..+..|..+ ..|+.|+|++|.+. +..|..+..+++|+.++|++|+
T Consensus 278 ~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 278 KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp BCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 6655555443 56778888888876 5666777788888888887774
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-31 Score=280.71 Aligned_cols=105 Identities=20% Similarity=0.357 Sum_probs=53.3
Q ss_pred CCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEec
Q 004020 90 SLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSA 168 (779)
Q Consensus 90 ~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l 168 (779)
+|++|+|++|++++.++ .|.++++|++|+|++|+++++++..|.++++|++|+|++|++.. +|..+. ++|+.|++
T Consensus 53 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~--l~~~~~--~~L~~L~l 128 (330)
T 1xku_A 53 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE--LPEKMP--KTLQELRV 128 (330)
T ss_dssp TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSB--CCSSCC--TTCCEEEC
T ss_pred CCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCc--cChhhc--ccccEEEC
Confidence 45555555555555444 45555555555555555555544555555555555555555543 333222 45555555
Q ss_pred cCceeEeecCCCccCCCCCcccEEEccCCCCC
Q 004020 169 NGANITGTIPDFLGGDTIPGLMHLHLAFNFLQ 200 (779)
Q Consensus 169 ~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~ 200 (779)
++|.+++..+..+. .+++|++|+|++|.++
T Consensus 129 ~~n~l~~~~~~~~~--~l~~L~~L~l~~n~l~ 158 (330)
T 1xku_A 129 HENEITKVRKSVFN--GLNQMIVVELGTNPLK 158 (330)
T ss_dssp CSSCCCBBCHHHHT--TCTTCCEEECCSSCCC
T ss_pred CCCcccccCHhHhc--CCccccEEECCCCcCC
Confidence 55555544443343 4555555555555553
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.2e-31 Score=315.53 Aligned_cols=335 Identities=18% Similarity=0.165 Sum_probs=248.9
Q ss_pred EEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCC-CCCCCcccccCCCCccEEEccc
Q 004020 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNN-FTSVPSDFFKGLTSLQTISLDY 145 (779)
Q Consensus 68 ~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~L~Ls~ 145 (779)
...|.++++++ .+|. -.++|++|+|++|+|++..+ .|.++++|++|+|++|. +..+++..|.++++|++|+|++
T Consensus 7 ~~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~ 82 (844)
T 3j0a_A 7 RIAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82 (844)
T ss_dssp EEEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTT
T ss_pred eEEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCC
Confidence 56788899999 6676 45799999999999999877 89999999999999994 5567788999999999999999
Q ss_pred CCCCCCCCcccccCCCCCceEeccCceeEeecCCC--ccCCCCCcccEEEccCCCCCCcCC-Ccccc-CCcceeeccCCC
Q 004020 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDF--LGGDTIPGLMHLHLAFNFLQGPIP-LSFGK-SSIQTLWLNGQK 221 (779)
Q Consensus 146 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~--~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~-~~L~~l~l~~n~ 221 (779)
|++.+ ..|..|.++++|++|+|++|.+++.+|.. +. .+++|++|+|++|.+++..+ ..++. .+|+.|++++|.
T Consensus 83 N~l~~-~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~--~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~ 159 (844)
T 3j0a_A 83 SKIYF-LHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFR--NLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQ 159 (844)
T ss_dssp CCCCE-ECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCS--SCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSC
T ss_pred CcCcc-cCHhHccCCcccCEeeCcCCCCCcccccCcccc--ccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCc
Confidence 99986 67999999999999999999999877665 65 79999999999999998765 46666 679999999998
Q ss_pred CCCCCCCchhhhcCCCCccEEEeecCcccCCCC-CCCCCCC------CcEEEccCCccccccChhhhCC-----------
Q 004020 222 GDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSS------LQDFSVRDNQLTGIVPSSLVNL----------- 283 (779)
Q Consensus 222 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~------L~~L~l~~N~l~~~~p~~l~~l----------- 283 (779)
+.......+..+.. ++|+.|+|++|.+.+..| .+..+++ |+.|++++|.+++.+|..+...
T Consensus 160 i~~~~~~~l~~l~~-~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l 238 (844)
T 3j0a_A 160 IFLVCEHELEPLQG-KTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLIL 238 (844)
T ss_dssp CCCCCSGGGHHHHH-CSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEEC
T ss_pred CCeeCHHHcccccC-CccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceec
Confidence 87766555443322 788889999998888766 3555544 8888888888877766655432
Q ss_pred ---------------------------CCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhh
Q 004020 284 ---------------------------HSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLS 336 (779)
Q Consensus 284 ---------------------------~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (779)
++|+.|+|++|.+.+..|..+.... +...+....+....
T Consensus 239 ~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~-------~L~~L~L~~n~i~~------- 304 (844)
T 3j0a_A 239 AHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLK-------DLKVLNLAYNKINK------- 304 (844)
T ss_dssp CSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCC-------CCCEEEEESCCCCE-------
T ss_pred ccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCC-------CCCEEECCCCcCCC-------
Confidence 4566666666666666555433221 00000000000000
Q ss_pred hcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccCccccccCCccCCC
Q 004020 337 IVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTT 416 (779)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~ 416 (779)
.....+...++|+.|+|++|.+++..|..|..+++|+.|+|++|+|++..|..+..
T Consensus 305 ------------------------~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~ 360 (844)
T 3j0a_A 305 ------------------------IADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKF 360 (844)
T ss_dssp ------------------------ECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCS
T ss_pred ------------------------CChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcC
Confidence 00001223457888888888888888888888888888899888888777777888
Q ss_pred CCCCCceeccCCcccccCCCCCCcceeeeCCCC
Q 004020 417 LPSLEMLDVSNNHLFGKVPNFRQNVIVKTDGNP 449 (779)
Q Consensus 417 l~~L~~L~Ls~N~l~g~iP~~~~~~~~~~~~n~ 449 (779)
+++|++|+|++|.+++ +|.+.....+.+.+|.
T Consensus 361 l~~L~~L~Ls~N~l~~-i~~~~~L~~L~l~~N~ 392 (844)
T 3j0a_A 361 LEKLQTLDLRDNALTT-IHFIPSIPDIFLSGNK 392 (844)
T ss_dssp CCCCCEEEEETCCSCC-CSSCCSCSEEEEESCC
T ss_pred CCCCCEEECCCCCCCc-ccCCCCcchhccCCCC
Confidence 8888899998888875 3333333344445554
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=305.55 Aligned_cols=174 Identities=26% Similarity=0.423 Sum_probs=152.1
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++.... ....+.+.+|+++|+.++|||||+++++|.+.+..|+||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 468999999999999999999875 79999999987543 344567899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCC--CcEEEEeecccee
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD--MRAKVADFGLVRL 745 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~--~~~kl~DFG~a~~ 745 (779)
|||++|+|.+++..+. ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+.
T Consensus 234 E~~~gg~L~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 234 EFMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp ECCCCCBHHHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred eecCCCcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 9999999999885432 258999999999999999999996 899999999999999854 8999999999998
Q ss_pred cCCCCCcccccccccCCcccccccccccC
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
+.... .....+||+.|||||++.+..
T Consensus 307 ~~~~~---~~~~~~GT~~y~APEv~~~~~ 332 (573)
T 3uto_A 307 LDPKQ---SVKVTTGTAEFAAPEVAEGKP 332 (573)
T ss_dssp CCTTS---EEEEECSSGGGCCHHHHTTCC
T ss_pred ccCCC---ceeeeEECccccCHHHhCCCC
Confidence 76532 224457999999999998753
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-30 Score=297.53 Aligned_cols=172 Identities=21% Similarity=0.245 Sum_probs=139.9
Q ss_pred CCCCCCCCcceeeEeCCCCcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCC
Q 004020 47 GWTDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFT 125 (779)
Q Consensus 47 ~w~~~~~C~w~gv~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~ 125 (779)
.|...-|..|..-.|.... ++.+.++.+++ .+|..+. +++++|||++|+|+++++ +|.++++|++|+|++|+|+
T Consensus 15 ~~~~~~p~~~~~c~~~~~~--~~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~ 89 (635)
T 4g8a_A 15 AANSSIPESWEPCVEVVPN--ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ 89 (635)
T ss_dssp ----------CCSEEEETT--TEEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred cccCCCCCCCCCccccCCC--CEEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCC
Confidence 4555556678765554332 35689999999 7887664 489999999999999887 8999999999999999999
Q ss_pred CCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCC-cCC
Q 004020 126 SVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQG-PIP 204 (779)
Q Consensus 126 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~-~~p 204 (779)
.+++++|.++++|++|+|++|+|++ ..+..|.++++|++|+|++|++++..+..|+ .+++|++|+|++|++++ .+|
T Consensus 90 ~i~~~~f~~L~~L~~L~Ls~N~l~~-l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~--~L~~L~~L~Ls~N~l~~~~~~ 166 (635)
T 4g8a_A 90 TIEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIG--HLKTLKELNVAHNLIQSFKLP 166 (635)
T ss_dssp EECTTTTTTCTTCCEEECTTCCCCE-ECGGGGTTCTTCCEEECTTSCCCCSTTCCCT--TCTTCCEEECCSSCCCCCCCC
T ss_pred CcChhHhcCCCCCCEEEccCCcCCC-CCHHHhcCCCCCCEEECCCCcCCCCChhhhh--cCcccCeeccccCccccCCCc
Confidence 9999999999999999999999987 5667899999999999999999987777786 79999999999999986 467
Q ss_pred Ccccc-CCcceeeccCCCCCCCC
Q 004020 205 LSFGK-SSIQTLWLNGQKGDSKL 226 (779)
Q Consensus 205 ~~~~~-~~L~~l~l~~n~~~~~~ 226 (779)
..++. ..|++|++++|++....
T Consensus 167 ~~~~~l~~L~~L~L~~N~l~~~~ 189 (635)
T 4g8a_A 167 EYFSNLTNLEHLDLSSNKIQSIY 189 (635)
T ss_dssp GGGGGCTTCCEEECCSSCCCEEC
T ss_pred hhhccchhhhhhcccCccccccc
Confidence 77766 68999999999876443
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=293.02 Aligned_cols=318 Identities=22% Similarity=0.334 Sum_probs=216.2
Q ss_pred CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcc
Q 004020 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 144 (779)
.++++|+|++|.+++..+ +..+++|++|+|++|++++.++ +.++++|++|++++|+++.+++ +.++++|++|+|+
T Consensus 68 ~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~ 142 (466)
T 1o6v_A 68 NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP-LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELS 142 (466)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEE
T ss_pred cCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh-hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECC
Confidence 468888888888885543 8888888888888888887766 8888888888888888888765 7888888888888
Q ss_pred cCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCcccc-CCcceeeccCCCCC
Q 004020 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGD 223 (779)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~L~~l~l~~n~~~ 223 (779)
+|++.+ ++ .+..+++|+.|+++ |++.+..+ +. .+++|++|++++|.+++. + .+.. .+|+.|++++|.+.
T Consensus 143 ~n~l~~--~~-~~~~l~~L~~L~l~-~~~~~~~~--~~--~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~ 212 (466)
T 1o6v_A 143 SNTISD--IS-ALSGLTSLQQLSFG-NQVTDLKP--LA--NLTTLERLDISSNKVSDI-S-VLAKLTNLESLIATNNQIS 212 (466)
T ss_dssp EEEECC--CG-GGTTCTTCSEEEEE-ESCCCCGG--GT--TCTTCCEEECCSSCCCCC-G-GGGGCTTCSEEECCSSCCC
T ss_pred CCccCC--Ch-hhccCCcccEeecC-CcccCchh--hc--cCCCCCEEECcCCcCCCC-h-hhccCCCCCEEEecCCccc
Confidence 888865 33 36677777777774 34443222 43 677888888888888743 3 2433 67888888888766
Q ss_pred CCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCC
Q 004020 224 SKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKF 303 (779)
Q Consensus 224 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~ 303 (779)
.... +..+++|+.|+|++|++++. +.+..+++|+.|++++|++.+..| +..+++|+.|+|++|++++..+ +
T Consensus 213 ~~~~-----~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~ 283 (466)
T 1o6v_A 213 DITP-----LGILTNLDELSLNGNQLKDI-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-L 283 (466)
T ss_dssp CCGG-----GGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG-G
T ss_pred cccc-----ccccCCCCEEECCCCCcccc-hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc-c
Confidence 5422 55678888888888887763 567777888888888888876544 7778888888888888876544 1
Q ss_pred CCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCcccc
Q 004020 304 NSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLS 383 (779)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~ 383 (779)
.....+ ..+....+.... . ......++|+.|+|++|+++
T Consensus 284 ~~l~~L--------~~L~L~~n~l~~-------------------------------~--~~~~~l~~L~~L~L~~n~l~ 322 (466)
T 1o6v_A 284 AGLTAL--------TNLELNENQLED-------------------------------I--SPISNLKNLTYLTLYFNNIS 322 (466)
T ss_dssp TTCTTC--------SEEECCSSCCSC-------------------------------C--GGGGGCTTCSEEECCSSCCS
T ss_pred cCCCcc--------CeEEcCCCcccC-------------------------------c--hhhcCCCCCCEEECcCCcCC
Confidence 111111 001000000000 0 00123347888888888888
Q ss_pred ccccccccccccCCeEeccCccccccCCccCCCCCCCCceeccCCcccccCCC--CCCcceeeeCCCCCC
Q 004020 384 GTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPN--FRQNVIVKTDGNPDI 451 (779)
Q Consensus 384 g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~--~~~~~~~~~~~n~~~ 451 (779)
+..| ++.+++|+.|+|++|++++. ..+..+++|++|++++|++++.+|- +.....+.+.+|++.
T Consensus 323 ~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~~~ 388 (466)
T 1o6v_A 323 DISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWT 388 (466)
T ss_dssp CCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGGGTTCTTCCEEECCCEEEE
T ss_pred Cchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccchhhcCCCCCEEeccCCccc
Confidence 7666 67888888888888888854 4677888888888888888887762 222334555555543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=277.86 Aligned_cols=283 Identities=21% Similarity=0.275 Sum_probs=241.3
Q ss_pred CcceeeEeCCC----------CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCC
Q 004020 54 CKWKHIQCSPS----------NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDN 122 (779)
Q Consensus 54 C~w~gv~c~~~----------~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N 122 (779)
|.|..+.|+.. .+++.|++++|++++..|..|..+++|++|+|++|++++.+| .|.++++|++|+|++|
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 68999999752 379999999999998888899999999999999999999877 8999999999999999
Q ss_pred CCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeE--eecCCCccCCCCCcccEEEccCCCCC
Q 004020 123 NFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANIT--GTIPDFLGGDTIPGLMHLHLAFNFLQ 200 (779)
Q Consensus 123 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~--~~~p~~~~~~~l~~L~~L~L~~N~l~ 200 (779)
+++.+|...+ ++|++|++++|++.. ..+..|.++++|+.|++++|.++ +..|..+. .+ +|++|++++|+++
T Consensus 113 ~l~~l~~~~~---~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~--~l-~L~~L~l~~n~l~ 185 (332)
T 2ft3_A 113 HLVEIPPNLP---SSLVELRIHDNRIRK-VPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD--GL-KLNYLRISEAKLT 185 (332)
T ss_dssp CCCSCCSSCC---TTCCEEECCSSCCCC-CCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSC--SC-CCSCCBCCSSBCS
T ss_pred cCCccCcccc---ccCCEEECCCCccCc-cCHhHhCCCccCCEEECCCCccccCCCCccccc--CC-ccCEEECcCCCCC
Confidence 9999998765 799999999999986 56677999999999999999996 36677775 45 9999999999999
Q ss_pred CcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCC-CCCCCCCcEEEccCCccccccChh
Q 004020 201 GPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSS 279 (779)
Q Consensus 201 ~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~ 279 (779)
+ +|..+. .+|+.|++++|.+..... ..+..+++|+.|+|++|++++.++. +..+++|++|++++|+++ .+|..
T Consensus 186 ~-l~~~~~-~~L~~L~l~~n~i~~~~~---~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~ 259 (332)
T 2ft3_A 186 G-IPKDLP-ETLNELHLDHNKIQAIEL---EDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAG 259 (332)
T ss_dssp S-CCSSSC-SSCSCCBCCSSCCCCCCT---TSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTT
T ss_pred c-cCcccc-CCCCEEECCCCcCCccCH---HHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChh
Confidence 5 777665 689999999998876543 3466889999999999999998884 889999999999999999 78999
Q ss_pred hhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCC
Q 004020 280 LVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNS 359 (779)
Q Consensus 280 l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (779)
+..+++|++|+|++|++++..+..+.....
T Consensus 260 l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~-------------------------------------------------- 289 (332)
T 2ft3_A 260 LPDLKLLQVVYLHTNNITKVGVNDFCPVGF-------------------------------------------------- 289 (332)
T ss_dssp GGGCTTCCEEECCSSCCCBCCTTSSSCSSC--------------------------------------------------
T ss_pred hhcCccCCEEECCCCCCCccChhHcccccc--------------------------------------------------
Confidence 999999999999999999877654332110
Q ss_pred CCCccccCCCCCeEEEEccCcccc--ccccccccccccCCeEeccCcc
Q 004020 360 DWKGVSCDAGGNITVVNLKNLGLS--GTISSNFSRLTSLRQLMLSGNE 405 (779)
Q Consensus 360 ~~~~~~~~~~~~L~~L~Ls~n~l~--g~~p~~~~~l~~L~~L~Ls~N~ 405 (779)
......|+.|++++|.+. +..|..|..+++|+.|+|++|+
T Consensus 290 ------~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 290 ------GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp ------CSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ------ccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 001236899999999988 6778899999999999999985
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-31 Score=289.32 Aligned_cols=310 Identities=13% Similarity=0.108 Sum_probs=232.3
Q ss_pred cCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCc
Q 004020 86 NSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQ 164 (779)
Q Consensus 86 ~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~ 164 (779)
..+++|++|++++|.++..++ .|.++++|++|+|++|.++.+++..|..+++|++|+|++|++.+ ..|..|.++++|+
T Consensus 42 ~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~ 120 (390)
T 3o6n_A 42 ITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLT 120 (390)
T ss_dssp GGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCC
T ss_pred cccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCc-CCHHHhcCCCCCC
Confidence 457899999999999998877 48999999999999999999999999999999999999999987 6778899999999
Q ss_pred eEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCcccc-CCcceeeccCCCCCCCCCCchhhhcCCCCccEEE
Q 004020 165 RFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLW 243 (779)
Q Consensus 165 ~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~ 243 (779)
+|++++|.++...+..+. .+++|++|+|++|++++..|..++. .+|+.|++++|.+... .+..+++|+.|+
T Consensus 121 ~L~L~~n~l~~l~~~~~~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~------~~~~l~~L~~L~ 192 (390)
T 3o6n_A 121 VLVLERNDLSSLPRGIFH--NTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV------DLSLIPSLFHAN 192 (390)
T ss_dssp EEECCSSCCCCCCTTTTT--TCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC------CGGGCTTCSEEE
T ss_pred EEECCCCccCcCCHHHhc--CCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc------ccccccccceee
Confidence 999999999954444455 7999999999999999888888876 7899999999988764 245689999999
Q ss_pred eecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCC
Q 004020 244 LHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDA 323 (779)
Q Consensus 244 L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~ 323 (779)
+++|.+++. ...++|+.|++++|++... |... .++|+.|+|++|++++. +.+.. ..+...+...
T Consensus 193 l~~n~l~~~----~~~~~L~~L~l~~n~l~~~-~~~~--~~~L~~L~l~~n~l~~~-~~l~~--------l~~L~~L~Ls 256 (390)
T 3o6n_A 193 VSYNLLSTL----AIPIAVEELDASHNSINVV-RGPV--NVELTILKLQHNNLTDT-AWLLN--------YPGLVEVDLS 256 (390)
T ss_dssp CCSSCCSEE----ECCSSCSEEECCSSCCCEE-ECCC--CSSCCEEECCSSCCCCC-GGGGG--------CTTCSEEECC
T ss_pred ccccccccc----CCCCcceEEECCCCeeeec-cccc--cccccEEECCCCCCccc-HHHcC--------CCCccEEECC
Confidence 999998863 2346899999999999854 4433 57999999999999864 21100 0111111110
Q ss_pred CcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccC
Q 004020 324 GVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSG 403 (779)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~ 403 (779)
.+..... ....+...++|+.|+|++|++++ +|..+..+++|++|+|++
T Consensus 257 ~n~l~~~-------------------------------~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~ 304 (390)
T 3o6n_A 257 YNELEKI-------------------------------MYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSH 304 (390)
T ss_dssp SSCCCEE-------------------------------ESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCS
T ss_pred CCcCCCc-------------------------------ChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCC
Confidence 0000000 00112234467777777777775 555666777777777777
Q ss_pred ccccccCCccCCCCCCCCceeccCCcccccCCC-CCCcceeeeCCCCCCCC
Q 004020 404 NELTGTIPKELTTLPSLEMLDVSNNHLFGKVPN-FRQNVIVKTDGNPDIGK 453 (779)
Q Consensus 404 N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~-~~~~~~~~~~~n~~~~~ 453 (779)
|+++ .+|..+..+++|++|+|++|+++..... +.....+.+.+|++.|.
T Consensus 305 n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~L~~L~l~~N~~~~~ 354 (390)
T 3o6n_A 305 NHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCN 354 (390)
T ss_dssp SCCC-CCGGGHHHHTTCSEEECCSSCCCCCCCCTTCCCSEEECCSSCEEHH
T ss_pred Ccce-ecCccccccCcCCEEECCCCccceeCchhhccCCEEEcCCCCccch
Confidence 7777 5666677777777777777777654322 33444666777777664
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=280.07 Aligned_cols=213 Identities=21% Similarity=0.361 Sum_probs=148.2
Q ss_pred CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcc
Q 004020 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 144 (779)
.++++|+++++++.. ++ .+..+++|++|+|++|++++.++ +.++++|++|++++|.++.++ .|..+++|++|+|+
T Consensus 44 ~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~-~~~l~~L~~L~L~~n~i~~~~--~~~~l~~L~~L~l~ 118 (347)
T 4fmz_A 44 ESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP-LSNLVKLTNLYIGTNKITDIS--ALQNLTNLRELYLN 118 (347)
T ss_dssp TTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEEECT
T ss_pred ccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh-hhcCCcCCEEEccCCcccCch--HHcCCCcCCEEECc
Confidence 367777777777763 44 37777788888888887776555 777777888888888777764 47777788888888
Q ss_pred cCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCcccc-CCcceeeccCCCCC
Q 004020 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGD 223 (779)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~L~~l~l~~n~~~ 223 (779)
+|++.+ ++. +..+++|+.|++++|.....++. +. .+++|++|++++|.+++..+ +.. .+|+.|++++|.+.
T Consensus 119 ~n~i~~--~~~-~~~l~~L~~L~l~~n~~~~~~~~-~~--~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~ 190 (347)
T 4fmz_A 119 EDNISD--ISP-LANLTKMYSLNLGANHNLSDLSP-LS--NMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIE 190 (347)
T ss_dssp TSCCCC--CGG-GTTCTTCCEEECTTCTTCCCCGG-GT--TCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCC
T ss_pred CCcccC--chh-hccCCceeEEECCCCCCcccccc-hh--hCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccc
Confidence 887765 333 77777788888877755544444 43 57777788888777775433 333 56777777777665
Q ss_pred CCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccc
Q 004020 224 SKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQG 298 (779)
Q Consensus 224 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g 298 (779)
... .+..+++|+.|++++|.+++..+ +..+++|++|++++|++++..+ +..+++|+.|++++|++++
T Consensus 191 ~~~-----~~~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~ 257 (347)
T 4fmz_A 191 DIS-----PLASLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD 257 (347)
T ss_dssp CCG-----GGGGCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred ccc-----cccCCCccceeecccCCCCCCch-hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCC
Confidence 432 25567777777777777776554 6667777777777777775433 7777777777777777764
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-30 Score=275.73 Aligned_cols=280 Identities=20% Similarity=0.277 Sum_probs=234.5
Q ss_pred CCCcceeeEeCCC----------CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecC
Q 004020 52 DPCKWKHIQCSPS----------NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFD 120 (779)
Q Consensus 52 ~~C~w~gv~c~~~----------~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~ 120 (779)
..|.|+.+.|+.. ..++.|+|++|++++..+..|..+++|++|+|++|++++..| .|.++++|++|+|+
T Consensus 29 c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 29 CQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp CEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 3478999999742 368999999999998877789999999999999999998876 89999999999999
Q ss_pred CCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEe--ecCCCccCCCCCcccEEEccCCC
Q 004020 121 DNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITG--TIPDFLGGDTIPGLMHLHLAFNF 198 (779)
Q Consensus 121 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~--~~p~~~~~~~l~~L~~L~L~~N~ 198 (779)
+|+++.+|...+ ++|++|++++|++.+ ..+..|.++++|+.|++++|.++. ..+..+. .+++|++|++++|+
T Consensus 109 ~n~l~~l~~~~~---~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~--~l~~L~~L~l~~n~ 182 (330)
T 1xku_A 109 KNQLKELPEKMP---KTLQELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ--GMKKLSYIRIADTN 182 (330)
T ss_dssp SSCCSBCCSSCC---TTCCEEECCSSCCCB-BCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGG--GCTTCCEEECCSSC
T ss_pred CCcCCccChhhc---ccccEEECCCCcccc-cCHhHhcCCccccEEECCCCcCCccCcChhhcc--CCCCcCEEECCCCc
Confidence 999999988755 799999999999976 566789999999999999999963 6677776 78999999999999
Q ss_pred CCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCC-CCCCCCCCcEEEccCCccccccC
Q 004020 199 LQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDNQLTGIVP 277 (779)
Q Consensus 199 l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p 277 (779)
++ .+|..+ .++|+.|+|++|++++..| .+..+++|+.|++++|++++..+
T Consensus 183 l~-~l~~~~----------------------------~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 233 (330)
T 1xku_A 183 IT-TIPQGL----------------------------PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDN 233 (330)
T ss_dssp CC-SCCSSC----------------------------CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECT
T ss_pred cc-cCCccc----------------------------cccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeCh
Confidence 98 455433 2689999999999999877 48899999999999999998888
Q ss_pred hhhhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCC
Q 004020 278 SSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPC 357 (779)
Q Consensus 278 ~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (779)
..+..+++|+.|+|++|+++ .+|..+
T Consensus 234 ~~~~~l~~L~~L~L~~N~l~-~lp~~l----------------------------------------------------- 259 (330)
T 1xku_A 234 GSLANTPHLRELHLNNNKLV-KVPGGL----------------------------------------------------- 259 (330)
T ss_dssp TTGGGSTTCCEEECCSSCCS-SCCTTT-----------------------------------------------------
T ss_pred hhccCCCCCCEEECCCCcCc-cCChhh-----------------------------------------------------
Confidence 89999999999999999998 344321
Q ss_pred CCCCCccccCCCCCeEEEEccCccccccccccccc------cccCCeEeccCccccc--cCCccCCCCCCCCceeccCCc
Q 004020 358 NSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSR------LTSLRQLMLSGNELTG--TIPKELTTLPSLEMLDVSNNH 429 (779)
Q Consensus 358 ~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~------l~~L~~L~Ls~N~l~g--~iP~~l~~l~~L~~L~Ls~N~ 429 (779)
...++|++|+|++|++++..+..|.. .+.|+.|+|++|.+.. ..|..+..+.+|+.++|++|+
T Consensus 260 ---------~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 260 ---------ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp ---------TTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred ---------ccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 11237899999999999877777754 3778999999999863 456788899999999999985
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-30 Score=279.32 Aligned_cols=281 Identities=23% Similarity=0.355 Sum_probs=240.9
Q ss_pred CCcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEc
Q 004020 64 SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143 (779)
Q Consensus 64 ~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 143 (779)
-.++++|++++|++++ +++ +..+++|++|+|++|.++.. +.+.++++|++|++++|+++.+++ +..+++|++|++
T Consensus 65 ~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~~-~~~~~l~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l 139 (347)
T 4fmz_A 65 LTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITDI-SALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNL 139 (347)
T ss_dssp CTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-GGGTTCTTCSEEECTTSCCCCCGG--GTTCTTCCEEEC
T ss_pred cCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCcccCc-hHHcCCCcCCEEECcCCcccCchh--hccCCceeEEEC
Confidence 3579999999999995 444 99999999999999999864 679999999999999999999877 889999999999
Q ss_pred ccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCcccc-CCcceeeccCCCC
Q 004020 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKG 222 (779)
Q Consensus 144 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~L~~l~l~~n~~ 222 (779)
++|.... .+..+..+++|++|++++|.+++..+ +. .+++|++|++++|.+++..+ +.. .+|+.|++++|.+
T Consensus 140 ~~n~~~~--~~~~~~~l~~L~~L~l~~~~~~~~~~--~~--~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l 211 (347)
T 4fmz_A 140 GANHNLS--DLSPLSNMTGLNYLTVTESKVKDVTP--IA--NLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQI 211 (347)
T ss_dssp TTCTTCC--CCGGGTTCTTCCEEECCSSCCCCCGG--GG--GCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCC
T ss_pred CCCCCcc--cccchhhCCCCcEEEecCCCcCCchh--hc--cCCCCCEEEccCCccccccc--ccCCCccceeecccCCC
Confidence 9997654 34559999999999999999986544 54 78999999999999985443 444 6899999999987
Q ss_pred CCCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCC
Q 004020 223 DSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK 302 (779)
Q Consensus 223 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~ 302 (779)
..... +..+++|+.|+|++|.+++..+ +..+++|++|++++|.+++. ..+..+++|+.|++++|++++. +.
T Consensus 212 ~~~~~-----~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~~ 282 (347)
T 4fmz_A 212 TDITP-----VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI-SV 282 (347)
T ss_dssp CCCGG-----GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-GG
T ss_pred CCCch-----hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC-hh
Confidence 75432 6789999999999999998766 88999999999999999864 5789999999999999998753 11
Q ss_pred CCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccc
Q 004020 303 FNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGL 382 (779)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l 382 (779)
....++|+.|+|++|.+
T Consensus 283 ---------------------------------------------------------------~~~l~~L~~L~L~~n~l 299 (347)
T 4fmz_A 283 ---------------------------------------------------------------LNNLSQLNSLFLNNNQL 299 (347)
T ss_dssp ---------------------------------------------------------------GGGCTTCSEEECCSSCC
T ss_pred ---------------------------------------------------------------hcCCCCCCEEECcCCcC
Confidence 11124799999999999
Q ss_pred cccccccccccccCCeEeccCccccccCCccCCCCCCCCceeccCCccc
Q 004020 383 SGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLF 431 (779)
Q Consensus 383 ~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~ 431 (779)
++..|..|+.+++|++|+|++|++++..| +..+++|++||+++|+|+
T Consensus 300 ~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 300 GNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp CGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred CCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 99999999999999999999999997666 889999999999999985
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-29 Score=284.73 Aligned_cols=301 Identities=24% Similarity=0.375 Sum_probs=235.6
Q ss_pred CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcc
Q 004020 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 144 (779)
.+++.|++++|.+++..+ +..+++|++|+|++|++++.++ +.++++|++|++++|+++.++. +..+++|++|+++
T Consensus 90 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~ 164 (466)
T 1o6v_A 90 TKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP-LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFG 164 (466)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG-GTTCTTCSEEEEEEEEECCCGG--GTTCTTCSEEEEE
T ss_pred ccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH-HcCCCCCCEEECCCCccCCChh--hccCCcccEeecC
Confidence 579999999999996654 9999999999999999998765 9999999999999999999763 8889999999997
Q ss_pred cCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCcccc-CCcceeeccCCCCC
Q 004020 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGD 223 (779)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~L~~l~l~~n~~~ 223 (779)
|.+.. . ..+.++++|+.|++++|.+++. + .+. .+++|++|++++|++++..| ++. .+|+.|++++|.+.
T Consensus 165 -~~~~~--~-~~~~~l~~L~~L~l~~n~l~~~-~-~l~--~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~ 234 (466)
T 1o6v_A 165 -NQVTD--L-KPLANLTTLERLDISSNKVSDI-S-VLA--KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLK 234 (466)
T ss_dssp -ESCCC--C-GGGTTCTTCCEEECCSSCCCCC-G-GGG--GCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC
T ss_pred -CcccC--c-hhhccCCCCCEEECcCCcCCCC-h-hhc--cCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcc
Confidence 45543 2 2388899999999999998753 3 344 68899999999999987665 433 67899999988876
Q ss_pred CCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCC
Q 004020 224 SKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKF 303 (779)
Q Consensus 224 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~ 303 (779)
.. ..+..+++|+.|+|++|.+++.++ +..+++|++|++++|++++..| +..+++|+.|+|++|++++..| .
T Consensus 235 ~~-----~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~ 305 (466)
T 1o6v_A 235 DI-----GTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP-I 305 (466)
T ss_dssp CC-----GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG-G
T ss_pred cc-----hhhhcCCCCCEEECCCCccccchh-hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh-h
Confidence 53 356778899999999999987665 7888899999999999986544 8888999999999999887654 1
Q ss_pred CCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCcccc
Q 004020 304 NSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLS 383 (779)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~ 383 (779)
... .++..+....+...+ . ......++|+.|++++|.++
T Consensus 306 ~~l--------~~L~~L~L~~n~l~~-------------------------------~--~~~~~l~~L~~L~l~~n~l~ 344 (466)
T 1o6v_A 306 SNL--------KNLTYLTLYFNNISD-------------------------------I--SPVSSLTKLQRLFFYNNKVS 344 (466)
T ss_dssp GGC--------TTCSEEECCSSCCSC-------------------------------C--GGGGGCTTCCEEECCSSCCC
T ss_pred cCC--------CCCCEEECcCCcCCC-------------------------------c--hhhccCccCCEeECCCCccC
Confidence 111 111111111110000 0 00123458999999999999
Q ss_pred ccccccccccccCCeEeccCccccccCCccCCCCCCCCceeccCCcccccC
Q 004020 384 GTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKV 434 (779)
Q Consensus 384 g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~i 434 (779)
+. ..+.++++|+.|+|++|++++.+| +..+++|+.|++++|++++..
T Consensus 345 ~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~p 391 (466)
T 1o6v_A 345 DV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAP 391 (466)
T ss_dssp CC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEECCC
T ss_pred Cc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccCCc
Confidence 85 478999999999999999998888 899999999999999999853
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-30 Score=275.07 Aligned_cols=178 Identities=23% Similarity=0.366 Sum_probs=157.6
Q ss_pred hhcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
..++|++.+.||+|+||.||+|+. .+|+.||+|++..........+++.+|+++++.++||||+++++++...+..|+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 456899999999999999999987 5799999999987766666778899999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++++|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++..
T Consensus 93 ~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEF 164 (328)
T ss_dssp ECCCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred EECCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence 99999999999986543 48899999999999999999997 89999999999999999999999999999876
Q ss_pred CCCCCcccccccccCCcccccccccccCCC
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAETSGM 776 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 776 (779)
.... .....+||+.|+|||++.+....
T Consensus 165 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~ 191 (328)
T 3fe3_A 165 TVGG---KLDAFCGAPPYAAPELFQGKKYD 191 (328)
T ss_dssp SSSC---GGGTTSSSGGGCCHHHHHTCCCC
T ss_pred CCCC---ccccccCCcceeCcccccCCCcC
Confidence 5432 23456799999999999876543
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.96 E-value=9.5e-30 Score=282.91 Aligned_cols=330 Identities=20% Similarity=0.220 Sum_probs=177.0
Q ss_pred CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCc-------------cEEecCCCCCCCCCcc
Q 004020 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSL-------------QEVLFDDNNFTSVPSD 130 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L-------------~~L~l~~N~l~~~~~~ 130 (779)
.++++|++++|++ |.+|++|+++++|++|++++|++.|.+| .++++++| ++|++++|.++++|..
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~~ 89 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPEL 89 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCSC
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCCC
Confidence 4677777777777 6777777777777777777777776665 56666543 5566666665555441
Q ss_pred cccCCCCccEEEcccCCCCCCCCcccc----------------cCC-CCCceEeccCceeEeecCCCccCCCCCcccEEE
Q 004020 131 FFKGLTSLQTISLDYNSFDSWVIPESL----------------KDA-TGLQRFSANGANITGTIPDFLGGDTIPGLMHLH 193 (779)
Q Consensus 131 ~~~~l~~L~~L~Ls~N~l~~~~~p~~~----------------~~l-~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~ 193 (779)
.++|++|++++|++.+ +|..+ ..+ ++|++|++++|++++ +| .++ .+++|++|+
T Consensus 90 ----~~~L~~L~l~~n~l~~--lp~~~~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l~~-lp-~~~--~l~~L~~L~ 159 (454)
T 1jl5_A 90 ----PPHLESLVASCNSLTE--LPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK-LP-ELQ--NSSFLKIID 159 (454)
T ss_dssp ----CTTCSEEECCSSCCSS--CCCCCTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCSS-CC-CCT--TCTTCCEEE
T ss_pred ----cCCCCEEEccCCcCCc--cccccCCCcEEECCCCccCcccCCCCCCCEEECcCCCCCC-Cc-ccC--CCCCCCEEE
Confidence 2344455554444443 22211 011 567777777777775 66 354 677788888
Q ss_pred ccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccc
Q 004020 194 LAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLT 273 (779)
Q Consensus 194 L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~ 273 (779)
+++|++++ +|..+ .+|++|++++|++... + .++.+++|+.|++++|++++. |.+ .++|++|++++|+++
T Consensus 160 l~~N~l~~-lp~~~--~~L~~L~L~~n~l~~l-~----~~~~l~~L~~L~l~~N~l~~l-~~~--~~~L~~L~l~~n~l~ 228 (454)
T 1jl5_A 160 VDNNSLKK-LPDLP--PSLEFIAAGNNQLEEL-P----ELQNLPFLTAIYADNNSLKKL-PDL--PLSLESIVAGNNILE 228 (454)
T ss_dssp CCSSCCSC-CCCCC--TTCCEEECCSSCCSSC-C----CCTTCTTCCEEECCSSCCSSC-CCC--CTTCCEEECCSSCCS
T ss_pred CCCCcCcc-cCCCc--ccccEEECcCCcCCcC-c----cccCCCCCCEEECCCCcCCcC-CCC--cCcccEEECcCCcCC
Confidence 88887774 55544 3677788877776652 1 356778888888888888763 332 257888888888887
Q ss_pred cccChhhhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCC----Cchhccc
Q 004020 274 GIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVG----YPAVLAE 349 (779)
Q Consensus 274 ~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 349 (779)
.+|. ++.+++|++|++++|++++..+.......+++ ..|.+.. ...... .+..+.-....+. .+..+..
T Consensus 229 -~lp~-~~~l~~L~~L~l~~N~l~~l~~~~~~L~~L~l--~~N~l~~--l~~~~~-~L~~L~ls~N~l~~l~~~~~~L~~ 301 (454)
T 1jl5_A 229 -ELPE-LQNLPFLTTIYADNNLLKTLPDLPPSLEALNV--RDNYLTD--LPELPQ-SLTFLDVSENIFSGLSELPPNLYY 301 (454)
T ss_dssp -SCCC-CTTCTTCCEEECCSSCCSSCCSCCTTCCEEEC--CSSCCSC--CCCCCT-TCCEEECCSSCCSEESCCCTTCCE
T ss_pred -cccc-cCCCCCCCEEECCCCcCCcccccccccCEEEC--CCCcccc--cCcccC-cCCEEECcCCccCcccCcCCcCCE
Confidence 5663 78888888888888888863322111111111 1111110 000000 0000000000000 0000100
Q ss_pred ccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccCccccccCCccCCCCCCCCceeccCCc
Q 004020 350 SWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNH 429 (779)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~ 429 (779)
..... +...+ .+..+.+|+.|++++|++++ +|.. +++|++|+|++|+++ .+|. .+++|++|+|++|+
T Consensus 302 L~l~~----N~l~~-i~~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~ 368 (454)
T 1jl5_A 302 LNASS----NEIRS-LCDLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNP 368 (454)
T ss_dssp EECCS----SCCSE-ECCCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSC
T ss_pred EECcC----CcCCc-ccCCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCC
Confidence 00110 11111 11223578888888888886 6654 578888888888888 5776 46788888888888
Q ss_pred ccc--cCCC
Q 004020 430 LFG--KVPN 436 (779)
Q Consensus 430 l~g--~iP~ 436 (779)
++| .+|.
T Consensus 369 l~~l~~ip~ 377 (454)
T 1jl5_A 369 LREFPDIPE 377 (454)
T ss_dssp CSSCCCCCT
T ss_pred CCcCCCChH
Confidence 888 6775
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.96 E-value=5e-29 Score=277.31 Aligned_cols=312 Identities=17% Similarity=0.160 Sum_probs=231.3
Q ss_pred CccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcc
Q 004020 76 NIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPE 155 (779)
Q Consensus 76 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~ 155 (779)
++.+..+..++++++|++|+|++|.|++. |.+..+++|++|+|++|++++++ +..+++|++|+|++|++.+ ++
T Consensus 29 ~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~~l~~l~~L~~L~Ls~n~l~~~~---~~~l~~L~~L~Ls~N~l~~--~~- 101 (457)
T 3bz5_A 29 EMQATDTISEEQLATLTSLDCHNSSITDM-TGIEKLTGLTKLICTSNNITTLD---LSQNTNLTYLACDSNKLTN--LD- 101 (457)
T ss_dssp TCCTTSEEEHHHHTTCCEEECCSSCCCCC-TTGGGCTTCSEEECCSSCCSCCC---CTTCTTCSEEECCSSCCSC--CC-
T ss_pred CcCcccccChhHcCCCCEEEccCCCcccC-hhhcccCCCCEEEccCCcCCeEc---cccCCCCCEEECcCCCCce--ee-
Confidence 44455666789999999999999999986 58999999999999999999985 8899999999999999987 33
Q ss_pred cccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCcccc-CCcceeeccCCCCCCCCCCchhhhc
Q 004020 156 SLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQ 234 (779)
Q Consensus 156 ~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~L~~l~l~~n~~~~~~~~~~~~~~ 234 (779)
++++++|++|++++|++++ +| ++ .+++|++|+|++|++++. + ++. .+|+.|++++|...... .+.
T Consensus 102 -~~~l~~L~~L~L~~N~l~~-l~--~~--~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~-----~~~ 167 (457)
T 3bz5_A 102 -VTPLTKLTYLNCDTNKLTK-LD--VS--QNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL-----DVT 167 (457)
T ss_dssp -CTTCTTCCEEECCSSCCSC-CC--CT--TCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC-----CCT
T ss_pred -cCCCCcCCEEECCCCcCCe-ec--CC--CCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc-----ccc
Confidence 8999999999999999997 44 54 799999999999999974 3 544 67999999999644333 256
Q ss_pred CCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCCCCCcccccccC
Q 004020 235 NMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKG 314 (779)
Q Consensus 235 ~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~ 314 (779)
.+++|+.|+|++|++++. | +..+++|+.|++++|++++. .+..+++|+.|+|++|++++ +| ......+..
T Consensus 168 ~l~~L~~L~ls~n~l~~l-~-l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip-~~~l~~L~~--- 237 (457)
T 3bz5_A 168 PQTQLTTLDCSFNKITEL-D-VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID-VTPLTQLTY--- 237 (457)
T ss_dssp TCTTCCEEECCSSCCCCC-C-CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC-CTTCTTCSE---
T ss_pred cCCcCCEEECCCCcccee-c-cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC-ccccCCCCE---
Confidence 789999999999999985 3 88899999999999999975 48999999999999999998 44 221111111
Q ss_pred CCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccc
Q 004020 315 SNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLT 394 (779)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~ 394 (779)
+....+...+.. ...... .....+ ...+|+.|++++|.+.|.+| ++.++
T Consensus 238 -----L~l~~N~l~~~~---~~~l~~--------------------L~~L~l-~~n~L~~L~l~~n~~~~~~~--~~~l~ 286 (457)
T 3bz5_A 238 -----FDCSVNPLTELD---VSTLSK--------------------LTTLHC-IQTDLLEIDLTHNTQLIYFQ--AEGCR 286 (457)
T ss_dssp -----EECCSSCCSCCC---CTTCTT--------------------CCEEEC-TTCCCSCCCCTTCTTCCEEE--CTTCT
T ss_pred -----EEeeCCcCCCcC---HHHCCC--------------------CCEEec-cCCCCCEEECCCCccCCccc--ccccc
Confidence 111111000000 000000 000000 11256777888888888777 56788
Q ss_pred cCCeEeccCccccccCCcc--------CCCCCCCCceeccCCcccccCCC--CCCcceeeeCCCCC
Q 004020 395 SLRQLMLSGNELTGTIPKE--------LTTLPSLEMLDVSNNHLFGKVPN--FRQNVIVKTDGNPD 450 (779)
Q Consensus 395 ~L~~L~Ls~N~l~g~iP~~--------l~~l~~L~~L~Ls~N~l~g~iP~--~~~~~~~~~~~n~~ 450 (779)
+|+.|+|++|.+.|.+|.. ++.+++|++|+|++|+|+| +|- ......+.+.+|..
T Consensus 287 ~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~-l~l~~l~~L~~L~l~~N~l 351 (457)
T 3bz5_A 287 KIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTE-LDVSHNTKLKSLSCVNAHI 351 (457)
T ss_dssp TCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSC-CCCTTCTTCSEEECCSSCC
T ss_pred cCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCcccc-cccccCCcCcEEECCCCCC
Confidence 8888888888888777753 4556788888888888888 341 22333455555543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.5e-30 Score=269.63 Aligned_cols=277 Identities=21% Similarity=0.284 Sum_probs=215.1
Q ss_pred CcceeeEeCCCCcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCC--cc
Q 004020 54 CKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVP--SD 130 (779)
Q Consensus 54 C~w~gv~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~--~~ 130 (779)
|.|.+|.|+. ++++ .+|..+. ++|++|+|++|+++..++ .|.++++|++|+|++|+++.+. +.
T Consensus 7 C~~~~l~c~~-----------~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 72 (306)
T 2z66_A 7 CSGTEIRCNS-----------KGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQ 72 (306)
T ss_dssp EETTEEECCS-----------SCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEH
T ss_pred eCCCEEEcCC-----------CCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCccc
Confidence 6787777763 3455 5666554 589999999999987766 5789999999999999998653 44
Q ss_pred cccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecC-CCccCCCCCcccEEEccCCCCCCcCCCcccc
Q 004020 131 FFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIP-DFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK 209 (779)
Q Consensus 131 ~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 209 (779)
.+..+++|++|+|++|.+.. +|..+..+++|+.|++++|++++..+ ..+. .+++|++|+|++|.+++..|..+.
T Consensus 73 ~~~~~~~L~~L~Ls~n~i~~--l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~- 147 (306)
T 2z66_A 73 SDFGTTSLKYLDLSFNGVIT--MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL--SLRNLIYLDISHTHTRVAFNGIFN- 147 (306)
T ss_dssp HHHSCSCCCEEECCSCSEEE--EEEEEETCTTCCEEECTTSEEESSTTTTTTT--TCTTCCEEECTTSCCEECSTTTTT-
T ss_pred ccccccccCEEECCCCcccc--ChhhcCCCCCCCEEECCCCcccccccchhhh--hccCCCEEECCCCcCCccchhhcc-
Confidence 56678999999999999875 77788999999999999999986655 4554 789999999999999877776654
Q ss_pred CCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccC-CCC-CCCCCCCCcEEEccCCccccccChhhhCCCCCC
Q 004020 210 SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTG-PLP-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLA 287 (779)
Q Consensus 210 ~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~-~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~ 287 (779)
.+++|++|+|++|.+++ .+| .+..+++|++|++++|++++..|..+..+++|+
T Consensus 148 -------------------------~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 202 (306)
T 2z66_A 148 -------------------------GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 202 (306)
T ss_dssp -------------------------TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred -------------------------cCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCC
Confidence 57888899999998887 344 588888999999999999887788888889999
Q ss_pred EEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccC
Q 004020 288 VVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCD 367 (779)
Q Consensus 288 ~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (779)
.|+|++|++++..+.. ..
T Consensus 203 ~L~L~~N~l~~~~~~~--------------------------------------------------------------~~ 220 (306)
T 2z66_A 203 VLNMSHNNFFSLDTFP--------------------------------------------------------------YK 220 (306)
T ss_dssp EEECTTSCCSBCCSGG--------------------------------------------------------------GT
T ss_pred EEECCCCccCccChhh--------------------------------------------------------------cc
Confidence 9999999887654421 11
Q ss_pred CCCCeEEEEccCccccccccccccccc-cCCeEeccCccccccCC--ccCCCCCCCCceeccCCcccccCCC
Q 004020 368 AGGNITVVNLKNLGLSGTISSNFSRLT-SLRQLMLSGNELTGTIP--KELTTLPSLEMLDVSNNHLFGKVPN 436 (779)
Q Consensus 368 ~~~~L~~L~Ls~n~l~g~~p~~~~~l~-~L~~L~Ls~N~l~g~iP--~~l~~l~~L~~L~Ls~N~l~g~iP~ 436 (779)
..++|+.|+|++|.+++..|..+..++ +|++|+|++|.+++.-+ ....-+..++.+.+..|.+....|.
T Consensus 221 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~ 292 (306)
T 2z66_A 221 CLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPS 292 (306)
T ss_dssp TCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESG
T ss_pred CcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCch
Confidence 224788899999999988888888884 89999999999986432 1112234455667777888877776
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.3e-29 Score=277.40 Aligned_cols=201 Identities=19% Similarity=0.244 Sum_probs=166.1
Q ss_pred EEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCC
Q 004020 69 RIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNS 147 (779)
Q Consensus 69 ~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 147 (779)
.++.++++++ .+|..+. ++|++|+|++|+|++.++ .|.++++|++|+|++|+++.+++..|.++++|++|+|++|+
T Consensus 58 ~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~ 134 (452)
T 3zyi_A 58 KVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134 (452)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence 4555566676 6776665 689999999999998877 79999999999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCC
Q 004020 148 FDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLN 227 (779)
Q Consensus 148 l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~ 227 (779)
+.. ..+..|..+++|++|+|++|.++...+..|. .+++|++|+|++|+..+.++...
T Consensus 135 l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~l~~~~~l~~i~~~~-------------------- 191 (452)
T 3zyi_A 135 LTV-IPSGAFEYLSKLRELWLRNNPIESIPSYAFN--RVPSLMRLDLGELKKLEYISEGA-------------------- 191 (452)
T ss_dssp CSB-CCTTTSSSCTTCCEEECCSCCCCEECTTTTT--TCTTCCEEECCCCTTCCEECTTT--------------------
T ss_pred CCc-cChhhhcccCCCCEEECCCCCcceeCHhHHh--cCCcccEEeCCCCCCccccChhh--------------------
Confidence 976 5666788999999999999999876666775 78999999999855444554321
Q ss_pred CchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCC
Q 004020 228 GSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTP 301 (779)
Q Consensus 228 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p 301 (779)
+..+++|+.|+|++|++++. |.+..+++|++|+|++|+|++..|..|.++++|+.|+|++|++++..|
T Consensus 192 -----~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 259 (452)
T 3zyi_A 192 -----FEGLFNLKYLNLGMCNIKDM-PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIER 259 (452)
T ss_dssp -----TTTCTTCCEEECTTSCCSSC-CCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECT
T ss_pred -----ccCCCCCCEEECCCCccccc-ccccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECH
Confidence 23688999999999999865 678888999999999999998888889888888888888888775544
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.3e-29 Score=275.41 Aligned_cols=203 Identities=19% Similarity=0.253 Sum_probs=166.9
Q ss_pred EEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEccc
Q 004020 67 VTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145 (779)
Q Consensus 67 v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 145 (779)
...++.++++++ .+|..+. +++++|+|++|+|++.++ .|.++++|++|+|++|+++.+++..|.++++|++|+|++
T Consensus 45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 121 (440)
T 3zyj_A 45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121 (440)
T ss_dssp SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence 345666777787 7787765 689999999999999886 899999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCC
Q 004020 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSK 225 (779)
Q Consensus 146 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~ 225 (779)
|+|.. ..+..|..+++|+.|+|++|.++...+..|. .+++|++|+|++|+..+.++...
T Consensus 122 n~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~--~l~~L~~L~l~~~~~l~~i~~~~------------------ 180 (440)
T 3zyj_A 122 NRLTT-IPNGAFVYLSKLKELWLRNNPIESIPSYAFN--RIPSLRRLDLGELKRLSYISEGA------------------ 180 (440)
T ss_dssp SCCSS-CCTTTSCSCSSCCEEECCSCCCCEECTTTTT--TCTTCCEEECCCCTTCCEECTTT------------------
T ss_pred CcCCe-eCHhHhhccccCceeeCCCCcccccCHHHhh--hCcccCEeCCCCCCCcceeCcch------------------
Confidence 99986 5566789999999999999999877776775 78899999999865444444321
Q ss_pred CCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCC
Q 004020 226 LNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTP 301 (779)
Q Consensus 226 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p 301 (779)
+..+++|++|+|++|+++. +|.+..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..+
T Consensus 181 -------~~~l~~L~~L~L~~n~l~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 248 (440)
T 3zyj_A 181 -------FEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIER 248 (440)
T ss_dssp -------TTTCSSCCEEECTTSCCSS-CCCCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECT
T ss_pred -------hhcccccCeecCCCCcCcc-ccccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEECh
Confidence 2367888899999998884 4577888888888888888888778888888888888888887765444
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-29 Score=286.53 Aligned_cols=281 Identities=22% Similarity=0.276 Sum_probs=234.4
Q ss_pred CCC-CCCCCcceeeEeC------C-CCcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEe
Q 004020 47 GWT-DPDPCKWKHIQCS------P-SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVL 118 (779)
Q Consensus 47 ~w~-~~~~C~w~gv~c~------~-~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~ 118 (779)
.|. +.+||.|+|..|. . ...++.|++++|+++ .+|..+. ++|++|+|++|+|+.+++ .+++|++|+
T Consensus 14 ~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~lp~---~l~~L~~L~ 87 (622)
T 3g06_A 14 AWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA---LPPELRTLE 87 (622)
T ss_dssp HHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSCCCC---CCTTCCEEE
T ss_pred HHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCCCCC---cCCCCCEEE
Confidence 464 4678999764322 1 235999999999999 8888776 799999999999996555 679999999
Q ss_pred cCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCC
Q 004020 119 FDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNF 198 (779)
Q Consensus 119 l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~ 198 (779)
|++|+|+.+|. .+++|++|+|++|++.+ +|. .+++|+.|++++|++++ +|.. +++|++|+|++|+
T Consensus 88 Ls~N~l~~lp~----~l~~L~~L~Ls~N~l~~--l~~---~l~~L~~L~L~~N~l~~-lp~~-----l~~L~~L~Ls~N~ 152 (622)
T 3g06_A 88 VSGNQLTSLPV----LPPGLLELSIFSNPLTH--LPA---LPSGLCKLWIFGNQLTS-LPVL-----PPGLQELSVSDNQ 152 (622)
T ss_dssp ECSCCCSCCCC----CCTTCCEEEECSCCCCC--CCC---CCTTCCEEECCSSCCSC-CCCC-----CTTCCEEECCSSC
T ss_pred cCCCcCCcCCC----CCCCCCEEECcCCcCCC--CCC---CCCCcCEEECCCCCCCc-CCCC-----CCCCCEEECcCCc
Confidence 99999999987 68999999999999986 555 67899999999999985 5653 5789999999999
Q ss_pred CCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccCh
Q 004020 199 LQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPS 278 (779)
Q Consensus 199 l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~ 278 (779)
+++ +|..+ .+|+.|++++|.+.... ..+++|+.|+|++|+|++.++. +++|+.|++++|.++ .+|.
T Consensus 153 l~~-l~~~~--~~L~~L~L~~N~l~~l~-------~~~~~L~~L~Ls~N~l~~l~~~---~~~L~~L~L~~N~l~-~l~~ 218 (622)
T 3g06_A 153 LAS-LPALP--SELCKLWAYNNQLTSLP-------MLPSGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLT-SLPA 218 (622)
T ss_dssp CSC-CCCCC--TTCCEEECCSSCCSCCC-------CCCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCS-SCCC
T ss_pred CCC-cCCcc--CCCCEEECCCCCCCCCc-------ccCCCCcEEECCCCCCCCCCCc---cchhhEEECcCCccc-ccCC
Confidence 995 55433 47999999999887643 3578999999999999975543 478999999999998 4664
Q ss_pred hhhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCC
Q 004020 279 SLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCN 358 (779)
Q Consensus 279 ~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (779)
. +++|+.|+|++|+|++. |.
T Consensus 219 ~---~~~L~~L~Ls~N~L~~l-p~-------------------------------------------------------- 238 (622)
T 3g06_A 219 L---PSGLKELIVSGNRLTSL-PV-------------------------------------------------------- 238 (622)
T ss_dssp C---CTTCCEEECCSSCCSCC-CC--------------------------------------------------------
T ss_pred C---CCCCCEEEccCCccCcC-CC--------------------------------------------------------
Confidence 3 47899999999999863 21
Q ss_pred CCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccCccccccCCccCCCCCCCCceeccCCcccccCCC
Q 004020 359 SDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPN 436 (779)
Q Consensus 359 ~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~ 436 (779)
..++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+++|.+|.
T Consensus 239 ---------~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~ 302 (622)
T 3g06_A 239 ---------LPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 302 (622)
T ss_dssp ---------CCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHH
T ss_pred ---------CCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHH
Confidence 1137999999999999 4666 6789999999999999 8999999999999999999999998875
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.6e-30 Score=280.70 Aligned_cols=183 Identities=25% Similarity=0.342 Sum_probs=155.2
Q ss_pred eHHHHHHhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccC-hhHHHHHHHHHHHHHcCCCCccceEeeEEE
Q 004020 581 SIQVLRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCL 658 (779)
Q Consensus 581 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 658 (779)
.+.+++...++|++.++||+|+||.||+|+.. +++.||+|++.+.... ......+.+|..++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34556666789999999999999999999876 5789999999753211 122234889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEE
Q 004020 659 DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 738 (779)
Q Consensus 659 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 738 (779)
+.+..|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~ 217 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLA 217 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEc
Confidence 9999999999999999999996532 258999999999999999999996 899999999999999999999999
Q ss_pred eeccceecCCCCCcccccccccCCccccccccc
Q 004020 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAA 771 (779)
Q Consensus 739 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~ 771 (779)
|||+|+....... ......+||+.|+|||++.
T Consensus 218 DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~ 249 (437)
T 4aw2_A 218 DFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQ 249 (437)
T ss_dssp CCTTCEECCTTSC-EECCSCCSCGGGCCHHHHH
T ss_pred chhhhhhcccCCC-cccccccCCcCeeChHHHh
Confidence 9999987655432 2234467999999999987
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.7e-29 Score=261.09 Aligned_cols=251 Identities=20% Similarity=0.262 Sum_probs=218.5
Q ss_pred cEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCC-CCcccccCCCCCceEeccC
Q 004020 92 TVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSW-VIPESLKDATGLQRFSANG 170 (779)
Q Consensus 92 ~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~p~~~~~l~~L~~L~l~~ 170 (779)
+.++.+++.++..+..+. ++|++|+|++|+++.+++..|.++++|++|+|++|++... ..+..+..+++|++|++++
T Consensus 10 ~~l~c~~~~l~~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~ 87 (306)
T 2z66_A 10 TEIRCNSKGLTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87 (306)
T ss_dssp TEEECCSSCCSSCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCS
T ss_pred CEEEcCCCCcccCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCC
Confidence 578999999987766554 6899999999999999999999999999999999999641 1267788899999999999
Q ss_pred ceeEeecCCCccCCCCCcccEEEccCCCCCCcCC-CccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcc
Q 004020 171 ANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIP-LSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSF 249 (779)
Q Consensus 171 n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l 249 (779)
|.++. +|..+. .+++|++|+|++|++++..+ ..+ ..+++|++|+|++|.+
T Consensus 88 n~i~~-l~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~--------------------------~~l~~L~~L~l~~n~l 138 (306)
T 2z66_A 88 NGVIT-MSSNFL--GLEQLEHLDFQHSNLKQMSEFSVF--------------------------LSLRNLIYLDISHTHT 138 (306)
T ss_dssp CSEEE-EEEEEE--TCTTCCEEECTTSEEESSTTTTTT--------------------------TTCTTCCEEECTTSCC
T ss_pred Ccccc-ChhhcC--CCCCCCEEECCCCcccccccchhh--------------------------hhccCCCEEECCCCcC
Confidence 99984 666665 69999999999999986544 233 3689999999999999
Q ss_pred cCCCCC-CCCCCCCcEEEccCCcccc-ccChhhhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCccc
Q 004020 250 TGPLPD-LSGLSSLQDFSVRDNQLTG-IVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVAC 327 (779)
Q Consensus 250 ~~~~~~-~~~l~~L~~L~l~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (779)
++.++. +..+++|++|++++|.+.+ .+|..+..+++|++|+|++|++++..|..+..
T Consensus 139 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~--------------------- 197 (306)
T 2z66_A 139 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS--------------------- 197 (306)
T ss_dssp EECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTT---------------------
T ss_pred CccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcC---------------------
Confidence 998885 8899999999999999987 68999999999999999999999877753321
Q ss_pred CccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccCcccc
Q 004020 328 DGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELT 407 (779)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 407 (779)
.++|+.|+|++|.+++..+..+..+++|++|+|++|+++
T Consensus 198 -----------------------------------------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 236 (306)
T 2z66_A 198 -----------------------------------------LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236 (306)
T ss_dssp -----------------------------------------CTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCC
T ss_pred -----------------------------------------CCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCc
Confidence 237999999999999988888999999999999999999
Q ss_pred ccCCccCCCCC-CCCceeccCCcccccCC
Q 004020 408 GTIPKELTTLP-SLEMLDVSNNHLFGKVP 435 (779)
Q Consensus 408 g~iP~~l~~l~-~L~~L~Ls~N~l~g~iP 435 (779)
+.+|..+..++ +|++|+|++|++++..+
T Consensus 237 ~~~~~~~~~~~~~L~~L~L~~N~~~~~c~ 265 (306)
T 2z66_A 237 TSKKQELQHFPSSLAFLNLTQNDFACTCE 265 (306)
T ss_dssp BCSSSSCCCCCTTCCEEECTTCCEECSGG
T ss_pred ccCHHHHHhhhccCCEEEccCCCeecccC
Confidence 99999999995 99999999999988643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=267.79 Aligned_cols=175 Identities=29% Similarity=0.427 Sum_probs=151.1
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
.++|++.+.||+|+||.||+|+.. +++.||+|++++... .......+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367999999999999999999876 689999999976432 233456788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+||+++.++++||+|||+++..
T Consensus 84 ~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence 99999999999886542 57899999999999999999996 89999999999999999999999999999864
Q ss_pred CCCCCcccccccccCCccccccccccc
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
..... .....+||+.|+|||++.+.
T Consensus 156 ~~~~~--~~~~~~gt~~y~aPE~~~~~ 180 (337)
T 1o6l_A 156 ISDGA--TMKTFCGTPEYLAPEVLEDN 180 (337)
T ss_dssp CCTTC--CBCCCEECGGGCCGGGGSSS
T ss_pred ccCCC--cccccccChhhCChhhhcCC
Confidence 33221 23456799999999998764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-29 Score=266.01 Aligned_cols=180 Identities=28% Similarity=0.393 Sum_probs=150.5
Q ss_pred hhcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
+.++|++.+.||+|+||.||+|+..+++.||+|++............+.+|++++++++||||+++++++.+.+..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 45789999999999999999999988999999999765544445577899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++ ++.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 99 e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 99 EFMEK-DLKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp ECCSE-EHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred cCCCC-CHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 99985 7888775433 258899999999999999999996 899999999999999999999999999998765
Q ss_pred CCCCcccccccccCCcccccccccccCCCC
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
.... ......||+.|+|||++.+...++
T Consensus 171 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~ 198 (311)
T 3niz_A 171 IPVR--SYTHEVVTLWYRAPDVLMGSKKYS 198 (311)
T ss_dssp SCCC-----CCCCCCTTCCHHHHTTCCSCC
T ss_pred CCcc--cccCCcccCCcCCHHHhcCCCCCC
Confidence 4322 223457899999999998755544
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.8e-30 Score=270.69 Aligned_cols=187 Identities=41% Similarity=0.784 Sum_probs=159.0
Q ss_pred eHHHHHHhhcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC
Q 004020 581 SIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG 660 (779)
Q Consensus 581 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 660 (779)
.+.++....++|++.+.||+|+||.||+|+.++++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 3344556778999999999999999999998889999999987553 34557899999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEee
Q 004020 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (779)
Q Consensus 661 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF 740 (779)
+..++||||+++++|.+++...... ...+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLP-TMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCC-SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCC
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCC-ccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeec
Confidence 9999999999999999998654322 2358999999999999999999996 89999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccCCccccccccccc
Q 004020 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 741 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
|+++...............||+.|+|||++.+.
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 216 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKG 216 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHC
T ss_pred ccccccccccccccccccCCCccccCHHHhcCC
Confidence 999875443222233445699999999998654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=277.98 Aligned_cols=183 Identities=27% Similarity=0.349 Sum_probs=154.9
Q ss_pred HHHHHHhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEe
Q 004020 582 IQVLRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD 659 (779)
Q Consensus 582 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 659 (779)
+++++...++|++.+.||+|+||.||+|+.. +++.||+|++.+... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3455556789999999999999999999876 588999999875321 11223457899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEe
Q 004020 660 GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 739 (779)
Q Consensus 660 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 739 (779)
.+..|+||||+++|+|.+++... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++++||+|
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~D 211 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD 211 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEec
Confidence 99999999999999999988543 47899999999999999999997 8999999999999999999999999
Q ss_pred eccceecCCCCCcccccccccCCcccccccccccC
Q 004020 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 740 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
||+|+....... ......+||+.|+|||++.+..
T Consensus 212 FG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~ 245 (410)
T 3v8s_A 212 FGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQG 245 (410)
T ss_dssp CTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTT
T ss_pred cceeEeeccCCc-ccccCCcCCccccCHHHhhccC
Confidence 999987654322 2233567999999999997654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=273.04 Aligned_cols=178 Identities=22% Similarity=0.265 Sum_probs=150.9
Q ss_pred hcCCcccceecccccEEEEEEE------EcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCC---CCccceEeeEEEe
Q 004020 589 TNNFSEENVLGRGGFGTVYKGE------LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR---HRHLVGLLGYCLD 659 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~ 659 (779)
.++|.+.+.||+|+||.||+|. ..+++.||+|++.... ..++.+|+++++.++ |+||+++++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 4679999999999999999993 4468999999986542 346778888888887 9999999999999
Q ss_pred CCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC--------
Q 004020 660 GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-------- 731 (779)
Q Consensus 660 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-------- 731 (779)
.+..++||||+++|+|.+++..........+++..++.|+.||+.||+|||+ ++|+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999976554444569999999999999999999996 89999999999999998
Q ss_pred ---CCcEEEEeeccceecCCCCCcccccccccCCcccccccccccC
Q 004020 732 ---DMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 732 ---~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
++.+||+|||+|+..............+||+.|||||++.+..
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 261 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP 261 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC
Confidence 8999999999998764332333345567999999999998754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=269.54 Aligned_cols=175 Identities=29% Similarity=0.450 Sum_probs=146.7
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 665 (779)
.++|++.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+.+|.++++.+ +||||+++++++.+.+..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468999999999999999999875 689999999976532 233456788999999988 69999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+|+.
T Consensus 102 v~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR-----RFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceee
Confidence 999999999999986543 58999999999999999999996 8999999999999999999999999999986
Q ss_pred cCCCCCcccccccccCCccccccccccc
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
..... ......+||+.|+|||++.+.
T Consensus 174 ~~~~~--~~~~~~~gt~~y~aPE~~~~~ 199 (353)
T 3txo_A 174 GICNG--VTTATFCGTPDYIAPEILQEM 199 (353)
T ss_dssp SCC-----------CCGGGCCHHHHHHH
T ss_pred cccCC--ccccccCCCcCeEChhhcCCC
Confidence 43322 223456799999999998654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5.6e-29 Score=269.82 Aligned_cols=181 Identities=28% Similarity=0.477 Sum_probs=153.2
Q ss_pred hcCCcccceecccccEEEEEEEEc--------CCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEe
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH--------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLD 659 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 659 (779)
.++|++.+.||+|+||.||+|+.. ++..||+|+++... .....+++.+|+++++++ +||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 468999999999999999999752 35679999997553 345667899999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCChhhHhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEE
Q 004020 660 GNERLLVYEYMPQGTLSRHLFNRKEE-----------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 728 (779)
Q Consensus 660 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIl 728 (779)
.+..|+||||+++|+|.+++...... ....+++..++.++.||+.||+|||+ ++|+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEE
Confidence 99999999999999999999765421 12357899999999999999999996 89999999999999
Q ss_pred EcCCCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 729 LGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 729 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
++.++.+||+|||+++...............||+.|+|||++.+.
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 280 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR 280 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC
Confidence 999999999999999877554333333445678999999998654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.3e-29 Score=260.26 Aligned_cols=174 Identities=26% Similarity=0.433 Sum_probs=151.2
Q ss_pred hhcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
..++|++.+.||+|+||.||+|+. .+++.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 356899999999999999999975 4789999999875442 2346788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++++|.+++... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++..
T Consensus 96 ~e~~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (297)
T ss_dssp EECCTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EECCCCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceec
Confidence 9999999999998543 47899999999999999999997 89999999999999999999999999999876
Q ss_pred CCCCCcccccccccCCcccccccccccC
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
..... ......||+.|+|||++.+..
T Consensus 167 ~~~~~--~~~~~~gt~~y~aPE~~~~~~ 192 (297)
T 3fxz_A 167 TPEQS--KRSTMVGTPYWMAPEVVTRKA 192 (297)
T ss_dssp CSTTC--CBCCCCSCGGGCCHHHHHCSC
T ss_pred CCccc--ccCCccCCcCccChhhhcCCC
Confidence 54322 234457999999999987653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=266.80 Aligned_cols=179 Identities=26% Similarity=0.409 Sum_probs=150.8
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
+.++|++.+.||+|+||.||+|+.. +++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4578999999999999999999876 789999999865432 22335688999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 155 (323)
T 3tki_A 84 LEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF 155 (323)
T ss_dssp EECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeecccee
Confidence 9999999999988543 258999999999999999999996 89999999999999999999999999999876
Q ss_pred CCCCCcccccccccCCcccccccccccCC
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
.............||+.|+|||++.+...
T Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 184 (323)
T 3tki_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREF 184 (323)
T ss_dssp EETTEECCBCSCCSCGGGSCHHHHHCSSB
T ss_pred ccCCcccccCCCccCcCccCcHHhccCCC
Confidence 44333233345679999999999876543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-29 Score=270.29 Aligned_cols=174 Identities=26% Similarity=0.414 Sum_probs=151.3
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccc-cChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367999999999999999999875 58899999987543 2223456788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 94 ~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN-----VHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp ECCCTTEEHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 9999999999998643 258999999999999999999996 89999999999999999999999999999876
Q ss_pred CCCCCcccccccccCCccccccccccc
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.... .....+||+.|+|||++.+.
T Consensus 166 ~~~~---~~~~~~gt~~Y~aPE~~~~~ 189 (384)
T 4fr4_A 166 PRET---QITTMAGTKPYMAPEMFSSR 189 (384)
T ss_dssp CTTC---CBCCCCSCGGGCCGGGTCCC
T ss_pred cCCC---ceeccCCCccccCCeeeccC
Confidence 5432 23456799999999999754
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=275.53 Aligned_cols=184 Identities=26% Similarity=0.330 Sum_probs=156.2
Q ss_pred eHHHHHHhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEE
Q 004020 581 SIQVLRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCL 658 (779)
Q Consensus 581 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 658 (779)
.+++.+...++|++.+.||+|+||.||+|+.+ +++.||+|++.+... .....+.+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 44555566789999999999999999999875 789999999975432 1223345889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEE
Q 004020 659 DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 738 (779)
Q Consensus 659 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 738 (779)
+.+..|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEe
Confidence 9999999999999999999996542 258899999999999999999996 899999999999999999999999
Q ss_pred eeccceecCCCCCcccccccccCCcccccccccc
Q 004020 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 739 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
|||+++....... ......+||+.|+|||++.+
T Consensus 205 DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~ 237 (412)
T 2vd5_A 205 DFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQA 237 (412)
T ss_dssp CCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHH
T ss_pred echhheeccCCCc-cccceeccccCcCCHHHHhh
Confidence 9999987755322 12234579999999999874
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=260.26 Aligned_cols=176 Identities=28% Similarity=0.487 Sum_probs=150.0
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.++|.+.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 357899999999999999999875 6899999988543 3556678999999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 87 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMV 159 (310)
T ss_dssp ECCTTCBHHHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence 9999999999996532 258999999999999999999997 899999999999999999999999999998764
Q ss_pred CCCCcc------------cccccccCCccccccccccc
Q 004020 748 DNGKHS------------IETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~~------------~~~~~~gt~~y~APE~l~~~ 773 (779)
...... ......||+.|+|||++.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 197 (310)
T 3s95_A 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR 197 (310)
T ss_dssp --------------------CCCCSCGGGCCHHHHTTC
T ss_pred cccccccccccccccccccccccCCCcceeCHHHhcCC
Confidence 432211 01145799999999998764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.6e-29 Score=270.02 Aligned_cols=176 Identities=25% Similarity=0.421 Sum_probs=149.7
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccCh-hHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE-KGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 665 (779)
.++|++.++||+|+||.||+|+.. +++.||+|++++..... ...+.+.+|..++.++ +||||+++++++.+.+..|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999876 57899999998654332 2335678899999887 79999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+|+.
T Consensus 131 V~E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEcCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 999999999999986543 58999999999999999999996 8999999999999999999999999999986
Q ss_pred cCCCCCcccccccccCCcccccccccccC
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
..... ......+||+.|+|||++.+..
T Consensus 203 ~~~~~--~~~~~~~gt~~Y~aPE~l~~~~ 229 (396)
T 4dc2_A 203 GLRPG--DTTSTFCGTPNYIAPEILRGED 229 (396)
T ss_dssp CCCTT--CCBCCCCBCGGGCCHHHHTTCC
T ss_pred cccCC--CccccccCCcccCCchhhcCCC
Confidence 43322 2234568999999999997653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.96 E-value=9.1e-29 Score=259.42 Aligned_cols=178 Identities=23% Similarity=0.349 Sum_probs=151.7
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
++|++.+.||+|+||.||+|+.. +++.||+|++............+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999875 68999999998665555566788999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++ ++.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~~-~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSE-EHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred cCCC-CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 9975 5656554322 258999999999999999999997 8999999999999999999999999999987654
Q ss_pred CCCcccccccccCCcccccccccccCCCC
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
... ......||+.|+|||++.+...++
T Consensus 154 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~ 180 (292)
T 3o0g_A 154 PVR--CYSAEVVTLWYRPPDVLFGAKLYS 180 (292)
T ss_dssp CCS--CCCSCCSCGGGCCHHHHTTCSCCC
T ss_pred ccc--cccCCccccCCcChHHHcCCCCcC
Confidence 322 224457899999999998765444
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-29 Score=266.97 Aligned_cols=193 Identities=43% Similarity=0.781 Sum_probs=162.7
Q ss_pred eeeeHHHHHHhhcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEE
Q 004020 578 MVISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657 (779)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 657 (779)
..++++++....++|++.+.||+|+||.||+|+..+++.||+|++..... ......+.+|+++++.++||||+++++++
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccC-chHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 46788999999999999999999999999999988899999999875432 12223688999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEE
Q 004020 658 LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 737 (779)
Q Consensus 658 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 737 (779)
...+..++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+.+..+|+||||||+||+++.++.+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPES-QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTT-CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred ecCCceEEEEEeccCCCHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 9999999999999999999999765432 335899999999999999999999732239999999999999999999999
Q ss_pred EeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 738 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+|||+++....... .......||+.|+|||++.+.
T Consensus 176 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~ 210 (326)
T 3uim_A 176 GDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTG 210 (326)
T ss_dssp CCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHS
T ss_pred ccCccccccCcccc-cccccccCCcCccCHHHhccC
Confidence 99999987654322 223445699999999998653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=265.26 Aligned_cols=175 Identities=27% Similarity=0.376 Sum_probs=151.4
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccCh----hHHHHHHHHHHHHHcCCCCccceEeeEEEeCCe
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE----KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 662 (779)
+.++|++.+.||+|+||.||+|+.. +|+.||+|++....... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4578999999999999999999876 68999999997654322 134678999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC----cEEEE
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM----RAKVA 738 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~----~~kl~ 738 (779)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++ .+||+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~ 161 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC-----SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEE
Confidence 99999999999999998543 258999999999999999999997 8999999999999998776 79999
Q ss_pred eeccceecCCCCCcccccccccCCccccccccccc
Q 004020 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 739 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
|||+++...... ......||+.|+|||++.+.
T Consensus 162 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~ 193 (361)
T 2yab_A 162 DFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYE 193 (361)
T ss_dssp CCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTC
T ss_pred ecCCceEcCCCC---ccccCCCCccEECchHHcCC
Confidence 999998775432 12345799999999998764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-29 Score=261.88 Aligned_cols=178 Identities=27% Similarity=0.392 Sum_probs=148.7
Q ss_pred cCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
++|++.+.||+|+||.||+|+..+++.||+|++..........+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57999999999999999999988899999999976543333446788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+++ +|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CSE-EHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred cCC-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 975 8988885432 257899999999999999999997 89999999999999999999999999999866432
Q ss_pred CCcccccccccCCcccccccccccCCCC
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
.. ......||+.|+|||++.+...++
T Consensus 154 ~~--~~~~~~~t~~y~aPE~~~~~~~~~ 179 (288)
T 1ob3_A 154 VR--KYTHEIVTLWYRAPDVLMGSKKYS 179 (288)
T ss_dssp ----------CCCTTCCHHHHTTCCSCC
T ss_pred cc--ccccccccccccCchheeCCCCCC
Confidence 11 123456899999999997765444
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=265.98 Aligned_cols=176 Identities=26% Similarity=0.449 Sum_probs=153.4
Q ss_pred HhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
.+.++|++.+.||+|+||.||+|... +++.||+|++..........+.+.+|++++++++||||+++++++.+.+..|+
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 35678999999999999999999875 68999999998766566667889999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCC---CcEEEEeecc
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD---MRAKVADFGL 742 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~---~~~kl~DFG~ 742 (779)
||||+++|+|.+++..+ ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.+ +.+||+|||+
T Consensus 106 v~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EECCCCSCBHHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 99999999999988543 258899999999999999999997 899999999999999865 4599999999
Q ss_pred ceecCCCCCcccccccccCCccccccccccc
Q 004020 743 VRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 743 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
++...... ......||+.|+|||++.+.
T Consensus 178 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~ 205 (362)
T 2bdw_A 178 AIEVNDSE---AWHGFAGTPGYLSPEVLKKD 205 (362)
T ss_dssp CBCCTTCC---SCCCSCSCTTTCCHHHHTTC
T ss_pred ceEecCCc---ccccCCCCccccCHHHHccC
Confidence 98765432 22345799999999998764
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=257.00 Aligned_cols=201 Identities=20% Similarity=0.305 Sum_probs=155.7
Q ss_pred EEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEccc
Q 004020 67 VTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145 (779)
Q Consensus 67 v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 145 (779)
.+++++++++++ .+|..+ .++|++|+|++|++++.++ .|.++++|++|+|++|+++.+++..|.++++|++|+|++
T Consensus 13 ~~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 13 KVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp SCEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CeEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 367888888888 566654 4689999999999998876 689999999999999999999888899999999999999
Q ss_pred CC-CCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCC
Q 004020 146 NS-FDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDS 224 (779)
Q Consensus 146 N~-l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~ 224 (779)
|+ +.. ..|..|..+++|+.|++++|.+++..|..+. .+++|++|+|++|++++..+..++
T Consensus 90 n~~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~---------------- 150 (285)
T 1ozn_A 90 NAQLRS-VDPATFHGLGRLHTLHLDRCGLQELGPGLFR--GLAALQYLYLQDNALQALPDDTFR---------------- 150 (285)
T ss_dssp CTTCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTT--TCTTCCEEECCSSCCCCCCTTTTT----------------
T ss_pred CCCccc-cCHHHhcCCcCCCEEECCCCcCCEECHhHhh--CCcCCCEEECCCCcccccCHhHhc----------------
Confidence 97 654 5577888888888888888888877777775 688888888888888865554444
Q ss_pred CCCCchhhhcCCCCccEEEeecCcccCCCCC-CCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCcccccc
Q 004020 225 KLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQ 299 (779)
Q Consensus 225 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ 299 (779)
.+++|++|+|++|++++.++. +..+++|++|++++|++++..|..+..+++|+.|+|++|++++.
T Consensus 151 ----------~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 216 (285)
T 1ozn_A 151 ----------DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSAL 216 (285)
T ss_dssp ----------TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCC
T ss_pred ----------cCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcC
Confidence 466677777777777665553 66667777777777777766666777777777777777766643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.2e-29 Score=262.13 Aligned_cols=180 Identities=32% Similarity=0.536 Sum_probs=146.0
Q ss_pred HhhcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
...++|++.+.||+|+||.||+|+. +++.||+|++..........+++.+|++++++++||||+++++++...+..++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3456899999999999999999977 588999999987666666678899999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--cEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
|||+++++|.+++...... ..+++..++.++.||+.||+|||+ .+ |+||||||+||+++.++.+||+|||+++
T Consensus 113 ~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAR--EQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp EECCTTCBHHHHHHSTTHH--HHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred EecCCCCcHHHHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 9999999999998654321 248899999999999999999996 77 9999999999999999999999999997
Q ss_pred ecCCCCCcccccccccCCcccccccccccC
Q 004020 745 LAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
...... .......||+.|+|||++.+..
T Consensus 188 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~ 215 (309)
T 3p86_A 188 LKASTF--LSSKSAAGTPEWMAPEVLRDEP 215 (309)
T ss_dssp ----------------CCTTSCHHHHTTCC
T ss_pred cccccc--cccccCCCCccccChhhhcCCC
Confidence 654321 1223457999999999987653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=263.55 Aligned_cols=180 Identities=29% Similarity=0.435 Sum_probs=148.3
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC-----
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN----- 661 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 661 (779)
..++|++.+.||+|+||.||+|+.. +++.||||++.... .....+.+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 4568999999999999999999876 79999999997543 3345578999999999999999999999986643
Q ss_pred ----------------------------------------------------eEEEEEEecCCCChhhHhhhcccCCCCC
Q 004020 662 ----------------------------------------------------ERLLVYEYMPQGTLSRHLFNRKEEGLKP 689 (779)
Q Consensus 662 ----------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~ 689 (779)
..++||||+++++|.+++...... ..
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~--~~ 160 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL--ED 160 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG--GG
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc--cc
Confidence 279999999999999999765432 34
Q ss_pred CCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCc----------ccccccc
Q 004020 690 LEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH----------SIETRLA 759 (779)
Q Consensus 690 ~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~----------~~~~~~~ 759 (779)
.++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++........ .......
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred hhhHHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence 5777889999999999999996 89999999999999999999999999999877554211 1223457
Q ss_pred cCCccccccccccc
Q 004020 760 GTFGYLAPEYAAET 773 (779)
Q Consensus 760 gt~~y~APE~l~~~ 773 (779)
||+.|+|||++.+.
T Consensus 238 gt~~y~aPE~~~~~ 251 (332)
T 3qd2_B 238 GTKLYMSPEQIHGN 251 (332)
T ss_dssp -CGGGSCHHHHHCC
T ss_pred CCcCccChHHhcCC
Confidence 99999999998764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-28 Score=273.21 Aligned_cols=177 Identities=23% Similarity=0.358 Sum_probs=152.8
Q ss_pred HhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
.+.++|++.+.||+|+||.||+|... +++.||+|++..........+.+.+|++++++++||||+++++++.+.+..|+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 45678999999999999999999764 78999999998766555666789999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEc---CCCcEEEEeecc
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG---DDMRAKVADFGL 742 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~---~~~~~kl~DFG~ 742 (779)
||||+++|+|.+++..+. .+++..+..++.||+.||+|||+ ++|+||||||+||+++ +++.+||+|||+
T Consensus 88 v~E~~~gg~L~~~i~~~~-----~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 88 IFDLVTGGELFEDIVARE-----YYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp EECCCBCCBHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEEeCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 999999999999886542 58999999999999999999997 8999999999999998 468899999999
Q ss_pred ceecCCCCCcccccccccCCccccccccccc
Q 004020 743 VRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 743 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
++....... ......||+.|+|||++.+.
T Consensus 160 a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~ 188 (444)
T 3soa_A 160 AIEVEGEQQ--AWFGFAGTPGYLSPEVLRKD 188 (444)
T ss_dssp CBCCCTTCC--BCCCSCSCGGGCCHHHHTTC
T ss_pred eEEecCCCc--eeecccCCcccCCHHHhcCC
Confidence 987654322 22446799999999998764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=263.55 Aligned_cols=174 Identities=26% Similarity=0.428 Sum_probs=150.9
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 666 (779)
++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+.+|..+++++ +||||+++++++.+.+..|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57999999999999999999876 688999999976543 334556788999999988 899999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++|+|.+++.... .+++..++.++.||+.||+|||+ ++|+||||||+||+++.++++||+|||+++..
T Consensus 89 ~e~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp ECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 99999999999986542 58899999999999999999997 89999999999999999999999999999864
Q ss_pred CCCCCcccccccccCCccccccccccc
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
..... .....+||+.|+|||++.+.
T Consensus 161 ~~~~~--~~~~~~gt~~y~aPE~~~~~ 185 (345)
T 3a8x_A 161 LRPGD--TTSTFCGTPNYIAPEILRGE 185 (345)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHTTC
T ss_pred cCCCC--cccccCCCccccCccccCCC
Confidence 33221 23456799999999998764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=258.97 Aligned_cols=178 Identities=25% Similarity=0.444 Sum_probs=147.6
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccc-cChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
+.++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+.+|+.++++++||||+++++++...+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 3568999999999999999999865 68999999986543 234456789999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||||+++++|.+++.... .+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.
T Consensus 89 v~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 160 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHG-----PLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKA 160 (294)
T ss_dssp EEECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred EEeCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence 999999999999986543 58999999999999999999996 8999999999999999999999999999976
Q ss_pred cCCCCCcccccccccCCcccccccccccC
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
...... .......||+.|+|||++.+..
T Consensus 161 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~ 188 (294)
T 4eqm_A 161 LSETSL-TQTNHVLGTVQYFSPEQAKGEA 188 (294)
T ss_dssp C--------------CCSSCCHHHHHTCC
T ss_pred cccccc-cccCccccCccccCHhHhcCCC
Confidence 543321 2223456999999999987654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=261.42 Aligned_cols=172 Identities=30% Similarity=0.463 Sum_probs=150.1
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccC-hhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
.++|++.+.||+|+||.||+|+.. +++.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367999999999999999999875 6899999999764321 23456788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+||+++.++++||+|||+++..
T Consensus 85 ~e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~ 156 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV 156 (318)
T ss_dssp ECCCCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred EeCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceec
Confidence 99999999999986532 58899999999999999999996 89999999999999999999999999999876
Q ss_pred CCCCCcccccccccCCccccccccccc
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
... ....+||+.|+|||++.+.
T Consensus 157 ~~~-----~~~~~gt~~y~aPE~~~~~ 178 (318)
T 1fot_A 157 PDV-----TYTLCGTPDYIAPEVVSTK 178 (318)
T ss_dssp SSC-----BCCCCSCTTTCCHHHHTTC
T ss_pred CCc-----cccccCCccccCHhHhcCC
Confidence 432 2345799999999998764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=265.63 Aligned_cols=180 Identities=23% Similarity=0.383 Sum_probs=151.1
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccC---hhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS---EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 663 (779)
+.++|++.+.||+|+||.||+|+.. +++.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3467999999999999999999875 6899999998643211 11356789999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCc---EEEEee
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR---AKVADF 740 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~---~kl~DF 740 (779)
|+||||+++++|.+++..+...+ ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++. +||+||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAG-FVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEeCCCCCCHHHHHHHhcccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecC
Confidence 99999999999998886654322 357899999999999999999996 89999999999999986554 999999
Q ss_pred ccceecCCCCCcccccccccCCccccccccccc
Q 004020 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 741 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
|+++....... .....+||+.|+|||++.+.
T Consensus 178 g~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~ 208 (351)
T 3c0i_A 178 GVAIQLGESGL--VAGGRVGTPHFMAPEVVKRE 208 (351)
T ss_dssp TTCEECCTTSC--BCCCCCSCGGGCCHHHHTTC
T ss_pred cceeEecCCCe--eecCCcCCcCccCHHHHcCC
Confidence 99987755322 22345799999999998765
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.8e-29 Score=264.51 Aligned_cols=176 Identities=27% Similarity=0.438 Sum_probs=150.3
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERL 664 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 664 (779)
..++|++.+.||+|+||.||+|+.+ +++.||+|+++.... .....+.+.+|..++..+ +||||+++++++.+.+..|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 4578999999999999999999876 689999999976432 123446678899999887 8999999999999999999
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+||+++.++++||+|||+++
T Consensus 95 lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 9999999999999986542 58899999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCcccccccccCCccccccccccc
Q 004020 745 LAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
...... ......+||+.|+|||++.+.
T Consensus 167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~ 193 (345)
T 1xjd_A 167 ENMLGD--AKTNTFCGTPDYIAPEILLGQ 193 (345)
T ss_dssp CCCCTT--CCBCCCCSCGGGCCHHHHTTC
T ss_pred hcccCC--CcccCCCCCcccCChhhhcCC
Confidence 643321 123456799999999998765
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.4e-28 Score=249.74 Aligned_cols=219 Identities=21% Similarity=0.346 Sum_probs=196.9
Q ss_pred CCCCcceeeEeCCCCcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCc
Q 004020 51 PDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPS 129 (779)
Q Consensus 51 ~~~C~w~gv~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~ 129 (779)
.|.|.|.|+.|.....++.+++++++++ .+|..+. ++|++|+|++|++++.++ .|.++++|++|+|++|+++.+++
T Consensus 2 ~~~C~~~~~~C~c~~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~ 78 (270)
T 2o6q_A 2 EALCKKDGGVCSCNNNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPA 78 (270)
T ss_dssp CCCBGGGTCSBEEETTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCT
T ss_pred CccCCCCCCCCEeCCCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeCh
Confidence 4889999999987777889999999999 5787665 689999999999998887 79999999999999999999999
Q ss_pred ccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCcccc
Q 004020 130 DFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK 209 (779)
Q Consensus 130 ~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 209 (779)
..|.++++|++|+|++|++.. ..+..|..+++|++|++++|++++..+..+. .+++|++|+|++|+|++..+..++
T Consensus 79 ~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~Ls~n~l~~~~~~~~~- 154 (270)
T 2o6q_A 79 GIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLKSLPPRVFD--SLTKLTYLSLGYNELQSLPKGVFD- 154 (270)
T ss_dssp TTTSSCTTCCEEECCSSCCCC-CCTTTTTTCSSCCEEECCSSCCCCCCTTTTT--TCTTCCEEECCSSCCCCCCTTTTT-
T ss_pred hhhcCCCCCCEEECCCCcCCc-CCHhHcccccCCCEEECCCCccCeeCHHHhC--cCcCCCEEECCCCcCCccCHhHcc-
Confidence 999999999999999999986 5667889999999999999999988777776 799999999999999965554443
Q ss_pred CCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCC-CCCCCCCcEEEccCCccccccChhhhCCCCCCE
Q 004020 210 SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAV 288 (779)
Q Consensus 210 ~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~ 288 (779)
.+++|+.|+|++|++++.++. +..+++|++|++++|++++..+..+..+++|+.
T Consensus 155 -------------------------~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 209 (270)
T 2o6q_A 155 -------------------------KLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKM 209 (270)
T ss_dssp -------------------------TCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred -------------------------CCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCE
Confidence 689999999999999998875 889999999999999999877778999999999
Q ss_pred EEccCccccccCC
Q 004020 289 VNLTNNLFQGQTP 301 (779)
Q Consensus 289 L~Ls~N~l~g~~p 301 (779)
|+|++|++.+..+
T Consensus 210 L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 210 LQLQENPWDCTCN 222 (270)
T ss_dssp EECCSSCBCCSSS
T ss_pred EEecCCCeeCCCc
Confidence 9999999987554
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=261.71 Aligned_cols=172 Identities=29% Similarity=0.433 Sum_probs=147.2
Q ss_pred hcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC----eEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN----ERL 664 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~ 664 (779)
.++|++.+.||+|+||.||+|+.. ++.||||++.... .......+|+.++++++||||+++++++.... ..+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 357999999999999999999876 7999999986542 33445667999999999999999999998754 369
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC----------CcEEcCCCCCCEEEcCCCc
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ----------SFIHRDLKPSNILLGDDMR 734 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~----------~ivHrDlkp~NIll~~~~~ 734 (779)
+||||+++|+|.+++... .+++..++.++.||+.||+|||+ . +|+||||||+||+++.++.
T Consensus 99 lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~ 169 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN------VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169 (322)
T ss_dssp EEEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred EEEecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCe
Confidence 999999999999999543 48899999999999999999996 6 9999999999999999999
Q ss_pred EEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 735 AKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 735 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+||+|||+++...............||+.|+|||++.+.
T Consensus 170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 208 (322)
T 3soc_A 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGA 208 (322)
T ss_dssp EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTC
T ss_pred EEEccCCcccccccccCccccccCccCccccCHhhcccc
Confidence 999999999877654333333446799999999999764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=264.06 Aligned_cols=176 Identities=28% Similarity=0.366 Sum_probs=150.4
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERL 664 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 664 (779)
..++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+.+|..++..+ +||+|+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3568999999999999999999876 478999999976532 223456788999999988 7999999999999999999
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+++
T Consensus 98 lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 9999999999999986542 48899999999999999999996 899999999999999999999999999998
Q ss_pred ecCCCCCcccccccccCCccccccccccc
Q 004020 745 LAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
....... .....+||+.|+|||++.+.
T Consensus 170 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~ 196 (353)
T 2i0e_A 170 ENIWDGV--TTKTFCGTPDYIAPEIIAYQ 196 (353)
T ss_dssp CCCCTTC--CBCCCCSCGGGCCHHHHTTC
T ss_pred ccccCCc--ccccccCCccccChhhhcCC
Confidence 6433221 23456799999999998754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=259.90 Aligned_cols=173 Identities=21% Similarity=0.297 Sum_probs=150.4
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
+.++|++.+.||+|+||.||+|... +++.||+|.+... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 4678999999999999999999875 6889999998643 23446788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC--CCcEEEEeeccce
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD--DMRAKVADFGLVR 744 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~--~~~~kl~DFG~a~ 744 (779)
|||+++++|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||+++
T Consensus 80 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~ 152 (321)
T 1tki_A 80 FEFISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp ECCCCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EEeCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence 99999999999985432 258999999999999999999996 89999999999999987 7899999999998
Q ss_pred ecCCCCCcccccccccCCccccccccccc
Q 004020 745 LAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
...... ......||+.|+|||++.+.
T Consensus 153 ~~~~~~---~~~~~~gt~~y~aPE~~~~~ 178 (321)
T 1tki_A 153 QLKPGD---NFRLLFTAPEYYAPEVHQHD 178 (321)
T ss_dssp ECCTTC---EEEEEESCGGGSCHHHHTTC
T ss_pred ECCCCC---ccccccCChhhcCcHHhcCC
Confidence 875432 22345799999999998764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=271.28 Aligned_cols=181 Identities=27% Similarity=0.380 Sum_probs=150.1
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC-----C
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG-----N 661 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~ 661 (779)
+.++|++.+.||+|+||.||+|+.. +++.||||++..........+++.+|++++++++||||+++++++... +
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 4578999999999999999999865 688999999987655556678899999999999999999999999876 5
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeec
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 741 (779)
..|+||||++ ++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFG 174 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFG 174 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecCC-cCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCC
Confidence 6899999986 5999988543 258999999999999999999997 899999999999999999999999999
Q ss_pred cceecCCCCCc--------------------ccccccccCCcccccccccccCCCC
Q 004020 742 LVRLAPDNGKH--------------------SIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 742 ~a~~~~~~~~~--------------------~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
+|+........ ...+..+||+.|+|||++.....++
T Consensus 175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~ 230 (432)
T 3n9x_A 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYT 230 (432)
T ss_dssp TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCC
T ss_pred CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCC
Confidence 99876543211 1124568999999999976555554
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.6e-28 Score=254.80 Aligned_cols=190 Identities=42% Similarity=0.717 Sum_probs=162.6
Q ss_pred eeeeHHHHHHhhcCCccc------ceecccccEEEEEEEEcCCcEEEEEEecccc--cChhHHHHHHHHHHHHHcCCCCc
Q 004020 578 MVISIQVLRNVTNNFSEE------NVLGRGGFGTVYKGELHDGTKIAVKRMESAV--VSEKGFAEFKSEIAVLTKVRHRH 649 (779)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~n 649 (779)
..+++.++..++++|... +.||+|+||.||+|.. +++.||+|++.... ......+.+.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 467889999999998877 8999999999999986 58899999987543 22344577999999999999999
Q ss_pred cceEeeEEEeCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEE
Q 004020 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 729 (779)
Q Consensus 650 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll 729 (779)
|+++++++.+.+..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+ .+|+||||||+||++
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili 166 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILL 166 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEE
Confidence 99999999999999999999999999999865432 2358999999999999999999996 899999999999999
Q ss_pred cCCCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 730 GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 730 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+.++.+||+|||+++...............||+.|+|||++.+.
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 210 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE 210 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCC
Confidence 99999999999999876544333333445799999999998764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=263.10 Aligned_cols=172 Identities=28% Similarity=0.370 Sum_probs=150.7
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 368999999999999999999875 689999999975432 223456788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++..
T Consensus 120 ~e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EECCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceec
Confidence 99999999999986542 48899999999999999999996 89999999999999999999999999999876
Q ss_pred CCCCCcccccccccCCccccccccccc
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
... ....+||+.|+|||++.+.
T Consensus 192 ~~~-----~~~~~gt~~y~aPE~~~~~ 213 (350)
T 1rdq_E 192 KGR-----TWTLCGTPEALAPEIILSK 213 (350)
T ss_dssp SSC-----BCCCEECGGGCCHHHHTTC
T ss_pred cCC-----cccccCCccccCHHHhcCC
Confidence 432 2345799999999998764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=276.03 Aligned_cols=181 Identities=25% Similarity=0.373 Sum_probs=139.8
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC-----C
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG-----N 661 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~ 661 (779)
+.++|++.+.||+|+||.||+|+.. +++.||||++..........+++.+|++++++++||||+++++++... .
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 3468999999999999999999765 789999999976655566678899999999999999999999998543 5
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeec
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 741 (779)
..|+||||++ ++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFG 201 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRTP-----VYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFG 201 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEeccc-cchhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccc
Confidence 6899999984 6898888543 258999999999999999999997 899999999999999999999999999
Q ss_pred cceecCCCCCc-------------------------ccccccccCCcccccccccccCCCC
Q 004020 742 LVRLAPDNGKH-------------------------SIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 742 ~a~~~~~~~~~-------------------------~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
+|+........ ...+..+||+.|+|||++.....++
T Consensus 202 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 262 (458)
T 3rp9_A 202 LARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYT 262 (458)
T ss_dssp TCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCC
T ss_pred cchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCC
Confidence 99876432110 1224467899999999876555444
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-28 Score=258.04 Aligned_cols=182 Identities=25% Similarity=0.383 Sum_probs=154.6
Q ss_pred eeeHHHHHHhhcC----------CcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCC
Q 004020 579 VISIQVLRNVTNN----------FSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH 647 (779)
Q Consensus 579 ~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h 647 (779)
.++.++++.+.+. |+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++|
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCC
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCC
Confidence 3566666665543 777889999999999999876 79999999987543 2345678899999999999
Q ss_pred CccceEeeEEEeCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCE
Q 004020 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNI 727 (779)
Q Consensus 648 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NI 727 (779)
|||+++++++...+..++||||+++++|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+||
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NI 172 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV------RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSI 172 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHE
Confidence 99999999999999999999999999999988432 48999999999999999999997 8999999999999
Q ss_pred EEcCCCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 728 LLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 728 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+++.++.+||+|||+++....... ......||+.|+|||++.+.
T Consensus 173 ll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~ 216 (321)
T 2c30_A 173 LLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRS 216 (321)
T ss_dssp EECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTC
T ss_pred EECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCC
Confidence 999999999999999987654321 22445799999999998654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=261.13 Aligned_cols=175 Identities=29% Similarity=0.476 Sum_probs=140.1
Q ss_pred hcCCcccceecccccEEEEEEEE----cCCcEEEEEEecccccC--hhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCe
Q 004020 589 TNNFSEENVLGRGGFGTVYKGEL----HDGTKIAVKRMESAVVS--EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 662 (779)
.++|++.+.||+|+||.||+|+. .+++.||+|+++..... ......+.+|+++++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999987 47899999999765321 2334567899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecc
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 742 (779)
.|+||||+++++|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG-----IFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEEEEeCCCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 999999999999999986542 47889999999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCCCcccccccccCCccccccccccc
Q 004020 743 VRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 743 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
++....... ......||+.|+|||++.+.
T Consensus 168 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~ 196 (327)
T 3a62_A 168 CKESIHDGT--VTHTFCGTIEYMAPEILMRS 196 (327)
T ss_dssp C------------CTTSSCCTTSCHHHHTTS
T ss_pred ccccccCCc--cccccCCCcCccCHhhCcCC
Confidence 876433221 22345799999999998764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=261.31 Aligned_cols=175 Identities=27% Similarity=0.441 Sum_probs=150.2
Q ss_pred hcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccCh-hHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSE-KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
.++|.+.+.||+|+||.||+|+. .+++.||+|++....... .....+.+|+++++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999987 578999999987543222 2235788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+ +|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++..
T Consensus 88 ~E~~-~g~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK-----RMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158 (336)
T ss_dssp ECCC-CEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred EECC-CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceec
Confidence 9999 689988886543 58899999999999999999996 89999999999999999999999999999866
Q ss_pred CCCCCcccccccccCCcccccccccccCC
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
.... .....+||+.|+|||++.+...
T Consensus 159 ~~~~---~~~~~~gt~~y~aPE~~~~~~~ 184 (336)
T 3h4j_B 159 TDGN---FLKTSCGSPNYAAPEVINGKLY 184 (336)
T ss_dssp TTSB---TTCCCTTSTTTSCGGGSCCSGG
T ss_pred cCCc---ccccccCCcCcCCHHHHcCCCC
Confidence 5432 2234579999999999987653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=266.42 Aligned_cols=182 Identities=32% Similarity=0.472 Sum_probs=143.6
Q ss_pred HHhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCC--
Q 004020 586 RNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGN-- 661 (779)
Q Consensus 586 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~-- 661 (779)
..+.++|++.+.||+|+||.||+|... +++.||+|++..........+++.+|+.+++.+. ||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 356789999999999999999999764 6899999999766555666778899999999997 999999999998654
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeec
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 741 (779)
..|+||||++ ++|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG 154 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFG 154 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEecccC-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCc
Confidence 6899999997 5898888542 47889999999999999999997 899999999999999999999999999
Q ss_pred cceecCCCCC-------------------cccccccccCCcccccccccccCCCC
Q 004020 742 LVRLAPDNGK-------------------HSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 742 ~a~~~~~~~~-------------------~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
+|+....... ....+..+||+.|+|||++.+...++
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 209 (388)
T 3oz6_A 155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYT 209 (388)
T ss_dssp TCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCC
T ss_pred ccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCC
Confidence 9987543110 11223467999999999998765554
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-28 Score=265.66 Aligned_cols=179 Identities=18% Similarity=0.283 Sum_probs=154.3
Q ss_pred hcCCcccceeccc--ccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 589 TNNFSEENVLGRG--GFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 589 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
.++|++.+.||+| +||.||+|+.. +++.||||++..........+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3579999999999 99999999876 69999999998776666667789999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||||+++++|.+++..... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||.+..
T Consensus 104 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFM---DGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEECCTTCBHHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEccCCCCHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 9999999999999865432 258899999999999999999997 8999999999999999999999999999875
Q ss_pred cCCCCCc-----ccccccccCCccccccccccc
Q 004020 746 APDNGKH-----SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 746 ~~~~~~~-----~~~~~~~gt~~y~APE~l~~~ 773 (779)
....+.. .......||+.|+|||++.+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 210 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQN 210 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTT
T ss_pred eccccccccccccccccccccccccCHHHHhcc
Confidence 4332111 112234789999999999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-28 Score=256.23 Aligned_cols=174 Identities=30% Similarity=0.359 Sum_probs=145.8
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 666 (779)
.++|++.++||+|+||.||+|+.. +++.||||++...........+...|+..+.++ +||||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 467999999999999999999876 799999999876554555555666677666665 899999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+ +++|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 136 ~e~~-~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EECC-CCBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred Eecc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 9999 678988886543 258999999999999999999997 79999999999999999999999999999876
Q ss_pred CCCCCcccccccccCCccccccccccc
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.... ......||+.|+|||++.+.
T Consensus 208 ~~~~---~~~~~~gt~~y~aPE~~~~~ 231 (311)
T 3p1a_A 208 GTAG---AGEVQEGDPRYMAPELLQGS 231 (311)
T ss_dssp C---------CCCCCGGGCCGGGGGTC
T ss_pred ccCC---CCcccCCCccccCHhHhcCC
Confidence 5432 22345699999999998763
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-28 Score=258.63 Aligned_cols=182 Identities=26% Similarity=0.389 Sum_probs=138.5
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... .....+.+.+|++++++++||||+++++++..++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 468999999999999999999765 68999999987543 2223467889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 668 EYMPQGTLSRHLFNRKEE-GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
||++ ++|.+++...... ....+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9998 5999988665322 22358899999999999999999996 89999999999999999999999999999876
Q ss_pred CCCCCcccccccccCCcccccccccccCCCC
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
..... ......||+.|+|||++.+...++
T Consensus 159 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~ 187 (317)
T 2pmi_A 159 GIPVN--TFSSEVVTLWYRAPDVLMGSRTYS 187 (317)
T ss_dssp TSCCC--CCCCCCSCCTTCCHHHHTTCCCCC
T ss_pred CCCcc--cCCCCcccccccCchHhhCCCCCC
Confidence 53321 223457899999999998755444
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-28 Score=255.49 Aligned_cols=175 Identities=31% Similarity=0.476 Sum_probs=143.8
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccCh------------------------hHHHHHHHHHHHHH
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE------------------------KGFAEFKSEIAVLT 643 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~------------------------~~~~~~~~E~~~l~ 643 (779)
.++|++.+.||+|+||.||+|+.. +++.||+|++....... ...+++.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 368999999999999999999865 68899999986543211 12356889999999
Q ss_pred cCCCCccceEeeEEEe--CCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcC
Q 004020 644 KVRHRHLVGLLGYCLD--GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRD 721 (779)
Q Consensus 644 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrD 721 (779)
+++||||+++++++.+ .+..++||||+++++|.+++.. ..+++..++.++.||+.||+|||+ .+|+|||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~D 162 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRD 162 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccC
Confidence 9999999999999987 5678999999999999876421 258999999999999999999997 7999999
Q ss_pred CCCCCEEEcCCCcEEEEeeccceecCCCCCcccccccccCCcccccccccccC
Q 004020 722 LKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 722 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
|||+||+++.++.+||+|||+++....... ......||+.|+|||++.+..
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~ 213 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETR 213 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTC
T ss_pred CCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCC
Confidence 999999999999999999999987654321 223457999999999987654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-28 Score=258.46 Aligned_cols=177 Identities=27% Similarity=0.451 Sum_probs=147.4
Q ss_pred hcCCcccceecccccEEEEEEEEc----CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 664 (779)
.++|++.+.||+|+||.||+|+.. .+..||||+++... .....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 467999999999999999999874 35569999997543 3455678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
+||||+++++|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 127 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp EEEECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEeeCCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 9999999999999985432 258999999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCc-ccccccccCCccccccccccc
Q 004020 745 LAPDNGKH-SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 745 ~~~~~~~~-~~~~~~~gt~~y~APE~l~~~ 773 (779)
........ .......+|+.|+|||++.+.
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 229 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHC
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCC
Confidence 76543221 122334567899999998654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-28 Score=257.24 Aligned_cols=175 Identities=26% Similarity=0.389 Sum_probs=150.5
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccCh----hHHHHHHHHHHHHHcCCCCccceEeeEEEeCCe
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE----KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 662 (779)
+.++|++.+.||+|+||.||+|+.. +++.||+|++....... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 4467999999999999999999875 68999999987654221 135678999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC----cEEEE
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM----RAKVA 738 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~----~~kl~ 738 (779)
.++||||+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++ .+||+
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 160 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKII 160 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTS-----SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEEcCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEE
Confidence 99999999999999998543 258999999999999999999996 8999999999999999887 89999
Q ss_pred eeccceecCCCCCcccccccccCCccccccccccc
Q 004020 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 739 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
|||+++....... .....||+.|+|||++.+.
T Consensus 161 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~ 192 (326)
T 2y0a_A 161 DFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYE 192 (326)
T ss_dssp CCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTC
T ss_pred ECCCCeECCCCCc---cccccCCcCcCCceeecCC
Confidence 9999987654321 2345799999999998654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.5e-28 Score=255.94 Aligned_cols=179 Identities=24% Similarity=0.335 Sum_probs=148.0
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+.+|++++++++||||+++++++...+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 468999999999999999999875 5899999998766545555677899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 82 e~~~~~~l~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ-----RGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLT 153 (311)
T ss_dssp ECCSEEHHHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EeCCCchHHHHHhhh-----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence 999999998877443 258899999999999999999996 899999999999999999999999999998765
Q ss_pred CCCCcccccccccCCcccccccccccCCCC
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
.... ......||+.|+|||++.+...++
T Consensus 154 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~ 181 (311)
T 4agu_A 154 GPSD--YYDDEVATRWYRSPELLVGDTQYG 181 (311)
T ss_dssp --------------GGGCCHHHHHTCSCCC
T ss_pred Cccc--ccCCCcCCccccChHHHhcCCCCC
Confidence 4322 223457899999999997755544
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-29 Score=269.28 Aligned_cols=169 Identities=21% Similarity=0.275 Sum_probs=139.6
Q ss_pred hcCCcccceecccccEEEEEEEEcCCcEEEEEEeccccc------ChhHHHHHHHHHHHHHcCC---------CCccceE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVV------SEKGFAEFKSEIAVLTKVR---------HRHLVGL 653 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~---------h~niv~~ 653 (779)
.++|++.+.||+|+||.||+|+. +++.||||++..... .....+.+.+|+++++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46789999999999999999987 689999999976532 2233467889999998886 6666666
Q ss_pred eeEEE-----------------e-------------CCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHH
Q 004020 654 LGYCL-----------------D-------------GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVA 703 (779)
Q Consensus 654 ~~~~~-----------------~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~ 703 (779)
.+.+. + .+..|+||||+++|++.+.+.+ ..+++..++.++.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHH
Confidence 66543 2 6789999999999977666632 2478999999999999
Q ss_pred HHHHHHH-cCCCCCcEEcCCCCCCEEEcCCC--------------------cEEEEeeccceecCCCCCcccccccccCC
Q 004020 704 RGVEYLH-GLAHQSFIHRDLKPSNILLGDDM--------------------RAKVADFGLVRLAPDNGKHSIETRLAGTF 762 (779)
Q Consensus 704 ~~L~~LH-~~~~~~ivHrDlkp~NIll~~~~--------------------~~kl~DFG~a~~~~~~~~~~~~~~~~gt~ 762 (779)
.||+||| + .+|+||||||+|||++.++ .+||+|||+|+..... ..+||+
T Consensus 172 ~aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~ 241 (336)
T 2vuw_A 172 ASLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCD 241 (336)
T ss_dssp HHHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCC
T ss_pred HHHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEee
Confidence 9999999 7 7999999999999999887 8999999999876532 247999
Q ss_pred cccccccccccC
Q 004020 763 GYLAPEYAAETS 774 (779)
Q Consensus 763 ~y~APE~l~~~~ 774 (779)
.|||||++.+..
T Consensus 242 ~y~aPE~~~g~~ 253 (336)
T 2vuw_A 242 VSMDEDLFTGDG 253 (336)
T ss_dssp CTTCSGGGCCCS
T ss_pred cccChhhhcCCC
Confidence 999999998765
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-28 Score=264.13 Aligned_cols=176 Identities=31% Similarity=0.440 Sum_probs=141.5
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccC-hhHHHHHHHHHHH-HHcCCCCccceEeeEEEeCCeEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAV-LTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
.++|++.+.||+|+||.||+|+.+ +++.||+|++.+.... ......+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357999999999999999999876 5889999999765432 2334556777776 567899999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+++.
T Consensus 117 v~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 999999999999986542 47889999999999999999996 8999999999999999999999999999986
Q ss_pred cCCCCCcccccccccCCcccccccccccC
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
..... ......+||+.|+|||++.+..
T Consensus 189 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~ 215 (373)
T 2r5t_A 189 NIEHN--STTSTFCGTPEYLAPEVLHKQP 215 (373)
T ss_dssp GBCCC--CCCCSBSCCCCCCCHHHHTTCC
T ss_pred cccCC--CccccccCCccccCHHHhCCCC
Confidence 43322 1234567999999999987653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.8e-28 Score=248.92 Aligned_cols=174 Identities=29% Similarity=0.429 Sum_probs=150.8
Q ss_pred hcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
.++|++.+.||+|+||.||+|+..++..||+|++..... ..+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC---cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 467999999999999999999999888999999976543 23568899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++++|.+++..... .+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGK----GLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp CCTTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred ccCCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 9999999999866432 48899999999999999999997 8999999999999999999999999999987655
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
... .......+|+.|+|||++.+.
T Consensus 157 ~~~-~~~~~~~~~~~y~aPE~~~~~ 180 (268)
T 3sxs_A 157 DQY-VSSVGTKFPVKWSAPEVFHYF 180 (268)
T ss_dssp TCE-EECCSCCCCGGGCCHHHHHHS
T ss_pred hhh-hcccCCCcCcccCCHHHHhcc
Confidence 422 222344577889999998653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-28 Score=272.44 Aligned_cols=179 Identities=31% Similarity=0.483 Sum_probs=153.4
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccC-hhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
.++|.+.+.||+|+||.||+|+.. +++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999875 6999999999765322 23456788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++|+|.+++...... ...+++..++.++.||+.||+|||+ ++|+||||||+||+++.+|++||+|||+++..
T Consensus 264 mE~~~gg~L~~~l~~~~~~-~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTT-SCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeccCCCHHHHHHHhhcc-cccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 9999999999998654321 2358999999999999999999997 89999999999999999999999999999876
Q ss_pred CCCCCcccccccccCCccccccccccc
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
..... .....+||+.|+|||++.+.
T Consensus 340 ~~~~~--~~~~~~GT~~Y~APE~l~~~ 364 (543)
T 3c4z_A 340 KAGQT--KTKGYAGTPGFMAPELLLGE 364 (543)
T ss_dssp CTTCC--CBCCCCSCTTTSCHHHHTTC
T ss_pred cCCCc--ccccccCCccccChhhhcCC
Confidence 54322 22345799999999999764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-28 Score=269.16 Aligned_cols=176 Identities=30% Similarity=0.470 Sum_probs=152.6
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccCh-hHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE-KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
.++|.+.+.||+|+||.||+|+.. +|+.||||++....... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 368999999999999999999876 79999999997543221 2346789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 95 ~E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 95 MEYVSGGELFDYICKN-----GRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp EECCSSEEHHHHTTSS-----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 9999999999998543 258999999999999999999996 89999999999999999999999999999876
Q ss_pred CCCCCcccccccccCCcccccccccccCC
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
.... .....+||+.|+|||++.+...
T Consensus 167 ~~~~---~~~~~~gt~~y~aPE~~~~~~~ 192 (476)
T 2y94_A 167 SDGE---FLRTSCGSPNYAAPEVISGRLY 192 (476)
T ss_dssp CTTC---CBCCCCSCSTTCCHHHHTTCCB
T ss_pred cccc---cccccCCCcCeEChhhccCCCC
Confidence 5432 2234579999999999987643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-28 Score=252.13 Aligned_cols=173 Identities=31% Similarity=0.489 Sum_probs=149.2
Q ss_pred cCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
++|++.+.||+|+||.||+|+..+++.||+|++...... .+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 578999999999999999999988999999999765432 35688999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+++++|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 87 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 87 MEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp CTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCcHHHHHHhcC----cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 99999999985533 258899999999999999999996 89999999999999999999999999999865432
Q ss_pred CCcccccccccCCccccccccccc
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
. ........||+.|+|||++.+.
T Consensus 160 ~-~~~~~~~~~~~~y~aPE~~~~~ 182 (269)
T 4hcu_A 160 Q-YTSSTGTKFPVKWASPEVFSFS 182 (269)
T ss_dssp H-HHSTTSTTCCGGGCCHHHHHHC
T ss_pred c-cccccCcccccccCCHHHhcCC
Confidence 1 1222344578899999998654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-28 Score=272.92 Aligned_cols=176 Identities=32% Similarity=0.494 Sum_probs=151.9
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccC-hhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
.++|++.+.||+|+||.||+|+.. +|+.||+|++...... ......+.+|++++++++||||+++++++.+.+..|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999875 7999999999764322 23346688999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++|+|.+++..... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+++..
T Consensus 263 mEy~~gg~L~~~l~~~~~---~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQ---AGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp ECCCCSCBHHHHHHSSSS---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 999999999998865432 248999999999999999999997 89999999999999999999999999999877
Q ss_pred CCCCCcccccccccCCccccccccccc
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
..... ....+||+.|+|||++.+.
T Consensus 337 ~~~~~---~~~~~GT~~Y~APEvl~~~ 360 (576)
T 2acx_A 337 PEGQT---IKGRVGTVGYMAPEVVKNE 360 (576)
T ss_dssp CTTCC---EECCCSCGGGCCHHHHTTC
T ss_pred ccCcc---ccccCCCccccCHHHHcCC
Confidence 54322 2345799999999998764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=262.57 Aligned_cols=186 Identities=32% Similarity=0.476 Sum_probs=153.6
Q ss_pred HHHHhhcCCcccceecccccEEEEEEEEc------CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEE
Q 004020 584 VLRNVTNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC 657 (779)
Q Consensus 584 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 657 (779)
.+....++|++.+.||+|+||.||+|+.. +++.||+|+++... .....+.+.+|++++++++||||+++++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 34445688999999999999999999874 34889999997543 344567899999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChhhHhhhcccCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcE
Q 004020 658 LDGNERLLVYEYMPQGTLSRHLFNRKEEG-------------------LKPLEWTRRLTIALDVARGVEYLHGLAHQSFI 718 (779)
Q Consensus 658 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iv 718 (779)
.+.+..++||||+++++|.+++....... ...+++.+++.++.||++||+|||+ ++|+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCee
Confidence 99999999999999999999997643211 1468999999999999999999997 8999
Q ss_pred EcCCCCCCEEEcCCCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 719 HRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 719 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
||||||+||+++.++.+||+|||+++...............||+.|+|||++.+.
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 251 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN 251 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC
Confidence 9999999999999999999999999866433222223345689999999988654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.5e-28 Score=262.94 Aligned_cols=181 Identities=31% Similarity=0.485 Sum_probs=153.4
Q ss_pred hcCCcccceecccccEEEEEEEEc--------CCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEe
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH--------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLD 659 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 659 (779)
.++|.+.+.||+|+||.||+|+.. ++..||+|++.... .....+++.+|+++++++ +||||+++++++..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 468999999999999999999753 24579999987653 455667899999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCChhhHhhhcccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEE
Q 004020 660 GNERLLVYEYMPQGTLSRHLFNRKEEG-----------LKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 728 (779)
Q Consensus 660 ~~~~~lv~e~~~~gsL~~~l~~~~~~~-----------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIl 728 (779)
.+..++||||+++|+|.+++......+ ...+++..++.++.||+.||+|||+ .+|+||||||+||+
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEE
Confidence 999999999999999999997654211 2358999999999999999999997 89999999999999
Q ss_pred EcCCCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 729 LGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 729 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
++.++.+||+|||+++...............||+.|+|||++.+.
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 268 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 268 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC
Confidence 999999999999999876554333333445688999999998654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-28 Score=265.60 Aligned_cols=177 Identities=28% Similarity=0.416 Sum_probs=148.8
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.++|++.+.||+|+||.||+|+.. +++.||||+++... .....+++.+|++++++++||||+++++++...+..++||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 357889999999999999999886 78999999987542 3444567899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++|+|.+++..... .+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 192 e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEGA----RLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp ECCTTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EcCCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 99999999999965432 47899999999999999999997 899999999999999999999999999998754
Q ss_pred CCCCcccccccccCCccccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
............+++.|+|||++.+.
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~ 290 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYG 290 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHC
T ss_pred CCceeecCCCCCCCcCcCCHhHhccC
Confidence 32111111122357789999988643
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-30 Score=271.49 Aligned_cols=204 Identities=22% Similarity=0.287 Sum_probs=134.7
Q ss_pred CCCCccEEEcccCCCCCCCCcccc--cCCCCCceEeccCceeEeecCCCccCCCC-----CcccEEEccCCCCCCcCCCc
Q 004020 134 GLTSLQTISLDYNSFDSWVIPESL--KDATGLQRFSANGANITGTIPDFLGGDTI-----PGLMHLHLAFNFLQGPIPLS 206 (779)
Q Consensus 134 ~l~~L~~L~Ls~N~l~~~~~p~~~--~~l~~L~~L~l~~n~l~~~~p~~~~~~~l-----~~L~~L~L~~N~l~~~~p~~ 206 (779)
++++|++|+|++|++.+ .+|..+ ..+++|++|++++|++++. |..++ .+ ++|++|+|++|++++..|..
T Consensus 93 ~l~~L~~L~L~~n~l~~-~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~--~l~~~~~~~L~~L~L~~N~l~~~~~~~ 168 (312)
T 1wwl_A 93 GISGLQELTLENLEVTG-TAPPPLLEATGPDLNILNLRNVSWATR-DAWLA--ELQQWLKPGLKVLSIAQAHSLNFSCEQ 168 (312)
T ss_dssp TTSCCCEEEEEEEBCBS-CCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHH--HHHTTCCTTCCEEEEESCSCCCCCTTT
T ss_pred CcCCccEEEccCCcccc-hhHHHHHHhcCCCccEEEccCCCCcch-hHHHH--HHHHhhcCCCcEEEeeCCCCccchHHH
Confidence 34555555555555543 333333 4555555555555555544 44443 23 66777777777776655555
Q ss_pred cccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCC---CCCC--CCCCCCcEEEccCCcccc--ccC-h
Q 004020 207 FGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGP---LPDL--SGLSSLQDFSVRDNQLTG--IVP-S 278 (779)
Q Consensus 207 ~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~--~~l~~L~~L~l~~N~l~~--~~p-~ 278 (779)
++ .+++|++|+|++|++.+. ++.+ ..+++|++|++++|+|++ .++ .
T Consensus 169 ~~--------------------------~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 222 (312)
T 1wwl_A 169 VR--------------------------VFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSA 222 (312)
T ss_dssp CC--------------------------CCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHH
T ss_pred hc--------------------------cCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHH
Confidence 44 467777777777777664 2233 677888888888888873 222 3
Q ss_pred hhhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCC
Q 004020 279 SLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCN 358 (779)
Q Consensus 279 ~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (779)
.+..+++|+.|+|++|++++.+|..
T Consensus 223 ~~~~l~~L~~L~Ls~N~l~~~~~~~------------------------------------------------------- 247 (312)
T 1wwl_A 223 LAAARVQLQGLDLSHNSLRDAAGAP------------------------------------------------------- 247 (312)
T ss_dssp HHHTTCCCSEEECTTSCCCSSCCCS-------------------------------------------------------
T ss_pred HHhcCCCCCEEECCCCcCCcccchh-------------------------------------------------------
Confidence 4457788888888888888766421
Q ss_pred CCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccCccccccCCccCCCCCCCCceeccCCccccc
Q 004020 359 SDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGK 433 (779)
Q Consensus 359 ~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ 433 (779)
.+...++|++|+|++|+|+ .+|..+. ++|++|+|++|+|++. |. +..+++|++|+|++|++++.
T Consensus 248 ------~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 248 ------SCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp ------CCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred ------hhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence 0111237888888888888 7787776 8899999999999855 66 88899999999999988763
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.7e-28 Score=250.85 Aligned_cols=179 Identities=26% Similarity=0.393 Sum_probs=152.9
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 665 (779)
..++|++.+.||+|+||.||+|+.. +++.||+|++...........++.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4578999999999999999999876 799999999987655555667889999999999 89999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCC-------------
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD------------- 732 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~------------- 732 (779)
||||+++++|.+++...... ...+++..++.++.||+.||+|||+ ++|+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRI-MSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC---------------
T ss_pred EEEecCCCcHHHHHHhhccc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 99999999999999765332 1258999999999999999999997 899999999999999844
Q ss_pred ------CcEEEEeeccceecCCCCCcccccccccCCcccccccccccCCC
Q 004020 733 ------MRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSGM 776 (779)
Q Consensus 733 ------~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 776 (779)
..+||+|||.++..... ....||+.|+|||++.+...+
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~ 208 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTH 208 (289)
T ss_dssp -----CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTT
T ss_pred cccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCC
Confidence 47999999999876543 223589999999999876443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=259.58 Aligned_cols=174 Identities=22% Similarity=0.348 Sum_probs=149.6
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
+.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 4568999999999999999999875 68899999987543 33446789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC--CCcEEEEeeccce
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD--DMRAKVADFGLVR 744 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~--~~~~kl~DFG~a~ 744 (779)
|||+++++|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||+++
T Consensus 127 ~E~~~gg~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~ 199 (387)
T 1kob_A 127 LEFLSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLAT 199 (387)
T ss_dssp EECCCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred EEcCCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccce
Confidence 99999999999885432 258999999999999999999997 89999999999999974 5789999999998
Q ss_pred ecCCCCCcccccccccCCccccccccccc
Q 004020 745 LAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
....... .....||+.|+|||++.+.
T Consensus 200 ~~~~~~~---~~~~~gt~~y~aPE~~~~~ 225 (387)
T 1kob_A 200 KLNPDEI---VKVTTATAEFAAPEIVDRE 225 (387)
T ss_dssp ECCTTSC---EEEECSSGGGCCHHHHTTC
T ss_pred ecCCCcc---eeeeccCCCccCchhccCC
Confidence 7754322 2334799999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=264.23 Aligned_cols=190 Identities=26% Similarity=0.404 Sum_probs=155.6
Q ss_pred eeHHHHHHhhcCCcccceecccccEEEEEEEEc------CCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccce
Q 004020 580 ISIQVLRNVTNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVG 652 (779)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 652 (779)
+.........++|++.+.||+|+||.||+|++. +++.||||++.... .....+.+.+|+++++++ +||||++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceee
Confidence 344555566789999999999999999999742 46789999997543 344557799999999999 7999999
Q ss_pred EeeEEEeCCe-EEEEEEecCCCChhhHhhhcccCC---------------------------------------------
Q 004020 653 LLGYCLDGNE-RLLVYEYMPQGTLSRHLFNRKEEG--------------------------------------------- 686 (779)
Q Consensus 653 ~~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------- 686 (779)
+++++.+.+. .++||||+++|+|.+++.......
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999987654 899999999999999997654210
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCC
Q 004020 687 ----------------LKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNG 750 (779)
Q Consensus 687 ----------------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 750 (779)
...+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 1128899999999999999999997 899999999999999999999999999998765543
Q ss_pred CcccccccccCCccccccccccc
Q 004020 751 KHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 751 ~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.........||+.|+|||++.+.
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~ 270 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDR 270 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHC
T ss_pred cchhccccCCCceeEChhhhcCC
Confidence 33344456789999999998654
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-28 Score=252.29 Aligned_cols=207 Identities=24% Similarity=0.322 Sum_probs=188.3
Q ss_pred CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCC-CCCCCcccccCCCCccEEE
Q 004020 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNN-FTSVPSDFFKGLTSLQTIS 142 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~L~ 142 (779)
.++++|++++|++++..+..|..+++|++|+|++|++++..+ .|.++++|++|+|++|. ++.+++..|..+++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 479999999999998888889999999999999999999876 89999999999999997 9999999999999999999
Q ss_pred cccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCC
Q 004020 143 LDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKG 222 (779)
Q Consensus 143 Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~ 222 (779)
|++|++.+ ..|..|.++++|++|++++|.+++..+..+. .+++|++|+|++|++++..+..+.
T Consensus 112 l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~-------------- 174 (285)
T 1ozn_A 112 LDRCGLQE-LGPGLFRGLAALQYLYLQDNALQALPDDTFR--DLGNLTHLFLHGNRISSVPERAFR-------------- 174 (285)
T ss_dssp CTTSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTT--TCTTCCEEECCSSCCCEECTTTTT--------------
T ss_pred CCCCcCCE-ECHhHhhCCcCCCEEECCCCcccccCHhHhc--cCCCccEEECCCCcccccCHHHhc--------------
Confidence 99999987 6688899999999999999999977777775 799999999999999965554454
Q ss_pred CCCCCCchhhhcCCCCccEEEeecCcccCCCC-CCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccC
Q 004020 223 DSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQT 300 (779)
Q Consensus 223 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~ 300 (779)
.+++|+.|+|++|.+++..| .+..+++|+.|++++|++++..+..+..+++|+.|+|++|++.+..
T Consensus 175 ------------~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~ 241 (285)
T 1ozn_A 175 ------------GLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241 (285)
T ss_dssp ------------TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred ------------CccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCC
Confidence 68999999999999999877 5899999999999999999877788999999999999999998643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.7e-28 Score=257.94 Aligned_cols=183 Identities=29% Similarity=0.480 Sum_probs=135.5
Q ss_pred hhcCCcccceecccccEEEEEEEEcCC----cEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELHDG----TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 663 (779)
..++|++.+.||+|+||.||+|+.... ..||+|++..........+++.+|++++++++||||+++++++...+..
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 456899999999999999999976533 2799999987655556678899999999999999999999999887655
Q ss_pred ------EEEEEecCCCChhhHhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEE
Q 004020 664 ------LLVYEYMPQGTLSRHLFNRKEE-GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 736 (779)
Q Consensus 664 ------~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 736 (779)
++||||+++++|.+++...... ....+++..++.++.||+.||+|||+ ++|+||||||+||++++++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEE
Confidence 9999999999999998654422 22258899999999999999999997 8999999999999999999999
Q ss_pred EEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 737 VADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 737 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
|+|||+++...............+++.|+|||++.+.
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 214 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN 214 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHC
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCC
Confidence 9999999876544333333345578899999998664
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.6e-28 Score=260.18 Aligned_cols=174 Identities=22% Similarity=0.356 Sum_probs=146.0
Q ss_pred hcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCC--CccceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH--RHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv 666 (779)
.++|++.+.||+|+||.||+|...+++.||+|++..........+.+.+|++++++++| |||+++++++...+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 35799999999999999999998889999999998666566667889999999999986 9999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|| +.+++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++ ++.+||+|||+++..
T Consensus 88 ~e-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EC-CCSEEHHHHHHHSC-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred Ee-CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 99 45789999986542 58899999999999999999996 8999999999999997 578999999999876
Q ss_pred CCCCCcccccccccCCcccccccccc
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
............+||+.|+|||++.+
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~ 183 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKD 183 (343)
T ss_dssp ------------CCCCSSCCHHHHHH
T ss_pred CcccccccCCCCcCCcCcCCHHHHhh
Confidence 54433333345679999999999865
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-28 Score=264.50 Aligned_cols=181 Identities=29% Similarity=0.433 Sum_probs=149.9
Q ss_pred hcCCcccceecccccEEEEEEEEc------CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCe
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 662 (779)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ......++.+|+.++++++||||+++++++...+.
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 467899999999999999999843 46789999986433 34555678999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhHhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC---cEEE
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEE--GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAKV 737 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~---~~kl 737 (779)
.++||||+++|+|.+++...... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEE
Confidence 99999999999999999765421 22358899999999999999999997 8999999999999999554 5999
Q ss_pred EeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 738 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+|||+++...............||+.|+|||++.+.
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 261 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG 261 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCC
Confidence 999999865332222223345689999999998654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-27 Score=247.78 Aligned_cols=175 Identities=26% Similarity=0.456 Sum_probs=153.3
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
+.++|++.+.||+|+||.||+|... +++.||+|++..........+.+.+|++++++++||||+++++++...+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4678999999999999999999875 689999999987766666778899999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCc---EEEEeeccc
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR---AKVADFGLV 743 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~---~kl~DFG~a 743 (779)
|||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||++
T Consensus 84 ~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~ 155 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE-----FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155 (284)
T ss_dssp ECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence 99999999998886543 58899999999999999999996 89999999999999986655 999999999
Q ss_pred eecCCCCCcccccccccCCccccccccccc
Q 004020 744 RLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
....... ......||+.|+|||++.+.
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~ 182 (284)
T 3kk8_A 156 IEVNDSE---AWHGFAGTPGYLSPEVLKKD 182 (284)
T ss_dssp EECCSSC---BCCCSCSCGGGCCHHHHTTC
T ss_pred EEcccCc---cccCCCCCcCCcCchhhcCC
Confidence 8765432 22345799999999998765
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=253.18 Aligned_cols=175 Identities=26% Similarity=0.411 Sum_probs=148.8
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC--eEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN--ERLL 665 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~l 665 (779)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... ....+.+.+|++++++++||||+++++++...+ ..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 457999999999999999999876 589999999975432 233567889999999999999999999998765 7799
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEE----cCCCcEEEEeec
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFG 741 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll----~~~~~~kl~DFG 741 (779)
||||+++++|.+++...... ..+++..++.++.||+.||+|||+ .+|+||||||+||++ +.++.+||+|||
T Consensus 87 v~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGT--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred EEeCCCCCCHHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 99999999999999765432 248999999999999999999997 899999999999999 788889999999
Q ss_pred cceecCCCCCcccccccccCCcccccccccc
Q 004020 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 742 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
+++....... .....||+.|+|||++.+
T Consensus 162 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~ 189 (319)
T 4euu_A 162 AARELEDDEQ---FVSLYGTEEYLHPDMYER 189 (319)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHH
T ss_pred CceecCCCCc---eeecccCCCccCHHHhhh
Confidence 9987755322 234569999999999863
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.4e-28 Score=254.81 Aligned_cols=181 Identities=28% Similarity=0.438 Sum_probs=152.6
Q ss_pred hcCCcccceecccccEEEEEEEE------cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCe
Q 004020 589 TNNFSEENVLGRGGFGTVYKGEL------HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 662 (779)
.++|.+.+.||+|+||.||+|.. .+++.||+|++.... .....+++.+|++++++++||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 46899999999999999999976 245789999987543 34556789999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhHhhhcccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCC
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEE-------------------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLK 723 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlk 723 (779)
.++||||+++++|.+++...... ....+++..++.++.||++||+|||+ ++|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccc
Confidence 99999999999999999765431 11347899999999999999999996 899999999
Q ss_pred CCCEEEcCCCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 724 PSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 724 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
|+||+++.++.+||+|||+++...............+|+.|+|||++.+.
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 227 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH 227 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC
Confidence 99999999999999999999877554333333445678899999988653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-28 Score=257.64 Aligned_cols=178 Identities=25% Similarity=0.439 Sum_probs=142.6
Q ss_pred hhcCCcccceecccccEEEEEEEE-cCCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCe---
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE--- 662 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 662 (779)
+.++|++.+.||+|+||.||+|+. .+++.||+|++..... .......+.+|++++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 457899999999999999999986 5789999999976543 23445678999999999999999999999876543
Q ss_pred -EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeec
Q 004020 663 -RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (779)
Q Consensus 663 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 741 (779)
.|+||||+++++|.+++.... .+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg 161 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFG 161 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCS
T ss_pred ccEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeecc
Confidence 499999999999999986542 58899999999999999999996 899999999999999999999999999
Q ss_pred cceecCCCCCc-ccccccccCCccccccccccc
Q 004020 742 LVRLAPDNGKH-SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 742 ~a~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~ 773 (779)
+++........ .......||+.|+|||++.+.
T Consensus 162 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 194 (311)
T 3ork_A 162 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194 (311)
T ss_dssp CC------------------CCTTCCHHHHHTC
T ss_pred CcccccccccccccccccCcCcccCCHHHhcCC
Confidence 99876543221 122345699999999998765
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=272.38 Aligned_cols=177 Identities=29% Similarity=0.424 Sum_probs=141.3
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
..++|++.+.||+|+||.||+|+.. +++.||+|++..... .......+.+|+++++.++||||+++++++...+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3468999999999999999999865 689999999976532 23345678899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 226 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp EECCCSSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EEeeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 999999999999886543 58899999999999999999995 37899999999999999999999999999986
Q ss_pred cCCCCCcccccccccCCccccccccccc
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
..... ......+||+.|+|||++.+.
T Consensus 299 ~~~~~--~~~~~~~gt~~y~aPE~~~~~ 324 (446)
T 4ejn_A 299 GIKDG--ATMKTFCGTPEYLAPEVLEDN 324 (446)
T ss_dssp TCC-------CCSSSCGGGCCHHHHHTS
T ss_pred ccCCC--cccccccCCccccCHhhcCCC
Confidence 43322 123446799999999998654
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.95 E-value=7.3e-27 Score=259.65 Aligned_cols=289 Identities=21% Similarity=0.274 Sum_probs=202.3
Q ss_pred CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcc
Q 004020 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 144 (779)
.+++.|++++|++++ +|.. .++|++|+|++|++++ +|.|.++++|++|++++|+++++|.. .++|++|+|+
T Consensus 111 ~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp~~~~l~~L~~L~l~~N~l~~lp~~----~~~L~~L~L~ 181 (454)
T 1jl5_A 111 QSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LPELQNSSFLKIIDVDNNSLKKLPDL----PPSLEFIAAG 181 (454)
T ss_dssp TTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CCCCTTCTTCCEEECCSSCCSCCCCC----CTTCCEEECC
T ss_pred CCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-CcccCCCCCCCEEECCCCcCcccCCC----cccccEEECc
Confidence 456777777777664 2221 1689999999999997 55799999999999999999998753 3599999999
Q ss_pred cCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCcccc-CCcceeeccCCCCC
Q 004020 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGD 223 (779)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~L~~l~l~~n~~~ 223 (779)
+|++.+ +| .+.++++|+.|++++|.+++ +|.. .++|++|++++|+++ .+|. ++. .+|+.|++++|++.
T Consensus 182 ~n~l~~--l~-~~~~l~~L~~L~l~~N~l~~-l~~~-----~~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~ 250 (454)
T 1jl5_A 182 NNQLEE--LP-ELQNLPFLTAIYADNNSLKK-LPDL-----PLSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLK 250 (454)
T ss_dssp SSCCSS--CC-CCTTCTTCCEEECCSSCCSS-CCCC-----CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCS
T ss_pred CCcCCc--Cc-cccCCCCCCEEECCCCcCCc-CCCC-----cCcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCC
Confidence 999986 56 58999999999999999985 5543 358999999999998 7775 555 67999999999887
Q ss_pred CCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCC
Q 004020 224 SKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKF 303 (779)
Q Consensus 224 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~ 303 (779)
.... .+++|+.|++++|++++. |.. +++|++|++++|++++ +|.. .++|+.|++++|++++...-.
T Consensus 251 ~l~~-------~~~~L~~L~l~~N~l~~l-~~~--~~~L~~L~ls~N~l~~-l~~~---~~~L~~L~l~~N~l~~i~~~~ 316 (454)
T 1jl5_A 251 TLPD-------LPPSLEALNVRDNYLTDL-PEL--PQSLTFLDVSENIFSG-LSEL---PPNLYYLNASSNEIRSLCDLP 316 (454)
T ss_dssp SCCS-------CCTTCCEEECCSSCCSCC-CCC--CTTCCEEECCSSCCSE-ESCC---CTTCCEEECCSSCCSEECCCC
T ss_pred cccc-------cccccCEEECCCCccccc-Ccc--cCcCCEEECcCCccCc-ccCc---CCcCCEEECcCCcCCcccCCc
Confidence 5322 247899999999999984 432 3789999999999986 2321 267889999999888754321
Q ss_pred CCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCcccc
Q 004020 304 NSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLS 383 (779)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~ 383 (779)
.....+++. .|.+. + .....++|+.|+|++|+++
T Consensus 317 ~~L~~L~Ls--~N~l~-------------------------------------------~-lp~~~~~L~~L~L~~N~l~ 350 (454)
T 1jl5_A 317 PSLEELNVS--NNKLI-------------------------------------------E-LPALPPRLERLIASFNHLA 350 (454)
T ss_dssp TTCCEEECC--SSCCS-------------------------------------------C-CCCCCTTCCEEECCSSCCS
T ss_pred CcCCEEECC--CCccc-------------------------------------------c-ccccCCcCCEEECCCCccc
Confidence 111111111 11100 0 0011247999999999999
Q ss_pred ccccccccccccCCeEeccCccccc--cCCccCCCC-------------CCCCceeccCCcccc--cCCCC
Q 004020 384 GTISSNFSRLTSLRQLMLSGNELTG--TIPKELTTL-------------PSLEMLDVSNNHLFG--KVPNF 437 (779)
Q Consensus 384 g~~p~~~~~l~~L~~L~Ls~N~l~g--~iP~~l~~l-------------~~L~~L~Ls~N~l~g--~iP~~ 437 (779)
+ +|. .+++|++|+|++|++++ .+|.++..+ ++|++||+++|+++| .+|..
T Consensus 351 ~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~~~~iP~s 417 (454)
T 1jl5_A 351 E-VPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIPES 417 (454)
T ss_dssp C-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC-------------------------------
T ss_pred c-ccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCccccchhh
Confidence 4 776 47999999999999999 899999888 889999999999998 88863
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.1e-28 Score=262.48 Aligned_cols=173 Identities=22% Similarity=0.354 Sum_probs=146.3
Q ss_pred cCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCC--CCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR--HRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~ 667 (779)
.+|++.+.||+|+||.||+|...+++.||||++..........+.+.+|++++++++ ||||+++++++...+..|+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 469999999999999999999888999999999766555666788999999999996 599999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
| +.+++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++ ++.+||+|||+++...
T Consensus 136 E-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp E-CCSEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred e-cCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 9 56889999986543 57888999999999999999996 8999999999999995 5789999999998765
Q ss_pred CCCCcccccccccCCcccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
...........+||+.|+|||++.+
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~ 230 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKD 230 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHC
T ss_pred CCCccccCCCCCcCCCccChHHhhh
Confidence 4332223345679999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=5.6e-28 Score=262.10 Aligned_cols=177 Identities=27% Similarity=0.473 Sum_probs=138.9
Q ss_pred hcCCcccceecccccEEEEEEEEc----CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 664 (779)
.++|++.+.||+|+||.||+|+.. ++..||||+++... .....+++.+|++++++++||||+++++++...+..+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 357999999999999999999765 57789999997543 3455678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
+||||+++++|.+++.... ..+++.+++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 123 lv~e~~~~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp EEEECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 9999999999999996532 258999999999999999999996 899999999999999999999999999998
Q ss_pred ecCCCCCcc-cccccccCCccccccccccc
Q 004020 745 LAPDNGKHS-IETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 745 ~~~~~~~~~-~~~~~~gt~~y~APE~l~~~ 773 (779)
......... ......+++.|+|||++.+.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 225 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225 (373)
T ss_dssp ------------------CTTSCHHHHHHC
T ss_pred ccccCCccceeccCCCcCCCccChhhhccC
Confidence 765432211 11223467889999998754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.95 E-value=9.1e-28 Score=259.36 Aligned_cols=173 Identities=24% Similarity=0.307 Sum_probs=140.9
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 468999999999999999999876 789999999975432 2256789999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCc--EEEEeecccee
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR--AKVADFGLVRL 745 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~ 745 (779)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++. +||+|||+++.
T Consensus 96 e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 96 EYASGGELYERICNAG-----RFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp ECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EeCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 9999999999986543 48999999999999999999996 89999999999999987765 99999999875
Q ss_pred cCCCCCcccccccccCCcccccccccccCC
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
.... .......||+.|+|||++.+...
T Consensus 168 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~ 194 (361)
T 3uc3_A 168 SVLH---SQPKSTVGTPAYIAPEVLLRQEY 194 (361)
T ss_dssp ----------------CTTSCHHHHHCSSC
T ss_pred cccc---CCCCCCcCCCCcCChhhhcCCCC
Confidence 4322 12234579999999999876543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-28 Score=258.29 Aligned_cols=180 Identities=24% Similarity=0.357 Sum_probs=141.9
Q ss_pred HhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
...++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+.+|++++++++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34578999999999999999999765 78999999997665444455678899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEc-----CCCcEEEEee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-----DDMRAKVADF 740 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~-----~~~~~kl~DF 740 (779)
||||++ ++|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+||+++ .++.+||+||
T Consensus 111 v~e~~~-~~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EEECCS-EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred EEecCC-CCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcC
Confidence 999997 59999886543 48899999999999999999997 8999999999999994 5556999999
Q ss_pred ccceecCCCCCcccccccccCCcccccccccccCCCC
Q 004020 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 741 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
|+++....... ......||+.|+|||++.+...++
T Consensus 182 g~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~ 216 (329)
T 3gbz_A 182 GLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYS 216 (329)
T ss_dssp THHHHHC-------------CCTTCCHHHHTTCCCCC
T ss_pred CCccccCCccc--ccCCCcCCccccCHHHhcCCCCCC
Confidence 99987643221 223456899999999998765444
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.95 E-value=8.3e-28 Score=250.87 Aligned_cols=174 Identities=29% Similarity=0.447 Sum_probs=146.9
Q ss_pred hcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
.++|++.+.||+|+||.||+|+..++..||+|++...... .+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 4578999999999999999999998899999999765432 3568899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++++|.+++..... .+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 100 ~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 100 YMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CCTTCBHHHHHHCGGG----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred ccCCCcHHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 9999999999865332 58999999999999999999996 8999999999999999999999999999986543
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. ........+|+.|+|||++.+.
T Consensus 173 ~~-~~~~~~~~~~~~y~aPE~~~~~ 196 (283)
T 3gen_A 173 DE-YTSSVGSKFPVRWSPPEVLMYS 196 (283)
T ss_dssp HH-HHSTTSTTSCGGGCCHHHHHHC
T ss_pred cc-cccccCCccCcccCCHHHhccC
Confidence 21 1122334578899999998754
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=262.93 Aligned_cols=274 Identities=20% Similarity=0.230 Sum_probs=192.5
Q ss_pred CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEc
Q 004020 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 143 (779)
.++++|++++|++++..+..|..+++|++|+|++|++++.++ .|.++++|++|+|++|+++.+++..|.++++|++|+|
T Consensus 52 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 131 (353)
T 2z80_A 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNL 131 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEEC
T ss_pred ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEEC
Confidence 589999999999998777799999999999999999999887 7999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCc--ccccCCCCCceEeccCce-eEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCC
Q 004020 144 DYNSFDSWVIP--ESLKDATGLQRFSANGAN-ITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQ 220 (779)
Q Consensus 144 s~N~l~~~~~p--~~~~~l~~L~~L~l~~n~-l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n 220 (779)
++|++.. +| ..+.++++|+.|++++|+ ++...+..+. .+++|++|++++|++++..|..++.
T Consensus 132 ~~n~l~~--l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~l~~----------- 196 (353)
T 2z80_A 132 LGNPYKT--LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA--GLTFLEELEIDASDLQSYEPKSLKS----------- 196 (353)
T ss_dssp TTCCCSS--SCSSCSCTTCTTCCEEEEEESSSCCEECTTTTT--TCCEEEEEEEEETTCCEECTTTTTT-----------
T ss_pred CCCCCcc--cCchhhhccCCCCcEEECCCCccccccCHHHcc--CCCCCCEEECCCCCcCccCHHHHhc-----------
Confidence 9999986 44 489999999999999994 7766677786 7999999999999999888888764
Q ss_pred CCCCCCCCchhhhcCCCCccEEEeecCcccCCCCC-CCCCCCCcEEEccCCccccccChhhh---CCCCCCEEEccCccc
Q 004020 221 KGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLV---NLHSLAVVNLTNNLF 296 (779)
Q Consensus 221 ~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~l~---~l~~L~~L~Ls~N~l 296 (779)
+++|++|+|++|.++..++. +..+++|+.|++++|++++..+..+. ....++.++|++|.+
T Consensus 197 ---------------l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l 261 (353)
T 2z80_A 197 ---------------IQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKI 261 (353)
T ss_dssp ---------------CSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBC
T ss_pred ---------------cccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccc
Confidence 44555555555554432222 22344555555555555443333222 234455555555554
Q ss_pred cccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEE
Q 004020 297 QGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVN 376 (779)
Q Consensus 297 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ 376 (779)
++..- ..+.. .....++|+.|+
T Consensus 262 ~~~~l---------------------------------~~l~~-------------------------~l~~l~~L~~L~ 283 (353)
T 2z80_A 262 TDESL---------------------------------FQVMK-------------------------LLNQISGLLELE 283 (353)
T ss_dssp CHHHH---------------------------------HHHHH-------------------------HHHTCTTCCEEE
T ss_pred cCcch---------------------------------hhhHH-------------------------HHhcccCCCEEE
Confidence 43100 00000 001112455566
Q ss_pred ccCcccccccccc-ccccccCCeEeccCccccccCCccCCCCCCCCceeccCCcccccC
Q 004020 377 LKNLGLSGTISSN-FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKV 434 (779)
Q Consensus 377 Ls~n~l~g~~p~~-~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~i 434 (779)
|++|+++ .+|.. |+.+++|++|+|++|.+++..| .++.|....+...+.+
T Consensus 284 Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~-------~l~~l~~~~~~~~~~~ 334 (353)
T 2z80_A 284 FSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP-------RIDYLSRWLNKNSQKE 334 (353)
T ss_dssp CCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH-------HHHHHHHHHHHTTTTE
T ss_pred CCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcCC-------CcHHHHHHHHhccccC
Confidence 6666665 34444 4788899999999998886554 3444444444444444
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-28 Score=258.70 Aligned_cols=178 Identities=26% Similarity=0.354 Sum_probs=151.8
Q ss_pred HhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccCh------hHHHHHHHHHHHHHcCCCCccceEeeEEEe
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE------KGFAEFKSEIAVLTKVRHRHLVGLLGYCLD 659 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 659 (779)
...++|++.+.||+|+||.||+|+.. +++.||||++....... .....+.+|++++++++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 45678999999999999999999864 68899999997653221 133457789999999999999999999999
Q ss_pred CCeEEEEEEecCCC-ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEE
Q 004020 660 GNERLLVYEYMPQG-TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 738 (779)
Q Consensus 660 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 738 (779)
.+..++||||+.+| +|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~ 172 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHP-----RLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLI 172 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEe
Confidence 99999999999777 9999885432 58999999999999999999996 899999999999999999999999
Q ss_pred eeccceecCCCCCcccccccccCCcccccccccccCC
Q 004020 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 739 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
|||+++....... .....||+.|+|||++.+...
T Consensus 173 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~ 206 (335)
T 3dls_A 173 DFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPY 206 (335)
T ss_dssp CCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCB
T ss_pred ecccceECCCCCc---eeccCCCccccChhhhcCCCC
Confidence 9999987754322 234579999999999877654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-27 Score=246.36 Aligned_cols=174 Identities=26% Similarity=0.416 Sum_probs=150.8
Q ss_pred HhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
.+.++|++.+.||+|+||.||+|... ++..||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL 83 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence 35678999999999999999999876 577899999876542 335678999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEE---cCCCcEEEEeecc
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGL 742 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DFG~ 742 (779)
||||+++++|.+++.... .+++..++.++.|++.||+|||+ ++|+||||||+||++ +.++.+||+|||+
T Consensus 84 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~ 155 (277)
T 3f3z_A 84 VMELCTGGELFERVVHKR-----VFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGL 155 (277)
T ss_dssp EEECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEeccCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEeccc
Confidence 999999999999886543 48899999999999999999996 899999999999999 7889999999999
Q ss_pred ceecCCCCCcccccccccCCccccccccccc
Q 004020 743 VRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 743 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+....... ......||+.|+|||++.+.
T Consensus 156 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~ 183 (277)
T 3f3z_A 156 AARFKPGK---MMRTKVGTPYYVSPQVLEGL 183 (277)
T ss_dssp CEECCTTS---CBCCCCSCTTTCCHHHHTTC
T ss_pred ceeccCcc---chhccCCCCCccChHHhccc
Confidence 98765432 22345699999999998764
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=259.38 Aligned_cols=175 Identities=29% Similarity=0.427 Sum_probs=145.1
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC-----
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN----- 661 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 661 (779)
+.++|++.+.||+|+||.||+|... +|+.||||++..........+++.+|+++++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 3578999999999999999999874 7999999999766555556678999999999999999999999998763
Q ss_pred -eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEee
Q 004020 662 -ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (779)
Q Consensus 662 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF 740 (779)
..|+||||+ +++|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Df 172 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDF 172 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEee
Confidence 469999999 78999988542 47899999999999999999997 89999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccCCcccccccccccCCCC
Q 004020 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 741 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
|+++..... ....+||+.|+|||++.+...++
T Consensus 173 g~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~ 204 (367)
T 1cm8_A 173 GLARQADSE-----MTGYVVTRWYRAPEVILNWMRYT 204 (367)
T ss_dssp TTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCC
T ss_pred ecccccccc-----cCcCcCCCCcCCHHHHhCCCCCC
Confidence 999876432 23457899999999988755444
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=7.1e-28 Score=253.03 Aligned_cols=177 Identities=29% Similarity=0.569 Sum_probs=144.6
Q ss_pred hcCCcccceecccccEEEEEEEE-----cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC--C
Q 004020 589 TNNFSEENVLGRGGFGTVYKGEL-----HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--N 661 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~ 661 (779)
.++|++.+.||+|+||.||+|++ .+++.||+|++.... ....+.+.+|++++++++||||+++++++... .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 46899999999999999999984 268899999987543 45567899999999999999999999998654 4
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeec
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 741 (779)
..++||||+++++|.+++..... .+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg 159 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFG 159 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGG----GCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred ceEEEEEeCCCCCHHHHHHhccc----ccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCc
Confidence 58999999999999999966532 48899999999999999999997 899999999999999999999999999
Q ss_pred cceecCCCCCc-ccccccccCCcccccccccccC
Q 004020 742 LVRLAPDNGKH-SIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 742 ~a~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~ 774 (779)
+++........ .......++..|+|||++.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 193 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK 193 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCC
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCC
Confidence 99876543221 1223345788899999987543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-29 Score=266.09 Aligned_cols=218 Identities=18% Similarity=0.215 Sum_probs=113.5
Q ss_pred CCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCc
Q 004020 109 SGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPG 188 (779)
Q Consensus 109 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~ 188 (779)
..+++|++|+|++|+++.+++..|..+++|++|+|++|++.+ .+. +..+++|++|++++|++++.. ..++
T Consensus 31 ~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~--~~~-~~~l~~L~~L~Ls~n~l~~l~-------~~~~ 100 (317)
T 3o53_A 31 QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLD-LESLSTLRTLDLNNNYVQELL-------VGPS 100 (317)
T ss_dssp TTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEE--EEE-ETTCTTCCEEECCSSEEEEEE-------ECTT
T ss_pred ccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCc--chh-hhhcCCCCEEECcCCcccccc-------CCCC
Confidence 334445555555555555554445555555555555555543 111 555555555555555555322 1245
Q ss_pred ccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCC-CCCCCCCCcEEEc
Q 004020 189 LMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSV 267 (779)
Q Consensus 189 L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l 267 (779)
|++|++++|++++..+. .+++|+.|+|++|++++..+ .+..+++|++|++
T Consensus 101 L~~L~l~~n~l~~~~~~-----------------------------~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 151 (317)
T 3o53_A 101 IETLHAANNNISRVSCS-----------------------------RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151 (317)
T ss_dssp CCEEECCSSCCSEEEEC-----------------------------CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEEC
T ss_pred cCEEECCCCccCCcCcc-----------------------------ccCCCCEEECCCCCCCCccchhhhccCCCCEEEC
Confidence 66666666666533221 13445555555555555544 3555555666666
Q ss_pred cCCccccccChhhh-CCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchh
Q 004020 268 RDNQLTGIVPSSLV-NLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAV 346 (779)
Q Consensus 268 ~~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (779)
++|++++..|..+. .+++|++|+|++|++++..+..
T Consensus 152 s~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~------------------------------------------- 188 (317)
T 3o53_A 152 KLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQV------------------------------------------- 188 (317)
T ss_dssp TTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCC-------------------------------------------
T ss_pred CCCCCCcccHHHHhhccCcCCEEECCCCcCccccccc-------------------------------------------
Confidence 66655555454443 4555666666666555431110
Q ss_pred cccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccCccccccCCccCCCCCCCCceecc
Q 004020 347 LAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVS 426 (779)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls 426 (779)
..++|+.|+|++|++++ +|..+..+++|+.|+|++|+|+ .+|..+..+++|+.|+|+
T Consensus 189 ---------------------~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~ 245 (317)
T 3o53_A 189 ---------------------VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLR 245 (317)
T ss_dssp ---------------------CCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECT
T ss_pred ---------------------ccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEcc
Confidence 01245566666666654 3333556666666666666666 455556666666666666
Q ss_pred CCccc
Q 004020 427 NNHLF 431 (779)
Q Consensus 427 ~N~l~ 431 (779)
+|+++
T Consensus 246 ~N~~~ 250 (317)
T 3o53_A 246 GNGFH 250 (317)
T ss_dssp TCCCB
T ss_pred CCCcc
Confidence 66665
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=267.14 Aligned_cols=172 Identities=27% Similarity=0.367 Sum_probs=141.9
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC------
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG------ 660 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 660 (779)
..++|++.+.||+|+||.||+|+.. +++.||||++..........+++.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 4578999999999999999999765 689999999987655566678899999999999999999999999755
Q ss_pred CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEee
Q 004020 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (779)
Q Consensus 661 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF 740 (779)
...|+||||+++ ++.+.+.. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DF 208 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 208 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred CeEEEEEeCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEE
Confidence 357999999976 46555521 37889999999999999999997 79999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccCCccccccccccc
Q 004020 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 741 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
|+|+...... ..+..+||+.|+|||++.+.
T Consensus 209 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~ 238 (464)
T 3ttj_A 209 GLARTAGTSF---MMTPYVVTRYYRAPEVILGM 238 (464)
T ss_dssp CCC-----CC---CC----CCCTTCCHHHHTTC
T ss_pred EeeeecCCCc---ccCCCcccccccCHHHHcCC
Confidence 9998765421 23456799999999999875
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-27 Score=246.39 Aligned_cols=178 Identities=26% Similarity=0.421 Sum_probs=152.7
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
..++|++.+.||+|+||.||+|+.. +++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 4568999999999999999999876 689999999875432 23457789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||.+...
T Consensus 84 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 84 LEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF 155 (276)
T ss_dssp EECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence 9999999999988533 258899999999999999999996 89999999999999999999999999999866
Q ss_pred CCCCCcccccccccCCcccccccccccC
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
.............||+.|+|||++.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 183 (276)
T 2yex_A 156 RYNNRERLLNKMCGTLPYVAPELLKRRE 183 (276)
T ss_dssp EETTEECCBCCCCSCGGGCCGGGGTCSS
T ss_pred CCCcchhcccCCccccCccChHHHhcCC
Confidence 4332222234457999999999987654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-27 Score=253.65 Aligned_cols=181 Identities=28% Similarity=0.496 Sum_probs=151.4
Q ss_pred hcCCcccceecccccEEEEEEEEc--------CCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEe
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH--------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLD 659 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 659 (779)
.++|++.+.||+|+||.||+|+.. ++..||+|++.... .....+++.+|+++++++ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 468999999999999999999863 46789999997543 345567899999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCChhhHhhhcccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEE
Q 004020 660 GNERLLVYEYMPQGTLSRHLFNRKEEG-----------LKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 728 (779)
Q Consensus 660 ~~~~~lv~e~~~~gsL~~~l~~~~~~~-----------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIl 728 (779)
.+..++||||+++++|.+++......+ ...+++..++.++.||+.||+|||+ .+|+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEE
Confidence 999999999999999999997654211 1247899999999999999999997 89999999999999
Q ss_pred EcCCCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 729 LGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 729 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
++.++.+||+|||+++...............+|+.|+|||++.+.
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 234 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR 234 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC
Confidence 999999999999999877654333333445678899999988653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-27 Score=249.02 Aligned_cols=175 Identities=27% Similarity=0.434 Sum_probs=142.8
Q ss_pred hhcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHc--CCCCccceEeeEEEeC----C
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTK--VRHRHLVGLLGYCLDG----N 661 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~----~ 661 (779)
+.++|++.+.||+|+||.||+|+. +++.||||++... ....+.+|.+++.. ++||||+++++++... .
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 467899999999999999999987 6899999998643 23455666776666 7899999999987653 4
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCcEEcCCCCCCEEEcCCCcEE
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA-----HQSFIHRDLKPSNILLGDDMRAK 736 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-----~~~ivHrDlkp~NIll~~~~~~k 736 (779)
..++||||+++|+|.+++... .+++..++.++.||+.||+|||+.. .++|+||||||+||+++.++.+|
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTTC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred eeEEehhhccCCCHHHHHhhc------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEE
Confidence 578999999999999998432 5899999999999999999999210 27999999999999999999999
Q ss_pred EEeeccceecCCCCCcc--cccccccCCcccccccccccC
Q 004020 737 VADFGLVRLAPDNGKHS--IETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 737 l~DFG~a~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~ 774 (779)
|+|||+++......... ......||+.|+|||++.+..
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 193 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETI 193 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCC
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcC
Confidence 99999998765432221 123347999999999997753
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-26 Score=258.33 Aligned_cols=237 Identities=20% Similarity=0.299 Sum_probs=205.0
Q ss_pred ceeeEeCCC----------CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCC
Q 004020 56 WKHIQCSPS----------NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNF 124 (779)
Q Consensus 56 w~gv~c~~~----------~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l 124 (779)
|..|.|... ..++.|+|++|++++..+..|.++++|++|+|++|+|++..+ .|.++++|++|+|++|+|
T Consensus 45 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 124 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124 (440)
T ss_dssp SCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence 567888742 368999999999999988999999999999999999998886 899999999999999999
Q ss_pred CCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCC-CccCCCCCcccEEEccCCCCCCcC
Q 004020 125 TSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD-FLGGDTIPGLMHLHLAFNFLQGPI 203 (779)
Q Consensus 125 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~-~~~~~~l~~L~~L~L~~N~l~~~~ 203 (779)
+.+++..|..+++|++|+|++|++.. ..+..|.++++|+.|++++|+..+.++. .|. .+++|++|+|++|+++ .+
T Consensus 125 ~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~--~l~~L~~L~L~~n~l~-~~ 200 (440)
T 3zyj_A 125 TTIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRLDLGELKRLSYISEGAFE--GLSNLRYLNLAMCNLR-EI 200 (440)
T ss_dssp SSCCTTTSCSCSSCCEEECCSCCCCE-ECTTTTTTCTTCCEEECCCCTTCCEECTTTTT--TCSSCCEEECTTSCCS-SC
T ss_pred CeeCHhHhhccccCceeeCCCCcccc-cCHHHhhhCcccCEeCCCCCCCcceeCcchhh--cccccCeecCCCCcCc-cc
Confidence 99999999999999999999999986 5667899999999999999655445554 565 7999999999999999 56
Q ss_pred CCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCC-CCCCCCCcEEEccCCccccccChhhhC
Q 004020 204 PLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVN 282 (779)
Q Consensus 204 p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~l~~ 282 (779)
|......+|+.|++++|++..... ..+..+++|+.|+|++|++++..+. |..+++|+.|+|++|+|++..+..|..
T Consensus 201 ~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 277 (440)
T 3zyj_A 201 PNLTPLIKLDELDLSGNHLSAIRP---GSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTP 277 (440)
T ss_dssp CCCTTCSSCCEEECTTSCCCEECT---TTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSS
T ss_pred cccCCCcccCEEECCCCccCccCh---hhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhcc
Confidence 753333789999999998876543 3466889999999999999988774 888999999999999999877788889
Q ss_pred CCCCCEEEccCcccccc
Q 004020 283 LHSLAVVNLTNNLFQGQ 299 (779)
Q Consensus 283 l~~L~~L~Ls~N~l~g~ 299 (779)
+++|+.|+|++|++...
T Consensus 278 l~~L~~L~L~~Np~~Cd 294 (440)
T 3zyj_A 278 LHHLERIHLHHNPWNCN 294 (440)
T ss_dssp CTTCCEEECCSSCEECS
T ss_pred ccCCCEEEcCCCCccCC
Confidence 99999999999998753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=7.5e-28 Score=252.04 Aligned_cols=175 Identities=33% Similarity=0.558 Sum_probs=138.1
Q ss_pred hhcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
..++|++.+.||+|+||.||+|+.. ..||+|+++.........+.+.+|++++++++||||+++++++ ..+..++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 3468999999999999999999764 4699999987665666778899999999999999999999965 556689999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 99 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 99 QWCEGSSLYHHLHASE----TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp ECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EecCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccc
Confidence 9999999999985433 358899999999999999999997 899999999999999999999999999998654
Q ss_pred CCCCcccccccccCCcccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
............||+.|+|||++..
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~ 196 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRM 196 (289)
T ss_dssp ------------CCCTTCCHHHHC-
T ss_pred cccccccccccCCCccccCchhhcc
Confidence 3222223344579999999999863
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-27 Score=255.21 Aligned_cols=170 Identities=31% Similarity=0.482 Sum_probs=146.5
Q ss_pred hcCCcccceecccccEEEEEEEE-cCCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
.+.|+..+.||+|+||.||+|+. .+++.||||++..... .....+++.+|++++++++||||+++++++...+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35688999999999999999986 5789999999875432 233456789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+. |++.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 133 ~e~~~-g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 204 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 204 (348)
T ss_dssp EECCS-EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EecCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence 99997 68888775433 258999999999999999999997 79999999999999999999999999999765
Q ss_pred CCCCCcccccccccCCcccccccccc
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
... ....||+.|+|||++.+
T Consensus 205 ~~~------~~~~gt~~y~aPE~~~~ 224 (348)
T 1u5q_A 205 APA------NSFVGTPYWMAPEVILA 224 (348)
T ss_dssp SSB------CCCCSCGGGCCHHHHHT
T ss_pred CCC------CcccCCcceeCHhhhcc
Confidence 432 33579999999999864
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-26 Score=258.94 Aligned_cols=237 Identities=19% Similarity=0.300 Sum_probs=205.5
Q ss_pred ceeeEeCCC----------CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCC
Q 004020 56 WKHIQCSPS----------NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNF 124 (779)
Q Consensus 56 w~gv~c~~~----------~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l 124 (779)
|..|.|... .+++.|+|++|+|++..|..|.++++|++|+|++|+|++.++ .|.++++|++|+|++|+|
T Consensus 56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l 135 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135 (452)
T ss_dssp SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcC
Confidence 567888642 379999999999999999999999999999999999999887 899999999999999999
Q ss_pred CCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCC-CccCCCCCcccEEEccCCCCCCcC
Q 004020 125 TSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPD-FLGGDTIPGLMHLHLAFNFLQGPI 203 (779)
Q Consensus 125 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~-~~~~~~l~~L~~L~L~~N~l~~~~ 203 (779)
+.+++..|..+++|++|+|++|++.. ..+..|.++++|+.|++++|+..+.++. .+. .+++|++|+|++|++++ +
T Consensus 136 ~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~--~l~~L~~L~L~~n~l~~-~ 211 (452)
T 3zyi_A 136 TVIPSGAFEYLSKLRELWLRNNPIES-IPSYAFNRVPSLMRLDLGELKKLEYISEGAFE--GLFNLKYLNLGMCNIKD-M 211 (452)
T ss_dssp SBCCTTTSSSCTTCCEEECCSCCCCE-ECTTTTTTCTTCCEEECCCCTTCCEECTTTTT--TCTTCCEEECTTSCCSS-C
T ss_pred CccChhhhcccCCCCEEECCCCCcce-eCHhHHhcCCcccEEeCCCCCCccccChhhcc--CCCCCCEEECCCCcccc-c
Confidence 99999999999999999999999986 5567899999999999999554445554 564 79999999999999995 4
Q ss_pred CCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCC-CCCCCCCcEEEccCCccccccChhhhC
Q 004020 204 PLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVN 282 (779)
Q Consensus 204 p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~l~~ 282 (779)
|......+|+.|++++|.+..... ..+..+++|+.|+|++|++++..+. |..+++|+.|+|++|+|++..+..|..
T Consensus 212 ~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 288 (452)
T 3zyi_A 212 PNLTPLVGLEELEMSGNHFPEIRP---GSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTP 288 (452)
T ss_dssp CCCTTCTTCCEEECTTSCCSEECG---GGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTT
T ss_pred ccccccccccEEECcCCcCcccCc---ccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcc
Confidence 643333789999999998876533 4567889999999999999988774 888999999999999999877788889
Q ss_pred CCCCCEEEccCcccccc
Q 004020 283 LHSLAVVNLTNNLFQGQ 299 (779)
Q Consensus 283 l~~L~~L~Ls~N~l~g~ 299 (779)
+++|+.|+|++|++...
T Consensus 289 l~~L~~L~L~~Np~~Cd 305 (452)
T 3zyi_A 289 LRYLVELHLHHNPWNCD 305 (452)
T ss_dssp CTTCCEEECCSSCEECS
T ss_pred ccCCCEEEccCCCcCCC
Confidence 99999999999998754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-27 Score=252.61 Aligned_cols=181 Identities=29% Similarity=0.452 Sum_probs=152.6
Q ss_pred hcCCcccceecccccEEEEEEEE------cCCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCC
Q 004020 589 TNNFSEENVLGRGGFGTVYKGEL------HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGN 661 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 661 (779)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... .....+.+.+|+++++++ +||||+++++++...+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 46899999999999999999975 246789999997543 334557899999999999 8999999999999999
Q ss_pred eEEEEEEecCCCChhhHhhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEE
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEE-------------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 728 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~-------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIl 728 (779)
..++||||+++|+|.+++...... ....+++..++.++.||+.||+|||+ ++|+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEE
Confidence 999999999999999999765321 12248999999999999999999997 89999999999999
Q ss_pred EcCCCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 729 LGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 729 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
++.++.+||+|||+++...............||+.|+|||++.+.
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 222 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC 222 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC
Confidence 999999999999999877654333333445688899999988654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=5.7e-28 Score=260.54 Aligned_cols=175 Identities=26% Similarity=0.368 Sum_probs=148.9
Q ss_pred hcCCcccceecccccEEEEEEEE----cCCcEEEEEEeccccc--ChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCC
Q 004020 589 TNNFSEENVLGRGGFGTVYKGEL----HDGTKIAVKRMESAVV--SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGN 661 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 661 (779)
.++|++.+.||+|+||.||+|+. .+++.||||+++.... .....+.+.+|+++++++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999987 3689999999875432 112334577899999999 6999999999999999
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeec
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 741 (779)
..++||||+++++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG 204 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFG 204 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred eEEEEeecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCC
Confidence 9999999999999999986543 58899999999999999999996 799999999999999999999999999
Q ss_pred cceecCCCCCcccccccccCCcccccccccc
Q 004020 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 742 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
+++...... .......+||+.|+|||++.+
T Consensus 205 ~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~ 234 (355)
T 1vzo_A 205 LSKEFVADE-TERAYDFCGTIEYMAPDIVRG 234 (355)
T ss_dssp EEEECCGGG-GGGGCGGGSCCTTCCHHHHTT
T ss_pred CCeecccCC-CCcccCcccCcCccChhhhcC
Confidence 998764322 122334579999999999975
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=256.80 Aligned_cols=182 Identities=29% Similarity=0.455 Sum_probs=149.2
Q ss_pred hhcCCcccceecccccEEEEEEEE------cCCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeC
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGEL------HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDG 660 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 660 (779)
..++|++.+.||+|+||.||+|+. .++..||+|++.... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 357899999999999999999986 245689999997543 233456789999999999 899999999999999
Q ss_pred CeEEEEEEecCCCChhhHhhhcccC------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCC
Q 004020 661 NERLLVYEYMPQGTLSRHLFNRKEE------------------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDL 722 (779)
Q Consensus 661 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDl 722 (779)
+..++||||+++|+|.+++...... ....+++..++.++.||+.||+|||+ ++|+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCC
Confidence 9999999999999999999764321 11247899999999999999999997 89999999
Q ss_pred CCCCEEEcCCCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 723 KPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 723 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
||+||+++.++.+||+|||+++...............||+.|+|||++.+.
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 249 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG 249 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC
Confidence 999999999999999999999876554333333445688999999988654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-27 Score=256.20 Aligned_cols=168 Identities=32% Similarity=0.441 Sum_probs=139.7
Q ss_pred ccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCC
Q 004020 594 EENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (779)
Q Consensus 594 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 672 (779)
..+.||+|+||.||+|+.. +++.||+|++.... ....+++.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 3678999999999999864 68999999987643 34557899999999999999999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEE--cCCCcEEEEeeccceecCCCC
Q 004020 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL--GDDMRAKVADFGLVRLAPDNG 750 (779)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll--~~~~~~kl~DFG~a~~~~~~~ 750 (779)
++|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++......
T Consensus 171 ~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 171 GELFDRIIDES----YNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp CEEHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 99999886543 258899999999999999999997 899999999999999 567899999999998775432
Q ss_pred CcccccccccCCccccccccccc
Q 004020 751 KHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 751 ~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
. .....||+.|+|||++.+.
T Consensus 244 ~---~~~~~gt~~y~aPE~~~~~ 263 (373)
T 2x4f_A 244 K---LKVNFGTPEFLAPEVVNYD 263 (373)
T ss_dssp B---CCCCCSSCTTCCHHHHTTC
T ss_pred c---cccccCCCcEeChhhccCC
Confidence 2 2334699999999998654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=268.15 Aligned_cols=175 Identities=30% Similarity=0.438 Sum_probs=150.6
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
+.++|++.+.||+|+||.||+|+.. +++.||||++............+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 5578999999999999999999875 789999999976544444567889999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEc---CCCcEEEEeeccc
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG---DDMRAKVADFGLV 743 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a 743 (779)
|||+++++|.+.+.... .+++..+..++.||+.||.|||+ .+|+||||||+||+++ .++.+||+|||++
T Consensus 100 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp ECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred EEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 99999999999886543 58999999999999999999997 8999999999999995 4567999999999
Q ss_pred eecCCCCCcccccccccCCccccccccccc
Q 004020 744 RLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+...... .....+||+.|+|||++.+.
T Consensus 172 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~ 198 (486)
T 3mwu_A 172 TCFQQNT---KMKDRIGTAYYIAPEVLRGT 198 (486)
T ss_dssp TTBCCC-------CCTTGGGGCCGGGGGSC
T ss_pred eECCCCC---ccCCCcCCCCCCCHHHhCCC
Confidence 8664432 22345799999999998764
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=256.53 Aligned_cols=185 Identities=24% Similarity=0.303 Sum_probs=148.0
Q ss_pred HHHhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc---ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC
Q 004020 585 LRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV---SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG 660 (779)
Q Consensus 585 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 660 (779)
+..+.++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3456778999999999999999999774 688999999875432 234567899999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhHhhhcccCC-----------------------------------CCCCCHHHHHHHHHHHHHH
Q 004020 661 NERLLVYEYMPQGTLSRHLFNRKEEG-----------------------------------LKPLEWTRRLTIALDVARG 705 (779)
Q Consensus 661 ~~~~lv~e~~~~gsL~~~l~~~~~~~-----------------------------------~~~~~~~~~~~i~~qi~~~ 705 (779)
+..++||||+++|+|.+++....... ...+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999985321110 1123567788999999999
Q ss_pred HHHHHcCCCCCcEEcCCCCCCEEEcCCC--cEEEEeeccceecCCCCC--cccccccccCCcccccccccc
Q 004020 706 VEYLHGLAHQSFIHRDLKPSNILLGDDM--RAKVADFGLVRLAPDNGK--HSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 706 L~~LH~~~~~~ivHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~APE~l~~ 772 (779)
|+|||+ .+|+||||||+||+++.++ .+||+|||+++....... ........||+.|+|||++.+
T Consensus 181 l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 248 (345)
T 3hko_A 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248 (345)
T ss_dssp HHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC
T ss_pred HHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc
Confidence 999997 7999999999999998776 899999999987643211 112344579999999999875
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=253.94 Aligned_cols=179 Identities=25% Similarity=0.413 Sum_probs=148.2
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 468999999999999999999876 5899999998766555555677889999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||++++++.++.... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 104 e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 104 EFVDHTILDDLELFP-----NGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp ECCSEEHHHHHHHST-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecCCcchHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 999999888775432 248899999999999999999996 899999999999999999999999999998664
Q ss_pred CCCCcccccccccCCcccccccccccCCCC
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
.... ......||+.|+|||++.+...++
T Consensus 176 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~ 203 (331)
T 4aaa_A 176 APGE--VYDDEVATRWYRAPELLVGDVKYG 203 (331)
T ss_dssp ----------CCCCCTTCCHHHHTTCTTCC
T ss_pred CCcc--ccCCCcCCccccCcccccCCCCcc
Confidence 4322 223456999999999998764443
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-27 Score=267.16 Aligned_cols=175 Identities=29% Similarity=0.430 Sum_probs=145.7
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
+.++|++.+.||+|+||.||+|+.. ++..||+|++............+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4567999999999999999999876 688999999976654444557789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC---CCcEEEEeeccc
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVADFGLV 743 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DFG~a 743 (779)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+||+++. ++.+||+|||++
T Consensus 115 ~e~~~~g~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 115 MECYKGGELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 99999999999886543 58899999999999999999996 89999999999999976 455999999999
Q ss_pred eecCCCCCcccccccccCCccccccccccc
Q 004020 744 RLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+...... .....+||+.|+|||++.+.
T Consensus 187 ~~~~~~~---~~~~~~gt~~y~aPE~l~~~ 213 (494)
T 3lij_A 187 AVFENQK---KMKERLGTAYYIAPEVLRKK 213 (494)
T ss_dssp EECBTTB---CBCCCCSCTTTCCHHHHTTC
T ss_pred eECCCCc---cccccCCCcCeeCHHHHccc
Confidence 8775432 22345799999999998653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=250.86 Aligned_cols=174 Identities=25% Similarity=0.431 Sum_probs=147.7
Q ss_pred hcCCcccceecccccEEEEEEEEcC-C-------cEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHD-G-------TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG 660 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 660 (779)
.++|++.+.||+|+||.||+|+... + ..||+|++.... ....+.+.+|++++++++||||+++++++.++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 4679999999999999999997652 3 579999986543 34557899999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCc------
Q 004020 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR------ 734 (779)
Q Consensus 661 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~------ 734 (779)
+..++||||+++++|.+++..... .+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKN----CINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGG----GCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred CCCEEEEECCCCCCHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCccccccc
Confidence 999999999999999999965432 48899999999999999999997 89999999999999998887
Q ss_pred --EEEEeeccceecCCCCCcccccccccCCcccccccccccCCCC
Q 004020 735 --AKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 735 --~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
+||+|||+++..... ....||+.|+|||++.+...++
T Consensus 158 ~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~ 196 (289)
T 4fvq_A 158 PFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLN 196 (289)
T ss_dssp CEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCC
T ss_pred ceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCC
Confidence 999999998654321 2345889999999998644433
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=256.12 Aligned_cols=181 Identities=25% Similarity=0.368 Sum_probs=150.0
Q ss_pred hcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC-------
Q 004020 589 TNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG------- 660 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------- 660 (779)
.++|++.+.||+|+||.||+|+. .+++.||+|++............+.+|+++++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36899999999999999999987 4789999999876554444456788999999999999999999999873
Q ss_pred -CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEe
Q 004020 661 -NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 739 (779)
Q Consensus 661 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 739 (779)
+..++||||+++ ++.+.+.... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~D 167 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLAD 167 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECC
T ss_pred CceEEEEEeccCC-CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEcc
Confidence 468999999975 7777764432 258999999999999999999996 8999999999999999999999999
Q ss_pred eccceecCCCCC--cccccccccCCcccccccccccCCCC
Q 004020 740 FGLVRLAPDNGK--HSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 740 FG~a~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
||+++....... ........||+.|+|||++.+...++
T Consensus 168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 207 (351)
T 3mi9_A 168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYG 207 (351)
T ss_dssp CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCC
T ss_pred chhcccccccccccccccCCcccccCccCchhhcCCCCCC
Confidence 999987653221 11224457899999999998765544
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-27 Score=247.84 Aligned_cols=177 Identities=28% Similarity=0.424 Sum_probs=146.4
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
+.++|.+.+.||+|+||.||+|+.. ++..||+|++.... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 4468999999999999999999875 68899999987654 233457789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEE---cCCCcEEEEeeccc
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLV 743 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a 743 (779)
|||+++++|.+++......+ ..+++..++.++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||++
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 99 METCEGGELLERIVSAQARG-KALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEeCCCCcHHHHHHhhhhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 99999999999886543222 358999999999999999999996 899999999999999 45688999999999
Q ss_pred eecCCCCCcccccccccCCcccccccccc
Q 004020 744 RLAPDNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
+...... ......||+.|+|||++.+
T Consensus 175 ~~~~~~~---~~~~~~~t~~y~aPE~~~~ 200 (285)
T 3is5_A 175 ELFKSDE---HSTNAAGTALYMAPEVFKR 200 (285)
T ss_dssp CC-------------CTTGGGCCHHHHTT
T ss_pred eecCCcc---cCcCcccccCcCChHHhcc
Confidence 8664432 2234569999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=255.56 Aligned_cols=171 Identities=29% Similarity=0.441 Sum_probs=133.5
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
+.++|++.+.||+|+||.||+|+.. +++.||+|++.... ..+.+.+|++++++++||||+++++++...+..++|
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 4678999999999999999999876 57899999987542 335688999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC---CCcEEEEeeccc
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVADFGLV 743 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DFG~a 743 (779)
|||+++++|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||++
T Consensus 127 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 127 LELVTGGELFDRIVEK-----GYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198 (349)
T ss_dssp ECCCCSCBHHHHHTTC-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred EEeCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence 9999999999988543 258899999999999999999997 79999999999999975 889999999999
Q ss_pred eecCCCCCcccccccccCCccccccccccc
Q 004020 744 RLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+...... ......||+.|+|||++.+.
T Consensus 199 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~ 225 (349)
T 2w4o_A 199 KIVEHQV---LMKTVCGTPGYCAPEILRGC 225 (349)
T ss_dssp -----------------CGGGSCHHHHTTC
T ss_pred cccCccc---ccccccCCCCccCHHHhcCC
Confidence 8664321 22345799999999998764
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-29 Score=265.97 Aligned_cols=263 Identities=18% Similarity=0.197 Sum_probs=209.8
Q ss_pred CCCCC-CCCcceeeEeCC-CCcEEEEEecCCCccccCCccccCCCCCcEEEcccCccc-cCCC-CCC-------CCCCcc
Q 004020 47 GWTDP-DPCKWKHIQCSP-SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLT-GQIP-SLS-------GLSSLQ 115 (779)
Q Consensus 47 ~w~~~-~~C~w~gv~c~~-~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~~~~-~~~-------~l~~L~ 115 (779)
+|... .|+.+..+.... ..+++.|++++|++ .+|..+... |++|+|++|+++ +.++ .+. ++++|+
T Consensus 23 ~~~~~~~c~~~~~~~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~ 98 (312)
T 1wwl_A 23 DWSSAFNCLGAADVELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98 (312)
T ss_dssp CGGGGGGSSSCSEEEEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCC
T ss_pred chHHHhhhhccccEEEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCcc
Confidence 56543 455565544322 34688899999999 788877765 999999999994 4455 344 799999
Q ss_pred EEecCCCCCCCCCcccc--cCCCCccEEEcccCCCCCCCCcccccCC-----CCCceEeccCceeEeecCCCccCCCCCc
Q 004020 116 EVLFDDNNFTSVPSDFF--KGLTSLQTISLDYNSFDSWVIPESLKDA-----TGLQRFSANGANITGTIPDFLGGDTIPG 188 (779)
Q Consensus 116 ~L~l~~N~l~~~~~~~~--~~l~~L~~L~Ls~N~l~~~~~p~~~~~l-----~~L~~L~l~~n~l~~~~p~~~~~~~l~~ 188 (779)
+|+|++|++++..+..+ ..+++|++|+|++|++.+ .|..+..+ ++|++|++++|++++..|+.++ .+++
T Consensus 99 ~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~--~l~~ 174 (312)
T 1wwl_A 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT--RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVR--VFPA 174 (312)
T ss_dssp EEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSS--SSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCC--CCSS
T ss_pred EEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcc--hhHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhc--cCCC
Confidence 99999999996544444 899999999999999987 38888887 9999999999999988888887 7999
Q ss_pred ccEEEccCCCCCCcC--CCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCC--C-C-CCCCCCC
Q 004020 189 LMHLHLAFNFLQGPI--PLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPL--P-D-LSGLSSL 262 (779)
Q Consensus 189 L~~L~L~~N~l~~~~--p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~-~-~~~l~~L 262 (779)
|++|+|++|++.+.+ |..+. +..+++|++|+|++|++++.. + . +..+++|
T Consensus 175 L~~L~Ls~N~l~~~~~~~~~~~------------------------~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L 230 (312)
T 1wwl_A 175 LSTLDLSDNPELGERGLISALC------------------------PLKFPTLQVLALRNAGMETPSGVCSALAAARVQL 230 (312)
T ss_dssp CCEEECCSCTTCHHHHHHHHSC------------------------TTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCC
T ss_pred CCEEECCCCCcCcchHHHHHHH------------------------hccCCCCCEEECCCCcCcchHHHHHHHHhcCCCC
Confidence 999999999988652 22221 136889999999999998532 2 2 4578899
Q ss_pred cEEEccCCccccccC-hhhhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccC
Q 004020 263 QDFSVRDNQLTGIVP-SSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSV 341 (779)
Q Consensus 263 ~~L~l~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (779)
++|++++|++++.+| ..+..+++|++|+|++|+|+ .+|..+.
T Consensus 231 ~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~------------------------------------ 273 (312)
T 1wwl_A 231 QGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP------------------------------------ 273 (312)
T ss_dssp SEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC------------------------------------
T ss_pred CEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc------------------------------------
Confidence 999999999998775 56667899999999999998 4443110
Q ss_pred CCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccCccccc
Q 004020 342 GYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTG 408 (779)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g 408 (779)
++|+.|+|++|+|++. |. +..+++|++|+|++|+|++
T Consensus 274 ----------------------------~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 274 ----------------------------AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp ----------------------------SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred ----------------------------CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 3799999999999976 66 9999999999999999985
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=254.11 Aligned_cols=175 Identities=31% Similarity=0.491 Sum_probs=139.6
Q ss_pred cCCcccceecccccEEEEEEEEc-CCc----EEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGT----KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 664 (779)
++|++.+.||+|+||.||+|++. +++ +||+|.+.... .....+++.+|+.++++++||||+++++++.... .+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 57999999999999999999864 344 45888775432 2344578999999999999999999999998755 78
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
+|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 93 ~v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEECCTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred EEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCccee
Confidence 9999999999999986643 258899999999999999999997 799999999999999999999999999998
Q ss_pred ecCCCCCcccccccccCCccccccccccc
Q 004020 745 LAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
...............||+.|+|||++.+.
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 194 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHR 194 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHC
T ss_pred EccCCcccccccCCCccccccChHHhccC
Confidence 77554333333445678899999998754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-27 Score=251.02 Aligned_cols=164 Identities=29% Similarity=0.392 Sum_probs=125.2
Q ss_pred cceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCCeEEEEEEecCC
Q 004020 595 ENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLLVYEYMPQ 672 (779)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~ 672 (779)
.+.||+|+||.||+|+.. +++.||||++... ....+.+|+.+++.+. ||||+++++++.+.+..|+||||+++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 378999999999999875 6899999998643 3456789999999997 99999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC---cEEEEeeccceecCCC
Q 004020 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAKVADFGLVRLAPDN 749 (779)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~---~~kl~DFG~a~~~~~~ 749 (779)
|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+||+++.++ .+||+|||+++.....
T Consensus 91 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 91 GELFERIKKKK-----HFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp CBHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 99999986542 58999999999999999999996 8999999999999997665 8999999999876543
Q ss_pred CCcccccccccCCccccccccccc
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. ......||+.|+|||++.+.
T Consensus 163 ~~--~~~~~~~t~~y~aPE~~~~~ 184 (325)
T 3kn6_A 163 NQ--PLKTPCFTLHYAAPELLNQN 184 (325)
T ss_dssp -----------------------C
T ss_pred CC--cccccCCCcCccCHHHhcCC
Confidence 22 22345689999999998654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=254.05 Aligned_cols=174 Identities=21% Similarity=0.293 Sum_probs=147.4
Q ss_pred hcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 666 (779)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .+++.+|+++++++ +||||+++++++...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 46899999999999999999986 5789999999865431 23578999999999 899999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCc-----EEEEeec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR-----AKVADFG 741 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~-----~kl~DFG 741 (779)
|||+ +++|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++.++. +||+|||
T Consensus 84 ~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg 155 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCD----RTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155 (330)
T ss_dssp EECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred EEeC-CCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence 9999 899999986542 258999999999999999999997 79999999999999998887 9999999
Q ss_pred cceecCCCCCcc-----cccccccCCcccccccccccC
Q 004020 742 LVRLAPDNGKHS-----IETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 742 ~a~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~ 774 (779)
+++......... ......||+.|+|||++.+..
T Consensus 156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 193 (330)
T 2izr_A 156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKE 193 (330)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC
T ss_pred cceeeecCCCCccccccccCCcCCCccccChHHHcCCC
Confidence 998765432211 123567999999999987643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-27 Score=275.06 Aligned_cols=176 Identities=28% Similarity=0.366 Sum_probs=150.8
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERL 664 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 664 (779)
..++|++.+.||+|+||.||+|+.. +++.||||+++.... .....+.+..|..++..+ +||+|+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3568999999999999999999875 688999999976432 223446788999999988 6999999999999999999
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
+||||+++|+|.+++.... .+++..++.|+.||+.||+|||+ ++|+||||||+|||++.++++||+|||+|+
T Consensus 419 lV~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEeCcCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceee
Confidence 9999999999999986543 58999999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCcccccccccCCccccccccccc
Q 004020 745 LAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
....... .....+||+.|+|||++.+.
T Consensus 491 ~~~~~~~--~~~~~~GT~~Y~APE~l~~~ 517 (674)
T 3pfq_A 491 ENIWDGV--TTKTFCGTPDYIAPEIIAYQ 517 (674)
T ss_dssp ECCCTTC--CBCCCCSCSSSCCHHHHTCC
T ss_pred ccccCCc--ccccccCCCcccCHhhhcCC
Confidence 6543322 23456899999999998754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.7e-27 Score=248.39 Aligned_cols=176 Identities=26% Similarity=0.520 Sum_probs=146.5
Q ss_pred cCCcccceecccccEEEEEEEE-----cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC--Ce
Q 004020 590 NNFSEENVLGRGGFGTVYKGEL-----HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--NE 662 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 662 (779)
++|++.+.||+|+||.||+|++ .+++.||+|++.... .....+.+.+|++++++++||||+++++++... ..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 4688999999999999999984 368999999997543 233457789999999999999999999999877 66
Q ss_pred EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecc
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 742 (779)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred EEEEEEeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccc
Confidence 899999999999999986543 258899999999999999999996 8999999999999999999999999999
Q ss_pred ceecCCCCCc-ccccccccCCccccccccccc
Q 004020 743 VRLAPDNGKH-SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 743 a~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~ 773 (779)
++........ .......||..|+|||++.+.
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 204 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQS 204 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHC
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCC
Confidence 9877554322 223345688899999988654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.94 E-value=4.3e-27 Score=250.18 Aligned_cols=175 Identities=27% Similarity=0.389 Sum_probs=150.7
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccCh----hHHHHHHHHHHHHHcCCCCccceEeeEEEeCCe
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE----KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 662 (779)
+.++|++.+.||+|+||.||+|+.. +++.||+|++....... ...+++.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 4567999999999999999999876 68999999997654222 135679999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC----cEEEE
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM----RAKVA 738 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~----~~kl~ 738 (779)
.++||||+++++|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++.++ .+||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEc
Confidence 99999999999999998543 257899999999999999999997 8999999999999999887 79999
Q ss_pred eeccceecCCCCCcccccccccCCccccccccccc
Q 004020 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 739 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
|||+++....... .....||+.|+|||++.+.
T Consensus 162 Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~ 193 (321)
T 2a2a_A 162 DFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYE 193 (321)
T ss_dssp CCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTC
T ss_pred cCccceecCcccc---ccccCCCCCccCcccccCC
Confidence 9999987654321 2345699999999998754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-27 Score=255.15 Aligned_cols=180 Identities=24% Similarity=0.315 Sum_probs=152.3
Q ss_pred eeHHHHHHhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-----CCccceE
Q 004020 580 ISIQVLRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-----HRHLVGL 653 (779)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~ 653 (779)
+++++...+.++|++.+.||+|+||.||+|+.. +++.||||++... ......+.+|+++++.+. ||||+++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 344444556789999999999999999999874 6899999998642 344566788999999996 9999999
Q ss_pred eeEEEeCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC--
Q 004020 654 LGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-- 731 (779)
Q Consensus 654 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-- 731 (779)
++++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~ 174 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNY---NGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPY 174 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTT
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEcccc
Confidence 99999999999999999 8999999865432 248899999999999999999996 89999999999999975
Q ss_pred -----------------------CCcEEEEeeccceecCCCCCcccccccccCCcccccccccccC
Q 004020 732 -----------------------DMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 732 -----------------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
++.+||+|||+++..... .....||+.|+|||++.+..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~ 235 (360)
T 3llt_A 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLG 235 (360)
T ss_dssp CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCC
T ss_pred ccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCC
Confidence 789999999999875432 23457999999999987653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.9e-28 Score=255.42 Aligned_cols=177 Identities=25% Similarity=0.396 Sum_probs=141.5
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
++|++.+.||+|+||.||+|+.. +++.||+|++..... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 57999999999999999999876 789999999865431 1112245679999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|++ ++|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp CCS-EEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred ccc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 997 58888886543 258899999999999999999996 8999999999999999999999999999986543
Q ss_pred CCCcccccccccCCcccccccccccCCCC
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
.. .......||+.|+|||++.+...++
T Consensus 153 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~ 179 (324)
T 3mtl_A 153 PT--KTYDNEVVTLWYRPPDILLGSTDYS 179 (324)
T ss_dssp ------------CGGGCCHHHHTTCCCCC
T ss_pred Cc--cccccccCcccccChhhhcCCCCCC
Confidence 21 1223456899999999998765544
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=243.42 Aligned_cols=175 Identities=27% Similarity=0.440 Sum_probs=151.3
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
.++|.+.+.||+|+||.||+|+.. +++.||+|++..... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467999999999999999999876 578999999876542 344567789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++++|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 94 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EECCTTCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 99999999999885542 58899999999999999999996 89999999999999999999999999999876
Q ss_pred CCCCCcccccccccCCccccccccccc
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
..... ......||+.|+|||++.+.
T Consensus 166 ~~~~~--~~~~~~~~~~y~aPE~~~~~ 190 (294)
T 2rku_A 166 EYDGE--RKKVLCGTPNYIAPEVLSKK 190 (294)
T ss_dssp CSTTC--CBCCCCSCCSSCCHHHHTTS
T ss_pred ccCcc--ccccccCCCCcCCcchhccC
Confidence 54322 22345799999999998654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.8e-27 Score=245.17 Aligned_cols=177 Identities=31% Similarity=0.520 Sum_probs=135.3
Q ss_pred hhcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccC-hhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
..++|++.+.||+|+||.||+|+. .+++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 346799999999999999999987 47899999998654321 1234678999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||||+++++|.+++.... ..+++..++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 89 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 161 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQ 161 (278)
T ss_dssp EEECCTTEEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEecCCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceee
Confidence 999999999999986532 358999999999999999999996 8999999999999999999999999999987
Q ss_pred cCCCCCcccccccccCCccccccccccc
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
...... ......||+.|+|||++.+.
T Consensus 162 ~~~~~~--~~~~~~~~~~y~aPE~~~~~ 187 (278)
T 3cok_A 162 LKMPHE--KHYTLCGTPNYISPEIATRS 187 (278)
T ss_dssp CC--------------------------
T ss_pred ccCCCC--cceeccCCCCcCCcchhcCC
Confidence 653321 12335689999999998754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-27 Score=245.12 Aligned_cols=172 Identities=22% Similarity=0.340 Sum_probs=149.8
Q ss_pred hcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC--CeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--NERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv 666 (779)
.++|++.+.||+|+||.||+|+.. ++.||+|++..........+++.+|+.++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 357999999999999999999885 89999999987665666678899999999999999999999999887 778999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--cEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
|||+++|+|.+++..... ..+++..++.++.||+.||+|||+ .+ |+||||||+||+++.++.++|+|||++.
T Consensus 88 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTN---FVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp EECCTTCBHHHHHHSCSS---CCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred ecccCCCcHHHHHhhccc---CCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEecccee
Confidence 999999999999965432 258999999999999999999996 67 9999999999999999999999999875
Q ss_pred ecCCCCCcccccccccCCcccccccccccC
Q 004020 745 LAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
.... ....||+.|+|||++.+..
T Consensus 162 ~~~~-------~~~~~t~~y~aPE~~~~~~ 184 (271)
T 3kmu_A 162 SFQS-------PGRMYAPAWVAPEALQKKP 184 (271)
T ss_dssp TTSC-------TTCBSCGGGSCHHHHHSCG
T ss_pred eecc-------cCccCCccccChhhhccCC
Confidence 4322 2346899999999987653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.8e-27 Score=263.92 Aligned_cols=175 Identities=27% Similarity=0.428 Sum_probs=147.4
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccCh-----------hHHHHHHHHHHHHHcCCCCccceEee
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE-----------KGFAEFKSEIAVLTKVRHRHLVGLLG 655 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv~~~~ 655 (779)
+.++|++.+.||+|+||.||+|+.. +++.||+|++....... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 5678999999999999999999875 58899999997644221 23467899999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC--
Q 004020 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-- 733 (779)
Q Consensus 656 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-- 733 (779)
++.+.+..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH-----KFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCC
Confidence 9999999999999999999999886543 58999999999999999999997 8999999999999998775
Q ss_pred -cEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 734 -RAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 734 -~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.+||+|||+++...... ......||+.|+|||++.+.
T Consensus 186 ~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~ 223 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLKKK 223 (504)
T ss_dssp SSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTTC
T ss_pred ccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhccC
Confidence 69999999998775432 22345799999999998753
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=252.20 Aligned_cols=186 Identities=31% Similarity=0.472 Sum_probs=142.0
Q ss_pred HHHhhcCCcccceecccccEEEEEEEEc----CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC
Q 004020 585 LRNVTNNFSEENVLGRGGFGTVYKGELH----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG 660 (779)
Q Consensus 585 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 660 (779)
.....++|.+.+.||+|+||.||+|+.. ++..||+|++..........+.+.+|+.++++++||||+++++++...
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 3344578999999999999999999764 345899999987665566678899999999999999999999999876
Q ss_pred Ce-----EEEEEEecCCCChhhHhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCc
Q 004020 661 NE-----RLLVYEYMPQGTLSRHLFNRKE-EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 734 (779)
Q Consensus 661 ~~-----~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 734 (779)
+. .++||||+++++|.+++..... .....+++..++.++.||+.||.|||+ ++|+||||||+||+++.++.
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSC
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCc
Confidence 53 4999999999999999854332 233468999999999999999999996 89999999999999999999
Q ss_pred EEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 735 AKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 735 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+||+|||+++...............+++.|+|||++.+.
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 224 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR 224 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSS
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCC
Confidence 999999999876543322223344678899999998654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.94 E-value=8.8e-27 Score=252.13 Aligned_cols=182 Identities=30% Similarity=0.456 Sum_probs=155.5
Q ss_pred eHHHHHHhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc--C----hhHHHHHHHHHHHHHcC-CCCccce
Q 004020 581 SIQVLRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV--S----EKGFAEFKSEIAVLTKV-RHRHLVG 652 (779)
Q Consensus 581 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~----~~~~~~~~~E~~~l~~l-~h~niv~ 652 (779)
.......+.++|++.+.||+|+||.||+|+.. +|+.||||++..... . ....+.+.+|+.+++++ +||||++
T Consensus 85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 164 (365)
T 2y7j_A 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164 (365)
T ss_dssp HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 44556677788999999999999999999885 799999999865431 1 12245688999999999 7999999
Q ss_pred EeeEEEeCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCC
Q 004020 653 LLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 732 (779)
Q Consensus 653 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~ 732 (779)
+++++...+..++||||+++++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.+
T Consensus 165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~ 236 (365)
T 2y7j_A 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEKV-----ALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDN 236 (365)
T ss_dssp EEEEEEBSSEEEEEECCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTT
T ss_pred EEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCC
Confidence 9999999999999999999999999986542 58899999999999999999996 799999999999999999
Q ss_pred CcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 733 MRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 733 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+.+||+|||++........ .....||+.|+|||++.+.
T Consensus 237 ~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~ 274 (365)
T 2y7j_A 237 MQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCS 274 (365)
T ss_dssp CCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHT
T ss_pred CCEEEEecCcccccCCCcc---cccCCCCCCccChhhcccc
Confidence 9999999999987654322 2345799999999998753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.94 E-value=4.7e-27 Score=259.02 Aligned_cols=174 Identities=26% Similarity=0.421 Sum_probs=137.9
Q ss_pred HhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccC------hhHHHHHHHHHHHHHcCCCCccceEeeEEEe
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS------EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD 659 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 659 (779)
...++|.+.+.||+|+||.||+|... +++.||+|++...... ......+.+|++++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45689999999999999999999765 6899999998754321 112235789999999999999999999975
Q ss_pred CCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCC---CcEE
Q 004020 660 GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD---MRAK 736 (779)
Q Consensus 660 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~---~~~k 736 (779)
.+..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.+ +.+|
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSS-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred cCceEEEEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEE
Confidence 45689999999999999888543 258999999999999999999996 799999999999999754 4599
Q ss_pred EEeeccceecCCCCCcccccccccCCcccccccccc
Q 004020 737 VADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 737 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
|+|||+++..... ......+||+.|+|||++.+
T Consensus 283 l~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~ 315 (419)
T 3i6u_A 283 ITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVS 315 (419)
T ss_dssp ECCSSTTTSCC--------------CTTCCTTTTC-
T ss_pred EeecccceecCCC---ccccccCCCCCccCceeeec
Confidence 9999999876432 22244679999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=248.88 Aligned_cols=175 Identities=27% Similarity=0.440 Sum_probs=151.5
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
.++|.+.+.||+|+||.||+|+.. +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467999999999999999999876 578999999876532 334567789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++++|.+++.... .+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++..
T Consensus 120 ~e~~~~~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp ECCCTTCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 99999999999886542 58899999999999999999996 89999999999999999999999999999876
Q ss_pred CCCCCcccccccccCCccccccccccc
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
..... ......||+.|+|||++.+.
T Consensus 192 ~~~~~--~~~~~~gt~~y~aPE~~~~~ 216 (335)
T 2owb_A 192 EYDGE--RKKVLCGTPNYIAPEVLSKK 216 (335)
T ss_dssp CSTTC--CBCCCCSCCSSCCHHHHHTS
T ss_pred ccCcc--cccccCCCccccCHHHhccC
Confidence 54322 22345799999999998654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-27 Score=253.95 Aligned_cols=181 Identities=28% Similarity=0.376 Sum_probs=143.5
Q ss_pred HhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccCh---hHHHHHHHHHHHHHcCCCCccceEeeEEEeCCe
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE---KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 662 (779)
...++|++.+.||+|+||.||+|+.. +++.||+|++....... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999875 68999999987543221 112467899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecc
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 742 (779)
.++||||+++ +|.+++.... ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGL 158 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred eEEEEEcCCC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEeccc
Confidence 9999999986 8888875432 257888999999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCCCcccccccccCCcccccccccccCCCC
Q 004020 743 VRLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 743 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
++....... ......||+.|+|||++.+...++
T Consensus 159 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~ 191 (346)
T 1ua2_A 159 AKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYG 191 (346)
T ss_dssp GSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCC
T ss_pred ceeccCCcc--cCCcccccccccCchHhhCCCCCC
Confidence 987644322 223457899999999997655443
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-27 Score=254.14 Aligned_cols=171 Identities=25% Similarity=0.410 Sum_probs=144.0
Q ss_pred HhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEE
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERL 664 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 664 (779)
.+.++|++.+.||+|+||.||+|+.. +++.||+|++..... ...+|++++.++ +||||+++++++.+.+..|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 92 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVY 92 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence 35678999999999999999999875 688999999975432 234688888888 7999999999999999999
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCC----CcEEEEee
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD----MRAKVADF 740 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~----~~~kl~DF 740 (779)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||++.++ +.+||+||
T Consensus 93 lv~E~~~gg~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Df 164 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQK-----FFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDF 164 (342)
T ss_dssp EEECCCCSCBHHHHHHTCT-----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCC
T ss_pred EEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEEC
Confidence 9999999999999886432 58999999999999999999997 899999999999998533 35999999
Q ss_pred ccceecCCCCCcccccccccCCccccccccccc
Q 004020 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 741 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
|+++....... .....+||+.|+|||++.+.
T Consensus 165 g~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~ 195 (342)
T 2qr7_A 165 GFAKQLRAENG--LLMTPCYTANFVAPEVLERQ 195 (342)
T ss_dssp TTCEECBCTTC--CBCCSSCCSSCCCHHHHHHH
T ss_pred CCcccCcCCCC--ceeccCCCccccCHHHhcCC
Confidence 99987654322 22345799999999998653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=5.3e-27 Score=244.20 Aligned_cols=174 Identities=32% Similarity=0.534 Sum_probs=146.2
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccCh-hHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE-KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
.++|++.+.||+|+||.||+|+.. +++.||+|++....... .....+.+|++++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 468999999999999999999765 57799999986543222 2346789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 88 ~e~~~~~~l~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp ECCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 99999999999986543 48899999999999999999995 89999999999999999999999999998654
Q ss_pred CCCCCcccccccccCCcccccccccccC
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
... ......||+.|+|||++.+..
T Consensus 160 ~~~----~~~~~~~~~~y~aPE~~~~~~ 183 (279)
T 3fdn_A 160 PSS----RRTDLCGTLDYLPPEMIEGRM 183 (279)
T ss_dssp ------------CCCCTTCCHHHHTTCC
T ss_pred Ccc----cccccCCCCCccCHhHhccCC
Confidence 332 123457999999999987643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=248.09 Aligned_cols=175 Identities=25% Similarity=0.396 Sum_probs=136.0
Q ss_pred hcCCcccceecccccEEEEEEEEcC----CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHD----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 664 (779)
.++|++.+.||+|+||.||+|+... +..||+|++.... .....+.+.+|+.++++++||||+++++++. .+..+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 4689999999999999999997642 4579999987543 3445678999999999999999999999974 56789
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 92 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp EEEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECcccccc
Confidence 9999999999999986543 258899999999999999999996 899999999999999999999999999998
Q ss_pred ecCCCCCcccccccccCCccccccccccc
Q 004020 745 LAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
....... .......+|+.|+|||++.+.
T Consensus 165 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 192 (281)
T 1mp8_A 165 YMEDSTY-YKASKGKLPIKWMAPESINFR 192 (281)
T ss_dssp ---------------CCGGGCCHHHHHHC
T ss_pred ccCcccc-cccccCCCcccccChhhcccC
Confidence 7654321 122334578899999998654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-27 Score=251.54 Aligned_cols=183 Identities=27% Similarity=0.473 Sum_probs=152.3
Q ss_pred HhhcCCcccceecccccEEEEEEEEc------CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG 660 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 660 (779)
...++|++.+.||+|+||.||+|... +++.||+|++.... ......++.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 34578999999999999999999754 36789999987543 344556789999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhHhhhccc-----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcE
Q 004020 661 NERLLVYEYMPQGTLSRHLFNRKE-----EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 735 (779)
Q Consensus 661 ~~~~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 735 (779)
+..++||||+++++|.+++..... .....+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeE
Confidence 999999999999999999876432 112356899999999999999999997 799999999999999999999
Q ss_pred EEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 736 KVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 736 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
||+|||+++...............||+.|+|||++.+.
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 215 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG 215 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccC
Confidence 99999999866443222223344678999999998654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=242.37 Aligned_cols=171 Identities=27% Similarity=0.400 Sum_probs=147.1
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEe----CCeEEE
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD----GNERLL 665 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~l 665 (779)
.|.+.+.||+|+||.||+|... ++..||+|++..........+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4778889999999999999765 68899999998776666777889999999999999999999999875 345799
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--cEEcCCCCCCEEEc-CCCcEEEEeecc
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLG-DDMRAKVADFGL 742 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~ 742 (779)
||||+++++|.+++.... .+++..++.++.||+.||+|||+ .+ |+||||||+||+++ +++.+||+|||+
T Consensus 107 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEecCCCCHHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 999999999999996542 57899999999999999999996 66 99999999999997 789999999999
Q ss_pred ceecCCCCCcccccccccCCccccccccccc
Q 004020 743 VRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 743 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+...... ......||+.|+|||++.+.
T Consensus 179 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~ 205 (290)
T 1t4h_A 179 ATLKRAS----FAKAVIGTPEFMAPEMYEEK 205 (290)
T ss_dssp GGGCCTT----SBEESCSSCCCCCGGGGGTC
T ss_pred ccccccc----ccccccCCcCcCCHHHHhcc
Confidence 9754332 22345699999999998754
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.7e-28 Score=270.21 Aligned_cols=171 Identities=18% Similarity=0.184 Sum_probs=121.4
Q ss_pred CCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEec
Q 004020 90 SLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSA 168 (779)
Q Consensus 90 ~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l 168 (779)
+|++|+|++|.|++.+| .|.++++|++|+|++|.++++++ |..+++|++|+|++|.|.+ +| ..++|+.|++
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~--l~----~~~~L~~L~L 106 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE--LL----VGPSIETLHA 106 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEE--EE----ECTTCCEEEC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCC--CC----CCCCcCEEEC
Confidence 67778888877777665 67777778888888777776665 7777778888888777754 22 2377788888
Q ss_pred cCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCc
Q 004020 169 NGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNS 248 (779)
Q Consensus 169 ~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~ 248 (779)
++|.+++..+.. +++|++|+|++|.|++..|..++ .+++|+.|+|++|.
T Consensus 107 ~~N~l~~~~~~~-----l~~L~~L~L~~N~l~~~~~~~~~--------------------------~l~~L~~L~Ls~N~ 155 (487)
T 3oja_A 107 ANNNISRVSCSR-----GQGKKNIYLANNKITMLRDLDEG--------------------------CRSRVQYLDLKLNE 155 (487)
T ss_dssp CSSCCCCEEECC-----CSSCEEEECCSSCCCSGGGBCGG--------------------------GGSSEEEEECTTSC
T ss_pred cCCcCCCCCccc-----cCCCCEEECCCCCCCCCCchhhc--------------------------CCCCCCEEECCCCC
Confidence 888877665542 46788888888888876666554 46778888888888
Q ss_pred ccCCCCC-CC-CCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCC
Q 004020 249 FTGPLPD-LS-GLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTP 301 (779)
Q Consensus 249 l~~~~~~-~~-~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p 301 (779)
+++.+|. +. .+++|+.|+|++|.|++..+ +..+++|+.|+|++|+|++.+|
T Consensus 156 l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~ 208 (487)
T 3oja_A 156 IDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGP 208 (487)
T ss_dssp CCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECG
T ss_pred CCCcChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCCCH
Confidence 8776653 44 57788888888888876522 3347777777777777765433
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-27 Score=254.34 Aligned_cols=175 Identities=29% Similarity=0.513 Sum_probs=141.9
Q ss_pred cCCcccceecccccEEEEEEEEc-CCc----EEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGT----KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 664 (779)
++|++.+.||+|+||.||+|++. +++ +||+|.+.... .....+.+.+|+.++++++||||+++++++. .+..+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 57999999999999999999864 444 37788775432 1223356778999999999999999999886 45689
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
+||||+++|+|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 91 ~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp EEEECCTTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred EEEEeCCCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCccc
Confidence 9999999999999986543 257888999999999999999997 799999999999999999999999999998
Q ss_pred ecCCCCCcccccccccCCccccccccccc
Q 004020 745 LAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
...............||+.|+|||++.+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 192 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFG 192 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHC
T ss_pred ccCcccccccccCCCCcccccChHHhccC
Confidence 77654433334556788899999998654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.94 E-value=6.5e-27 Score=246.46 Aligned_cols=180 Identities=27% Similarity=0.426 Sum_probs=144.9
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEe-------
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD------- 659 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------- 659 (779)
..++|++.+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|++++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 4568999999999999999999875 7899999998643 3455788999999999999999999998865
Q ss_pred ------CCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC
Q 004020 660 ------GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 733 (779)
Q Consensus 660 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 733 (779)
.+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++.++
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~ 153 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESR 153 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTS
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCC
Confidence 346789999999999999996533 257788999999999999999997 7999999999999999999
Q ss_pred cEEEEeeccceecCCCCC------------cccccccccCCcccccccccccCCCC
Q 004020 734 RAKVADFGLVRLAPDNGK------------HSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 734 ~~kl~DFG~a~~~~~~~~------------~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
.+||+|||+++....... ........||+.|+|||++.+...++
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 209 (303)
T 1zy4_A 154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYN 209 (303)
T ss_dssp CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCC
T ss_pred CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCc
Confidence 999999999876543210 11123456899999999998654443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-27 Score=264.32 Aligned_cols=175 Identities=27% Similarity=0.452 Sum_probs=148.1
Q ss_pred hhcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
..++|++.+.||+|+||.||+|+..++..||||+++... ...+++.+|++++++++||||+++++++. .+..++||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 456789999999999999999999889999999997643 23568999999999999999999999986 56789999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++|+|.+++..... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 262 e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp CCCTTCBHHHHHHSHHH---HTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred eecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 99999999999965432 147888999999999999999997 899999999999999999999999999998764
Q ss_pred CCCCcccccccccCCccccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. .........+++.|+|||++.+.
T Consensus 336 ~~-~~~~~~~~~~~~~y~aPE~~~~~ 360 (454)
T 1qcf_A 336 DN-EYTAREGAKFPIKWTAPEAINFG 360 (454)
T ss_dssp CH-HHHTTCSSSSCGGGSCHHHHHHC
T ss_pred CC-ceeccCCCcccccccCHHHhccC
Confidence 32 11112334567899999998643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4e-27 Score=251.03 Aligned_cols=183 Identities=28% Similarity=0.369 Sum_probs=152.2
Q ss_pred HHHHHHhhcCCccc-ceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeEEE
Q 004020 582 IQVLRNVTNNFSEE-NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCL 658 (779)
Q Consensus 582 ~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 658 (779)
++....+.++|.+. +.||+|+||.||+|+.. +++.||+|++...........++.+|+.+++.+. ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 44456677788887 89999999999999876 6899999999876544555678999999999995 699999999999
Q ss_pred eCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC---CCcE
Q 004020 659 DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRA 735 (779)
Q Consensus 659 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~~~ 735 (779)
..+..++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+ .+|+||||||+||+++. ++.+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPEL---AEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCE
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcE
Confidence 9999999999999999999885432 2358999999999999999999996 89999999999999987 7899
Q ss_pred EEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 736 KVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 736 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
||+|||+++....... .....||+.|+|||++.+.
T Consensus 174 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~ 208 (327)
T 3lm5_A 174 KIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYD 208 (327)
T ss_dssp EECCGGGCEEC------------CCCGGGCCHHHHTTC
T ss_pred EEeeCccccccCCccc---cccccCCcCccCCeeecCC
Confidence 9999999987654321 2345799999999998754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.8e-27 Score=255.12 Aligned_cols=187 Identities=25% Similarity=0.373 Sum_probs=148.3
Q ss_pred eeHHHHHHhhcCCcccceecccccEEEEEEEEcCCcEEEEEEeccccc---------ChhHHHHHHHHHHHHHcCCCCcc
Q 004020 580 ISIQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVV---------SEKGFAEFKSEIAVLTKVRHRHL 650 (779)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~~E~~~l~~l~h~ni 650 (779)
...+++..+.++|++.+.||+|+||.||+|...+++.||||++..... .....+.+.+|++++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 346778889999999999999999999999988899999999865432 12234789999999999999999
Q ss_pred ceEeeEEEeC-----CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCC
Q 004020 651 VGLLGYCLDG-----NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPS 725 (779)
Q Consensus 651 v~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~ 725 (779)
+++++++... ...++||||++ |+|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~ 163 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR----IVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPG 163 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGG
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChH
Confidence 9999998643 35799999997 68888875432 358999999999999999999997 79999999999
Q ss_pred CEEEcCCCcEEEEeeccceecCCCCCcccccccccCCcccccccccccCCCC
Q 004020 726 NILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 726 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
||+++.++.+||+|||+++...... ......||+.|+|||++.+...++
T Consensus 164 NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~ 212 (362)
T 3pg1_A 164 NILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFT 212 (362)
T ss_dssp GEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCC
T ss_pred HEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCC
Confidence 9999999999999999997554322 223457899999999988755444
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=248.77 Aligned_cols=181 Identities=27% Similarity=0.421 Sum_probs=144.8
Q ss_pred HHHHHHhhcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcC--CCCccceEeeEEEe
Q 004020 582 IQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV--RHRHLVGLLGYCLD 659 (779)
Q Consensus 582 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~ 659 (779)
......+.++|++.+.||+|+||.||+|+.. ++.||||++... ....+.+|.+++... +||||+++++++..
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 3444566789999999999999999999876 899999998543 223445566666555 89999999999988
Q ss_pred C----CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCcEEcCCCCCCEEEc
Q 004020 660 G----NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA-----HQSFIHRDLKPSNILLG 730 (779)
Q Consensus 660 ~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-----~~~ivHrDlkp~NIll~ 730 (779)
. ...++||||+++|+|.+++... .+++..++.++.|++.||+|||+.+ +.+|+||||||+||+++
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~ 176 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK 176 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC
Confidence 7 6789999999999999999543 4889999999999999999999610 12999999999999999
Q ss_pred CCCcEEEEeeccceecCCCCCcc--cccccccCCcccccccccccC
Q 004020 731 DDMRAKVADFGLVRLAPDNGKHS--IETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 731 ~~~~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~ 774 (779)
.++.+||+|||+++......... ......||+.|+|||++.+..
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 222 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL 222 (337)
T ss_dssp TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCC
T ss_pred CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccccc
Confidence 99999999999998765432211 112457999999999987654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-27 Score=265.46 Aligned_cols=175 Identities=30% Similarity=0.487 Sum_probs=149.8
Q ss_pred hcCCcccceecccccEEEEEEEEcC-CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.++|++.+.||+|+||.||+|++.. +..||||+++... ...+++.+|++++++++||||+++++++...+..++||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 4578899999999999999998874 8899999997543 23567999999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++|+|.+++..... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 296 E~~~~g~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 296 EFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp ECCTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EccCCCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 99999999999965432 358899999999999999999996 899999999999999999999999999998765
Q ss_pred CCCCcccccccccCCccccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
... ........+++.|+|||++.+.
T Consensus 370 ~~~-~~~~~~~~~~~~y~aPE~~~~~ 394 (495)
T 1opk_A 370 GDT-YTAHAGAKFPIKWTAPESLAYN 394 (495)
T ss_dssp TCC-EECCTTCCCCGGGCCHHHHHHC
T ss_pred CCc-eeecCCCcCCcceeCHhHHhcC
Confidence 432 2222334567899999998643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-27 Score=250.53 Aligned_cols=190 Identities=26% Similarity=0.403 Sum_probs=155.5
Q ss_pred eeHHHHHHhhcCCcccceecccccEEEEEEEE------cCCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccce
Q 004020 580 ISIQVLRNVTNNFSEENVLGRGGFGTVYKGEL------HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVG 652 (779)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 652 (779)
+.........++|++.+.||+|+||.||+|+. .+++.||+|++.... .....+.+.+|+++++++ +||||++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeee
Confidence 34445555678999999999999999999974 246889999997653 344556799999999999 6999999
Q ss_pred EeeEEEeCC-eEEEEEEecCCCChhhHhhhcccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEc
Q 004020 653 LLGYCLDGN-ERLLVYEYMPQGTLSRHLFNRKEEG-----------LKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHR 720 (779)
Q Consensus 653 ~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~-----------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHr 720 (779)
+++++...+ ..++||||+++++|.+++....... ...+++..++.++.||+.||+|||+ .+|+||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccc
Confidence 999988765 4899999999999999997654210 1237889999999999999999997 899999
Q ss_pred CCCCCCEEEcCCCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 721 DLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 721 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
||||+||+++.++.+||+|||+++...............||+.|+|||++.+.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 225 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR 225 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccc
Confidence 99999999999999999999999876554333333445689999999988654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-27 Score=255.51 Aligned_cols=175 Identities=28% Similarity=0.427 Sum_probs=133.6
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC------
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG------ 660 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 660 (779)
+.++|++.+.||+|+||.||+|... +++.||||++..........+++.+|+++++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 4578999999999999999999764 689999999976655556667889999999999999999999999754
Q ss_pred CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEee
Q 004020 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (779)
Q Consensus 661 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF 740 (779)
...++||||+ +++|.+++.. ..+++..+..++.||++||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DF 176 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 176 (367)
T ss_dssp CCCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-
T ss_pred CeEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeec
Confidence 5679999999 6899888743 258899999999999999999997 89999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccCCcccccccccccCCCC
Q 004020 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 741 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
|+++..... ....+||+.|+|||++.+...++
T Consensus 177 G~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~ 208 (367)
T 2fst_X 177 GLARHTADE-----MTGYVATRWYRAPEIMLNWMHYN 208 (367)
T ss_dssp -------------------CCCTTCCHHHHTTCCSCC
T ss_pred ccccccccc-----CCCcCcCcCccChHHHcCCcCCC
Confidence 999875432 23457999999999998755444
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.8e-27 Score=243.55 Aligned_cols=173 Identities=31% Similarity=0.477 Sum_probs=148.9
Q ss_pred cCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
++|++.+.||+|+||.||+|+..+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 57899999999999999999998889999999976543 235789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+++++|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 85 MEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CTTCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCcHHHHHhhCc----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 99999999986543 257899999999999999999996 89999999999999999999999999998765432
Q ss_pred CCcccccccccCCccccccccccc
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.........|++.|+|||++.+.
T Consensus 158 -~~~~~~~~~~~~~y~aPE~~~~~ 180 (267)
T 3t9t_A 158 -QYTSSTGTKFPVKWASPEVFSFS 180 (267)
T ss_dssp -HHHSTTSTTCCGGGCCHHHHHHC
T ss_pred -cccccccccccccccChhhhcCC
Confidence 11122334578899999998654
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-27 Score=251.70 Aligned_cols=267 Identities=18% Similarity=0.215 Sum_probs=228.0
Q ss_pred CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEc
Q 004020 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 143 (779)
.+++.++++.+++...+...+..+++|++|+|++|++++.++ .|.++++|++|+|++|+++++++ |..+++|++|+|
T Consensus 10 ~~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~L 87 (317)
T 3o53_A 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDL 87 (317)
T ss_dssp TEEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEEC
T ss_pred CceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEEC
Confidence 467778888888886666667778899999999999999887 79999999999999999998876 899999999999
Q ss_pred ccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCC
Q 004020 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGD 223 (779)
Q Consensus 144 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~ 223 (779)
++|++.+ + ..+++|+.|++++|++++..+.. +++|++|+|++|++++..|..++
T Consensus 88 s~n~l~~--l----~~~~~L~~L~l~~n~l~~~~~~~-----~~~L~~L~l~~N~l~~~~~~~~~--------------- 141 (317)
T 3o53_A 88 NNNYVQE--L----LVGPSIETLHAANNNISRVSCSR-----GQGKKNIYLANNKITMLRDLDEG--------------- 141 (317)
T ss_dssp CSSEEEE--E----EECTTCCEEECCSSCCSEEEECC-----CSSCEEEECCSSCCCSGGGBCTG---------------
T ss_pred cCCcccc--c----cCCCCcCEEECCCCccCCcCccc-----cCCCCEEECCCCCCCCccchhhh---------------
Confidence 9999965 2 24589999999999999776553 57899999999999976665554
Q ss_pred CCCCCchhhhcCCCCccEEEeecCcccCCCCC-C-CCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCC
Q 004020 224 SKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-L-SGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTP 301 (779)
Q Consensus 224 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~-~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p 301 (779)
.+++|++|+|++|.+++..+. + ..+++|++|++++|+|++. |. ...+++|++|+|++|++++.++
T Consensus 142 -----------~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~ 208 (317)
T 3o53_A 142 -----------CRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGP 208 (317)
T ss_dssp -----------GGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECG
T ss_pred -----------ccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCcchh
Confidence 589999999999999997764 5 4789999999999999965 33 3459999999999999987655
Q ss_pred CCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCcc
Q 004020 302 KFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLG 381 (779)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~ 381 (779)
.+ . ..++|+.|+|++|+
T Consensus 209 ~~-~--------------------------------------------------------------~l~~L~~L~L~~N~ 225 (317)
T 3o53_A 209 EF-Q--------------------------------------------------------------SAAGVTWISLRNNK 225 (317)
T ss_dssp GG-G--------------------------------------------------------------GGTTCSEEECTTSC
T ss_pred hh-c--------------------------------------------------------------ccCcccEEECcCCc
Confidence 31 0 12379999999999
Q ss_pred ccccccccccccccCCeEeccCcccc-ccCCccCCCCCCCCceecc-CCcccccCCC
Q 004020 382 LSGTISSNFSRLTSLRQLMLSGNELT-GTIPKELTTLPSLEMLDVS-NNHLFGKVPN 436 (779)
Q Consensus 382 l~g~~p~~~~~l~~L~~L~Ls~N~l~-g~iP~~l~~l~~L~~L~Ls-~N~l~g~iP~ 436 (779)
++ .+|..+..+++|+.|+|++|.++ +.+|..+..++.|+.|+++ .+.++|..|.
T Consensus 226 l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 226 LV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp CC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred cc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 99 57888999999999999999999 8899999999999999999 5667777664
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=245.57 Aligned_cols=177 Identities=24% Similarity=0.351 Sum_probs=143.7
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccC-hhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
..++|++.+.||+|+||.||+|+.. +++.||+|++...... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3578999999999999999999875 6889999999765432 3345779999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||||+++++|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 112 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~ 183 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQG-----PLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASA 183 (309)
T ss_dssp EEECCCCEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred EEEecCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence 999999999999986542 58899999999999999999996 8999999999999999999999999999876
Q ss_pred cCCCCCcccccccccCCccccccccccc
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
...... .......||+.|+|||++.+.
T Consensus 184 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 210 (309)
T 2h34_A 184 TTDEKL-TQLGNTVGTLYYMAPERFSES 210 (309)
T ss_dssp --------------CCGGGCCGGGTCC-
T ss_pred cccccc-ccccccCCCcCccCHHHHcCC
Confidence 644321 122345699999999998754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=242.20 Aligned_cols=174 Identities=26% Similarity=0.419 Sum_probs=147.2
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccCh----hHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE----KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 663 (779)
.++|++.+.||+|+||.||+|+.. +++.||+|++....... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 467999999999999999999876 68999999987654222 1357799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC----cEEEEe
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM----RAKVAD 739 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~----~~kl~D 739 (779)
++||||+++++|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+||+++.++ .+||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE-----SLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEeecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEe
Confidence 99999999999999986532 58899999999999999999996 8999999999999998877 899999
Q ss_pred eccceecCCCCCcccccccccCCccccccccccc
Q 004020 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 740 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
||+++....... .....||+.|+|||++.+.
T Consensus 156 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~ 186 (283)
T 3bhy_A 156 FGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYE 186 (283)
T ss_dssp CTTCEECC-----------CCCGGGCCHHHHTTC
T ss_pred cccceeccCCCc---ccccCCCcCccCcceecCC
Confidence 999987654321 2345689999999998654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.7e-27 Score=256.68 Aligned_cols=175 Identities=26% Similarity=0.405 Sum_probs=148.4
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC--eEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN--ERLL 665 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~l 665 (779)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... ....+.+.+|++++++++||||+++++++...+ ..++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 457999999999999999999876 589999999975432 233567789999999999999999999998765 6799
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEE----cCCCcEEEEeec
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFG 741 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll----~~~~~~kl~DFG 741 (779)
||||+++|+|.+++...... ..+++..++.++.||+.||+|||+ .+|+||||||+||++ +.++.+||+|||
T Consensus 87 v~e~~~~g~L~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGT--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred EEecCCCCCHHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 99999999999998664432 238999999999999999999997 899999999999999 778889999999
Q ss_pred cceecCCCCCcccccccccCCcccccccccc
Q 004020 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 742 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
+++...... ......||+.|+|||++.+
T Consensus 162 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~ 189 (396)
T 4eut_A 162 AARELEDDE---QFVSLYGTEEYLHPDMYER 189 (396)
T ss_dssp GCEECCCGG---GSSCSSSCCTTCCHHHHHH
T ss_pred CceEccCCC---ccccccCCccccCHHHhhc
Confidence 998765432 2234579999999999864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=247.96 Aligned_cols=175 Identities=28% Similarity=0.475 Sum_probs=148.8
Q ss_pred cCCcccceecccccEEEEEEEE-----cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEe--CCe
Q 004020 590 NNFSEENVLGRGGFGTVYKGEL-----HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD--GNE 662 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~ 662 (779)
++|++.+.||+|+||.||+|++ .+++.||+|++.... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 5799999999999999999984 368899999987543 4455779999999999999999999999874 456
Q ss_pred EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecc
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 742 (779)
.++||||+++++|.+++..... .+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRA----RLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred EEEEEeecCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEccccc
Confidence 8999999999999999966432 48999999999999999999996 8999999999999999999999999999
Q ss_pred ceecCCCCCcc-cccccccCCccccccccccc
Q 004020 743 VRLAPDNGKHS-IETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 743 a~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~ 773 (779)
++......... ......||+.|+|||++.+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 205 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHC
T ss_pred ceecccCCccceeeccCCccccccCHHHhccC
Confidence 98775443221 22345688899999988654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=254.16 Aligned_cols=169 Identities=23% Similarity=0.349 Sum_probs=134.3
Q ss_pred hcCCccc-ceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHc-CCCCccceEeeEEEe----CC
Q 004020 589 TNNFSEE-NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTK-VRHRHLVGLLGYCLD----GN 661 (779)
Q Consensus 589 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~----~~ 661 (779)
.++|.+. +.||+|+||.||+|+.. +++.||||++... ..+.+|++++.+ .+||||+++++++.. .+
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 4567766 78999999999999875 6899999998632 346778888744 579999999999875 55
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC---CCcEEEE
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVA 738 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~~~kl~ 738 (779)
..|+||||+++|+|.+++..... ..+++..+..|+.||+.||+|||+ .+|+||||||+|||++. ++.+||+
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~ 206 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLT 206 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred EEEEEEEeCCCCcHHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEE
Confidence 68999999999999999965432 358999999999999999999996 89999999999999997 7899999
Q ss_pred eeccceecCCCCCcccccccccCCccccccccccc
Q 004020 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 739 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
|||+++...... .....+||+.|+|||++.+.
T Consensus 207 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~ 238 (400)
T 1nxk_A 207 DFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPE 238 (400)
T ss_dssp CCTTCEECC--------------CTTCCGGGSCCC
T ss_pred ecccccccCCCC---ccccCCCCCCccCHhhcCCC
Confidence 999998765322 22345799999999998654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.3e-27 Score=246.09 Aligned_cols=177 Identities=29% Similarity=0.416 Sum_probs=142.5
Q ss_pred hhcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccC---hhHHHHHHHHHHHHHcCC---CCccceEeeEEEeC
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVS---EKGFAEFKSEIAVLTKVR---HRHLVGLLGYCLDG 660 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~ 660 (779)
..++|++.+.||+|+||.||+|+. .+++.||+|++...... ......+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467999999999999999999986 47899999998754321 111245667777777664 99999999999876
Q ss_pred C-----eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcE
Q 004020 661 N-----ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 735 (779)
Q Consensus 661 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 735 (779)
. ..++||||++ ++|.+++..... ..+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP---PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCE
Confidence 5 4789999997 599999865432 248999999999999999999997 899999999999999999999
Q ss_pred EEEeeccceecCCCCCcccccccccCCcccccccccccC
Q 004020 736 KVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 736 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
||+|||+++...... ......||+.|+|||++.+..
T Consensus 160 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~ 195 (308)
T 3g33_A 160 KLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQST 195 (308)
T ss_dssp EECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSC
T ss_pred EEeeCccccccCCCc---ccCCccccccccCchHHcCCC
Confidence 999999998664332 224467999999999986543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.6e-27 Score=255.70 Aligned_cols=177 Identities=23% Similarity=0.366 Sum_probs=143.5
Q ss_pred HhhcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC-----
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG----- 660 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----- 660 (779)
...++|++.+.||+|+||.||+|+. .+++.||+|++.... ....+|+++++.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 4567899999999999999999976 478999999986542 1234799999999999999999998543
Q ss_pred ---------------------------------CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHH
Q 004020 661 ---------------------------------NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707 (779)
Q Consensus 661 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~ 707 (779)
...++||||++ ++|.+.+......+ ..+++..+..++.||++||+
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~-~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSG-RSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTT-CCCCHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHH
Confidence 34789999998 58888776543322 36899999999999999999
Q ss_pred HHHcCCCCCcEEcCCCCCCEEEc-CCCcEEEEeeccceecCCCCCcccccccccCCcccccccccccCCCC
Q 004020 708 YLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 708 ~LH~~~~~~ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
|||+ .+|+||||||+||+++ .++.+||+|||+|+....... .....||+.|+|||++.+...++
T Consensus 156 ~LH~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~ 220 (383)
T 3eb0_A 156 FIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYT 220 (383)
T ss_dssp HHHT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCC
T ss_pred HHHH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCC
Confidence 9996 8999999999999998 689999999999987654322 23457899999999998766554
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-27 Score=265.03 Aligned_cols=175 Identities=29% Similarity=0.450 Sum_probs=151.2
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccC-hhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
+.++|++.+.||+|+||.||+|+.. +++.||||++...... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4568999999999999999999876 7899999998654322 3345779999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEE---cCCCcEEEEeecc
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGL 742 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DFG~ 742 (779)
||||+.+++|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+||++ +.++.+||+|||+
T Consensus 104 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRK-----RFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EECCCCSCBHHHHHHTCS-----CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 999999999999886542 58899999999999999999997 899999999999999 5678999999999
Q ss_pred ceecCCCCCcccccccccCCccccccccccc
Q 004020 743 VRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 743 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
++....... ....+||+.|+|||++.+.
T Consensus 176 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~ 203 (484)
T 3nyv_A 176 STHFEASKK---MKDKIGTAYYIAPEVLHGT 203 (484)
T ss_dssp HHHBCCCCS---HHHHTTGGGTCCHHHHHTC
T ss_pred eEEcccccc---cccCCCCccccCceeecCC
Confidence 987654322 2345799999999998763
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5e-27 Score=244.35 Aligned_cols=179 Identities=25% Similarity=0.417 Sum_probs=150.6
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEe--CCeEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD--GNERLL 665 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 665 (779)
.++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+.+|++++++++||||+++++++.. .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999875 68999999998766556667889999999999999999999998854 567899
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-----cEEcCCCCCCEEEcCCCcEEEEee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS-----FIHRDLKPSNILLGDDMRAKVADF 740 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~-----ivHrDlkp~NIll~~~~~~kl~DF 740 (779)
||||+++++|.+++...... ...+++..++.++.|++.||+|||+ .+ |+||||||+||+++.++.+||+||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEeCCCCCCHHHHHHhhccc-CCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 99999999999999765432 2358999999999999999999997 56 999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccCCccccccccccc
Q 004020 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 741 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
|+++...... .......||+.|+|||++.+.
T Consensus 161 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~ 191 (279)
T 2w5a_A 161 GLARILNHDT--SFAKTFVGTPYYMSPEQMNRM 191 (279)
T ss_dssp CHHHHC---C--HHHHHHHSCCTTCCHHHHHCC
T ss_pred chheeecccc--ccccccCCCccccChHHhccC
Confidence 9987664321 122335689999999998754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=246.56 Aligned_cols=175 Identities=26% Similarity=0.391 Sum_probs=141.9
Q ss_pred hhcCCccc-ceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEE
Q 004020 588 VTNNFSEE-NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERL 664 (779)
Q Consensus 588 ~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 664 (779)
+.+.|++. +.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++.++ +||||+++++++.+.+..+
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 34678874 78999999999999754 78999999987543 23456789999999985 7999999999999999999
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCc---EEEEeec
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR---AKVADFG 741 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~---~kl~DFG 741 (779)
+||||+++++|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+||+++.++. +||+|||
T Consensus 88 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg 159 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRR-----HFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFD 159 (316)
T ss_dssp EEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred EEEEcCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence 9999999999999986543 57899999999999999999997 79999999999999998766 9999999
Q ss_pred cceecCCCCCc-----ccccccccCCcccccccccc
Q 004020 742 LVRLAPDNGKH-----SIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 742 ~a~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~ 772 (779)
+++........ .......||+.|+|||++.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 195 (316)
T 2ac3_A 160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEA 195 (316)
T ss_dssp CCC-------------------CCSGGGCCHHHHHH
T ss_pred CccccccCCccccccccccccccCCcCccChHHhhc
Confidence 98765432211 11123469999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=241.87 Aligned_cols=173 Identities=29% Similarity=0.487 Sum_probs=147.0
Q ss_pred hcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
.++|++.+.||+|+||.||+|+..++..||+|++..... ..+.+.+|++++++++||||+++++++. .+..++|||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 467999999999999999999988888999999875432 3467899999999999999999999886 456899999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++++|.+++..... ..+++..++.++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 88 ~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CCTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 9999999999865432 147899999999999999999996 8999999999999999999999999999987754
Q ss_pred CCCcccccccccCCcccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
.. ........+++.|+|||++.+
T Consensus 162 ~~-~~~~~~~~~~~~y~aPE~~~~ 184 (279)
T 1qpc_A 162 NE-YTAREGAKFPIKWTAPEAINY 184 (279)
T ss_dssp SC-EECCTTCCCCTTTSCHHHHHH
T ss_pred cc-cccccCCCCccCccChhhhcc
Confidence 32 222234457889999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=241.06 Aligned_cols=175 Identities=30% Similarity=0.464 Sum_probs=143.6
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccC-hhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
.++|++.+.||+|+||.||+|+.. +++.||+|++...... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999876 7899999998754321 22346789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 90 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG-----RVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 99999999999986542 47899999999999999999996 89999999999999999999999999998876
Q ss_pred CCCCCcccccccccCCcccccccccccC
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
.... ......||+.|+|||++.+..
T Consensus 162 ~~~~---~~~~~~~~~~y~aPE~~~~~~ 186 (276)
T 2h6d_A 162 SDGE---FLRTSCGSPNYAAPEVISGRL 186 (276)
T ss_dssp CC----------------CCTGGGTTSC
T ss_pred CCCc---ceecccCCccccCHHHHcCCC
Confidence 4432 123346899999999987654
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=245.64 Aligned_cols=217 Identities=19% Similarity=0.266 Sum_probs=148.6
Q ss_pred CCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceE
Q 004020 87 SLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRF 166 (779)
Q Consensus 87 ~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L 166 (779)
..+++++|+|++|+++..++.+.++++|++|+|++|+++.+|. .+.++++|++|+|++|++.. +|..+.++++
T Consensus 79 ~~~~l~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~n~l~~lp~-~~~~l~~L~~L~Ls~n~l~~--lp~~l~~l~~---- 151 (328)
T 4fcg_A 79 TQPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLMELPD-TMQQFAGLETLTLARNPLRA--LPASIASLNR---- 151 (328)
T ss_dssp TSTTCCEEEEESSCCSSCCSCGGGGTTCSEEEEESSCCCCCCS-CGGGGTTCSEEEEESCCCCC--CCGGGGGCTT----
T ss_pred cccceeEEEccCCCchhcChhhhhCCCCCEEECCCCCccchhH-HHhccCCCCEEECCCCcccc--CcHHHhcCcC----
Confidence 3467888888888888655577777788888888877775553 46667777777777777652 4444544444
Q ss_pred eccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeec
Q 004020 167 SANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHG 246 (779)
Q Consensus 167 ~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~ 246 (779)
|++|+|++|++.+.+|..++.. .+ ...+..+++|++|+|++
T Consensus 152 ----------------------L~~L~L~~n~~~~~~p~~~~~~-----~~------------~~~~~~l~~L~~L~L~~ 192 (328)
T 4fcg_A 152 ----------------------LRELSIRACPELTELPEPLAST-----DA------------SGEHQGLVNLQSLRLEW 192 (328)
T ss_dssp ----------------------CCEEEEEEETTCCCCCSCSEEE-----C-------------CCCEEESTTCCEEEEEE
T ss_pred ----------------------CCEEECCCCCCccccChhHhhc-----cc------------hhhhccCCCCCEEECcC
Confidence 4444444444444444443210 00 00123467777777777
Q ss_pred CcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcc
Q 004020 247 NSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVA 326 (779)
Q Consensus 247 N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (779)
|+++..++.+..+++|++|++++|++++ +|..+..+++|++|+|++|++
T Consensus 193 n~l~~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~------------------------------ 241 (328)
T 4fcg_A 193 TGIRSLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTA------------------------------ 241 (328)
T ss_dssp ECCCCCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTT------------------------------
T ss_pred CCcCcchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcc------------------------------
Confidence 7777333346666666666666666663 455566666666665555554
Q ss_pred cCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccCccc
Q 004020 327 CDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNEL 406 (779)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l 406 (779)
.+.+|..|+.+++|++|+|++|++
T Consensus 242 --------------------------------------------------------~~~~p~~~~~l~~L~~L~L~~n~~ 265 (328)
T 4fcg_A 242 --------------------------------------------------------LRNYPPIFGGRAPLKRLILKDCSN 265 (328)
T ss_dssp --------------------------------------------------------CCBCCCCTTCCCCCCEEECTTCTT
T ss_pred --------------------------------------------------------hhhhHHHhcCCCCCCEEECCCCCc
Confidence 445666788899999999999999
Q ss_pred cccCCccCCCCCCCCceeccCCcccccCCC
Q 004020 407 TGTIPKELTTLPSLEMLDVSNNHLFGKVPN 436 (779)
Q Consensus 407 ~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~ 436 (779)
.+.+|..+..+++|++|+|++|++.|.+|.
T Consensus 266 ~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~ 295 (328)
T 4fcg_A 266 LLTLPLDIHRLTQLEKLDLRGCVNLSRLPS 295 (328)
T ss_dssp CCBCCTTGGGCTTCCEEECTTCTTCCCCCG
T ss_pred hhhcchhhhcCCCCCEEeCCCCCchhhccH
Confidence 999999999999999999999999999996
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-26 Score=244.30 Aligned_cols=174 Identities=30% Similarity=0.516 Sum_probs=146.4
Q ss_pred cCC-cccceecccccEEEEEEEEc-----CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC--C
Q 004020 590 NNF-SEENVLGRGGFGTVYKGELH-----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG--N 661 (779)
Q Consensus 590 ~~~-~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~ 661 (779)
++| ++.+.||+|+||.||++.+. +++.||+|++.... .....+.+.+|++++++++||||+++++++.+. .
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 344 88999999999999998653 68899999997653 345567899999999999999999999999874 5
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeec
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 741 (779)
..++||||+++++|.+++... .+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg 179 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFG 179 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGG
T ss_pred eEEEEEecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcc
Confidence 789999999999999998543 37899999999999999999997 899999999999999999999999999
Q ss_pred cceecCCCCCc-ccccccccCCccccccccccc
Q 004020 742 LVRLAPDNGKH-SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 742 ~a~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~ 773 (779)
+++........ .......||+.|+|||++.+.
T Consensus 180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 212 (318)
T 3lxp_A 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 212 (318)
T ss_dssp GCEECCTTCSEEEC---CCCCGGGCCHHHHHHC
T ss_pred ccccccccccccccccCCCCCceeeChHHhcCC
Confidence 99887654322 123345688899999998653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.3e-27 Score=251.62 Aligned_cols=182 Identities=27% Similarity=0.431 Sum_probs=151.6
Q ss_pred hhcCCcccceecccccEEEEEEEEcC------CcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeC
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELHD------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDG 660 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 660 (779)
..++|++.+.||+|+||.||+|.... ...||+|.+.... .....+.+.+|+++++++ +||||+++++++...
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 35789999999999999999998642 2479999987543 344567799999999999 899999999999999
Q ss_pred CeEEEEEEecCCCChhhHhhhcccC---------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC
Q 004020 661 NERLLVYEYMPQGTLSRHLFNRKEE---------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 731 (779)
Q Consensus 661 ~~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~ 731 (779)
+..++||||+++|+|.+++...... ....+++..++.++.||+.||+|||+ .+|+||||||+||+++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECC
Confidence 9999999999999999998764321 12357899999999999999999997 79999999999999999
Q ss_pred CCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 732 DMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 732 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
++.+||+|||+++...............||+.|+|||++.+.
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 241 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC 241 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccC
Confidence 999999999999876544333333445678899999988654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=257.50 Aligned_cols=169 Identities=35% Similarity=0.552 Sum_probs=144.1
Q ss_pred hcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC-eEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN-ERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~ 667 (779)
.++|++.+.||+|+||.||+|... ++.||||+++... ..+++.+|++++++++||||+++++++...+ ..++||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 467899999999999999999876 7899999997543 3467899999999999999999999987765 789999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++|+|.+++..... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 267 e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp ECCTTCBHHHHHHHHCT---TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 99999999999975432 247889999999999999999997 899999999999999999999999999998653
Q ss_pred CCCCcccccccccCCccccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. .....+++.|+|||++.+.
T Consensus 341 ~~-----~~~~~~~~~y~aPE~~~~~ 361 (450)
T 1k9a_A 341 ST-----QDTGKLPVKWTAPEALREK 361 (450)
T ss_dssp -----------CCCTTTSCHHHHHSS
T ss_pred cc-----ccCCCCCcceeCHHHhcCC
Confidence 32 1223578899999998654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.94 E-value=9.3e-27 Score=243.75 Aligned_cols=175 Identities=26% Similarity=0.341 Sum_probs=135.5
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 468999999999999999999874 7899999999765433344444556666688889999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-CcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ-SFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
||++ |+|.+++...... ...+++..++.++.|++.||+|||+ + +|+||||||+||+++.++.+||+|||+++..
T Consensus 86 e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDK-GQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp ECCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred ehhc-cchHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 9997 5888877653322 2368999999999999999999996 5 9999999999999999999999999999876
Q ss_pred CCCCCcccccccccCCccccccccc
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAA 771 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~ 771 (779)
..... .....||+.|+|||++.
T Consensus 161 ~~~~~---~~~~~~t~~y~aPE~~~ 182 (290)
T 3fme_A 161 VDDVA---KDIDAGCKPYMAPERIN 182 (290)
T ss_dssp ------------CCCCCCSCHHHHS
T ss_pred ccccc---ccccCCCccccChhhcC
Confidence 54321 23346999999999973
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.6e-27 Score=243.18 Aligned_cols=172 Identities=33% Similarity=0.579 Sum_probs=147.1
Q ss_pred HhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEe------
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD------ 659 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------ 659 (779)
....+|++.+.||+|+||.||+|+.. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 35568999999999999999999876 79999999987543 346789999999999999999998864
Q ss_pred ----------CCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEE
Q 004020 660 ----------GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 729 (779)
Q Consensus 660 ----------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll 729 (779)
....++||||+++++|.+++..... ..+++..++.++.||+.||+|||+ .+|+||||||+||++
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~ 155 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFL 155 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEE
Confidence 3457899999999999999976532 258899999999999999999996 899999999999999
Q ss_pred cCCCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 730 GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 730 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
++++.+||+|||+++....... .....||+.|+|||++.+.
T Consensus 156 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~ 196 (284)
T 2a19_B 156 VDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQ 196 (284)
T ss_dssp EETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCS
T ss_pred cCCCCEEECcchhheecccccc---ccccCCcccccChhhhccC
Confidence 9999999999999987755322 2345699999999998754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=7.2e-27 Score=252.75 Aligned_cols=173 Identities=27% Similarity=0.404 Sum_probs=148.8
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... .....+.+.+|++++++++||||+++++++..++..++||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 467999999999999999999876 68999999987653 3455678999999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++++|.+++.... .+++..+..++.|++.||+|||+ +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 111 e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp CCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred ECCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--hCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 9999999999986543 47899999999999999999996 2389999999999999999999999999987553
Q ss_pred CCCCcccccccccCCccccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. ......||+.|+|||++.+.
T Consensus 184 ~~----~~~~~~gt~~y~aPE~~~~~ 205 (360)
T 3eqc_A 184 DS----MANSFVGTRSYMSPERLQGT 205 (360)
T ss_dssp HH----C----CCCCTTCCHHHHTTC
T ss_pred cc----cccCCCCCCCeECHHHHcCC
Confidence 21 12345799999999998764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=240.85 Aligned_cols=173 Identities=28% Similarity=0.504 Sum_probs=149.1
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccCh-hHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE-KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
.++|++.+.||+|+||.||+|+.. +++.||+|++....... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 467999999999999999999876 57889999986543211 2346789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 93 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG-----RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp ECCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 99999999999986542 47899999999999999999996 89999999999999999999999999998765
Q ss_pred CCCCCcccccccccCCccccccccccc
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.... .....|++.|+|||++.+.
T Consensus 165 ~~~~----~~~~~~~~~y~aPE~~~~~ 187 (284)
T 2vgo_A 165 PSLR----RRTMCGTLDYLPPEMIEGK 187 (284)
T ss_dssp SSSC----BCCCCSCGGGCCHHHHTTC
T ss_pred cccc----cccccCCCCcCCHHHhccC
Confidence 4321 2345699999999998764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=250.53 Aligned_cols=179 Identities=27% Similarity=0.447 Sum_probs=149.0
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC-----C
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG-----N 661 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~ 661 (779)
+.++|++.+.||+|+||.||+|+.. +++.||+|++.... .....+.+.+|++++++++||||+++++++... .
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 3468999999999999999999865 68899999987532 344557789999999999999999999999765 3
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeec
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 741 (779)
..++||||++ ++|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg 173 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFG 173 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEcccC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCc
Confidence 6899999997 5898888542 48899999999999999999996 899999999999999999999999999
Q ss_pred cceecCCCCCc-ccccccccCCcccccccccccCCCC
Q 004020 742 LVRLAPDNGKH-SIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 742 ~a~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
+++........ .......||+.|+|||++.+...++
T Consensus 174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 210 (364)
T 3qyz_A 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210 (364)
T ss_dssp TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCS
T ss_pred ceEecCCCCCccccccccccccCCCCCHHhcCCCCCC
Confidence 99876543211 1123457999999999987655444
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-26 Score=242.94 Aligned_cols=179 Identities=24% Similarity=0.376 Sum_probs=146.3
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccC--hhHHHHHHHHHHHHHcCCCCccceEeeEEE--eCCe
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS--EKGFAEFKSEIAVLTKVRHRHLVGLLGYCL--DGNE 662 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~ 662 (779)
..++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+.+|++++++++||||+++++++. +.+.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 4578999999999999999999874 6889999999764321 234577999999999999999999999985 3457
Q ss_pred EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecc
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 742 (779)
.++||||++++ +.+++..... ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~ 155 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPE---KRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGV 155 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTT---CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEehhccCC-HHHHHHhCcc---cccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccc
Confidence 89999999876 7777654332 358899999999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCCCcccccccccCCccccccccccc
Q 004020 743 VRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 743 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
++...............||+.|+|||++.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 186 (305)
T 2wtk_C 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGL 186 (305)
T ss_dssp CEECCTTCSSCEECCCCSCGGGCCHHHHTCC
T ss_pred ccccCccccccccccCCCCCCCcChhhccCc
Confidence 9876543332333445699999999998754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-26 Score=240.44 Aligned_cols=170 Identities=35% Similarity=0.654 Sum_probs=142.6
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhH-----HHHHHHHHHHHHcCCCCccceEeeEEEeCCe
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKG-----FAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 662 (779)
.++|++.+.||+|+||.||+|+.. +++.||+|++......... .+++.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 368999999999999999999874 7899999998654322211 167899999999999999999999987655
Q ss_pred EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--cEEcCCCCCCEEEcCCCc-----E
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLGDDMR-----A 735 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~--ivHrDlkp~NIll~~~~~-----~ 735 (779)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+ |+||||||+||+++.++. +
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred -eEEEEecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeE
Confidence 79999999999998885543 358999999999999999999996 67 999999999999988776 9
Q ss_pred EEEeeccceecCCCCCcccccccccCCcccccccccc
Q 004020 736 KVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 736 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
||+|||+++..... .....||+.|+|||++.+
T Consensus 169 kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~ 200 (287)
T 4f0f_A 169 KVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGA 200 (287)
T ss_dssp EECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSC
T ss_pred EeCCCCcccccccc-----ccccCCCccccCchhhcc
Confidence 99999999754331 234579999999999843
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-26 Score=243.26 Aligned_cols=180 Identities=27% Similarity=0.430 Sum_probs=141.2
Q ss_pred hhcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccc-cChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
..++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+++.+|++++++++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 345799999999999999999986 478999999987532 234556789999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||||+++++|.+++...... ...+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 110 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQ-KRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRF 185 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred EEecCCCCCHHHHHHHhccc-ccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence 99999999999998654322 2358899999999999999999996 8999999999999999999999999999886
Q ss_pred cCCCCCcccccccccCCccccccccccc
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
...... ......|++.|+|||++.+.
T Consensus 186 ~~~~~~--~~~~~~~~~~y~aPE~~~~~ 211 (310)
T 2wqm_A 186 FSSKTT--AAHSLVGTPYYMSPERIHEN 211 (310)
T ss_dssp ---------------CCSSCCHHHHTTC
T ss_pred ecCCCc--cccccCCCeeEeChHHhCCC
Confidence 644321 12345689999999998654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=6e-27 Score=260.81 Aligned_cols=174 Identities=32% Similarity=0.524 Sum_probs=142.4
Q ss_pred hcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
.++|++.+.||+|+||.||+|.+..+..||||+++.... ..+++.+|++++++++||||+++++++.+ +..++|||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 467889999999999999999998888999999976542 24678999999999999999999999876 67899999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++|+|.+++..... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 259 ~~~~gsL~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 259 YMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CCTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred hhcCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 9999999999965432 247899999999999999999996 8999999999999999999999999999987654
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. ........+++.|+|||++.+.
T Consensus 333 ~~-~~~~~~~~~~~~y~aPE~~~~~ 356 (452)
T 1fmk_A 333 NE-YTARQGAKFPIKWTAPEAALYG 356 (452)
T ss_dssp -----------CCGGGSCHHHHHHC
T ss_pred Cc-eecccCCcccccccCHhHHhcC
Confidence 32 1222334578899999988654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=6.7e-27 Score=244.61 Aligned_cols=176 Identities=31% Similarity=0.479 Sum_probs=151.0
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
..++|++.+.||+|+||.||+|... ++..||+|++.... ...+++.+|++++++++||||+++++++.+.+..++|
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 3567999999999999999999876 48899999987542 3457789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++++|.+++..... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 88 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EECCTTEEHHHHHHHCCT---TTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEcCCCCcHHHHHHhccc---CCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 999999999999965432 358999999999999999999996 89999999999999999999999999999876
Q ss_pred CCCCCcccccccccCCccccccccccc
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.... ........+|+.|+|||++.+.
T Consensus 162 ~~~~-~~~~~~~~~~~~y~aPE~~~~~ 187 (288)
T 3kfa_A 162 TGDT-YTAHAGAKFPIKWTAPESLAYN 187 (288)
T ss_dssp CSSS-SEEETTEEECGGGCCHHHHHHC
T ss_pred cCCc-cccccCCccccCcCChhhhccC
Confidence 5432 2223345678899999998654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=240.44 Aligned_cols=171 Identities=32% Similarity=0.540 Sum_probs=134.7
Q ss_pred hcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccC--hhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVS--EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
.++|++.+.||+|+||.||+|+.. ++.||+|++...... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 468999999999999999999875 899999998754322 22346789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC---cEEcCCCCCCEEEcC--------CCcE
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS---FIHRDLKPSNILLGD--------DMRA 735 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~---ivHrDlkp~NIll~~--------~~~~ 735 (779)
|||+++++|.+++.. ..+++..++.++.|++.||+|||+ ++ |+||||||+||+++. ++.+
T Consensus 85 ~e~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~ 155 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155 (271)
T ss_dssp EECCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred EEcCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcce
Confidence 999999999998842 258899999999999999999997 56 999999999999986 6789
Q ss_pred EEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 736 KVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 736 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
||+|||+++...... .....||+.|+|||++.+.
T Consensus 156 kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~ 189 (271)
T 3dtc_A 156 KITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRAS 189 (271)
T ss_dssp EECCCCC-----------------CCGGGSCHHHHHHC
T ss_pred EEccCCccccccccc----ccCCCCccceeCHHHhccC
Confidence 999999998664432 2244699999999998654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=243.74 Aligned_cols=177 Identities=31% Similarity=0.474 Sum_probs=143.9
Q ss_pred hcCCcccceecccccEEEEEEEEcC----CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEe-CCeE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHD----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD-GNER 663 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~ 663 (779)
..+|++.+.||+|+||.||+|+..+ ...||+|.+.... .....+.+.+|++++++++||||+++++++.. ++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 3468889999999999999997642 3368999887533 34556789999999999999999999998654 5678
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccc
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 743 (779)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a 175 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLA 175 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred EEEEeCCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECccccc
Confidence 99999999999999985432 257899999999999999999996 89999999999999999999999999999
Q ss_pred eecCCCCCc--ccccccccCCccccccccccc
Q 004020 744 RLAPDNGKH--SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 744 ~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~ 773 (779)
+........ .......||+.|+|||++.+.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 207 (298)
T 3f66_A 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 207 (298)
T ss_dssp CCCSCGGGCBC-----CCBCGGGSCHHHHHHC
T ss_pred ccccccchhccccccCCCCCccccChHHhcCC
Confidence 866443211 122345678899999998654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-26 Score=245.35 Aligned_cols=180 Identities=27% Similarity=0.422 Sum_probs=150.3
Q ss_pred HHHHHHhhcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHc--CCCCccceEeeEEEe
Q 004020 582 IQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTK--VRHRHLVGLLGYCLD 659 (779)
Q Consensus 582 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~ 659 (779)
+.....+.++|++.+.||+|+||.||+|+. +++.||+|++... ....+.+|++++.. ++||||+++++++..
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 344556778999999999999999999987 4899999998643 33567788888887 789999999999988
Q ss_pred CC----eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCCcEEcCCCCCCEEEc
Q 004020 660 GN----ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL-----AHQSFIHRDLKPSNILLG 730 (779)
Q Consensus 660 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-----~~~~ivHrDlkp~NIll~ 730 (779)
.+ ..++||||+++|+|.+++... .+++..++.++.|++.||+|||.. +..+|+||||||+||+++
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 181 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC
T ss_pred cCCccceeEEEEeecCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC
Confidence 76 789999999999999999543 478999999999999999999921 027999999999999999
Q ss_pred CCCcEEEEeeccceecCCCCCcc--cccccccCCccccccccccc
Q 004020 731 DDMRAKVADFGLVRLAPDNGKHS--IETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 731 ~~~~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~ 773 (779)
.++.+||+|||+++......... ......||+.|+|||++.+.
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 226 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 226 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhccc
Confidence 99999999999998765543211 12345799999999998765
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-26 Score=241.60 Aligned_cols=175 Identities=20% Similarity=0.319 Sum_probs=147.8
Q ss_pred hhcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 665 (779)
..++|++.+.||+|+||.||+|+. .+++.||+|++.... ..+.+.+|+++++++ +|++++++++++......++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 356899999999999999999986 578999999986433 224578899999999 79999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCc-----EEEEee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR-----AKVADF 740 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~-----~kl~DF 740 (779)
||||+ +++|.+++.... ..+++..++.++.||+.||+|||+ ++|+||||||+||+++.++. +||+||
T Consensus 84 v~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df 155 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDF 155 (298)
T ss_dssp EEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred EEEec-CCCHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence 99999 999999996542 258999999999999999999996 89999999999999987776 999999
Q ss_pred ccceecCCCCCc-----ccccccccCCcccccccccccC
Q 004020 741 GLVRLAPDNGKH-----SIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 741 G~a~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~ 774 (779)
|+++........ .......||+.|+|||++.+..
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 194 (298)
T 1csn_A 156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE 194 (298)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC
T ss_pred ccccccccccccccccccCccCCCCCcccCCchhhcCCC
Confidence 999876553221 1124457999999999987643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.7e-26 Score=240.90 Aligned_cols=173 Identities=28% Similarity=0.478 Sum_probs=150.1
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.+.|++.+.||+|+||.||+|+.. +++.||+|++..... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 457999999999999999999764 689999999875532 334578999999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 100 e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 100 EYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170 (303)
T ss_dssp ECCTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred EeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecC
Confidence 99999999998843 258899999999999999999996 899999999999999999999999999998765
Q ss_pred CCCCcccccccccCCccccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
... .......||+.|+|||++.+.
T Consensus 171 ~~~--~~~~~~~~~~~y~aPE~~~~~ 194 (303)
T 3a7i_A 171 DTQ--IKRNTFVGTPFWMAPEVIKQS 194 (303)
T ss_dssp TTB--CCBCCCCSCGGGCCHHHHTTC
T ss_pred ccc--cccCccCCCcCccCHHHHhcC
Confidence 432 122345799999999998754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-26 Score=249.73 Aligned_cols=172 Identities=27% Similarity=0.375 Sum_probs=138.7
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC-----
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN----- 661 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 661 (779)
..++|++.+.||+|+||.||+|+.. +++.||||++..........+.+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 3578999999999999999999765 6889999999765555566678899999999999999999999998765
Q ss_pred -eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEee
Q 004020 662 -ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (779)
Q Consensus 662 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF 740 (779)
..++||||+++ +|.+.+.. .+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+||
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Df 171 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 171 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cceEEEEEcCCC-CHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEe
Confidence 68999999975 78777731 37889999999999999999997 89999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccCCccccccccccc
Q 004020 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 741 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
|+++...... ......||+.|+|||++.+.
T Consensus 172 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~ 201 (371)
T 2xrw_A 172 GLARTAGTSF---MMTPYVVTRYYRAPEVILGM 201 (371)
T ss_dssp CC-------------------CTTCCHHHHTTC
T ss_pred eccccccccc---ccCCceecCCccCHHHhcCC
Confidence 9998664321 22345799999999998764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=246.15 Aligned_cols=173 Identities=27% Similarity=0.422 Sum_probs=141.7
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccC------hhHHHHHHHHHHHHHcCCCCccceEeeEEEeC
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS------EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG 660 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 660 (779)
+.++|++.+.||+|+||.||+|+.. +++.||||++...... ......+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4568999999999999999999875 5889999998754321 12234588999999999999999999998765
Q ss_pred CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCc---EEE
Q 004020 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR---AKV 737 (779)
Q Consensus 661 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~---~kl 737 (779)
+ .++||||+++++|.+++... ..+++..++.++.||+.||+|||+ ++|+||||||+||+++.++. +||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEE
T ss_pred c-eEEEEecCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEE
Confidence 5 89999999999999988543 258899999999999999999996 89999999999999987654 999
Q ss_pred EeeccceecCCCCCcccccccccCCcccccccccc
Q 004020 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 738 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
+|||+++..... .......||+.|+|||++.+
T Consensus 159 ~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~ 190 (322)
T 2ycf_A 159 TDFGHSKILGET---SLMRTLCGTPTYLAPEVLVS 190 (322)
T ss_dssp CCCTTCEECCCC---HHHHHHHSCCTTCCHHHHHH
T ss_pred ccCccceecccc---cccccccCCcCccCchhhcc
Confidence 999999876432 12234569999999999853
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.94 E-value=6.8e-27 Score=253.26 Aligned_cols=179 Identities=20% Similarity=0.290 Sum_probs=141.6
Q ss_pred hhcCCcccceecccccEEEEEEEEcC------CcEEEEEEecccccChh---------HHHHHHHHHHHHHcCCCCccce
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELHD------GTKIAVKRMESAVVSEK---------GFAEFKSEIAVLTKVRHRHLVG 652 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~ 652 (779)
..++|++.+.||+|+||.||+|.+.. ++.||+|++........ ....+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999998764 47899999865431100 0123445667778889999999
Q ss_pred EeeEEEeC----CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEE
Q 004020 653 LLGYCLDG----NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 728 (779)
Q Consensus 653 ~~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIl 728 (779)
+++++... ...++||||+ +++|.+++.... ..+++..++.|+.||+.||+|||+ ++|+||||||+|||
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nil 184 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLL 184 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEE
Confidence 99998765 4579999999 999999986532 358999999999999999999997 79999999999999
Q ss_pred Ec--CCCcEEEEeeccceecCCCCCcc-----cccccccCCcccccccccccC
Q 004020 729 LG--DDMRAKVADFGLVRLAPDNGKHS-----IETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 729 l~--~~~~~kl~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~ 774 (779)
++ .++.+||+|||+++.+....... ......||+.|+|||++.+..
T Consensus 185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 237 (364)
T 3op5_A 185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA 237 (364)
T ss_dssp EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC
T ss_pred EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC
Confidence 99 88999999999998765432111 113345999999999987654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-26 Score=239.66 Aligned_cols=175 Identities=25% Similarity=0.435 Sum_probs=145.7
Q ss_pred cCCcccc-eecccccEEEEEEEEc---CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 590 NNFSEEN-VLGRGGFGTVYKGELH---DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 590 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
++|.+.+ .||+|+||.||+|... ++..||+|+++... .....+++.+|++++++++||||+++++++ ..+..++
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 4566666 9999999999999753 57889999997643 345567899999999999999999999999 5567899
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||||+++++|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 87 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEeCCCCCHHHHHHhCC----ccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceee
Confidence 999999999999985432 358999999999999999999996 8999999999999999999999999999987
Q ss_pred cCCCCCcc-cccccccCCccccccccccc
Q 004020 746 APDNGKHS-IETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 746 ~~~~~~~~-~~~~~~gt~~y~APE~l~~~ 773 (779)
........ ......||+.|+|||++.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 188 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFR 188 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHC
T ss_pred eccCcceeeccccccccccccCHHHhccC
Confidence 75432221 12234578999999998643
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.4e-27 Score=248.07 Aligned_cols=176 Identities=31% Similarity=0.488 Sum_probs=137.9
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCc----EEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGT----KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 663 (779)
.++|++.+.||+|+||.||+|++. +++ +||+|.+.... .....+++.+|+.++++++||||+++++++.... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence 367999999999999999999864 444 35777765432 2345578899999999999999999999998765 7
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccc
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 743 (779)
++|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||++
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred eEEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 89999999999999986543 258899999999999999999997 89999999999999999999999999999
Q ss_pred eecCCCCCcccccccccCCccccccccccc
Q 004020 744 RLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+...............||+.|+|||++.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 194 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHR 194 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHC
T ss_pred eEccCccccccccCCCccccccCHHHHcCC
Confidence 876544333333445678899999998754
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=260.71 Aligned_cols=223 Identities=18% Similarity=0.216 Sum_probs=194.2
Q ss_pred CCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCc
Q 004020 109 SGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPG 188 (779)
Q Consensus 109 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~ 188 (779)
..+++|++|+|++|.++.+++..|..+++|++|+|++|.+.+ .+| +..+++|+.|+|++|.|++..+ .++
T Consensus 31 ~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~--l~~l~~L~~L~Ls~N~l~~l~~-------~~~ 100 (487)
T 3oja_A 31 QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-TLD--LESLSTLRTLDLNNNYVQELLV-------GPS 100 (487)
T ss_dssp TTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEE-EEE--CTTCTTCCEEECCSSEEEEEEE-------CTT
T ss_pred ccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCC-Ccc--cccCCCCCEEEecCCcCCCCCC-------CCC
Confidence 456689999999999999999999999999999999999976 333 9999999999999999996542 378
Q ss_pred ccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCC-CCCCCCCCcEEEc
Q 004020 189 LMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSV 267 (779)
Q Consensus 189 L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l 267 (779)
|++|+|++|.|++..+. .+++|+.|+|++|.+++.+| .+..+++|+.|+|
T Consensus 101 L~~L~L~~N~l~~~~~~-----------------------------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 151 (487)
T 3oja_A 101 IETLHAANNNISRVSCS-----------------------------RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151 (487)
T ss_dssp CCEEECCSSCCCCEEEC-----------------------------CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEEC
T ss_pred cCEEECcCCcCCCCCcc-----------------------------ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEEC
Confidence 99999999999965442 35789999999999999877 5888999999999
Q ss_pred cCCccccccChhhh-CCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchh
Q 004020 268 RDNQLTGIVPSSLV-NLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAV 346 (779)
Q Consensus 268 ~~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (779)
++|.|++.+|..+. .+++|+.|+|++|.|++..+..
T Consensus 152 s~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~~------------------------------------------- 188 (487)
T 3oja_A 152 KLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQV------------------------------------------- 188 (487)
T ss_dssp TTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCC-------------------------------------------
T ss_pred CCCCCCCcChHHHhhhCCcccEEecCCCccccccccc-------------------------------------------
Confidence 99999999998887 7999999999999998764321
Q ss_pred cccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccCccccccCCccCCCCCCCCceecc
Q 004020 347 LAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVS 426 (779)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls 426 (779)
..++|+.|+|++|.|++. |..|..+++|+.|+|++|+|++ +|..+..+++|+.|+|+
T Consensus 189 ---------------------~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~ 245 (487)
T 3oja_A 189 ---------------------VFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLR 245 (487)
T ss_dssp ---------------------CCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECT
T ss_pred ---------------------cCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcC
Confidence 123799999999999985 4459999999999999999994 89999999999999999
Q ss_pred CCccc-ccCCC
Q 004020 427 NNHLF-GKVPN 436 (779)
Q Consensus 427 ~N~l~-g~iP~ 436 (779)
+|+++ +.+|.
T Consensus 246 ~N~l~c~~~~~ 256 (487)
T 3oja_A 246 GNGFHCGTLRD 256 (487)
T ss_dssp TCCBCHHHHHH
T ss_pred CCCCcCcchHH
Confidence 99998 66554
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.6e-27 Score=254.49 Aligned_cols=175 Identities=23% Similarity=0.376 Sum_probs=140.8
Q ss_pred hcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCe------
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE------ 662 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------ 662 (779)
..+|++.+.||+|+||.||+|+...+..||+|++..... ...+|+++++.++||||+++++++...+.
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 357999999999999999999988777899998864321 12379999999999999999999965443
Q ss_pred EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEc-CCCcEEEEeec
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFG 741 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~-~~~~~kl~DFG 741 (779)
.++||||++++.+ +.+..... ....+++..+..++.||++||+|||+ .+|+||||||+||+++ .++.+||+|||
T Consensus 113 ~~lv~e~~~~~l~-~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 113 LNLVLEYVPETVY-RASRHYAK-LKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEEECCSEEHH-HHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEeeccCccHH-HHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 7899999987544 33332221 12368899999999999999999997 8999999999999999 79999999999
Q ss_pred cceecCCCCCcccccccccCCcccccccccccCCCC
Q 004020 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 742 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
+|+....... .....||+.|+|||++.+...++
T Consensus 188 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~ 220 (394)
T 4e7w_A 188 SAKILIAGEP---NVSYICSRYYRAPELIFGATNYT 220 (394)
T ss_dssp TCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCC
T ss_pred CcccccCCCC---CcccccCcCccCHHHHcCCCCCC
Confidence 9987644322 23457899999999998766554
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=245.87 Aligned_cols=180 Identities=31% Similarity=0.419 Sum_probs=146.9
Q ss_pred hcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEe----CCeE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD----GNER 663 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~ 663 (779)
.++|++.+.||+|+||.||+|+. .+++.||+|++... .....+.+.+|++++++++||||+++++++.. ....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 46799999999999999999987 57899999998653 34556789999999999999999999999873 3468
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccc
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 743 (779)
++||||+++++|.+++...... ...+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDK-GNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred EEEEEeCCCCcHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 8999999999999998764332 2368999999999999999999997 79999999999999999999999999998
Q ss_pred eecCCCCCcc-------cccccccCCcccccccccccC
Q 004020 744 RLAPDNGKHS-------IETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 744 ~~~~~~~~~~-------~~~~~~gt~~y~APE~l~~~~ 774 (779)
+......... ......||+.|+|||++.+..
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 219 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQS 219 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCS
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCC
Confidence 7653211100 012345799999999987543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-26 Score=239.81 Aligned_cols=175 Identities=29% Similarity=0.366 Sum_probs=149.7
Q ss_pred HhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc---C----hhHHHHHHHHHHHHHcCC-CCccceEeeEE
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV---S----EKGFAEFKSEIAVLTKVR-HRHLVGLLGYC 657 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~----~~~~~~~~~E~~~l~~l~-h~niv~~~~~~ 657 (779)
...++|++.+.||+|+||.||+|+.. +++.||+|++..... . ....+.+.+|+++++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 45678999999999999999999875 689999999865421 1 123456889999999996 99999999999
Q ss_pred EeCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEE
Q 004020 658 LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 737 (779)
Q Consensus 658 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 737 (779)
...+..++||||+++++|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl 165 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKL 165 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEE
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEE
Confidence 99999999999999999999986542 58899999999999999999996 89999999999999999999999
Q ss_pred EeeccceecCCCCCcccccccccCCcccccccccc
Q 004020 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 738 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
+|||+++....... .....||+.|+|||++.+
T Consensus 166 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~ 197 (298)
T 1phk_A 166 TDFGFSCQLDPGEK---LREVCGTPSYLAPEIIEC 197 (298)
T ss_dssp CCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHH
T ss_pred ecccchhhcCCCcc---cccccCCccccCHHHhcc
Confidence 99999987654322 234568999999999863
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-26 Score=245.96 Aligned_cols=177 Identities=27% Similarity=0.481 Sum_probs=141.5
Q ss_pred hcCCcccceecccccEEEEEEEEcC-----CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHD-----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 663 (779)
.++|++.+.||+|+||.||+|+... +..||+|++.... ......++.+|++++++++||||+++++++...+..
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 3578889999999999999997653 2469999987543 344556799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccc
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 743 (779)
++||||+++++|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred EEEEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcc
Confidence 99999999999999986532 258899999999999999999997 79999999999999999999999999999
Q ss_pred eecCCCCCc-ccccccccCCccccccccccc
Q 004020 744 RLAPDNGKH-SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 744 ~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~ 773 (779)
+........ .......+|+.|+|||++.+.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 225 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSC
T ss_pred hhhccccccccccCCCCccccccCchhcccC
Confidence 876543211 112233468899999998654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-27 Score=257.36 Aligned_cols=175 Identities=19% Similarity=0.230 Sum_probs=140.5
Q ss_pred hcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccc-cChhHHHHHHHHH---HHHHcCCCCccceEe-------eE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAV-VSEKGFAEFKSEI---AVLTKVRHRHLVGLL-------GY 656 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~---~~l~~l~h~niv~~~-------~~ 656 (779)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ......+.+.+|+ +.+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46789999999999999999986 469999999997542 2334567889999 455556899999998 66
Q ss_pred EEeCCe-----------------EEEEEEecCCCChhhHhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCc
Q 004020 657 CLDGNE-----------------RLLVYEYMPQGTLSRHLFNRKEEG--LKPLEWTRRLTIALDVARGVEYLHGLAHQSF 717 (779)
Q Consensus 657 ~~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~i 717 (779)
+.+.+. .|+||||+ +|+|.+++....... ...+++..++.|+.||+.||+|||+ ++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 665532 78999999 689999997643211 1234458888999999999999997 799
Q ss_pred EEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 718 IHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 718 vHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+||||||+|||++.++.+||+|||+|+.... ......| +.|+|||++.+.
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~ 277 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARR 277 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhccc
Confidence 9999999999999999999999999986432 2234567 999999999876
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-26 Score=242.86 Aligned_cols=172 Identities=29% Similarity=0.477 Sum_probs=146.3
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
+.++|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 4568999999999999999999875 78999999987543 22335688999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEE---cCCCcEEEEeeccc
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLV 743 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a 743 (779)
|||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||++
T Consensus 85 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~ 156 (304)
T 2jam_A 85 MQLVSGGELFDRILERG-----VYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLS 156 (304)
T ss_dssp ECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTT
T ss_pred EEcCCCccHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcc
Confidence 99999999999886542 47899999999999999999996 899999999999999 78899999999998
Q ss_pred eecCCCCCcccccccccCCccccccccccc
Q 004020 744 RLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+..... ......||+.|+|||++.+.
T Consensus 157 ~~~~~~----~~~~~~~~~~y~aPE~~~~~ 182 (304)
T 2jam_A 157 KMEQNG----IMSTACGTPGYVAPEVLAQK 182 (304)
T ss_dssp CCCCCB----TTHHHHSCCCBCCTTTBSSC
T ss_pred eecCCC----ccccccCCCCccChHHhccC
Confidence 764332 12334689999999998754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-26 Score=240.67 Aligned_cols=176 Identities=27% Similarity=0.405 Sum_probs=143.5
Q ss_pred hcCCcccc-eecccccEEEEEEEEc---CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEE
Q 004020 589 TNNFSEEN-VLGRGGFGTVYKGELH---DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (779)
Q Consensus 589 ~~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 664 (779)
.++|++.+ .||+|+||.||+|... +++.||+|++..........+++.+|+++++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35788877 9999999999999643 468899999976654444567899999999999999999999999 567789
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
+||||+++++|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 94 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEECCTTEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEeCCCCCHHHHHHhCc-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 9999999999999996532 48899999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCcc-cccccccCCccccccccccc
Q 004020 745 LAPDNGKHS-IETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 745 ~~~~~~~~~-~~~~~~gt~~y~APE~l~~~ 773 (779)
......... ......+++.|+|||++.+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 195 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYY 195 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHC
T ss_pred eeccCCCcccccccCCCCceeeChHHhccC
Confidence 765443221 12233567899999998653
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=250.13 Aligned_cols=176 Identities=26% Similarity=0.440 Sum_probs=151.0
Q ss_pred hcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChh---------------HHHHHHHHHHHHHcCCCCccceE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEK---------------GFAEFKSEIAVLTKVRHRHLVGL 653 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~E~~~l~~l~h~niv~~ 653 (779)
.++|++.+.||+|+||.||+|+. +++.||+|++........ ..+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999988 899999999875432211 12789999999999999999999
Q ss_pred eeEEEeCCeEEEEEEecCCCChhhH------hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCE
Q 004020 654 LGYCLDGNERLLVYEYMPQGTLSRH------LFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNI 727 (779)
Q Consensus 654 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NI 727 (779)
++++.+.+..++||||+++++|.++ +... ....+++..++.++.||+.||+|||+ ..+|+||||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN---YTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS---SCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc---cccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhE
Confidence 9999999999999999999999998 4321 12468999999999999999999995 37999999999999
Q ss_pred EEcCCCcEEEEeeccceecCCCCCcccccccccCCcccccccccccC
Q 004020 728 LLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 728 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
+++.++.+||+|||.++..... ......||+.|+|||++.+..
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~ 226 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNES 226 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCC
T ss_pred EEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCC
Confidence 9999999999999999876443 224457999999999998763
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=244.79 Aligned_cols=170 Identities=34% Similarity=0.541 Sum_probs=137.3
Q ss_pred cCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
++|++.+.||+|+||.||+|+.. ++.||+|++... ...+.+.+|++++++++||||+++++++. +..++||||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~ 80 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEY 80 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEEC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEc
Confidence 57889999999999999999875 788999998643 34567899999999999999999999876 447999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCc-EEEEeeccceecCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR-AKVADFGLVRLAPD 748 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~-~kl~DFG~a~~~~~ 748 (779)
+++++|.+++..... ...+++..++.++.|+++||+|||+.+.++|+||||||+||+++.++. +||+|||+++....
T Consensus 81 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 81 AEGGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp CTTCBHHHHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCCCHHHHHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 999999999965432 224788899999999999999999643378999999999999998886 79999999876543
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
. .....||+.|+|||++.+.
T Consensus 159 ~-----~~~~~gt~~y~aPE~~~~~ 178 (307)
T 2eva_A 159 H-----MTNNKGSAAWMAPEVFEGS 178 (307)
T ss_dssp -----------CCTTSSCHHHHTCC
T ss_pred c-----cccCCCCCceEChhhhCCC
Confidence 2 1234699999999998764
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-26 Score=249.94 Aligned_cols=174 Identities=25% Similarity=0.407 Sum_probs=145.9
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeE---
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER--- 663 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--- 663 (779)
+.++|.+.+.||+|+||.||+|... +++.||+|++..........+++.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 4578999999999999999999765 689999999987655566678899999999999999999999999877654
Q ss_pred ---EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEee
Q 004020 664 ---LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (779)
Q Consensus 664 ---~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF 740 (779)
++||||++ ++|.+++. ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Df 188 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDF 188 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECST
T ss_pred eeEEEEEcccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEec
Confidence 99999997 68877762 148899999999999999999997 79999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccCCcccccccccccCCCC
Q 004020 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 741 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
|+++..... .....||+.|+|||++.+...++
T Consensus 189 g~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~ 220 (371)
T 4exu_A 189 GLARHADAE-----MTGYVVTRWYRAPEVILSWMHYN 220 (371)
T ss_dssp TCC-------------CTTCCCTTSCHHHHSCCSCCC
T ss_pred CcccccccC-----cCCcccCccccCHHHhcCCCCCC
Confidence 999865432 23457899999999998754444
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=247.08 Aligned_cols=181 Identities=29% Similarity=0.424 Sum_probs=145.3
Q ss_pred hcCCcccceecccccEEEEEEEE------cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCe
Q 004020 589 TNNFSEENVLGRGGFGTVYKGEL------HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 662 (779)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... ......++.+|+.++++++||||+++++++...+.
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 46899999999999999999973 357789999996443 34556678999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhHhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC---CCcEEE
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEE--GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKV 737 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~~~kl 737 (779)
.++||||+++++|.+++...... ....+++..++.++.||+.||+|||+ .+|+||||||+||+++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999999765421 12358899999999999999999996 89999999999999984 456999
Q ss_pred EeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 738 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+|||+++...............||+.|+|||++.+.
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 220 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG 220 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCC
Confidence 999998765443222223345689999999998654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-26 Score=255.38 Aligned_cols=174 Identities=25% Similarity=0.404 Sum_probs=139.7
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC----C--e
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG----N--E 662 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~--~ 662 (779)
.+|++.+.||+|+||.||+|+.. +++.||||++.... ....+|++++++++||||+++++++... + .
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 36889999999999999999875 68999999986432 1234799999999999999999998642 2 3
Q ss_pred EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCC-CcEEEEeec
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFG 741 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DFG 741 (779)
.++||||+++ ++.+.+..... ....+++..+..++.||++||+|||+ ++|+||||||+|||++.+ +.+||+|||
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEeehhcccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccch
Confidence 5789999975 66666544322 22368999999999999999999996 899999999999999955 678999999
Q ss_pred cceecCCCCCcccccccccCCcccccccccccCCCC
Q 004020 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 742 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
+++....... ....+||+.|+|||++.+...++
T Consensus 203 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~ 235 (420)
T 1j1b_A 203 SAKQLVRGEP---NVSYICSRYYRAPELIFGATDYT 235 (420)
T ss_dssp TCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCC
T ss_pred hhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCC
Confidence 9987654321 23457899999999998765544
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=3.8e-26 Score=243.93 Aligned_cols=170 Identities=19% Similarity=0.344 Sum_probs=145.7
Q ss_pred hcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeEEEe--CCeEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLD--GNERL 664 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~ 664 (779)
.++|++.+.||+|+||.||+|+. .+++.||+|++... ..+.+.+|++++++++ ||||+++++++.+ ....+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 36799999999999999999976 47899999998643 2357889999999997 9999999999998 56789
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC-cEEEEeeccc
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLV 743 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a 743 (779)
+||||+++++|.+++. .+++..+..++.||+.||+|||+ ++|+||||||+||+++.++ .+||+|||++
T Consensus 110 lv~e~~~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a 178 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178 (330)
T ss_dssp EEEECCCCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEeccCchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCc
Confidence 9999999999998872 37888999999999999999996 8999999999999999776 8999999999
Q ss_pred eecCCCCCcccccccccCCcccccccccccCCCC
Q 004020 744 RLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
+....... .....||+.|+|||++.+...++
T Consensus 179 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~ 209 (330)
T 3nsz_A 179 EFYHPGQE---YNVRVASRYFKGPELLVDYQMYD 209 (330)
T ss_dssp EECCTTCC---CCSCCSCGGGCCHHHHTTCCCCC
T ss_pred eEcCCCCc---cccccccccccChhhhcCCCcCC
Confidence 87654322 23457899999999997755444
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-26 Score=247.04 Aligned_cols=170 Identities=32% Similarity=0.510 Sum_probs=135.8
Q ss_pred hcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHH--HHcCCCCccceEeeEEEe-----CC
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAV--LTKVRHRHLVGLLGYCLD-----GN 661 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~-----~~ 661 (779)
.++|++.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++.+.. ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 46899999999999999999976 58999999986432 2333444444 455899999999986543 23
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC---------CcEEcCCCCCCEEEcCC
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ---------SFIHRDLKPSNILLGDD 732 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~---------~ivHrDlkp~NIll~~~ 732 (779)
..++||||+++|+|.+++... ..++..++.++.||+.||+|||+ . +|+||||||+|||++.+
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~ 156 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKND 156 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTT
T ss_pred eEEEEEecCCCCcHHHHHhhc------ccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCC
Confidence 568999999999999999543 24788999999999999999996 5 99999999999999999
Q ss_pred CcEEEEeeccceecCCCCC------cccccccccCCccccccccccc
Q 004020 733 MRAKVADFGLVRLAPDNGK------HSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 733 ~~~kl~DFG~a~~~~~~~~------~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+.+||+|||+++....... ........||+.|+|||++.+.
T Consensus 157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 203 (336)
T 3g2f_A 157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGA 203 (336)
T ss_dssp SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTC
T ss_pred CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCC
Confidence 9999999999987654321 1112345699999999998763
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.1e-27 Score=267.14 Aligned_cols=165 Identities=22% Similarity=0.246 Sum_probs=125.6
Q ss_pred eecccccEEEEEEE-EcCCcEEEEEEeccccc--------ChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEEEE
Q 004020 597 VLGRGGFGTVYKGE-LHDGTKIAVKRMESAVV--------SEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 597 ~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--------~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 666 (779)
..+.|+.|.+..++ ...|+.|++|.+..... .+...++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 46677777777663 44689999999965421 123456799999999999 699999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||++|++|.+++.... +++.. +|+.||+.||+|+|+ +|||||||||+|||++++|++||+|||+|+..
T Consensus 321 MEyv~G~~L~d~i~~~~-----~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE-----EIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EECCCSEEHHHHHHTTC-----CCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EecCCCCcHHHHHHhCC-----CCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 99999999999996542 35543 588999999999996 89999999999999999999999999999876
Q ss_pred CCCCCcccccccccCCcccccccccccC
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
..... .....+||+.|||||++.+..
T Consensus 390 ~~~~~--~~~t~vGTp~YmAPE~l~g~~ 415 (569)
T 4azs_A 390 PQDCS--WPTNLVQSFFVFVNELFAENK 415 (569)
T ss_dssp C---C--CSHHHHHHHHHHHHHHC----
T ss_pred CCCCc--cccCceechhhccHHHhCCCC
Confidence 54322 234567999999999998764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.4e-27 Score=247.17 Aligned_cols=183 Identities=26% Similarity=0.414 Sum_probs=133.0
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
..++|++.+.||+|+||.||+|+.. +++.||+|++..... ....+++.+|++++++++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 3568999999999999999999754 689999999865432 23456788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccc
Q 004020 667 YEYMPQGTLSRHLFNRKEE---GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 743 (779)
|||+++++|.+++...... ....+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999998653211 12358999999999999999999997 89999999999999999999999999998
Q ss_pred eecCCCCCc---ccccccccCCcccccccccccC
Q 004020 744 RLAPDNGKH---SIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 744 ~~~~~~~~~---~~~~~~~gt~~y~APE~l~~~~ 774 (779)
+........ .......||+.|+|||++.+..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 202 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR 202 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHH
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhcccc
Confidence 765432211 1123456999999999987543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.9e-26 Score=241.21 Aligned_cols=174 Identities=31% Similarity=0.457 Sum_probs=144.3
Q ss_pred HhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
...++|++.+.||+|+||.||+|... +++.||+|++.... ..+++.+|++++++++||||+++++++...+..++
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 45678999999999999999999876 58999999986542 33578899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 102 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRN----KTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQ 174 (314)
T ss_dssp EEECCTTEEHHHHHHHHT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EeecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchh
Confidence 999999999999986432 258899999999999999999996 8999999999999999999999999999987
Q ss_pred cCCCCCcccccccccCCccccccccccc
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
...... ......||+.|+|||++.+.
T Consensus 175 ~~~~~~--~~~~~~~~~~y~aPE~~~~~ 200 (314)
T 3com_A 175 LTDTMA--KRNTVIGTPFWMAPEVIQEI 200 (314)
T ss_dssp CBTTBS--CBCCCCSCGGGCCHHHHSSS
T ss_pred hhhhcc--ccCccCCCCCccChhhcCCC
Confidence 654321 22345789999999998764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=251.20 Aligned_cols=175 Identities=30% Similarity=0.480 Sum_probs=134.2
Q ss_pred CCcccceecccccEEEEEEEEc--C--CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEe-CCeEEE
Q 004020 591 NFSEENVLGRGGFGTVYKGELH--D--GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD-GNERLL 665 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~l 665 (779)
.|++.+.||+|+||.||+|+.. + +..||+|.++... .....+++.+|+.++++++||||+++++++.. .+..++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 4677899999999999999764 2 2468999886532 34456789999999999999999999998765 457899
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||||+++|+|.+++.... ..+++..++.++.||++||+|||+ ++|+||||||+||+++.++.+||+|||+++.
T Consensus 169 v~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 241 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARD 241 (373)
T ss_dssp EEECCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEECCCCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccc
Confidence 999999999999985432 247889999999999999999997 8999999999999999999999999999986
Q ss_pred cCCCCCc--ccccccccCCccccccccccc
Q 004020 746 APDNGKH--SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 746 ~~~~~~~--~~~~~~~gt~~y~APE~l~~~ 773 (779)
....... .......+|+.|+|||++.+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 271 (373)
T 3c1x_A 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271 (373)
T ss_dssp ----------------CCGGGSCHHHHHHC
T ss_pred ccccccccccccCCCCCcccccChHHhcCC
Confidence 6433211 112334678899999998654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=244.27 Aligned_cols=173 Identities=25% Similarity=0.432 Sum_probs=143.2
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
..++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+++.+|++++++++||||+++++++...+..++|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 4578999999999999999999876 58999999987543 33457889999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++++|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 95 ~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELD----RGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp EECCTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred EEeCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 99999999999886532 258899999999999999999997 89999999999999999999999999987543
Q ss_pred CCCCCcccccccccCCccccccccc
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAA 771 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~ 771 (779)
... ........||+.|+|||++.
T Consensus 168 ~~~--~~~~~~~~~~~~y~aPE~~~ 190 (302)
T 2j7t_A 168 LKT--LQKRDSFIGTPYWMAPEVVM 190 (302)
T ss_dssp HHH--HHC-----CCGGGCCHHHHH
T ss_pred ccc--ccccccccCChhhcCCeeec
Confidence 211 11123346899999999985
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.8e-26 Score=243.49 Aligned_cols=176 Identities=29% Similarity=0.560 Sum_probs=147.4
Q ss_pred hcCCcccceecccccEEEEEEEE-----cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC--
Q 004020 589 TNNFSEENVLGRGGFGTVYKGEL-----HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN-- 661 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-- 661 (779)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 35789999999999999999984 368899999987542 445678999999999999999999999987654
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeec
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 741 (779)
..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg 190 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFG 190 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred ceEEEEECCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCc
Confidence 6799999999999999996543 258899999999999999999996 899999999999999999999999999
Q ss_pred cceecCCCCCcc-cccccccCCccccccccccc
Q 004020 742 LVRLAPDNGKHS-IETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 742 ~a~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~ 773 (779)
+++......... ......++..|+|||++.+.
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 223 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTES 223 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC
T ss_pred chhhccccccccccccCCCCceeEECchhhcCC
Confidence 998775543221 12334578889999998653
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-26 Score=239.04 Aligned_cols=178 Identities=30% Similarity=0.429 Sum_probs=152.9
Q ss_pred HHHhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeE
Q 004020 585 LRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (779)
Q Consensus 585 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 663 (779)
...+.++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+.+|++++++++||||+++++++...+..
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 4556789999999999999999999876 689999999976654455667899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCC---CcEEEEee
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD---MRAKVADF 740 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~---~~~kl~DF 740 (779)
++||||+++++|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+||+++.+ +.+||+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Df 168 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDF 168 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECST
T ss_pred EEEEEccCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEecc
Confidence 99999999999999886543 58899999999999999999996 899999999999999754 47999999
Q ss_pred ccceecCCCCCcccccccccCCccccccccccc
Q 004020 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 741 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
|+++....... .....||+.|+|||++.+.
T Consensus 169 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~ 198 (287)
T 2wei_A 169 GLSTCFQQNTK---MKDRIGTAYYIAPEVLRGT 198 (287)
T ss_dssp TGGGTBCCCSS---CSCHHHHHTTCCHHHHTTC
T ss_pred CcceeecCCCc---cccccCcccccChHHhcCC
Confidence 99886644321 1234589999999998764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=263.88 Aligned_cols=175 Identities=32% Similarity=0.522 Sum_probs=147.5
Q ss_pred hhcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
..++|++.+.||+|+||.||+|++..+..||||+++.... ..+++.+|++++++++||||+++++++.+ +..++||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 3467889999999999999999998888999999976542 24678999999999999999999999876 6789999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++|+|.+++..... ..+++.+++.++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++...
T Consensus 341 e~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp CCCTTEEHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred ehhcCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 99999999999965432 247899999999999999999996 899999999999999999999999999998654
Q ss_pred CCCCcccccccccCCccccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. .........++..|+|||++.+.
T Consensus 415 ~~-~~~~~~~~~~~~~y~aPE~~~~~ 439 (535)
T 2h8h_A 415 DN-EYTARQGAKFPIKWTAPEAALYG 439 (535)
T ss_dssp CH-HHHTTCSTTSCGGGSCHHHHHHC
T ss_pred CC-ceecccCCcCcccccCHHHhccC
Confidence 32 11112334577899999988653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-26 Score=238.38 Aligned_cols=175 Identities=25% Similarity=0.421 Sum_probs=142.9
Q ss_pred hcCCcccceecccccEEEEEEEEcC----CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHD----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 664 (779)
.++|++.+.||+|+||.||+|+... +..||+|.+.... .....+++.+|++++++++||||+++++++.+ +..+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 4679999999999999999997642 3469999987653 34456789999999999999999999999765 4568
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 89 ~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred EEEecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCc
Confidence 9999999999999986543 257899999999999999999996 899999999999999999999999999998
Q ss_pred ecCCCCCcccccccccCCccccccccccc
Q 004020 745 LAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
....... .......+|+.|+|||++.+.
T Consensus 162 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 189 (281)
T 3cc6_A 162 YIEDEDY-YKASVTRLPIKWMSPESINFR 189 (281)
T ss_dssp CC----------CCCCCGGGCCHHHHHHC
T ss_pred ccccccc-cccccCCCCcceeCchhhccC
Confidence 6644321 122334578899999998644
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-26 Score=240.61 Aligned_cols=175 Identities=28% Similarity=0.428 Sum_probs=144.2
Q ss_pred CCcccceecccccEEEEEEEEcC----CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeE-EE
Q 004020 591 NFSEENVLGRGGFGTVYKGELHD----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER-LL 665 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~l 665 (779)
.|...+.||+|+||.||+|+..+ +..||+|++.... .....+.+.+|++++++++||||+++++++.+.+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 45667999999999999997542 2379999987533 345567899999999999999999999999877665 99
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||||+.+++|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 101 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp EECCCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred EEecccCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 999999999999986532 357899999999999999999996 7999999999999999999999999999986
Q ss_pred cCCCCC--cccccccccCCccccccccccc
Q 004020 746 APDNGK--HSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 746 ~~~~~~--~~~~~~~~gt~~y~APE~l~~~ 773 (779)
...... ........+|+.|+|||++.+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 203 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTY 203 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTC
T ss_pred ccCCcccccccCcCCCCCccccChhhhccC
Confidence 543221 1122345688999999998754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-26 Score=243.31 Aligned_cols=177 Identities=36% Similarity=0.558 Sum_probs=142.7
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEE--EEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKI--AVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~v--avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 665 (779)
++|++.+.||+|+||.||+|+.. ++..+ |+|.+.... .....+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 57999999999999999999765 56544 899886432 234456789999999999 89999999999999999999
Q ss_pred EEEecCCCChhhHhhhccc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCc
Q 004020 666 VYEYMPQGTLSRHLFNRKE-----------EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 734 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 734 (779)
||||+++++|.+++..... .....+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCe
Confidence 9999999999999966431 112368999999999999999999996 89999999999999999999
Q ss_pred EEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 735 AKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 735 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+||+|||+++..... .......+++.|+|||++.+.
T Consensus 181 ~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~ 216 (327)
T 1fvr_A 181 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYS 216 (327)
T ss_dssp EEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHC
T ss_pred EEEcccCcCcccccc---ccccCCCCCccccChhhhccc
Confidence 999999998743221 112234578899999988654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-26 Score=245.20 Aligned_cols=177 Identities=30% Similarity=0.454 Sum_probs=143.9
Q ss_pred HHHhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEe---
Q 004020 585 LRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLD--- 659 (779)
Q Consensus 585 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--- 659 (779)
+....++|++.+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 3445778999999999999999999874 78999999986543 2346788999999999 79999999999987
Q ss_pred ---CCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEE
Q 004020 660 ---GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 736 (779)
Q Consensus 660 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 736 (779)
.+..++||||+++++|.+++..... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEE
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEE
Confidence 4678999999999999999976432 257899999999999999999996 8999999999999999999999
Q ss_pred EEeeccceecCCCCCcccccccccCCcccccccccc
Q 004020 737 VADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 737 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
|+|||+++...... .......||+.|+|||++.+
T Consensus 170 l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~ 203 (326)
T 2x7f_A 170 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIAC 203 (326)
T ss_dssp ECCCTTTC---------------CCGGGCCHHHHC-
T ss_pred EeeCcCceecCcCc--cccccccCCccccChhhhcc
Confidence 99999987654321 11234569999999999863
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-26 Score=242.57 Aligned_cols=175 Identities=22% Similarity=0.348 Sum_probs=144.8
Q ss_pred hhcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCC--CCccceEeeEEEeCCeEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR--HRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~l 665 (779)
..++|++.+.||+|+||.||+|...+++.||+|++..........+.+.+|++++++++ ||||+++++++...+..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 45679999999999999999999888999999999766555666788999999999997 5999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||| +.+++|.+++.... .+++..++.++.||++||+|||+ .+|+||||||+||++++ +.+||+|||+++.
T Consensus 106 v~e-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQ 175 (313)
T ss_dssp EEC-CCSEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred EEe-cCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeecccccc
Confidence 999 56789999986542 57899999999999999999996 79999999999999965 8999999999987
Q ss_pred cCCCCCcccccccccCCcccccccccc
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
..............||+.|+|||++.+
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKD 202 (313)
T ss_dssp --------------CCGGGCCHHHHTT
T ss_pred ccCccccccccCCCCCCCcCCHHHHhh
Confidence 654332222334579999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.8e-26 Score=236.94 Aligned_cols=174 Identities=25% Similarity=0.401 Sum_probs=144.3
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
+|.....||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 4555679999999999999864 68899999987543 33456789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC-CCcEEEEeeccceecCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLVRLAPD 748 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~~~ 748 (779)
+++++|.+++..... ...+++..+..++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||+++....
T Consensus 101 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 101 VPGGSLSALLRSKWG--PLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp CSEEEHHHHHHHTTC--CCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred CCCCCHHHHHHhhcc--CCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 999999999865432 2346788899999999999999996 89999999999999987 89999999999987654
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. .......||+.|+|||++.+.
T Consensus 176 ~~--~~~~~~~~~~~y~aPE~~~~~ 198 (295)
T 2clq_A 176 IN--PCTETFTGTLQYMAPEIIDKG 198 (295)
T ss_dssp -------CCCCCCGGGCCHHHHHHG
T ss_pred CC--CcccccCCCccccChhhhcCC
Confidence 21 112345799999999998654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.5e-26 Score=244.54 Aligned_cols=178 Identities=27% Similarity=0.422 Sum_probs=146.1
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC-----C
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG-----N 661 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~ 661 (779)
+.++|++.+.||+|+||.||+|+.. +++.||||++.... ......++.+|++++++++||||+++++++... .
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 4578999999999999999999876 68999999986432 344556788999999999999999999988754 6
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeec
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 741 (779)
..++||||++ ++|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFG 157 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEeccC-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecc
Confidence 7899999997 6898888542 48899999999999999999997 899999999999999999999999999
Q ss_pred cceecCCCCCcc--------cccccccCCcccccccccccCCC
Q 004020 742 LVRLAPDNGKHS--------IETRLAGTFGYLAPEYAAETSGM 776 (779)
Q Consensus 742 ~a~~~~~~~~~~--------~~~~~~gt~~y~APE~l~~~~~~ 776 (779)
+++......... ......||+.|+|||++.+...+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 200 (353)
T 2b9h_A 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKY 200 (353)
T ss_dssp TCEECC----------------CCCCCCGGGCCHHHHHSCCCC
T ss_pred cccccccccccccCccccccchhhccccccccCCeeeccCCCc
Confidence 998765322111 12235789999999988654443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-26 Score=253.88 Aligned_cols=182 Identities=29% Similarity=0.413 Sum_probs=132.9
Q ss_pred hhcCCcc-cceecccccEEEEEEEEc---CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEe--CC
Q 004020 588 VTNNFSE-ENVLGRGGFGTVYKGELH---DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD--GN 661 (779)
Q Consensus 588 ~~~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~ 661 (779)
+.+.|++ .++||+|+||.||+|+.. +++.||+|++..... ...+.+|++++++++||||+++++++.. ..
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 3455666 458999999999999865 578999999975432 2457899999999999999999999965 66
Q ss_pred eEEEEEEecCCCChhhHhhhcccC----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEE----cCCC
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEE----GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDM 733 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll----~~~~ 733 (779)
..++||||++ ++|.+++...... ....+++..++.|+.||+.||+|||+ .+|+||||||+|||+ +.++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTT
T ss_pred eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCC
Confidence 8899999997 5788777543321 12248899999999999999999997 899999999999999 6778
Q ss_pred cEEEEeeccceecCCCCCc-ccccccccCCcccccccccccCCCC
Q 004020 734 RAKVADFGLVRLAPDNGKH-SIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 734 ~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
.+||+|||+|+........ ......+||+.|+|||++.+...++
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 214 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYT 214 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCccc
Confidence 9999999999876542211 1223467999999999998755444
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.8e-26 Score=245.52 Aligned_cols=174 Identities=25% Similarity=0.404 Sum_probs=145.0
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCe----
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE---- 662 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 662 (779)
+.++|.+.+.||+|+||.||+|+.. +|+.||||++..........+++.+|+.+++.++||||+++++++...+.
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 3468999999999999999999875 68999999997765555566789999999999999999999999987654
Q ss_pred --EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEee
Q 004020 663 --RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (779)
Q Consensus 663 --~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF 740 (779)
.++||||++ ++|.+++. ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Df 170 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDF 170 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECST
T ss_pred eeEEEEecccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeec
Confidence 499999997 58877762 147899999999999999999996 89999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccCCcccccccccccCCCC
Q 004020 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 741 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
|+++..... .....||+.|+|||++.+...++
T Consensus 171 g~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~ 202 (353)
T 3coi_A 171 GLARHADAE-----MTGYVVTRWYRAPEVILSWMHYN 202 (353)
T ss_dssp TCTTC-------------CCSBCCSCHHHHSCCSCCC
T ss_pred ccccCCCCC-----ccccccCcCcCCHHHHhCcCCCC
Confidence 998765332 23457899999999987754443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-26 Score=264.40 Aligned_cols=169 Identities=27% Similarity=0.407 Sum_probs=138.8
Q ss_pred ceecccccEEEEEEEEc---CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCC
Q 004020 596 NVLGRGGFGTVYKGELH---DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 672 (779)
+.||+|+||.||+|.+. +++.||||+++.........+++.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 57999999999999653 46789999998765555567889999999999999999999999864 568899999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCc
Q 004020 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (779)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 752 (779)
|+|.+++.... .+++..++.|+.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 454 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 454 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 99999996432 58899999999999999999997 89999999999999999999999999999876543221
Q ss_pred -ccccccccCCccccccccccc
Q 004020 753 -SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 753 -~~~~~~~gt~~y~APE~l~~~ 773 (779)
.......||+.|+|||++.+.
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~ 547 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYY 547 (635)
T ss_dssp ---------CGGGSCHHHHHHC
T ss_pred cccccCCCCceeeeChhhhcCC
Confidence 222334578899999998654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-26 Score=247.08 Aligned_cols=176 Identities=20% Similarity=0.262 Sum_probs=139.0
Q ss_pred hcCCcccceecccccEEEEEEEEc----CCcEEEEEEecccccCh---------hHHHHHHHHHHHHHcCCCCccceEee
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH----DGTKIAVKRMESAVVSE---------KGFAEFKSEIAVLTKVRHRHLVGLLG 655 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~~~~ 655 (779)
.++|++.+.||+|+||.||+|+.. ++..||+|++....... .....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999875 57889999986543111 01134678899999999999999999
Q ss_pred EEEe----CCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC
Q 004020 656 YCLD----GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 731 (779)
Q Consensus 656 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~ 731 (779)
++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+||+++.
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGY 186 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEES
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEcc
Confidence 9988 67889999999 999999986543 58999999999999999999997 79999999999999998
Q ss_pred CC--cEEEEeeccceecCCCCCc-----ccccccccCCccccccccccc
Q 004020 732 DM--RAKVADFGLVRLAPDNGKH-----SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 732 ~~--~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~ 773 (779)
++ .+||+|||+++........ .......||+.|+|||++.+.
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 235 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV 235 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC
Confidence 77 9999999999876432211 112345799999999998765
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-25 Score=231.89 Aligned_cols=210 Identities=20% Similarity=0.256 Sum_probs=134.7
Q ss_pred EEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEccc
Q 004020 67 VTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145 (779)
Q Consensus 67 v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 145 (779)
+++|++++|++++..+..|..+++|++|+|++|++++.++ .|.++++|++|+|++|+++.+++..|.++++|++|++++
T Consensus 30 l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~ 109 (276)
T 2z62_A 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE 109 (276)
T ss_dssp CCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred ccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCC
Confidence 5555555555554444455555555555555555555444 455555555555555555555555555555555555555
Q ss_pred CCCCCCCCcccccCCCCCceEeccCceeEee-cCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCC
Q 004020 146 NSFDSWVIPESLKDATGLQRFSANGANITGT-IPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDS 224 (779)
Q Consensus 146 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~-~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~ 224 (779)
|++.+ ..+..+..+++|+.|++++|.+++. +|..+. .+++|++|+|++|++++..+..
T Consensus 110 n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~--~l~~L~~L~Ls~N~l~~~~~~~------------------ 168 (276)
T 2z62_A 110 TNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFS--NLTNLEHLDLSSNKIQSIYCTD------------------ 168 (276)
T ss_dssp SCCCC-STTCCCTTCTTCCEEECCSSCCCCCCCCGGGG--GCTTCCEEECCSSCCCEECGGG------------------
T ss_pred CCccc-cCchhcccCCCCCEEECcCCccceecCchhhc--cCCCCCEEECCCCCCCcCCHHH------------------
Confidence 55544 2333455555555555555555542 355544 4555555555555555433333
Q ss_pred CCCCchhhhcCCCCcc-EEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCC
Q 004020 225 KLNGSVAVIQNMTSLT-QLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK 302 (779)
Q Consensus 225 ~~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~ 302 (779)
+..+..++.|. .|+|++|.+++.++......+|+.|++++|++++..+..+..+++|+.|+|++|++++..|.
T Consensus 169 -----~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 242 (276)
T 2z62_A 169 -----LRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 242 (276)
T ss_dssp -----GHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTT
T ss_pred -----hhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCc
Confidence 33344555555 89999999999888766667999999999999987777789999999999999999987664
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.4e-26 Score=262.72 Aligned_cols=174 Identities=24% Similarity=0.429 Sum_probs=139.1
Q ss_pred CCcccc-eecccccEEEEEEEEc---CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 591 NFSEEN-VLGRGGFGTVYKGELH---DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 591 ~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
++.+.+ .||+|+||.||+|.+. ++..||||+++... .....+++.+|++++++++||||+++++++.. +..++|
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 344444 7999999999999764 46679999997653 33456789999999999999999999999976 568999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++|+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 414 ~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp EECCTTCBHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred EEeCCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 99999999999985432 358999999999999999999997 89999999999999999999999999999876
Q ss_pred CCCCCc-ccccccccCCccccccccccc
Q 004020 747 PDNGKH-SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 747 ~~~~~~-~~~~~~~gt~~y~APE~l~~~ 773 (779)
...... .......+++.|+|||++.+.
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~ 514 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFR 514 (613)
T ss_dssp C--------------CCTTSCHHHHHHC
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCC
Confidence 433211 111223467899999998653
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.7e-25 Score=253.41 Aligned_cols=248 Identities=24% Similarity=0.293 Sum_probs=209.9
Q ss_pred CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcc
Q 004020 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 144 (779)
.+++.|+|++|+|+ .+|. .+++|++|+|++|+|+++++ .+++|++|+|++|+++.+|. .+++|++|+|+
T Consensus 61 ~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~l~~l~~----~l~~L~~L~L~ 129 (622)
T 3g06_A 61 AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTSLPV---LPPGLLELSIFSNPLTHLPA----LPSGLCKLWIF 129 (622)
T ss_dssp TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSCCCC---CCTTCCEEEECSCCCCCCCC----CCTTCCEEECC
T ss_pred CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCcCCC---CCCCCCEEECcCCcCCCCCC----CCCCcCEEECC
Confidence 47999999999999 5666 67999999999999997655 78999999999999999987 57899999999
Q ss_pred cCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCC
Q 004020 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDS 224 (779)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~ 224 (779)
+|+|.. +|.. +++|++|++++|++++ +|.. +++|+.|+|++|+|++ +|.. ..+|+.|++++|.+..
T Consensus 130 ~N~l~~--lp~~---l~~L~~L~Ls~N~l~~-l~~~-----~~~L~~L~L~~N~l~~-l~~~--~~~L~~L~Ls~N~l~~ 195 (622)
T 3g06_A 130 GNQLTS--LPVL---PPGLQELSVSDNQLAS-LPAL-----PSELCKLWAYNNQLTS-LPML--PSGLQELSVSDNQLAS 195 (622)
T ss_dssp SSCCSC--CCCC---CTTCCEEECCSSCCSC-CCCC-----CTTCCEEECCSSCCSC-CCCC--CTTCCEEECCSSCCSC
T ss_pred CCCCCc--CCCC---CCCCCEEECcCCcCCC-cCCc-----cCCCCEEECCCCCCCC-Cccc--CCCCcEEECCCCCCCC
Confidence 999986 5554 4899999999999985 5543 5689999999999995 6632 2679999999999876
Q ss_pred CCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCCC
Q 004020 225 KLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFN 304 (779)
Q Consensus 225 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~ 304 (779)
... .+++|+.|++++|.++..++. +++|+.|++++|+|++ +| ..+++|+.|+|++|+|++. |.
T Consensus 196 l~~-------~~~~L~~L~L~~N~l~~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~l-p~-- 258 (622)
T 3g06_A 196 LPT-------LPSELYKLWAYNNRLTSLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTSL-PM-- 258 (622)
T ss_dssp CCC-------CCTTCCEEECCSSCCSSCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCC-CC--
T ss_pred CCC-------ccchhhEEECcCCcccccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCcC-Cc--
Confidence 332 358899999999999965532 4889999999999996 66 5668999999999999843 32
Q ss_pred CCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccc
Q 004020 305 SPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG 384 (779)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g 384 (779)
..++|+.|+|++|+|+
T Consensus 259 ---------------------------------------------------------------~~~~L~~L~Ls~N~L~- 274 (622)
T 3g06_A 259 ---------------------------------------------------------------LPSGLLSLSVYRNQLT- 274 (622)
T ss_dssp ---------------------------------------------------------------CCTTCCEEECCSSCCC-
T ss_pred ---------------------------------------------------------------ccccCcEEeCCCCCCC-
Confidence 1137999999999999
Q ss_pred cccccccccccCCeEeccCccccccCCccCCCCC
Q 004020 385 TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLP 418 (779)
Q Consensus 385 ~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~ 418 (779)
.+|..|.++++|+.|+|++|.|+|.+|..+..++
T Consensus 275 ~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 275 RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 7899999999999999999999999998776655
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.3e-26 Score=241.90 Aligned_cols=174 Identities=29% Similarity=0.366 Sum_probs=130.2
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeEEEe--------
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLD-------- 659 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~-------- 659 (779)
.+|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++++. ||||+++++++..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc--hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 47899999999999999999865 78999999985442 445577899999999996 9999999999953
Q ss_pred CCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--cEEcCCCCCCEEEcCCCcEEE
Q 004020 660 GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLGDDMRAKV 737 (779)
Q Consensus 660 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~--ivHrDlkp~NIll~~~~~~kl 737 (779)
....++||||+. |+|.+++...... ..+++..++.++.||+.||+|||+ .+ |+||||||+||+++.++.+||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESR--GPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTT--CSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred CceEEEEEEecC-CCHHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEE
Confidence 334789999996 7999988654322 258999999999999999999996 67 999999999999999999999
Q ss_pred EeeccceecCCCCCcc----------cccccccCCccccccccc
Q 004020 738 ADFGLVRLAPDNGKHS----------IETRLAGTFGYLAPEYAA 771 (779)
Q Consensus 738 ~DFG~a~~~~~~~~~~----------~~~~~~gt~~y~APE~l~ 771 (779)
+|||+++......... ......||+.|+|||++.
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 223 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIID 223 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhh
Confidence 9999998765432211 111346899999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=247.61 Aligned_cols=172 Identities=24% Similarity=0.306 Sum_probs=145.3
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcC------CCCccceEeeEEEeC
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV------RHRHLVGLLGYCLDG 660 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~ 660 (779)
+..+|++.+.||+|+||.||+|... +++.||||++... .....++.+|+++++.+ .|+||+++++++...
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 4568999999999999999999765 5899999998753 33445677888888877 577999999999999
Q ss_pred CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCc--EEEE
Q 004020 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR--AKVA 738 (779)
Q Consensus 661 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~--~kl~ 738 (779)
+..++||||+. ++|.+++..... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++. +||+
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~ 244 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKF---QGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVI 244 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEEC
T ss_pred CeEEEEEeccC-CCHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEe
Confidence 99999999996 689988865432 248999999999999999999996 79999999999999999887 9999
Q ss_pred eeccceecCCCCCcccccccccCCcccccccccccC
Q 004020 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 739 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
|||+++..... ....+||+.|+|||++.+..
T Consensus 245 DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~ 275 (429)
T 3kvw_A 245 DFGSSCYEHQR-----VYTYIQSRFYRAPEVILGAR 275 (429)
T ss_dssp CCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBC
T ss_pred ecccceecCCc-----ccccCCCCCccChHHHhCCC
Confidence 99999765432 23457999999999987653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.93 E-value=8.2e-26 Score=240.86 Aligned_cols=177 Identities=29% Similarity=0.427 Sum_probs=144.6
Q ss_pred hhcCCcccceecccccEEEEEEEE--cCCcEEEEEEecccccChhHHHHHHHHHHHHHcC---CCCccceEeeEEE----
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGEL--HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV---RHRHLVGLLGYCL---- 658 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~---- 658 (779)
..++|++.+.||+|+||.||+|+. .+++.||+|++............+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999987 3688999999875543332233566777777666 8999999999987
Q ss_pred -eCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEE
Q 004020 659 -DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 737 (779)
Q Consensus 659 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 737 (779)
.....++||||++ |+|.+++..... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl 161 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKL 161 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEE
Confidence 4567899999998 699999865432 248899999999999999999996 89999999999999999999999
Q ss_pred EeeccceecCCCCCcccccccccCCcccccccccccC
Q 004020 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 738 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
+|||+++..... .......||+.|+|||++.+..
T Consensus 162 ~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~ 195 (326)
T 1blx_A 162 ADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSS 195 (326)
T ss_dssp CSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCC
T ss_pred ecCcccccccCC---CCccccccccceeCHHHHhcCC
Confidence 999998765432 1234457899999999987643
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=238.70 Aligned_cols=178 Identities=24% Similarity=0.396 Sum_probs=139.4
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEE--------
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCL-------- 658 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-------- 658 (779)
+.++|++.+.||+|+||.||+|... +++.||+|++... .....+++.+|++++++++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 4578999999999999999999876 5899999998654 3455678999999999999999999999874
Q ss_pred ------eCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEc-C
Q 004020 659 ------DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-D 731 (779)
Q Consensus 659 ------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~-~ 731 (779)
..+..++||||++ |+|.+++.. ..+++..++.++.|++.||+|||+ ++|+||||||+||+++ +
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~ 156 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTE 156 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETT
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCC
Confidence 3467899999997 699998843 247899999999999999999996 8999999999999997 5
Q ss_pred CCcEEEEeeccceecCCCCC-cccccccccCCcccccccccccCCCC
Q 004020 732 DMRAKVADFGLVRLAPDNGK-HSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 732 ~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
++.+||+|||+++....... ........||+.|+|||++.+...++
T Consensus 157 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 203 (320)
T 2i6l_A 157 DLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYT 203 (320)
T ss_dssp TTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCC
T ss_pred CCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCC
Confidence 67999999999987643211 11123346799999999987644433
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.1e-26 Score=264.77 Aligned_cols=167 Identities=24% Similarity=0.397 Sum_probs=142.6
Q ss_pred hcCCcccceecccccEEEEEEEEc--CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCe----
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH--DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE---- 662 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 662 (779)
.++|++.+.||+|+||.||+|.+. +++.||||++.... .......+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 478999999999999999999875 58999999986532 34455678999999999999999999999987665
Q ss_pred -EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeec
Q 004020 663 -RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (779)
Q Consensus 663 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 741 (779)
.|+||||+++++|.+++.. .+++.+++.|+.||+.||+|||+ ++|+||||||+||+++.+ .+||+|||
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp EEEEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCT
T ss_pred eeEEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecc
Confidence 6999999999999887632 48899999999999999999997 899999999999999875 89999999
Q ss_pred cceecCCCCCcccccccccCCccccccccccc
Q 004020 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 742 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+++..... ....||+.|+|||++.+.
T Consensus 227 ~a~~~~~~------~~~~gt~~y~aPE~~~~~ 252 (681)
T 2pzi_A 227 AVSRINSF------GYLYGTPGFQAPEIVRTG 252 (681)
T ss_dssp TCEETTCC------SCCCCCTTTSCTTHHHHC
T ss_pred cchhcccC------CccCCCccccCHHHHcCC
Confidence 99876543 335699999999998754
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.2e-26 Score=244.45 Aligned_cols=186 Identities=25% Similarity=0.306 Sum_probs=136.7
Q ss_pred HHHHHhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC
Q 004020 583 QVLRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN 661 (779)
Q Consensus 583 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 661 (779)
.......++|++.+.||+|+||.||+|+.. +++.||||++.... ....++.+|++.++.++||||+++++++...+
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 345566789999999999999999999875 68999999885432 22235667888889999999999999997644
Q ss_pred e-------EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC-CC
Q 004020 662 E-------RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DM 733 (779)
Q Consensus 662 ~-------~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-~~ 733 (779)
. .++||||+++ ++.+.+..... ....+++..+..++.|++.||.|||.. ..+|+||||||+||+++. ++
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTT
T ss_pred cccccceeEEEEeecccc-cHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCC
Confidence 3 7899999986 55554433222 223578899999999999999999921 289999999999999996 89
Q ss_pred cEEEEeeccceecCCCCCcccccccccCCcccccccccccCCCC
Q 004020 734 RAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 734 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
.+||+|||+++....... .....||+.|+|||++.+...++
T Consensus 170 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~ 210 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYT 210 (360)
T ss_dssp EEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCC
T ss_pred cEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCC
Confidence 999999999987654322 23457899999999997765444
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.7e-26 Score=245.59 Aligned_cols=170 Identities=11% Similarity=0.072 Sum_probs=126.6
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcC--CCCccceEe-------eEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKV--RHRHLVGLL-------GYCL 658 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l--~h~niv~~~-------~~~~ 658 (779)
.+|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45889999999999999999865 789999999987553 234456677885544444 699988755 4554
Q ss_pred eC-----------------CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHH------HHHHHHHHHHHHHHHcCCCC
Q 004020 659 DG-----------------NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRR------LTIALDVARGVEYLHGLAHQ 715 (779)
Q Consensus 659 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~------~~i~~qi~~~L~~LH~~~~~ 715 (779)
.. ...|+||||++ |+|.+++..... .+++..+ ..++.||+.||+|||+ +
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~ 213 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF----VYVFRGDEGILALHILTAQLIRLAANLQS---K 213 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHHHHH---T
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc----ccchhhhhhhhhHHHHHHHHHHHHHHHHH---C
Confidence 33 23799999998 899999976532 2344445 6788999999999996 8
Q ss_pred CcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCcccccccccCCcccccccccc
Q 004020 716 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 716 ~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
+|+||||||+|||++.++.+||+|||+|+..... .....+|+.|+|||++.+
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~ 265 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNA 265 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTC
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccC
Confidence 9999999999999999999999999999876432 113457799999999975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.2e-26 Score=236.57 Aligned_cols=169 Identities=35% Similarity=0.545 Sum_probs=137.3
Q ss_pred hcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC-CeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG-NERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~ 667 (779)
.++|++.+.||+|+||.||+|+.. ++.||+|++.... ..+.+.+|++++++++||||+++++++... +..++||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 467999999999999999999875 8899999987542 446789999999999999999999997655 4689999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++++|.+++..... ..+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 95 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CCCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred ecCCCCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 99999999999865432 137889999999999999999996 899999999999999999999999999987654
Q ss_pred CCCCcccccccccCCccccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
... ....+++.|+|||++.+.
T Consensus 169 ~~~-----~~~~~~~~y~aPE~~~~~ 189 (278)
T 1byg_A 169 STQ-----DTGKLPVKWTAPEALREK 189 (278)
T ss_dssp ------------CCTTTSCHHHHHHC
T ss_pred ccc-----cCCCccccccCHHHhCCC
Confidence 321 223578999999998654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.7e-26 Score=246.26 Aligned_cols=171 Identities=16% Similarity=0.286 Sum_probs=141.9
Q ss_pred hcCCcccceecccccEEEEEEEEcC---------CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccce-------
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHD---------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVG------- 652 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------- 652 (779)
.++|++.+.||+|+||.||+|+... ++.||+|++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 3689999999999999999998763 789999998643 35789999999999999987
Q ss_pred --------EeeEEEe-CCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCC
Q 004020 653 --------LLGYCLD-GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLK 723 (779)
Q Consensus 653 --------~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlk 723 (779)
+++++.. .+..++||||+ +++|.+++..... ..+++..++.++.||+.||+|||+ ++|+|||||
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dik 186 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK---HVLSERSVLQVACRLLDALEFLHE---NEYVHGNVT 186 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCC
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc---CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCC
Confidence 6777776 67889999999 9999999976422 258999999999999999999997 799999999
Q ss_pred CCCEEEcCCC--cEEEEeeccceecCCCCCc-----ccccccccCCccccccccccc
Q 004020 724 PSNILLGDDM--RAKVADFGLVRLAPDNGKH-----SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 724 p~NIll~~~~--~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~ 773 (779)
|+||+++.++ .+||+|||+++........ .......||+.|+|||++.+.
T Consensus 187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 243 (352)
T 2jii_A 187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC 243 (352)
T ss_dssp GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC
T ss_pred HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC
Confidence 9999999998 8999999999866432211 112334799999999998764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.4e-26 Score=236.22 Aligned_cols=177 Identities=32% Similarity=0.521 Sum_probs=137.0
Q ss_pred hcCCcccceecccccEEEEEEEEc--CCc--EEEEEEecccccC-hhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH--DGT--KIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 663 (779)
.++|++.+.||+|+||.||+|++. +++ .||+|+++..... ....+++.+|++++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357999999999999999999753 233 6899998765422 345678999999999999999999999998765 8
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccc
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 743 (779)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eeeEecccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccccc
Confidence 89999999999999987643 257899999999999999999996 89999999999999999999999999999
Q ss_pred eecCCCCCcc-cccccccCCccccccccccc
Q 004020 744 RLAPDNGKHS-IETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 744 ~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~ 773 (779)
+......... ......+|+.|+|||++.+.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 199 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHC
T ss_pred ccccccccchhhhccCCCCceeeCchhhcCC
Confidence 8775543221 22334678899999998653
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=239.57 Aligned_cols=175 Identities=27% Similarity=0.361 Sum_probs=128.0
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHH-HHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIA-VLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
.++|++.+.||+|+||.||+|... +++.||+|++.... ......++.+|+. +++.++||||+++++++...+..++|
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 368899999999999999999875 78999999997653 2334455566666 77778999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-CcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ-SFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
|||+++ +|.+++..........+++..+..++.|++.||.|||+ . +|+||||||+||+++.++.+||+|||+++.
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999985 88877754332223468999999999999999999996 6 999999999999999999999999999987
Q ss_pred cCCCCCcccccccccCCccccccccc
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAA 771 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~ 771 (779)
..... ......||+.|+|||++.
T Consensus 176 ~~~~~---~~~~~~gt~~y~aPE~~~ 198 (327)
T 3aln_A 176 LVDSI---AKTRDAGCRPYMAPERID 198 (327)
T ss_dssp --------------------------
T ss_pred ccccc---ccccCCCCccccCceeec
Confidence 64432 123346999999999984
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7e-25 Score=227.75 Aligned_cols=174 Identities=21% Similarity=0.238 Sum_probs=110.6
Q ss_pred EEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCC
Q 004020 70 IQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSF 148 (779)
Q Consensus 70 l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 148 (779)
++..+.+++ .+|..+. ++|++|+|++|++++.++ .|.++++|++|+|++|+++.+++..|.++++|++|+|++|++
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 88 (276)
T 2z62_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (276)
T ss_dssp EECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCcc
Confidence 344455555 5666554 478888888888887776 788888888888888888887777777777777777777776
Q ss_pred CCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCC
Q 004020 149 DSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNG 228 (779)
Q Consensus 149 ~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~ 228 (779)
.+ ..++.+. .+++|++|++++|++++..+..++
T Consensus 89 ~~-------------------------~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~-------------------- 121 (276)
T 2z62_A 89 QS-------------------------LALGAFS--GLSSLQKLVAVETNLASLENFPIG-------------------- 121 (276)
T ss_dssp CE-------------------------ECTTTTT--TCTTCCEEECTTSCCCCSTTCCCT--------------------
T ss_pred Cc-------------------------cChhhhc--CCccccEEECCCCCccccCchhcc--------------------
Confidence 43 3334443 455666666666666543333332
Q ss_pred chhhhcCCCCccEEEeecCcccCC-CC-CCCCCCCCcEEEccCCccccccChhhhCCCCCC----EEEccCcccccc
Q 004020 229 SVAVIQNMTSLTQLWLHGNSFTGP-LP-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLA----VVNLTNNLFQGQ 299 (779)
Q Consensus 229 ~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~----~L~Ls~N~l~g~ 299 (779)
.+++|++|+|++|.+++. +| .+..+++|++|++++|++++..+..+..+++|+ .|++++|++++.
T Consensus 122 ------~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~ 192 (276)
T 2z62_A 122 ------HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFI 192 (276)
T ss_dssp ------TCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEE
T ss_pred ------cCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCccccc
Confidence 456666666666666552 23 355666666666666666655555665555555 556666655543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.6e-26 Score=241.22 Aligned_cols=179 Identities=28% Similarity=0.378 Sum_probs=140.6
Q ss_pred HHHhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccCh----hHHHHHHHHHHHHHcC----CCCccceEee
Q 004020 585 LRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE----KGFAEFKSEIAVLTKV----RHRHLVGLLG 655 (779)
Q Consensus 585 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l----~h~niv~~~~ 655 (779)
.....++|++.+.||+|+||.||+|+.. +++.||+|++....... .....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3445678999999999999999999764 68899999997543222 1223466799999998 8999999999
Q ss_pred EEEeCCeEEEEEEe-cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEc-CCC
Q 004020 656 YCLDGNERLLVYEY-MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DDM 733 (779)
Q Consensus 656 ~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~-~~~ 733 (779)
++...+..++|||| +.+++|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+||+++ .++
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKG-----PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTT
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCC
Confidence 99999999999999 78999999986542 48899999999999999999996 7999999999999999 889
Q ss_pred cEEEEeeccceecCCCCCcccccccccCCcccccccccccCC
Q 004020 734 RAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 734 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
.+||+|||+++...... .....||+.|+|||++.+...
T Consensus 178 ~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~ 215 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQY 215 (312)
T ss_dssp EEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCB
T ss_pred eEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCC
Confidence 99999999998765432 234569999999999876543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=5.3e-26 Score=241.59 Aligned_cols=179 Identities=26% Similarity=0.358 Sum_probs=149.3
Q ss_pred HHHhhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccCh----hHHHHHHHHHHHHHcCC--CCccceEeeEE
Q 004020 585 LRNVTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE----KGFAEFKSEIAVLTKVR--HRHLVGLLGYC 657 (779)
Q Consensus 585 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~niv~~~~~~ 657 (779)
.....++|++.+.||+|+||.||+|+.. +++.||+|++....... ...+.+.+|+.++++++ ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 3446678999999999999999999764 68999999997654322 12245678999999996 59999999999
Q ss_pred EeCCeEEEEEEecCC-CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEc-CCCcE
Q 004020 658 LDGNERLLVYEYMPQ-GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMRA 735 (779)
Q Consensus 658 ~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~-~~~~~ 735 (779)
...+..++||||+.+ ++|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+||+++ +++.+
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEE
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCE
Confidence 999999999999986 89999986542 57899999999999999999996 8999999999999999 78999
Q ss_pred EEEeeccceecCCCCCcccccccccCCcccccccccccCC
Q 004020 736 KVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSG 775 (779)
Q Consensus 736 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 775 (779)
||+|||+++...... .....||+.|+|||++.+...
T Consensus 190 kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~ 225 (320)
T 3a99_A 190 KLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRY 225 (320)
T ss_dssp EECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCB
T ss_pred EEeeCcccccccccc----ccCCCCCccCCChHHhccCCC
Confidence 999999998765431 234569999999999876543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-25 Score=231.74 Aligned_cols=181 Identities=22% Similarity=0.275 Sum_probs=90.1
Q ss_pred ccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCc
Q 004020 85 LNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQ 164 (779)
Q Consensus 85 l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~ 164 (779)
+..+++|+.|++++|.++. ++.+..+++|++|+|++|++++++ .+..+++|++|+|++|++.+ ..+..|.++++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-~~~l~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~ 112 (272)
T 3rfs_A 37 QNELNSIDQIIANNSDIKS-VQGIQYLPNVRYLALGGNKLHDIS--ALKELTNLTYLILTGNQLQS-LPNGVFDKLTNLK 112 (272)
T ss_dssp HHHHTTCCEEECTTSCCCC-CTTGGGCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCC
T ss_pred cccccceeeeeeCCCCccc-ccccccCCCCcEEECCCCCCCCch--hhcCCCCCCEEECCCCccCc-cChhHhcCCcCCC
Confidence 3344555555555555542 234555555555555555555542 34555555555555555543 3333344444444
Q ss_pred eEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEe
Q 004020 165 RFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWL 244 (779)
Q Consensus 165 ~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L 244 (779)
+|++++|++++..+..+. .+++|++|+|++|++++..+..++ .+++|+.|+|
T Consensus 113 ~L~L~~n~l~~~~~~~~~--~l~~L~~L~L~~n~l~~~~~~~~~--------------------------~l~~L~~L~l 164 (272)
T 3rfs_A 113 ELVLVENQLQSLPDGVFD--KLTNLTYLNLAHNQLQSLPKGVFD--------------------------KLTNLTELDL 164 (272)
T ss_dssp EEECTTSCCCCCCTTTTT--TCTTCCEEECCSSCCCCCCTTTTT--------------------------TCTTCCEEEC
T ss_pred EEECCCCcCCccCHHHhc--cCCCCCEEECCCCccCccCHHHhc--------------------------cCccCCEEEC
Confidence 444444444444444343 345555555555555533333222 3455555555
Q ss_pred ecCcccCCCCC-CCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCcccc
Q 004020 245 HGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297 (779)
Q Consensus 245 ~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 297 (779)
++|++++.++. +..+++|++|++++|++++..|..+..+++|+.|+|++|++.
T Consensus 165 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 218 (272)
T 3rfs_A 165 SYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD 218 (272)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcc
Confidence 55555554443 445555555555555555544444555555555555555443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-25 Score=233.98 Aligned_cols=176 Identities=23% Similarity=0.396 Sum_probs=140.3
Q ss_pred HhhcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEE-EeCCeEE
Q 004020 587 NVTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC-LDGNERL 664 (779)
Q Consensus 587 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~ 664 (779)
.+.++|++.+.||+|+||.||+|+. .+++.||+|++.... ...++.+|+++++.++|++++..+.++ ...+..+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc----cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 3567899999999999999999986 578999999865433 223578899999999988777666555 6677889
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEE---cCCCcEEEEeec
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFG 741 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DFG 741 (779)
+||||+ +++|.+++.... ..+++..++.++.||+.||+|||+ ++|+||||||+||++ ++++.+||+|||
T Consensus 82 lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg 153 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp EEEECC-CCBHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred EEEEcc-CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCc
Confidence 999999 899999986432 258999999999999999999997 899999999999999 788999999999
Q ss_pred cceecCCCCCc-----ccccccccCCcccccccccccC
Q 004020 742 LVRLAPDNGKH-----SIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 742 ~a~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~ 774 (779)
+++........ .......||+.|+|||++.+..
T Consensus 154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 191 (296)
T 4hgt_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE 191 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC
T ss_pred cceeccCcccCccCCCCcccccCCCccccchHHhcCCC
Confidence 99876553221 1123457999999999987653
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.8e-25 Score=236.91 Aligned_cols=171 Identities=25% Similarity=0.392 Sum_probs=145.2
Q ss_pred hhcCCcccceecccccEEEEEEEE--cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCC------ccceEeeEEEe
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGEL--HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR------HLVGLLGYCLD 659 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~ 659 (779)
+.++|++.+.||+|+||.||+|.. .+++.||+|+++.. ....+.+.+|+++++.++|+ +|+++++++..
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 456899999999999999999986 36889999998643 34456788999999988765 49999999999
Q ss_pred CCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC--------
Q 004020 660 GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-------- 731 (779)
Q Consensus 660 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-------- 731 (779)
.+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKENGF---LPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC
T ss_pred CCcEEEEEcCC-CCCHHHHHHhcCC---CCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccC
Confidence 99999999999 8899999865432 357899999999999999999997 89999999999999987
Q ss_pred -----------CCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 732 -----------DMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 732 -----------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
++.+||+|||+++..... .....||+.|+|||++.+.
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~ 209 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILAL 209 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTS
T ss_pred CccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCC
Confidence 668999999999875432 2345799999999998764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-25 Score=232.45 Aligned_cols=175 Identities=23% Similarity=0.397 Sum_probs=144.0
Q ss_pred hhcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEE-EeCCeEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYC-LDGNERLL 665 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~l 665 (779)
+.++|++.+.||+|+||.||+|+. .+++.||+|++..... .+++.+|+++++.++|++++..+.++ ...+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 457899999999999999999986 5789999999865432 23588999999999988866665555 56678899
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEE---cCCCcEEEEeecc
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGL 742 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DFG~ 742 (779)
||||+ +++|.+++.... ..+++..++.++.||+.||+|||+ ++|+||||||+||++ ++++.+||+|||+
T Consensus 83 v~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 154 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred EEEec-CCCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence 99999 899999986432 258999999999999999999996 899999999999999 4888999999999
Q ss_pred ceecCCCCCcc-----cccccccCCcccccccccccC
Q 004020 743 VRLAPDNGKHS-----IETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 743 a~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~ 774 (779)
++......... ......||+.|+|||++.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 191 (296)
T 3uzp_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE 191 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC
T ss_pred cccccccccccccccccccccccccccCChhhhcCCC
Confidence 98765542211 123457999999999987653
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-25 Score=258.93 Aligned_cols=176 Identities=24% Similarity=0.388 Sum_probs=143.7
Q ss_pred hhcCCcccceecccccEEEEEEEEc----CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH----DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 663 (779)
..++|++.+.||+|+||.||+|.+. .+..||+|++.... .....+.+.+|+.++++++||||+++++++. .+..
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 3567999999999999999999864 25679999886533 3445578999999999999999999999984 4668
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccc
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 743 (779)
++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred EEEEEcCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCC
Confidence 99999999999999986542 258899999999999999999997 89999999999999999999999999999
Q ss_pred eecCCCCCcccccccccCCccccccccccc
Q 004020 744 RLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+....... .......+|+.|+|||++.+.
T Consensus 539 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~ 567 (656)
T 2j0j_A 539 RYMEDSTY-YKASKGKLPIKWMAPESINFR 567 (656)
T ss_dssp CSCCC-----------CCGGGCCHHHHHHC
T ss_pred eecCCCcc-eeccCCCCCcceeCHHHhcCC
Confidence 87654322 222334578899999998654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-25 Score=243.97 Aligned_cols=172 Identities=27% Similarity=0.332 Sum_probs=142.6
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCC--------CCccceEeeEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR--------HRHLVGLLGYCL 658 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~ 658 (779)
+.++|++.+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|+++++.++ |+||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 3578999999999999999999764 6889999998743 344567889999999985 788999999988
Q ss_pred ----eCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-CcEEcCCCCCCEEEcCCC
Q 004020 659 ----DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ-SFIHRDLKPSNILLGDDM 733 (779)
Q Consensus 659 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~-~ivHrDlkp~NIll~~~~ 733 (779)
.....++||||+ ++++.+++..... ..+++..++.++.||+.||+|||+ + +|+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 112 ISGVNGTHICMVFEVL-GHHLLKWIIKSNY---QGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNE 184 (397)
T ss_dssp EEETTEEEEEEEECCC-CCBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCH
T ss_pred ecCCCCceEEEEEecc-CccHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccc
Confidence 455789999999 5566666644321 358999999999999999999997 6 999999999999999775
Q ss_pred -------------------------------------------------cEEEEeeccceecCCCCCcccccccccCCcc
Q 004020 734 -------------------------------------------------RAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764 (779)
Q Consensus 734 -------------------------------------------------~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y 764 (779)
.+||+|||+++..... .....||+.|
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y 259 (397)
T 1wak_A 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQY 259 (397)
T ss_dssp HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGG
T ss_pred hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcc
Confidence 7999999999876432 2345799999
Q ss_pred cccccccccC
Q 004020 765 LAPEYAAETS 774 (779)
Q Consensus 765 ~APE~l~~~~ 774 (779)
+|||++.+..
T Consensus 260 ~aPE~~~~~~ 269 (397)
T 1wak_A 260 RSLEVLIGSG 269 (397)
T ss_dssp CCHHHHHTSC
T ss_pred cCChhhcCCC
Confidence 9999987653
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.8e-25 Score=246.61 Aligned_cols=175 Identities=23% Similarity=0.392 Sum_probs=144.6
Q ss_pred hhcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCC-CccceEeeEEEeCCeEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH-RHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~l 665 (779)
+.++|++.++||+|+||.||+|+. .+++.||||++..... ..++.+|+++++.++| ++|..+..++...+..++
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 457899999999999999999986 4789999998765432 2347889999999986 566666777778888999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEE---cCCCcEEEEeecc
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGL 742 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DFG~ 742 (779)
||||+ +++|.+++.... ..+++..++.|+.||+.||+|||+ ++|+||||||+|||| +.++.+||+|||+
T Consensus 81 vme~~-g~sL~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (483)
T ss_dssp EEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred EEECC-CCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCc
Confidence 99999 899999986432 258999999999999999999996 899999999999999 6889999999999
Q ss_pred ceecCCCCCc-----ccccccccCCcccccccccccC
Q 004020 743 VRLAPDNGKH-----SIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 743 a~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~ 774 (779)
++........ .......||+.|+|||++.+..
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~ 189 (483)
T 3sv0_A 153 AKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIE 189 (483)
T ss_dssp CEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC
T ss_pred ceeccCCccccccccccccccCCCccccCHHHhcCCC
Confidence 9877554321 1123567999999999987653
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.92 E-value=5.9e-28 Score=270.54 Aligned_cols=231 Identities=18% Similarity=0.199 Sum_probs=140.4
Q ss_pred cEEEEEecCCCccc----cCCccccCCCCCcEEEcccCccccCCC-C-CCCCC----CccEEecCCCCCCC----CCccc
Q 004020 66 RVTRIQIGGQNIEG----TLPKELNSLSSLTVLEVMKNKLTGQIP-S-LSGLS----SLQEVLFDDNNFTS----VPSDF 131 (779)
Q Consensus 66 ~v~~l~l~~~~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~-~~~l~----~L~~L~l~~N~l~~----~~~~~ 131 (779)
++++|+|++|+++. .++..+..+++|++|+|++|+++...+ . +..++ +|++|+|++|+++. ..+..
T Consensus 29 ~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~ 108 (461)
T 1z7x_W 29 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 108 (461)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHH
Confidence 56677777777664 345566666777777777777655322 1 22233 57777777777764 23455
Q ss_pred ccCCCCccEEEcccCCCCCCCCccc-----ccCCCCCceEeccCceeEeec----CCCccCCCCCcccEEEccCCCCCCc
Q 004020 132 FKGLTSLQTISLDYNSFDSWVIPES-----LKDATGLQRFSANGANITGTI----PDFLGGDTIPGLMHLHLAFNFLQGP 202 (779)
Q Consensus 132 ~~~l~~L~~L~Ls~N~l~~~~~p~~-----~~~l~~L~~L~l~~n~l~~~~----p~~~~~~~l~~L~~L~L~~N~l~~~ 202 (779)
+..+++|++|+|++|.+.. ..+.. +...++|++|++++|++++.. +..+. .+++|++|+|++|.++..
T Consensus 109 l~~~~~L~~L~Ls~n~i~~-~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~--~~~~L~~L~L~~n~i~~~ 185 (461)
T 1z7x_W 109 LRTLPTLQELHLSDNLLGD-AGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLR--AKPDFKELTVSNNDINEA 185 (461)
T ss_dssp TTSCTTCCEEECCSSBCHH-HHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHH--HCTTCCEEECCSSBCHHH
T ss_pred HccCCceeEEECCCCcCch-HHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHh--hCCCCCEEECcCCCcchH
Confidence 6677777777777777643 11111 122456777777777766532 33333 356777777777777654
Q ss_pred CCCcccc------CCcceeeccCCCCCCCCCC-chhhhcCCCCccEEEeecCcccCCC-----CC-CCCCCCCcEEEccC
Q 004020 203 IPLSFGK------SSIQTLWLNGQKGDSKLNG-SVAVIQNMTSLTQLWLHGNSFTGPL-----PD-LSGLSSLQDFSVRD 269 (779)
Q Consensus 203 ~p~~~~~------~~L~~l~l~~n~~~~~~~~-~~~~~~~l~~L~~L~L~~N~l~~~~-----~~-~~~l~~L~~L~l~~ 269 (779)
.+..+.. .+|+.|++++|.+...... ....+..+++|++|+|++|.++... +. +..+++|++|++++
T Consensus 186 ~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~ 265 (461)
T 1z7x_W 186 GVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWE 265 (461)
T ss_dssp HHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred HHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcC
Confidence 4444332 3677777777765432111 2344556777778888877776531 22 33567778888888
Q ss_pred Cccccc----cChhhhCCCCCCEEEccCcccccc
Q 004020 270 NQLTGI----VPSSLVNLHSLAVVNLTNNLFQGQ 299 (779)
Q Consensus 270 N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~g~ 299 (779)
|+++.. ++..+..+++|++|+|++|++++.
T Consensus 266 n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~ 299 (461)
T 1z7x_W 266 CGITAKGCGDLCRVLRAKESLKELSLAGNELGDE 299 (461)
T ss_dssp SCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHH
T ss_pred CCCCHHHHHHHHHHHhhCCCcceEECCCCCCchH
Confidence 877753 566677777788888888777643
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.1e-25 Score=234.98 Aligned_cols=169 Identities=26% Similarity=0.355 Sum_probs=120.8
Q ss_pred hhcCCcccc-eecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEe----CC
Q 004020 588 VTNNFSEEN-VLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD----GN 661 (779)
Q Consensus 588 ~~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~ 661 (779)
+.++|.+.+ .||+|+||.||+|+.. +++.||+|++.... . ...+....++.+.||||+++++++.. ..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 456888854 6999999999999876 68999999986432 1 12223334566789999999999976 44
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC---CCcEEEE
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVA 738 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~~~kl~ 738 (779)
..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+ ++|+||||||+||+++. ++.+||+
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGD---QAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-C---CCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred eEEEEEeccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEe
Confidence 57999999999999999965432 358999999999999999999996 79999999999999976 4559999
Q ss_pred eeccceecCCCCCcccccccccCCcccccccccc
Q 004020 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 739 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
|||+++...... .....||+.|+|||++.+
T Consensus 174 Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~ 203 (336)
T 3fhr_A 174 DFGFAKETTQNA----LQTPCYTPYYVAPEVLGP 203 (336)
T ss_dssp CCTTCEEC--------------------------
T ss_pred ccccceeccccc----cccCCCCcCccChhhhCC
Confidence 999998764321 234568999999999854
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.1e-26 Score=241.69 Aligned_cols=176 Identities=24% Similarity=0.435 Sum_probs=142.9
Q ss_pred hhcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
..++|++.+.||+|+||.||+|+... .||+|++..........+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 45789999999999999999998753 4999998765443444456788999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++++|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++ ++.+||+|||+++...
T Consensus 109 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp BCCCSEEHHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred ecccCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 9999999999985432 258899999999999999999996 8999999999999998 6799999999987543
Q ss_pred CCCC---cccccccccCCccccccccccc
Q 004020 748 DNGK---HSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~---~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.... ........||+.|+|||++.+.
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 209 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQL 209 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCB
T ss_pred cccccccccccccCCCcccccChHHhhhc
Confidence 2111 1112334689999999998763
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.4e-25 Score=234.29 Aligned_cols=174 Identities=26% Similarity=0.368 Sum_probs=128.4
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+.++..+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467999999999999999999875 7899999999765433333444556666788889999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+ ++.+..+..... ..+++..+..++.|++.||+|||+ +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 104 e~~-~~~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQ----GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH--HHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHh--hCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 455554443221 258899999999999999999996 2389999999999999999999999999987664
Q ss_pred CCCCcccccccccCCcccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
... ......||+.|+|||++.+
T Consensus 177 ~~~---~~~~~~~~~~y~aPE~~~~ 198 (318)
T 2dyl_A 177 DDK---AKDRSAGCAAYMAPERIDP 198 (318)
T ss_dssp -------------CCTTCCHHHHC-
T ss_pred CCc---cccccCCCccccChhhccc
Confidence 422 1234569999999999863
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.8e-25 Score=244.18 Aligned_cols=170 Identities=26% Similarity=0.406 Sum_probs=133.8
Q ss_pred cCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 668 (779)
.+|...+.||+|+||.||.....+++.||||++..... ..+.+|+++++.+ +||||+++++++.+.+..|+|||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 46888999999999997766667899999999865432 2356899999999 79999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC-----CCcEEEEeeccc
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-----DMRAKVADFGLV 743 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-----~~~~kl~DFG~a 743 (779)
|++ |+|.+++..... ...+..++.++.||+.||+|||+ .+|+||||||+||+++. ...+||+|||+|
T Consensus 99 ~~~-g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDF----AHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp CCS-EEHHHHHHSSSC----CCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred CCC-CCHHHHHHhcCC----CccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 996 599999865432 23444567899999999999997 89999999999999953 346889999999
Q ss_pred eecCCCCC-cccccccccCCcccccccccc
Q 004020 744 RLAPDNGK-HSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 744 ~~~~~~~~-~~~~~~~~gt~~y~APE~l~~ 772 (779)
+....... ........||+.|+|||++.+
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 200 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSC
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhc
Confidence 87654321 122344679999999999975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-24 Score=235.97 Aligned_cols=174 Identities=23% Similarity=0.282 Sum_probs=145.2
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CC-----ccceEeeEEEeC
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HR-----HLVGLLGYCLDG 660 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~ 660 (779)
+.++|++.+.||+|+||.||+|+.. +++.||||+++.. .....++.+|+++++.++ |+ +|+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 4679999999999999999999865 6889999998743 334567788999988885 55 499999999999
Q ss_pred CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEc--CCCcEEEE
Q 004020 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVA 738 (779)
Q Consensus 661 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~--~~~~~kl~ 738 (779)
+..++||||++ ++|.+++..... ..+++..+..++.||+.||.|||+. +.+|+||||||+|||++ .++.+||+
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNF---RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred CceEEEEecCC-CCHHHHHhhcCc---CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 99999999996 599999865432 2588999999999999999999952 37899999999999994 57889999
Q ss_pred eeccceecCCCCCcccccccccCCcccccccccccC
Q 004020 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 739 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
|||+++..... .....||+.|+|||++.+..
T Consensus 204 DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~ 234 (382)
T 2vx3_A 204 DFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMP 234 (382)
T ss_dssp CCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCC
T ss_pred eccCceecccc-----cccccCCccccChHHHcCCC
Confidence 99999876432 23457999999999987653
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.6e-25 Score=245.11 Aligned_cols=174 Identities=28% Similarity=0.331 Sum_probs=132.0
Q ss_pred cCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 668 (779)
+.|...+.||+|+||+||.+...+|+.||||++.... .+.+.+|+++++++ +||||+++++++.+.+..++|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 4556678999999999988777789999999986432 34578899999886 89999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCC-------------C
Q 004020 669 YMPQGTLSRHLFNRKEEGL--KPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-------------M 733 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~-------------~ 733 (779)
|+. |+|.+++........ ....+..++.++.||+.||+|||+ .+|+||||||+|||++.+ +
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCce
Confidence 996 699999965432211 111333467899999999999997 899999999999999754 4
Q ss_pred cEEEEeeccceecCCCCCcc--cccccccCCcccccccccc
Q 004020 734 RAKVADFGLVRLAPDNGKHS--IETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 734 ~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~APE~l~~ 772 (779)
.+||+|||+++......... ......||+.|+|||++.+
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 206 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE 206 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSC
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcc
Confidence 89999999998775432211 1234579999999999976
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.91 E-value=7.2e-28 Score=269.83 Aligned_cols=311 Identities=18% Similarity=0.204 Sum_probs=224.7
Q ss_pred CcEEEEEecCCCccccCCcccc-CCC----CCcEEEcccCcccc----CCC-CCCCCCCccEEecCCCCCCCCCccc---
Q 004020 65 NRVTRIQIGGQNIEGTLPKELN-SLS----SLTVLEVMKNKLTG----QIP-SLSGLSSLQEVLFDDNNFTSVPSDF--- 131 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~~p~~l~-~l~----~L~~L~Ls~N~l~~----~~~-~~~~l~~L~~L~l~~N~l~~~~~~~--- 131 (779)
.++++|+|++|.+....+..+. .++ +|++|+|++|+++. .++ .+..+++|++|+|++|.++......
T Consensus 56 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 135 (461)
T 1z7x_W 56 PALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCE 135 (461)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHH
T ss_pred CCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHH
Confidence 5789999999998865554443 355 69999999999884 334 7888999999999999987543332
Q ss_pred --ccCCCCccEEEcccCCCCCCC---CcccccCCCCCceEeccCceeEeecCCCccC---CCCCcccEEEccCCCCCCc-
Q 004020 132 --FKGLTSLQTISLDYNSFDSWV---IPESLKDATGLQRFSANGANITGTIPDFLGG---DTIPGLMHLHLAFNFLQGP- 202 (779)
Q Consensus 132 --~~~l~~L~~L~Ls~N~l~~~~---~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~---~~l~~L~~L~L~~N~l~~~- 202 (779)
+..+++|++|+|++|++.... ++..+..+++|+.|++++|.++...+..+.. ...++|++|+|++|.+++.
T Consensus 136 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~ 215 (461)
T 1z7x_W 136 GLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDN 215 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTH
T ss_pred HHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHH
Confidence 334668999999999886421 3566777899999999999987554444320 1245899999999999864
Q ss_pred ---CCCcccc-CCcceeeccCCCCCCCCCCc--hhhhcCCCCccEEEeecCcccCC----CC-CCCCCCCCcEEEccCCc
Q 004020 203 ---IPLSFGK-SSIQTLWLNGQKGDSKLNGS--VAVIQNMTSLTQLWLHGNSFTGP----LP-DLSGLSSLQDFSVRDNQ 271 (779)
Q Consensus 203 ---~p~~~~~-~~L~~l~l~~n~~~~~~~~~--~~~~~~l~~L~~L~L~~N~l~~~----~~-~~~~l~~L~~L~l~~N~ 271 (779)
++..+.. .+|+.|++++|.+....... ......+++|++|+|++|.++.. ++ .+..+++|++|++++|.
T Consensus 216 ~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~ 295 (461)
T 1z7x_W 216 CRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNE 295 (461)
T ss_dssp HHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCC
T ss_pred HHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCC
Confidence 4555544 67999999998765321111 11223578999999999999873 33 46678999999999999
Q ss_pred cccccChhhhCC-----CCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchh
Q 004020 272 LTGIVPSSLVNL-----HSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAV 346 (779)
Q Consensus 272 l~~~~p~~l~~l-----~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (779)
+.+..+..+... ++|+.|+|++|.+++..... +..
T Consensus 296 i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~------------------------------l~~---------- 335 (461)
T 1z7x_W 296 LGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSH------------------------------FSS---------- 335 (461)
T ss_dssp CHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH------------------------------HHH----------
T ss_pred CchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHH------------------------------HHH----------
Confidence 986655555543 68999999999887532110 000
Q ss_pred cccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccc-----cccCCeEeccCccccc----cCCccCCCC
Q 004020 347 LAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSR-----LTSLRQLMLSGNELTG----TIPKELTTL 417 (779)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~-----l~~L~~L~Ls~N~l~g----~iP~~l~~l 417 (779)
.....++|+.|+|++|.+++..+..+.. .++|++|+|++|++++ .+|..+..+
T Consensus 336 ------------------~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~ 397 (461)
T 1z7x_W 336 ------------------VLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLAN 397 (461)
T ss_dssp ------------------HHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHC
T ss_pred ------------------HHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhC
Confidence 0011237889999999988876665553 6789999999999986 788888888
Q ss_pred CCCCceeccCCccccc
Q 004020 418 PSLEMLDVSNNHLFGK 433 (779)
Q Consensus 418 ~~L~~L~Ls~N~l~g~ 433 (779)
++|++|||++|++++.
T Consensus 398 ~~L~~L~l~~N~i~~~ 413 (461)
T 1z7x_W 398 HSLRELDLSNNCLGDA 413 (461)
T ss_dssp CCCCEEECCSSSCCHH
T ss_pred CCccEEECCCCCCCHH
Confidence 9999999999998764
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-24 Score=233.00 Aligned_cols=171 Identities=25% Similarity=0.386 Sum_probs=142.7
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CC-cEEEEEEecccccChhHHHHHHHHHHHHHcCCCCc------cceEeeEEEe
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DG-TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH------LVGLLGYCLD 659 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~ 659 (779)
+.++|++.+.||+|+||.||+|... ++ +.||+|++... ....+.+.+|++++++++|++ ++.+++++..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 3578999999999999999999875 34 68999998643 344567889999999997665 8999999999
Q ss_pred CCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEE----------
Q 004020 660 GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---------- 729 (779)
Q Consensus 660 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll---------- 729 (779)
.+..++||||+ ++++.+++.... ...+++..++.++.||+.||+|||+ ++|+||||||+||++
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKENN---FQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEEC
T ss_pred CCeEEEEEecc-CCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccc
Confidence 99999999999 567777765432 2358899999999999999999996 899999999999999
Q ss_pred ---------cCCCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 730 ---------GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 730 ---------~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+.++.+||+|||+++..... .....||+.|+|||++.+.
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~ 214 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILEL 214 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTC
T ss_pred ccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecC
Confidence 56789999999999875432 2345799999999998754
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=7.5e-24 Score=221.14 Aligned_cols=203 Identities=23% Similarity=0.253 Sum_probs=177.1
Q ss_pred eCCCCcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCcc
Q 004020 61 CSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139 (779)
Q Consensus 61 c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 139 (779)
|....+++++++++++++ .+|..+. ++|++|+|++|+|++.++ .|.++++|++|+|++|+++.+++. ..+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 344457899999999998 6777665 689999999999998876 799999999999999999998764 7899999
Q ss_pred EEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccC
Q 004020 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNG 219 (779)
Q Consensus 140 ~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~ 219 (779)
+|+|++|++.. +|..+..+++|+.|++++|+|++..|..|. .+++|++|+|++|+|++..+..+.
T Consensus 81 ~L~Ls~N~l~~--l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~----------- 145 (290)
T 1p9a_G 81 TLDLSHNQLQS--LPLLGQTLPALTVLDVSFNRLTSLPLGALR--GLGELQELYLKGNELKTLPPGLLT----------- 145 (290)
T ss_dssp EEECCSSCCSS--CCCCTTTCTTCCEEECCSSCCCCCCSSTTT--TCTTCCEEECTTSCCCCCCTTTTT-----------
T ss_pred EEECCCCcCCc--CchhhccCCCCCEEECCCCcCcccCHHHHc--CCCCCCEEECCCCCCCccChhhcc-----------
Confidence 99999999975 788889999999999999999977777786 789999999999999965554443
Q ss_pred CCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCC-CCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccc
Q 004020 220 QKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQG 298 (779)
Q Consensus 220 n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g 298 (779)
.+++|+.|+|++|+|++.++. +..+++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|++.+
T Consensus 146 ---------------~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 146 ---------------PTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp ---------------TCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred ---------------cccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 689999999999999988775 788999999999999999 789999999999999999999875
Q ss_pred c
Q 004020 299 Q 299 (779)
Q Consensus 299 ~ 299 (779)
.
T Consensus 210 ~ 210 (290)
T 1p9a_G 210 N 210 (290)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=5.3e-24 Score=220.45 Aligned_cols=204 Identities=22% Similarity=0.282 Sum_probs=181.5
Q ss_pred CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcc
Q 004020 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 144 (779)
.+++.|+++++.++. + +.+..+++|++|+|++|++++. +.+.++++|++|+|++|+++++++..|.++++|++|+|+
T Consensus 41 ~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 117 (272)
T 3rfs_A 41 NSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLV 117 (272)
T ss_dssp TTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred cceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECC
Confidence 479999999999883 3 3589999999999999999874 589999999999999999999999999999999999999
Q ss_pred cCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCC
Q 004020 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDS 224 (779)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~ 224 (779)
+|++.+ ..+..|..+++|++|++++|++++..+..+. .+++|++|+|++|++++..+..++
T Consensus 118 ~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~---------------- 178 (272)
T 3rfs_A 118 ENQLQS-LPDGVFDKLTNLTYLNLAHNQLQSLPKGVFD--KLTNLTELDLSYNQLQSLPEGVFD---------------- 178 (272)
T ss_dssp TSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTT--TCTTCCEEECCSSCCCCCCTTTTT----------------
T ss_pred CCcCCc-cCHHHhccCCCCCEEECCCCccCccCHHHhc--cCccCCEEECCCCCcCccCHHHhc----------------
Confidence 999986 6677799999999999999999977777775 799999999999999976665544
Q ss_pred CCCCchhhhcCCCCccEEEeecCcccCCCCC-CCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCC
Q 004020 225 KLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKF 303 (779)
Q Consensus 225 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~ 303 (779)
.+++|+.|+|++|++++.++. +..+++|+.|++++|.+.+. +++|+.|+++.|+++|.+|..
T Consensus 179 ----------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~ 241 (272)
T 3rfs_A 179 ----------KLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNS 241 (272)
T ss_dssp ----------TCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCT
T ss_pred ----------CCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCc
Confidence 689999999999999998886 78999999999999999865 557999999999999999986
Q ss_pred CCCc
Q 004020 304 NSPV 307 (779)
Q Consensus 304 ~~~~ 307 (779)
....
T Consensus 242 ~~~~ 245 (272)
T 3rfs_A 242 AGSV 245 (272)
T ss_dssp TSCB
T ss_pred cccc
Confidence 6543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.5e-25 Score=251.14 Aligned_cols=176 Identities=29% Similarity=0.432 Sum_probs=146.0
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEe------CC
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD------GN 661 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~ 661 (779)
.++|++.+.||+|+||.||+|... +++.||+|++.... .....+++.+|++++++++||||+++++++.. .+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 468999999999999999999764 68999999987543 45556789999999999999999999998765 56
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCc---EEEE
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR---AKVA 738 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~---~kl~ 738 (779)
..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++. +||+
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred eEEEEEEeCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEc
Confidence 78999999999999999865432 2257888999999999999999997 89999999999999997665 9999
Q ss_pred eeccceecCCCCCcccccccccCCccccccccccc
Q 004020 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 739 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
|||+++...... ......||+.|+|||++.+.
T Consensus 167 DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~ 198 (676)
T 3qa8_A 167 DLGYAKELDQGE---LCTEFVGTLQYLAPELLEQK 198 (676)
T ss_dssp SCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCS
T ss_pred cccccccccccc---ccccccCCcccCChHHhccC
Confidence 999998765432 22445799999999998754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-24 Score=236.22 Aligned_cols=171 Identities=23% Similarity=0.339 Sum_probs=142.9
Q ss_pred hcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-----------CCccceEeeE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-----------HRHLVGLLGY 656 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~ 656 (779)
.++|++.+.||+|+||.||+|+. .+++.||+|++... ....+.+.+|++++++++ ||||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 35899999999999999999986 47899999998743 234467889999999886 8999999999
Q ss_pred EEeCC----eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-CcEEcCCCCCCEEEc-
Q 004020 657 CLDGN----ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQ-SFIHRDLKPSNILLG- 730 (779)
Q Consensus 657 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~-~ivHrDlkp~NIll~- 730 (779)
+...+ ..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+ + +|+||||||+||+++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~ 167 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEI 167 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEE
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhhc---cCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEec
Confidence 98654 689999999 8899999865432 248899999999999999999997 6 999999999999994
Q ss_pred -----CCCcEEEEeeccceecCCCCCcccccccccCCcccccccccccC
Q 004020 731 -----DDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 731 -----~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
..+.+||+|||+++..... .....||+.|+|||++.+..
T Consensus 168 ~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~ 211 (373)
T 1q8y_A 168 VDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAP 211 (373)
T ss_dssp EETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCC
T ss_pred cCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCC
Confidence 4458999999999876432 23347899999999987653
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.91 E-value=8.4e-24 Score=216.20 Aligned_cols=190 Identities=20% Similarity=0.320 Sum_probs=132.5
Q ss_pred CCCcceeeEeCCCCcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcc
Q 004020 52 DPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSD 130 (779)
Q Consensus 52 ~~C~w~gv~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~ 130 (779)
+||.|.|.+|.. ..+++++++++++ .+|..+. ++|++|+|++|++++.++ .|.++++|++|+|++|+++++++.
T Consensus 3 ~Cp~~~gC~C~~--~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 77 (251)
T 3m19_A 3 TCETVTGCTCNE--GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAG 77 (251)
T ss_dssp -CHHHHSSEEEG--GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTT
T ss_pred cCCCCCceEcCC--CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHh
Confidence 577999999953 3567999999998 6777665 589999999999998887 789999999999999999999988
Q ss_pred cccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccC
Q 004020 131 FFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKS 210 (779)
Q Consensus 131 ~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~ 210 (779)
.|..+++|++|+|++|++.+ ..+..|..+++|++|+|++|+|++..+..+.
T Consensus 78 ~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~---------------------------- 128 (251)
T 3m19_A 78 VFDDLTELGTLGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFD---------------------------- 128 (251)
T ss_dssp TTTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTT----------------------------
T ss_pred HhccCCcCCEEECCCCcccc-cChhHhcccCCCCEEEcCCCcCCCcChhHhc----------------------------
Confidence 88889999999999998865 3344445555555555554444433333232
Q ss_pred CcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCC-CCCCCCCCcEEEccCCccccccChhhhCCCCCCEE
Q 004020 211 SIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVV 289 (779)
Q Consensus 211 ~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L 289 (779)
.+++|+.|+|++|+|++.++ .+..+++|++|+|++|+|++..+..+..+++|+.|
T Consensus 129 ------------------------~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 184 (251)
T 3m19_A 129 ------------------------RLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTI 184 (251)
T ss_dssp ------------------------TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred ------------------------cCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEE
Confidence 34555555555555555555 25555666666666666665555566666666666
Q ss_pred EccCcccccc
Q 004020 290 NLTNNLFQGQ 299 (779)
Q Consensus 290 ~Ls~N~l~g~ 299 (779)
+|++|++++.
T Consensus 185 ~l~~N~~~c~ 194 (251)
T 3m19_A 185 TLFGNQFDCS 194 (251)
T ss_dssp ECCSCCBCTT
T ss_pred EeeCCceeCC
Confidence 6666666654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.5e-25 Score=249.74 Aligned_cols=161 Identities=17% Similarity=0.219 Sum_probs=124.3
Q ss_pred cccceecccccEEEEEEEEcCCcEEEEEEecccccChh------HHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 593 SEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEK------GFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 593 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
...+.||+|+||.||+|+. .++.+++|+......... ..+++.+|++++++++||||+++..++...+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999944 578889998654332211 235689999999999999999776677777888999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++++|.+++.. +..++.|+++||+|||+ ++|+||||||+|||++. ++||+|||+|+..
T Consensus 418 mE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 418 MSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 999999999999843 45899999999999996 89999999999999998 9999999999987
Q ss_pred CCCCCcc-----cccccccCCcccccccccc
Q 004020 747 PDNGKHS-----IETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 747 ~~~~~~~-----~~~~~~gt~~y~APE~l~~ 772 (779)
....... ......||+.|||||++.+
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~ 510 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWER 510 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHH
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHH
Confidence 5432111 1235679999999999875
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=5e-23 Score=212.90 Aligned_cols=178 Identities=22% Similarity=0.314 Sum_probs=124.6
Q ss_pred CCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEecc
Q 004020 90 SLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSAN 169 (779)
Q Consensus 90 ~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~ 169 (779)
+++.+++++|+++.++..+. ++|++|+|++|+++.+++..|.++++|++|+|++|++.. ..+..|.++++|++|+++
T Consensus 17 ~~~~l~~~~~~l~~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLTAIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSC-CCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCCccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCe-eChhhhcCCCCCCEEECC
Confidence 57789999998887655554 678889999999988888888888888888888888875 444556777777777777
Q ss_pred CceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcc
Q 004020 170 GANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSF 249 (779)
Q Consensus 170 ~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l 249 (779)
+|.+++..+..+. .+++|++|+|++|++++..+..++ .+++|++|+|++|.+
T Consensus 94 ~n~l~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~--------------------------~l~~L~~L~Ls~n~l 145 (270)
T 2o6q_A 94 DNKLQALPIGVFD--QLVNLAELRLDRNQLKSLPPRVFD--------------------------SLTKLTYLSLGYNEL 145 (270)
T ss_dssp SSCCCCCCTTTTT--TCSSCCEEECCSSCCCCCCTTTTT--------------------------TCTTCCEEECCSSCC
T ss_pred CCcCCcCCHhHcc--cccCCCEEECCCCccCeeCHHHhC--------------------------cCcCCCEEECCCCcC
Confidence 7777755555554 566777777777777654444433 466677777777777
Q ss_pred cCCCCC-CCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccc
Q 004020 250 TGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQG 298 (779)
Q Consensus 250 ~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g 298 (779)
++.++. +..+++|++|++++|++++..+..|..+++|++|+|++|++++
T Consensus 146 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 195 (270)
T 2o6q_A 146 QSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKR 195 (270)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred CccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCc
Confidence 665554 5666667777777776665555556666666666666666553
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=3.3e-23 Score=216.23 Aligned_cols=204 Identities=28% Similarity=0.324 Sum_probs=144.1
Q ss_pred CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCC
Q 004020 107 SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTI 186 (779)
Q Consensus 107 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l 186 (779)
.++++++|+++++++|.++.+|+... ++|++|+|++|++.+ ..+..|..+++|+.|++++|.|++..+. + .+
T Consensus 5 ~~~~l~~l~~l~~~~~~l~~ip~~~~---~~l~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~--~l 76 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLTALPPDLP---KDTTILHLSENLLYT-FSLATLMPYTRLTQLNLDRAELTKLQVD--G--TL 76 (290)
T ss_dssp EEECSTTCCEEECTTSCCSSCCSCCC---TTCCEEECTTSCCSE-EEGGGGTTCTTCCEEECTTSCCCEEECC--S--CC
T ss_pred cccccCCccEEECCCCCCCcCCCCCC---CCCCEEEcCCCcCCc-cCHHHhhcCCCCCEEECCCCccCcccCC--C--CC
Confidence 46778889999999999998887643 578888888888865 4566777777777777777777754433 2 46
Q ss_pred CcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCC-CCCCCCCcEE
Q 004020 187 PGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDF 265 (779)
Q Consensus 187 ~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L 265 (779)
++|++|+|++|+|+ .+|..+. .+++|++|+|++|+|++.++. |..+++|++|
T Consensus 77 ~~L~~L~Ls~N~l~-~l~~~~~--------------------------~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L 129 (290)
T 1p9a_G 77 PVLGTLDLSHNQLQ-SLPLLGQ--------------------------TLPALTVLDVSFNRLTSLPLGALRGLGELQEL 129 (290)
T ss_dssp TTCCEEECCSSCCS-SCCCCTT--------------------------TCTTCCEEECCSSCCCCCCSSTTTTCTTCCEE
T ss_pred CcCCEEECCCCcCC-cCchhhc--------------------------cCCCCCEEECCCCcCcccCHHHHcCCCCCCEE
Confidence 67777777777776 4444332 456667777777777666553 6666666666
Q ss_pred EccCCccccccChhhhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCch
Q 004020 266 SVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPA 345 (779)
Q Consensus 266 ~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (779)
+|++|+|++..+..|..+++|+.|+|++|+|++
T Consensus 130 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~----------------------------------------------- 162 (290)
T 1p9a_G 130 YLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE----------------------------------------------- 162 (290)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC-----------------------------------------------
T ss_pred ECCCCCCCccChhhcccccCCCEEECCCCcCCc-----------------------------------------------
Confidence 666666665555556666666666666666553
Q ss_pred hcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccCccccccCCccCCCCCCCCceec
Q 004020 346 VLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDV 425 (779)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L 425 (779)
..+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.|+|
T Consensus 163 ---------------------------------------l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L 202 (290)
T 1p9a_G 163 ---------------------------------------LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFL 202 (290)
T ss_dssp ---------------------------------------CCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEEC
T ss_pred ---------------------------------------cCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEe
Confidence 23334567788888888888888 88888888888888888
Q ss_pred cCCcccc
Q 004020 426 SNNHLFG 432 (779)
Q Consensus 426 s~N~l~g 432 (779)
++|++..
T Consensus 203 ~~Np~~C 209 (290)
T 1p9a_G 203 HGNPWLC 209 (290)
T ss_dssp CSCCBCC
T ss_pred CCCCccC
Confidence 8887753
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-23 Score=211.50 Aligned_cols=194 Identities=18% Similarity=0.195 Sum_probs=98.4
Q ss_pred cEEEEEecCCCccccCCccccCCCCCcEEEcccCc-cccCCC-CCCCCCCccEEecCC-CCCCCCCcccccCCCCccEEE
Q 004020 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNK-LTGQIP-SLSGLSSLQEVLFDD-NNFTSVPSDFFKGLTSLQTIS 142 (779)
Q Consensus 66 ~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~~-~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~L~ 142 (779)
.++.|++++|++++..+..|..+++|++|+|++|+ ++.+++ .|.++++|++|+|++ |+++.+++..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 34555555555554444445555555555555554 444444 445555555555554 555555555555555555555
Q ss_pred cccCCCCCCCCcccccCCCCCc---eEeccCc-eeEeecCCCccCCCCCccc-EEEccCCCCCCcCCCccccCCcceeec
Q 004020 143 LDYNSFDSWVIPESLKDATGLQ---RFSANGA-NITGTIPDFLGGDTIPGLM-HLHLAFNFLQGPIPLSFGKSSIQTLWL 217 (779)
Q Consensus 143 Ls~N~l~~~~~p~~~~~l~~L~---~L~l~~n-~l~~~~p~~~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~~~L~~l~l 217 (779)
|++|++.+ +|. |..+++|+ .|++++| ++++..+..|. .+++|+ +|+|++|+++ .+|....
T Consensus 112 l~~n~l~~--lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~--~l~~L~~~L~l~~n~l~-~i~~~~~--------- 176 (239)
T 2xwt_C 112 IFNTGLKM--FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQ--GLCNETLTLKLYNNGFT-SVQGYAF--------- 176 (239)
T ss_dssp EEEECCCS--CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTT--TTBSSEEEEECCSCCCC-EECTTTT---------
T ss_pred CCCCCCcc--ccc-cccccccccccEEECCCCcchhhcCccccc--chhcceeEEEcCCCCCc-ccCHhhc---------
Confidence 55555543 333 44444444 5555555 44444333343 344555 5555555554 3332211
Q ss_pred cCCCCCCCCCCchhhhcCCCCccEEEeecCc-ccCCCCC-CCCC-CCCcEEEccCCccccccChhhhCCCCCCEEEccCc
Q 004020 218 NGQKGDSKLNGSVAVIQNMTSLTQLWLHGNS-FTGPLPD-LSGL-SSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294 (779)
Q Consensus 218 ~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~-~~~l-~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N 294 (779)
..++|+.|+|++|+ +++.++. |..+ ++|+.|++++|++++ +|.. .+++|+.|+++++
T Consensus 177 -----------------~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 177 -----------------NGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--GLEHLKELIARNT 236 (239)
T ss_dssp -----------------TTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT--TCTTCSEEECTTC
T ss_pred -----------------CCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc-CChh--HhccCceeeccCc
Confidence 12556666666663 6655443 5556 666666666666663 3332 4556666666554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.5e-23 Score=216.82 Aligned_cols=146 Identities=12% Similarity=0.046 Sum_probs=128.7
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccC-hhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
+.++|++.+.||+|+||.||+|+.. +++.||+|++...... ....+.+.+|+..+++++||||+++++++.+.+..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 3468999999999999999999876 5899999999865433 4455789999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccc
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 743 (779)
||||+++++|.+++... ....++.+|+.||+.||+|||+ ++|+||||||+||+++.++.+||+++|..
T Consensus 109 v~e~~~g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~~~ 176 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPATM 176 (286)
T ss_dssp EEECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred EEEecCCCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecccc
Confidence 99999999999998431 2455788999999999999997 89999999999999999999999988764
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.9e-24 Score=226.06 Aligned_cols=202 Identities=18% Similarity=0.209 Sum_probs=134.2
Q ss_pred CccEEEcccCCCCCCCCcccc--cCCCCCceEeccCceeEeecC----CCccCCCCCcccEEEccCCCCCCcCCCccccC
Q 004020 137 SLQTISLDYNSFDSWVIPESL--KDATGLQRFSANGANITGTIP----DFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKS 210 (779)
Q Consensus 137 ~L~~L~Ls~N~l~~~~~p~~~--~~l~~L~~L~l~~n~l~~~~p----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~ 210 (779)
+|++|+|++|++.+ ..|..+ ..+++|+.|++++|.+++..+ ..+. .+++|++|+|++|++++..|..++
T Consensus 92 ~L~~L~l~~n~l~~-~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~--~~~~L~~L~Ls~n~l~~~~~~~~~-- 166 (310)
T 4glp_A 92 RLKELTLEDLKITG-TMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQW--LKPGLKVLSIAQAHSPAFSCEQVR-- 166 (310)
T ss_dssp CCCEEEEESCCCBS-CCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTT--BCSCCCEEEEECCSSCCCCTTSCC--
T ss_pred ceeEEEeeCCEecc-chhhhhhhccCCCCCEEEeecccccchhhhhHHHHhh--hccCCCEEEeeCCCcchhhHHHhc--
Confidence 34444444444433 233333 444444444444444443333 1121 467777888888887766665554
Q ss_pred CcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccC---CCCC--CCCCCCCcEEEccCCccccccCh----hhh
Q 004020 211 SIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTG---PLPD--LSGLSSLQDFSVRDNQLTGIVPS----SLV 281 (779)
Q Consensus 211 ~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~---~~~~--~~~l~~L~~L~l~~N~l~~~~p~----~l~ 281 (779)
.+++|++|+|++|++.+ .++. +..+++|++|++++|+++. +|. .+.
T Consensus 167 ------------------------~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~ 221 (310)
T 4glp_A 167 ------------------------AFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAA 221 (310)
T ss_dssp ------------------------CCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHH
T ss_pred ------------------------cCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHh
Confidence 47778888888887765 2222 3577888888888888863 333 357
Q ss_pred CCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCC
Q 004020 282 NLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDW 361 (779)
Q Consensus 282 ~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (779)
.+++|++|+|++|++++..|..+..
T Consensus 222 ~l~~L~~L~Ls~N~l~~~~p~~~~~------------------------------------------------------- 246 (310)
T 4glp_A 222 AGVQPHSLDLSHNSLRATVNPSAPR------------------------------------------------------- 246 (310)
T ss_dssp HTCCCSSEECTTSCCCCCCCSCCSS-------------------------------------------------------
T ss_pred cCCCCCEEECCCCCCCccchhhHHh-------------------------------------------------------
Confidence 7888999999999988876643211
Q ss_pred CccccCCCCCeEEEEccCccccccccccccccccCCeEeccCccccccCCccCCCCCCCCceeccCCcccc
Q 004020 362 KGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFG 432 (779)
Q Consensus 362 ~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g 432 (779)
+...++|+.|+|++|+|+ .+|..+. ++|++|+|++|+|++ +|. +..+++|+.|+|++|+|+.
T Consensus 247 ----~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~-~~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 247 ----CMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNR-APQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp ----CCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCS-CCC-TTSCCCCSCEECSSTTTSC
T ss_pred ----ccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCC-Cch-hhhCCCccEEECcCCCCCC
Confidence 111247888999999998 6787775 799999999999995 344 6788999999999999874
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.1e-25 Score=241.12 Aligned_cols=105 Identities=10% Similarity=0.092 Sum_probs=65.2
Q ss_pred EEecCCCccccCCccccCCCCCcEEEcccCccccCCC-----CCCCCC-CccEEecCCCCCCCCCcccccCC-----CCc
Q 004020 70 IQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-----SLSGLS-SLQEVLFDDNNFTSVPSDFFKGL-----TSL 138 (779)
Q Consensus 70 l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-----~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l-----~~L 138 (779)
.++++|+++|.+|..+...++|++|+|++|.|++..+ .|.+++ +|++|+|++|+++...+..+..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 4667777777777666666667777777777776553 356666 67777777777777666555554 677
Q ss_pred cEEEcccCCCCCCCCccc----ccCC-CCCceEeccCceeEe
Q 004020 139 QTISLDYNSFDSWVIPES----LKDA-TGLQRFSANGANITG 175 (779)
Q Consensus 139 ~~L~Ls~N~l~~~~~p~~----~~~l-~~L~~L~l~~n~l~~ 175 (779)
++|+|++|++.. ..+.. +..+ ++|+.|++++|.+++
T Consensus 83 ~~L~Ls~n~l~~-~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~ 123 (362)
T 3goz_A 83 TSLNLSGNFLSY-KSSDELVKTLAAIPFTITVLDLGWNDFSS 123 (362)
T ss_dssp CEEECCSSCGGG-SCHHHHHHHHHTSCTTCCEEECCSSCGGG
T ss_pred cEEECcCCcCCh-HHHHHHHHHHHhCCCCccEEECcCCcCCc
Confidence 777777777654 22322 2222 455555555555543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.89 E-value=5.7e-23 Score=216.61 Aligned_cols=190 Identities=25% Similarity=0.390 Sum_probs=123.8
Q ss_pred cEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEccc
Q 004020 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145 (779)
Q Consensus 66 ~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 145 (779)
++++|++++++++. +| .+..+++|++|+|++|++++.++ +.++++|++|+|++|+++.++ .+..+++|++|+|++
T Consensus 42 ~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~-~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~l~~ 116 (308)
T 1h6u_A 42 GITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNVS--AIAGLQSIKTLDLTS 116 (308)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCCG--GGTTCTTCCEEECTT
T ss_pred CcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh-HccCCCCCEEEccCCcCCCch--hhcCCCCCCEEECCC
Confidence 56777777777763 44 56677777777777777766555 677777777777777777664 366677777777777
Q ss_pred CCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCC
Q 004020 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSK 225 (779)
Q Consensus 146 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~ 225 (779)
|++.+ ++. +..+++|+.|++++|.+++..+ +. .+++|++|+|++|++++..+
T Consensus 117 n~l~~--~~~-l~~l~~L~~L~l~~n~l~~~~~--l~--~l~~L~~L~l~~n~l~~~~~--------------------- 168 (308)
T 1h6u_A 117 TQITD--VTP-LAGLSNLQVLYLDLNQITNISP--LA--GLTNLQYLSIGNAQVSDLTP--------------------- 168 (308)
T ss_dssp SCCCC--CGG-GTTCTTCCEEECCSSCCCCCGG--GG--GCTTCCEEECCSSCCCCCGG---------------------
T ss_pred CCCCC--chh-hcCCCCCCEEECCCCccCcCcc--cc--CCCCccEEEccCCcCCCChh---------------------
Confidence 77754 332 6666666777776666664333 33 46666666666666663221
Q ss_pred CCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccc
Q 004020 226 LNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQG 298 (779)
Q Consensus 226 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g 298 (779)
+..+++|+.|+|++|++++.++ +..+++|++|++++|++++.. .+..+++|+.|+|++|++++
T Consensus 169 -------l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 169 -------LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp -------GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEEC
T ss_pred -------hcCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeec
Confidence 2256777777777777765443 666777777777777776543 26677777777777777764
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-23 Score=221.23 Aligned_cols=204 Identities=17% Similarity=0.115 Sum_probs=110.0
Q ss_pred CCCcEEEcccCccccCCC-CC--CCCCCccEEecCCCCCCCCCc----ccccCCCCccEEEcccCCCCCCCCcccccCCC
Q 004020 89 SSLTVLEVMKNKLTGQIP-SL--SGLSSLQEVLFDDNNFTSVPS----DFFKGLTSLQTISLDYNSFDSWVIPESLKDAT 161 (779)
Q Consensus 89 ~~L~~L~Ls~N~l~~~~~-~~--~~l~~L~~L~l~~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~ 161 (779)
++|++|+|++|.+++.+| .+ ..+++|++|+|++|++++..+ ..+..+++|++|+|++|++.+ ..+..|..++
T Consensus 91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~-~~~~~~~~l~ 169 (310)
T 4glp_A 91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPA-FSCEQVRAFP 169 (310)
T ss_dssp SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCC-CCTTSCCCCT
T ss_pred CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcch-hhHHHhccCC
Confidence 345555555555544444 33 445555555555555544221 222344455555555555533 3344445555
Q ss_pred CCceEeccCceeEee--cCCCccCCCCCcccEEEccCCCCCCcCCC---c-ccc-CCcceeeccCCCCCCCCCCchhhhc
Q 004020 162 GLQRFSANGANITGT--IPDFLGGDTIPGLMHLHLAFNFLQGPIPL---S-FGK-SSIQTLWLNGQKGDSKLNGSVAVIQ 234 (779)
Q Consensus 162 ~L~~L~l~~n~l~~~--~p~~~~~~~l~~L~~L~L~~N~l~~~~p~---~-~~~-~~L~~l~l~~n~~~~~~~~~~~~~~ 234 (779)
+|++|+|++|++++. ++.......+++|++|+|++|+++. +|. . ++. .+|++|++++|++....+.....+.
T Consensus 170 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 248 (310)
T 4glp_A 170 ALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCM 248 (310)
T ss_dssp TCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCC
T ss_pred CCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhcc
Confidence 555555555544331 1111100134455555555555541 111 1 111 3444445544444443222222233
Q ss_pred CCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccc
Q 004020 235 NMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQG 298 (779)
Q Consensus 235 ~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g 298 (779)
.+++|++|+|++|+|+..++.+. ++|++|+|++|+|++. |. +..+++|+.|+|++|+|+.
T Consensus 249 ~~~~L~~L~Ls~N~l~~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 249 WSSALNSLNLSFAGLEQVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCTTCCCEECCSSCCCSCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred CcCcCCEEECCCCCCCchhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 34799999999999996544554 8999999999999964 44 6788999999999999874
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-22 Score=206.05 Aligned_cols=197 Identities=19% Similarity=0.231 Sum_probs=129.0
Q ss_pred CccEEecCCCCCCCCCcccccCCCCccEEEcccCC-CCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccE
Q 004020 113 SLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNS-FDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMH 191 (779)
Q Consensus 113 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~ 191 (779)
+|++|+|++|+++.+++..|.++++|++|+|++|+ +.. ..+..|. .+++|++
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~-------------------------i~~~~f~--~l~~L~~ 84 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQ-------------------------LESHSFY--NLSKVTH 84 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCE-------------------------ECTTTEE--SCTTCCE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcce-------------------------eCHhHcC--CCcCCcE
Confidence 66777777777777666666666666666666665 543 3333343 4555555
Q ss_pred EEccC-CCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCc---EEEc
Q 004020 192 LHLAF-NFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQ---DFSV 267 (779)
Q Consensus 192 L~L~~-N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~---~L~l 267 (779)
|+|++ |++++..+..|. .+++|++|+|++|++++ +|++..+++|+ +|++
T Consensus 85 L~l~~~n~l~~i~~~~f~--------------------------~l~~L~~L~l~~n~l~~-lp~~~~l~~L~~L~~L~l 137 (239)
T 2xwt_C 85 IEIRNTRNLTYIDPDALK--------------------------ELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEI 137 (239)
T ss_dssp EEEEEETTCCEECTTSEE--------------------------CCTTCCEEEEEEECCCS-CCCCTTCCBCCSEEEEEE
T ss_pred EECCCCCCeeEcCHHHhC--------------------------CCCCCCEEeCCCCCCcc-ccccccccccccccEEEC
Confidence 55555 555533333332 45666666666666665 33455666666 7777
Q ss_pred cCC-ccccccChhhhCCCCCC-EEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCch
Q 004020 268 RDN-QLTGIVPSSLVNLHSLA-VVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPA 345 (779)
Q Consensus 268 ~~N-~l~~~~p~~l~~l~~L~-~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (779)
++| ++++..+..|..+++|+ .|+|++|+++...+..+.
T Consensus 138 ~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~---------------------------------------- 177 (239)
T 2xwt_C 138 TDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFN---------------------------------------- 177 (239)
T ss_dssp ESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTT----------------------------------------
T ss_pred CCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcC----------------------------------------
Confidence 777 77665556677777777 777777777633222110
Q ss_pred hcccccCCCCCCCCCCCccccCCCCCeEEEEccCcc-cccccccccccc-ccCCeEeccCccccccCCccCCCCCCCCce
Q 004020 346 VLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLG-LSGTISSNFSRL-TSLRQLMLSGNELTGTIPKELTTLPSLEML 423 (779)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~-l~g~~p~~~~~l-~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L 423 (779)
. .+|+.|+|++|+ +++..+..|..+ ++|+.|+|++|+|+ .+|.. .+++|+.|
T Consensus 178 ----------------------~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~--~~~~L~~L 231 (239)
T 2xwt_C 178 ----------------------G-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK--GLEHLKEL 231 (239)
T ss_dssp ----------------------T-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC-CCCCT--TCTTCSEE
T ss_pred ----------------------C-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccc-cCChh--HhccCcee
Confidence 0 268888888884 886667788889 99999999999999 66665 67889999
Q ss_pred eccCCc
Q 004020 424 DVSNNH 429 (779)
Q Consensus 424 ~Ls~N~ 429 (779)
+++++.
T Consensus 232 ~l~~~~ 237 (239)
T 2xwt_C 232 IARNTW 237 (239)
T ss_dssp ECTTC-
T ss_pred eccCcc
Confidence 998763
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=6.2e-22 Score=202.29 Aligned_cols=159 Identities=21% Similarity=0.280 Sum_probs=110.4
Q ss_pred cEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEc
Q 004020 115 QEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHL 194 (779)
Q Consensus 115 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L 194 (779)
++++++++.++.+|.... ++|++|+|++|++.+ ..+..|.++++|++|+|++|.+++..|..+. .+++|++|+|
T Consensus 17 ~~l~~~~~~l~~~p~~~~---~~l~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~L 90 (251)
T 3m19_A 17 KEVDCQGKSLDSVPSGIP---ADTEKLDLQSTGLAT-LSDATFRGLTKLTWLNLDYNQLQTLSAGVFD--DLTELGTLGL 90 (251)
T ss_dssp TEEECTTCCCSSCCSCCC---TTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTT--TCTTCCEEEC
T ss_pred eEEecCCCCccccCCCCC---CCCCEEEccCCCcCc-cCHhHhcCcccCCEEECCCCcCCccCHhHhc--cCCcCCEEEC
Confidence 344444444444443321 244444444444433 3333444444444555555555555555564 6788888888
Q ss_pred cCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCC-CCCCCCCcEEEccCCccc
Q 004020 195 AFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLT 273 (779)
Q Consensus 195 ~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~ 273 (779)
++|+|++..+..+. .+++|++|+|++|+|++.++. +..+++|++|+|++|+|+
T Consensus 91 ~~n~l~~~~~~~~~--------------------------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 144 (251)
T 3m19_A 91 ANNQLASLPLGVFD--------------------------HLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ 144 (251)
T ss_dssp TTSCCCCCCTTTTT--------------------------TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCcccccChhHhc--------------------------ccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCC
Confidence 88888865555443 588999999999999988876 788999999999999999
Q ss_pred cccChhhhCCCCCCEEEccCccccccCCCCCC
Q 004020 274 GIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNS 305 (779)
Q Consensus 274 ~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~ 305 (779)
+..+..|..+++|++|+|++|++++.++..+.
T Consensus 145 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 176 (251)
T 3m19_A 145 SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFD 176 (251)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTT
T ss_pred ccCHHHcCcCcCCCEEECCCCcCCccCHHHHh
Confidence 87778999999999999999999998886554
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.6e-22 Score=217.43 Aligned_cols=201 Identities=15% Similarity=0.168 Sum_probs=152.9
Q ss_pred EEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCC-CCcccccCCCCccE-EEcccC
Q 004020 70 IQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTS-VPSDFFKGLTSLQT-ISLDYN 146 (779)
Q Consensus 70 l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~-L~Ls~N 146 (779)
++.++++++ .+|..+ .++|++|+|++|+|+.+++ +|.++++|++|+|++|++.+ +++++|.++++|++ ++++.|
T Consensus 14 v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N 90 (350)
T 4ay9_X 14 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90 (350)
T ss_dssp EEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEET
T ss_pred EEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCC
Confidence 444567777 678766 3689999999999998887 79999999999999999754 78888999998775 667788
Q ss_pred CCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccC-CCCCCcCCCccccCCcceeeccCCCCCCC
Q 004020 147 SFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAF-NFLQGPIPLSFGKSSIQTLWLNGQKGDSK 225 (779)
Q Consensus 147 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~~~L~~l~l~~n~~~~~ 225 (779)
++.. ..|..|..+++|++|++++|.+++..+..+. ...++..|++.+ |+++...+..+..
T Consensus 91 ~l~~-l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~--~~~~l~~l~l~~~~~i~~l~~~~f~~---------------- 151 (350)
T 4ay9_X 91 NLLY-INPEAFQNLPNLQYLLISNTGIKHLPDVHKI--HSLQKVLLDIQDNINIHTIERNSFVG---------------- 151 (350)
T ss_dssp TCCE-ECTTSBCCCTTCCEEEEEEECCSSCCCCTTC--CBSSCEEEEEESCTTCCEECTTSSTT----------------
T ss_pred cccc-cCchhhhhccccccccccccccccCCchhhc--ccchhhhhhhccccccccccccchhh----------------
Confidence 8876 5678888999999999999998865555543 466777888865 5566333333321
Q ss_pred CCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccC-CccccccChhhhCCCCCCEEEccCccccccCC
Q 004020 226 LNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRD-NQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTP 301 (779)
Q Consensus 226 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~-N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p 301 (779)
....++.|+|++|+|+..++......+|++|++.+ |.++...++.|..+++|++|||++|+|+..++
T Consensus 152 ---------~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~ 219 (350)
T 4ay9_X 152 ---------LSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS 219 (350)
T ss_dssp ---------SBSSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCS
T ss_pred ---------cchhhhhhccccccccCCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccCh
Confidence 12468889999999998777766677899999975 66664444678889999999999998875443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2e-22 Score=211.88 Aligned_cols=148 Identities=22% Similarity=0.384 Sum_probs=127.3
Q ss_pred hhcCCccc-ceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHH-HcCCCCccceEeeEEEe----C
Q 004020 588 VTNNFSEE-NVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVL-TKVRHRHLVGLLGYCLD----G 660 (779)
Q Consensus 588 ~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~----~ 660 (779)
+.++|.+. +.||+|+||.||+|... +++.||+|++... ..+.+|++++ +..+||||+++++++.. .
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 34677776 78999999999999874 6899999998642 3567888888 55689999999999987 6
Q ss_pred CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC---CCcEEE
Q 004020 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKV 737 (779)
Q Consensus 661 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~~~kl 737 (779)
...++||||+++++|.+++..... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++. ++.+||
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl 161 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKL 161 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEE
T ss_pred ceEEEEEeecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEE
Confidence 678999999999999999976432 358999999999999999999997 89999999999999997 789999
Q ss_pred EeeccceecCC
Q 004020 738 ADFGLVRLAPD 748 (779)
Q Consensus 738 ~DFG~a~~~~~ 748 (779)
+|||+++....
T Consensus 162 ~Dfg~a~~~~~ 172 (299)
T 3m2w_A 162 TDFGFAKETTG 172 (299)
T ss_dssp CCCTTCEECTT
T ss_pred ecccccccccc
Confidence 99999987654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=2.6e-22 Score=211.49 Aligned_cols=176 Identities=24% Similarity=0.381 Sum_probs=128.7
Q ss_pred ccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCc
Q 004020 85 LNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQ 164 (779)
Q Consensus 85 l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~ 164 (779)
+.++++|++|++++|.++.. +.+..+++|++|+|++|+++.+++ +..+++|++|+|++|++.+ + ..+..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~l-~~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~--~-~~~~~l~~L~ 110 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVTTI-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN--V-SAIAGLQSIK 110 (308)
T ss_dssp HHHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC--C-GGGTTCTTCC
T ss_pred HHHcCCcCEEEeeCCCccCc-hhhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC--c-hhhcCCCCCC
Confidence 34567788888888877753 467778888888888888887776 7778888888888888765 3 3577788888
Q ss_pred eEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEe
Q 004020 165 RFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWL 244 (779)
Q Consensus 165 ~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L 244 (779)
.|++++|++++. +. +. .+++|++|+|++|++++..+ + ..+++|+.|+|
T Consensus 111 ~L~l~~n~l~~~-~~-l~--~l~~L~~L~l~~n~l~~~~~--l--------------------------~~l~~L~~L~l 158 (308)
T 1h6u_A 111 TLDLTSTQITDV-TP-LA--GLSNLQVLYLDLNQITNISP--L--------------------------AGLTNLQYLSI 158 (308)
T ss_dssp EEECTTSCCCCC-GG-GT--TCTTCCEEECCSSCCCCCGG--G--------------------------GGCTTCCEEEC
T ss_pred EEECCCCCCCCc-hh-hc--CCCCCCEEECCCCccCcCcc--c--------------------------cCCCCccEEEc
Confidence 888888887753 33 43 67788888888888774322 2 25777888888
Q ss_pred ecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCC
Q 004020 245 HGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTP 301 (779)
Q Consensus 245 ~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p 301 (779)
++|++++..+ +..+++|+.|++++|++++..+ +..+++|+.|+|++|++++..|
T Consensus 159 ~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~ 212 (308)
T 1h6u_A 159 GNAQVSDLTP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP 212 (308)
T ss_dssp CSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG
T ss_pred cCCcCCCChh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc
Confidence 8888876554 7777888888888888875433 7778888888888888876654
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=8e-25 Score=234.28 Aligned_cols=211 Identities=15% Similarity=0.244 Sum_probs=145.0
Q ss_pred CCCcceeeEeCCCCcEEEEEecCCCccccCCccccCC--CCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCC-C
Q 004020 52 DPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSL--SSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSV-P 128 (779)
Q Consensus 52 ~~C~w~gv~c~~~~~v~~l~l~~~~l~~~~p~~l~~l--~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~-~ 128 (779)
-|..|.++.|+ ...++.++++++++. +..+..+ ++++.|++++|.+.+.++.+.++++|++|+|++|.++.. .
T Consensus 35 vc~~W~~~~~~-~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~ 110 (336)
T 2ast_B 35 VCKRWYRLASD-ESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 110 (336)
T ss_dssp SCHHHHHHHTC-STTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHH
T ss_pred HHHHHHHHhcC-chhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHH
Confidence 34479999887 346889999999887 5667777 899999999999999888888899999999999988764 5
Q ss_pred cccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCc-eeEee-cCCCccCCCCCcccEEEccCC-CCCCc-CC
Q 004020 129 SDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGA-NITGT-IPDFLGGDTIPGLMHLHLAFN-FLQGP-IP 204 (779)
Q Consensus 129 ~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n-~l~~~-~p~~~~~~~l~~L~~L~L~~N-~l~~~-~p 204 (779)
+..+..+++|++|+|++|++.+ ..+..+..+++|++|++++| .+++. ++..+. .+++|++|+|++| .+++. ++
T Consensus 111 ~~~~~~~~~L~~L~L~~~~l~~-~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~--~~~~L~~L~l~~~~~l~~~~~~ 187 (336)
T 2ast_B 111 HGILSQCSKLQNLSLEGLRLSD-PIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLS--SCSRLDELNLSWCFDFTEKHVQ 187 (336)
T ss_dssp HHHHTTBCCCSEEECTTCBCCH-HHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHH--HCTTCCEEECCCCTTCCHHHHH
T ss_pred HHHHhhCCCCCEEeCcCcccCH-HHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHh--cCCCCCEEcCCCCCCcChHHHH
Confidence 5567888888888888888754 45666777777777777777 45542 444443 4667777777777 66532 22
Q ss_pred CccccCCcceeeccCCCCCCCCCCchhhhcCCC-CccEEEeecC--ccc-CCCC-CCCCCCCCcEEEccCCc-cccccCh
Q 004020 205 LSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMT-SLTQLWLHGN--SFT-GPLP-DLSGLSSLQDFSVRDNQ-LTGIVPS 278 (779)
Q Consensus 205 ~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~-~L~~L~L~~N--~l~-~~~~-~~~~l~~L~~L~l~~N~-l~~~~p~ 278 (779)
. .+..++ +|++|+|++| .++ +.++ .+..+++|+.|++++|. +++..+.
T Consensus 188 ~--------------------------~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~ 241 (336)
T 2ast_B 188 V--------------------------AVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQ 241 (336)
T ss_dssp H--------------------------HHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGG
T ss_pred H--------------------------HHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHH
Confidence 2 123456 6666666666 333 2223 24455666666666666 5555555
Q ss_pred hhhCCCCCCEEEccCcc
Q 004020 279 SLVNLHSLAVVNLTNNL 295 (779)
Q Consensus 279 ~l~~l~~L~~L~Ls~N~ 295 (779)
.+..+++|+.|+|++|.
T Consensus 242 ~l~~l~~L~~L~l~~~~ 258 (336)
T 2ast_B 242 EFFQLNYLQHLSLSRCY 258 (336)
T ss_dssp GGGGCTTCCEEECTTCT
T ss_pred HHhCCCCCCEeeCCCCC
Confidence 66666666666666654
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=3e-25 Score=242.36 Aligned_cols=251 Identities=18% Similarity=0.221 Sum_probs=168.0
Q ss_pred cCCccccCCCCCcEEEcccCccccCCC-----CCCCCCCccEEecCCCCCCCCC---ccc-------ccCCCCccEEEcc
Q 004020 80 TLPKELNSLSSLTVLEVMKNKLTGQIP-----SLSGLSSLQEVLFDDNNFTSVP---SDF-------FKGLTSLQTISLD 144 (779)
Q Consensus 80 ~~p~~l~~l~~L~~L~Ls~N~l~~~~~-----~~~~l~~L~~L~l~~N~l~~~~---~~~-------~~~l~~L~~L~Ls 144 (779)
.++..+..+++|++|+|++|+|+...+ .+..+++|++|+|++|.+..+. +.. +..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 567788889999999999999987532 4788999999999997665432 222 3678888899998
Q ss_pred cCCCCCC---CCcccccCCCCCceEeccCceeEeecCCCccC--CCC---------CcccEEEccCCCCC-CcCCCcccc
Q 004020 145 YNSFDSW---VIPESLKDATGLQRFSANGANITGTIPDFLGG--DTI---------PGLMHLHLAFNFLQ-GPIPLSFGK 209 (779)
Q Consensus 145 ~N~l~~~---~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~--~~l---------~~L~~L~L~~N~l~-~~~p~~~~~ 209 (779)
+|++... .+|..+..+++|+.|+|++|.++...+..+.. ..+ ++|++|+|++|+++ +.+|. +
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~-l-- 179 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKE-W-- 179 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHH-H--
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHH-H--
Confidence 8888642 25567777888888888888776443333320 012 67777777777765 22221 0
Q ss_pred CCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCccc--C---CCC-CCCCCCCCcEEEccCCccc----cccChh
Q 004020 210 SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFT--G---PLP-DLSGLSSLQDFSVRDNQLT----GIVPSS 279 (779)
Q Consensus 210 ~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~--~---~~~-~~~~l~~L~~L~l~~N~l~----~~~p~~ 279 (779)
...+..+++|++|+|++|+++ | ..+ .+..+++|+.|+|++|.|+ +.+|..
T Consensus 180 --------------------~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~ 239 (386)
T 2ca6_A 180 --------------------AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 239 (386)
T ss_dssp --------------------HHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHH
T ss_pred --------------------HHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHH
Confidence 123445677777777777776 2 344 5666777777777777775 556777
Q ss_pred hhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCC
Q 004020 280 LVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNS 359 (779)
Q Consensus 280 l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (779)
+..+++|+.|+|++|++++....
T Consensus 240 l~~~~~L~~L~L~~n~i~~~~~~--------------------------------------------------------- 262 (386)
T 2ca6_A 240 LKSWPNLRELGLNDCLLSARGAA--------------------------------------------------------- 262 (386)
T ss_dssp GGGCTTCCEEECTTCCCCHHHHH---------------------------------------------------------
T ss_pred HccCCCcCEEECCCCCCchhhHH---------------------------------------------------------
Confidence 77777777777777766532110
Q ss_pred CCCccccCCCCCeEEEEccCccccccccccc--cccccCCeEeccCccccc----cCCccC-CCCCCCCceeccCCcccc
Q 004020 360 DWKGVSCDAGGNITVVNLKNLGLSGTISSNF--SRLTSLRQLMLSGNELTG----TIPKEL-TTLPSLEMLDVSNNHLFG 432 (779)
Q Consensus 360 ~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~--~~l~~L~~L~Ls~N~l~g----~iP~~l-~~l~~L~~L~Ls~N~l~g 432 (779)
.+|..+ +.+++|+.|+|++|+|++ .+|..+ .++++|++|+|++|++++
T Consensus 263 -------------------------~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~ 317 (386)
T 2ca6_A 263 -------------------------AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 317 (386)
T ss_dssp -------------------------HHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred -------------------------HHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCc
Confidence 134444 336777777777777776 477766 557778888888887776
Q ss_pred cCC
Q 004020 433 KVP 435 (779)
Q Consensus 433 ~iP 435 (779)
..|
T Consensus 318 ~~~ 320 (386)
T 2ca6_A 318 EDD 320 (386)
T ss_dssp TSH
T ss_pred chh
Confidence 654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-22 Score=228.84 Aligned_cols=197 Identities=24% Similarity=0.352 Sum_probs=162.1
Q ss_pred CCCCC-----cceee-EeCCCCcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCC
Q 004020 50 DPDPC-----KWKHI-QCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNN 123 (779)
Q Consensus 50 ~~~~C-----~w~gv-~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~ 123 (779)
+.++| .|.++ .|. .++++.|+|++|+|++ +|..+. ++|++|+|++|+|+.+ | ..+++|++|+|++|+
T Consensus 39 ~~~~~~~~~~~~~~l~~C~-~~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~~i-p--~~l~~L~~L~Ls~N~ 111 (571)
T 3cvr_A 39 QALPGENRNEAVSLLKECL-INQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALISL-P--ELPASLEYLDACDNR 111 (571)
T ss_dssp TCCTTCCHHHHHHHHHHHH-HTTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCSCC-C--CCCTTCCEEECCSSC
T ss_pred cCCccccccchhhhccccc-cCCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCccc-c--cccCCCCEEEccCCC
Confidence 45677 79999 786 3589999999999997 887774 7999999999999954 4 568999999999999
Q ss_pred CCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcC
Q 004020 124 FTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPI 203 (779)
Q Consensus 124 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~ 203 (779)
|+++|. +.+ +|++|+|++|+|++ +|. .+++|+.|++++|.|++ +|. .+++|++|+|++|+|++ +
T Consensus 112 l~~ip~--l~~--~L~~L~Ls~N~l~~--lp~---~l~~L~~L~Ls~N~l~~-lp~-----~l~~L~~L~Ls~N~L~~-l 175 (571)
T 3cvr_A 112 LSTLPE--LPA--SLKHLDVDNNQLTM--LPE---LPALLEYINADNNQLTM-LPE-----LPTSLEVLSVRNNQLTF-L 175 (571)
T ss_dssp CSCCCC--CCT--TCCEEECCSSCCSC--CCC---CCTTCCEEECCSSCCSC-CCC-----CCTTCCEEECCSSCCSC-C
T ss_pred CCCcch--hhc--CCCEEECCCCcCCC--CCC---cCccccEEeCCCCccCc-CCC-----cCCCcCEEECCCCCCCC-c
Confidence 999887 554 99999999999987 565 68999999999999986 665 26789999999999996 6
Q ss_pred CCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCC-------cEEEccCCcccccc
Q 004020 204 PLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSL-------QDFSVRDNQLTGIV 276 (779)
Q Consensus 204 p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L-------~~L~l~~N~l~~~~ 276 (779)
|. ++ ++|+.|+|++|+|+..++ +.. +| +.|+|++|+|+ .+
T Consensus 176 p~-l~----------------------------~~L~~L~Ls~N~L~~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~l 222 (571)
T 3cvr_A 176 PE-LP----------------------------ESLEALDVSTNLLESLPA-VPV--RNHHSEETEIFFRCRENRIT-HI 222 (571)
T ss_dssp CC-CC----------------------------TTCCEEECCSSCCSSCCC-CC----------CCEEEECCSSCCC-CC
T ss_pred ch-hh----------------------------CCCCEEECcCCCCCchhh-HHH--hhhcccccceEEecCCCcce-ec
Confidence 65 42 678888888888885444 543 66 88999999998 57
Q ss_pred ChhhhCCCCCCEEEccCccccccCCC
Q 004020 277 PSSLVNLHSLAVVNLTNNLFQGQTPK 302 (779)
Q Consensus 277 p~~l~~l~~L~~L~Ls~N~l~g~~p~ 302 (779)
|..+..+++|+.|+|++|+|++.+|.
T Consensus 223 p~~l~~l~~L~~L~L~~N~l~~~~p~ 248 (571)
T 3cvr_A 223 PENILSLDPTCTIILEDNPLSSRIRE 248 (571)
T ss_dssp CGGGGGSCTTEEEECCSSSCCHHHHH
T ss_pred CHHHhcCCCCCEEEeeCCcCCCcCHH
Confidence 88888899999999999999887775
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=210.56 Aligned_cols=156 Identities=14% Similarity=0.063 Sum_probs=122.2
Q ss_pred HHHHHHhhcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccCh----------------hHHHHHHHHHHHHHcC
Q 004020 582 IQVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSE----------------KGFAEFKSEIAVLTKV 645 (779)
Q Consensus 582 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~~E~~~l~~l 645 (779)
+..+......|.+.+.||+|+||.||+|+..+|+.||+|.++...... .....+.+|+++++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 344455566788889999999999999988779999999986432111 1346789999999999
Q ss_pred CCCccceEeeEEEeCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCC
Q 004020 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPS 725 (779)
Q Consensus 646 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~ 725 (779)
+| +++.+++.. +..++||||+++++|.+ +.. .....++.|++.||+|||+ .+|+||||||+
T Consensus 162 ~~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~ 222 (282)
T 1zar_A 162 QG---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQY 222 (282)
T ss_dssp TT---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTT
T ss_pred cC---CCcCeEEec-cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHH
Confidence 94 556665443 55699999999999987 411 1234799999999999996 89999999999
Q ss_pred CEEEcCCCcEEEEeeccceecCCCCCcccccccccCCcccccccccc
Q 004020 726 NILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 726 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
|||++ ++.+||+|||+|+.. ..|+|||++.+
T Consensus 223 NILl~-~~~vkl~DFG~a~~~---------------~~~~a~e~l~r 253 (282)
T 1zar_A 223 NVLVS-EEGIWIIDFPQSVEV---------------GEEGWREILER 253 (282)
T ss_dssp SEEEE-TTEEEECCCTTCEET---------------TSTTHHHHHHH
T ss_pred HEEEE-CCcEEEEECCCCeEC---------------CCCCHHHHHHH
Confidence 99999 999999999998643 34678887753
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.87 E-value=5.6e-23 Score=225.93 Aligned_cols=172 Identities=21% Similarity=0.232 Sum_probs=126.4
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccc-cChhHHHHHHHHHHHHHcCCC-Cccc---------e-----
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAV-VSEKGFAEFKSEIAVLTKVRH-RHLV---------G----- 652 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h-~niv---------~----- 652 (779)
..|...+.||+|+||.||+|++. +|+.||||++.... ......+.+.+|+.+++.++| ++.. .
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45778899999999999999854 79999999987332 222335779999999999987 2211 1
Q ss_pred -------EeeEEEe-----CCeEEEEEEecCCCChhhHhhhcc--cCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcE
Q 004020 653 -------LLGYCLD-----GNERLLVYEYMPQGTLSRHLFNRK--EEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFI 718 (779)
Q Consensus 653 -------~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iv 718 (779)
+..++.. ....+++|+++ +++|.+++.... ......+++..++.++.||++||+|||+ ++|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcc
Confidence 1111111 12356777765 689998884221 1112357788999999999999999996 8999
Q ss_pred EcCCCCCCEEEcCCCcEEEEeeccceecCCCCCcccccccccCCccccccccc
Q 004020 719 HRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAA 771 (779)
Q Consensus 719 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~ 771 (779)
||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++.
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~ 280 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTA 280 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhh
Confidence 9999999999999999999999998875432 234567 9999999984
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.87 E-value=3.6e-22 Score=197.83 Aligned_cols=183 Identities=23% Similarity=0.362 Sum_probs=133.4
Q ss_pred CcceeeEeCCCCcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccc
Q 004020 54 CKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFF 132 (779)
Q Consensus 54 C~w~gv~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~ 132 (779)
|.|.+|.|+. ++++ .+|..+ .++|++|+|++|++++.++ .|.++++|++|+|++|+++.+++..|
T Consensus 7 C~~~~v~c~~-----------~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 72 (208)
T 2o6s_A 7 CSGTTVECYS-----------QGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVF 72 (208)
T ss_dssp EETTEEECCS-----------SCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTT
T ss_pred ECCCEEEecC-----------CCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhc
Confidence 6899988874 3344 455544 3589999999999998777 58899999999999999999999888
Q ss_pred cCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCc
Q 004020 133 KGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSI 212 (779)
Q Consensus 133 ~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L 212 (779)
..+++|++|+|++|++.+ ..+..|..+++|++|++++|++++..+..+. .+++|++|+|++|++++..+..+.
T Consensus 73 ~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~l~~N~l~~~~~~~~~---- 145 (208)
T 2o6s_A 73 NKLTSLTYLNLSTNQLQS-LPNGVFDKLTQLKELALNTNQLQSLPDGVFD--KLTQLKDLRLYQNQLKSVPDGVFD---- 145 (208)
T ss_dssp TTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTT--TCTTCCEEECCSSCCSCCCTTTTT----
T ss_pred CCCCCcCEEECCCCcCCc-cCHhHhcCccCCCEEEcCCCcCcccCHhHhc--cCCcCCEEECCCCccceeCHHHhc----
Confidence 999999999999999975 4455667777777777777777765555554 567777777777777754443333
Q ss_pred ceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCC
Q 004020 213 QTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHS 285 (779)
Q Consensus 213 ~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~ 285 (779)
.+++|+.|+|++|.+.+. +++|++|+++.|+++|.+|.+++.++.
T Consensus 146 ----------------------~l~~L~~L~l~~N~~~~~------~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 146 ----------------------RLTSLQYIWLHDNPWDCT------CPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp ----------------------TCTTCCEEECCSCCBCCC------TTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred ----------------------cCCCccEEEecCCCeecC------CCCHHHHHHHHHhCCceeeccCccccC
Confidence 466677777777765542 345666667777777777766665543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.9e-21 Score=208.97 Aligned_cols=242 Identities=14% Similarity=0.127 Sum_probs=172.0
Q ss_pred cEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCce-EeccC
Q 004020 92 TVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQR-FSANG 170 (779)
Q Consensus 92 ~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~-L~l~~ 170 (779)
++++-++|+|+.+|..+ .++|++|+|++|+|+.+++++|.++++|++|+|++|++.+...+..|.++++|.. +.+..
T Consensus 12 ~~v~C~~~~Lt~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~ 89 (350)
T 4ay9_X 12 RVFLCQESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89 (350)
T ss_dssp TEEEEESTTCCSCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred CEEEecCCCCCccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence 56888999999766555 3689999999999999999999999999999999999866344567888888765 66677
Q ss_pred ceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeec-Ccc
Q 004020 171 ANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHG-NSF 249 (779)
Q Consensus 171 n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~-N~l 249 (779)
|+++...|+.|. .+++|++|++++|+|++..+..+. ...++..|++.+ |++
T Consensus 90 N~l~~l~~~~f~--~l~~L~~L~l~~n~l~~~~~~~~~--------------------------~~~~l~~l~l~~~~~i 141 (350)
T 4ay9_X 90 NNLLYINPEAFQ--NLPNLQYLLISNTGIKHLPDVHKI--------------------------HSLQKVLLDIQDNINI 141 (350)
T ss_dssp TTCCEECTTSBC--CCTTCCEEEEEEECCSSCCCCTTC--------------------------CBSSCEEEEEESCTTC
T ss_pred CcccccCchhhh--hccccccccccccccccCCchhhc--------------------------ccchhhhhhhcccccc
Confidence 889887788876 788999999999999855443332 345677788866 466
Q ss_pred cCCCC-CCCCC-CCCcEEEccCCccccccChhhhCCCCCCEEEccC-ccccccCCCCCCCcccccccCCCCcccCCCCcc
Q 004020 250 TGPLP-DLSGL-SSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTN-NLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVA 326 (779)
Q Consensus 250 ~~~~~-~~~~l-~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~-N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (779)
....+ .|..+ ..++.|+|++|+|+. +|.......+|+.|++++ |.++...++.+..
T Consensus 142 ~~l~~~~f~~~~~~l~~L~L~~N~i~~-i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~-------------------- 200 (350)
T 4ay9_X 142 HTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHG-------------------- 200 (350)
T ss_dssp CEECTTSSTTSBSSCEEEECCSSCCCE-ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTT--------------------
T ss_pred ccccccchhhcchhhhhhccccccccC-CChhhccccchhHHhhccCCcccCCCHHHhcc--------------------
Confidence 65555 36655 468889999999884 555555667788888875 5555433332221
Q ss_pred cCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccCccc
Q 004020 327 CDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNEL 406 (779)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l 406 (779)
.++|+.|+|++|+|+...+..|.+ |+.|.+.++.-
T Consensus 201 ------------------------------------------l~~L~~LdLs~N~l~~lp~~~~~~---L~~L~~l~~~~ 235 (350)
T 4ay9_X 201 ------------------------------------------ASGPVILDISRTRIHSLPSYGLEN---LKKLRARSTYN 235 (350)
T ss_dssp ------------------------------------------EECCSEEECTTSCCCCCCSSSCTT---CCEEECTTCTT
T ss_pred ------------------------------------------CcccchhhcCCCCcCccChhhhcc---chHhhhccCCC
Confidence 126788888888888544434444 44444333332
Q ss_pred cccCCccCCCCCCCCceeccCCcc
Q 004020 407 TGTIPKELTTLPSLEMLDVSNNHL 430 (779)
Q Consensus 407 ~g~iP~~l~~l~~L~~L~Ls~N~l 430 (779)
-..+| .+..+++|+.++++++.-
T Consensus 236 l~~lP-~l~~l~~L~~l~l~~~~~ 258 (350)
T 4ay9_X 236 LKKLP-TLEKLVALMEASLTYPSH 258 (350)
T ss_dssp CCCCC-CTTTCCSCCEEECSCHHH
T ss_pred cCcCC-CchhCcChhhCcCCCCcc
Confidence 33677 477788888888876654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=5.6e-21 Score=216.04 Aligned_cols=195 Identities=24% Similarity=0.349 Sum_probs=115.0
Q ss_pred CccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEE
Q 004020 113 SLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHL 192 (779)
Q Consensus 113 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L 192 (779)
+|+.|+|++|+|+++|...+ ++|++|+|++|+|.. +| ..+++|+.|++++|+|++ +|. +. . +|++|
T Consensus 60 ~L~~L~Ls~n~L~~lp~~l~---~~L~~L~Ls~N~l~~--ip---~~l~~L~~L~Ls~N~l~~-ip~-l~--~--~L~~L 125 (571)
T 3cvr_A 60 QFSELQLNRLNLSSLPDNLP---PQITVLEITQNALIS--LP---ELPASLEYLDACDNRLST-LPE-LP--A--SLKHL 125 (571)
T ss_dssp TCSEEECCSSCCSCCCSCCC---TTCSEEECCSSCCSC--CC---CCCTTCCEEECCSSCCSC-CCC-CC--T--TCCEE
T ss_pred CccEEEeCCCCCCccCHhHc---CCCCEEECcCCCCcc--cc---cccCCCCEEEccCCCCCC-cch-hh--c--CCCEE
Confidence 34444444444444433321 344444444444432 23 223444444444444444 454 43 1 67777
Q ss_pred EccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCcc
Q 004020 193 HLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQL 272 (779)
Q Consensus 193 ~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l 272 (779)
+|++|+|++ +|. .+++|+.|+|++|+|++. |. .+++|++|+|++|+|
T Consensus 126 ~Ls~N~l~~-lp~-----------------------------~l~~L~~L~Ls~N~l~~l-p~--~l~~L~~L~Ls~N~L 172 (571)
T 3cvr_A 126 DVDNNQLTM-LPE-----------------------------LPALLEYINADNNQLTML-PE--LPTSLEVLSVRNNQL 172 (571)
T ss_dssp ECCSSCCSC-CCC-----------------------------CCTTCCEEECCSSCCSCC-CC--CCTTCCEEECCSSCC
T ss_pred ECCCCcCCC-CCC-----------------------------cCccccEEeCCCCccCcC-CC--cCCCcCEEECCCCCC
Confidence 777777765 443 146677777777777763 33 467777888888877
Q ss_pred ccccChhhhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccC
Q 004020 273 TGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWK 352 (779)
Q Consensus 273 ~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (779)
++ +|. |. ++|+.|+|++|+|+ .+|.+ .. . +
T Consensus 173 ~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~~-~~-~--L----------------------------------------- 202 (571)
T 3cvr_A 173 TF-LPE-LP--ESLEALDVSTNLLE-SLPAV-PV-R--N----------------------------------------- 202 (571)
T ss_dssp SC-CCC-CC--TTCCEEECCSSCCS-SCCCC-C-----------------------------------------------
T ss_pred CC-cch-hh--CCCCEEECcCCCCC-chhhH-HH-h--h-----------------------------------------
Confidence 75 566 55 77888888888877 33321 10 0 0
Q ss_pred CCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccCccccccCCccCCCCC
Q 004020 353 GNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLP 418 (779)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~ 418 (779)
......|+.|+|++|+|+ .+|..+..+++|+.|+|++|.|+|.+|..+..++
T Consensus 203 -------------~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 254 (571)
T 3cvr_A 203 -------------HHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254 (571)
T ss_dssp ------------------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred -------------hcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence 000113578888888887 4777777788888888888888888887766654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=6.4e-21 Score=188.80 Aligned_cols=80 Identities=20% Similarity=0.260 Sum_probs=45.4
Q ss_pred cEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCc
Q 004020 92 TVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGA 171 (779)
Q Consensus 92 ~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n 171 (779)
+.++.+++.++..+..+ .++|++|+|++|+++.+++..|.++++|++|+|++|++.+ ..+..|..+++|++|++++|
T Consensus 10 ~~v~c~~~~l~~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRTSVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCSSCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC-CCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCccCCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCc-cChhhcCCCCCcCEEECCCC
Confidence 45666666666554433 2466777777777776666666666666666666666653 22333444444444444444
Q ss_pred eeE
Q 004020 172 NIT 174 (779)
Q Consensus 172 ~l~ 174 (779)
+++
T Consensus 87 ~l~ 89 (208)
T 2o6s_A 87 QLQ 89 (208)
T ss_dssp CCC
T ss_pred cCC
Confidence 444
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.85 E-value=3.1e-23 Score=221.86 Aligned_cols=251 Identities=14% Similarity=0.166 Sum_probs=193.6
Q ss_pred CCCcEEEcccCccccCCCCCCCC--CCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceE
Q 004020 89 SSLTVLEVMKNKLTGQIPSLSGL--SSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRF 166 (779)
Q Consensus 89 ~~L~~L~Ls~N~l~~~~~~~~~l--~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L 166 (779)
..++.|++++|.+.. ..+..+ ++++.|++++|.+++.++. +..+++|++|+|++|.+....++..+..+++|+.|
T Consensus 47 ~~~~~l~l~~~~~~~--~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 47 SLWQTLDLTGKNLHP--DVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TTSSEEECTTCBCCH--HHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hhheeeccccccCCH--HHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 348899999998762 245666 8899999999999988877 44789999999999988653377788899999999
Q ss_pred eccCceeEeecCCCccCCCCCcccEEEccCC-CCCCc-CCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEe
Q 004020 167 SANGANITGTIPDFLGGDTIPGLMHLHLAFN-FLQGP-IPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWL 244 (779)
Q Consensus 167 ~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L 244 (779)
++++|.+++..|..++ .+++|++|+|++| .+++. ++. .+..+++|++|+|
T Consensus 124 ~L~~~~l~~~~~~~l~--~~~~L~~L~L~~~~~l~~~~l~~--------------------------~~~~~~~L~~L~l 175 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLA--KNSNLVRLNLSGCSGFSEFALQT--------------------------LLSSCSRLDELNL 175 (336)
T ss_dssp ECTTCBCCHHHHHHHT--TCTTCSEEECTTCBSCCHHHHHH--------------------------HHHHCTTCCEEEC
T ss_pred eCcCcccCHHHHHHHh--cCCCCCEEECCCCCCCCHHHHHH--------------------------HHhcCCCCCEEcC
Confidence 9999998888888776 6889999999999 57642 222 2446899999999
Q ss_pred ecC-cccCC-CC-CCCCCC-CCcEEEccCC--ccc-cccChhhhCCCCCCEEEccCcc-ccccCCCCCCCcccccccCCC
Q 004020 245 HGN-SFTGP-LP-DLSGLS-SLQDFSVRDN--QLT-GIVPSSLVNLHSLAVVNLTNNL-FQGQTPKFNSPVRFDMAKGSN 316 (779)
Q Consensus 245 ~~N-~l~~~-~~-~~~~l~-~L~~L~l~~N--~l~-~~~p~~l~~l~~L~~L~Ls~N~-l~g~~p~~~~~~~~~~~~~~~ 316 (779)
++| .+++. ++ .+..++ +|++|++++| .++ +.+|..+..+++|+.|+|++|. +++..+..+
T Consensus 176 ~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l------------ 243 (336)
T 2ast_B 176 SWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEF------------ 243 (336)
T ss_dssp CCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGG------------
T ss_pred CCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHH------------
Confidence 999 99863 34 377788 9999999999 555 5678888999999999999998 665433211
Q ss_pred CcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCcc-cccccccccccccc
Q 004020 317 SFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLG-LSGTISSNFSRLTS 395 (779)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~-l~g~~p~~~~~l~~ 395 (779)
...++|+.|+|++|. +.......++++++
T Consensus 244 --------------------------------------------------~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~ 273 (336)
T 2ast_B 244 --------------------------------------------------FQLNYLQHLSLSRCYDIIPETLLELGEIPT 273 (336)
T ss_dssp --------------------------------------------------GGCTTCCEEECTTCTTCCGGGGGGGGGCTT
T ss_pred --------------------------------------------------hCCCCCCEeeCCCCCCCCHHHHHHHhcCCC
Confidence 112479999999995 33333336888999
Q ss_pred CCeEeccCccccccCCc-cCCCC-CCCCceeccCCcccccCCCC
Q 004020 396 LRQLMLSGNELTGTIPK-ELTTL-PSLEMLDVSNNHLFGKVPNF 437 (779)
Q Consensus 396 L~~L~Ls~N~l~g~iP~-~l~~l-~~L~~L~Ls~N~l~g~iP~~ 437 (779)
|+.|+|++| +|. .+..+ ..|..|++++|+++|..|..
T Consensus 274 L~~L~l~~~-----i~~~~~~~l~~~l~~L~l~~n~l~~~~~~~ 312 (336)
T 2ast_B 274 LKTLQVFGI-----VPDGTLQLLKEALPHLQINCSHFTTIARPT 312 (336)
T ss_dssp CCEEECTTS-----SCTTCHHHHHHHSTTSEESCCCSCCTTCSS
T ss_pred CCEEeccCc-----cCHHHHHHHHhhCcceEEecccCccccCCc
Confidence 999999999 333 23334 34888889999999998863
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.84 E-value=7.2e-23 Score=221.27 Aligned_cols=263 Identities=16% Similarity=0.198 Sum_probs=196.7
Q ss_pred EEEcccCccccCCCCCCC-CCCccEEecCCCCCCCCCc----ccccCCC-CccEEEcccCCCCCCCCcccccCC-----C
Q 004020 93 VLEVMKNKLTGQIPSLSG-LSSLQEVLFDDNNFTSVPS----DFFKGLT-SLQTISLDYNSFDSWVIPESLKDA-----T 161 (779)
Q Consensus 93 ~L~Ls~N~l~~~~~~~~~-l~~L~~L~l~~N~l~~~~~----~~~~~l~-~L~~L~Ls~N~l~~~~~p~~~~~l-----~ 161 (779)
+++|+.|.+++.+|.+.. .++|++|+|++|+++.++. ..|..++ +|++|+|++|++.. ..+..+..+ +
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~-~~~~~l~~~l~~~~~ 80 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGF-KNSDELVQILAAIPA 80 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGG-SCHHHHHHHHHTSCT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCH-HHHHHHHHHHhccCC
Confidence 578999999999886544 4559999999999999998 7888999 99999999999976 456666664 8
Q ss_pred CCceEeccCceeEeecCCCccC--CCC-CcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcC-CC
Q 004020 162 GLQRFSANGANITGTIPDFLGG--DTI-PGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQN-MT 237 (779)
Q Consensus 162 ~L~~L~l~~n~l~~~~p~~~~~--~~l-~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~-l~ 237 (779)
+|+.|+|++|.+++..+..++. ..+ ++|++|+|++|++++..+..++ ..+.. .+
T Consensus 81 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~----------------------~~l~~~~~ 138 (362)
T 3goz_A 81 NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFK----------------------QAFSNLPA 138 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH----------------------HHHTTSCT
T ss_pred CccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHH----------------------HHHHhCCC
Confidence 9999999999998766664431 023 7899999999999865554443 12334 36
Q ss_pred CccEEEeecCcccCCCC-----CCCCCC-CCcEEEccCCccccccChhhhC----C-CCCCEEEccCccccccCCCCCCC
Q 004020 238 SLTQLWLHGNSFTGPLP-----DLSGLS-SLQDFSVRDNQLTGIVPSSLVN----L-HSLAVVNLTNNLFQGQTPKFNSP 306 (779)
Q Consensus 238 ~L~~L~L~~N~l~~~~~-----~~~~l~-~L~~L~l~~N~l~~~~p~~l~~----l-~~L~~L~Ls~N~l~g~~p~~~~~ 306 (779)
+|++|+|++|.++.... .+..++ +|++|+|++|++++..+..+.. + ++|+.|+|++|++++.....
T Consensus 139 ~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~--- 215 (362)
T 3goz_A 139 SITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAE--- 215 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHH---
T ss_pred ceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHH---
Confidence 89999999999986433 134444 8999999999998777765554 4 59999999999987532110
Q ss_pred cccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccc
Q 004020 307 VRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTI 386 (779)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~ 386 (779)
+.... ....++|+.|+|++|.+++..
T Consensus 216 ---------------------------l~~~l---------------------------~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 216 ---------------------------LAYIF---------------------------SSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp ---------------------------HHHHH---------------------------HHSCTTCCEEECCSSCCCCCC
T ss_pred ---------------------------HHHHH---------------------------hcCCCCceEEECcCCCCCcHH
Confidence 00000 001137899999999998755
Q ss_pred c----ccccccccCCeEeccCccccc-------cCCccCCCCCCCCceeccCCcccccCC
Q 004020 387 S----SNFSRLTSLRQLMLSGNELTG-------TIPKELTTLPSLEMLDVSNNHLFGKVP 435 (779)
Q Consensus 387 p----~~~~~l~~L~~L~Ls~N~l~g-------~iP~~l~~l~~L~~L~Ls~N~l~g~iP 435 (779)
+ ..+..+++|+.|+|++|++++ .++..+..+++|++|||++|++.+..|
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 4 445778999999999999553 345578899999999999999987644
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.84 E-value=7.1e-22 Score=231.77 Aligned_cols=224 Identities=17% Similarity=0.149 Sum_probs=113.5
Q ss_pred ChhHHHHHHHHHHHcCC---CCCCCCCC--CCCCcceeeEeCCCCcEEEEEecCCCccccCCccccCCCCCcEEEcccCc
Q 004020 26 SSSDAAAMQALKTSLGN---PASLGWTD--PDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNK 100 (779)
Q Consensus 26 ~~~~~~~l~~~k~~~~~---~~~~~w~~--~~~C~w~gv~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~ 100 (779)
...+.++|.++..+... .....|.. ...+.|.++.++. .+++.|+|.++++.. ++. ..|+.++|+.|.
T Consensus 130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-~~~~~l~L~~n~~~~-~~~-----~~l~~l~Ls~~~ 202 (727)
T 4b8c_D 130 VDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST-PLTPKIELFANGKDE-ANQ-----ALLQHKKLSQYS 202 (727)
T ss_dssp --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred cccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC-CccceEEeeCCCCCc-chh-----hHhhcCccCccc
Confidence 35567888888877621 22235643 3467899998874 689999999999985 333 245666666666
Q ss_pred cccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCC
Q 004020 101 LTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDF 180 (779)
Q Consensus 101 l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~ 180 (779)
|.+ ++++.|++. ++++.|..+++|++|+|++|++.. +|..+.++++|++|+|++|.|+ .+|..
T Consensus 203 i~~-------------~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~~--l~~~~~~l~~L~~L~Ls~N~l~-~lp~~ 265 (727)
T 4b8c_D 203 IDE-------------DDDIENRMV-MPKDSKYDDQLWHALDLSNLQIFN--ISANIFKYDFLTRLYLNGNSLT-ELPAE 265 (727)
T ss_dssp ---------------------------------CCCCCCEEECTTSCCSC--CCGGGGGCCSCSCCBCTTSCCS-CCCGG
T ss_pred ccC-------------cccccccee-cChhhhccCCCCcEEECCCCCCCC--CChhhcCCCCCCEEEeeCCcCc-ccChh
Confidence 553 234455555 455567777777777777777753 5656667777777777777777 67777
Q ss_pred ccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCC
Q 004020 181 LGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLS 260 (779)
Q Consensus 181 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~ 260 (779)
|+ .+++|++|+|++|+|+ .+|..++ .+++|++|+|++|.|+..++.|..++
T Consensus 266 ~~--~l~~L~~L~Ls~N~l~-~lp~~~~--------------------------~l~~L~~L~L~~N~l~~lp~~~~~l~ 316 (727)
T 4b8c_D 266 IK--NLSNLRVLDLSHNRLT-SLPAELG--------------------------SCFQLKYFYFFDNMVTTLPWEFGNLC 316 (727)
T ss_dssp GG--GGTTCCEEECTTSCCS-SCCSSGG--------------------------GGTTCSEEECCSSCCCCCCSSTTSCT
T ss_pred hh--CCCCCCEEeCcCCcCC-ccChhhc--------------------------CCCCCCEEECCCCCCCccChhhhcCC
Confidence 75 6888888888888888 6677665 57888888888888875555688888
Q ss_pred CCcEEEccCCccccccChhhhCCCC-CCEEEccCccccccCCC
Q 004020 261 SLQDFSVRDNQLTGIVPSSLVNLHS-LAVVNLTNNLFQGQTPK 302 (779)
Q Consensus 261 ~L~~L~l~~N~l~~~~p~~l~~l~~-L~~L~Ls~N~l~g~~p~ 302 (779)
+|+.|+|++|.|++.+|..+..+.. +..|+|++|.++|.+|.
T Consensus 317 ~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~ 359 (727)
T 4b8c_D 317 NLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH 359 (727)
T ss_dssp TCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred CccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence 8888888888888888887766432 23467888888877775
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.83 E-value=1.5e-22 Score=220.87 Aligned_cols=206 Identities=20% Similarity=0.278 Sum_probs=161.2
Q ss_pred CcEEEEEecCCCccccCC----ccccCCCCCcEEEcccC---ccccCCC-C-------CCCCCCccEEecCCCCCCC---
Q 004020 65 NRVTRIQIGGQNIEGTLP----KELNSLSSLTVLEVMKN---KLTGQIP-S-------LSGLSSLQEVLFDDNNFTS--- 126 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~~p----~~l~~l~~L~~L~Ls~N---~l~~~~~-~-------~~~l~~L~~L~l~~N~l~~--- 126 (779)
.+++.|+|++|++++..+ ..|..+++|++|+|++| ++++.+| . +..+++|++|+|++|+++.
T Consensus 32 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~ 111 (386)
T 2ca6_A 32 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 111 (386)
T ss_dssp SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred CCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHH
Confidence 469999999999987644 45779999999999996 4555544 3 3789999999999999998
Q ss_pred -CCcccccCCCCccEEEcccCCCCCC---CCcccccCC---------CCCceEeccCceeE-eecC---CCccCCCCCcc
Q 004020 127 -VPSDFFKGLTSLQTISLDYNSFDSW---VIPESLKDA---------TGLQRFSANGANIT-GTIP---DFLGGDTIPGL 189 (779)
Q Consensus 127 -~~~~~~~~l~~L~~L~Ls~N~l~~~---~~p~~~~~l---------~~L~~L~l~~n~l~-~~~p---~~~~~~~l~~L 189 (779)
..+..+..+++|++|+|++|.+... .++..+..+ ++|+.|++++|+++ +.+| ..+. .+++|
T Consensus 112 ~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~--~~~~L 189 (386)
T 2ca6_A 112 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ--SHRLL 189 (386)
T ss_dssp HHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHH--HCTTC
T ss_pred HHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHH--hCCCc
Confidence 3455688999999999999998531 123334444 89999999999997 4444 3444 57899
Q ss_pred cEEEccCCCCCC-----cCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCccc----CCCC-CCCCC
Q 004020 190 MHLHLAFNFLQG-----PIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFT----GPLP-DLSGL 259 (779)
Q Consensus 190 ~~L~L~~N~l~~-----~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~----~~~~-~~~~l 259 (779)
++|+|++|+++. ..|. .+..+++|+.|+|++|.++ +.+| .+..+
T Consensus 190 ~~L~L~~n~l~~~g~~~l~~~--------------------------~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~ 243 (386)
T 2ca6_A 190 HTVKMVQNGIRPEGIEHLLLE--------------------------GLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 243 (386)
T ss_dssp CEEECCSSCCCHHHHHHHHHT--------------------------TGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGC
T ss_pred CEEECcCCCCCHhHHHHHHHH--------------------------HhhcCCCccEEECcCCCCCcHHHHHHHHHHccC
Confidence 999999999972 1221 2446899999999999996 4455 48889
Q ss_pred CCCcEEEccCCccccc----cChhhhC--CCCCCEEEccCccccc
Q 004020 260 SSLQDFSVRDNQLTGI----VPSSLVN--LHSLAVVNLTNNLFQG 298 (779)
Q Consensus 260 ~~L~~L~l~~N~l~~~----~p~~l~~--l~~L~~L~Ls~N~l~g 298 (779)
++|+.|+|++|+|++. +|..+.. +++|+.|+|++|++++
T Consensus 244 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~ 288 (386)
T 2ca6_A 244 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 288 (386)
T ss_dssp TTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred CCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCH
Confidence 9999999999999876 5677744 7888888888887764
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.82 E-value=5.3e-20 Score=210.49 Aligned_cols=189 Identities=22% Similarity=0.354 Sum_probs=142.8
Q ss_pred EecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCC
Q 004020 71 QIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDS 150 (779)
Q Consensus 71 ~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 150 (779)
++..+.+...++ +..|++|+.|+|++|.|... +.+..+++|+.|+|++|+|+++++ +..+++|+.|+|++|+|.+
T Consensus 27 ~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~ 101 (605)
T 1m9s_A 27 NLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD 101 (605)
T ss_dssp HTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-TTGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred hccCCCcccccc--hhcCCCCCEEECcCCCCCCC-hHHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC
Confidence 344444443332 45677777788888777644 467777888888888888877776 7778888888888888765
Q ss_pred CCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCch
Q 004020 151 WVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSV 230 (779)
Q Consensus 151 ~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~ 230 (779)
+| .+..+++|+.|+|++|++++ ++ .+. .+++|+.|+|++|+|++. ..
T Consensus 102 --l~-~l~~l~~L~~L~Ls~N~l~~-l~-~l~--~l~~L~~L~Ls~N~l~~l--~~------------------------ 148 (605)
T 1m9s_A 102 --LS-SLKDLKKLKSLSLEHNGISD-IN-GLV--HLPQLESLYLGNNKITDI--TV------------------------ 148 (605)
T ss_dssp --CT-TSTTCTTCCEEECTTSCCCC-CG-GGG--GCTTCSEEECCSSCCCCC--GG------------------------
T ss_pred --Ch-hhccCCCCCEEEecCCCCCC-Cc-ccc--CCCccCEEECCCCccCCc--hh------------------------
Confidence 23 67777788888888887774 33 343 578888888888888753 22
Q ss_pred hhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCC
Q 004020 231 AVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK 302 (779)
Q Consensus 231 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~ 302 (779)
+..+++|+.|+|++|.|++.+| +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++++.+..
T Consensus 149 --l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~ 215 (605)
T 1m9s_A 149 --LSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPIN 215 (605)
T ss_dssp --GGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCC
T ss_pred --hcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCccc
Confidence 3468999999999999998877 88899999999999999864 4689999999999999999875443
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.82 E-value=8.3e-20 Score=183.53 Aligned_cols=151 Identities=18% Similarity=0.258 Sum_probs=88.0
Q ss_pred CCCCCCCCcceeeEeCCC----------CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCcc
Q 004020 47 GWTDPDPCKWKHIQCSPS----------NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQ 115 (779)
Q Consensus 47 ~w~~~~~C~w~gv~c~~~----------~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~ 115 (779)
.|.+.+.|.|++|.|+.. .+++.|+|++|++++..|..|..+++|++|+|++|+|+..++ .|.++++|+
T Consensus 12 ~~~~~~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~ 91 (229)
T 3e6j_A 12 ACPSQCSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLT 91 (229)
T ss_dssp CCCTTCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred cCCCCCEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcC
Confidence 456678899999999752 235555555555555555555555555555555555554444 345555555
Q ss_pred EEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEcc
Q 004020 116 EVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLA 195 (779)
Q Consensus 116 ~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~ 195 (779)
+|+|++|+|+.+++..|..+++|++|+|++|+|.. +|..+..+++|+.|+|++|+|++..+..+. .+++|++|+|+
T Consensus 92 ~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~--lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~l~ 167 (229)
T 3e6j_A 92 VLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTE--LPRGIERLTHLTHLALDQNQLKSIPHGAFD--RLSSLTHAYLF 167 (229)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCS--CCTTGGGCTTCSEEECCSSCCCCCCTTTTT--TCTTCCEEECT
T ss_pred EEECCCCcCCccChhHhCcchhhCeEeccCCcccc--cCcccccCCCCCEEECCCCcCCccCHHHHh--CCCCCCEEEee
Confidence 55555555555555555555555555555555542 455555555555555555555544444443 45555555555
Q ss_pred CCCCCC
Q 004020 196 FNFLQG 201 (779)
Q Consensus 196 ~N~l~~ 201 (779)
+|.+..
T Consensus 168 ~N~~~c 173 (229)
T 3e6j_A 168 GNPWDC 173 (229)
T ss_dssp TSCBCT
T ss_pred CCCccC
Confidence 555553
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.81 E-value=8.6e-20 Score=190.48 Aligned_cols=174 Identities=24% Similarity=0.364 Sum_probs=125.1
Q ss_pred cCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCce
Q 004020 86 NSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQR 165 (779)
Q Consensus 86 ~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~ 165 (779)
..+++|++|++++|.+... +.+..+++|++|+|++|+++++++ +..+++|++|+|++|++.+ + ..+..+++|+.
T Consensus 43 ~~l~~L~~L~l~~~~i~~~-~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~--~-~~l~~l~~L~~ 116 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD--L-SSLKDLKKLKS 116 (291)
T ss_dssp HHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC--G-GGGTTCTTCCE
T ss_pred hhcCcccEEEccCCCcccC-hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC--C-hhhccCCCCCE
Confidence 4556677777777766644 446666777777777777776665 6667777777777777654 2 23666777777
Q ss_pred EeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEee
Q 004020 166 FSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLH 245 (779)
Q Consensus 166 L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~ 245 (779)
|++++|++++. +.+. .+++|++|+|++|++++. .. +..+++|+.|+|+
T Consensus 117 L~L~~n~i~~~--~~l~--~l~~L~~L~l~~n~l~~~--~~--------------------------l~~l~~L~~L~L~ 164 (291)
T 1h6t_A 117 LSLEHNGISDI--NGLV--HLPQLESLYLGNNKITDI--TV--------------------------LSRLTKLDTLSLE 164 (291)
T ss_dssp EECTTSCCCCC--GGGG--GCTTCCEEECCSSCCCCC--GG--------------------------GGGCTTCSEEECC
T ss_pred EECCCCcCCCC--hhhc--CCCCCCEEEccCCcCCcc--hh--------------------------hccCCCCCEEEcc
Confidence 77777776642 2343 577888888888888743 22 3367889999999
Q ss_pred cCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccC
Q 004020 246 GNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQT 300 (779)
Q Consensus 246 ~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~ 300 (779)
+|++++.++ +..+++|+.|++++|+|++ +| .+..+++|+.|+|++|+++...
T Consensus 165 ~N~l~~~~~-l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~~~ 216 (291)
T 1h6t_A 165 DNQISDIVP-LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNKP 216 (291)
T ss_dssp SSCCCCCGG-GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEECCC
T ss_pred CCccccchh-hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccCCc
Confidence 999888766 8888999999999999985 44 4888999999999999987643
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.80 E-value=7.3e-22 Score=228.34 Aligned_cols=323 Identities=17% Similarity=0.120 Sum_probs=220.9
Q ss_pred CcEEEEEecCCCcccc----CCccccCCCCCcEEEcccCccccCC----C-CCCCCCCccEEecCCCCCCCCCcccccCC
Q 004020 65 NRVTRIQIGGQNIEGT----LPKELNSLSSLTVLEVMKNKLTGQI----P-SLSGLSSLQEVLFDDNNFTSVPSDFFKGL 135 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~----~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 135 (779)
.++++|+|++|.+++. ++..+..+++|++|+|++|.+++.. + .+.++++|++|+|++|.+.+++ ..+.++
T Consensus 164 ~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~-~~~~~~ 242 (592)
T 3ogk_B 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELV-GFFKAA 242 (592)
T ss_dssp TTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGH-HHHHHC
T ss_pred CCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHH-HHHhhh
Confidence 5799999999998766 4555678899999999999997432 2 3577899999999999999876 568899
Q ss_pred CCccEEEcccCCCC--CCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCc-ccc-CC
Q 004020 136 TSLQTISLDYNSFD--SWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLS-FGK-SS 211 (779)
Q Consensus 136 ~~L~~L~Ls~N~l~--~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~-~~ 211 (779)
++|++|+++.+... ....+..+..+++|+.|.++++.. +.+|..+. .+++|++|+|++|.+++..... +.. .+
T Consensus 243 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~--~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~ 319 (592)
T 3ogk_B 243 ANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFP--FAAQIRKLDLLYALLETEDHCTLIQKCPN 319 (592)
T ss_dssp TTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT-TTGGGGGG--GGGGCCEEEETTCCCCHHHHHHHHTTCTT
T ss_pred hHHHhhcccccccccchHHHHHHhhccccccccCccccch-hHHHHHHh--hcCCCcEEecCCCcCCHHHHHHHHHhCcC
Confidence 99999999854322 123456778888999999887533 35666664 6889999999999977544422 233 57
Q ss_pred cceeeccCCCCCCCCCCchhhhcCCCCccEEEee-----------cCcccCC-CCC-CCCCCCCcEEEccCCccccccCh
Q 004020 212 IQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLH-----------GNSFTGP-LPD-LSGLSSLQDFSVRDNQLTGIVPS 278 (779)
Q Consensus 212 L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~-----------~N~l~~~-~~~-~~~l~~L~~L~l~~N~l~~~~p~ 278 (779)
|+.|++.++ +.. .+.......+++|++|+|+ .|.+++. ++. ...+++|++|+++.|++++..+.
T Consensus 320 L~~L~L~~~-~~~--~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~ 396 (592)
T 3ogk_B 320 LEVLETRNV-IGD--RGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLE 396 (592)
T ss_dssp CCEEEEEGG-GHH--HHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHH
T ss_pred CCEEeccCc-cCH--HHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHH
Confidence 888888733 211 1122334567889999999 3566542 222 34578899999988999887777
Q ss_pred hhhC-CCCCCEEEcc----CccccccCCC---------CCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCc
Q 004020 279 SLVN-LHSLAVVNLT----NNLFQGQTPK---------FNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYP 344 (779)
Q Consensus 279 ~l~~-l~~L~~L~Ls----~N~l~g~~p~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (779)
.+.. +++|+.|+|+ .|.+++.+.+ +.....+++....+. . ....+..
T Consensus 397 ~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~---------l--~~~~~~~-------- 457 (592)
T 3ogk_B 397 SIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGG---------L--TDLGLSY-------- 457 (592)
T ss_dssp HHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGG---------C--CHHHHHH--------
T ss_pred HHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCC---------c--cHHHHHH--------
Confidence 7776 8899999996 6677653211 000000000000000 0 0000000
Q ss_pred hhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccc-cccccccccccCCeEeccCcccccc-CCccCCCCCCCCc
Q 004020 345 AVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG-TISSNFSRLTSLRQLMLSGNELTGT-IPKELTTLPSLEM 422 (779)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g-~~p~~~~~l~~L~~L~Ls~N~l~g~-iP~~l~~l~~L~~ 422 (779)
.....++|+.|+|++|++++ .++..+..+++|++|+|++|.|++. ++.....+++|++
T Consensus 458 --------------------~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 517 (592)
T 3ogk_B 458 --------------------IGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRY 517 (592)
T ss_dssp --------------------HHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCE
T ss_pred --------------------HHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCe
Confidence 00113478999999999887 4566668889999999999998765 4444567889999
Q ss_pred eeccCCccccc
Q 004020 423 LDVSNNHLFGK 433 (779)
Q Consensus 423 L~Ls~N~l~g~ 433 (779)
|+|++|++++.
T Consensus 518 L~ls~n~it~~ 528 (592)
T 3ogk_B 518 LWVQGYRASMT 528 (592)
T ss_dssp EEEESCBCCTT
T ss_pred eECcCCcCCHH
Confidence 99999998765
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.6e-19 Score=178.62 Aligned_cols=156 Identities=21% Similarity=0.241 Sum_probs=133.2
Q ss_pred ccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCC--CCCCCCCcEEE
Q 004020 189 LMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD--LSGLSSLQDFS 266 (779)
Q Consensus 189 L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--~~~l~~L~~L~ 266 (779)
-+.+++++|.++ .+|..+. ..++.|+|++|+|++.++. |..+++|++|+
T Consensus 13 ~~~l~~s~n~l~-~iP~~~~----------------------------~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~ 63 (220)
T 2v70_A 13 GTTVDCSNQKLN-KIPEHIP----------------------------QYTAELRLNNNEFTVLEATGIFKKLPQLRKIN 63 (220)
T ss_dssp TTEEECCSSCCS-SCCSCCC----------------------------TTCSEEECCSSCCCEECCCCCGGGCTTCCEEE
T ss_pred CCEeEeCCCCcc-cCccCCC----------------------------CCCCEEEcCCCcCCccCchhhhccCCCCCEEE
Confidence 358899999998 5776553 4568899999999987653 78899999999
Q ss_pred ccCCccccccChhhhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchh
Q 004020 267 VRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAV 346 (779)
Q Consensus 267 l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (779)
|++|+|++..|..|..+++|++|+|++|++++.+|..+.
T Consensus 64 L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~----------------------------------------- 102 (220)
T 2v70_A 64 FSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFK----------------------------------------- 102 (220)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGT-----------------------------------------
T ss_pred CCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhc-----------------------------------------
Confidence 999999988888999999999999999999876654221
Q ss_pred cccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccCccccccCCccCCCCCCCCceecc
Q 004020 347 LAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVS 426 (779)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls 426 (779)
..++|++|+|++|++++..|..|..+++|++|+|++|+|++..|..+..+++|++|+|+
T Consensus 103 ---------------------~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 161 (220)
T 2v70_A 103 ---------------------GLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLL 161 (220)
T ss_dssp ---------------------TCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECC
T ss_pred ---------------------CCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEec
Confidence 22378999999999999889999999999999999999998889999999999999999
Q ss_pred CCcccccCC
Q 004020 427 NNHLFGKVP 435 (779)
Q Consensus 427 ~N~l~g~iP 435 (779)
+|++++..+
T Consensus 162 ~N~l~c~c~ 170 (220)
T 2v70_A 162 ANPFNCNCY 170 (220)
T ss_dssp SCCEECSGG
T ss_pred CcCCcCCCc
Confidence 999998765
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=2.4e-19 Score=193.45 Aligned_cols=174 Identities=19% Similarity=0.259 Sum_probs=122.4
Q ss_pred EEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCC-CCCCccEEecCCCCCCCCCcccccCCCCccEEEcccC
Q 004020 69 RIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLS-GLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146 (779)
Q Consensus 69 ~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~-~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N 146 (779)
.+++++++++ .+|..+. ..+++|+|++|+|++.++ .|. ++++|++|+|++|+|+.+++..|.++++|++|+|++|
T Consensus 22 ~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 5777888888 5777665 368999999999998887 566 8999999999999999998888888888888888888
Q ss_pred CCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCC
Q 004020 147 SFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKL 226 (779)
Q Consensus 147 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~ 226 (779)
+|.. ..+..|..+++|+.|+|++|+|++..|..|. .
T Consensus 99 ~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~--~----------------------------------------- 134 (361)
T 2xot_A 99 HLHT-LDEFLFSDLQALEVLLLYNNHIVVVDRNAFE--D----------------------------------------- 134 (361)
T ss_dssp CCCE-ECTTTTTTCTTCCEEECCSSCCCEECTTTTT--T-----------------------------------------
T ss_pred cCCc-CCHHHhCCCcCCCEEECCCCcccEECHHHhC--C-----------------------------------------
Confidence 8864 3334455555555555555555544444443 3
Q ss_pred CCchhhhcCCCCccEEEeecCcccCCCCC-C---CCCCCCcEEEccCCccccccChhhhCCCC--CCEEEccCccccc
Q 004020 227 NGSVAVIQNMTSLTQLWLHGNSFTGPLPD-L---SGLSSLQDFSVRDNQLTGIVPSSLVNLHS--LAVVNLTNNLFQG 298 (779)
Q Consensus 227 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~---~~l~~L~~L~l~~N~l~~~~p~~l~~l~~--L~~L~Ls~N~l~g 298 (779)
+++|+.|+|++|+|++.++. + ..+++|+.|+|++|+|++..+..+..++. |+.|+|++|++..
T Consensus 135 ---------l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 135 ---------MAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp ---------CTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred ---------cccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccC
Confidence 45555555555555544433 2 45677777778788877655577777776 4889999998875
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=7.1e-19 Score=175.48 Aligned_cols=155 Identities=25% Similarity=0.316 Sum_probs=104.3
Q ss_pred EEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEcc
Q 004020 116 EVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLA 195 (779)
Q Consensus 116 ~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~ 195 (779)
.+++++|.++.+|... ...+++|+|++|+|.+...+..|..+++|+.|+|++|.|++..+..|. .+++|++|+|+
T Consensus 15 ~l~~s~n~l~~iP~~~---~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~--~l~~L~~L~Ls 89 (220)
T 2v70_A 15 TVDCSNQKLNKIPEHI---PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFE--GASGVNEILLT 89 (220)
T ss_dssp EEECCSSCCSSCCSCC---CTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTT--TCTTCCEEECC
T ss_pred EeEeCCCCcccCccCC---CCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhC--CCCCCCEEECC
Confidence 4444444444444322 123345555555554311223455555555555555555656666665 67788888888
Q ss_pred CCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCC-CCCCCCCcEEEccCCcccc
Q 004020 196 FNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTG 274 (779)
Q Consensus 196 ~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~ 274 (779)
+|+|++..|..+. .+++|++|+|++|+|++.+|. +..+++|++|+|++|+|++
T Consensus 90 ~N~l~~~~~~~~~--------------------------~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 143 (220)
T 2v70_A 90 SNRLENVQHKMFK--------------------------GLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITT 143 (220)
T ss_dssp SSCCCCCCGGGGT--------------------------TCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCC
T ss_pred CCccCccCHhHhc--------------------------CCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCE
Confidence 8888765554443 578888888888888887764 8888889999999999988
Q ss_pred ccChhhhCCCCCCEEEccCccccccCC
Q 004020 275 IVPSSLVNLHSLAVVNLTNNLFQGQTP 301 (779)
Q Consensus 275 ~~p~~l~~l~~L~~L~Ls~N~l~g~~p 301 (779)
..|..|..+++|+.|+|++|++++..+
T Consensus 144 ~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 144 VAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp BCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred ECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 888888889999999999998886544
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.79 E-value=9e-19 Score=174.70 Aligned_cols=151 Identities=21% Similarity=0.293 Sum_probs=128.4
Q ss_pred EEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCC
Q 004020 69 RIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNS 147 (779)
Q Consensus 69 ~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 147 (779)
.+++++++++ .+|..+. ++|++|+|++|+|++.++ .|.++++|++|+|++|+++.++++.|.++++|++|+|++|+
T Consensus 15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 3555566777 6677665 689999999999998887 79999999999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCC
Q 004020 148 FDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLN 227 (779)
Q Consensus 148 l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~ 227 (779)
|.. ..+..|..+++|+.|+|++|.|++..|..|. .+++|++|+|++|+|++..+..+.
T Consensus 92 l~~-l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~------------------- 149 (220)
T 2v9t_B 92 ITE-LPKSLFEGLFSLQLLLLNANKINCLRVDAFQ--DLHNLNLLSLYDNKLQTIAKGTFS------------------- 149 (220)
T ss_dssp CCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTT--TCTTCCEEECCSSCCSCCCTTTTT-------------------
T ss_pred CCc-cCHhHccCCCCCCEEECCCCCCCEeCHHHcC--CCCCCCEEECCCCcCCEECHHHHh-------------------
Confidence 986 5556788999999999999999988888886 789999999999999976665554
Q ss_pred CchhhhcCCCCccEEEeecCcccC
Q 004020 228 GSVAVIQNMTSLTQLWLHGNSFTG 251 (779)
Q Consensus 228 ~~~~~~~~l~~L~~L~L~~N~l~~ 251 (779)
.+++|+.|+|++|.+..
T Consensus 150 -------~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 150 -------PLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp -------TCTTCCEEECCSSCEEC
T ss_pred -------CCCCCCEEEeCCCCcCC
Confidence 57788888888887763
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.78 E-value=5.7e-19 Score=176.17 Aligned_cols=145 Identities=21% Similarity=0.402 Sum_probs=134.1
Q ss_pred CcceeeEeCCC----------CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCC
Q 004020 54 CKWKHIQCSPS----------NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDN 122 (779)
Q Consensus 54 C~w~gv~c~~~----------~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N 122 (779)
|.|..|.|+.. ..++.|+|++|+|++..+..|..+++|++|+|++|+|++..| .|.++++|++|+|++|
T Consensus 11 C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp EETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred ECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 68999999752 369999999999998888899999999999999999999877 8999999999999999
Q ss_pred CCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCC
Q 004020 123 NFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQG 201 (779)
Q Consensus 123 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~ 201 (779)
+|+.+++..|.++++|++|+|++|+|.+ ..|..|..+++|+.|+|++|+|++..++.+. .+++|++|+|++|.+..
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS--PLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCSCCCTTTTT--TCTTCCEEECCSSCEEC
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCE-eCHHHcCCCCCCCEEECCCCcCCEECHHHHh--CCCCCCEEEeCCCCcCC
Confidence 9999999999999999999999999987 6788999999999999999999988777786 79999999999999873
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.78 E-value=3.5e-19 Score=185.91 Aligned_cols=170 Identities=25% Similarity=0.377 Sum_probs=149.0
Q ss_pred CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcc
Q 004020 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 144 (779)
.+++.|++++|++... + .+..+++|++|+|++|++++.++ +.++++|++|+|++|+++.++. +..+++|++|+|+
T Consensus 46 ~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~ 120 (291)
T 1h6t_A 46 NSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLE 120 (291)
T ss_dssp HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCGGG--GTTCTTCCEEECT
T ss_pred CcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCCCChh--hccCCCCCEEECC
Confidence 4799999999999854 4 58999999999999999998777 9999999999999999999764 8999999999999
Q ss_pred cCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCC
Q 004020 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDS 224 (779)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~ 224 (779)
+|++.+ + ..+..+++|+.|++++|++++. ..+. .+++|++|+|++|++++..| +.
T Consensus 121 ~n~i~~--~-~~l~~l~~L~~L~l~~n~l~~~--~~l~--~l~~L~~L~L~~N~l~~~~~--l~---------------- 175 (291)
T 1h6t_A 121 HNGISD--I-NGLVHLPQLESLYLGNNKITDI--TVLS--RLTKLDTLSLEDNQISDIVP--LA---------------- 175 (291)
T ss_dssp TSCCCC--C-GGGGGCTTCCEEECCSSCCCCC--GGGG--GCTTCSEEECCSSCCCCCGG--GT----------------
T ss_pred CCcCCC--C-hhhcCCCCCCEEEccCCcCCcc--hhhc--cCCCCCEEEccCCccccchh--hc----------------
Confidence 999976 3 5789999999999999999965 4554 79999999999999996544 33
Q ss_pred CCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccc
Q 004020 225 KLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGI 275 (779)
Q Consensus 225 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~ 275 (779)
.+++|+.|+|++|.+++. +.+..+++|+.|++++|++...
T Consensus 176 ----------~l~~L~~L~L~~N~i~~l-~~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 176 ----------GLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp ----------TCTTCCEEECCSSCCCBC-GGGTTCTTCSEEEEEEEEEECC
T ss_pred ----------CCCccCEEECCCCcCCCC-hhhccCCCCCEEECcCCcccCC
Confidence 689999999999999875 5688899999999999999853
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.78 E-value=1e-21 Score=227.10 Aligned_cols=344 Identities=12% Similarity=0.062 Sum_probs=235.1
Q ss_pred cEEEEEecCCC-ccc-cCCccccCCCCCcEEEcccCccccCC----C-CCCCCCCccEEecCCCCCCCCCcc----cccC
Q 004020 66 RVTRIQIGGQN-IEG-TLPKELNSLSSLTVLEVMKNKLTGQI----P-SLSGLSSLQEVLFDDNNFTSVPSD----FFKG 134 (779)
Q Consensus 66 ~v~~l~l~~~~-l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~----~-~~~~l~~L~~L~l~~N~l~~~~~~----~~~~ 134 (779)
++++|+|+++. ++. .++..+..+++|++|+|++|.+++.. + .+.++++|++|+|++|.++++... .+.+
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 49999999887 221 22333458899999999999987653 2 346789999999999999865543 4568
Q ss_pred CCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeE---eecCCCccCCCCCcccEEEccCCCCCCcCCCcccc-C
Q 004020 135 LTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANIT---GTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-S 210 (779)
Q Consensus 135 l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~---~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~ 210 (779)
+++|++|+|++|.+.+ +|..+..+++|+.|+++.+... +..+..+. .+++|+.|+++++... .+|..+.. .
T Consensus 219 ~~~L~~L~L~~~~~~~--l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~--~~~~L~~L~l~~~~~~-~l~~~~~~~~ 293 (592)
T 3ogk_B 219 CRSLVSVKVGDFEILE--LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLV--FPRKLCRLGLSYMGPN-EMPILFPFAA 293 (592)
T ss_dssp CTTCCEEECSSCBGGG--GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCC--CCTTCCEEEETTCCTT-TGGGGGGGGG
T ss_pred CCCCcEEeccCccHHH--HHHHHhhhhHHHhhcccccccccchHHHHHHhh--ccccccccCccccchh-HHHHHHhhcC
Confidence 8999999999999976 7899999999999999864432 22233443 6889999999986443 66766655 6
Q ss_pred CcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCC-CCCCCCCcEEEcc-----------CCccccc-cC
Q 004020 211 SIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVR-----------DNQLTGI-VP 277 (779)
Q Consensus 211 ~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~-----------~N~l~~~-~p 277 (779)
+|+.|++++|.+... .....+..+++|+.|+|+++...+.++. ...+++|++|+++ .|.+++. ++
T Consensus 294 ~L~~L~Ls~~~l~~~--~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~ 371 (592)
T 3ogk_B 294 QIRKLDLLYALLETE--DHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLI 371 (592)
T ss_dssp GCCEEEETTCCCCHH--HHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHH
T ss_pred CCcEEecCCCcCCHH--HHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHH
Confidence 899999999874322 1224467899999999994433334444 3568899999999 4677654 33
Q ss_pred hhhhCCCCCCEEEccCccccccCCCCC-----CCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccC
Q 004020 278 SSLVNLHSLAVVNLTNNLFQGQTPKFN-----SPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWK 352 (779)
Q Consensus 278 ~~l~~l~~L~~L~Ls~N~l~g~~p~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (779)
..+..+++|++|+++.|++++..+..+ ....+.+........+.+.. .+ ..+.
T Consensus 372 ~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p--~~---~~~~----------------- 429 (592)
T 3ogk_B 372 ALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLP--LD---NGVR----------------- 429 (592)
T ss_dssp HHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCC--CH---HHHH-----------------
T ss_pred HHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCch--HH---HHHH-----------------
Confidence 445669999999999999987544211 11111111000000000000 00 0000
Q ss_pred CCCCCCCCCCccccCCCCCeEEEEccCc--cccccccccccc-cccCCeEeccCccccc-cCCccCCCCCCCCceeccCC
Q 004020 353 GNNPCNSDWKGVSCDAGGNITVVNLKNL--GLSGTISSNFSR-LTSLRQLMLSGNELTG-TIPKELTTLPSLEMLDVSNN 428 (779)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~L~~L~Ls~n--~l~g~~p~~~~~-l~~L~~L~Ls~N~l~g-~iP~~l~~l~~L~~L~Ls~N 428 (779)
......++|+.|+|+++ .+++..+..++. +++|++|+|++|++++ .++..+..+++|++|+|++|
T Consensus 430 -----------~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n 498 (592)
T 3ogk_B 430 -----------SLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGC 498 (592)
T ss_dssp -----------HHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESC
T ss_pred -----------HHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCC
Confidence 00112358999999854 478777776654 8999999999999987 45666788999999999999
Q ss_pred ccccc-CCC----CCCcceeeeCCCC
Q 004020 429 HLFGK-VPN----FRQNVIVKTDGNP 449 (779)
Q Consensus 429 ~l~g~-iP~----~~~~~~~~~~~n~ 449 (779)
++++. ++. +.....+.+.+|.
T Consensus 499 ~l~~~~~~~~~~~l~~L~~L~ls~n~ 524 (592)
T 3ogk_B 499 CFSERAIAAAVTKLPSLRYLWVQGYR 524 (592)
T ss_dssp CCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred CCcHHHHHHHHHhcCccCeeECcCCc
Confidence 98764 222 3344456666665
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=4.2e-19 Score=203.06 Aligned_cols=176 Identities=24% Similarity=0.346 Sum_probs=152.8
Q ss_pred CCcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEc
Q 004020 64 SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143 (779)
Q Consensus 64 ~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 143 (779)
-.+++.|++++|.+.. ++ .|..+++|++|+|++|+|++.++ +..+++|+.|+|++|+|+.++ .+..+++|++|+|
T Consensus 42 L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~l~--~l~~l~~L~~L~L 116 (605)
T 1m9s_A 42 LNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP-LTNLKNLGWLFLDENKIKDLS--SLKDLKKLKSLSL 116 (605)
T ss_dssp HTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCCCCT--TSTTCTTCCEEEC
T ss_pred CCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh-hccCCCCCEEECcCCCCCCCh--hhccCCCCCEEEe
Confidence 3578999999999984 44 69999999999999999998777 999999999999999999986 5899999999999
Q ss_pred ccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCC
Q 004020 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGD 223 (779)
Q Consensus 144 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~ 223 (779)
++|+|.+ + ..+..+++|+.|+|++|.+++. ..+. .+++|++|+|++|+|++..| +.
T Consensus 117 s~N~l~~--l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~--~l~~L~~L~Ls~N~l~~~~~--l~--------------- 172 (605)
T 1m9s_A 117 EHNGISD--I-NGLVHLPQLESLYLGNNKITDI--TVLS--RLTKLDTLSLEDNQISDIVP--LA--------------- 172 (605)
T ss_dssp TTSCCCC--C-GGGGGCTTCSEEECCSSCCCCC--GGGG--SCTTCSEEECCSSCCCCCGG--GT---------------
T ss_pred cCCCCCC--C-ccccCCCccCEEECCCCccCCc--hhhc--ccCCCCEEECcCCcCCCchh--hc---------------
Confidence 9999976 3 5699999999999999999965 4554 79999999999999997655 33
Q ss_pred CCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhh
Q 004020 224 SKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSL 280 (779)
Q Consensus 224 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l 280 (779)
.+++|+.|+|++|+|++. |.+..+++|+.|+|++|++.+.....+
T Consensus 173 -----------~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l~~~p~~~~ 217 (605)
T 1m9s_A 173 -----------GLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLNKPINHQ 217 (605)
T ss_dssp -----------TCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEEECCCCCCC
T ss_pred -----------cCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcCcCCccccc
Confidence 689999999999999975 678899999999999999986433333
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.78 E-value=3.6e-19 Score=191.96 Aligned_cols=146 Identities=19% Similarity=0.275 Sum_probs=122.9
Q ss_pred CcceeeEeCCC----------CcEEEEEecCCCccccCCcccc-CCCCCcEEEcccCccccCCC-CCCCCCCccEEecCC
Q 004020 54 CKWKHIQCSPS----------NRVTRIQIGGQNIEGTLPKELN-SLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDD 121 (779)
Q Consensus 54 C~w~gv~c~~~----------~~v~~l~l~~~~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~ 121 (779)
|.|..+.|+.. ..++.|+|++|+|++..+..+. .+++|++|+|++|+|++.++ .|.++++|++|+|++
T Consensus 18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 57888999752 3588999999999988888787 99999999999999999887 799999999999999
Q ss_pred CCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccC-CCCCcccEEEccCCCCC
Q 004020 122 NNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGG-DTIPGLMHLHLAFNFLQ 200 (779)
Q Consensus 122 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~-~~l~~L~~L~L~~N~l~ 200 (779)
|+|+.+++..|.++++|++|+|++|+|.. ..|..|..+++|+.|+|++|+|++..+..+.+ ..+++|++|+|++|+|+
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccE-ECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 99999999999999999999999999986 56889999999999999999998533333311 13566666666666666
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=3.2e-19 Score=182.58 Aligned_cols=141 Identities=23% Similarity=0.229 Sum_probs=107.9
Q ss_pred CCcccceecccccEEEEEEEE-cCCcE--EEEEEecccccC----------------------hhHHHHHHHHHHHHHcC
Q 004020 591 NFSEENVLGRGGFGTVYKGEL-HDGTK--IAVKRMESAVVS----------------------EKGFAEFKSEIAVLTKV 645 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~----------------------~~~~~~~~~E~~~l~~l 645 (779)
-|++.+.||+|+||.||+|.. .+|+. ||||+++..... ......+.+|++++.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999987 68889 999987543211 01123688999999999
Q ss_pred CCCcc--ceEeeEEEeCCeEEEEEEecCC-C----ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCc
Q 004020 646 RHRHL--VGLLGYCLDGNERLLVYEYMPQ-G----TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH-GLAHQSF 717 (779)
Q Consensus 646 ~h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH-~~~~~~i 717 (779)
.|+++ +.++++ +..++||||+.+ | +|.+.... .++..+..++.|++.||.||| + .+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~---~gi 192 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQE---AEL 192 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHT---SCE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHH---CCE
Confidence 88764 334432 356899999942 3 66655421 123456789999999999999 6 799
Q ss_pred EEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 718 IHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 718 vHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
+||||||+|||+++ .++|+|||+|.....
T Consensus 193 vHrDlkp~NILl~~--~~~liDFG~a~~~~~ 221 (258)
T 1zth_A 193 VHADLSEYNIMYID--KVYFIDMGQAVTLRH 221 (258)
T ss_dssp ECSSCSTTSEEESS--SEEECCCTTCEETTS
T ss_pred EeCCCCHHHEEEcC--cEEEEECcccccCCC
Confidence 99999999999988 899999999987643
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=4e-21 Score=218.46 Aligned_cols=182 Identities=18% Similarity=0.217 Sum_probs=111.0
Q ss_pred cCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCC-------------CCCCCcccccCCCCccEEE-cccCCCCCC
Q 004020 86 NSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNN-------------FTSVPSDFFKGLTSLQTIS-LDYNSFDSW 151 (779)
Q Consensus 86 ~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~-------------l~~~~~~~~~~l~~L~~L~-Ls~N~l~~~ 151 (779)
..+++|+.|+|++|+|+.+++.++++++|+.|++++|. +.+.++..+..+++|+.|+ ++.|.+..
T Consensus 346 ~~~~~L~~L~Ls~n~L~~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~- 424 (567)
T 1dce_A 346 ATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDD- 424 (567)
T ss_dssp STTTTSSSCCCCHHHHHHHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHH-
T ss_pred ccCccceeccCChhhHHhhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccch-
Confidence 67888999999999998666688899999999987775 5566667777888888887 66665421
Q ss_pred CCcc------cccC--CCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCC
Q 004020 152 VIPE------SLKD--ATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGD 223 (779)
Q Consensus 152 ~~p~------~~~~--l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~ 223 (779)
++. .+.. ...|+.|+|++|+|++ +|. ++ .+++|++|+|++|+|+ .+|..+
T Consensus 425 -L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~--~l~~L~~L~Ls~N~l~-~lp~~~---------------- 482 (567)
T 1dce_A 425 -LRSKFLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LE--QLLLVTHLDLSHNRLR-ALPPAL---------------- 482 (567)
T ss_dssp -HHHHHHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GG--GGTTCCEEECCSSCCC-CCCGGG----------------
T ss_pred -hhhhhhhcccccccCccCceEEEecCCCCCC-CcC-cc--ccccCcEeecCccccc-ccchhh----------------
Confidence 000 0000 0124444444444443 333 32 3444444444444444 334333
Q ss_pred CCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCcccccc-ChhhhCCCCCCEEEccCccccccCC
Q 004020 224 SKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIV-PSSLVNLHSLAVVNLTNNLFQGQTP 301 (779)
Q Consensus 224 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~g~~p 301 (779)
+.+++|+.|+|++|+|++ +|.+..+++|+.|+|++|+|++.+ |..++.+++|+.|+|++|+|++.+|
T Consensus 483 ----------~~l~~L~~L~Ls~N~l~~-lp~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 483 ----------AALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp ----------GGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred ----------hcCCCCCEEECCCCCCCC-CcccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 246666666666666665 336666666666666666666554 6666666666666666666665544
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.76 E-value=5.4e-18 Score=170.23 Aligned_cols=154 Identities=20% Similarity=0.282 Sum_probs=86.5
Q ss_pred cEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCc
Q 004020 92 TVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGA 171 (779)
Q Consensus 92 ~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n 171 (779)
+.++.++++++.++..+. ++|++|+|++|+++++++..|.++++|++|+|++|+|.. ..+..|..
T Consensus 22 ~~v~c~~~~l~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~-i~~~~~~~------------ 86 (229)
T 3e6j_A 22 TTVDCRSKRHASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDS------------ 86 (229)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTT------------
T ss_pred CEeEccCCCcCccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCC-cChhhccc------------
Confidence 456666666655444333 566666666666666666666666666666666666643 22233344
Q ss_pred eeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccC
Q 004020 172 NITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTG 251 (779)
Q Consensus 172 ~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~ 251 (779)
+++|++|+|++|+|++..+..+. .+++|+.|+|++|+|+.
T Consensus 87 --------------l~~L~~L~Ls~N~l~~l~~~~~~--------------------------~l~~L~~L~Ls~N~l~~ 126 (229)
T 3e6j_A 87 --------------LTQLTVLDLGTNQLTVLPSAVFD--------------------------RLVHLKELFMCCNKLTE 126 (229)
T ss_dssp --------------CTTCCEEECCSSCCCCCCTTTTT--------------------------TCTTCCEEECCSSCCCS
T ss_pred --------------CCCcCEEECCCCcCCccChhHhC--------------------------cchhhCeEeccCCcccc
Confidence 45555555555555533333222 35555566666666554
Q ss_pred CCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccC
Q 004020 252 PLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQT 300 (779)
Q Consensus 252 ~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~ 300 (779)
.+..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++++..
T Consensus 127 lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 127 LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp CCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred cCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 4334555666666666666666554555666666666666666665543
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=7.5e-19 Score=180.38 Aligned_cols=173 Identities=24% Similarity=0.287 Sum_probs=118.8
Q ss_pred CCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEe
Q 004020 88 LSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFS 167 (779)
Q Consensus 88 l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~ 167 (779)
+.+++.+++++|.++..+ .+..+++|++|++++|+++.++ .+..+++|++|+|++|++.+ ++. +..+++|+.|+
T Consensus 18 l~~l~~l~l~~~~i~~~~-~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~L~~N~i~~--~~~-l~~l~~L~~L~ 91 (263)
T 1xeu_A 18 LANAVKQNLGKQSVTDLV-SQKELSGVQNFNGDNSNIQSLA--GMQFFTNLKELHLSHNQISD--LSP-LKDLTKLEELS 91 (263)
T ss_dssp HHHHHHHHHTCSCTTSEE-CHHHHTTCSEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC--CGG-GTTCSSCCEEE
T ss_pred HHHHHHHHhcCCCccccc-chhhcCcCcEEECcCCCcccch--HHhhCCCCCEEECCCCccCC--Chh-hccCCCCCEEE
Confidence 445555666666665443 5566666666666666666665 35666666677776666654 333 66666666666
Q ss_pred ccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecC
Q 004020 168 ANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGN 247 (779)
Q Consensus 168 l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N 247 (779)
+++|++++ +|... . ++|++|+|++|++++. + . +..+++|+.|+|++|
T Consensus 92 L~~N~l~~-l~~~~---~-~~L~~L~L~~N~l~~~-~-~--------------------------l~~l~~L~~L~Ls~N 138 (263)
T 1xeu_A 92 VNRNRLKN-LNGIP---S-ACLSRLFLDNNELRDT-D-S--------------------------LIHLKNLEILSIRNN 138 (263)
T ss_dssp CCSSCCSC-CTTCC---C-SSCCEEECCSSCCSBS-G-G--------------------------GTTCTTCCEEECTTS
T ss_pred CCCCccCC-cCccc---c-CcccEEEccCCccCCC-h-h--------------------------hcCcccccEEECCCC
Confidence 66666664 33322 2 6778888888887742 2 1 336788888888888
Q ss_pred cccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCC
Q 004020 248 SFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPK 302 (779)
Q Consensus 248 ~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~ 302 (779)
++++. +.+..+++|++|++++|++++. ..+..+++|+.|+|++|++++....
T Consensus 139 ~i~~~-~~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~~~~ 190 (263)
T 1xeu_A 139 KLKSI-VMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNEPVK 190 (263)
T ss_dssp CCCBC-GGGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECCCEE
T ss_pred cCCCC-hHHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCCccc
Confidence 88875 4677888888888888888865 6788888899999999988876443
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=3.1e-18 Score=167.79 Aligned_cols=155 Identities=12% Similarity=0.181 Sum_probs=99.2
Q ss_pred CCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCc
Q 004020 109 SGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPG 188 (779)
Q Consensus 109 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~ 188 (779)
..+++|++|++++|.++.++ .+..+++|++|++++|.+.. +..+..+++|++|++++|.+++..|..+. .+++
T Consensus 41 ~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~l~~n~~~~---~~~l~~l~~L~~L~l~~n~l~~~~~~~l~--~l~~ 113 (197)
T 4ezg_A 41 AQMNSLTYITLANINVTDLT--GIEYAHNIKDLTINNIHATN---YNPISGLSNLERLRIMGKDVTSDKIPNLS--GLTS 113 (197)
T ss_dssp HHHHTCCEEEEESSCCSCCT--TGGGCTTCSEEEEESCCCSC---CGGGTTCTTCCEEEEECTTCBGGGSCCCT--TCTT
T ss_pred hhcCCccEEeccCCCccChH--HHhcCCCCCEEEccCCCCCc---chhhhcCCCCCEEEeECCccCcccChhhc--CCCC
Confidence 34455555555555555544 25555566666666665432 23555666666666666666655666665 5777
Q ss_pred ccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEcc
Q 004020 189 LMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVR 268 (779)
Q Consensus 189 L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~ 268 (779)
|++|+|++|++++..|..++ .+++|++|+|++|.+.+.+|.+..+++|++|+++
T Consensus 114 L~~L~Ls~n~i~~~~~~~l~--------------------------~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~ 167 (197)
T 4ezg_A 114 LTLLDISHSAHDDSILTKIN--------------------------TLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQ 167 (197)
T ss_dssp CCEEECCSSBCBGGGHHHHT--------------------------TCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECT
T ss_pred CCEEEecCCccCcHhHHHHh--------------------------hCCCCCEEEccCCCCccccHhhcCCCCCCEEECC
Confidence 88888888877765554433 5777888888888733344567778888888888
Q ss_pred CCccccccChhhhCCCCCCEEEccCccccc
Q 004020 269 DNQLTGIVPSSLVNLHSLAVVNLTNNLFQG 298 (779)
Q Consensus 269 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g 298 (779)
+|++++ ++ .+..+++|+.|++++|++.+
T Consensus 168 ~n~i~~-~~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 168 FDGVHD-YR-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp TBCCCC-CT-TGGGCSSCCEEEECBC----
T ss_pred CCCCcC-hH-HhccCCCCCEEEeeCcccCC
Confidence 888875 44 67888888888888888754
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.74 E-value=1.9e-20 Score=216.53 Aligned_cols=228 Identities=16% Similarity=0.186 Sum_probs=136.5
Q ss_pred CcEEEEEecCCCccccCCcccc-CCCCCcEEEcccC-ccccC-CC-CCCCCCCccEEecCCCCCCCCCccccc----CCC
Q 004020 65 NRVTRIQIGGQNIEGTLPKELN-SLSSLTVLEVMKN-KLTGQ-IP-SLSGLSSLQEVLFDDNNFTSVPSDFFK----GLT 136 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~~p~~l~-~l~~L~~L~Ls~N-~l~~~-~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~----~l~ 136 (779)
.++++|+|+++.+++..+..+. .+++|++|+|++| .++.. ++ .+.++++|++|+|++|.++......+. .++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 4789999999998887777775 6889999999998 55542 33 345789999999999998876554443 677
Q ss_pred CccEEEcccCC--CCCCCCcccccCCCCCceEeccCc-eeEeecCCCccCCCCCcccEEEccCCC---------------
Q 004020 137 SLQTISLDYNS--FDSWVIPESLKDATGLQRFSANGA-NITGTIPDFLGGDTIPGLMHLHLAFNF--------------- 198 (779)
Q Consensus 137 ~L~~L~Ls~N~--l~~~~~p~~~~~l~~L~~L~l~~n-~l~~~~p~~~~~~~l~~L~~L~L~~N~--------------- 198 (779)
+|++|+|++|. +....++..+.++++|+.|++++| .+++ +|..+. .+++|++|+++.+.
T Consensus 185 ~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~--~~~~L~~L~l~~~~~~~~~~~~~~l~~~l 261 (594)
T 2p1m_B 185 SLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQ--RAPQLEELGTGGYTAEVRPDVYSGLSVAL 261 (594)
T ss_dssp CCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHH--HCTTCSEEECSBCCCCCCHHHHHHHHHHH
T ss_pred cCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHh--cCCcceEcccccccCccchhhHHHHHHHH
Confidence 99999999887 211112233455789999999988 3333 555554 56777777755442
Q ss_pred -----------CCCcCCCccc----c-CCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccC-CCCCC-CCCC
Q 004020 199 -----------LQGPIPLSFG----K-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTG-PLPDL-SGLS 260 (779)
Q Consensus 199 -----------l~~~~p~~~~----~-~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~-~~l~ 260 (779)
+....+..+. . .+|+.|++++|.+... +....+..+++|+.|+|++| ++. .++.+ ..++
T Consensus 262 ~~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~--~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~ 338 (594)
T 2p1m_B 262 SGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSY--DLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCK 338 (594)
T ss_dssp HTCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHH--HHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCT
T ss_pred hcCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHH--HHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCC
Confidence 1111111111 1 4566666666653311 11222445666666666666 321 11221 2356
Q ss_pred CCcEEEc---------cCCccccccChhhh-CCCCCCEEEccCccccc
Q 004020 261 SLQDFSV---------RDNQLTGIVPSSLV-NLHSLAVVNLTNNLFQG 298 (779)
Q Consensus 261 ~L~~L~l---------~~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~g 298 (779)
+|++|++ ..|.+++.....+. .+++|+.|+++.|.+++
T Consensus 339 ~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~ 386 (594)
T 2p1m_B 339 DLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTN 386 (594)
T ss_dssp TCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCH
T ss_pred CCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCH
Confidence 6666666 23344433233333 35666666666666554
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.3e-19 Score=210.46 Aligned_cols=228 Identities=18% Similarity=0.124 Sum_probs=115.9
Q ss_pred CCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEec
Q 004020 89 SSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSA 168 (779)
Q Consensus 89 ~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l 168 (779)
+.++.|+|++|.+...+. ..|+.++|++|.|. .++++.|++. ..+..+..++.|+.|+|
T Consensus 173 ~~~~~l~L~~n~~~~~~~-----~~l~~l~Ls~~~i~--------------~~~~~~n~~~--~~~~~~~~l~~L~~L~L 231 (727)
T 4b8c_D 173 PLTPKIELFANGKDEANQ-----ALLQHKKLSQYSID--------------EDDDIENRMV--MPKDSKYDDQLWHALDL 231 (727)
T ss_dssp ----------------------------------------------------------------------CCCCCCEEEC
T ss_pred CccceEEeeCCCCCcchh-----hHhhcCccCccccc--------------Ccccccccee--cChhhhccCCCCcEEEC
Confidence 457777887777766433 23455666666543 3455666664 46788889999999999
Q ss_pred cCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCc
Q 004020 169 NGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNS 248 (779)
Q Consensus 169 ~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~ 248 (779)
++|.++ .+|..++ .+++|++|+|++|+|+ .+|..++ .+++|++|+|++|.
T Consensus 232 s~n~l~-~l~~~~~--~l~~L~~L~Ls~N~l~-~lp~~~~--------------------------~l~~L~~L~Ls~N~ 281 (727)
T 4b8c_D 232 SNLQIF-NISANIF--KYDFLTRLYLNGNSLT-ELPAEIK--------------------------NLSNLRVLDLSHNR 281 (727)
T ss_dssp TTSCCS-CCCGGGG--GCCSCSCCBCTTSCCS-CCCGGGG--------------------------GGTTCCEEECTTSC
T ss_pred CCCCCC-CCChhhc--CCCCCCEEEeeCCcCc-ccChhhh--------------------------CCCCCCEEeCcCCc
Confidence 999988 6777665 6889999999999998 7777665 68999999999999
Q ss_pred ccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccC
Q 004020 249 FTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACD 328 (779)
Q Consensus 249 l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (779)
|+..+..+..+++|++|+|++|.|+ .+|..|+.+++|++|+|++|+|++.+|..+.....
T Consensus 282 l~~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~------------------- 341 (727)
T 4b8c_D 282 LTSLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSV------------------- 341 (727)
T ss_dssp CSSCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHH-------------------
T ss_pred CCccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcch-------------------
Confidence 9955446899999999999999997 78888999999999999999999887753211100
Q ss_pred ccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccCc----
Q 004020 329 GRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGN---- 404 (779)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N---- 404 (779)
....++|++|.++|.+|.. |+.|+|++|
T Consensus 342 ------------------------------------------~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~ 373 (727)
T 4b8c_D 342 ------------------------------------------TGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQ 373 (727)
T ss_dssp ------------------------------------------HHHHHHHHHCCCCCCCCCC-------------------
T ss_pred ------------------------------------------hhhHHhhccCcccCcCccc------cceeEeecccccc
Confidence 1123567888888888853 556667766
Q ss_pred ----cccccCCccCCCCCCCCceeccCCcccccCC
Q 004020 405 ----ELTGTIPKELTTLPSLEMLDVSNNHLFGKVP 435 (779)
Q Consensus 405 ----~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP 435 (779)
.|.+.++..+..+..+....+++|-+.+...
T Consensus 374 ~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~~~~ 408 (727)
T 4b8c_D 374 REYDSLQQSTEHLATDLAKRTFTVLSYNTLCQHYA 408 (727)
T ss_dssp ----------------------------CCCGGGC
T ss_pred cccCCccccccchhhcccccceeeeeccccccccC
Confidence 4555555556677777778888887765443
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.2e-20 Score=214.52 Aligned_cols=122 Identities=20% Similarity=0.217 Sum_probs=82.4
Q ss_pred CccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCCCCCcccccccCCCC
Q 004020 238 SLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNS 317 (779)
Q Consensus 238 ~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~ 317 (779)
.|+.|+|++|+|++. |.+..+++|+.|+|++|+|+ .+|..++.+++|+.|+|++|+|++ +|.+
T Consensus 442 ~L~~L~Ls~n~l~~l-p~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp~l-------------- 504 (567)
T 1dce_A 442 DVRVLHLAHKDLTVL-CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGV-------------- 504 (567)
T ss_dssp TCSEEECTTSCCSSC-CCGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CGGG--------------
T ss_pred CceEEEecCCCCCCC-cCccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cccc--------------
Confidence 477888888888874 45778888888888888887 678888888888888888888775 2310
Q ss_pred cccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccc-cccccccccC
Q 004020 318 FCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTI-SSNFSRLTSL 396 (779)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~-p~~~~~l~~L 396 (779)
...++|+.|+|++|+|++.+ |..|+.+++|
T Consensus 505 -------------------------------------------------~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L 535 (567)
T 1dce_A 505 -------------------------------------------------ANLPRLQELLLCNNRLQQSAAIQPLVSCPRL 535 (567)
T ss_dssp -------------------------------------------------TTCSSCCEEECCSSCCCSSSTTGGGGGCTTC
T ss_pred -------------------------------------------------CCCCCCcEEECCCCCCCCCCCcHHHhcCCCC
Confidence 11225666777777776665 6667777777
Q ss_pred CeEeccCccccccCCcc---CCCCCCCCceec
Q 004020 397 RQLMLSGNELTGTIPKE---LTTLPSLEMLDV 425 (779)
Q Consensus 397 ~~L~Ls~N~l~g~iP~~---l~~l~~L~~L~L 425 (779)
+.|+|++|+|++.+|.. +..+++|+.||+
T Consensus 536 ~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 536 VLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp CEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 77777777777544321 122566666653
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=5e-18 Score=166.33 Aligned_cols=103 Identities=19% Similarity=0.254 Sum_probs=50.9
Q ss_pred cEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEccc
Q 004020 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145 (779)
Q Consensus 66 ~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 145 (779)
+++.|++++|+++ .+| .+..+++|++|++++|.++. ++.+..+++|++|++++|+++...+..|..+++|++|+|++
T Consensus 45 ~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~ 121 (197)
T 4ezg_A 45 SLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISH 121 (197)
T ss_dssp TCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCS
T ss_pred CccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecC
Confidence 4555555555555 344 45555555555555554432 22455555555555555555544334455555555555555
Q ss_pred CCCCCCCCcccccCCCCCceEeccCce
Q 004020 146 NSFDSWVIPESLKDATGLQRFSANGAN 172 (779)
Q Consensus 146 N~l~~~~~p~~~~~l~~L~~L~l~~n~ 172 (779)
|++.+ ..|..+..+++|+.|++++|.
T Consensus 122 n~i~~-~~~~~l~~l~~L~~L~L~~n~ 147 (197)
T 4ezg_A 122 SAHDD-SILTKINTLPKVNSIDLSYNG 147 (197)
T ss_dssp SBCBG-GGHHHHTTCSSCCEEECCSCT
T ss_pred CccCc-HhHHHHhhCCCCCEEEccCCC
Confidence 55533 233344444444444444443
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=6.1e-18 Score=173.58 Aligned_cols=168 Identities=17% Similarity=0.250 Sum_probs=137.8
Q ss_pred cEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEccc
Q 004020 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145 (779)
Q Consensus 66 ~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 145 (779)
+++.++++++.+++.. .+..+++|++|++++|+++.. +.+..+++|++|+|++|+++++++ +..+++|++|+|++
T Consensus 20 ~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l-~~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~ 94 (263)
T 1xeu_A 20 NAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSL-AGMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNR 94 (263)
T ss_dssp HHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCS
T ss_pred HHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccc-hHHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCC
Confidence 3556677788887443 578889999999999999854 478889999999999999999887 88999999999999
Q ss_pred CCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCC
Q 004020 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSK 225 (779)
Q Consensus 146 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~ 225 (779)
|++.+ +|.... ++|+.|++++|++++ ++ .+. .+++|++|+|++|++++. + .
T Consensus 95 N~l~~--l~~~~~--~~L~~L~L~~N~l~~-~~-~l~--~l~~L~~L~Ls~N~i~~~-~-~------------------- 145 (263)
T 1xeu_A 95 NRLKN--LNGIPS--ACLSRLFLDNNELRD-TD-SLI--HLKNLEILSIRNNKLKSI-V-M------------------- 145 (263)
T ss_dssp SCCSC--CTTCCC--SSCCEEECCSSCCSB-SG-GGT--TCTTCCEEECTTSCCCBC-G-G-------------------
T ss_pred CccCC--cCcccc--CcccEEEccCCccCC-Ch-hhc--CcccccEEECCCCcCCCC-h-H-------------------
Confidence 99976 444333 899999999999986 34 354 789999999999999853 2 2
Q ss_pred CCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccc
Q 004020 226 LNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGI 275 (779)
Q Consensus 226 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~ 275 (779)
+..+++|+.|+|++|++++. +.+..+++|+.|++++|++.+.
T Consensus 146 -------l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 146 -------LGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp -------GGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEECC
T ss_pred -------HccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccCC
Confidence 33688999999999999987 6788899999999999999865
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.70 E-value=1.6e-19 Score=208.79 Aligned_cols=328 Identities=13% Similarity=0.105 Sum_probs=206.6
Q ss_pred CcEEEEEecCC-Ccccc-CCccccCCCCCcEEEcccCccccCCC-----CCCCCCCccEEecCCCCCCCCCcccc----c
Q 004020 65 NRVTRIQIGGQ-NIEGT-LPKELNSLSSLTVLEVMKNKLTGQIP-----SLSGLSSLQEVLFDDNNFTSVPSDFF----K 133 (779)
Q Consensus 65 ~~v~~l~l~~~-~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~~-----~~~~l~~L~~L~l~~N~l~~~~~~~~----~ 133 (779)
.++++|+|++| .++.. ++..+..+++|++|+|++|.+++..+ ....+++|++|++++|. ..+....+ .
T Consensus 130 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~~~~~l~~l~~ 208 (594)
T 2p1m_B 130 KNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEVSFSALERLVT 208 (594)
T ss_dssp TTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCCCHHHHHHHHH
T ss_pred CCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcCCHHHHHHHHH
Confidence 47999999999 55543 44445589999999999999876443 23478899999999998 44444333 4
Q ss_pred CCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCce--------------------------eE----eecCCCccC
Q 004020 134 GLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGAN--------------------------IT----GTIPDFLGG 183 (779)
Q Consensus 134 ~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~--------------------------l~----~~~p~~~~~ 183 (779)
++++|++|+|++|.... .++..+..+++|+.|++..+. +. +.++..+.
T Consensus 209 ~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~- 286 (594)
T 2p1m_B 209 RCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYS- 286 (594)
T ss_dssp HCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGGGHH-
T ss_pred hCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHHHHHH-
Confidence 56999999999983222 266777778888888765442 11 11222221
Q ss_pred CCCCcccEEEccCCCCCCcCCCcc-cc-CCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeec---------CcccCC
Q 004020 184 DTIPGLMHLHLAFNFLQGPIPLSF-GK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHG---------NSFTGP 252 (779)
Q Consensus 184 ~~l~~L~~L~L~~N~l~~~~p~~~-~~-~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~---------N~l~~~ 252 (779)
.+++|++|+|++|.+++.....+ .. .+|+.|++.+| +. ..+.......+++|+.|+|++ |.+++.
T Consensus 287 -~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~--~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~ 362 (594)
T 2p1m_B 287 -VCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IE--DAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQ 362 (594)
T ss_dssp -HHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GH--HHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHH
T ss_pred -hhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cC--HHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHH
Confidence 46899999999999875433332 22 67999999987 21 111222333589999999954 444432
Q ss_pred C-CCC-CCCCCCcEEEccCCccccccChhhh-CCCCCCEEEcc--C----ccccccCCCCCCCcccccccCCCCcccCCC
Q 004020 253 L-PDL-SGLSSLQDFSVRDNQLTGIVPSSLV-NLHSLAVVNLT--N----NLFQGQTPKFNSPVRFDMAKGSNSFCLDDA 323 (779)
Q Consensus 253 ~-~~~-~~l~~L~~L~l~~N~l~~~~p~~l~-~l~~L~~L~Ls--~----N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~ 323 (779)
. ..+ ..+++|+.|.++.|.+++..+..+. .+++|+.|+|+ + |.+++...+.. ...-.....++..+...
T Consensus 363 ~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~--~~~l~~~~~~L~~L~L~ 440 (594)
T 2p1m_B 363 GLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIG--FGAIVEHCKDLRRLSLS 440 (594)
T ss_dssp HHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHH--HHHHHHHCTTCCEEECC
T ss_pred HHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhH--HHHHHhhCCCccEEeec
Confidence 1 122 2478999999999999877777776 58999999999 4 55553211000 00000000000000000
Q ss_pred CcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccc-cccccCCeEecc
Q 004020 324 GVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNF-SRLTSLRQLMLS 402 (779)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~-~~l~~L~~L~Ls 402 (779)
. .... ..+.. .....++|+.|+|++|.+++..+..+ ..+++|+.|+|+
T Consensus 441 ~-~l~~--~~~~~----------------------------l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~ 489 (594)
T 2p1m_B 441 G-LLTD--KVFEY----------------------------IGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIR 489 (594)
T ss_dssp S-SCCH--HHHHH----------------------------HHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEE
T ss_pred C-cccH--HHHHH----------------------------HHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECc
Confidence 0 0000 00000 00013478899999998877666555 678889999999
Q ss_pred CccccccCCcc-CCCCCCCCceeccCCcccc
Q 004020 403 GNELTGTIPKE-LTTLPSLEMLDVSNNHLFG 432 (779)
Q Consensus 403 ~N~l~g~iP~~-l~~l~~L~~L~Ls~N~l~g 432 (779)
+|.+++..+.. ...+++|++|+|++|+++.
T Consensus 490 ~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~ 520 (594)
T 2p1m_B 490 DCPFGDKALLANASKLETMRSLWMSSCSVSF 520 (594)
T ss_dssp SCSCCHHHHHHTGGGGGGSSEEEEESSCCBH
T ss_pred CCCCcHHHHHHHHHhCCCCCEEeeeCCCCCH
Confidence 99987655543 3457889999999998853
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.69 E-value=1.1e-16 Score=155.78 Aligned_cols=133 Identities=20% Similarity=0.254 Sum_probs=113.1
Q ss_pred cEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccCh-hhhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCc
Q 004020 240 TQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPS-SLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSF 318 (779)
Q Consensus 240 ~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~ 318 (779)
+.+++++|+++..+..+. .+|++|++++|+|++..+. .|..+++|++|+|++|+|++.+|..+..
T Consensus 11 ~~l~~s~~~l~~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~------------ 76 (192)
T 1w8a_A 11 TTVDCTGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEG------------ 76 (192)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTT------------
T ss_pred CEEEcCCCCcCcCccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCC------------
Confidence 688999999976555554 3899999999999876664 4889999999999999999877764332
Q ss_pred ccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCe
Q 004020 319 CLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQ 398 (779)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~ 398 (779)
.++|++|+|++|+|++..|..|..+++|++
T Consensus 77 --------------------------------------------------l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 106 (192)
T 1w8a_A 77 --------------------------------------------------ASHIQELQLGENKIKEISNKMFLGLHQLKT 106 (192)
T ss_dssp --------------------------------------------------CTTCCEEECCSCCCCEECSSSSTTCTTCCE
T ss_pred --------------------------------------------------cccCCEEECCCCcCCccCHHHhcCCCCCCE
Confidence 237899999999999988888999999999
Q ss_pred EeccCccccccCCccCCCCCCCCceeccCCcccccCCC
Q 004020 399 LMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPN 436 (779)
Q Consensus 399 L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~ 436 (779)
|+|++|+|++.+|..+..+++|++|+|++|++++..|.
T Consensus 107 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 144 (192)
T 1w8a_A 107 LNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144 (192)
T ss_dssp EECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred EECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence 99999999999999999999999999999999988763
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.69 E-value=8e-17 Score=156.90 Aligned_cols=131 Identities=18% Similarity=0.300 Sum_probs=117.8
Q ss_pred EEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCC--CCCCCCccEEecCCCCCCCCCcccccCCCCccEEEccc
Q 004020 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPS--LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145 (779)
Q Consensus 68 ~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~--~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 145 (779)
+.|++++++++ .+|..+.. +|++|+|++|+|++.++. |.++++|++|+|++|+|+++++..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 46777788886 78877755 999999999999988873 89999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCC
Q 004020 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIP 204 (779)
Q Consensus 146 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p 204 (779)
|+|.+ ..+..|.++++|+.|+|++|+|++..|..+. .+++|++|+|++|.+++..+
T Consensus 88 N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKE-ISNKMFLGLHQLKTLNLYDNQISCVMPGSFE--HLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCE-ECSSSSTTCTTCCEEECCSSCCCEECTTSST--TCTTCCEEECTTCCBCCSGG
T ss_pred CcCCc-cCHHHhcCCCCCCEEECCCCcCCeeCHHHhh--cCCCCCEEEeCCCCccCcCc
Confidence 99987 6677899999999999999999999999986 79999999999999997554
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.6e-16 Score=168.46 Aligned_cols=148 Identities=12% Similarity=0.096 Sum_probs=105.6
Q ss_pred HHHHhhcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccC------------hhH--------HHHHHHHHHHHH
Q 004020 584 VLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVS------------EKG--------FAEFKSEIAVLT 643 (779)
Q Consensus 584 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------~~~--------~~~~~~E~~~l~ 643 (779)
.+..-..-|.+.+.||+|+||.||+|...+|+.||||+++....+ ... .....+|...+.
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 333333449999999999999999999989999999987532110 000 112346777777
Q ss_pred cCCCCccceEeeEEEeCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCC
Q 004020 644 KVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLK 723 (779)
Q Consensus 644 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlk 723 (779)
++.+.++....-+... ..++||||++|+.+.++.. . .....++.|++.+|.|||. .||||||||
T Consensus 169 rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~---------~--~~~~~l~~qll~~l~~lH~---~gIVHrDLK 232 (397)
T 4gyi_A 169 ALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSS---------V--PDPASLYADLIALILRLAK---HGLIHGDFN 232 (397)
T ss_dssp HHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCC---------C--SCHHHHHHHHHHHHHHHHH---TTEECSCCS
T ss_pred HHHhcCCCCCeeeecc--CceEEEEecCCccHhhhcc---------c--HHHHHHHHHHHHHHHHHHH---CCCcCCCCC
Confidence 7765544322222222 2379999999988865431 1 1235688999999999996 899999999
Q ss_pred CCCEEEcCCC----------cEEEEeeccceecC
Q 004020 724 PSNILLGDDM----------RAKVADFGLVRLAP 747 (779)
Q Consensus 724 p~NIll~~~~----------~~kl~DFG~a~~~~ 747 (779)
|.|||+++++ .+.|+||+-+....
T Consensus 233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp TTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred HHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 9999998776 38999999876543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.65 E-value=4.5e-16 Score=149.52 Aligned_cols=134 Identities=22% Similarity=0.369 Sum_probs=112.1
Q ss_pred CcceeeEeCCCCcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccc
Q 004020 54 CKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFF 132 (779)
Q Consensus 54 C~w~gv~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~ 132 (779)
|.|.+|.|+ +++++ .+|..+. ++|++|+|++|++++.++ .|.++++|++|+|++|+++.+++..|
T Consensus 7 C~~~~l~~~-----------~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 72 (177)
T 2o6r_A 7 CSGTEIRCN-----------SKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVF 72 (177)
T ss_dssp EETTEEECC-----------SSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTT
T ss_pred eCCCEEEec-----------CCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHc
Confidence 567776665 44555 4565443 689999999999998877 68999999999999999999999999
Q ss_pred cCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCC
Q 004020 133 KGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIP 204 (779)
Q Consensus 133 ~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p 204 (779)
..+++|++|+|++|+|++ ..+..|..+++|+.|++++|++++..+..+. .+++|++|+|++|.+++..|
T Consensus 73 ~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~--~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 73 DKLTKLTILYLHENKLQS-LPNGVFDKLTQLKELALDTNQLKSVPDGIFD--RLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp TTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCSCCCTTTTT--TCTTCCEEECCSSCBCCCHH
T ss_pred cCCCccCEEECCCCCccc-cCHHHhhCCcccCEEECcCCcceEeCHHHhc--CCcccCEEEecCCCeeccCc
Confidence 999999999999999986 5666789999999999999999966555554 68999999999999987554
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1.2e-16 Score=152.08 Aligned_cols=138 Identities=17% Similarity=0.172 Sum_probs=119.8
Q ss_pred CcEEEEEecCCCcc-ccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEc
Q 004020 65 NRVTRIQIGGQNIE-GTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143 (779)
Q Consensus 65 ~~v~~l~l~~~~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 143 (779)
.++++|++++|+++ +.+|..+..+++|++|+|++|.|++. +.+..+++|++|+|++|+++..++..+..+++|++|+|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 102 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence 57999999999998 88898899999999999999999887 88999999999999999999977777888999999999
Q ss_pred ccCCCCCCCCcccccCCCCCceEeccCceeEeecC---CCccCCCCCcccEEEccCCCCCCcCCCc
Q 004020 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIP---DFLGGDTIPGLMHLHLAFNFLQGPIPLS 206 (779)
Q Consensus 144 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p---~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 206 (779)
++|++.+...+..+..+++|+.|++++|.+++..+ ..+. .+++|++|++++|.+. .+|..
T Consensus 103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~--~l~~L~~L~l~~n~~~-~~~~~ 165 (168)
T 2ell_A 103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFK--LLPQLTYLDGYDREDQ-EAPDS 165 (168)
T ss_dssp BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHT--TCSSCCEETTEETTSC-BCCSS
T ss_pred cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHH--hCccCcEecCCCCChh-hcccc
Confidence 99999863233789999999999999999986544 3554 7899999999999988 55543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.2e-15 Score=148.64 Aligned_cols=127 Identities=22% Similarity=0.338 Sum_probs=110.8
Q ss_pred EEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCC
Q 004020 69 RIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSF 148 (779)
Q Consensus 69 ~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 148 (779)
.+++++++++ .+|..+. ++|++|+|++|+|+.++..|.++++|++|+|++|+|+.+++..|.++++|++|+|++|+|
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l 90 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence 5777788888 6777664 589999999999986666899999999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCC
Q 004020 149 DSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQG 201 (779)
Q Consensus 149 ~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~ 201 (779)
.+ ..|..|..+++|+.|+|++|+|+...+..|. .+++|++|+|++|.+..
T Consensus 91 ~~-i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 91 RC-IPPRTFDGLKSLRLLSLHGNDISVVPEGAFN--DLSALSHLAIGANPLYC 140 (193)
T ss_dssp CB-CCTTTTTTCTTCCEEECCSSCCCBCCTTTTT--TCTTCCEEECCSSCEEC
T ss_pred CE-eCHHHhCCCCCCCEEECCCCCCCeeChhhhh--cCccccEEEeCCCCeec
Confidence 87 6677899999999999999999966666675 68999999999999873
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.3e-15 Score=144.90 Aligned_cols=86 Identities=20% Similarity=0.201 Sum_probs=67.5
Q ss_pred CCcccEEEccCCCCC-CcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcE
Q 004020 186 IPGLMHLHLAFNFLQ-GPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQD 264 (779)
Q Consensus 186 l~~L~~L~L~~N~l~-~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~ 264 (779)
.++|++|+|++|.++ +.+|..+. .+++|+.|+|++|.+++. +.+..+++|++
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~--------------------------~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~ 75 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTA--------------------------EFVNLEFLSLINVGLISV-SNLPKLPKLKK 75 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCG--------------------------GGGGCCEEEEESSCCCCC-SSCCCCSSCCE
T ss_pred cccCCEEECCCCCCChhhHHHHHH--------------------------hCCCCCEEeCcCCCCCCh-hhhccCCCCCE
Confidence 467888888888887 66666544 477888888888888876 66788888888
Q ss_pred EEccCCccccccChhhhCCCCCCEEEccCccccc
Q 004020 265 FSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQG 298 (779)
Q Consensus 265 L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g 298 (779)
|++++|++++.+|..+..+++|++|+|++|++++
T Consensus 76 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 109 (168)
T 2ell_A 76 LELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD 109 (168)
T ss_dssp EEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCS
T ss_pred EECcCCcCchHHHHHHhhCCCCCEEeccCCccCc
Confidence 8888888887778877778888888888887764
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.61 E-value=2.6e-16 Score=146.50 Aligned_cols=129 Identities=18% Similarity=0.217 Sum_probs=101.4
Q ss_pred CcEEEEEecCCCcc-ccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEc
Q 004020 65 NRVTRIQIGGQNIE-GTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143 (779)
Q Consensus 65 ~~v~~l~l~~~~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 143 (779)
.+++.|++++|+++ +.+|..+..+++|++|+|++|++++. +.+.++++|++|+|++|++++..+..+..+++|++|+|
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 95 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence 46888888888888 78888888888888888888888877 77888888888888888888866667777888888888
Q ss_pred ccCCCCCCCCcccccCCCCCceEeccCceeEeecC---CCccCCCCCcccEEEccC
Q 004020 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIP---DFLGGDTIPGLMHLHLAF 196 (779)
Q Consensus 144 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p---~~~~~~~l~~L~~L~L~~ 196 (779)
++|++.+...+..+..+++|+.|++++|.+++..+ ..+. .+++|++|++++
T Consensus 96 s~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~--~l~~L~~L~l~d 149 (149)
T 2je0_A 96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFK--LLPQLTYLDGYD 149 (149)
T ss_dssp TTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHH--HCTTCCEETTBC
T ss_pred CCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHH--HCCCcccccCCC
Confidence 88888652233778888888888888888875544 3454 577888887753
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.60 E-value=3.6e-15 Score=143.11 Aligned_cols=135 Identities=21% Similarity=0.241 Sum_probs=110.0
Q ss_pred CccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCCCCCcccccccCCCC
Q 004020 238 SLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNS 317 (779)
Q Consensus 238 ~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~ 317 (779)
..+.+++++|+++..+..+. ++|+.|++++|++++..+..|..+++|++|+|++|++++..+..+.
T Consensus 8 ~~~~l~~~~~~l~~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~------------ 73 (177)
T 2o6r_A 8 SGTEIRCNSKGLTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFD------------ 73 (177)
T ss_dssp ETTEEECCSSCCSSCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTT------------
T ss_pred CCCEEEecCCCCccCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHcc------------
Confidence 35678888888887655443 6889999999999877777788899999999999988866554222
Q ss_pred cccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCC
Q 004020 318 FCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLR 397 (779)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~ 397 (779)
..++|+.|+|++|++++..+..|..+++|+
T Consensus 74 --------------------------------------------------~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 103 (177)
T 2o6r_A 74 --------------------------------------------------KLTKLTILYLHENKLQSLPNGVFDKLTQLK 103 (177)
T ss_dssp --------------------------------------------------TCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred --------------------------------------------------CCCccCEEECCCCCccccCHHHhhCCcccC
Confidence 123788999999999987777889999999
Q ss_pred eEeccCccccccCCccCCCCCCCCceeccCCcccccCCC
Q 004020 398 QLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPN 436 (779)
Q Consensus 398 ~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~ 436 (779)
+|+|++|+|++..+..+..+++|++|+|++|++++..|.
T Consensus 104 ~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 104 ELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp EEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred EEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 999999999966566678899999999999999998874
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.60 E-value=1.8e-16 Score=168.55 Aligned_cols=283 Identities=13% Similarity=0.177 Sum_probs=146.2
Q ss_pred cEEEEEecCCCccccCCccccC-CCCCcEEEcccCccc--cCCCCCCCCCCccEEecCCCCCCCCCcccccC--------
Q 004020 66 RVTRIQIGGQNIEGTLPKELNS-LSSLTVLEVMKNKLT--GQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKG-------- 134 (779)
Q Consensus 66 ~v~~l~l~~~~l~~~~p~~l~~-l~~L~~L~Ls~N~l~--~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-------- 134 (779)
++++|+++++ +...--..+.. +++|++|||++|++. ...+ +.++.++.+.+..| .|+..+|.+
T Consensus 26 ~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~--~~~~~~~~~~~~~~---~I~~~aF~~~~~~~~~g 99 (329)
T 3sb4_A 26 SITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKA--GTYPNGKFYIYMAN---FVPAYAFSNVVNGVTKG 99 (329)
T ss_dssp HCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESS--SSSGGGCCEEECTT---EECTTTTEEEETTEEEE
T ss_pred ceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCcc--cccccccccccccc---ccCHHHhcccccccccc
Confidence 4666666643 11111112323 677888888887776 2221 11222444444444 456666666
Q ss_pred CCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCC----CCcCCCcccc-
Q 004020 135 LTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFL----QGPIPLSFGK- 209 (779)
Q Consensus 135 l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l----~~~~p~~~~~- 209 (779)
+++|++|+|+. .+.. +.+..|.++++|+.|++.+|.++...+..|. .+.++..+.+..+.. .......|..
T Consensus 100 ~~~L~~l~L~~-~i~~-I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~--~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~ 175 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKN-IEDAAFKGCDNLKICQIRKKTAPNLLPEALA--DSVTAIFIPLGSSDAYRFKNRWEHFAFIEG 175 (329)
T ss_dssp CTTCCC-CBCT-TCCE-ECTTTTTTCTTCCEEEBCCSSCCEECTTSSC--TTTCEEEECTTCTHHHHTSTTTTTSCEEES
T ss_pred cCCCcEEECCc-cccc-hhHHHhhcCcccceEEcCCCCccccchhhhc--CCCceEEecCcchhhhhccccccccccccc
Confidence 77777777777 5654 3455677777777777777777655555554 355555555544221 1111111211
Q ss_pred CCcc-eeeccCCCCCCCCCC-chhhhcCCCCccEEEeecCcccCCCCCC-CCCCCCcEEEccCCccccccChhhhCCCCC
Q 004020 210 SSIQ-TLWLNGQKGDSKLNG-SVAVIQNMTSLTQLWLHGNSFTGPLPDL-SGLSSLQDFSVRDNQLTGIVPSSLVNLHSL 286 (779)
Q Consensus 210 ~~L~-~l~l~~n~~~~~~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L 286 (779)
..|+ .+.+..... +.. .........++..+.+.++-.......+ ..+++|+.++|++|+++...+.+|.++++|
T Consensus 176 ~~L~~~i~~~~~~~---l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L 252 (329)
T 3sb4_A 176 EPLETTIQVGAMGK---LEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYL 252 (329)
T ss_dssp CCCEEEEEECTTCC---HHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTC
T ss_pred cccceeEEecCCCc---HHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCC
Confidence 1121 111111000 000 0000001334444444443211111111 125666666666666665555566666667
Q ss_pred CEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCcccc
Q 004020 287 AVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSC 366 (779)
Q Consensus 287 ~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (779)
+.|+|.+| ++...+..|.
T Consensus 253 ~~l~l~~n-i~~I~~~aF~------------------------------------------------------------- 270 (329)
T 3sb4_A 253 LKIKLPHN-LKTIGQRVFS------------------------------------------------------------- 270 (329)
T ss_dssp CEEECCTT-CCEECTTTTT-------------------------------------------------------------
T ss_pred CEEECCcc-cceehHHHhh-------------------------------------------------------------
Confidence 76666665 4433222211
Q ss_pred CCCCCeE-EEEccCccccccccccccccccCCeEeccCccccccCCccCCCCCCCCceec
Q 004020 367 DAGGNIT-VVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDV 425 (779)
Q Consensus 367 ~~~~~L~-~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L 425 (779)
...+|+ .++|.+ +++..-+..|.++++|+.|+|++|+++..-+..|..+++|+.++.
T Consensus 271 -~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 271 -NCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp -TCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred -CChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 112465 666666 555455667888888888888888888555668888888888763
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=5.6e-15 Score=143.74 Aligned_cols=130 Identities=22% Similarity=0.284 Sum_probs=111.2
Q ss_pred ccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCc
Q 004020 239 LTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSF 318 (779)
Q Consensus 239 L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~ 318 (779)
-+.+++++|.++..+..+. ++|++|++++|+|+ .+|..|..+++|+.|+|++|+|++..+..+..
T Consensus 12 ~~~l~~~~~~l~~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~------------ 76 (193)
T 2wfh_A 12 DTVVRCSNKGLKVLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSN------------ 76 (193)
T ss_dssp TTEEECTTSCCSSCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTT------------
T ss_pred CCEEEcCCCCCCcCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccC------------
Confidence 3679999999997665553 68999999999998 78899999999999999999999876653322
Q ss_pred ccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCe
Q 004020 319 CLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQ 398 (779)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~ 398 (779)
.++|+.|+|++|+|++..|..|..+++|++
T Consensus 77 --------------------------------------------------l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~ 106 (193)
T 2wfh_A 77 --------------------------------------------------MTQLLTLILSYNRLRCIPPRTFDGLKSLRL 106 (193)
T ss_dssp --------------------------------------------------CTTCCEEECCSSCCCBCCTTTTTTCTTCCE
T ss_pred --------------------------------------------------CCCCCEEECCCCccCEeCHHHhCCCCCCCE
Confidence 237999999999999988889999999999
Q ss_pred EeccCccccccCCccCCCCCCCCceeccCCccccc
Q 004020 399 LMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGK 433 (779)
Q Consensus 399 L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~ 433 (779)
|+|++|+|++..+..+..+++|+.|+|++|++...
T Consensus 107 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 107 LSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp EECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred EECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 99999999966666799999999999999998754
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.8e-15 Score=140.74 Aligned_cols=85 Identities=19% Similarity=0.189 Sum_probs=58.6
Q ss_pred CCcccEEEccCCCCC-CcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcE
Q 004020 186 IPGLMHLHLAFNFLQ-GPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQD 264 (779)
Q Consensus 186 l~~L~~L~L~~N~l~-~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~ 264 (779)
.++|++|++++|.++ +.+|..+. .+++|+.|+|++|.+++. +.+..+++|++
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~--------------------------~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~ 68 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTD--------------------------EFEELEFLSTINVGLTSI-ANLPKLNKLKK 68 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCT--------------------------TCTTCCEEECTTSCCCCC-TTCCCCTTCCE
T ss_pred CccCeEEEccCCcCChhHHHHHHh--------------------------hcCCCcEEECcCCCCCCc-hhhhcCCCCCE
Confidence 456777777777776 56665443 466777777777777766 55677777777
Q ss_pred EEccCCccccccChhhhCCCCCCEEEccCcccc
Q 004020 265 FSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297 (779)
Q Consensus 265 L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 297 (779)
|++++|++++.+|..+..+++|++|+|++|+++
T Consensus 69 L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~ 101 (149)
T 2je0_A 69 LELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101 (149)
T ss_dssp EECCSSCCCSCTHHHHHHCTTCCEEECTTSCCC
T ss_pred EECCCCcccchHHHHhhhCCCCCEEECCCCcCC
Confidence 777777777666776666777777777777665
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.59 E-value=9.3e-16 Score=163.06 Aligned_cols=257 Identities=14% Similarity=0.093 Sum_probs=175.7
Q ss_pred CCcEEEEEecCCCcc--ccCCccccCCCCCcEEEcccCccccCCC-CCCC--------CCCccEEecCCCCCCCCCcccc
Q 004020 64 SNRVTRIQIGGQNIE--GTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSG--------LSSLQEVLFDDNNFTSVPSDFF 132 (779)
Q Consensus 64 ~~~v~~l~l~~~~l~--~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~--------l~~L~~L~l~~N~l~~~~~~~~ 132 (779)
..+++.|||++|+|. ...+..+ +.+..+.+..|. +++ +|.+ +++|+.|+|.+ +++.|+..+|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~---I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF 120 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANF---VPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAF 120 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTE---ECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTT
T ss_pred hccCeEEecCcceeEEecCccccc---cccccccccccc---cCHHHhcccccccccccCCCcEEECCc-cccchhHHHh
Confidence 357999999999998 3332222 235666666663 223 6777 99999999998 8999999999
Q ss_pred cCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCcee----EeecCCCccCCCCCccc-EEEccCCCCCCcCCCcc
Q 004020 133 KGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANI----TGTIPDFLGGDTIPGLM-HLHLAFNFLQGPIPLSF 207 (779)
Q Consensus 133 ~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l----~~~~p~~~~~~~l~~L~-~L~L~~N~l~~~~p~~~ 207 (779)
.++++|++|+|++|.+.. ..+..|..+.++..+.+..+.. ...-...|. .+..|+ .+++.... .++..+
T Consensus 121 ~~~~~L~~l~l~~n~i~~-i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~--~~~~L~~~i~~~~~~---~l~~~~ 194 (329)
T 3sb4_A 121 KGCDNLKICQIRKKTAPN-LLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFI--EGEPLETTIQVGAMG---KLEDEI 194 (329)
T ss_dssp TTCTTCCEEEBCCSSCCE-ECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEE--ESCCCEEEEEECTTC---CHHHHH
T ss_pred hcCcccceEEcCCCCccc-cchhhhcCCCceEEecCcchhhhhccccccccccc--cccccceeEEecCCC---cHHHHH
Confidence 999999999999998865 5667888887777777665322 111112222 344444 34443221 122211
Q ss_pred c-----cCCcceeeccCCCCCCCCCCchhhh-cCCCCccEEEeecCcccCCCC-CCCCCCCCcEEEccCCccccccChhh
Q 004020 208 G-----KSSIQTLWLNGQKGDSKLNGSVAVI-QNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDNQLTGIVPSSL 280 (779)
Q Consensus 208 ~-----~~~L~~l~l~~n~~~~~~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~l 280 (779)
. ..++..+.+.++-.. .....+ ..+++|+.|+|++|+++...+ .|.++++|+.+++.+| +..+-+.+|
T Consensus 195 ~~~~~~~~~~~~l~~~~~l~~----~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF 269 (329)
T 3sb4_A 195 MKAGLQPRDINFLTIEGKLDN----ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVF 269 (329)
T ss_dssp HHTTCCGGGCSEEEEEECCCH----HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTT
T ss_pred hhcccCccccceEEEeeeecH----HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHh
Confidence 1 123444444433110 011111 237999999999999998776 4999999999999998 876777899
Q ss_pred hCCCCCC-EEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCC
Q 004020 281 VNLHSLA-VVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNS 359 (779)
Q Consensus 281 ~~l~~L~-~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (779)
.++++|+ .|+|.+ +++...+..|
T Consensus 270 ~~~~~L~~~l~l~~-~l~~I~~~aF------------------------------------------------------- 293 (329)
T 3sb4_A 270 SNCGRLAGTLELPA-SVTAIEFGAF------------------------------------------------------- 293 (329)
T ss_dssp TTCTTCCEEEEECT-TCCEECTTTT-------------------------------------------------------
T ss_pred hCChhccEEEEEcc-cceEEchhhh-------------------------------------------------------
Confidence 9999999 999988 6654443322
Q ss_pred CCCccccCCCCCeEEEEccCccccccccccccccccCCeEec
Q 004020 360 DWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLML 401 (779)
Q Consensus 360 ~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L 401 (779)
....+|+.++|+.|++...-+..|.++++|+.++.
T Consensus 294 -------~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 294 -------MGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp -------TTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred -------hCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 22348999999999999887889999999999874
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.53 E-value=6.2e-15 Score=141.33 Aligned_cols=128 Identities=16% Similarity=0.244 Sum_probs=108.5
Q ss_pred CcEEEEEecCCCccccCCccccCCC-CCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEc
Q 004020 65 NRVTRIQIGGQNIEGTLPKELNSLS-SLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 143 (779)
..+++|++++|+++. +|. +..+. +|++|+|++|+|++. +.|.++++|++|+|++|+|+.+++..|..+++|++|+|
T Consensus 19 ~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 95 (176)
T 1a9n_A 19 VRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 95 (176)
T ss_dssp TSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred CCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEEC
Confidence 478999999999984 454 55555 999999999999876 78999999999999999999998888899999999999
Q ss_pred ccCCCCCCCCcc--cccCCCCCceEeccCceeEeecCCC----ccCCCCCcccEEEccCCCCC
Q 004020 144 DYNSFDSWVIPE--SLKDATGLQRFSANGANITGTIPDF----LGGDTIPGLMHLHLAFNFLQ 200 (779)
Q Consensus 144 s~N~l~~~~~p~--~~~~l~~L~~L~l~~n~l~~~~p~~----~~~~~l~~L~~L~L~~N~l~ 200 (779)
++|+|.. +|. .+..+++|+.|++++|.++ .+|.. +. .+++|++|++++|.+.
T Consensus 96 ~~N~i~~--~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~--~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 96 TNNSLVE--LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIY--KVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CSCCCCC--GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHH--HCTTCSEETTEECCHH
T ss_pred CCCcCCc--chhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHH--HCCccceeCCCcCCHH
Confidence 9999965 565 7889999999999999997 55664 54 6889999999998875
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.51 E-value=3.6e-14 Score=135.02 Aligned_cols=104 Identities=22% Similarity=0.381 Sum_probs=86.1
Q ss_pred EEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccC
Q 004020 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146 (779)
Q Consensus 68 ~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N 146 (779)
++|++++|+++ .+|..+. ++|++|+|++|+|++.+| .|.++++|++|+|++|+|+.+++..|.++++|++|+|++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 46788888888 5777664 789999999999999877 7899999999999999999999998999999999999999
Q ss_pred CCCCCCCcccccCCCCCceEeccCceeEe
Q 004020 147 SFDSWVIPESLKDATGLQRFSANGANITG 175 (779)
Q Consensus 147 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~ 175 (779)
+|.+ ..+..|..+++|+.|+|++|.++.
T Consensus 89 ~l~~-~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 89 QLKS-IPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp CCCC-CCTTTTTTCTTCCEEECCSSCBCT
T ss_pred ccCE-eCHHHhcCCCCCCEEEeCCCCCCC
Confidence 9976 444567777777777777776664
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.50 E-value=9.1e-13 Score=143.10 Aligned_cols=110 Identities=12% Similarity=0.169 Sum_probs=66.0
Q ss_pred CCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceE
Q 004020 88 LSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRF 166 (779)
Q Consensus 88 l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L 166 (779)
+..++.+.+.++ ++.+.. +|.++ +|+.+.|.+| ++.|...+|.++ +|++++|.. .+.. ..+..|.++++|+.+
T Consensus 112 ~~~l~~i~ip~~-i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~-I~~~aF~~c~~L~~l 185 (401)
T 4fdw_A 112 LKGYNEIILPNS-VKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQ-LKEDIFYYCYNLKKA 185 (401)
T ss_dssp CSSCSEEECCTT-CCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCE-ECSSTTTTCTTCCEE
T ss_pred cCCccEEEECCc-cCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccE-ehHHHhhCcccCCee
Confidence 356666666543 444444 56664 6777777655 777777777664 577777764 4433 344667777777777
Q ss_pred eccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCcc
Q 004020 167 SANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSF 207 (779)
Q Consensus 167 ~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~ 207 (779)
++.+|+++......|. ..+|+.+.|..+ ++..-...|
T Consensus 186 ~l~~n~l~~I~~~aF~---~~~L~~l~lp~~-l~~I~~~aF 222 (401)
T 4fdw_A 186 DLSKTKITKLPASTFV---YAGIEEVLLPVT-LKEIGSQAF 222 (401)
T ss_dssp ECTTSCCSEECTTTTT---TCCCSEEECCTT-CCEECTTTT
T ss_pred ecCCCcceEechhhEe---ecccCEEEeCCc-hheehhhHh
Confidence 7777777644444442 467777777633 553333333
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.49 E-value=3.8e-14 Score=135.79 Aligned_cols=134 Identities=16% Similarity=0.121 Sum_probs=82.8
Q ss_pred CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCC
Q 004020 107 SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTI 186 (779)
Q Consensus 107 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l 186 (779)
.+.++++|++|++++|+++.++ ......++|++|+|++|+|. +. +.+. .+
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~i~-~~~~~~~~L~~L~Ls~N~l~-------------------------~~--~~l~--~l 63 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPVIE-NLGATLDQFDAIDFSDNEIR-------------------------KL--DGFP--LL 63 (176)
T ss_dssp EEECTTSCEEEECTTSCCCSCC-CGGGGTTCCSEEECCSSCCC-------------------------EE--CCCC--CC
T ss_pred hcCCcCCceEEEeeCCCCchhH-HhhhcCCCCCEEECCCCCCC-------------------------cc--cccc--cC
Confidence 4555666666666666666553 22222225666666665554 32 2333 46
Q ss_pred CcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCC--CCCCCCCCcE
Q 004020 187 PGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP--DLSGLSSLQD 264 (779)
Q Consensus 187 ~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~l~~L~~ 264 (779)
++|++|+|++|+|++..|..+ ..+++|++|+|++|+++..++ .+..+++|+.
T Consensus 64 ~~L~~L~Ls~N~l~~~~~~~~--------------------------~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~ 117 (176)
T 1a9n_A 64 RRLKTLLVNNNRICRIGEGLD--------------------------QALPDLTELILTNNSLVELGDLDPLASLKSLTY 117 (176)
T ss_dssp SSCCEEECCSSCCCEECSCHH--------------------------HHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCE
T ss_pred CCCCEEECCCCcccccCcchh--------------------------hcCCCCCEEECCCCcCCcchhhHhhhcCCCCCE
Confidence 667777777777663322221 246677777777777765444 4667778888
Q ss_pred EEccCCccccccChh----hhCCCCCCEEEccCcccc
Q 004020 265 FSVRDNQLTGIVPSS----LVNLHSLAVVNLTNNLFQ 297 (779)
Q Consensus 265 L~l~~N~l~~~~p~~----l~~l~~L~~L~Ls~N~l~ 297 (779)
|++++|.++ .+|.. +..+++|+.||+++|.+.
T Consensus 118 L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 118 LCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp EECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred EEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 888888887 45553 888888888888888765
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.47 E-value=1.4e-13 Score=131.46 Aligned_cols=103 Identities=20% Similarity=0.348 Sum_probs=85.6
Q ss_pred EEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccC
Q 004020 68 TRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146 (779)
Q Consensus 68 ~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N 146 (779)
+.+++++|+++ .+|..+. ++|++|+|++|+|++.+| .|.++++|++|+|++|+|+++++..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 57899999996 7787775 799999999999999877 7899999999999999999999988899999999999999
Q ss_pred CCCCCCCcccccCCCCCceEeccCceeE
Q 004020 147 SFDSWVIPESLKDATGLQRFSANGANIT 174 (779)
Q Consensus 147 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~ 174 (779)
+|.+ ..+..|..+++|+.|+|++|.+.
T Consensus 92 ~l~~-l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKS-IPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCC-CCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccce-eCHHHhccccCCCEEEeCCCCcc
Confidence 9975 33444666666666666666665
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.46 E-value=7.6e-16 Score=150.82 Aligned_cols=161 Identities=20% Similarity=0.293 Sum_probs=106.5
Q ss_pred ccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCc
Q 004020 85 LNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQ 164 (779)
Q Consensus 85 l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~ 164 (779)
+.....++.++++.|.+++..|.+ +.+|. .|..+++|++|+|++|++.+ +| .+..+++|+
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l----------------~~l~~-~~~~l~~L~~L~ls~n~l~~--l~-~~~~l~~L~ 73 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPI----------------EKMDA-TLSTLKACKHLALSTNNIEK--IS-SLSGMENLR 73 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTC----------------CCCHH-HHHHTTTCSEEECSEEEESC--CC-CHHHHTTCC
T ss_pred HHhcccccCcchheeEeccccCcH----------------hhhhH-HHhcCCCCCEEECCCCCCcc--cc-ccccCCCCC
Confidence 444556666666666666654421 11221 45566666666666666654 44 666666666
Q ss_pred eEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEe
Q 004020 165 RFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWL 244 (779)
Q Consensus 165 ~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L 244 (779)
.|++++|.++ .+|..+. .+++|++|+|++|++++ +| . +..+++|+.|+|
T Consensus 74 ~L~l~~n~l~-~l~~~~~--~~~~L~~L~L~~N~l~~-l~-~--------------------------~~~l~~L~~L~l 122 (198)
T 1ds9_A 74 ILSLGRNLIK-KIENLDA--VADTLEELWISYNQIAS-LS-G--------------------------IEKLVNLRVLYM 122 (198)
T ss_dssp EEEEEEEEEC-SCSSHHH--HHHHCSEEEEEEEECCC-HH-H--------------------------HHHHHHSSEEEE
T ss_pred EEECCCCCcc-cccchhh--cCCcCCEEECcCCcCCc-CC-c--------------------------cccCCCCCEEEC
Confidence 6666666666 4565554 45778888888887774 22 2 335778888888
Q ss_pred ecCcccCCCC--CCCCCCCCcEEEccCCccccccCh----------hhhCCCCCCEEEccCccccc
Q 004020 245 HGNSFTGPLP--DLSGLSSLQDFSVRDNQLTGIVPS----------SLVNLHSLAVVNLTNNLFQG 298 (779)
Q Consensus 245 ~~N~l~~~~~--~~~~l~~L~~L~l~~N~l~~~~p~----------~l~~l~~L~~L~Ls~N~l~g 298 (779)
++|++++..+ .+..+++|++|++++|++.+.+|. .+..+++|+.|| +|.++.
T Consensus 123 ~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 123 SNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV 186 (198)
T ss_dssp SEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred CCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence 8888886443 477888888888888888876665 388899999887 676653
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.46 E-value=1.6e-16 Score=155.68 Aligned_cols=134 Identities=21% Similarity=0.263 Sum_probs=113.3
Q ss_pred CcEEEEEecCCCccccCCc------cccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCc
Q 004020 65 NRVTRIQIGGQNIEGTLPK------ELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSL 138 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~~p~------~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 138 (779)
.+++.++++.+++.|.+|. .|..+++|++|+|++|++++. |.+.++++|++|++++|+++.+|. .+..+++|
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l-~~~~~l~~L~~L~l~~n~l~~l~~-~~~~~~~L 95 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKI-SSLSGMENLRILSLGRNLIKKIEN-LDAVADTL 95 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESCC-CCHHHHTTCCEEEEEEEEECSCSS-HHHHHHHC
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCccc-cccccCCCCCEEECCCCCcccccc-hhhcCCcC
Confidence 3566677777777777776 899999999999999999985 489999999999999999998875 56778999
Q ss_pred cEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecC-CCccCCCCCcccEEEccCCCCCCcCCC
Q 004020 139 QTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIP-DFLGGDTIPGLMHLHLAFNFLQGPIPL 205 (779)
Q Consensus 139 ~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~~~l~~L~~L~L~~N~l~~~~p~ 205 (779)
++|+|++|++.+ +| .+..+++|+.|++++|++++..+ +.+. .+++|++|++++|.+++.+|.
T Consensus 96 ~~L~L~~N~l~~--l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~--~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 96 EELWISYNQIAS--LS-GIEKLVNLRVLYMSNNKITNWGEIDKLA--ALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp SEEEEEEEECCC--HH-HHHHHHHSSEEEESEEECCCHHHHHHHT--TTTTCSEEEECSCHHHHHHHT
T ss_pred CEEECcCCcCCc--CC-ccccCCCCCEEECCCCcCCchhHHHHHh--cCCCCCEEEecCCcccccccc
Confidence 999999999976 55 68899999999999999985432 3554 689999999999999876664
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.43 E-value=4.3e-13 Score=127.49 Aligned_cols=108 Identities=19% Similarity=0.251 Sum_probs=96.3
Q ss_pred CcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccC
Q 004020 91 LTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANG 170 (779)
Q Consensus 91 L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~ 170 (779)
.++|++++|+|+.++..+. ++|++|+|++|+|+++++..|.++++|++|+|++|+|++ ..+..|..+++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLASVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTV-LPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC-CCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcCccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCc-cChhhccCCCCCCEEECCC
Confidence 5789999999998766653 899999999999999999999999999999999999986 5667789999999999999
Q ss_pred ceeEeecCCCccCCCCCcccEEEccCCCCCCcC
Q 004020 171 ANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPI 203 (779)
Q Consensus 171 n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~ 203 (779)
|+|++..++.|. .+++|++|+|++|.++...
T Consensus 88 N~l~~~~~~~~~--~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 88 NQLKSIPRGAFD--NLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp SCCCCCCTTTTT--TCTTCCEEECCSSCBCTTB
T ss_pred CccCEeCHHHhc--CCCCCCEEEeCCCCCCCCc
Confidence 999977777776 7999999999999998543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.40 E-value=8.5e-13 Score=125.88 Aligned_cols=106 Identities=16% Similarity=0.257 Sum_probs=93.8
Q ss_pred CcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccC
Q 004020 91 LTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANG 170 (779)
Q Consensus 91 L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~ 170 (779)
-+.+++++|+|+.+++.+. ++|++|+|++|+|+++++..|.++++|++|+|++|+|.+ ..+..|.++++|+.|+|++
T Consensus 14 ~~~l~~~~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA-IPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCc-cChhHhCCcchhhEEECCC
Confidence 3789999999987666664 899999999999999999999999999999999999987 4556689999999999999
Q ss_pred ceeEeecCCCccCCCCCcccEEEccCCCCCC
Q 004020 171 ANITGTIPDFLGGDTIPGLMHLHLAFNFLQG 201 (779)
Q Consensus 171 n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~ 201 (779)
|+|++..+..|. .+++|++|+|++|.+..
T Consensus 91 N~l~~l~~~~~~--~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 91 NHLKSIPRGAFD--NLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp SCCCCCCTTTTT--TCTTCSEEECCSSCBCT
T ss_pred CccceeCHHHhc--cccCCCEEEeCCCCccc
Confidence 999976666675 79999999999999984
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.40 E-value=6.2e-12 Score=136.55 Aligned_cols=260 Identities=12% Similarity=0.151 Sum_probs=175.2
Q ss_pred EEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEccc
Q 004020 67 VTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145 (779)
Q Consensus 67 v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 145 (779)
++.+.+. ++++.+-..+|.+. +|+.++|..| ++.+.. +|.++ +|+.+.|.+ .++.|...+|.++++|+.++|+.
T Consensus 115 l~~i~ip-~~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~ 189 (401)
T 4fdw_A 115 YNEIILP-NSVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSK 189 (401)
T ss_dssp CSEEECC-TTCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTT
T ss_pred ccEEEEC-CccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCC
Confidence 3444443 34564556678775 7999999887 776666 78884 799999996 89999999999999999999999
Q ss_pred CCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCC
Q 004020 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSK 225 (779)
Q Consensus 146 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~ 225 (779)
|++.. .....|. ..+|+.+.+..+ ++..-...|. .+++|+.++|..| ++..-...|..
T Consensus 190 n~l~~-I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~--~~~~L~~l~l~~~-l~~I~~~aF~~---------------- 247 (401)
T 4fdw_A 190 TKITK-LPASTFV-YAGIEEVLLPVT-LKEIGSQAFL--KTSQLKTIEIPEN-VSTIGQEAFRE---------------- 247 (401)
T ss_dssp SCCSE-ECTTTTT-TCCCSEEECCTT-CCEECTTTTT--TCTTCCCEECCTT-CCEECTTTTTT----------------
T ss_pred CcceE-echhhEe-ecccCEEEeCCc-hheehhhHhh--CCCCCCEEecCCC-ccCcccccccc----------------
Confidence 99976 3334554 799999999855 7756566665 7899999999875 55333334432
Q ss_pred CCCchhhhcCCCCccEEEeecCcccCCCC-CCCCCCCCcEEEccCCccc-----cccChhhhCCCCCCEEEccCcccccc
Q 004020 226 LNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDNQLT-----GIVPSSLVNLHSLAVVNLTNNLFQGQ 299 (779)
Q Consensus 226 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~-----~~~p~~l~~l~~L~~L~Ls~N~l~g~ 299 (779)
++|+.+.| .|.++...+ .|.++++|+.+++.+|.+. ...+.+|.++++|+.++|.+ .++..
T Consensus 248 -----------~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I 314 (401)
T 4fdw_A 248 -----------SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRIL 314 (401)
T ss_dssp -----------CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEE
T ss_pred -----------CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEE
Confidence 45666666 334444333 3666666666666666553 34456666677777777663 24322
Q ss_pred CCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccC
Q 004020 300 TPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKN 379 (779)
Q Consensus 300 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~ 379 (779)
....| ....+|+.++|..
T Consensus 315 ~~~aF--------------------------------------------------------------~~c~~L~~l~lp~ 332 (401)
T 4fdw_A 315 GQGLL--------------------------------------------------------------GGNRKVTQLTIPA 332 (401)
T ss_dssp CTTTT--------------------------------------------------------------TTCCSCCEEEECT
T ss_pred hhhhh--------------------------------------------------------------cCCCCccEEEECc
Confidence 22111 1112566666644
Q ss_pred ccccccccccccccccCCeEeccCccccccCCccCCCCC-CCCceeccCCcc
Q 004020 380 LGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLP-SLEMLDVSNNHL 430 (779)
Q Consensus 380 n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~-~L~~L~Ls~N~l 430 (779)
| ++..-+..|.++ +|+.|++++|.+.-..+..|..++ .+..|++..|.+
T Consensus 333 ~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 333 N-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV 382 (401)
T ss_dssp T-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred c-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence 3 554445678888 899999999988855556677774 678888877754
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.33 E-value=2.2e-12 Score=138.01 Aligned_cols=106 Identities=20% Similarity=0.328 Sum_probs=82.3
Q ss_pred CcceeeEeCCCCcEEEEEecCC-CccccCCccccCCCCCcEEEccc-CccccCCC-CCCCCCCccEEecCCCCCCCCCcc
Q 004020 54 CKWKHIQCSPSNRVTRIQIGGQ-NIEGTLPKELNSLSSLTVLEVMK-NKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSD 130 (779)
Q Consensus 54 C~w~gv~c~~~~~v~~l~l~~~-~l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~ 130 (779)
|.|..|.|+ ++ +|+ .+|. |..+++|++|+|++ |+|+++++ .|.+|++|++|+|++|+|+++++.
T Consensus 8 C~~~~v~~~-----------~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 74 (347)
T 2ifg_A 8 HGSSGLRCT-----------RDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74 (347)
T ss_dssp SSSSCEECC-----------SSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred ccCCEEEcC-----------CCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH
Confidence 666666664 44 677 5788 99999999999996 99998887 799999999999999999999999
Q ss_pred cccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeE
Q 004020 131 FFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANIT 174 (779)
Q Consensus 131 ~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~ 174 (779)
.|.+|++|++|+|++|+|.+ ..+..|..++ |+.|+|.+|.+.
T Consensus 75 ~~~~l~~L~~L~l~~N~l~~-~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 75 AFHFTPRLSRLNLSFNALES-LSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp GGGSCSCCCEEECCSSCCSC-CCSTTTCSCC-CCEEECCSSCCC
T ss_pred HhcCCcCCCEEeCCCCccce-eCHHHcccCC-ceEEEeeCCCcc
Confidence 99999999999999999975 3333343333 555555555544
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=8.4e-12 Score=127.83 Aligned_cols=149 Identities=16% Similarity=0.090 Sum_probs=115.9
Q ss_pred HHHhhcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCCeE
Q 004020 585 LRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNER 663 (779)
Q Consensus 585 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 663 (779)
+....+.|++...++.|+.+.||++... ++.+++|+...... .....+.+|+++++.+. +..+.++++++...+..
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~ 85 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence 3455678988899999999999999754 68999999865321 11235889999999885 67788999999998999
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCC------------------------------
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA------------------------------ 713 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~------------------------------ 713 (779)
|+||||++|.++.+.+. +......++.++++++..||+..
T Consensus 86 ~lv~e~i~G~~l~~~~~----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYE----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEECCSSEEHHHHCC----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred EEEEEecCCeehhhccC----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence 99999999999876531 11123477889999999999710
Q ss_pred --------------------------CCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 714 --------------------------HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 714 --------------------------~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
...++|+|++|.||+++++..+.|+||+.+...
T Consensus 156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence 145899999999999987656679999987543
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.21 E-value=1.7e-13 Score=147.42 Aligned_cols=67 Identities=21% Similarity=0.183 Sum_probs=46.5
Q ss_pred hcCCCCccEEEeecCcccCCC----C-CCCCCCCCcEEEccCCccccc----cChhhhCCCCCCEEEccCcccccc
Q 004020 233 IQNMTSLTQLWLHGNSFTGPL----P-DLSGLSSLQDFSVRDNQLTGI----VPSSLVNLHSLAVVNLTNNLFQGQ 299 (779)
Q Consensus 233 ~~~l~~L~~L~L~~N~l~~~~----~-~~~~l~~L~~L~l~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~g~ 299 (779)
+..+++|++|+|++|.|+..- . .+...++|+.|+|++|.|+.. ++..+...++|++|+|++|.|+..
T Consensus 179 L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 179 LAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp HHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred HhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence 345677888888888776421 2 255567788888888888643 445566678888888888888643
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.21 E-value=2.1e-11 Score=130.45 Aligned_cols=105 Identities=17% Similarity=0.240 Sum_probs=88.8
Q ss_pred cEEEcccC-ccccCCCCCCCCCCccEEecCC-CCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEecc
Q 004020 92 TVLEVMKN-KLTGQIPSLSGLSSLQEVLFDD-NNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSAN 169 (779)
Q Consensus 92 ~~L~Ls~N-~l~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~ 169 (779)
..++++++ +|+.+++ +..+++|++|+|++ |+|+++++..|.+|++|++|+|++|+|.+ ..|..|.++++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF-VAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCE-ECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccce-eCHHHhcCCcCCCEEeCC
Confidence 35688888 8998777 99999999999996 99999999999999999999999999987 677788999999999999
Q ss_pred CceeEeecCCCccCCCCCcccEEEccCCCCCC
Q 004020 170 GANITGTIPDFLGGDTIPGLMHLHLAFNFLQG 201 (779)
Q Consensus 170 ~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~ 201 (779)
+|+|++..+..+. .++ |++|+|++|.|..
T Consensus 89 ~N~l~~~~~~~~~--~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 89 FNALESLSWKTVQ--GLS-LQELVLSGNPLHC 117 (347)
T ss_dssp SSCCSCCCSTTTC--SCC-CCEEECCSSCCCC
T ss_pred CCccceeCHHHcc--cCC-ceEEEeeCCCccC
Confidence 9999865555553 343 8999999998873
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.20 E-value=1.8e-13 Score=147.16 Aligned_cols=46 Identities=24% Similarity=0.335 Sum_probs=26.0
Q ss_pred cccccccccCCeEeccCccccc----cCCccCCCCCCCCceeccCCcccc
Q 004020 387 SSNFSRLTSLRQLMLSGNELTG----TIPKELTTLPSLEMLDVSNNHLFG 432 (779)
Q Consensus 387 p~~~~~l~~L~~L~Ls~N~l~g----~iP~~l~~l~~L~~L~Ls~N~l~g 432 (779)
+..+...+.|+.|+|++|+|+. .++..+...++|++|||++|.|+.
T Consensus 204 ~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 204 AAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp HHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred HHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence 3444455566666666666653 233344445666666666666653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.14 E-value=3.9e-11 Score=122.61 Aligned_cols=140 Identities=17% Similarity=0.126 Sum_probs=102.3
Q ss_pred hcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCc--cceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH--LVGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv 666 (779)
...|.+....+.|..+.||++...+|..+++|..... ....+.+|+++++.+.+.+ +.+++++...++..++|
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 3445554443456669999998777888999987543 1235778999998886444 56688888888889999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA--------------------------------- 713 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--------------------------------- 713 (779)
|||++|.++. .. ..+ ...++.++++.|..||+..
T Consensus 94 ~e~i~G~~l~--~~--------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (264)
T 1nd4_A 94 LGEVPGQDLL--SS--------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE 160 (264)
T ss_dssp EECCSSEETT--TS--------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred EEecCCcccC--cC--------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence 9999998873 21 011 2356778888888888632
Q ss_pred ----------------------CCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 714 ----------------------HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 714 ----------------------~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
...++|+|++|.||++++++.+.|+|||.+...
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 112999999999999987766779999998654
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.13 E-value=1.9e-09 Score=117.26 Aligned_cols=290 Identities=15% Similarity=0.132 Sum_probs=159.0
Q ss_pred CccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCC-----------
Q 004020 82 PKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFD----------- 149 (779)
Q Consensus 82 p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~----------- 149 (779)
..+|.++++|+.+.|..+ ++.+.. +|.++++|+.++|.++ ++.|...+|.++.+|+.+.+..+--.
T Consensus 64 ~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~~~aF~~~~~ 141 (394)
T 4fs7_A 64 YAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIGVEAFKGCDF 141 (394)
T ss_dssp TTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEECTTTTTTCCC
T ss_pred HHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceeeecceeeecccc
Confidence 345666666666666533 444433 5666666666666543 55555566666666655554332100
Q ss_pred ---------CCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCcccc-CCcceeeccC
Q 004020 150 ---------SWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNG 219 (779)
Q Consensus 150 ---------~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~L~~l~l~~ 219 (779)
.......|.++++|+.+.+.++..+ .-...|. .+.+|+.+++..| ++......+.. ..|+.+.+..
T Consensus 142 ~~~~~~~~~~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~--~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~ 217 (394)
T 4fs7_A 142 KEITIPEGVTVIGDEAFATCESLEYVSLPDSMET-LHNGLFS--GCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPN 217 (394)
T ss_dssp SEEECCTTCCEECTTTTTTCTTCCEEECCTTCCE-ECTTTTT--TCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCT
T ss_pred cccccCccccccchhhhcccCCCcEEecCCccce-ecccccc--CCCCceEEEcCCC-ceEeCchhhccccccceeecCC
Confidence 0012356888888999888765432 3344453 6788888888766 44333344443 4566665544
Q ss_pred CCCCCCCCCchhhhcCCCCccEEEeecCcccCCCC-CCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccc
Q 004020 220 QKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQG 298 (779)
Q Consensus 220 n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g 298 (779)
+.... -......++|+.+.+..+ ++.... .+.++..|+.+.+..+... .....|..+..|+.+.+..+.+..
T Consensus 218 ~~~~i-----~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~~ 290 (394)
T 4fs7_A 218 SLYYL-----GDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVPE 290 (394)
T ss_dssp TCCEE-----CTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEECT
T ss_pred CceEe-----ehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeecc
Confidence 32111 011224567777777643 332222 4677788888888777554 556777778888877776654321
Q ss_pred cCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEcc
Q 004020 299 QTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLK 378 (779)
Q Consensus 299 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls 378 (779)
.. +.....+. . +..+..+. .++ ...+....+|+.++|.
T Consensus 291 ~~--F~~~~~L~--------~---------------------i~l~~~i~--~I~---------~~aF~~c~~L~~i~lp 328 (394)
T 4fs7_A 291 KT--FYGCSSLT--------E---------------------VKLLDSVK--FIG---------EEAFESCTSLVSIDLP 328 (394)
T ss_dssp TT--TTTCTTCC--------E---------------------EEECTTCC--EEC---------TTTTTTCTTCCEECCC
T ss_pred cc--cccccccc--------c---------------------cccccccc--eec---------hhhhcCCCCCCEEEeC
Confidence 10 00000000 0 00000000 000 0012223467777776
Q ss_pred CccccccccccccccccCCeEeccCccccccCCccCCCCCCCCceeccCC
Q 004020 379 NLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNN 428 (779)
Q Consensus 379 ~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N 428 (779)
++ ++..-...|.++++|+.++|..| ++-.-..+|..+++|+.++|..|
T Consensus 329 ~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 329 YL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp TT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred Cc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 44 55444567888888888888776 66344567888888888888654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.99 E-value=1.5e-09 Score=116.39 Aligned_cols=145 Identities=15% Similarity=0.220 Sum_probs=107.3
Q ss_pred cccceecccccEEEEEEEEcCCcEEEEEEec--ccccChhHHHHHHHHHHHHHcCC--CCccceEeeEEEeC---CeEEE
Q 004020 593 SEENVLGRGGFGTVYKGELHDGTKIAVKRME--SAVVSEKGFAEFKSEIAVLTKVR--HRHLVGLLGYCLDG---NERLL 665 (779)
Q Consensus 593 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~---~~~~l 665 (779)
...+.++.|.++.||++... +..+++|+.. .... ......+.+|.++++.+. +..+++++.++.+. +..|+
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS-SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred ceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 34678999999999999876 4678888775 3221 122356788999999997 45678888888766 45899
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--------------------------------
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA-------------------------------- 713 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-------------------------------- 713 (779)
||||++|..+.+.. ...++..++..++.++++.|..||+..
T Consensus 119 vme~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET 191 (359)
T ss_dssp EEECCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred EEEecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence 99999998774321 123567788899999999999999731
Q ss_pred -----------------------CCCcEEcCCCCCCEEEcCCCc--EEEEeeccceec
Q 004020 714 -----------------------HQSFIHRDLKPSNILLGDDMR--AKVADFGLVRLA 746 (779)
Q Consensus 714 -----------------------~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~ 746 (779)
...++|+|++|.||+++.++. +.|+||+.+..-
T Consensus 192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 256899999999999987653 689999998753
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.98 E-value=3.2e-08 Score=107.46 Aligned_cols=122 Identities=17% Similarity=0.186 Sum_probs=67.6
Q ss_pred EEEEEecCCCccccCCccccCCCCCcEEEcccCc---cccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEE
Q 004020 67 VTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNK---LTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTIS 142 (779)
Q Consensus 67 v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~---l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 142 (779)
++.+.+.. .++.+-..+|.++++|+.+.+..|. ++.+.. +|.++.+|+.+.+.++ ++.+...+|..+.+|+.+.
T Consensus 66 L~sI~iP~-svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~ 143 (394)
T 4gt6_A 66 LTSVQIPD-TVTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVT 143 (394)
T ss_dssp CCEEEECT-TCCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEE
T ss_pred CEEEEECC-CeeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhccccccc
Confidence 55555543 2444445566667777777766653 443333 5666666666666543 5666666666777777777
Q ss_pred cccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccC
Q 004020 143 LDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAF 196 (779)
Q Consensus 143 Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~ 196 (779)
+..+.- . .....|..+.+|+.+.+.++ ++..-...|. ...|+.+.+..
T Consensus 144 lp~~~~-~-I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~---~~~l~~i~ip~ 191 (394)
T 4gt6_A 144 IPEGVT-S-VADGMFSYCYSLHTVTLPDS-VTAIEERAFT---GTALTQIHIPA 191 (394)
T ss_dssp CCTTCC-E-ECTTTTTTCTTCCEEECCTT-CCEECTTTTT---TCCCSEEEECT
T ss_pred ccceee-e-ecccceecccccccccccce-eeEecccccc---ccceeEEEECC
Confidence 654432 1 23455666666666666544 3322233332 34555555543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.96 E-value=1.8e-08 Score=109.48 Aligned_cols=271 Identities=11% Similarity=0.023 Sum_probs=174.4
Q ss_pred cccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCcee------
Q 004020 101 LTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANI------ 173 (779)
Q Consensus 101 l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l------ 173 (779)
++.+.. +|.++++|+.+.|.+ .++.|...+|.++++|++++|..+ +.. .....|.++.+|+.+.+..+-.
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~-I~~~aF~~c~~L~~i~~p~~l~~i~~~a 135 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKM-IGRCTFSGCYALKSILLPLMLKSIGVEA 135 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCE-ECTTTTTTCTTCCCCCCCTTCCEECTTT
T ss_pred EeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceE-ccchhhcccccchhhcccCceeeeccee
Confidence 555555 899999999999985 599999999999999999999866 433 3456788888888777654311
Q ss_pred ---------------EeecCCCccCCCCCcccEEEccCCCCCCcCCCcccc-CCcceeeccCCCCCCCCCCchhhhcCCC
Q 004020 174 ---------------TGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMT 237 (779)
Q Consensus 174 ---------------~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~L~~l~l~~n~~~~~~~~~~~~~~~l~ 237 (779)
...-...|. .+++|+.+.+.++..+ .....|.. .+|+.+.+..+ +... ...++.++.
T Consensus 136 F~~~~~~~~~~~~~~~~i~~~aF~--~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I---~~~~F~~~~ 208 (394)
T 4fs7_A 136 FKGCDFKEITIPEGVTVIGDEAFA--TCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKII---RDYCFAECI 208 (394)
T ss_dssp TTTCCCSEEECCTTCCEECTTTTT--TCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEE---CTTTTTTCT
T ss_pred eecccccccccCccccccchhhhc--ccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEe---Cchhhcccc
Confidence 111122333 6789999999766432 33444544 56888887655 2211 123466788
Q ss_pred CccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCCCCCc-ccccccCCC
Q 004020 238 SLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPV-RFDMAKGSN 316 (779)
Q Consensus 238 ~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~-~~~~~~~~~ 316 (779)
.|+.+.+..+...- -.......+|+.+.+.++. +..-...+..+..|+.+.+..+...- ....+... .+......
T Consensus 209 ~L~~i~~~~~~~~i-~~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~~i-~~~~F~~~~~l~~~~~~- 284 (394)
T 4fs7_A 209 LLENMEFPNSLYYL-GDFALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKLRI-GGSLFYNCSGLKKVIYG- 284 (394)
T ss_dssp TCCBCCCCTTCCEE-CTTTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTCEE-CSCTTTTCTTCCEEEEC-
T ss_pred ccceeecCCCceEe-ehhhcccCCCceEEECCCc-eecccccccccccceeEEcCCCccee-eccccccccccceeccC-
Confidence 89888887765432 2234456789999987553 43556788899999999998775431 11111110 00000000
Q ss_pred CcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccC
Q 004020 317 SFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSL 396 (779)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L 396 (779)
... . ....+....+|+.+.+..+ +...-...|.++++|
T Consensus 285 ----------------------------~~~----i---------~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L 322 (394)
T 4fs7_A 285 ----------------------------SVI----V---------PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSL 322 (394)
T ss_dssp ----------------------------SSE----E---------CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTC
T ss_pred ----------------------------cee----e---------ccccccccccccccccccc-cceechhhhcCCCCC
Confidence 000 0 0011223347888888755 554456678999999
Q ss_pred CeEeccCccccccCCccCCCCCCCCceeccCC
Q 004020 397 RQLMLSGNELTGTIPKELTTLPSLEMLDVSNN 428 (779)
Q Consensus 397 ~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N 428 (779)
+.++|..+ ++-.-..+|..+++|+.+++..|
T Consensus 323 ~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 323 VSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp CEECCCTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred CEEEeCCc-ccEEhHHhccCCCCCCEEEECcc
Confidence 99999754 77333577889999999998766
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.81 E-value=3.3e-10 Score=120.68 Aligned_cols=82 Identities=15% Similarity=0.200 Sum_probs=43.3
Q ss_pred CCcEEEEEecCCCccc-c-------CCccccCCCCCcEEEcccCcccc---------CC-CCCCCCCCccEEecCCCCCC
Q 004020 64 SNRVTRIQIGGQNIEG-T-------LPKELNSLSSLTVLEVMKNKLTG---------QI-PSLSGLSSLQEVLFDDNNFT 125 (779)
Q Consensus 64 ~~~v~~l~l~~~~l~~-~-------~p~~l~~l~~L~~L~Ls~N~l~~---------~~-~~~~~l~~L~~L~l~~N~l~ 125 (779)
..+|+.|.+......| . +..++..+++|+.|.+.++.... .+ +.+..+++|+.|+|++|.-.
T Consensus 106 ~~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l 185 (362)
T 2ra8_A 106 LPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL 185 (362)
T ss_dssp GGGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC
T ss_pred chhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc
Confidence 3468888888766553 2 23345567888888886653311 11 12344556666666555211
Q ss_pred CCCcccccCCCCccEEEcccCCC
Q 004020 126 SVPSDFFKGLTSLQTISLDYNSF 148 (779)
Q Consensus 126 ~~~~~~~~~l~~L~~L~Ls~N~l 148 (779)
.+++ + .+++|++|+|..+.+
T Consensus 186 ~l~~--~-~~~~L~~L~L~~~~l 205 (362)
T 2ra8_A 186 SIGK--K-PRPNLKSLEIISGGL 205 (362)
T ss_dssp BCCS--C-BCTTCSEEEEECSBC
T ss_pred eecc--c-cCCCCcEEEEecCCC
Confidence 2222 2 245555555555544
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.79 E-value=1.3e-09 Score=116.10 Aligned_cols=57 Identities=19% Similarity=0.321 Sum_probs=27.8
Q ss_pred CeEEEEccCcccccc----ccccccccccCCeEeccCccccccCCccCCC-CCCCCceeccCCc
Q 004020 371 NITVVNLKNLGLSGT----ISSNFSRLTSLRQLMLSGNELTGTIPKELTT-LPSLEMLDVSNNH 429 (779)
Q Consensus 371 ~L~~L~Ls~n~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~-l~~L~~L~Ls~N~ 429 (779)
+|+.|+|+.|.+.+. ++..+..+++|+.|+|++|.|+...-..+.. + ...+++++|+
T Consensus 280 ~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 280 QLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp GCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred CCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 344444444444432 3334445667777777777666432222221 1 2345666654
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.78 E-value=2.7e-07 Score=100.09 Aligned_cols=158 Identities=12% Similarity=0.123 Sum_probs=108.4
Q ss_pred cCCccccCCC-CCcEEEcccCccccCCC-CCCCCCCccEEecCCCC---CCCCCcccccCCCCccEEEcccCCCCCCCCc
Q 004020 80 TLPKELNSLS-SLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNN---FTSVPSDFFKGLTSLQTISLDYNSFDSWVIP 154 (779)
Q Consensus 80 ~~p~~l~~l~-~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~---l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p 154 (779)
+-..+|.+.. .|+.+.+-.+ ++.+.. +|.++++|+.+.+.+|. ++.|...+|.++.+|+.+.+..+ +.. ...
T Consensus 54 Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~-I~~ 130 (394)
T 4gt6_A 54 IGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTE-IDS 130 (394)
T ss_dssp ECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSE-ECT
T ss_pred cCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cce-ehh
Confidence 3345677774 5999999765 766665 89999999999998875 88889999999999999988766 332 345
Q ss_pred ccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhc
Q 004020 155 ESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQ 234 (779)
Q Consensus 155 ~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~ 234 (779)
..|..+.+|+.+.+..+- +......|. .+..|+.+.+..+ ++..-...|....|+.+.+..+-.. -...++.
T Consensus 131 ~aF~~c~~L~~i~lp~~~-~~I~~~~F~--~c~~L~~i~~~~~-~~~I~~~aF~~~~l~~i~ip~~~~~----i~~~af~ 202 (394)
T 4gt6_A 131 EAFHHCEELDTVTIPEGV-TSVADGMFS--YCYSLHTVTLPDS-VTAIEERAFTGTALTQIHIPAKVTR----IGTNAFS 202 (394)
T ss_dssp TTTTTCTTCCEEECCTTC-CEECTTTTT--TCTTCCEEECCTT-CCEECTTTTTTCCCSEEEECTTCCE----ECTTTTT
T ss_pred hhhhhhccccccccccee-eeeccccee--cccccccccccce-eeEeccccccccceeEEEECCcccc----cccchhh
Confidence 788999999999997553 334444554 6889999998765 4434445555566777766543211 0112344
Q ss_pred CCCCccEEEeecCc
Q 004020 235 NMTSLTQLWLHGNS 248 (779)
Q Consensus 235 ~l~~L~~L~L~~N~ 248 (779)
.+.++.......+.
T Consensus 203 ~c~~l~~~~~~~~~ 216 (394)
T 4gt6_A 203 ECFALSTITSDSES 216 (394)
T ss_dssp TCTTCCEEEECCSS
T ss_pred hccccceecccccc
Confidence 55666666555443
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.61 E-value=7.3e-10 Score=111.86 Aligned_cols=22 Identities=14% Similarity=-0.064 Sum_probs=15.3
Q ss_pred CCcceeeEeCCCC-cEEEEEecC
Q 004020 53 PCKWKHIQCSPSN-RVTRIQIGG 74 (779)
Q Consensus 53 ~C~w~gv~c~~~~-~v~~l~l~~ 74 (779)
.|.|.|+.|++.+ +|+.+-..+
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~ 99 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSS 99 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEEC
T ss_pred HHhcCcEEECCCCCEEEEEEecC
Confidence 4889999998643 665555543
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.51 E-value=7.1e-06 Score=88.33 Aligned_cols=59 Identities=15% Similarity=0.152 Sum_probs=44.0
Q ss_pred CCCeEEEEccCccccccccccccccccCCeEeccCccccccCCccCCCCCCCCceeccCC
Q 004020 369 GGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNN 428 (779)
Q Consensus 369 ~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N 428 (779)
..+|+.+++.++.+...-...|.++++|+.++|..+ ++-.-..+|.++++|+.+.+..+
T Consensus 285 c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 285 CSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp CTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred ccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 347888888888887656678888899999999754 66233457888888888877544
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.50 E-value=2.6e-07 Score=96.35 Aligned_cols=137 Identities=18% Similarity=0.258 Sum_probs=98.8
Q ss_pred cceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCc--cceEeeEEEeCC---eEEEEEE
Q 004020 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRH--LVGLLGYCLDGN---ERLLVYE 668 (779)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e 668 (779)
.+.++.|....||++. ..+++|+.... .....+.+|.++++.+. +.. +.+++......+ ..|+|||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 4668999999999863 56888875432 34567889999998884 333 344444433332 3489999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----------------------------------
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA----------------------------------- 713 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~----------------------------------- 713 (779)
+++|.++.+... ..++..++..++.|+++.+..||+..
T Consensus 97 ~i~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 97 KIKGVPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp CCCCEECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred ccCCeECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence 999988865332 13566777788888888888888511
Q ss_pred --------------------CCCcEEcCCCCCCEEEcC--CCcEEEEeeccceec
Q 004020 714 --------------------HQSFIHRDLKPSNILLGD--DMRAKVADFGLVRLA 746 (779)
Q Consensus 714 --------------------~~~ivHrDlkp~NIll~~--~~~~kl~DFG~a~~~ 746 (779)
...++|+|++|.||++++ ...+.|+||+.+...
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 135799999999999998 456889999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=1.2e-06 Score=89.53 Aligned_cols=137 Identities=17% Similarity=0.159 Sum_probs=98.5
Q ss_pred ceecccccE-EEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCCeEEEEEEecCC
Q 004020 596 NVLGRGGFG-TVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLLVYEYMPQ 672 (779)
Q Consensus 596 ~~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~ 672 (779)
+.+..|..+ .||+.... ++..+++|+-... ...++.+|...++.+. +--+.++++++.+.+..|+|||+++|
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 345556554 68988665 4667889975432 3456788999998885 33467888999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------------
Q 004020 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA--------------------------------------- 713 (779)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--------------------------------------- 713 (779)
.++.+..... ......+..+++..|..||+..
T Consensus 105 ~~~~~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (272)
T 4gkh_A 105 KTAFQVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP 175 (272)
T ss_dssp EEHHHHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred ccccccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence 8887654221 1123356667777777777521
Q ss_pred ----------------CCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 714 ----------------HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 714 ----------------~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
...++|+|+.|.||++++++.+-|+||+.+..-
T Consensus 176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 112789999999999998777789999988654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=1.9e-06 Score=89.75 Aligned_cols=137 Identities=18% Similarity=0.190 Sum_probs=95.3
Q ss_pred cceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCC---ccceEeeEEE-eCCeEEEEEEec
Q 004020 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR---HLVGLLGYCL-DGNERLLVYEYM 670 (779)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~ 670 (779)
.+.++.|....||+. +..+++|+-.. ......+.+|.++++.+.+. .+.+.+.++. ..+..++||||+
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 466888888999998 56788887432 23456789999999999752 3566777664 345678999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcC--------------------------------------
Q 004020 671 PQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL-------------------------------------- 712 (779)
Q Consensus 671 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-------------------------------------- 712 (779)
+|..+.+.... .++..+...++.++++.|..||+.
T Consensus 96 ~G~~l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 96 QGQILGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp CSEECHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred CCeECchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 99887653211 133444455555555555555532
Q ss_pred -------------------CCCCcEEcCCCCCCEEEcC---CCc-EEEEeeccceec
Q 004020 713 -------------------AHQSFIHRDLKPSNILLGD---DMR-AKVADFGLVRLA 746 (779)
Q Consensus 713 -------------------~~~~ivHrDlkp~NIll~~---~~~-~kl~DFG~a~~~ 746 (779)
....++|+|++|.||+++. ++. +.|+||+.+..-
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 1235699999999999987 455 489999988654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.26 E-value=7.5e-08 Score=92.38 Aligned_cols=66 Identities=17% Similarity=0.224 Sum_probs=40.8
Q ss_pred hhcCCCCccEEEeecC-cccCC----C-CCCCCCCCCcEEEccCCccccc----cChhhhCCCCCCEEEccCcccc
Q 004020 232 VIQNMTSLTQLWLHGN-SFTGP----L-PDLSGLSSLQDFSVRDNQLTGI----VPSSLVNLHSLAVVNLTNNLFQ 297 (779)
Q Consensus 232 ~~~~l~~L~~L~L~~N-~l~~~----~-~~~~~l~~L~~L~l~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~ 297 (779)
.+...++|++|+|++| .+... + ..+...++|++|+|++|+|... +...+...++|++|+|++|.|+
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 3455677888888887 76531 1 1245566777777777777532 3344455566777777777665
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=3.2e-06 Score=90.22 Aligned_cols=83 Identities=10% Similarity=-0.007 Sum_probs=55.9
Q ss_pred ccee-cccccEEEEEEEEc-------CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCC-C--CccceEeeEEEeC--
Q 004020 595 ENVL-GRGGFGTVYKGELH-------DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVR-H--RHLVGLLGYCLDG-- 660 (779)
Q Consensus 595 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~-- 660 (779)
.+.| +.|....+|+.... +++.+++|+...... .......+.+|+.+++.+. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4667 88889999998764 267888987654220 0001135678888888874 3 3467778777655
Q ss_pred -CeEEEEEEecCCCChhh
Q 004020 661 -NERLLVYEYMPQGTLSR 677 (779)
Q Consensus 661 -~~~~lv~e~~~~gsL~~ 677 (779)
+..|+||||++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999877653
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.16 E-value=1.7e-07 Score=89.86 Aligned_cols=64 Identities=16% Similarity=0.176 Sum_probs=43.7
Q ss_pred cCCCCccEEEeecCcccCC-----CCCCCCCCCCcEEEc--cCCccccc----cChhhhCCCCCCEEEccCcccc
Q 004020 234 QNMTSLTQLWLHGNSFTGP-----LPDLSGLSSLQDFSV--RDNQLTGI----VPSSLVNLHSLAVVNLTNNLFQ 297 (779)
Q Consensus 234 ~~l~~L~~L~L~~N~l~~~-----~~~~~~l~~L~~L~l--~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~ 297 (779)
...++|++|+|++|.|+.. ...+...++|++|+| ++|.|... +...+...++|+.|+|++|.+.
T Consensus 90 ~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 90 KVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3456677777777777642 123555677888888 77887643 3455666688999999988875
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.10 E-value=0.00022 Score=76.45 Aligned_cols=57 Identities=9% Similarity=0.135 Sum_probs=43.1
Q ss_pred CeEEEEccCccccccccccccccccCCeEeccCccccccCCccCCCCCCCCceeccCC
Q 004020 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNN 428 (779)
Q Consensus 371 ~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N 428 (779)
+|+.+.+..+ +...-...|.++++|+.+++.++.++-.-...|..+.+|+.++|..+
T Consensus 264 ~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~ 320 (379)
T 4h09_A 264 ALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA 320 (379)
T ss_dssp TCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT
T ss_pred hhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc
Confidence 5666666543 44344557889999999999999998444678899999999999654
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.07 E-value=1.9e-06 Score=86.86 Aligned_cols=66 Identities=32% Similarity=0.366 Sum_probs=56.8
Q ss_pred CCCeEEEEccCccccc--cccccccccccCCeEeccCccccccCCccCCCCC--CCCceeccCCcccccCCC
Q 004020 369 GGNITVVNLKNLGLSG--TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLP--SLEMLDVSNNHLFGKVPN 436 (779)
Q Consensus 369 ~~~L~~L~Ls~n~l~g--~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~--~L~~L~Ls~N~l~g~iP~ 436 (779)
.++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..++ +|++|+|++|++++.+|.
T Consensus 169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~ 238 (267)
T 3rw6_A 169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRD 238 (267)
T ss_dssp CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSS
T ss_pred CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCc
Confidence 3589999999999999 6778889999999999999999965 3344444 999999999999998873
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.96 E-value=7.4e-05 Score=78.91 Aligned_cols=144 Identities=19% Similarity=0.238 Sum_probs=80.2
Q ss_pred cceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-----CCccceEe-e--EEEeCCeEEEE
Q 004020 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-----HRHLVGLL-G--YCLDGNERLLV 666 (779)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~-~--~~~~~~~~~lv 666 (779)
.+.|+.|..+.||++...++ .+++|+.... . .++..|..+++.+. .|.++... + +....+..+++
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l 109 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVV 109 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEE
Confidence 34566677899999987654 5889988642 1 23334555554442 24433311 1 22346678999
Q ss_pred EEecCCCChh--------------hHhhhcccCC--C-------CCCCHHHH----------------------------
Q 004020 667 YEYMPQGTLS--------------RHLFNRKEEG--L-------KPLEWTRR---------------------------- 695 (779)
Q Consensus 667 ~e~~~~gsL~--------------~~l~~~~~~~--~-------~~~~~~~~---------------------------- 695 (779)
|||++|..+. ..++.....- . ..-.|...
T Consensus 110 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 189 (346)
T 2q83_A 110 YDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYL 189 (346)
T ss_dssp EECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHH
T ss_pred EEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHH
Confidence 9999986542 1122111100 0 00122111
Q ss_pred ---HHHHHHHHHHHHHHHc----------CCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 696 ---LTIALDVARGVEYLHG----------LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 696 ---~~i~~qi~~~L~~LH~----------~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
..+..++..++++|+. .....++|+|+++.||+++.++.+.|+||+.+..
T Consensus 190 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 190 QEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111223445666652 0147899999999999998888899999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.86 E-value=4.5e-05 Score=82.53 Aligned_cols=77 Identities=13% Similarity=0.103 Sum_probs=49.9
Q ss_pred cceecccccEEEEEEEEc-CCcEEEEEEeccccc--Ch---hHHHHHHHHHHHHHcCCC--C-ccceEeeEEEeCCeEEE
Q 004020 595 ENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV--SE---KGFAEFKSEIAVLTKVRH--R-HLVGLLGYCLDGNERLL 665 (779)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~---~~~~~~~~E~~~l~~l~h--~-niv~~~~~~~~~~~~~l 665 (779)
.+.+|.|.++.||+++.. +++.+++|....... .. ....++..|.++++.+.. | .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 568999999999999754 468899998653321 00 122456778888887742 3 34455543 4555689
Q ss_pred EEEecCCC
Q 004020 666 VYEYMPQG 673 (779)
Q Consensus 666 v~e~~~~g 673 (779)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00021 Score=74.00 Aligned_cols=142 Identities=17% Similarity=0.166 Sum_probs=93.0
Q ss_pred cccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCC---CCccceEeeEEEeCCeEEEEEEe
Q 004020 593 SEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR---HRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 593 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
...+.|+.|....+|+... ++..+++|+.... ....+.+|.+.++.+. ...+++++.+....+..++||||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 3456799999999999876 4678888976532 2456888999888884 35688889888888889999999
Q ss_pred cCCCChhh-----------Hhhhccc-CC--C--------------CCCCHHHHH---HHH----------------HHH
Q 004020 670 MPQGTLSR-----------HLFNRKE-EG--L--------------KPLEWTRRL---TIA----------------LDV 702 (779)
Q Consensus 670 ~~~gsL~~-----------~l~~~~~-~~--~--------------~~~~~~~~~---~i~----------------~qi 702 (779)
+++..+.. .++.... .. . -.-+|.... ++. .++
T Consensus 113 l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l 192 (312)
T 3jr1_A 113 LNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLI 192 (312)
T ss_dssp CCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHH
T ss_pred ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHH
Confidence 99875421 1222211 00 0 012344321 111 112
Q ss_pred HHHH-HHHHc-CCCCCcEEcCCCCCCEEEcCCCcEEEEeec
Q 004020 703 ARGV-EYLHG-LAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (779)
Q Consensus 703 ~~~L-~~LH~-~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 741 (779)
+..+ ..|.. .....++|+|+.+.|++++.++ +.|+||.
T Consensus 193 ~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 193 VQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2122 23321 1246799999999999999887 8999984
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00014 Score=74.85 Aligned_cols=79 Identities=22% Similarity=0.259 Sum_probs=56.0
Q ss_pred CCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCC---ccceEeeEEEeCCeEEEEE
Q 004020 591 NFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR---HLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~~lv~ 667 (779)
.....+.+|.|..+.||+++..+|+.|++|+...... .....+.+|++.|+.+.-. -+++++++ . ..++||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~ 89 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAM 89 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEE
Confidence 3455678999999999999999999999998654321 1223578899999888421 24455543 2 247899
Q ss_pred EecCCCCh
Q 004020 668 EYMPQGTL 675 (779)
Q Consensus 668 e~~~~gsL 675 (779)
||++++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00031 Score=76.51 Aligned_cols=76 Identities=16% Similarity=0.203 Sum_probs=46.0
Q ss_pred ccceecccccEEEEEEEEcCCcEEEEEEeccccc--Ch-----hHHHHHHHHHHHHH-cCCCCccceEeeEEEeCCeEEE
Q 004020 594 EENVLGRGGFGTVYKGELHDGTKIAVKRMESAVV--SE-----KGFAEFKSEIAVLT-KVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 594 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~-----~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~l 665 (779)
..+.+|.|..+.||++.. +++.++||....... .. .....+..|+..+. ......+++++.+. .+..++
T Consensus 38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 357789999999999964 467899994322110 00 02223334443332 12234566777665 566799
Q ss_pred EEEec-CC
Q 004020 666 VYEYM-PQ 672 (779)
Q Consensus 666 v~e~~-~~ 672 (779)
||||+ ++
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00058 Score=71.30 Aligned_cols=160 Identities=14% Similarity=0.153 Sum_probs=87.3
Q ss_pred eHHHHHHhhcCCcc-----cceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCc--cceE
Q 004020 581 SIQVLRNVTNNFSE-----ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH--LVGL 653 (779)
Q Consensus 581 ~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~ 653 (779)
+.+++..+..+|.. .+.|+.|....+|++...++ .+++|...... ...++..|..++..+.... +.++
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 44556666666654 34566788899999987655 67889876521 1134556777776663211 2333
Q ss_pred ee------EEEeCCeEEEEEEecCCCChhh--------------HhhhcccC-CCC---CC---CHHHHHH---------
Q 004020 654 LG------YCLDGNERLLVYEYMPQGTLSR--------------HLFNRKEE-GLK---PL---EWTRRLT--------- 697 (779)
Q Consensus 654 ~~------~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~-~~~---~~---~~~~~~~--------- 697 (779)
+. +....+..+++|+|++|..+.. .++..... ... .. .|.....
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 32 1123456789999999865321 01111000 000 00 1211100
Q ss_pred ---HHHHHHHHHHHHHcC----CCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 698 ---IALDVARGVEYLHGL----AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 698 ---i~~qi~~~L~~LH~~----~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
+...+.+.+++++.. ...+++|+|+++.||++++++.+.|+||+.+..
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011233445555421 135789999999999998876668999998754
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.27 E-value=6.2e-05 Score=70.20 Aligned_cols=82 Identities=15% Similarity=0.098 Sum_probs=47.5
Q ss_pred cEEEEEecCCCccccCCccccCCCCCcEEEcccCc-cccCC-CCCCCC----CCccEEecCCCC-CCCCCcccccCCCCc
Q 004020 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNK-LTGQI-PSLSGL----SSLQEVLFDDNN-FTSVPSDFFKGLTSL 138 (779)
Q Consensus 66 ~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~-~~~~~l----~~L~~L~l~~N~-l~~~~~~~~~~l~~L 138 (779)
++++||++++.|+..--..+..+++|++|+|+++. |+..- ..++.+ ++|++|+|++|. +|.---..+.++++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 57777777777665444456677777777777764 54321 133332 356666666653 554333345556666
Q ss_pred cEEEcccCC
Q 004020 139 QTISLDYNS 147 (779)
Q Consensus 139 ~~L~Ls~N~ 147 (779)
++|+|+++.
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 666666554
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.23 E-value=6.5e-05 Score=70.05 Aligned_cols=67 Identities=9% Similarity=0.099 Sum_probs=39.1
Q ss_pred CCccccCCCCCcEEEcccCccccCC-CCCCCCCCccEEecCCCC-CCCCCcccccCC----CCccEEEcccCC
Q 004020 81 LPKELNSLSSLTVLEVMKNKLTGQI-PSLSGLSSLQEVLFDDNN-FTSVPSDFFKGL----TSLQTISLDYNS 147 (779)
Q Consensus 81 ~p~~l~~l~~L~~L~Ls~N~l~~~~-~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l----~~L~~L~Ls~N~ 147 (779)
+|.....-.+|++|||+++.++..- ..+.++++|+.|+|++|. ++.---..+..+ ++|++|+|+++.
T Consensus 53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~ 125 (176)
T 3e4g_A 53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCG 125 (176)
T ss_dssp SCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCT
T ss_pred CCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCC
Confidence 3433323346888888888765432 256677777777777774 554332334443 356677776654
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00048 Score=61.15 Aligned_cols=37 Identities=27% Similarity=0.525 Sum_probs=27.6
Q ss_pred CccEEecCCCCCCCCCcccccCCCCccEEEcccCCCC
Q 004020 113 SLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFD 149 (779)
Q Consensus 113 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 149 (779)
+|++|+|++|+|+.++++.|..+++|++|+|++|.+.
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4677777777777777777777777788888877764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00092 Score=69.07 Aligned_cols=74 Identities=11% Similarity=0.151 Sum_probs=45.4
Q ss_pred CcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCcc-ceEeeEEEeCCeEEEEEEec
Q 004020 592 FSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL-VGLLGYCLDGNERLLVYEYM 670 (779)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~ 670 (779)
+.-.+.|+.|....+|++ ..+++|+..... ....+..+|..+++.+....+ .+++.+ +.+.-++++||+
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i 89 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYI 89 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECC
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeec
Confidence 333678999999999998 568888775431 111123467777776642222 455543 344457899999
Q ss_pred -CCCCh
Q 004020 671 -PQGTL 675 (779)
Q Consensus 671 -~~gsL 675 (779)
++.++
T Consensus 90 ~~g~~l 95 (301)
T 3dxq_A 90 AGAQTM 95 (301)
T ss_dssp TTCEEC
T ss_pred CCCccC
Confidence 66544
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0041 Score=64.97 Aligned_cols=145 Identities=12% Similarity=0.060 Sum_probs=81.7
Q ss_pred ceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCC--ccceEeeE-----EEeCCeEEEEEE
Q 004020 596 NVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR--HLVGLLGY-----CLDGNERLLVYE 668 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~-----~~~~~~~~lv~e 668 (779)
+.++ |....||++...+|+.+++|....... ....+..|..++..+... .+++++.. ....+..+++||
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 4566 788899998777777899999864322 224566677777776421 23444432 223456788999
Q ss_pred ecCCCChhh-----H---------hhhcccC----CCCCCCHHHH----------------------HHHHHHHHHHHHH
Q 004020 669 YMPQGTLSR-----H---------LFNRKEE----GLKPLEWTRR----------------------LTIALDVARGVEY 708 (779)
Q Consensus 669 ~~~~gsL~~-----~---------l~~~~~~----~~~~~~~~~~----------------------~~i~~qi~~~L~~ 708 (779)
|++|..+.. . ++..... .....++... ...+.+++..++-
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 998854321 0 1111100 0011222111 0111122222222
Q ss_pred HHc-CCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 709 LHG-LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 709 LH~-~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
.-. .....++|+|+++.||+++ + .+.|+||+.+..-
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 211 1235689999999999998 4 8999999887653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.04 E-value=0.001 Score=72.41 Aligned_cols=73 Identities=18% Similarity=0.214 Sum_probs=49.0
Q ss_pred cceecccccEEEEEEEEcC--------CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCc-cceEeeEEEeCCeEEE
Q 004020 595 ENVLGRGGFGTVYKGELHD--------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH-LVGLLGYCLDGNERLL 665 (779)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~l 665 (779)
.+.|+.|-...+|++...+ ++.+++|+..... . ...+.+|..+++.+...+ .+++++.+. + .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CE
Confidence 4678888889999998753 5789999874321 1 134457888888875333 356666543 2 38
Q ss_pred EEEecCCCCh
Q 004020 666 VYEYMPQGTL 675 (779)
Q Consensus 666 v~e~~~~gsL 675 (779)
|+||++|.++
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999986444
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0039 Score=68.13 Aligned_cols=74 Identities=11% Similarity=0.093 Sum_probs=47.5
Q ss_pred cceecccccEEEEEEEEcC-CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCcc-ceEeeEEEeCCeEEEEEEecCC
Q 004020 595 ENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL-VGLLGYCLDGNERLLVYEYMPQ 672 (779)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~ 672 (779)
.+.|+.|-...+|++...+ +..+++|+..... . ...+..+|..+++.+...++ .++++.+. + .+||||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--D-EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C--C-SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--h-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 4678888889999998765 5788899874321 1 11112578888888864444 56676652 2 359999987
Q ss_pred CCh
Q 004020 673 GTL 675 (779)
Q Consensus 673 gsL 675 (779)
.++
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0035 Score=65.63 Aligned_cols=145 Identities=14% Similarity=0.103 Sum_probs=74.0
Q ss_pred ceecccccEE-EEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-C-CccceEeeEEEeCCeEEEEEEecCC
Q 004020 596 NVLGRGGFGT-VYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-H-RHLVGLLGYCLDGNERLLVYEYMPQ 672 (779)
Q Consensus 596 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-~niv~~~~~~~~~~~~~lv~e~~~~ 672 (779)
+.|+.|.... +|+....++..+++|...... ..++..|+.+++.+. + -.+.+++.+....+ +++||++.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~-----~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~ 96 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE-----GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGD 96 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT-----TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCS
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC-----CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCC
Confidence 4566565554 667765446778787654321 023445666666664 2 23556666533333 789999977
Q ss_pred CChhhHhhhccc---------------------CCCCCCCHHHHH-------H-------------HHHHHHHHHHHHH-
Q 004020 673 GTLSRHLFNRKE---------------------EGLKPLEWTRRL-------T-------------IALDVARGVEYLH- 710 (779)
Q Consensus 673 gsL~~~l~~~~~---------------------~~~~~~~~~~~~-------~-------------i~~qi~~~L~~LH- 710 (779)
..+.+.+..... .....++..... . ....+...++.+.
T Consensus 97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~ 176 (333)
T 3csv_A 97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS 176 (333)
T ss_dssp CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence 666544322110 001112211100 0 0001112222221
Q ss_pred --cCCCCCcEEcCCCCCCEEEcCC----CcEEEEeeccceecC
Q 004020 711 --GLAHQSFIHRDLKPSNILLGDD----MRAKVADFGLVRLAP 747 (779)
Q Consensus 711 --~~~~~~ivHrDlkp~NIll~~~----~~~kl~DFG~a~~~~ 747 (779)
......++|+|+.+.||+++.+ +.+.|+||+.+..-.
T Consensus 177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 1124679999999999999874 689999999887643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0026 Score=67.59 Aligned_cols=144 Identities=14% Similarity=0.169 Sum_probs=82.8
Q ss_pred cceecccccEEEEEEEEc--------CCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCCeEEE
Q 004020 595 ENVLGRGGFGTVYKGELH--------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l 665 (779)
.+.+..|-...+|++... +++.+++|+..... .......+|.++++.+. +.-..++++++.+ .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 356777888889999764 24789999863321 23345668999988885 3333566665543 29
Q ss_pred EEEecCCCChhhH-----------------hhhcccCCCCCCC--HHHHHHHHHHHHH-------------------HHH
Q 004020 666 VYEYMPQGTLSRH-----------------LFNRKEEGLKPLE--WTRRLTIALDVAR-------------------GVE 707 (779)
Q Consensus 666 v~e~~~~gsL~~~-----------------l~~~~~~~~~~~~--~~~~~~i~~qi~~-------------------~L~ 707 (779)
||||++|..+... ++.......+... +.++.++..++.. .++
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 9999998655321 1111111011122 3444445443321 223
Q ss_pred HHH----c-CCCCCcEEcCCCCCCEEEcCC----CcEEEEeecccee
Q 004020 708 YLH----G-LAHQSFIHRDLKPSNILLGDD----MRAKVADFGLVRL 745 (779)
Q Consensus 708 ~LH----~-~~~~~ivHrDlkp~NIll~~~----~~~kl~DFG~a~~ 745 (779)
.|. . .....++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 332 1 123468999999999999876 7899999998864
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0024 Score=56.60 Aligned_cols=57 Identities=19% Similarity=0.209 Sum_probs=47.6
Q ss_pred cEEEeecCccc--CCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccc
Q 004020 240 TQLWLHGNSFT--GPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQG 298 (779)
Q Consensus 240 ~~L~L~~N~l~--~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g 298 (779)
..++.+++.|+ ..+..+. ++|+.|+|++|+|+...+..|..+++|+.|+|++|.+..
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~C 69 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRC 69 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeec
Confidence 47899999998 5554443 579999999999997777888999999999999999864
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0028 Score=67.51 Aligned_cols=74 Identities=15% Similarity=0.130 Sum_probs=44.1
Q ss_pred cceecccccEEEEEEEEcC---------CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCc-cceEeeEEEeCCeEE
Q 004020 595 ENVLGRGGFGTVYKGELHD---------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH-LVGLLGYCLDGNERL 664 (779)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~ 664 (779)
.+.++.|....+|++...+ ++.+++|+..... ....+...|.++++.+...+ ..++++.. . -+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec--C--Cc
Confidence 4567788888999998654 2688888865422 11112356788887775223 44666543 2 26
Q ss_pred EEEEecCCCCh
Q 004020 665 LVYEYMPQGTL 675 (779)
Q Consensus 665 lv~e~~~~gsL 675 (779)
+||||++|..+
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.44 E-value=0.015 Score=60.95 Aligned_cols=32 Identities=25% Similarity=0.446 Sum_probs=28.4
Q ss_pred CCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 715 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 715 ~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
..++|+|+.+.||++++++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 56899999999999998888999999887654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.43 E-value=0.0005 Score=65.32 Aligned_cols=117 Identities=16% Similarity=0.143 Sum_probs=73.8
Q ss_pred ccCCCCCceEeccCc-eeEee----cCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchh
Q 004020 157 LKDATGLQRFSANGA-NITGT----IPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVA 231 (779)
Q Consensus 157 ~~~l~~L~~L~l~~n-~l~~~----~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~ 231 (779)
+.+-+.|+.|+|++| +|... +.+.+. .-..|++|+|++|+|...--..++ .
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~--~N~~L~~L~L~~n~igd~ga~alA----------------------~ 92 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAAC--NSKHIEKFSLANTAISDSEARGLI----------------------E 92 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHT--TCSCCCEEECTTSCCBHHHHTTHH----------------------H
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHh--hCCCcCEEEccCCCCChHHHHHHH----------------------H
Confidence 344567777777775 55311 222232 345677777777777643333332 3
Q ss_pred hhcCCCCccEEEeecCcccCCC-----CCCCCCCCCcEEEccCC---cccc----ccChhhhCCCCCCEEEccCcccc
Q 004020 232 VIQNMTSLTQLWLHGNSFTGPL-----PDLSGLSSLQDFSVRDN---QLTG----IVPSSLVNLHSLAVVNLTNNLFQ 297 (779)
Q Consensus 232 ~~~~l~~L~~L~L~~N~l~~~~-----~~~~~l~~L~~L~l~~N---~l~~----~~p~~l~~l~~L~~L~Ls~N~l~ 297 (779)
.+..-+.|+.|+|++|.|...- ..+..-+.|++|+|++| .+.. .+...+..-+.|..|+++.|.+.
T Consensus 93 aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 93 LIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 3445578999999999997521 13566677999999865 3432 24456667789999999888754
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.39 E-value=0.0006 Score=64.78 Aligned_cols=15 Identities=13% Similarity=0.383 Sum_probs=9.2
Q ss_pred CCcccEEEccCCCCC
Q 004020 186 IPGLMHLHLAFNFLQ 200 (779)
Q Consensus 186 l~~L~~L~L~~N~l~ 200 (779)
-+.|+.|+|+.|.+.
T Consensus 156 N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 156 NESLLRVGISFASME 170 (197)
T ss_dssp CSSCCEEECCCCCHH
T ss_pred CCCcCeEeccCCCcc
Confidence 346677777666543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.93 E-value=0.056 Score=58.15 Aligned_cols=74 Identities=12% Similarity=0.107 Sum_probs=47.8
Q ss_pred cceecccccEEEEEEEEcC--------CcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCCeEEE
Q 004020 595 ENVLGRGGFGTVYKGELHD--------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l 665 (779)
.+.+..|-...+|++...+ ++.+++|+..... ....+..+|..+++.+. +.-..++++.+ . -++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCE
Confidence 4667778889999998753 5789999864322 11112356888887774 33345555433 2 278
Q ss_pred EEEecCCCCh
Q 004020 666 VYEYMPQGTL 675 (779)
Q Consensus 666 v~e~~~~gsL 675 (779)
||||++|..+
T Consensus 148 I~efI~G~~l 157 (424)
T 3mes_A 148 IEEFIDGEPL 157 (424)
T ss_dssp EEECCCSEEC
T ss_pred EEEEeCCccC
Confidence 9999998654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.78 E-value=0.24 Score=52.99 Aligned_cols=30 Identities=30% Similarity=0.501 Sum_probs=25.3
Q ss_pred CcEEcCCCCCCEEE------cCCCcEEEEeecccee
Q 004020 716 SFIHRDLKPSNILL------GDDMRAKVADFGLVRL 745 (779)
Q Consensus 716 ~ivHrDlkp~NIll------~~~~~~kl~DFG~a~~ 745 (779)
.++|+|+.+.||++ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4567799999998865
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.01 E-value=0.055 Score=36.85 Aligned_cols=27 Identities=33% Similarity=0.607 Sum_probs=11.0
Q ss_pred cEEEehhHHHHHHHHHHHheeeEEeec
Q 004020 492 KIVGSVVGVVCGAFIVGLGFCLYTRKR 518 (779)
Q Consensus 492 ~i~g~v~g~~~~~~~~~~~~~~~~~~r 518 (779)
.+++.++|.++++++++++++++.|+|
T Consensus 12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr 38 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVALGIGLFMRRR 38 (44)
T ss_dssp SSTHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eEEeehhHHHHHHHHHHHHHHHHhhhh
Confidence 344444443333334444444443333
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.61 E-value=0.049 Score=36.99 Aligned_cols=29 Identities=38% Similarity=0.611 Sum_probs=12.5
Q ss_pred cccEEEehhHHHHHHHHHHHheeeEEeec
Q 004020 490 TGKIVGSVVGVVCGAFIVGLGFCLYTRKR 518 (779)
Q Consensus 490 ~~~i~g~v~g~~~~~~~~~~~~~~~~~~r 518 (779)
+..+++.++|.++++++++++++++.|+|
T Consensus 9 ~~aIA~gVVgGv~~v~ii~~~~~~~~RRR 37 (44)
T 2l2t_A 9 TPLIAAGVIGGLFILVIVGLTFAVYVRRK 37 (44)
T ss_dssp SHHHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cceEEEeehHHHHHHHHHHHHHHHHhhhh
Confidence 34444444443434444444444444433
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=86.27 E-value=0.064 Score=35.35 Aligned_cols=25 Identities=24% Similarity=0.320 Sum_probs=16.1
Q ss_pred CCcccEEEehhHHHHHHHHHHHhee
Q 004020 488 SNTGKIVGSVVGVVCGAFIVGLGFC 512 (779)
Q Consensus 488 ~~~~~i~g~v~g~~~~~~~~~~~~~ 512 (779)
.+.+.++|+++|.++++++++...+
T Consensus 8 ls~GaIAGiVvG~v~gv~li~~l~~ 32 (38)
T 2k1k_A 8 LTGGEIVAVIFGLLLGAALLLGILV 32 (38)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCceeeeehHHHHHHHHHHHHHH
Confidence 3456778888888776665544433
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.04 E-value=0.14 Score=55.93 Aligned_cols=63 Identities=10% Similarity=0.083 Sum_probs=18.2
Q ss_pred ccceecccccEEEEEEEEcC-CcEEEE------EEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEe
Q 004020 594 EENVLGRGGFGTVYKGELHD-GTKIAV------KRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD 659 (779)
Q Consensus 594 ~~~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 659 (779)
+.+.+| ||.||++.+.. ..+||+ |..+....+.+....+.+|..+++.++|||+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 446666 99999998753 367888 7766544445555678899999999999999999887653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=81.51 E-value=2.6 Score=40.17 Aligned_cols=87 Identities=10% Similarity=0.077 Sum_probs=61.2
Q ss_pred CCCccceEeeEEEeCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHH-HHHcCCCCCcEEcCCCC
Q 004020 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE-YLHGLAHQSFIHRDLKP 724 (779)
Q Consensus 646 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~-~LH~~~~~~ivHrDlkp 724 (779)
.||++ -..+-.+.+...+.++.-+++.=...+ +..+...+++++.+|+.... +++ .-+|--+.|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i--------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P 112 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI--------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCP 112 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH--------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH--------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeC
Confidence 57887 444556677766666654333222222 14678889999999887766 554 367889999
Q ss_pred CCEEEcCCCcEEEEeeccceecC
Q 004020 725 SNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 725 ~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
+||++|.++.+++.-.|+-..++
T Consensus 113 ~NL~f~~~~~p~i~hRGi~~~lp 135 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVKESLP 135 (219)
T ss_dssp GGEEECTTCCEEESCCEETTTBS
T ss_pred ceEEEeCCCcEEEEEcCCcccCC
Confidence 99999999999999999754443
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=80.59 E-value=0.1 Score=35.34 Aligned_cols=29 Identities=24% Similarity=0.560 Sum_probs=15.2
Q ss_pred ccEEEehhHHHHHHHHHHHheeeEEeeccc
Q 004020 491 GKIVGSVVGVVCGAFIVGLGFCLYTRKRKR 520 (779)
Q Consensus 491 ~~i~g~v~g~~~~~~~~~~~~~~~~~~r~~ 520 (779)
..+++.++| ++.++++++++++|.|||+.
T Consensus 12 ~~Ia~~vVG-vll~vi~~l~~~~~~RRR~~ 40 (44)
T 2jwa_A 12 TSIISAVVG-ILLVVVLGVVFGILIKRRQQ 40 (44)
T ss_dssp HHHHHHHHH-HHHHHHHHHHHHHHHHHHCS
T ss_pred cchHHHHHH-HHHHHHHHHHHHhheehhhh
Confidence 345666677 33444555555555554443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 779 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-50 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-50 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-49 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-48 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-48 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-48 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-47 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-47 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-47 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-47 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-47 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-46 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-46 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-46 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-46 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-45 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-45 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-44 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-44 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-44 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-43 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-42 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-42 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-40 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-40 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-38 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-37 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-37 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-37 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-36 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-36 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-35 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-34 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-34 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-33 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-33 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-33 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-33 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-32 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-28 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-25 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-24 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-20 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-12 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-11 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.004 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 8e-10 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 8e-10 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-08 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-08 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 9e-07 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 5e-08 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-07 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 8e-07 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 4e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 6e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 7e-56
Identities = 56/180 (31%), Positives = 91/180 (50%), Gaps = 10/180 (5%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
+ +G G FGTVYKG+ H +AVK + + + FK+E+ VL K RH +
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
++ +GY + +V ++ +L HL + E + + IA A+G++YL
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYL 120
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEY 769
H +S IHRDLK +NI L +D+ K+ DFGL + +L+G+ ++APE
Sbjct: 121 H---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 1e-50
Identities = 46/183 (25%), Positives = 78/183 (42%), Gaps = 13/183 (7%)
Query: 589 TNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH 647
++F + + LG G G V+K G +A K + + + E+ VL +
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNS 63
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
++VG G E + E+M G+L + L + +++ V +G+
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLT 118
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
YL +HRD+KPSNIL+ K+ DFG+ D+ +S GT Y++P
Sbjct: 119 YLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF----VGTRSYMSP 172
Query: 768 EYA 770
E
Sbjct: 173 ERL 175
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 3e-50
Identities = 52/180 (28%), Positives = 84/180 (46%), Gaps = 11/180 (6%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
LG G FG V+ G + TK+AVK ++ +S F +E ++ +++H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQR 69
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
LV L ++ EYM G+L L L + L +A +A G+ ++
Sbjct: 70 LVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFI 125
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEY 769
+++IHRDL+ +NIL+ D + K+ADFGL RL DN + + APE
Sbjct: 126 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-REGAKFPIKWTAPEA 181
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 176 bits (447), Expect = 4e-50
Identities = 49/185 (26%), Positives = 78/185 (42%), Gaps = 16/185 (8%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTK 644
+ FS+ +G G FG VY + + +A+K+M S S + + + E+ L K
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
+RH + + G L + LV EY ++ KPL+ + +
Sbjct: 72 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQ 126
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
G+ YLH + IHRD+K NILL + K+ DFG + GT +
Sbjct: 127 GLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYW 177
Query: 765 LAPEY 769
+APE
Sbjct: 178 MAPEV 182
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 2e-49
Identities = 52/180 (28%), Positives = 76/180 (42%), Gaps = 11/180 (6%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
+ + LG G FG V G+ +A+K ++ +SE EF E V+ + H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEK 60
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
LV L G C ++ EYM G L +L + + + L + DV +EYL
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYL 116
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEY 769
+ F+HRDL N L+ D KV+DFGL R D+ S + PE
Sbjct: 117 E---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEV 172
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 5e-48
Identities = 48/186 (25%), Positives = 77/186 (41%), Gaps = 12/186 (6%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
N + + LG G FG VYK + + A K +++ SE+ ++ EI +L
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASC 66
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARG 705
H ++V LL N ++ E+ G + + + +PL ++ +
Sbjct: 67 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE----RPLTESQIQVVCKQTLDA 122
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYL 765
+ YLH IHRDLK NIL D K+ADFG+ + GT ++
Sbjct: 123 LNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWM 177
Query: 766 APEYAA 771
APE
Sbjct: 178 APEVVM 183
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 7e-48
Identities = 43/184 (23%), Positives = 79/184 (42%), Gaps = 8/184 (4%)
Query: 591 NFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
++ +G G +G K DG + K ++ ++E SE+ +L +++H +
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 650 LVGLLGYCLDGNERLL--VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
+V +D L V EY G L+ + +E + L+ L + + ++
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTLALK 123
Query: 708 YLH--GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYL 765
H + +HRDLKP+N+ L K+ DFGL R+ + + GT Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KAFVGTPYYM 181
Query: 766 APEY 769
+PE
Sbjct: 182 SPEQ 185
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 7e-48
Identities = 55/181 (30%), Positives = 84/181 (46%), Gaps = 11/181 (6%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
+ + +G G FG V+ G + K+A+K + +SE+ +F E V+ K+ H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPK 61
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
LV L G CL+ LV+E+M G LS +L ++ L + LDV G+ YL
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYL 117
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEY 769
IHRDL N L+G++ KV+DFG+ R D+ S + +PE
Sbjct: 118 E---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT-KFPVKWASPEV 173
Query: 770 A 770
Sbjct: 174 F 174
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 9e-48
Identities = 49/181 (27%), Positives = 85/181 (46%), Gaps = 13/181 (7%)
Query: 594 EENVLGRGGFGTVYKGELHD---GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL 650
E+ LG G FGTV KG +AVK +++ E +E V+ ++ + ++
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 651 VGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
V ++G C + +LV E G L+++L + ++ + + V+ G++YL
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE 124
Query: 711 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPDNGKHSIETRLAGTFGYLAPEY 769
+F+HRDL N+LL AK++DFGL + L D + +T + APE
Sbjct: 125 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 770 A 770
Sbjct: 182 I 182
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 1e-47
Identities = 53/206 (25%), Positives = 85/206 (41%), Gaps = 29/206 (14%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHD------GTKIAVKRMESAVVSEKGFAEFKSEIAVLT 643
N VLG G FG V + ++AVK ++ SE+ ++T
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMT 95
Query: 644 KV-RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRK------------------E 684
++ H ++V LLG C L++EY G L +L +++ E
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 685 EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
E L L + L A VA+G+E+L +S +HRDL N+L+ K+ DFGL R
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLAR 212
Query: 745 LAPDNGKHSIETRLAGTFGYLAPEYA 770
+ + + ++APE
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESL 238
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (427), Expect = 2e-47
Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 29/206 (14%)
Query: 590 NNFSEENVLGRGGFGTVYKGEL------HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLT 643
NN +G G FG V++ T +AVK ++ S A+F+ E A++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMA 71
Query: 644 KVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEE------------------ 685
+ + ++V LLG C G L++EYM G L+ L +
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 686 -GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
G PL +L IA VA G+ YL + F+HRDL N L+G++M K+ADFGL R
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSR 188
Query: 745 LAPDNGKHSIETRLAGTFGYLAPEYA 770
+ + A ++ PE
Sbjct: 189 NIYSADYYKADGNDAIPIRWMPPESI 214
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 2e-47
Identities = 55/182 (30%), Positives = 84/182 (46%), Gaps = 14/182 (7%)
Query: 590 NNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRH 647
+F LG+G FG VY +A+K + A + + G + E+ + + +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
+++ L GY D L+ EY P GT+ R L + R T ++A +
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALS 120
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
Y H + IHRD+KP N+LLG K+ADFG AP + + ++ GT YL P
Sbjct: 121 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL----CGTLDYLPP 173
Query: 768 EY 769
E
Sbjct: 174 EM 175
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 2e-47
Identities = 60/182 (32%), Positives = 94/182 (51%), Gaps = 17/182 (9%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
+G+G FG V G+ + G K+AVK +++ ++ F +E +V+T++RH +
Sbjct: 7 KELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSN 61
Query: 650 LVGLLGYCLDGNERL-LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
LV LLG ++ L +V EYM +G+L +L +R G L L +LDV +EY
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEY 118
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
L +F+HRDL N+L+ +D AKV+DFGL + A S + + APE
Sbjct: 119 LE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPE 170
Query: 769 YA 770
Sbjct: 171 AL 172
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 5e-47
Identities = 46/181 (25%), Positives = 74/181 (40%), Gaps = 10/181 (5%)
Query: 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR 648
++ LG G +G V +AVK ++ + K EI + + H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHE 63
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
++V G+ +GN + L EY G L + + + GV Y
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVY 118
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
LH HRD+KP N+LL + K++DFGL + N + + ++ GT Y+APE
Sbjct: 119 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 769 Y 769
Sbjct: 176 L 176
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 1e-46
Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 24/200 (12%)
Query: 590 NNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLT 643
N S LG G FG V + + +AVK ++ + SE+ VL+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLS 81
Query: 644 KV-RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRK-------------EEGLKP 689
+ H ++V LLG C G L++ EY G L L ++ E+
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 690 LEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
L+ L+ + VA+G+ +L ++ IHRDL NILL K+ DFGL R ++
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 750 GKHSIETRLAGTFGYLAPEY 769
+ ++ ++APE
Sbjct: 199 SNYVVKGNARLPVKWMAPES 218
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 4e-46
Identities = 45/186 (24%), Positives = 87/186 (46%), Gaps = 14/186 (7%)
Query: 589 TNNFSEENV-LGRGGFGTVYKGELH---DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTK 644
+N ++ LG G FG+V +G +A+K ++ + E E ++ +
Sbjct: 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQ 65
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
+ + ++V L+G C +LV E G L + L ++ + + + + V+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSM 120
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPDNGKHSIETRLAGTFG 763
G++YL ++F+HRDL N+LL + AK++DFGL + L D+ ++ +
Sbjct: 121 GMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 764 YLAPEY 769
+ APE
Sbjct: 178 WYAPEC 183
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 4e-46
Identities = 48/181 (26%), Positives = 79/181 (43%), Gaps = 16/181 (8%)
Query: 595 ENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGL 653
+ +GRG F TVYKG + ++A ++ +++ FK E +L ++H ++V
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 654 LGYCLDGNER----LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+ +LV E M GTL +L K ++ + + +G+++L
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFL 128
Query: 710 HGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
H IHRDLK NI + G K+ D GL L S + GT ++APE
Sbjct: 129 H-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPE 183
Query: 769 Y 769
Sbjct: 184 M 184
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 4e-46
Identities = 57/181 (31%), Positives = 90/181 (49%), Gaps = 11/181 (6%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
+ E LG+G FG V+ G + T++A+K ++ +S + F E V+ K+RH
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEK 73
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
LV L +V EYM +G+L L K L + + +A +A G+ Y+
Sbjct: 74 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYV 129
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEY 769
+++HRDL+ +NIL+G+++ KVADFGL RL DN + + APE
Sbjct: 130 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKWTAPEA 185
Query: 770 A 770
A
Sbjct: 186 A 186
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 164 bits (416), Expect = 4e-46
Identities = 50/205 (24%), Positives = 88/205 (42%), Gaps = 24/205 (11%)
Query: 581 SIQVLRNVTNNFSEE---------NVLGRGGFGTVYKGELHDGTK----IAVKRMESAVV 627
+ + F++E V+G G FG V G L K +A+K ++S
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY- 66
Query: 628 SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGL 687
+EK +F SE +++ + H +++ L G +++ E+M G+L L
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND---- 122
Query: 688 KPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747
+ + + +A G++YL +++HRDL NIL+ ++ KV+DFGL R
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 748 DNGKHSIETR---LAGTFGYLAPEY 769
D+ T + APE
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEA 204
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 6e-45
Identities = 54/194 (27%), Positives = 83/194 (42%), Gaps = 16/194 (8%)
Query: 582 IQVLRNVTNNFSEENVLGRGGFGTVYKGELHD-----GTKIAVKRMESAVVSEKGFAEFK 636
+++L+ F + VLG G FGTVYKG +A+K + A S K E
Sbjct: 3 LRILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEIL 59
Query: 637 SEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRL 696
E V+ V + H+ LLG CL +L + + MP G L ++ K + L
Sbjct: 60 DEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHK----DNIGSQYLL 114
Query: 697 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIET 756
+ +A+G+ YL + +HRDL N+L+ K+ DFGL +L K
Sbjct: 115 NWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 171
Query: 757 RLAGTFGYLAPEYA 770
++A E
Sbjct: 172 GGKVPIKWMALESI 185
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 8e-45
Identities = 49/194 (25%), Positives = 81/194 (41%), Gaps = 21/194 (10%)
Query: 595 ENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLL 654
+ +G+G FG V++G+ G ++AVK S E+ ++EI +RH +++G +
Sbjct: 8 QESIGKGRFGEVWRGK-WRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFI 63
Query: 655 GYCLDGN----ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLH 710
N + LV +Y G+L +L + + +AL A G+ +LH
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLH 117
Query: 711 -----GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHS--IETRLAGTFG 763
+ HRDLK NIL+ + +AD GL GT
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 764 YLAPEYAAETSGMT 777
Y+APE ++ M
Sbjct: 178 YMAPEVLDDSINMK 191
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 159 bits (404), Expect = 1e-44
Identities = 53/181 (29%), Positives = 87/181 (48%), Gaps = 11/181 (6%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR 648
+ + ++ LG G +G VY+G +AVK ++ + + EF E AV+ +++H
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHP 73
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
+LV LLG C ++ E+M G L +L + + L +A ++ +EY
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEY 130
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
L ++FIHRDL N L+G++ KVADFGL RL + + + APE
Sbjct: 131 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPE 186
Query: 769 Y 769
Sbjct: 187 S 187
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 2e-44
Identities = 50/191 (26%), Positives = 89/191 (46%), Gaps = 15/191 (7%)
Query: 590 NNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLT 643
+ LG+G FG VY+G T++A+K + A S + EF +E +V+
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMK 78
Query: 644 KVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRK-----EEGLKPLEWTRRLTI 698
+ H+V LLG G L++ E M +G L +L + + L P ++ + +
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 699 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRL 758
A ++A G+ YL+ F+HRDL N ++ +D K+ DFG+ R + + +
Sbjct: 139 AGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 759 AGTFGYLAPEY 769
+++PE
Sbjct: 196 LLPVRWMSPES 206
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 3e-44
Identities = 49/181 (27%), Positives = 77/181 (42%), Gaps = 10/181 (5%)
Query: 591 NFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKVRHR 648
+F +LG G F TV EL + A+K +E ++ E E V++++ H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
V L D + Y G L +++ + T ++ +EY
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEY 123
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
LH + IHRDLKP NILL +DM ++ DFG ++ K + GT Y++PE
Sbjct: 124 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 769 Y 769
Sbjct: 181 L 181
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 9e-44
Identities = 47/187 (25%), Positives = 90/187 (48%), Gaps = 14/187 (7%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGT-----KIAVKRMESAVVSEKGFAEFKSEIAVLTK 644
+ + + V+G G FG VYKG L + +A+K +++ +EK +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQ 65
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
H +++ L G +++ EYM G L + L + + + + +A
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAA 121
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSI-ETRLAGTFG 763
G++YL + +++HRDL NIL+ ++ KV+DFGL R+ D+ + + +
Sbjct: 122 GMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 764 YLAPEYA 770
+ APE
Sbjct: 179 WTAPEAI 185
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 9e-43
Identities = 63/195 (32%), Positives = 86/195 (44%), Gaps = 22/195 (11%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDG---TKIAVKRMESAVVSEKGFAEFKSEIAVLTKV- 645
N+ ++V+G G FG V K + A+KRM S+ +F E+ VL K+
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLG 68
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHL-----------FNRKEEGLKPLEWTR 694
H +++ LLG C L EY P G L L F L +
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 695 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSI 754
L A DVARG++YL + FIHRDL NIL+G++ AK+ADFGL R K
Sbjct: 129 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK-- 183
Query: 755 ETRLAGTFGYLAPEY 769
T ++A E
Sbjct: 184 -TMGRLPVRWMAIES 197
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-42
Identities = 55/187 (29%), Positives = 81/187 (43%), Gaps = 14/187 (7%)
Query: 590 NNFSEENVLGRGGFGTVYKGELH----DGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTK 644
+ LG G FG V +GE +AVK ++ V+S+ + F E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
+ HR+L+ L G L ++ V E P G+L L + A+ VA
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAE 122
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSI-ETRLAGTFG 763
G+ YL + FIHRDL N+LL K+ DFGL+R P N H + + F
Sbjct: 123 GMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 764 YLAPEYA 770
+ APE
Sbjct: 180 WCAPESL 186
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 155 bits (392), Expect = 3e-42
Identities = 50/187 (26%), Positives = 82/187 (43%), Gaps = 15/187 (8%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
+V +++ LG G FG V++ E G A K + + S+K + EI ++ +
Sbjct: 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMSVL 80
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARG 705
RH LV L D NE +++YE+M G L + + + + V +G
Sbjct: 81 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKG 136
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDM--RAKVADFGLVRLAPDNGKHSIETRLAGTFG 763
+ ++H +++H DLKP NI+ K+ DFGL + T GT
Sbjct: 137 LCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAE 190
Query: 764 YLAPEYA 770
+ APE A
Sbjct: 191 FAAPEVA 197
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 4e-42
Identities = 49/203 (24%), Positives = 94/203 (46%), Gaps = 17/203 (8%)
Query: 568 SDLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAV 626
SD ++E ++S+ + ++ +G+G GTVY ++ G ++A+++M
Sbjct: 1 SDEEILEKLRSIVSV---GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ- 56
Query: 627 VSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEG 686
+ +EI V+ + ++ ++V L L G+E +V EY+ G+L+ +
Sbjct: 57 -QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----- 110
Query: 687 LKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746
++ + + + + +E+LH IHRD+K NILLG D K+ DFG
Sbjct: 111 -TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166
Query: 747 PDNGKHSIETRLAGTFGYLAPEY 769
+ + GT ++APE
Sbjct: 167 TPEQSKR--STMVGTPYWMAPEV 187
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 7e-41
Identities = 56/191 (29%), Positives = 86/191 (45%), Gaps = 17/191 (8%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKGELHD----GTKIAVKRMESAVVSEKGFAEFKSEIAVL 642
++ +F+E V+GRG FG VY G L D AVK + + + ++F +E ++
Sbjct: 26 SLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIM 82
Query: 643 TKVRHRHLVGLLGYCLDG-NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALD 701
H +++ LLG CL L+V YM G L + N + L
Sbjct: 83 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQ 138
Query: 702 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIE--TRLA 759
VA+G+++L + F+HRDL N +L + KVADFGL R D S+ T
Sbjct: 139 VAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 195
Query: 760 GTFGYLAPEYA 770
++A E
Sbjct: 196 LPVKWMALESL 206
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-40
Identities = 48/193 (24%), Positives = 84/193 (43%), Gaps = 8/193 (4%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
+V ++ + +G G +G V + + ++A+K++ S + EI +L +
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRF 63
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARG 705
RH +++G+ + Y+ + L+ + L + RG
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRG 121
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-PDNGKHSIETRLAGTFGY 764
++Y+H + +HRDLKPSN+LL K+ DFGL R+A PD+ T T Y
Sbjct: 122 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 765 LAPEYAAETSGMT 777
APE + G T
Sbjct: 179 RAPEIMLNSKGYT 191
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 149 bits (376), Expect = 5e-40
Identities = 42/187 (22%), Positives = 75/187 (40%), Gaps = 15/187 (8%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTK 644
+V + + LG G FG V++ E G K + + +K K+EI+++ +
Sbjct: 25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMNQ 82
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
+ H L+ L D E +L+ E++ G L + + +
Sbjct: 83 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED----YKMSEAEVINYMRQACE 138
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILL--GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF 762
G++++H S +H D+KP NI+ K+ DFGL + + T T
Sbjct: 139 GLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATA 192
Query: 763 GYLAPEY 769
+ APE
Sbjct: 193 EFAAPEI 199
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-39
Identities = 42/184 (22%), Positives = 76/184 (41%), Gaps = 14/184 (7%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHD----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
+G G FG V++G +A+K ++ S+ +F E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQF 65
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARG 705
H H+V L+G + ++ E G L L RK L+ + A ++
Sbjct: 66 DHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTA 120
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYL 765
+ YL + F+HRD+ N+L+ + K+ DFGL R D+ + ++ ++
Sbjct: 121 LAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-ASKGKLPIKWM 176
Query: 766 APEY 769
APE
Sbjct: 177 APES 180
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 144 bits (364), Expect = 3e-39
Identities = 52/188 (27%), Positives = 77/188 (40%), Gaps = 20/188 (10%)
Query: 591 NFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRME-------SAVVSEKGFAEFKSEIAVL 642
N+ + +LGRG V + + AVK ++ SA ++ E+ +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 643 TKVR-HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALD 701
KV H +++ L LV++ M +G L +L + L I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRA 118
Query: 702 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGT 761
+ + LH + +HRDLKP NILL DDM K+ DFG K + GT
Sbjct: 119 LLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGT 172
Query: 762 FGYLAPEY 769
YLAPE
Sbjct: 173 PSYLAPEI 180
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 146 bits (369), Expect = 4e-39
Identities = 46/185 (24%), Positives = 81/185 (43%), Gaps = 17/185 (9%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKG----FAEFKSEIAVLTK 644
N+FS ++GRGGFG VY D G A+K ++ + K + +++++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
+V + ++ + + M G L HL A ++
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIIL 118
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGY 764
G+E++H ++ ++RDLKP+NILL + +++D GL H+ GT GY
Sbjct: 119 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGY 171
Query: 765 LAPEY 769
+APE
Sbjct: 172 MAPEV 176
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 5e-39
Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 24/200 (12%)
Query: 590 NNFSEENVLGRGGFGTVYKGEL--------HDGTKIAVKRMESAVVSEKGFAEFKSEIAV 641
+ LG G FG V E + TK+AVK ++S +EK ++ SE+ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEM 71
Query: 642 LTKV-RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGL-----------KP 689
+ + +H++++ LLG C ++ EY +G L +L R+ GL +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 690 LEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749
L ++ A VARG+EYL + IHRDL N+L+ +D K+ADFGL R
Sbjct: 132 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 750 GKHSIETRLAGTFGYLAPEY 769
+ T ++APE
Sbjct: 189 DYYKKTTNGRLPVKWMAPEA 208
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-38
Identities = 48/199 (24%), Positives = 81/199 (40%), Gaps = 21/199 (10%)
Query: 590 NNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLT 643
+ LGRG FG V + + +AVK ++ + A ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 644 KVRHRHLVGLLGYCL-DGNERLLVYEYMPQGTLSRHLFNRKEEGL-----------KPLE 691
H ++V LLG C G +++ E+ G LS +L +++ E + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 692 WTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGK 751
+ + VA+G+E+L + IHRDL NILL + K+ DFGL R +
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 752 HSIETRLAGTFGYLAPEYA 770
+ + ++APE
Sbjct: 190 YVRKGDARLPLKWMAPETI 208
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 139 bits (351), Expect = 2e-37
Identities = 48/191 (25%), Positives = 82/191 (42%), Gaps = 15/191 (7%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTK 644
++++ + +LG GG V+ L +AVK + + + + F F+ E
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 645 VRHRHLVGLLGYCLD----GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIAL 700
+ H +V + G +V EY+ TL + P+ R + +
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIA 118
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIET-RLA 759
D + + + H IHRD+KP+NI++ KV DFG+ R D+G +T +
Sbjct: 119 DACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175
Query: 760 GTFGYLAPEYA 770
GT YL+PE A
Sbjct: 176 GTAQYLSPEQA 186
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 140 bits (354), Expect = 2e-37
Identities = 49/187 (26%), Positives = 82/187 (43%), Gaps = 16/187 (8%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
++ + + +VLG G F V E +A+K + + K ++EIAVL K+
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-EGSMENEIAVLHKI 64
Query: 646 RHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARG 705
+H ++V L G L+ + + G L + + + V
Sbjct: 65 KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDA 119
Query: 706 VEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF 762
V+YLH +HRDLKP N+L +D + ++DFGL ++ S+ + GT
Sbjct: 120 VKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG---SVLSTACGTP 173
Query: 763 GYLAPEY 769
GY+APE
Sbjct: 174 GYVAPEV 180
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 139 bits (351), Expect = 5e-37
Identities = 52/182 (28%), Positives = 78/182 (42%), Gaps = 15/182 (8%)
Query: 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAE-FKSEIAVLTKVRH 647
+F LG G FG V+ H+G A+K ++ +V E E +L+ V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
++ + G D + ++ +Y+ G L L + A +V +E
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALE 118
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
YLH + I+RDLKP NILL + K+ DFG + PD L GT Y+AP
Sbjct: 119 YLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAP 170
Query: 768 EY 769
E
Sbjct: 171 EV 172
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 2e-36
Identities = 47/183 (25%), Positives = 75/183 (40%), Gaps = 13/183 (7%)
Query: 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKV-R 646
+F +LG+G FG V+ E A+K ++ V+ + E VL+
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 647 HRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGV 706
H L + V EY+ G L H+ + + +R A ++ G+
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGL 116
Query: 707 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLA 766
++LH + ++RDLK NILL D K+ADFG+ + GT Y+A
Sbjct: 117 QFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYIA 171
Query: 767 PEY 769
PE
Sbjct: 172 PEI 174
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 3e-36
Identities = 47/189 (24%), Positives = 80/189 (42%), Gaps = 10/189 (5%)
Query: 591 NFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
NF + +G G +G VYK G +A+K++ +E + EI++L ++ H +
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+V LL N+ LV+E++ Q + + + + +G+ +
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL----TGIPLPLIKSYLFQLLQGLAFC 118
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEY 769
H +HRDLKP N+L+ + K+ADFGL R + T T Y APE
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEI 173
Query: 770 AAETSGMTW 778
+
Sbjct: 174 LLGCKYYST 182
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 135 bits (341), Expect = 5e-36
Identities = 45/188 (23%), Positives = 78/188 (41%), Gaps = 10/188 (5%)
Query: 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH 649
+ +G G +G VYK + + G A+K++ E + EI++L +++H +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 650 LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYL 709
+V L +LV+E++ Q LE + L + G+ Y
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYC 116
Query: 710 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEY 769
H + +HRDLKP N+L+ + K+ADFGL R + T Y AP+
Sbjct: 117 H---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE--IVTLWYRAPDV 171
Query: 770 AAETSGMT 777
+ +
Sbjct: 172 LMGSKKYS 179
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 9e-36
Identities = 46/196 (23%), Positives = 77/196 (39%), Gaps = 19/196 (9%)
Query: 590 NNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAE----FKSEIAVLTK 644
+ + +LG GGFG+VY G + D +A+K +E +S+ G E+ +L K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 645 VRHRH--LVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDV 702
V ++ LL + + +L+ E + L+ + V
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQV 119
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPDNGKHSIETRLAGT 761
V + H + +HRD+K NIL+ + K+ DFG L D ++ T GT
Sbjct: 120 LEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYTDFDGT 172
Query: 762 FGYLAPEYAAETSGMT 777
Y PE+
Sbjct: 173 RVYSPPEWIRYHRYHG 188
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 3e-35
Identities = 51/179 (28%), Positives = 79/179 (44%), Gaps = 14/179 (7%)
Query: 596 NVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKG---FAEFKSEIAVLTKVRHRHLV 651
+ LG G F TVYK + +A+K+++ SE EI +L ++ H +++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 652 GLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHG 711
GLL + LV+++M N L + L +G+EYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLH- 117
Query: 712 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYA 770
+HRDLKP+N+LL ++ K+ADFGL + + T T Y APE
Sbjct: 118 --QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELL 172
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 4e-34
Identities = 45/200 (22%), Positives = 80/200 (40%), Gaps = 22/200 (11%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTK 644
R ++++ V+G G FG VY+ +L D G +A+K++ + E+ ++ K
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRK 69
Query: 645 VRHRHLVGLLGYCLDGNER------LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTI 698
+ H ++V L + E+ LV +Y+P+ + + L
Sbjct: 70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ--TLPVIYVKLY 127
Query: 699 ALDVARGVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPDNGKHSIETR 757
+ R + Y+H HRD+KP N+LL D K+ DFG + +
Sbjct: 128 MYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VS 181
Query: 758 LAGTFGYLAPEYAAETSGMT 777
+ Y APE + T
Sbjct: 182 YICSRYYRAPELIFGATDYT 201
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 6e-34
Identities = 37/187 (19%), Positives = 69/187 (36%), Gaps = 16/187 (8%)
Query: 586 RNVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTK 644
+ + + LGRG FG V++ E K ++ + K EI++L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV---LVKKEISILNI 57
Query: 645 VRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVAR 704
RHR+++ L E ++++E++ + + L ++ V
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA----FELNEREIVSYVHQVCE 113
Query: 705 GVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRLAPDNGKHSIETRLAGTF 762
+++LH + H D++P NI+ K+ +FG R L
Sbjct: 114 ALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAP 167
Query: 763 GYLAPEY 769
Y APE
Sbjct: 168 EYYAPEV 174
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 9e-34
Identities = 47/192 (24%), Positives = 77/192 (40%), Gaps = 20/192 (10%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEK----GFAEFKSEIAV 641
NV + + LG G F V K E G + A K ++ + + E+++
Sbjct: 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 642 LTKVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALD 701
L +++H +++ L + + +L+ E + G L L + + L
Sbjct: 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQ 121
Query: 702 VARGVEYLHGLAHQSFIHRDLKPSNILLGDD----MRAKVADFGLVRLAPDNGKHSIETR 757
+ GV YLH H DLKP NI+L D R K+ DFGL +
Sbjct: 122 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KN 175
Query: 758 LAGTFGYLAPEY 769
+ GT ++APE
Sbjct: 176 IFGTPEFVAPEI 187
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-33
Identities = 44/187 (23%), Positives = 71/187 (37%), Gaps = 12/187 (6%)
Query: 589 TNNFSEENVLGRGGFGTVYKGE--LHDGTKIAVKRMESAVVSEKGFAEFKSEIAV---LT 643
+ +G G +G V+K + G +A+KR+ E E+AV L
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65
Query: 644 KVRHRHLVGLLGYCLDGNERLLVYEYMPQGTLSR-HLFNRKEEGLKPLEWTRRLTIALDV 702
H ++V L C + + + + + + +
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF 762
RG+++LH +HRDLKP NIL+ + K+ADFGL R+ T + T
Sbjct: 126 LRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTL 179
Query: 763 GYLAPEY 769
Y APE
Sbjct: 180 WYRAPEV 186
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 1e-33
Identities = 39/184 (21%), Positives = 70/184 (38%), Gaps = 25/184 (13%)
Query: 595 ENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVG 652
VLG G G V + K A+K ++ + + E+ + + + H+V
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVR 69
Query: 653 LLGYCLD----GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
++ + L+V E + G L + ++ G + I + ++Y
Sbjct: 70 IVDVYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQY 126
Query: 709 LHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYL 765
LH + HRD+KP N+L + K+ DFG + + T T Y+
Sbjct: 127 LH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYV 180
Query: 766 APEY 769
APE
Sbjct: 181 APEV 184
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 2e-33
Identities = 52/198 (26%), Positives = 80/198 (40%), Gaps = 22/198 (11%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
V + + +G G +G V + G K+A+K++ SE E+ +L +
Sbjct: 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74
Query: 646 RHRHLVGLLGYCLDGN------ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIA 699
RH +++GLL + LV +M GT L + L R +
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKH-----EKLGEDRIQFLV 127
Query: 700 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLA 759
+ +G+ Y+H IHRDLKP N+ + +D K+ DFGL R A + TR
Sbjct: 128 YQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTR-- 182
Query: 760 GTFGYLAPEYAAETSGMT 777
Y APE T
Sbjct: 183 ---WYRAPEVILNWMRYT 197
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 2e-33
Identities = 44/199 (22%), Positives = 77/199 (38%), Gaps = 19/199 (9%)
Query: 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR 648
+ + + +G+G FG V+K G K+A+K++ E EI +L ++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 649 HLVGLLGYCLDGNER--------LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIAL 700
++V L+ C LV+++ + L +R+ L
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL--APDNGKHSIETRL 758
+ L+ + +HRD+K +N+L+ D K+ADFGL R N + + T
Sbjct: 127 -----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 759 AGTFGYLAPEYAAETSGMT 777
T Y PE
Sbjct: 182 VVTLWYRPPELLLGERDYG 200
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (319), Expect = 5e-33
Identities = 41/192 (21%), Positives = 72/192 (37%), Gaps = 22/192 (11%)
Query: 588 VTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR 646
V N + +G G FG +Y G + G ++A+K + + E + ++
Sbjct: 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV----KTKHPQLHIESKIYKMMQ 60
Query: 647 HRHLVGLLGYCL-DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARG 705
+ + +C +G+ ++V E + F + L +A +
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS-----RKFSLKTVLLLADQMISR 115
Query: 706 VEYLHGLAHQSFIHRDLKPSNIL---LGDDMRAKVADFGLVRLAPDNGKHSIE-----TR 757
+EY+H ++FIHRD+KP N L + DFGL + D H
Sbjct: 116 IEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172
Query: 758 LAGTFGYLAPEY 769
L GT Y +
Sbjct: 173 LTGTARYASINT 184
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 6e-33
Identities = 39/190 (20%), Positives = 78/190 (41%), Gaps = 11/190 (5%)
Query: 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHR 648
+ + +G G +GTV+K + +A+KR+ E + EI +L +++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 649 HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEY 708
++V L + LV+E+ Q + + + + +G+ +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-----DPEIVKSFLFQLLKGLGF 116
Query: 709 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPE 768
H ++ +HRDLKP N+L+ + K+A+FGL R + + T Y P+
Sbjct: 117 CH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPD 171
Query: 769 YAAETSGMTW 778
+
Sbjct: 172 VLFGAKLYST 181
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 1e-32
Identities = 50/182 (27%), Positives = 74/182 (40%), Gaps = 12/182 (6%)
Query: 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKVRH 647
N+F +LG+G FG V G A+K + ++++ A +E VL RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
L L + V EY G L HL + R ++ +E
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALE 119
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
YLH + ++RD+K N++L D K+ DFGL + +G GT YLAP
Sbjct: 120 YLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAP 174
Query: 768 EY 769
E
Sbjct: 175 EV 176
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 125 bits (315), Expect = 2e-32
Identities = 34/194 (17%), Positives = 68/194 (35%), Gaps = 24/194 (12%)
Query: 588 VTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR 646
V ++ +G G FG +++G L + ++A+K + + E +
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP----RRSDAPQLRDEYRTYKLLA 58
Query: 647 HR-HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARG 705
+ + + +G +LV + + + A +
Sbjct: 59 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG-----RKFSVKTVAMAAKQMLAR 113
Query: 706 VEYLHGLAHQSFIHRDLKPSNILLGDDM-----RAKVADFGLVRLAPDNGKHSIE----- 755
V+ +H +S ++RD+KP N L+G V DFG+V+ D
Sbjct: 114 VQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170
Query: 756 TRLAGTFGYLAPEY 769
L+GT Y++
Sbjct: 171 KNLSGTARYMSINT 184
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 7e-32
Identities = 45/190 (23%), Positives = 72/190 (37%), Gaps = 21/190 (11%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKG-ELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
V + +G G G V + +A+K++ ++ E+ ++ V
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 646 RHRHLVGLLGYCL------DGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIA 699
H++++ LL + + LV E M E R +
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE--------RMSYLL 125
Query: 700 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLA 759
+ G+++LH IHRDLKPSNI++ D K+ DFGL R A + T
Sbjct: 126 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYV 179
Query: 760 GTFGYLAPEY 769
T Y APE
Sbjct: 180 VTRYYRAPEV 189
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 124 bits (311), Expect = 2e-31
Identities = 50/182 (27%), Positives = 67/182 (36%), Gaps = 15/182 (8%)
Query: 590 NNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRME-SAVVSEKGFAEFKSEIAVLTKVRH 647
+ F LG G FG V + G A+K ++ VV K +E +L V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 648 RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVE 707
LV L D + +V EY+ G + HL A + E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFE 155
Query: 708 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAP 767
YLH I+RDLKP N+L+ +V DFG + L GT LAP
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWTLCGTPEALAP 207
Query: 768 EY 769
E
Sbjct: 208 EI 209
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 115 bits (289), Expect = 8e-29
Identities = 38/214 (17%), Positives = 81/214 (37%), Gaps = 35/214 (16%)
Query: 569 DLHVVEAGSMVISIQVLRNVTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVV 627
+ HVVE G+ +++ LGRG + V++ + + K+ VK +
Sbjct: 25 ESHVVEWGNQ-----------DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL----- 68
Query: 628 SEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERL--LVYEYMPQGTLSRHLFNRKE 684
+ K EI +L +R +++ L D R LV+E++ +
Sbjct: 69 KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL------ 122
Query: 685 EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFGLV 743
+ L ++ + ++Y H +HRD+KP N+++ + + ++ D+GL
Sbjct: 123 --YQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 177
Query: 744 RLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMT 777
++ + + PE +
Sbjct: 178 EFYHPGQEY---NVRVASRYFKGPELLVDYQMYD 208
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 4e-28
Identities = 45/198 (22%), Positives = 78/198 (39%), Gaps = 20/198 (10%)
Query: 587 NVTNNFSEENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV 645
V + + +G G +G+V G ++AVK++ S E+ +L +
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 646 RHRHLVGLLGYCLDGN-----ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIAL 700
+H +++GLL + + ++ G ++ + L +
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKC-----QKLTDDHVQFLIY 128
Query: 701 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAG 760
+ RG++Y+H IHRDLKPSN+ + +D K+ DFGL R D + TR
Sbjct: 129 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 182
Query: 761 TFGYLAPEYAAETSGMTW 778
Y APE
Sbjct: 183 --WYRAPEIMLNWMHYNQ 198
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 8e-26
Identities = 47/187 (25%), Positives = 73/187 (39%), Gaps = 16/187 (8%)
Query: 590 NNFSEENVLGRGGFGTVYKGEL----HDGTKIAVKRM--ESAVVSEKGFAEFKSEIAVLT 643
NF VLG G +G V+ G A+K + + V K ++E VL
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 644 KVRHR-HLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDV 702
+R LV L + L+ +Y+ G L HL R+ ++
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEI 138
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTF 762
+E+LH I+RD+K NILL + + DFGL + + + GT
Sbjct: 139 VLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-ETERAYDFCGTI 194
Query: 763 GYLAPEY 769
Y+AP+
Sbjct: 195 EYMAPDI 201
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 101 bits (251), Expect = 4e-25
Identities = 26/161 (16%), Positives = 45/161 (27%), Gaps = 28/161 (17%)
Query: 596 NVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEK--------GFAEFKSEIAVLTKVRH 647
++G G V+ + VK + S K G F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 648 RHLVGLLGYC----LDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVA 703
R L L G ++ E + L R +E + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDE------------VLDMIL 113
Query: 704 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744
V + H+ +H DL N+L+ + + DF
Sbjct: 114 EEVAKFY---HRGIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (253), Expect = 6e-24
Identities = 37/188 (19%), Positives = 68/188 (36%), Gaps = 18/188 (9%)
Query: 595 ENVLGRGGFGTVYKGE-LHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH------ 647
LG G F TV+ + + + T +A+K + V + + EI +L +V
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE---AAEDEIKLLQRVNDADNTKE 74
Query: 648 -----RHLVGLLGYCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDV 702
H++ LL + + + + L K+ + + I+ +
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 703 ARGVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPDNGKHSIETRLAGT 761
G++Y+H IH D+KP N+L+ D + + L T T
Sbjct: 135 LLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192
Query: 762 FGYLAPEY 769
Y +PE
Sbjct: 193 REYRSPEV 200
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 90.6 bits (223), Expect = 2e-20
Identities = 61/306 (19%), Positives = 108/306 (35%), Gaps = 16/306 (5%)
Query: 26 SSSDAAAMQALKTSLGNPASL-GW---TDPDPCKWKHIQCSPSN---RVTRIQIGGQNIE 78
+ D A+ +K LGNP +L W TD W + C RV + + G N+
Sbjct: 4 NPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 79 G--TLPKELNSLSSLTV--LEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKG 134
+P L +L L + + N + P+++ L+ L + N + DF
Sbjct: 64 KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
Query: 135 LTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHL 194
+ +L T+ YN+ +P S+ L + +G I+G IPD G +
Sbjct: 124 IKTLVTLDFSYNALS-GTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTIS 182
Query: 195 AFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP 254
P + +
Sbjct: 183 RNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGL 242
Query: 255 DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKG 314
+L +R+N++ G +P L L L +N++ N G+ P+ + RFD++
Sbjct: 243 S----KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAY 298
Query: 315 SNSFCL 320
+N+ CL
Sbjct: 299 ANNKCL 304
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 70.9 bits (172), Expect = 7e-14
Identities = 31/110 (28%), Positives = 47/110 (42%), Gaps = 7/110 (6%)
Query: 327 CDGR-VNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGN---ITVVNLKNLGL 382
C+ + LL I K +G P L+ + CN W GV CD + ++L L L
Sbjct: 3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 383 SG--TISSNFSRLTSLRQLMLSGNE-LTGTIPKELTTLPSLEMLDVSNNH 429
I S+ + L L L + G L G IP + L L L +++ +
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTN 112
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 66.3 bits (160), Expect = 2e-12
Identities = 48/258 (18%), Positives = 91/258 (35%), Gaps = 12/258 (4%)
Query: 189 LMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSV-AVIQNMTSLTQLWLHGN 247
+ +L L+ L P P+ +++ L G + L G + I +T L L++
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111
Query: 248 SFTGPLPDLSGLSS-LQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQ---TPKF 303
+ +G +PD L N L+G +P S+ +L +L + N G +
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 304 NSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESW------KGNNPC 357
S + M N + + + + A +
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231
Query: 358 NSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTL 417
+ + N+ ++L+N + GT+ ++L L L +S N L G IP + L
Sbjct: 232 SLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNL 290
Query: 418 PSLEMLDVSNNHLFGKVP 435
++ +NN P
Sbjct: 291 QRFDVSAYANNKCLCGSP 308
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 86.2 bits (212), Expect = 1e-18
Identities = 63/379 (16%), Positives = 118/379 (31%), Gaps = 44/379 (11%)
Query: 67 VTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTS 126
+ +G N+ T+ + L +T L+ + + I + L++L ++ F +N T
Sbjct: 24 KMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNNQLTD 80
Query: 127 VPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTI 186
+ K LT L I ++ N +L + TGL F+ +I
Sbjct: 81 ITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLE 138
Query: 187 PGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLN--------GQKGDSKLNGSVAVIQNMTS 238
+ + T S ++V+ +T+
Sbjct: 139 LSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTN 198
Query: 239 LTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQG 298
L L N + P ++L + S+ NQL I +L +L +L ++L NN
Sbjct: 199 LESLIATNNQISDITPLGIL-TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISN 255
Query: 299 QTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAV--LAESWKGNNP 356
P + L + + L
Sbjct: 256 LAPLSG----------------------LTKLTELKLGANQISNISPLAGLTALTNLELN 293
Query: 357 CNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTT 416
N N+T + L +S S LT L++L + N+++ L
Sbjct: 294 ENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLAN 349
Query: 417 LPSLEMLDVSNNHLFGKVP 435
L ++ L +N + P
Sbjct: 350 LTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 85.1 bits (209), Expect = 4e-18
Identities = 42/247 (17%), Positives = 82/247 (33%), Gaps = 43/247 (17%)
Query: 48 WTDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPS 107
+ + + I P + + +L L + N+L I +
Sbjct: 180 LDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD-IGT 236
Query: 108 LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFS 167
L+ L++L ++ +N +++ GLT L + L N + L T
Sbjct: 237 LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALT------ 288
Query: 168 ANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLN 227
N + D + L +L L FN + P+S
Sbjct: 289 -NLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVS--------------------- 326
Query: 228 GSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLA 287
++T L +L+ N + L+ L+++ S NQ++ + P L NL +
Sbjct: 327 -------SLTKLQRLFFANNKVSDV-SSLANLTNINWLSAGHNQISDLTP--LANLTRIT 376
Query: 288 VVNLTNN 294
+ L +
Sbjct: 377 QLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 83.9 bits (206), Expect = 9e-18
Identities = 68/426 (15%), Positives = 139/426 (32%), Gaps = 55/426 (12%)
Query: 15 LLSATLSVNSQSSS---DAAAMQALKTSLGNPASLGWTDPDPCKWKHIQCSPSNRVTRIQ 71
L SAT++ ++ + D A + +KT LG TD + + ++VT +Q
Sbjct: 1 LGSATITQDTPINQIFTDTALAEKMKTVLGKT---NVTDT-------VSQTDLDQVTTLQ 50
Query: 72 IGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDF 131
I+ + L++LT + N+LT I L L+ L ++L ++N +
Sbjct: 51 ADRLGIKSI--DGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQIADITPLA 107
Query: 132 FKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMH 191
+ T+ + + + + + L + + + + +
Sbjct: 108 NLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTD 167
Query: 192 LHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLN------GSVAVIQNMTSLTQLWLH 245
L N L L + + +T+L +L L+
Sbjct: 168 LKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLN 227
Query: 246 GNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNS 305
GN L+ L++L D + +NQ++ + P L L L + L N +P
Sbjct: 228 GNQLKDI-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGL 284
Query: 306 PVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVS 365
++ N + L V
Sbjct: 285 TALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPV------------------- 325
Query: 366 CDAGGNITVVNLKNLGLSG---TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEM 422
++T L+ L + + S+ + LT++ L N+++ P L L +
Sbjct: 326 ----SSLT--KLQRLFFANNKVSDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQ 377
Query: 423 LDVSNN 428
L +++
Sbjct: 378 LGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 56.2 bits (134), Expect = 7e-09
Identities = 44/284 (15%), Positives = 90/284 (31%), Gaps = 36/284 (12%)
Query: 173 ITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAV 232
I D + M L + + + + TL + G ++G
Sbjct: 12 INQIFTD----TALAEKMKTVLGKTNVTDTVSQT-DLDQVTTLQADR-LGIKSIDG---- 61
Query: 233 IQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSL------ 286
++ + +LTQ+ N T + L L+ L D + +NQ+ I P + + +
Sbjct: 62 VEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNN 120
Query: 287 ---------------AVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRV 331
+ +N + + ++ + A + R+
Sbjct: 121 QITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERL 180
Query: 332 NVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFS 391
++ + V + A L N N+ ++L L +
Sbjct: 181 DISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDI--GTLA 238
Query: 392 RLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVP 435
LT+L L L+ N+++ P L+ L L L + N + P
Sbjct: 239 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP 280
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 79.7 bits (195), Expect = 8e-17
Identities = 53/283 (18%), Positives = 90/283 (31%), Gaps = 46/283 (16%)
Query: 54 CKWKHIQCS-------PSN---RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTG 103
C + +QCS P + + + I + +L +L L ++ NK++
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 104 QIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSF-------------- 148
P + + L L+ + N +P K L L+ +
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV 129
Query: 149 --------DSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQ 200
S + + + L NIT TIP L P L LHL N +
Sbjct: 130 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL----PPSLTELHLDGNKIT 184
Query: 201 GPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLS 260
S + L G +S + N L +L L+ N L+
Sbjct: 185 KVDAASL--KGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHK 242
Query: 261 SLQDFSVRDNQLTGI------VPSSLVNLHSLAVVNLTNNLFQ 297
+Q + +N ++ I P S + V+L +N Q
Sbjct: 243 YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 72.8 bits (177), Expect = 2e-14
Identities = 45/301 (14%), Positives = 78/301 (25%), Gaps = 32/301 (10%)
Query: 113 SLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGAN 172
L+ V D VP D + L N + + K+ L
Sbjct: 11 HLRVVQCSDLGLEKVPKDLP---PDTALLDLQNNKI-TEIKDGDFKNLKNLHTLILINNK 66
Query: 173 ITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAV 232
I+ P + L L+L+ N L+ +P ++Q L ++ +
Sbjct: 67 ISKISPGAFAP--LVKLERLYLSKNQLKE-LPEKM-PKTLQELRVHENEITKVRKSVFNG 122
Query: 233 IQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLT 292
+ M + S G+ L + D +T I +L L +L
Sbjct: 123 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTEL---HLD 179
Query: 293 NNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWK 352
N + G + + L
Sbjct: 180 GNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL---------------REL 224
Query: 353 GNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNF------SRLTSLRQLMLSGNEL 406
N I VV L N +S S++F ++ S + L N +
Sbjct: 225 HLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 284
Query: 407 T 407
Sbjct: 285 Q 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 61.6 bits (148), Expect = 9e-11
Identities = 34/207 (16%), Positives = 66/207 (31%), Gaps = 23/207 (11%)
Query: 237 TSLTQLWLHGNSFTGPLP-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNL 295
L L N T D L +L + +N+++ I P + L L + L+ N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 296 FQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNN 355
+ K ++ + + + ++ V+
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV--------------------E 130
Query: 356 PCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSR--LTSLRQLMLSGNELTGTIPKE 413
+ K + G + L + ++ T + + SL +L L GN++T
Sbjct: 131 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAAS 190
Query: 414 LTTLPSLEMLDVSNNHLFGKVPNFRQN 440
L L +L L +S N + N
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSLAN 217
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.7 bits (130), Expect = 1e-08
Identities = 20/85 (23%), Positives = 35/85 (41%), Gaps = 10/85 (11%)
Query: 356 PCNSDWKGVSCDAGG----------NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNE 405
C + V C G + +++L+N ++ +F L +L L+L N+
Sbjct: 7 RCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK 66
Query: 406 LTGTIPKELTTLPSLEMLDVSNNHL 430
++ P L LE L +S N L
Sbjct: 67 ISKISPGAFAPLVKLERLYLSKNQL 91
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 66.2 bits (160), Expect = 1e-12
Identities = 34/216 (15%), Positives = 76/216 (35%), Gaps = 15/216 (6%)
Query: 87 SLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146
+L++ + K+ +T + + + L + + T++ + L +L + L N
Sbjct: 17 ALANAIKIAAGKSNVTDTV-TQADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELKDN 73
Query: 147 SFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDT---------IPGLMHLHLAFN 197
++L T L+ N++ + L L
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 198 FLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLS 257
++ L + + + N++ LT L N + + L+
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISPLA 192
Query: 258 GLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTN 293
L +L + +++NQ++ + P L N +L +V LTN
Sbjct: 193 SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 62.0 bits (149), Expect = 2e-11
Identities = 31/206 (15%), Positives = 75/206 (36%), Gaps = 6/206 (2%)
Query: 222 GDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLV 281
G S + +V ++ +T L G T + + L++L ++DNQ+T + P +
Sbjct: 27 GKSNVTDTVT-QADLDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDNQITDLAPLKNL 84
Query: 282 NLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSV 341
+ ++ S D+ + AG++ + + L+ + ++
Sbjct: 85 TKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNI 144
Query: 342 GYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLML 401
A L + +T + + +S + L +L ++ L
Sbjct: 145 SPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHL 202
Query: 402 SGNELTGTIPKELTTLPSLEMLDVSN 427
N+++ P L +L ++ ++N
Sbjct: 203 KNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 57.0 bits (136), Expect = 1e-09
Identities = 29/201 (14%), Positives = 65/201 (32%), Gaps = 5/201 (2%)
Query: 235 NMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+ + ++ ++ T + + L + S +T I + L++L + L +N
Sbjct: 17 ALANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 295 LFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGN 354
P N ++ N A + L+ + + S
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 355 NPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKEL 414
+ + G + L + + + L+ L L N+++ P L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 415 TTLPSLEMLDVSNNHLFGKVP 435
+LP+L + + NN + P
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP 212
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 6e-05
Identities = 18/59 (30%), Positives = 30/59 (50%), Gaps = 3/59 (5%)
Query: 85 LNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143
L +LS LT L+ NK++ I L+ L +L EV +N + V ++L ++L
Sbjct: 169 LANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.8 bits (156), Expect = 6e-12
Identities = 45/323 (13%), Positives = 87/323 (26%), Gaps = 52/323 (16%)
Query: 112 SSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGA 171
+VP + Q I L N S V S + L +
Sbjct: 11 EPKVTTSCPQQGLQAVPVGIP---AASQRIFLHGNRI-SHVPAASFRACRNLTILWLHSN 66
Query: 172 NITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSV 230
+ G + L+ P +F + TL L+ G
Sbjct: 67 VLARIDAAAFTGLALLE-QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPG-- 123
Query: 231 AVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVV 289
+ + + +L L+L N+ D L +L + N+++ + + LHSL +
Sbjct: 124 -LFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182
Query: 290 NLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAE 349
L N P ++F + N
Sbjct: 183 LLHQNRVAHVHP--------------HAFRDLGRLMTLYLFAN----------------- 211
Query: 350 SWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGT 409
S + + + L + L++ S +E+ +
Sbjct: 212 -------NLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCS 263
Query: 410 IPKELTTLPSLEMLDVSNNHLFG 432
+P+ L ++ ++ N L G
Sbjct: 264 LPQRLA---GRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.8 bits (156), Expect = 6e-12
Identities = 49/274 (17%), Positives = 83/274 (30%), Gaps = 37/274 (13%)
Query: 54 CKWKHIQCSPSN---RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP---- 106
C + +Q P RI + G I + +LT+L + N L
Sbjct: 18 CPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFT 77
Query: 107 ----------------------SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144
+ GL L + D + F+GL +LQ + L
Sbjct: 78 GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQ 137
Query: 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIP 204
N+ + ++ +D L +G I+ G + L L L N + P
Sbjct: 138 DNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRG--LHSLDRLLLHQNRVAHVHP 194
Query: 205 LSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQD 264
+F S L + + +L L L+ N + + LQ
Sbjct: 195 HAFRDLGRLMTLYLFANNLSALP--TEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQK 252
Query: 265 FSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQG 298
F +++ +P L + L N QG
Sbjct: 253 FRGSSSEVPCSLPQRLAGRD---LKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 3e-04
Identities = 24/178 (13%), Positives = 53/178 (29%), Gaps = 13/178 (7%)
Query: 260 SSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFC 319
++ Q + N+++ + +S +L ++ L +N+ + + +
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 320 LDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKN 379
+ L L G + + L++
Sbjct: 92 QLRSVDPATFHGLGRLH---------TLHLDRCGLQELGPGLFRGLA----ALQYLYLQD 138
Query: 380 LGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNF 437
L F L +L L L GN ++ + L SL+ L + N + P+
Sbjct: 139 NALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (85), Expect = 0.004
Identities = 10/67 (14%), Positives = 21/67 (31%), Gaps = 7/67 (10%)
Query: 356 PCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELT 415
PC C +T + GL + + +++ L GN ++
Sbjct: 1 PCPG---ACVCYNEPKVTT-SCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFR 53
Query: 416 TLPSLEM 422
+L +
Sbjct: 54 ACRNLTI 60
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.1 bits (144), Expect = 2e-10
Identities = 33/203 (16%), Positives = 56/203 (27%), Gaps = 10/203 (4%)
Query: 233 IQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLT 292
+ + S ++ + T PDL + +N L ++L+ L +NL
Sbjct: 6 VSKVASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 293 NNLFQGQTPKFNSPV-------RFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPA 345
PV + A D N L S+
Sbjct: 64 RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
Query: 346 VLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNE 405
+ + ++L N L+ + + L +L L+L N
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183
Query: 406 LTGTIPKELTTLPSLEMLDVSNN 428
L TIPK L + N
Sbjct: 184 LY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.0 bits (136), Expect = 2e-09
Identities = 35/215 (16%), Positives = 63/215 (29%), Gaps = 12/215 (5%)
Query: 84 ELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143
E++ ++S + K LT +P + +N + T L ++L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP-KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPI 203
D + +L L + + + L L
Sbjct: 63 DRAELTKLQVDGTLPV---LGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119
Query: 204 PLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSL 262
G+ L N K ++ L +L L N+ T L+GL +L
Sbjct: 120 LRGLGELQELYLKGNELKTLPP-----GLLTPTPKLEKLSLANNNLTELPAGLLNGLENL 174
Query: 263 QDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQ 297
+++N L +P H L L N +
Sbjct: 175 DTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (99), Expect = 8e-05
Identities = 11/65 (16%), Positives = 17/65 (26%), Gaps = 3/65 (4%)
Query: 365 SCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLD 424
+ VN L+ + + L LS N L L L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 425 VSNNH 429
+
Sbjct: 62 LDRAE 66
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.6 bits (140), Expect = 8e-10
Identities = 44/277 (15%), Positives = 92/277 (33%), Gaps = 19/277 (6%)
Query: 191 HLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFT 250
L L L + + S ++ +A + + + L +
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQGVIAFRCPR----SFMDQPLAEHFSPFRVQHMDLSNSVIE 59
Query: 251 --GPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVR 308
LS S LQ+ S+ +L+ + ++L +L +NL+ ++
Sbjct: 60 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGF-----SEFALQ 114
Query: 309 FDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDA 368
++ S L+ + +V +++ L S N SD +
Sbjct: 115 TLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRC 174
Query: 369 GGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSG-NELTGTIPKELTTLPSLEMLDVSN 427
+ + ++ L F +L L+ L LS ++ EL +P+L+ L V
Sbjct: 175 PNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 234
Query: 428 NHLFGKVPNFRQNVIVKTDGNPDIGKDSSSFTPKSPP 464
G + ++ + P + + S FT + P
Sbjct: 235 IVPDGTLQLLKEAL-------PHLQINCSHFTTIARP 264
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 57.3 bits (137), Expect = 8e-10
Identities = 26/198 (13%), Positives = 64/198 (32%), Gaps = 15/198 (7%)
Query: 235 NMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+ L S T + + L+S+ ++ + + + L ++ + L N
Sbjct: 22 AFAETIKDNLKKKSVTDAVT-QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78
Query: 295 LFQGQT-----PKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAE 349
+ S D + + +S + + + L
Sbjct: 79 KLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLES 138
Query: 350 SWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGT 409
+ GNN +++ + + + + LT L+ L LS N ++
Sbjct: 139 LYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-----PLAGLTKLQNLYLSKNHISD- 192
Query: 410 IPKELTTLPSLEMLDVSN 427
+ L L +L++L++ +
Sbjct: 193 -LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 53.1 bits (126), Expect = 2e-08
Identities = 29/229 (12%), Positives = 77/229 (33%), Gaps = 27/229 (11%)
Query: 71 QIGGQNIEGTLPKELNSLSSLTVLE------VMKNKLTGQIPSLSGLSSLQEVLFDDNNF 124
+G + I T+P + + S + K +T + + + L+S+ +++ ++++
Sbjct: 2 PLGSETI--TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAV-TQNELNSIDQIIANNSDI 58
Query: 125 TSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGD 184
SV + L ++ + L+ N +LK+ L +++
Sbjct: 59 KSVQG--IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKS 116
Query: 185 TIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWL 244
+ L + + + +
Sbjct: 117 LSLEHNGISDINGL--------------VHLPQLESLYLGNNKITDITVLSRLTKLDTLS 162
Query: 245 HGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTN 293
++ + L+GL+ LQ+ + N ++ + +L L +L V+ L +
Sbjct: 163 LEDNQISDIVPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFS 209
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 52.7 bits (125), Expect = 2e-08
Identities = 30/189 (15%), Positives = 60/189 (31%), Gaps = 5/189 (2%)
Query: 235 NMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNN 294
+ + L + T + + L + + I + L++L +N +NN
Sbjct: 16 ALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 72
Query: 295 LFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGN 354
TP N D+ +N + L + + +
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 355 NPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKEL 414
+S+ G ++ L T + LT+L +L +S N+++ L
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISVL 190
Query: 415 TTLPSLEML 423
L +LE L
Sbjct: 191 AKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 9e-07
Identities = 37/200 (18%), Positives = 67/200 (33%), Gaps = 18/200 (9%)
Query: 88 LSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNS 147
L+ + K +T S + L + + D S+ + L +L I+ N
Sbjct: 17 LAEKMKTVLGKTNVTD-TVSQTDLDQVTTLQADRLGIKSIDG--VEYLNNLTQINFSNNQ 73
Query: 148 FDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSF 207
N + + + I L +L ++
Sbjct: 74 LTDI-------------TPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITD 120
Query: 208 GKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSV 267
LN + S ++ + +TSL QL N T L L+ L++L+ +
Sbjct: 121 IDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTD-LKPLANLTTLERLDI 179
Query: 268 RDNQLTGI-VPSSLVNLHSL 286
N+++ I V + L NL SL
Sbjct: 180 SSNKVSDISVLAKLTNLESL 199
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 51.7 bits (122), Expect = 5e-08
Identities = 31/185 (16%), Positives = 56/185 (30%), Gaps = 12/185 (6%)
Query: 113 SLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGAN 172
V +P D + L+ N L +
Sbjct: 9 EGTTVDCTGRGLKEIPRDIP---LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQ 65
Query: 173 ITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDSKLNGSVA 231
+TG P+ G + + L N ++ F ++TL L + + GS
Sbjct: 66 LTGIEPNAFEGASHIQELQLG--ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGS-- 121
Query: 232 VIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNL 291
+++ SLT L L N F L+ S+ PS + ++ +L
Sbjct: 122 -FEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIK---DL 177
Query: 292 TNNLF 296
++ F
Sbjct: 178 PHSEF 182
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.4 bits (121), Expect = 1e-07
Identities = 34/242 (14%), Positives = 66/242 (27%), Gaps = 15/242 (6%)
Query: 54 CKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLS 112
C + C ++VT I P +L + L + KL + SG
Sbjct: 8 CSNRVFLCQ-ESKVTEI-----------PSDL--PRNAIELRFVLTKLRVIQKGAFSGFG 53
Query: 113 SLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGAN 172
L+++ N+ V + + I ++
Sbjct: 54 DLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNT 113
Query: 173 ITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAV 232
+PD ++ ++ + SF S +++ L K + + A
Sbjct: 114 GIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAF 173
Query: 233 IQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLT 292
L + N P G S + ++ + L NL L +
Sbjct: 174 NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233
Query: 293 NN 294
N
Sbjct: 234 NL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 1e-04
Identities = 7/39 (17%), Positives = 10/39 (25%)
Query: 390 FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNN 428
F + L +S + L L L N
Sbjct: 197 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (85), Expect = 0.004
Identities = 12/84 (14%), Positives = 30/84 (35%), Gaps = 4/84 (4%)
Query: 48 WTDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKE-LNSLSSLTVLEVMKNKLTGQIP 106
W + + + H ++ + + N LP + + S +L++ + ++
Sbjct: 159 WLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS 218
Query: 107 S-LSGLSSLQEVLFDDNNFTSVPS 129
L L L+ N +P+
Sbjct: 219 YGLENLKKLR--ARSTYNLKKLPT 240
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.6 bits (112), Expect = 8e-07
Identities = 10/45 (22%), Positives = 21/45 (46%), Gaps = 1/45 (2%)
Query: 387 SSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLF 431
++ ++ R+L L G ++ I TL + +D S+N +
Sbjct: 11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR 54
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (107), Expect = 4e-06
Identities = 18/142 (12%), Positives = 33/142 (23%), Gaps = 4/142 (2%)
Query: 101 LTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDA 160
L Q + +E+ + + L I N L
Sbjct: 7 LIEQAAQYTNAVRDRELDLRGYKIPVIE-NLGATLDQFDAIDFSDNEIRKLDGFPLL--- 62
Query: 161 TGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQ 220
L+ N I + L G + S+ L +
Sbjct: 63 RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 122
Query: 221 KGDSKLNGSVAVIQNMTSLTQL 242
+K + + VI + + L
Sbjct: 123 PVTNKKHYRLYVIYKVPQVRVL 144
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.4 bits (116), Expect = 8e-07
Identities = 22/113 (19%), Positives = 41/113 (36%), Gaps = 8/113 (7%)
Query: 48 WTDPDPCKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPS 107
S + + + + SL L V NKL ++P+
Sbjct: 243 PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA 301
Query: 108 LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSW-VIPESLKD 159
L L+ ++ N+ VP +L+ + ++YN + IPES++D
Sbjct: 302 L--PPRLERLIASFNHLAEVPEL----PQNLKQLHVEYNPLREFPDIPESVED 348
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.8 bits (104), Expect = 3e-05
Identities = 14/56 (25%), Positives = 25/56 (44%), Gaps = 5/56 (8%)
Query: 376 NLKNLGLSGT-ISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+L+ L +S + + L +L+ S N L +P+ +L+ L V N L
Sbjct: 285 SLEELNVSNNKLIELPALPPRLERLIASFNHLA-EVPELP---QNLKQLHVEYNPL 336
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.3 bits (100), Expect = 9e-05
Identities = 15/77 (19%), Positives = 29/77 (37%), Gaps = 12/77 (15%)
Query: 210 SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRD 269
S++ L ++ N + + L +L N +P+L +L+ V
Sbjct: 284 PSLEELNVSN-------NKLIELPALPPRLERLIASFNHLAE-VPEL--PQNLKQLHVEY 333
Query: 270 NQLTGI--VPSSLVNLH 284
N L +P S+ +L
Sbjct: 334 NPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.1 bits (97), Expect = 2e-04
Identities = 23/87 (26%), Positives = 30/87 (34%), Gaps = 5/87 (5%)
Query: 354 NNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKE 413
+ D + S I S SL +L +S N+L +P
Sbjct: 244 QSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL 302
Query: 414 LTTLPSLEMLDVSNNHLFGKVPNFRQN 440
P LE L S NHL +VP QN
Sbjct: 303 P---PRLERLIASFNHL-AEVPELPQN 325
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.1 bits (97), Expect = 2e-04
Identities = 16/72 (22%), Positives = 25/72 (34%), Gaps = 7/72 (9%)
Query: 227 NGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSL 286
N ++ SL +L + N LP L L+ N L + P NL L
Sbjct: 274 NEIRSLCDLPPSLEELNVSNNKLIE-LPAL--PPRLERLIASFNHLAEV-PELPQNLKQL 329
Query: 287 AVVNLTNNLFQG 298
++ N +
Sbjct: 330 ---HVEYNPLRE 338
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 0.001
Identities = 11/48 (22%), Positives = 19/48 (39%), Gaps = 2/48 (4%)
Query: 376 NLKNLGLSGT-ISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEM 422
L+ L S ++ +L+QL + N L P ++ L M
Sbjct: 305 RLERLIASFNHLAEVPELPQNLKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.0 bits (89), Expect = 0.002
Identities = 16/79 (20%), Positives = 29/79 (36%), Gaps = 12/79 (15%)
Query: 186 IPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLH 245
P L L+++ N L +P ++ L + N V + +L QL +
Sbjct: 283 PPSLEELNVSNNKLIE-LPALPP--RLERLIASF-------NHLAEVPELPQNLKQLHVE 332
Query: 246 GNSFTGPLPDL-SGLSSLQ 263
N PD+ + L+
Sbjct: 333 YNPLRE-FPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.7 bits (88), Expect = 0.002
Identities = 20/62 (32%), Positives = 28/62 (45%), Gaps = 8/62 (12%)
Query: 371 NITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHL 430
+ L NLGLS ++ L L+ S N LT +P+ SL+ L V NN+L
Sbjct: 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELPQ---SLKSLLVDNNNL 90
Query: 431 FG 432
Sbjct: 91 KA 92
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.7 bits (88), Expect = 0.002
Identities = 14/69 (20%), Positives = 28/69 (40%), Gaps = 7/69 (10%)
Query: 89 SSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSF 148
LE+ L+ +P L L+ ++ N+ T +P SL+++ +D N+
Sbjct: 38 RQAHELELNNLGLS-SLPEL--PPHLESLVASCNSLTELPE----LPQSLKSLLVDNNNL 90
Query: 149 DSWVIPESL 157
+ L
Sbjct: 91 KALSDLPPL 99
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 2e-06
Identities = 12/66 (18%), Positives = 25/66 (37%), Gaps = 10/66 (15%)
Query: 375 VNLKNLGLSGT------ISSNFSRLTSLRQLMLSGNELTG----TIPKELTTLPSLEMLD 424
+++++L + + L + + L LT I L P+L L+
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 425 VSNNHL 430
+ +N L
Sbjct: 62 LRSNEL 67
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 1e-04
Identities = 15/83 (18%), Positives = 26/83 (31%), Gaps = 10/83 (12%)
Query: 231 AVIQNMTSLTQLWLHGNSFTG----PLPD-LSGLSSLQDFSVRDNQLTGIVPSSLV---- 281
+ Q + L LWL + L L SL++ + +N L LV
Sbjct: 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR 422
Query: 282 -NLHSLAVVNLTNNLFQGQTPKF 303
L + L + + +
Sbjct: 423 QPGCLLEQLVLYDIYWSEEMEDR 445
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 20/112 (17%), Positives = 36/112 (32%), Gaps = 17/112 (15%)
Query: 354 NNPCNSDWKGVSCDAGGNITVVNLKNLGLSGT---------ISSNFSRLTSLRQLMLSGN 404
+N D G L+ L L+ +++ SLR+L LS N
Sbjct: 348 SNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNN 407
Query: 405 ELTGTIPKELTT-----LPSLEMLDVSNNHLFGKVPNFRQNVIVKTDGNPDI 451
L +L LE L + + + ++ + Q + P +
Sbjct: 408 CLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKD---KPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.001
Identities = 17/68 (25%), Positives = 25/68 (36%), Gaps = 9/68 (13%)
Query: 371 NITVVNLKNLGLSG----TISSNFSRLTSLRQLMLSGNELTGTIPKEL-----TTLPSLE 421
VV L + GL+ ISS +L +L L NEL + T ++
Sbjct: 28 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQ 87
Query: 422 MLDVSNNH 429
L + N
Sbjct: 88 KLSLQNCC 95
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.7 bits (105), Expect = 3e-06
Identities = 22/115 (19%), Positives = 41/115 (35%), Gaps = 5/115 (4%)
Query: 80 TLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139
T+ L L +T L++ N+L P+L+ L L+ + DN +V LQ
Sbjct: 11 TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANL--PRLQ 68
Query: 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGG--DTIPGLMHL 192
+ L N + L L + G ++ + +P + +
Sbjct: 69 ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.4 bits (86), Expect = 0.001
Identities = 17/89 (19%), Positives = 29/89 (32%), Gaps = 23/89 (25%)
Query: 233 IQNMTSLTQLWLHGNSFTGPLPDLSGLSSL----------------------QDFSVRDN 270
++ + +T L L N P L+ L L Q+ + +N
Sbjct: 16 LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANLPRLQELLLCNN 75
Query: 271 QLTGI-VPSSLVNLHSLAVVNLTNNLFQG 298
+L LV+ L ++NL N
Sbjct: 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.0 bits (85), Expect = 0.001
Identities = 20/119 (16%), Positives = 40/119 (33%), Gaps = 15/119 (12%)
Query: 176 TIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQN 235
T+ L + + HL L+ N L+ P + + ++G + N
Sbjct: 11 TVLCHLEQ--LLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDG----VAN 63
Query: 236 MTSLTQLWLHGNSFTG--PLPDLSGLSSLQDFSVRDNQLTGI------VPSSLVNLHSL 286
+ L +L L N + L L +++ N L + L ++ S+
Sbjct: 64 LPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.0 bits (85), Expect = 0.001
Identities = 22/162 (13%), Positives = 39/162 (24%), Gaps = 47/162 (29%)
Query: 266 SVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGV 325
+ LT + L L + ++L++N + P +
Sbjct: 4 HLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPALAA-------------------- 41
Query: 326 ACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGT 385
L N+ + + L N L +
Sbjct: 42 ---------------------LRCLEVLQASDNALENVDGVANLPRLQELLLCNNRLQQS 80
Query: 386 IS-SNFSRLTSLRQLMLSGNELT---GTIPKELTTLPSLEML 423
+ L L L GN L G + LPS+ +
Sbjct: 81 AAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.0 bits (94), Expect = 4e-04
Identities = 36/333 (10%), Positives = 80/333 (24%), Gaps = 17/333 (5%)
Query: 107 SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSW---VIPESLKDATGL 163
S+ G S L+ + SV + + S++ I L N+ + + E++ L
Sbjct: 4 SIEGKS-LKLDAITTEDEKSVFAVLLE-DDSVKEIVLSGNTIGTEAARWLSENIASKKDL 61
Query: 164 QRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGD 223
+ + + + L +FG ++ + L K
Sbjct: 62 EIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHT 121
Query: 224 SKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNL 283
+ + L+ N+L
Sbjct: 122 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 181
Query: 284 HSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGY 343
+ T + Q ++ ++
Sbjct: 182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 241
Query: 344 PAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGT----------ISSNFSRL 393
L E + ++ DA + + L+ L L + ++
Sbjct: 242 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 301
Query: 394 TSLRQLMLSGNELT--GTIPKELTTLPSLEMLD 424
L L L+GN + + E+ + S
Sbjct: 302 PDLLFLELNGNRFSEEDDVVDEIREVFSTRGRG 334
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.6 bits (93), Expect = 6e-04
Identities = 34/313 (10%), Positives = 81/313 (25%), Gaps = 21/313 (6%)
Query: 137 SLQTISLDYNSF---DSWVIPESLKDATGLQRFSANGANITG----TIPDFLGGDTIPGL 189
S++ SL ++ D + L + ++ +G I + + + + L
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIA--SKKDL 61
Query: 190 MHLHLAFNFL-QGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQL--WLHG 246
+ F + + + L K + A H
Sbjct: 62 EIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHT 121
Query: 247 NSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSP 306
L + R Q + + +++ N L G ++
Sbjct: 122 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 181
Query: 307 VRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSC 366
+ + + + + L ++ + ++ +
Sbjct: 182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 241
Query: 367 DAGGNITVVNLKNLGLSGTIS----SNFSRLTSLRQLMLSGNELTGTIPKELTT-----L 417
+N L G + + L+ L L NE+ + L T +
Sbjct: 242 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 301
Query: 418 PSLEMLDVSNNHL 430
P L L+++ N
Sbjct: 302 PDLLFLELNGNRF 314
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 39.7 bits (91), Expect = 6e-04
Identities = 18/76 (23%), Positives = 30/76 (39%), Gaps = 9/76 (11%)
Query: 83 KELNSLSSLTVLEVMKNKLTGQIP-------SLSGLSSLQEVLFDDNNFTSVPSDFFKGL 135
+ S+ E K +L G IP +LS L + + + NN + S G+
Sbjct: 12 RIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKISS--LSGM 69
Query: 136 TSLQTISLDYNSFDSW 151
+L+ +SL N
Sbjct: 70 ENLRILSLGRNLIKKI 85
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 779 | |||
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.98 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.97 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.97 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.97 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.97 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.97 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.97 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.97 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.97 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.97 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.97 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.97 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.97 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.97 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.97 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.97 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.97 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.96 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.96 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.96 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.96 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.96 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.96 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.96 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.96 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.96 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.91 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.89 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.81 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.76 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.76 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.74 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.72 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.72 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.57 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.52 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.52 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.46 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.44 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.44 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.43 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.42 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.34 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.28 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.26 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.25 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.24 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.23 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.51 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.31 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.04 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.0 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.59 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.25 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.18 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.96 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.69 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.49 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.16 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.01 |
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=2.9e-42 Score=363.58 Aligned_cols=295 Identities=27% Similarity=0.489 Sum_probs=223.2
Q ss_pred CCChhHHHHHHHHHHHcCCCCC-CCC-CCCCCC--cceeeEeCCC---CcEEEEEecCCCccc--cCCccccCCCCCcEE
Q 004020 24 SQSSSDAAAMQALKTSLGNPAS-LGW-TDPDPC--KWKHIQCSPS---NRVTRIQIGGQNIEG--TLPKELNSLSSLTVL 94 (779)
Q Consensus 24 ~~~~~~~~~l~~~k~~~~~~~~-~~w-~~~~~C--~w~gv~c~~~---~~v~~l~l~~~~l~~--~~p~~l~~l~~L~~L 94 (779)
-|.++|++||++||+++.++.. .+| .+.||| .|.||+|+.. .||++|+|++++++| .+|++|++|++|++|
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L 81 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEE
T ss_pred CCCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccccc
Confidence 3789999999999999988764 367 467999 4999999864 389999999999998 589999999999999
Q ss_pred Eccc-CccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCce
Q 004020 95 EVMK-NKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGAN 172 (779)
Q Consensus 95 ~Ls~-N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~ 172 (779)
+|++ |+++|.+| .|++|++|++|+|++|++.++++..+..+..|+++++++|++.. .+|..+.+++.|+.+++++|.
T Consensus 82 ~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~-~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSG-TLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEES-CCCGGGGGCTTCCEEECCSSC
T ss_pred ccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccc-cCchhhccCcccceeeccccc
Confidence 9997 89998877 79999999999999999998888888888888888888887755 566666666666666666666
Q ss_pred eEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCC
Q 004020 173 ITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGP 252 (779)
Q Consensus 173 l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~ 252 (779)
+++.+|+.++ .+..+ ++.+++++|++++.
T Consensus 161 l~~~ip~~~~--~l~~l-------------------------------------------------~~~l~~~~n~l~~~ 189 (313)
T d1ogqa_ 161 ISGAIPDSYG--SFSKL-------------------------------------------------FTSMTISRNRLTGK 189 (313)
T ss_dssp CEEECCGGGG--CCCTT-------------------------------------------------CCEEECCSSEEEEE
T ss_pred cccccccccc--ccccc-------------------------------------------------cccccccccccccc
Confidence 6666665554 23222 24444444444444
Q ss_pred CCC-CCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccc
Q 004020 253 LPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRV 331 (779)
Q Consensus 253 ~~~-~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (779)
.|. +..+ .+..+++++|.+.+.+|..+..+++|+.+++++|.+++.+|...
T Consensus 190 ~~~~~~~l-~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~--------------------------- 241 (313)
T d1ogqa_ 190 IPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVG--------------------------- 241 (313)
T ss_dssp CCGGGGGC-CCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCC---------------------------
T ss_pred cccccccc-cccccccccccccccccccccccccccccccccccccccccccc---------------------------
Confidence 443 2222 33356666666666677777777777777777777766555311
Q ss_pred hhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccCccccccCC
Q 004020 332 NVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIP 411 (779)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP 411 (779)
..++|+.|+|++|+++|.+|.+|+++++|++|+|++|+|+|.||
T Consensus 242 ------------------------------------~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP 285 (313)
T d1ogqa_ 242 ------------------------------------LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285 (313)
T ss_dssp ------------------------------------CCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC
T ss_pred ------------------------------------cccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCC
Confidence 11267778888888888889999999999999999999999999
Q ss_pred ccCCCCCCCCceeccCCc-cccc-CC
Q 004020 412 KELTTLPSLEMLDVSNNH-LFGK-VP 435 (779)
Q Consensus 412 ~~l~~l~~L~~L~Ls~N~-l~g~-iP 435 (779)
+++.+++|+.+++++|+ ++|. +|
T Consensus 286 -~~~~L~~L~~l~l~~N~~l~g~plp 310 (313)
T d1ogqa_ 286 -QGGNLQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp -CSTTGGGSCGGGTCSSSEEESTTSS
T ss_pred -CcccCCCCCHHHhCCCccccCCCCC
Confidence 46889999999999997 5554 44
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-37 Score=315.23 Aligned_cols=179 Identities=26% Similarity=0.407 Sum_probs=152.9
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ....+++.+|++++++++|||||++++++.+++..|+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 467999999999999999999875 689999999975432 233467899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++|+|.+++... ..+++.++..++.||++||+|||+ ++|+||||||+|||+++++++||+|||+|+...
T Consensus 83 Ey~~gg~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 83 EYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFR 154 (271)
T ss_dssp ECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred eccCCCcHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeec
Confidence 999999999998543 258999999999999999999997 899999999999999999999999999999775
Q ss_pred CCCCcccccccccCCcccccccccccCCC
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAETSGM 776 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 776 (779)
...........+||+.|||||++.+...+
T Consensus 155 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~ 183 (271)
T d1nvra_ 155 YNNRERLLNKMCGTLPYVAPELLKRREFH 183 (271)
T ss_dssp ETTEECCBCCCCSCGGGSCTHHHHCSSBC
T ss_pred cCCccccccceeeCcCccCHhHhcCCCCC
Confidence 44333334567899999999999876544
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-36 Score=305.54 Aligned_cols=176 Identities=32% Similarity=0.557 Sum_probs=146.5
Q ss_pred hcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
.++|++.+.||+|+||.||+|+.+ ..||||+++.........++|.+|++++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467999999999999999999865 469999998766566677899999999999999999999998754 56899999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++|+|.+++.... ..+++..+..|+.||++||+|||+ ++||||||||+|||++.++.+||+|||+|+....
T Consensus 84 y~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp CCCEEEHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred cCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 999999999986543 258999999999999999999997 8999999999999999999999999999987654
Q ss_pred CCCcccccccccCCcccccccccccC
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
...........||+.|||||++.+..
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~ 182 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQD 182 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCS
T ss_pred cCCcccccccccCcccCCHHHHhccc
Confidence 33333345567999999999997653
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-35 Score=303.90 Aligned_cols=173 Identities=26% Similarity=0.439 Sum_probs=151.4
Q ss_pred hcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.++|++.+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 35799999999999999999986 4799999999875542 23467899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++|+|.+++.+. .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+|+...
T Consensus 97 Ey~~gg~L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~ 167 (293)
T d1yhwa1 97 EYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (293)
T ss_dssp ECCTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeec
Confidence 999999999887432 48899999999999999999997 899999999999999999999999999999875
Q ss_pred CCCCcccccccccCCcccccccccccC
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
.... .....+||+.|||||++.+..
T Consensus 168 ~~~~--~~~~~~gt~~Y~aPE~~~~~~ 192 (293)
T d1yhwa1 168 PEQS--KRSTMVGTPYWMAPEVVTRKA 192 (293)
T ss_dssp STTC--CBCCCCSCGGGCCHHHHSSSC
T ss_pred cccc--cccccccCCCccChhhhcCCC
Confidence 4322 234567999999999998753
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-36 Score=304.67 Aligned_cols=183 Identities=24% Similarity=0.407 Sum_probs=143.5
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEe--CCeEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD--GNERLL 665 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 665 (779)
.++|++.+.||+|+||.||+|+.. +|+.||+|++......+...+.+.+|++++++++|||||++++++.+ .+..|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 367999999999999999999875 68999999998776666677889999999999999999999999875 456899
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCcEEcCCCCCCEEEcCCCcEEEEeeccc
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA--HQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 743 (779)
|||||++|+|.+++.+..... ..+++..++.++.||+.||+|||+.. ..+|+||||||+|||++.++.+||+|||+|
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEecCCCCcHHHHHHhccccC-CCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 999999999999986544322 36899999999999999999999721 134999999999999999999999999999
Q ss_pred eecCCCCCcccccccccCCcccccccccccC
Q 004020 744 RLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
+...... ......+||+.|||||++.+..
T Consensus 162 ~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~ 190 (269)
T d2java1 162 RILNHDT--SFAKAFVGTPYYMSPEQMNRMS 190 (269)
T ss_dssp HHC-------------CCCSCCCHHHHTTCC
T ss_pred eecccCC--CccccCCCCcccCCHHHHcCCC
Confidence 8765432 2234567999999999997653
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-35 Score=305.80 Aligned_cols=177 Identities=28% Similarity=0.459 Sum_probs=150.3
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999875 789999999975432 2334567999999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+|+...
T Consensus 88 Ey~~gg~L~~~~~~~~-----~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp CCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EccCCCCHHHhhhccC-----CCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecc
Confidence 9999999999886543 58999999999999999999996 899999999999999999999999999999876
Q ss_pred CCCCcccccccccCCcccccccccccC
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
...........+||+.|||||++.+..
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~ 186 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLTEKS 186 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTCC
T ss_pred cCCcccccccccCCccccCceeeccCC
Confidence 543333344567999999999997654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-35 Score=299.68 Aligned_cols=173 Identities=32% Similarity=0.540 Sum_probs=151.7
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccC-hhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
++|++.+.||+|+||.||+|+.+ +++.||+|++.+.... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999875 6899999998754322 233567899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++|+|.+++.... .+++..+..++.||++||+|||+ ++|+||||||+|||++.++++||+|||+|+...
T Consensus 86 Ey~~~g~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp ECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred eecCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecC
Confidence 9999999999986543 58999999999999999999997 899999999999999999999999999998765
Q ss_pred CCCCcccccccccCCcccccccccccC
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
... .....||+.|||||++.+..
T Consensus 158 ~~~----~~~~~Gt~~Y~APE~~~~~~ 180 (263)
T d2j4za1 158 SSR----RTTLCGTLDYLPPEMIEGRM 180 (263)
T ss_dssp CCC----CEETTEEGGGCCHHHHTTCC
T ss_pred CCc----ccccCCCCcccCHHHHcCCC
Confidence 432 23457999999999998754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-35 Score=311.85 Aligned_cols=174 Identities=26% Similarity=0.402 Sum_probs=151.1
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.++|++.+.||+|+||+||+|+.. +|+.||+|+++... .....+++.+|+.++++++|||||+++++|.+.+..|+||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 568999999999999999999875 68999999987543 3444578899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++|+|.+++.+.. .+++..+..++.|++.||+|||+ +++|+||||||+|||+++++++||+|||+|+...
T Consensus 84 Ey~~gg~L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp ECCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EcCCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 9999999999996543 58999999999999999999996 2489999999999999999999999999998664
Q ss_pred CCCCcccccccccCCcccccccccccC
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
.. .....+||+.|||||++.+..
T Consensus 157 ~~----~~~~~~GT~~Y~APEvl~~~~ 179 (322)
T d1s9ja_ 157 DS----MANSFVGTRSYMSPERLQGTH 179 (322)
T ss_dssp HH----TC---CCSSCCCCHHHHHCSC
T ss_pred CC----ccccccCCccccCchHHcCCC
Confidence 32 224568999999999998753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-35 Score=303.08 Aligned_cols=173 Identities=27% Similarity=0.421 Sum_probs=150.1
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.+.|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 357899999999999999999875 68999999987543 344567899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
|||++|+|.+++.+.. ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+|+...
T Consensus 89 Ey~~~g~L~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~ 161 (288)
T d2jfla1 89 EFCAGGAVDAVMLELE----RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT 161 (288)
T ss_dssp ECCTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECH
T ss_pred ecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccC
Confidence 9999999999876543 258999999999999999999997 899999999999999999999999999997653
Q ss_pred CCCCcccccccccCCcccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAE 772 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~ 772 (779)
.. ........||+.|||||++.+
T Consensus 162 ~~--~~~~~~~~Gt~~y~APE~l~~ 184 (288)
T d2jfla1 162 RT--IQRRDSFIGTPYWMAPEVVMC 184 (288)
T ss_dssp HH--HHHHTCCCSCCTTCCHHHHTT
T ss_pred CC--cccccccccccccCCHHHHhh
Confidence 31 112234679999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-34 Score=293.91 Aligned_cols=169 Identities=28% Similarity=0.407 Sum_probs=145.6
Q ss_pred cccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEe----CCeEEEEE
Q 004020 593 SEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLD----GNERLLVY 667 (779)
Q Consensus 593 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 667 (779)
+..++||+|+||+||+|+.. +++.||+|++..........+.+.+|++++++++|||||++++++.+ ....|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56678999999999999875 68899999998776666677889999999999999999999999875 34579999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--cEEcCCCCCCEEEc-CCCcEEEEeeccce
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLG-DDMRAKVADFGLVR 744 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~ 744 (779)
||+++|+|.+++.+.. .+++..+..++.||++||+|||+ ++ |+||||||+|||++ +++.+||+|||+|+
T Consensus 92 E~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp ECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eCCCCCcHHHHHhccc-----cccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 9999999999996543 58899999999999999999996 55 99999999999996 57899999999997
Q ss_pred ecCCCCCcccccccccCCccccccccccc
Q 004020 745 LAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
..... .....+||+.|||||++.+.
T Consensus 164 ~~~~~----~~~~~~GT~~Y~aPE~~~~~ 188 (270)
T d1t4ha_ 164 LKRAS----FAKAVIGTPEFMAPEMYEEK 188 (270)
T ss_dssp GCCTT----SBEESCSSCCCCCGGGGGTC
T ss_pred eccCC----ccCCcccCccccCHHHhCCC
Confidence 64332 22456799999999998764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-35 Score=296.73 Aligned_cols=174 Identities=30% Similarity=0.482 Sum_probs=142.0
Q ss_pred cCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
++|++.+.||+|+||.||+|++.+++.||||+++.... ..+++.+|++++++++|||||++++++..++..++||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC---cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 47889999999999999999998899999999976432 336789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+++|+|.+++.... ..+++..++.|+.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+.....
T Consensus 82 ~~~g~L~~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp CTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred cCCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCC
Confidence 99999999886543 358899999999999999999996 89999999999999999999999999999876543
Q ss_pred CCcccccccccCCcccccccccccC
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
.. .......||+.|||||++.+..
T Consensus 155 ~~-~~~~~~~gt~~y~aPE~l~~~~ 178 (263)
T d1sm2a_ 155 QY-TSSTGTKFPVKWASPEVFSFSR 178 (263)
T ss_dssp -----------CTTSCCHHHHTTCC
T ss_pred Cc-eeecceecCcccCChHHhcCCC
Confidence 22 2223457999999999987654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-34 Score=302.29 Aligned_cols=170 Identities=28% Similarity=0.446 Sum_probs=148.2
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccC-hhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
+.|+..+.||+|+||.||+|+.. +++.||||++...... ....+++.+|++++++++|||||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35899999999999999999865 6889999999765433 344577999999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
|||++|++..++..+ ..+++..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+...
T Consensus 95 E~~~~g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp ECCSEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccC
Confidence 999999987665433 258999999999999999999997 899999999999999999999999999998654
Q ss_pred CCCCcccccccccCCccccccccccc
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. ....||+.|||||++.+.
T Consensus 167 ~~------~~~~GT~~Y~APE~~~~~ 186 (309)
T d1u5ra_ 167 PA------NSFVGTPYWMAPEVILAM 186 (309)
T ss_dssp SB------CCCCSCGGGCCHHHHTTT
T ss_pred CC------CccccCccccCHHHHhcc
Confidence 32 345799999999999754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-34 Score=302.05 Aligned_cols=176 Identities=29% Similarity=0.426 Sum_probs=153.6
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
.++|++.+.||+|+||.||+|+.. +++.||||++++... .....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 357999999999999999999874 799999999976532 233457789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
||||++|+|.+++.... .+++..++.++.||+.||+|||+ ++|+||||||+|||++++|++||+|||+|+..
T Consensus 84 ~ey~~gg~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred eeccCCCchhhhhhccc-----CCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeeccccccc
Confidence 99999999999986543 57899999999999999999997 89999999999999999999999999999876
Q ss_pred CCCCCcccccccccCCcccccccccccC
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
..... .....+||+.|||||++.+..
T Consensus 156 ~~~~~--~~~~~~GT~~Y~aPE~~~~~~ 181 (337)
T d1o6la_ 156 ISDGA--TMKTFCGTPEYLAPEVLEDND 181 (337)
T ss_dssp CCTTC--CBCCCEECGGGCCGGGGSSSC
T ss_pred ccCCc--ccccceeCHHHhhhhhccCCC
Confidence 44322 234568999999999998754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-34 Score=295.39 Aligned_cols=174 Identities=29% Similarity=0.486 Sum_probs=149.6
Q ss_pred hcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
.++|++.+.||+|+||.||+|++++++.||||+++.... ..+++.+|++++++++|||||++++++.+ +..++|||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC---CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 457889999999999999999998889999999975432 34679999999999999999999998754 56799999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++|+|.+++..... ..+++..++.|+.||++||+|||+ ++|+||||||+|||+++++.+||+|||+|+....
T Consensus 88 y~~~g~L~~~~~~~~~---~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp CCTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred eCCCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccC
Confidence 9999999998755443 248999999999999999999996 8999999999999999999999999999998765
Q ss_pred CCCcccccccccCCccccccccccc
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.. ........||+.|||||++.+.
T Consensus 162 ~~-~~~~~~~~gt~~y~APE~~~~~ 185 (272)
T d1qpca_ 162 NE-YTAREGAKFPIKWTAPEAINYG 185 (272)
T ss_dssp SC-EECCTTCCCCTTTSCHHHHHHC
T ss_pred Cc-cccccccCCcccccChHHHhCC
Confidence 32 2333456799999999998754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-34 Score=299.31 Aligned_cols=176 Identities=31% Similarity=0.483 Sum_probs=152.0
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.++|++.+.||+|+||.||+|++. +++.||||+++... ...+++.+|++++++++|||||++++++.+++..++||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 457888999999999999999876 58899999987543 23467999999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++|+|.+++..... ..+++..+..|+.||++||+|||+ ++|+||||||+|||+++++.+||+|||+|+...
T Consensus 93 E~~~~g~l~~~l~~~~~---~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp ECCTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred ecccCcchHHHhhhccc---cchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecC
Confidence 99999999999865432 368999999999999999999996 899999999999999999999999999998765
Q ss_pred CCCCcccccccccCCcccccccccccC
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
... ........||+.|||||++.+..
T Consensus 167 ~~~-~~~~~~~~g~~~y~aPE~~~~~~ 192 (287)
T d1opja_ 167 GDT-YTAHAGAKFPIKWTAPESLAYNK 192 (287)
T ss_dssp SSS-SEEETTEEECGGGCCHHHHHHCC
T ss_pred CCC-ceeeccccccccccChHHHcCCC
Confidence 432 22334456899999999987653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.2e-34 Score=300.55 Aligned_cols=174 Identities=26% Similarity=0.423 Sum_probs=151.8
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 468999999999999999999875 78999999997553 344577899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEc--CCCcEEEEeecccee
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRL 745 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~--~~~~~kl~DFG~a~~ 745 (779)
|||++|+|.+++.... ..+++..+..|+.||+.||+|||+ ++||||||||+|||++ .++.+||+|||+|+.
T Consensus 103 E~~~gg~L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 103 EFMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp CCCCSCBHHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EcCCCCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence 9999999999885432 258999999999999999999997 8999999999999996 468899999999988
Q ss_pred cCCCCCcccccccccCCcccccccccccC
Q 004020 746 APDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 746 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
..... ......||+.|||||++.+..
T Consensus 176 ~~~~~---~~~~~~gT~~Y~aPEv~~~~~ 201 (350)
T d1koaa2 176 LDPKQ---SVKVTTGTAEFAAPEVAEGKP 201 (350)
T ss_dssp CCTTS---CEEEECSCTTTCCHHHHHTCC
T ss_pred ccccc---ccceecCcccccCHHHHcCCC
Confidence 75432 224457999999999997653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-34 Score=298.92 Aligned_cols=175 Identities=27% Similarity=0.463 Sum_probs=135.5
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
+.+.|++.+.||+|+||.||+|+.. +++.||||++...... ...+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 5578999999999999999999875 6899999999765432 2345688999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEc---CCCcEEEEeeccc
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG---DDMRAKVADFGLV 743 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a 743 (779)
||||++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+||++. +++.+||+|||+|
T Consensus 86 mE~~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp ECCCCSCBHHHHHHTC-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred EeccCCCcHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEecccee
Confidence 9999999999999643 258999999999999999999996 8999999999999994 5789999999999
Q ss_pred eecCCCCCcccccccccCCcccccccccccC
Q 004020 744 RLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
+...... .....+||+.|||||++.+..
T Consensus 158 ~~~~~~~---~~~~~~GT~~y~APE~~~~~~ 185 (307)
T d1a06a_ 158 KMEDPGS---VLSTACGTPGYVAPEVLAQKP 185 (307)
T ss_dssp ------------------CTTSCHHHHTTCC
T ss_pred EEccCCC---eeeeeeeCccccCcHHHcCCC
Confidence 8765432 223467999999999998753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7e-34 Score=297.16 Aligned_cols=172 Identities=30% Similarity=0.468 Sum_probs=150.9
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
++|++.+.||+|+||+||+|+.+ +|+.||||+++.... .....+.+.+|+.++++++|||||++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999875 699999999975532 2234577899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+++|++.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.+|.+||+|||+|+...
T Consensus 84 E~~~gg~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp CCCCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eecCCccccccccccc-----cccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEec
Confidence 9999999998886543 47888899999999999999996 899999999999999999999999999998865
Q ss_pred CCCCcccccccccCCcccccccccccC
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
.. ....+||+.|||||++.+..
T Consensus 156 ~~-----~~~~~Gt~~Y~APE~l~~~~ 177 (316)
T d1fota_ 156 DV-----TYTLCGTPDYIAPEVVSTKP 177 (316)
T ss_dssp SC-----BCCCCSCTTTCCHHHHTTCC
T ss_pred cc-----cccccCcccccCHHHHcCCC
Confidence 43 23467999999999997653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-33 Score=285.55 Aligned_cols=174 Identities=28% Similarity=0.443 Sum_probs=152.5
Q ss_pred cCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
++|++.+.||+|+||.||+|++++++.||||+++.... ..+++.+|++++++++||||+++++++.+++..++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC---CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 57899999999999999999999899999999976543 335789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+++|++.+++..... .+++..+++++.||++||+|||+ ++|+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~~~g~l~~~~~~~~~----~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 81 MANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp CTTEEHHHHHHSGGG----CCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred cCCCcHHHhhhcccc----CCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 999999998765543 57899999999999999999996 89999999999999999999999999999876554
Q ss_pred CCcccccccccCCcccccccccccC
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
.. .......||+.|+|||++.+..
T Consensus 154 ~~-~~~~~~~~t~~y~aPE~~~~~~ 177 (258)
T d1k2pa_ 154 EY-TSSVGSKFPVRWSPPEVLMYSK 177 (258)
T ss_dssp SC-CCCCCSCCCGGGCCHHHHHHCC
T ss_pred Cc-eeecccCCCCCcCCcHHhcCCC
Confidence 22 2334467999999999987654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.1e-33 Score=297.65 Aligned_cols=175 Identities=23% Similarity=0.359 Sum_probs=151.6
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
+.++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3468999999999999999999874 79999999987653 33456788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEc--CCCcEEEEeeccce
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVR 744 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~--~~~~~kl~DFG~a~ 744 (779)
||||++|+|.+++.... ..+++.+++.|+.||+.||+|||+ ++|+||||||+|||++ .++.+||+|||+|+
T Consensus 105 mE~~~gg~L~~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~ 177 (352)
T d1koba_ 105 LEFLSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLAT 177 (352)
T ss_dssp EECCCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred EEcCCCChHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccce
Confidence 99999999988774432 258999999999999999999996 8999999999999998 67899999999999
Q ss_pred ecCCCCCcccccccccCCcccccccccccC
Q 004020 745 LAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
...... ......||+.|||||++.+..
T Consensus 178 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~ 204 (352)
T d1koba_ 178 KLNPDE---IVKVTTATAEFAAPEIVDREP 204 (352)
T ss_dssp ECCTTS---CEEEECSSGGGCCHHHHTTCC
T ss_pred ecCCCC---ceeeccCcccccCHHHHcCCC
Confidence 876532 223457999999999997653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-33 Score=290.11 Aligned_cols=176 Identities=26% Similarity=0.388 Sum_probs=152.4
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccCh----hHHHHHHHHHHHHHcCCCCccceEeeEEEeCCe
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE----KGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 662 (779)
+.++|++.+.||+|+||.||+|+.. +|+.||||++++..... ...+.+.+|++++++++|||||++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 4578999999999999999999874 78999999997544322 235789999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC----cEEEE
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM----RAKVA 738 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~----~~kl~ 738 (779)
.|+|||||++|+|.+++.... .+++..++.++.||+.||+|||+ ++|+||||||+||+++.++ .+||+
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~-----~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~ 159 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKII 159 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEEcCCCccccchhcccc-----ccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEec
Confidence 999999999999999986543 58999999999999999999997 8999999999999998776 59999
Q ss_pred eeccceecCCCCCcccccccccCCcccccccccccC
Q 004020 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 739 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
|||+|+....... .....||+.|||||++.+..
T Consensus 160 DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~ 192 (293)
T d1jksa_ 160 DFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEP 192 (293)
T ss_dssp CCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCC
T ss_pred chhhhhhcCCCcc---ccccCCCCcccCHHHHcCCC
Confidence 9999988754322 23457999999999997653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.6e-34 Score=294.54 Aligned_cols=176 Identities=27% Similarity=0.457 Sum_probs=138.0
Q ss_pred cCCcccceecccccEEEEEEEEcC-C---cEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHD-G---TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
++|++.+.||+|+||+||+|+++. + ..||||++.... .....++|.+|++++++++|||||++++++.+++..++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 568888999999999999998752 3 358899886543 34556789999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
|||||++|+|.+++.... ..+++.++..|+.||++||+|||+ ++|+||||||+|||++.++++||+|||+|+.
T Consensus 105 v~Ey~~~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp EEECCTTEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEecCCCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceE
Confidence 999999999999885433 258999999999999999999997 8999999999999999999999999999987
Q ss_pred cCCCCCccc---ccccccCCccccccccccc
Q 004020 746 APDNGKHSI---ETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 746 ~~~~~~~~~---~~~~~gt~~y~APE~l~~~ 773 (779)
......... .....||+.|||||++.+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 208 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 208 (299)
T ss_dssp ------------------CGGGSCHHHHHSC
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhcC
Confidence 654322211 1234579999999998754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-33 Score=296.88 Aligned_cols=182 Identities=29% Similarity=0.459 Sum_probs=149.2
Q ss_pred hcCCcccceecccccEEEEEEEEcC------CcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCC
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHD------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGN 661 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 661 (779)
.++|++.+.||+|+||+||+|+... ...||+|++.... .......+.+|+.++.++ +|||||++++++.+.+
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 3679999999999999999998653 2368999886543 233446789999999998 8999999999999999
Q ss_pred eEEEEEEecCCCChhhHhhhcccC------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCC
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEE------------------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLK 723 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlk 723 (779)
..++|||||++|+|.++++.++.. ....+++..++.|+.||++||+|||+ ++|||||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCc
Confidence 999999999999999999765421 12358899999999999999999997 899999999
Q ss_pred CCCEEEcCCCcEEEEeeccceecCCCCCcccccccccCCcccccccccccC
Q 004020 724 PSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 724 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
|+||+++.++++||+|||+|+...............||+.|||||++.+..
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 242 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI 242 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC
Confidence 999999999999999999998776554433444567899999999987543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-33 Score=288.72 Aligned_cols=177 Identities=27% Similarity=0.483 Sum_probs=142.1
Q ss_pred cCCcccceecccccEEEEEEEEcCC-----cEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHDG-----TKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 664 (779)
+.|+..++||+|+||.||+|.++.. ..||||++.... ......+|.+|++++++++|||||++++++.+.+..+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 4688889999999999999987532 479999987543 3445567999999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
+||||+.++++.+++.... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+
T Consensus 86 ~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp EEEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEecccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhh
Confidence 9999999999998875443 358999999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCc-ccccccccCCcccccccccccC
Q 004020 745 LAPDNGKH-SIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 745 ~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~ 774 (779)
........ .......||+.|||||++.+..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~ 189 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRK 189 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCC
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCC
Confidence 76543221 2233456899999999987653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-33 Score=287.46 Aligned_cols=169 Identities=27% Similarity=0.403 Sum_probs=139.3
Q ss_pred ceecccccEEEEEEEEc---CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEecCC
Q 004020 596 NVLGRGGFGTVYKGELH---DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEYMPQ 672 (779)
Q Consensus 596 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 672 (779)
++||+|+||.||+|.++ +++.||||+++....+....+++.+|++++++++|||||++++++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999764 35689999997655445556789999999999999999999999865 467899999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCc
Q 004020 673 GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKH 752 (779)
Q Consensus 673 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 752 (779)
|+|.+++.... .+++..++.|+.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+........
T Consensus 92 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 92 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 99999986543 58999999999999999999997 89999999999999999999999999999977554322
Q ss_pred c-cccccccCCccccccccccc
Q 004020 753 S-IETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 753 ~-~~~~~~gt~~y~APE~l~~~ 773 (779)
. ......||+.|||||++.+.
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~ 185 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYY 185 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHC
T ss_pred cccccccCCCceecCchhhcCC
Confidence 2 22345799999999998654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-33 Score=286.74 Aligned_cols=175 Identities=25% Similarity=0.445 Sum_probs=146.4
Q ss_pred cCCcccce-ecccccEEEEEEEEc---CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEE
Q 004020 590 NNFSEENV-LGRGGFGTVYKGELH---DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 590 ~~~~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 665 (779)
++|.+.+. ||+|+||.||+|.++ ++..||||+++... .....++|.+|++++++++|||||++++++.+ +..|+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 45666674 999999999999764 35679999997543 44566789999999999999999999999865 56899
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
||||+++|+|.+++...+ ..+++..+..++.||++||+|||+ ++|+||||||+||+++.++.+||+|||+|+.
T Consensus 86 vmE~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEeCCCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhc
Confidence 999999999999875433 258999999999999999999997 8999999999999999999999999999998
Q ss_pred cCCCCCc-ccccccccCCccccccccccc
Q 004020 746 APDNGKH-SIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 746 ~~~~~~~-~~~~~~~gt~~y~APE~l~~~ 773 (779)
....... .......||+.|||||++.+.
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 187 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFR 187 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHC
T ss_pred ccccccccccccccccCccccChHHHhCC
Confidence 7654322 222345689999999998654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-33 Score=295.95 Aligned_cols=172 Identities=28% Similarity=0.373 Sum_probs=151.9
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVY 667 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 667 (779)
++|++.+.||+|+||.||+|+.+ +|+.||||++..... .....+.+.+|+++++.++|||||++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999875 799999999875432 2234567899999999999999999999999999999999
Q ss_pred EecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecC
Q 004020 668 EYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 747 (779)
Q Consensus 668 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 747 (779)
||+.+|+|.+++.... .+++..+..++.||+.||.|||+ ++||||||||+|||++.++++||+|||+|+...
T Consensus 121 e~~~~g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred ccccccchhhhHhhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence 9999999999986543 58999999999999999999996 899999999999999999999999999999875
Q ss_pred CCCCcccccccccCCcccccccccccC
Q 004020 748 DNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 748 ~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
.. .....||+.|||||++.+..
T Consensus 193 ~~-----~~~~~Gt~~Y~APE~~~~~~ 214 (350)
T d1rdqe_ 193 GR-----TWTLCGTPEALAPEIILSKG 214 (350)
T ss_dssp SC-----BCCCEECGGGCCHHHHTTCC
T ss_pred cc-----cccccCccccCCHHHHcCCC
Confidence 42 23457999999999998754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.9e-33 Score=283.09 Aligned_cols=174 Identities=28% Similarity=0.356 Sum_probs=151.7
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccC-------hhHHHHHHHHHHHHHcCC-CCccceEeeEEEe
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVS-------EKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLD 659 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 659 (779)
.++|++.+.||+|+||+||+|+.. +++.||||++...... +...+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 478999999999999999999874 7899999998754322 122356889999999997 9999999999999
Q ss_pred CCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEe
Q 004020 660 GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 739 (779)
Q Consensus 660 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 739 (779)
++..|+||||+++|+|.+++..+. .+++.++..++.||++||+|||+ ++|+||||||+||+++.++.+||+|
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~D 153 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTD 153 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEcc
Confidence 999999999999999999996543 58999999999999999999996 8999999999999999999999999
Q ss_pred eccceecCCCCCcccccccccCCccccccccccc
Q 004020 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 740 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
||+++...... .....+||+.|+|||++.+.
T Consensus 154 FG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~ 184 (277)
T d1phka_ 154 FGFSCQLDPGE---KLREVCGTPSYLAPEIIECS 184 (277)
T ss_dssp CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHH
T ss_pred chheeEccCCC---ceeeeeccCCCCCHHHhhcc
Confidence 99999875532 22446799999999998753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.6e-33 Score=296.03 Aligned_cols=177 Identities=25% Similarity=0.389 Sum_probs=148.8
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChh-HHH---HHHHHHHHHHcCCCCccceEeeEEEeCCeE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEK-GFA---EFKSEIAVLTKVRHRHLVGLLGYCLDGNER 663 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 663 (779)
.++|++.+.||+|+||.||+|+.. +|+.||||++.+...... ... +..+|+++++.++|||||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 368999999999999999999875 699999999865432211 122 334457778888999999999999999999
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccc
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 743 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 743 (779)
|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++||||||||+|||++.+|.+||+|||+|
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla 154 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLA 154 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTC
T ss_pred EEEEEecCCCcHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeecee
Confidence 99999999999999986543 57889999999999999999996 89999999999999999999999999999
Q ss_pred eecCCCCCcccccccccCCcccccccccccCCCC
Q 004020 744 RLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 744 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
+...... ....+||+.|||||++.+...++
T Consensus 155 ~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~ 184 (364)
T d1omwa3 155 CDFSKKK----PHASVGTHGYMAPEVLQKGVAYD 184 (364)
T ss_dssp EECSSSC----CCSCCSCGGGCCHHHHSTTCCCC
T ss_pred eecCCCc----ccccccccccchhHHhhcCCCCC
Confidence 8775432 23457999999999997655554
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=2.8e-33 Score=287.83 Aligned_cols=174 Identities=32% Similarity=0.518 Sum_probs=143.4
Q ss_pred cCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
++|++.+.||+|+||.||+|++++++.||||+++.... ..++|.+|+.++++++|||||++++++. .+..++||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey 92 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 92 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC---CHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEe
Confidence 57999999999999999999999888999999975542 3367999999999999999999999985 4568999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+++|++.+++..... ..+++.+++.|+.||+.||+|||+ ++|+||||||+|||+++++++||+|||+|+.....
T Consensus 93 ~~~g~l~~~~~~~~~---~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 93 MSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp CTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred cCCCchhhhhhhccc---ccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 999999988866443 258999999999999999999996 89999999999999999999999999999876543
Q ss_pred CCcccccccccCCcccccccccccC
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
.. .......||+.|+|||++.+..
T Consensus 167 ~~-~~~~~~~gt~~y~aPE~~~~~~ 190 (285)
T d1fmka3 167 EY-TARQGAKFPIKWTAPEAALYGR 190 (285)
T ss_dssp ----------CCGGGSCHHHHHHCC
T ss_pred Cc-eeeccccccccccChHHHhCCC
Confidence 22 2234457999999999987543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=7.9e-33 Score=288.24 Aligned_cols=189 Identities=32% Similarity=0.483 Sum_probs=156.5
Q ss_pred HHHHHHhhcCCcccceecccccEEEEEEEEc------CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEee
Q 004020 582 IQVLRNVTNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLG 655 (779)
Q Consensus 582 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 655 (779)
+.+++...++|++.+.||+|+||.||+|+.+ +++.||||+++... .....+++.+|++++++++||||+++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~ 83 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLG 83 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCccccee
Confidence 3445556788999999999999999999864 35789999987543 3455678999999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCChhhHhhhccc-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 004020 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKE-------------------EGLKPLEWTRRLTIALDVARGVEYLHGLAHQS 716 (779)
Q Consensus 656 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ 716 (779)
++...+..++||||+++|+|.+++..... .....+++..++.|+.|++.||+|||+ ++
T Consensus 84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ 160 (301)
T d1lufa_ 84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RK 160 (301)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CC
Confidence 99999999999999999999999865321 112347899999999999999999996 89
Q ss_pred cEEcCCCCCCEEEcCCCcEEEEeeccceecCCCCCcccccccccCCcccccccccccC
Q 004020 717 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 717 ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
||||||||+|||+|.++++||+|||+|+...............||+.|+|||++.+..
T Consensus 161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 218 (301)
T d1lufa_ 161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR 218 (301)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC
T ss_pred eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC
Confidence 9999999999999999999999999998765543333344567899999999987653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.5e-32 Score=285.86 Aligned_cols=175 Identities=27% Similarity=0.443 Sum_probs=149.5
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEeccccc-ChhHHHHHHHHHHHHH-cCCCCccceEeeEEEeCCeEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVV-SEKGFAEFKSEIAVLT-KVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv 666 (779)
++|++.+.||+|+||+||+|+.. +++.||||++++... .....+.+.+|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999875 789999999975432 2334456777777765 68999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
|||+++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||+++++++||+|||+|+..
T Consensus 82 mEy~~~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EeecCCCcHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhc
Confidence 99999999999996543 47899999999999999999997 89999999999999999999999999999865
Q ss_pred CCCCCcccccccccCCcccccccccccC
Q 004020 747 PDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 747 ~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
.... .......||+.|+|||++.+..
T Consensus 154 ~~~~--~~~~~~~gt~~y~aPE~~~~~~ 179 (320)
T d1xjda_ 154 MLGD--AKTNTFCGTPDYIAPEILLGQK 179 (320)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHTTCC
T ss_pred cccc--ccccccCCCCCcCCHHHHcCCC
Confidence 4432 2234467999999999998754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.3e-32 Score=286.20 Aligned_cols=179 Identities=27% Similarity=0.407 Sum_probs=147.9
Q ss_pred cCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
++|++.+.||+|+||.||+|+. .+++.||||+++.....+...+++.+|++++++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999987 478999999997655444445789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+.++ +.+++.... ...+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~~~~-~~~~~~~~~---~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASA---LTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154 (298)
T ss_dssp CCSEE-HHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ecCCc-hhhhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccC
Confidence 99764 444443322 2358999999999999999999996 8999999999999999999999999999987654
Q ss_pred CCCcccccccccCCcccccccccccCCCC
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
.. .......||+.|+|||++.....++
T Consensus 155 ~~--~~~~~~~gt~~y~apE~~~~~~~~~ 181 (298)
T d1gz8a_ 155 PV--RTYTHEVVTLWYRAPEILLGCKYYS 181 (298)
T ss_dssp CS--BCTTCCBCCCTTCCHHHHTTCSSCC
T ss_pred Cc--ccceeecccceeeehhhhccccCCC
Confidence 32 2234457999999999987776554
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.97 E-value=3.3e-32 Score=280.23 Aligned_cols=178 Identities=25% Similarity=0.414 Sum_probs=144.0
Q ss_pred hhcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccC-hhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC----
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN---- 661 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 661 (779)
+.++|++.+.||+|+||.||+|+. .+++.||||+++..... ....+++.+|++++++++||||+++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 357899999999999999999986 47999999999765433 345567999999999999999999999998654
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeec
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 741 (779)
..|+||||+++++|.+++.... .+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.++++|||
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~ 156 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFG 156 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCT
T ss_pred eEEEEEECCCCCEehhhhcccC-----CCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhh
Confidence 3789999999999998886543 58999999999999999999996 899999999999999999999999999
Q ss_pred cceecCCCCC-cccccccccCCccccccccccc
Q 004020 742 LVRLAPDNGK-HSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 742 ~a~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.++....... .......+||+.|||||++.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~ 189 (277)
T d1o6ya_ 157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 189 (277)
T ss_dssp TCEECC----------------TTCCHHHHTTC
T ss_pred hhhhhccccccccccccccCcccccCHHHHcCC
Confidence 9876543221 2223456799999999998765
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.1e-32 Score=287.25 Aligned_cols=174 Identities=29% Similarity=0.353 Sum_probs=142.0
Q ss_pred ccceecccccEEEEEEEEc-CCcEEEEEEecccccChh---HHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 594 EENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEK---GFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 594 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
..++||+|+||+||+|+.. +|+.||||+++....... ..+.+.+|+.++++++|||||++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4578999999999999875 689999999975432221 234688999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
++++++..+.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~ 153 (299)
T d1ua2a_ 82 METDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153 (299)
T ss_dssp CSEEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred hcchHHhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCC
Confidence 9988776554322 357888999999999999999996 89999999999999999999999999999876543
Q ss_pred CCcccccccccCCcccccccccccCCCC
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
.. .....+||+.|||||++.+...++
T Consensus 154 ~~--~~~~~~gt~~y~aPE~~~~~~~~~ 179 (299)
T d1ua2a_ 154 NR--AYTHQVVTRWYRAPELLFGARMYG 179 (299)
T ss_dssp CC--CCCCSCCCCTTCCHHHHTTCSCCC
T ss_pred cc--cccceecChhhccHHHHccCCCCC
Confidence 22 223457999999999998766554
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.7e-32 Score=284.10 Aligned_cols=174 Identities=21% Similarity=0.289 Sum_probs=149.8
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEE
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 666 (779)
+.++|++.+.||+|+||+||+|... +++.||||+++... .....+.+|++++++++|||||++++++.+++..|+|
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 5678999999999999999999875 68899999997643 3345688999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC--CCcEEEEeeccce
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD--DMRAKVADFGLVR 744 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~--~~~~kl~DFG~a~ 744 (779)
||||++|+|.+++.... ..+++.++..|+.||+.||+|||+ ++|+||||||+|||++. ...+||+|||+++
T Consensus 80 mE~~~gg~L~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~ 152 (321)
T d1tkia_ 80 FEFISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp ECCCCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhh
Confidence 99999999999985432 258999999999999999999996 89999999999999985 4589999999998
Q ss_pred ecCCCCCcccccccccCCcccccccccccC
Q 004020 745 LAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
...... ......||+.|+|||.+.+..
T Consensus 153 ~~~~~~---~~~~~~~t~~y~ape~~~~~~ 179 (321)
T d1tkia_ 153 QLKPGD---NFRLLFTAPEYYAPEVHQHDV 179 (321)
T ss_dssp ECCTTC---EEEEEESCGGGSCHHHHTTCE
T ss_pred ccccCC---cccccccccccccchhccCCC
Confidence 765432 223457899999999886543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.7e-32 Score=285.13 Aligned_cols=176 Identities=31% Similarity=0.483 Sum_probs=141.8
Q ss_pred cCCcccceecccccEEEEEEEEc-CCc----EEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGT----KIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 664 (779)
.+|++.+.||+|+||.||+|++. +|+ +||+|+++... .....+++.+|++++++++|||||++++++.++ ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 46999999999999999999765 343 68888886543 334567899999999999999999999999865 567
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
++|||+.+|+|.+++.... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+|+
T Consensus 87 ~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp EEEECCTTCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred EEEEeccCCcccccccccc----cCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccce
Confidence 8899999999998876543 368999999999999999999997 799999999999999999999999999999
Q ss_pred ecCCCCCcccccccccCCcccccccccccC
Q 004020 745 LAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
...............||+.|||||++.+..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 189 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRI 189 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCC
T ss_pred ecccccccccccccccCccccChHHHhcCC
Confidence 776544433344557999999999987653
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.97 E-value=3.8e-32 Score=281.35 Aligned_cols=179 Identities=26% Similarity=0.358 Sum_probs=151.0
Q ss_pred cCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEEe
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYEY 669 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 669 (779)
++|++.++||+|+||.||+|+.++|+.||||++......+...+++.+|+.++++++||||+++++++.+.+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 68999999999999999999999999999999976654444567899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
+.++.+..+.... ..+++..+..++.||+.||+|||+ .+||||||||+|||++.++.+|++|||.|......
T Consensus 82 ~~~~~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9877666554322 358999999999999999999996 89999999999999999999999999999876543
Q ss_pred CCcccccccccCCcccccccccccCCCCC
Q 004020 750 GKHSIETRLAGTFGYLAPEYAAETSGMTW 778 (779)
Q Consensus 750 ~~~~~~~~~~gt~~y~APE~l~~~~~~t~ 778 (779)
.. ......|++.|+|||.+.+...++.
T Consensus 154 ~~--~~~~~~~~~~y~~pE~~~~~~~~~~ 180 (286)
T d1ob3a_ 154 VR--KYTHEIVTLWYRAPDVLMGSKKYST 180 (286)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCT
T ss_pred cc--ccceecccchhhhHHHHhCCCCCCc
Confidence 22 2234468999999999987766553
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.3e-32 Score=279.15 Aligned_cols=176 Identities=27% Similarity=0.364 Sum_probs=147.5
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccCh----hHHHHHHHHHHHHHcCC--CCccceEeeEEEeCC
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSE----KGFAEFKSEIAVLTKVR--HRHLVGLLGYCLDGN 661 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~ 661 (779)
.++|++.+.||+|+||.||+|+.. +++.||||++....... ....++.+|+.++++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 468999999999999999999875 78999999997543322 12234678999999996 899999999999999
Q ss_pred eEEEEEEecCC-CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC-CCcEEEEe
Q 004020 662 ERLLVYEYMPQ-GTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVAD 739 (779)
Q Consensus 662 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kl~D 739 (779)
..++||||+.+ +++.+++.... .+++..+..++.||++||+|||+ ++|+||||||+|||++. ++.+||+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~-----~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECC
T ss_pred eEEEEEEeccCcchHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECc
Confidence 99999999976 57777775432 58999999999999999999996 89999999999999985 47999999
Q ss_pred eccceecCCCCCcccccccccCCcccccccccccCCC
Q 004020 740 FGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSGM 776 (779)
Q Consensus 740 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 776 (779)
||+|+..... ..+...||+.|||||++.+...+
T Consensus 155 FG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~ 187 (273)
T d1xwsa_ 155 FGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYH 187 (273)
T ss_dssp CTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBC
T ss_pred cccceecccc----cccccccCCCcCCHHHHcCCCCC
Confidence 9999876432 22456799999999999876544
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.6e-31 Score=281.62 Aligned_cols=171 Identities=23% Similarity=0.344 Sum_probs=142.9
Q ss_pred hhcCCcccc-eecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEe----C
Q 004020 588 VTNNFSEEN-VLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLD----G 660 (779)
Q Consensus 588 ~~~~~~~~~-~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~ 660 (779)
+.++|.+.+ .||+|+||.||+|+. .+++.||||+++.. ..+.+|++++.++ +|||||+++++|.+ .
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 356898765 699999999999986 47899999998642 3567899987655 79999999999876 3
Q ss_pred CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC---CCcEEE
Q 004020 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKV 737 (779)
Q Consensus 661 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~~~kl 737 (779)
...|+|||||++|+|.+++..+. ...+++.++..|+.||+.||+|||+ ++|+||||||+|||+++ .+.+||
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl 155 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKL 155 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEE
T ss_pred CEEEEEEECCCCCcHHHHHHhcC---CCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccc
Confidence 56899999999999999996542 2368999999999999999999996 89999999999999985 567999
Q ss_pred EeeccceecCCCCCcccccccccCCcccccccccccC
Q 004020 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 738 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
+|||+|+....... ....+||+.|||||++.+..
T Consensus 156 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~ 189 (335)
T d2ozaa1 156 TDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEK 189 (335)
T ss_dssp CCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGG
T ss_pred cccceeeeccCCCc---cccccCCcccCCcHHHcCCC
Confidence 99999987755322 24457999999999987653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.8e-32 Score=280.76 Aligned_cols=183 Identities=27% Similarity=0.431 Sum_probs=142.5
Q ss_pred hhcCCcccceecccccEEEEEEEEc------CCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeC
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDG 660 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 660 (779)
..++|++.+.||+|+||.||+|+.. +++.||||+++... .....+.+.+|...+.++ +|+||+.+++++...
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 3468999999999999999999764 34689999987543 344556788888888877 689999999988765
Q ss_pred -CeEEEEEEecCCCChhhHhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEE
Q 004020 661 -NERLLVYEYMPQGTLSRHLFNRKEE-----------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 728 (779)
Q Consensus 661 -~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIl 728 (779)
+..++|||||++|+|.++++..... ....+++.++..++.||++||+|||+ ++||||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCcccee
Confidence 4689999999999999999765431 12358899999999999999999997 89999999999999
Q ss_pred EcCCCcEEEEeeccceecCCCCCcccccccccCCcccccccccccC
Q 004020 729 LGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 729 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
+++++++||+|||+|+...............||+.|||||++.+..
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 212 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 212 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCC
Confidence 9999999999999998765544433445567999999999987643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.5e-31 Score=278.26 Aligned_cols=175 Identities=27% Similarity=0.388 Sum_probs=140.8
Q ss_pred hcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC----eEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN----ERL 664 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~ 664 (779)
..+|...+.||+|+||.||+|+. +|+.||||++.... ......+.|+..+.+++||||+++++++.+.+ ..|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 35788899999999999999986 58999999986432 11122334555556789999999999998654 578
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCCcEEcCCCCCCEEEcCCCcEEEEe
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGL-----AHQSFIHRDLKPSNILLGDDMRAKVAD 739 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-----~~~~ivHrDlkp~NIll~~~~~~kl~D 739 (779)
+||||+++|+|.+++++. .+++..+++++.|++.||+|+|+. ..++||||||||+||||++++++||+|
T Consensus 78 lv~Ey~~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D 151 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEecccCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence 999999999999999643 478999999999999999999963 136999999999999999999999999
Q ss_pred eccceecCCCCCcc--cccccccCCccccccccccc
Q 004020 740 FGLVRLAPDNGKHS--IETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 740 FG~a~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~ 773 (779)
||+++......... .....+||+.|||||++.+.
T Consensus 152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 187 (303)
T d1vjya_ 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 187 (303)
T ss_dssp CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTC
T ss_pred cCccccccCCCcceeccccceecccCcCChhhcccc
Confidence 99998775543221 22346799999999998764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.6e-32 Score=275.96 Aligned_cols=176 Identities=24% Similarity=0.393 Sum_probs=137.0
Q ss_pred hcCCcccceecccccEEEEEEEEcC----CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHD----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 664 (779)
.++|++.+.||+|+||.||+|++.. +..||||.++... .....+.+.+|++++++++||||+++++++. .+..|
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 3679999999999999999997642 4568999886543 3455678999999999999999999999985 46789
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
+||||+++|++.+++.... ..+++..++.++.||++||+|||+ ++|+||||||+||+++.++.+||+|||+|+
T Consensus 84 iv~E~~~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp EEEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEeccCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhhe
Confidence 9999999999998875443 258999999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCcccccccccCCcccccccccccC
Q 004020 745 LAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
...... ........||+.|+|||++.+..
T Consensus 157 ~~~~~~-~~~~~~~~gt~~y~apE~l~~~~ 185 (273)
T d1mp8a_ 157 YMEDST-YYKASKGKLPIKWMAPESINFRR 185 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCC
T ss_pred eccCCc-ceeccceecCcccchhhHhccCC
Confidence 765432 22234456899999999987543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2e-31 Score=278.74 Aligned_cols=182 Identities=29% Similarity=0.448 Sum_probs=155.1
Q ss_pred hcCCcccceecccccEEEEEEEEc------CCcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCC
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGN 661 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 661 (779)
.++|++.+.||+|+||.||+|++. +++.||||+++... ......++.+|+.+++++ +|||||++++++.+++
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 368889999999999999999752 46789999997654 344566799999999999 6999999999999999
Q ss_pred eEEEEEEecCCCChhhHhhhccc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEE
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKE-------------EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 728 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIl 728 (779)
..++|||||++|+|.++++.... .....+++..+..++.||++||+|||+ ++||||||||+||+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccccccc
Confidence 99999999999999999976542 122358899999999999999999997 89999999999999
Q ss_pred EcCCCcEEEEeeccceecCCCCCcccccccccCCcccccccccccC
Q 004020 729 LGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 729 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
++.++.+|++|||.++...............||+.|+|||++.+..
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 223 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV 223 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC
Confidence 9999999999999999876654444455678999999999987543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.5e-31 Score=279.15 Aligned_cols=182 Identities=27% Similarity=0.477 Sum_probs=154.8
Q ss_pred hcCCcccceecccccEEEEEEEEc------CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCe
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH------DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNE 662 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 662 (779)
.++|++.+.||+|+||.||+|.+. +++.||||+++... .......+.+|++++++++||||+++++++...+.
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 368889999999999999999763 35789999997543 44556779999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhHhhhccc-----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEE
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKE-----EGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 737 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl 737 (779)
.++||||+++|+|.+++..... .....+++..+.+++.|+++||.|||+ ++|+||||||+|||+++++++||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEE
Confidence 9999999999999999865431 122357899999999999999999997 79999999999999999999999
Q ss_pred EeeccceecCCCCCcccccccccCCcccccccccccC
Q 004020 738 ADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 738 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
+|||+|+...............||+.|+|||.+.+..
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~ 211 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV 211 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCC
Confidence 9999998775544434445557999999999987654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.3e-31 Score=271.99 Aligned_cols=169 Identities=35% Similarity=0.552 Sum_probs=138.6
Q ss_pred cCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC-CeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG-NERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e 668 (779)
++|++.+.||+|+||.||+|+++ |..||||+++... ..+++.+|++++++++||||+++++++.+. +..++|||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 56888999999999999999985 7899999996542 346789999999999999999999998654 56899999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
|+++|+|.+++..+.. ..+++..+++|+.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 82 y~~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred ccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCC
Confidence 9999999999976532 247999999999999999999997 8999999999999999999999999999987543
Q ss_pred CCCcccccccccCCcccccccccccC
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
. .....+|+.|+|||++.+..
T Consensus 156 ~-----~~~~~~~~~y~aPE~l~~~~ 176 (262)
T d1byga_ 156 T-----QDTGKLPVKWTAPEALREKK 176 (262)
T ss_dssp -----------CCTTTSCHHHHHHCC
T ss_pred C-----CccccccccCCChHHHhCCC
Confidence 2 22346889999999987653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.2e-31 Score=272.37 Aligned_cols=177 Identities=31% Similarity=0.511 Sum_probs=137.8
Q ss_pred cCCcccceecccccEEEEEEEEcC----CcEEEEEEecccccC-hhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELHD----GTKIAVKRMESAVVS-EKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERL 664 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 664 (779)
++|++.+.||+|+||.||+|+... ...||||+++..... +...++|.+|++++++++||||+++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 579999999999999999997642 247899998765432 3445789999999999999999999999975 4678
Q ss_pred EEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccce
Q 004020 665 LVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 744 (779)
Q Consensus 665 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 744 (779)
+||||+++|++.+++..+.. .+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 87 lv~e~~~~~~l~~~~~~~~~----~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGG----GSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeeeecCcchhhhhhcccC----CCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhh
Confidence 99999999999998865542 58999999999999999999997 899999999999999999999999999999
Q ss_pred ecCCCCCccc-ccccccCCcccccccccccC
Q 004020 745 LAPDNGKHSI-ETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 745 ~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~ 774 (779)
.......... .....|+..|+|||++.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 190 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCE
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCC
Confidence 8755433222 23446888999999987643
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.5e-31 Score=275.21 Aligned_cols=181 Identities=31% Similarity=0.471 Sum_probs=149.1
Q ss_pred hcCCcccceecccccEEEEEEEEcC--------CcEEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEe
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELHD--------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLD 659 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 659 (779)
.++|++.+.||+|+||.||+|+... +..||||+++... ......++.+|...+.++ +|||||++++++.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 4688999999999999999997532 3479999997654 445567889999999888 79999999999999
Q ss_pred CCeEEEEEEecCCCChhhHhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEE
Q 004020 660 GNERLLVYEYMPQGTLSRHLFNRKEE-----------GLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 728 (779)
Q Consensus 660 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIl 728 (779)
++..++||||+++|+|.+++..+... ....+++.+++.++.||+.||+|||+ ++||||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeeccccee
Confidence 99999999999999999999765422 13468999999999999999999997 89999999999999
Q ss_pred EcCCCcEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 729 LGDDMRAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 729 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
++.++.+||+|||+++...............||+.|+|||++.+.
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~ 212 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 212 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC
Confidence 999999999999999877654444444556799999999998764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.2e-31 Score=275.27 Aligned_cols=177 Identities=36% Similarity=0.548 Sum_probs=144.0
Q ss_pred cCCcccceecccccEEEEEEEEc-CCc--EEEEEEecccccChhHHHHHHHHHHHHHcC-CCCccceEeeEEEeCCeEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGT--KIAVKRMESAVVSEKGFAEFKSEIAVLTKV-RHRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 665 (779)
++|++.++||+|+||.||+|+++ ++. .||||++.... .....+++.+|+++++++ +|||||++++++.+.+..++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 67889999999999999999875 444 46788775433 234556799999999999 79999999999999999999
Q ss_pred EEEecCCCChhhHhhhcc-----------cCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCc
Q 004020 666 VYEYMPQGTLSRHLFNRK-----------EEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 734 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 734 (779)
||||+++|+|.++++... ......+++..+.+++.||++||.|+|+ ++|+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCc
Confidence 999999999999996542 1223468999999999999999999997 89999999999999999999
Q ss_pred EEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 735 AKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 735 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
+||+|||+|+...... ......||..|+|||.+.+.
T Consensus 166 ~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~ 201 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS 201 (309)
T ss_dssp EEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHC
T ss_pred eEEccccccccccccc---cccceecCCcccchHHhccC
Confidence 9999999998654321 12344689999999998654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.3e-31 Score=278.52 Aligned_cols=176 Identities=28% Similarity=0.419 Sum_probs=145.8
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC-----
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN----- 661 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 661 (779)
+.++|++.+.||+|+||.||+|+.. +|+.||||+++.....+...+.+.+|++++++++|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 4578999999999999999999865 6999999999876666666788999999999999999999999998664
Q ss_pred -eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEee
Q 004020 662 -ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (779)
Q Consensus 662 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF 740 (779)
..|+||||+ +.++..+.... .+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+|++||
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Df 165 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDF 165 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEEecc-cccHHHHHHhc------cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccc
Confidence 469999999 56777766432 48999999999999999999996 89999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccCCcccccccccccCCCCC
Q 004020 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMTW 778 (779)
Q Consensus 741 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t~ 778 (779)
|+|+..... .+...||+.|+|||++.+...++.
T Consensus 166 g~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~ 198 (346)
T d1cm8a_ 166 GLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQ 198 (346)
T ss_dssp TTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCT
T ss_pred cceeccCCc-----cccccccccccCHHHHcCCCCCCc
Confidence 999876442 244579999999999987655543
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=1.4e-30 Score=273.66 Aligned_cols=232 Identities=27% Similarity=0.451 Sum_probs=182.9
Q ss_pred ccCCCCccEEEccc-CCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccC
Q 004020 132 FKGLTSLQTISLDY-NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKS 210 (779)
Q Consensus 132 ~~~l~~L~~L~Ls~-N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~ 210 (779)
+.+|++|++|+|++ |++.+ .+|..|+++++|++|+|++|++++..+..+. .+..|+++++++|++.+.+|..++
T Consensus 72 l~~L~~L~~L~Ls~~N~l~g-~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~--~~~~L~~l~l~~N~~~~~~p~~l~-- 146 (313)
T d1ogqa_ 72 LANLPYLNFLYIGGINNLVG-PIPPAIAKLTQLHYLYITHTNVSGAIPDFLS--QIKTLVTLDFSYNALSGTLPPSIS-- 146 (313)
T ss_dssp GGGCTTCSEEEEEEETTEES-CCCGGGGGCTTCSEEEEEEECCEEECCGGGG--GCTTCCEEECCSSEEESCCCGGGG--
T ss_pred HhcCcccccccccccccccc-ccccccccccccchhhhcccccccccccccc--chhhhcccccccccccccCchhhc--
Confidence 44455555555543 45543 4566666666666666666666777776665 677888888888888877777665
Q ss_pred CcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCC-CCCCCCC-cEEEccCCccccccChhhhCCCCCCE
Q 004020 211 SIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSL-QDFSVRDNQLTGIVPSSLVNLHSLAV 288 (779)
Q Consensus 211 ~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L-~~L~l~~N~l~~~~p~~l~~l~~L~~ 288 (779)
.++.|+.+++++|.+++.+|+ +..+.++ +.+++++|++++..|..+.++..+ .
T Consensus 147 ------------------------~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~ 201 (313)
T d1ogqa_ 147 ------------------------SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-F 201 (313)
T ss_dssp ------------------------GCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-E
T ss_pred ------------------------cCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-c
Confidence 578888899999998887774 6676665 899999999999999999888654 7
Q ss_pred EEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCC
Q 004020 289 VNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDA 368 (779)
Q Consensus 289 L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (779)
+++++|.+.|.+|.....
T Consensus 202 l~l~~~~~~~~~~~~~~~-------------------------------------------------------------- 219 (313)
T d1ogqa_ 202 VDLSRNMLEGDASVLFGS-------------------------------------------------------------- 219 (313)
T ss_dssp EECCSSEEEECCGGGCCT--------------------------------------------------------------
T ss_pred cccccccccccccccccc--------------------------------------------------------------
Confidence 999999999888753221
Q ss_pred CCCeEEEEccCccccccccccccccccCCeEeccCccccccCCccCCCCCCCCceeccCCcccccCCCCCC---cceeee
Q 004020 369 GGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFRQ---NVIVKT 445 (779)
Q Consensus 369 ~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~~~---~~~~~~ 445 (779)
..+++.+++++|.+++.+| .++.+++|++|+|++|+|+|.+|..++.+++|++|||++|+|+|.||.+.. ...+.+
T Consensus 220 ~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l 298 (313)
T d1ogqa_ 220 DKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAY 298 (313)
T ss_dssp TSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGT
T ss_pred ccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHh
Confidence 2378899999999998776 689999999999999999999999999999999999999999999998643 335667
Q ss_pred CCCCCCCCCCC
Q 004020 446 DGNPDIGKDSS 456 (779)
Q Consensus 446 ~~n~~~~~~~~ 456 (779)
.+|+.+|+.|.
T Consensus 299 ~~N~~l~g~pl 309 (313)
T d1ogqa_ 299 ANNKCLCGSPL 309 (313)
T ss_dssp CSSSEEESTTS
T ss_pred CCCccccCCCC
Confidence 89999999764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.6e-30 Score=269.49 Aligned_cols=172 Identities=31% Similarity=0.504 Sum_probs=143.6
Q ss_pred cceecccccEEEEEEEEcC----CcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC-CeEEEEEEe
Q 004020 595 ENVLGRGGFGTVYKGELHD----GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG-NERLLVYEY 669 (779)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~ 669 (779)
.++||+|+||+||+|++.. ...||||+++... .....++|.+|++++++++||||+++++++... +..++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 4789999999999998753 2368999987432 455678899999999999999999999998764 588999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCCC
Q 004020 670 MPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDN 749 (779)
Q Consensus 670 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 749 (779)
|++|+|.+++.... ...++..+++++.|+++||.|+|+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 111 ~~~g~l~~~~~~~~----~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 111 MKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp CTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred eecCchhhhhcccc----ccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 99999999886543 246788899999999999999996 89999999999999999999999999999876543
Q ss_pred CCc--ccccccccCCcccccccccccC
Q 004020 750 GKH--SIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 750 ~~~--~~~~~~~gt~~y~APE~l~~~~ 774 (779)
... .......||+.|+|||++.+..
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~ 210 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQK 210 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCC
T ss_pred ccccceecccccccccccChHHHhcCC
Confidence 222 1223457899999999987543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.7e-30 Score=273.38 Aligned_cols=182 Identities=24% Similarity=0.336 Sum_probs=146.4
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC-------
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG------- 660 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------- 660 (779)
.++|++.+.||+|+||+||+|+.. +|+.||||++......+....++.+|++++++++||||+++++++...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 468999999999999999999874 799999999876655555567789999999999999999999988653
Q ss_pred -CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEe
Q 004020 661 -NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 739 (779)
Q Consensus 661 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 739 (779)
+..|+||||++++.+...... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~-----~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~d 160 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLAD 160 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT-----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECC
T ss_pred CceEEEEEeccCCCccchhhhc-----ccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeee
Confidence 457999999988766544322 2357889999999999999999996 8999999999999999999999999
Q ss_pred eccceecCCCCCc--ccccccccCCcccccccccccCCCCC
Q 004020 740 FGLVRLAPDNGKH--SIETRLAGTFGYLAPEYAAETSGMTW 778 (779)
Q Consensus 740 FG~a~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~t~ 778 (779)
||+++........ ......+||+.|+|||++.+..+++.
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~ 201 (318)
T d3blha1 161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGP 201 (318)
T ss_dssp CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCT
T ss_pred cceeeecccccccccccccceecCHHHhhHHHHcCCCCCCc
Confidence 9999876543221 12233579999999999988766654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.6e-30 Score=273.40 Aligned_cols=180 Identities=26% Similarity=0.421 Sum_probs=145.7
Q ss_pred hhcCCcccceecccccEEEEEEEE-cCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCC----e
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGEL-HDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGN----E 662 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~ 662 (779)
+.++|++.+.||+|+||+||+|+. .+|+.||||++.... .....+++.+|++++++++||||+++++++.... .
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 346799999999999999999976 479999999997543 3445678899999999999999999999997653 2
Q ss_pred EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecc
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 742 (779)
.+++++|+.+|+|.+++..+ .+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+
T Consensus 85 ~~~l~~~~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~ 155 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGL 155 (345)
T ss_dssp CEEEEEECCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEeecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCc
Confidence 35555667799999998543 48999999999999999999996 8999999999999999999999999999
Q ss_pred ceecCCCCCc-ccccccccCCcccccccccccCCCC
Q 004020 743 VRLAPDNGKH-SIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 743 a~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
|+........ ......+||+.|+|||++.....++
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ 191 (345)
T d1pmea_ 156 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 191 (345)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCS
T ss_pred eeeccCCCccceeeccccccceechHHHhhcCCCCC
Confidence 9876443221 1234467999999999987765544
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7e-30 Score=265.35 Aligned_cols=178 Identities=22% Similarity=0.321 Sum_probs=154.7
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeCCeEEEEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDGNERLLVYE 668 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 668 (779)
++|++.+.||+|+||+||+|+.. +++.||||+++..........++.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999874 78999999997665555667889999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeeccceecCC
Q 004020 669 YMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPD 748 (779)
Q Consensus 669 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 748 (779)
++.++++..++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||.|+....
T Consensus 82 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 82 FCDQDLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSEEHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eccccccccccccc-----cccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccC
Confidence 99999888776443 257889999999999999999996 8999999999999999999999999999987755
Q ss_pred CCCcccccccccCCcccccccccccCCCC
Q 004020 749 NGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 749 ~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
... ......+++.|+|||++.+...++
T Consensus 154 ~~~--~~~~~~~~~~~~~pe~~~~~~~~~ 180 (292)
T d1unla_ 154 PVR--CYSAEVVTLWYRPPDVLFGAKLYS 180 (292)
T ss_dssp CCS--CCCSCCSCGGGCCHHHHTTCSCCC
T ss_pred CCc--cceeeccccchhhhhHhccCCCCC
Confidence 332 223446789999999998776554
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.96 E-value=6.9e-30 Score=269.72 Aligned_cols=169 Identities=19% Similarity=0.347 Sum_probs=144.2
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeC--CeEEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDG--NERLL 665 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~l 665 (779)
++|++.+.||+|+||+||+|+.. +++.||||+++.. ..+++.+|+++++++. ||||+++++++... ...++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 58999999999999999999874 7899999998643 2357889999999995 99999999999854 56899
Q ss_pred EEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC-cEEEEeeccce
Q 004020 666 VYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVR 744 (779)
Q Consensus 666 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~ 744 (779)
||||+++++|..+. +.+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+|+
T Consensus 110 v~e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 110 VFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp EEECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred EEeecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccce
Confidence 99999999987653 258899999999999999999997 8999999999999998654 69999999998
Q ss_pred ecCCCCCcccccccccCCcccccccccccCCCC
Q 004020 745 LAPDNGKHSIETRLAGTFGYLAPEYAAETSGMT 777 (779)
Q Consensus 745 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t 777 (779)
....... ....+||+.|+|||.+.+...++
T Consensus 179 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~ 208 (328)
T d3bqca1 179 FYHPGQE---YNVRVASRYFKGPELLVDYQMYD 208 (328)
T ss_dssp ECCTTCC---CCSCCSCGGGCCHHHHTTCCCCC
T ss_pred eccCCCc---ccccccCccccCcccccCCCCCC
Confidence 7754322 24457999999999998776554
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3e-30 Score=274.63 Aligned_cols=174 Identities=24% Similarity=0.372 Sum_probs=140.3
Q ss_pred CCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC------CeE
Q 004020 591 NFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG------NER 663 (779)
Q Consensus 591 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~ 663 (779)
+|+..++||+|+||+||+|+.. +++.||||++..... ...+|++++++++||||++++++|... .+.
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 5888899999999999999875 699999999865431 234799999999999999999998653 246
Q ss_pred EEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC-cEEEEeecc
Q 004020 664 LLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGL 742 (779)
Q Consensus 664 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFG~ 742 (779)
++||||++++.+. .+..... ....+++.++..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 95 ~lv~Ey~~~~~~~-~l~~~~~-~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 95 NLVLDYVPETVYR-VARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp EEEEECCSEEHHH-HHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEEEeccCCccHH-HHHhhhh-ccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccc
Confidence 8999999865443 3332221 22368999999999999999999996 8999999999999999775 899999999
Q ss_pred ceecCCCCCcccccccccCCcccccccccccCCCCC
Q 004020 743 VRLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMTW 778 (779)
Q Consensus 743 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t~ 778 (779)
++...... .....+||+.|+|||.+.+...++.
T Consensus 170 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~ 202 (350)
T d1q5ka_ 170 AKQLVRGE---PNVSYICSRYYRAPELIFGATDYTS 202 (350)
T ss_dssp CEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCT
T ss_pred hhhccCCc---ccccccccccccChHHhhcccCCCc
Confidence 98765432 2234579999999999887666553
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.7e-30 Score=270.15 Aligned_cols=176 Identities=28% Similarity=0.387 Sum_probs=141.3
Q ss_pred hcCCcccceecccccEEEEEEEEc-C-CcEEEEEEecccccChhHHHHHHHHHHHHHcC---CCCccceEeeEEEe----
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-D-GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKV---RHRHLVGLLGYCLD---- 659 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~---- 659 (779)
.++|++.+.||+|+||+||+|+.. + ++.||||+++.....+.....+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999874 4 56799999976544333334566777777665 79999999999863
Q ss_pred -CCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEE
Q 004020 660 -GNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 738 (779)
Q Consensus 660 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 738 (779)
....+++|||++++.+....... ...+++..+..++.|++.||+|||+ ++||||||||+|||++.++.+||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCceEEEEEEeccCCchhhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeec
Confidence 24678999999987765443222 2358899999999999999999996 899999999999999999999999
Q ss_pred eeccceecCCCCCcccccccccCCcccccccccccC
Q 004020 739 DFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 739 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
|||+++..... .......||+.|||||++.+..
T Consensus 159 dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~ 191 (305)
T d1blxa_ 159 DFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSS 191 (305)
T ss_dssp SCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCC
T ss_pred chhhhhhhccc---ccCCCcccChhhcCcchhcCCC
Confidence 99998765332 2334567999999999987653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.96 E-value=2.3e-29 Score=260.54 Aligned_cols=174 Identities=20% Similarity=0.313 Sum_probs=144.6
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCC-CccceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH-RHLVGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv 666 (779)
.++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+|++.++.+.| +|++.+++++..+...++|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 468999999999999999999865 68999999875433 12346789999999975 8999999999999999999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC-----CCcEEEEeec
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-----DMRAKVADFG 741 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-----~~~~kl~DFG 741 (779)
|||+ +++|.+++.... ..+++.++..++.|++.||+|||+ ++|+||||||+||+++. ++.+||+|||
T Consensus 80 me~~-~~~l~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG 151 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151 (293)
T ss_dssp EECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEec-CCCHHHHHHhhc----cchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccc
Confidence 9999 679988875433 258899999999999999999995 89999999999999974 5789999999
Q ss_pred cceecCCCCCc-----ccccccccCCcccccccccccC
Q 004020 742 LVRLAPDNGKH-----SIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 742 ~a~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~ 774 (779)
+|+........ ......+||+.|||||++.+..
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~ 189 (293)
T d1csna_ 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE 189 (293)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC
T ss_pred eeEEcccCccccceeecccCceEEchhhcCHHHhcCCC
Confidence 99976543211 1223467999999999998753
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.9e-29 Score=268.91 Aligned_cols=177 Identities=25% Similarity=0.378 Sum_probs=147.4
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC-----C
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG-----N 661 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~ 661 (779)
+.++|++.+.||+|+||+||+|+.. +|+.||||++.....+....+++.+|++++++++|||||++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 3578999999999999999999864 799999999987665666677899999999999999999999998643 3
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeec
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 741 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 741 (779)
..+++|+|+.+|+|.+++..+ .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg 166 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 166 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred ceEEEEEeecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccc
Confidence 446777888899999988432 48999999999999999999996 899999999999999999999999999
Q ss_pred cceecCCCCCcccccccccCCcccccccccccCCCCC
Q 004020 742 LVRLAPDNGKHSIETRLAGTFGYLAPEYAAETSGMTW 778 (779)
Q Consensus 742 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~t~ 778 (779)
.+..... ......||+.|+|||++.+...++.
T Consensus 167 ~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~ 198 (348)
T d2gfsa1 167 LARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQ 198 (348)
T ss_dssp ---CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCT
T ss_pred hhcccCc-----ccccccccccccCchhhcCCccCCc
Confidence 9876532 2234579999999999887665543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4e-29 Score=266.39 Aligned_cols=172 Identities=26% Similarity=0.355 Sum_probs=137.1
Q ss_pred hhcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccceEeeEEEeC------
Q 004020 588 VTNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLVGLLGYCLDG------ 660 (779)
Q Consensus 588 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 660 (779)
+.++|++.++||+|+||+||+|++. +|+.||||++..........+++.+|+.++++++||||++++++|...
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 3468999999999999999999875 699999999987766666677899999999999999999999999643
Q ss_pred CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEee
Q 004020 661 NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 740 (779)
Q Consensus 661 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF 740 (779)
...|+||||+.++.+ +.+. ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+|++||
T Consensus 95 ~~~~iv~Ey~~~~l~-~~~~-------~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df 163 (355)
T d2b1pa1 95 QDVYLVMELMDANLC-QVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_dssp CEEEEEEECCSEEHH-HHHT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred ceeEEEEeccchHHH-Hhhh-------cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeech
Confidence 578999999976544 4432 247899999999999999999997 89999999999999999999999999
Q ss_pred ccceecCCCCCcccccccccCCccccccccccc
Q 004020 741 GLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 741 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
|+++...... ......||+.|+|||++.+.
T Consensus 164 ~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~ 193 (355)
T d2b1pa1 164 GLARTAGTSF---MMTPYVVTRYYRAPEVILGM 193 (355)
T ss_dssp CC------------------CCTTCCHHHHTTC
T ss_pred hhhhcccccc---ccccccccccccChhhhcCC
Confidence 9987664432 23455799999999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.6e-29 Score=264.86 Aligned_cols=176 Identities=27% Similarity=0.369 Sum_probs=149.2
Q ss_pred cCCcccceecccccEEEEEEEEc----CCcEEEEEEeccccc--ChhHHHHHHHHHHHHHcCCC-CccceEeeEEEeCCe
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH----DGTKIAVKRMESAVV--SEKGFAEFKSEIAVLTKVRH-RHLVGLLGYCLDGNE 662 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~ 662 (779)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 57999999999999999999752 588999999976532 12234568899999999976 899999999999999
Q ss_pred EEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcEEEEeecc
Q 004020 663 RLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 742 (779)
Q Consensus 663 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 742 (779)
.++||||+.+|+|.+++.... .+.+..+..++.||+.||+|+|+ .+|+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eeeeeecccccHHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccc
Confidence 999999999999999986554 46788899999999999999996 8999999999999999999999999999
Q ss_pred ceecCCCCCcccccccccCCcccccccccccC
Q 004020 743 VRLAPDNGKHSIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 743 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 774 (779)
|+...... ........|++.|+|||.+.+..
T Consensus 176 a~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~ 206 (322)
T d1vzoa_ 176 SKEFVADE-TERAYDFCGTIEYMAPDIVRGGD 206 (322)
T ss_dssp EEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC
T ss_pred hhhhcccc-cccccccccccccchhHHhhcCC
Confidence 98765432 22234457999999999997543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.95 E-value=2.4e-28 Score=254.23 Aligned_cols=174 Identities=23% Similarity=0.345 Sum_probs=139.1
Q ss_pred hcCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCcc-ceEeeEEEeCCeEEEE
Q 004020 589 TNNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHL-VGLLGYCLDGNERLLV 666 (779)
Q Consensus 589 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv 666 (779)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ..+++.+|+++++.++|+++ +.+.+++.+.+..++|
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT----TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc----cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 467999999999999999999864 68999999876543 22357889999999987665 5556666778889999
Q ss_pred EEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcC---CCcEEEEeeccc
Q 004020 667 YEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVADFGLV 743 (779)
Q Consensus 667 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DFG~a 743 (779)
|||+. +++.+.+.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++. +..+||+|||+|
T Consensus 82 me~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a 153 (299)
T d1ckia_ 82 MELLG-PSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153 (299)
T ss_dssp EECCC-CBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred EEEcC-Cchhhhhhhcc----CCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcc
Confidence 99995 56666654332 258999999999999999999997 89999999999999863 557999999999
Q ss_pred eecCCCCCc-----ccccccccCCcccccccccccC
Q 004020 744 RLAPDNGKH-----SIETRLAGTFGYLAPEYAAETS 774 (779)
Q Consensus 744 ~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~ 774 (779)
+........ .......||+.|||||++.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 189 (299)
T d1ckia_ 154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE 189 (299)
T ss_dssp EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC
T ss_pred eeccccccccceeccccCCcCCCccccCHHHHhCCC
Confidence 987553321 1223457999999999988754
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=9.6e-26 Score=235.39 Aligned_cols=272 Identities=20% Similarity=0.303 Sum_probs=207.7
Q ss_pred CcceeeEeCCCCcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccc
Q 004020 54 CKWKHIQCSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFF 132 (779)
Q Consensus 54 C~w~gv~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~ 132 (779)
|.|.+|.|+ +++++ .+|..+. ++|++|+|++|+|+.+++ +|.++++|++|++++|.++.+++..|
T Consensus 10 c~~~~~~C~-----------~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f 75 (305)
T d1xkua_ 10 CHLRVVQCS-----------DLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF 75 (305)
T ss_dssp EETTEEECT-----------TSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTT
T ss_pred ecCCEEEec-----------CCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhh
Confidence 567777776 35566 6777764 689999999999998887 79999999999999999999999999
Q ss_pred cCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCc
Q 004020 133 KGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSI 212 (779)
Q Consensus 133 ~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L 212 (779)
.++++|++|++++|+++. +|..+ ...+..|++.+|.+.+..+..+. ....+..++...|......
T Consensus 76 ~~l~~L~~L~l~~n~l~~--l~~~~--~~~l~~L~~~~n~l~~l~~~~~~--~~~~~~~l~~~~n~~~~~~--------- 140 (305)
T d1xkua_ 76 APLVKLERLYLSKNQLKE--LPEKM--PKTLQELRVHENEITKVRKSVFN--GLNQMIVVELGTNPLKSSG--------- 140 (305)
T ss_dssp TTCTTCCEEECCSSCCSB--CCSSC--CTTCCEEECCSSCCCBBCHHHHT--TCTTCCEEECCSSCCCGGG---------
T ss_pred hCCCccCEecccCCccCc--Cccch--hhhhhhhhccccchhhhhhhhhh--ccccccccccccccccccC---------
Confidence 999999999999999875 44332 34566677777776644433332 3455556666665543111
Q ss_pred ceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEcc
Q 004020 213 QTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLT 292 (779)
Q Consensus 213 ~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls 292 (779)
.....+..+++|+.+++++|.++..+..+ +++|+.|++++|.+.+..+..+..++.++.|+++
T Consensus 141 ---------------~~~~~~~~l~~L~~l~l~~n~l~~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s 203 (305)
T d1xkua_ 141 ---------------IENGAFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLS 203 (305)
T ss_dssp ---------------BCTTGGGGCTTCCEEECCSSCCCSCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECC
T ss_pred ---------------CCccccccccccCccccccCCccccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccc
Confidence 11123456889999999999998654333 5899999999999999999999999999999999
Q ss_pred CccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCe
Q 004020 293 NNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNI 372 (779)
Q Consensus 293 ~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 372 (779)
+|.+++..+.++.. .++|
T Consensus 204 ~n~l~~~~~~~~~~--------------------------------------------------------------l~~L 221 (305)
T d1xkua_ 204 FNSISAVDNGSLAN--------------------------------------------------------------TPHL 221 (305)
T ss_dssp SSCCCEECTTTGGG--------------------------------------------------------------STTC
T ss_pred cccccccccccccc--------------------------------------------------------------cccc
Confidence 99998776653221 2378
Q ss_pred EEEEccCccccccccccccccccCCeEeccCccccccCCc-------cCCCCCCCCceeccCCccc-ccCC
Q 004020 373 TVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPK-------ELTTLPSLEMLDVSNNHLF-GKVP 435 (779)
Q Consensus 373 ~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~-------~l~~l~~L~~L~Ls~N~l~-g~iP 435 (779)
++|+|++|+|+ .+|.+|.++++|++|+|++|+|+ .|+. .+..+.+|+.|+|++|+++ ..+|
T Consensus 222 ~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~-~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~ 290 (305)
T d1xkua_ 222 RELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ 290 (305)
T ss_dssp CEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSC
T ss_pred eeeeccccccc-ccccccccccCCCEEECCCCccC-ccChhhccCcchhcccCCCCEEECCCCcCccCcCC
Confidence 99999999998 57889999999999999999999 5543 2345788999999999885 4554
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.94 E-value=7.9e-26 Score=244.08 Aligned_cols=285 Identities=26% Similarity=0.395 Sum_probs=202.4
Q ss_pred CCcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEc
Q 004020 64 SNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISL 143 (779)
Q Consensus 64 ~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 143 (779)
-..+++|++++++|+. + +.+..+++|++|+|++|+|++.++ ++++++|++|++++|+++.+++ +..+++|+.|++
T Consensus 43 l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~~-l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L~~ 117 (384)
T d2omza2 43 LDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL 117 (384)
T ss_dssp HTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred hCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCcc-ccCCcccccccccccccccccc--cccccccccccc
Confidence 3479999999999984 4 468899999999999999997654 9999999999999999999875 889999999999
Q ss_pred ccCCCCCCCCcccccCCCCCceEeccCceeEee-----------------------------------------cCCCcc
Q 004020 144 DYNSFDSWVIPESLKDATGLQRFSANGANITGT-----------------------------------------IPDFLG 182 (779)
Q Consensus 144 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~-----------------------------------------~p~~~~ 182 (779)
++|.+.+ + ........+..+....|.+... ....+
T Consensus 118 ~~~~~~~--~-~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 193 (384)
T d2omza2 118 FNNQITD--I-DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL- 193 (384)
T ss_dssp CSSCCCC--C-GGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGG-
T ss_pred ccccccc--c-ccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccccccccccccc-
Confidence 9999865 1 2233344444444444443211 11112
Q ss_pred CCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCC
Q 004020 183 GDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSL 262 (779)
Q Consensus 183 ~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L 262 (779)
..+++++.|++++|.+++..|.. ...+|+.|++++|.+... ..+..+++|+.|++++|.+++.+ .+..+++|
T Consensus 194 -~~l~~~~~l~l~~n~i~~~~~~~-~~~~L~~L~l~~n~l~~~-----~~l~~l~~L~~L~l~~n~l~~~~-~~~~~~~L 265 (384)
T d2omza2 194 -AKLTNLESLIATNNQISDITPLG-ILTNLDELSLNGNQLKDI-----GTLASLTNLTDLDLANNQISNLA-PLSGLTKL 265 (384)
T ss_dssp -GGCTTCSEEECCSSCCCCCGGGG-GCTTCCEEECCSSCCCCC-----GGGGGCTTCSEEECCSSCCCCCG-GGTTCTTC
T ss_pred -ccccccceeeccCCccCCCCccc-ccCCCCEEECCCCCCCCc-----chhhcccccchhccccCccCCCC-cccccccC
Confidence 25678889999999998765532 235788999998877653 34667889999999999988754 47778899
Q ss_pred cEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCC
Q 004020 263 QDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVG 342 (779)
Q Consensus 263 ~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (779)
+.|++++|++++.. .+..++.++.+++++|++++...
T Consensus 266 ~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~~~----------------------------------------- 302 (384)
T d2omza2 266 TELKLGANQISNIS--PLAGLTALTNLELNENQLEDISP----------------------------------------- 302 (384)
T ss_dssp SEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCCGG-----------------------------------------
T ss_pred CEeeccCcccCCCC--ccccccccccccccccccccccc-----------------------------------------
Confidence 99999999998643 37788889999999988875311
Q ss_pred CchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccCccccccCCccCCCCCCCCc
Q 004020 343 YPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEM 422 (779)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~ 422 (779)
....++++.|++++|++++..| +..+++|++|+|++|+|+ .+| .+..+++|++
T Consensus 303 -----------------------~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~ 355 (384)
T d2omza2 303 -----------------------ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVS-DVS-SLANLTNINW 355 (384)
T ss_dssp -----------------------GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCE
T ss_pred -----------------------cchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCC-CCh-hHcCCCCCCE
Confidence 0011245566666666665322 556666666666666666 333 4566666666
Q ss_pred eeccCCcccccCC
Q 004020 423 LDVSNNHLFGKVP 435 (779)
Q Consensus 423 L~Ls~N~l~g~iP 435 (779)
|||++|++++.+|
T Consensus 356 L~l~~N~l~~l~~ 368 (384)
T d2omza2 356 LSAGHNQISDLTP 368 (384)
T ss_dssp EECCSSCCCBCGG
T ss_pred EECCCCcCCCChh
Confidence 6666666665544
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=7.7e-26 Score=233.45 Aligned_cols=266 Identities=18% Similarity=0.264 Sum_probs=183.7
Q ss_pred EEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcc-cC
Q 004020 69 RIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD-YN 146 (779)
Q Consensus 69 ~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls-~N 146 (779)
.++.++++++ .+|..+. +.+++|+|++|+|+.+++ +|.++++|++|++++|+++.+++..+..++.++.++.. .|
T Consensus 15 ~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp EEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred EEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 3456667777 6776654 578999999999988777 78999999999999999999999888889999998875 55
Q ss_pred CCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCC
Q 004020 147 SFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKL 226 (779)
Q Consensus 147 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~ 226 (779)
.+.. ..+..|.++++|+.|++++|.+....+..+. ...+|+.+++++|+|++..+..|.
T Consensus 92 ~~~~-l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~--~~~~L~~l~l~~N~l~~i~~~~f~------------------ 150 (284)
T d1ozna_ 92 QLRS-VDPATFHGLGRLHTLHLDRCGLQELGPGLFR--GLAALQYLYLQDNALQALPDDTFR------------------ 150 (284)
T ss_dssp TCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTT--TCTTCCEEECCSSCCCCCCTTTTT------------------
T ss_pred cccc-ccchhhcccccCCEEecCCcccccccccccc--hhcccchhhhccccccccChhHhc------------------
Confidence 5544 5678888899999999999988766666664 678888999999998865555554
Q ss_pred CCchhhhcCCCCccEEEeecCcccCCCCC-CCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCCCC
Q 004020 227 NGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNS 305 (779)
Q Consensus 227 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~ 305 (779)
.+++|+.|+|++|+|++.++. |.++++|+.+++++|++++..|..|..+++|++|++++|++++.+|..+
T Consensus 151 --------~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~- 221 (284)
T d1ozna_ 151 --------DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEAL- 221 (284)
T ss_dssp --------TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHH-
T ss_pred --------cccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccccccccccccccccc-
Confidence 356666666666666665553 5666666666666666666666666666666666666666665443211
Q ss_pred CcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCcccccc
Q 004020 306 PVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGT 385 (779)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~ 385 (779)
....+|++|+|++|.+...
T Consensus 222 -------------------------------------------------------------~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 222 -------------------------------------------------------------APLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp -------------------------------------------------------------TTCTTCCEEECCSSCEECS
T ss_pred -------------------------------------------------------------ccccccCEEEecCCCCCCC
Confidence 1112456666666666543
Q ss_pred ccccccccccCCeEeccCccccccCCccCCCCCCCCceeccCCcccc
Q 004020 386 ISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFG 432 (779)
Q Consensus 386 ~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g 432 (779)
-+. ..-...++.+....+++....|..+.. +..++++.+.|+|
T Consensus 241 C~~-~~l~~~l~~~~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~g 283 (284)
T d1ozna_ 241 CRA-RPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283 (284)
T ss_dssp GGG-HHHHHHHHHCCSEECCCBEEESGGGTT---CBGGGSCGGGSCC
T ss_pred ccc-hHHHHHHHhCcCCCCceEeCCchHHcC---CccccCCHHHCCC
Confidence 221 111223556666677777777776653 4556667777766
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.93 E-value=7.5e-25 Score=236.32 Aligned_cols=292 Identities=23% Similarity=0.300 Sum_probs=221.5
Q ss_pred EecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCC
Q 004020 71 QIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDS 150 (779)
Q Consensus 71 ~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 150 (779)
+++.+++++.++ ..++.+|++|++++|.|+. ++.+..+++|++|+|++|+|+.+++ +.++++|++|++++|++.+
T Consensus 28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~ 102 (384)
T d2omza2 28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD 102 (384)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-CTTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred HhCCCCCCCccC--HHHhCCCCEEECCCCCCCC-ccccccCCCCCEEeCcCCcCCCCcc--ccCCccccccccccccccc
Confidence 445555665554 3567799999999999985 4678899999999999999999975 9999999999999999976
Q ss_pred CCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCc----------------------------
Q 004020 151 WVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGP---------------------------- 202 (779)
Q Consensus 151 ~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~---------------------------- 202 (779)
++ .+.++++|+.|++++|.+++..+... ...+..+....|.+...
T Consensus 103 --i~-~l~~l~~L~~L~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (384)
T d2omza2 103 --IT-PLANLTNLTGLTLFNNQITDIDPLKN----LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLT 175 (384)
T ss_dssp --CG-GGTTCTTCCEEECCSSCCCCCGGGTT----CTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCT
T ss_pred --cc-cccccccccccccccccccccccccc----cccccccccccccccccccccccccccccccccccchhhhhcccc
Confidence 33 48899999999999999986544332 33444444443332211
Q ss_pred -------------CCCcccc-CCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEcc
Q 004020 203 -------------IPLSFGK-SSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVR 268 (779)
Q Consensus 203 -------------~p~~~~~-~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~ 268 (779)
.+..+.. .++..+++++|.+.... ....+++|+.|++++|+++. ++.+..+++|+.|+++
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~-----~~~~~~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~l~ 249 (384)
T d2omza2 176 TLERLDISSNKVSDISVLAKLTNLESLIATNNQISDIT-----PLGILTNLDELSLNGNQLKD-IGTLASLTNLTDLDLA 249 (384)
T ss_dssp TCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCG-----GGGGCTTCCEEECCSSCCCC-CGGGGGCTTCSEEECC
T ss_pred ccccccccccccccccccccccccceeeccCCccCCCC-----cccccCCCCEEECCCCCCCC-cchhhcccccchhccc
Confidence 1111111 56888899988776542 24567899999999999986 4568889999999999
Q ss_pred CCccccccChhhhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcc
Q 004020 269 DNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLA 348 (779)
Q Consensus 269 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (779)
+|++++.. .+..+++|+.|++++|++++..+-
T Consensus 250 ~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~~~---------------------------------------------- 281 (384)
T d2omza2 250 NNQISNLA--PLSGLTKLTELKLGANQISNISPL---------------------------------------------- 281 (384)
T ss_dssp SSCCCCCG--GGTTCTTCSEEECCSSCCCCCGGG----------------------------------------------
T ss_pred cCccCCCC--cccccccCCEeeccCcccCCCCcc----------------------------------------------
Confidence 99999754 388899999999999998764331
Q ss_pred cccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccCccccccCCccCCCCCCCCceeccCC
Q 004020 349 ESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNN 428 (779)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N 428 (779)
.....+..+++..|.+++ ...+..+++++.|+|++|+|++.. .+..+++|++|+|++|
T Consensus 282 ------------------~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n 339 (384)
T d2omza2 282 ------------------AGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANN 339 (384)
T ss_dssp ------------------TTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSS
T ss_pred ------------------cccccccccccccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCC
Confidence 112257788999999986 345888999999999999999653 3788999999999999
Q ss_pred cccccCCC---CCCcceeeeCCCCCC
Q 004020 429 HLFGKVPN---FRQNVIVKTDGNPDI 451 (779)
Q Consensus 429 ~l~g~iP~---~~~~~~~~~~~n~~~ 451 (779)
+|++ +|. +.....+.+.+|...
T Consensus 340 ~l~~-l~~l~~l~~L~~L~l~~N~l~ 364 (384)
T d2omza2 340 KVSD-VSSLANLTNINWLSAGHNQIS 364 (384)
T ss_dssp CCCC-CGGGGGCTTCCEEECCSSCCC
T ss_pred CCCC-ChhHcCCCCCCEEECCCCcCC
Confidence 9986 443 334446677777543
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.4e-24 Score=223.80 Aligned_cols=216 Identities=22% Similarity=0.310 Sum_probs=191.0
Q ss_pred ceeeEeCCC----------CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecC-CCC
Q 004020 56 WKHIQCSPS----------NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFD-DNN 123 (779)
Q Consensus 56 w~gv~c~~~----------~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~-~N~ 123 (779)
|.-|.|+.. ..+++|+|++|+|+...+.+|..+++|++|++++|++..+.+ .+.++..++.++.. .|.
T Consensus 13 ~~~v~c~~~~L~~iP~~ip~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~ 92 (284)
T d1ozna_ 13 KVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92 (284)
T ss_dssp SCEEECCSSCCSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred CeEEEcCCCCCCccCCCCCCCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 445777652 257899999999997777789999999999999999998887 78889999998764 788
Q ss_pred CCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcC
Q 004020 124 FTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPI 203 (779)
Q Consensus 124 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~ 203 (779)
++.+++..|.++++|++|++++|.+.. ..+..+..+.+|+.+++++|++++..+..|. .+++|++|+|++|+|++..
T Consensus 93 ~~~l~~~~~~~l~~L~~L~l~~n~~~~-~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~--~~~~L~~L~l~~N~l~~l~ 169 (284)
T d1ozna_ 93 LRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQALPDDTFR--DLGNLTHLFLHGNRISSVP 169 (284)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTT--TCTTCCEEECCSSCCCEEC
T ss_pred cccccchhhcccccCCEEecCCccccc-ccccccchhcccchhhhccccccccChhHhc--cccchhhcccccCcccccc
Confidence 999999999999999999999999976 5677888999999999999999977677775 6889999999999999766
Q ss_pred CCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCC-CCCCCCCcEEEccCCccccccChhhhC
Q 004020 204 PLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVN 282 (779)
Q Consensus 204 p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~l~~ 282 (779)
+..+. .+++|+.|++++|++++..|. |..+++|++|++++|++.+..|..|..
T Consensus 170 ~~~f~--------------------------~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~ 223 (284)
T d1ozna_ 170 ERAFR--------------------------GLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAP 223 (284)
T ss_dssp TTTTT--------------------------TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTT
T ss_pred hhhhc--------------------------cccccchhhhhhccccccChhHhhhhhhccccccccccccccccccccc
Confidence 66654 689999999999999998875 899999999999999999988899999
Q ss_pred CCCCCEEEccCccccccC
Q 004020 283 LHSLAVVNLTNNLFQGQT 300 (779)
Q Consensus 283 l~~L~~L~Ls~N~l~g~~ 300 (779)
+++|++|+|++|++.+..
T Consensus 224 ~~~L~~L~l~~N~l~C~C 241 (284)
T d1ozna_ 224 LRALQYLRLNDNPWVCDC 241 (284)
T ss_dssp CTTCCEEECCSSCEECSG
T ss_pred ccccCEEEecCCCCCCCc
Confidence 999999999999998643
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.91 E-value=1e-23 Score=219.80 Aligned_cols=264 Identities=19% Similarity=0.225 Sum_probs=212.0
Q ss_pred CCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEecc
Q 004020 90 SLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSAN 169 (779)
Q Consensus 90 ~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~ 169 (779)
.++.+|=++++|+.+|+.+. ++|++|+|++|+|+.+++..|.++++|++|++++|.+.. ..|..|.++++|+.|+++
T Consensus 11 ~~~~~~C~~~~L~~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~-i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK-ISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCCSCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCC-BCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCCccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccc-cchhhhhCCCccCEeccc
Confidence 46678888888987766664 689999999999999999999999999999999999986 567889999999999999
Q ss_pred CceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcc
Q 004020 170 GANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSF 249 (779)
Q Consensus 170 ~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l 249 (779)
+|+++ .+|..+ .+.+..|++++|.+.+..+..+ .....+..++...|..
T Consensus 88 ~n~l~-~l~~~~----~~~l~~L~~~~n~l~~l~~~~~--------------------------~~~~~~~~l~~~~n~~ 136 (305)
T d1xkua_ 88 KNQLK-ELPEKM----PKTLQELRVHENEITKVRKSVF--------------------------NGLNQMIVVELGTNPL 136 (305)
T ss_dssp SSCCS-BCCSSC----CTTCCEEECCSSCCCBBCHHHH--------------------------TTCTTCCEEECCSSCC
T ss_pred CCccC-cCccch----hhhhhhhhccccchhhhhhhhh--------------------------hccccccccccccccc
Confidence 99998 566654 4678899999999885433322 2456777888888866
Q ss_pred cCC--CC-CCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcc
Q 004020 250 TGP--LP-DLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVA 326 (779)
Q Consensus 250 ~~~--~~-~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (779)
... .+ .+..+++|+.+++++|.+. .+|..+ +++|+.|++++|.+++.++..+.
T Consensus 137 ~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~--------------------- 192 (305)
T d1xkua_ 137 KSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLK--------------------- 192 (305)
T ss_dssp CGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGT---------------------
T ss_pred cccCCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhh---------------------
Confidence 543 23 3788999999999999998 466554 68999999999998877664221
Q ss_pred cCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccCccc
Q 004020 327 CDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNEL 406 (779)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l 406 (779)
....++.|++++|.+.+..+..|.++++|++|+|++|+|
T Consensus 193 -----------------------------------------~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L 231 (305)
T d1xkua_ 193 -----------------------------------------GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 231 (305)
T ss_dssp -----------------------------------------TCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCC
T ss_pred -----------------------------------------ccccccccccccccccccccccccccccceeeecccccc
Confidence 223688999999999999999999999999999999999
Q ss_pred cccCCccCCCCCCCCceeccCCcccccCCC----------CCCcceeeeCCCCCCCC
Q 004020 407 TGTIPKELTTLPSLEMLDVSNNHLFGKVPN----------FRQNVIVKTDGNPDIGK 453 (779)
Q Consensus 407 ~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~----------~~~~~~~~~~~n~~~~~ 453 (779)
+ .+|.++..+++|++|+|++|+|+.--+. ......+.+.+|++.+.
T Consensus 232 ~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~ 287 (305)
T d1xkua_ 232 V-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287 (305)
T ss_dssp S-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred c-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccC
Confidence 9 8899999999999999999999843221 12233567788886543
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=3.5e-24 Score=218.47 Aligned_cols=202 Identities=22% Similarity=0.238 Sum_probs=177.7
Q ss_pred eCCCCcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCcc
Q 004020 61 CSPSNRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQ 139 (779)
Q Consensus 61 c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 139 (779)
|+......+++.++++|+ .+|+.+. ++|++|+|++|+|++.++ .|.++++|++|+|++|+|+.++. +..+++|+
T Consensus 6 ~~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~--~~~l~~L~ 80 (266)
T d1p9ag_ 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLG 80 (266)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCC
T ss_pred EcccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccccc--cccccccc
Confidence 555556677899999999 6788775 589999999999998886 79999999999999999998875 57899999
Q ss_pred EEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccC
Q 004020 140 TISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNG 219 (779)
Q Consensus 140 ~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~ 219 (779)
+|+|++|++.. .+..+..+++|+.|++++|.+.+..+..+. .+.++++|++++|.++...+..+.
T Consensus 81 ~L~Ls~N~l~~--~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~--~l~~l~~L~l~~n~l~~l~~~~~~----------- 145 (266)
T d1p9ag_ 81 TLDLSHNQLQS--LPLLGQTLPALTVLDVSFNRLTSLPLGALR--GLGELQELYLKGNELKTLPPGLLT----------- 145 (266)
T ss_dssp EEECCSSCCSS--CCCCTTTCTTCCEEECCSSCCCCCCSSTTT--TCTTCCEEECTTSCCCCCCTTTTT-----------
T ss_pred ccccccccccc--cccccccccccccccccccccceeeccccc--cccccccccccccccceecccccc-----------
Confidence 99999999975 678899999999999999999877666665 789999999999999955544433
Q ss_pred CCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCC-CCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccc
Q 004020 220 QKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQG 298 (779)
Q Consensus 220 n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g 298 (779)
.+++|+.|++++|+|++.+++ +..+++|++|+|++|+|+ .+|+.+..+++|+.|+|++|++..
T Consensus 146 ---------------~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 146 ---------------PTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp ---------------TCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred ---------------ccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 588999999999999998885 888999999999999999 789999999999999999999875
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.89 E-value=8.5e-24 Score=226.14 Aligned_cols=172 Identities=23% Similarity=0.284 Sum_probs=134.3
Q ss_pred cCCcccceecccccEEEEEEEEc-CCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-----------CCccceEeeEE
Q 004020 590 NNFSEENVLGRGGFGTVYKGELH-DGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-----------HRHLVGLLGYC 657 (779)
Q Consensus 590 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~ 657 (779)
++|++.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+++++.++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 35999999999999999999874 79999999997542 23456788999888775 57899999888
Q ss_pred EeC--CeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCC--
Q 004020 658 LDG--NERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-- 733 (779)
Q Consensus 658 ~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-- 733 (779)
... ...+++|+++..+.......... ....+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETT
T ss_pred eeccccceeeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcc
Confidence 643 56677777776554433332222 23467889999999999999999996 47899999999999998654
Q ss_pred ----cEEEEeeccceecCCCCCcccccccccCCccccccccccc
Q 004020 734 ----RAKVADFGLVRLAPDNGKHSIETRLAGTFGYLAPEYAAET 773 (779)
Q Consensus 734 ----~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 773 (779)
.+|++|||.|+..... ....+||+.|+|||++.+.
T Consensus 166 ~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~ 204 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGA 204 (362)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTC
T ss_pred cccceeeEeecccccccccc-----cccccccccccChhhcccc
Confidence 3999999999865432 2345799999999988754
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=1.8e-22 Score=205.56 Aligned_cols=203 Identities=26% Similarity=0.262 Sum_probs=123.5
Q ss_pred CCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCC
Q 004020 108 LSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIP 187 (779)
Q Consensus 108 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~ 187 (779)
+.+...+.+++.++++|+.+|++.. ++|++|+|++|+|.+ ..+..|.++++|++|+|++|+|+. +|. ++ .++
T Consensus 6 ~~~~~~~~~v~C~~~~L~~iP~~lp---~~l~~L~Ls~N~i~~-l~~~~f~~l~~L~~L~L~~N~l~~-l~~-~~--~l~ 77 (266)
T d1p9ag_ 6 VSKVASHLEVNCDKRNLTALPPDLP---KDTTILHLSENLLYT-FSLATLMPYTRLTQLNLDRAELTK-LQV-DG--TLP 77 (266)
T ss_dssp EECSTTCCEEECTTSCCSSCCSCCC---TTCCEEECTTSCCSE-EEGGGGTTCTTCCEEECTTSCCCE-EEC-CS--CCT
T ss_pred EcccCCCeEEEccCCCCCeeCcCcC---cCCCEEECcCCcCCC-cCHHHhhccccccccccccccccc-ccc-cc--ccc
Confidence 4556677777888888888876532 467788888888765 333556666666666666666653 222 11 345
Q ss_pred cccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEc
Q 004020 188 GLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSV 267 (779)
Q Consensus 188 ~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l 267 (779)
+|++|+|++|+++ +.++.+..+++|++|++
T Consensus 78 ~L~~L~Ls~N~l~--------------------------------------------------~~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 78 VLGTLDLSHNQLQ--------------------------------------------------SLPLLGQTLPALTVLDV 107 (266)
T ss_dssp TCCEEECCSSCCS--------------------------------------------------SCCCCTTTCTTCCEEEC
T ss_pred ccccccccccccc--------------------------------------------------ccccccccccccccccc
Confidence 5555555555554 33333444444444444
Q ss_pred cCCccccccChhhhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhc
Q 004020 268 RDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVL 347 (779)
Q Consensus 268 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (779)
++|.+.+..+..+..+.+++.|++++|.++...+..+.
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~------------------------------------------ 145 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLT------------------------------------------ 145 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTT------------------------------------------
T ss_pred cccccceeeccccccccccccccccccccceecccccc------------------------------------------
Confidence 44444444444444444455555555544433332111
Q ss_pred ccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccCccccccCCccCCCCCCCCceeccC
Q 004020 348 AESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSN 427 (779)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~ 427 (779)
..++++.+++++|+|++..+..|..+++|++|+|++|+|+ .+|.++..+++|+.|+|++
T Consensus 146 --------------------~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~ 204 (266)
T d1p9ag_ 146 --------------------PTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHG 204 (266)
T ss_dssp --------------------TCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCS
T ss_pred --------------------ccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecC
Confidence 1124455555555555555566778889999999999999 8999999999999999988
Q ss_pred Cccc
Q 004020 428 NHLF 431 (779)
Q Consensus 428 N~l~ 431 (779)
|++.
T Consensus 205 Np~~ 208 (266)
T d1p9ag_ 205 NPWL 208 (266)
T ss_dssp CCBC
T ss_pred CCCC
Confidence 8764
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=1e-21 Score=189.07 Aligned_cols=137 Identities=15% Similarity=0.148 Sum_probs=107.4
Q ss_pred CcccceecccccEEEEEEEEcCCcEEEEEEecccccC----------------hhHHHHHHHHHHHHHcCCCCccceEee
Q 004020 592 FSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVS----------------EKGFAEFKSEIAVLTKVRHRHLVGLLG 655 (779)
Q Consensus 592 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------~~~~~~~~~E~~~l~~l~h~niv~~~~ 655 (779)
+.+.+.||+|+||.||+|+..+|+.||||+++..... ........+|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 3567899999999999999889999999987532110 111234567899999999999998876
Q ss_pred EEEeCCeEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCcEEcCCCCCCEEEcCCCcE
Q 004020 656 YCLDGNERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 735 (779)
Q Consensus 656 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 735 (779)
+. ..+++|||+++..+.+ ++...+..++.|++++++|||+ ++|+||||||+|||++++ .+
T Consensus 82 ~~----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EE
T ss_pred ec----CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CE
Confidence 53 2379999998765432 2333456889999999999996 899999999999999865 48
Q ss_pred EEEeeccceecCC
Q 004020 736 KVADFGLVRLAPD 748 (779)
Q Consensus 736 kl~DFG~a~~~~~ 748 (779)
+|+|||.|+....
T Consensus 142 ~liDFG~a~~~~~ 154 (191)
T d1zara2 142 WIIDFPQSVEVGE 154 (191)
T ss_dssp EECCCTTCEETTS
T ss_pred EEEECCCcccCCC
Confidence 9999999987653
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.81 E-value=8.8e-18 Score=177.76 Aligned_cols=304 Identities=20% Similarity=0.257 Sum_probs=192.2
Q ss_pred cEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEccc
Q 004020 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145 (779)
Q Consensus 66 ~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 145 (779)
++++|||++++++ .+|+. +++|++|+|++|+|+..+.. +.+|+.|++++|+++.++.- .+.|++|+|++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~lp~~---~~~L~~L~l~~n~l~~l~~l----p~~L~~L~L~~ 107 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTELPEL---PQSLKSLLVDNNNLKALSDL----PPLLEYLGVSN 107 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSSCCCC---CTTCCEEECCSSCCSCCCSC----CTTCCEEECCS
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCcccccc---hhhhhhhhhhhcccchhhhh----ccccccccccc
Confidence 5789999999998 67853 57899999999999955434 45799999999999987631 24799999999
Q ss_pred CCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCcccc-CCcceeeccCCCCCC
Q 004020 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-SSIQTLWLNGQKGDS 224 (779)
Q Consensus 146 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~L~~l~l~~n~~~~ 224 (779)
|.+.. +|. +..+++|+.|++++|.++.. +.. ...+..+.+..+.... +..+.. ..++.+++..|....
T Consensus 108 n~l~~--lp~-~~~l~~L~~L~l~~~~~~~~-~~~-----~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n~~~~ 176 (353)
T d1jl5a_ 108 NQLEK--LPE-LQNSSFLKIIDVDNNSLKKL-PDL-----PPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSLKK 176 (353)
T ss_dssp SCCSS--CCC-CTTCTTCCEEECCSSCCSCC-CCC-----CTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSSCCSS
T ss_pred ccccc--ccc-hhhhccceeecccccccccc-ccc-----cccccchhhccccccc--cccccccccceecccccccccc
Confidence 99975 554 67899999999999988743 322 3467777777766652 223332 456677777665543
Q ss_pred CCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCCC
Q 004020 225 KLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFN 304 (779)
Q Consensus 225 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~ 304 (779)
... .....+.+.+..+.+. .++.+..++.|+.+++++|.... +|. ...++..+.+.+|.+........
T Consensus 177 ~~~-------~~~~~~~l~~~~~~~~-~~~~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~~~~~~~ 244 (353)
T d1jl5a_ 177 LPD-------LPLSLESIVAGNNILE-ELPELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTDLPELPQ 244 (353)
T ss_dssp CCC-------CCTTCCEEECCSSCCS-SCCCCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSCCCCCCT
T ss_pred ccc-------cccccccccccccccc-ccccccccccccccccccccccc-ccc---ccccccccccccccccccccccc
Confidence 221 1223445555554444 45556677788888888877663 443 23456777777777664332211
Q ss_pred CCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccc
Q 004020 305 SPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSG 384 (779)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g 384 (779)
.......... ....+. ...... .. ..+...........+++|++|+|++|+|+
T Consensus 245 ~l~~~~~~~~-~~~~l~--------------~l~~~~------~~-----~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~- 297 (353)
T d1jl5a_ 245 SLTFLDVSEN-IFSGLS--------------ELPPNL------YY-----LNASSNEIRSLCDLPPSLEELNVSNNKLI- 297 (353)
T ss_dssp TCCEEECCSS-CCSEES--------------CCCTTC------CE-----EECCSSCCSEECCCCTTCCEEECCSSCCS-
T ss_pred cccccccccc-cccccc--------------cccchh------cc-----cccccCccccccccCCCCCEEECCCCccC-
Confidence 1100000000 000000 000000 00 00000011111233568999999999998
Q ss_pred cccccccccccCCeEeccCccccccCCccCCCCCCCCceeccCCcccccCCCCC
Q 004020 385 TISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVPNFR 438 (779)
Q Consensus 385 ~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~~ 438 (779)
.+|.. +++|+.|+|++|+|+ .+|.. +.+|++|+|++|+|+ .+|...
T Consensus 298 ~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~ 343 (353)
T d1jl5a_ 298 ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIP 343 (353)
T ss_dssp CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCC
T ss_pred ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCccc
Confidence 57754 578999999999999 78864 467999999999987 567543
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=3e-18 Score=171.47 Aligned_cols=219 Identities=16% Similarity=0.158 Sum_probs=126.3
Q ss_pred EEEecCCCccccCCccccCCCCCcEEEcccCccccCCC-CCCCCCCccEEecCCCCCCC-CCcccccCCCCccEEEccc-
Q 004020 69 RIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTS-VPSDFFKGLTSLQTISLDY- 145 (779)
Q Consensus 69 ~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~Ls~- 145 (779)
.++.++.+++ .+|+.+. +++++|+|++|+|+.+++ +|.++++|++|+|++|.+.. +++..|.+++++++|++..
T Consensus 12 ~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 12 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp EEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred EEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 4666677777 7776653 467788888888776665 57777777777777776654 4555666666666666543
Q ss_pred CCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCC
Q 004020 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSK 225 (779)
Q Consensus 146 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~ 225 (779)
|++ +...+..|. .+++|++|++++|+++...+...
T Consensus 89 n~l-------------------------~~~~~~~~~--~l~~L~~l~l~~~~l~~~~~~~~------------------ 123 (242)
T d1xwdc1 89 NNL-------------------------LYINPEAFQ--NLPNLQYLLISNTGIKHLPDVHK------------------ 123 (242)
T ss_dssp TTC-------------------------CEECTTSEE--CCTTCCEEEEESCCCCSCCCCTT------------------
T ss_pred ccc-------------------------ccccccccc--ccccccccccchhhhcccccccc------------------
Confidence 333 334444443 46666666666666653222111
Q ss_pred CCCchhhhcCCCCccEEEeecCcccCCCC-CCCCC-CCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCC
Q 004020 226 LNGSVAVIQNMTSLTQLWLHGNSFTGPLP-DLSGL-SSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKF 303 (779)
Q Consensus 226 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l-~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~ 303 (779)
+..+..+..+..+++.+....+ .+.++ ..++.|++++|+++. ++....+..++.
T Consensus 124 -------~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~-i~~~~~~~~~l~---------------- 179 (242)
T d1xwdc1 124 -------IHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNCAFNGTQLD---------------- 179 (242)
T ss_dssp -------TCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE-ECTTTTTTCCEE----------------
T ss_pred -------cccccccccccccccccccccccccccccccceeeecccccccc-cccccccchhhh----------------
Confidence 1134455555555555554433 24333 245555555555553 222222222222
Q ss_pred CCCcccccccCCCCcccCCCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCcccc
Q 004020 304 NSPVRFDMAKGSNSFCLDDAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLS 383 (779)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~ 383 (779)
+.+++++|+++
T Consensus 180 ---------------------------------------------------------------------~~~~l~~n~l~ 190 (242)
T d1xwdc1 180 ---------------------------------------------------------------------ELNLSDNNNLE 190 (242)
T ss_dssp ---------------------------------------------------------------------EEECTTCTTCC
T ss_pred ---------------------------------------------------------------------ccccccccccc
Confidence 22334555555
Q ss_pred ccccccccccccCCeEeccCccccccCCccCCCCCCCCceeccCC
Q 004020 384 GTISSNFSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVSNN 428 (779)
Q Consensus 384 g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N 428 (779)
...+..|.++++|++|+|++|+|+...+..|..++.|++|++.+.
T Consensus 191 ~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~l 235 (242)
T d1xwdc1 191 ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235 (242)
T ss_dssp CCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEESS
T ss_pred cccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCCC
Confidence 333345777888999999999998433445777888887777543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=1.7e-18 Score=171.33 Aligned_cols=185 Identities=24% Similarity=0.379 Sum_probs=115.7
Q ss_pred cEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEccc
Q 004020 66 RVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDY 145 (779)
Q Consensus 66 ~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 145 (779)
.++.|++.+|+|+. ++ .+..+++|++|+|++|++++..+ +.++++|++|++++|.++.++ .+.++++|+++++++
T Consensus 42 ~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~-l~~l~~l~~l~~~~n~~~~i~--~l~~l~~L~~l~l~~ 116 (227)
T d1h6ua2 42 GITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNVS--AIAGLQSIKTLDLTS 116 (227)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCCG--GGTTCTTCCEEECTT
T ss_pred CcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc-ccccccccccccccccccccc--ccccccccccccccc
Confidence 45666666666653 32 35566666666666666554332 555566666666666665543 245566666666665
Q ss_pred CCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCC
Q 004020 146 NSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSK 225 (779)
Q Consensus 146 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~ 225 (779)
+.... ...+...+.+..+.++++.+....+ +. .+++|++|++++|.++..
T Consensus 117 ~~~~~---~~~~~~~~~~~~l~~~~~~~~~~~~--~~--~~~~L~~L~l~~n~~~~~----------------------- 166 (227)
T d1h6ua2 117 TQITD---VTPLAGLSNLQVLYLDLNQITNISP--LA--GLTNLQYLSIGNAQVSDL----------------------- 166 (227)
T ss_dssp SCCCC---CGGGTTCTTCCEEECCSSCCCCCGG--GG--GCTTCCEEECCSSCCCCC-----------------------
T ss_pred ccccc---cchhccccchhhhhchhhhhchhhh--hc--cccccccccccccccccc-----------------------
Confidence 55532 2234445555555555555543222 11 345555555555555421
Q ss_pred CCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccC
Q 004020 226 LNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTN 293 (779)
Q Consensus 226 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~ 293 (779)
..++++++|+.|+|++|++++ ++.+..+++|++|++++|++++. | .+.++++|+.|+|++
T Consensus 167 -----~~l~~l~~L~~L~Ls~n~l~~-l~~l~~l~~L~~L~Ls~N~lt~i-~-~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 167 -----TPLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDV-S-PLANTSNLFIVTLTN 226 (227)
T ss_dssp -----GGGTTCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECTTSCCCBC-G-GGTTCTTCCEEEEEE
T ss_pred -----hhhcccccceecccCCCccCC-ChhhcCCCCCCEEECcCCcCCCC-c-ccccCCCCCEEEeeC
Confidence 124578999999999999986 45688899999999999999864 4 388999999999974
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=1.4e-18 Score=173.87 Aligned_cols=212 Identities=18% Similarity=0.204 Sum_probs=165.3
Q ss_pred CcceeeEeCCC----------CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCC--CCCCCCCccEEecCC
Q 004020 54 CKWKHIQCSPS----------NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDD 121 (779)
Q Consensus 54 C~w~gv~c~~~----------~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~--~~~~l~~L~~L~l~~ 121 (779)
|.+..|.|+.. ..+++|+|++|.|+...+.+|.++++|++|+|++|.+...++ .|.+++++++|++.+
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 67778899742 269999999999996666689999999999999999877554 689999999999764
Q ss_pred -CCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCC
Q 004020 122 -NNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQ 200 (779)
Q Consensus 122 -N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~ 200 (779)
|++..+++..|.++++|++|++++|++........+..+..+..+...++.+....+..+.+ ....++.|++++|+++
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~-~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG-LSFESVILWLNKNGIQ 166 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTT-SBSSCEEEECCSSCCC
T ss_pred cccccccccccccccccccccccchhhhccccccccccccccccccccccccccccccccccc-ccccceeeeccccccc
Confidence 78999999999999999999999999976434445666777888888888888666666641 2347888999999998
Q ss_pred CcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEE-EeecCcccCCCCC-CCCCCCCcEEEccCCccccccCh
Q 004020 201 GPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQL-WLHGNSFTGPLPD-LSGLSSLQDFSVRDNQLTGIVPS 278 (779)
Q Consensus 201 ~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L-~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~ 278 (779)
...+..+ ..++++.+ ++++|+++..++. |.++++|++|++++|+|+...+.
T Consensus 167 ~i~~~~~---------------------------~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~ 219 (242)
T d1xwdc1 167 EIHNCAF---------------------------NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSY 219 (242)
T ss_dssp EECTTTT---------------------------TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSS
T ss_pred ccccccc---------------------------cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHH
Confidence 5433332 24555444 5677888876664 78899999999999999865556
Q ss_pred hhhCCCCCCEEEccC
Q 004020 279 SLVNLHSLAVVNLTN 293 (779)
Q Consensus 279 ~l~~l~~L~~L~Ls~ 293 (779)
.|.++++|+.+++.+
T Consensus 220 ~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 220 GLENLKKLRARSTYN 234 (242)
T ss_dssp SCTTCCEEESSSEES
T ss_pred HHcCCcccccCcCCC
Confidence 677777777776654
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=2.8e-18 Score=167.32 Aligned_cols=179 Identities=23% Similarity=0.359 Sum_probs=121.9
Q ss_pred ecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCC
Q 004020 72 IGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSW 151 (779)
Q Consensus 72 l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 151 (779)
++.+.+++.++. .++.+|++|++++|.++.. +.+..+++|++|+|++|+++.+++ +..+++|++|++++|++++
T Consensus 31 l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~~l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l~~n~i~~- 104 (210)
T d1h6ta2 31 LKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD- 104 (210)
T ss_dssp TTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-
T ss_pred hCcCccCCccCH--HHhcCccEEECcCCCCCCc-hhHhhCCCCCEEeCCCccccCccc--cccCccccccccccccccc-
Confidence 334444444332 2355667777777776643 346667777777777777776653 4567777777777777754
Q ss_pred CCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchh
Q 004020 152 VIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVA 231 (779)
Q Consensus 152 ~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~ 231 (779)
+| .+.++++|+.|++++|.+.. ++ .+. .++.|+++++++|.+++.. .
T Consensus 105 -l~-~l~~l~~L~~L~l~~~~~~~-~~-~l~--~l~~l~~l~~~~n~l~~~~--~------------------------- 151 (210)
T d1h6ta2 105 -LS-SLKDLKKLKSLSLEHNGISD-IN-GLV--HLPQLESLYLGNNKITDIT--V------------------------- 151 (210)
T ss_dssp -GG-GGTTCTTCCEEECTTSCCCC-CG-GGG--GCTTCCEEECCSSCCCCCG--G-------------------------
T ss_pred -cc-cccccccccccccccccccc-cc-ccc--ccccccccccccccccccc--c-------------------------
Confidence 33 46667777777777776652 33 333 5777888888888876321 1
Q ss_pred hhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccC
Q 004020 232 VIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTN 293 (779)
Q Consensus 232 ~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~ 293 (779)
+..+++|+.+++++|++++. +++.++++|++|++++|+|+. +| .+..+++|++|+|++
T Consensus 152 -~~~l~~L~~l~l~~n~l~~i-~~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 152 -LSRLTKLDTLSLEDNQISDI-VPLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp -GGGCTTCSEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred -cccccccccccccccccccc-ccccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 23578899999999998864 458888999999999999984 55 588999999999874
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=3.7e-18 Score=168.91 Aligned_cols=35 Identities=17% Similarity=0.399 Sum_probs=23.0
Q ss_pred ccccccCCeEeccCccccccCCccCCCCCCCCceecc
Q 004020 390 FSRLTSLRQLMLSGNELTGTIPKELTTLPSLEMLDVS 426 (779)
Q Consensus 390 ~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls 426 (779)
++++++|++|+|++|+|+ .+| .+..+++|++|+|+
T Consensus 191 l~~l~~L~~L~Ls~N~lt-~i~-~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 191 LASLPNLIEVHLKNNQIS-DVS-PLANTSNLFIVTLT 225 (227)
T ss_dssp GGGCTTCCEEECTTSCCC-BCG-GGTTCTTCCEEEEE
T ss_pred hcCCCCCCEEECcCCcCC-CCc-ccccCCCCCEEEee
Confidence 556667777777777776 343 26677777777775
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.74 E-value=1.9e-18 Score=166.14 Aligned_cols=170 Identities=17% Similarity=0.257 Sum_probs=134.0
Q ss_pred EEEecCCCccccCCccccCCCCCcEEEcccCccccCCC--CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccC
Q 004020 69 RIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIP--SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYN 146 (779)
Q Consensus 69 ~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~--~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N 146 (779)
++++++++++ .+|+.+. +++++|+|++|+|++.++ .|.++++|+.|+|++|++..++++.|..+++|++|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 4566677888 7787764 689999999999987553 6899999999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCC
Q 004020 147 SFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKL 226 (779)
Q Consensus 147 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~ 226 (779)
+|.. +.|..|.++++|+.|+|++|+|++..|+.|. .+++|++|+|++|.+....+....
T Consensus 89 ~l~~-l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~--~l~~L~~l~L~~N~~~~~~~~~~~------------------ 147 (192)
T d1w8aa_ 89 KIKE-ISNKMFLGLHQLKTLNLYDNQISCVMPGSFE--HLNSLTSLNLASNPFNCNCHLAWF------------------ 147 (192)
T ss_dssp CCCE-ECSSSSTTCTTCCEEECCSSCCCEECTTSST--TCTTCCEEECTTCCBCCSGGGHHH------------------
T ss_pred cccc-cCHHHHhCCCcccccccCCccccccCHHHhc--CCcccccccccccccccccchHHH------------------
Confidence 9987 6778899999999999999999988888886 789999999999999754332111
Q ss_pred CCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccc
Q 004020 227 NGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLT 273 (779)
Q Consensus 227 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~ 273 (779)
...++.+.+..|.++...|. .+..++.++++.|.+.
T Consensus 148 ---------~~~l~~~~l~~~~~~c~~p~--~l~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 148 ---------AEWLRKKSLNGGAARCGAPS--KVRDVQIKDLPHSEFK 183 (192)
T ss_dssp ---------HHHHHHHCCSGGGCBBCSST--TTTTSBGGGSCTTTCC
T ss_pred ---------hhhhhhhcccCCCeEeCCCh--hhcCCEeeecCHhhCc
Confidence 11234445555666544342 2345566677777765
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=1.2e-17 Score=161.41 Aligned_cols=175 Identities=25% Similarity=0.395 Sum_probs=118.4
Q ss_pred ecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCC
Q 004020 72 IGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSW 151 (779)
Q Consensus 72 l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 151 (779)
++.+++++.++ ..++.+|++|++++|.++. ++.+..+++|++|++++|+++.+++ +.++++|++|++++|.+..
T Consensus 25 l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~- 98 (199)
T d2omxa2 25 LGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD- 98 (199)
T ss_dssp TTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-CTTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-
T ss_pred hCCCCCCCccC--HHHhcCCCEEECCCCCCCC-ccccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-
Confidence 44445554432 2345677777777777763 3456677777777777777777654 6777777777777777654
Q ss_pred CCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchh
Q 004020 152 VIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVA 231 (779)
Q Consensus 152 ~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~ 231 (779)
++ .+.++++|+.|++++|.+.... .+. .+++|+.|++++|++.. ++ .
T Consensus 99 -~~-~l~~l~~L~~L~l~~~~~~~~~--~~~--~l~~L~~L~l~~n~l~~-~~-~------------------------- 145 (199)
T d2omxa2 99 -IT-PLANLTNLTGLTLFNNQITDID--PLK--NLTNLNRLELSSNTISD-IS-A------------------------- 145 (199)
T ss_dssp -CG-GGTTCTTCSEEECCSSCCCCCG--GGT--TCTTCSEEECCSSCCCC-CG-G-------------------------
T ss_pred -cc-cccccccccccccccccccccc--ccc--hhhhhHHhhhhhhhhcc-cc-c-------------------------
Confidence 33 3667777777777777766432 233 57788888888887763 22 1
Q ss_pred hhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEE
Q 004020 232 VIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVV 289 (779)
Q Consensus 232 ~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L 289 (779)
+..+++|+.|++++|++++. +.+.++++|++|++++|+++. ++ .++.+++|+.|
T Consensus 146 -l~~~~~L~~L~l~~n~l~~l-~~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 146 -LSGLTSLQQLNFSSNQVTDL-KPLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp -GTTCTTCSEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred -ccccccccccccccccccCC-ccccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 23577888888888888764 457788888888888888874 43 57788888765
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.72 E-value=2e-18 Score=165.88 Aligned_cols=176 Identities=20% Similarity=0.243 Sum_probs=125.5
Q ss_pred cEEEcccCccccCCCCCCCCCCccEEecCCCCCCC-CCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccC
Q 004020 92 TVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTS-VPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANG 170 (779)
Q Consensus 92 ~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~ 170 (779)
++++.++|+|+.+|+.+. +++++|+|++|+|+. ++...|.++++|++|+|++|++.. ..+..|..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~-~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCC-BCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcCccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccc-ccccccccccccceeeecc
Confidence 578888888886665553 678888888888875 667778888888888888888876 5677788888888888888
Q ss_pred ceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCccc
Q 004020 171 ANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFT 250 (779)
Q Consensus 171 n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 250 (779)
|+|+...|+.|. .+++|++|+|++|+|++..|..|. .+++|++|+|++|.+.
T Consensus 88 N~l~~l~~~~F~--~l~~L~~L~L~~N~l~~i~~~~f~--------------------------~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 88 NKIKEISNKMFL--GLHQLKTLNLYDNQISCVMPGSFE--------------------------HLNSLTSLNLASNPFN 139 (192)
T ss_dssp CCCCEECSSSST--TCTTCCEEECCSSCCCEECTTSST--------------------------TCTTCCEEECTTCCBC
T ss_pred ccccccCHHHHh--CCCcccccccCCccccccCHHHhc--------------------------CCcccccccccccccc
Confidence 888877777775 678888888888888865555553 5777888888888777
Q ss_pred CCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCC
Q 004020 251 GPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTP 301 (779)
Q Consensus 251 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p 301 (779)
...+...-...++.+.+..|.++...|..+ ..++.++|+.|.|+...+
T Consensus 140 ~~~~~~~~~~~l~~~~l~~~~~~c~~p~~l---~~~~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 140 CNCHLAWFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp CSGGGHHHHHHHHHHCCSGGGCBBCSSTTT---TTSBGGGSCTTTCCCCCC
T ss_pred cccchHHHhhhhhhhcccCCCeEeCCChhh---cCCEeeecCHhhCcCCCC
Confidence 654321112235555666677766666544 345666777777765443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.72 E-value=1.3e-15 Score=160.72 Aligned_cols=298 Identities=21% Similarity=0.225 Sum_probs=192.4
Q ss_pred CCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEec
Q 004020 89 SSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSA 168 (779)
Q Consensus 89 ~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l 168 (779)
.+|++|||++|.|+..++ .+++|++|+|++|+|+.+|.. +.+|++|++++|+++. ++.. .+.|++|++
T Consensus 38 ~~l~~LdLs~~~L~~lp~---~~~~L~~L~Ls~N~l~~lp~~----~~~L~~L~l~~n~l~~--l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLSSLPE---LPPHLESLVASCNSLTELPEL----PQSLKSLLVDNNNLKA--LSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCSCCCS---CCTTCSEEECCSSCCSSCCCC----CTTCCEEECCSSCCSC--CCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCCCCCC---CCCCCCEEECCCCCCcccccc----hhhhhhhhhhhcccch--hhhh---ccccccccc
Confidence 479999999999986553 357899999999999999853 5689999999999975 3332 246999999
Q ss_pred cCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCc
Q 004020 169 NGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNS 248 (779)
Q Consensus 169 ~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~ 248 (779)
++|.++ .+|.. + .+++|++|++++|.++.. |... ..+..+.+..+..... ..+..++.++.|++++|.
T Consensus 106 ~~n~l~-~lp~~-~--~l~~L~~L~l~~~~~~~~-~~~~--~~l~~l~~~~~~~~~~-----~~l~~l~~l~~L~l~~n~ 173 (353)
T d1jl5a_ 106 SNNQLE-KLPEL-Q--NSSFLKIIDVDNNSLKKL-PDLP--PSLEFIAAGNNQLEEL-----PELQNLPFLTAIYADNNS 173 (353)
T ss_dssp CSSCCS-SCCCC-T--TCTTCCEEECCSSCCSCC-CCCC--TTCCEEECCSSCCSSC-----CCCTTCTTCCEEECCSSC
T ss_pred cccccc-cccch-h--hhccceeecccccccccc-cccc--ccccchhhcccccccc-----ccccccccceeccccccc
Confidence 999998 56653 3 689999999999999843 3332 2345555554433221 234568889999999999
Q ss_pred ccCCCCCCCCCCCCcEEEccCCccccccChhhhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccCCCCcccC
Q 004020 249 FTGPLPDLSGLSSLQDFSVRDNQLTGIVPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLDDAGVACD 328 (779)
Q Consensus 249 l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (779)
+...+... ...+.+...++.+. .+| .+..++.|+.+++++|................+.. +... ..
T Consensus 174 ~~~~~~~~---~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~~~~~~~~l~~~~~~~--~~~~-~~------ 239 (353)
T d1jl5a_ 174 LKKLPDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRD--NYLT-DL------ 239 (353)
T ss_dssp CSSCCCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSCCSCCTTCCEEECCS--SCCS-CC------
T ss_pred cccccccc---cccccccccccccc-ccc-ccccccccccccccccccccccccccccccccccc--cccc-cc------
Confidence 88654322 34567777777776 344 46789999999999998765332211111111000 0000 00
Q ss_pred ccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCccccccccccccccccCCeEeccCccccc
Q 004020 329 GRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGTISSNFSRLTSLRQLMLSGNELTG 408 (779)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~g 408 (779)
......+.... .. .....+ ...........++..+.+.+. ...+++|++|+|++|+|+
T Consensus 240 ------~~~~~~l~~~~------~~----~~~~~~-l~~l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~- 297 (353)
T d1jl5a_ 240 ------PELPQSLTFLD------VS----ENIFSG-LSELPPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLI- 297 (353)
T ss_dssp ------CCCCTTCCEEE------CC----SSCCSE-ESCCCTTCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCS-
T ss_pred ------ccccccccccc------cc----cccccc-cccccchhcccccccCccccc----cccCCCCCEEECCCCccC-
Confidence 00000000000 00 000000 011123455667777776643 234679999999999999
Q ss_pred cCCccCCCCCCCCceeccCCcccccCCCCC-CcceeeeCCCCC
Q 004020 409 TIPKELTTLPSLEMLDVSNNHLFGKVPNFR-QNVIVKTDGNPD 450 (779)
Q Consensus 409 ~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~~-~~~~~~~~~n~~ 450 (779)
.+|.. +++|+.|+|++|+|+ .+|... ....+.+.+|+.
T Consensus 298 ~lp~~---~~~L~~L~L~~N~L~-~l~~~~~~L~~L~L~~N~L 336 (353)
T d1jl5a_ 298 ELPAL---PPRLERLIASFNHLA-EVPELPQNLKQLHVEYNPL 336 (353)
T ss_dssp CCCCC---CTTCCEEECCSSCCS-CCCCCCTTCCEEECCSSCC
T ss_pred ccccc---cCCCCEEECCCCcCC-ccccccCCCCEEECcCCcC
Confidence 78864 578999999999998 577643 344677777764
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=4.2e-17 Score=158.85 Aligned_cols=164 Identities=25% Similarity=0.369 Sum_probs=138.7
Q ss_pred CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcc
Q 004020 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 144 (779)
..++.|+++++.++.. + .+..+++|++|+|++|+|++.+ .++++++|++|++++|+++.++ .+..+++|+.|+++
T Consensus 46 ~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~-~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 46 NSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK-PLANLKNLGWLFLDENKVKDLS--SLKDLKKLKSLSLE 120 (210)
T ss_dssp HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCGG--GGTTCTTCCEEECT
T ss_pred cCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc-ccccCccccccccccccccccc--cccccccccccccc
Confidence 3689999999999854 3 4889999999999999999755 5789999999999999999987 38899999999999
Q ss_pred cCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCC
Q 004020 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDS 224 (779)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~ 224 (779)
+|.+.. ...+.+++.|+.+++++|.++.. ..+. .+++|+++++++|++++..+
T Consensus 121 ~~~~~~---~~~l~~l~~l~~l~~~~n~l~~~--~~~~--~l~~L~~l~l~~n~l~~i~~-------------------- 173 (210)
T d1h6ta2 121 HNGISD---INGLVHLPQLESLYLGNNKITDI--TVLS--RLTKLDTLSLEDNQISDIVP-------------------- 173 (210)
T ss_dssp TSCCCC---CGGGGGCTTCCEEECCSSCCCCC--GGGG--GCTTCSEEECCSSCCCCCGG--------------------
T ss_pred cccccc---ccccccccccccccccccccccc--cccc--cccccccccccccccccccc--------------------
Confidence 999864 35788999999999999999843 2333 68999999999999985322
Q ss_pred CCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEEEccC
Q 004020 225 KLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDFSVRD 269 (779)
Q Consensus 225 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~ 269 (779)
+.++++|+.|+|++|+++. +|.+.++++|++|+|++
T Consensus 174 --------l~~l~~L~~L~Ls~N~i~~-l~~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 174 --------LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFS 209 (210)
T ss_dssp --------GTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEEEEE
T ss_pred --------ccCCCCCCEEECCCCCCCC-ChhhcCCCCCCEEEccC
Confidence 3368999999999999985 46788999999999864
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=1e-16 Score=154.66 Aligned_cols=160 Identities=26% Similarity=0.437 Sum_probs=136.1
Q ss_pred CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcc
Q 004020 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 144 (779)
.++++|++++++++. + +.+..+++|++|+|++|+|++..+ +.++++|++|++++|.+..+++ +.++++|++|+++
T Consensus 40 ~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~~~~~--l~~l~~L~~L~l~ 114 (199)
T d2omxa2 40 DQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLF 114 (199)
T ss_dssp TTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEECC
T ss_pred cCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc-ccCCcccccccccccccccccc--ccccccccccccc
Confidence 478999999999984 4 358899999999999999997665 8999999999999999998874 8899999999999
Q ss_pred cCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCCcceeeccCCCCCC
Q 004020 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDS 224 (779)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~ 224 (779)
+|.+.. ...+..+++|+.|++++|++.. ++ .+. .+++|++|++++|++++..+
T Consensus 115 ~~~~~~---~~~~~~l~~L~~L~l~~n~l~~-~~-~l~--~~~~L~~L~l~~n~l~~l~~-------------------- 167 (199)
T d2omxa2 115 NNQITD---IDPLKNLTNLNRLELSSNTISD-IS-ALS--GLTSLQQLNFSSNQVTDLKP-------------------- 167 (199)
T ss_dssp SSCCCC---CGGGTTCTTCSEEECCSSCCCC-CG-GGT--TCTTCSEEECCSSCCCCCGG--------------------
T ss_pred cccccc---ccccchhhhhHHhhhhhhhhcc-cc-ccc--ccccccccccccccccCCcc--------------------
Confidence 999864 3468899999999999999973 44 344 68999999999999985321
Q ss_pred CCCCchhhhcCCCCccEEEeecCcccCCCCCCCCCCCCcEE
Q 004020 225 KLNGSVAVIQNMTSLTQLWLHGNSFTGPLPDLSGLSSLQDF 265 (779)
Q Consensus 225 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L 265 (779)
+.++++|+.|+|++|+++. ++.+..+++|++|
T Consensus 168 --------l~~l~~L~~L~ls~N~i~~-i~~l~~L~~L~~L 199 (199)
T d2omxa2 168 --------LANLTTLERLDISSNKVSD-ISVLAKLTNLESL 199 (199)
T ss_dssp --------GTTCTTCCEEECCSSCCCC-CGGGGGCTTCSEE
T ss_pred --------ccCCCCCCEEECCCCCCCC-CccccCCCCCCcC
Confidence 3468999999999999986 4568888888876
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=1.8e-17 Score=181.95 Aligned_cols=109 Identities=17% Similarity=0.204 Sum_probs=70.9
Q ss_pred cEEEEEecCCCccccC-CccccCCCCCcEEEcccCccccC----CC-CCCCCCCccEEecCCCCCCCCCc----ccc-cC
Q 004020 66 RVTRIQIGGQNIEGTL-PKELNSLSSLTVLEVMKNKLTGQ----IP-SLSGLSSLQEVLFDDNNFTSVPS----DFF-KG 134 (779)
Q Consensus 66 ~v~~l~l~~~~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~----~~-~~~~l~~L~~L~l~~N~l~~~~~----~~~-~~ 134 (779)
++++||++++++++.- .+-+..+++|++|+|++|+|+.. +. .+..+++|++|||++|+|+.... ..+ ..
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 5788888888887532 23355667788888888877631 12 45677888888888887763211 112 12
Q ss_pred CCCccEEEcccCCCCCC---CCcccccCCCCCceEeccCceeE
Q 004020 135 LTSLQTISLDYNSFDSW---VIPESLKDATGLQRFSANGANIT 174 (779)
Q Consensus 135 l~~L~~L~Ls~N~l~~~---~~p~~~~~l~~L~~L~l~~n~l~ 174 (779)
..+|++|+|++|+++.. .++..+..+++|++|++++|.++
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 34788888888877531 13455677788888888888764
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.52 E-value=5.3e-15 Score=130.04 Aligned_cols=102 Identities=22% Similarity=0.312 Sum_probs=73.3
Q ss_pred EEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCC
Q 004020 69 RIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSF 148 (779)
Q Consensus 69 ~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 148 (779)
.|+|++|+|+ .++ .+..+++|++|+|++|+|+..++.|+.+++|++|++++|+|+.++. +..+++|++|++++|+|
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~l~~--~~~l~~L~~L~l~~N~i 77 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG--VANLPRLQELLLCNNRL 77 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCcchhhhhhhhcccccccccccccccCc--cccccccCeEECCCCcc
Confidence 5777888887 444 4777778888888888887665567777888888888888877752 77777888888888877
Q ss_pred CCCCCcccccCCCCCceEeccCceeE
Q 004020 149 DSWVIPESLKDATGLQRFSANGANIT 174 (779)
Q Consensus 149 ~~~~~p~~~~~l~~L~~L~l~~n~l~ 174 (779)
........+..+++|+.|++++|.++
T Consensus 78 ~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 78 QQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred CCCCCchhhcCCCCCCEEECCCCcCC
Confidence 65333355666777777777777765
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=4.9e-15 Score=137.03 Aligned_cols=124 Identities=15% Similarity=0.211 Sum_probs=95.6
Q ss_pred CcEEEEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcc
Q 004020 65 NRVTRIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLD 144 (779)
Q Consensus 65 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 144 (779)
-++++|+|++|+|+ .++..+..+++|++|+|++|+|+.. +.|..+++|++|++++|+++.+++..+..+++|++|+|+
T Consensus 18 ~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~ 95 (162)
T d1a9na_ 18 VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 95 (162)
T ss_dssp TSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred CcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc-CCcccCcchhhhhcccccccCCCccccccccccccceec
Confidence 36788899998888 4566667788899999999988754 668888889999999999888888878888889999999
Q ss_pred cCCCCCCCCcccccCCCCCceEeccCceeEeecCC----CccCCCCCcccEEE
Q 004020 145 YNSFDSWVIPESLKDATGLQRFSANGANITGTIPD----FLGGDTIPGLMHLH 193 (779)
Q Consensus 145 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~----~~~~~~l~~L~~L~ 193 (779)
+|+|.....-..+..+++|+.|++++|.++ ..|. .+. .+|+|++||
T Consensus 96 ~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~--~lp~L~~LD 145 (162)
T d1a9na_ 96 NNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIY--KVPQVRVLD 145 (162)
T ss_dssp SCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHH--HCTTCSEET
T ss_pred cccccccccccccccccccchhhcCCCccc-cccchHHHHHH--HCCCcCeeC
Confidence 888875222246778888888888888876 3343 233 577777776
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.46 E-value=1.1e-13 Score=121.55 Aligned_cols=103 Identities=19% Similarity=0.255 Sum_probs=88.3
Q ss_pred cEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCc
Q 004020 92 TVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGA 171 (779)
Q Consensus 92 ~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n 171 (779)
++|+|++|+|+.. +.+.++++|++|++++|+|+.+|+. |..+++|++|++++|+|++ +| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~~l-~~l~~l~~L~~L~ls~N~l~~lp~~-~~~l~~L~~L~l~~N~i~~--l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTVL-CHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALEN--VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSSC-CCGGGGTTCCEEECCSSCCCCCCGG-GGGCTTCCEEECCSSCCCC--CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCCC-cccccCCCCCEEECCCCccCcchhh-hhhhhcccccccccccccc--cC-ccccccccCeEECCCC
Confidence 5899999999844 5699999999999999999999864 8899999999999999976 44 5899999999999999
Q ss_pred eeEeecC-CCccCCCCCcccEEEccCCCCCC
Q 004020 172 NITGTIP-DFLGGDTIPGLMHLHLAFNFLQG 201 (779)
Q Consensus 172 ~l~~~~p-~~~~~~~l~~L~~L~L~~N~l~~ 201 (779)
+|+.... ..+. .+++|++|++++|.++.
T Consensus 76 ~i~~~~~~~~l~--~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLV--SCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGG--GCTTCCEEECTTSGGGG
T ss_pred ccCCCCCchhhc--CCCCCCEEECCCCcCCc
Confidence 9985432 3454 68999999999999974
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.44 E-value=3.7e-15 Score=157.00 Aligned_cols=196 Identities=16% Similarity=0.167 Sum_probs=115.0
Q ss_pred cCCccccCCCCCcEEEcccCccccCC-----CCCCCCCCccEEecCCCCCCCCCc----------ccccCCCCccEEEcc
Q 004020 80 TLPKELNSLSSLTVLEVMKNKLTGQI-----PSLSGLSSLQEVLFDDNNFTSVPS----------DFFKGLTSLQTISLD 144 (779)
Q Consensus 80 ~~p~~l~~l~~L~~L~Ls~N~l~~~~-----~~~~~l~~L~~L~l~~N~l~~~~~----------~~~~~l~~L~~L~Ls 144 (779)
.+..++.+.+.|++|+|++|.|.... ..+...++|+.|+++++.+..+.. ..+..+++|++|+|+
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~ 101 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence 34456777888999999999885421 257778889999998887654321 224567788888888
Q ss_pred cCCCCCCC---CcccccCCCCCceEeccCceeEeecCCCcc-----------CCCCCcccEEEccCCCCCCcCCCccccC
Q 004020 145 YNSFDSWV---IPESLKDATGLQRFSANGANITGTIPDFLG-----------GDTIPGLMHLHLAFNFLQGPIPLSFGKS 210 (779)
Q Consensus 145 ~N~l~~~~---~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~-----------~~~l~~L~~L~L~~N~l~~~~p~~~~~~ 210 (779)
+|.+.... +...+..+++|+.|++++|.++..-...++ ....+.|+.|++++|+++...-..+
T Consensus 102 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l--- 178 (344)
T d2ca6a1 102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW--- 178 (344)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHH---
T ss_pred ccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccc---
Confidence 88875421 223445566777777777765311111110 0023455566666665542111111
Q ss_pred CcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCC-----C-CCCCCCCCCcEEEccCCccccc----cChhh
Q 004020 211 SIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGP-----L-PDLSGLSSLQDFSVRDNQLTGI----VPSSL 280 (779)
Q Consensus 211 ~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~-----~-~~~~~l~~L~~L~l~~N~l~~~----~p~~l 280 (779)
...+..++.|+.|+|++|+++.. + ..+..+++|+.|++++|.|+.. +...+
T Consensus 179 -------------------~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l 239 (344)
T d2ca6a1 179 -------------------AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL 239 (344)
T ss_dssp -------------------HHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHG
T ss_pred -------------------cchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccc
Confidence 12334556677777777776531 1 2355566677777777766432 33455
Q ss_pred hCCCCCCEEEccCcccc
Q 004020 281 VNLHSLAVVNLTNNLFQ 297 (779)
Q Consensus 281 ~~l~~L~~L~Ls~N~l~ 297 (779)
..+++|+.|+|++|.|+
T Consensus 240 ~~~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 240 KSWPNLRELGLNDCLLS 256 (344)
T ss_dssp GGCTTCCEEECTTCCCC
T ss_pred cccccchhhhhhcCccC
Confidence 56666777777777665
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=3.4e-14 Score=131.26 Aligned_cols=112 Identities=15% Similarity=0.124 Sum_probs=90.8
Q ss_pred ccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCC
Q 004020 83 KELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATG 162 (779)
Q Consensus 83 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~ 162 (779)
+.+.+..+|++|+|++|+|+.++..+..+++|+.|+|++|+|+.++ .|..+++|++|+|++|++.. ..+..+..+++
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~~l~--~~~~l~~L~~L~ls~N~i~~-l~~~~~~~l~~ 88 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLD--GFPLLRRLKTLLVNNNRICR-IGEGLDQALPD 88 (162)
T ss_dssp CEEECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCEEC--CCCCCSSCCEEECCSSCCCE-ECSCHHHHCTT
T ss_pred HhccCcCcCcEEECCCCCCCccCccccccccCCEEECCCCCCCccC--CcccCcchhhhhcccccccC-CCccccccccc
Confidence 3467888899999999999877555678899999999999999884 38889999999999999976 34455678899
Q ss_pred CceEeccCceeEeecC--CCccCCCCCcccEEEccCCCCC
Q 004020 163 LQRFSANGANITGTIP--DFLGGDTIPGLMHLHLAFNFLQ 200 (779)
Q Consensus 163 L~~L~l~~n~l~~~~p--~~~~~~~l~~L~~L~L~~N~l~ 200 (779)
|+.|++++|+|+. ++ ..+. .+++|++|++++|.++
T Consensus 89 L~~L~L~~N~i~~-~~~l~~l~--~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 89 LTELILTNNSLVE-LGDLDPLA--SLKSLTYLCILRNPVT 125 (162)
T ss_dssp CCEEECCSCCCCC-GGGGGGGG--GCTTCCEEECCSSGGG
T ss_pred cccceeccccccc-cccccccc--cccccchhhcCCCccc
Confidence 9999999999874 33 2444 6888999999999887
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=3.1e-16 Score=171.83 Aligned_cols=311 Identities=20% Similarity=0.221 Sum_probs=178.3
Q ss_pred CCcEEEcccCccccCC--CCCCCCCCccEEecCCCCCCCC----CcccccCCCCccEEEcccCCCCCCC---Cccccc-C
Q 004020 90 SLTVLEVMKNKLTGQI--PSLSGLSSLQEVLFDDNNFTSV----PSDFFKGLTSLQTISLDYNSFDSWV---IPESLK-D 159 (779)
Q Consensus 90 ~L~~L~Ls~N~l~~~~--~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~---~p~~~~-~ 159 (779)
+|+.||+++|++++.. .-+..+++|++|+|++|.++.. ....+..+++|++|||++|+|.... +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 6899999999998743 2467789999999999998842 2345678999999999999984211 122332 2
Q ss_pred CCCCceEeccCceeEee----cCCCccCCCCCcccEEEccCCCCCCcCCCcccc--------------------------
Q 004020 160 ATGLQRFSANGANITGT----IPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGK-------------------------- 209 (779)
Q Consensus 160 l~~L~~L~l~~n~l~~~----~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-------------------------- 209 (779)
..+|+.|+|++|+++.. ++..+. .+++|++|+|++|.++......+..
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~--~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 160 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLR--TLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP 160 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTT--SCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH
T ss_pred CCCCCEEECCCCCccccccccccchhh--ccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcc
Confidence 35899999999999743 344454 6889999999999876321111100
Q ss_pred --------CCcceeeccCCCCCCC-------------------------CCC-----chhhhcCCCCccEEEeecCcccC
Q 004020 210 --------SSIQTLWLNGQKGDSK-------------------------LNG-----SVAVIQNMTSLTQLWLHGNSFTG 251 (779)
Q Consensus 210 --------~~L~~l~l~~n~~~~~-------------------------~~~-----~~~~~~~l~~L~~L~L~~N~l~~ 251 (779)
..++.++++.+..... ... ....+...+.++.+++++|.+..
T Consensus 161 ~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~ 240 (460)
T d1z7xw1 161 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD 240 (460)
T ss_dssp HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccc
Confidence 1233333333321100 000 01223345566677777666532
Q ss_pred C-----CCC-CCCCCCCcEEEccCCccccc----cChhhhCCCCCCEEEccCccccccCCCCCCCcccccccCCCCcccC
Q 004020 252 P-----LPD-LSGLSSLQDFSVRDNQLTGI----VPSSLVNLHSLAVVNLTNNLFQGQTPKFNSPVRFDMAKGSNSFCLD 321 (779)
Q Consensus 252 ~-----~~~-~~~l~~L~~L~l~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~~ 321 (779)
. .+. ......++.+++++|.+... ....+...+.++.+++++|.++......+..... ........+.
T Consensus 241 ~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~--~~~~~L~~l~ 318 (460)
T d1z7xw1 241 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLL--EPGCQLESLW 318 (460)
T ss_dssp HHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHT--STTCCCCEEE
T ss_pred cccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccc--cccccccccc
Confidence 1 111 33456677777777776532 2234455677777777777765321100000000 0000000000
Q ss_pred CCCcccCccc-hhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccCcccccc----cccccc-cccc
Q 004020 322 DAGVACDGRV-NVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKNLGLSGT----ISSNFS-RLTS 395 (779)
Q Consensus 322 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~g~----~p~~~~-~l~~ 395 (779)
.......... ..+.. ......+|+.|+|++|++++. ++..+. ..+.
T Consensus 319 l~~~~l~~~~~~~l~~----------------------------~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~ 370 (460)
T d1z7xw1 319 VKSCSFTAACCSHFSS----------------------------VLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSV 370 (460)
T ss_dssp CTTSCCBGGGHHHHHH----------------------------HHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCC
T ss_pred ccccchhhhhhhhccc----------------------------ccccccchhhhheeeecccCcccchhhhhhhcccCC
Confidence 0000000000 00000 011223688999999998753 344443 4567
Q ss_pred CCeEeccCccccc----cCCccCCCCCCCCceeccCCcccc
Q 004020 396 LRQLMLSGNELTG----TIPKELTTLPSLEMLDVSNNHLFG 432 (779)
Q Consensus 396 L~~L~Ls~N~l~g----~iP~~l~~l~~L~~L~Ls~N~l~g 432 (779)
|++|+|++|+|+. .++..+..+++|++|||++|+|+.
T Consensus 371 L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp CCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred CCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence 9999999999974 355666777889999999999875
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=7e-15 Score=149.99 Aligned_cols=223 Identities=14% Similarity=0.193 Sum_probs=145.8
Q ss_pred EEEecCCCccccCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCC-CcccccCCCCccEEEcccCC
Q 004020 69 RIQIGGQNIEGTLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSV-PSDFFKGLTSLQTISLDYNS 147 (779)
Q Consensus 69 ~l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~ 147 (779)
.|||+++.+.......+.. ..+..+.++...+...+.......+|++|||+++.++.. ....+.++++|++|+|+++.
T Consensus 4 ~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~ 82 (284)
T d2astb2 4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82 (284)
T ss_dssp EEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCB
T ss_pred EEECCCCCCCchHHHHHHh-ccceEeeccccccccchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccC
Confidence 6788877775433333322 245666777666654444455566788888888877643 33456778888888888887
Q ss_pred CCCCCCcccccCCCCCceEeccCc-eeEeecCCCccCCCCCcccEEEccCC-CCCCc-CCCcccc--CCcceeeccCCCC
Q 004020 148 FDSWVIPESLKDATGLQRFSANGA-NITGTIPDFLGGDTIPGLMHLHLAFN-FLQGP-IPLSFGK--SSIQTLWLNGQKG 222 (779)
Q Consensus 148 l~~~~~p~~~~~l~~L~~L~l~~n-~l~~~~p~~~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~--~~L~~l~l~~n~~ 222 (779)
+.. ..+..+..+++|+.|++++| .++...-..+. ..+++|++|+++++ .++.. +...+.. ..|+.|+++++..
T Consensus 83 l~~-~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~-~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~ 160 (284)
T d2astb2 83 LSD-PIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL-SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK 160 (284)
T ss_dssp CCH-HHHHHHTTCTTCSEEECTTCBSCCHHHHHHHH-HHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGG
T ss_pred CCc-HHHHHHhcCCCCcCccccccccccccccchhh-HHHHhccccccccccccccccchhhhcccccccchhhhccccc
Confidence 754 45566777888888888885 44421111111 14678888888875 34421 1112222 4678888876532
Q ss_pred CCCCCCchhhhcCCCCccEEEeecC-cccCC-CCCCCCCCCCcEEEccCC-ccccccChhhhCCCCCCEEEccCc
Q 004020 223 DSKLNGSVAVIQNMTSLTQLWLHGN-SFTGP-LPDLSGLSSLQDFSVRDN-QLTGIVPSSLVNLHSLAVVNLTNN 294 (779)
Q Consensus 223 ~~~~~~~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~l~~L~~L~l~~N-~l~~~~p~~l~~l~~L~~L~Ls~N 294 (779)
.....+......++++|++|+|++| .+++. +..+..+++|++|++++| .+++.....++++++|+.|+++++
T Consensus 161 ~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 161 NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred ccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 2222222334457899999999986 46653 345888999999999995 687777778899999999999876
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=5e-14 Score=143.56 Aligned_cols=250 Identities=13% Similarity=0.154 Sum_probs=153.4
Q ss_pred cEEEcccCccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccC
Q 004020 92 TVLEVMKNKLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANG 170 (779)
Q Consensus 92 ~~L~Ls~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~ 170 (779)
++|||+++.+..... .+.. ..+..+.++...+...... .....+|++|||+++.+....++..+.++++|++|++++
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~-~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~ 80 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred CEEECCCCCCCchHHHHHHh-ccceEeeccccccccchhh-hccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence 478999887753221 1111 2355667776666554433 335668999999988875434556678889999999999
Q ss_pred ceeEeecCCCccCCCCCcccEEEccCC-CCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecC-c
Q 004020 171 ANITGTIPDFLGGDTIPGLMHLHLAFN-FLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGN-S 248 (779)
Q Consensus 171 n~l~~~~p~~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N-~ 248 (779)
|.++...+..++ .+++|++|+|+++ .++... + ......+++|++|+|+++ .
T Consensus 81 ~~l~~~~~~~l~--~~~~L~~L~Ls~c~~itd~~---l----------------------~~l~~~~~~L~~L~ls~c~~ 133 (284)
T d2astb2 81 LRLSDPIVNTLA--KNSNLVRLNLSGCSGFSEFA---L----------------------QTLLSSCSRLDELNLSWCFD 133 (284)
T ss_dssp CBCCHHHHHHHT--TCTTCSEEECTTCBSCCHHH---H----------------------HHHHHHCTTCCEEECCCCTT
T ss_pred cCCCcHHHHHHh--cCCCCcCccccccccccccc---c----------------------chhhHHHHhccccccccccc
Confidence 988777777775 6788999998885 454210 0 011235677888888774 3
Q ss_pred ccCC-CC-CC-CCCCCCcEEEccCC--ccccc-cChhhhCCCCCCEEEccCcc-ccccCCCCCCCcccccccCCCCcccC
Q 004020 249 FTGP-LP-DL-SGLSSLQDFSVRDN--QLTGI-VPSSLVNLHSLAVVNLTNNL-FQGQTPKFNSPVRFDMAKGSNSFCLD 321 (779)
Q Consensus 249 l~~~-~~-~~-~~l~~L~~L~l~~N--~l~~~-~p~~l~~l~~L~~L~Ls~N~-l~g~~p~~~~~~~~~~~~~~~~~~~~ 321 (779)
++.. +. .+ ...++|+.|+++++ .++.. +...+.++++|++|+|++|. +++.....
T Consensus 134 ~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~------------------ 195 (284)
T d2astb2 134 FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQE------------------ 195 (284)
T ss_dssp CCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGG------------------
T ss_pred cccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhh------------------
Confidence 4321 11 12 22467888888764 23322 33444567888888888753 44322110
Q ss_pred CCCcccCccchhhhhhcccCCCchhcccccCCCCCCCCCCCccccCCCCCeEEEEccC-ccccccccccccccccCCeEe
Q 004020 322 DAGVACDGRVNVLLSIVKSVGYPAVLAESWKGNNPCNSDWKGVSCDAGGNITVVNLKN-LGLSGTISSNFSRLTSLRQLM 400 (779)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~-n~l~g~~p~~~~~l~~L~~L~ 400 (779)
....++|++|+|++ +.+++.....++++++|+.|+
T Consensus 196 --------------------------------------------l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~ 231 (284)
T d2astb2 196 --------------------------------------------FFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQ 231 (284)
T ss_dssp --------------------------------------------GGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEE
T ss_pred --------------------------------------------hcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEe
Confidence 01123688888888 467777777788889999999
Q ss_pred ccCccccccCCccCCCCCCCCceeccCCcccccCC
Q 004020 401 LSGNELTGTIPKELTTLPSLEMLDVSNNHLFGKVP 435 (779)
Q Consensus 401 Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP 435 (779)
++++--.+.++.-... +..|++..+++++..+
T Consensus 232 l~~~~~d~~l~~l~~~---lp~L~i~~~~ls~~~~ 263 (284)
T d2astb2 232 VFGIVPDGTLQLLKEA---LPHLQINCSHFTTIAR 263 (284)
T ss_dssp CTTSSCTTCHHHHHHH---STTSEESCCCSCCTTC
T ss_pred eeCCCCHHHHHHHHHh---CccccccCccCCCCCC
Confidence 9887222222221122 4445667788877654
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.28 E-value=8.7e-14 Score=146.26 Aligned_cols=211 Identities=18% Similarity=0.202 Sum_probs=143.2
Q ss_pred CCcEEEEEecCCCccc----cCCccccCCCCCcEEEcccCccccCC-----------CCCCCCCCccEEecCCCCCCCCC
Q 004020 64 SNRVTRIQIGGQNIEG----TLPKELNSLSSLTVLEVMKNKLTGQI-----------PSLSGLSSLQEVLFDDNNFTSVP 128 (779)
Q Consensus 64 ~~~v~~l~l~~~~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~-----------~~~~~l~~L~~L~l~~N~l~~~~ 128 (779)
...+++|+|++|.+.. .+...+...++|+.|+++++.+.... ..+..+++|+.|+|++|.++...
T Consensus 30 ~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~ 109 (344)
T d2ca6a1 30 DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTA 109 (344)
T ss_dssp CSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTT
T ss_pred CCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccccccccc
Confidence 3568999999998854 34456778899999999987654221 13567899999999999998753
Q ss_pred c----ccccCCCCccEEEcccCCCCCCC------------CcccccCCCCCceEeccCceeEee----cCCCccCCCCCc
Q 004020 129 S----DFFKGLTSLQTISLDYNSFDSWV------------IPESLKDATGLQRFSANGANITGT----IPDFLGGDTIPG 188 (779)
Q Consensus 129 ~----~~~~~l~~L~~L~Ls~N~l~~~~------------~p~~~~~l~~L~~L~l~~n~l~~~----~p~~~~~~~l~~ 188 (779)
. ..+..+++|++|++++|.+.... ........+.|+.+.+++|+++.. +...+. ..+.
T Consensus 110 ~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~--~~~~ 187 (344)
T d2ca6a1 110 QEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ--SHRL 187 (344)
T ss_dssp HHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHH--HCTT
T ss_pred ccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhh--hhhh
Confidence 3 34557899999999999873100 001124567899999999987522 222232 4678
Q ss_pred ccEEEccCCCCCCcCCCccccCCcceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCC----C-CCCCCCCCCc
Q 004020 189 LMHLHLAFNFLQGPIPLSFGKSSIQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGP----L-PDLSGLSSLQ 263 (779)
Q Consensus 189 L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~----~-~~~~~l~~L~ 263 (779)
|++|+|++|+++..-...+ ....+..+++|+.|+|++|.++.. + ..+..+++|+
T Consensus 188 L~~L~L~~n~i~~~g~~~~---------------------l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~ 246 (344)
T d2ca6a1 188 LHTVKMVQNGIRPEGIEHL---------------------LLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246 (344)
T ss_dssp CCEEECCSSCCCHHHHHHH---------------------HHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCC
T ss_pred hcccccccccccccccccc---------------------hhhhhcchhhhcccccccccccccccccccccccccccch
Confidence 9999999999873210000 011244678899999999988642 1 2366788999
Q ss_pred EEEccCCccccccChhh----hC--CCCCCEEEccCcccc
Q 004020 264 DFSVRDNQLTGIVPSSL----VN--LHSLAVVNLTNNLFQ 297 (779)
Q Consensus 264 ~L~l~~N~l~~~~p~~l----~~--l~~L~~L~Ls~N~l~ 297 (779)
+|+|++|.|++.-...+ .. .+.|+.|+|++|+++
T Consensus 247 ~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~ 286 (344)
T d2ca6a1 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 286 (344)
T ss_dssp EEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCB
T ss_pred hhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCC
Confidence 99999999875433333 22 245777777777664
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.26 E-value=9.5e-14 Score=132.92 Aligned_cols=125 Identities=21% Similarity=0.286 Sum_probs=68.3
Q ss_pred ccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEeecCCCccCCCCCcccEEEccCCCCCCcCCCccccCC
Q 004020 132 FKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQGPIPLSFGKSS 211 (779)
Q Consensus 132 ~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~ 211 (779)
+..+++|++|+|++|+|+. ++ .+..+++|+.|++++|.|+ .+|..+. .+++|++|++++|+++.. +
T Consensus 44 l~~L~~L~~L~Ls~n~I~~--i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~--~~~~L~~L~l~~N~i~~l-~------- 109 (198)
T d1m9la_ 44 LSTLKACKHLALSTNNIEK--IS-SLSGMENLRILSLGRNLIK-KIENLDA--VADTLEELWISYNQIASL-S------- 109 (198)
T ss_dssp HHHTTTCCEEECSEEEESC--CC-CHHHHTTCCEEECCEEEEC-SCSSHHH--HHHHCCEEECSEEECCCH-H-------
T ss_pred HhcccccceeECcccCCCC--cc-cccCCccccChhhcccccc-ccccccc--cccccccccccccccccc-c-------
Confidence 4444444555555554443 22 2444455555555555544 3333332 244566666666666521 1
Q ss_pred cceeeccCCCCCCCCCCchhhhcCCCCccEEEeecCcccCCCC--CCCCCCCCcEEEccCCccccccCh----------h
Q 004020 212 IQTLWLNGQKGDSKLNGSVAVIQNMTSLTQLWLHGNSFTGPLP--DLSGLSSLQDFSVRDNQLTGIVPS----------S 279 (779)
Q Consensus 212 L~~l~l~~n~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~l~~L~~L~l~~N~l~~~~p~----------~ 279 (779)
.+..+++|+.|+|++|+++.... .+..+++|+.|++++|++....+. .
T Consensus 110 --------------------~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~v 169 (198)
T d1m9la_ 110 --------------------GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEV 169 (198)
T ss_dssp --------------------HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHH
T ss_pred --------------------cccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHH
Confidence 13345667777777777765432 366677777777777776544332 2
Q ss_pred hhCCCCCCEEE
Q 004020 280 LVNLHSLAVVN 290 (779)
Q Consensus 280 l~~l~~L~~L~ 290 (779)
+..+++|+.||
T Consensus 170 i~~lp~L~~LD 180 (198)
T d1m9la_ 170 VKRLPNLKKLD 180 (198)
T ss_dssp HHHCSSCCEES
T ss_pred HHHCCCcCEeC
Confidence 66788888876
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.25 E-value=6.4e-12 Score=114.87 Aligned_cols=101 Identities=19% Similarity=0.260 Sum_probs=74.6
Q ss_pred EEecCCCccccCCccccCCCCCcEEEcccC-ccccCCC-CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCC
Q 004020 70 IQIGGQNIEGTLPKELNSLSSLTVLEVMKN-KLTGQIP-SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNS 147 (779)
Q Consensus 70 l~l~~~~l~~~~p~~l~~l~~L~~L~Ls~N-~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 147 (779)
++++++++. .+|..+..+++|++|++++| .|+.+.+ +|.++++|+.|+|++|+|+.+++++|..+++|++|+|++|+
T Consensus 13 l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~ 91 (156)
T d2ifga3 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (156)
T ss_dssp EECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence 344455555 56777888899999999766 4877665 78999999999999999999988889999999999999999
Q ss_pred CCCCCCcccccCCCCCceEeccCcee
Q 004020 148 FDSWVIPESLKDATGLQRFSANGANI 173 (779)
Q Consensus 148 l~~~~~p~~~~~l~~L~~L~l~~n~l 173 (779)
|+. ..+..|. ..+|+.|+|++|.+
T Consensus 92 l~~-l~~~~~~-~~~l~~L~L~~Np~ 115 (156)
T d2ifga3 92 LES-LSWKTVQ-GLSLQELVLSGNPL 115 (156)
T ss_dssp CSC-CCSTTTC-SCCCCEEECCSSCC
T ss_pred Ccc-cChhhhc-cccccccccCCCcc
Confidence 875 2223332 23455555555554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.24 E-value=1.2e-11 Score=113.09 Aligned_cols=110 Identities=15% Similarity=0.198 Sum_probs=91.4
Q ss_pred CCCCCcEEEcccCccccCCCCCCCCCCccEEecCCC-CCCCCCcccccCCCCccEEEcccCCCCCCCCcccccCCCCCce
Q 004020 87 SLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDN-NFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQR 165 (779)
Q Consensus 87 ~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~ 165 (779)
.....+.++.+++.+...+..+..+++|++|++++| .|+.++++.|.++++|++|+|++|+|+. +.+..|..+++|+.
T Consensus 6 ~c~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~-i~~~~f~~l~~L~~ 84 (156)
T d2ifga3 6 CPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF-VAPDAFHFTPRLSR 84 (156)
T ss_dssp CCSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCE-ECTTGGGSCSCCCE
T ss_pred CcCCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCC-cccccccccccccc
Confidence 344566789999999877778999999999999766 5999999999999999999999999986 56788999999999
Q ss_pred EeccCceeEeecCCCccCCCCCcccEEEccCCCCC
Q 004020 166 FSANGANITGTIPDFLGGDTIPGLMHLHLAFNFLQ 200 (779)
Q Consensus 166 L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~ 200 (779)
|+|++|+|+...++.+ ....|++|+|++|.+.
T Consensus 85 L~Ls~N~l~~l~~~~~---~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 85 LNLSFNALESLSWKTV---QGLSLQELVLSGNPLH 116 (156)
T ss_dssp EECCSSCCSCCCSTTT---CSCCCCEEECCSSCCC
T ss_pred eeccCCCCcccChhhh---ccccccccccCCCccc
Confidence 9999999984444444 3447889999999885
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.23 E-value=1.4e-14 Score=138.77 Aligned_cols=119 Identities=21% Similarity=0.243 Sum_probs=98.0
Q ss_pred cCCccccCCCCCcEEEcccCccccCCCCCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCcccccC
Q 004020 80 TLPKELNSLSSLTVLEVMKNKLTGQIPSLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIPESLKD 159 (779)
Q Consensus 80 ~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~ 159 (779)
.++.+|..+++|++|+|++|+|+.+ +.+.++++|++|+|++|+|+.++. .+..+++|++|++++|+++. + ..+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~~i-~~l~~l~~L~~L~Ls~N~i~~i~~-~~~~~~~L~~L~l~~N~i~~--l-~~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIEKI-SSLSGMENLRILSLGRNLIKKIEN-LDAVADTLEELWISYNQIAS--L-SGIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEESCC-CCHHHHTTCCEEECCEEEECSCSS-HHHHHHHCCEEECSEEECCC--H-HHHHH
T ss_pred hhhhHHhcccccceeECcccCCCCc-ccccCCccccChhhcccccccccc-cccccccccccccccccccc--c-ccccc
Confidence 5667899999999999999999854 678999999999999999999874 35556789999999999975 3 45888
Q ss_pred CCCCceEeccCceeEeecC-CCccCCCCCcccEEEccCCCCCCcCCC
Q 004020 160 ATGLQRFSANGANITGTIP-DFLGGDTIPGLMHLHLAFNFLQGPIPL 205 (779)
Q Consensus 160 l~~L~~L~l~~n~l~~~~p-~~~~~~~l~~L~~L~L~~N~l~~~~p~ 205 (779)
+++|+.|++++|+|+.... ..+. .+++|++|+|++|.++...+.
T Consensus 114 l~~L~~L~L~~N~i~~~~~~~~l~--~l~~L~~L~L~~N~l~~~~~~ 158 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITNWGEIDKLA--ALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp HHHSSEEEESEEECCCHHHHHHHT--TTTTCSEEEECSSHHHHHHCT
T ss_pred cccccccccccchhcccccccccc--CCCccceeecCCCccccCccc
Confidence 9999999999999984322 3454 689999999999998754443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.51 E-value=2.1e-07 Score=92.28 Aligned_cols=151 Identities=16% Similarity=0.105 Sum_probs=103.1
Q ss_pred HHHHHhhcCCcccceecccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCC
Q 004020 583 QVLRNVTNNFSEENVLGRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGN 661 (779)
Q Consensus 583 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 661 (779)
.++....+.|+..+..+-++.+.||+... +++.+++|+..... ......+.+|...+..+. +--+.+++.+...++
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~--~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~ 83 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRY--KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGG--TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCc--ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCC
Confidence 45666667887766655455578999864 46667888875443 112234677888877764 434677888888888
Q ss_pred eEEEEEEecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCC----------------------------
Q 004020 662 ERLLVYEYMPQGTLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA---------------------------- 713 (779)
Q Consensus 662 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---------------------------- 713 (779)
..++||++++|.++.+..... .....++.++++.+..||+..
T Consensus 84 ~~~lv~~~l~G~~~~~~~~~~----------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEYEDE----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV 153 (263)
T ss_dssp EEEEEEECCSSEEHHHHTTTC----------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred ceEEEEEeccccccccccccc----------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhh
Confidence 999999999998876543211 112334556666666676421
Q ss_pred ----------------------------CCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 714 ----------------------------HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 714 ----------------------------~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
...++|+|+.|.||++++++.+-|+||+.+..-
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp CGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred hhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence 112789999999999998766679999987653
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.31 E-value=4.9e-09 Score=95.93 Aligned_cols=66 Identities=12% Similarity=0.204 Sum_probs=31.7
Q ss_pred CCCCCccEEecCCCCCCCCCc--ccccCCCCccEEEcccCCCCCCCCcccccCCCCCceEeccCceeEe
Q 004020 109 SGLSSLQEVLFDDNNFTSVPS--DFFKGLTSLQTISLDYNSFDSWVIPESLKDATGLQRFSANGANITG 175 (779)
Q Consensus 109 ~~l~~L~~L~l~~N~l~~~~~--~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~ 175 (779)
.++++|++|+|++|+|+.+.+ ..+..+++|+.|+|++|+|+. ..+-.+....+|+.|++++|.++.
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhccccceeecCCCCcCc
Confidence 345555555555555555432 334455555555555555543 111122233345555555555543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.04 E-value=6e-06 Score=80.93 Aligned_cols=132 Identities=19% Similarity=0.157 Sum_probs=87.0
Q ss_pred eeccccc-EEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCC--CccceEeeEEEeCCeEEEEEEecCCC
Q 004020 597 VLGRGGF-GTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRH--RHLVGLLGYCLDGNERLLVYEYMPQG 673 (779)
Q Consensus 597 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g 673 (779)
.+..|.. +.||+....++..+++|...... ...+.+|...++.+.. --+.+++.+..+++..++||||++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 4455543 67999988888888999765432 1246677777776642 33667788888888899999999886
Q ss_pred ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHcCC----------------------------------------
Q 004020 674 TLSRHLFNRKEEGLKPLEWTRRLTIALDVARGVEYLHGLA---------------------------------------- 713 (779)
Q Consensus 674 sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---------------------------------------- 713 (779)
++.+.. ... ...+.++.+.|.-||+..
T Consensus 92 ~~~~~~----------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (255)
T d1nd4a_ 92 DLLSSH----------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 158 (255)
T ss_dssp ETTTSC----------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred cccccc----------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHH
Confidence 653311 110 112223333344444210
Q ss_pred ---------------CCCcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 714 ---------------HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 714 ---------------~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
...++|+|+.|.||+++++..+-|+||+.+..-
T Consensus 159 ~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~g 206 (255)
T d1nd4a_ 159 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 206 (255)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcccC
Confidence 123799999999999998766789999987653
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.00 E-value=4.1e-07 Score=82.78 Aligned_cols=87 Identities=18% Similarity=0.093 Sum_probs=67.6
Q ss_pred cCCccccCCCCCcEEEcccCccccCCC---CCCCCCCccEEecCCCCCCCCCcccccCCCCccEEEcccCCCCCCCCc--
Q 004020 80 TLPKELNSLSSLTVLEVMKNKLTGQIP---SLSGLSSLQEVLFDDNNFTSVPSDFFKGLTSLQTISLDYNSFDSWVIP-- 154 (779)
Q Consensus 80 ~~p~~l~~l~~L~~L~Ls~N~l~~~~~---~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p-- 154 (779)
.++..+..+++|++|+|++|+|+...+ .+..+++|+.|+|++|+++.+++-.+....+|++|+|++|.+.. ...
T Consensus 56 ~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~-~~~~~ 134 (162)
T d1koha1 56 TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD-TFRDQ 134 (162)
T ss_dssp HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSS-SSSSH
T ss_pred hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCc-Ccccc
Confidence 444455678999999999999987643 36789999999999999999988656666789999999999965 222
Q ss_pred -----ccccCCCCCceEe
Q 004020 155 -----ESLKDATGLQRFS 167 (779)
Q Consensus 155 -----~~~~~l~~L~~L~ 167 (779)
..+..+++|+.||
T Consensus 135 ~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 135 STYISAIRERFPKLLRLD 152 (162)
T ss_dssp HHHHHHHHTTSTTCCEET
T ss_pred hhHHHHHHHHCCCCCEEC
Confidence 2355567777665
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.59 E-value=0.0001 Score=76.86 Aligned_cols=78 Identities=13% Similarity=0.118 Sum_probs=49.4
Q ss_pred cceecccccEEEEEEEEcC-CcEEEEEEecccccC-----hhHHHHHHHHHHHHHcCC-C--CccceEeeEEEeCCeEEE
Q 004020 595 ENVLGRGGFGTVYKGELHD-GTKIAVKRMESAVVS-----EKGFAEFKSEIAVLTKVR-H--RHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-----~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~~l 665 (779)
.+.||.|....||++...+ ++.+++|.-...... .....+...|.+.++.+. + ..+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3578999999999997654 678999975432110 112234567888877663 2 345555543 5566789
Q ss_pred EEEecCCCC
Q 004020 666 VYEYMPQGT 674 (779)
Q Consensus 666 v~e~~~~gs 674 (779)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998754
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.25 E-value=2.5e-05 Score=70.85 Aligned_cols=64 Identities=19% Similarity=0.144 Sum_probs=40.1
Q ss_pred hcCCCCccEEEeecCcccCCC-----CCCCCCCCCcEEEccCCcccc-------ccChhhhCCCCCCEEEccCccc
Q 004020 233 IQNMTSLTQLWLHGNSFTGPL-----PDLSGLSSLQDFSVRDNQLTG-------IVPSSLVNLHSLAVVNLTNNLF 296 (779)
Q Consensus 233 ~~~l~~L~~L~L~~N~l~~~~-----~~~~~l~~L~~L~l~~N~l~~-------~~p~~l~~l~~L~~L~Ls~N~l 296 (779)
+...+.|+.|+|++|.++..- ..+...++|++|++++|.+.. .+...+...++|+.|+++.+..
T Consensus 68 L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 68 IETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred hhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 334566777777777665421 125556777777777775442 1445566678888888877654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.18 E-value=4.4e-05 Score=69.15 Aligned_cols=83 Identities=10% Similarity=0.057 Sum_probs=36.2
Q ss_pred cEEEEEecCC-Ccccc----CCccccCCCCCcEEEcccCccccCC--C---CCCCCCCccEEecCCCCCCCC----Cccc
Q 004020 66 RVTRIQIGGQ-NIEGT----LPKELNSLSSLTVLEVMKNKLTGQI--P---SLSGLSSLQEVLFDDNNFTSV----PSDF 131 (779)
Q Consensus 66 ~v~~l~l~~~-~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~--~---~~~~l~~L~~L~l~~N~l~~~----~~~~ 131 (779)
++++|+|+++ .++.. +-.++...++|++|+|++|.++... . .+...+.|++|+|++|.++.- ....
T Consensus 16 ~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~a 95 (167)
T d1pgva_ 16 DLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRS 95 (167)
T ss_dssp SCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHH
T ss_pred CCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHH
Confidence 4555555542 23221 2233444555555555555554211 1 133344555555555555421 1112
Q ss_pred ccCCCCccEEEcccCCC
Q 004020 132 FKGLTSLQTISLDYNSF 148 (779)
Q Consensus 132 ~~~l~~L~~L~Ls~N~l 148 (779)
+...+.|++|+|++|++
T Consensus 96 L~~n~sL~~L~l~~n~~ 112 (167)
T d1pgva_ 96 TLVTQSIVEFKADNQRQ 112 (167)
T ss_dssp TTTTCCCSEEECCCCSS
T ss_pred HHhCCcCCEEECCCCcC
Confidence 33344455555554443
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.96 E-value=0.0011 Score=66.87 Aligned_cols=138 Identities=12% Similarity=0.036 Sum_probs=77.9
Q ss_pred EEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCccc--eEe-----eEEEeCCeEEEEEEecCCCChh
Q 004020 604 GTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRHLV--GLL-----GYCLDGNERLLVYEYMPQGTLS 676 (779)
Q Consensus 604 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv--~~~-----~~~~~~~~~~lv~e~~~~gsL~ 676 (779)
-.||+++..+|+.|++|+...... ..+++..|...+..+....+. ... ..+...+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~---s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC---CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 589999999999999999876532 234567788888777422221 111 2234456778999999874321
Q ss_pred h-----H---------hhh----cccCCCCCCCHH----------------------HHHHHHHHHHHHHHHHH-cCCCC
Q 004020 677 R-----H---------LFN----RKEEGLKPLEWT----------------------RRLTIALDVARGVEYLH-GLAHQ 715 (779)
Q Consensus 677 ~-----~---------l~~----~~~~~~~~~~~~----------------------~~~~i~~qi~~~L~~LH-~~~~~ 715 (779)
. + ++. .........+.. .....+.++...+.-.- +....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 1 0 111 000001111111 11222223333222221 11235
Q ss_pred CcEEcCCCCCCEEEcCCCcEEEEeeccceec
Q 004020 716 SFIHRDLKPSNILLGDDMRAKVADFGLVRLA 746 (779)
Q Consensus 716 ~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 746 (779)
++||+|+.|.|||++++ ..++||+-+..-
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~g 221 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARNG 221 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCEE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhcccC
Confidence 78999999999999743 468999987653
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.69 E-value=0.0018 Score=64.80 Aligned_cols=161 Identities=11% Similarity=0.013 Sum_probs=84.6
Q ss_pred eeHHHHHHhhcCCccccee-----cccccEEEEEEEEcCCcEEEEEEecccccChhHHHHHHHHHHHHHcCCCCc-----
Q 004020 580 ISIQVLRNVTNNFSEENVL-----GRGGFGTVYKGELHDGTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVRHRH----- 649 (779)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~l-----g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n----- 649 (779)
.+.+++..+..+|.+.+.. ..|---+.|+.+..+| .+++|++.... ..+++..|++++..+...+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~----~~~~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC----CHHHHHHHHHHHHhhhhccccccc
Confidence 3567788888889775444 3555577899987765 48899876432 1234555666776664222
Q ss_pred cceEe---eEEEeCCeEEEEEEecCCCChhhH--------------hhhcc----cCCCCCCC-----------------
Q 004020 650 LVGLL---GYCLDGNERLLVYEYMPQGTLSRH--------------LFNRK----EEGLKPLE----------------- 691 (779)
Q Consensus 650 iv~~~---~~~~~~~~~~lv~e~~~~gsL~~~--------------l~~~~----~~~~~~~~----------------- 691 (779)
.+... .+....+....++.++.+...... ++... ........
T Consensus 78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (316)
T d2ppqa1 78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 157 (316)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence 22111 112234456677777766432110 00000 00000000
Q ss_pred -HHHHHHHHHHHHHHHHHHHc-CCCCCcEEcCCCCCCEEEcCCCcEEEEeecccee
Q 004020 692 -WTRRLTIALDVARGVEYLHG-LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 745 (779)
Q Consensus 692 -~~~~~~i~~qi~~~L~~LH~-~~~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 745 (779)
.......+..+...+.-.+. .-..++||+|+.++||+++.+...-|+||+.+..
T Consensus 158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 00011222222222222221 1246899999999999999887778999998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.49 E-value=0.0036 Score=64.73 Aligned_cols=73 Identities=15% Similarity=0.161 Sum_probs=48.8
Q ss_pred cceecccccEEEEEEEEcC--------CcEEEEEEecccccChhHHHHHHHHHHHHHcCC-CCccceEeeEEEeCCeEEE
Q 004020 595 ENVLGRGGFGTVYKGELHD--------GTKIAVKRMESAVVSEKGFAEFKSEIAVLTKVR-HRHLVGLLGYCLDGNERLL 665 (779)
Q Consensus 595 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l 665 (779)
.+.|+-|-.-.+|++...+ .+.|.+++.-.. .......+|..+++.+. +.-..++++++.. .+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc----chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 4678888889999998653 346677665421 12234567888888885 4434577776642 68
Q ss_pred EEEecCCCCh
Q 004020 666 VYEYMPQGTL 675 (779)
Q Consensus 666 v~e~~~~gsL 675 (779)
||||++|..+
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 9999987544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.16 E-value=0.00011 Score=66.25 Aligned_cols=111 Identities=13% Similarity=0.170 Sum_probs=52.1
Q ss_pred cCCCCCcEEEccc-CccccCC-----CCCCCCCCccEEecCCCCCCCCC----cccccCCCCccEEEcccCCCCCCC---
Q 004020 86 NSLSSLTVLEVMK-NKLTGQI-----PSLSGLSSLQEVLFDDNNFTSVP----SDFFKGLTSLQTISLDYNSFDSWV--- 152 (779)
Q Consensus 86 ~~l~~L~~L~Ls~-N~l~~~~-----~~~~~l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~--- 152 (779)
.+.+.|++|+|++ +.++... .++...++|++|+|++|.++.-. ...+...+.|+.|++++|.+....
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 4455666666665 3343211 13445566666666666655321 123444556666666666653211
Q ss_pred CcccccCCCCCceEec--cCceeEe----ecCCCccCCCCCcccEEEccCCC
Q 004020 153 IPESLKDATGLQRFSA--NGANITG----TIPDFLGGDTIPGLMHLHLAFNF 198 (779)
Q Consensus 153 ~p~~~~~l~~L~~L~l--~~n~l~~----~~p~~~~~~~l~~L~~L~L~~N~ 198 (779)
+-..+...++|+.++| ++|.+.. .+.+.+. ..+.|++|+++.+.
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~--~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLE--KNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHH--HCSSCCEEECCCSS
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHH--hCCCcCEEeCcCCC
Confidence 1133444455554333 3334421 1222222 34556666665544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.01 E-value=0.00028 Score=63.61 Aligned_cols=65 Identities=15% Similarity=0.156 Sum_probs=41.1
Q ss_pred hcCCCCccEEEeecCcccCCC-----CCCCCCCCCcEEEc--cCCcccc----ccChhhhCCCCCCEEEccCcccc
Q 004020 233 IQNMTSLTQLWLHGNSFTGPL-----PDLSGLSSLQDFSV--RDNQLTG----IVPSSLVNLHSLAVVNLTNNLFQ 297 (779)
Q Consensus 233 ~~~l~~L~~L~L~~N~l~~~~-----~~~~~l~~L~~L~l--~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~ 297 (779)
+...++++.|++++|.++..- ..+...++|+.++| ++|.+.. .+...+...++|+.|+++.|...
T Consensus 70 l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 70 LKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 334567777777777765321 23556677776555 4556643 34566677888999988877643
|